trial_record_id,patient_id,age,sex,site_name,trial_phase,drug_code,therapeutic_area,study_arm,enrollment_date,visit_date,baseline_marker,followup_marker,systolic_bp,diastolic_bp,heart_rate,adverse_event,adverse_event_severity,outcome,success_flag
1,PT-00001,52,M,Fortis Mumbai,Phase I,ORX-202,Diabetes,Placebo,2023-04-15,2023-07-14,7.03,7.22,155,79,74,None,None,Improved,0
2,PT-00002,70,M,Apollo Chennai,Phase I,ORX-505,Infectious Disease,Low Dose,2024-07-28,2024-08-11,8.12,7.3,137,76,71,Headache,None,No Change,0
3,PT-00003,48,F,Indore Medical Institute,Phase III,ORX-202,Diabetes,High Dose,2023-12-15,2024-01-12,4.9,2.95,117,69,82,Dizziness,None,Improved,1
4,PT-00004,30,M,PGI Chandigarh,Phase II,ORX-303,Cardiology,Low Dose,2023-02-14,2023-04-11,5.51,6.42,123,82,58,Fever,None,Improved,0
5,PT-00005,36,F,PGI Chandigarh,Phase III,ORX-505,Infectious Disease,Placebo,2023-03-13,2023-03-20,7.33,5.9,134,74,73,Headache,Severe,No Change,0
6,PT-00006,35,M,NIMHANS Bengaluru,Phase IV,ORX-303,Cardiology,Low Dose,2024-01-09,2024-01-23,9.42,9.01,108,91,60,None,None,Improved,1
7,PT-00007,48,F,Bhopal Research Hospital,Phase III,ORX-505,Infectious Disease,Low Dose,2024-06-30,2024-07-14,4.85,3.25,131,90,80,None,None,Improved,1
8,PT-00008,43,M,Indore Medical Institute,Phase III,ORX-202,Diabetes,High Dose,2023-11-20,2024-01-15,6.84,5.11,115,76,92,None,None,Improved,1
9,PT-00009,50,F,Kolkata Clinical Center,Phase II,ORX-404,Neurology,High Dose,2024-10-20,2024-12-15,5.08,4.98,121,73,86,None,None,Improved,1
10,PT-00010,61,F,NIMHANS Bengaluru,Phase III,ORX-505,Infectious Disease,Low Dose,2023-08-13,2023-08-27,8.32,7.16,122,85,91,None,None,Improved,1
11,PT-00011,37,M,AIIMS Delhi,Phase IV,ORX-606,Rheumatology,Placebo,2024-11-27,2025-01-22,6.98,5.58,106,91,96,None,None,No Change,0
12,PT-00012,43,F,Indore Medical Institute,Phase III,ORX-606,Rheumatology,High Dose,2024-11-29,2025-02-27,8.4,,116,86,99,Headache,None,No Change,0
13,PT-00013,44,F,Kolkata Clinical Center,Phase III,ORX-101,Oncology,High Dose,2023-09-27,2023-12-26,9.08,6.32,142,83,73,None,None,No Change,0
14,PT-00014,46,M,Fortis Mumbai,Phase IV,ORX-606,Rheumatology,Low Dose,2023-07-23,2023-08-06,4.81,4.22,134,99,70,None,None,Improved,1
15,PT-00015,32,M,Kolkata Clinical Center,Phase III,ORX-101,Oncology,Placebo,2024-01-07,2024-02-04,6.6,7.02,133,75,85,None,None,Improved,0
16,PT-00016,46,M,Kolkata Clinical Center,Phase I,ORX-101,Oncology,High Dose,2024-06-29,2024-07-13,8.36,,122,77,57,None,None,Improved,1
17,PT-00017,49,M,NIMHANS Bengaluru,Phase II,ORX-202,Diabetes,High Dose,2023-07-25,2023-08-22,7.51,7.12,123,65,72,Headache,None,Improved,1
18,PT-00018,39,F,Apollo Chennai,Phase I,ORX-101,Oncology,Low Dose,2024-08-25,2024-11-23,6.24,5.69,135,104,80,None,None,Improved,1
19,PT-00019,49,M,Indore Medical Institute,Phase III,ORX-202,Diabetes,Placebo,2023-02-02,2023-03-02,7.11,4.98,127,82,112,None,None,Improved,1
20,PT-00020,41,F,AIIMS Delhi,Phase II,ORX-606,Rheumatology,High Dose,2024-08-07,2024-11-05,7.56,7.13,106,95,88,Headache,Moderate,Improved,1
21,PT-00021,57,M,NIMHANS Bengaluru,Phase I,ORX-303,Cardiology,Low Dose,2024-04-23,2024-04-30,6.11,6.97,102,89,108,Fever,None,No Change,0
22,PT-00022,29,F,Bhopal Research Hospital,Phase III,ORX-202,Diabetes,Placebo,2024-07-03,2024-08-28,6.52,6.21,118,63,78,None,None,Improved,1
23,PT-00023,28,F,Bhopal Research Hospital,Phase II,ORX-404,Neurology,High Dose,2024-07-17,2024-07-24,7.77,6.54,155,72,73,Fever,Moderate,Improved,1
24,PT-00024,58,M,Apollo Chennai,Phase IV,ORX-202,Diabetes,Low Dose,2024-05-07,2024-05-21,5.72,5.53,151,62,80,Fatigue,None,Worsened,0
25,PT-00025,49,M,Fortis Mumbai,Phase IV,ORX-404,Neurology,Placebo,2024-07-23,2024-09-17,8.14,6.62,104,88,82,None,None,Improved,1
26,PT-00026,49,M,Indore Medical Institute,Phase III,ORX-606,Rheumatology,Low Dose,2023-02-21,2023-05-22,7.62,6.6,132,85,67,Fatigue,None,Improved,1
27,PT-00027,74,M,Bhopal Research Hospital,Phase IV,ORX-202,Diabetes,Placebo,2023-03-11,2023-03-25,7.77,6.3,139,70,89,Dizziness,Mild,Improved,1
28,PT-00028,63,M,NIMHANS Bengaluru,Phase III,ORX-606,Rheumatology,Low Dose,2024-06-19,2024-07-17,6.22,6.68,135,91,104,None,None,Worsened,0
29,PT-00029,41,F,NIMHANS Bengaluru,Phase II,ORX-202,Diabetes,High Dose,2023-11-04,2023-12-30,6.3,5.09,113,81,82,Headache,None,Improved,1
30,PT-00030,49,F,Bhopal Research Hospital,Phase III,ORX-101,Oncology,Low Dose,2024-06-02,2024-06-30,8.19,7.8,154,78,116,None,None,Improved,1
31,PT-00031,55,M,PGI Chandigarh,Phase IV,ORX-303,Cardiology,Placebo,2024-07-10,2024-08-07,6.17,4.81,136,79,87,Fever,Mild,No Change,0
32,PT-00032,52,M,Fortis Mumbai,Phase III,ORX-606,Rheumatology,Placebo,2023-05-18,2023-06-15,7.11,5.95,100,76,89,None,None,Improved,1
33,PT-00033,48,M,Apollo Chennai,Phase II,ORX-606,Rheumatology,Low Dose,2024-10-11,2024-11-08,5.71,5.46,134,71,80,None,None,Improved,1
34,PT-00034,45,M,NIMHANS Bengaluru,Phase I,ORX-303,Cardiology,Placebo,2023-12-08,2023-12-22,5.83,,138,94,92,None,None,No Change,0
35,PT-00035,22,F,NIMHANS Bengaluru,Phase III,ORX-505,Infectious Disease,Placebo,2023-03-19,2023-04-02,6.07,6.14,137,88,130,Rash,Mild,Improved,0
36,PT-00036,54,M,Indore Medical Institute,Phase III,ORX-303,Cardiology,Low Dose,2023-02-10,2023-03-10,8.56,9.02,139,78,88,None,None,Improved,0
37,PT-00037,32,M,NIMHANS Bengaluru,Phase II,ORX-505,Infectious Disease,High Dose,2023-08-31,2023-09-14,6.92,6.08,129,109,51,Rash,Moderate,Worsened,0
38,PT-00038,55,M,PGI Chandigarh,Phase II,ORX-404,Neurology,High Dose,2023-09-12,2023-10-10,5.26,4.44,147,82,62,Headache,None,Improved,1
39,PT-00039,33,M,Apollo Chennai,Phase IV,ORX-202,Diabetes,High Dose,2024-04-16,2024-05-14,8.02,6.96,131,82,68,Rash,None,Improved,1
40,PT-00040,79,M,NIMHANS Bengaluru,Phase III,ORX-303,Cardiology,Placebo,2023-03-13,2023-04-10,7.96,5.74,131,74,89,None,None,Improved,1
41,PT-00041,32,F,Bhopal Research Hospital,Phase IV,ORX-303,Cardiology,Placebo,2023-09-29,2023-10-06,7.06,7.12,143,67,73,None,None,Improved,0
42,PT-00042,37,F,Bhopal Research Hospital,Phase III,ORX-404,Neurology,High Dose,2023-07-14,2023-08-11,6.42,7.6,135,66,90,None,None,Improved,0
43,PT-00043,78,M,Bhopal Research Hospital,Phase II,ORX-606,Rheumatology,High Dose,2024-09-30,2024-10-28,8.44,6.67,119,97,68,None,None,No Change,0
44,PT-00044,52,F,NIMHANS Bengaluru,Phase III,ORX-303,Cardiology,Low Dose,2023-10-30,2024-01-28,8.13,6.9,126,50,63,None,None,Improved,1
45,PT-00045,40,F,AIIMS Delhi,Phase III,ORX-505,Infectious Disease,Low Dose,2024-02-20,2024-05-20,5.7,6.77,102,76,79,None,None,No Change,0
46,PT-00046,68,M,PGI Chandigarh,Phase III,ORX-404,Neurology,Low Dose,2024-11-22,2024-12-06,5.48,6.12,128,70,84,Rash,Severe,Improved,0
47,PT-00047,48,M,Fortis Mumbai,Phase III,ORX-505,Infectious Disease,High Dose,2024-09-26,2024-10-24,6.48,6.14,121,83,87,Dizziness,None,Improved,1
48,PT-00048,70,F,Apollo Chennai,Phase II,ORX-202,Diabetes,Placebo,2023-09-08,2023-11-03,5.71,7.23,92,80,86,Headache,None,No Change,0
49,PT-00049,49,M,NIMHANS Bengaluru,Phase III,ORX-404,Neurology,Low Dose,2023-06-01,2023-06-08,6.45,5.87,119,74,89,Fatigue,Moderate,Worsened,0
50,PT-00050,50,F,Kolkata Clinical Center,Phase II,ORX-101,Oncology,Low Dose,2023-05-05,2023-06-30,6.37,6.78,133,91,86,None,None,Improved,0
51,PT-00051,31,F,Kolkata Clinical Center,Phase IV,ORX-505,Infectious Disease,High Dose,2024-05-31,2024-07-26,6.53,6.8,138,81,79,None,None,No Change,0
52,PT-00052,65,M,Kolkata Clinical Center,Phase III,ORX-404,Neurology,Placebo,2023-09-11,2023-10-09,6.49,6.58,124,79,93,None,None,No Change,0
53,PT-00053,58,M,Bhopal Research Hospital,Phase II,ORX-606,Rheumatology,Placebo,2023-10-06,2023-11-03,8.18,8.95,128,90,73,None,None,Improved,0
54,PT-00054,50,M,NIMHANS Bengaluru,Phase II,ORX-606,Rheumatology,Placebo,2023-08-08,2023-08-15,7.04,6.73,138,72,107,None,None,Improved,1
55,PT-00055,28,F,Apollo Chennai,Phase III,ORX-404,Neurology,Low Dose,2024-08-21,2024-08-28,5.74,6.39,142,89,86,Headache,None,Worsened,0
56,PT-00056,44,M,Fortis Mumbai,Phase IV,ORX-404,Neurology,High Dose,2024-03-05,2024-06-03,6.12,5.79,115,93,75,None,None,No Change,0
57,PT-00057,31,M,Fortis Mumbai,Phase III,ORX-404,Neurology,Low Dose,2024-02-03,2024-03-02,6.81,6.79,117,72,81,Rash,Mild,No Change,0
58,PT-00058,48,F,Indore Medical Institute,Phase IV,ORX-404,Neurology,Low Dose,2024-11-09,2024-11-16,6.59,5.77,132,64,58,None,None,Improved,1
59,PT-00059,33,F,Fortis Mumbai,Phase II,ORX-404,Neurology,Low Dose,2024-04-10,2024-05-08,6.94,6.82,154,92,75,Fatigue,None,Improved,1
60,PT-00060,44,F,Bhopal Research Hospital,Phase II,ORX-404,Neurology,Placebo,2024-07-06,2024-07-13,6.0,5.58,122,85,66,None,None,Worsened,0
61,PT-00061,53,M,Indore Medical Institute,Phase III,ORX-101,Oncology,High Dose,2023-07-24,2023-07-31,9.04,8.54,135,90,72,None,None,No Change,0
62,PT-00062,48,F,Apollo Chennai,Phase III,ORX-404,Neurology,High Dose,2024-01-13,2024-01-27,7.22,6.9,114,82,84,Fever,Mild,No Change,0
63,PT-00063,68,M,Bhopal Research Hospital,Phase IV,ORX-505,Infectious Disease,Placebo,2023-11-16,2024-02-14,8.35,9.89,114,92,80,Dizziness,None,No Change,0
64,PT-00064,80,M,Apollo Chennai,Phase I,ORX-101,Oncology,High Dose,2023-11-05,2024-02-03,6.23,5.07,117,56,70,Rash,Mild,No Change,0
65,PT-00065,32,M,NIMHANS Bengaluru,Phase II,ORX-606,Rheumatology,Low Dose,2024-06-02,2024-06-30,7.38,7.29,161,93,69,None,None,Improved,1
66,PT-00066,30,F,PGI Chandigarh,Phase I,ORX-606,Rheumatology,High Dose,2024-04-15,2024-04-29,7.79,6.2,160,96,71,Headache,Severe,Improved,1
67,PT-00067,18,F,Kolkata Clinical Center,Phase III,ORX-404,Neurology,Low Dose,2024-08-29,2024-09-26,8.82,8.32,150,62,69,None,None,Improved,1
68,PT-00068,45,M,Kolkata Clinical Center,Phase II,ORX-202,Diabetes,High Dose,2024-08-06,2024-11-04,7.26,6.45,139,69,76,None,None,No Change,0
69,PT-00069,46,F,AIIMS Delhi,Phase IV,ORX-404,Neurology,Placebo,2023-09-22,2023-10-20,7.82,8.06,107,63,95,Nausea,Moderate,Improved,0
70,PT-00070,50,M,Apollo Chennai,Phase III,ORX-101,Oncology,Placebo,2024-02-21,2024-04-17,6.3,7.3,130,96,78,None,None,No Change,0
71,PT-00071,77,F,Kolkata Clinical Center,Phase III,ORX-404,Neurology,High Dose,2023-04-06,2023-05-04,9.31,8.68,145,89,97,Headache,None,Improved,1
72,PT-00072,29,F,PGI Chandigarh,Phase III,ORX-404,Neurology,High Dose,2024-07-17,2024-08-14,8.02,8.58,96,67,49,None,None,Improved,0
73,PT-00073,40,F,Bhopal Research Hospital,Phase II,ORX-606,Rheumatology,Placebo,2023-05-03,2023-08-01,8.06,9.01,129,101,58,Headache,None,Worsened,0
74,PT-00074,18,F,Fortis Mumbai,Phase II,ORX-101,Oncology,High Dose,2023-10-31,2023-11-14,7.13,7.08,127,57,76,None,None,Improved,1
75,PT-00075,24,M,Indore Medical Institute,Phase II,ORX-505,Infectious Disease,Placebo,2023-05-10,2023-07-05,8.0,7.93,111,75,63,None,None,Improved,1
76,PT-00076,43,F,Kolkata Clinical Center,Phase III,ORX-303,Cardiology,Placebo,2023-02-22,2023-03-22,8.35,7.06,137,75,66,None,None,Worsened,0
77,PT-00077,43,M,Bhopal Research Hospital,Phase III,ORX-505,Infectious Disease,Low Dose,2023-02-24,2023-03-10,5.96,5.06,106,105,78,Nausea,None,Improved,1
78,PT-00078,33,M,NIMHANS Bengaluru,Phase I,ORX-505,Infectious Disease,Low Dose,2024-09-25,2024-10-09,7.46,6.96,124,89,88,None,None,No Change,0
79,PT-00079,36,F,NIMHANS Bengaluru,Phase II,ORX-303,Cardiology,Low Dose,2023-03-03,2023-06-01,6.51,5.86,90,63,97,None,None,Worsened,0
80,PT-00080,71,M,Fortis Mumbai,Phase III,ORX-606,Rheumatology,Placebo,2023-09-03,2023-09-17,6.9,7.02,133,118,93,None,None,No Change,0
81,PT-00081,42,F,Kolkata Clinical Center,Phase III,ORX-303,Cardiology,Placebo,2023-10-23,2023-11-20,6.05,4.21,131,72,58,None,None,No Change,0
82,PT-00082,34,M,Apollo Chennai,Phase IV,ORX-404,Neurology,Placebo,2023-08-19,2023-09-02,5.9,7.02,143,81,98,Rash,None,Worsened,0
83,PT-00083,46,M,Fortis Mumbai,Phase III,ORX-404,Neurology,Placebo,2023-11-08,2024-01-03,6.17,7.14,137,69,75,None,None,Worsened,0
84,PT-00084,30,F,Indore Medical Institute,Phase III,ORX-404,Neurology,High Dose,2024-09-10,2024-10-08,5.54,5.97,162,65,85,None,None,Improved,0
85,PT-00085,34,M,Fortis Mumbai,Phase IV,ORX-505,Infectious Disease,Placebo,2023-06-29,2023-08-24,6.62,5.68,112,82,66,None,None,Improved,1
86,PT-00086,49,F,NIMHANS Bengaluru,Phase II,ORX-606,Rheumatology,High Dose,2023-04-04,2023-05-30,7.14,6.52,111,75,88,None,None,Improved,1
87,PT-00087,53,M,PGI Chandigarh,Phase IV,ORX-404,Neurology,High Dose,2023-10-23,2023-12-18,6.03,5.72,141,61,85,Nausea,None,No Change,0
88,PT-00088,34,F,Bhopal Research Hospital,Phase II,ORX-404,Neurology,High Dose,2023-01-02,2023-04-02,7.88,6.8,95,62,78,None,None,Improved,1
89,PT-00089,49,F,Kolkata Clinical Center,Phase III,ORX-606,Rheumatology,Low Dose,2023-02-22,2023-03-08,6.11,6.29,98,81,61,None,None,Improved,0
90,PT-00090,34,F,Kolkata Clinical Center,Phase III,ORX-101,Oncology,Placebo,2024-10-07,2025-01-05,7.26,6.08,121,94,69,Headache,None,No Change,0
91,PT-00091,58,M,Bhopal Research Hospital,Phase III,ORX-202,Diabetes,High Dose,2023-04-27,2023-06-22,5.84,5.92,153,52,66,Nausea,None,Worsened,0
92,PT-00092,54,F,Fortis Mumbai,Phase III,ORX-404,Neurology,High Dose,2024-04-28,2024-05-12,6.96,6.89,117,83,75,None,None,Improved,1
93,PT-00093,63,M,AIIMS Delhi,Phase IV,ORX-101,Oncology,Placebo,2024-02-29,2024-03-28,7.51,7.41,120,76,71,None,None,Worsened,0
94,PT-00094,51,M,Fortis Mumbai,Phase II,ORX-505,Infectious Disease,Low Dose,2024-11-06,2025-01-01,6.69,6.56,165,92,73,None,None,Worsened,0
95,PT-00095,64,F,NIMHANS Bengaluru,Phase II,ORX-404,Neurology,High Dose,2023-07-13,2023-07-27,6.71,4.48,109,59,73,None,None,No Change,0
96,PT-00096,45,F,Kolkata Clinical Center,Phase I,ORX-606,Rheumatology,High Dose,2024-01-26,2024-03-22,9.21,9.11,124,91,47,Rash,Mild,Worsened,0
97,PT-00097,48,M,Indore Medical Institute,Phase III,ORX-202,Diabetes,Low Dose,2024-08-27,2024-09-24,8.13,6.39,148,86,72,Fatigue,None,Worsened,0
98,PT-00098,55,F,AIIMS Delhi,Phase I,ORX-404,Neurology,High Dose,2023-06-08,2023-06-15,9.92,9.69,132,76,66,Fever,None,Improved,1
99,PT-00099,58,F,PGI Chandigarh,Phase III,ORX-606,Rheumatology,High Dose,2024-01-25,2024-02-22,6.17,5.84,119,87,82,Fatigue,None,No Change,0
100,PT-00100,61,M,Apollo Chennai,Phase III,ORX-606,Rheumatology,High Dose,2023-10-22,2023-11-05,6.59,,110,76,83,None,None,No Change,0
101,PT-00101,57,M,Bhopal Research Hospital,Phase III,ORX-404,Neurology,Placebo,2023-11-03,2023-11-10,6.09,6.48,152,86,104,Rash,None,Improved,0
102,PT-00102,32,F,Apollo Chennai,Phase III,ORX-505,Infectious Disease,Low Dose,2024-11-29,2024-12-13,5.71,3.71,154,89,77,None,None,Improved,1
103,PT-00103,49,F,Apollo Chennai,Phase III,ORX-404,Neurology,High Dose,2023-05-27,2023-06-10,5.85,7.65,130,83,88,None,None,Improved,0
104,PT-00104,52,F,Kolkata Clinical Center,Phase III,ORX-303,Cardiology,High Dose,2023-06-11,2023-06-18,7.47,6.36,136,104,96,None,None,Improved,1
105,PT-00105,70,F,NIMHANS Bengaluru,Phase III,ORX-606,Rheumatology,Placebo,2023-11-06,2023-11-20,6.59,5.3,125,82,93,Fatigue,None,Worsened,0
106,PT-00106,18,F,Fortis Mumbai,Phase III,ORX-606,Rheumatology,Placebo,2024-11-05,2024-12-31,9.04,8.49,120,69,54,Nausea,Mild,Improved,1
107,PT-00107,58,M,Kolkata Clinical Center,Phase IV,ORX-303,Cardiology,High Dose,2023-08-24,2023-11-22,7.29,5.73,104,77,101,None,None,No Change,0
108,PT-00108,40,M,AIIMS Delhi,Phase III,ORX-606,Rheumatology,Placebo,2024-10-04,2024-10-11,5.4,4.78,123,50,77,None,None,Improved,1
109,PT-00109,41,F,Bhopal Research Hospital,Phase III,ORX-303,Cardiology,Low Dose,2024-03-01,2024-03-15,8.04,9.3,148,78,62,Headache,Moderate,Improved,0
110,PT-00110,85,F,Fortis Mumbai,Phase III,ORX-202,Diabetes,Placebo,2024-05-08,2024-06-05,7.27,6.88,127,84,75,None,None,No Change,0
111,PT-00111,35,M,Bhopal Research Hospital,Phase III,ORX-202,Diabetes,High Dose,2023-08-20,2023-10-15,6.54,6.11,118,73,79,Rash,None,Worsened,0
112,PT-00112,40,F,Bhopal Research Hospital,Phase I,ORX-404,Neurology,Low Dose,2024-11-19,2024-12-17,9.0,6.22,147,96,48,Rash,Moderate,No Change,0
113,PT-00113,39,M,Kolkata Clinical Center,Phase III,ORX-101,Oncology,Low Dose,2024-07-28,2024-08-25,6.75,5.09,113,68,102,None,None,Worsened,0
114,PT-00114,59,M,Kolkata Clinical Center,Phase III,ORX-606,Rheumatology,Low Dose,2024-02-23,2024-03-01,8.73,8.98,107,75,84,Dizziness,None,Improved,0
115,PT-00115,25,F,Apollo Chennai,Phase I,ORX-505,Infectious Disease,Placebo,2024-04-09,2024-05-07,8.06,7.44,121,90,84,Headache,Moderate,No Change,0
116,PT-00116,39,F,AIIMS Delhi,Phase III,ORX-404,Neurology,High Dose,2024-05-16,2024-08-14,8.59,7.22,139,89,73,Dizziness,None,Improved,1
117,PT-00117,50,F,Kolkata Clinical Center,Phase II,ORX-202,Diabetes,High Dose,2023-04-12,2023-05-10,5.7,6.13,124,75,92,Fever,None,Improved,0
118,PT-00118,33,F,Bhopal Research Hospital,Phase II,ORX-404,Neurology,Placebo,2023-08-06,2023-11-04,5.51,3.71,138,66,102,None,None,Worsened,0
119,PT-00119,18,F,AIIMS Delhi,Phase II,ORX-505,Infectious Disease,Placebo,2024-07-21,2024-08-04,9.24,9.03,126,75,83,Rash,None,No Change,0
120,PT-00120,44,M,Indore Medical Institute,Phase III,ORX-303,Cardiology,High Dose,2023-05-29,2023-06-12,8.52,8.23,130,77,77,Rash,None,Improved,1
121,PT-00121,49,M,PGI Chandigarh,Phase I,ORX-202,Diabetes,Low Dose,2023-01-17,2023-01-31,5.15,3.53,141,84,75,None,None,Improved,1
122,PT-00122,45,F,Bhopal Research Hospital,Phase III,ORX-404,Neurology,Low Dose,2024-01-06,2024-04-05,7.62,6.73,113,84,64,None,None,No Change,0
123,PT-00123,51,M,Indore Medical Institute,Phase IV,ORX-606,Rheumatology,High Dose,2024-11-05,2025-02-03,5.16,5.68,136,85,91,Nausea,None,Improved,0
124,PT-00124,71,F,NIMHANS Bengaluru,Phase III,ORX-606,Rheumatology,Placebo,2024-03-30,2024-04-06,8.42,6.36,104,74,78,None,None,Worsened,0
125,PT-00125,53,M,Fortis Mumbai,Phase I,ORX-505,Infectious Disease,Low Dose,2024-07-15,2024-08-12,6.33,6.1,114,74,58,Nausea,None,Improved,1
126,PT-00126,30,F,Bhopal Research Hospital,Phase I,ORX-606,Rheumatology,High Dose,2024-07-18,2024-08-01,5.58,4.3,146,70,114,Fatigue,None,Improved,1
127,PT-00127,52,F,Bhopal Research Hospital,Phase II,ORX-303,Cardiology,Low Dose,2024-11-12,2024-12-10,7.42,6.25,140,75,79,None,None,Improved,1
128,PT-00128,85,F,Bhopal Research Hospital,Phase I,ORX-101,Oncology,Low Dose,2024-01-17,2024-01-31,7.08,7.72,115,81,102,Nausea,Mild,No Change,0
129,PT-00129,34,F,NIMHANS Bengaluru,Phase III,ORX-303,Cardiology,High Dose,2024-03-09,2024-03-16,9.37,9.61,117,89,91,Nausea,None,Worsened,0
130,PT-00130,54,M,Kolkata Clinical Center,Phase II,ORX-202,Diabetes,High Dose,2023-12-25,2024-03-24,5.32,4.26,123,81,86,Headache,Mild,Improved,1
131,PT-00131,47,F,Indore Medical Institute,Phase III,ORX-505,Infectious Disease,High Dose,2023-10-01,2023-10-08,5.6,5.54,138,88,93,Headache,None,Improved,1
132,PT-00132,58,F,AIIMS Delhi,Phase II,ORX-202,Diabetes,Low Dose,2024-02-15,2024-02-22,7.75,7.29,98,87,80,Nausea,None,Improved,1
133,PT-00133,49,M,Kolkata Clinical Center,Phase II,ORX-303,Cardiology,Placebo,2023-11-16,2023-12-14,5.67,4.29,146,81,87,Nausea,None,No Change,0
134,PT-00134,45,M,Indore Medical Institute,Phase II,ORX-606,Rheumatology,Placebo,2024-03-29,2024-05-24,7.24,7.68,118,83,71,None,None,Improved,0
135,PT-00135,38,F,Bhopal Research Hospital,Phase II,ORX-303,Cardiology,Low Dose,2023-10-18,2024-01-16,6.83,6.63,119,97,65,Nausea,None,Improved,1
136,PT-00136,42,F,Indore Medical Institute,Phase IV,ORX-101,Oncology,Placebo,2023-08-05,2023-08-19,6.67,7.57,131,94,57,None,None,No Change,0
137,PT-00137,49,M,NIMHANS Bengaluru,Phase I,ORX-202,Diabetes,Placebo,2024-06-29,2024-07-13,8.27,7.94,147,75,97,Rash,Moderate,Improved,1
138,PT-00138,81,M,Indore Medical Institute,Phase II,ORX-404,Neurology,Placebo,2023-03-21,2023-04-18,6.76,5.96,154,100,70,Nausea,Mild,No Change,0
139,PT-00139,38,F,NIMHANS Bengaluru,Phase II,ORX-101,Oncology,High Dose,2023-06-25,2023-09-23,6.86,5.25,111,69,67,Headache,None,Improved,1
140,PT-00140,44,F,Apollo Chennai,Phase III,ORX-404,Neurology,Low Dose,2024-06-20,2024-06-27,7.48,8.48,110,93,75,None,None,Improved,0
141,PT-00141,44,F,AIIMS Delhi,Phase II,ORX-101,Oncology,Low Dose,2023-04-27,2023-07-26,8.01,6.6,134,83,84,Fatigue,None,Improved,1
142,PT-00142,49,M,AIIMS Delhi,Phase II,ORX-303,Cardiology,Placebo,2024-09-08,2024-09-22,10.15,9.17,118,74,70,Nausea,None,No Change,0
143,PT-00143,34,F,Kolkata Clinical Center,Phase III,ORX-606,Rheumatology,High Dose,2024-08-01,2024-10-30,8.63,9.51,117,72,84,Fever,None,Improved,0
144,PT-00144,36,F,Kolkata Clinical Center,Phase I,ORX-606,Rheumatology,Low Dose,2023-10-09,2024-01-07,7.96,7.74,100,100,103,None,None,Improved,1
145,PT-00145,35,F,Indore Medical Institute,Phase III,ORX-101,Oncology,Low Dose,2023-10-21,2023-10-28,6.73,6.59,134,89,106,Fever,None,No Change,0
146,PT-00146,42,F,Indore Medical Institute,Phase III,ORX-404,Neurology,High Dose,2024-08-08,2024-08-22,6.24,4.6,114,81,103,None,None,Improved,1
147,PT-00147,36,M,Kolkata Clinical Center,Phase IV,ORX-101,Oncology,High Dose,2023-12-18,2023-12-25,7.47,7.05,149,112,70,None,None,Improved,1
148,PT-00148,37,M,Kolkata Clinical Center,Phase III,ORX-505,Infectious Disease,Low Dose,2023-06-12,2023-07-10,8.45,8.67,161,89,72,None,None,Improved,0
149,PT-00149,54,F,Indore Medical Institute,Phase III,ORX-606,Rheumatology,Low Dose,2023-03-09,2023-04-06,8.53,8.87,137,94,94,Headache,None,Improved,0
150,PT-00150,67,M,AIIMS Delhi,Phase II,ORX-303,Cardiology,Low Dose,2024-11-02,2024-12-28,7.98,7.43,130,96,66,Headache,None,Improved,1
151,PT-00151,50,F,PGI Chandigarh,Phase III,ORX-202,Diabetes,High Dose,2024-06-23,2024-06-30,6.73,6.35,151,84,78,None,None,No Change,0
152,PT-00152,23,F,Fortis Mumbai,Phase I,ORX-202,Diabetes,High Dose,2023-12-16,2024-02-10,8.1,8.28,166,78,81,Fever,None,Improved,0
153,PT-00153,48,F,Bhopal Research Hospital,Phase III,ORX-505,Infectious Disease,High Dose,2024-06-23,2024-06-30,9.09,8.61,133,89,80,Fatigue,Mild,No Change,0
154,PT-00154,37,F,AIIMS Delhi,Phase II,ORX-606,Rheumatology,High Dose,2023-06-19,2023-08-14,7.43,8.0,109,83,68,None,None,Improved,0
155,PT-00155,64,M,Fortis Mumbai,Phase IV,ORX-606,Rheumatology,High Dose,2023-08-28,2023-11-26,5.37,4.47,134,100,77,Fever,Mild,Improved,1
156,PT-00156,36,M,Kolkata Clinical Center,Phase II,ORX-404,Neurology,High Dose,2024-01-27,2024-04-26,9.46,7.75,90,87,70,Fever,Moderate,Improved,1
157,PT-00157,28,M,Indore Medical Institute,Phase IV,ORX-606,Rheumatology,Low Dose,2024-01-16,2024-04-15,8.05,7.87,117,66,90,Headache,None,Worsened,0
158,PT-00158,55,M,AIIMS Delhi,Phase II,ORX-303,Cardiology,Low Dose,2024-06-09,2024-06-23,7.08,8.34,108,63,68,None,None,No Change,0
159,PT-00159,44,M,PGI Chandigarh,Phase III,ORX-101,Oncology,Low Dose,2024-02-10,2024-05-10,7.49,6.87,134,66,98,None,None,Improved,1
160,PT-00160,43,M,Indore Medical Institute,Phase II,ORX-303,Cardiology,High Dose,2024-10-27,2024-11-24,8.54,8.45,136,88,84,None,None,No Change,0
161,PT-00161,55,F,Kolkata Clinical Center,Phase IV,ORX-606,Rheumatology,High Dose,2024-04-25,2024-06-20,8.79,8.57,140,80,98,Fatigue,None,No Change,0
162,PT-00162,34,M,NIMHANS Bengaluru,Phase III,ORX-101,Oncology,High Dose,2023-09-01,2023-09-29,9.36,8.92,102,83,68,None,None,Improved,1
163,PT-00163,58,F,Kolkata Clinical Center,Phase I,ORX-505,Infectious Disease,Low Dose,2024-10-09,2025-01-07,6.42,5.62,93,76,45,Headache,None,No Change,0
164,PT-00164,19,M,Apollo Chennai,Phase III,ORX-505,Infectious Disease,Low Dose,2024-11-11,2024-11-18,8.11,8.42,135,70,77,None,None,Improved,0
165,PT-00165,44,M,Kolkata Clinical Center,Phase II,ORX-101,Oncology,Low Dose,2024-01-18,2024-02-15,5.81,6.76,143,79,78,None,None,No Change,0
166,PT-00166,48,M,Bhopal Research Hospital,Phase II,ORX-505,Infectious Disease,High Dose,2023-12-07,2023-12-21,4.75,4.13,115,69,74,None,None,Improved,1
167,PT-00167,73,M,Kolkata Clinical Center,Phase III,ORX-606,Rheumatology,Low Dose,2023-07-06,2023-07-20,7.97,7.05,138,98,90,Headache,None,Improved,1
168,PT-00168,45,F,Apollo Chennai,Phase II,ORX-101,Oncology,Low Dose,2023-11-14,2024-02-12,6.42,6.65,135,92,86,Rash,None,Improved,0
169,PT-00169,61,M,Apollo Chennai,Phase III,ORX-303,Cardiology,Low Dose,2023-02-18,2023-03-18,6.56,7.34,131,106,68,Rash,None,Improved,0
170,PT-00170,72,F,NIMHANS Bengaluru,Phase III,ORX-303,Cardiology,High Dose,2024-05-23,2024-07-18,7.44,6.45,119,78,83,Rash,None,Improved,1
171,PT-00171,53,M,Bhopal Research Hospital,Phase III,ORX-404,Neurology,Low Dose,2023-07-04,2023-10-02,6.51,6.09,166,102,84,None,None,Improved,1
172,PT-00172,45,F,Fortis Mumbai,Phase III,ORX-404,Neurology,Low Dose,2024-03-12,2024-03-26,7.34,7.5,109,78,54,None,None,No Change,0
173,PT-00173,51,M,PGI Chandigarh,Phase III,ORX-505,Infectious Disease,High Dose,2023-10-09,2023-10-16,7.98,7.14,156,67,57,Nausea,None,Improved,1
174,PT-00174,48,M,AIIMS Delhi,Phase IV,ORX-505,Infectious Disease,High Dose,2024-03-24,2024-03-31,8.46,9.57,119,94,77,None,None,Improved,0
175,PT-00175,42,F,Indore Medical Institute,Phase II,ORX-505,Infectious Disease,Placebo,2024-04-05,2024-05-03,8.26,8.45,99,99,97,Headache,Mild,Improved,0
176,PT-00176,34,F,Fortis Mumbai,Phase II,ORX-202,Diabetes,High Dose,2023-01-27,2023-02-10,7.67,7.72,132,75,68,None,None,Improved,0
177,PT-00177,44,M,Fortis Mumbai,Phase II,ORX-606,Rheumatology,Low Dose,2024-09-18,2024-10-16,8.61,8.7,121,91,45,Fever,None,No Change,0
178,PT-00178,63,M,Kolkata Clinical Center,Phase IV,ORX-202,Diabetes,High Dose,2024-03-31,2024-04-07,5.11,4.39,107,66,94,Fever,Severe,No Change,0
179,PT-00179,37,F,Fortis Mumbai,Phase III,ORX-303,Cardiology,High Dose,2024-10-15,2024-10-29,7.62,7.17,136,82,60,None,None,No Change,0
180,PT-00180,60,M,AIIMS Delhi,Phase IV,ORX-202,Diabetes,High Dose,2023-01-27,2023-02-24,6.61,4.81,120,100,89,None,None,No Change,0
181,PT-00181,39,M,Bhopal Research Hospital,Phase III,ORX-101,Oncology,Low Dose,2024-05-05,2024-08-03,6.78,6.09,165,86,84,None,None,Improved,1
182,PT-00182,61,M,PGI Chandigarh,Phase I,ORX-606,Rheumatology,Placebo,2024-04-22,2024-07-21,7.49,6.85,124,81,77,Fatigue,Mild,Improved,1
183,PT-00183,56,M,AIIMS Delhi,Phase III,ORX-404,Neurology,Low Dose,2023-02-26,2023-03-05,7.26,7.52,126,82,50,None,None,Improved,0
184,PT-00184,59,M,Apollo Chennai,Phase II,ORX-303,Cardiology,High Dose,2024-06-15,2024-07-13,7.62,8.11,90,107,76,None,None,No Change,0
185,PT-00185,62,F,Fortis Mumbai,Phase I,ORX-505,Infectious Disease,Low Dose,2024-05-29,2024-06-12,5.95,6.1,109,74,104,Nausea,None,No Change,0
186,PT-00186,41,F,Indore Medical Institute,Phase III,ORX-101,Oncology,Placebo,2024-10-18,2025-01-16,7.46,7.84,136,83,83,None,None,Improved,0
187,PT-00187,83,F,Indore Medical Institute,Phase III,ORX-404,Neurology,High Dose,2024-07-12,2024-08-09,7.13,6.91,146,95,94,None,None,No Change,0
188,PT-00188,55,M,NIMHANS Bengaluru,Phase III,ORX-303,Cardiology,Low Dose,2023-03-03,2023-03-17,5.83,6.9,107,85,67,None,None,Improved,0
189,PT-00189,43,M,AIIMS Delhi,Phase II,ORX-303,Cardiology,High Dose,2023-11-23,2023-12-21,7.59,,135,101,84,None,None,Worsened,0
190,PT-00190,41,F,Bhopal Research Hospital,Phase III,ORX-303,Cardiology,Placebo,2023-05-06,2023-06-03,8.36,9.03,105,89,87,None,None,Improved,0
191,PT-00191,40,M,NIMHANS Bengaluru,Phase II,ORX-505,Infectious Disease,Low Dose,2023-06-13,2023-07-11,8.85,8.32,130,79,78,Headache,None,Worsened,0
192,PT-00192,27,M,Kolkata Clinical Center,Phase III,ORX-404,Neurology,High Dose,2024-05-24,2024-05-31,5.47,6.51,112,70,47,None,None,Improved,0
193,PT-00193,34,F,Apollo Chennai,Phase IV,ORX-505,Infectious Disease,Low Dose,2023-02-21,2023-03-21,5.61,6.69,146,73,109,Fatigue,Mild,Improved,0
194,PT-00194,60,F,Indore Medical Institute,Phase II,ORX-101,Oncology,Low Dose,2023-09-28,2023-10-26,6.81,4.16,169,65,54,None,None,No Change,0
195,PT-00195,61,F,Apollo Chennai,Phase I,ORX-303,Cardiology,Low Dose,2023-03-17,2023-05-12,10.13,10.97,138,89,89,Headache,None,Improved,0
196,PT-00196,57,M,Bhopal Research Hospital,Phase I,ORX-404,Neurology,Low Dose,2023-12-14,2024-03-13,7.54,7.23,126,72,74,Headache,None,Worsened,0
197,PT-00197,18,F,Indore Medical Institute,Phase III,ORX-101,Oncology,Placebo,2023-12-08,2024-02-02,7.08,5.79,108,84,97,None,None,Improved,1
198,PT-00198,59,M,PGI Chandigarh,Phase II,ORX-202,Diabetes,Low Dose,2024-09-23,2024-10-21,5.32,4.02,144,70,74,None,None,No Change,0
199,PT-00199,53,F,Fortis Mumbai,Phase III,ORX-404,Neurology,High Dose,2024-01-13,2024-02-10,6.04,5.73,103,74,82,Fever,Mild,No Change,0
200,PT-00200,19,M,Fortis Mumbai,Phase III,ORX-606,Rheumatology,High Dose,2024-08-15,2024-11-13,7.73,7.31,137,84,97,None,None,Improved,1
201,PT-00201,47,F,NIMHANS Bengaluru,Phase II,ORX-202,Diabetes,High Dose,2023-09-06,2023-09-13,6.68,6.39,137,82,78,Headache,None,No Change,0
202,PT-00202,33,F,AIIMS Delhi,Phase II,ORX-404,Neurology,High Dose,2024-02-25,2024-05-25,6.4,4.74,159,67,68,Dizziness,Moderate,No Change,0
203,PT-00203,33,M,Apollo Chennai,Phase III,ORX-505,Infectious Disease,Low Dose,2024-11-09,2025-01-04,8.27,7.61,150,73,81,None,None,Improved,1
204,PT-00204,31,M,PGI Chandigarh,Phase III,ORX-505,Infectious Disease,Low Dose,2024-11-28,2024-12-26,9.77,8.31,133,89,83,None,None,No Change,0
205,PT-00205,42,M,Fortis Mumbai,Phase II,ORX-202,Diabetes,High Dose,2023-11-01,2023-11-29,7.04,6.68,125,93,108,Headache,None,No Change,0
206,PT-00206,36,F,Fortis Mumbai,Phase II,ORX-303,Cardiology,Placebo,2024-11-23,2025-02-21,5.56,5.08,174,72,100,Fever,Moderate,Improved,1
207,PT-00207,71,M,Fortis Mumbai,Phase II,ORX-606,Rheumatology,Placebo,2024-03-28,2024-04-25,6.54,6.65,157,77,75,None,None,No Change,0
208,PT-00208,35,F,Fortis Mumbai,Phase IV,ORX-202,Diabetes,Placebo,2024-08-23,2024-09-06,5.98,5.0,105,82,67,Nausea,None,Improved,1
209,PT-00209,48,M,NIMHANS Bengaluru,Phase I,ORX-303,Cardiology,High Dose,2023-04-13,2023-04-27,5.33,5.23,143,58,83,Nausea,Moderate,Improved,1
210,PT-00210,64,F,Kolkata Clinical Center,Phase III,ORX-404,Neurology,High Dose,2023-10-22,2023-11-19,5.75,6.85,135,73,77,None,None,Improved,0
211,PT-00211,53,M,Apollo Chennai,Phase III,ORX-505,Infectious Disease,High Dose,2023-02-08,2023-02-22,7.29,7.38,111,84,58,Rash,Moderate,Improved,0
212,PT-00212,43,M,NIMHANS Bengaluru,Phase IV,ORX-404,Neurology,Placebo,2023-10-24,2023-10-31,6.12,5.05,150,95,86,Nausea,None,Improved,1
213,PT-00213,27,F,Kolkata Clinical Center,Phase II,ORX-202,Diabetes,High Dose,2024-04-24,2024-05-22,6.82,7.51,130,109,83,None,None,Improved,0
214,PT-00214,48,M,Fortis Mumbai,Phase III,ORX-606,Rheumatology,Placebo,2023-12-12,2024-01-09,6.83,6.55,125,90,91,Headache,None,No Change,0
215,PT-00215,32,F,PGI Chandigarh,Phase III,ORX-101,Oncology,Low Dose,2023-04-08,2023-04-22,5.6,3.55,137,68,47,None,None,Worsened,0
216,PT-00216,51,M,NIMHANS Bengaluru,Phase I,ORX-202,Diabetes,Low Dose,2023-10-01,2023-10-29,10.19,9.79,143,82,76,Headache,None,Improved,1
217,PT-00217,59,F,Indore Medical Institute,Phase III,ORX-606,Rheumatology,Placebo,2023-11-11,2023-11-25,6.85,6.69,133,73,91,None,None,Improved,1
218,PT-00218,42,F,Fortis Mumbai,Phase III,ORX-303,Cardiology,Low Dose,2023-08-13,2023-08-27,6.29,6.38,111,82,77,None,None,Improved,0
219,PT-00219,62,F,Kolkata Clinical Center,Phase III,ORX-505,Infectious Disease,High Dose,2023-08-12,2023-08-26,7.77,7.35,142,98,85,Nausea,Mild,No Change,0
220,PT-00220,45,F,PGI Chandigarh,Phase III,ORX-101,Oncology,High Dose,2023-04-25,2023-05-02,5.63,4.27,122,74,75,Fatigue,None,No Change,0
221,PT-00221,45,M,Kolkata Clinical Center,Phase II,ORX-101,Oncology,High Dose,2024-08-20,2024-10-15,7.84,7.37,136,82,50,None,None,Improved,1
222,PT-00222,29,M,NIMHANS Bengaluru,Phase III,ORX-404,Neurology,Low Dose,2024-07-26,2024-09-20,7.03,5.54,138,100,95,None,None,No Change,0
223,PT-00223,41,M,Indore Medical Institute,Phase II,ORX-606,Rheumatology,Placebo,2023-03-16,2023-03-23,8.99,8.72,121,74,73,Headache,None,Improved,1
224,PT-00224,38,M,Bhopal Research Hospital,Phase IV,ORX-404,Neurology,Placebo,2024-02-23,2024-03-08,7.4,7.15,128,87,94,Headache,Severe,No Change,0
225,PT-00225,60,F,NIMHANS Bengaluru,Phase II,ORX-404,Neurology,High Dose,2024-01-22,2024-03-18,5.42,2.72,144,65,74,Fever,Moderate,Improved,1
226,PT-00226,26,M,PGI Chandigarh,Phase III,ORX-101,Oncology,Placebo,2024-07-04,2024-08-29,5.04,5.12,141,75,45,Headache,None,Improved,0
227,PT-00227,36,M,Fortis Mumbai,Phase III,ORX-404,Neurology,High Dose,2024-07-11,2024-09-05,7.67,5.94,131,81,86,Rash,None,Improved,1
228,PT-00228,46,F,Apollo Chennai,Phase II,ORX-606,Rheumatology,High Dose,2023-02-02,2023-03-30,6.03,6.71,125,81,64,Dizziness,Moderate,No Change,0
229,PT-00229,37,M,Bhopal Research Hospital,Phase II,ORX-505,Infectious Disease,Placebo,2024-09-04,2024-09-11,6.14,5.58,158,65,55,None,None,Improved,1
230,PT-00230,68,F,Apollo Chennai,Phase II,ORX-101,Oncology,Placebo,2023-10-24,2023-11-07,6.95,5.95,146,74,103,Headache,None,No Change,0
231,PT-00231,55,F,AIIMS Delhi,Phase II,ORX-606,Rheumatology,Low Dose,2024-02-28,2024-03-27,6.61,8.16,117,90,82,Nausea,Mild,Improved,0
232,PT-00232,65,M,NIMHANS Bengaluru,Phase III,ORX-505,Infectious Disease,Low Dose,2023-12-19,2024-02-13,9.07,8.7,114,87,68,None,None,No Change,0
233,PT-00233,77,F,Fortis Mumbai,Phase III,ORX-404,Neurology,Placebo,2024-07-04,2024-08-29,7.36,6.64,131,65,64,None,None,Improved,1
234,PT-00234,64,M,Indore Medical Institute,Phase III,ORX-505,Infectious Disease,Low Dose,2024-03-02,2024-05-31,6.41,5.07,137,96,88,None,None,Improved,1
235,PT-00235,60,F,Bhopal Research Hospital,Phase II,ORX-404,Neurology,High Dose,2023-04-05,2023-07-04,6.29,4.61,155,78,74,None,None,No Change,0
236,PT-00236,66,F,Indore Medical Institute,Phase II,ORX-101,Oncology,Placebo,2024-08-24,2024-11-22,7.87,7.88,166,74,90,None,None,Improved,0
237,PT-00237,45,F,Indore Medical Institute,Phase II,ORX-202,Diabetes,High Dose,2023-05-01,2023-06-26,7.52,8.5,137,88,93,Headache,Mild,Worsened,0
238,PT-00238,39,F,PGI Chandigarh,Phase IV,ORX-303,Cardiology,Low Dose,2024-06-30,2024-07-28,6.19,4.85,92,106,62,None,None,Improved,1
239,PT-00239,41,F,Kolkata Clinical Center,Phase III,ORX-303,Cardiology,High Dose,2024-01-15,2024-02-12,6.87,6.74,142,92,69,Nausea,None,Improved,1
240,PT-00240,42,M,NIMHANS Bengaluru,Phase I,ORX-303,Cardiology,Placebo,2023-12-04,2023-12-18,7.54,6.92,156,87,88,Rash,None,Improved,1
241,PT-00241,55,F,Kolkata Clinical Center,Phase II,ORX-606,Rheumatology,Low Dose,2024-05-17,2024-07-12,8.61,8.37,104,86,68,Rash,None,Improved,1
242,PT-00242,36,F,Indore Medical Institute,Phase II,ORX-505,Infectious Disease,Placebo,2023-03-18,2023-03-25,7.9,8.62,128,85,101,None,None,No Change,0
243,PT-00243,48,M,AIIMS Delhi,Phase I,ORX-101,Oncology,Placebo,2024-04-11,2024-05-09,10.32,10.43,96,91,83,Nausea,Moderate,Improved,0
244,PT-00244,65,F,Indore Medical Institute,Phase III,ORX-101,Oncology,Low Dose,2024-02-26,2024-03-04,8.01,7.48,105,79,66,Headache,None,Improved,1
245,PT-00245,35,F,NIMHANS Bengaluru,Phase I,ORX-202,Diabetes,Placebo,2023-04-09,2023-07-08,7.91,9.01,135,67,84,None,None,Improved,0
246,PT-00246,64,F,Fortis Mumbai,Phase III,ORX-404,Neurology,Placebo,2024-02-20,2024-04-16,6.47,5.95,128,72,87,Fever,None,No Change,0
247,PT-00247,43,M,Indore Medical Institute,Phase III,ORX-101,Oncology,Low Dose,2024-01-22,2024-04-21,7.7,6.5,120,90,72,Nausea,Mild,Improved,1
248,PT-00248,72,M,NIMHANS Bengaluru,Phase III,ORX-606,Rheumatology,High Dose,2024-08-02,2024-08-09,6.72,6.52,144,64,53,Fatigue,None,Worsened,0
249,PT-00249,20,F,Bhopal Research Hospital,Phase II,ORX-606,Rheumatology,High Dose,2024-07-10,2024-10-08,8.72,7.82,174,75,80,None,None,No Change,0
250,PT-00250,69,F,Apollo Chennai,Phase I,ORX-505,Infectious Disease,Placebo,2024-02-12,2024-02-19,9.61,11.06,149,94,86,Nausea,Mild,Improved,0
251,PT-00251,57,F,PGI Chandigarh,Phase III,ORX-404,Neurology,High Dose,2023-05-24,2023-05-31,6.54,5.4,127,79,71,Fever,None,Improved,1
252,PT-00252,56,F,Bhopal Research Hospital,Phase II,ORX-303,Cardiology,Low Dose,2024-09-20,2024-12-19,8.35,8.03,154,68,75,Headache,None,Improved,1
253,PT-00253,33,F,Kolkata Clinical Center,Phase III,ORX-404,Neurology,Placebo,2024-07-20,2024-09-14,4.96,4.49,125,100,86,Headache,Mild,Improved,1
254,PT-00254,28,M,Fortis Mumbai,Phase III,ORX-202,Diabetes,High Dose,2023-03-26,2023-04-23,9.42,10.12,138,79,64,Headache,Mild,Improved,0
255,PT-00255,39,F,Bhopal Research Hospital,Phase II,ORX-101,Oncology,Placebo,2023-11-12,2024-01-07,8.51,9.8,155,76,62,None,None,Improved,0
256,PT-00256,47,M,NIMHANS Bengaluru,Phase I,ORX-404,Neurology,Low Dose,2024-06-08,2024-08-03,5.08,4.97,125,76,55,None,None,Improved,1
257,PT-00257,53,M,PGI Chandigarh,Phase III,ORX-404,Neurology,Placebo,2024-02-28,2024-04-24,6.56,5.11,90,81,102,Headache,Mild,No Change,0
258,PT-00258,71,M,AIIMS Delhi,Phase III,ORX-606,Rheumatology,Low Dose,2023-05-23,2023-06-20,6.65,5.71,136,70,82,None,None,Improved,1
259,PT-00259,57,M,Fortis Mumbai,Phase II,ORX-404,Neurology,Placebo,2023-03-20,2023-04-17,8.67,8.18,124,71,66,None,None,Improved,1
260,PT-00260,41,F,Apollo Chennai,Phase III,ORX-404,Neurology,Placebo,2023-11-08,2023-11-15,7.64,8.06,113,99,74,None,None,Worsened,0
261,PT-00261,44,F,PGI Chandigarh,Phase III,ORX-404,Neurology,Low Dose,2024-10-28,2025-01-26,6.3,3.72,143,90,74,None,None,Improved,1
262,PT-00262,46,M,AIIMS Delhi,Phase III,ORX-404,Neurology,High Dose,2023-10-26,2023-12-21,7.82,6.01,118,91,60,Headache,None,Worsened,0
263,PT-00263,49,F,NIMHANS Bengaluru,Phase III,ORX-303,Cardiology,Placebo,2024-07-31,2024-08-14,5.57,5.59,127,62,94,None,None,No Change,0
264,PT-00264,33,M,Kolkata Clinical Center,Phase IV,ORX-606,Rheumatology,Placebo,2023-10-26,2023-11-02,6.23,6.01,148,69,78,Rash,None,No Change,0
265,PT-00265,51,F,Fortis Mumbai,Phase I,ORX-202,Diabetes,Placebo,2023-06-07,2023-08-02,8.03,7.79,121,72,79,None,None,No Change,0
266,PT-00266,27,F,NIMHANS Bengaluru,Phase III,ORX-505,Infectious Disease,Placebo,2024-01-04,2024-04-03,3.69,3.69,144,53,63,Fatigue,None,No Change,0
267,PT-00267,54,M,PGI Chandigarh,Phase III,ORX-202,Diabetes,Low Dose,2023-02-15,2023-05-16,9.67,9.29,114,79,97,Headache,None,Worsened,0
268,PT-00268,34,F,NIMHANS Bengaluru,Phase IV,ORX-101,Oncology,Placebo,2023-09-22,2023-10-06,6.24,5.41,110,83,100,None,None,Improved,1
269,PT-00269,50,M,NIMHANS Bengaluru,Phase III,ORX-404,Neurology,High Dose,2024-08-25,2024-11-23,6.9,6.23,99,92,76,Fever,None,Improved,1
270,PT-00270,42,F,Bhopal Research Hospital,Phase III,ORX-101,Oncology,High Dose,2023-05-26,2023-06-23,11.03,10.9,114,76,94,None,None,Improved,1
271,PT-00271,46,M,PGI Chandigarh,Phase III,ORX-404,Neurology,Placebo,2024-04-08,2024-05-06,5.47,5.9,115,104,93,None,None,Improved,0
272,PT-00272,37,M,PGI Chandigarh,Phase I,ORX-606,Rheumatology,Placebo,2023-06-18,2023-07-02,8.74,8.4,143,87,66,Nausea,None,Improved,1
273,PT-00273,34,F,Apollo Chennai,Phase IV,ORX-404,Neurology,Low Dose,2023-07-10,2023-09-04,8.44,7.73,120,70,83,Headache,Moderate,Improved,1
274,PT-00274,78,F,NIMHANS Bengaluru,Phase III,ORX-101,Oncology,High Dose,2023-07-30,2023-08-27,5.92,5.54,153,81,84,Rash,None,No Change,0
275,PT-00275,28,M,AIIMS Delhi,Phase III,ORX-303,Cardiology,Low Dose,2024-04-13,2024-04-20,7.71,7.15,145,96,114,Fatigue,None,Improved,1
276,PT-00276,54,F,NIMHANS Bengaluru,Phase III,ORX-505,Infectious Disease,Placebo,2023-12-27,2024-02-21,7.59,7.37,121,86,73,Rash,Mild,No Change,0
277,PT-00277,47,F,Bhopal Research Hospital,Phase IV,ORX-606,Rheumatology,Placebo,2023-05-01,2023-05-15,8.78,7.48,148,97,76,None,None,Improved,1
278,PT-00278,18,M,NIMHANS Bengaluru,Phase III,ORX-505,Infectious Disease,Placebo,2024-01-28,2024-03-24,6.47,7.24,127,70,70,Nausea,Mild,Improved,0
279,PT-00279,58,M,Kolkata Clinical Center,Phase III,ORX-303,Cardiology,Placebo,2023-11-19,2024-01-14,7.86,7.24,121,77,65,Fatigue,Severe,No Change,0
280,PT-00280,70,F,NIMHANS Bengaluru,Phase I,ORX-505,Infectious Disease,Low Dose,2024-05-21,2024-07-16,6.81,7.51,155,93,71,None,None,No Change,0
281,PT-00281,51,F,Bhopal Research Hospital,Phase III,ORX-505,Infectious Disease,Placebo,2023-08-14,2023-09-11,7.17,5.96,133,67,94,None,None,Improved,1
282,PT-00282,37,F,Kolkata Clinical Center,Phase II,ORX-505,Infectious Disease,High Dose,2024-05-22,2024-08-20,7.44,7.3,123,89,71,Nausea,None,Improved,1
283,PT-00283,58,F,Indore Medical Institute,Phase III,ORX-606,Rheumatology,Low Dose,2023-08-12,2023-10-07,5.58,5.3,162,69,68,Rash,Mild,Improved,1
284,PT-00284,53,F,Indore Medical Institute,Phase IV,ORX-404,Neurology,Placebo,2023-03-31,2023-05-26,7.42,7.33,136,89,93,None,None,Worsened,0
285,PT-00285,51,M,PGI Chandigarh,Phase II,ORX-606,Rheumatology,Low Dose,2024-03-14,2024-03-28,6.91,7.12,162,80,64,Headache,Moderate,No Change,0
286,PT-00286,62,M,Fortis Mumbai,Phase III,ORX-505,Infectious Disease,Low Dose,2023-11-28,2023-12-26,7.06,4.7,143,75,76,None,None,Improved,1
287,PT-00287,50,M,NIMHANS Bengaluru,Phase I,ORX-101,Oncology,High Dose,2024-11-02,2024-11-16,7.43,7.67,120,88,74,None,None,No Change,0
288,PT-00288,56,M,Apollo Chennai,Phase III,ORX-606,Rheumatology,Low Dose,2023-05-26,2023-08-24,7.94,6.7,147,75,89,Nausea,None,No Change,0
289,PT-00289,50,M,Bhopal Research Hospital,Phase III,ORX-404,Neurology,Low Dose,2023-10-12,2023-11-09,9.41,8.8,121,81,73,None,None,Improved,1
290,PT-00290,57,M,Bhopal Research Hospital,Phase IV,ORX-606,Rheumatology,High Dose,2024-10-12,2024-11-09,5.26,3.91,108,93,101,Rash,None,Worsened,0
291,PT-00291,43,F,Kolkata Clinical Center,Phase III,ORX-303,Cardiology,Low Dose,2023-10-18,2023-11-15,7.0,6.66,148,70,81,None,None,Improved,1
292,PT-00292,60,F,Indore Medical Institute,Phase III,ORX-101,Oncology,Placebo,2024-04-15,2024-04-22,7.8,7.57,146,50,87,Fatigue,None,Improved,1
293,PT-00293,34,M,NIMHANS Bengaluru,Phase IV,ORX-202,Diabetes,High Dose,2023-05-16,2023-06-13,5.0,5.06,152,80,91,Dizziness,None,Improved,0
294,PT-00294,70,F,PGI Chandigarh,Phase II,ORX-606,Rheumatology,High Dose,2023-06-19,2023-06-26,8.78,9.85,141,82,55,None,None,Improved,0
295,PT-00295,41,M,Bhopal Research Hospital,Phase III,ORX-606,Rheumatology,Placebo,2023-08-07,2023-10-02,6.19,7.74,124,83,85,Nausea,None,Improved,0
296,PT-00296,45,F,PGI Chandigarh,Phase I,ORX-101,Oncology,High Dose,2024-03-08,2024-03-22,9.23,8.27,131,73,59,None,None,Improved,1
297,PT-00297,35,M,Bhopal Research Hospital,Phase III,ORX-101,Oncology,Low Dose,2023-11-03,2023-11-17,7.16,6.37,115,65,76,Rash,Moderate,Improved,1
298,PT-00298,20,M,Indore Medical Institute,Phase I,ORX-505,Infectious Disease,High Dose,2024-03-26,2024-04-23,8.11,7.79,101,78,67,Nausea,None,No Change,0
299,PT-00299,50,F,Kolkata Clinical Center,Phase III,ORX-202,Diabetes,Placebo,2023-04-13,2023-04-27,8.81,6.72,130,80,87,Nausea,None,No Change,0
300,PT-00300,48,F,AIIMS Delhi,Phase II,ORX-202,Diabetes,Placebo,2023-03-28,2023-04-11,6.3,5.61,113,94,78,Nausea,Mild,No Change,0
301,PT-00301,75,M,Fortis Mumbai,Phase III,ORX-202,Diabetes,Low Dose,2024-06-05,2024-06-19,7.13,6.09,100,60,55,None,None,No Change,0
302,PT-00302,49,M,Apollo Chennai,Phase III,ORX-404,Neurology,Low Dose,2023-09-04,2023-10-30,7.81,5.99,144,76,80,None,None,No Change,0
303,PT-00303,70,M,PGI Chandigarh,Phase IV,ORX-202,Diabetes,Low Dose,2024-08-05,2024-09-30,8.28,7.63,111,56,67,Headache,Mild,Improved,1
304,PT-00304,41,M,Bhopal Research Hospital,Phase I,ORX-101,Oncology,Placebo,2023-02-10,2023-02-17,6.02,5.5,129,79,68,None,None,Worsened,0
305,PT-00305,47,F,NIMHANS Bengaluru,Phase III,ORX-404,Neurology,High Dose,2023-03-26,2023-06-24,7.73,6.35,153,80,78,None,None,Improved,1
306,PT-00306,56,M,Apollo Chennai,Phase II,ORX-202,Diabetes,Low Dose,2024-02-05,2024-05-05,7.48,7.94,133,74,83,Rash,Mild,No Change,0
307,PT-00307,26,M,NIMHANS Bengaluru,Phase II,ORX-606,Rheumatology,High Dose,2023-09-02,2023-09-09,7.33,6.9,124,80,51,Dizziness,None,Improved,1
308,PT-00308,36,M,AIIMS Delhi,Phase II,ORX-101,Oncology,Placebo,2023-05-21,2023-05-28,7.31,7.06,109,97,65,Dizziness,None,Improved,1
309,PT-00309,60,F,AIIMS Delhi,Phase II,ORX-606,Rheumatology,High Dose,2023-10-03,2023-10-10,7.71,6.73,159,67,90,None,None,No Change,0
310,PT-00310,61,F,Bhopal Research Hospital,Phase II,ORX-303,Cardiology,High Dose,2024-08-13,2024-08-20,6.4,7.25,123,85,81,None,None,Improved,0
311,PT-00311,42,M,AIIMS Delhi,Phase III,ORX-303,Cardiology,Placebo,2023-04-16,2023-07-15,8.17,8.49,96,97,54,None,None,No Change,0
312,PT-00312,61,M,Indore Medical Institute,Phase I,ORX-202,Diabetes,Placebo,2024-01-08,2024-03-04,8.55,,120,68,74,None,None,Worsened,0
313,PT-00313,40,M,NIMHANS Bengaluru,Phase III,ORX-202,Diabetes,Low Dose,2024-03-02,2024-03-30,8.14,8.91,153,75,75,None,None,Improved,0
314,PT-00314,18,F,Indore Medical Institute,Phase I,ORX-202,Diabetes,Placebo,2024-06-12,2024-06-19,6.23,6.7,157,67,69,None,None,Worsened,0
315,PT-00315,44,F,Fortis Mumbai,Phase IV,ORX-303,Cardiology,Placebo,2024-04-12,2024-04-19,7.54,6.41,135,76,77,None,None,Improved,1
316,PT-00316,53,F,Apollo Chennai,Phase III,ORX-404,Neurology,Low Dose,2024-05-20,2024-06-03,7.21,6.41,126,80,72,None,None,No Change,0
317,PT-00317,40,M,NIMHANS Bengaluru,Phase II,ORX-101,Oncology,Placebo,2023-12-21,2023-12-28,9.12,9.22,122,90,73,None,None,Worsened,0
318,PT-00318,63,F,Fortis Mumbai,Phase III,ORX-101,Oncology,Placebo,2023-09-01,2023-10-27,7.64,7.15,136,63,62,None,None,Improved,1
319,PT-00319,25,M,Bhopal Research Hospital,Phase III,ORX-101,Oncology,High Dose,2024-06-16,2024-08-11,7.37,8.53,168,89,85,None,None,No Change,0
320,PT-00320,18,M,AIIMS Delhi,Phase III,ORX-606,Rheumatology,High Dose,2023-03-18,2023-06-16,6.55,5.44,116,79,71,None,None,No Change,0
321,PT-00321,18,M,Fortis Mumbai,Phase II,ORX-303,Cardiology,High Dose,2024-02-07,2024-03-06,8.1,6.73,132,106,65,None,None,Improved,1
322,PT-00322,18,M,AIIMS Delhi,Phase IV,ORX-505,Infectious Disease,Placebo,2023-04-19,2023-05-03,6.86,7.45,163,67,84,None,None,Improved,0
323,PT-00323,37,M,Apollo Chennai,Phase III,ORX-404,Neurology,Low Dose,2023-09-29,2023-10-06,7.07,9.05,100,85,84,Rash,None,Improved,0
324,PT-00324,62,M,PGI Chandigarh,Phase II,ORX-202,Diabetes,Placebo,2023-09-12,2023-10-10,7.32,7.19,120,85,73,None,None,Improved,1
325,PT-00325,54,F,AIIMS Delhi,Phase II,ORX-101,Oncology,High Dose,2024-04-08,2024-07-07,6.76,6.7,127,95,77,None,None,No Change,0
326,PT-00326,18,F,AIIMS Delhi,Phase I,ORX-101,Oncology,Placebo,2023-08-16,2023-08-30,8.71,7.5,116,74,97,None,None,Improved,1
327,PT-00327,18,M,Fortis Mumbai,Phase III,ORX-101,Oncology,Placebo,2023-03-08,2023-03-22,10.97,11.52,132,81,81,None,None,Worsened,0
328,PT-00328,53,M,PGI Chandigarh,Phase I,ORX-101,Oncology,Placebo,2024-04-17,2024-04-24,7.97,8.07,129,79,75,Nausea,Moderate,Improved,0
329,PT-00329,41,F,NIMHANS Bengaluru,Phase III,ORX-606,Rheumatology,Low Dose,2023-12-29,2024-01-12,8.56,8.69,90,89,80,None,None,Worsened,0
330,PT-00330,44,F,Indore Medical Institute,Phase IV,ORX-505,Infectious Disease,Low Dose,2023-09-09,2023-10-07,6.73,7.35,145,72,83,Fatigue,None,Improved,0
331,PT-00331,29,M,AIIMS Delhi,Phase II,ORX-404,Neurology,Placebo,2024-06-22,2024-07-06,5.54,4.58,143,93,85,Rash,Mild,No Change,0
332,PT-00332,56,F,PGI Chandigarh,Phase III,ORX-404,Neurology,Low Dose,2024-05-11,2024-06-08,7.82,6.84,135,91,88,None,None,Worsened,0
333,PT-00333,64,F,Indore Medical Institute,Phase II,ORX-303,Cardiology,Low Dose,2023-01-31,2023-02-28,8.05,7.97,147,81,65,Fever,None,Improved,1
334,PT-00334,42,M,Bhopal Research Hospital,Phase IV,ORX-202,Diabetes,High Dose,2023-09-30,2023-12-29,6.31,5.3,125,72,73,Fatigue,None,No Change,0
335,PT-00335,18,M,NIMHANS Bengaluru,Phase III,ORX-303,Cardiology,High Dose,2023-06-27,2023-07-11,7.46,7.06,113,89,91,None,None,Improved,1
336,PT-00336,19,F,Indore Medical Institute,Phase IV,ORX-606,Rheumatology,High Dose,2024-08-04,2024-11-02,6.28,5.19,111,91,75,Dizziness,Moderate,Improved,1
337,PT-00337,40,F,AIIMS Delhi,Phase III,ORX-404,Neurology,Placebo,2023-02-27,2023-03-13,4.8,4.97,105,82,81,None,None,No Change,0
338,PT-00338,66,F,Apollo Chennai,Phase I,ORX-202,Diabetes,Low Dose,2023-07-01,2023-07-29,5.63,2.51,131,103,95,None,None,Improved,1
339,PT-00339,48,M,PGI Chandigarh,Phase III,ORX-101,Oncology,Low Dose,2024-11-09,2025-01-04,6.61,6.94,110,87,85,None,None,No Change,0
340,PT-00340,61,F,AIIMS Delhi,Phase I,ORX-606,Rheumatology,High Dose,2024-10-16,2024-12-11,10.51,10.46,118,81,53,None,None,No Change,0
341,PT-00341,33,F,AIIMS Delhi,Phase II,ORX-404,Neurology,Low Dose,2023-10-29,2023-11-12,6.71,5.84,130,72,93,None,None,Improved,1
342,PT-00342,45,F,Indore Medical Institute,Phase IV,ORX-202,Diabetes,Low Dose,2024-09-18,2024-10-02,7.19,6.49,130,91,65,None,None,No Change,0
343,PT-00343,34,F,Bhopal Research Hospital,Phase I,ORX-202,Diabetes,Low Dose,2023-11-24,2023-12-08,6.84,5.22,113,76,90,Fever,Moderate,No Change,0
344,PT-00344,49,F,Fortis Mumbai,Phase III,ORX-202,Diabetes,Placebo,2023-03-11,2023-04-08,7.43,7.8,125,86,76,None,None,Improved,0
345,PT-00345,49,M,Kolkata Clinical Center,Phase I,ORX-606,Rheumatology,Low Dose,2023-06-20,2023-08-15,6.5,3.91,125,99,90,None,None,Improved,1
346,PT-00346,60,F,Kolkata Clinical Center,Phase I,ORX-505,Infectious Disease,High Dose,2023-08-19,2023-09-02,8.68,8.36,131,74,73,Rash,None,Improved,1
347,PT-00347,54,M,Bhopal Research Hospital,Phase II,ORX-101,Oncology,Low Dose,2024-01-20,2024-02-03,8.64,8.12,119,82,86,None,None,No Change,0
348,PT-00348,21,M,Kolkata Clinical Center,Phase II,ORX-606,Rheumatology,Placebo,2024-10-31,2024-11-14,4.44,3.55,106,75,75,None,None,No Change,0
349,PT-00349,37,M,Apollo Chennai,Phase I,ORX-202,Diabetes,Low Dose,2024-07-21,2024-10-19,8.94,8.84,133,89,62,None,None,Improved,1
350,PT-00350,61,M,NIMHANS Bengaluru,Phase I,ORX-505,Infectious Disease,Low Dose,2024-05-17,2024-05-31,7.11,7.31,108,63,89,None,None,Improved,0
351,PT-00351,51,M,Kolkata Clinical Center,Phase II,ORX-202,Diabetes,Placebo,2023-07-31,2023-08-14,6.12,4.93,148,67,100,Fever,None,No Change,0
352,PT-00352,30,M,NIMHANS Bengaluru,Phase II,ORX-404,Neurology,Low Dose,2024-11-07,2024-12-05,7.97,7.27,138,75,75,None,None,Improved,1
353,PT-00353,45,M,NIMHANS Bengaluru,Phase II,ORX-303,Cardiology,Placebo,2023-02-15,2023-03-15,6.0,6.26,118,79,64,None,None,Improved,0
354,PT-00354,18,F,AIIMS Delhi,Phase III,ORX-606,Rheumatology,High Dose,2023-03-29,2023-04-26,6.97,8.74,142,81,74,None,None,No Change,0
355,PT-00355,45,M,NIMHANS Bengaluru,Phase III,ORX-505,Infectious Disease,Low Dose,2024-07-02,2024-08-27,7.86,,148,90,88,None,None,No Change,0
356,PT-00356,52,F,Indore Medical Institute,Phase I,ORX-505,Infectious Disease,Low Dose,2024-06-13,2024-09-11,7.22,7.43,138,77,69,Nausea,None,No Change,0
357,PT-00357,46,F,AIIMS Delhi,Phase II,ORX-202,Diabetes,High Dose,2023-05-10,2023-05-17,9.06,7.54,101,83,78,Fever,None,Improved,1
358,PT-00358,47,M,Fortis Mumbai,Phase III,ORX-303,Cardiology,High Dose,2023-03-10,2023-03-17,7.49,6.89,154,62,66,None,None,Improved,1
359,PT-00359,43,F,Kolkata Clinical Center,Phase IV,ORX-101,Oncology,High Dose,2024-09-30,2024-12-29,5.23,4.67,157,82,81,None,None,Improved,1
360,PT-00360,24,F,Bhopal Research Hospital,Phase I,ORX-101,Oncology,Low Dose,2023-04-14,2023-05-12,6.46,5.72,122,97,85,Fatigue,Moderate,Worsened,0
361,PT-00361,27,F,Kolkata Clinical Center,Phase II,ORX-505,Infectious Disease,Low Dose,2023-02-08,2023-02-22,7.5,7.54,148,100,63,None,None,Improved,0
362,PT-00362,32,F,PGI Chandigarh,Phase I,ORX-606,Rheumatology,Placebo,2024-05-01,2024-05-29,5.69,5.08,136,93,76,None,None,Worsened,0
363,PT-00363,39,F,Kolkata Clinical Center,Phase II,ORX-606,Rheumatology,High Dose,2023-08-22,2023-09-05,7.38,6.23,165,62,80,Headache,Mild,Improved,1
364,PT-00364,77,F,NIMHANS Bengaluru,Phase II,ORX-505,Infectious Disease,Low Dose,2023-07-12,2023-09-06,7.21,6.64,121,79,97,Rash,Mild,Improved,1
365,PT-00365,18,F,AIIMS Delhi,Phase III,ORX-101,Oncology,Low Dose,2024-06-02,2024-07-28,9.04,7.36,123,76,86,Fatigue,Moderate,Improved,1
366,PT-00366,19,M,Apollo Chennai,Phase II,ORX-101,Oncology,Placebo,2024-04-12,2024-04-19,7.75,9.18,103,84,68,Headache,None,Worsened,0
367,PT-00367,51,F,Bhopal Research Hospital,Phase III,ORX-606,Rheumatology,Placebo,2024-01-17,2024-03-13,7.22,6.25,136,103,75,None,None,No Change,0
368,PT-00368,56,F,PGI Chandigarh,Phase III,ORX-303,Cardiology,Placebo,2023-09-22,2023-09-29,5.65,4.39,136,99,82,None,None,Improved,1
369,PT-00369,39,M,Apollo Chennai,Phase IV,ORX-202,Diabetes,Low Dose,2024-11-24,2024-12-08,7.2,5.67,138,92,71,None,None,Improved,1
370,PT-00370,37,M,Indore Medical Institute,Phase IV,ORX-404,Neurology,High Dose,2024-10-24,2024-11-07,7.52,6.73,126,107,74,None,None,No Change,0
371,PT-00371,39,F,Fortis Mumbai,Phase III,ORX-606,Rheumatology,High Dose,2024-10-20,2024-11-17,6.42,6.69,124,74,96,None,None,Improved,0
372,PT-00372,67,F,Apollo Chennai,Phase III,ORX-404,Neurology,Low Dose,2024-06-17,2024-09-15,6.48,4.4,146,73,89,None,None,Improved,1
373,PT-00373,18,F,Fortis Mumbai,Phase III,ORX-303,Cardiology,High Dose,2024-05-08,2024-05-15,8.27,,141,82,64,None,None,Improved,1
374,PT-00374,38,F,Fortis Mumbai,Phase IV,ORX-606,Rheumatology,High Dose,2024-10-29,2024-11-26,8.02,7.72,138,105,56,None,None,Improved,1
375,PT-00375,70,M,NIMHANS Bengaluru,Phase IV,ORX-606,Rheumatology,Low Dose,2023-05-24,2023-05-31,7.33,6.12,104,79,90,Fever,None,No Change,0
376,PT-00376,42,F,Indore Medical Institute,Phase III,ORX-505,Infectious Disease,High Dose,2024-08-08,2024-08-22,9.01,7.31,127,66,83,Headache,Mild,Improved,1
377,PT-00377,59,F,PGI Chandigarh,Phase IV,ORX-505,Infectious Disease,Low Dose,2023-06-24,2023-09-22,6.7,3.95,131,87,83,None,None,Improved,1
378,PT-00378,64,M,AIIMS Delhi,Phase III,ORX-606,Rheumatology,High Dose,2024-11-01,2024-11-08,5.91,6.13,149,60,82,None,None,Improved,0
379,PT-00379,36,F,PGI Chandigarh,Phase III,ORX-303,Cardiology,Placebo,2023-10-29,2023-12-24,7.1,7.02,119,73,78,None,None,Worsened,0
380,PT-00380,27,M,Apollo Chennai,Phase III,ORX-505,Infectious Disease,Placebo,2024-11-28,2025-01-23,5.9,6.11,107,89,84,None,None,Improved,0
381,PT-00381,18,M,Apollo Chennai,Phase I,ORX-303,Cardiology,Low Dose,2024-08-06,2024-10-01,6.39,7.06,110,76,84,Fatigue,None,Improved,0
382,PT-00382,57,M,AIIMS Delhi,Phase III,ORX-303,Cardiology,Low Dose,2023-01-05,2023-03-02,6.9,5.96,153,102,91,Headache,None,Improved,1
383,PT-00383,46,M,Bhopal Research Hospital,Phase III,ORX-202,Diabetes,Low Dose,2024-10-10,2024-12-05,6.23,5.08,137,87,97,Fever,None,Improved,1
384,PT-00384,55,M,PGI Chandigarh,Phase III,ORX-101,Oncology,High Dose,2024-06-27,2024-07-11,5.4,5.94,110,77,81,None,None,Improved,0
385,PT-00385,76,M,PGI Chandigarh,Phase II,ORX-303,Cardiology,Placebo,2024-01-28,2024-04-27,10.93,11.08,124,88,90,None,None,No Change,0
386,PT-00386,39,M,Fortis Mumbai,Phase II,ORX-404,Neurology,High Dose,2024-09-02,2024-12-01,9.35,9.16,136,89,83,Fatigue,Severe,Improved,1
387,PT-00387,58,F,Kolkata Clinical Center,Phase IV,ORX-303,Cardiology,High Dose,2023-06-18,2023-08-13,6.46,5.56,108,87,88,None,None,Improved,1
388,PT-00388,52,M,Indore Medical Institute,Phase II,ORX-505,Infectious Disease,Low Dose,2023-05-07,2023-06-04,9.21,8.8,140,68,72,Rash,None,No Change,0
389,PT-00389,56,F,Indore Medical Institute,Phase III,ORX-505,Infectious Disease,High Dose,2024-11-08,2024-11-15,8.22,7.55,126,63,73,None,None,No Change,0
390,PT-00390,59,M,NIMHANS Bengaluru,Phase III,ORX-101,Oncology,Low Dose,2024-04-30,2024-05-14,7.89,7.94,128,82,68,Headache,None,Improved,0
391,PT-00391,56,F,Fortis Mumbai,Phase III,ORX-505,Infectious Disease,Low Dose,2023-05-21,2023-07-16,7.71,7.75,118,56,93,None,None,No Change,0
392,PT-00392,37,M,Bhopal Research Hospital,Phase II,ORX-404,Neurology,Placebo,2023-07-24,2023-08-21,6.16,6.39,120,94,86,Fever,None,No Change,0
393,PT-00393,55,F,Indore Medical Institute,Phase II,ORX-505,Infectious Disease,Low Dose,2023-08-01,2023-09-26,5.56,6.25,132,77,80,None,None,Improved,0
394,PT-00394,18,M,Kolkata Clinical Center,Phase IV,ORX-202,Diabetes,High Dose,2024-06-07,2024-06-14,7.69,6.36,103,63,93,None,None,No Change,0
395,PT-00395,34,F,Kolkata Clinical Center,Phase III,ORX-303,Cardiology,Placebo,2023-02-21,2023-02-28,9.04,8.16,97,68,95,Fatigue,Moderate,No Change,0
396,PT-00396,42,F,PGI Chandigarh,Phase III,ORX-404,Neurology,High Dose,2023-04-08,2023-04-15,6.54,6.29,137,95,98,None,None,Improved,1
397,PT-00397,39,M,Kolkata Clinical Center,Phase II,ORX-505,Infectious Disease,Placebo,2023-04-06,2023-05-04,5.61,4.84,132,70,64,None,None,No Change,0
398,PT-00398,50,F,Kolkata Clinical Center,Phase III,ORX-303,Cardiology,High Dose,2024-05-04,2024-06-29,7.14,6.77,114,79,65,Rash,None,No Change,0
399,PT-00399,59,M,AIIMS Delhi,Phase IV,ORX-101,Oncology,Low Dose,2024-08-27,2024-10-22,8.44,6.38,111,64,68,Headache,None,No Change,0
400,PT-00400,43,F,Indore Medical Institute,Phase III,ORX-606,Rheumatology,High Dose,2023-05-14,2023-07-09,5.46,4.23,109,84,78,None,None,Worsened,0
401,PT-00401,33,F,Bhopal Research Hospital,Phase III,ORX-303,Cardiology,High Dose,2023-01-13,2023-04-13,7.41,6.52,123,102,96,Nausea,Mild,No Change,0
402,PT-00402,24,F,Bhopal Research Hospital,Phase III,ORX-404,Neurology,High Dose,2023-09-12,2023-11-07,8.2,8.53,107,91,99,Headache,None,Improved,0
403,PT-00403,27,M,AIIMS Delhi,Phase I,ORX-505,Infectious Disease,High Dose,2024-05-22,2024-06-05,6.1,6.61,132,88,82,None,None,Improved,0
404,PT-00404,51,M,Fortis Mumbai,Phase II,ORX-101,Oncology,Low Dose,2024-07-17,2024-09-11,5.61,6.15,149,79,77,None,None,Improved,0
405,PT-00405,20,F,Kolkata Clinical Center,Phase III,ORX-101,Oncology,High Dose,2024-04-02,2024-04-30,7.82,7.93,126,95,73,None,None,Improved,0
406,PT-00406,54,M,NIMHANS Bengaluru,Phase I,ORX-101,Oncology,Low Dose,2023-01-01,2023-01-08,5.98,5.56,124,84,72,Fever,Mild,No Change,0
407,PT-00407,42,M,Kolkata Clinical Center,Phase III,ORX-303,Cardiology,Low Dose,2023-02-25,2023-03-11,8.19,7.4,99,102,97,None,None,No Change,0
408,PT-00408,24,F,PGI Chandigarh,Phase III,ORX-606,Rheumatology,Low Dose,2023-04-10,2023-04-24,8.03,7.17,132,85,74,None,None,Improved,1
409,PT-00409,32,F,PGI Chandigarh,Phase III,ORX-606,Rheumatology,Placebo,2023-06-18,2023-08-13,6.37,5.15,113,81,67,Headache,Mild,Improved,1
410,PT-00410,55,M,Apollo Chennai,Phase II,ORX-202,Diabetes,Placebo,2024-02-07,2024-02-21,8.98,8.06,132,87,84,Headache,Mild,Improved,1
411,PT-00411,46,M,Indore Medical Institute,Phase III,ORX-606,Rheumatology,High Dose,2024-08-25,2024-09-01,8.09,8.13,105,92,90,None,None,No Change,0
412,PT-00412,32,M,Indore Medical Institute,Phase IV,ORX-505,Infectious Disease,High Dose,2024-07-20,2024-09-14,7.25,7.46,124,94,111,None,None,No Change,0
413,PT-00413,32,M,AIIMS Delhi,Phase III,ORX-606,Rheumatology,High Dose,2023-04-17,2023-06-12,5.54,5.42,140,79,98,Nausea,None,No Change,0
414,PT-00414,23,F,Apollo Chennai,Phase III,ORX-303,Cardiology,Low Dose,2023-12-18,2024-01-15,8.03,7.09,158,105,67,None,None,Improved,1
415,PT-00415,36,F,Fortis Mumbai,Phase III,ORX-606,Rheumatology,Low Dose,2023-11-18,2024-02-16,8.23,7.48,127,82,51,None,None,No Change,0
416,PT-00416,44,F,AIIMS Delhi,Phase III,ORX-606,Rheumatology,High Dose,2023-07-02,2023-09-30,6.37,5.53,153,66,89,Nausea,Mild,Improved,1
417,PT-00417,40,F,NIMHANS Bengaluru,Phase III,ORX-606,Rheumatology,High Dose,2024-06-30,2024-07-28,6.86,7.18,134,88,91,None,None,Worsened,0
418,PT-00418,39,M,Indore Medical Institute,Phase III,ORX-404,Neurology,Placebo,2024-11-17,2024-11-24,6.47,5.09,113,117,95,Headache,None,Improved,1
419,PT-00419,23,F,AIIMS Delhi,Phase III,ORX-101,Oncology,High Dose,2023-10-30,2023-11-13,5.61,5.65,137,88,74,None,None,No Change,0
420,PT-00420,42,F,Apollo Chennai,Phase I,ORX-606,Rheumatology,Low Dose,2024-02-03,2024-02-17,7.59,7.27,90,79,66,Rash,Mild,Improved,1
421,PT-00421,47,M,NIMHANS Bengaluru,Phase IV,ORX-404,Neurology,High Dose,2023-11-17,2024-02-15,10.78,10.71,122,93,84,Headache,None,Improved,1
422,PT-00422,51,F,PGI Chandigarh,Phase III,ORX-505,Infectious Disease,Low Dose,2024-09-09,2024-09-23,7.93,9.38,107,87,65,Fever,None,No Change,0
423,PT-00423,53,M,Bhopal Research Hospital,Phase IV,ORX-202,Diabetes,High Dose,2024-06-10,2024-06-17,6.1,5.32,122,93,90,None,None,Improved,1
424,PT-00424,25,F,Fortis Mumbai,Phase I,ORX-101,Oncology,Low Dose,2023-06-08,2023-06-15,7.27,6.23,105,79,73,None,None,Improved,1
425,PT-00425,83,M,Fortis Mumbai,Phase III,ORX-404,Neurology,High Dose,2024-07-17,2024-08-14,7.72,,117,94,107,Headache,None,Improved,1
426,PT-00426,19,M,AIIMS Delhi,Phase III,ORX-404,Neurology,Low Dose,2024-02-18,2024-02-25,4.94,6.23,135,71,85,Fatigue,Mild,Improved,0
427,PT-00427,18,F,Apollo Chennai,Phase II,ORX-505,Infectious Disease,Low Dose,2024-07-28,2024-08-04,7.2,7.1,144,69,79,None,None,Improved,1
428,PT-00428,30,M,Apollo Chennai,Phase IV,ORX-101,Oncology,High Dose,2023-11-25,2024-01-20,7.51,6.3,120,70,87,Dizziness,None,Worsened,0
429,PT-00429,58,F,PGI Chandigarh,Phase I,ORX-505,Infectious Disease,High Dose,2024-04-01,2024-05-27,6.92,6.55,101,78,77,Fatigue,None,Improved,1
430,PT-00430,85,M,AIIMS Delhi,Phase IV,ORX-505,Infectious Disease,Low Dose,2024-10-03,2024-10-10,5.87,6.78,145,85,102,Nausea,None,Improved,0
431,PT-00431,50,F,Apollo Chennai,Phase III,ORX-505,Infectious Disease,High Dose,2024-03-21,2024-03-28,7.67,7.22,150,95,69,None,None,No Change,0
432,PT-00432,23,F,Indore Medical Institute,Phase III,ORX-101,Oncology,Placebo,2023-07-02,2023-07-30,6.96,5.84,126,96,71,Nausea,None,No Change,0
433,PT-00433,44,F,Kolkata Clinical Center,Phase III,ORX-606,Rheumatology,Low Dose,2023-11-20,2023-11-27,7.27,7.63,90,74,80,None,None,Improved,0
434,PT-00434,64,M,Bhopal Research Hospital,Phase III,ORX-606,Rheumatology,Low Dose,2023-03-16,2023-04-13,6.61,4.52,139,74,61,None,None,Worsened,0
435,PT-00435,35,F,Fortis Mumbai,Phase III,ORX-404,Neurology,Low Dose,2024-11-07,2024-11-14,6.98,6.03,90,92,95,None,None,Improved,1
436,PT-00436,55,M,Fortis Mumbai,Phase III,ORX-606,Rheumatology,Placebo,2024-11-24,2024-12-22,5.83,5.25,127,89,87,None,None,Worsened,0
437,PT-00437,33,M,Indore Medical Institute,Phase I,ORX-505,Infectious Disease,Low Dose,2024-07-04,2024-10-02,7.3,7.31,154,90,89,None,None,Worsened,0
438,PT-00438,46,F,AIIMS Delhi,Phase II,ORX-202,Diabetes,Placebo,2024-09-23,2024-10-21,8.89,8.86,112,98,87,None,None,Improved,1
439,PT-00439,37,M,Kolkata Clinical Center,Phase IV,ORX-606,Rheumatology,Low Dose,2023-10-25,2023-11-01,6.62,6.49,136,84,82,None,None,Improved,1
440,PT-00440,72,F,PGI Chandigarh,Phase IV,ORX-202,Diabetes,High Dose,2023-08-29,2023-09-05,8.49,8.26,144,69,83,None,None,Improved,1
441,PT-00441,73,M,Kolkata Clinical Center,Phase II,ORX-303,Cardiology,Low Dose,2023-11-10,2024-02-08,6.94,5.78,116,68,67,Nausea,Moderate,Improved,1
442,PT-00442,39,F,PGI Chandigarh,Phase II,ORX-202,Diabetes,High Dose,2024-10-18,2024-12-13,5.51,5.13,144,71,99,None,None,Improved,1
443,PT-00443,53,F,Kolkata Clinical Center,Phase IV,ORX-404,Neurology,Low Dose,2023-11-09,2024-01-04,8.44,7.44,143,68,90,None,None,No Change,0
444,PT-00444,47,M,AIIMS Delhi,Phase III,ORX-505,Infectious Disease,Placebo,2024-10-03,2024-10-10,7.86,6.41,111,89,64,Fatigue,Moderate,No Change,0
445,PT-00445,52,M,NIMHANS Bengaluru,Phase III,ORX-505,Infectious Disease,Placebo,2023-02-07,2023-05-08,5.56,5.92,105,88,86,Fatigue,None,Improved,0
446,PT-00446,33,M,Apollo Chennai,Phase II,ORX-505,Infectious Disease,High Dose,2023-10-25,2023-11-08,7.9,7.73,118,69,50,None,None,Improved,1
447,PT-00447,50,F,Indore Medical Institute,Phase II,ORX-606,Rheumatology,Placebo,2024-09-20,2024-10-04,5.32,5.01,123,90,73,None,None,No Change,0
448,PT-00448,39,M,AIIMS Delhi,Phase II,ORX-606,Rheumatology,High Dose,2024-01-03,2024-01-10,8.08,7.98,133,87,56,None,None,Improved,1
449,PT-00449,57,M,Apollo Chennai,Phase II,ORX-101,Oncology,High Dose,2024-06-14,2024-07-12,7.93,6.62,123,81,76,Fatigue,Moderate,Improved,1
450,PT-00450,50,M,PGI Chandigarh,Phase IV,ORX-101,Oncology,High Dose,2024-06-17,2024-07-15,8.92,9.49,104,89,96,None,None,No Change,0
451,PT-00451,51,M,NIMHANS Bengaluru,Phase II,ORX-303,Cardiology,Low Dose,2023-03-21,2023-06-19,8.51,9.92,146,84,92,Fever,None,Improved,0
452,PT-00452,47,F,PGI Chandigarh,Phase II,ORX-404,Neurology,High Dose,2024-09-10,2024-09-17,7.23,6.51,156,72,99,None,None,Improved,1
453,PT-00453,52,M,Fortis Mumbai,Phase II,ORX-202,Diabetes,Placebo,2023-06-11,2023-07-09,5.52,5.45,90,89,90,Rash,Mild,No Change,0
454,PT-00454,35,F,Bhopal Research Hospital,Phase III,ORX-404,Neurology,High Dose,2024-05-05,2024-05-19,7.35,8.71,118,69,98,Nausea,None,No Change,0
455,PT-00455,76,M,AIIMS Delhi,Phase I,ORX-202,Diabetes,Low Dose,2023-02-10,2023-05-11,7.2,7.71,152,73,71,None,None,Improved,0
456,PT-00456,64,M,NIMHANS Bengaluru,Phase III,ORX-505,Infectious Disease,High Dose,2024-10-14,2024-10-21,9.22,9.33,112,105,70,Headache,Moderate,Worsened,0
457,PT-00457,39,M,Kolkata Clinical Center,Phase II,ORX-404,Neurology,Placebo,2024-02-25,2024-05-25,7.61,8.61,143,86,84,Nausea,Mild,Improved,0
458,PT-00458,45,F,PGI Chandigarh,Phase II,ORX-404,Neurology,Low Dose,2023-03-12,2023-03-26,7.87,5.19,122,84,61,None,None,Improved,1
459,PT-00459,51,M,NIMHANS Bengaluru,Phase II,ORX-202,Diabetes,Low Dose,2023-07-01,2023-08-26,6.95,,156,76,75,Nausea,Moderate,Worsened,0
460,PT-00460,43,M,AIIMS Delhi,Phase I,ORX-505,Infectious Disease,Low Dose,2023-01-02,2023-02-27,6.66,6.43,114,68,86,None,None,Improved,1
461,PT-00461,55,M,NIMHANS Bengaluru,Phase III,ORX-202,Diabetes,High Dose,2024-05-08,2024-07-03,6.23,6.64,116,85,89,Rash,Moderate,Improved,0
462,PT-00462,44,M,Fortis Mumbai,Phase III,ORX-404,Neurology,High Dose,2023-03-27,2023-04-24,7.75,6.88,124,79,67,None,None,No Change,0
463,PT-00463,42,F,Indore Medical Institute,Phase II,ORX-505,Infectious Disease,Low Dose,2024-06-16,2024-06-23,5.34,4.5,122,78,74,None,None,Improved,1
464,PT-00464,44,F,Bhopal Research Hospital,Phase III,ORX-202,Diabetes,Low Dose,2024-08-22,2024-09-19,7.78,8.16,116,67,63,None,None,Improved,0
465,PT-00465,37,F,NIMHANS Bengaluru,Phase III,ORX-202,Diabetes,Low Dose,2024-07-24,2024-09-18,6.78,5.68,104,76,80,Nausea,None,Improved,1
466,PT-00466,54,F,NIMHANS Bengaluru,Phase III,ORX-606,Rheumatology,Placebo,2024-11-06,2024-11-13,6.53,5.76,111,81,66,None,None,No Change,0
467,PT-00467,54,M,NIMHANS Bengaluru,Phase I,ORX-303,Cardiology,High Dose,2024-09-20,2024-09-27,5.06,4.33,133,84,115,Fever,None,Improved,1
468,PT-00468,50,M,Kolkata Clinical Center,Phase III,ORX-505,Infectious Disease,Low Dose,2023-03-07,2023-04-04,6.0,5.51,96,81,66,None,None,Improved,1
469,PT-00469,59,M,NIMHANS Bengaluru,Phase III,ORX-505,Infectious Disease,High Dose,2023-10-21,2024-01-19,6.54,6.04,116,102,73,Headache,None,Improved,1
470,PT-00470,74,F,Apollo Chennai,Phase III,ORX-606,Rheumatology,High Dose,2024-06-14,2024-07-12,8.18,8.21,134,86,51,Headache,None,Improved,0
471,PT-00471,40,M,Indore Medical Institute,Phase III,ORX-303,Cardiology,Placebo,2023-01-01,2023-01-15,8.21,7.77,102,81,101,None,None,Improved,1
472,PT-00472,64,F,NIMHANS Bengaluru,Phase II,ORX-404,Neurology,Low Dose,2024-06-14,2024-06-21,7.13,7.58,121,61,65,None,None,No Change,0
473,PT-00473,70,M,PGI Chandigarh,Phase III,ORX-303,Cardiology,High Dose,2023-10-11,2023-10-25,6.87,6.25,122,104,100,None,None,No Change,0
474,PT-00474,80,F,Fortis Mumbai,Phase III,ORX-202,Diabetes,Low Dose,2023-04-20,2023-07-19,7.01,6.88,100,99,61,None,None,Improved,1
475,PT-00475,48,M,Fortis Mumbai,Phase III,ORX-505,Infectious Disease,High Dose,2024-08-11,2024-09-08,5.88,4.95,112,74,70,Fever,Mild,No Change,0
476,PT-00476,36,M,Kolkata Clinical Center,Phase III,ORX-606,Rheumatology,Low Dose,2024-08-23,2024-08-30,8.2,6.81,131,96,70,None,None,Improved,1
477,PT-00477,33,F,Apollo Chennai,Phase III,ORX-606,Rheumatology,High Dose,2023-11-20,2024-01-15,6.92,7.59,131,75,84,None,None,Worsened,0
478,PT-00478,27,M,Fortis Mumbai,Phase III,ORX-202,Diabetes,Placebo,2024-02-13,2024-03-12,8.02,7.99,122,71,65,Dizziness,None,Improved,1
479,PT-00479,53,F,Fortis Mumbai,Phase II,ORX-202,Diabetes,High Dose,2024-11-30,2024-12-14,8.67,7.7,136,56,69,None,None,Improved,1
480,PT-00480,44,M,Apollo Chennai,Phase IV,ORX-202,Diabetes,Placebo,2023-09-13,2023-12-12,6.11,4.87,115,85,75,Headache,None,Improved,1
481,PT-00481,18,M,Kolkata Clinical Center,Phase III,ORX-505,Infectious Disease,Placebo,2024-07-08,2024-07-15,4.66,3.71,136,50,71,None,None,No Change,0
482,PT-00482,36,F,Fortis Mumbai,Phase III,ORX-404,Neurology,Placebo,2024-06-07,2024-07-05,8.87,8.12,134,83,48,Headache,None,Improved,1
483,PT-00483,57,F,Indore Medical Institute,Phase III,ORX-505,Infectious Disease,Low Dose,2023-06-28,2023-08-23,7.46,7.52,190,56,102,Headache,None,Worsened,0
484,PT-00484,40,M,Apollo Chennai,Phase I,ORX-404,Neurology,Low Dose,2023-11-30,2023-12-28,7.54,7.1,120,75,82,None,None,No Change,0
485,PT-00485,20,F,Kolkata Clinical Center,Phase II,ORX-505,Infectious Disease,Low Dose,2023-07-08,2023-09-02,8.1,7.33,107,76,95,None,None,Improved,1
486,PT-00486,36,F,NIMHANS Bengaluru,Phase II,ORX-303,Cardiology,Low Dose,2024-08-08,2024-08-22,7.63,6.57,141,90,103,Headache,Moderate,Worsened,0
487,PT-00487,42,F,NIMHANS Bengaluru,Phase III,ORX-404,Neurology,Placebo,2023-06-03,2023-07-29,8.0,7.69,151,73,88,None,None,No Change,0
488,PT-00488,41,F,PGI Chandigarh,Phase I,ORX-404,Neurology,Low Dose,2024-07-29,2024-10-27,7.12,6.81,132,80,81,None,None,Improved,1
489,PT-00489,70,M,Fortis Mumbai,Phase I,ORX-404,Neurology,High Dose,2023-04-09,2023-06-04,8.38,8.76,119,71,91,None,None,No Change,0
490,PT-00490,59,F,Fortis Mumbai,Phase III,ORX-303,Cardiology,Placebo,2023-05-05,2023-06-02,8.97,8.02,123,62,72,Fever,None,Worsened,0
491,PT-00491,60,M,Fortis Mumbai,Phase IV,ORX-303,Cardiology,Low Dose,2024-06-06,2024-08-01,6.64,6.82,124,85,61,None,None,No Change,0
492,PT-00492,46,M,Fortis Mumbai,Phase II,ORX-404,Neurology,Low Dose,2023-05-29,2023-06-12,3.61,3.04,98,96,88,Dizziness,None,No Change,0
493,PT-00493,52,F,Bhopal Research Hospital,Phase III,ORX-101,Oncology,Placebo,2023-08-22,2023-09-19,9.03,7.77,159,93,74,None,None,Improved,1
494,PT-00494,63,F,NIMHANS Bengaluru,Phase III,ORX-303,Cardiology,High Dose,2024-01-07,2024-04-06,5.87,4.73,117,75,63,None,None,Improved,1
495,PT-00495,64,M,Indore Medical Institute,Phase II,ORX-202,Diabetes,High Dose,2024-11-08,2024-12-06,6.89,6.81,117,60,81,Headache,None,Worsened,0
496,PT-00496,18,M,Bhopal Research Hospital,Phase II,ORX-101,Oncology,High Dose,2024-04-29,2024-07-28,7.12,5.49,163,92,79,Headache,None,Improved,1
497,PT-00497,65,M,AIIMS Delhi,Phase I,ORX-101,Oncology,High Dose,2024-02-04,2024-03-03,6.18,6.27,131,85,95,Headache,None,Improved,0
498,PT-00498,56,M,AIIMS Delhi,Phase I,ORX-101,Oncology,Placebo,2024-01-01,2024-01-29,7.55,5.66,110,80,79,None,None,Worsened,0
499,PT-00499,26,F,AIIMS Delhi,Phase III,ORX-606,Rheumatology,Low Dose,2024-08-28,2024-11-26,10.09,11.06,138,82,75,Headache,Moderate,Improved,0
500,PT-00500,29,F,Fortis Mumbai,Phase III,ORX-303,Cardiology,Low Dose,2023-08-21,2023-08-28,7.29,7.12,105,86,75,None,None,Improved,1
501,PT-00501,18,F,Indore Medical Institute,Phase II,ORX-101,Oncology,Low Dose,2023-05-20,2023-06-17,6.17,5.4,161,88,59,None,None,Improved,1
502,PT-00502,52,F,Kolkata Clinical Center,Phase IV,ORX-303,Cardiology,Placebo,2024-03-16,2024-04-13,5.34,5.92,119,80,96,Rash,None,No Change,0
503,PT-00503,24,M,NIMHANS Bengaluru,Phase III,ORX-404,Neurology,Placebo,2024-10-23,2024-12-18,5.52,4.6,146,63,45,None,None,No Change,0
504,PT-00504,37,M,Apollo Chennai,Phase III,ORX-505,Infectious Disease,High Dose,2024-09-19,2024-10-17,7.86,8.54,119,77,94,Headache,Moderate,Improved,0
505,PT-00505,18,F,Bhopal Research Hospital,Phase II,ORX-202,Diabetes,Placebo,2023-04-24,2023-06-19,6.73,6.51,136,75,78,None,None,No Change,0
506,PT-00506,18,F,Indore Medical Institute,Phase II,ORX-202,Diabetes,Placebo,2024-07-01,2024-07-08,6.41,6.42,110,82,84,None,None,Improved,0
507,PT-00507,39,F,Kolkata Clinical Center,Phase I,ORX-606,Rheumatology,Placebo,2023-04-03,2023-04-17,7.4,6.14,124,89,80,None,None,Improved,1
508,PT-00508,35,F,Kolkata Clinical Center,Phase II,ORX-303,Cardiology,Low Dose,2023-02-02,2023-03-02,7.47,7.71,91,95,73,Headache,None,Improved,0
509,PT-00509,51,F,Bhopal Research Hospital,Phase III,ORX-505,Infectious Disease,Low Dose,2023-07-16,2023-08-13,8.64,7.0,115,78,67,Rash,None,No Change,0
510,PT-00510,72,M,Kolkata Clinical Center,Phase II,ORX-202,Diabetes,High Dose,2023-02-04,2023-02-18,6.17,5.27,131,67,72,Headache,None,Improved,1
511,PT-00511,50,M,Fortis Mumbai,Phase III,ORX-303,Cardiology,Placebo,2023-02-13,2023-05-14,6.8,6.32,118,63,82,None,None,Improved,1
512,PT-00512,73,F,Indore Medical Institute,Phase II,ORX-606,Rheumatology,Placebo,2023-04-26,2023-05-10,7.22,7.02,140,66,101,None,None,No Change,0
513,PT-00513,48,M,Bhopal Research Hospital,Phase III,ORX-404,Neurology,High Dose,2023-01-10,2023-01-17,9.16,8.1,160,91,85,Headache,Mild,No Change,0
514,PT-00514,48,M,Bhopal Research Hospital,Phase II,ORX-202,Diabetes,Placebo,2023-04-04,2023-07-03,6.9,7.58,130,58,62,Fever,Mild,Improved,0
515,PT-00515,42,M,AIIMS Delhi,Phase I,ORX-606,Rheumatology,Low Dose,2023-04-20,2023-05-04,7.57,7.12,149,58,80,None,None,Improved,1
516,PT-00516,18,F,Kolkata Clinical Center,Phase III,ORX-606,Rheumatology,Placebo,2024-01-22,2024-02-19,8.11,7.63,135,71,95,None,None,No Change,0
517,PT-00517,61,M,Kolkata Clinical Center,Phase III,ORX-505,Infectious Disease,Placebo,2024-05-16,2024-05-30,7.9,7.38,138,73,89,None,None,No Change,0
518,PT-00518,71,F,Fortis Mumbai,Phase III,ORX-505,Infectious Disease,High Dose,2024-07-21,2024-08-04,8.48,7.43,134,66,86,None,None,Improved,1
519,PT-00519,52,F,PGI Chandigarh,Phase III,ORX-404,Neurology,Placebo,2024-10-15,2025-01-13,4.96,3.51,122,78,61,None,None,Improved,1
520,PT-00520,51,M,PGI Chandigarh,Phase III,ORX-505,Infectious Disease,Placebo,2023-03-06,2023-06-04,7.5,6.93,114,94,101,None,None,No Change,0
521,PT-00521,37,F,AIIMS Delhi,Phase III,ORX-505,Infectious Disease,Placebo,2024-02-24,2024-03-23,6.47,6.51,121,80,88,None,None,Improved,0
522,PT-00522,18,M,AIIMS Delhi,Phase I,ORX-202,Diabetes,High Dose,2023-07-26,2023-08-02,8.78,8.45,120,80,77,None,None,Improved,1
523,PT-00523,18,F,Fortis Mumbai,Phase III,ORX-101,Oncology,Low Dose,2024-09-12,2024-09-19,8.99,8.63,135,93,63,Dizziness,Mild,Improved,1
524,PT-00524,52,M,Indore Medical Institute,Phase III,ORX-303,Cardiology,Low Dose,2024-03-01,2024-03-29,6.88,7.24,90,80,69,None,None,No Change,0
525,PT-00525,51,F,Bhopal Research Hospital,Phase III,ORX-303,Cardiology,Placebo,2023-08-10,2023-11-08,7.76,6.73,115,80,65,Headache,None,Improved,1
526,PT-00526,58,M,Apollo Chennai,Phase II,ORX-505,Infectious Disease,Low Dose,2023-07-03,2023-10-01,6.76,3.74,121,69,55,None,None,No Change,0
527,PT-00527,25,M,PGI Chandigarh,Phase III,ORX-606,Rheumatology,Low Dose,2024-11-12,2025-01-07,7.33,8.13,133,74,84,None,None,Worsened,0
528,PT-00528,37,M,PGI Chandigarh,Phase III,ORX-606,Rheumatology,Placebo,2024-09-06,2024-11-01,6.37,4.93,96,77,80,Fatigue,Mild,Worsened,0
529,PT-00529,43,F,NIMHANS Bengaluru,Phase III,ORX-606,Rheumatology,Low Dose,2023-11-28,2024-02-26,6.7,5.45,138,66,88,None,None,Improved,1
530,PT-00530,28,F,Fortis Mumbai,Phase III,ORX-303,Cardiology,High Dose,2024-04-03,2024-05-29,6.3,4.58,118,93,85,None,None,Improved,1
531,PT-00531,60,F,AIIMS Delhi,Phase III,ORX-303,Cardiology,Placebo,2023-08-16,2023-08-30,7.83,6.43,122,72,96,None,None,Worsened,0
532,PT-00532,25,F,AIIMS Delhi,Phase IV,ORX-101,Oncology,Placebo,2023-12-31,2024-01-14,8.27,8.68,160,77,87,None,None,Improved,0
533,PT-00533,81,M,Fortis Mumbai,Phase II,ORX-101,Oncology,Low Dose,2024-08-05,2024-08-19,6.46,4.68,94,90,51,Headache,Mild,No Change,0
534,PT-00534,39,M,Bhopal Research Hospital,Phase III,ORX-505,Infectious Disease,Low Dose,2023-02-08,2023-05-09,7.72,7.49,135,84,95,Headache,Moderate,Improved,1
535,PT-00535,29,F,NIMHANS Bengaluru,Phase II,ORX-404,Neurology,High Dose,2023-05-04,2023-05-18,6.39,5.29,142,92,84,Rash,Moderate,No Change,0
536,PT-00536,63,F,Indore Medical Institute,Phase I,ORX-303,Cardiology,Low Dose,2023-06-03,2023-07-01,5.79,6.89,155,90,102,None,None,Improved,0
537,PT-00537,18,M,NIMHANS Bengaluru,Phase III,ORX-404,Neurology,High Dose,2024-08-12,2024-11-10,6.57,5.51,140,69,88,None,None,Improved,1
538,PT-00538,66,F,PGI Chandigarh,Phase I,ORX-101,Oncology,Low Dose,2023-02-20,2023-05-21,8.03,7.89,110,71,95,None,None,Improved,1
539,PT-00539,57,F,AIIMS Delhi,Phase III,ORX-202,Diabetes,Low Dose,2023-07-22,2023-09-16,7.15,6.38,91,69,104,Nausea,Mild,Improved,1
540,PT-00540,24,M,Fortis Mumbai,Phase II,ORX-404,Neurology,Low Dose,2024-08-12,2024-08-19,7.43,7.93,105,84,91,None,None,Improved,0
541,PT-00541,45,F,PGI Chandigarh,Phase II,ORX-303,Cardiology,Low Dose,2023-01-25,2023-02-22,10.64,8.74,147,79,88,None,None,Improved,1
542,PT-00542,52,F,Kolkata Clinical Center,Phase III,ORX-101,Oncology,High Dose,2023-08-28,2023-09-11,6.32,6.13,94,89,82,None,None,No Change,0
543,PT-00543,55,M,Indore Medical Institute,Phase I,ORX-202,Diabetes,High Dose,2023-06-01,2023-06-29,8.47,8.4,130,71,68,Headache,None,Improved,1
544,PT-00544,63,F,PGI Chandigarh,Phase III,ORX-202,Diabetes,High Dose,2023-08-05,2023-08-19,8.92,8.31,128,71,94,Headache,None,Improved,1
545,PT-00545,55,M,Indore Medical Institute,Phase III,ORX-404,Neurology,Low Dose,2024-11-10,2025-02-08,9.53,8.34,121,84,87,None,None,Improved,1
546,PT-00546,41,F,Fortis Mumbai,Phase II,ORX-101,Oncology,Low Dose,2023-01-09,2023-01-16,6.15,,140,71,96,None,None,Improved,0
547,PT-00547,63,F,Indore Medical Institute,Phase IV,ORX-303,Cardiology,High Dose,2024-10-26,2024-12-21,7.36,7.03,137,71,78,None,None,Improved,1
548,PT-00548,18,M,Kolkata Clinical Center,Phase IV,ORX-505,Infectious Disease,Low Dose,2023-07-10,2023-07-24,8.25,6.45,155,78,75,None,None,Improved,1
549,PT-00549,34,M,Fortis Mumbai,Phase I,ORX-303,Cardiology,Low Dose,2023-06-10,2023-06-17,6.85,7.73,90,97,82,None,None,Improved,0
550,PT-00550,25,F,Fortis Mumbai,Phase II,ORX-101,Oncology,Low Dose,2024-02-01,2024-02-08,5.91,7.02,110,68,93,Dizziness,None,Worsened,0
551,PT-00551,50,F,AIIMS Delhi,Phase IV,ORX-101,Oncology,High Dose,2024-06-17,2024-09-15,6.07,5.87,109,95,92,Headache,None,Worsened,0
552,PT-00552,53,M,Fortis Mumbai,Phase III,ORX-505,Infectious Disease,Low Dose,2024-07-09,2024-07-23,7.63,8.82,127,67,84,None,None,Improved,0
553,PT-00553,78,M,Fortis Mumbai,Phase IV,ORX-606,Rheumatology,High Dose,2024-06-20,2024-07-04,5.98,5.26,135,81,64,Fatigue,Mild,Improved,1
554,PT-00554,62,M,Bhopal Research Hospital,Phase II,ORX-202,Diabetes,Low Dose,2023-05-30,2023-06-06,9.98,9.76,111,63,81,Fatigue,None,No Change,0
555,PT-00555,62,F,Fortis Mumbai,Phase II,ORX-202,Diabetes,High Dose,2023-04-20,2023-05-04,7.77,7.37,117,68,89,Headache,Mild,Improved,1
556,PT-00556,59,F,Apollo Chennai,Phase III,ORX-505,Infectious Disease,Placebo,2023-01-27,2023-02-24,5.35,6.38,138,98,59,Headache,None,Improved,0
557,PT-00557,23,F,PGI Chandigarh,Phase III,ORX-202,Diabetes,High Dose,2024-05-18,2024-07-13,7.02,7.07,160,90,74,None,None,Improved,0
558,PT-00558,28,M,Indore Medical Institute,Phase III,ORX-303,Cardiology,High Dose,2023-08-16,2023-08-30,8.68,7.41,157,78,100,None,None,No Change,0
559,PT-00559,55,F,Kolkata Clinical Center,Phase IV,ORX-606,Rheumatology,Low Dose,2024-04-13,2024-04-27,7.04,6.17,121,87,79,Headache,Mild,Improved,1
560,PT-00560,35,F,NIMHANS Bengaluru,Phase III,ORX-505,Infectious Disease,High Dose,2024-08-08,2024-11-06,7.0,6.67,90,87,64,Nausea,Mild,Improved,1
561,PT-00561,26,M,Kolkata Clinical Center,Phase III,ORX-404,Neurology,High Dose,2023-02-13,2023-02-27,5.18,3.16,103,73,105,None,None,Improved,1
562,PT-00562,36,M,Indore Medical Institute,Phase III,ORX-202,Diabetes,Placebo,2024-02-12,2024-03-11,7.41,7.37,130,81,61,None,None,No Change,0
563,PT-00563,68,M,Indore Medical Institute,Phase III,ORX-606,Rheumatology,Low Dose,2023-05-26,2023-07-21,9.37,7.45,109,78,64,None,None,No Change,0
564,PT-00564,53,M,AIIMS Delhi,Phase II,ORX-404,Neurology,Low Dose,2024-04-06,2024-04-13,6.33,7.87,149,84,92,Nausea,Mild,Improved,0
565,PT-00565,62,M,Bhopal Research Hospital,Phase IV,ORX-303,Cardiology,Low Dose,2024-10-26,2024-11-09,6.52,5.39,129,92,79,None,None,No Change,0
566,PT-00566,19,M,PGI Chandigarh,Phase III,ORX-101,Oncology,Low Dose,2024-01-29,2024-04-28,6.24,5.77,126,105,58,None,None,No Change,0
567,PT-00567,53,F,AIIMS Delhi,Phase I,ORX-303,Cardiology,Low Dose,2024-11-06,2024-11-20,8.99,10.63,120,87,85,None,None,Improved,0
568,PT-00568,48,M,Fortis Mumbai,Phase III,ORX-606,Rheumatology,High Dose,2024-04-01,2024-04-29,7.08,7.07,90,90,79,None,None,No Change,0
569,PT-00569,41,M,Indore Medical Institute,Phase IV,ORX-505,Infectious Disease,High Dose,2023-01-13,2023-03-10,9.66,8.65,120,105,66,None,None,Improved,1
570,PT-00570,36,M,Kolkata Clinical Center,Phase III,ORX-202,Diabetes,Placebo,2024-11-06,2025-01-01,7.02,7.38,131,66,70,None,None,Improved,0
571,PT-00571,35,M,Fortis Mumbai,Phase II,ORX-505,Infectious Disease,Low Dose,2023-08-01,2023-08-08,7.11,7.09,135,60,92,None,None,Improved,1
572,PT-00572,49,F,Indore Medical Institute,Phase I,ORX-606,Rheumatology,Low Dose,2024-09-09,2024-10-07,8.86,8.86,147,87,96,None,None,Improved,1
573,PT-00573,53,M,AIIMS Delhi,Phase III,ORX-202,Diabetes,High Dose,2024-09-17,2024-12-16,7.08,8.73,144,88,60,Nausea,Severe,No Change,0
574,PT-00574,24,F,Bhopal Research Hospital,Phase IV,ORX-303,Cardiology,Low Dose,2024-01-24,2024-01-31,7.55,7.28,116,83,100,Rash,None,No Change,0
575,PT-00575,56,F,Fortis Mumbai,Phase I,ORX-303,Cardiology,Low Dose,2024-06-21,2024-07-05,5.83,5.33,113,77,72,Nausea,None,No Change,0
576,PT-00576,37,M,Fortis Mumbai,Phase III,ORX-404,Neurology,Low Dose,2023-11-21,2023-12-19,5.69,5.18,117,50,106,Fever,None,Improved,1
577,PT-00577,62,M,Kolkata Clinical Center,Phase III,ORX-505,Infectious Disease,High Dose,2024-05-24,2024-07-19,6.75,,106,102,104,Fatigue,None,No Change,0
578,PT-00578,47,F,Indore Medical Institute,Phase IV,ORX-101,Oncology,Placebo,2024-10-02,2024-10-09,8.43,8.19,103,77,79,None,None,No Change,0
579,PT-00579,37,F,PGI Chandigarh,Phase III,ORX-303,Cardiology,Low Dose,2024-10-14,2024-10-28,6.94,6.46,126,82,63,None,None,Improved,1
580,PT-00580,33,F,Bhopal Research Hospital,Phase II,ORX-303,Cardiology,Low Dose,2024-07-17,2024-08-14,5.66,6.14,90,95,97,None,None,No Change,0
581,PT-00581,40,F,Indore Medical Institute,Phase II,ORX-202,Diabetes,Placebo,2023-12-13,2024-02-07,4.08,3.35,126,69,70,Rash,Mild,Worsened,0
582,PT-00582,69,F,Kolkata Clinical Center,Phase II,ORX-505,Infectious Disease,High Dose,2024-04-18,2024-06-13,8.0,6.77,99,78,75,None,None,Worsened,0
583,PT-00583,52,F,PGI Chandigarh,Phase III,ORX-505,Infectious Disease,Low Dose,2023-08-02,2023-10-31,6.56,6.62,162,91,77,Rash,Moderate,No Change,0
584,PT-00584,42,F,AIIMS Delhi,Phase I,ORX-303,Cardiology,High Dose,2023-12-14,2024-02-08,6.77,7.43,116,82,78,Rash,Mild,No Change,0
585,PT-00585,36,F,Bhopal Research Hospital,Phase II,ORX-303,Cardiology,High Dose,2023-11-19,2023-11-26,5.55,5.44,126,88,70,None,None,Improved,1
586,PT-00586,64,M,Fortis Mumbai,Phase II,ORX-202,Diabetes,Low Dose,2023-06-29,2023-07-06,6.15,7.29,96,87,84,None,None,Improved,0
587,PT-00587,32,M,Kolkata Clinical Center,Phase IV,ORX-505,Infectious Disease,Placebo,2024-05-09,2024-08-07,7.71,8.46,90,88,45,None,None,Improved,0
588,PT-00588,29,F,Fortis Mumbai,Phase III,ORX-303,Cardiology,Placebo,2023-04-11,2023-07-10,9.15,8.23,106,79,106,None,None,No Change,0
589,PT-00589,18,M,Bhopal Research Hospital,Phase III,ORX-101,Oncology,Low Dose,2023-02-15,2023-05-16,5.94,6.89,161,80,60,None,None,Worsened,0
590,PT-00590,78,M,Fortis Mumbai,Phase I,ORX-101,Oncology,Low Dose,2023-11-16,2023-11-30,9.11,9.32,113,81,75,None,None,Improved,0
591,PT-00591,50,F,Kolkata Clinical Center,Phase III,ORX-606,Rheumatology,Placebo,2023-06-02,2023-06-16,8.94,9.33,108,98,82,None,None,Improved,0
592,PT-00592,55,M,PGI Chandigarh,Phase II,ORX-505,Infectious Disease,Low Dose,2023-05-25,2023-06-22,8.96,7.56,127,75,56,None,None,No Change,0
593,PT-00593,50,F,PGI Chandigarh,Phase III,ORX-505,Infectious Disease,Low Dose,2023-05-14,2023-05-21,10.21,8.16,127,89,79,Headache,None,Improved,1
594,PT-00594,43,M,NIMHANS Bengaluru,Phase I,ORX-202,Diabetes,High Dose,2024-08-29,2024-10-24,5.64,5.45,114,55,94,None,None,No Change,0
595,PT-00595,60,M,Bhopal Research Hospital,Phase III,ORX-404,Neurology,Low Dose,2023-04-06,2023-06-01,7.26,7.07,147,84,90,None,None,Improved,1
596,PT-00596,40,F,Apollo Chennai,Phase III,ORX-202,Diabetes,High Dose,2024-09-23,2024-10-21,8.77,8.66,131,66,82,None,None,Worsened,0
597,PT-00597,31,F,PGI Chandigarh,Phase III,ORX-404,Neurology,Low Dose,2023-03-08,2023-05-03,6.43,5.3,108,107,96,None,None,Improved,1
598,PT-00598,75,M,PGI Chandigarh,Phase II,ORX-505,Infectious Disease,Low Dose,2024-06-04,2024-06-11,5.73,5.4,104,73,65,Headache,None,Improved,1
599,PT-00599,64,M,Kolkata Clinical Center,Phase III,ORX-404,Neurology,Low Dose,2023-09-02,2023-12-01,6.72,7.29,138,109,57,None,None,Improved,0
600,PT-00600,65,F,PGI Chandigarh,Phase II,ORX-202,Diabetes,High Dose,2024-08-28,2024-10-23,8.58,7.3,146,86,74,None,None,No Change,0
601,PT-00601,31,F,Apollo Chennai,Phase III,ORX-202,Diabetes,High Dose,2023-03-21,2023-06-19,6.34,7.78,128,91,66,None,None,No Change,0
602,PT-00602,32,F,Bhopal Research Hospital,Phase II,ORX-404,Neurology,Placebo,2024-02-20,2024-02-27,8.5,6.88,120,82,79,Headache,Mild,No Change,0
603,PT-00603,42,F,Indore Medical Institute,Phase II,ORX-101,Oncology,Placebo,2023-05-23,2023-08-21,7.67,7.9,141,70,74,Nausea,None,Worsened,0
604,PT-00604,64,M,Kolkata Clinical Center,Phase III,ORX-505,Infectious Disease,Placebo,2024-09-22,2024-12-21,8.27,6.64,134,58,78,None,None,Improved,1
605,PT-00605,75,F,Fortis Mumbai,Phase II,ORX-404,Neurology,High Dose,2023-12-19,2023-12-26,6.06,4.91,141,63,69,Nausea,None,No Change,0
606,PT-00606,54,M,Indore Medical Institute,Phase IV,ORX-303,Cardiology,High Dose,2023-02-24,2023-03-03,6.44,5.83,141,87,81,Rash,None,No Change,0
607,PT-00607,39,F,Apollo Chennai,Phase IV,ORX-404,Neurology,High Dose,2024-02-08,2024-03-07,7.64,7.13,136,76,75,None,None,No Change,0
608,PT-00608,29,F,AIIMS Delhi,Phase III,ORX-404,Neurology,Placebo,2024-07-22,2024-09-16,7.16,6.03,107,85,80,None,None,No Change,0
609,PT-00609,57,F,AIIMS Delhi,Phase II,ORX-202,Diabetes,Placebo,2024-10-25,2024-11-01,6.68,6.65,137,87,66,Fatigue,Mild,Improved,1
610,PT-00610,47,M,NIMHANS Bengaluru,Phase I,ORX-404,Neurology,High Dose,2024-09-10,2024-11-05,7.64,7.24,90,83,108,None,None,No Change,0
611,PT-00611,39,F,Kolkata Clinical Center,Phase III,ORX-404,Neurology,Low Dose,2023-07-10,2023-09-04,6.33,6.26,133,96,60,Nausea,Moderate,No Change,0
612,PT-00612,56,M,Fortis Mumbai,Phase III,ORX-404,Neurology,High Dose,2024-08-13,2024-09-10,7.91,7.38,134,94,90,None,None,Improved,1
613,PT-00613,26,F,Bhopal Research Hospital,Phase III,ORX-505,Infectious Disease,Low Dose,2023-03-23,2023-04-06,8.18,7.73,129,82,75,None,None,No Change,0
614,PT-00614,64,F,Bhopal Research Hospital,Phase III,ORX-505,Infectious Disease,High Dose,2023-04-01,2023-04-15,7.1,5.69,120,84,95,Headache,Severe,Improved,1
615,PT-00615,54,M,Fortis Mumbai,Phase III,ORX-505,Infectious Disease,Placebo,2023-12-18,2024-03-17,6.18,8.02,132,97,75,None,None,No Change,0
616,PT-00616,53,F,PGI Chandigarh,Phase III,ORX-404,Neurology,Low Dose,2023-10-29,2023-11-26,8.21,8.9,147,92,73,Headache,Mild,Improved,0
617,PT-00617,35,F,Fortis Mumbai,Phase III,ORX-101,Oncology,Low Dose,2024-08-15,2024-08-29,7.6,8.04,123,94,98,Nausea,None,No Change,0
618,PT-00618,30,M,Bhopal Research Hospital,Phase II,ORX-202,Diabetes,Low Dose,2023-10-12,2023-11-09,6.2,5.67,133,75,96,None,None,Improved,1
619,PT-00619,51,F,Bhopal Research Hospital,Phase I,ORX-505,Infectious Disease,Placebo,2024-08-28,2024-09-11,7.25,5.56,104,85,48,None,None,No Change,0
620,PT-00620,61,M,Apollo Chennai,Phase II,ORX-404,Neurology,Placebo,2024-06-24,2024-07-01,7.01,9.53,169,79,76,None,None,Improved,0
621,PT-00621,60,M,AIIMS Delhi,Phase III,ORX-404,Neurology,High Dose,2024-02-27,2024-04-23,9.24,7.37,95,74,86,None,None,Improved,1
622,PT-00622,52,M,PGI Chandigarh,Phase II,ORX-101,Oncology,Low Dose,2023-04-29,2023-05-06,8.48,7.0,90,92,66,None,None,Improved,1
623,PT-00623,18,F,Apollo Chennai,Phase III,ORX-404,Neurology,High Dose,2024-02-04,2024-03-31,7.37,7.69,125,76,75,None,None,Improved,0
624,PT-00624,39,F,Kolkata Clinical Center,Phase I,ORX-404,Neurology,High Dose,2024-06-26,2024-07-03,5.58,4.54,137,85,80,None,None,Improved,1
625,PT-00625,29,F,NIMHANS Bengaluru,Phase IV,ORX-505,Infectious Disease,High Dose,2023-10-07,2023-11-04,6.98,4.62,131,99,57,Rash,None,Improved,1
626,PT-00626,35,F,Apollo Chennai,Phase III,ORX-606,Rheumatology,High Dose,2023-07-19,2023-10-17,7.59,8.32,119,73,50,Headache,None,Improved,0
627,PT-00627,46,M,Bhopal Research Hospital,Phase III,ORX-101,Oncology,Low Dose,2024-06-21,2024-06-28,9.65,9.5,127,85,77,None,None,No Change,0
628,PT-00628,31,F,Indore Medical Institute,Phase II,ORX-101,Oncology,Low Dose,2023-02-28,2023-05-29,8.19,7.99,128,70,96,Rash,Severe,No Change,0
629,PT-00629,55,M,Bhopal Research Hospital,Phase III,ORX-101,Oncology,High Dose,2023-05-14,2023-07-09,6.54,7.04,119,72,67,Fatigue,Mild,No Change,0
630,PT-00630,18,M,AIIMS Delhi,Phase IV,ORX-303,Cardiology,Placebo,2024-11-07,2024-11-14,7.77,5.72,105,57,76,Dizziness,None,No Change,0
631,PT-00631,42,F,PGI Chandigarh,Phase III,ORX-303,Cardiology,Placebo,2023-03-17,2023-04-14,6.81,5.47,106,87,70,None,None,No Change,0
632,PT-00632,50,F,Fortis Mumbai,Phase IV,ORX-303,Cardiology,Placebo,2023-03-13,2023-05-08,6.14,5.9,151,89,72,None,None,Worsened,0
633,PT-00633,49,F,Kolkata Clinical Center,Phase II,ORX-101,Oncology,Placebo,2024-03-17,2024-03-31,6.91,6.52,122,80,80,None,None,No Change,0
634,PT-00634,29,F,Bhopal Research Hospital,Phase III,ORX-101,Oncology,Placebo,2024-08-08,2024-09-05,5.98,4.33,99,67,80,None,None,No Change,0
635,PT-00635,30,F,Indore Medical Institute,Phase I,ORX-101,Oncology,High Dose,2023-09-30,2023-10-14,7.82,7.45,92,89,89,Fatigue,Mild,No Change,0
636,PT-00636,29,F,NIMHANS Bengaluru,Phase III,ORX-606,Rheumatology,High Dose,2023-03-13,2023-06-11,7.7,6.53,129,66,52,None,None,Improved,1
637,PT-00637,38,F,PGI Chandigarh,Phase I,ORX-303,Cardiology,High Dose,2024-02-15,2024-02-22,7.05,6.29,106,77,81,Dizziness,None,No Change,0
638,PT-00638,44,F,Kolkata Clinical Center,Phase I,ORX-303,Cardiology,Low Dose,2023-06-30,2023-09-28,7.42,6.42,149,67,84,None,None,Improved,1
639,PT-00639,63,M,NIMHANS Bengaluru,Phase II,ORX-101,Oncology,Low Dose,2024-01-03,2024-02-28,7.78,7.19,118,94,58,Nausea,Mild,Improved,1
640,PT-00640,29,M,Indore Medical Institute,Phase I,ORX-606,Rheumatology,High Dose,2023-09-02,2023-10-28,6.72,7.44,134,70,73,Rash,Mild,Improved,0
641,PT-00641,35,F,Kolkata Clinical Center,Phase III,ORX-101,Oncology,Placebo,2023-02-27,2023-03-27,6.35,6.83,103,101,89,None,None,No Change,0
642,PT-00642,62,M,Kolkata Clinical Center,Phase II,ORX-606,Rheumatology,High Dose,2024-07-03,2024-07-17,6.64,6.11,102,75,84,None,None,No Change,0
643,PT-00643,65,M,AIIMS Delhi,Phase I,ORX-404,Neurology,High Dose,2024-04-27,2024-07-26,5.87,5.14,125,65,86,Headache,None,Improved,1
644,PT-00644,33,M,Fortis Mumbai,Phase III,ORX-101,Oncology,Low Dose,2023-06-24,2023-09-22,6.97,6.16,113,81,74,Rash,None,Improved,1
645,PT-00645,39,M,Apollo Chennai,Phase I,ORX-404,Neurology,Low Dose,2024-11-25,2025-01-20,6.33,6.21,157,83,91,Fever,Mild,Improved,1
646,PT-00646,22,M,Apollo Chennai,Phase II,ORX-101,Oncology,Low Dose,2023-12-10,2023-12-17,7.39,6.0,101,73,94,None,None,Improved,1
647,PT-00647,60,F,PGI Chandigarh,Phase II,ORX-505,Infectious Disease,Placebo,2023-09-07,2023-12-06,7.49,5.71,124,85,80,None,None,Improved,1
648,PT-00648,18,F,Indore Medical Institute,Phase III,ORX-404,Neurology,Placebo,2023-01-08,2023-01-22,6.13,5.67,137,55,75,Headache,Mild,Worsened,0
649,PT-00649,47,F,Kolkata Clinical Center,Phase III,ORX-606,Rheumatology,Placebo,2023-05-27,2023-06-24,8.22,8.44,138,72,51,None,None,Improved,0
650,PT-00650,38,M,Indore Medical Institute,Phase III,ORX-505,Infectious Disease,Placebo,2024-05-26,2024-08-24,8.4,9.26,140,87,83,Nausea,Mild,Worsened,0
651,PT-00651,36,F,Apollo Chennai,Phase III,ORX-202,Diabetes,Placebo,2024-06-26,2024-07-03,7.04,8.15,111,101,73,Fatigue,Severe,No Change,0
652,PT-00652,66,M,Apollo Chennai,Phase III,ORX-303,Cardiology,Placebo,2023-04-26,2023-05-10,5.51,5.64,114,65,81,Fever,None,No Change,0
653,PT-00653,61,M,Indore Medical Institute,Phase II,ORX-101,Oncology,Low Dose,2023-10-19,2023-11-02,6.19,4.44,126,80,85,None,None,Improved,1
654,PT-00654,60,F,Indore Medical Institute,Phase I,ORX-505,Infectious Disease,Placebo,2023-01-30,2023-03-27,7.13,8.4,132,77,55,None,None,Improved,0
655,PT-00655,40,M,PGI Chandigarh,Phase III,ORX-404,Neurology,Placebo,2024-11-24,2024-12-22,6.8,7.26,136,67,80,None,None,Improved,0
656,PT-00656,55,M,NIMHANS Bengaluru,Phase I,ORX-202,Diabetes,Low Dose,2023-08-14,2023-08-21,9.03,9.43,141,82,83,None,None,Improved,0
657,PT-00657,64,F,Kolkata Clinical Center,Phase I,ORX-202,Diabetes,Low Dose,2023-05-20,2023-07-15,5.6,4.89,114,86,95,Nausea,Severe,No Change,0
658,PT-00658,35,M,Indore Medical Institute,Phase II,ORX-606,Rheumatology,Low Dose,2023-10-15,2023-10-29,4.33,3.56,144,88,83,None,None,Improved,1
659,PT-00659,40,F,PGI Chandigarh,Phase II,ORX-202,Diabetes,High Dose,2024-09-10,2024-09-24,5.67,5.73,112,108,85,Nausea,Mild,No Change,0
660,PT-00660,35,M,Apollo Chennai,Phase III,ORX-101,Oncology,Low Dose,2024-06-18,2024-08-13,6.47,5.98,123,95,80,None,None,Worsened,0
661,PT-00661,33,F,Fortis Mumbai,Phase III,ORX-101,Oncology,High Dose,2023-09-10,2023-09-24,9.47,9.11,141,74,83,Nausea,Moderate,Improved,1
662,PT-00662,49,M,Indore Medical Institute,Phase IV,ORX-404,Neurology,High Dose,2023-02-11,2023-04-08,4.93,6.35,151,77,62,None,None,No Change,0
663,PT-00663,50,F,Kolkata Clinical Center,Phase III,ORX-606,Rheumatology,High Dose,2024-04-08,2024-06-03,7.3,7.22,131,88,98,Nausea,None,Improved,1
664,PT-00664,54,F,AIIMS Delhi,Phase IV,ORX-303,Cardiology,Placebo,2024-10-25,2024-11-01,5.94,6.77,157,119,62,Nausea,None,Improved,0
665,PT-00665,48,F,Indore Medical Institute,Phase IV,ORX-404,Neurology,Low Dose,2023-05-22,2023-07-17,4.7,4.8,118,105,67,Fatigue,Mild,Improved,0
666,PT-00666,18,M,Bhopal Research Hospital,Phase IV,ORX-404,Neurology,High Dose,2023-12-07,2024-03-06,6.63,4.46,141,57,78,None,None,Improved,1
667,PT-00667,18,F,Apollo Chennai,Phase III,ORX-606,Rheumatology,Placebo,2023-12-10,2023-12-17,6.82,7.89,134,71,77,Fatigue,None,Improved,0
668,PT-00668,45,M,PGI Chandigarh,Phase I,ORX-404,Neurology,Low Dose,2024-01-10,2024-02-07,7.77,6.14,138,50,69,Nausea,None,Improved,1
669,PT-00669,37,M,PGI Chandigarh,Phase I,ORX-202,Diabetes,Low Dose,2024-10-26,2024-12-21,7.96,7.58,102,70,80,Headache,Moderate,No Change,0
670,PT-00670,43,M,Apollo Chennai,Phase III,ORX-303,Cardiology,Low Dose,2023-10-01,2023-12-30,6.51,5.67,140,75,76,None,None,No Change,0
671,PT-00671,79,M,Kolkata Clinical Center,Phase II,ORX-404,Neurology,Low Dose,2023-05-06,2023-07-01,5.49,3.42,142,73,73,Headache,None,No Change,0
672,PT-00672,32,F,PGI Chandigarh,Phase III,ORX-606,Rheumatology,High Dose,2023-03-09,2023-03-23,6.89,7.93,142,92,58,None,None,Worsened,0
673,PT-00673,26,M,AIIMS Delhi,Phase II,ORX-303,Cardiology,High Dose,2023-03-20,2023-03-27,3.79,2.66,145,88,74,None,None,Improved,1
674,PT-00674,44,M,Apollo Chennai,Phase III,ORX-505,Infectious Disease,High Dose,2023-01-24,2023-02-21,6.37,6.16,141,62,82,Headache,Moderate,Improved,1
675,PT-00675,59,F,Kolkata Clinical Center,Phase II,ORX-606,Rheumatology,Low Dose,2023-10-26,2023-11-09,6.7,6.93,178,80,83,Fatigue,None,Improved,0
676,PT-00676,33,F,PGI Chandigarh,Phase III,ORX-606,Rheumatology,Low Dose,2023-12-01,2024-01-26,7.42,7.43,131,69,80,Headache,Moderate,No Change,0
677,PT-00677,68,F,AIIMS Delhi,Phase III,ORX-303,Cardiology,Placebo,2023-09-24,2023-10-08,7.74,8.2,123,90,81,Fever,Mild,Improved,0
678,PT-00678,29,M,Fortis Mumbai,Phase I,ORX-404,Neurology,High Dose,2024-09-25,2024-10-09,7.58,6.29,116,84,82,None,None,No Change,0
679,PT-00679,25,M,AIIMS Delhi,Phase III,ORX-202,Diabetes,Placebo,2023-02-12,2023-03-12,8.46,8.58,115,63,75,None,None,No Change,0
680,PT-00680,37,F,Indore Medical Institute,Phase II,ORX-606,Rheumatology,Low Dose,2023-12-19,2024-01-02,7.34,6.61,91,77,73,None,None,Improved,1
681,PT-00681,55,M,Bhopal Research Hospital,Phase III,ORX-101,Oncology,Low Dose,2024-05-26,2024-06-09,6.36,7.47,93,97,74,Dizziness,None,Worsened,0
682,PT-00682,58,F,Fortis Mumbai,Phase III,ORX-404,Neurology,High Dose,2024-08-10,2024-08-24,7.3,7.92,121,68,97,Headache,Moderate,No Change,0
683,PT-00683,43,F,Kolkata Clinical Center,Phase III,ORX-101,Oncology,Placebo,2024-07-18,2024-07-25,7.47,8.18,109,89,69,None,None,Improved,0
684,PT-00684,42,M,Bhopal Research Hospital,Phase III,ORX-303,Cardiology,Placebo,2024-10-18,2024-11-01,7.29,5.54,113,98,90,None,None,No Change,0
685,PT-00685,43,F,Bhopal Research Hospital,Phase II,ORX-505,Infectious Disease,High Dose,2024-11-24,2024-12-01,7.49,,152,79,81,None,None,Worsened,0
686,PT-00686,63,F,Indore Medical Institute,Phase II,ORX-606,Rheumatology,Low Dose,2023-06-01,2023-07-27,6.27,7.27,100,101,72,None,None,Improved,0
687,PT-00687,41,F,Fortis Mumbai,Phase II,ORX-404,Neurology,High Dose,2023-03-31,2023-04-14,4.93,4.12,109,74,76,None,None,No Change,0
688,PT-00688,60,F,Fortis Mumbai,Phase III,ORX-202,Diabetes,High Dose,2024-03-10,2024-05-05,7.45,7.33,108,71,103,Nausea,None,Improved,1
689,PT-00689,33,M,PGI Chandigarh,Phase II,ORX-101,Oncology,High Dose,2024-08-27,2024-10-22,9.19,8.57,128,94,95,None,None,Improved,1
690,PT-00690,43,F,Kolkata Clinical Center,Phase III,ORX-606,Rheumatology,Low Dose,2023-05-21,2023-06-04,6.73,6.28,134,92,78,None,None,Improved,1
691,PT-00691,54,F,Fortis Mumbai,Phase I,ORX-505,Infectious Disease,Low Dose,2024-07-26,2024-09-20,9.17,9.11,133,63,45,Rash,None,Improved,1
692,PT-00692,51,F,Kolkata Clinical Center,Phase IV,ORX-101,Oncology,High Dose,2023-10-22,2023-12-17,7.09,6.22,132,81,93,Fatigue,Mild,Improved,1
693,PT-00693,46,M,Fortis Mumbai,Phase I,ORX-404,Neurology,High Dose,2023-03-10,2023-06-08,6.3,6.79,124,88,71,Nausea,Mild,No Change,0
694,PT-00694,34,F,Kolkata Clinical Center,Phase III,ORX-606,Rheumatology,High Dose,2024-01-18,2024-04-17,7.3,6.91,136,78,52,None,None,No Change,0
695,PT-00695,38,F,Indore Medical Institute,Phase II,ORX-202,Diabetes,Low Dose,2023-05-19,2023-06-16,8.15,7.48,123,93,68,None,None,Improved,1
696,PT-00696,20,F,PGI Chandigarh,Phase III,ORX-101,Oncology,Placebo,2024-06-26,2024-07-03,7.01,6.17,110,79,84,Headache,None,Improved,1
697,PT-00697,44,M,AIIMS Delhi,Phase III,ORX-505,Infectious Disease,Low Dose,2023-11-20,2023-12-18,7.57,8.8,121,85,70,Headache,None,Improved,0
698,PT-00698,31,F,Indore Medical Institute,Phase III,ORX-202,Diabetes,Low Dose,2024-01-17,2024-03-13,6.5,5.67,134,110,67,Dizziness,None,Improved,1
699,PT-00699,38,M,Apollo Chennai,Phase II,ORX-202,Diabetes,High Dose,2024-07-26,2024-10-24,7.12,7.08,132,97,45,Dizziness,Moderate,No Change,0
700,PT-00700,18,M,Bhopal Research Hospital,Phase III,ORX-101,Oncology,High Dose,2023-01-18,2023-03-15,6.6,7.19,99,50,85,Headache,None,Improved,0
701,PT-00701,48,F,PGI Chandigarh,Phase IV,ORX-202,Diabetes,High Dose,2023-01-30,2023-02-06,5.89,4.6,110,83,69,Fatigue,None,Improved,1
702,PT-00702,52,M,Apollo Chennai,Phase II,ORX-202,Diabetes,High Dose,2024-03-11,2024-03-18,3.77,2.6,107,78,70,Headache,Mild,Improved,1
703,PT-00703,57,M,Indore Medical Institute,Phase II,ORX-606,Rheumatology,Low Dose,2023-03-02,2023-04-27,4.97,4.61,138,104,71,None,None,Improved,1
704,PT-00704,50,M,Indore Medical Institute,Phase II,ORX-101,Oncology,High Dose,2024-09-08,2024-09-22,5.04,2.48,143,81,94,None,None,No Change,0
705,PT-00705,23,F,AIIMS Delhi,Phase I,ORX-606,Rheumatology,High Dose,2024-08-16,2024-09-13,7.82,9.11,135,85,78,Fatigue,Mild,Improved,0
706,PT-00706,19,M,Bhopal Research Hospital,Phase III,ORX-101,Oncology,High Dose,2023-01-15,2023-04-15,8.83,7.88,137,63,61,None,None,Improved,1
707,PT-00707,67,F,Indore Medical Institute,Phase II,ORX-606,Rheumatology,Placebo,2023-08-08,2023-11-06,6.78,7.69,126,59,90,None,None,Worsened,0
708,PT-00708,35,M,Bhopal Research Hospital,Phase III,ORX-202,Diabetes,High Dose,2024-01-24,2024-03-20,8.04,7.66,100,83,108,None,None,Improved,1
709,PT-00709,52,M,PGI Chandigarh,Phase III,ORX-101,Oncology,Low Dose,2024-06-16,2024-06-30,7.13,7.7,131,84,62,None,None,Improved,0
710,PT-00710,48,F,Indore Medical Institute,Phase III,ORX-101,Oncology,Low Dose,2023-04-29,2023-06-24,8.44,7.29,153,80,65,Nausea,None,Improved,1
711,PT-00711,60,F,NIMHANS Bengaluru,Phase II,ORX-303,Cardiology,High Dose,2024-03-14,2024-03-28,6.86,7.14,122,81,84,Fatigue,Moderate,Worsened,0
712,PT-00712,49,F,Kolkata Clinical Center,Phase II,ORX-606,Rheumatology,Placebo,2024-03-24,2024-06-22,4.81,3.4,144,80,70,None,None,No Change,0
713,PT-00713,23,M,Bhopal Research Hospital,Phase II,ORX-606,Rheumatology,High Dose,2023-06-22,2023-06-29,5.9,3.68,126,74,64,None,None,Improved,1
714,PT-00714,43,M,NIMHANS Bengaluru,Phase III,ORX-101,Oncology,Placebo,2024-03-10,2024-05-05,7.64,9.12,100,95,91,Headache,Mild,Improved,0
715,PT-00715,32,F,NIMHANS Bengaluru,Phase III,ORX-303,Cardiology,Low Dose,2024-09-09,2024-11-04,7.44,6.63,131,100,86,None,None,Worsened,0
716,PT-00716,53,M,Bhopal Research Hospital,Phase III,ORX-101,Oncology,Placebo,2024-05-24,2024-06-07,6.68,4.95,124,96,56,None,None,No Change,0
717,PT-00717,28,M,Bhopal Research Hospital,Phase III,ORX-404,Neurology,High Dose,2023-07-03,2023-08-28,7.35,6.07,113,76,58,None,None,No Change,0
718,PT-00718,29,F,Bhopal Research Hospital,Phase III,ORX-101,Oncology,High Dose,2024-06-16,2024-08-11,8.04,6.47,99,74,88,None,None,No Change,0
719,PT-00719,41,F,Fortis Mumbai,Phase III,ORX-505,Infectious Disease,Low Dose,2024-07-07,2024-10-05,6.64,6.28,96,87,83,Headache,Severe,Improved,1
720,PT-00720,38,M,PGI Chandigarh,Phase II,ORX-404,Neurology,Low Dose,2023-02-06,2023-02-13,8.41,6.99,148,83,73,Nausea,Mild,Improved,1
721,PT-00721,44,M,AIIMS Delhi,Phase III,ORX-303,Cardiology,High Dose,2024-05-14,2024-05-21,7.07,7.77,108,72,92,None,None,No Change,0
722,PT-00722,35,F,AIIMS Delhi,Phase III,ORX-505,Infectious Disease,Placebo,2023-09-27,2023-11-22,8.28,9.41,120,90,61,None,None,No Change,0
723,PT-00723,57,F,Fortis Mumbai,Phase III,ORX-303,Cardiology,Placebo,2024-08-27,2024-09-03,7.44,7.47,116,62,85,None,None,Improved,0
724,PT-00724,18,M,PGI Chandigarh,Phase III,ORX-404,Neurology,Placebo,2023-12-20,2024-01-17,6.82,7.27,131,105,92,None,None,Improved,0
725,PT-00725,34,M,Fortis Mumbai,Phase II,ORX-505,Infectious Disease,Placebo,2023-03-09,2023-04-06,7.23,6.79,99,70,70,None,None,Improved,1
726,PT-00726,18,F,NIMHANS Bengaluru,Phase I,ORX-505,Infectious Disease,Low Dose,2024-03-07,2024-04-04,7.26,6.63,97,86,88,None,None,Improved,1
727,PT-00727,48,M,NIMHANS Bengaluru,Phase IV,ORX-505,Infectious Disease,Low Dose,2024-08-09,2024-08-16,6.81,6.94,140,85,66,None,None,No Change,0
728,PT-00728,49,M,PGI Chandigarh,Phase II,ORX-202,Diabetes,Low Dose,2024-01-08,2024-03-04,8.63,7.7,165,75,78,Nausea,Severe,Improved,1
729,PT-00729,34,M,Apollo Chennai,Phase III,ORX-303,Cardiology,Placebo,2023-11-01,2024-01-30,7.47,5.5,118,68,79,None,None,Improved,1
730,PT-00730,60,M,Bhopal Research Hospital,Phase III,ORX-505,Infectious Disease,Low Dose,2023-03-10,2023-06-08,7.98,5.44,164,85,67,None,None,No Change,0
731,PT-00731,47,M,Bhopal Research Hospital,Phase II,ORX-606,Rheumatology,High Dose,2024-05-31,2024-06-28,7.41,6.41,131,74,72,None,None,Improved,1
732,PT-00732,34,M,Fortis Mumbai,Phase III,ORX-505,Infectious Disease,Low Dose,2024-11-18,2025-02-16,5.48,5.21,138,88,89,None,None,Improved,1
733,PT-00733,50,M,Apollo Chennai,Phase III,ORX-606,Rheumatology,High Dose,2024-04-23,2024-05-21,6.56,6.92,103,71,64,None,None,Worsened,0
734,PT-00734,62,F,Indore Medical Institute,Phase IV,ORX-505,Infectious Disease,Placebo,2024-04-18,2024-05-02,8.33,8.37,147,71,82,Headache,Mild,Improved,0
735,PT-00735,42,F,Bhopal Research Hospital,Phase III,ORX-606,Rheumatology,Placebo,2024-02-27,2024-03-26,8.22,7.71,121,88,90,Nausea,None,No Change,0
736,PT-00736,34,M,Bhopal Research Hospital,Phase III,ORX-202,Diabetes,Placebo,2023-09-09,2023-10-07,7.13,5.77,90,84,86,Nausea,None,Improved,1
737,PT-00737,49,M,Fortis Mumbai,Phase II,ORX-202,Diabetes,Placebo,2023-10-12,2024-01-10,4.86,4.14,90,98,62,Fatigue,Severe,Improved,1
738,PT-00738,65,F,Indore Medical Institute,Phase III,ORX-101,Oncology,Low Dose,2023-11-02,2023-11-09,8.34,7.12,107,86,66,None,None,Worsened,0
739,PT-00739,46,F,Bhopal Research Hospital,Phase III,ORX-404,Neurology,High Dose,2023-05-24,2023-06-07,6.62,4.62,90,84,70,Headache,Moderate,Improved,1
740,PT-00740,36,F,Bhopal Research Hospital,Phase III,ORX-202,Diabetes,Low Dose,2023-11-17,2023-12-15,8.04,8.69,123,77,85,Headache,Moderate,No Change,0
741,PT-00741,23,M,Apollo Chennai,Phase IV,ORX-202,Diabetes,Placebo,2023-08-08,2023-09-05,7.47,7.56,140,58,67,None,None,Improved,0
742,PT-00742,30,M,PGI Chandigarh,Phase III,ORX-606,Rheumatology,High Dose,2023-11-21,2024-02-19,7.32,7.35,154,76,71,Headache,Severe,Improved,0
743,PT-00743,63,M,PGI Chandigarh,Phase II,ORX-303,Cardiology,Placebo,2024-09-12,2024-09-19,7.56,8.3,133,68,59,Nausea,Moderate,No Change,0
744,PT-00744,20,M,NIMHANS Bengaluru,Phase II,ORX-303,Cardiology,Low Dose,2024-01-07,2024-01-14,7.99,8.66,161,92,94,None,None,Improved,0
745,PT-00745,35,F,NIMHANS Bengaluru,Phase II,ORX-303,Cardiology,Low Dose,2023-08-30,2023-09-27,5.81,6.18,135,83,83,Fatigue,Moderate,Improved,0
746,PT-00746,50,F,NIMHANS Bengaluru,Phase IV,ORX-101,Oncology,Placebo,2023-03-24,2023-05-19,8.74,9.51,137,92,85,None,None,Improved,0
747,PT-00747,37,F,Bhopal Research Hospital,Phase III,ORX-202,Diabetes,High Dose,2024-06-02,2024-06-09,8.11,6.45,146,67,82,Nausea,Moderate,Improved,1
748,PT-00748,31,F,Indore Medical Institute,Phase III,ORX-101,Oncology,Low Dose,2023-07-08,2023-09-02,7.86,7.43,99,87,69,None,None,No Change,0
749,PT-00749,59,F,Fortis Mumbai,Phase II,ORX-303,Cardiology,Low Dose,2023-04-24,2023-05-08,7.2,7.16,110,74,71,Headache,Mild,Improved,1
750,PT-00750,58,M,NIMHANS Bengaluru,Phase III,ORX-303,Cardiology,Low Dose,2023-05-17,2023-06-14,9.21,8.09,147,55,61,Nausea,None,Improved,1
751,PT-00751,29,F,NIMHANS Bengaluru,Phase II,ORX-303,Cardiology,Placebo,2024-01-22,2024-04-21,5.58,3.75,135,79,83,Dizziness,Moderate,Improved,1
752,PT-00752,56,M,Kolkata Clinical Center,Phase IV,ORX-202,Diabetes,Placebo,2023-06-22,2023-06-29,7.52,7.71,126,67,92,None,None,Improved,0
753,PT-00753,35,F,PGI Chandigarh,Phase I,ORX-202,Diabetes,High Dose,2023-05-01,2023-05-08,6.08,5.52,111,76,82,None,None,No Change,0
754,PT-00754,50,F,Kolkata Clinical Center,Phase III,ORX-101,Oncology,Placebo,2023-07-28,2023-08-11,6.12,5.28,147,87,107,Rash,None,Worsened,0
755,PT-00755,63,F,NIMHANS Bengaluru,Phase II,ORX-202,Diabetes,Low Dose,2023-10-17,2023-10-31,8.57,6.92,141,81,70,None,None,Improved,1
756,PT-00756,47,M,Fortis Mumbai,Phase I,ORX-202,Diabetes,Low Dose,2023-09-12,2023-10-10,8.33,8.39,112,90,69,Nausea,None,No Change,0
757,PT-00757,48,F,PGI Chandigarh,Phase I,ORX-606,Rheumatology,Low Dose,2023-08-06,2023-10-01,6.84,6.24,141,69,105,Headache,None,No Change,0
758,PT-00758,18,M,Indore Medical Institute,Phase III,ORX-303,Cardiology,High Dose,2024-04-27,2024-05-25,6.48,6.42,138,80,77,Dizziness,Severe,Worsened,0
759,PT-00759,51,M,NIMHANS Bengaluru,Phase I,ORX-303,Cardiology,High Dose,2024-11-18,2024-12-16,6.92,7.78,143,92,64,Fatigue,None,Improved,0
760,PT-00760,43,M,Kolkata Clinical Center,Phase II,ORX-303,Cardiology,High Dose,2023-05-16,2023-05-23,6.84,5.53,134,75,87,None,None,Improved,1
761,PT-00761,27,M,PGI Chandigarh,Phase II,ORX-101,Oncology,High Dose,2024-05-26,2024-06-23,9.26,8.06,131,91,70,Dizziness,None,No Change,0
762,PT-00762,58,F,Fortis Mumbai,Phase III,ORX-505,Infectious Disease,Low Dose,2023-06-18,2023-07-16,5.72,6.63,128,74,73,None,None,No Change,0
763,PT-00763,57,M,Kolkata Clinical Center,Phase III,ORX-101,Oncology,Placebo,2023-02-25,2023-03-11,6.5,5.42,124,67,103,None,None,Improved,1
764,PT-00764,35,M,NIMHANS Bengaluru,Phase III,ORX-101,Oncology,High Dose,2024-05-21,2024-05-28,8.2,7.99,110,81,88,Fever,Mild,Improved,1
765,PT-00765,41,F,AIIMS Delhi,Phase III,ORX-101,Oncology,Low Dose,2023-07-28,2023-08-25,8.63,9.15,144,76,62,None,None,Improved,0
766,PT-00766,35,F,Apollo Chennai,Phase III,ORX-505,Infectious Disease,High Dose,2023-01-05,2023-04-05,7.44,7.53,90,81,80,None,None,No Change,0
767,PT-00767,40,M,Kolkata Clinical Center,Phase II,ORX-606,Rheumatology,Placebo,2023-12-03,2023-12-10,8.75,8.73,151,79,91,Fever,None,Improved,1
768,PT-00768,71,F,Bhopal Research Hospital,Phase III,ORX-303,Cardiology,Placebo,2023-03-25,2023-05-20,8.77,7.39,123,77,84,Nausea,None,No Change,0
769,PT-00769,55,F,Indore Medical Institute,Phase III,ORX-303,Cardiology,High Dose,2024-11-02,2025-01-31,6.19,5.85,91,99,70,None,None,Worsened,0
770,PT-00770,45,M,Indore Medical Institute,Phase II,ORX-606,Rheumatology,Placebo,2023-02-26,2023-03-05,6.83,7.46,90,81,76,Nausea,None,Improved,0
771,PT-00771,37,F,NIMHANS Bengaluru,Phase II,ORX-101,Oncology,Placebo,2023-08-02,2023-08-16,9.27,8.07,141,86,95,None,None,Improved,1
772,PT-00772,34,M,Kolkata Clinical Center,Phase I,ORX-404,Neurology,High Dose,2023-11-14,2024-02-12,6.32,6.91,135,63,70,Nausea,Moderate,Improved,0
773,PT-00773,51,M,NIMHANS Bengaluru,Phase III,ORX-404,Neurology,Placebo,2024-09-06,2024-11-01,8.21,7.19,90,88,60,None,None,Improved,1
774,PT-00774,18,F,NIMHANS Bengaluru,Phase III,ORX-606,Rheumatology,Low Dose,2023-02-11,2023-05-12,3.8,4.13,130,79,97,None,None,Improved,0
775,PT-00775,55,M,AIIMS Delhi,Phase III,ORX-404,Neurology,Low Dose,2024-10-24,2025-01-22,9.14,7.49,127,62,74,None,None,Improved,1
776,PT-00776,41,M,Kolkata Clinical Center,Phase IV,ORX-303,Cardiology,Placebo,2023-05-11,2023-06-08,7.95,7.59,139,90,108,None,None,No Change,0
777,PT-00777,39,F,Bhopal Research Hospital,Phase III,ORX-101,Oncology,Low Dose,2024-06-06,2024-08-01,6.07,5.89,113,99,74,None,None,Improved,1
778,PT-00778,35,F,Bhopal Research Hospital,Phase II,ORX-505,Infectious Disease,Placebo,2024-11-08,2025-01-03,6.63,6.88,125,74,101,None,None,Improved,0
779,PT-00779,31,F,NIMHANS Bengaluru,Phase I,ORX-606,Rheumatology,Placebo,2024-08-24,2024-10-19,7.24,7.43,98,87,63,None,None,No Change,0
780,PT-00780,58,F,AIIMS Delhi,Phase II,ORX-202,Diabetes,Placebo,2024-09-10,2024-10-08,6.04,6.27,147,92,81,None,None,Worsened,0
781,PT-00781,41,M,Bhopal Research Hospital,Phase I,ORX-101,Oncology,Placebo,2024-05-03,2024-06-28,6.51,7.43,115,69,87,Fatigue,Severe,No Change,0
782,PT-00782,32,F,PGI Chandigarh,Phase II,ORX-606,Rheumatology,High Dose,2024-11-22,2025-01-17,6.06,4.36,119,81,81,None,None,No Change,0
783,PT-00783,60,M,Bhopal Research Hospital,Phase I,ORX-101,Oncology,High Dose,2023-07-12,2023-07-19,7.83,7.26,124,88,95,Nausea,Mild,Improved,1
784,PT-00784,47,F,Apollo Chennai,Phase III,ORX-101,Oncology,Low Dose,2024-04-19,2024-05-03,6.64,5.34,101,89,86,None,None,Improved,1
785,PT-00785,54,M,Kolkata Clinical Center,Phase IV,ORX-404,Neurology,Low Dose,2024-04-05,2024-07-04,7.05,7.91,119,93,77,None,None,Improved,0
786,PT-00786,35,F,Indore Medical Institute,Phase I,ORX-101,Oncology,Low Dose,2024-03-18,2024-05-13,7.91,7.88,134,82,77,Headache,Mild,No Change,0
787,PT-00787,83,F,NIMHANS Bengaluru,Phase I,ORX-404,Neurology,Low Dose,2024-09-18,2024-11-13,8.62,8.87,130,94,85,None,None,Improved,0
788,PT-00788,45,M,PGI Chandigarh,Phase III,ORX-505,Infectious Disease,Placebo,2024-10-25,2024-12-20,6.84,6.36,90,84,71,None,None,Worsened,0
789,PT-00789,70,F,NIMHANS Bengaluru,Phase III,ORX-101,Oncology,Placebo,2023-07-16,2023-09-10,7.22,5.75,127,69,84,None,None,Improved,1
790,PT-00790,49,M,PGI Chandigarh,Phase III,ORX-505,Infectious Disease,High Dose,2024-11-03,2024-12-29,8.35,7.24,128,65,87,None,None,Improved,1
791,PT-00791,53,F,PGI Chandigarh,Phase IV,ORX-404,Neurology,High Dose,2023-06-15,2023-09-13,7.79,7.4,135,101,74,Headache,None,Improved,1
792,PT-00792,47,F,Apollo Chennai,Phase I,ORX-202,Diabetes,Low Dose,2023-04-14,2023-06-09,5.9,4.72,129,95,74,None,None,Worsened,0
793,PT-00793,41,M,Indore Medical Institute,Phase II,ORX-101,Oncology,Low Dose,2023-09-25,2023-10-23,6.71,5.83,133,64,95,None,None,No Change,0
794,PT-00794,34,M,PGI Chandigarh,Phase III,ORX-404,Neurology,Placebo,2023-08-21,2023-08-28,8.07,6.52,140,90,83,None,None,No Change,0
795,PT-00795,29,F,Indore Medical Institute,Phase III,ORX-505,Infectious Disease,Placebo,2023-06-04,2023-09-02,7.5,6.03,123,94,89,None,None,No Change,0
796,PT-00796,45,M,Kolkata Clinical Center,Phase IV,ORX-404,Neurology,High Dose,2023-04-24,2023-05-01,6.03,6.21,128,54,88,Nausea,Moderate,No Change,0
797,PT-00797,44,M,Indore Medical Institute,Phase III,ORX-505,Infectious Disease,Placebo,2024-10-07,2024-10-14,8.64,7.26,90,85,82,Fatigue,None,Worsened,0
798,PT-00798,18,F,Kolkata Clinical Center,Phase III,ORX-606,Rheumatology,High Dose,2023-06-07,2023-07-05,6.03,8.11,122,90,68,None,None,Improved,0
799,PT-00799,18,M,NIMHANS Bengaluru,Phase III,ORX-101,Oncology,Placebo,2024-04-30,2024-05-28,7.0,6.36,120,80,81,None,None,Improved,1
800,PT-00800,42,F,NIMHANS Bengaluru,Phase II,ORX-303,Cardiology,Low Dose,2023-09-09,2023-09-23,5.68,5.72,92,57,88,None,None,No Change,0
801,PT-00801,53,M,NIMHANS Bengaluru,Phase I,ORX-404,Neurology,High Dose,2024-04-14,2024-07-13,7.13,5.48,115,78,55,None,None,No Change,0
802,PT-00802,33,M,Indore Medical Institute,Phase III,ORX-606,Rheumatology,High Dose,2023-03-13,2023-03-20,7.98,8.87,120,91,51,None,None,Improved,0
803,PT-00803,55,M,NIMHANS Bengaluru,Phase III,ORX-101,Oncology,High Dose,2024-10-18,2024-11-01,6.24,6.11,123,97,65,None,None,Worsened,0
804,PT-00804,55,F,Fortis Mumbai,Phase III,ORX-606,Rheumatology,High Dose,2023-12-19,2023-12-26,6.86,6.32,124,71,77,Fatigue,Mild,No Change,0
805,PT-00805,43,M,Kolkata Clinical Center,Phase III,ORX-606,Rheumatology,Placebo,2024-07-11,2024-10-09,7.49,7.17,142,93,63,Nausea,Mild,No Change,0
806,PT-00806,58,F,Fortis Mumbai,Phase III,ORX-101,Oncology,Placebo,2023-12-09,2024-02-03,5.78,5.91,139,59,79,Headache,None,No Change,0
807,PT-00807,37,F,Fortis Mumbai,Phase II,ORX-505,Infectious Disease,Low Dose,2024-10-12,2024-10-26,6.29,7.11,116,72,79,Fatigue,None,Improved,0
808,PT-00808,55,F,Fortis Mumbai,Phase II,ORX-606,Rheumatology,Low Dose,2024-06-01,2024-06-08,7.03,7.68,137,55,70,Rash,None,No Change,0
809,PT-00809,36,F,Bhopal Research Hospital,Phase I,ORX-404,Neurology,Placebo,2023-01-06,2023-03-03,7.78,5.01,173,88,80,None,None,Improved,1
810,PT-00810,63,M,Fortis Mumbai,Phase II,ORX-606,Rheumatology,High Dose,2024-08-09,2024-08-23,10.01,10.4,145,83,76,None,None,No Change,0
811,PT-00811,37,M,Apollo Chennai,Phase I,ORX-303,Cardiology,Low Dose,2023-05-31,2023-07-26,6.21,5.19,103,81,54,None,None,No Change,0
812,PT-00812,48,M,AIIMS Delhi,Phase III,ORX-404,Neurology,Placebo,2023-03-21,2023-04-18,7.16,6.89,118,118,97,None,None,No Change,0
813,PT-00813,25,F,Kolkata Clinical Center,Phase IV,ORX-606,Rheumatology,Low Dose,2024-03-26,2024-05-21,7.48,6.53,109,65,84,None,None,No Change,0
814,PT-00814,34,M,AIIMS Delhi,Phase I,ORX-404,Neurology,High Dose,2023-05-13,2023-08-11,8.36,8.86,152,71,84,None,None,Worsened,0
815,PT-00815,55,M,Indore Medical Institute,Phase III,ORX-606,Rheumatology,Placebo,2024-07-26,2024-08-23,6.63,5.54,156,84,86,None,None,Worsened,0
816,PT-00816,31,F,PGI Chandigarh,Phase I,ORX-505,Infectious Disease,Placebo,2024-06-19,2024-07-03,5.74,4.82,125,69,77,None,None,Improved,1
817,PT-00817,18,F,Kolkata Clinical Center,Phase II,ORX-101,Oncology,High Dose,2023-05-26,2023-08-24,5.86,6.06,138,77,63,Dizziness,None,Improved,0
818,PT-00818,28,F,Kolkata Clinical Center,Phase II,ORX-101,Oncology,Placebo,2023-12-24,2023-12-31,6.75,6.93,144,76,61,None,None,Worsened,0
819,PT-00819,49,F,PGI Chandigarh,Phase III,ORX-404,Neurology,Low Dose,2024-09-12,2024-09-26,6.21,5.35,151,91,80,None,None,No Change,0
820,PT-00820,24,F,Kolkata Clinical Center,Phase III,ORX-202,Diabetes,High Dose,2023-11-30,2023-12-07,7.45,8.01,121,98,96,Nausea,None,No Change,0
821,PT-00821,71,M,PGI Chandigarh,Phase IV,ORX-505,Infectious Disease,Placebo,2024-11-17,2025-01-12,7.57,7.69,153,87,70,Nausea,Moderate,No Change,0
822,PT-00822,37,M,Fortis Mumbai,Phase III,ORX-505,Infectious Disease,Low Dose,2024-10-21,2025-01-19,7.49,5.92,125,95,47,Dizziness,None,Improved,1
823,PT-00823,69,M,Apollo Chennai,Phase IV,ORX-404,Neurology,Low Dose,2023-01-20,2023-01-27,8.55,7.73,137,82,95,None,None,No Change,0
824,PT-00824,60,M,Apollo Chennai,Phase II,ORX-202,Diabetes,High Dose,2024-08-16,2024-10-11,5.52,5.65,124,82,67,None,None,Improved,0
825,PT-00825,72,F,Indore Medical Institute,Phase III,ORX-404,Neurology,High Dose,2023-01-24,2023-02-21,8.45,7.38,103,77,84,None,None,Improved,1
826,PT-00826,48,F,Bhopal Research Hospital,Phase II,ORX-101,Oncology,High Dose,2024-07-08,2024-07-22,8.7,9.01,145,85,58,None,None,Improved,0
827,PT-00827,41,M,NIMHANS Bengaluru,Phase II,ORX-606,Rheumatology,Placebo,2024-09-21,2024-10-19,8.47,8.03,137,78,63,Headache,None,Improved,1
828,PT-00828,43,M,NIMHANS Bengaluru,Phase II,ORX-303,Cardiology,Placebo,2023-05-04,2023-05-11,7.57,6.58,123,70,93,Headache,Mild,Improved,1
829,PT-00829,40,F,NIMHANS Bengaluru,Phase III,ORX-101,Oncology,Placebo,2023-11-22,2024-01-17,8.94,9.92,126,69,48,None,None,No Change,0
830,PT-00830,21,M,Apollo Chennai,Phase III,ORX-101,Oncology,Placebo,2024-08-23,2024-08-30,5.55,6.39,130,86,46,Nausea,Mild,Improved,0
831,PT-00831,25,F,Kolkata Clinical Center,Phase III,ORX-101,Oncology,High Dose,2024-05-27,2024-06-10,8.26,8.12,125,88,100,None,None,No Change,0
832,PT-00832,41,M,NIMHANS Bengaluru,Phase III,ORX-505,Infectious Disease,Low Dose,2023-01-02,2023-02-27,7.28,7.06,171,56,87,Nausea,Mild,Worsened,0
833,PT-00833,43,M,Kolkata Clinical Center,Phase I,ORX-303,Cardiology,Low Dose,2024-11-27,2025-01-22,7.88,6.89,127,90,121,Rash,None,Worsened,0
834,PT-00834,57,F,Bhopal Research Hospital,Phase I,ORX-303,Cardiology,Placebo,2023-05-06,2023-05-20,6.18,5.4,119,60,73,Fever,Moderate,No Change,0
835,PT-00835,56,M,PGI Chandigarh,Phase III,ORX-606,Rheumatology,High Dose,2024-10-12,2024-11-09,5.67,6.21,136,73,76,Headache,None,Worsened,0
836,PT-00836,70,F,Kolkata Clinical Center,Phase II,ORX-505,Infectious Disease,Low Dose,2023-05-17,2023-05-24,8.08,7.69,123,82,70,None,None,No Change,0
837,PT-00837,18,M,NIMHANS Bengaluru,Phase III,ORX-505,Infectious Disease,High Dose,2024-05-15,2024-07-10,9.65,9.39,135,81,67,Headache,Mild,Improved,1
838,PT-00838,42,M,Kolkata Clinical Center,Phase III,ORX-606,Rheumatology,Placebo,2024-01-21,2024-04-20,5.28,6.93,105,69,71,None,None,Improved,0
839,PT-00839,65,M,PGI Chandigarh,Phase I,ORX-202,Diabetes,Low Dose,2023-08-15,2023-08-22,7.22,5.7,150,90,85,Headache,Mild,No Change,0
840,PT-00840,56,M,Fortis Mumbai,Phase I,ORX-606,Rheumatology,Placebo,2024-05-20,2024-06-17,10.07,11.64,115,101,83,None,None,Improved,0
841,PT-00841,52,M,NIMHANS Bengaluru,Phase I,ORX-101,Oncology,High Dose,2024-08-05,2024-11-03,5.17,4.62,113,91,92,Nausea,Mild,Improved,1
842,PT-00842,18,M,AIIMS Delhi,Phase I,ORX-606,Rheumatology,Placebo,2023-09-23,2023-12-22,7.17,7.78,124,90,82,Fatigue,Mild,Worsened,0
843,PT-00843,50,F,Indore Medical Institute,Phase II,ORX-606,Rheumatology,High Dose,2024-09-21,2024-10-19,6.87,5.38,107,90,78,Fatigue,None,No Change,0
844,PT-00844,42,F,Indore Medical Institute,Phase III,ORX-303,Cardiology,Low Dose,2024-02-21,2024-03-20,6.69,6.02,146,77,59,None,None,Improved,1
845,PT-00845,56,F,Indore Medical Institute,Phase II,ORX-606,Rheumatology,Placebo,2023-10-12,2023-12-07,6.95,6.58,156,81,82,None,None,Improved,1
846,PT-00846,26,F,Bhopal Research Hospital,Phase II,ORX-505,Infectious Disease,High Dose,2023-08-20,2023-10-15,6.94,7.08,100,84,79,Fatigue,None,Worsened,0
847,PT-00847,45,F,Bhopal Research Hospital,Phase II,ORX-101,Oncology,Low Dose,2023-01-25,2023-04-25,8.44,8.35,154,70,79,Dizziness,Moderate,No Change,0
848,PT-00848,46,M,Apollo Chennai,Phase I,ORX-303,Cardiology,High Dose,2023-12-08,2024-03-07,5.92,6.38,169,81,85,Dizziness,Mild,No Change,0
849,PT-00849,46,F,Kolkata Clinical Center,Phase III,ORX-505,Infectious Disease,Placebo,2023-03-04,2023-03-11,6.34,4.31,115,65,101,Fatigue,Mild,Improved,1
850,PT-00850,43,M,Kolkata Clinical Center,Phase I,ORX-101,Oncology,Low Dose,2024-10-03,2024-11-28,6.78,7.19,107,72,78,Headache,Mild,Improved,0
851,PT-00851,61,F,NIMHANS Bengaluru,Phase III,ORX-101,Oncology,Low Dose,2024-02-25,2024-03-10,7.8,7.63,129,86,80,Headache,Mild,Worsened,0
852,PT-00852,28,F,NIMHANS Bengaluru,Phase II,ORX-505,Infectious Disease,Low Dose,2023-12-14,2023-12-21,7.26,5.89,129,76,113,None,None,Improved,1
853,PT-00853,44,M,Indore Medical Institute,Phase I,ORX-505,Infectious Disease,High Dose,2024-08-30,2024-09-13,5.51,4.99,137,102,69,None,None,Worsened,0
854,PT-00854,19,F,Kolkata Clinical Center,Phase II,ORX-606,Rheumatology,Low Dose,2023-07-10,2023-07-24,8.18,6.54,120,78,77,None,None,Improved,1
855,PT-00855,56,M,NIMHANS Bengaluru,Phase II,ORX-505,Infectious Disease,High Dose,2024-01-02,2024-01-30,6.38,5.73,127,83,79,None,None,No Change,0
856,PT-00856,51,M,Fortis Mumbai,Phase I,ORX-505,Infectious Disease,Low Dose,2024-01-13,2024-01-20,8.21,8.17,136,63,78,Nausea,None,Improved,1
857,PT-00857,52,M,Indore Medical Institute,Phase III,ORX-404,Neurology,Low Dose,2023-07-25,2023-08-08,8.07,7.05,116,75,85,None,None,No Change,0
858,PT-00858,61,F,Kolkata Clinical Center,Phase III,ORX-505,Infectious Disease,High Dose,2024-08-15,2024-11-13,6.71,7.13,130,80,75,Nausea,None,Worsened,0
859,PT-00859,56,M,Indore Medical Institute,Phase I,ORX-404,Neurology,Placebo,2023-01-04,2023-01-18,7.59,9.24,112,88,70,None,None,No Change,0
860,PT-00860,31,M,PGI Chandigarh,Phase II,ORX-606,Rheumatology,Low Dose,2024-02-14,2024-02-28,7.19,6.91,180,79,62,None,None,No Change,0
861,PT-00861,49,M,Indore Medical Institute,Phase I,ORX-505,Infectious Disease,Placebo,2023-10-25,2023-12-20,4.71,4.23,128,91,91,Nausea,Mild,Improved,1
862,PT-00862,36,M,Apollo Chennai,Phase IV,ORX-202,Diabetes,Placebo,2023-08-13,2023-09-10,7.02,5.93,107,85,60,None,None,No Change,0
863,PT-00863,38,M,Indore Medical Institute,Phase II,ORX-202,Diabetes,High Dose,2023-04-14,2023-04-21,6.01,6.1,160,66,52,None,None,No Change,0
864,PT-00864,43,M,Apollo Chennai,Phase II,ORX-303,Cardiology,Low Dose,2024-01-14,2024-02-11,7.22,7.02,119,79,83,Dizziness,Severe,No Change,0
865,PT-00865,61,F,Bhopal Research Hospital,Phase IV,ORX-101,Oncology,Placebo,2023-05-14,2023-05-28,4.85,4.12,131,70,102,None,None,Improved,1
866,PT-00866,34,F,NIMHANS Bengaluru,Phase II,ORX-606,Rheumatology,Placebo,2023-02-17,2023-05-18,7.15,7.25,117,59,71,Fatigue,None,No Change,0
867,PT-00867,61,M,Indore Medical Institute,Phase II,ORX-606,Rheumatology,High Dose,2023-05-10,2023-08-08,6.8,5.63,144,78,70,Fatigue,None,Worsened,0
868,PT-00868,47,M,Bhopal Research Hospital,Phase III,ORX-202,Diabetes,Low Dose,2024-10-22,2025-01-20,8.12,9.87,142,95,70,None,None,Improved,0
869,PT-00869,28,M,PGI Chandigarh,Phase II,ORX-505,Infectious Disease,High Dose,2024-05-21,2024-07-16,7.27,6.97,108,79,83,None,None,Improved,1
870,PT-00870,50,M,Apollo Chennai,Phase II,ORX-404,Neurology,High Dose,2024-02-10,2024-02-24,7.81,7.67,118,75,61,Fatigue,Mild,Improved,1
871,PT-00871,73,F,Bhopal Research Hospital,Phase II,ORX-202,Diabetes,High Dose,2023-10-30,2023-12-25,7.22,6.61,111,117,62,None,None,Improved,1
872,PT-00872,38,M,PGI Chandigarh,Phase III,ORX-404,Neurology,Low Dose,2024-03-18,2024-05-13,7.7,7.84,145,103,85,None,None,Improved,0
873,PT-00873,28,F,AIIMS Delhi,Phase II,ORX-404,Neurology,Placebo,2024-10-22,2024-10-29,6.89,6.77,165,65,94,None,None,Improved,1
874,PT-00874,47,M,Apollo Chennai,Phase III,ORX-101,Oncology,Placebo,2024-01-04,2024-01-11,8.21,7.71,112,91,87,None,None,Improved,1
875,PT-00875,60,F,Fortis Mumbai,Phase II,ORX-202,Diabetes,High Dose,2023-05-22,2023-08-20,7.18,6.24,99,91,83,None,None,Worsened,0
876,PT-00876,29,F,PGI Chandigarh,Phase II,ORX-404,Neurology,High Dose,2024-08-16,2024-08-23,6.55,5.73,101,72,62,None,None,Improved,1
877,PT-00877,38,M,Apollo Chennai,Phase IV,ORX-202,Diabetes,High Dose,2023-08-03,2023-09-28,6.31,4.45,164,97,67,Nausea,Mild,Improved,1
878,PT-00878,49,F,Kolkata Clinical Center,Phase III,ORX-303,Cardiology,High Dose,2023-11-17,2023-12-01,7.7,8.37,113,95,70,Dizziness,None,Improved,0
879,PT-00879,23,F,Indore Medical Institute,Phase III,ORX-303,Cardiology,Placebo,2023-05-12,2023-06-09,8.07,8.83,174,67,87,None,None,Worsened,0
880,PT-00880,38,F,NIMHANS Bengaluru,Phase II,ORX-404,Neurology,High Dose,2024-02-18,2024-05-18,8.14,6.42,105,72,79,Nausea,Mild,Improved,1
881,PT-00881,34,M,AIIMS Delhi,Phase IV,ORX-303,Cardiology,Low Dose,2024-09-09,2024-12-08,7.99,8.52,138,101,83,None,None,No Change,0
882,PT-00882,25,F,NIMHANS Bengaluru,Phase II,ORX-101,Oncology,Low Dose,2023-07-12,2023-09-06,8.84,7.89,144,100,84,Nausea,None,Improved,1
883,PT-00883,21,F,Bhopal Research Hospital,Phase I,ORX-606,Rheumatology,Low Dose,2023-02-02,2023-05-03,6.1,6.89,124,82,88,None,None,Improved,0
884,PT-00884,56,M,NIMHANS Bengaluru,Phase IV,ORX-303,Cardiology,Placebo,2023-10-26,2024-01-24,7.53,6.95,122,92,85,None,None,Improved,1
885,PT-00885,40,M,NIMHANS Bengaluru,Phase II,ORX-404,Neurology,Placebo,2023-04-24,2023-05-08,8.5,7.98,112,72,64,None,None,Improved,1
886,PT-00886,40,M,Apollo Chennai,Phase II,ORX-202,Diabetes,High Dose,2023-11-14,2024-01-09,8.68,7.56,131,74,74,Nausea,None,No Change,0
887,PT-00887,20,F,Kolkata Clinical Center,Phase III,ORX-303,Cardiology,Placebo,2023-05-27,2023-07-22,6.94,6.36,137,84,61,None,None,Improved,1
888,PT-00888,62,M,Kolkata Clinical Center,Phase III,ORX-404,Neurology,Low Dose,2023-02-10,2023-02-17,7.45,7.23,127,75,81,Fatigue,None,Improved,1
889,PT-00889,52,F,AIIMS Delhi,Phase II,ORX-404,Neurology,Placebo,2024-09-24,2024-11-19,5.1,4.22,123,85,94,Fatigue,None,Improved,1
890,PT-00890,32,M,Indore Medical Institute,Phase II,ORX-202,Diabetes,High Dose,2023-06-11,2023-07-09,6.6,5.74,113,77,88,None,None,Worsened,0
891,PT-00891,28,M,Apollo Chennai,Phase III,ORX-404,Neurology,Low Dose,2024-07-20,2024-07-27,7.71,5.78,117,78,101,None,None,Worsened,0
892,PT-00892,40,M,PGI Chandigarh,Phase III,ORX-404,Neurology,Low Dose,2023-09-16,2023-09-30,4.56,2.36,128,89,83,None,None,Improved,1
893,PT-00893,47,M,Kolkata Clinical Center,Phase III,ORX-404,Neurology,Low Dose,2024-02-13,2024-02-27,8.59,7.71,144,62,65,None,None,Improved,1
894,PT-00894,18,M,AIIMS Delhi,Phase III,ORX-303,Cardiology,High Dose,2024-04-20,2024-06-15,6.87,6.43,130,82,65,None,None,Improved,1
895,PT-00895,41,M,Kolkata Clinical Center,Phase III,ORX-202,Diabetes,Low Dose,2023-10-13,2023-10-27,5.4,6.23,122,76,100,None,None,Improved,0
896,PT-00896,25,M,Bhopal Research Hospital,Phase II,ORX-505,Infectious Disease,High Dose,2023-06-22,2023-06-29,5.85,4.46,126,87,88,None,None,No Change,0
897,PT-00897,85,F,PGI Chandigarh,Phase II,ORX-202,Diabetes,Placebo,2023-02-05,2023-05-06,4.5,4.65,117,74,69,Headache,Moderate,Improved,0
898,PT-00898,30,M,Fortis Mumbai,Phase II,ORX-404,Neurology,Placebo,2023-01-05,2023-01-12,9.22,9.58,128,98,56,Headache,Moderate,No Change,0
899,PT-00899,23,F,Apollo Chennai,Phase IV,ORX-101,Oncology,Placebo,2023-01-29,2023-02-05,4.59,3.56,130,83,80,None,None,Improved,1
900,PT-00900,22,M,Bhopal Research Hospital,Phase II,ORX-606,Rheumatology,Placebo,2023-06-21,2023-06-28,8.16,7.98,141,59,82,None,None,Improved,1
901,PT-00901,25,F,Apollo Chennai,Phase II,ORX-505,Infectious Disease,Placebo,2024-07-08,2024-09-02,6.72,6.8,129,71,78,None,None,Worsened,0
902,PT-00902,20,M,PGI Chandigarh,Phase I,ORX-202,Diabetes,Placebo,2024-10-31,2024-11-28,8.58,8.0,148,75,70,None,None,Improved,1
903,PT-00903,32,M,Fortis Mumbai,Phase I,ORX-606,Rheumatology,Low Dose,2023-02-14,2023-02-21,8.25,7.21,139,77,50,None,None,Worsened,0
904,PT-00904,35,F,Bhopal Research Hospital,Phase IV,ORX-606,Rheumatology,Low Dose,2024-08-05,2024-08-19,5.79,5.42,106,93,76,None,None,Improved,1
905,PT-00905,42,F,NIMHANS Bengaluru,Phase IV,ORX-606,Rheumatology,High Dose,2023-05-17,2023-06-14,7.99,8.45,127,72,53,Headache,Mild,Improved,0
906,PT-00906,34,F,Indore Medical Institute,Phase I,ORX-505,Infectious Disease,High Dose,2024-04-04,2024-05-30,6.46,6.16,121,90,69,Headache,None,Improved,1
907,PT-00907,44,M,Bhopal Research Hospital,Phase II,ORX-303,Cardiology,Placebo,2024-03-14,2024-03-28,8.62,8.53,126,74,69,None,None,No Change,0
908,PT-00908,31,F,Apollo Chennai,Phase III,ORX-202,Diabetes,Low Dose,2024-10-19,2024-10-26,6.55,6.83,124,65,102,Headache,Severe,Improved,0
909,PT-00909,50,F,PGI Chandigarh,Phase III,ORX-202,Diabetes,Placebo,2024-10-21,2024-10-28,5.51,4.71,129,102,62,Fever,Mild,Improved,1
910,PT-00910,60,F,Apollo Chennai,Phase III,ORX-606,Rheumatology,Low Dose,2023-09-06,2023-09-20,8.88,7.91,123,69,75,Fatigue,Mild,Improved,1
911,PT-00911,44,M,Apollo Chennai,Phase III,ORX-505,Infectious Disease,High Dose,2024-06-17,2024-07-15,7.99,8.57,114,58,77,Nausea,None,Improved,0
912,PT-00912,49,F,Apollo Chennai,Phase I,ORX-101,Oncology,Low Dose,2023-05-25,2023-06-08,7.5,6.81,130,100,83,None,None,Improved,1
913,PT-00913,39,M,Bhopal Research Hospital,Phase II,ORX-404,Neurology,High Dose,2023-11-15,2023-11-29,6.6,6.05,157,79,77,None,None,No Change,0
914,PT-00914,37,M,Fortis Mumbai,Phase III,ORX-303,Cardiology,Low Dose,2024-10-12,2024-10-26,8.52,9.88,136,82,78,Headache,None,Improved,0
915,PT-00915,18,F,AIIMS Delhi,Phase II,ORX-404,Neurology,Low Dose,2024-06-01,2024-08-30,8.09,7.81,135,73,72,Headache,Moderate,No Change,0
916,PT-00916,38,F,NIMHANS Bengaluru,Phase I,ORX-404,Neurology,High Dose,2023-11-04,2024-02-02,8.43,7.69,165,87,60,Nausea,None,Improved,1
917,PT-00917,42,F,Kolkata Clinical Center,Phase III,ORX-303,Cardiology,Low Dose,2024-09-12,2024-11-07,6.42,4.04,156,90,85,None,None,Improved,1
918,PT-00918,47,F,Apollo Chennai,Phase II,ORX-101,Oncology,Placebo,2024-05-27,2024-06-24,5.54,4.71,143,69,45,Dizziness,Moderate,Improved,1
919,PT-00919,41,F,Fortis Mumbai,Phase II,ORX-606,Rheumatology,High Dose,2023-03-14,2023-05-09,7.03,6.75,141,89,81,Fever,None,Worsened,0
920,PT-00920,64,M,NIMHANS Bengaluru,Phase II,ORX-303,Cardiology,High Dose,2023-12-23,2024-03-22,5.38,5.43,139,67,56,Nausea,None,No Change,0
921,PT-00921,33,M,NIMHANS Bengaluru,Phase III,ORX-606,Rheumatology,Placebo,2024-05-04,2024-05-11,6.41,6.68,116,71,69,None,None,Worsened,0
922,PT-00922,62,M,AIIMS Delhi,Phase III,ORX-303,Cardiology,Low Dose,2024-11-28,2024-12-12,7.22,6.65,126,97,67,Nausea,Severe,Improved,1
923,PT-00923,66,M,Bhopal Research Hospital,Phase I,ORX-606,Rheumatology,High Dose,2024-01-29,2024-03-25,7.45,6.91,173,69,73,Fever,None,No Change,0
924,PT-00924,25,M,AIIMS Delhi,Phase IV,ORX-404,Neurology,Placebo,2023-11-06,2024-02-04,8.34,9.46,158,96,75,Nausea,None,Worsened,0
925,PT-00925,39,F,Bhopal Research Hospital,Phase III,ORX-101,Oncology,Low Dose,2023-12-19,2024-01-02,5.19,6.63,136,76,96,None,None,Improved,0
926,PT-00926,29,F,Indore Medical Institute,Phase III,ORX-202,Diabetes,High Dose,2023-01-02,2023-01-09,7.69,7.13,139,81,57,Headache,None,Improved,1
927,PT-00927,46,F,AIIMS Delhi,Phase III,ORX-202,Diabetes,Low Dose,2023-05-18,2023-06-01,8.46,8.03,141,69,77,None,None,Improved,1
928,PT-00928,35,M,Apollo Chennai,Phase III,ORX-202,Diabetes,Placebo,2023-07-07,2023-07-21,8.1,7.72,140,95,87,Fatigue,None,Improved,1
929,PT-00929,49,M,AIIMS Delhi,Phase IV,ORX-101,Oncology,Placebo,2024-01-22,2024-01-29,6.0,5.6,118,77,72,None,None,Improved,1
930,PT-00930,29,M,Bhopal Research Hospital,Phase III,ORX-101,Oncology,Placebo,2023-01-08,2023-04-08,4.85,3.85,131,65,78,None,None,No Change,0
931,PT-00931,75,M,Indore Medical Institute,Phase III,ORX-404,Neurology,Low Dose,2023-09-30,2023-11-25,8.43,9.51,135,96,67,None,None,Improved,0
932,PT-00932,34,F,PGI Chandigarh,Phase II,ORX-303,Cardiology,High Dose,2024-01-05,2024-03-01,3.91,4.58,155,75,74,None,None,Improved,0
933,PT-00933,32,F,Bhopal Research Hospital,Phase IV,ORX-101,Oncology,Low Dose,2024-02-16,2024-03-01,7.66,8.27,96,86,74,None,None,Improved,0
934,PT-00934,46,F,Apollo Chennai,Phase IV,ORX-303,Cardiology,Low Dose,2024-11-05,2024-12-31,7.75,7.18,126,79,91,Nausea,None,Improved,1
935,PT-00935,51,F,PGI Chandigarh,Phase I,ORX-101,Oncology,High Dose,2023-11-30,2024-01-25,7.46,5.92,121,92,78,None,None,Improved,1
936,PT-00936,55,M,Kolkata Clinical Center,Phase II,ORX-606,Rheumatology,High Dose,2023-04-13,2023-06-08,9.32,9.85,129,75,45,None,None,Improved,0
937,PT-00937,42,M,Indore Medical Institute,Phase IV,ORX-202,Diabetes,Low Dose,2023-03-31,2023-04-28,6.81,6.76,125,78,53,Fever,Severe,No Change,0
938,PT-00938,29,F,Kolkata Clinical Center,Phase II,ORX-101,Oncology,Low Dose,2024-07-07,2024-07-21,7.77,8.92,126,85,91,None,None,Improved,0
939,PT-00939,32,M,Indore Medical Institute,Phase I,ORX-202,Diabetes,High Dose,2023-12-01,2024-01-26,7.64,6.57,143,83,82,None,None,No Change,0
940,PT-00940,32,F,Bhopal Research Hospital,Phase III,ORX-606,Rheumatology,Placebo,2024-07-01,2024-08-26,8.05,9.52,109,77,81,Headache,Moderate,Improved,0
941,PT-00941,57,M,NIMHANS Bengaluru,Phase III,ORX-606,Rheumatology,High Dose,2024-01-26,2024-04-25,6.53,3.58,152,91,53,None,None,Worsened,0
942,PT-00942,35,M,Bhopal Research Hospital,Phase II,ORX-303,Cardiology,Placebo,2023-04-02,2023-04-30,9.08,9.98,144,79,79,Dizziness,Mild,No Change,0
943,PT-00943,42,M,AIIMS Delhi,Phase III,ORX-303,Cardiology,High Dose,2024-08-13,2024-08-20,8.55,7.37,113,94,77,Nausea,None,Improved,1
944,PT-00944,67,F,PGI Chandigarh,Phase IV,ORX-303,Cardiology,High Dose,2023-05-10,2023-08-08,6.39,5.94,111,82,57,Nausea,None,No Change,0
945,PT-00945,37,M,Kolkata Clinical Center,Phase III,ORX-303,Cardiology,Placebo,2023-10-31,2023-11-14,5.48,5.7,140,61,96,None,None,Improved,0
946,PT-00946,84,F,Indore Medical Institute,Phase I,ORX-505,Infectious Disease,Low Dose,2024-05-29,2024-06-05,7.26,6.28,178,66,78,Rash,Mild,Improved,1
947,PT-00947,47,M,NIMHANS Bengaluru,Phase III,ORX-101,Oncology,High Dose,2023-12-08,2023-12-22,8.81,8.74,119,70,73,None,None,No Change,0
948,PT-00948,28,M,Indore Medical Institute,Phase III,ORX-202,Diabetes,High Dose,2024-02-06,2024-03-05,7.26,6.35,101,97,71,Nausea,Moderate,Worsened,0
949,PT-00949,24,M,PGI Chandigarh,Phase III,ORX-404,Neurology,High Dose,2023-12-23,2024-02-17,7.0,6.66,96,85,63,None,None,Improved,1
950,PT-00950,72,F,Apollo Chennai,Phase II,ORX-606,Rheumatology,High Dose,2024-02-08,2024-02-15,7.83,7.07,114,80,86,Headache,Mild,Improved,1
951,PT-00951,44,M,Fortis Mumbai,Phase III,ORX-404,Neurology,High Dose,2024-08-14,2024-08-28,6.94,6.59,117,77,48,None,None,Improved,1
952,PT-00952,60,M,Apollo Chennai,Phase II,ORX-606,Rheumatology,High Dose,2024-01-06,2024-04-05,7.56,6.46,162,83,63,Headache,Moderate,Improved,1
953,PT-00953,58,F,NIMHANS Bengaluru,Phase IV,ORX-606,Rheumatology,High Dose,2023-02-27,2023-03-06,7.68,7.63,120,87,74,None,None,Improved,1
954,PT-00954,53,M,PGI Chandigarh,Phase I,ORX-505,Infectious Disease,Low Dose,2023-06-02,2023-07-28,4.91,4.12,158,72,69,None,None,Improved,1
955,PT-00955,37,F,AIIMS Delhi,Phase III,ORX-606,Rheumatology,High Dose,2024-11-17,2024-11-24,5.74,3.35,123,83,77,Fatigue,Mild,No Change,0
956,PT-00956,42,F,Kolkata Clinical Center,Phase III,ORX-303,Cardiology,Placebo,2023-04-30,2023-05-07,7.25,7.77,124,75,74,Nausea,Moderate,Improved,0
957,PT-00957,54,M,Kolkata Clinical Center,Phase I,ORX-303,Cardiology,High Dose,2023-04-07,2023-07-06,8.89,7.93,129,86,64,None,None,Improved,1
958,PT-00958,45,F,AIIMS Delhi,Phase II,ORX-101,Oncology,Low Dose,2024-07-04,2024-07-18,5.44,3.45,134,77,80,Headache,None,Improved,1
959,PT-00959,44,F,Bhopal Research Hospital,Phase I,ORX-202,Diabetes,High Dose,2023-05-01,2023-05-15,6.03,5.59,105,98,59,Headache,None,Worsened,0
960,PT-00960,41,F,Bhopal Research Hospital,Phase III,ORX-101,Oncology,Placebo,2023-07-31,2023-08-14,5.95,6.06,122,75,89,None,None,Improved,0
961,PT-00961,45,M,Bhopal Research Hospital,Phase I,ORX-505,Infectious Disease,Placebo,2024-07-11,2024-07-25,7.82,6.54,102,83,73,Dizziness,None,Improved,1
962,PT-00962,55,F,Fortis Mumbai,Phase I,ORX-606,Rheumatology,Low Dose,2023-05-24,2023-08-22,7.1,6.89,98,104,75,None,None,Improved,1
963,PT-00963,56,F,Apollo Chennai,Phase III,ORX-606,Rheumatology,Placebo,2023-02-15,2023-03-01,6.2,6.07,104,87,73,None,None,Improved,1
964,PT-00964,45,M,Apollo Chennai,Phase IV,ORX-505,Infectious Disease,Low Dose,2023-05-12,2023-08-10,8.04,6.53,115,87,107,None,None,Improved,1
965,PT-00965,42,F,AIIMS Delhi,Phase II,ORX-404,Neurology,Low Dose,2023-09-18,2023-11-13,7.91,7.41,162,61,79,None,None,Worsened,0
966,PT-00966,18,M,Fortis Mumbai,Phase I,ORX-606,Rheumatology,High Dose,2023-07-17,2023-08-14,4.19,4.06,130,78,76,Nausea,None,No Change,0
967,PT-00967,85,M,AIIMS Delhi,Phase III,ORX-303,Cardiology,High Dose,2024-03-20,2024-05-15,6.89,6.95,116,85,74,Nausea,None,Improved,0
968,PT-00968,38,M,NIMHANS Bengaluru,Phase III,ORX-101,Oncology,Low Dose,2023-04-02,2023-04-30,9.38,10.04,130,54,72,Headache,None,Worsened,0
969,PT-00969,85,M,Bhopal Research Hospital,Phase II,ORX-404,Neurology,High Dose,2023-08-16,2023-10-11,6.92,7.52,153,84,66,Headache,None,Worsened,0
970,PT-00970,18,F,Kolkata Clinical Center,Phase III,ORX-101,Oncology,Low Dose,2024-08-08,2024-09-05,8.02,6.89,131,67,74,Nausea,Moderate,No Change,0
971,PT-00971,45,M,NIMHANS Bengaluru,Phase II,ORX-202,Diabetes,Low Dose,2024-11-25,2025-02-23,7.52,6.12,149,74,54,Fatigue,None,No Change,0
972,PT-00972,43,M,AIIMS Delhi,Phase II,ORX-606,Rheumatology,Placebo,2024-01-23,2024-04-22,7.24,6.99,152,79,76,None,None,No Change,0
973,PT-00973,27,F,Apollo Chennai,Phase III,ORX-606,Rheumatology,Low Dose,2024-04-13,2024-04-27,8.18,7.95,120,59,98,None,None,Improved,1
974,PT-00974,25,F,Fortis Mumbai,Phase III,ORX-404,Neurology,Low Dose,2023-08-23,2023-09-20,6.49,6.41,106,64,48,None,None,No Change,0
975,PT-00975,56,F,PGI Chandigarh,Phase III,ORX-101,Oncology,Low Dose,2023-03-20,2023-04-03,6.55,8.78,110,70,70,None,None,Worsened,0
976,PT-00976,48,M,Fortis Mumbai,Phase I,ORX-505,Infectious Disease,High Dose,2023-01-11,2023-03-08,6.64,6.79,110,65,52,Dizziness,None,No Change,0
977,PT-00977,18,F,Bhopal Research Hospital,Phase III,ORX-404,Neurology,Placebo,2023-07-14,2023-07-21,6.58,5.91,116,96,95,Headache,Mild,No Change,0
978,PT-00978,39,M,Indore Medical Institute,Phase IV,ORX-505,Infectious Disease,Low Dose,2023-06-22,2023-09-20,5.05,4.14,117,74,68,None,None,Worsened,0
979,PT-00979,34,F,PGI Chandigarh,Phase III,ORX-101,Oncology,Low Dose,2024-01-24,2024-02-07,6.74,5.76,131,86,65,None,None,Improved,1
980,PT-00980,65,M,Bhopal Research Hospital,Phase III,ORX-303,Cardiology,Placebo,2023-10-28,2023-11-25,6.02,4.17,134,72,82,Headache,Mild,Improved,1
981,PT-00981,18,M,Indore Medical Institute,Phase IV,ORX-404,Neurology,High Dose,2024-05-14,2024-05-21,8.87,9.08,100,64,101,Nausea,None,Improved,0
982,PT-00982,33,F,PGI Chandigarh,Phase I,ORX-606,Rheumatology,Placebo,2023-12-30,2024-01-06,6.2,3.76,121,79,88,None,None,Improved,1
983,PT-00983,22,M,AIIMS Delhi,Phase III,ORX-404,Neurology,Placebo,2024-05-14,2024-05-21,5.38,5.38,146,63,93,Nausea,None,Improved,0
984,PT-00984,45,F,PGI Chandigarh,Phase II,ORX-404,Neurology,High Dose,2024-07-03,2024-07-31,8.51,8.05,90,80,92,None,None,Improved,1
985,PT-00985,30,F,PGI Chandigarh,Phase II,ORX-606,Rheumatology,Low Dose,2024-01-03,2024-01-17,6.73,6.18,90,102,65,None,None,Improved,1
986,PT-00986,53,M,PGI Chandigarh,Phase II,ORX-101,Oncology,Placebo,2023-07-23,2023-09-17,7.1,7.83,135,79,65,Fever,None,Worsened,0
987,PT-00987,57,F,AIIMS Delhi,Phase III,ORX-303,Cardiology,High Dose,2024-02-14,2024-05-14,4.95,5.13,108,97,80,Headache,Moderate,No Change,0
988,PT-00988,55,M,Bhopal Research Hospital,Phase I,ORX-101,Oncology,Placebo,2023-12-19,2024-03-18,7.3,5.32,112,90,80,Headache,None,Improved,1
989,PT-00989,63,F,Indore Medical Institute,Phase III,ORX-404,Neurology,Low Dose,2023-10-16,2023-12-11,7.68,6.41,113,83,45,None,None,Improved,1
990,PT-00990,71,M,AIIMS Delhi,Phase III,ORX-202,Diabetes,Placebo,2023-04-28,2023-05-26,7.73,8.43,99,96,109,None,None,Worsened,0
991,PT-00991,23,F,Bhopal Research Hospital,Phase II,ORX-606,Rheumatology,High Dose,2024-09-17,2024-10-01,8.13,7.73,100,87,89,Fatigue,Mild,Improved,1
992,PT-00992,35,M,AIIMS Delhi,Phase II,ORX-404,Neurology,Placebo,2023-07-16,2023-07-30,8.6,6.7,101,83,78,Nausea,None,Improved,1
993,PT-00993,33,M,Fortis Mumbai,Phase II,ORX-606,Rheumatology,Low Dose,2023-08-25,2023-09-08,8.17,8.25,143,80,86,None,None,Improved,0
994,PT-00994,37,F,Fortis Mumbai,Phase III,ORX-101,Oncology,Placebo,2023-10-15,2023-11-12,9.66,8.53,165,82,58,None,None,No Change,0
995,PT-00995,66,M,Indore Medical Institute,Phase II,ORX-101,Oncology,High Dose,2023-11-26,2023-12-10,7.35,7.72,150,86,69,None,None,Improved,0
996,PT-00996,60,M,Fortis Mumbai,Phase III,ORX-404,Neurology,Low Dose,2023-11-08,2023-11-15,7.2,7.42,90,87,69,None,None,Improved,0
997,PT-00997,71,M,PGI Chandigarh,Phase II,ORX-606,Rheumatology,High Dose,2024-06-25,2024-09-23,7.95,7.76,136,70,100,Nausea,None,Improved,1
998,PT-00998,76,F,Bhopal Research Hospital,Phase I,ORX-202,Diabetes,Low Dose,2024-09-08,2024-09-15,7.67,8.7,117,72,78,Fever,Moderate,Improved,0
999,PT-00999,51,M,Kolkata Clinical Center,Phase II,ORX-101,Oncology,Placebo,2024-07-13,2024-10-11,6.73,6.81,133,70,85,Headache,Severe,Improved,0
1000,PT-01000,58,M,AIIMS Delhi,Phase III,ORX-101,Oncology,Placebo,2024-03-04,2024-06-02,7.41,8.04,106,87,61,Fatigue,Mild,No Change,0
1001,PT-01001,27,F,Kolkata Clinical Center,Phase IV,ORX-606,Rheumatology,High Dose,2024-03-22,2024-03-29,6.44,5.2,118,79,89,None,None,Improved,1
1002,PT-01002,39,M,Fortis Mumbai,Phase II,ORX-606,Rheumatology,High Dose,2023-10-24,2023-10-31,5.3,5.92,112,81,84,None,None,Worsened,0
1003,PT-01003,48,M,NIMHANS Bengaluru,Phase III,ORX-404,Neurology,High Dose,2024-06-09,2024-06-16,8.51,8.54,112,108,80,Headache,None,Improved,0
1004,PT-01004,42,F,Fortis Mumbai,Phase III,ORX-202,Diabetes,Placebo,2023-06-13,2023-09-11,8.36,8.18,135,111,74,Headache,Moderate,Improved,1
1005,PT-01005,39,F,Fortis Mumbai,Phase III,ORX-303,Cardiology,High Dose,2023-10-31,2023-11-28,7.34,7.9,100,58,69,None,None,No Change,0
1006,PT-01006,18,M,Fortis Mumbai,Phase III,ORX-101,Oncology,Low Dose,2023-10-12,2023-10-26,6.69,6.74,111,64,78,Rash,Mild,Improved,0
1007,PT-01007,58,M,Apollo Chennai,Phase IV,ORX-505,Infectious Disease,Placebo,2024-10-26,2024-11-23,5.17,5.5,142,93,95,Fever,None,No Change,0
1008,PT-01008,80,F,NIMHANS Bengaluru,Phase III,ORX-505,Infectious Disease,Placebo,2023-02-28,2023-03-07,6.77,6.47,120,82,99,None,None,No Change,0
1009,PT-01009,23,F,Indore Medical Institute,Phase II,ORX-505,Infectious Disease,High Dose,2024-08-20,2024-08-27,6.17,7.01,146,77,89,Headache,Moderate,No Change,0
1010,PT-01010,50,F,Apollo Chennai,Phase IV,ORX-404,Neurology,Placebo,2023-10-03,2023-10-17,9.0,8.67,146,113,86,Rash,Mild,No Change,0
1011,PT-01011,45,M,NIMHANS Bengaluru,Phase III,ORX-303,Cardiology,Placebo,2024-05-05,2024-05-12,8.07,7.34,170,84,74,None,None,Improved,1
1012,PT-01012,31,M,Kolkata Clinical Center,Phase II,ORX-606,Rheumatology,Placebo,2023-10-16,2023-10-23,8.52,8.9,119,88,56,Fatigue,Moderate,Improved,0
1013,PT-01013,47,M,Bhopal Research Hospital,Phase I,ORX-404,Neurology,Placebo,2024-10-22,2024-12-17,7.74,8.88,114,66,65,None,None,Improved,0
1014,PT-01014,23,M,NIMHANS Bengaluru,Phase III,ORX-404,Neurology,Placebo,2023-01-14,2023-01-21,8.8,9.8,133,96,79,Headache,None,Improved,0
1015,PT-01015,43,M,Indore Medical Institute,Phase III,ORX-101,Oncology,Low Dose,2023-12-13,2023-12-20,6.8,6.12,100,85,77,None,None,Improved,1
1016,PT-01016,56,F,Fortis Mumbai,Phase III,ORX-303,Cardiology,Low Dose,2023-09-07,2023-09-14,7.31,6.77,112,82,88,None,None,Improved,1
1017,PT-01017,26,M,Indore Medical Institute,Phase I,ORX-101,Oncology,Low Dose,2023-04-16,2023-07-15,7.3,7.11,115,74,81,None,None,Worsened,0
1018,PT-01018,26,M,Indore Medical Institute,Phase IV,ORX-202,Diabetes,Low Dose,2023-05-31,2023-06-28,7.62,6.41,147,110,65,None,None,No Change,0
1019,PT-01019,53,F,Bhopal Research Hospital,Phase III,ORX-404,Neurology,Placebo,2023-04-23,2023-05-07,6.33,6.86,105,87,65,Dizziness,None,Improved,0
1020,PT-01020,41,F,Bhopal Research Hospital,Phase I,ORX-101,Oncology,Low Dose,2023-07-02,2023-08-27,5.96,6.3,112,88,73,Nausea,Mild,Improved,0
1021,PT-01021,43,M,Fortis Mumbai,Phase IV,ORX-505,Infectious Disease,High Dose,2023-12-23,2023-12-30,7.38,6.29,131,100,67,None,None,Improved,1
1022,PT-01022,63,F,Bhopal Research Hospital,Phase IV,ORX-101,Oncology,High Dose,2023-06-02,2023-06-16,9.0,7.86,101,85,70,None,None,Improved,1
1023,PT-01023,74,F,Bhopal Research Hospital,Phase III,ORX-505,Infectious Disease,Low Dose,2023-10-13,2023-10-27,7.24,6.12,107,95,70,Fever,None,Improved,1
1024,PT-01024,45,F,Kolkata Clinical Center,Phase II,ORX-404,Neurology,Low Dose,2024-02-28,2024-05-28,8.35,7.51,127,81,87,None,None,No Change,0
1025,PT-01025,54,M,Kolkata Clinical Center,Phase II,ORX-505,Infectious Disease,Low Dose,2024-06-29,2024-09-27,6.94,6.59,121,64,81,None,None,No Change,0
1026,PT-01026,75,F,Apollo Chennai,Phase III,ORX-606,Rheumatology,Placebo,2024-01-06,2024-01-13,6.14,5.04,112,90,84,Fatigue,None,Improved,1
1027,PT-01027,42,F,Bhopal Research Hospital,Phase IV,ORX-101,Oncology,High Dose,2024-01-05,2024-01-19,6.1,5.78,99,83,90,None,None,Improved,1
1028,PT-01028,24,F,Apollo Chennai,Phase II,ORX-101,Oncology,High Dose,2023-05-01,2023-05-15,5.36,6.38,116,95,75,None,None,Improved,0
1029,PT-01029,42,F,Bhopal Research Hospital,Phase II,ORX-606,Rheumatology,Low Dose,2024-05-03,2024-08-01,7.73,6.53,130,77,59,None,None,Worsened,0
1030,PT-01030,50,F,Apollo Chennai,Phase I,ORX-101,Oncology,Placebo,2024-03-02,2024-03-16,6.88,6.34,106,101,90,None,None,No Change,0
1031,PT-01031,60,M,Fortis Mumbai,Phase III,ORX-404,Neurology,Low Dose,2023-12-12,2024-02-06,6.83,4.88,163,81,67,Headache,None,No Change,0
1032,PT-01032,51,M,Indore Medical Institute,Phase I,ORX-505,Infectious Disease,High Dose,2024-05-30,2024-06-13,8.6,8.18,151,94,62,Rash,Mild,Improved,1
1033,PT-01033,34,F,Fortis Mumbai,Phase III,ORX-505,Infectious Disease,Low Dose,2023-08-21,2023-10-16,8.35,5.51,125,64,71,None,None,Worsened,0
1034,PT-01034,40,M,AIIMS Delhi,Phase III,ORX-606,Rheumatology,Placebo,2024-09-25,2024-10-02,6.77,5.87,108,109,104,None,None,Improved,1
1035,PT-01035,26,M,Kolkata Clinical Center,Phase III,ORX-404,Neurology,Low Dose,2024-10-19,2024-12-14,9.1,8.34,130,81,68,None,None,No Change,0
1036,PT-01036,60,F,Apollo Chennai,Phase III,ORX-303,Cardiology,Placebo,2023-03-21,2023-04-18,7.35,6.52,104,71,55,Rash,None,No Change,0
1037,PT-01037,45,F,Bhopal Research Hospital,Phase II,ORX-101,Oncology,Placebo,2023-01-12,2023-02-09,5.76,5.12,152,96,77,None,None,Improved,1
1038,PT-01038,43,M,Bhopal Research Hospital,Phase II,ORX-505,Infectious Disease,Low Dose,2024-07-31,2024-09-25,9.46,9.52,122,64,83,None,None,Improved,0
1039,PT-01039,58,F,PGI Chandigarh,Phase I,ORX-303,Cardiology,High Dose,2024-05-27,2024-06-10,6.44,6.3,121,79,45,None,None,Improved,1
1040,PT-01040,41,F,Bhopal Research Hospital,Phase IV,ORX-303,Cardiology,Low Dose,2024-05-30,2024-06-06,8.36,7.39,128,72,83,Headache,None,Improved,1
1041,PT-01041,41,F,Indore Medical Institute,Phase III,ORX-303,Cardiology,Placebo,2024-11-29,2025-01-24,6.07,6.87,144,74,84,Nausea,Severe,Improved,0
1042,PT-01042,53,M,AIIMS Delhi,Phase IV,ORX-606,Rheumatology,Placebo,2024-05-28,2024-08-26,7.97,6.05,146,75,72,Nausea,None,Worsened,0
1043,PT-01043,85,F,AIIMS Delhi,Phase III,ORX-303,Cardiology,Placebo,2024-09-30,2024-11-25,7.56,6.81,90,98,59,Headache,Mild,Improved,1
1044,PT-01044,28,M,Bhopal Research Hospital,Phase II,ORX-202,Diabetes,Low Dose,2024-05-24,2024-05-31,6.8,7.68,141,80,82,None,None,No Change,0
1045,PT-01045,35,F,Bhopal Research Hospital,Phase III,ORX-404,Neurology,Placebo,2023-11-18,2023-12-02,7.37,7.03,145,93,84,None,None,Worsened,0
1046,PT-01046,39,F,PGI Chandigarh,Phase III,ORX-101,Oncology,Placebo,2024-04-16,2024-05-14,8.09,7.61,108,77,79,Fever,Mild,Worsened,0
1047,PT-01047,59,F,AIIMS Delhi,Phase III,ORX-101,Oncology,High Dose,2024-05-14,2024-05-21,6.98,5.49,129,83,80,None,None,Improved,1
1048,PT-01048,59,F,AIIMS Delhi,Phase IV,ORX-404,Neurology,Low Dose,2024-10-01,2024-10-29,8.42,7.49,116,69,87,Headache,None,Improved,1
1049,PT-01049,68,F,Indore Medical Institute,Phase IV,ORX-505,Infectious Disease,High Dose,2023-02-28,2023-03-14,6.82,6.2,154,88,84,Nausea,None,No Change,0
1050,PT-01050,25,M,AIIMS Delhi,Phase II,ORX-505,Infectious Disease,Low Dose,2023-03-16,2023-03-30,8.01,6.78,107,77,69,None,None,Improved,1
1051,PT-01051,41,M,Kolkata Clinical Center,Phase II,ORX-606,Rheumatology,Low Dose,2024-04-21,2024-04-28,5.47,5.93,148,58,91,Headache,Moderate,Improved,0
1052,PT-01052,32,F,Apollo Chennai,Phase III,ORX-404,Neurology,Low Dose,2023-11-21,2023-12-19,8.23,7.77,128,79,94,None,None,Worsened,0
1053,PT-01053,25,F,Kolkata Clinical Center,Phase I,ORX-101,Oncology,Low Dose,2024-04-26,2024-05-10,7.93,8.52,140,109,70,None,None,No Change,0
1054,PT-01054,60,M,NIMHANS Bengaluru,Phase IV,ORX-101,Oncology,High Dose,2024-01-06,2024-03-02,7.07,7.78,127,77,96,None,None,Worsened,0
1055,PT-01055,37,M,NIMHANS Bengaluru,Phase IV,ORX-303,Cardiology,Placebo,2023-06-30,2023-07-07,5.5,4.64,139,98,79,None,None,Improved,1
1056,PT-01056,66,M,Kolkata Clinical Center,Phase II,ORX-404,Neurology,Low Dose,2024-11-16,2024-12-14,5.57,4.77,122,80,79,None,None,Improved,1
1057,PT-01057,56,F,Fortis Mumbai,Phase II,ORX-202,Diabetes,Placebo,2024-03-05,2024-04-30,6.67,6.39,127,70,76,Headache,None,Improved,1
1058,PT-01058,42,F,NIMHANS Bengaluru,Phase II,ORX-101,Oncology,Low Dose,2024-09-03,2024-09-17,7.0,6.63,129,76,95,Nausea,Mild,Improved,1
1059,PT-01059,26,F,PGI Chandigarh,Phase III,ORX-101,Oncology,Placebo,2024-04-14,2024-04-28,6.33,8.44,109,65,88,None,None,Improved,0
1060,PT-01060,18,F,Indore Medical Institute,Phase II,ORX-404,Neurology,High Dose,2023-05-09,2023-07-04,6.92,8.45,100,58,57,Nausea,None,No Change,0
1061,PT-01061,59,M,AIIMS Delhi,Phase III,ORX-505,Infectious Disease,Low Dose,2023-12-23,2024-01-06,8.55,7.69,140,98,103,Fever,Mild,Worsened,0
1062,PT-01062,41,M,PGI Chandigarh,Phase II,ORX-101,Oncology,Low Dose,2023-11-11,2024-02-09,4.44,3.3,120,78,75,None,None,No Change,0
1063,PT-01063,62,F,Kolkata Clinical Center,Phase III,ORX-404,Neurology,Low Dose,2023-12-27,2024-03-26,8.73,8.17,147,86,78,Fever,None,Improved,1
1064,PT-01064,59,M,PGI Chandigarh,Phase III,ORX-202,Diabetes,Low Dose,2023-06-16,2023-09-14,7.29,8.74,102,75,76,None,None,Improved,0
1065,PT-01065,52,F,Bhopal Research Hospital,Phase III,ORX-101,Oncology,High Dose,2023-04-17,2023-04-24,8.72,8.3,102,92,88,Nausea,None,No Change,0
1066,PT-01066,18,F,Bhopal Research Hospital,Phase III,ORX-606,Rheumatology,Low Dose,2024-08-18,2024-08-25,7.2,5.36,116,71,89,Fatigue,None,No Change,0
1067,PT-01067,46,F,Bhopal Research Hospital,Phase III,ORX-202,Diabetes,High Dose,2023-05-08,2023-06-05,5.66,6.05,102,85,66,Fatigue,None,Worsened,0
1068,PT-01068,39,F,PGI Chandigarh,Phase I,ORX-202,Diabetes,Low Dose,2023-10-02,2023-10-30,7.81,7.87,152,81,82,Fatigue,Moderate,Improved,0
1069,PT-01069,37,M,NIMHANS Bengaluru,Phase I,ORX-101,Oncology,Placebo,2023-06-07,2023-07-05,7.42,7.41,126,60,82,None,None,No Change,0
1070,PT-01070,50,F,NIMHANS Bengaluru,Phase II,ORX-202,Diabetes,Low Dose,2024-02-05,2024-02-19,6.38,4.83,154,87,74,None,None,No Change,0
1071,PT-01071,26,M,NIMHANS Bengaluru,Phase III,ORX-202,Diabetes,High Dose,2024-02-04,2024-02-18,6.21,6.99,130,75,85,None,None,Improved,0
1072,PT-01072,31,M,Bhopal Research Hospital,Phase III,ORX-606,Rheumatology,High Dose,2024-05-31,2024-06-07,9.0,9.82,119,74,45,Headache,Moderate,No Change,0
1073,PT-01073,21,F,AIIMS Delhi,Phase III,ORX-303,Cardiology,Placebo,2023-04-06,2023-04-13,5.59,5.31,122,65,74,Nausea,Mild,Improved,1
1074,PT-01074,53,M,Bhopal Research Hospital,Phase III,ORX-505,Infectious Disease,Low Dose,2023-05-14,2023-07-09,7.83,5.72,125,65,90,Headache,None,No Change,0
1075,PT-01075,57,M,Apollo Chennai,Phase II,ORX-606,Rheumatology,High Dose,2024-01-23,2024-02-20,6.12,5.03,119,54,82,None,None,No Change,0
1076,PT-01076,40,M,Bhopal Research Hospital,Phase III,ORX-101,Oncology,Low Dose,2024-09-02,2024-09-09,8.36,6.98,116,63,63,None,None,Improved,1
1077,PT-01077,26,M,Kolkata Clinical Center,Phase I,ORX-303,Cardiology,High Dose,2023-08-01,2023-09-26,8.4,7.37,130,77,60,Rash,None,Improved,1
1078,PT-01078,42,F,Bhopal Research Hospital,Phase IV,ORX-202,Diabetes,High Dose,2024-01-20,2024-02-17,7.92,6.43,142,71,71,None,None,No Change,0
1079,PT-01079,53,M,Indore Medical Institute,Phase II,ORX-202,Diabetes,High Dose,2024-10-08,2025-01-06,6.4,6.04,122,83,45,None,None,Worsened,0
1080,PT-01080,18,F,Kolkata Clinical Center,Phase IV,ORX-505,Infectious Disease,Low Dose,2023-01-06,2023-01-20,7.94,8.47,111,79,82,None,None,Improved,0
1081,PT-01081,56,M,Indore Medical Institute,Phase II,ORX-505,Infectious Disease,Placebo,2024-06-08,2024-06-22,4.77,3.57,122,90,112,None,None,Improved,1
1082,PT-01082,41,M,AIIMS Delhi,Phase I,ORX-202,Diabetes,Placebo,2023-05-10,2023-06-07,5.51,5.47,151,83,65,None,None,Improved,1
1083,PT-01083,60,M,Fortis Mumbai,Phase II,ORX-404,Neurology,High Dose,2024-05-22,2024-07-17,8.0,6.67,134,93,94,None,None,Improved,1
1084,PT-01084,43,M,Apollo Chennai,Phase II,ORX-606,Rheumatology,High Dose,2023-10-15,2023-12-10,6.77,7.47,106,87,58,Rash,Mild,Improved,0
1085,PT-01085,62,M,Kolkata Clinical Center,Phase III,ORX-404,Neurology,High Dose,2024-03-09,2024-06-07,6.89,7.63,136,67,97,Rash,Mild,No Change,0
1086,PT-01086,69,F,PGI Chandigarh,Phase III,ORX-303,Cardiology,High Dose,2023-03-07,2023-05-02,8.26,7.17,122,83,68,None,None,Improved,1
1087,PT-01087,72,F,Fortis Mumbai,Phase III,ORX-505,Infectious Disease,High Dose,2024-10-22,2025-01-20,7.37,4.54,134,77,76,None,None,Improved,1
1088,PT-01088,39,M,NIMHANS Bengaluru,Phase III,ORX-202,Diabetes,Low Dose,2023-03-16,2023-03-30,8.17,8.78,133,77,77,None,None,No Change,0
1089,PT-01089,45,F,PGI Chandigarh,Phase I,ORX-606,Rheumatology,Placebo,2023-12-03,2023-12-17,6.24,6.36,136,100,95,Rash,Moderate,Improved,0
1090,PT-01090,34,M,Apollo Chennai,Phase II,ORX-505,Infectious Disease,Placebo,2024-07-28,2024-08-25,8.18,6.93,140,75,63,Dizziness,Moderate,No Change,0
1091,PT-01091,49,M,NIMHANS Bengaluru,Phase III,ORX-606,Rheumatology,High Dose,2023-11-22,2023-12-20,3.99,2.01,124,82,72,None,None,Improved,1
1092,PT-01092,19,F,Fortis Mumbai,Phase III,ORX-404,Neurology,Placebo,2024-04-08,2024-04-22,6.22,6.17,138,81,94,Nausea,None,No Change,0
1093,PT-01093,51,M,Indore Medical Institute,Phase II,ORX-404,Neurology,Placebo,2024-02-17,2024-02-24,6.3,5.65,102,80,93,Fatigue,None,Worsened,0
1094,PT-01094,55,M,Bhopal Research Hospital,Phase I,ORX-404,Neurology,High Dose,2023-10-09,2023-11-06,8.88,8.21,152,79,98,None,None,No Change,0
1095,PT-01095,44,F,Indore Medical Institute,Phase III,ORX-404,Neurology,Placebo,2024-04-10,2024-06-05,8.05,8.98,124,84,96,Fever,None,No Change,0
1096,PT-01096,42,F,Bhopal Research Hospital,Phase IV,ORX-101,Oncology,Placebo,2023-01-11,2023-01-25,5.61,7.14,119,83,94,None,None,Improved,0
1097,PT-01097,35,F,Bhopal Research Hospital,Phase II,ORX-202,Diabetes,High Dose,2024-01-13,2024-04-12,5.99,5.82,95,78,81,Dizziness,Moderate,Worsened,0
1098,PT-01098,40,F,Indore Medical Institute,Phase IV,ORX-101,Oncology,Placebo,2023-11-08,2023-11-15,5.35,6.38,129,99,74,Headache,Mild,Improved,0
1099,PT-01099,30,F,AIIMS Delhi,Phase II,ORX-202,Diabetes,Low Dose,2023-05-03,2023-05-17,7.52,6.93,106,99,69,None,None,Improved,1
1100,PT-01100,18,F,Bhopal Research Hospital,Phase III,ORX-505,Infectious Disease,Low Dose,2024-08-14,2024-10-09,8.79,7.94,117,60,102,Fever,None,No Change,0
1101,PT-01101,24,F,Fortis Mumbai,Phase II,ORX-303,Cardiology,High Dose,2023-12-28,2024-03-27,7.27,7.69,135,81,54,None,None,No Change,0
1102,PT-01102,32,M,Bhopal Research Hospital,Phase III,ORX-404,Neurology,Placebo,2023-01-14,2023-01-28,7.43,6.32,131,90,91,None,None,Improved,1
1103,PT-01103,25,F,Apollo Chennai,Phase I,ORX-505,Infectious Disease,High Dose,2024-06-10,2024-07-08,9.84,10.13,127,95,111,None,None,No Change,0
1104,PT-01104,21,F,Bhopal Research Hospital,Phase III,ORX-202,Diabetes,Placebo,2024-01-08,2024-03-04,6.93,4.39,131,86,77,Fatigue,None,Worsened,0
1105,PT-01105,34,F,Fortis Mumbai,Phase II,ORX-404,Neurology,Placebo,2023-11-11,2024-02-09,4.74,4.68,154,74,84,None,None,No Change,0
1106,PT-01106,19,M,Apollo Chennai,Phase III,ORX-101,Oncology,High Dose,2023-07-11,2023-08-08,7.75,6.99,114,72,72,Nausea,None,Improved,1
1107,PT-01107,51,F,Bhopal Research Hospital,Phase I,ORX-303,Cardiology,Low Dose,2023-06-04,2023-07-30,5.63,4.87,127,68,103,None,None,Improved,1
1108,PT-01108,31,M,PGI Chandigarh,Phase III,ORX-101,Oncology,Placebo,2024-01-27,2024-03-23,6.4,5.12,160,88,64,None,None,Improved,1
1109,PT-01109,62,M,Kolkata Clinical Center,Phase III,ORX-505,Infectious Disease,Low Dose,2024-11-28,2024-12-05,7.44,7.27,121,73,82,Dizziness,None,No Change,0
1110,PT-01110,36,M,Fortis Mumbai,Phase IV,ORX-202,Diabetes,Placebo,2023-04-14,2023-05-12,9.38,7.84,155,80,82,Nausea,Mild,Improved,1
1111,PT-01111,58,F,Apollo Chennai,Phase II,ORX-606,Rheumatology,High Dose,2023-10-02,2023-11-27,6.44,6.82,90,73,65,Headache,None,Improved,0
1112,PT-01112,24,F,Fortis Mumbai,Phase III,ORX-606,Rheumatology,Placebo,2023-07-09,2023-10-07,6.94,6.89,140,84,68,Nausea,Mild,Worsened,0
1113,PT-01113,50,M,Bhopal Research Hospital,Phase II,ORX-202,Diabetes,Placebo,2024-04-11,2024-04-25,7.35,7.79,141,82,65,Nausea,None,Worsened,0
1114,PT-01114,34,M,Fortis Mumbai,Phase II,ORX-101,Oncology,Placebo,2023-01-10,2023-04-10,6.54,5.86,132,90,77,None,None,Improved,1
1115,PT-01115,45,M,Apollo Chennai,Phase III,ORX-404,Neurology,Placebo,2023-01-18,2023-04-18,7.37,6.51,111,60,68,None,None,No Change,0
1116,PT-01116,52,M,AIIMS Delhi,Phase III,ORX-202,Diabetes,High Dose,2023-04-13,2023-05-11,6.36,5.74,136,88,62,None,None,No Change,0
1117,PT-01117,60,F,Fortis Mumbai,Phase III,ORX-606,Rheumatology,Low Dose,2024-01-09,2024-03-05,8.55,7.14,113,96,75,None,None,Improved,1
1118,PT-01118,18,F,Kolkata Clinical Center,Phase IV,ORX-101,Oncology,Placebo,2024-06-15,2024-06-22,5.52,4.9,107,77,78,None,None,Improved,1
1119,PT-01119,68,M,AIIMS Delhi,Phase III,ORX-303,Cardiology,Low Dose,2023-09-08,2023-12-07,6.85,7.42,153,99,81,Fever,None,No Change,0
1120,PT-01120,18,M,NIMHANS Bengaluru,Phase II,ORX-606,Rheumatology,Placebo,2023-10-08,2024-01-06,7.75,8.3,126,102,90,None,None,Worsened,0
1121,PT-01121,54,M,PGI Chandigarh,Phase II,ORX-303,Cardiology,Low Dose,2024-03-03,2024-03-31,8.5,8.4,90,76,94,None,None,Improved,1
1122,PT-01122,32,F,Bhopal Research Hospital,Phase III,ORX-404,Neurology,High Dose,2024-08-03,2024-08-31,6.93,5.59,160,102,65,Fever,None,Improved,1
1123,PT-01123,47,M,AIIMS Delhi,Phase III,ORX-505,Infectious Disease,High Dose,2024-09-30,2024-12-29,6.38,6.54,137,91,82,None,None,No Change,0
1124,PT-01124,85,F,Fortis Mumbai,Phase I,ORX-101,Oncology,Low Dose,2023-08-11,2023-09-08,5.97,4.03,120,63,57,None,None,No Change,0
1125,PT-01125,28,F,NIMHANS Bengaluru,Phase II,ORX-303,Cardiology,High Dose,2023-01-01,2023-01-08,6.09,4.83,137,75,75,None,None,Improved,1
1126,PT-01126,59,F,AIIMS Delhi,Phase III,ORX-101,Oncology,High Dose,2023-05-27,2023-06-10,6.28,5.64,134,58,45,Fatigue,None,Improved,1
1127,PT-01127,50,M,PGI Chandigarh,Phase III,ORX-202,Diabetes,High Dose,2024-10-14,2024-12-09,7.79,9.25,130,91,75,Fever,None,Improved,0
1128,PT-01128,49,F,Fortis Mumbai,Phase IV,ORX-202,Diabetes,Low Dose,2024-11-26,2024-12-24,9.2,6.89,135,107,81,None,None,No Change,0
1129,PT-01129,71,M,NIMHANS Bengaluru,Phase II,ORX-505,Infectious Disease,Placebo,2023-11-09,2023-11-16,6.44,6.02,128,55,61,Dizziness,None,Improved,1
1130,PT-01130,27,M,NIMHANS Bengaluru,Phase II,ORX-101,Oncology,Placebo,2024-03-28,2024-04-25,8.19,8.57,133,91,75,Headache,None,Improved,0
1131,PT-01131,64,F,NIMHANS Bengaluru,Phase III,ORX-404,Neurology,Low Dose,2024-07-26,2024-08-02,7.21,6.86,123,90,72,None,None,Worsened,0
1132,PT-01132,60,M,Fortis Mumbai,Phase III,ORX-202,Diabetes,Low Dose,2024-01-18,2024-02-01,5.84,4.45,140,80,71,Fatigue,Moderate,No Change,0
1133,PT-01133,59,M,NIMHANS Bengaluru,Phase III,ORX-202,Diabetes,Low Dose,2023-01-07,2023-03-04,6.47,5.89,153,100,100,Fatigue,None,No Change,0
1134,PT-01134,40,M,Fortis Mumbai,Phase I,ORX-606,Rheumatology,Placebo,2024-08-31,2024-09-07,8.68,7.42,111,53,101,Nausea,Mild,No Change,0
1135,PT-01135,31,M,Indore Medical Institute,Phase I,ORX-606,Rheumatology,Placebo,2023-05-28,2023-08-26,7.05,5.83,140,77,59,None,None,No Change,0
1136,PT-01136,52,M,AIIMS Delhi,Phase IV,ORX-303,Cardiology,Low Dose,2023-01-07,2023-03-04,5.48,4.33,90,64,80,None,None,No Change,0
1137,PT-01137,18,M,Bhopal Research Hospital,Phase I,ORX-505,Infectious Disease,Placebo,2023-07-29,2023-08-05,5.42,5.02,118,105,103,Rash,None,Improved,1
1138,PT-01138,31,M,Fortis Mumbai,Phase IV,ORX-404,Neurology,Low Dose,2023-07-08,2023-07-22,7.87,8.14,117,64,77,None,None,No Change,0
1139,PT-01139,42,F,Bhopal Research Hospital,Phase IV,ORX-404,Neurology,Placebo,2023-01-23,2023-02-06,6.68,6.68,114,68,79,Headache,None,Improved,1
1140,PT-01140,51,M,Fortis Mumbai,Phase III,ORX-303,Cardiology,High Dose,2024-08-25,2024-10-20,5.79,6.22,96,75,74,None,None,Improved,0
1141,PT-01141,34,F,Bhopal Research Hospital,Phase III,ORX-404,Neurology,Low Dose,2024-03-11,2024-03-25,6.52,7.81,112,111,84,None,None,Improved,0
1142,PT-01142,46,F,Fortis Mumbai,Phase I,ORX-101,Oncology,Low Dose,2024-11-03,2025-02-01,7.77,9.65,110,68,67,Fatigue,None,Improved,0
1143,PT-01143,45,M,Kolkata Clinical Center,Phase III,ORX-303,Cardiology,Placebo,2023-06-12,2023-07-10,5.13,4.75,158,83,73,Fatigue,None,Improved,1
1144,PT-01144,35,F,AIIMS Delhi,Phase III,ORX-606,Rheumatology,Placebo,2024-11-02,2025-01-31,8.28,7.13,161,105,81,Headache,Mild,Improved,1
1145,PT-01145,44,F,Fortis Mumbai,Phase III,ORX-404,Neurology,Placebo,2024-10-22,2024-12-17,8.44,9.02,113,75,59,None,None,Improved,0
1146,PT-01146,51,M,Fortis Mumbai,Phase III,ORX-202,Diabetes,High Dose,2024-08-25,2024-11-23,8.0,6.39,119,65,65,Nausea,None,Improved,1
1147,PT-01147,53,M,AIIMS Delhi,Phase I,ORX-202,Diabetes,Placebo,2023-04-19,2023-06-14,6.32,5.65,98,84,77,None,None,Worsened,0
1148,PT-01148,33,M,Apollo Chennai,Phase IV,ORX-101,Oncology,High Dose,2023-06-28,2023-08-23,6.97,6.74,113,64,103,None,None,No Change,0
1149,PT-01149,34,M,Fortis Mumbai,Phase I,ORX-101,Oncology,Placebo,2023-03-16,2023-05-11,7.08,7.59,190,67,84,Nausea,Moderate,No Change,0
1150,PT-01150,33,M,Kolkata Clinical Center,Phase II,ORX-404,Neurology,Placebo,2024-10-14,2025-01-12,6.55,5.51,107,81,57,None,None,No Change,0
1151,PT-01151,60,F,Fortis Mumbai,Phase III,ORX-202,Diabetes,Placebo,2023-06-15,2023-08-10,7.27,7.25,119,77,82,Rash,None,No Change,0
1152,PT-01152,26,M,Bhopal Research Hospital,Phase III,ORX-202,Diabetes,Placebo,2023-05-24,2023-05-31,6.77,5.6,111,56,96,None,None,Improved,1
1153,PT-01153,34,M,Kolkata Clinical Center,Phase II,ORX-202,Diabetes,High Dose,2024-08-07,2024-10-02,8.6,9.16,104,68,113,None,None,Improved,0
1154,PT-01154,73,M,Kolkata Clinical Center,Phase III,ORX-404,Neurology,Low Dose,2023-03-14,2023-06-12,7.16,6.99,116,87,67,Headache,None,Improved,1
1155,PT-01155,18,M,Indore Medical Institute,Phase III,ORX-505,Infectious Disease,Low Dose,2023-01-24,2023-02-07,5.61,5.23,107,81,62,None,None,No Change,0
1156,PT-01156,32,F,PGI Chandigarh,Phase II,ORX-101,Oncology,High Dose,2023-06-11,2023-07-09,8.22,8.05,127,92,84,Nausea,Moderate,Improved,1
1157,PT-01157,68,F,Indore Medical Institute,Phase II,ORX-505,Infectious Disease,High Dose,2023-04-24,2023-07-23,6.65,5.86,104,76,91,Fatigue,None,Improved,1
1158,PT-01158,65,M,NIMHANS Bengaluru,Phase I,ORX-303,Cardiology,Placebo,2023-03-02,2023-03-16,8.35,6.34,147,59,90,Rash,None,Improved,1
1159,PT-01159,39,M,Bhopal Research Hospital,Phase II,ORX-505,Infectious Disease,High Dose,2023-02-06,2023-03-06,8.04,6.44,149,64,68,Dizziness,Mild,Worsened,0
1160,PT-01160,29,M,Kolkata Clinical Center,Phase IV,ORX-202,Diabetes,Placebo,2023-02-12,2023-02-19,5.09,4.78,160,114,79,None,None,Improved,1
1161,PT-01161,62,F,Fortis Mumbai,Phase III,ORX-202,Diabetes,Placebo,2023-02-26,2023-03-05,7.48,7.53,121,84,85,Rash,None,No Change,0
1162,PT-01162,35,F,Indore Medical Institute,Phase III,ORX-505,Infectious Disease,Low Dose,2024-02-01,2024-03-28,7.11,6.65,142,69,77,None,None,No Change,0
1163,PT-01163,75,F,Bhopal Research Hospital,Phase III,ORX-404,Neurology,Placebo,2024-09-22,2024-10-20,8.6,9.41,128,85,92,None,None,Improved,0
1164,PT-01164,69,M,Bhopal Research Hospital,Phase II,ORX-505,Infectious Disease,Placebo,2024-02-27,2024-05-27,4.86,3.27,151,78,68,Fever,None,No Change,0
1165,PT-01165,24,M,Bhopal Research Hospital,Phase III,ORX-101,Oncology,Placebo,2023-07-04,2023-08-01,6.53,,165,81,77,None,None,Improved,1
1166,PT-01166,54,M,AIIMS Delhi,Phase IV,ORX-505,Infectious Disease,Low Dose,2024-11-04,2024-11-11,8.35,8.81,147,74,73,None,None,No Change,0
1167,PT-01167,57,M,PGI Chandigarh,Phase III,ORX-202,Diabetes,Low Dose,2023-11-06,2023-12-04,6.57,6.16,135,91,53,None,None,No Change,0
1168,PT-01168,56,M,Fortis Mumbai,Phase III,ORX-303,Cardiology,High Dose,2024-05-30,2024-06-06,6.92,7.16,141,101,96,Fatigue,Mild,Improved,0
1169,PT-01169,66,F,Apollo Chennai,Phase II,ORX-202,Diabetes,High Dose,2024-06-17,2024-07-01,8.93,8.79,128,92,88,Nausea,None,Improved,1
1170,PT-01170,40,M,Apollo Chennai,Phase I,ORX-606,Rheumatology,Low Dose,2024-04-09,2024-04-16,7.69,7.25,112,97,78,Rash,None,Improved,1
1171,PT-01171,77,F,Bhopal Research Hospital,Phase II,ORX-101,Oncology,Placebo,2024-09-16,2024-11-11,5.25,4.35,128,95,83,Fatigue,None,Improved,1
1172,PT-01172,49,M,NIMHANS Bengaluru,Phase II,ORX-202,Diabetes,High Dose,2024-06-29,2024-07-06,5.85,4.41,133,65,70,None,None,No Change,0
1173,PT-01173,53,F,PGI Chandigarh,Phase IV,ORX-303,Cardiology,High Dose,2024-08-28,2024-09-11,6.02,7.07,150,63,64,None,None,No Change,0
1174,PT-01174,18,F,Indore Medical Institute,Phase IV,ORX-101,Oncology,Low Dose,2024-11-25,2024-12-23,6.26,6.55,120,87,56,Dizziness,None,Worsened,0
1175,PT-01175,57,F,NIMHANS Bengaluru,Phase II,ORX-404,Neurology,High Dose,2023-09-01,2023-09-15,6.53,6.14,126,66,61,None,None,Worsened,0
1176,PT-01176,60,F,Apollo Chennai,Phase I,ORX-505,Infectious Disease,Placebo,2024-08-07,2024-10-02,7.68,8.22,133,83,53,None,None,Improved,0
1177,PT-01177,40,F,Indore Medical Institute,Phase III,ORX-101,Oncology,Low Dose,2024-11-07,2024-12-05,7.17,8.52,140,100,86,Rash,None,No Change,0
1178,PT-01178,33,M,Kolkata Clinical Center,Phase III,ORX-101,Oncology,High Dose,2024-05-06,2024-08-04,7.34,7.15,111,77,75,None,None,Improved,1
1179,PT-01179,70,M,PGI Chandigarh,Phase II,ORX-101,Oncology,Low Dose,2023-09-22,2023-10-20,4.7,5.39,111,65,94,None,None,Improved,0
1180,PT-01180,56,M,AIIMS Delhi,Phase III,ORX-505,Infectious Disease,High Dose,2023-08-27,2023-09-03,8.71,9.03,165,88,75,None,None,No Change,0
1181,PT-01181,50,F,Indore Medical Institute,Phase III,ORX-505,Infectious Disease,High Dose,2023-03-04,2023-04-01,8.69,7.59,116,78,48,None,None,Worsened,0
1182,PT-01182,47,F,Indore Medical Institute,Phase III,ORX-505,Infectious Disease,Placebo,2023-04-22,2023-04-29,4.94,4.58,143,76,101,None,None,Improved,1
1183,PT-01183,21,M,PGI Chandigarh,Phase II,ORX-505,Infectious Disease,Low Dose,2024-11-28,2025-01-23,8.63,8.84,97,114,77,None,None,Improved,0
1184,PT-01184,30,F,PGI Chandigarh,Phase I,ORX-505,Infectious Disease,High Dose,2023-12-10,2024-02-04,5.51,4.91,125,83,73,None,None,Worsened,0
1185,PT-01185,55,F,AIIMS Delhi,Phase III,ORX-303,Cardiology,Placebo,2023-06-03,2023-09-01,6.73,4.59,125,53,82,Nausea,Moderate,Improved,1
1186,PT-01186,29,F,NIMHANS Bengaluru,Phase IV,ORX-505,Infectious Disease,Placebo,2023-06-03,2023-07-29,7.4,8.18,110,94,71,Nausea,Severe,No Change,0
1187,PT-01187,73,M,NIMHANS Bengaluru,Phase III,ORX-505,Infectious Disease,High Dose,2024-06-24,2024-07-01,6.76,5.61,140,76,66,Nausea,None,No Change,0
1188,PT-01188,37,F,Fortis Mumbai,Phase II,ORX-202,Diabetes,Low Dose,2024-01-06,2024-01-20,7.15,7.95,93,82,86,Headache,None,Improved,0
1189,PT-01189,48,M,NIMHANS Bengaluru,Phase III,ORX-303,Cardiology,Placebo,2024-07-27,2024-10-25,8.77,8.3,124,89,79,None,None,Improved,1
1190,PT-01190,38,F,Kolkata Clinical Center,Phase III,ORX-404,Neurology,Placebo,2023-05-09,2023-08-07,7.82,6.83,116,75,96,Fatigue,Mild,Improved,1
1191,PT-01191,18,M,Fortis Mumbai,Phase III,ORX-303,Cardiology,Low Dose,2023-03-25,2023-05-20,7.67,7.31,97,85,84,Fever,Mild,Improved,1
1192,PT-01192,54,M,Kolkata Clinical Center,Phase IV,ORX-101,Oncology,Placebo,2024-03-04,2024-04-01,4.02,4.85,114,90,88,Headache,None,No Change,0
1193,PT-01193,30,M,Indore Medical Institute,Phase I,ORX-404,Neurology,Placebo,2023-06-20,2023-06-27,7.99,7.25,90,96,67,Fatigue,Moderate,Improved,1
1194,PT-01194,31,F,NIMHANS Bengaluru,Phase II,ORX-606,Rheumatology,Low Dose,2023-10-28,2023-11-04,6.72,6.56,126,88,59,Rash,None,Improved,1
1195,PT-01195,33,M,Indore Medical Institute,Phase IV,ORX-101,Oncology,High Dose,2023-12-30,2024-02-24,7.06,8.37,125,95,78,Nausea,Mild,Worsened,0
1196,PT-01196,37,F,Kolkata Clinical Center,Phase II,ORX-606,Rheumatology,Placebo,2023-07-07,2023-10-05,6.9,6.35,138,98,83,Dizziness,None,Worsened,0
1197,PT-01197,63,M,PGI Chandigarh,Phase III,ORX-606,Rheumatology,Low Dose,2024-01-24,2024-02-21,6.04,5.27,114,85,72,None,None,Improved,1
1198,PT-01198,56,F,Bhopal Research Hospital,Phase IV,ORX-202,Diabetes,Placebo,2023-12-16,2023-12-23,6.08,5.72,140,57,107,Fatigue,Mild,No Change,0
1199,PT-01199,40,F,NIMHANS Bengaluru,Phase II,ORX-303,Cardiology,High Dose,2023-05-27,2023-06-03,4.77,4.51,128,81,91,Headache,Severe,No Change,0
1200,PT-01200,56,M,Fortis Mumbai,Phase III,ORX-505,Infectious Disease,High Dose,2023-11-18,2023-11-25,7.56,7.56,126,103,57,None,None,Improved,0
1201,PT-01201,47,F,Kolkata Clinical Center,Phase II,ORX-202,Diabetes,High Dose,2023-10-23,2023-11-20,7.28,7.61,112,61,80,Headache,Moderate,Worsened,0
1202,PT-01202,49,F,Apollo Chennai,Phase I,ORX-505,Infectious Disease,High Dose,2023-06-22,2023-06-29,8.99,7.44,148,110,72,None,None,No Change,0
1203,PT-01203,24,M,Indore Medical Institute,Phase I,ORX-303,Cardiology,Placebo,2024-08-07,2024-10-02,6.71,6.32,138,74,99,None,None,No Change,0
1204,PT-01204,27,F,Bhopal Research Hospital,Phase II,ORX-606,Rheumatology,High Dose,2023-05-03,2023-06-28,5.11,5.71,90,79,121,None,None,Worsened,0
1205,PT-01205,44,M,Fortis Mumbai,Phase IV,ORX-606,Rheumatology,High Dose,2023-12-29,2024-01-05,5.86,5.4,127,83,87,None,None,No Change,0
1206,PT-01206,28,M,PGI Chandigarh,Phase II,ORX-303,Cardiology,Low Dose,2024-06-09,2024-06-16,9.23,9.05,141,74,96,None,None,No Change,0
1207,PT-01207,40,M,PGI Chandigarh,Phase III,ORX-202,Diabetes,High Dose,2024-11-07,2024-11-14,7.53,6.29,110,90,71,Nausea,None,Worsened,0
1208,PT-01208,31,F,Apollo Chennai,Phase IV,ORX-606,Rheumatology,Placebo,2024-04-26,2024-05-10,6.43,6.66,116,80,78,None,None,Improved,0
1209,PT-01209,18,F,Apollo Chennai,Phase II,ORX-606,Rheumatology,High Dose,2024-06-12,2024-06-26,5.43,5.34,114,94,91,None,None,Improved,1
1210,PT-01210,56,M,Indore Medical Institute,Phase III,ORX-404,Neurology,High Dose,2024-09-20,2024-11-15,9.38,8.91,139,74,112,None,None,No Change,0
1211,PT-01211,76,F,AIIMS Delhi,Phase III,ORX-303,Cardiology,High Dose,2023-10-27,2023-12-22,7.21,7.16,152,80,68,Nausea,Mild,Improved,1
1212,PT-01212,58,F,Apollo Chennai,Phase II,ORX-101,Oncology,High Dose,2023-10-22,2023-12-17,7.29,7.06,112,61,81,None,None,Worsened,0
1213,PT-01213,59,F,Kolkata Clinical Center,Phase I,ORX-303,Cardiology,High Dose,2023-12-22,2024-02-16,6.93,7.82,115,69,77,Headache,None,No Change,0
1214,PT-01214,43,F,Apollo Chennai,Phase III,ORX-101,Oncology,Placebo,2024-06-03,2024-06-17,8.12,7.03,152,105,77,Headache,None,Worsened,0
1215,PT-01215,64,F,PGI Chandigarh,Phase II,ORX-404,Neurology,Low Dose,2024-03-28,2024-05-23,5.93,6.5,146,92,77,Fatigue,None,Improved,0
1216,PT-01216,18,M,Indore Medical Institute,Phase II,ORX-303,Cardiology,Low Dose,2023-08-15,2023-11-13,6.43,5.47,110,83,72,None,None,Worsened,0
1217,PT-01217,31,M,PGI Chandigarh,Phase IV,ORX-202,Diabetes,Low Dose,2023-01-21,2023-01-28,5.93,4.89,148,74,70,None,None,No Change,0
1218,PT-01218,37,F,Bhopal Research Hospital,Phase IV,ORX-606,Rheumatology,Placebo,2023-08-04,2023-09-01,7.61,7.62,90,94,98,Fever,Moderate,Improved,0
1219,PT-01219,28,F,Apollo Chennai,Phase IV,ORX-303,Cardiology,High Dose,2024-01-18,2024-02-15,6.03,5.23,114,84,50,Nausea,None,Improved,1
1220,PT-01220,27,M,Indore Medical Institute,Phase I,ORX-505,Infectious Disease,Placebo,2024-02-12,2024-04-08,9.05,7.81,150,86,52,None,None,Improved,1
1221,PT-01221,55,M,Apollo Chennai,Phase II,ORX-101,Oncology,Placebo,2023-05-07,2023-07-02,7.06,6.25,132,87,87,None,None,No Change,0
1222,PT-01222,63,F,Bhopal Research Hospital,Phase IV,ORX-101,Oncology,Low Dose,2024-03-01,2024-03-08,7.69,6.05,119,117,88,Rash,Mild,Improved,1
1223,PT-01223,82,M,NIMHANS Bengaluru,Phase I,ORX-202,Diabetes,High Dose,2023-11-16,2023-12-14,8.87,8.69,133,81,53,Headache,None,Improved,1
1224,PT-01224,45,F,Fortis Mumbai,Phase II,ORX-606,Rheumatology,Low Dose,2024-01-21,2024-02-18,8.65,7.71,135,92,65,None,None,Improved,1
1225,PT-01225,37,F,Kolkata Clinical Center,Phase III,ORX-303,Cardiology,High Dose,2024-06-30,2024-09-28,5.98,4.84,104,71,97,None,None,Improved,1
1226,PT-01226,30,F,PGI Chandigarh,Phase III,ORX-505,Infectious Disease,High Dose,2024-04-08,2024-04-22,7.35,6.5,149,97,90,None,None,No Change,0
1227,PT-01227,49,M,Kolkata Clinical Center,Phase III,ORX-505,Infectious Disease,Placebo,2023-11-15,2023-12-13,6.92,5.45,162,72,87,Nausea,None,Improved,1
1228,PT-01228,61,M,Kolkata Clinical Center,Phase II,ORX-505,Infectious Disease,Placebo,2023-05-25,2023-07-20,6.53,7.07,141,102,71,None,None,No Change,0
1229,PT-01229,24,M,Kolkata Clinical Center,Phase I,ORX-303,Cardiology,Low Dose,2023-12-12,2023-12-26,6.59,6.38,129,77,51,Headache,Mild,Improved,1
1230,PT-01230,52,M,Apollo Chennai,Phase II,ORX-505,Infectious Disease,High Dose,2024-07-12,2024-09-06,9.57,9.58,138,88,83,Nausea,None,Improved,0
1231,PT-01231,59,F,Bhopal Research Hospital,Phase III,ORX-101,Oncology,Low Dose,2023-03-21,2023-05-16,7.67,6.99,113,79,82,None,None,Improved,1
1232,PT-01232,39,M,Kolkata Clinical Center,Phase II,ORX-101,Oncology,Placebo,2024-03-10,2024-05-05,7.58,7.57,142,97,79,Rash,None,Improved,1
1233,PT-01233,24,F,Fortis Mumbai,Phase II,ORX-101,Oncology,Low Dose,2023-10-29,2023-11-26,6.79,6.43,94,98,79,Nausea,None,Improved,1
1234,PT-01234,51,M,Apollo Chennai,Phase I,ORX-505,Infectious Disease,High Dose,2024-01-16,2024-04-15,8.84,7.87,138,80,75,None,None,No Change,0
1235,PT-01235,32,M,AIIMS Delhi,Phase IV,ORX-202,Diabetes,Low Dose,2024-04-30,2024-05-07,9.2,8.46,140,59,94,None,None,Improved,1
1236,PT-01236,61,F,Indore Medical Institute,Phase I,ORX-303,Cardiology,High Dose,2023-07-24,2023-07-31,7.32,6.71,135,109,53,None,None,Improved,1
1237,PT-01237,57,M,AIIMS Delhi,Phase III,ORX-101,Oncology,Low Dose,2024-07-26,2024-08-09,6.11,5.69,123,76,77,None,None,Improved,1
1238,PT-01238,26,M,NIMHANS Bengaluru,Phase II,ORX-505,Infectious Disease,High Dose,2024-01-12,2024-04-11,8.44,6.42,137,78,61,Dizziness,Mild,No Change,0
1239,PT-01239,48,M,AIIMS Delhi,Phase I,ORX-101,Oncology,High Dose,2023-10-14,2023-10-28,5.33,4.97,102,87,65,None,None,Improved,1
1240,PT-01240,37,F,Fortis Mumbai,Phase II,ORX-606,Rheumatology,High Dose,2024-11-15,2025-01-10,7.55,6.46,126,63,86,None,None,Improved,1
1241,PT-01241,73,M,Bhopal Research Hospital,Phase IV,ORX-505,Infectious Disease,Placebo,2023-06-18,2023-08-13,10.55,10.23,142,60,99,None,None,Worsened,0
1242,PT-01242,57,M,Kolkata Clinical Center,Phase I,ORX-404,Neurology,High Dose,2023-12-01,2023-12-29,6.62,,123,76,84,None,None,Improved,0
1243,PT-01243,27,F,NIMHANS Bengaluru,Phase II,ORX-606,Rheumatology,Low Dose,2023-11-16,2024-02-14,8.43,7.08,109,71,88,None,None,Improved,1
1244,PT-01244,35,M,Fortis Mumbai,Phase IV,ORX-606,Rheumatology,Placebo,2024-03-23,2024-06-21,5.58,4.64,127,67,61,Headache,None,Improved,1
1245,PT-01245,78,M,NIMHANS Bengaluru,Phase III,ORX-606,Rheumatology,Low Dose,2023-01-26,2023-02-23,6.17,5.48,121,76,86,Headache,None,Worsened,0
1246,PT-01246,60,F,Apollo Chennai,Phase II,ORX-404,Neurology,Low Dose,2023-01-11,2023-01-25,6.83,5.32,150,80,102,None,None,Improved,1
1247,PT-01247,18,M,PGI Chandigarh,Phase III,ORX-101,Oncology,High Dose,2023-09-17,2023-12-16,7.43,8.76,121,79,82,Nausea,None,Worsened,0
1248,PT-01248,36,F,NIMHANS Bengaluru,Phase III,ORX-101,Oncology,High Dose,2023-09-17,2023-10-15,6.83,6.12,116,96,84,Fever,Moderate,No Change,0
1249,PT-01249,49,F,Kolkata Clinical Center,Phase IV,ORX-404,Neurology,Placebo,2024-10-25,2025-01-23,8.17,7.53,114,74,78,None,None,No Change,0
1250,PT-01250,28,M,AIIMS Delhi,Phase III,ORX-606,Rheumatology,High Dose,2023-05-15,2023-05-22,6.6,5.74,166,50,75,Rash,None,Improved,1
1251,PT-01251,72,M,Fortis Mumbai,Phase II,ORX-202,Diabetes,High Dose,2023-01-18,2023-02-15,7.35,7.62,129,73,46,Rash,None,No Change,0
1252,PT-01252,48,M,PGI Chandigarh,Phase IV,ORX-505,Infectious Disease,Placebo,2024-11-11,2025-01-06,6.27,5.15,119,102,111,Nausea,None,Improved,1
1253,PT-01253,48,M,AIIMS Delhi,Phase III,ORX-606,Rheumatology,Placebo,2023-06-26,2023-08-21,6.64,5.18,136,103,74,Nausea,Mild,Improved,1
1254,PT-01254,18,F,Indore Medical Institute,Phase II,ORX-303,Cardiology,Placebo,2023-12-26,2024-01-02,8.0,8.49,99,84,84,Nausea,Mild,Improved,0
1255,PT-01255,43,F,Bhopal Research Hospital,Phase I,ORX-202,Diabetes,High Dose,2023-07-10,2023-08-07,6.25,6.77,120,64,49,Fever,Mild,No Change,0
1256,PT-01256,65,M,PGI Chandigarh,Phase II,ORX-404,Neurology,Placebo,2023-09-10,2023-10-08,7.94,7.62,120,75,62,Nausea,Moderate,No Change,0
1257,PT-01257,38,M,AIIMS Delhi,Phase III,ORX-303,Cardiology,Placebo,2023-10-21,2023-11-04,4.66,3.59,122,89,77,Nausea,None,Improved,1
1258,PT-01258,57,M,Apollo Chennai,Phase II,ORX-202,Diabetes,High Dose,2023-09-23,2023-11-18,8.82,9.37,136,82,64,None,None,Improved,0
1259,PT-01259,56,F,Kolkata Clinical Center,Phase II,ORX-606,Rheumatology,High Dose,2023-06-24,2023-07-01,9.22,9.12,162,63,61,Nausea,None,Worsened,0
1260,PT-01260,58,M,NIMHANS Bengaluru,Phase IV,ORX-303,Cardiology,Low Dose,2024-11-29,2024-12-27,7.52,8.3,127,71,75,Headache,None,Improved,0
1261,PT-01261,20,F,Apollo Chennai,Phase I,ORX-303,Cardiology,Placebo,2023-09-25,2023-10-02,5.85,6.32,143,86,53,None,None,Worsened,0
1262,PT-01262,39,M,Kolkata Clinical Center,Phase III,ORX-505,Infectious Disease,Low Dose,2024-07-31,2024-09-25,5.73,6.39,117,68,78,Fatigue,None,No Change,0
1263,PT-01263,34,M,Indore Medical Institute,Phase III,ORX-202,Diabetes,Low Dose,2023-12-09,2024-01-06,8.98,7.92,102,56,77,None,None,No Change,0
1264,PT-01264,36,F,Kolkata Clinical Center,Phase II,ORX-505,Infectious Disease,Placebo,2023-01-23,2023-03-20,5.49,6.16,140,81,97,None,None,No Change,0
1265,PT-01265,55,F,Kolkata Clinical Center,Phase III,ORX-202,Diabetes,Placebo,2024-01-18,2024-04-17,6.21,4.88,142,86,80,Headache,None,Improved,1
1266,PT-01266,31,M,Bhopal Research Hospital,Phase III,ORX-404,Neurology,Low Dose,2023-10-03,2024-01-01,7.93,6.85,126,99,68,None,None,Improved,1
1267,PT-01267,19,M,Apollo Chennai,Phase IV,ORX-505,Infectious Disease,High Dose,2023-05-14,2023-06-11,5.94,6.43,132,80,70,None,None,No Change,0
1268,PT-01268,52,M,AIIMS Delhi,Phase II,ORX-303,Cardiology,Low Dose,2023-06-19,2023-08-14,6.18,6.06,114,71,69,None,None,Improved,1
1269,PT-01269,38,M,Bhopal Research Hospital,Phase II,ORX-202,Diabetes,Placebo,2023-07-28,2023-09-22,7.14,6.95,90,72,72,None,None,Improved,1
1270,PT-01270,69,F,AIIMS Delhi,Phase I,ORX-303,Cardiology,Placebo,2024-07-17,2024-09-11,5.9,5.65,154,66,83,Fatigue,Mild,No Change,0
1271,PT-01271,32,F,Bhopal Research Hospital,Phase III,ORX-404,Neurology,Placebo,2023-05-17,2023-07-12,6.59,5.47,114,114,89,Fatigue,Moderate,No Change,0
1272,PT-01272,62,F,Bhopal Research Hospital,Phase III,ORX-303,Cardiology,Low Dose,2024-08-23,2024-08-30,7.79,5.94,135,94,66,Nausea,Mild,Improved,1
1273,PT-01273,60,F,Indore Medical Institute,Phase II,ORX-505,Infectious Disease,Low Dose,2024-02-12,2024-02-19,8.05,9.31,120,68,72,None,None,No Change,0
1274,PT-01274,67,M,Fortis Mumbai,Phase I,ORX-404,Neurology,Placebo,2024-01-29,2024-02-12,5.01,2.74,129,76,78,None,None,Improved,1
1275,PT-01275,60,F,Kolkata Clinical Center,Phase III,ORX-101,Oncology,Placebo,2024-03-07,2024-03-21,6.54,4.45,164,70,63,Headache,Moderate,Improved,1
1276,PT-01276,62,F,PGI Chandigarh,Phase III,ORX-606,Rheumatology,High Dose,2024-11-02,2024-12-28,6.74,6.28,136,95,73,None,None,No Change,0
1277,PT-01277,69,F,NIMHANS Bengaluru,Phase I,ORX-606,Rheumatology,Low Dose,2024-05-12,2024-07-07,4.64,4.92,112,98,79,None,None,Improved,0
1278,PT-01278,34,F,Bhopal Research Hospital,Phase II,ORX-505,Infectious Disease,High Dose,2024-04-06,2024-07-05,8.0,8.4,139,69,71,None,None,Improved,0
1279,PT-01279,44,F,PGI Chandigarh,Phase III,ORX-101,Oncology,High Dose,2024-03-10,2024-06-08,7.15,7.43,91,86,73,Fatigue,None,No Change,0
1280,PT-01280,31,M,Fortis Mumbai,Phase II,ORX-202,Diabetes,Low Dose,2024-09-21,2024-11-16,6.31,5.72,90,73,65,None,None,Improved,1
1281,PT-01281,53,M,Kolkata Clinical Center,Phase I,ORX-404,Neurology,Low Dose,2024-09-05,2024-10-03,6.23,5.64,155,93,90,None,None,Improved,1
1282,PT-01282,37,F,Indore Medical Institute,Phase III,ORX-505,Infectious Disease,Placebo,2023-10-28,2023-11-25,7.85,7.24,124,86,69,None,None,Improved,1
1283,PT-01283,68,F,Bhopal Research Hospital,Phase III,ORX-303,Cardiology,High Dose,2024-06-28,2024-08-23,7.01,7.16,154,94,58,None,None,Improved,0
1284,PT-01284,52,M,AIIMS Delhi,Phase I,ORX-606,Rheumatology,Low Dose,2023-10-09,2023-11-06,8.22,8.62,107,74,91,Headache,None,Worsened,0
1285,PT-01285,32,F,PGI Chandigarh,Phase I,ORX-303,Cardiology,Placebo,2024-09-15,2024-09-22,6.84,7.86,127,73,65,Fever,None,Improved,0
1286,PT-01286,50,F,Indore Medical Institute,Phase III,ORX-202,Diabetes,High Dose,2023-09-21,2023-09-28,5.6,4.98,133,97,87,None,None,No Change,0
1287,PT-01287,33,M,Fortis Mumbai,Phase III,ORX-303,Cardiology,Low Dose,2024-07-06,2024-07-20,8.61,7.94,105,79,98,None,None,No Change,0
1288,PT-01288,47,F,NIMHANS Bengaluru,Phase II,ORX-303,Cardiology,High Dose,2023-07-10,2023-08-07,7.22,8.29,102,66,55,None,None,Improved,0
1289,PT-01289,50,F,Fortis Mumbai,Phase IV,ORX-303,Cardiology,Placebo,2023-08-01,2023-08-08,7.4,8.39,132,77,78,Nausea,None,No Change,0
1290,PT-01290,46,F,PGI Chandigarh,Phase III,ORX-101,Oncology,Placebo,2023-01-19,2023-02-16,5.19,7.23,137,84,86,Nausea,Mild,Improved,0
1291,PT-01291,56,F,PGI Chandigarh,Phase III,ORX-505,Infectious Disease,Low Dose,2024-07-25,2024-08-01,7.03,6.06,138,86,66,None,None,Improved,1
1292,PT-01292,67,F,Kolkata Clinical Center,Phase II,ORX-202,Diabetes,Low Dose,2023-06-24,2023-08-19,7.55,7.81,153,82,82,None,None,Improved,0
1293,PT-01293,57,M,PGI Chandigarh,Phase III,ORX-101,Oncology,Placebo,2024-06-26,2024-07-24,6.33,5.98,130,70,110,Headache,None,Improved,1
1294,PT-01294,22,F,AIIMS Delhi,Phase I,ORX-505,Infectious Disease,Low Dose,2024-03-17,2024-05-12,5.64,6.43,140,69,86,None,None,Worsened,0
1295,PT-01295,68,F,Kolkata Clinical Center,Phase III,ORX-202,Diabetes,Low Dose,2024-07-04,2024-07-18,7.16,9.1,96,90,94,Dizziness,None,Improved,0
1296,PT-01296,59,F,Bhopal Research Hospital,Phase II,ORX-505,Infectious Disease,Placebo,2023-06-12,2023-08-07,6.95,6.29,135,91,86,None,None,No Change,0
1297,PT-01297,61,M,Fortis Mumbai,Phase III,ORX-303,Cardiology,High Dose,2024-10-07,2024-10-14,5.98,5.37,111,77,92,Headache,Mild,No Change,0
1298,PT-01298,46,F,NIMHANS Bengaluru,Phase III,ORX-202,Diabetes,High Dose,2024-05-21,2024-07-16,10.33,10.1,129,83,69,Dizziness,None,Improved,1
1299,PT-01299,44,M,Indore Medical Institute,Phase III,ORX-505,Infectious Disease,High Dose,2024-04-20,2024-05-04,8.55,8.26,113,70,71,None,None,No Change,0
1300,PT-01300,46,F,NIMHANS Bengaluru,Phase IV,ORX-202,Diabetes,Low Dose,2024-09-25,2024-10-09,8.63,7.03,122,83,52,Nausea,Severe,Improved,1
1301,PT-01301,31,F,PGI Chandigarh,Phase IV,ORX-505,Infectious Disease,Placebo,2024-08-05,2024-09-30,6.38,5.27,131,80,70,Dizziness,None,No Change,0
1302,PT-01302,51,F,Apollo Chennai,Phase III,ORX-202,Diabetes,Low Dose,2023-09-03,2023-09-17,9.27,10.34,93,88,75,Headache,None,Improved,0
1303,PT-01303,47,M,Indore Medical Institute,Phase II,ORX-202,Diabetes,Low Dose,2024-04-15,2024-04-29,6.72,6.43,130,75,65,None,None,No Change,0
1304,PT-01304,37,M,Kolkata Clinical Center,Phase III,ORX-505,Infectious Disease,Low Dose,2024-09-10,2024-10-08,7.48,7.62,143,76,81,Fatigue,None,Worsened,0
1305,PT-01305,60,M,Indore Medical Institute,Phase I,ORX-606,Rheumatology,High Dose,2024-06-16,2024-08-11,8.6,8.15,124,84,61,None,None,Worsened,0
1306,PT-01306,41,F,Bhopal Research Hospital,Phase IV,ORX-606,Rheumatology,High Dose,2024-10-24,2025-01-22,8.09,8.27,123,84,66,None,None,No Change,0
1307,PT-01307,56,M,NIMHANS Bengaluru,Phase II,ORX-606,Rheumatology,High Dose,2024-01-08,2024-03-04,7.11,6.46,121,81,71,None,None,No Change,0
1308,PT-01308,55,F,Bhopal Research Hospital,Phase III,ORX-101,Oncology,Placebo,2023-09-26,2023-12-25,6.73,7.76,154,71,78,None,None,No Change,0
1309,PT-01309,34,M,PGI Chandigarh,Phase II,ORX-202,Diabetes,High Dose,2024-05-09,2024-05-23,6.81,8.21,122,86,85,None,None,Improved,0
1310,PT-01310,28,M,Kolkata Clinical Center,Phase III,ORX-202,Diabetes,High Dose,2023-12-17,2024-01-14,6.17,4.69,112,50,85,None,None,No Change,0
1311,PT-01311,77,F,Fortis Mumbai,Phase III,ORX-505,Infectious Disease,Placebo,2023-05-24,2023-06-07,7.38,5.7,116,76,63,None,None,Improved,1
1312,PT-01312,58,F,Fortis Mumbai,Phase III,ORX-303,Cardiology,High Dose,2023-06-12,2023-09-10,8.17,6.73,141,100,104,None,None,No Change,0
1313,PT-01313,85,F,AIIMS Delhi,Phase III,ORX-606,Rheumatology,High Dose,2023-05-12,2023-05-26,6.12,8.26,121,74,82,Fatigue,None,No Change,0
1314,PT-01314,35,M,Apollo Chennai,Phase I,ORX-505,Infectious Disease,Low Dose,2024-08-21,2024-08-28,7.68,6.09,123,97,77,Headache,Mild,Improved,1
1315,PT-01315,47,F,AIIMS Delhi,Phase III,ORX-303,Cardiology,Low Dose,2024-08-24,2024-11-22,7.77,8.42,98,89,74,None,None,Improved,0
1316,PT-01316,47,F,Kolkata Clinical Center,Phase III,ORX-202,Diabetes,Low Dose,2024-01-24,2024-01-31,8.47,7.0,109,58,70,None,None,No Change,0
1317,PT-01317,66,M,Apollo Chennai,Phase II,ORX-202,Diabetes,Placebo,2023-05-03,2023-05-17,7.06,5.45,119,64,62,None,None,Improved,1
1318,PT-01318,51,M,Apollo Chennai,Phase III,ORX-606,Rheumatology,Placebo,2024-11-11,2024-11-18,5.79,6.39,126,83,74,None,None,Improved,0
1319,PT-01319,57,F,Fortis Mumbai,Phase III,ORX-505,Infectious Disease,High Dose,2024-07-04,2024-07-11,8.14,8.04,138,79,85,None,None,Worsened,0
1320,PT-01320,39,M,AIIMS Delhi,Phase II,ORX-606,Rheumatology,High Dose,2023-09-08,2023-09-22,7.2,6.56,119,73,84,None,None,No Change,0
1321,PT-01321,65,M,Fortis Mumbai,Phase IV,ORX-505,Infectious Disease,Placebo,2023-07-14,2023-07-21,8.61,7.07,151,78,86,None,None,Worsened,0
1322,PT-01322,30,F,Apollo Chennai,Phase I,ORX-202,Diabetes,Low Dose,2024-08-18,2024-10-13,7.37,7.25,101,89,96,None,None,Improved,1
1323,PT-01323,42,M,Bhopal Research Hospital,Phase II,ORX-202,Diabetes,Low Dose,2024-03-28,2024-04-04,8.83,8.26,143,55,111,None,None,Improved,1
1324,PT-01324,68,M,Fortis Mumbai,Phase III,ORX-505,Infectious Disease,Placebo,2024-03-16,2024-03-23,6.86,4.68,133,64,84,None,None,No Change,0
1325,PT-01325,51,M,Kolkata Clinical Center,Phase III,ORX-101,Oncology,Placebo,2024-02-21,2024-05-21,6.07,6.68,142,93,78,Nausea,None,Improved,0
1326,PT-01326,22,F,Fortis Mumbai,Phase III,ORX-303,Cardiology,High Dose,2023-09-12,2023-10-10,8.37,7.73,102,98,107,Nausea,None,Improved,1
1327,PT-01327,44,F,AIIMS Delhi,Phase I,ORX-404,Neurology,Placebo,2024-06-05,2024-07-31,9.79,9.47,121,74,100,None,None,Improved,1
1328,PT-01328,32,F,Bhopal Research Hospital,Phase III,ORX-404,Neurology,Low Dose,2024-07-05,2024-07-19,8.08,7.18,119,94,72,None,None,Improved,1
1329,PT-01329,38,M,Fortis Mumbai,Phase II,ORX-303,Cardiology,High Dose,2024-04-28,2024-05-05,8.56,9.6,139,74,70,Dizziness,None,No Change,0
1330,PT-01330,46,M,Apollo Chennai,Phase II,ORX-404,Neurology,High Dose,2023-06-11,2023-09-09,7.59,6.3,141,83,53,None,None,No Change,0
1331,PT-01331,30,F,NIMHANS Bengaluru,Phase III,ORX-606,Rheumatology,Placebo,2023-09-27,2023-11-22,6.6,6.13,162,84,66,Rash,None,Worsened,0
1332,PT-01332,48,F,PGI Chandigarh,Phase II,ORX-606,Rheumatology,Low Dose,2023-11-12,2024-01-07,6.78,6.67,138,96,77,Headache,None,No Change,0
1333,PT-01333,71,F,NIMHANS Bengaluru,Phase I,ORX-303,Cardiology,Low Dose,2023-05-24,2023-07-19,8.29,7.25,167,85,66,None,None,No Change,0
1334,PT-01334,71,M,Fortis Mumbai,Phase II,ORX-303,Cardiology,High Dose,2023-01-25,2023-02-22,9.69,9.26,118,79,88,None,None,Improved,1
1335,PT-01335,65,M,Kolkata Clinical Center,Phase III,ORX-303,Cardiology,Placebo,2023-09-06,2023-09-20,7.88,7.58,154,78,92,None,None,Improved,1
1336,PT-01336,40,F,Indore Medical Institute,Phase IV,ORX-606,Rheumatology,Low Dose,2024-05-13,2024-05-27,7.72,7.22,126,77,96,Nausea,None,Improved,1
1337,PT-01337,33,M,PGI Chandigarh,Phase I,ORX-303,Cardiology,Low Dose,2024-03-24,2024-04-21,6.31,7.82,145,53,70,None,None,Improved,0
1338,PT-01338,18,M,NIMHANS Bengaluru,Phase II,ORX-202,Diabetes,High Dose,2024-08-26,2024-09-23,6.06,2.83,125,68,78,Nausea,None,No Change,0
1339,PT-01339,18,F,Fortis Mumbai,Phase III,ORX-505,Infectious Disease,Low Dose,2023-10-26,2023-11-02,7.3,6.53,155,98,88,Headache,Moderate,Improved,1
1340,PT-01340,39,F,PGI Chandigarh,Phase IV,ORX-404,Neurology,High Dose,2023-08-08,2023-08-22,9.58,7.78,102,80,109,None,None,Improved,1
1341,PT-01341,41,F,Fortis Mumbai,Phase II,ORX-303,Cardiology,Low Dose,2023-01-24,2023-02-07,6.98,5.28,145,93,89,None,None,Improved,1
1342,PT-01342,34,F,Indore Medical Institute,Phase III,ORX-505,Infectious Disease,Placebo,2024-06-08,2024-07-06,6.35,4.79,129,69,61,None,None,Improved,1
1343,PT-01343,38,M,PGI Chandigarh,Phase IV,ORX-505,Infectious Disease,Low Dose,2024-08-11,2024-09-08,6.61,5.73,136,82,73,Headache,Mild,No Change,0
1344,PT-01344,47,M,Bhopal Research Hospital,Phase III,ORX-505,Infectious Disease,High Dose,2024-09-16,2024-09-30,6.01,5.7,130,63,91,Headache,None,No Change,0
1345,PT-01345,30,F,AIIMS Delhi,Phase III,ORX-606,Rheumatology,Low Dose,2023-07-06,2023-10-04,7.31,7.96,144,82,72,None,None,Improved,0
1346,PT-01346,60,F,NIMHANS Bengaluru,Phase IV,ORX-505,Infectious Disease,Placebo,2024-09-30,2024-11-25,8.01,7.05,113,57,80,None,None,Improved,1
1347,PT-01347,43,F,Apollo Chennai,Phase II,ORX-505,Infectious Disease,High Dose,2023-12-01,2024-02-29,8.56,8.49,152,73,93,Nausea,Mild,Improved,1
1348,PT-01348,36,F,AIIMS Delhi,Phase IV,ORX-202,Diabetes,High Dose,2023-07-31,2023-08-28,8.13,6.42,132,58,74,None,None,Improved,1
1349,PT-01349,52,M,PGI Chandigarh,Phase III,ORX-101,Oncology,Low Dose,2023-11-19,2023-12-03,6.57,5.23,143,80,71,None,None,No Change,0
1350,PT-01350,45,M,Fortis Mumbai,Phase III,ORX-202,Diabetes,High Dose,2023-08-11,2023-09-08,10.36,11.0,148,87,80,Fatigue,Moderate,Improved,0
1351,PT-01351,18,M,NIMHANS Bengaluru,Phase III,ORX-101,Oncology,Low Dose,2023-08-02,2023-09-27,6.39,5.55,94,68,50,None,None,Improved,1
1352,PT-01352,44,M,NIMHANS Bengaluru,Phase II,ORX-505,Infectious Disease,High Dose,2023-04-06,2023-04-20,8.18,8.78,135,70,50,Nausea,None,Improved,0
1353,PT-01353,18,M,Bhopal Research Hospital,Phase III,ORX-404,Neurology,High Dose,2024-01-02,2024-01-30,5.68,4.48,125,69,82,None,None,Improved,1
1354,PT-01354,41,M,PGI Chandigarh,Phase III,ORX-404,Neurology,Placebo,2023-04-25,2023-06-20,7.21,,106,87,77,None,None,Improved,0
1355,PT-01355,39,F,Bhopal Research Hospital,Phase III,ORX-303,Cardiology,Low Dose,2023-11-14,2023-11-21,8.26,8.65,110,79,81,Rash,None,Improved,0
1356,PT-01356,40,M,NIMHANS Bengaluru,Phase III,ORX-404,Neurology,Placebo,2023-10-09,2023-11-06,7.9,7.76,160,63,76,Rash,None,Improved,1
1357,PT-01357,30,M,AIIMS Delhi,Phase I,ORX-202,Diabetes,High Dose,2023-02-09,2023-02-16,7.92,6.07,134,74,67,None,None,No Change,0
1358,PT-01358,21,F,NIMHANS Bengaluru,Phase II,ORX-202,Diabetes,Low Dose,2023-06-28,2023-09-26,6.64,7.22,127,89,101,Headache,Moderate,Worsened,0
1359,PT-01359,49,M,Bhopal Research Hospital,Phase II,ORX-202,Diabetes,Placebo,2023-07-28,2023-08-25,6.53,6.55,118,75,56,None,None,Improved,0
1360,PT-01360,59,F,Indore Medical Institute,Phase III,ORX-101,Oncology,Low Dose,2024-04-26,2024-05-03,6.74,6.5,109,87,67,None,None,No Change,0
1361,PT-01361,42,F,NIMHANS Bengaluru,Phase I,ORX-505,Infectious Disease,High Dose,2023-06-23,2023-07-07,8.25,8.57,127,60,119,None,None,Improved,0
1362,PT-01362,72,M,Bhopal Research Hospital,Phase I,ORX-101,Oncology,High Dose,2024-04-20,2024-06-15,8.07,6.99,125,75,95,None,None,Worsened,0
1363,PT-01363,49,M,Indore Medical Institute,Phase IV,ORX-303,Cardiology,Low Dose,2023-09-21,2023-10-05,6.26,5.44,148,101,99,None,None,Improved,1
1364,PT-01364,57,M,Apollo Chennai,Phase III,ORX-202,Diabetes,Placebo,2023-05-13,2023-05-27,6.9,3.58,133,81,79,None,None,Improved,1
1365,PT-01365,45,M,Fortis Mumbai,Phase III,ORX-505,Infectious Disease,Placebo,2023-08-20,2023-09-17,5.61,5.71,139,90,91,Nausea,None,Improved,0
1366,PT-01366,54,F,Fortis Mumbai,Phase III,ORX-202,Diabetes,Low Dose,2024-01-19,2024-02-02,6.71,6.24,129,83,91,Dizziness,None,No Change,0
1367,PT-01367,55,F,Apollo Chennai,Phase III,ORX-202,Diabetes,Placebo,2024-10-11,2024-10-18,9.69,11.28,129,50,95,None,None,No Change,0
1368,PT-01368,36,F,Kolkata Clinical Center,Phase II,ORX-404,Neurology,High Dose,2023-07-12,2023-10-10,6.24,5.48,119,89,56,Fever,None,Improved,1
1369,PT-01369,27,F,Bhopal Research Hospital,Phase III,ORX-606,Rheumatology,Placebo,2024-06-10,2024-07-08,7.61,7.77,139,72,64,Fatigue,None,Improved,0
1370,PT-01370,36,F,Kolkata Clinical Center,Phase III,ORX-606,Rheumatology,Placebo,2023-12-17,2024-03-16,7.49,8.42,91,79,59,Headache,None,Improved,0
1371,PT-01371,18,M,AIIMS Delhi,Phase IV,ORX-101,Oncology,Placebo,2024-04-13,2024-04-20,8.36,8.45,136,93,71,Headache,None,Improved,0
1372,PT-01372,38,F,NIMHANS Bengaluru,Phase II,ORX-505,Infectious Disease,High Dose,2023-03-26,2023-06-24,9.82,9.2,141,82,52,Rash,Moderate,Improved,1
1373,PT-01373,18,M,Apollo Chennai,Phase I,ORX-101,Oncology,Placebo,2023-12-29,2024-03-28,6.51,7.06,142,92,64,None,None,No Change,0
1374,PT-01374,70,M,PGI Chandigarh,Phase III,ORX-505,Infectious Disease,Placebo,2024-06-27,2024-07-11,6.04,5.83,127,79,96,None,None,Improved,1
1375,PT-01375,33,M,Apollo Chennai,Phase III,ORX-606,Rheumatology,Placebo,2024-09-16,2024-11-11,5.58,5.2,120,120,87,None,None,Worsened,0
1376,PT-01376,38,F,NIMHANS Bengaluru,Phase II,ORX-404,Neurology,Low Dose,2023-05-20,2023-06-17,5.93,3.84,109,83,97,None,None,Improved,1
1377,PT-01377,62,F,Bhopal Research Hospital,Phase II,ORX-101,Oncology,High Dose,2023-05-24,2023-06-07,7.47,6.78,132,75,102,None,None,Improved,1
1378,PT-01378,41,M,AIIMS Delhi,Phase II,ORX-606,Rheumatology,Low Dose,2024-08-28,2024-09-11,7.1,4.7,124,92,63,None,None,Improved,1
1379,PT-01379,32,M,Fortis Mumbai,Phase IV,ORX-202,Diabetes,High Dose,2023-05-07,2023-08-05,8.15,6.42,147,75,72,None,None,Worsened,0
1380,PT-01380,27,F,Fortis Mumbai,Phase I,ORX-303,Cardiology,Placebo,2023-05-01,2023-07-30,7.65,9.47,142,71,93,None,None,Improved,0
1381,PT-01381,39,F,Kolkata Clinical Center,Phase II,ORX-303,Cardiology,High Dose,2024-07-08,2024-10-06,8.85,9.18,90,69,91,None,None,Improved,0
1382,PT-01382,47,F,Indore Medical Institute,Phase IV,ORX-404,Neurology,High Dose,2023-09-19,2023-09-26,5.97,5.0,93,80,108,None,None,No Change,0
1383,PT-01383,57,M,Kolkata Clinical Center,Phase IV,ORX-303,Cardiology,Placebo,2023-04-16,2023-04-23,9.83,10.22,146,105,83,Nausea,Mild,Worsened,0
1384,PT-01384,42,F,Kolkata Clinical Center,Phase II,ORX-606,Rheumatology,High Dose,2024-03-07,2024-03-14,8.44,9.35,119,73,79,Fatigue,None,No Change,0
1385,PT-01385,58,F,PGI Chandigarh,Phase IV,ORX-404,Neurology,High Dose,2023-09-15,2023-10-13,8.16,6.48,162,74,74,None,None,Improved,1
1386,PT-01386,30,F,Kolkata Clinical Center,Phase II,ORX-202,Diabetes,Low Dose,2024-11-12,2024-12-10,10.44,10.26,112,92,88,Headache,Mild,Improved,1
1387,PT-01387,41,F,NIMHANS Bengaluru,Phase III,ORX-101,Oncology,Low Dose,2024-08-27,2024-09-03,8.21,7.07,119,57,59,None,None,No Change,0
1388,PT-01388,73,M,NIMHANS Bengaluru,Phase II,ORX-404,Neurology,High Dose,2023-02-10,2023-03-10,9.17,8.83,157,80,74,None,None,No Change,0
1389,PT-01389,45,F,Indore Medical Institute,Phase III,ORX-404,Neurology,High Dose,2024-10-05,2024-11-30,7.05,6.46,148,83,87,None,None,No Change,0
1390,PT-01390,61,M,PGI Chandigarh,Phase I,ORX-101,Oncology,Placebo,2024-02-27,2024-03-05,7.67,6.39,103,83,75,Rash,None,No Change,0
1391,PT-01391,46,F,Apollo Chennai,Phase II,ORX-303,Cardiology,Low Dose,2023-02-18,2023-03-18,7.18,9.11,104,58,82,Fever,None,Improved,0
1392,PT-01392,38,M,PGI Chandigarh,Phase II,ORX-606,Rheumatology,Low Dose,2023-12-23,2024-01-06,7.58,7.7,151,63,70,Fatigue,None,No Change,0
1393,PT-01393,51,M,Fortis Mumbai,Phase II,ORX-101,Oncology,High Dose,2023-04-03,2023-05-29,8.12,9.7,145,81,65,None,None,Improved,0
1394,PT-01394,35,M,Apollo Chennai,Phase III,ORX-303,Cardiology,High Dose,2024-05-12,2024-06-09,6.49,6.68,132,66,71,None,None,Improved,0
1395,PT-01395,59,F,AIIMS Delhi,Phase III,ORX-303,Cardiology,Placebo,2023-07-14,2023-10-12,7.62,7.73,134,101,81,None,None,Improved,0
1396,PT-01396,38,F,AIIMS Delhi,Phase III,ORX-404,Neurology,Low Dose,2023-03-19,2023-04-02,6.1,5.93,90,79,75,Headache,Moderate,Improved,1
1397,PT-01397,23,F,AIIMS Delhi,Phase IV,ORX-606,Rheumatology,Low Dose,2023-12-29,2024-02-23,6.09,6.41,132,83,82,None,None,Improved,0
1398,PT-01398,46,F,Bhopal Research Hospital,Phase III,ORX-303,Cardiology,High Dose,2024-03-29,2024-04-05,8.69,8.4,101,101,83,None,None,Improved,1
1399,PT-01399,35,F,Apollo Chennai,Phase I,ORX-606,Rheumatology,High Dose,2023-09-09,2023-09-23,5.7,5.65,125,100,73,Rash,None,Improved,1
1400,PT-01400,31,F,Indore Medical Institute,Phase II,ORX-505,Infectious Disease,Low Dose,2024-03-25,2024-05-20,8.27,8.71,131,90,77,Fever,None,No Change,0
1401,PT-01401,48,M,NIMHANS Bengaluru,Phase III,ORX-606,Rheumatology,Low Dose,2024-02-01,2024-02-29,8.6,8.76,124,98,45,Fever,Moderate,No Change,0
1402,PT-01402,77,F,PGI Chandigarh,Phase III,ORX-202,Diabetes,Low Dose,2024-01-01,2024-01-08,5.15,4.19,127,80,92,None,None,Worsened,0
1403,PT-01403,28,M,AIIMS Delhi,Phase III,ORX-101,Oncology,High Dose,2024-06-03,2024-07-29,7.51,6.59,133,81,79,None,None,Improved,1
1404,PT-01404,36,M,Apollo Chennai,Phase III,ORX-404,Neurology,Placebo,2023-02-24,2023-04-21,6.59,6.45,144,74,65,None,None,No Change,0
1405,PT-01405,54,F,AIIMS Delhi,Phase I,ORX-101,Oncology,Low Dose,2024-07-26,2024-08-02,7.16,7.51,111,60,70,None,None,Worsened,0
1406,PT-01406,32,M,PGI Chandigarh,Phase I,ORX-101,Oncology,High Dose,2023-10-10,2024-01-08,7.11,6.13,141,78,80,Fatigue,None,Improved,1
1407,PT-01407,47,F,AIIMS Delhi,Phase III,ORX-404,Neurology,Placebo,2024-04-07,2024-05-05,7.43,7.01,137,72,97,Headache,None,Improved,1
1408,PT-01408,41,F,PGI Chandigarh,Phase I,ORX-101,Oncology,High Dose,2023-02-24,2023-03-24,5.63,5.4,112,89,108,Headache,None,No Change,0
1409,PT-01409,32,M,AIIMS Delhi,Phase III,ORX-606,Rheumatology,Placebo,2024-09-07,2024-09-21,7.6,5.62,136,71,69,None,None,No Change,0
1410,PT-01410,27,F,PGI Chandigarh,Phase III,ORX-101,Oncology,Placebo,2024-02-18,2024-05-18,8.08,8.59,128,71,100,Headache,Moderate,No Change,0
1411,PT-01411,32,F,AIIMS Delhi,Phase III,ORX-303,Cardiology,Placebo,2023-11-15,2023-12-13,4.61,4.62,108,93,72,None,None,Improved,0
1412,PT-01412,54,F,AIIMS Delhi,Phase III,ORX-303,Cardiology,Low Dose,2023-08-21,2023-09-18,8.88,7.39,117,81,99,Nausea,None,Worsened,0
1413,PT-01413,34,M,Indore Medical Institute,Phase III,ORX-505,Infectious Disease,Placebo,2024-07-24,2024-07-31,6.49,6.52,117,83,56,None,None,No Change,0
1414,PT-01414,80,M,Indore Medical Institute,Phase IV,ORX-101,Oncology,Low Dose,2023-11-10,2023-11-17,5.58,4.89,127,104,59,Nausea,None,No Change,0
1415,PT-01415,76,M,Apollo Chennai,Phase IV,ORX-606,Rheumatology,Low Dose,2023-07-06,2023-10-04,8.11,8.08,110,88,67,None,None,Improved,1
1416,PT-01416,65,M,AIIMS Delhi,Phase III,ORX-404,Neurology,High Dose,2023-07-01,2023-09-29,6.03,5.53,118,70,88,Rash,None,Improved,1
1417,PT-01417,53,M,Bhopal Research Hospital,Phase IV,ORX-303,Cardiology,High Dose,2023-04-21,2023-05-19,8.65,6.65,147,112,71,Nausea,None,No Change,0
1418,PT-01418,75,M,AIIMS Delhi,Phase III,ORX-505,Infectious Disease,High Dose,2024-04-10,2024-07-09,6.88,5.25,122,94,66,Headache,Moderate,No Change,0
1419,PT-01419,35,M,PGI Chandigarh,Phase II,ORX-202,Diabetes,Placebo,2024-05-17,2024-05-31,7.91,7.52,138,84,84,None,None,No Change,0
1420,PT-01420,38,M,Kolkata Clinical Center,Phase IV,ORX-606,Rheumatology,High Dose,2024-08-28,2024-09-04,7.48,6.24,151,74,93,None,None,No Change,0
1421,PT-01421,41,F,NIMHANS Bengaluru,Phase IV,ORX-505,Infectious Disease,Low Dose,2023-10-17,2023-11-14,7.44,6.6,109,61,63,Headache,None,Improved,1
1422,PT-01422,39,F,NIMHANS Bengaluru,Phase III,ORX-101,Oncology,Low Dose,2024-05-18,2024-05-25,7.45,7.96,119,71,57,None,None,Improved,0
1423,PT-01423,52,F,Fortis Mumbai,Phase II,ORX-606,Rheumatology,High Dose,2024-06-24,2024-07-01,8.86,9.6,140,89,101,None,None,Improved,0
1424,PT-01424,50,M,Indore Medical Institute,Phase III,ORX-505,Infectious Disease,Placebo,2023-11-07,2024-01-02,7.98,7.29,103,73,77,Fever,None,Improved,1
1425,PT-01425,45,F,AIIMS Delhi,Phase III,ORX-505,Infectious Disease,Low Dose,2023-02-15,2023-03-01,9.51,9.18,149,76,73,Dizziness,Moderate,Improved,1
1426,PT-01426,23,F,Apollo Chennai,Phase I,ORX-404,Neurology,Placebo,2024-10-17,2025-01-15,6.31,6.38,128,93,80,Dizziness,None,Improved,0
1427,PT-01427,39,M,Indore Medical Institute,Phase IV,ORX-202,Diabetes,High Dose,2023-12-05,2023-12-19,9.78,9.29,148,77,87,Rash,None,Worsened,0
1428,PT-01428,59,F,AIIMS Delhi,Phase I,ORX-505,Infectious Disease,Placebo,2024-11-15,2024-12-13,7.45,4.93,128,96,85,None,None,Worsened,0
1429,PT-01429,52,F,Fortis Mumbai,Phase II,ORX-404,Neurology,High Dose,2024-03-01,2024-04-26,5.13,4.08,135,86,95,Rash,None,Improved,1
1430,PT-01430,42,F,Indore Medical Institute,Phase II,ORX-606,Rheumatology,High Dose,2023-02-12,2023-04-09,7.69,7.3,110,54,84,Headache,None,Improved,1
1431,PT-01431,47,M,Kolkata Clinical Center,Phase I,ORX-101,Oncology,Placebo,2023-12-02,2023-12-16,6.46,4.6,139,78,85,None,None,Worsened,0
1432,PT-01432,74,F,Fortis Mumbai,Phase II,ORX-303,Cardiology,High Dose,2023-09-25,2023-10-02,4.63,3.6,124,99,55,None,None,No Change,0
1433,PT-01433,75,M,Kolkata Clinical Center,Phase IV,ORX-202,Diabetes,Placebo,2023-02-06,2023-04-03,7.36,6.88,124,76,92,None,None,Improved,1
1434,PT-01434,27,M,AIIMS Delhi,Phase III,ORX-101,Oncology,High Dose,2023-03-11,2023-03-25,7.61,6.87,114,113,83,None,None,Improved,1
1435,PT-01435,54,M,Indore Medical Institute,Phase III,ORX-606,Rheumatology,High Dose,2023-07-13,2023-07-27,8.57,6.89,159,51,67,None,None,No Change,0
1436,PT-01436,37,M,PGI Chandigarh,Phase IV,ORX-303,Cardiology,High Dose,2023-12-25,2024-02-19,7.9,7.69,124,81,64,Nausea,None,Improved,1
1437,PT-01437,21,M,Bhopal Research Hospital,Phase IV,ORX-202,Diabetes,Placebo,2023-07-19,2023-08-16,8.07,8.3,156,72,87,None,None,No Change,0
1438,PT-01438,40,F,Apollo Chennai,Phase I,ORX-505,Infectious Disease,Low Dose,2024-07-24,2024-08-07,8.63,9.15,131,77,91,Fever,None,Improved,0
1439,PT-01439,55,M,Indore Medical Institute,Phase III,ORX-505,Infectious Disease,High Dose,2023-11-26,2023-12-24,6.38,4.78,122,100,94,Fatigue,Mild,Improved,1
1440,PT-01440,27,M,Indore Medical Institute,Phase II,ORX-404,Neurology,High Dose,2023-05-03,2023-05-17,5.8,6.55,107,88,69,None,None,No Change,0
1441,PT-01441,70,M,Kolkata Clinical Center,Phase I,ORX-505,Infectious Disease,Low Dose,2023-10-17,2024-01-15,6.28,6.9,131,85,50,Fatigue,None,Improved,0
1442,PT-01442,18,F,PGI Chandigarh,Phase III,ORX-606,Rheumatology,Low Dose,2023-06-06,2023-08-01,6.94,6.76,107,68,85,None,None,Improved,1
1443,PT-01443,54,M,AIIMS Delhi,Phase II,ORX-404,Neurology,High Dose,2023-06-14,2023-07-12,7.03,7.34,106,77,101,None,None,No Change,0
1444,PT-01444,46,F,Kolkata Clinical Center,Phase I,ORX-404,Neurology,High Dose,2024-07-08,2024-07-22,7.35,9.03,102,91,101,None,None,Worsened,0
1445,PT-01445,39,F,NIMHANS Bengaluru,Phase II,ORX-404,Neurology,High Dose,2024-04-16,2024-06-11,8.23,6.95,115,86,89,None,None,Improved,1
1446,PT-01446,62,F,NIMHANS Bengaluru,Phase II,ORX-202,Diabetes,High Dose,2023-07-30,2023-08-13,9.08,8.62,149,77,90,None,None,Improved,1
1447,PT-01447,48,M,PGI Chandigarh,Phase IV,ORX-404,Neurology,Low Dose,2024-02-23,2024-03-22,7.73,7.72,99,68,79,None,None,No Change,0
1448,PT-01448,18,M,Kolkata Clinical Center,Phase III,ORX-303,Cardiology,High Dose,2024-09-30,2024-11-25,8.2,8.58,133,68,97,None,None,Improved,0
1449,PT-01449,77,M,NIMHANS Bengaluru,Phase III,ORX-202,Diabetes,High Dose,2023-01-25,2023-02-08,7.38,7.44,131,88,76,Nausea,None,Improved,0
1450,PT-01450,44,M,Apollo Chennai,Phase III,ORX-202,Diabetes,Low Dose,2024-04-24,2024-05-08,8.29,10.0,102,80,61,None,None,Worsened,0
1451,PT-01451,70,F,Indore Medical Institute,Phase II,ORX-606,Rheumatology,Placebo,2023-03-08,2023-03-15,6.49,4.8,139,102,87,Dizziness,Moderate,Improved,1
1452,PT-01452,48,F,PGI Chandigarh,Phase IV,ORX-303,Cardiology,Placebo,2023-06-04,2023-06-18,7.69,8.56,112,80,71,None,None,Improved,0
1453,PT-01453,26,F,Kolkata Clinical Center,Phase III,ORX-404,Neurology,Low Dose,2023-06-29,2023-07-27,6.81,7.4,138,89,80,Rash,None,Improved,0
1454,PT-01454,53,M,Bhopal Research Hospital,Phase II,ORX-505,Infectious Disease,High Dose,2024-02-24,2024-03-09,6.24,5.56,131,85,82,Nausea,Mild,No Change,0
1455,PT-01455,42,F,Apollo Chennai,Phase III,ORX-101,Oncology,High Dose,2023-05-31,2023-07-26,6.75,9.19,144,86,74,None,None,Improved,0
1456,PT-01456,37,F,Kolkata Clinical Center,Phase III,ORX-202,Diabetes,High Dose,2024-08-23,2024-09-20,7.04,6.91,94,63,69,Nausea,None,Worsened,0
1457,PT-01457,48,M,PGI Chandigarh,Phase IV,ORX-303,Cardiology,High Dose,2024-01-14,2024-01-21,6.91,7.84,101,72,99,Nausea,Mild,Improved,0
1458,PT-01458,47,M,Apollo Chennai,Phase I,ORX-606,Rheumatology,Low Dose,2023-03-27,2023-04-24,8.26,9.71,115,80,74,Rash,None,No Change,0
1459,PT-01459,18,F,PGI Chandigarh,Phase IV,ORX-303,Cardiology,Placebo,2023-10-14,2024-01-12,6.83,7.22,137,89,72,None,None,Worsened,0
1460,PT-01460,34,F,Indore Medical Institute,Phase IV,ORX-606,Rheumatology,Placebo,2023-11-10,2023-12-08,8.72,7.88,133,83,98,None,None,Improved,1
1461,PT-01461,60,M,Kolkata Clinical Center,Phase II,ORX-606,Rheumatology,Placebo,2024-07-18,2024-07-25,5.65,4.18,138,81,71,Fever,Mild,Improved,1
1462,PT-01462,61,M,Apollo Chennai,Phase II,ORX-404,Neurology,Low Dose,2023-02-06,2023-03-06,7.42,7.07,142,77,99,None,None,No Change,0
1463,PT-01463,32,F,PGI Chandigarh,Phase III,ORX-202,Diabetes,High Dose,2023-09-25,2023-12-24,7.99,8.88,103,77,93,None,None,Improved,0
1464,PT-01464,63,M,Bhopal Research Hospital,Phase IV,ORX-606,Rheumatology,High Dose,2024-06-05,2024-06-12,6.99,5.93,145,96,61,None,None,Improved,1
1465,PT-01465,25,M,AIIMS Delhi,Phase II,ORX-303,Cardiology,Placebo,2024-08-08,2024-08-22,7.47,7.64,122,90,68,Fatigue,None,No Change,0
1466,PT-01466,18,M,PGI Chandigarh,Phase III,ORX-505,Infectious Disease,Placebo,2024-08-19,2024-10-14,6.69,6.35,123,68,52,None,None,No Change,0
1467,PT-01467,36,M,Indore Medical Institute,Phase III,ORX-606,Rheumatology,Placebo,2023-03-25,2023-04-08,8.28,9.01,149,72,61,Dizziness,None,Improved,0
1468,PT-01468,52,M,Bhopal Research Hospital,Phase II,ORX-404,Neurology,Low Dose,2024-06-26,2024-07-10,7.96,7.92,91,71,77,None,None,Improved,1
1469,PT-01469,52,F,AIIMS Delhi,Phase III,ORX-404,Neurology,Placebo,2024-11-23,2025-02-21,8.12,7.85,133,83,87,None,None,Worsened,0
1470,PT-01470,50,M,Bhopal Research Hospital,Phase III,ORX-202,Diabetes,High Dose,2023-09-27,2023-10-11,7.28,6.64,129,87,81,Nausea,None,Worsened,0
1471,PT-01471,51,M,Bhopal Research Hospital,Phase III,ORX-202,Diabetes,Placebo,2023-11-26,2023-12-10,8.81,8.65,116,92,58,Nausea,Mild,Improved,1
1472,PT-01472,27,F,Fortis Mumbai,Phase III,ORX-202,Diabetes,Low Dose,2023-12-20,2024-01-03,7.6,7.67,105,77,69,Nausea,Severe,Improved,0
1473,PT-01473,37,F,AIIMS Delhi,Phase II,ORX-101,Oncology,Placebo,2024-05-20,2024-06-17,8.33,8.57,127,75,59,None,None,Worsened,0
1474,PT-01474,67,F,Kolkata Clinical Center,Phase I,ORX-101,Oncology,High Dose,2024-11-21,2024-11-28,7.91,6.87,140,81,73,Headache,Moderate,Improved,1
1475,PT-01475,51,M,PGI Chandigarh,Phase III,ORX-404,Neurology,Low Dose,2024-05-06,2024-06-03,6.31,5.6,130,76,87,Headache,None,Improved,1
1476,PT-01476,74,M,AIIMS Delhi,Phase II,ORX-101,Oncology,High Dose,2024-02-24,2024-04-20,6.29,4.4,91,80,68,None,None,Worsened,0
1477,PT-01477,48,F,Kolkata Clinical Center,Phase III,ORX-404,Neurology,Placebo,2024-01-30,2024-03-26,7.36,5.52,95,85,79,Fatigue,Mild,Worsened,0
1478,PT-01478,38,F,AIIMS Delhi,Phase IV,ORX-404,Neurology,Low Dose,2024-03-20,2024-04-03,5.21,5.24,150,85,66,Dizziness,None,Improved,0
1479,PT-01479,45,M,AIIMS Delhi,Phase II,ORX-303,Cardiology,Low Dose,2023-01-23,2023-03-20,5.56,6.11,129,60,73,None,None,Improved,0
1480,PT-01480,52,F,Kolkata Clinical Center,Phase II,ORX-505,Infectious Disease,High Dose,2024-03-19,2024-05-14,6.8,6.15,105,88,68,None,None,Worsened,0
1481,PT-01481,18,M,Bhopal Research Hospital,Phase II,ORX-101,Oncology,High Dose,2024-05-03,2024-08-01,6.75,7.24,121,102,84,None,None,Improved,0
1482,PT-01482,50,F,NIMHANS Bengaluru,Phase III,ORX-404,Neurology,Placebo,2023-11-12,2023-11-26,7.05,6.58,123,78,85,None,None,Improved,1
1483,PT-01483,30,F,AIIMS Delhi,Phase III,ORX-505,Infectious Disease,Placebo,2024-01-18,2024-02-01,5.91,4.5,164,88,82,Fever,None,Improved,1
1484,PT-01484,28,F,Apollo Chennai,Phase II,ORX-202,Diabetes,High Dose,2023-08-28,2023-09-25,7.95,7.44,131,70,80,Fatigue,None,No Change,0
1485,PT-01485,38,F,PGI Chandigarh,Phase III,ORX-606,Rheumatology,Placebo,2023-05-11,2023-06-08,6.28,6.54,100,88,87,Nausea,Moderate,No Change,0
1486,PT-01486,30,M,Apollo Chennai,Phase III,ORX-404,Neurology,Low Dose,2023-01-20,2023-02-17,6.22,5.61,133,80,84,None,None,Improved,1
1487,PT-01487,73,M,Bhopal Research Hospital,Phase III,ORX-505,Infectious Disease,Low Dose,2024-09-09,2024-10-07,6.59,4.65,142,102,83,None,None,Improved,1
1488,PT-01488,27,M,Fortis Mumbai,Phase III,ORX-606,Rheumatology,Placebo,2023-03-02,2023-04-27,7.05,5.64,139,65,73,Nausea,None,Improved,1
1489,PT-01489,28,F,Fortis Mumbai,Phase III,ORX-303,Cardiology,Low Dose,2023-11-18,2024-02-16,7.35,6.62,131,82,64,None,None,Worsened,0
1490,PT-01490,55,M,Bhopal Research Hospital,Phase IV,ORX-303,Cardiology,High Dose,2023-07-19,2023-10-17,7.14,5.85,168,87,75,None,None,No Change,0
1491,PT-01491,67,F,Indore Medical Institute,Phase III,ORX-303,Cardiology,Placebo,2023-05-28,2023-06-25,9.41,8.88,134,70,75,Nausea,Mild,Improved,1
1492,PT-01492,41,M,AIIMS Delhi,Phase II,ORX-404,Neurology,Low Dose,2024-07-22,2024-08-05,7.42,7.32,138,84,61,Headache,None,No Change,0
1493,PT-01493,29,F,Apollo Chennai,Phase III,ORX-606,Rheumatology,Low Dose,2023-10-19,2023-11-02,6.54,5.89,146,68,72,None,None,No Change,0
1494,PT-01494,60,M,PGI Chandigarh,Phase I,ORX-505,Infectious Disease,Low Dose,2023-05-26,2023-06-23,6.84,6.85,125,85,74,None,None,No Change,0
1495,PT-01495,55,M,PGI Chandigarh,Phase III,ORX-404,Neurology,Placebo,2024-09-19,2024-09-26,5.35,4.62,133,88,98,None,None,No Change,0
1496,PT-01496,38,M,Indore Medical Institute,Phase IV,ORX-606,Rheumatology,High Dose,2023-05-16,2023-07-11,8.98,7.98,151,91,65,None,None,Improved,1
1497,PT-01497,49,M,AIIMS Delhi,Phase I,ORX-606,Rheumatology,Placebo,2024-01-04,2024-02-01,7.14,7.3,123,78,97,None,None,Improved,0
1498,PT-01498,43,M,Indore Medical Institute,Phase III,ORX-505,Infectious Disease,Low Dose,2024-02-10,2024-02-24,8.19,7.59,157,73,69,None,None,Improved,1
1499,PT-01499,69,M,Bhopal Research Hospital,Phase III,ORX-303,Cardiology,Placebo,2023-02-27,2023-05-28,6.67,7.71,144,80,52,Nausea,Mild,Improved,0
1500,PT-01500,44,F,Apollo Chennai,Phase I,ORX-202,Diabetes,High Dose,2023-05-21,2023-08-19,7.32,7.97,156,73,89,None,None,Improved,0
1501,PT-01501,57,F,Fortis Mumbai,Phase I,ORX-404,Neurology,Placebo,2024-02-29,2024-05-29,8.49,8.54,93,80,61,None,None,Improved,0
1502,PT-01502,41,M,Kolkata Clinical Center,Phase II,ORX-101,Oncology,Low Dose,2023-03-24,2023-06-22,8.38,8.25,148,86,59,None,None,Worsened,0
1503,PT-01503,18,M,AIIMS Delhi,Phase II,ORX-505,Infectious Disease,Placebo,2024-10-04,2025-01-02,7.38,6.79,110,61,67,Nausea,None,Improved,1
1504,PT-01504,41,M,Fortis Mumbai,Phase III,ORX-303,Cardiology,Placebo,2023-09-24,2023-11-19,8.0,7.77,156,69,90,None,None,Improved,1
1505,PT-01505,45,M,NIMHANS Bengaluru,Phase III,ORX-202,Diabetes,Placebo,2023-02-12,2023-04-09,8.03,7.24,147,85,68,Headache,Moderate,No Change,0
1506,PT-01506,44,M,Fortis Mumbai,Phase III,ORX-606,Rheumatology,High Dose,2024-08-30,2024-09-27,6.91,6.95,106,81,83,None,None,Improved,0
1507,PT-01507,45,M,Fortis Mumbai,Phase III,ORX-202,Diabetes,Low Dose,2023-11-14,2023-11-21,8.82,9.11,127,84,82,None,None,Improved,0
1508,PT-01508,51,F,NIMHANS Bengaluru,Phase II,ORX-606,Rheumatology,Low Dose,2024-02-05,2024-05-05,5.01,4.34,101,97,77,Dizziness,None,No Change,0
1509,PT-01509,41,F,Apollo Chennai,Phase III,ORX-101,Oncology,Low Dose,2023-01-01,2023-01-08,8.28,8.26,107,81,73,Fatigue,Moderate,No Change,0
1510,PT-01510,18,M,NIMHANS Bengaluru,Phase II,ORX-606,Rheumatology,Low Dose,2023-06-13,2023-06-20,6.37,5.81,125,64,94,None,None,Improved,1
1511,PT-01511,43,M,PGI Chandigarh,Phase IV,ORX-101,Oncology,Placebo,2024-10-31,2024-11-07,7.25,7.21,113,87,72,None,None,Improved,1
1512,PT-01512,30,M,Fortis Mumbai,Phase II,ORX-404,Neurology,High Dose,2023-07-29,2023-08-05,7.89,8.83,141,93,70,Headache,Mild,Worsened,0
1513,PT-01513,19,M,Kolkata Clinical Center,Phase IV,ORX-202,Diabetes,Placebo,2023-03-30,2023-04-13,8.99,10.44,155,77,61,Fatigue,Mild,Improved,0
1514,PT-01514,27,F,Kolkata Clinical Center,Phase II,ORX-101,Oncology,High Dose,2023-06-06,2023-06-20,5.18,4.68,156,80,82,Headache,None,Improved,1
1515,PT-01515,67,F,Kolkata Clinical Center,Phase III,ORX-404,Neurology,Placebo,2023-01-14,2023-04-14,6.72,8.15,163,80,69,Nausea,Severe,Worsened,0
1516,PT-01516,56,F,Kolkata Clinical Center,Phase III,ORX-202,Diabetes,High Dose,2023-01-25,2023-02-22,6.78,5.34,151,96,80,None,None,Worsened,0
1517,PT-01517,24,F,Indore Medical Institute,Phase III,ORX-505,Infectious Disease,High Dose,2024-03-21,2024-06-19,5.72,5.42,119,77,92,None,None,Worsened,0
1518,PT-01518,56,M,Indore Medical Institute,Phase III,ORX-303,Cardiology,Low Dose,2024-09-04,2024-10-02,8.85,7.56,121,91,84,None,None,Improved,1
1519,PT-01519,69,M,PGI Chandigarh,Phase II,ORX-606,Rheumatology,Low Dose,2023-05-30,2023-06-27,7.7,8.97,137,94,73,None,None,No Change,0
1520,PT-01520,45,M,PGI Chandigarh,Phase III,ORX-404,Neurology,High Dose,2023-10-27,2023-11-10,8.29,9.34,141,81,97,Headache,None,No Change,0
1521,PT-01521,18,F,NIMHANS Bengaluru,Phase II,ORX-101,Oncology,Low Dose,2023-05-21,2023-06-18,5.49,5.71,128,89,78,Nausea,None,Worsened,0
1522,PT-01522,54,M,PGI Chandigarh,Phase IV,ORX-505,Infectious Disease,High Dose,2024-10-02,2024-10-16,6.22,6.34,145,96,106,None,None,No Change,0
1523,PT-01523,48,M,AIIMS Delhi,Phase IV,ORX-202,Diabetes,High Dose,2024-02-10,2024-02-17,7.53,5.76,118,79,92,Fatigue,Severe,No Change,0
1524,PT-01524,35,M,Indore Medical Institute,Phase III,ORX-303,Cardiology,High Dose,2024-11-11,2024-11-25,8.16,7.75,124,84,72,Headache,Mild,No Change,0
1525,PT-01525,38,F,PGI Chandigarh,Phase I,ORX-505,Infectious Disease,High Dose,2024-06-19,2024-08-14,5.15,4.53,119,75,83,None,None,Improved,1
1526,PT-01526,55,F,Bhopal Research Hospital,Phase III,ORX-202,Diabetes,Low Dose,2024-04-09,2024-04-23,7.48,7.97,138,78,71,Fatigue,None,No Change,0
1527,PT-01527,50,M,Bhopal Research Hospital,Phase IV,ORX-404,Neurology,Placebo,2023-03-15,2023-04-12,7.89,8.75,149,75,76,None,None,Improved,0
1528,PT-01528,55,M,Bhopal Research Hospital,Phase III,ORX-202,Diabetes,Placebo,2023-02-01,2023-03-01,8.48,8.93,126,66,64,None,None,Improved,0
1529,PT-01529,49,M,Kolkata Clinical Center,Phase I,ORX-101,Oncology,Low Dose,2024-01-02,2024-02-27,7.61,6.22,128,89,61,Nausea,None,Improved,1
1530,PT-01530,62,F,NIMHANS Bengaluru,Phase II,ORX-505,Infectious Disease,Low Dose,2024-05-04,2024-08-02,6.75,7.48,118,69,71,Headache,Severe,No Change,0
1531,PT-01531,43,F,Indore Medical Institute,Phase II,ORX-303,Cardiology,High Dose,2024-01-28,2024-04-27,6.73,6.14,134,79,77,None,None,No Change,0
1532,PT-01532,18,F,Kolkata Clinical Center,Phase IV,ORX-101,Oncology,Low Dose,2024-05-14,2024-05-21,7.67,7.19,156,70,52,None,None,Improved,1
1533,PT-01533,54,M,Bhopal Research Hospital,Phase II,ORX-404,Neurology,Low Dose,2023-12-12,2023-12-26,7.62,6.31,100,100,97,None,None,No Change,0
1534,PT-01534,18,F,Kolkata Clinical Center,Phase II,ORX-202,Diabetes,Low Dose,2023-04-08,2023-04-15,6.65,7.75,119,76,74,Nausea,Mild,No Change,0
1535,PT-01535,27,M,Kolkata Clinical Center,Phase IV,ORX-101,Oncology,Low Dose,2024-04-19,2024-05-17,5.15,5.7,94,84,90,None,None,No Change,0
1536,PT-01536,21,M,Bhopal Research Hospital,Phase II,ORX-606,Rheumatology,Low Dose,2023-06-28,2023-08-23,6.09,6.78,137,74,94,None,None,Improved,0
1537,PT-01537,64,F,NIMHANS Bengaluru,Phase III,ORX-101,Oncology,High Dose,2023-03-20,2023-04-03,7.52,6.31,120,85,75,None,None,Improved,1
1538,PT-01538,60,F,AIIMS Delhi,Phase III,ORX-404,Neurology,Placebo,2023-07-07,2023-07-21,5.36,3.62,131,76,69,Headache,Moderate,Improved,1
1539,PT-01539,18,M,Bhopal Research Hospital,Phase III,ORX-101,Oncology,Placebo,2023-05-16,2023-08-14,7.22,6.78,139,82,76,None,None,No Change,0
1540,PT-01540,63,F,NIMHANS Bengaluru,Phase III,ORX-101,Oncology,High Dose,2024-01-13,2024-04-12,5.63,5.71,97,71,61,None,None,Improved,0
1541,PT-01541,57,F,NIMHANS Bengaluru,Phase III,ORX-101,Oncology,Placebo,2023-09-27,2023-10-25,7.12,6.71,108,78,67,None,None,Improved,1
1542,PT-01542,51,M,AIIMS Delhi,Phase IV,ORX-101,Oncology,Placebo,2023-03-30,2023-06-28,6.01,6.81,97,72,101,None,None,Improved,0
1543,PT-01543,38,F,Kolkata Clinical Center,Phase III,ORX-101,Oncology,High Dose,2024-11-03,2024-11-17,5.62,5.42,119,71,62,None,None,No Change,0
1544,PT-01544,85,M,AIIMS Delhi,Phase II,ORX-303,Cardiology,Placebo,2024-02-05,2024-02-12,6.9,4.77,154,89,67,None,None,Improved,1
1545,PT-01545,30,M,Fortis Mumbai,Phase I,ORX-505,Infectious Disease,Low Dose,2023-11-07,2023-11-21,8.01,7.39,93,103,71,None,None,Improved,1
1546,PT-01546,68,F,Apollo Chennai,Phase III,ORX-606,Rheumatology,Low Dose,2024-05-05,2024-05-19,8.73,7.43,146,74,51,None,None,Improved,1
1547,PT-01547,38,M,AIIMS Delhi,Phase I,ORX-505,Infectious Disease,Placebo,2023-03-11,2023-05-06,7.68,6.86,122,95,79,Fever,Mild,Improved,1
1548,PT-01548,31,M,NIMHANS Bengaluru,Phase III,ORX-606,Rheumatology,Low Dose,2023-08-19,2023-09-16,8.04,7.82,90,87,83,Headache,None,Improved,1
1549,PT-01549,45,F,Indore Medical Institute,Phase III,ORX-202,Diabetes,High Dose,2024-01-18,2024-03-14,8.27,7.26,134,63,83,Rash,None,Improved,1
1550,PT-01550,76,M,NIMHANS Bengaluru,Phase III,ORX-606,Rheumatology,High Dose,2024-10-12,2024-10-26,6.01,4.92,115,83,63,None,None,Improved,1
1551,PT-01551,51,F,NIMHANS Bengaluru,Phase III,ORX-505,Infectious Disease,Placebo,2023-03-09,2023-06-07,8.22,8.3,96,93,91,Fatigue,None,Improved,0
1552,PT-01552,58,M,NIMHANS Bengaluru,Phase II,ORX-303,Cardiology,Low Dose,2023-12-16,2024-01-13,7.65,7.45,146,105,64,Nausea,Moderate,No Change,0
1553,PT-01553,62,F,NIMHANS Bengaluru,Phase III,ORX-606,Rheumatology,Low Dose,2024-07-27,2024-10-25,7.1,6.58,100,78,64,Headache,None,No Change,0
1554,PT-01554,37,F,Kolkata Clinical Center,Phase I,ORX-303,Cardiology,Low Dose,2024-09-23,2024-09-30,5.88,5.08,120,83,55,None,None,Improved,1
1555,PT-01555,21,F,Apollo Chennai,Phase IV,ORX-303,Cardiology,High Dose,2023-11-28,2023-12-12,7.63,6.52,147,84,86,None,None,No Change,0
1556,PT-01556,67,F,PGI Chandigarh,Phase II,ORX-505,Infectious Disease,High Dose,2023-10-13,2023-11-10,6.83,5.91,143,88,75,Nausea,None,No Change,0
1557,PT-01557,67,M,Fortis Mumbai,Phase III,ORX-202,Diabetes,High Dose,2024-01-06,2024-04-05,6.95,6.57,128,70,79,None,None,No Change,0
1558,PT-01558,67,F,AIIMS Delhi,Phase III,ORX-101,Oncology,High Dose,2023-10-26,2023-11-09,7.73,7.36,125,85,88,Headache,Moderate,Improved,1
1559,PT-01559,54,M,Kolkata Clinical Center,Phase IV,ORX-303,Cardiology,Placebo,2024-05-10,2024-06-07,6.8,6.69,136,69,80,None,None,Worsened,0
1560,PT-01560,18,F,Bhopal Research Hospital,Phase I,ORX-303,Cardiology,Placebo,2024-01-21,2024-04-20,7.78,7.97,141,77,82,None,None,Worsened,0
1561,PT-01561,67,M,Fortis Mumbai,Phase III,ORX-404,Neurology,Low Dose,2024-07-17,2024-10-15,8.9,8.47,130,95,56,None,None,No Change,0
1562,PT-01562,39,F,Indore Medical Institute,Phase II,ORX-404,Neurology,Low Dose,2024-05-16,2024-08-14,8.8,9.28,134,63,77,None,None,Improved,0
1563,PT-01563,35,F,AIIMS Delhi,Phase I,ORX-101,Oncology,Low Dose,2023-02-25,2023-03-04,7.6,6.47,109,57,95,None,None,No Change,0
1564,PT-01564,38,F,Bhopal Research Hospital,Phase I,ORX-606,Rheumatology,High Dose,2023-07-29,2023-08-05,7.39,6.99,108,66,63,Nausea,None,Worsened,0
1565,PT-01565,33,F,Fortis Mumbai,Phase IV,ORX-303,Cardiology,Low Dose,2023-08-25,2023-09-08,7.64,6.52,159,94,89,Nausea,None,No Change,0
1566,PT-01566,43,F,AIIMS Delhi,Phase III,ORX-101,Oncology,Low Dose,2023-11-21,2023-12-05,9.02,8.42,127,84,87,Fever,None,Improved,1
1567,PT-01567,55,M,Bhopal Research Hospital,Phase IV,ORX-505,Infectious Disease,High Dose,2023-10-04,2023-11-29,6.63,5.75,139,90,72,None,None,Improved,1
1568,PT-01568,19,F,Kolkata Clinical Center,Phase II,ORX-505,Infectious Disease,Placebo,2023-06-27,2023-07-11,6.95,7.11,160,67,72,None,None,Improved,0
1569,PT-01569,38,F,NIMHANS Bengaluru,Phase III,ORX-404,Neurology,Placebo,2023-04-13,2023-04-20,8.83,8.4,111,88,72,None,None,Improved,1
1570,PT-01570,25,M,NIMHANS Bengaluru,Phase III,ORX-505,Infectious Disease,High Dose,2023-01-24,2023-04-24,6.13,7.29,134,83,74,None,None,No Change,0
1571,PT-01571,49,F,PGI Chandigarh,Phase III,ORX-303,Cardiology,Placebo,2024-06-03,2024-09-01,7.54,7.4,130,92,78,None,None,Improved,1
1572,PT-01572,29,M,Bhopal Research Hospital,Phase II,ORX-505,Infectious Disease,High Dose,2024-11-30,2025-01-25,6.47,4.28,164,92,66,None,None,Improved,1
1573,PT-01573,40,M,NIMHANS Bengaluru,Phase II,ORX-303,Cardiology,Placebo,2023-10-25,2023-11-08,6.44,7.42,102,83,76,Fatigue,Severe,Improved,0
1574,PT-01574,58,M,Bhopal Research Hospital,Phase III,ORX-404,Neurology,High Dose,2023-01-23,2023-03-20,7.08,5.09,123,70,79,None,None,No Change,0
1575,PT-01575,67,M,Kolkata Clinical Center,Phase III,ORX-404,Neurology,Placebo,2023-09-19,2023-10-17,5.11,3.99,118,77,88,None,None,Improved,1
1576,PT-01576,42,F,AIIMS Delhi,Phase III,ORX-202,Diabetes,High Dose,2024-10-22,2025-01-20,7.7,6.74,132,91,67,Rash,Moderate,No Change,0
1577,PT-01577,57,F,Apollo Chennai,Phase II,ORX-101,Oncology,High Dose,2023-06-12,2023-06-19,7.26,7.8,124,86,77,Nausea,None,No Change,0
1578,PT-01578,43,F,Fortis Mumbai,Phase III,ORX-202,Diabetes,High Dose,2023-10-13,2023-10-27,7.51,7.59,105,99,51,None,None,Improved,0
1579,PT-01579,34,M,Bhopal Research Hospital,Phase II,ORX-505,Infectious Disease,Placebo,2024-11-01,2024-11-15,7.09,7.06,156,59,70,None,None,Improved,1
1580,PT-01580,18,F,Apollo Chennai,Phase IV,ORX-101,Oncology,High Dose,2023-07-20,2023-10-18,7.24,7.08,156,83,92,None,None,No Change,0
1581,PT-01581,54,M,AIIMS Delhi,Phase II,ORX-505,Infectious Disease,Placebo,2024-04-18,2024-07-17,6.68,5.01,132,64,96,Headache,None,No Change,0
1582,PT-01582,42,M,Indore Medical Institute,Phase II,ORX-303,Cardiology,High Dose,2023-10-06,2024-01-04,8.63,7.8,132,84,77,None,None,No Change,0
1583,PT-01583,38,M,AIIMS Delhi,Phase II,ORX-101,Oncology,Low Dose,2023-05-16,2023-05-30,7.67,6.44,106,96,88,Rash,Mild,Worsened,0
1584,PT-01584,46,F,Kolkata Clinical Center,Phase III,ORX-202,Diabetes,High Dose,2023-09-12,2023-09-26,9.2,8.56,151,84,63,Headache,None,No Change,0
1585,PT-01585,74,F,Fortis Mumbai,Phase I,ORX-404,Neurology,Low Dose,2024-05-16,2024-07-11,8.39,7.88,141,77,89,Headache,Moderate,No Change,0
1586,PT-01586,18,F,PGI Chandigarh,Phase IV,ORX-505,Infectious Disease,Low Dose,2024-02-19,2024-03-18,5.98,6.46,123,84,59,None,None,Improved,0
1587,PT-01587,74,F,Indore Medical Institute,Phase I,ORX-202,Diabetes,Placebo,2024-01-12,2024-02-09,8.63,8.05,120,94,105,Fatigue,None,Improved,1
1588,PT-01588,60,F,PGI Chandigarh,Phase II,ORX-404,Neurology,Placebo,2023-01-17,2023-01-31,9.81,8.58,113,67,84,Nausea,None,Improved,1
1589,PT-01589,47,M,Fortis Mumbai,Phase III,ORX-404,Neurology,Placebo,2023-01-17,2023-01-31,7.02,7.35,150,63,69,None,None,Worsened,0
1590,PT-01590,58,F,Kolkata Clinical Center,Phase III,ORX-303,Cardiology,High Dose,2024-04-19,2024-05-03,6.64,,146,66,73,None,None,Improved,1
1591,PT-01591,50,M,Bhopal Research Hospital,Phase IV,ORX-303,Cardiology,Low Dose,2023-12-25,2024-02-19,6.51,6.82,117,98,76,Fatigue,Moderate,Worsened,0
1592,PT-01592,55,M,PGI Chandigarh,Phase III,ORX-505,Infectious Disease,Low Dose,2023-02-11,2023-04-08,8.1,7.13,91,86,79,None,None,Improved,1
1593,PT-01593,53,F,AIIMS Delhi,Phase IV,ORX-101,Oncology,High Dose,2023-05-30,2023-08-28,6.93,6.14,164,64,88,None,None,Improved,1
1594,PT-01594,35,M,PGI Chandigarh,Phase III,ORX-101,Oncology,Low Dose,2023-12-09,2024-03-08,6.8,6.11,113,88,97,Nausea,None,Improved,1
1595,PT-01595,52,M,Bhopal Research Hospital,Phase III,ORX-404,Neurology,High Dose,2024-03-19,2024-06-17,7.32,6.04,137,107,72,Headache,Mild,Improved,1
1596,PT-01596,38,M,AIIMS Delhi,Phase IV,ORX-404,Neurology,Low Dose,2024-03-26,2024-04-23,6.53,5.69,90,86,66,Headache,None,Improved,1
1597,PT-01597,19,F,Apollo Chennai,Phase II,ORX-101,Oncology,Placebo,2023-01-13,2023-01-27,8.1,6.73,121,99,58,Nausea,None,Improved,1
1598,PT-01598,20,M,Fortis Mumbai,Phase III,ORX-202,Diabetes,Placebo,2023-03-09,2023-03-23,7.52,8.16,99,86,86,None,None,Worsened,0
1599,PT-01599,18,F,Apollo Chennai,Phase III,ORX-404,Neurology,High Dose,2023-06-19,2023-08-14,8.16,8.55,122,97,93,Nausea,Moderate,Improved,0
1600,PT-01600,46,F,PGI Chandigarh,Phase III,ORX-404,Neurology,High Dose,2023-09-22,2023-12-21,6.66,5.38,127,88,73,Fatigue,Moderate,No Change,0
1601,PT-01601,18,F,PGI Chandigarh,Phase III,ORX-505,Infectious Disease,Placebo,2024-11-29,2025-02-27,8.72,8.49,121,92,99,None,None,Improved,1
1602,PT-01602,18,M,Indore Medical Institute,Phase II,ORX-404,Neurology,Low Dose,2023-12-03,2024-03-02,7.72,6.04,136,83,86,Fever,Severe,Improved,1
1603,PT-01603,37,M,Fortis Mumbai,Phase IV,ORX-303,Cardiology,Placebo,2023-06-01,2023-08-30,4.95,4.15,135,94,61,Headache,Moderate,Improved,1
1604,PT-01604,61,M,AIIMS Delhi,Phase III,ORX-101,Oncology,High Dose,2024-06-01,2024-06-29,6.42,6.35,118,84,90,None,None,Improved,1
1605,PT-01605,25,F,Apollo Chennai,Phase II,ORX-202,Diabetes,Low Dose,2024-11-09,2024-11-16,6.38,6.15,171,71,106,Dizziness,None,No Change,0
1606,PT-01606,77,F,AIIMS Delhi,Phase III,ORX-404,Neurology,Low Dose,2023-02-01,2023-03-01,7.08,6.41,115,81,58,None,None,Worsened,0
1607,PT-01607,43,M,Kolkata Clinical Center,Phase III,ORX-404,Neurology,Low Dose,2024-02-20,2024-04-16,9.0,8.05,123,61,83,None,None,No Change,0
1608,PT-01608,49,M,PGI Chandigarh,Phase II,ORX-505,Infectious Disease,Low Dose,2023-03-26,2023-04-02,7.28,6.68,122,88,77,Rash,None,Improved,1
1609,PT-01609,50,F,Bhopal Research Hospital,Phase III,ORX-606,Rheumatology,Low Dose,2023-02-22,2023-03-01,7.46,8.07,140,84,99,None,None,Improved,0
1610,PT-01610,51,F,PGI Chandigarh,Phase IV,ORX-606,Rheumatology,High Dose,2024-01-01,2024-03-31,8.77,8.91,94,97,79,None,None,Improved,0
1611,PT-01611,44,F,Indore Medical Institute,Phase II,ORX-505,Infectious Disease,Placebo,2023-02-10,2023-05-11,7.54,6.83,132,74,95,Dizziness,Mild,Improved,1
1612,PT-01612,43,F,Kolkata Clinical Center,Phase III,ORX-101,Oncology,Placebo,2023-10-26,2024-01-24,6.74,5.51,132,84,83,None,None,No Change,0
1613,PT-01613,28,F,Kolkata Clinical Center,Phase I,ORX-505,Infectious Disease,High Dose,2023-06-11,2023-09-09,5.28,5.44,154,69,100,Nausea,Mild,Improved,0
1614,PT-01614,49,M,PGI Chandigarh,Phase II,ORX-606,Rheumatology,Placebo,2024-04-29,2024-06-24,7.19,6.43,103,93,67,None,None,Improved,1
1615,PT-01615,32,F,NIMHANS Bengaluru,Phase III,ORX-404,Neurology,High Dose,2023-08-29,2023-09-26,8.39,6.3,100,81,82,None,None,No Change,0
1616,PT-01616,52,F,AIIMS Delhi,Phase I,ORX-101,Oncology,Placebo,2024-08-24,2024-08-31,6.84,8.72,123,79,66,Fever,None,Improved,0
1617,PT-01617,46,M,PGI Chandigarh,Phase II,ORX-606,Rheumatology,Low Dose,2023-09-02,2023-10-28,7.94,8.62,101,79,84,None,None,Improved,0
1618,PT-01618,54,F,Apollo Chennai,Phase IV,ORX-404,Neurology,High Dose,2024-01-08,2024-01-22,7.21,7.3,113,100,91,None,None,Improved,0
1619,PT-01619,23,M,Fortis Mumbai,Phase I,ORX-404,Neurology,Placebo,2024-05-24,2024-07-19,5.91,4.57,140,66,73,None,None,No Change,0
1620,PT-01620,52,F,PGI Chandigarh,Phase III,ORX-606,Rheumatology,High Dose,2024-03-08,2024-04-05,7.12,6.95,108,89,69,Headache,Moderate,Worsened,0
1621,PT-01621,39,M,AIIMS Delhi,Phase I,ORX-303,Cardiology,Low Dose,2024-05-13,2024-06-10,7.49,7.18,128,72,73,Fatigue,None,Improved,1
1622,PT-01622,45,F,Apollo Chennai,Phase IV,ORX-606,Rheumatology,Placebo,2023-02-09,2023-02-16,5.55,4.73,134,66,94,Headache,Moderate,No Change,0
1623,PT-01623,65,F,Bhopal Research Hospital,Phase II,ORX-404,Neurology,High Dose,2024-05-28,2024-06-11,5.71,6.53,125,87,71,None,None,Improved,0
1624,PT-01624,59,F,Apollo Chennai,Phase III,ORX-404,Neurology,High Dose,2023-02-10,2023-04-07,7.69,6.55,107,64,80,Nausea,None,Worsened,0
1625,PT-01625,54,F,PGI Chandigarh,Phase I,ORX-101,Oncology,Low Dose,2024-10-04,2024-10-11,7.98,7.47,107,73,94,Fatigue,Moderate,Improved,1
1626,PT-01626,37,M,Apollo Chennai,Phase IV,ORX-404,Neurology,Placebo,2024-10-29,2024-11-05,7.37,6.0,134,76,92,Nausea,Mild,No Change,0
1627,PT-01627,57,F,Apollo Chennai,Phase II,ORX-101,Oncology,Placebo,2024-04-05,2024-04-19,6.61,6.09,118,64,65,None,None,Improved,1
1628,PT-01628,48,M,Fortis Mumbai,Phase III,ORX-505,Infectious Disease,High Dose,2024-07-13,2024-09-07,7.59,7.32,122,93,78,Fatigue,Mild,Improved,1
1629,PT-01629,56,F,Indore Medical Institute,Phase III,ORX-404,Neurology,High Dose,2023-08-07,2023-11-05,5.07,1.14,133,64,75,None,None,No Change,0
1630,PT-01630,40,M,NIMHANS Bengaluru,Phase IV,ORX-505,Infectious Disease,High Dose,2023-07-01,2023-09-29,9.1,9.06,130,92,83,None,None,No Change,0
1631,PT-01631,37,F,Apollo Chennai,Phase I,ORX-404,Neurology,Placebo,2023-05-13,2023-06-10,8.49,7.09,133,63,80,None,None,Improved,1
1632,PT-01632,48,F,NIMHANS Bengaluru,Phase III,ORX-202,Diabetes,High Dose,2024-01-06,2024-01-13,9.21,7.4,117,91,82,None,None,No Change,0
1633,PT-01633,47,M,AIIMS Delhi,Phase I,ORX-101,Oncology,High Dose,2023-01-04,2023-01-18,6.05,5.12,150,81,83,Headache,Mild,Improved,1
1634,PT-01634,43,F,Bhopal Research Hospital,Phase IV,ORX-404,Neurology,Low Dose,2024-05-27,2024-08-25,5.78,6.22,137,109,63,None,None,Improved,0
1635,PT-01635,58,F,PGI Chandigarh,Phase III,ORX-101,Oncology,Low Dose,2024-02-02,2024-02-16,5.63,5.37,145,57,75,None,None,Improved,1
1636,PT-01636,35,M,Bhopal Research Hospital,Phase IV,ORX-101,Oncology,Placebo,2023-12-17,2023-12-31,6.36,6.3,148,80,80,Headache,None,Improved,1
1637,PT-01637,46,F,NIMHANS Bengaluru,Phase I,ORX-404,Neurology,Placebo,2024-06-08,2024-08-03,7.2,5.82,147,85,83,None,None,Improved,1
1638,PT-01638,32,F,Bhopal Research Hospital,Phase III,ORX-606,Rheumatology,Placebo,2024-11-03,2024-12-29,6.65,6.09,100,61,69,None,None,No Change,0
1639,PT-01639,53,F,Apollo Chennai,Phase III,ORX-101,Oncology,Placebo,2023-07-12,2023-07-19,6.42,5.1,113,76,73,None,None,No Change,0
1640,PT-01640,79,F,NIMHANS Bengaluru,Phase III,ORX-606,Rheumatology,High Dose,2023-11-19,2024-01-14,8.47,8.99,149,70,60,Rash,Mild,Improved,0
1641,PT-01641,27,M,Kolkata Clinical Center,Phase III,ORX-404,Neurology,Low Dose,2024-07-18,2024-08-15,8.8,7.91,105,76,74,Rash,Mild,Improved,1
1642,PT-01642,49,F,NIMHANS Bengaluru,Phase II,ORX-303,Cardiology,Placebo,2023-04-20,2023-04-27,7.5,6.36,140,74,75,Nausea,Severe,Worsened,0
1643,PT-01643,55,F,AIIMS Delhi,Phase III,ORX-303,Cardiology,Low Dose,2024-02-26,2024-03-04,6.43,5.52,138,71,72,None,None,Worsened,0
1644,PT-01644,53,F,Fortis Mumbai,Phase II,ORX-404,Neurology,Placebo,2023-10-19,2023-11-16,9.66,9.81,136,88,62,None,None,Improved,0
1645,PT-01645,46,M,Bhopal Research Hospital,Phase IV,ORX-303,Cardiology,Placebo,2023-09-28,2023-10-26,7.16,7.05,130,86,73,None,None,Improved,1
1646,PT-01646,45,M,Bhopal Research Hospital,Phase III,ORX-202,Diabetes,Placebo,2023-11-15,2024-02-13,5.73,5.04,153,85,77,Fatigue,None,No Change,0
1647,PT-01647,75,F,Fortis Mumbai,Phase IV,ORX-101,Oncology,High Dose,2023-02-11,2023-03-11,5.57,4.17,158,82,74,None,None,Worsened,0
1648,PT-01648,25,F,Indore Medical Institute,Phase II,ORX-202,Diabetes,Placebo,2024-08-25,2024-09-01,7.74,7.83,108,80,73,None,None,Improved,0
1649,PT-01649,49,F,NIMHANS Bengaluru,Phase III,ORX-505,Infectious Disease,Placebo,2023-06-12,2023-09-10,5.86,6.58,144,77,74,Fatigue,None,Worsened,0
1650,PT-01650,42,F,Bhopal Research Hospital,Phase II,ORX-606,Rheumatology,High Dose,2024-04-26,2024-05-10,6.27,5.47,123,101,91,None,None,No Change,0
1651,PT-01651,59,M,Indore Medical Institute,Phase IV,ORX-606,Rheumatology,Low Dose,2023-10-07,2024-01-05,7.64,6.24,127,93,60,Headache,None,No Change,0
1652,PT-01652,55,M,Apollo Chennai,Phase I,ORX-505,Infectious Disease,High Dose,2023-07-17,2023-10-15,9.99,10.54,153,84,91,None,None,Improved,0
1653,PT-01653,33,F,Fortis Mumbai,Phase IV,ORX-303,Cardiology,Placebo,2023-05-08,2023-07-03,8.16,8.34,133,97,70,Nausea,None,Improved,0
1654,PT-01654,42,M,Apollo Chennai,Phase III,ORX-606,Rheumatology,Placebo,2023-05-12,2023-08-10,7.31,5.99,132,61,92,Nausea,None,Improved,1
1655,PT-01655,45,M,Indore Medical Institute,Phase I,ORX-202,Diabetes,High Dose,2023-02-17,2023-02-24,6.57,5.42,123,90,85,None,None,No Change,0
1656,PT-01656,33,M,Bhopal Research Hospital,Phase II,ORX-505,Infectious Disease,Placebo,2023-08-04,2023-08-11,6.18,6.38,114,82,79,None,None,No Change,0
1657,PT-01657,49,M,Kolkata Clinical Center,Phase II,ORX-202,Diabetes,Placebo,2024-10-25,2024-11-01,8.23,6.69,93,75,103,None,None,Worsened,0
1658,PT-01658,77,F,Fortis Mumbai,Phase II,ORX-404,Neurology,High Dose,2024-10-12,2024-10-26,9.4,8.82,95,53,69,None,None,Improved,1
1659,PT-01659,41,M,Fortis Mumbai,Phase III,ORX-404,Neurology,Placebo,2023-01-04,2023-03-01,8.76,9.14,132,71,64,None,None,Improved,0
1660,PT-01660,49,M,Fortis Mumbai,Phase III,ORX-202,Diabetes,Low Dose,2023-10-22,2023-11-05,8.04,7.99,109,89,83,None,None,Improved,1
1661,PT-01661,27,M,Bhopal Research Hospital,Phase III,ORX-505,Infectious Disease,Low Dose,2023-11-07,2023-11-21,6.26,6.48,123,101,85,Headache,None,Improved,0
1662,PT-01662,37,F,Fortis Mumbai,Phase IV,ORX-202,Diabetes,Low Dose,2024-03-24,2024-04-07,7.19,6.84,114,71,87,None,None,Improved,1
1663,PT-01663,58,F,AIIMS Delhi,Phase II,ORX-101,Oncology,Placebo,2024-01-15,2024-04-14,7.92,8.89,118,102,65,None,None,Improved,0
1664,PT-01664,28,F,Indore Medical Institute,Phase III,ORX-101,Oncology,Low Dose,2023-04-20,2023-05-04,5.09,4.29,118,88,81,None,None,Worsened,0
1665,PT-01665,25,M,AIIMS Delhi,Phase III,ORX-606,Rheumatology,Low Dose,2024-06-25,2024-07-02,6.73,5.99,96,70,67,None,None,Improved,1
1666,PT-01666,67,F,Indore Medical Institute,Phase III,ORX-404,Neurology,Placebo,2023-04-22,2023-05-20,7.43,7.63,101,96,96,None,None,No Change,0
1667,PT-01667,18,F,NIMHANS Bengaluru,Phase III,ORX-606,Rheumatology,High Dose,2024-09-08,2024-12-07,6.35,6.4,139,73,73,None,None,No Change,0
1668,PT-01668,35,F,Apollo Chennai,Phase III,ORX-303,Cardiology,Placebo,2023-12-11,2024-01-08,7.33,8.01,114,94,67,None,None,Improved,0
1669,PT-01669,31,F,NIMHANS Bengaluru,Phase III,ORX-505,Infectious Disease,Placebo,2023-03-20,2023-03-27,8.18,8.61,143,66,71,None,None,No Change,0
1670,PT-01670,58,F,Apollo Chennai,Phase IV,ORX-404,Neurology,Low Dose,2023-03-16,2023-03-23,7.25,5.88,136,73,103,Fever,None,No Change,0
1671,PT-01671,69,M,Apollo Chennai,Phase II,ORX-202,Diabetes,Low Dose,2023-02-07,2023-03-07,7.92,8.75,129,91,98,Nausea,None,Improved,0
1672,PT-01672,48,F,Kolkata Clinical Center,Phase III,ORX-202,Diabetes,Placebo,2023-08-31,2023-11-29,6.89,4.96,126,91,91,Rash,Mild,Improved,1
1673,PT-01673,53,M,Fortis Mumbai,Phase I,ORX-505,Infectious Disease,Placebo,2023-01-07,2023-03-04,6.55,4.37,119,78,73,None,None,No Change,0
1674,PT-01674,54,F,Bhopal Research Hospital,Phase IV,ORX-101,Oncology,Low Dose,2023-08-23,2023-11-21,9.58,9.29,124,78,79,None,None,Improved,1
1675,PT-01675,31,F,Kolkata Clinical Center,Phase IV,ORX-505,Infectious Disease,High Dose,2023-01-28,2023-02-04,7.34,7.35,131,87,84,Nausea,Mild,Worsened,0
1676,PT-01676,18,M,AIIMS Delhi,Phase II,ORX-202,Diabetes,High Dose,2023-07-03,2023-07-17,7.96,6.96,108,68,84,None,None,No Change,0
1677,PT-01677,41,F,Kolkata Clinical Center,Phase III,ORX-202,Diabetes,Low Dose,2023-02-02,2023-02-09,5.18,5.21,102,83,81,Headache,None,No Change,0
1678,PT-01678,59,F,NIMHANS Bengaluru,Phase III,ORX-202,Diabetes,High Dose,2023-06-12,2023-08-07,9.34,7.71,127,78,84,None,None,Improved,1
1679,PT-01679,48,M,NIMHANS Bengaluru,Phase III,ORX-101,Oncology,Placebo,2023-06-11,2023-06-25,6.78,5.98,107,93,84,None,None,Improved,1
1680,PT-01680,59,F,AIIMS Delhi,Phase II,ORX-303,Cardiology,High Dose,2024-07-22,2024-10-20,6.83,5.84,108,86,63,Dizziness,Moderate,Worsened,0
1681,PT-01681,74,F,AIIMS Delhi,Phase IV,ORX-505,Infectious Disease,Low Dose,2024-08-03,2024-08-17,5.63,5.48,156,89,80,None,None,Worsened,0
1682,PT-01682,29,F,Fortis Mumbai,Phase II,ORX-505,Infectious Disease,Placebo,2023-01-21,2023-02-04,5.54,5.83,155,76,62,None,None,Improved,0
1683,PT-01683,18,F,Bhopal Research Hospital,Phase IV,ORX-606,Rheumatology,Placebo,2023-02-25,2023-03-11,6.02,5.52,156,90,82,None,None,No Change,0
1684,PT-01684,38,M,NIMHANS Bengaluru,Phase III,ORX-606,Rheumatology,Low Dose,2023-05-19,2023-05-26,6.5,7.37,131,56,68,None,None,Improved,0
1685,PT-01685,31,M,Apollo Chennai,Phase III,ORX-101,Oncology,Low Dose,2024-09-13,2024-12-12,6.54,6.65,126,81,96,None,None,Worsened,0
1686,PT-01686,33,M,Bhopal Research Hospital,Phase II,ORX-303,Cardiology,Placebo,2024-07-16,2024-07-30,9.44,8.43,129,78,79,None,None,No Change,0
1687,PT-01687,52,F,Apollo Chennai,Phase IV,ORX-202,Diabetes,High Dose,2023-08-14,2023-08-21,7.72,6.64,107,112,71,Nausea,None,Improved,1
1688,PT-01688,56,M,PGI Chandigarh,Phase III,ORX-404,Neurology,Placebo,2023-10-10,2023-11-07,5.27,4.62,125,87,45,Headache,Mild,Improved,1
1689,PT-01689,47,M,Indore Medical Institute,Phase IV,ORX-101,Oncology,Low Dose,2024-10-14,2025-01-12,5.82,5.71,109,71,74,Headache,None,Improved,1
1690,PT-01690,28,M,PGI Chandigarh,Phase III,ORX-101,Oncology,High Dose,2024-09-11,2024-09-18,6.63,5.16,95,94,59,Fever,None,No Change,0
1691,PT-01691,42,M,Fortis Mumbai,Phase III,ORX-303,Cardiology,Placebo,2023-03-29,2023-06-27,8.1,7.15,113,84,93,Nausea,Mild,No Change,0
1692,PT-01692,26,F,Bhopal Research Hospital,Phase II,ORX-202,Diabetes,Placebo,2023-10-23,2024-01-21,7.02,5.06,120,82,66,None,None,No Change,0
1693,PT-01693,37,F,NIMHANS Bengaluru,Phase III,ORX-404,Neurology,Placebo,2024-09-05,2024-09-12,5.51,5.18,147,68,69,None,None,Improved,1
1694,PT-01694,53,M,PGI Chandigarh,Phase II,ORX-101,Oncology,Low Dose,2024-06-12,2024-07-10,8.65,6.91,124,85,76,None,None,Improved,1
1695,PT-01695,18,M,AIIMS Delhi,Phase II,ORX-303,Cardiology,Low Dose,2023-11-26,2023-12-24,7.8,8.77,130,69,70,None,None,No Change,0
1696,PT-01696,73,M,NIMHANS Bengaluru,Phase III,ORX-606,Rheumatology,Placebo,2023-02-10,2023-04-07,8.29,8.47,134,74,75,None,None,Improved,0
1697,PT-01697,43,F,Kolkata Clinical Center,Phase III,ORX-505,Infectious Disease,Low Dose,2023-01-18,2023-04-18,7.86,8.82,148,64,81,Dizziness,Moderate,No Change,0
1698,PT-01698,56,M,Indore Medical Institute,Phase I,ORX-303,Cardiology,High Dose,2023-05-06,2023-07-01,7.94,6.98,180,66,62,None,None,Improved,1
1699,PT-01699,48,M,Fortis Mumbai,Phase II,ORX-606,Rheumatology,Placebo,2024-04-30,2024-06-25,9.74,8.59,123,94,77,None,None,Worsened,0
1700,PT-01700,39,M,Apollo Chennai,Phase II,ORX-505,Infectious Disease,Low Dose,2024-02-14,2024-03-13,7.88,7.72,146,97,82,Headache,None,Improved,1
1701,PT-01701,49,F,Fortis Mumbai,Phase III,ORX-606,Rheumatology,Placebo,2024-08-08,2024-09-05,7.46,7.5,128,81,94,None,None,Improved,0
1702,PT-01702,69,M,AIIMS Delhi,Phase IV,ORX-303,Cardiology,High Dose,2024-06-25,2024-08-20,5.39,5.0,115,78,83,None,None,Improved,1
1703,PT-01703,55,F,Indore Medical Institute,Phase I,ORX-404,Neurology,Placebo,2024-10-08,2024-12-03,7.07,4.94,110,92,45,Dizziness,None,Improved,1
1704,PT-01704,63,F,Indore Medical Institute,Phase IV,ORX-202,Diabetes,Low Dose,2023-08-23,2023-09-20,7.83,8.61,124,57,84,Headache,None,Improved,0
1705,PT-01705,65,M,Kolkata Clinical Center,Phase III,ORX-404,Neurology,Low Dose,2023-10-14,2023-11-11,8.31,7.31,129,75,66,Dizziness,None,Improved,1
1706,PT-01706,60,M,Bhopal Research Hospital,Phase III,ORX-303,Cardiology,Placebo,2024-05-27,2024-08-25,5.76,4.56,108,64,80,Fever,None,Improved,1
1707,PT-01707,63,M,Indore Medical Institute,Phase III,ORX-606,Rheumatology,High Dose,2023-02-08,2023-03-08,6.98,5.22,143,102,68,None,None,No Change,0
1708,PT-01708,37,F,Apollo Chennai,Phase II,ORX-202,Diabetes,High Dose,2023-12-30,2024-01-13,7.82,8.88,118,66,86,None,None,No Change,0
1709,PT-01709,57,F,Bhopal Research Hospital,Phase IV,ORX-404,Neurology,High Dose,2023-05-25,2023-06-01,7.21,6.31,145,88,67,Headache,None,Improved,1
1710,PT-01710,45,F,Bhopal Research Hospital,Phase III,ORX-505,Infectious Disease,Placebo,2023-07-23,2023-08-06,5.58,5.8,123,76,77,Nausea,None,No Change,0
1711,PT-01711,45,M,PGI Chandigarh,Phase I,ORX-202,Diabetes,Placebo,2024-02-21,2024-02-28,8.27,8.41,125,91,83,Dizziness,Moderate,No Change,0
1712,PT-01712,38,F,PGI Chandigarh,Phase III,ORX-404,Neurology,Placebo,2024-05-27,2024-07-22,7.05,6.52,137,77,72,Headache,None,No Change,0
1713,PT-01713,76,M,AIIMS Delhi,Phase I,ORX-202,Diabetes,High Dose,2023-01-31,2023-05-01,8.33,7.24,138,83,83,Headache,None,Improved,1
1714,PT-01714,47,M,Indore Medical Institute,Phase III,ORX-202,Diabetes,High Dose,2023-12-08,2024-02-02,8.63,8.54,126,94,81,None,None,No Change,0
1715,PT-01715,46,F,Bhopal Research Hospital,Phase III,ORX-606,Rheumatology,High Dose,2023-01-04,2023-04-04,7.58,7.09,128,74,67,None,None,No Change,0
1716,PT-01716,29,F,Indore Medical Institute,Phase I,ORX-101,Oncology,Low Dose,2023-03-14,2023-03-21,5.53,4.34,124,83,74,Nausea,Mild,Worsened,0
1717,PT-01717,18,M,Apollo Chennai,Phase III,ORX-202,Diabetes,Low Dose,2024-05-03,2024-05-31,9.09,9.67,136,104,64,Nausea,Mild,No Change,0
1718,PT-01718,75,F,AIIMS Delhi,Phase II,ORX-202,Diabetes,Low Dose,2024-06-01,2024-06-15,6.04,5.86,105,82,83,None,None,Improved,1
1719,PT-01719,42,F,Bhopal Research Hospital,Phase II,ORX-101,Oncology,Placebo,2023-02-07,2023-03-07,8.06,7.75,118,75,89,None,None,Improved,1
1720,PT-01720,34,M,Indore Medical Institute,Phase III,ORX-303,Cardiology,Placebo,2024-02-09,2024-04-05,8.3,9.0,97,95,106,Rash,None,Improved,0
1721,PT-01721,49,M,AIIMS Delhi,Phase I,ORX-404,Neurology,High Dose,2023-01-19,2023-01-26,7.92,8.45,123,84,59,Fatigue,None,Worsened,0
1722,PT-01722,47,M,NIMHANS Bengaluru,Phase II,ORX-505,Infectious Disease,Placebo,2023-01-28,2023-03-25,7.8,7.86,147,72,70,None,None,Improved,0
1723,PT-01723,75,F,Apollo Chennai,Phase IV,ORX-101,Oncology,High Dose,2023-08-12,2023-09-09,7.02,6.8,126,72,100,None,None,Worsened,0
1724,PT-01724,36,F,AIIMS Delhi,Phase III,ORX-404,Neurology,Low Dose,2024-05-12,2024-07-07,5.85,5.04,91,74,64,Nausea,Moderate,Improved,1
1725,PT-01725,54,M,Fortis Mumbai,Phase IV,ORX-303,Cardiology,High Dose,2023-02-11,2023-02-18,6.39,6.79,153,91,74,Fatigue,None,Improved,0
1726,PT-01726,47,F,PGI Chandigarh,Phase III,ORX-303,Cardiology,Placebo,2024-11-14,2025-02-12,5.37,4.85,112,90,114,None,None,No Change,0
1727,PT-01727,52,F,Apollo Chennai,Phase I,ORX-606,Rheumatology,Low Dose,2023-05-08,2023-05-15,4.81,4.09,130,83,67,None,None,Improved,1
1728,PT-01728,48,M,Indore Medical Institute,Phase III,ORX-505,Infectious Disease,Low Dose,2024-08-01,2024-10-30,5.71,4.46,139,69,85,Rash,None,No Change,0
1729,PT-01729,23,M,Kolkata Clinical Center,Phase IV,ORX-303,Cardiology,Low Dose,2023-06-19,2023-08-14,9.32,8.22,123,85,70,Headache,Mild,No Change,0
1730,PT-01730,47,F,NIMHANS Bengaluru,Phase III,ORX-606,Rheumatology,Placebo,2024-07-19,2024-10-17,7.89,8.35,142,79,75,Headache,Mild,No Change,0
1731,PT-01731,82,F,Fortis Mumbai,Phase I,ORX-202,Diabetes,Low Dose,2024-01-10,2024-04-09,8.34,7.11,129,77,76,Dizziness,None,Improved,1
1732,PT-01732,25,F,Fortis Mumbai,Phase III,ORX-101,Oncology,High Dose,2023-11-14,2024-02-12,6.71,7.94,138,52,95,Fever,None,No Change,0
1733,PT-01733,62,M,Bhopal Research Hospital,Phase IV,ORX-202,Diabetes,High Dose,2023-08-17,2023-09-14,6.77,7.01,112,76,98,Headache,None,No Change,0
1734,PT-01734,40,M,Indore Medical Institute,Phase III,ORX-505,Infectious Disease,Low Dose,2024-02-12,2024-02-19,4.96,4.5,126,96,78,None,None,Improved,1
1735,PT-01735,38,M,AIIMS Delhi,Phase III,ORX-606,Rheumatology,Placebo,2024-07-29,2024-08-12,8.45,8.16,114,95,80,None,None,Improved,1
1736,PT-01736,45,F,AIIMS Delhi,Phase III,ORX-606,Rheumatology,High Dose,2023-01-18,2023-02-15,7.41,6.05,118,82,75,Fatigue,Severe,No Change,0
1737,PT-01737,65,M,NIMHANS Bengaluru,Phase IV,ORX-303,Cardiology,Placebo,2023-05-31,2023-07-26,7.46,7.83,128,94,83,None,None,No Change,0
1738,PT-01738,45,M,Fortis Mumbai,Phase III,ORX-101,Oncology,High Dose,2024-01-27,2024-04-26,7.18,,137,81,70,None,None,Improved,1
1739,PT-01739,62,M,Apollo Chennai,Phase IV,ORX-101,Oncology,Low Dose,2024-03-12,2024-03-19,5.7,4.92,146,85,77,Headache,None,No Change,0
1740,PT-01740,49,M,PGI Chandigarh,Phase III,ORX-505,Infectious Disease,Low Dose,2023-05-04,2023-06-01,7.42,5.65,121,101,68,Headache,None,No Change,0
1741,PT-01741,39,M,Fortis Mumbai,Phase II,ORX-505,Infectious Disease,Placebo,2023-02-11,2023-02-18,6.55,6.07,117,87,80,None,None,No Change,0
1742,PT-01742,57,M,NIMHANS Bengaluru,Phase I,ORX-505,Infectious Disease,Low Dose,2024-02-03,2024-02-10,5.94,5.23,123,87,66,None,None,Worsened,0
1743,PT-01743,59,F,Bhopal Research Hospital,Phase III,ORX-101,Oncology,High Dose,2024-09-18,2024-10-16,8.62,7.33,119,75,114,Rash,None,No Change,0
1744,PT-01744,38,M,Indore Medical Institute,Phase II,ORX-505,Infectious Disease,Low Dose,2023-03-24,2023-04-21,9.21,7.67,110,73,66,None,None,No Change,0
1745,PT-01745,40,F,NIMHANS Bengaluru,Phase I,ORX-202,Diabetes,High Dose,2024-06-18,2024-07-02,6.35,5.21,148,96,91,Dizziness,Mild,Worsened,0
1746,PT-01746,53,M,PGI Chandigarh,Phase I,ORX-202,Diabetes,Low Dose,2023-10-04,2023-10-11,7.31,6.46,110,86,61,None,None,Worsened,0
1747,PT-01747,29,F,Indore Medical Institute,Phase II,ORX-606,Rheumatology,High Dose,2023-05-24,2023-07-19,8.58,9.89,135,95,74,None,None,No Change,0
1748,PT-01748,23,M,PGI Chandigarh,Phase III,ORX-101,Oncology,Low Dose,2023-04-05,2023-05-31,7.93,8.05,129,79,91,Rash,Moderate,No Change,0
1749,PT-01749,29,M,Bhopal Research Hospital,Phase IV,ORX-303,Cardiology,Placebo,2024-06-20,2024-09-18,6.27,4.96,129,68,68,Fever,None,Improved,1
1750,PT-01750,33,F,AIIMS Delhi,Phase II,ORX-303,Cardiology,Low Dose,2023-06-25,2023-07-09,6.89,5.15,129,96,79,Fever,None,Improved,1
1751,PT-01751,69,M,Apollo Chennai,Phase III,ORX-202,Diabetes,High Dose,2023-03-22,2023-06-20,8.8,9.1,129,82,88,None,None,Improved,0
1752,PT-01752,38,M,Apollo Chennai,Phase III,ORX-505,Infectious Disease,High Dose,2023-11-22,2023-12-06,4.94,4.98,107,70,78,None,None,Improved,0
1753,PT-01753,43,F,Apollo Chennai,Phase II,ORX-202,Diabetes,Low Dose,2024-11-14,2025-02-12,5.51,5.25,145,68,95,None,None,Improved,1
1754,PT-01754,20,M,AIIMS Delhi,Phase III,ORX-505,Infectious Disease,Low Dose,2023-05-25,2023-07-20,9.74,8.97,130,59,77,None,None,Improved,1
1755,PT-01755,48,M,Fortis Mumbai,Phase III,ORX-101,Oncology,Placebo,2023-07-29,2023-08-26,7.1,6.19,110,95,78,None,None,No Change,0
1756,PT-01756,69,M,Kolkata Clinical Center,Phase IV,ORX-606,Rheumatology,High Dose,2024-11-14,2025-02-12,6.57,5.78,142,62,61,None,None,Improved,1
1757,PT-01757,62,M,Bhopal Research Hospital,Phase III,ORX-404,Neurology,High Dose,2024-08-26,2024-11-24,5.79,3.76,161,65,80,None,None,No Change,0
1758,PT-01758,46,M,NIMHANS Bengaluru,Phase II,ORX-202,Diabetes,Low Dose,2023-12-15,2024-02-09,3.83,3.19,136,86,90,Headache,None,No Change,0
1759,PT-01759,38,F,Apollo Chennai,Phase IV,ORX-505,Infectious Disease,Placebo,2023-04-28,2023-07-27,8.06,7.03,102,66,57,Headache,None,Improved,1
1760,PT-01760,61,M,Kolkata Clinical Center,Phase II,ORX-606,Rheumatology,Placebo,2024-08-25,2024-11-23,5.38,5.23,123,80,97,None,None,No Change,0
1761,PT-01761,37,M,Indore Medical Institute,Phase III,ORX-404,Neurology,High Dose,2024-05-23,2024-06-06,7.93,7.57,125,109,57,None,None,Worsened,0
1762,PT-01762,65,M,Indore Medical Institute,Phase IV,ORX-303,Cardiology,High Dose,2024-01-21,2024-04-20,7.99,7.16,157,59,70,Nausea,None,Improved,1
1763,PT-01763,25,M,PGI Chandigarh,Phase III,ORX-606,Rheumatology,Placebo,2024-02-07,2024-03-06,7.69,6.29,135,79,71,None,None,Improved,1
1764,PT-01764,51,F,Fortis Mumbai,Phase IV,ORX-404,Neurology,Low Dose,2023-03-16,2023-06-14,6.88,5.5,178,76,46,Dizziness,None,No Change,0
1765,PT-01765,31,M,NIMHANS Bengaluru,Phase II,ORX-404,Neurology,High Dose,2023-02-10,2023-05-11,5.68,6.02,133,86,72,Headache,None,No Change,0
1766,PT-01766,40,F,Fortis Mumbai,Phase III,ORX-505,Infectious Disease,High Dose,2023-06-12,2023-06-26,6.75,6.28,143,86,85,None,None,Worsened,0
1767,PT-01767,52,F,Apollo Chennai,Phase III,ORX-606,Rheumatology,High Dose,2024-03-19,2024-06-17,8.26,8.12,134,96,68,None,None,No Change,0
1768,PT-01768,31,F,Fortis Mumbai,Phase III,ORX-505,Infectious Disease,Low Dose,2024-09-16,2024-12-15,5.78,5.54,94,87,76,None,None,No Change,0
1769,PT-01769,63,M,Kolkata Clinical Center,Phase II,ORX-606,Rheumatology,Low Dose,2024-04-13,2024-04-20,6.39,5.81,148,98,68,None,None,No Change,0
1770,PT-01770,47,F,Apollo Chennai,Phase IV,ORX-505,Infectious Disease,Low Dose,2024-02-04,2024-03-31,7.55,7.49,123,97,51,Headache,Mild,Improved,1
1771,PT-01771,38,M,Kolkata Clinical Center,Phase IV,ORX-303,Cardiology,Low Dose,2023-03-21,2023-06-19,7.74,7.75,152,96,74,Nausea,Severe,Improved,0
1772,PT-01772,65,F,Kolkata Clinical Center,Phase III,ORX-404,Neurology,Low Dose,2024-09-30,2024-12-29,6.34,6.78,160,96,79,None,None,Worsened,0
1773,PT-01773,39,M,AIIMS Delhi,Phase III,ORX-303,Cardiology,Low Dose,2023-07-20,2023-09-14,5.37,5.25,107,72,61,None,None,Worsened,0
1774,PT-01774,37,F,Indore Medical Institute,Phase III,ORX-404,Neurology,Low Dose,2024-11-29,2024-12-13,7.17,7.01,117,94,75,Headache,Moderate,Improved,1
1775,PT-01775,32,F,NIMHANS Bengaluru,Phase III,ORX-404,Neurology,High Dose,2023-12-06,2024-01-31,7.47,8.84,134,77,56,None,None,No Change,0
1776,PT-01776,41,M,AIIMS Delhi,Phase II,ORX-606,Rheumatology,Low Dose,2024-01-19,2024-02-16,7.48,6.73,98,71,98,Dizziness,None,Improved,1
1777,PT-01777,67,F,PGI Chandigarh,Phase II,ORX-505,Infectious Disease,Placebo,2024-10-15,2024-10-29,6.14,6.34,106,98,81,None,None,No Change,0
1778,PT-01778,60,F,Apollo Chennai,Phase III,ORX-202,Diabetes,Low Dose,2024-08-09,2024-08-16,5.14,5.35,127,92,90,None,None,Improved,0
1779,PT-01779,46,M,PGI Chandigarh,Phase III,ORX-202,Diabetes,Low Dose,2023-12-12,2024-02-06,6.48,6.78,126,71,65,Dizziness,None,Improved,0
1780,PT-01780,21,M,Apollo Chennai,Phase III,ORX-606,Rheumatology,Placebo,2024-06-26,2024-09-24,6.59,7.18,131,75,89,None,None,No Change,0
1781,PT-01781,31,M,Bhopal Research Hospital,Phase IV,ORX-505,Infectious Disease,High Dose,2024-01-14,2024-02-11,7.31,6.75,142,63,66,Nausea,None,Improved,1
1782,PT-01782,18,F,PGI Chandigarh,Phase IV,ORX-101,Oncology,Low Dose,2024-05-14,2024-06-11,6.89,7.58,118,75,90,None,None,No Change,0
1783,PT-01783,62,M,Bhopal Research Hospital,Phase II,ORX-606,Rheumatology,High Dose,2024-08-13,2024-08-20,7.09,7.31,108,98,108,None,None,Worsened,0
1784,PT-01784,53,F,AIIMS Delhi,Phase III,ORX-101,Oncology,Placebo,2023-12-08,2024-03-07,4.7,3.8,139,76,95,Rash,None,Improved,1
1785,PT-01785,54,F,Fortis Mumbai,Phase II,ORX-101,Oncology,Low Dose,2024-04-09,2024-04-16,6.35,5.98,111,79,70,None,None,Improved,1
1786,PT-01786,63,M,AIIMS Delhi,Phase II,ORX-303,Cardiology,Low Dose,2023-08-08,2023-10-03,9.74,8.05,93,79,56,Rash,None,Improved,1
1787,PT-01787,45,M,Kolkata Clinical Center,Phase III,ORX-303,Cardiology,Placebo,2024-09-27,2024-10-25,8.1,9.04,131,79,50,None,None,Worsened,0
1788,PT-01788,45,M,Bhopal Research Hospital,Phase II,ORX-101,Oncology,High Dose,2023-07-01,2023-08-26,7.29,7.46,115,76,57,None,None,Improved,0
1789,PT-01789,18,M,Kolkata Clinical Center,Phase III,ORX-505,Infectious Disease,Placebo,2023-05-15,2023-07-10,5.87,4.06,134,75,70,None,None,Improved,1
1790,PT-01790,29,M,PGI Chandigarh,Phase III,ORX-404,Neurology,Placebo,2023-05-21,2023-06-18,3.5,4.46,109,77,57,Fatigue,Mild,No Change,0
1791,PT-01791,60,F,PGI Chandigarh,Phase I,ORX-505,Infectious Disease,Low Dose,2024-04-05,2024-07-04,7.37,6.23,120,102,76,None,None,Improved,1
1792,PT-01792,42,M,PGI Chandigarh,Phase I,ORX-505,Infectious Disease,Low Dose,2024-11-16,2024-12-14,6.07,3.97,125,85,93,None,None,Improved,1
1793,PT-01793,18,F,PGI Chandigarh,Phase IV,ORX-606,Rheumatology,High Dose,2023-10-22,2023-11-05,5.85,4.93,127,80,76,None,None,Improved,1
1794,PT-01794,51,M,NIMHANS Bengaluru,Phase IV,ORX-303,Cardiology,Placebo,2023-01-07,2023-01-14,6.12,6.56,135,78,100,Rash,None,Improved,0
1795,PT-01795,69,M,Apollo Chennai,Phase III,ORX-101,Oncology,High Dose,2023-05-15,2023-05-22,8.32,5.2,156,91,106,Fatigue,None,No Change,0
1796,PT-01796,64,M,Kolkata Clinical Center,Phase II,ORX-101,Oncology,Low Dose,2024-10-10,2024-12-05,9.09,9.48,152,105,81,None,None,No Change,0
1797,PT-01797,19,M,Fortis Mumbai,Phase II,ORX-505,Infectious Disease,Low Dose,2024-01-28,2024-03-24,6.83,6.78,129,67,55,Fever,None,No Change,0
1798,PT-01798,33,F,Apollo Chennai,Phase IV,ORX-404,Neurology,Low Dose,2024-10-14,2024-12-09,8.17,9.19,144,94,76,None,None,No Change,0
1799,PT-01799,18,F,Indore Medical Institute,Phase I,ORX-202,Diabetes,Low Dose,2024-06-11,2024-06-25,6.65,6.02,119,82,84,None,None,Worsened,0
1800,PT-01800,58,M,AIIMS Delhi,Phase III,ORX-606,Rheumatology,Low Dose,2023-04-19,2023-05-03,6.87,4.75,119,82,95,None,None,Improved,1
1801,PT-01801,35,M,Indore Medical Institute,Phase III,ORX-606,Rheumatology,Low Dose,2023-04-05,2023-04-12,7.82,7.68,128,93,68,None,None,Improved,1
1802,PT-01802,35,M,NIMHANS Bengaluru,Phase III,ORX-303,Cardiology,Low Dose,2023-07-28,2023-10-26,7.19,6.21,137,73,81,None,None,Improved,1
1803,PT-01803,43,M,NIMHANS Bengaluru,Phase III,ORX-505,Infectious Disease,High Dose,2024-11-12,2025-01-07,7.46,6.64,121,83,80,None,None,Improved,1
1804,PT-01804,44,F,PGI Chandigarh,Phase III,ORX-303,Cardiology,High Dose,2024-01-07,2024-04-06,9.25,7.95,126,63,83,None,None,No Change,0
1805,PT-01805,27,F,Indore Medical Institute,Phase II,ORX-303,Cardiology,Placebo,2023-04-03,2023-07-02,6.87,6.13,133,75,69,Fatigue,Mild,No Change,0
1806,PT-01806,67,F,Apollo Chennai,Phase IV,ORX-606,Rheumatology,Placebo,2023-02-24,2023-05-25,7.54,,123,101,74,Headache,Severe,Worsened,0
1807,PT-01807,33,F,Kolkata Clinical Center,Phase II,ORX-606,Rheumatology,Placebo,2024-03-29,2024-04-12,6.38,5.48,117,66,62,Nausea,Severe,Worsened,0
1808,PT-01808,31,M,AIIMS Delhi,Phase II,ORX-202,Diabetes,Low Dose,2024-08-03,2024-11-01,7.91,7.17,124,97,96,None,None,Improved,1
1809,PT-01809,40,M,NIMHANS Bengaluru,Phase IV,ORX-303,Cardiology,High Dose,2024-08-22,2024-08-29,6.44,5.26,140,79,72,None,None,No Change,0
1810,PT-01810,31,M,AIIMS Delhi,Phase II,ORX-303,Cardiology,High Dose,2023-09-08,2023-12-07,6.28,6.16,104,93,70,None,None,Worsened,0
1811,PT-01811,42,F,Fortis Mumbai,Phase III,ORX-303,Cardiology,Low Dose,2024-05-15,2024-07-10,5.6,5.18,122,81,98,Fatigue,None,No Change,0
1812,PT-01812,47,F,Indore Medical Institute,Phase II,ORX-505,Infectious Disease,Low Dose,2023-09-17,2023-12-16,6.25,5.21,138,97,81,Headache,Mild,No Change,0
1813,PT-01813,56,M,Kolkata Clinical Center,Phase II,ORX-505,Infectious Disease,High Dose,2024-08-19,2024-10-14,7.93,8.81,92,90,91,Nausea,None,Improved,0
1814,PT-01814,23,M,Apollo Chennai,Phase I,ORX-606,Rheumatology,High Dose,2024-04-24,2024-07-23,6.14,4.97,114,76,81,Headache,None,Worsened,0
1815,PT-01815,58,F,Apollo Chennai,Phase I,ORX-202,Diabetes,Placebo,2024-11-22,2024-11-29,8.5,7.34,112,97,87,None,None,Improved,1
1816,PT-01816,46,M,AIIMS Delhi,Phase III,ORX-101,Oncology,High Dose,2023-09-29,2023-12-28,7.77,7.34,137,77,81,Rash,Mild,Improved,1
1817,PT-01817,20,F,Kolkata Clinical Center,Phase III,ORX-303,Cardiology,High Dose,2024-01-17,2024-04-16,6.37,5.37,121,70,70,None,None,Improved,1
1818,PT-01818,20,F,Indore Medical Institute,Phase IV,ORX-202,Diabetes,Placebo,2023-11-06,2023-11-20,7.86,7.38,97,71,82,Nausea,Moderate,Worsened,0
1819,PT-01819,36,F,Bhopal Research Hospital,Phase I,ORX-303,Cardiology,High Dose,2023-06-16,2023-06-30,6.36,5.9,134,64,85,Nausea,Moderate,Worsened,0
1820,PT-01820,32,M,AIIMS Delhi,Phase I,ORX-606,Rheumatology,Low Dose,2024-08-23,2024-09-20,7.18,6.75,118,69,74,None,None,No Change,0
1821,PT-01821,71,M,Apollo Chennai,Phase III,ORX-101,Oncology,Low Dose,2023-07-21,2023-07-28,5.57,6.69,123,82,62,Fever,None,No Change,0
1822,PT-01822,32,F,Bhopal Research Hospital,Phase I,ORX-202,Diabetes,Low Dose,2024-10-10,2024-10-24,6.6,5.26,124,77,103,None,None,No Change,0
1823,PT-01823,26,M,Kolkata Clinical Center,Phase I,ORX-404,Neurology,Low Dose,2024-11-07,2024-11-21,7.32,7.15,108,90,72,Nausea,Mild,Improved,1
1824,PT-01824,18,M,NIMHANS Bengaluru,Phase I,ORX-404,Neurology,Placebo,2023-07-05,2023-07-12,7.99,6.59,109,90,73,Headache,None,Improved,1
1825,PT-01825,59,F,Kolkata Clinical Center,Phase III,ORX-202,Diabetes,Placebo,2024-09-29,2024-10-13,8.65,7.67,142,72,109,Nausea,None,Improved,1
1826,PT-01826,33,F,Indore Medical Institute,Phase II,ORX-606,Rheumatology,Placebo,2024-10-28,2024-11-25,8.43,8.79,133,73,75,None,None,No Change,0
1827,PT-01827,18,F,Bhopal Research Hospital,Phase II,ORX-303,Cardiology,Placebo,2024-07-25,2024-09-19,7.47,7.38,130,50,60,None,None,No Change,0
1828,PT-01828,33,F,PGI Chandigarh,Phase IV,ORX-202,Diabetes,Placebo,2023-10-21,2023-12-16,7.55,7.41,124,89,63,Rash,Mild,Improved,1
1829,PT-01829,54,F,PGI Chandigarh,Phase IV,ORX-606,Rheumatology,Low Dose,2023-03-09,2023-03-16,7.77,7.71,124,103,84,None,None,No Change,0
1830,PT-01830,29,F,Kolkata Clinical Center,Phase I,ORX-101,Oncology,High Dose,2023-08-23,2023-10-18,7.5,7.78,117,95,83,None,None,Improved,0
1831,PT-01831,18,F,PGI Chandigarh,Phase IV,ORX-505,Infectious Disease,Low Dose,2023-11-11,2023-11-25,7.56,6.79,137,93,80,None,None,Improved,1
1832,PT-01832,71,M,AIIMS Delhi,Phase IV,ORX-101,Oncology,Placebo,2024-05-08,2024-05-15,6.99,7.15,142,80,88,None,None,Improved,0
1833,PT-01833,35,M,Kolkata Clinical Center,Phase III,ORX-303,Cardiology,Placebo,2024-09-05,2024-12-04,6.69,5.11,132,85,94,Headache,Severe,Improved,1
1834,PT-01834,57,F,Indore Medical Institute,Phase III,ORX-404,Neurology,Placebo,2023-05-10,2023-06-07,6.86,5.4,135,95,88,Dizziness,None,Improved,1
1835,PT-01835,62,F,AIIMS Delhi,Phase II,ORX-606,Rheumatology,Low Dose,2023-01-08,2023-01-22,6.95,6.13,114,81,76,Fatigue,None,No Change,0
1836,PT-01836,48,M,PGI Chandigarh,Phase I,ORX-404,Neurology,High Dose,2024-07-31,2024-09-25,7.04,6.52,114,93,79,Fatigue,None,Improved,1
1837,PT-01837,42,M,PGI Chandigarh,Phase II,ORX-303,Cardiology,Placebo,2023-06-26,2023-07-10,6.3,4.7,151,88,55,Rash,None,Improved,1
1838,PT-01838,57,F,Indore Medical Institute,Phase III,ORX-101,Oncology,Placebo,2023-03-02,2023-03-09,8.31,8.02,156,84,58,None,None,No Change,0
1839,PT-01839,50,M,NIMHANS Bengaluru,Phase II,ORX-505,Infectious Disease,Placebo,2024-04-05,2024-05-31,7.49,6.55,138,61,91,Dizziness,None,Improved,1
1840,PT-01840,30,F,Indore Medical Institute,Phase III,ORX-505,Infectious Disease,Placebo,2024-11-17,2024-12-15,6.02,5.52,135,83,67,None,None,Improved,1
1841,PT-01841,36,M,Bhopal Research Hospital,Phase IV,ORX-303,Cardiology,High Dose,2024-04-19,2024-04-26,5.84,5.24,147,81,90,None,None,Improved,1
1842,PT-01842,68,F,Indore Medical Institute,Phase I,ORX-404,Neurology,High Dose,2023-12-07,2023-12-14,6.49,5.93,167,99,54,Rash,None,Worsened,0
1843,PT-01843,51,F,Apollo Chennai,Phase III,ORX-404,Neurology,Placebo,2023-07-21,2023-07-28,7.2,7.54,114,71,68,None,None,Improved,0
1844,PT-01844,35,F,PGI Chandigarh,Phase III,ORX-404,Neurology,Low Dose,2024-03-15,2024-06-13,8.18,6.72,116,60,92,None,None,Improved,1
1845,PT-01845,65,M,PGI Chandigarh,Phase III,ORX-202,Diabetes,High Dose,2023-07-25,2023-10-23,6.81,6.14,136,99,83,Rash,Moderate,Improved,1
1846,PT-01846,33,F,NIMHANS Bengaluru,Phase IV,ORX-404,Neurology,Low Dose,2023-06-02,2023-06-09,5.26,3.85,129,74,80,None,None,Improved,1
1847,PT-01847,36,M,Kolkata Clinical Center,Phase III,ORX-101,Oncology,Placebo,2023-09-30,2023-11-25,5.93,4.47,156,92,102,None,None,Improved,1
1848,PT-01848,53,F,Indore Medical Institute,Phase III,ORX-101,Oncology,High Dose,2023-02-21,2023-04-18,6.68,7.48,127,84,77,Nausea,None,No Change,0
1849,PT-01849,18,F,Fortis Mumbai,Phase I,ORX-505,Infectious Disease,Placebo,2024-07-19,2024-07-26,9.13,9.17,133,81,80,Nausea,Mild,No Change,0
1850,PT-01850,35,F,PGI Chandigarh,Phase III,ORX-202,Diabetes,High Dose,2023-03-09,2023-04-06,7.94,6.36,131,88,75,None,None,No Change,0
1851,PT-01851,50,M,Fortis Mumbai,Phase III,ORX-606,Rheumatology,High Dose,2024-05-23,2024-07-18,6.01,4.74,132,90,51,None,None,No Change,0
1852,PT-01852,53,F,Bhopal Research Hospital,Phase III,ORX-202,Diabetes,Low Dose,2024-03-25,2024-04-01,6.55,5.97,103,71,91,None,None,No Change,0
1853,PT-01853,45,F,NIMHANS Bengaluru,Phase I,ORX-101,Oncology,Placebo,2024-05-11,2024-06-08,6.74,6.24,136,87,76,None,None,Worsened,0
1854,PT-01854,62,F,AIIMS Delhi,Phase II,ORX-303,Cardiology,Low Dose,2023-08-04,2023-11-02,8.36,8.34,128,89,82,Nausea,Mild,No Change,0
1855,PT-01855,61,M,Kolkata Clinical Center,Phase IV,ORX-101,Oncology,Placebo,2023-09-28,2023-10-12,8.28,6.96,108,73,91,Rash,Severe,Worsened,0
1856,PT-01856,19,M,Kolkata Clinical Center,Phase I,ORX-101,Oncology,Low Dose,2024-07-07,2024-07-21,7.67,7.6,148,84,59,None,None,Improved,1
1857,PT-01857,29,M,Indore Medical Institute,Phase III,ORX-606,Rheumatology,High Dose,2024-10-04,2024-11-01,5.78,4.9,124,68,98,Dizziness,Moderate,Improved,1
1858,PT-01858,23,M,Kolkata Clinical Center,Phase II,ORX-202,Diabetes,High Dose,2023-03-27,2023-05-22,8.82,9.48,144,73,82,Headache,None,Worsened,0
1859,PT-01859,24,F,Indore Medical Institute,Phase IV,ORX-101,Oncology,High Dose,2024-02-13,2024-03-12,8.29,7.83,120,67,45,None,None,Improved,1
1860,PT-01860,28,M,PGI Chandigarh,Phase III,ORX-505,Infectious Disease,Low Dose,2023-08-27,2023-11-25,8.54,7.77,124,89,103,Fever,None,Worsened,0
1861,PT-01861,66,M,Indore Medical Institute,Phase III,ORX-101,Oncology,Placebo,2023-02-17,2023-04-14,6.03,3.88,170,109,80,None,None,Improved,1
1862,PT-01862,24,M,AIIMS Delhi,Phase III,ORX-202,Diabetes,Low Dose,2023-03-29,2023-04-26,8.36,7.86,125,92,82,None,None,No Change,0
1863,PT-01863,26,M,Kolkata Clinical Center,Phase IV,ORX-606,Rheumatology,High Dose,2023-10-04,2023-10-18,6.81,7.01,137,85,91,None,None,No Change,0
1864,PT-01864,39,M,NIMHANS Bengaluru,Phase III,ORX-505,Infectious Disease,High Dose,2024-11-17,2025-01-12,7.41,3.98,119,91,72,None,None,No Change,0
1865,PT-01865,37,M,Apollo Chennai,Phase III,ORX-606,Rheumatology,Placebo,2023-04-01,2023-06-30,5.95,6.45,137,91,53,None,None,Improved,0
1866,PT-01866,42,M,Apollo Chennai,Phase III,ORX-202,Diabetes,Low Dose,2024-11-21,2025-02-19,6.86,6.21,116,77,89,None,None,No Change,0
1867,PT-01867,18,F,Kolkata Clinical Center,Phase II,ORX-505,Infectious Disease,High Dose,2024-11-05,2024-12-31,9.33,9.37,127,92,57,Nausea,Moderate,Improved,0
1868,PT-01868,34,F,Fortis Mumbai,Phase III,ORX-505,Infectious Disease,Low Dose,2024-07-13,2024-07-27,7.05,7.88,127,87,69,Dizziness,None,No Change,0
1869,PT-01869,52,F,Fortis Mumbai,Phase III,ORX-202,Diabetes,Placebo,2023-01-12,2023-01-26,9.21,9.71,126,90,86,None,None,No Change,0
1870,PT-01870,53,M,PGI Chandigarh,Phase II,ORX-505,Infectious Disease,High Dose,2024-10-07,2024-12-02,8.53,9.13,125,89,72,None,None,Improved,0
1871,PT-01871,30,M,Apollo Chennai,Phase III,ORX-303,Cardiology,Low Dose,2024-06-29,2024-09-27,6.88,6.41,98,92,45,None,None,Improved,1
1872,PT-01872,85,F,Fortis Mumbai,Phase I,ORX-404,Neurology,Low Dose,2024-06-23,2024-08-18,9.0,8.37,128,85,69,None,None,No Change,0
1873,PT-01873,48,M,Bhopal Research Hospital,Phase III,ORX-101,Oncology,Placebo,2023-08-08,2023-08-15,7.03,6.54,131,66,78,Headache,Mild,No Change,0
1874,PT-01874,47,F,AIIMS Delhi,Phase III,ORX-202,Diabetes,High Dose,2023-04-21,2023-05-05,7.35,6.76,148,77,81,Headache,Moderate,Improved,1
1875,PT-01875,65,F,Apollo Chennai,Phase II,ORX-101,Oncology,High Dose,2023-11-25,2024-02-23,7.1,6.9,126,96,74,None,None,Improved,1
1876,PT-01876,65,M,PGI Chandigarh,Phase IV,ORX-303,Cardiology,High Dose,2024-05-22,2024-06-05,7.08,5.9,140,78,86,Nausea,None,Improved,1
1877,PT-01877,18,M,Fortis Mumbai,Phase IV,ORX-303,Cardiology,Placebo,2024-08-03,2024-09-28,7.21,6.39,108,75,69,None,None,Improved,1
1878,PT-01878,44,F,Bhopal Research Hospital,Phase IV,ORX-505,Infectious Disease,Placebo,2023-09-22,2023-12-21,5.56,5.44,152,85,89,Headache,Mild,Improved,1
1879,PT-01879,62,M,Kolkata Clinical Center,Phase IV,ORX-505,Infectious Disease,Placebo,2023-10-06,2023-10-13,8.68,9.97,119,73,88,None,None,Improved,0
1880,PT-01880,56,M,PGI Chandigarh,Phase III,ORX-505,Infectious Disease,Placebo,2024-02-08,2024-04-04,8.13,9.43,128,87,64,None,None,Worsened,0
1881,PT-01881,79,M,NIMHANS Bengaluru,Phase III,ORX-606,Rheumatology,Low Dose,2024-03-26,2024-04-23,6.8,6.12,121,74,67,None,None,Worsened,0
1882,PT-01882,36,F,Bhopal Research Hospital,Phase III,ORX-303,Cardiology,Low Dose,2023-09-25,2023-10-23,5.56,4.45,163,90,90,None,None,No Change,0
1883,PT-01883,63,M,AIIMS Delhi,Phase III,ORX-101,Oncology,High Dose,2024-05-04,2024-06-01,9.4,7.41,105,72,71,Dizziness,Moderate,Improved,1
1884,PT-01884,40,M,Bhopal Research Hospital,Phase II,ORX-404,Neurology,Placebo,2024-11-30,2024-12-07,6.66,6.46,128,73,47,Nausea,Mild,Improved,1
1885,PT-01885,29,F,PGI Chandigarh,Phase II,ORX-202,Diabetes,Low Dose,2024-10-25,2024-11-08,6.54,5.92,107,76,62,Nausea,None,Improved,1
1886,PT-01886,42,M,Indore Medical Institute,Phase II,ORX-101,Oncology,Placebo,2024-11-02,2025-01-31,5.91,4.75,104,80,65,None,None,Improved,1
1887,PT-01887,59,F,Fortis Mumbai,Phase II,ORX-404,Neurology,High Dose,2024-11-29,2024-12-27,7.69,7.22,113,86,87,Headache,Mild,No Change,0
1888,PT-01888,47,F,NIMHANS Bengaluru,Phase III,ORX-101,Oncology,Low Dose,2024-03-22,2024-04-19,9.12,9.14,144,83,87,Rash,Moderate,Improved,0
1889,PT-01889,32,F,PGI Chandigarh,Phase III,ORX-404,Neurology,High Dose,2023-12-15,2024-03-14,6.65,6.56,134,88,93,Nausea,Mild,Worsened,0
1890,PT-01890,22,F,Apollo Chennai,Phase III,ORX-202,Diabetes,High Dose,2024-09-15,2024-09-22,6.03,5.84,114,120,85,None,None,Improved,1
1891,PT-01891,43,F,NIMHANS Bengaluru,Phase II,ORX-404,Neurology,High Dose,2024-10-10,2024-10-24,6.58,5.75,128,83,71,None,None,No Change,0
1892,PT-01892,40,F,NIMHANS Bengaluru,Phase I,ORX-606,Rheumatology,Low Dose,2024-09-14,2024-10-12,8.81,9.66,132,65,85,None,None,Improved,0
1893,PT-01893,69,F,AIIMS Delhi,Phase II,ORX-101,Oncology,Placebo,2023-10-29,2023-11-12,8.84,9.1,153,82,86,Rash,None,Worsened,0
1894,PT-01894,34,F,Kolkata Clinical Center,Phase III,ORX-303,Cardiology,Low Dose,2023-11-20,2024-02-18,7.55,8.35,117,71,79,None,None,Improved,0
1895,PT-01895,41,M,Bhopal Research Hospital,Phase II,ORX-101,Oncology,Low Dose,2024-05-30,2024-06-27,7.98,7.17,158,66,95,None,None,Improved,1
1896,PT-01896,32,F,Indore Medical Institute,Phase IV,ORX-505,Infectious Disease,Placebo,2024-04-30,2024-07-29,5.04,4.86,123,68,54,None,None,Improved,1
1897,PT-01897,44,F,AIIMS Delhi,Phase IV,ORX-202,Diabetes,High Dose,2023-06-27,2023-09-25,8.37,8.5,129,87,77,Dizziness,None,No Change,0
1898,PT-01898,22,M,Fortis Mumbai,Phase IV,ORX-404,Neurology,Placebo,2024-02-23,2024-03-22,5.49,4.91,125,92,88,Nausea,None,Worsened,0
1899,PT-01899,54,M,AIIMS Delhi,Phase III,ORX-101,Oncology,Placebo,2023-09-15,2023-09-29,6.86,5.22,135,88,45,Fatigue,None,No Change,0
1900,PT-01900,31,F,NIMHANS Bengaluru,Phase II,ORX-505,Infectious Disease,Placebo,2024-07-21,2024-08-18,6.37,6.08,113,81,75,Nausea,None,Worsened,0
1901,PT-01901,42,F,AIIMS Delhi,Phase IV,ORX-303,Cardiology,Placebo,2024-11-18,2025-02-16,6.34,5.37,108,86,85,None,None,No Change,0
1902,PT-01902,32,F,PGI Chandigarh,Phase IV,ORX-303,Cardiology,Placebo,2024-11-23,2025-01-18,9.02,8.34,155,74,49,Nausea,None,Improved,1
1903,PT-01903,51,F,AIIMS Delhi,Phase II,ORX-202,Diabetes,High Dose,2023-03-20,2023-03-27,7.5,7.13,116,81,70,None,None,Improved,1
1904,PT-01904,40,F,Kolkata Clinical Center,Phase II,ORX-606,Rheumatology,High Dose,2023-03-28,2023-05-23,8.21,7.98,138,79,73,Headache,Mild,Improved,1
1905,PT-01905,26,M,AIIMS Delhi,Phase III,ORX-404,Neurology,Placebo,2023-07-16,2023-10-14,6.76,3.37,117,81,85,Headache,Moderate,Improved,1
1906,PT-01906,40,F,Indore Medical Institute,Phase II,ORX-606,Rheumatology,Low Dose,2023-03-10,2023-06-08,7.62,5.26,126,61,61,Fever,Moderate,No Change,0
1907,PT-01907,42,F,Apollo Chennai,Phase II,ORX-101,Oncology,Low Dose,2023-08-24,2023-09-21,8.73,8.67,128,81,68,None,None,No Change,0
1908,PT-01908,36,M,Apollo Chennai,Phase II,ORX-303,Cardiology,High Dose,2023-11-09,2023-11-16,7.71,6.07,138,77,89,Dizziness,Mild,Improved,1
1909,PT-01909,60,M,NIMHANS Bengaluru,Phase III,ORX-404,Neurology,Low Dose,2023-10-21,2024-01-19,5.19,4.27,112,60,63,Rash,None,Worsened,0
1910,PT-01910,84,M,Fortis Mumbai,Phase II,ORX-606,Rheumatology,High Dose,2023-09-25,2023-10-23,7.93,9.26,142,73,72,Rash,None,Improved,0
1911,PT-01911,54,F,Kolkata Clinical Center,Phase III,ORX-505,Infectious Disease,Low Dose,2024-04-06,2024-07-05,7.73,6.81,100,120,76,Nausea,Mild,Improved,1
1912,PT-01912,39,F,Bhopal Research Hospital,Phase II,ORX-202,Diabetes,Low Dose,2024-05-29,2024-08-27,7.34,6.72,130,97,76,Fatigue,Mild,No Change,0
1913,PT-01913,26,F,AIIMS Delhi,Phase IV,ORX-606,Rheumatology,Low Dose,2023-11-10,2023-12-08,7.01,6.19,153,96,79,Headache,Moderate,Improved,1
1914,PT-01914,24,M,Kolkata Clinical Center,Phase II,ORX-606,Rheumatology,Placebo,2024-01-21,2024-02-04,5.73,5.34,134,77,71,None,None,Improved,1
1915,PT-01915,35,F,AIIMS Delhi,Phase III,ORX-303,Cardiology,Placebo,2023-07-28,2023-10-26,7.17,4.63,108,74,94,Nausea,None,No Change,0
1916,PT-01916,31,M,Bhopal Research Hospital,Phase II,ORX-202,Diabetes,High Dose,2024-10-23,2025-01-21,7.42,7.22,151,97,77,None,None,Improved,1
1917,PT-01917,37,M,Apollo Chennai,Phase IV,ORX-202,Diabetes,Low Dose,2024-06-11,2024-06-18,6.4,5.79,120,88,83,Nausea,None,No Change,0
1918,PT-01918,54,M,Bhopal Research Hospital,Phase I,ORX-101,Oncology,Placebo,2023-06-29,2023-07-06,8.71,9.99,130,95,73,Headache,None,Improved,0
1919,PT-01919,63,F,Indore Medical Institute,Phase II,ORX-101,Oncology,Low Dose,2024-10-08,2025-01-06,8.47,8.98,129,73,58,Nausea,Moderate,No Change,0
1920,PT-01920,44,F,Bhopal Research Hospital,Phase III,ORX-101,Oncology,Low Dose,2023-10-30,2023-11-13,9.04,8.36,142,92,74,Rash,None,Improved,1
1921,PT-01921,66,M,Fortis Mumbai,Phase IV,ORX-303,Cardiology,Low Dose,2024-10-18,2024-10-25,3.71,2.21,111,72,82,Headache,Mild,No Change,0
1922,PT-01922,49,F,AIIMS Delhi,Phase III,ORX-202,Diabetes,Low Dose,2024-02-23,2024-05-23,7.67,7.81,110,67,83,Headache,None,Improved,0
1923,PT-01923,34,M,Indore Medical Institute,Phase II,ORX-404,Neurology,High Dose,2024-02-18,2024-03-03,5.32,5.79,153,100,80,Rash,None,Improved,0
1924,PT-01924,55,F,NIMHANS Bengaluru,Phase IV,ORX-404,Neurology,High Dose,2023-12-06,2023-12-13,8.84,7.87,147,85,90,None,None,Worsened,0
1925,PT-01925,47,F,NIMHANS Bengaluru,Phase IV,ORX-404,Neurology,Placebo,2023-03-17,2023-03-24,8.76,8.56,101,99,64,None,None,Worsened,0
1926,PT-01926,65,F,Bhopal Research Hospital,Phase II,ORX-606,Rheumatology,Placebo,2023-08-19,2023-09-16,7.09,7.75,148,87,85,None,None,Improved,0
1927,PT-01927,51,F,Fortis Mumbai,Phase I,ORX-505,Infectious Disease,Low Dose,2024-06-19,2024-09-17,4.78,4.49,107,84,61,Headache,Mild,Improved,1
1928,PT-01928,26,F,Apollo Chennai,Phase III,ORX-303,Cardiology,Low Dose,2024-01-22,2024-04-21,9.13,9.69,127,84,74,Nausea,None,No Change,0
1929,PT-01929,54,F,Indore Medical Institute,Phase III,ORX-505,Infectious Disease,Placebo,2024-03-19,2024-06-17,6.39,6.88,123,76,78,Fatigue,Mild,No Change,0
1930,PT-01930,35,F,Kolkata Clinical Center,Phase III,ORX-505,Infectious Disease,Placebo,2023-02-01,2023-03-01,7.59,6.71,136,96,67,None,None,No Change,0
1931,PT-01931,42,F,Bhopal Research Hospital,Phase III,ORX-505,Infectious Disease,Low Dose,2024-01-22,2024-01-29,7.75,6.96,136,88,93,None,None,No Change,0
1932,PT-01932,35,M,AIIMS Delhi,Phase IV,ORX-404,Neurology,High Dose,2024-01-03,2024-02-28,6.07,5.39,110,88,61,Nausea,Mild,No Change,0
1933,PT-01933,82,M,Fortis Mumbai,Phase II,ORX-101,Oncology,Low Dose,2023-01-06,2023-04-06,8.76,8.37,143,62,113,None,None,Improved,1
1934,PT-01934,35,M,PGI Chandigarh,Phase III,ORX-303,Cardiology,Low Dose,2023-05-01,2023-06-26,7.06,4.99,136,68,79,None,None,Improved,1
1935,PT-01935,36,M,AIIMS Delhi,Phase III,ORX-404,Neurology,Placebo,2024-09-08,2024-09-22,5.91,4.78,132,66,67,None,None,No Change,0
1936,PT-01936,55,M,NIMHANS Bengaluru,Phase II,ORX-202,Diabetes,Low Dose,2023-07-01,2023-07-15,10.32,10.35,111,77,78,Dizziness,None,Improved,0
1937,PT-01937,39,M,Fortis Mumbai,Phase III,ORX-606,Rheumatology,High Dose,2023-09-30,2023-10-14,8.28,8.08,144,78,96,Nausea,Mild,Improved,1
1938,PT-01938,42,F,Indore Medical Institute,Phase III,ORX-303,Cardiology,Low Dose,2024-06-01,2024-06-15,6.03,7.59,95,73,69,Nausea,None,Improved,0
1939,PT-01939,85,F,Indore Medical Institute,Phase III,ORX-606,Rheumatology,Low Dose,2023-02-20,2023-02-27,9.37,10.31,122,111,83,None,None,No Change,0
1940,PT-01940,60,F,Indore Medical Institute,Phase III,ORX-404,Neurology,Placebo,2023-05-20,2023-06-17,7.42,6.97,123,79,86,None,None,No Change,0
1941,PT-01941,50,M,PGI Chandigarh,Phase III,ORX-606,Rheumatology,High Dose,2023-10-14,2023-10-21,7.16,8.12,90,88,88,None,None,Improved,0
1942,PT-01942,63,M,Fortis Mumbai,Phase II,ORX-606,Rheumatology,Low Dose,2023-04-03,2023-04-17,7.12,6.91,145,99,73,None,None,Worsened,0
1943,PT-01943,49,F,Bhopal Research Hospital,Phase I,ORX-101,Oncology,High Dose,2024-07-29,2024-08-05,9.21,6.9,115,99,93,Nausea,Severe,Improved,1
1944,PT-01944,53,M,Bhopal Research Hospital,Phase III,ORX-606,Rheumatology,Placebo,2023-07-10,2023-09-04,6.66,5.47,117,100,69,Fatigue,Mild,Improved,1
1945,PT-01945,46,M,Kolkata Clinical Center,Phase IV,ORX-101,Oncology,High Dose,2023-05-20,2023-06-03,6.3,6.65,118,80,54,None,None,Improved,0
1946,PT-01946,19,F,Indore Medical Institute,Phase III,ORX-101,Oncology,High Dose,2023-09-20,2023-09-27,7.21,5.62,165,57,66,Nausea,None,Worsened,0
1947,PT-01947,45,F,Apollo Chennai,Phase III,ORX-606,Rheumatology,Placebo,2024-08-04,2024-11-02,6.76,5.37,110,70,73,Nausea,Mild,Improved,1
1948,PT-01948,76,F,Fortis Mumbai,Phase II,ORX-303,Cardiology,High Dose,2023-04-29,2023-06-24,7.29,7.96,137,95,45,None,None,No Change,0
1949,PT-01949,40,M,Apollo Chennai,Phase IV,ORX-303,Cardiology,High Dose,2023-03-26,2023-04-09,8.77,7.85,159,99,71,Headache,None,Worsened,0
1950,PT-01950,36,F,AIIMS Delhi,Phase II,ORX-303,Cardiology,High Dose,2024-11-10,2025-02-08,5.98,5.02,105,87,57,Headache,None,Improved,1
1951,PT-01951,54,F,PGI Chandigarh,Phase II,ORX-404,Neurology,Placebo,2023-09-05,2023-10-03,7.95,6.06,155,88,88,None,None,Worsened,0
1952,PT-01952,32,M,Fortis Mumbai,Phase III,ORX-505,Infectious Disease,Low Dose,2024-03-15,2024-05-10,7.95,8.56,126,106,78,None,None,Improved,0
1953,PT-01953,63,F,Apollo Chennai,Phase IV,ORX-505,Infectious Disease,Low Dose,2023-07-01,2023-07-29,7.55,7.68,97,86,67,None,None,No Change,0
1954,PT-01954,31,F,AIIMS Delhi,Phase III,ORX-505,Infectious Disease,Placebo,2023-12-09,2023-12-16,9.29,8.7,109,77,59,None,None,Improved,1
1955,PT-01955,67,F,NIMHANS Bengaluru,Phase III,ORX-303,Cardiology,Low Dose,2023-12-10,2024-01-07,6.37,6.44,152,75,85,Fever,None,Improved,0
1956,PT-01956,28,M,Indore Medical Institute,Phase III,ORX-505,Infectious Disease,Placebo,2023-12-08,2024-01-05,10.13,10.58,124,72,76,None,None,Improved,0
1957,PT-01957,39,F,Bhopal Research Hospital,Phase III,ORX-202,Diabetes,Placebo,2023-03-27,2023-04-03,9.54,8.04,130,81,76,None,None,Improved,1
1958,PT-01958,43,F,Indore Medical Institute,Phase I,ORX-202,Diabetes,Low Dose,2023-10-30,2023-12-25,7.06,7.45,138,87,45,None,None,No Change,0
1959,PT-01959,49,M,Indore Medical Institute,Phase II,ORX-404,Neurology,High Dose,2024-01-15,2024-01-29,5.21,5.39,154,70,74,Fatigue,None,Improved,0
1960,PT-01960,35,M,Indore Medical Institute,Phase III,ORX-101,Oncology,High Dose,2023-07-06,2023-08-31,8.68,8.37,159,86,81,Headache,Moderate,Worsened,0
1961,PT-01961,46,F,Indore Medical Institute,Phase IV,ORX-101,Oncology,Placebo,2024-03-03,2024-03-10,8.18,6.22,129,81,88,None,None,Improved,1
1962,PT-01962,41,M,AIIMS Delhi,Phase IV,ORX-303,Cardiology,High Dose,2024-11-01,2025-01-30,5.95,5.56,108,58,88,Nausea,Mild,Improved,1
1963,PT-01963,54,M,Indore Medical Institute,Phase III,ORX-404,Neurology,Placebo,2024-03-29,2024-04-12,7.76,8.53,116,64,77,None,None,No Change,0
1964,PT-01964,39,M,PGI Chandigarh,Phase IV,ORX-606,Rheumatology,Placebo,2023-08-25,2023-09-01,6.19,5.72,116,59,71,Fever,None,Improved,1
1965,PT-01965,26,M,Indore Medical Institute,Phase IV,ORX-202,Diabetes,High Dose,2024-08-15,2024-08-22,7.48,6.49,148,101,87,None,None,Improved,1
1966,PT-01966,20,M,NIMHANS Bengaluru,Phase IV,ORX-101,Oncology,Low Dose,2023-10-19,2023-10-26,9.01,10.02,128,97,70,None,None,Improved,0
1967,PT-01967,18,M,PGI Chandigarh,Phase IV,ORX-505,Infectious Disease,Low Dose,2023-06-28,2023-09-26,6.29,7.44,101,81,78,Headache,None,Improved,0
1968,PT-01968,36,F,PGI Chandigarh,Phase III,ORX-202,Diabetes,Placebo,2024-02-02,2024-02-09,6.67,6.33,117,64,81,None,None,Improved,1
1969,PT-01969,62,F,Indore Medical Institute,Phase III,ORX-606,Rheumatology,Placebo,2024-08-07,2024-10-02,8.24,7.11,105,78,99,Fatigue,None,Worsened,0
1970,PT-01970,55,M,Kolkata Clinical Center,Phase III,ORX-404,Neurology,Placebo,2023-09-05,2023-10-31,8.04,8.45,135,83,87,Headache,None,Improved,0
1971,PT-01971,36,M,Fortis Mumbai,Phase III,ORX-303,Cardiology,Low Dose,2024-01-19,2024-02-02,5.5,5.75,150,68,89,None,None,Improved,0
1972,PT-01972,71,F,AIIMS Delhi,Phase II,ORX-303,Cardiology,Low Dose,2023-08-12,2023-08-26,7.2,6.06,130,75,69,Rash,None,No Change,0
1973,PT-01973,51,M,PGI Chandigarh,Phase IV,ORX-303,Cardiology,Placebo,2024-02-05,2024-02-19,5.28,3.58,128,81,82,None,None,Improved,1
1974,PT-01974,75,F,Indore Medical Institute,Phase II,ORX-606,Rheumatology,Placebo,2024-08-09,2024-08-23,7.33,7.46,110,91,70,None,None,Improved,0
1975,PT-01975,46,F,Bhopal Research Hospital,Phase IV,ORX-101,Oncology,High Dose,2023-02-02,2023-05-03,7.07,7.6,104,54,75,Fatigue,None,Improved,0
1976,PT-01976,52,M,Indore Medical Institute,Phase II,ORX-606,Rheumatology,High Dose,2024-07-07,2024-10-05,7.38,8.09,135,75,45,None,None,Worsened,0
1977,PT-01977,41,M,Bhopal Research Hospital,Phase I,ORX-101,Oncology,Low Dose,2024-03-30,2024-04-13,8.43,7.68,128,87,63,Nausea,None,No Change,0
1978,PT-01978,54,F,Kolkata Clinical Center,Phase IV,ORX-303,Cardiology,High Dose,2024-07-30,2024-10-28,9.16,8.61,107,81,46,None,None,No Change,0
1979,PT-01979,50,F,AIIMS Delhi,Phase IV,ORX-101,Oncology,Placebo,2024-08-30,2024-10-25,7.74,8.85,124,86,65,None,None,Improved,0
1980,PT-01980,39,M,Apollo Chennai,Phase IV,ORX-404,Neurology,High Dose,2023-07-03,2023-07-10,5.37,4.79,122,85,69,None,None,Worsened,0
1981,PT-01981,46,F,AIIMS Delhi,Phase II,ORX-101,Oncology,Placebo,2024-04-19,2024-04-26,6.8,6.1,129,82,88,None,None,No Change,0
1982,PT-01982,43,F,PGI Chandigarh,Phase I,ORX-202,Diabetes,Placebo,2024-07-17,2024-07-24,6.78,6.22,115,77,106,None,None,Improved,1
1983,PT-01983,30,M,AIIMS Delhi,Phase I,ORX-101,Oncology,Low Dose,2024-06-21,2024-06-28,6.87,6.12,123,78,81,Fatigue,Mild,Improved,1
1984,PT-01984,18,F,NIMHANS Bengaluru,Phase III,ORX-101,Oncology,High Dose,2024-05-30,2024-07-25,8.44,8.61,105,54,64,None,None,Improved,0
1985,PT-01985,41,M,PGI Chandigarh,Phase III,ORX-505,Infectious Disease,High Dose,2024-04-26,2024-05-10,10.3,10.39,95,73,77,None,None,No Change,0
1986,PT-01986,49,M,PGI Chandigarh,Phase III,ORX-202,Diabetes,Low Dose,2024-09-10,2024-09-24,5.62,5.1,115,68,81,Fever,Mild,Improved,1
1987,PT-01987,57,M,Kolkata Clinical Center,Phase III,ORX-202,Diabetes,High Dose,2023-10-10,2023-11-07,8.21,8.33,119,90,82,None,None,Worsened,0
1988,PT-01988,47,M,AIIMS Delhi,Phase III,ORX-202,Diabetes,High Dose,2024-05-03,2024-05-17,6.47,5.62,129,111,82,None,None,Improved,1
1989,PT-01989,35,M,AIIMS Delhi,Phase III,ORX-606,Rheumatology,High Dose,2023-08-23,2023-09-06,6.2,5.36,167,77,90,None,None,No Change,0
1990,PT-01990,38,F,Fortis Mumbai,Phase I,ORX-404,Neurology,High Dose,2024-11-01,2024-11-15,7.51,,117,74,101,Dizziness,Moderate,No Change,0
1991,PT-01991,60,M,PGI Chandigarh,Phase I,ORX-505,Infectious Disease,Low Dose,2023-07-20,2023-07-27,8.15,8.46,136,106,78,Headache,Mild,No Change,0
1992,PT-01992,54,M,Apollo Chennai,Phase I,ORX-101,Oncology,Placebo,2023-06-02,2023-06-16,5.46,4.32,106,97,45,None,None,Worsened,0
1993,PT-01993,38,F,AIIMS Delhi,Phase III,ORX-606,Rheumatology,High Dose,2023-09-07,2023-10-05,3.61,2.46,119,98,83,None,None,No Change,0
1994,PT-01994,31,M,NIMHANS Bengaluru,Phase III,ORX-303,Cardiology,High Dose,2024-02-21,2024-03-20,8.48,8.1,128,67,64,None,None,Improved,1
1995,PT-01995,31,M,Apollo Chennai,Phase II,ORX-404,Neurology,Low Dose,2023-12-31,2024-02-25,7.26,6.93,155,86,45,None,None,Worsened,0
1996,PT-01996,49,M,Bhopal Research Hospital,Phase I,ORX-606,Rheumatology,Placebo,2023-06-15,2023-09-13,5.46,4.19,113,74,58,Headache,Moderate,Improved,1
1997,PT-01997,48,M,NIMHANS Bengaluru,Phase III,ORX-505,Infectious Disease,Placebo,2023-06-12,2023-09-10,5.51,5.43,168,66,74,None,None,No Change,0
1998,PT-01998,18,M,Indore Medical Institute,Phase IV,ORX-303,Cardiology,Placebo,2024-07-08,2024-08-05,6.84,7.02,140,82,90,None,None,Improved,0
1999,PT-01999,85,M,Bhopal Research Hospital,Phase II,ORX-202,Diabetes,High Dose,2024-03-05,2024-04-30,9.25,8.38,101,77,64,None,None,Improved,1
2000,PT-02000,52,F,PGI Chandigarh,Phase III,ORX-404,Neurology,High Dose,2024-02-07,2024-04-03,5.78,5.32,143,80,64,Fatigue,None,Worsened,0
2001,PT-02001,63,M,AIIMS Delhi,Phase III,ORX-101,Oncology,Low Dose,2024-02-08,2024-03-07,4.95,4.25,127,82,80,None,None,Improved,1
2002,PT-02002,54,F,Fortis Mumbai,Phase III,ORX-303,Cardiology,High Dose,2024-03-27,2024-05-22,7.16,6.43,120,74,89,None,None,Improved,1
2003,PT-02003,34,F,Apollo Chennai,Phase III,ORX-606,Rheumatology,Placebo,2024-03-02,2024-03-30,8.22,7.83,118,89,67,Nausea,None,Improved,1
2004,PT-02004,55,F,AIIMS Delhi,Phase II,ORX-404,Neurology,Placebo,2023-05-01,2023-05-08,7.46,6.52,137,88,94,None,None,Improved,1
2005,PT-02005,60,M,AIIMS Delhi,Phase III,ORX-606,Rheumatology,Low Dose,2024-11-01,2025-01-30,7.79,6.37,172,65,91,None,None,No Change,0
2006,PT-02006,51,M,Indore Medical Institute,Phase I,ORX-505,Infectious Disease,High Dose,2024-08-31,2024-11-29,5.79,5.28,126,97,68,Nausea,None,Improved,1
2007,PT-02007,40,M,Bhopal Research Hospital,Phase III,ORX-606,Rheumatology,Low Dose,2024-11-30,2025-01-25,4.4,5.56,108,85,76,None,None,Improved,0
2008,PT-02008,43,F,AIIMS Delhi,Phase III,ORX-606,Rheumatology,High Dose,2023-10-16,2023-12-11,8.17,9.28,132,89,82,None,None,Worsened,0
2009,PT-02009,61,F,PGI Chandigarh,Phase III,ORX-505,Infectious Disease,Placebo,2023-09-09,2023-10-07,6.64,7.21,147,94,68,Dizziness,None,Worsened,0
2010,PT-02010,42,M,PGI Chandigarh,Phase I,ORX-606,Rheumatology,Low Dose,2024-02-20,2024-02-27,7.49,5.85,156,81,81,Headache,None,Improved,1
2011,PT-02011,35,F,NIMHANS Bengaluru,Phase III,ORX-606,Rheumatology,Low Dose,2023-10-03,2023-11-28,5.61,4.66,131,90,80,None,None,Improved,1
2012,PT-02012,50,F,PGI Chandigarh,Phase III,ORX-202,Diabetes,Low Dose,2023-09-03,2023-10-29,6.8,6.84,154,90,89,None,None,Improved,0
2013,PT-02013,49,F,NIMHANS Bengaluru,Phase II,ORX-101,Oncology,Low Dose,2023-10-15,2023-10-29,5.4,4.06,136,81,84,None,None,Improved,1
2014,PT-02014,71,F,Indore Medical Institute,Phase I,ORX-505,Infectious Disease,Low Dose,2024-09-25,2024-10-23,8.07,8.8,129,72,77,Rash,None,Improved,0
2015,PT-02015,32,F,PGI Chandigarh,Phase III,ORX-303,Cardiology,Low Dose,2024-02-11,2024-03-10,9.07,9.38,137,96,49,None,None,No Change,0
2016,PT-02016,54,M,Fortis Mumbai,Phase I,ORX-202,Diabetes,Placebo,2024-08-25,2024-09-01,5.63,5.22,122,89,81,None,None,Improved,1
2017,PT-02017,66,F,Fortis Mumbai,Phase I,ORX-606,Rheumatology,Low Dose,2023-07-20,2023-08-03,6.48,6.72,130,62,65,None,None,No Change,0
2018,PT-02018,42,F,Fortis Mumbai,Phase III,ORX-303,Cardiology,High Dose,2023-08-07,2023-08-14,8.53,8.55,106,80,106,None,None,Improved,0
2019,PT-02019,46,F,Indore Medical Institute,Phase II,ORX-101,Oncology,Low Dose,2023-05-05,2023-06-30,6.81,6.85,141,76,85,Rash,Moderate,Worsened,0
2020,PT-02020,39,M,Bhopal Research Hospital,Phase IV,ORX-303,Cardiology,High Dose,2024-04-02,2024-04-09,8.06,7.82,136,72,66,Nausea,None,Worsened,0
2021,PT-02021,60,M,Fortis Mumbai,Phase II,ORX-606,Rheumatology,High Dose,2024-03-19,2024-06-17,7.1,6.96,122,92,69,None,None,No Change,0
2022,PT-02022,42,F,Kolkata Clinical Center,Phase I,ORX-202,Diabetes,Low Dose,2023-06-17,2023-06-24,8.14,8.8,118,105,82,None,None,No Change,0
2023,PT-02023,28,F,AIIMS Delhi,Phase IV,ORX-202,Diabetes,High Dose,2024-04-18,2024-06-13,7.64,6.9,135,81,79,None,None,Improved,1
2024,PT-02024,30,F,Apollo Chennai,Phase III,ORX-404,Neurology,Placebo,2023-10-13,2023-10-20,8.39,6.95,108,86,100,None,None,No Change,0
2025,PT-02025,39,F,Kolkata Clinical Center,Phase III,ORX-505,Infectious Disease,Placebo,2024-01-12,2024-02-09,8.04,8.61,142,78,62,Nausea,None,No Change,0
2026,PT-02026,18,M,Kolkata Clinical Center,Phase IV,ORX-606,Rheumatology,Placebo,2023-05-12,2023-05-19,6.88,7.54,107,90,64,None,None,Improved,0
2027,PT-02027,46,M,Indore Medical Institute,Phase I,ORX-505,Infectious Disease,Low Dose,2024-08-10,2024-08-17,8.05,7.06,131,77,87,None,None,No Change,0
2028,PT-02028,48,F,Bhopal Research Hospital,Phase III,ORX-404,Neurology,High Dose,2023-02-05,2023-02-19,7.27,8.27,139,73,76,None,None,Improved,0
2029,PT-02029,43,F,AIIMS Delhi,Phase II,ORX-505,Infectious Disease,High Dose,2023-06-30,2023-07-07,7.3,9.17,134,57,70,None,None,No Change,0
2030,PT-02030,18,F,PGI Chandigarh,Phase III,ORX-202,Diabetes,High Dose,2024-09-22,2024-10-20,6.8,4.62,112,63,83,Fatigue,Mild,No Change,0
2031,PT-02031,45,M,AIIMS Delhi,Phase I,ORX-606,Rheumatology,High Dose,2024-03-29,2024-04-12,7.56,7.07,102,88,104,None,None,No Change,0
2032,PT-02032,51,M,PGI Chandigarh,Phase I,ORX-404,Neurology,High Dose,2023-08-16,2023-09-13,6.69,5.0,111,87,93,None,None,Improved,1
2033,PT-02033,49,F,PGI Chandigarh,Phase I,ORX-101,Oncology,Low Dose,2023-04-04,2023-04-11,8.16,8.4,137,74,80,None,None,No Change,0
2034,PT-02034,31,M,Kolkata Clinical Center,Phase II,ORX-101,Oncology,High Dose,2023-06-12,2023-06-26,7.22,7.12,158,66,84,None,None,Improved,1
2035,PT-02035,68,F,NIMHANS Bengaluru,Phase I,ORX-101,Oncology,Low Dose,2024-07-20,2024-08-03,8.11,8.46,138,97,62,Nausea,Mild,Worsened,0
2036,PT-02036,22,M,Kolkata Clinical Center,Phase III,ORX-606,Rheumatology,High Dose,2024-10-07,2024-12-02,7.19,4.85,150,96,71,Headache,None,Worsened,0
2037,PT-02037,39,F,Kolkata Clinical Center,Phase III,ORX-202,Diabetes,Low Dose,2023-09-26,2023-10-10,7.11,6.76,130,88,75,Fever,Severe,Improved,1
2038,PT-02038,60,M,AIIMS Delhi,Phase I,ORX-606,Rheumatology,Low Dose,2024-10-11,2024-10-18,7.74,6.79,152,65,76,None,None,No Change,0
2039,PT-02039,60,M,AIIMS Delhi,Phase II,ORX-606,Rheumatology,High Dose,2024-10-08,2024-10-22,6.33,6.21,137,71,76,Dizziness,None,Improved,1
2040,PT-02040,42,F,PGI Chandigarh,Phase II,ORX-202,Diabetes,Low Dose,2023-02-20,2023-04-17,6.54,8.21,114,94,72,Fatigue,Mild,Improved,0
2041,PT-02041,27,F,Apollo Chennai,Phase IV,ORX-101,Oncology,High Dose,2023-04-28,2023-07-27,7.32,7.51,144,100,119,None,None,Improved,0
2042,PT-02042,49,F,Apollo Chennai,Phase II,ORX-101,Oncology,Low Dose,2023-11-19,2023-12-03,6.4,6.41,123,93,59,Dizziness,Mild,Worsened,0
2043,PT-02043,82,F,Bhopal Research Hospital,Phase I,ORX-202,Diabetes,High Dose,2023-06-28,2023-08-23,8.23,6.31,115,91,94,None,None,No Change,0
2044,PT-02044,24,F,Apollo Chennai,Phase III,ORX-505,Infectious Disease,High Dose,2024-04-29,2024-05-27,8.06,5.9,126,95,70,None,None,Improved,1
2045,PT-02045,20,F,Indore Medical Institute,Phase III,ORX-303,Cardiology,Low Dose,2024-08-05,2024-08-12,7.38,6.43,139,71,67,Dizziness,Mild,No Change,0
2046,PT-02046,18,F,Fortis Mumbai,Phase I,ORX-101,Oncology,Placebo,2024-11-20,2024-12-18,7.4,6.86,106,84,92,None,None,Improved,1
2047,PT-02047,41,M,NIMHANS Bengaluru,Phase III,ORX-505,Infectious Disease,High Dose,2024-08-28,2024-09-25,7.52,7.37,106,106,71,None,None,Improved,1
2048,PT-02048,55,M,Indore Medical Institute,Phase I,ORX-202,Diabetes,Placebo,2023-06-22,2023-08-17,8.12,7.6,138,84,58,Nausea,None,Worsened,0
2049,PT-02049,39,F,Bhopal Research Hospital,Phase I,ORX-202,Diabetes,Low Dose,2023-07-26,2023-10-24,6.46,5.65,104,95,100,Headache,Moderate,Improved,1
2050,PT-02050,60,F,Kolkata Clinical Center,Phase III,ORX-404,Neurology,Placebo,2024-06-19,2024-08-14,8.72,8.01,116,72,87,None,None,Improved,1
2051,PT-02051,48,F,Apollo Chennai,Phase IV,ORX-101,Oncology,High Dose,2023-07-09,2023-07-23,7.11,7.87,135,71,68,None,None,Improved,0
2052,PT-02052,55,M,PGI Chandigarh,Phase III,ORX-606,Rheumatology,Low Dose,2024-06-27,2024-09-25,8.45,8.55,162,101,84,Nausea,None,No Change,0
2053,PT-02053,31,M,Apollo Chennai,Phase III,ORX-606,Rheumatology,High Dose,2023-11-13,2023-11-27,5.63,,141,103,83,None,None,Improved,1
2054,PT-02054,63,F,Apollo Chennai,Phase II,ORX-101,Oncology,High Dose,2024-11-19,2025-02-17,6.91,7.07,142,58,72,None,None,No Change,0
2055,PT-02055,60,M,AIIMS Delhi,Phase I,ORX-101,Oncology,Low Dose,2023-12-27,2024-01-03,7.53,6.05,90,77,76,None,None,No Change,0
2056,PT-02056,30,F,Fortis Mumbai,Phase II,ORX-505,Infectious Disease,Low Dose,2023-10-18,2023-12-13,7.37,7.43,140,53,59,None,None,Improved,0
2057,PT-02057,40,M,Kolkata Clinical Center,Phase III,ORX-404,Neurology,Low Dose,2024-07-11,2024-09-05,7.89,7.93,136,77,73,None,None,Improved,0
2058,PT-02058,33,F,Fortis Mumbai,Phase III,ORX-101,Oncology,Low Dose,2023-07-26,2023-09-20,8.12,6.89,143,84,77,None,None,Worsened,0
2059,PT-02059,34,M,PGI Chandigarh,Phase II,ORX-101,Oncology,Placebo,2023-09-08,2023-10-06,5.57,4.59,122,53,75,None,None,Improved,1
2060,PT-02060,59,M,NIMHANS Bengaluru,Phase I,ORX-303,Cardiology,Low Dose,2024-09-23,2024-10-07,7.88,7.03,128,75,80,None,None,Worsened,0
2061,PT-02061,69,M,PGI Chandigarh,Phase IV,ORX-202,Diabetes,Low Dose,2024-01-25,2024-02-08,8.36,8.43,119,90,54,None,None,Improved,0
2062,PT-02062,40,F,Indore Medical Institute,Phase III,ORX-202,Diabetes,Low Dose,2023-04-23,2023-05-07,7.9,8.17,140,85,75,None,None,Improved,0
2063,PT-02063,53,M,Apollo Chennai,Phase III,ORX-101,Oncology,High Dose,2024-09-20,2024-10-18,6.06,4.9,129,84,52,Nausea,Mild,Worsened,0
2064,PT-02064,52,F,PGI Chandigarh,Phase III,ORX-303,Cardiology,Low Dose,2024-03-21,2024-04-04,8.13,7.66,170,73,72,None,None,Improved,1
2065,PT-02065,38,F,Fortis Mumbai,Phase IV,ORX-606,Rheumatology,Placebo,2023-09-21,2023-09-28,7.11,6.41,102,75,76,None,None,No Change,0
2066,PT-02066,64,M,Apollo Chennai,Phase II,ORX-505,Infectious Disease,Placebo,2023-09-22,2023-10-20,9.84,10.64,114,73,75,None,None,No Change,0
2067,PT-02067,73,F,Fortis Mumbai,Phase IV,ORX-101,Oncology,Low Dose,2024-11-23,2025-02-21,7.0,5.41,118,91,87,None,None,Improved,1
2068,PT-02068,41,F,AIIMS Delhi,Phase III,ORX-505,Infectious Disease,High Dose,2023-08-12,2023-11-10,8.02,5.57,129,92,66,None,None,No Change,0
2069,PT-02069,31,F,AIIMS Delhi,Phase I,ORX-101,Oncology,High Dose,2024-08-07,2024-10-02,4.96,5.99,115,84,86,Headache,None,Improved,0
2070,PT-02070,69,F,Kolkata Clinical Center,Phase III,ORX-303,Cardiology,Low Dose,2024-06-15,2024-07-13,7.02,6.13,131,97,75,Nausea,Mild,Improved,1
2071,PT-02071,29,F,AIIMS Delhi,Phase II,ORX-202,Diabetes,Placebo,2023-01-11,2023-01-18,5.35,3.85,143,78,69,Nausea,Moderate,Improved,1
2072,PT-02072,33,F,AIIMS Delhi,Phase IV,ORX-606,Rheumatology,Low Dose,2024-08-03,2024-08-10,7.3,6.69,123,98,99,None,None,No Change,0
2073,PT-02073,19,F,Bhopal Research Hospital,Phase I,ORX-202,Diabetes,High Dose,2024-04-17,2024-05-15,7.59,6.49,123,85,75,Fatigue,None,Worsened,0
2074,PT-02074,48,F,PGI Chandigarh,Phase II,ORX-606,Rheumatology,High Dose,2024-04-27,2024-05-04,8.01,7.87,116,74,57,None,None,No Change,0
2075,PT-02075,31,M,Apollo Chennai,Phase IV,ORX-101,Oncology,Placebo,2024-01-05,2024-04-04,9.55,8.44,106,85,76,None,None,Improved,1
2076,PT-02076,41,F,Apollo Chennai,Phase II,ORX-101,Oncology,Placebo,2024-07-09,2024-10-07,8.89,8.99,118,76,70,Fatigue,None,Improved,0
2077,PT-02077,58,M,NIMHANS Bengaluru,Phase II,ORX-202,Diabetes,High Dose,2023-05-19,2023-05-26,6.83,4.82,127,63,108,None,None,Worsened,0
2078,PT-02078,29,F,Fortis Mumbai,Phase II,ORX-404,Neurology,Placebo,2023-04-21,2023-04-28,7.01,6.84,122,78,83,Nausea,Mild,Improved,1
2079,PT-02079,69,F,NIMHANS Bengaluru,Phase III,ORX-505,Infectious Disease,High Dose,2023-02-03,2023-05-04,8.12,9.05,109,85,80,Fever,Mild,No Change,0
2080,PT-02080,50,M,Fortis Mumbai,Phase III,ORX-404,Neurology,High Dose,2023-02-21,2023-03-07,8.85,8.25,120,88,53,Nausea,Mild,Worsened,0
2081,PT-02081,41,F,Fortis Mumbai,Phase III,ORX-101,Oncology,Low Dose,2023-07-12,2023-07-19,7.04,5.81,147,69,76,Rash,None,Improved,1
2082,PT-02082,49,M,PGI Chandigarh,Phase III,ORX-101,Oncology,Placebo,2024-07-26,2024-10-24,8.82,8.41,144,90,79,None,None,Worsened,0
2083,PT-02083,27,F,PGI Chandigarh,Phase II,ORX-606,Rheumatology,High Dose,2023-06-13,2023-06-27,5.48,5.17,118,93,88,None,None,Improved,1
2084,PT-02084,42,M,Apollo Chennai,Phase III,ORX-101,Oncology,Placebo,2023-05-18,2023-06-15,5.81,5.87,109,72,64,Fever,None,Improved,0
2085,PT-02085,42,M,Apollo Chennai,Phase II,ORX-202,Diabetes,Placebo,2024-04-24,2024-06-19,8.6,8.2,120,63,85,Headache,Mild,Improved,1
2086,PT-02086,32,F,PGI Chandigarh,Phase III,ORX-101,Oncology,Low Dose,2024-03-13,2024-03-27,7.34,6.62,143,80,77,Nausea,None,No Change,0
2087,PT-02087,52,F,Indore Medical Institute,Phase II,ORX-202,Diabetes,Placebo,2024-01-15,2024-01-29,9.73,10.13,126,82,70,Dizziness,None,Improved,0
2088,PT-02088,29,M,Fortis Mumbai,Phase III,ORX-404,Neurology,Placebo,2023-01-30,2023-02-13,6.54,5.44,139,69,96,Fatigue,Mild,Improved,1
2089,PT-02089,57,M,Fortis Mumbai,Phase I,ORX-404,Neurology,Placebo,2024-08-18,2024-08-25,7.22,6.82,117,85,93,Headache,Severe,Improved,1
2090,PT-02090,33,M,PGI Chandigarh,Phase II,ORX-101,Oncology,Low Dose,2024-02-28,2024-03-27,5.36,5.59,133,68,67,None,None,No Change,0
2091,PT-02091,31,M,Kolkata Clinical Center,Phase III,ORX-606,Rheumatology,Low Dose,2024-05-22,2024-06-19,6.33,5.64,123,74,67,None,None,No Change,0
2092,PT-02092,41,M,Indore Medical Institute,Phase IV,ORX-404,Neurology,Low Dose,2024-07-08,2024-07-22,7.4,6.72,148,88,55,Dizziness,None,Improved,1
2093,PT-02093,53,F,PGI Chandigarh,Phase III,ORX-505,Infectious Disease,High Dose,2023-03-07,2023-03-21,7.93,7.14,101,82,77,Nausea,Moderate,Improved,1
2094,PT-02094,27,F,Fortis Mumbai,Phase II,ORX-606,Rheumatology,Placebo,2024-06-03,2024-06-17,5.46,4.98,123,76,76,None,None,Worsened,0
2095,PT-02095,27,M,Bhopal Research Hospital,Phase III,ORX-202,Diabetes,Placebo,2023-03-28,2023-04-04,6.68,6.76,121,61,71,None,None,Worsened,0
2096,PT-02096,27,F,Indore Medical Institute,Phase IV,ORX-202,Diabetes,High Dose,2024-07-20,2024-09-14,7.52,7.41,98,91,62,Headache,None,No Change,0
2097,PT-02097,69,M,Indore Medical Institute,Phase III,ORX-404,Neurology,Placebo,2023-02-06,2023-02-20,7.14,5.62,107,86,72,None,None,No Change,0
2098,PT-02098,43,F,AIIMS Delhi,Phase III,ORX-505,Infectious Disease,Low Dose,2023-04-23,2023-06-18,9.14,8.11,129,99,81,None,None,Improved,1
2099,PT-02099,19,F,Fortis Mumbai,Phase IV,ORX-202,Diabetes,Placebo,2024-04-10,2024-04-24,7.81,6.36,153,72,119,None,None,Improved,1
2100,PT-02100,68,F,Bhopal Research Hospital,Phase I,ORX-404,Neurology,Placebo,2024-11-26,2024-12-24,6.24,5.86,141,91,84,None,None,No Change,0
2101,PT-02101,65,F,Apollo Chennai,Phase III,ORX-202,Diabetes,High Dose,2023-01-02,2023-04-02,7.05,6.32,121,92,83,None,None,No Change,0
2102,PT-02102,49,F,Kolkata Clinical Center,Phase II,ORX-101,Oncology,Low Dose,2024-06-15,2024-08-10,8.15,5.91,133,84,101,Nausea,None,Improved,1
2103,PT-02103,20,F,AIIMS Delhi,Phase III,ORX-101,Oncology,High Dose,2024-09-20,2024-11-15,9.07,8.74,136,102,85,Headache,None,No Change,0
2104,PT-02104,51,F,Kolkata Clinical Center,Phase II,ORX-404,Neurology,Placebo,2023-07-06,2023-08-31,7.49,6.66,127,73,77,Nausea,None,Improved,1
2105,PT-02105,18,F,Fortis Mumbai,Phase III,ORX-202,Diabetes,Low Dose,2024-05-24,2024-07-19,7.71,7.21,121,84,57,None,None,Improved,1
2106,PT-02106,75,F,Indore Medical Institute,Phase III,ORX-404,Neurology,Placebo,2024-02-13,2024-03-12,7.08,6.55,110,82,97,None,None,Improved,1
2107,PT-02107,61,M,PGI Chandigarh,Phase I,ORX-505,Infectious Disease,High Dose,2023-06-11,2023-06-25,8.23,8.32,121,64,75,None,None,No Change,0
2108,PT-02108,41,F,NIMHANS Bengaluru,Phase IV,ORX-202,Diabetes,Placebo,2024-08-28,2024-09-25,8.46,8.34,157,96,71,Nausea,Mild,Improved,1
2109,PT-02109,18,M,Kolkata Clinical Center,Phase III,ORX-606,Rheumatology,High Dose,2023-06-07,2023-08-02,8.86,9.69,103,100,83,Nausea,None,Improved,0
2110,PT-02110,47,M,NIMHANS Bengaluru,Phase I,ORX-101,Oncology,Low Dose,2023-09-23,2023-12-22,9.14,9.95,139,87,86,Nausea,Mild,Improved,0
2111,PT-02111,38,M,Bhopal Research Hospital,Phase II,ORX-202,Diabetes,High Dose,2023-02-11,2023-02-18,7.13,5.92,122,77,69,None,None,Improved,1
2112,PT-02112,47,M,AIIMS Delhi,Phase III,ORX-101,Oncology,High Dose,2023-03-27,2023-04-10,6.81,6.86,98,80,79,None,None,Worsened,0
2113,PT-02113,40,M,PGI Chandigarh,Phase III,ORX-606,Rheumatology,Placebo,2024-11-09,2024-11-16,6.99,5.17,134,89,84,None,None,No Change,0
2114,PT-02114,61,F,Kolkata Clinical Center,Phase III,ORX-404,Neurology,Placebo,2023-01-09,2023-01-16,7.44,7.47,130,90,55,None,None,No Change,0
2115,PT-02115,30,F,Indore Medical Institute,Phase II,ORX-404,Neurology,Low Dose,2023-11-09,2023-11-23,9.1,6.49,125,96,76,Headache,None,No Change,0
2116,PT-02116,38,F,Kolkata Clinical Center,Phase II,ORX-404,Neurology,Low Dose,2024-05-06,2024-05-20,7.36,6.64,128,73,93,None,None,No Change,0
2117,PT-02117,67,F,Fortis Mumbai,Phase III,ORX-404,Neurology,High Dose,2023-05-02,2023-07-31,7.04,5.39,118,79,85,None,None,Improved,1
2118,PT-02118,28,F,Bhopal Research Hospital,Phase III,ORX-505,Infectious Disease,Placebo,2024-03-22,2024-04-05,6.28,6.34,144,74,59,None,None,Improved,0
2119,PT-02119,85,M,Bhopal Research Hospital,Phase II,ORX-101,Oncology,Placebo,2024-09-18,2024-10-16,8.14,7.5,143,80,90,Rash,None,Improved,1
2120,PT-02120,47,F,Bhopal Research Hospital,Phase IV,ORX-101,Oncology,Low Dose,2024-09-21,2024-11-16,7.31,6.81,101,105,64,Headache,Mild,Improved,1
2121,PT-02121,23,F,Bhopal Research Hospital,Phase III,ORX-606,Rheumatology,Placebo,2023-07-23,2023-07-30,6.94,5.68,127,90,91,None,None,No Change,0
2122,PT-02122,58,M,NIMHANS Bengaluru,Phase IV,ORX-404,Neurology,Placebo,2023-06-22,2023-06-29,6.83,6.48,135,60,85,None,None,Improved,1
2123,PT-02123,21,M,PGI Chandigarh,Phase III,ORX-202,Diabetes,Low Dose,2023-07-13,2023-07-20,9.65,8.88,124,72,69,Nausea,None,Improved,1
2124,PT-02124,81,M,Apollo Chennai,Phase II,ORX-505,Infectious Disease,High Dose,2023-12-30,2024-03-29,8.33,6.53,155,96,74,Dizziness,Moderate,No Change,0
2125,PT-02125,49,M,Indore Medical Institute,Phase III,ORX-101,Oncology,Low Dose,2024-06-30,2024-08-25,7.18,8.56,113,83,72,None,None,Improved,0
2126,PT-02126,22,F,Apollo Chennai,Phase IV,ORX-202,Diabetes,High Dose,2023-07-31,2023-10-29,9.83,8.37,131,61,72,None,None,No Change,0
2127,PT-02127,51,M,Kolkata Clinical Center,Phase II,ORX-404,Neurology,High Dose,2023-03-27,2023-06-25,6.21,6.34,123,95,97,None,None,Improved,0
2128,PT-02128,35,F,Kolkata Clinical Center,Phase II,ORX-101,Oncology,Placebo,2024-07-19,2024-08-16,7.29,7.06,139,82,80,None,None,Worsened,0
2129,PT-02129,41,M,AIIMS Delhi,Phase II,ORX-202,Diabetes,High Dose,2024-09-15,2024-09-29,7.34,8.11,139,90,88,None,None,Improved,0
2130,PT-02130,42,M,AIIMS Delhi,Phase II,ORX-404,Neurology,High Dose,2023-03-06,2023-06-04,7.58,6.21,150,50,76,Headache,Mild,Improved,1
2131,PT-02131,63,M,Kolkata Clinical Center,Phase III,ORX-404,Neurology,Low Dose,2024-10-28,2024-11-04,5.56,5.52,115,77,91,Nausea,None,Improved,1
2132,PT-02132,48,M,Bhopal Research Hospital,Phase I,ORX-606,Rheumatology,High Dose,2023-09-11,2023-09-18,4.76,3.48,145,87,102,None,None,No Change,0
2133,PT-02133,71,F,Bhopal Research Hospital,Phase IV,ORX-404,Neurology,High Dose,2023-04-24,2023-05-22,6.79,8.64,128,70,69,None,None,Worsened,0
2134,PT-02134,18,M,Fortis Mumbai,Phase III,ORX-303,Cardiology,High Dose,2023-07-02,2023-07-09,9.13,10.16,109,79,79,Rash,None,Worsened,0
2135,PT-02135,29,F,NIMHANS Bengaluru,Phase II,ORX-505,Infectious Disease,Low Dose,2023-06-24,2023-09-22,5.09,4.5,122,77,81,Nausea,None,Worsened,0
2136,PT-02136,67,F,Fortis Mumbai,Phase III,ORX-505,Infectious Disease,Low Dose,2024-08-02,2024-08-16,6.84,6.59,141,88,69,None,None,Improved,1
2137,PT-02137,46,F,Indore Medical Institute,Phase III,ORX-404,Neurology,High Dose,2023-05-20,2023-08-18,7.86,6.44,150,99,67,None,None,Worsened,0
2138,PT-02138,48,F,AIIMS Delhi,Phase III,ORX-505,Infectious Disease,Low Dose,2024-08-27,2024-09-24,7.97,7.08,136,83,57,None,None,Improved,1
2139,PT-02139,52,F,Indore Medical Institute,Phase III,ORX-505,Infectious Disease,High Dose,2024-04-13,2024-05-11,5.88,6.33,115,80,97,None,None,No Change,0
2140,PT-02140,52,F,Fortis Mumbai,Phase III,ORX-404,Neurology,Placebo,2024-06-05,2024-06-19,5.9,4.59,117,86,83,Rash,Moderate,No Change,0
2141,PT-02141,31,M,Apollo Chennai,Phase III,ORX-303,Cardiology,High Dose,2024-06-15,2024-07-13,5.8,5.65,124,107,78,Headache,None,Improved,1
2142,PT-02142,74,M,Fortis Mumbai,Phase IV,ORX-505,Infectious Disease,Low Dose,2023-09-29,2023-10-27,5.8,3.98,107,96,102,Rash,None,Improved,1
2143,PT-02143,32,F,PGI Chandigarh,Phase IV,ORX-202,Diabetes,Placebo,2023-02-02,2023-02-16,6.65,5.2,95,90,81,Fever,None,Improved,1
2144,PT-02144,45,F,Indore Medical Institute,Phase II,ORX-101,Oncology,High Dose,2023-07-03,2023-07-31,5.52,6.6,118,88,57,None,None,Improved,0
2145,PT-02145,41,M,Indore Medical Institute,Phase III,ORX-505,Infectious Disease,High Dose,2024-08-09,2024-11-07,7.55,7.44,130,87,62,Nausea,None,Improved,1
2146,PT-02146,48,F,Apollo Chennai,Phase II,ORX-505,Infectious Disease,Low Dose,2024-04-30,2024-05-28,7.34,7.15,129,66,59,Headache,None,No Change,0
2147,PT-02147,18,F,Apollo Chennai,Phase III,ORX-101,Oncology,Placebo,2024-04-02,2024-04-30,8.18,8.53,143,85,48,None,None,Worsened,0
2148,PT-02148,28,M,PGI Chandigarh,Phase I,ORX-606,Rheumatology,Low Dose,2024-11-26,2025-01-21,7.4,7.13,123,86,78,Fatigue,Mild,Improved,1
2149,PT-02149,46,F,Indore Medical Institute,Phase III,ORX-303,Cardiology,Low Dose,2023-04-10,2023-07-09,6.43,6.92,120,66,67,Nausea,Moderate,Improved,0
2150,PT-02150,39,F,Indore Medical Institute,Phase III,ORX-505,Infectious Disease,High Dose,2023-01-20,2023-01-27,8.39,7.95,124,67,88,None,None,Improved,1
2151,PT-02151,34,M,Apollo Chennai,Phase I,ORX-404,Neurology,Low Dose,2023-05-06,2023-05-13,7.08,8.01,137,62,53,Fatigue,None,Improved,0
2152,PT-02152,43,F,Indore Medical Institute,Phase I,ORX-404,Neurology,Low Dose,2024-11-12,2024-12-10,5.74,5.93,128,83,68,Nausea,Moderate,Worsened,0
2153,PT-02153,72,F,Indore Medical Institute,Phase II,ORX-404,Neurology,Placebo,2023-05-10,2023-05-17,10.61,9.96,134,83,74,None,None,Improved,1
2154,PT-02154,31,F,AIIMS Delhi,Phase IV,ORX-303,Cardiology,High Dose,2023-07-02,2023-07-16,5.9,4.48,135,75,45,None,None,Worsened,0
2155,PT-02155,52,M,Apollo Chennai,Phase II,ORX-606,Rheumatology,Low Dose,2023-10-29,2023-12-24,7.15,7.97,134,64,46,None,None,No Change,0
2156,PT-02156,33,F,NIMHANS Bengaluru,Phase III,ORX-303,Cardiology,Low Dose,2023-11-30,2023-12-28,6.45,6.9,127,95,59,Nausea,None,No Change,0
2157,PT-02157,60,M,Apollo Chennai,Phase III,ORX-505,Infectious Disease,Placebo,2023-01-07,2023-03-04,8.07,5.85,151,83,83,Fever,None,No Change,0
2158,PT-02158,31,F,AIIMS Delhi,Phase II,ORX-606,Rheumatology,High Dose,2024-09-02,2024-09-09,8.73,,142,91,64,None,None,Improved,1
2159,PT-02159,76,M,Bhopal Research Hospital,Phase III,ORX-101,Oncology,High Dose,2024-04-28,2024-05-12,7.48,7.67,100,107,60,Nausea,Mild,Worsened,0
2160,PT-02160,61,F,NIMHANS Bengaluru,Phase III,ORX-303,Cardiology,Low Dose,2024-07-12,2024-07-26,6.01,5.05,142,94,60,Nausea,Mild,No Change,0
2161,PT-02161,62,F,AIIMS Delhi,Phase III,ORX-202,Diabetes,Low Dose,2023-11-09,2023-11-23,8.45,7.21,156,64,69,None,None,No Change,0
2162,PT-02162,52,F,Bhopal Research Hospital,Phase I,ORX-505,Infectious Disease,Low Dose,2024-01-13,2024-04-12,6.18,6.01,132,79,89,None,None,Improved,1
2163,PT-02163,41,F,Indore Medical Institute,Phase IV,ORX-303,Cardiology,Low Dose,2023-04-05,2023-05-03,7.48,8.11,142,91,61,None,None,Improved,0
2164,PT-02164,53,F,PGI Chandigarh,Phase II,ORX-606,Rheumatology,Placebo,2023-05-25,2023-06-22,6.15,4.59,126,71,89,None,None,Improved,1
2165,PT-02165,58,F,Kolkata Clinical Center,Phase I,ORX-101,Oncology,Low Dose,2023-11-04,2024-02-02,4.92,3.77,101,76,84,None,None,Improved,1
2166,PT-02166,41,M,Apollo Chennai,Phase I,ORX-404,Neurology,Low Dose,2023-02-01,2023-02-15,6.49,7.26,90,96,70,None,None,Improved,0
2167,PT-02167,43,F,Bhopal Research Hospital,Phase I,ORX-606,Rheumatology,Placebo,2024-10-21,2025-01-19,6.57,7.56,105,82,85,Fever,None,Worsened,0
2168,PT-02168,19,M,AIIMS Delhi,Phase III,ORX-505,Infectious Disease,Placebo,2023-06-28,2023-08-23,6.1,5.56,112,72,73,None,None,Improved,1
2169,PT-02169,55,F,NIMHANS Bengaluru,Phase III,ORX-202,Diabetes,Low Dose,2023-03-06,2023-04-03,6.79,7.36,110,66,104,None,None,Improved,0
2170,PT-02170,34,F,Apollo Chennai,Phase III,ORX-303,Cardiology,High Dose,2024-05-09,2024-08-07,5.63,3.66,147,77,74,None,None,Improved,1
2171,PT-02171,42,M,Kolkata Clinical Center,Phase II,ORX-202,Diabetes,Placebo,2024-01-26,2024-03-22,8.42,7.85,170,83,92,None,None,Improved,1
2172,PT-02172,57,F,NIMHANS Bengaluru,Phase IV,ORX-505,Infectious Disease,High Dose,2023-11-14,2023-11-28,7.16,6.23,133,88,69,None,None,Improved,1
2173,PT-02173,47,F,NIMHANS Bengaluru,Phase IV,ORX-303,Cardiology,High Dose,2023-12-16,2023-12-23,8.68,10.15,143,104,69,Nausea,Mild,No Change,0
2174,PT-02174,56,M,PGI Chandigarh,Phase I,ORX-404,Neurology,Placebo,2023-01-18,2023-04-18,8.81,7.6,119,102,64,Rash,Mild,Worsened,0
2175,PT-02175,23,F,Bhopal Research Hospital,Phase II,ORX-505,Infectious Disease,Low Dose,2024-11-10,2025-02-08,9.03,9.71,135,81,71,None,None,Improved,0
2176,PT-02176,49,F,Fortis Mumbai,Phase II,ORX-505,Infectious Disease,High Dose,2024-11-17,2025-02-15,9.1,8.91,167,71,77,Nausea,None,No Change,0
2177,PT-02177,39,F,Kolkata Clinical Center,Phase III,ORX-303,Cardiology,Low Dose,2024-08-07,2024-09-04,5.9,5.36,135,88,108,None,None,No Change,0
2178,PT-02178,52,M,Indore Medical Institute,Phase III,ORX-202,Diabetes,Placebo,2024-03-27,2024-06-25,8.58,8.24,158,110,85,None,None,Improved,1
2179,PT-02179,29,M,Fortis Mumbai,Phase III,ORX-505,Infectious Disease,Low Dose,2024-10-16,2025-01-14,6.54,6.4,136,90,84,None,None,Worsened,0
2180,PT-02180,45,M,PGI Chandigarh,Phase III,ORX-505,Infectious Disease,Low Dose,2023-09-26,2023-10-24,6.44,6.4,161,94,85,Headache,Mild,No Change,0
2181,PT-02181,61,M,AIIMS Delhi,Phase III,ORX-505,Infectious Disease,High Dose,2024-06-19,2024-06-26,6.75,5.9,114,80,72,Headache,Mild,Improved,1
2182,PT-02182,64,M,PGI Chandigarh,Phase III,ORX-404,Neurology,High Dose,2023-04-27,2023-05-04,6.63,5.51,162,76,80,Nausea,Severe,No Change,0
2183,PT-02183,52,M,PGI Chandigarh,Phase II,ORX-505,Infectious Disease,Placebo,2023-01-24,2023-04-24,5.84,6.55,139,100,68,Fatigue,Moderate,No Change,0
2184,PT-02184,46,M,Kolkata Clinical Center,Phase III,ORX-404,Neurology,Low Dose,2024-01-15,2024-02-12,7.25,7.08,101,83,58,Fatigue,Moderate,Improved,1
2185,PT-02185,50,M,PGI Chandigarh,Phase II,ORX-101,Oncology,Low Dose,2024-11-03,2024-12-01,4.65,2.58,142,75,64,None,None,No Change,0
2186,PT-02186,65,M,Kolkata Clinical Center,Phase III,ORX-606,Rheumatology,Placebo,2024-11-15,2024-12-13,7.59,7.98,125,114,69,Headache,None,Improved,0
2187,PT-02187,72,M,Apollo Chennai,Phase I,ORX-505,Infectious Disease,Placebo,2023-09-12,2023-12-11,7.13,5.24,136,85,63,Nausea,None,Improved,1
2188,PT-02188,30,M,PGI Chandigarh,Phase III,ORX-303,Cardiology,Placebo,2024-03-12,2024-03-19,7.17,7.09,90,94,71,Headache,None,No Change,0
2189,PT-02189,23,M,Bhopal Research Hospital,Phase IV,ORX-101,Oncology,Placebo,2023-03-04,2023-03-18,8.33,7.91,149,87,77,Headache,None,Improved,1
2190,PT-02190,42,M,Kolkata Clinical Center,Phase IV,ORX-202,Diabetes,Low Dose,2024-02-16,2024-03-01,7.78,7.01,112,89,75,None,None,Worsened,0
2191,PT-02191,45,F,NIMHANS Bengaluru,Phase III,ORX-505,Infectious Disease,Placebo,2023-12-28,2024-01-11,8.51,8.0,128,74,84,None,None,No Change,0
2192,PT-02192,50,M,PGI Chandigarh,Phase III,ORX-404,Neurology,Placebo,2024-10-10,2024-11-07,8.28,7.36,119,91,81,None,None,Improved,1
2193,PT-02193,30,F,NIMHANS Bengaluru,Phase IV,ORX-202,Diabetes,Low Dose,2024-08-04,2024-08-18,8.77,6.84,142,66,104,Headache,None,Improved,1
2194,PT-02194,20,F,NIMHANS Bengaluru,Phase II,ORX-606,Rheumatology,Low Dose,2024-11-06,2024-11-20,8.58,8.11,121,84,86,Fatigue,None,No Change,0
2195,PT-02195,30,M,AIIMS Delhi,Phase III,ORX-505,Infectious Disease,Low Dose,2024-10-27,2024-12-22,6.22,6.41,97,74,120,None,None,Improved,0
2196,PT-02196,29,M,Bhopal Research Hospital,Phase II,ORX-404,Neurology,High Dose,2023-09-20,2023-09-27,8.58,,137,89,93,Headache,None,No Change,0
2197,PT-02197,41,M,Kolkata Clinical Center,Phase III,ORX-303,Cardiology,Low Dose,2023-07-29,2023-08-26,9.59,8.66,132,84,62,Rash,Moderate,Improved,1
2198,PT-02198,40,F,Indore Medical Institute,Phase III,ORX-303,Cardiology,High Dose,2023-02-08,2023-02-22,7.39,6.6,171,71,94,None,None,No Change,0
2199,PT-02199,58,M,Apollo Chennai,Phase III,ORX-101,Oncology,Placebo,2024-05-13,2024-07-08,7.18,6.0,114,75,52,None,None,Improved,1
2200,PT-02200,28,M,Fortis Mumbai,Phase II,ORX-606,Rheumatology,Placebo,2023-04-29,2023-07-28,5.42,6.23,139,91,86,None,None,No Change,0
2201,PT-02201,47,F,Indore Medical Institute,Phase III,ORX-505,Infectious Disease,Low Dose,2023-02-15,2023-04-12,8.95,8.0,129,90,59,None,None,Improved,1
2202,PT-02202,85,M,AIIMS Delhi,Phase III,ORX-505,Infectious Disease,Low Dose,2023-10-12,2024-01-10,7.23,6.96,150,92,78,Headache,Moderate,Improved,1
2203,PT-02203,47,F,Apollo Chennai,Phase I,ORX-303,Cardiology,Low Dose,2024-04-09,2024-04-23,5.4,4.49,137,87,95,None,None,No Change,0
2204,PT-02204,43,F,Indore Medical Institute,Phase IV,ORX-606,Rheumatology,High Dose,2024-07-20,2024-10-18,5.54,6.09,153,92,75,Headache,Mild,Worsened,0
2205,PT-02205,61,F,Indore Medical Institute,Phase III,ORX-202,Diabetes,Low Dose,2023-08-02,2023-10-31,11.31,11.02,104,74,86,None,None,Improved,1
2206,PT-02206,19,M,Apollo Chennai,Phase III,ORX-505,Infectious Disease,Low Dose,2024-10-29,2024-11-26,7.4,7.35,155,97,90,None,None,Worsened,0
2207,PT-02207,18,M,Fortis Mumbai,Phase II,ORX-404,Neurology,Low Dose,2023-09-15,2023-09-22,8.31,8.54,132,61,67,None,None,Improved,0
2208,PT-02208,26,M,Bhopal Research Hospital,Phase III,ORX-303,Cardiology,Placebo,2024-10-14,2024-12-09,4.78,4.38,113,113,75,None,None,Worsened,0
2209,PT-02209,65,M,PGI Chandigarh,Phase II,ORX-303,Cardiology,High Dose,2023-02-10,2023-03-10,5.32,4.44,129,71,72,Rash,Moderate,Improved,1
2210,PT-02210,41,M,Indore Medical Institute,Phase IV,ORX-606,Rheumatology,High Dose,2024-04-06,2024-06-01,6.92,8.19,134,87,85,None,None,Improved,0
2211,PT-02211,54,F,Indore Medical Institute,Phase I,ORX-606,Rheumatology,High Dose,2024-08-28,2024-09-25,7.1,6.41,131,95,93,None,None,Improved,1
2212,PT-02212,41,F,Apollo Chennai,Phase II,ORX-505,Infectious Disease,Low Dose,2023-03-02,2023-05-31,8.12,7.55,128,76,75,Nausea,None,Improved,1
2213,PT-02213,66,M,Fortis Mumbai,Phase I,ORX-505,Infectious Disease,High Dose,2023-01-29,2023-04-29,7.31,7.03,101,78,74,Nausea,None,No Change,0
2214,PT-02214,31,F,NIMHANS Bengaluru,Phase IV,ORX-202,Diabetes,Placebo,2024-01-18,2024-01-25,7.23,6.44,129,83,64,Rash,Mild,Worsened,0
2215,PT-02215,38,M,Fortis Mumbai,Phase II,ORX-606,Rheumatology,Low Dose,2023-08-08,2023-08-22,7.29,7.96,132,74,83,None,None,Improved,0
2216,PT-02216,72,M,Fortis Mumbai,Phase I,ORX-404,Neurology,Low Dose,2023-04-12,2023-06-07,8.3,8.39,141,99,93,None,None,Improved,0
2217,PT-02217,54,M,Kolkata Clinical Center,Phase III,ORX-606,Rheumatology,High Dose,2023-02-27,2023-03-13,8.48,7.11,100,83,78,None,None,No Change,0
2218,PT-02218,36,F,Apollo Chennai,Phase III,ORX-404,Neurology,High Dose,2024-02-29,2024-03-14,8.19,6.11,118,76,55,None,None,Improved,1
2219,PT-02219,68,F,Indore Medical Institute,Phase IV,ORX-101,Oncology,Low Dose,2024-05-02,2024-07-31,5.57,4.64,144,89,62,None,None,Improved,1
2220,PT-02220,55,F,PGI Chandigarh,Phase II,ORX-505,Infectious Disease,High Dose,2023-01-27,2023-03-24,7.55,9.25,135,80,66,None,None,Improved,0
2221,PT-02221,33,M,Indore Medical Institute,Phase III,ORX-606,Rheumatology,Low Dose,2023-06-14,2023-06-21,6.21,7.04,128,88,99,None,None,Improved,0
2222,PT-02222,18,F,Kolkata Clinical Center,Phase III,ORX-101,Oncology,High Dose,2024-05-22,2024-06-05,8.73,8.38,135,72,67,None,None,Improved,1
2223,PT-02223,52,F,Fortis Mumbai,Phase II,ORX-606,Rheumatology,Low Dose,2023-04-25,2023-06-20,10.06,10.56,150,79,69,None,None,Improved,0
2224,PT-02224,32,M,Indore Medical Institute,Phase III,ORX-404,Neurology,Placebo,2023-09-08,2023-11-03,6.61,4.37,114,75,75,Fever,Moderate,Improved,1
2225,PT-02225,47,F,AIIMS Delhi,Phase II,ORX-202,Diabetes,Low Dose,2023-04-06,2023-06-01,7.63,7.22,117,58,69,None,None,Improved,1
2226,PT-02226,29,M,Fortis Mumbai,Phase IV,ORX-101,Oncology,Placebo,2024-11-11,2024-11-18,7.76,8.18,144,91,76,None,None,No Change,0
2227,PT-02227,36,F,Kolkata Clinical Center,Phase III,ORX-202,Diabetes,Low Dose,2023-01-24,2023-02-07,6.3,4.55,145,79,60,None,None,No Change,0
2228,PT-02228,31,F,Apollo Chennai,Phase II,ORX-202,Diabetes,Low Dose,2023-03-22,2023-05-17,6.16,5.8,147,77,46,None,None,No Change,0
2229,PT-02229,41,M,AIIMS Delhi,Phase IV,ORX-303,Cardiology,High Dose,2024-01-03,2024-04-02,7.01,6.41,116,84,78,None,None,Improved,1
2230,PT-02230,44,M,Bhopal Research Hospital,Phase I,ORX-505,Infectious Disease,High Dose,2023-11-24,2024-02-22,7.7,6.91,119,98,85,Rash,None,No Change,0
2231,PT-02231,58,F,NIMHANS Bengaluru,Phase III,ORX-606,Rheumatology,Placebo,2024-09-13,2024-12-12,8.67,8.74,144,63,80,None,None,Worsened,0
2232,PT-02232,42,F,NIMHANS Bengaluru,Phase III,ORX-202,Diabetes,Placebo,2024-01-24,2024-01-31,9.21,9.65,116,86,80,None,None,Worsened,0
2233,PT-02233,52,F,Fortis Mumbai,Phase II,ORX-101,Oncology,Low Dose,2023-08-25,2023-10-20,5.98,5.9,123,85,67,Nausea,None,No Change,0
2234,PT-02234,35,M,Kolkata Clinical Center,Phase III,ORX-303,Cardiology,Low Dose,2024-08-03,2024-08-17,8.61,7.26,110,81,67,None,None,Improved,1
2235,PT-02235,30,M,Apollo Chennai,Phase III,ORX-404,Neurology,Low Dose,2024-10-02,2024-10-16,7.33,5.57,109,106,84,Headache,Severe,No Change,0
2236,PT-02236,33,F,NIMHANS Bengaluru,Phase III,ORX-303,Cardiology,Low Dose,2023-02-10,2023-05-11,7.7,7.81,145,80,91,None,None,Improved,0
2237,PT-02237,18,F,NIMHANS Bengaluru,Phase II,ORX-202,Diabetes,Placebo,2023-01-10,2023-01-24,5.93,5.68,133,71,81,None,None,Improved,1
2238,PT-02238,35,F,AIIMS Delhi,Phase III,ORX-101,Oncology,Low Dose,2023-12-03,2023-12-10,6.87,7.39,144,70,63,Headache,None,Worsened,0
2239,PT-02239,38,M,NIMHANS Bengaluru,Phase I,ORX-202,Diabetes,High Dose,2024-02-17,2024-04-13,7.17,6.18,146,86,83,None,None,Improved,1
2240,PT-02240,24,M,Bhopal Research Hospital,Phase I,ORX-101,Oncology,Placebo,2024-02-20,2024-02-27,8.6,5.66,143,93,71,Dizziness,Moderate,Improved,1
2241,PT-02241,65,F,AIIMS Delhi,Phase III,ORX-202,Diabetes,Placebo,2024-05-21,2024-06-04,7.12,6.78,134,120,96,Headache,Mild,Worsened,0
2242,PT-02242,56,F,Indore Medical Institute,Phase III,ORX-404,Neurology,Placebo,2023-12-11,2024-01-08,6.1,5.83,113,91,79,Rash,None,Improved,1
2243,PT-02243,27,F,Fortis Mumbai,Phase III,ORX-404,Neurology,Placebo,2023-02-21,2023-02-28,7.3,6.13,130,71,78,Rash,Severe,Worsened,0
2244,PT-02244,57,F,Apollo Chennai,Phase III,ORX-404,Neurology,Placebo,2023-04-10,2023-04-24,7.14,6.38,131,90,62,None,None,Worsened,0
2245,PT-02245,49,M,Bhopal Research Hospital,Phase III,ORX-303,Cardiology,Placebo,2024-09-10,2024-12-09,8.78,8.9,129,89,84,Headache,None,No Change,0
2246,PT-02246,57,M,Fortis Mumbai,Phase III,ORX-202,Diabetes,High Dose,2023-07-13,2023-08-10,4.77,2.97,146,63,83,Nausea,None,No Change,0
2247,PT-02247,39,M,Apollo Chennai,Phase II,ORX-303,Cardiology,Low Dose,2023-01-31,2023-03-28,6.0,5.92,131,107,69,Dizziness,Mild,Improved,1
2248,PT-02248,68,F,Fortis Mumbai,Phase II,ORX-404,Neurology,Low Dose,2023-06-01,2023-06-08,7.62,6.63,142,88,78,Nausea,None,Improved,1
2249,PT-02249,49,M,Bhopal Research Hospital,Phase III,ORX-606,Rheumatology,Low Dose,2023-05-22,2023-06-05,6.48,5.34,141,79,76,Nausea,Mild,Improved,1
2250,PT-02250,49,M,NIMHANS Bengaluru,Phase I,ORX-202,Diabetes,Placebo,2023-12-21,2024-03-20,7.52,5.83,151,83,75,None,None,Worsened,0
2251,PT-02251,51,F,Kolkata Clinical Center,Phase IV,ORX-202,Diabetes,High Dose,2024-01-03,2024-01-17,7.48,7.77,137,90,96,None,None,Improved,0
2252,PT-02252,59,M,Kolkata Clinical Center,Phase II,ORX-101,Oncology,Placebo,2023-03-31,2023-04-14,7.01,5.6,158,79,71,Fever,Mild,No Change,0
2253,PT-02253,18,M,PGI Chandigarh,Phase III,ORX-101,Oncology,Low Dose,2024-03-04,2024-03-11,7.61,7.34,100,87,71,Headache,Severe,No Change,0
2254,PT-02254,85,F,Fortis Mumbai,Phase III,ORX-606,Rheumatology,High Dose,2024-02-12,2024-02-19,6.52,5.73,112,97,72,None,None,Worsened,0
2255,PT-02255,33,M,Fortis Mumbai,Phase II,ORX-404,Neurology,Low Dose,2023-02-25,2023-03-04,8.05,6.41,139,103,85,None,None,Improved,1
2256,PT-02256,55,M,Indore Medical Institute,Phase III,ORX-101,Oncology,High Dose,2023-06-29,2023-07-13,8.24,9.38,149,87,90,None,None,Worsened,0
2257,PT-02257,30,F,Bhopal Research Hospital,Phase I,ORX-202,Diabetes,Placebo,2023-09-28,2023-12-27,8.13,6.83,121,50,83,None,None,No Change,0
2258,PT-02258,34,F,PGI Chandigarh,Phase III,ORX-202,Diabetes,High Dose,2023-09-22,2023-10-20,8.53,8.48,148,68,92,None,None,Improved,1
2259,PT-02259,78,F,AIIMS Delhi,Phase III,ORX-404,Neurology,Low Dose,2023-08-13,2023-09-10,8.12,8.43,131,75,88,Fever,None,Improved,0
2260,PT-02260,20,M,Indore Medical Institute,Phase II,ORX-303,Cardiology,Low Dose,2024-10-02,2024-10-16,6.7,4.7,115,89,85,None,None,Worsened,0
2261,PT-02261,45,M,PGI Chandigarh,Phase II,ORX-505,Infectious Disease,High Dose,2023-03-27,2023-05-22,7.4,5.31,121,73,68,None,None,Worsened,0
2262,PT-02262,54,M,Bhopal Research Hospital,Phase IV,ORX-606,Rheumatology,High Dose,2024-04-14,2024-04-28,6.17,5.22,90,78,62,Fever,None,Improved,1
2263,PT-02263,46,F,NIMHANS Bengaluru,Phase III,ORX-303,Cardiology,High Dose,2024-02-14,2024-02-28,6.06,5.75,125,102,84,None,None,Worsened,0
2264,PT-02264,18,M,Kolkata Clinical Center,Phase IV,ORX-404,Neurology,High Dose,2024-03-28,2024-06-26,5.68,5.33,111,50,96,None,None,Worsened,0
2265,PT-02265,56,F,Bhopal Research Hospital,Phase III,ORX-606,Rheumatology,Placebo,2023-03-03,2023-03-17,7.83,6.88,135,73,80,None,None,Improved,1
2266,PT-02266,30,M,Fortis Mumbai,Phase III,ORX-505,Infectious Disease,Low Dose,2023-11-05,2023-11-19,9.02,7.21,150,82,71,None,None,Improved,1
2267,PT-02267,47,F,Fortis Mumbai,Phase III,ORX-101,Oncology,Low Dose,2024-03-05,2024-04-30,8.08,8.91,133,71,78,Dizziness,None,Improved,0
2268,PT-02268,74,F,NIMHANS Bengaluru,Phase III,ORX-303,Cardiology,Low Dose,2023-12-31,2024-01-14,8.82,9.24,142,90,94,Nausea,None,Improved,0
2269,PT-02269,37,F,Fortis Mumbai,Phase III,ORX-303,Cardiology,Low Dose,2023-04-01,2023-04-08,5.57,5.24,113,69,67,Headache,None,Improved,1
2270,PT-02270,84,M,Bhopal Research Hospital,Phase III,ORX-505,Infectious Disease,Placebo,2023-09-13,2023-09-20,7.36,7.29,105,59,66,None,None,Worsened,0
2271,PT-02271,68,F,Fortis Mumbai,Phase II,ORX-505,Infectious Disease,High Dose,2024-05-29,2024-06-12,7.6,7.74,141,74,97,None,None,No Change,0
2272,PT-02272,34,F,NIMHANS Bengaluru,Phase III,ORX-505,Infectious Disease,Placebo,2024-02-19,2024-04-15,8.89,8.89,95,73,53,Headache,None,Improved,1
2273,PT-02273,63,M,Indore Medical Institute,Phase III,ORX-202,Diabetes,Placebo,2024-01-15,2024-02-12,7.17,4.76,134,75,57,Headache,None,Improved,1
2274,PT-02274,71,M,Indore Medical Institute,Phase II,ORX-101,Oncology,High Dose,2023-02-22,2023-03-22,7.33,6.66,120,63,59,Dizziness,None,No Change,0
2275,PT-02275,65,M,Bhopal Research Hospital,Phase III,ORX-606,Rheumatology,High Dose,2024-06-01,2024-07-27,6.63,6.25,91,66,86,None,None,Improved,1
2276,PT-02276,51,M,Apollo Chennai,Phase I,ORX-101,Oncology,Low Dose,2024-07-17,2024-10-15,9.3,10.11,123,87,73,Fatigue,None,No Change,0
2277,PT-02277,77,M,Indore Medical Institute,Phase III,ORX-101,Oncology,Placebo,2024-05-01,2024-05-08,8.58,8.33,131,99,86,Headache,None,Improved,1
2278,PT-02278,69,M,Kolkata Clinical Center,Phase III,ORX-606,Rheumatology,Low Dose,2023-02-16,2023-02-23,4.57,4.58,118,103,99,Headache,Moderate,Worsened,0
2279,PT-02279,45,M,PGI Chandigarh,Phase III,ORX-606,Rheumatology,High Dose,2023-02-22,2023-05-23,9.04,10.25,129,111,77,Nausea,None,Improved,0
2280,PT-02280,41,F,PGI Chandigarh,Phase III,ORX-303,Cardiology,High Dose,2024-10-05,2024-10-12,8.24,7.52,129,98,78,Dizziness,None,Improved,1
2281,PT-02281,18,F,Bhopal Research Hospital,Phase III,ORX-101,Oncology,Low Dose,2023-06-20,2023-09-18,7.64,6.61,143,90,98,Fatigue,None,Improved,1
2282,PT-02282,59,M,Kolkata Clinical Center,Phase III,ORX-505,Infectious Disease,High Dose,2023-08-21,2023-10-16,8.51,7.51,142,105,68,None,None,Improved,1
2283,PT-02283,73,F,Bhopal Research Hospital,Phase I,ORX-505,Infectious Disease,Low Dose,2023-06-08,2023-06-22,6.54,5.37,133,90,90,Headache,Moderate,Worsened,0
2284,PT-02284,29,F,Kolkata Clinical Center,Phase II,ORX-101,Oncology,Low Dose,2024-05-11,2024-06-08,7.72,6.7,101,70,67,None,None,No Change,0
2285,PT-02285,53,F,Bhopal Research Hospital,Phase III,ORX-101,Oncology,Placebo,2023-10-21,2024-01-19,8.58,6.86,134,67,86,Headache,None,Improved,1
2286,PT-02286,35,F,Indore Medical Institute,Phase III,ORX-101,Oncology,Placebo,2023-09-21,2023-10-19,5.94,6.26,117,78,46,Headache,None,Improved,0
2287,PT-02287,60,F,AIIMS Delhi,Phase IV,ORX-101,Oncology,Low Dose,2023-02-08,2023-04-05,8.19,7.79,100,96,68,Headache,Mild,No Change,0
2288,PT-02288,37,F,Kolkata Clinical Center,Phase II,ORX-101,Oncology,Low Dose,2024-03-29,2024-04-26,9.97,8.94,141,88,83,Nausea,None,Improved,1
2289,PT-02289,49,F,AIIMS Delhi,Phase III,ORX-101,Oncology,Low Dose,2023-04-29,2023-06-24,7.65,7.5,127,100,59,Rash,None,Worsened,0
2290,PT-02290,61,M,Indore Medical Institute,Phase III,ORX-202,Diabetes,Placebo,2023-02-17,2023-05-18,8.19,8.42,148,80,51,Fatigue,None,No Change,0
2291,PT-02291,43,M,Bhopal Research Hospital,Phase III,ORX-505,Infectious Disease,Low Dose,2023-08-16,2023-11-14,6.01,4.95,105,76,69,None,None,Improved,1
2292,PT-02292,18,F,Apollo Chennai,Phase III,ORX-101,Oncology,Placebo,2023-04-20,2023-06-15,8.04,9.64,138,79,77,Rash,Moderate,No Change,0
2293,PT-02293,38,F,Indore Medical Institute,Phase IV,ORX-202,Diabetes,Placebo,2023-03-14,2023-05-09,7.31,6.87,112,102,57,None,None,Improved,1
2294,PT-02294,56,F,NIMHANS Bengaluru,Phase III,ORX-606,Rheumatology,High Dose,2023-08-25,2023-11-23,7.08,8.39,134,77,74,None,None,Worsened,0
2295,PT-02295,45,M,PGI Chandigarh,Phase I,ORX-101,Oncology,High Dose,2023-10-10,2023-12-05,5.83,4.74,95,70,79,Headache,None,Improved,1
2296,PT-02296,49,F,Bhopal Research Hospital,Phase IV,ORX-303,Cardiology,Low Dose,2024-07-19,2024-08-16,4.82,4.3,138,80,69,Headache,Moderate,Improved,1
2297,PT-02297,38,M,Bhopal Research Hospital,Phase III,ORX-404,Neurology,High Dose,2023-12-04,2023-12-11,6.55,5.58,131,109,67,Nausea,Mild,Improved,1
2298,PT-02298,39,F,PGI Chandigarh,Phase III,ORX-303,Cardiology,Placebo,2024-01-21,2024-01-28,7.14,6.12,147,53,70,Rash,None,No Change,0
2299,PT-02299,58,M,Indore Medical Institute,Phase III,ORX-202,Diabetes,Placebo,2023-10-27,2023-12-22,6.85,5.71,135,92,80,Rash,None,No Change,0
2300,PT-02300,32,F,Kolkata Clinical Center,Phase III,ORX-404,Neurology,Placebo,2024-01-02,2024-01-09,7.75,6.99,141,99,45,None,None,Improved,1
2301,PT-02301,46,M,Kolkata Clinical Center,Phase I,ORX-101,Oncology,Low Dose,2023-09-27,2023-11-22,5.12,6.91,119,90,77,Nausea,None,Improved,0
2302,PT-02302,32,M,Kolkata Clinical Center,Phase II,ORX-303,Cardiology,Low Dose,2023-08-22,2023-11-20,6.09,7.12,145,105,78,None,None,Improved,0
2303,PT-02303,49,F,Bhopal Research Hospital,Phase II,ORX-303,Cardiology,Low Dose,2023-11-29,2024-01-24,6.88,6.22,109,83,66,None,None,No Change,0
2304,PT-02304,52,M,PGI Chandigarh,Phase III,ORX-303,Cardiology,High Dose,2024-02-08,2024-05-08,7.4,7.26,158,81,88,None,None,Improved,1
2305,PT-02305,77,F,Fortis Mumbai,Phase II,ORX-101,Oncology,Low Dose,2024-03-14,2024-04-11,8.77,9.41,122,84,59,None,None,Improved,0
2306,PT-02306,52,F,AIIMS Delhi,Phase III,ORX-404,Neurology,High Dose,2023-07-31,2023-08-28,7.53,7.15,146,67,100,None,None,Improved,1
2307,PT-02307,59,F,AIIMS Delhi,Phase III,ORX-303,Cardiology,Low Dose,2023-08-12,2023-11-10,7.12,6.58,136,100,79,None,None,Improved,1
2308,PT-02308,47,F,NIMHANS Bengaluru,Phase III,ORX-606,Rheumatology,High Dose,2023-09-27,2023-12-26,7.22,8.43,121,81,98,None,None,Worsened,0
2309,PT-02309,47,F,Apollo Chennai,Phase III,ORX-202,Diabetes,Placebo,2023-12-09,2024-01-06,8.56,7.34,124,99,68,None,None,No Change,0
2310,PT-02310,42,F,AIIMS Delhi,Phase III,ORX-404,Neurology,Placebo,2024-03-04,2024-03-11,7.51,6.22,120,83,78,None,None,Worsened,0
2311,PT-02311,65,F,Fortis Mumbai,Phase III,ORX-101,Oncology,Low Dose,2024-11-29,2024-12-27,9.05,7.88,130,90,99,None,None,Improved,1
2312,PT-02312,56,F,Kolkata Clinical Center,Phase III,ORX-404,Neurology,High Dose,2023-12-19,2024-01-16,7.55,7.75,140,70,80,Fatigue,Mild,Improved,0
2313,PT-02313,68,M,Fortis Mumbai,Phase II,ORX-202,Diabetes,High Dose,2024-05-03,2024-05-17,6.95,6.67,123,54,78,Headache,None,Worsened,0
2314,PT-02314,49,M,AIIMS Delhi,Phase II,ORX-202,Diabetes,High Dose,2023-05-31,2023-07-26,6.59,5.15,112,91,105,Headache,Moderate,Improved,1
2315,PT-02315,67,F,Kolkata Clinical Center,Phase III,ORX-404,Neurology,Low Dose,2024-05-18,2024-05-25,5.59,5.96,116,75,71,None,None,Improved,0
2316,PT-02316,56,F,PGI Chandigarh,Phase II,ORX-101,Oncology,Placebo,2024-07-19,2024-09-13,8.35,7.86,126,87,85,None,None,No Change,0
2317,PT-02317,63,F,Bhopal Research Hospital,Phase II,ORX-404,Neurology,High Dose,2023-01-09,2023-01-23,5.66,5.28,108,81,74,Rash,None,No Change,0
2318,PT-02318,44,M,Indore Medical Institute,Phase III,ORX-101,Oncology,High Dose,2023-09-30,2023-10-14,6.24,4.5,90,80,71,None,None,No Change,0
2319,PT-02319,34,M,Indore Medical Institute,Phase I,ORX-101,Oncology,Low Dose,2023-01-20,2023-02-03,8.79,7.61,153,101,50,None,None,No Change,0
2320,PT-02320,46,M,Indore Medical Institute,Phase III,ORX-303,Cardiology,High Dose,2023-02-03,2023-03-03,6.72,3.7,101,91,106,None,None,No Change,0
2321,PT-02321,59,F,AIIMS Delhi,Phase III,ORX-303,Cardiology,High Dose,2024-01-21,2024-04-20,7.59,7.17,158,107,69,None,None,Improved,1
2322,PT-02322,18,F,Fortis Mumbai,Phase II,ORX-404,Neurology,Low Dose,2023-09-05,2023-12-04,4.68,5.47,127,84,52,None,None,Improved,0
2323,PT-02323,32,M,PGI Chandigarh,Phase III,ORX-303,Cardiology,Placebo,2023-12-25,2024-03-24,6.85,6.63,120,69,67,Rash,Mild,No Change,0
2324,PT-02324,64,M,Apollo Chennai,Phase III,ORX-606,Rheumatology,Low Dose,2023-05-11,2023-07-06,7.49,7.64,111,50,70,Fever,None,No Change,0
2325,PT-02325,31,M,Bhopal Research Hospital,Phase II,ORX-404,Neurology,Placebo,2024-10-29,2024-11-05,7.62,10.18,140,114,85,Headache,Moderate,Improved,0
2326,PT-02326,34,M,NIMHANS Bengaluru,Phase I,ORX-606,Rheumatology,Low Dose,2024-02-09,2024-03-08,7.62,8.82,160,75,81,None,None,No Change,0
2327,PT-02327,22,M,Fortis Mumbai,Phase III,ORX-303,Cardiology,High Dose,2024-08-25,2024-10-20,8.19,9.19,128,73,83,Headache,Mild,Improved,0
2328,PT-02328,51,M,Indore Medical Institute,Phase III,ORX-505,Infectious Disease,High Dose,2024-03-21,2024-04-18,7.3,7.06,124,93,88,None,None,No Change,0
2329,PT-02329,29,F,NIMHANS Bengaluru,Phase IV,ORX-101,Oncology,Placebo,2024-07-12,2024-07-19,5.99,5.36,141,83,68,Dizziness,Mild,No Change,0
2330,PT-02330,49,M,AIIMS Delhi,Phase III,ORX-202,Diabetes,High Dose,2024-01-16,2024-02-13,6.8,7.2,133,78,81,None,None,Worsened,0
2331,PT-02331,66,M,Indore Medical Institute,Phase II,ORX-505,Infectious Disease,Placebo,2023-06-10,2023-07-08,6.52,6.48,126,87,68,None,None,Worsened,0
2332,PT-02332,46,M,AIIMS Delhi,Phase I,ORX-202,Diabetes,Low Dose,2023-02-11,2023-02-25,8.53,7.29,104,66,61,Fatigue,Moderate,No Change,0
2333,PT-02333,54,F,Indore Medical Institute,Phase IV,ORX-101,Oncology,Low Dose,2023-08-20,2023-09-17,5.51,4.84,139,86,72,Rash,Mild,Improved,1
2334,PT-02334,48,M,NIMHANS Bengaluru,Phase II,ORX-505,Infectious Disease,Low Dose,2024-07-21,2024-10-19,7.33,6.73,124,108,89,Headache,Mild,Improved,1
2335,PT-02335,84,M,AIIMS Delhi,Phase II,ORX-303,Cardiology,High Dose,2024-02-08,2024-02-22,6.6,6.13,104,72,104,None,None,No Change,0
2336,PT-02336,36,M,Apollo Chennai,Phase II,ORX-101,Oncology,Placebo,2023-10-03,2023-10-31,9.5,7.98,109,77,77,Fatigue,None,Improved,1
2337,PT-02337,59,F,NIMHANS Bengaluru,Phase III,ORX-303,Cardiology,High Dose,2024-09-18,2024-12-17,7.74,6.97,125,78,65,Dizziness,None,No Change,0
2338,PT-02338,30,M,NIMHANS Bengaluru,Phase IV,ORX-202,Diabetes,Placebo,2024-04-15,2024-05-13,8.43,6.39,157,77,67,None,None,No Change,0
2339,PT-02339,56,M,NIMHANS Bengaluru,Phase IV,ORX-202,Diabetes,Low Dose,2023-10-02,2023-10-09,8.98,9.59,137,95,53,Fatigue,None,No Change,0
2340,PT-02340,36,M,AIIMS Delhi,Phase III,ORX-404,Neurology,Low Dose,2023-08-23,2023-08-30,6.11,6.81,121,92,85,None,None,Improved,0
2341,PT-02341,31,F,NIMHANS Bengaluru,Phase I,ORX-303,Cardiology,Low Dose,2023-06-04,2023-09-02,6.5,7.26,114,83,67,None,None,No Change,0
2342,PT-02342,39,F,AIIMS Delhi,Phase I,ORX-606,Rheumatology,Placebo,2024-09-27,2024-11-22,7.14,6.04,110,85,66,Rash,None,Improved,1
2343,PT-02343,32,M,AIIMS Delhi,Phase III,ORX-606,Rheumatology,High Dose,2024-06-29,2024-07-27,6.07,5.6,144,100,67,None,None,Improved,1
2344,PT-02344,79,M,Bhopal Research Hospital,Phase II,ORX-101,Oncology,Low Dose,2023-08-24,2023-09-21,5.99,6.57,115,71,67,None,None,Improved,0
2345,PT-02345,44,F,AIIMS Delhi,Phase II,ORX-101,Oncology,Low Dose,2023-04-18,2023-05-16,7.9,8.1,111,70,65,Rash,None,Improved,0
2346,PT-02346,43,F,Kolkata Clinical Center,Phase III,ORX-606,Rheumatology,Placebo,2024-04-22,2024-07-21,6.95,5.69,132,109,70,None,None,Worsened,0
2347,PT-02347,38,F,AIIMS Delhi,Phase IV,ORX-101,Oncology,Low Dose,2023-08-30,2023-09-27,7.87,6.97,140,73,103,Headache,Mild,No Change,0
2348,PT-02348,50,M,Indore Medical Institute,Phase III,ORX-303,Cardiology,High Dose,2024-05-09,2024-07-04,6.46,5.53,118,98,60,None,None,Improved,1
2349,PT-02349,34,F,Apollo Chennai,Phase III,ORX-202,Diabetes,High Dose,2023-06-24,2023-09-22,6.53,6.11,123,64,72,Nausea,None,No Change,0
2350,PT-02350,43,F,Indore Medical Institute,Phase IV,ORX-202,Diabetes,Low Dose,2024-07-09,2024-08-06,6.45,6.66,144,81,81,None,None,Worsened,0
2351,PT-02351,18,F,PGI Chandigarh,Phase III,ORX-606,Rheumatology,Low Dose,2023-07-16,2023-10-14,6.69,7.2,120,73,109,Headache,Mild,Improved,0
2352,PT-02352,74,F,AIIMS Delhi,Phase I,ORX-101,Oncology,High Dose,2023-09-30,2023-11-25,7.76,8.39,90,72,71,Nausea,Mild,Improved,0
2353,PT-02353,41,F,Apollo Chennai,Phase II,ORX-606,Rheumatology,High Dose,2024-01-18,2024-01-25,6.61,3.92,134,88,100,None,None,No Change,0
2354,PT-02354,32,M,PGI Chandigarh,Phase II,ORX-101,Oncology,High Dose,2024-06-30,2024-07-14,6.16,3.34,122,92,69,Rash,Moderate,Improved,1
2355,PT-02355,79,F,Fortis Mumbai,Phase II,ORX-404,Neurology,Placebo,2024-02-26,2024-03-11,6.89,6.62,103,85,50,None,None,No Change,0
2356,PT-02356,56,M,Bhopal Research Hospital,Phase III,ORX-202,Diabetes,High Dose,2023-09-09,2023-10-07,8.07,8.89,109,83,85,Nausea,None,Improved,0
2357,PT-02357,52,M,NIMHANS Bengaluru,Phase III,ORX-404,Neurology,Placebo,2024-03-30,2024-04-06,6.16,3.61,134,80,70,None,None,Improved,1
2358,PT-02358,57,F,PGI Chandigarh,Phase IV,ORX-101,Oncology,High Dose,2024-01-05,2024-03-01,7.15,5.56,93,68,111,None,None,Improved,1
2359,PT-02359,56,F,Indore Medical Institute,Phase III,ORX-606,Rheumatology,Placebo,2023-03-18,2023-03-25,7.43,6.86,123,96,71,None,None,No Change,0
2360,PT-02360,54,M,Apollo Chennai,Phase II,ORX-505,Infectious Disease,Low Dose,2023-05-18,2023-06-01,6.78,8.13,141,96,69,None,None,Improved,0
2361,PT-02361,61,M,Apollo Chennai,Phase IV,ORX-404,Neurology,High Dose,2023-02-17,2023-04-14,6.82,6.52,157,69,80,Dizziness,None,Worsened,0
2362,PT-02362,52,F,PGI Chandigarh,Phase III,ORX-404,Neurology,Placebo,2023-04-24,2023-06-19,7.82,7.02,165,66,98,None,None,No Change,0
2363,PT-02363,64,F,NIMHANS Bengaluru,Phase IV,ORX-303,Cardiology,Placebo,2024-06-22,2024-07-20,9.48,7.65,112,99,51,Nausea,None,Improved,1
2364,PT-02364,19,M,NIMHANS Bengaluru,Phase II,ORX-101,Oncology,Low Dose,2024-03-11,2024-03-25,6.61,6.39,156,79,69,Headache,None,Worsened,0
2365,PT-02365,49,M,Bhopal Research Hospital,Phase III,ORX-101,Oncology,Low Dose,2024-09-24,2024-10-22,7.76,7.76,124,58,65,None,None,Improved,1
2366,PT-02366,67,F,Apollo Chennai,Phase II,ORX-606,Rheumatology,Placebo,2023-12-24,2024-01-21,7.42,6.73,148,68,74,None,None,Worsened,0
2367,PT-02367,47,M,Kolkata Clinical Center,Phase III,ORX-404,Neurology,High Dose,2024-02-02,2024-05-02,6.67,6.36,124,65,80,Dizziness,Moderate,Improved,1
2368,PT-02368,23,M,Apollo Chennai,Phase III,ORX-303,Cardiology,Low Dose,2023-07-04,2023-10-02,7.4,8.24,122,67,76,Rash,Moderate,Worsened,0
2369,PT-02369,31,M,PGI Chandigarh,Phase III,ORX-101,Oncology,Low Dose,2024-03-27,2024-04-03,7.91,7.38,158,95,75,Rash,None,Worsened,0
2370,PT-02370,56,M,AIIMS Delhi,Phase II,ORX-101,Oncology,High Dose,2023-10-21,2024-01-19,6.73,6.36,121,91,98,None,None,Improved,1
2371,PT-02371,57,F,Kolkata Clinical Center,Phase I,ORX-202,Diabetes,Placebo,2023-12-20,2024-02-14,8.31,8.74,137,68,101,Rash,None,No Change,0
2372,PT-02372,73,F,Kolkata Clinical Center,Phase III,ORX-505,Infectious Disease,High Dose,2023-01-12,2023-01-26,6.92,6.19,139,88,75,None,None,Improved,1
2373,PT-02373,24,F,NIMHANS Bengaluru,Phase III,ORX-202,Diabetes,Low Dose,2024-08-04,2024-08-11,7.57,7.66,141,86,74,None,None,Improved,0
2374,PT-02374,60,M,Fortis Mumbai,Phase III,ORX-101,Oncology,High Dose,2023-01-04,2023-04-04,7.28,6.46,124,61,75,None,None,Improved,1
2375,PT-02375,56,F,PGI Chandigarh,Phase III,ORX-404,Neurology,High Dose,2023-10-02,2023-10-16,7.61,8.58,123,87,89,Headache,None,Improved,0
2376,PT-02376,82,M,Indore Medical Institute,Phase III,ORX-505,Infectious Disease,High Dose,2024-05-03,2024-08-01,7.37,6.03,143,104,73,Headache,None,Improved,1
2377,PT-02377,58,F,NIMHANS Bengaluru,Phase III,ORX-606,Rheumatology,Placebo,2023-08-16,2023-10-11,8.67,9.19,130,73,76,Fatigue,None,Improved,0
2378,PT-02378,52,M,NIMHANS Bengaluru,Phase III,ORX-606,Rheumatology,Low Dose,2024-07-09,2024-09-03,8.29,8.19,121,88,90,Fever,None,No Change,0
2379,PT-02379,51,F,NIMHANS Bengaluru,Phase II,ORX-404,Neurology,Placebo,2024-02-02,2024-02-16,6.2,5.63,145,65,48,Dizziness,Moderate,Improved,1
2380,PT-02380,69,M,Fortis Mumbai,Phase II,ORX-606,Rheumatology,Placebo,2024-01-17,2024-04-16,7.81,7.96,108,90,81,Nausea,Moderate,No Change,0
2381,PT-02381,19,M,AIIMS Delhi,Phase III,ORX-505,Infectious Disease,High Dose,2023-01-12,2023-04-12,8.91,8.65,120,77,49,None,None,Improved,1
2382,PT-02382,54,F,NIMHANS Bengaluru,Phase III,ORX-101,Oncology,Placebo,2023-08-30,2023-09-27,7.51,6.94,151,65,69,Fatigue,None,Improved,1
2383,PT-02383,31,M,Apollo Chennai,Phase II,ORX-404,Neurology,Placebo,2024-03-11,2024-06-09,6.87,6.53,135,77,65,None,None,Improved,1
2384,PT-02384,71,F,Kolkata Clinical Center,Phase III,ORX-606,Rheumatology,Placebo,2024-02-19,2024-04-15,10.09,9.82,114,99,57,Fatigue,None,No Change,0
2385,PT-02385,39,M,AIIMS Delhi,Phase II,ORX-404,Neurology,Low Dose,2024-05-01,2024-07-30,6.36,4.92,122,71,78,Headache,Mild,No Change,0
2386,PT-02386,45,F,NIMHANS Bengaluru,Phase III,ORX-303,Cardiology,Placebo,2023-12-04,2024-03-03,6.45,5.72,123,91,75,None,None,No Change,0
2387,PT-02387,58,F,NIMHANS Bengaluru,Phase III,ORX-202,Diabetes,Low Dose,2023-06-23,2023-09-21,7.9,8.02,152,68,71,Fatigue,None,No Change,0
2388,PT-02388,73,F,Indore Medical Institute,Phase IV,ORX-606,Rheumatology,High Dose,2024-10-14,2024-11-11,6.89,3.96,124,83,45,Rash,Mild,No Change,0
2389,PT-02389,66,M,Bhopal Research Hospital,Phase I,ORX-606,Rheumatology,Low Dose,2023-09-26,2023-12-25,6.34,6.24,123,66,63,Headache,None,Improved,1
2390,PT-02390,30,F,Kolkata Clinical Center,Phase III,ORX-101,Oncology,Low Dose,2023-07-30,2023-08-13,8.5,7.97,118,70,94,Headache,None,No Change,0
2391,PT-02391,68,M,Indore Medical Institute,Phase III,ORX-404,Neurology,Placebo,2024-08-17,2024-11-15,8.62,8.66,133,67,74,Rash,Moderate,Improved,0
2392,PT-02392,34,M,AIIMS Delhi,Phase III,ORX-404,Neurology,Placebo,2023-06-07,2023-08-02,5.01,5.56,115,96,90,Fever,Mild,No Change,0
2393,PT-02393,53,M,Kolkata Clinical Center,Phase III,ORX-606,Rheumatology,High Dose,2023-01-07,2023-04-07,7.94,6.98,161,82,82,Rash,Mild,Improved,1
2394,PT-02394,34,M,Fortis Mumbai,Phase III,ORX-202,Diabetes,Placebo,2024-08-28,2024-11-26,6.08,6.11,131,72,57,Nausea,Severe,No Change,0
2395,PT-02395,24,M,Apollo Chennai,Phase III,ORX-303,Cardiology,Low Dose,2024-10-17,2025-01-15,8.64,7.68,121,99,62,None,None,No Change,0
2396,PT-02396,33,F,NIMHANS Bengaluru,Phase III,ORX-404,Neurology,Placebo,2024-01-25,2024-04-24,6.28,7.33,163,91,88,Nausea,Moderate,Improved,0
2397,PT-02397,35,F,PGI Chandigarh,Phase II,ORX-303,Cardiology,High Dose,2024-06-27,2024-07-11,9.54,9.38,143,80,74,None,None,Worsened,0
2398,PT-02398,71,F,Apollo Chennai,Phase III,ORX-101,Oncology,High Dose,2024-11-25,2024-12-02,7.85,8.75,132,71,69,None,None,Improved,0
2399,PT-02399,46,F,Indore Medical Institute,Phase III,ORX-404,Neurology,Low Dose,2024-10-18,2024-11-15,6.45,5.05,149,75,79,Headache,None,No Change,0
2400,PT-02400,49,M,Fortis Mumbai,Phase I,ORX-505,Infectious Disease,High Dose,2024-11-04,2024-11-18,6.49,7.4,107,85,81,Nausea,None,Worsened,0
2401,PT-02401,44,M,Kolkata Clinical Center,Phase II,ORX-101,Oncology,Placebo,2023-02-25,2023-05-26,5.64,6.03,141,73,87,None,None,Worsened,0
2402,PT-02402,50,F,Indore Medical Institute,Phase I,ORX-202,Diabetes,Placebo,2024-10-06,2025-01-04,5.66,4.49,148,85,70,Nausea,Moderate,Improved,1
2403,PT-02403,31,M,NIMHANS Bengaluru,Phase III,ORX-202,Diabetes,Low Dose,2024-09-07,2024-11-02,6.58,5.78,112,61,93,Nausea,Mild,No Change,0
2404,PT-02404,60,F,PGI Chandigarh,Phase III,ORX-101,Oncology,High Dose,2023-01-20,2023-03-17,5.67,5.39,111,78,73,None,None,Improved,1
2405,PT-02405,38,F,AIIMS Delhi,Phase IV,ORX-606,Rheumatology,Low Dose,2024-10-08,2024-11-05,9.6,8.81,113,72,92,None,None,Improved,1
2406,PT-02406,18,M,Bhopal Research Hospital,Phase III,ORX-606,Rheumatology,Low Dose,2024-01-30,2024-02-06,6.28,7.19,132,84,107,None,None,Improved,0
2407,PT-02407,48,F,Indore Medical Institute,Phase I,ORX-505,Infectious Disease,Placebo,2023-01-18,2023-02-01,6.35,5.7,107,97,86,None,None,No Change,0
2408,PT-02408,62,M,NIMHANS Bengaluru,Phase IV,ORX-202,Diabetes,High Dose,2023-09-28,2023-10-26,8.66,7.88,110,81,65,None,None,Improved,1
2409,PT-02409,47,F,AIIMS Delhi,Phase III,ORX-606,Rheumatology,Placebo,2024-06-18,2024-08-13,8.56,8.01,130,80,89,None,None,Worsened,0
2410,PT-02410,34,M,Fortis Mumbai,Phase III,ORX-606,Rheumatology,High Dose,2023-05-27,2023-06-24,4.56,4.59,145,87,69,Fatigue,None,Improved,0
2411,PT-02411,26,M,AIIMS Delhi,Phase III,ORX-202,Diabetes,Low Dose,2023-09-12,2023-09-19,7.79,7.52,125,103,64,Fatigue,Mild,Improved,1
2412,PT-02412,73,F,Indore Medical Institute,Phase III,ORX-202,Diabetes,Low Dose,2024-10-26,2024-12-21,7.24,5.19,124,93,72,Fatigue,None,Improved,1
2413,PT-02413,21,F,Fortis Mumbai,Phase II,ORX-101,Oncology,Low Dose,2023-08-16,2023-10-11,7.0,5.83,136,91,63,Headache,Mild,Improved,1
2414,PT-02414,33,F,Fortis Mumbai,Phase III,ORX-606,Rheumatology,Placebo,2023-09-06,2023-11-01,8.11,6.94,108,67,82,None,None,No Change,0
2415,PT-02415,49,M,Kolkata Clinical Center,Phase I,ORX-404,Neurology,Placebo,2024-01-14,2024-02-11,6.38,5.98,155,70,50,None,None,Worsened,0
2416,PT-02416,52,M,AIIMS Delhi,Phase IV,ORX-202,Diabetes,Low Dose,2024-01-26,2024-03-22,7.07,6.03,139,92,47,Nausea,Mild,No Change,0
2417,PT-02417,34,F,Bhopal Research Hospital,Phase II,ORX-202,Diabetes,Low Dose,2023-11-14,2024-02-12,9.98,10.11,140,96,78,Fever,Moderate,No Change,0
2418,PT-02418,57,M,Indore Medical Institute,Phase I,ORX-303,Cardiology,Placebo,2024-06-21,2024-08-16,8.06,8.15,122,84,69,Fever,Mild,Improved,0
2419,PT-02419,45,M,NIMHANS Bengaluru,Phase I,ORX-404,Neurology,Placebo,2024-04-09,2024-07-08,5.8,4.69,122,70,70,None,None,No Change,0
2420,PT-02420,42,F,AIIMS Delhi,Phase II,ORX-505,Infectious Disease,High Dose,2024-09-09,2024-12-08,7.68,8.14,119,98,91,None,None,Improved,0
2421,PT-02421,53,F,NIMHANS Bengaluru,Phase IV,ORX-505,Infectious Disease,Low Dose,2024-05-22,2024-07-17,7.38,7.27,149,96,96,None,None,No Change,0
2422,PT-02422,45,F,Bhopal Research Hospital,Phase I,ORX-202,Diabetes,Placebo,2023-06-26,2023-07-03,7.87,,116,78,78,Fatigue,None,Improved,0
2423,PT-02423,59,M,Apollo Chennai,Phase I,ORX-505,Infectious Disease,Low Dose,2023-07-14,2023-10-12,8.3,7.69,100,84,65,Fever,None,Improved,1
2424,PT-02424,21,M,Bhopal Research Hospital,Phase I,ORX-303,Cardiology,Placebo,2024-10-30,2024-12-25,5.68,5.58,152,82,80,None,None,Worsened,0
2425,PT-02425,63,M,Fortis Mumbai,Phase IV,ORX-606,Rheumatology,High Dose,2023-08-21,2023-08-28,5.35,5.41,127,88,71,Headache,Mild,Worsened,0
2426,PT-02426,31,M,Indore Medical Institute,Phase II,ORX-202,Diabetes,Low Dose,2024-08-11,2024-10-06,7.37,8.45,143,75,59,Fatigue,Moderate,Improved,0
2427,PT-02427,18,F,NIMHANS Bengaluru,Phase I,ORX-606,Rheumatology,Low Dose,2024-11-18,2025-01-13,8.78,7.52,122,97,55,Headache,Mild,Improved,1
2428,PT-02428,68,M,Indore Medical Institute,Phase II,ORX-303,Cardiology,Low Dose,2024-10-26,2024-11-09,6.9,5.46,123,73,84,None,None,Improved,1
2429,PT-02429,34,F,Indore Medical Institute,Phase III,ORX-505,Infectious Disease,High Dose,2024-03-12,2024-05-07,4.91,4.31,103,84,61,Rash,Mild,No Change,0
2430,PT-02430,37,F,NIMHANS Bengaluru,Phase III,ORX-202,Diabetes,High Dose,2024-08-05,2024-11-03,7.42,6.83,132,90,61,Fever,None,Worsened,0
2431,PT-02431,43,F,AIIMS Delhi,Phase III,ORX-101,Oncology,Placebo,2024-11-05,2024-12-03,3.5,3.32,122,70,82,Dizziness,None,Improved,1
2432,PT-02432,63,F,NIMHANS Bengaluru,Phase III,ORX-505,Infectious Disease,Low Dose,2024-05-06,2024-05-20,6.63,5.38,130,65,68,Nausea,Mild,No Change,0
2433,PT-02433,64,F,Indore Medical Institute,Phase III,ORX-303,Cardiology,Placebo,2023-11-11,2024-01-06,7.27,5.18,95,83,90,Headache,None,Improved,1
2434,PT-02434,19,M,Kolkata Clinical Center,Phase III,ORX-606,Rheumatology,Low Dose,2024-02-19,2024-02-26,7.74,8.54,161,85,85,None,None,Improved,0
2435,PT-02435,18,F,AIIMS Delhi,Phase II,ORX-101,Oncology,Low Dose,2023-12-25,2024-01-01,9.72,8.8,111,78,99,None,None,Improved,1
2436,PT-02436,80,M,AIIMS Delhi,Phase IV,ORX-606,Rheumatology,Low Dose,2024-09-28,2024-12-27,7.35,7.85,128,69,98,None,None,No Change,0
2437,PT-02437,35,M,Apollo Chennai,Phase III,ORX-202,Diabetes,Low Dose,2023-07-14,2023-08-11,9.04,9.81,139,103,109,Rash,Moderate,No Change,0
2438,PT-02438,42,F,Kolkata Clinical Center,Phase II,ORX-303,Cardiology,Low Dose,2023-01-01,2023-01-29,6.23,4.15,168,76,93,None,None,Improved,1
2439,PT-02439,33,F,Apollo Chennai,Phase IV,ORX-303,Cardiology,High Dose,2023-01-06,2023-03-03,9.05,8.02,106,79,70,None,None,Improved,1
2440,PT-02440,54,M,Indore Medical Institute,Phase III,ORX-606,Rheumatology,Low Dose,2024-01-01,2024-01-08,7.14,7.3,122,74,69,None,None,Improved,0
2441,PT-02441,77,M,PGI Chandigarh,Phase IV,ORX-101,Oncology,Placebo,2024-01-28,2024-02-11,7.47,5.28,118,83,103,None,None,Worsened,0
2442,PT-02442,61,M,PGI Chandigarh,Phase III,ORX-505,Infectious Disease,Placebo,2023-12-21,2024-03-20,6.09,7.87,127,96,61,Headache,Moderate,No Change,0
2443,PT-02443,18,F,Kolkata Clinical Center,Phase IV,ORX-303,Cardiology,Placebo,2024-09-26,2024-11-21,5.51,2.18,166,84,65,None,None,No Change,0
2444,PT-02444,52,M,Indore Medical Institute,Phase IV,ORX-606,Rheumatology,Low Dose,2024-04-29,2024-05-06,7.43,7.59,149,78,65,None,None,Improved,0
2445,PT-02445,58,M,Indore Medical Institute,Phase IV,ORX-606,Rheumatology,Low Dose,2023-11-16,2023-11-23,8.16,7.85,167,76,65,Fever,Severe,Improved,1
2446,PT-02446,51,M,AIIMS Delhi,Phase III,ORX-202,Diabetes,Placebo,2024-07-06,2024-07-13,6.39,6.44,113,77,104,Nausea,None,No Change,0
2447,PT-02447,38,M,Indore Medical Institute,Phase III,ORX-202,Diabetes,Low Dose,2024-07-11,2024-10-09,6.24,6.89,109,73,86,Dizziness,Mild,Improved,0
2448,PT-02448,60,M,Indore Medical Institute,Phase III,ORX-202,Diabetes,Low Dose,2023-06-11,2023-09-09,8.66,7.59,138,76,69,None,None,No Change,0
2449,PT-02449,64,F,NIMHANS Bengaluru,Phase II,ORX-606,Rheumatology,Low Dose,2023-07-28,2023-08-11,6.54,6.39,130,69,91,None,None,Improved,1
2450,PT-02450,53,M,Apollo Chennai,Phase I,ORX-505,Infectious Disease,High Dose,2023-11-04,2023-12-02,4.82,4.67,114,95,57,None,None,Worsened,0
2451,PT-02451,39,M,NIMHANS Bengaluru,Phase III,ORX-404,Neurology,Placebo,2024-09-11,2024-12-10,7.63,7.28,141,63,101,Fever,Mild,Improved,1
2452,PT-02452,53,M,Bhopal Research Hospital,Phase IV,ORX-505,Infectious Disease,High Dose,2023-04-05,2023-07-04,8.83,9.22,127,66,70,Rash,Mild,No Change,0
2453,PT-02453,70,F,Bhopal Research Hospital,Phase IV,ORX-101,Oncology,Placebo,2023-05-29,2023-07-24,8.86,7.9,90,79,73,None,None,Improved,1
2454,PT-02454,41,F,Indore Medical Institute,Phase III,ORX-303,Cardiology,Placebo,2024-02-13,2024-02-27,7.83,8.22,145,87,52,None,None,Improved,0
2455,PT-02455,39,F,Kolkata Clinical Center,Phase I,ORX-606,Rheumatology,High Dose,2023-06-12,2023-06-26,9.96,9.9,134,86,83,None,None,Improved,1
2456,PT-02456,18,F,Kolkata Clinical Center,Phase III,ORX-404,Neurology,High Dose,2024-01-08,2024-02-05,6.91,6.48,151,82,54,Headache,Severe,Improved,1
2457,PT-02457,51,M,AIIMS Delhi,Phase IV,ORX-606,Rheumatology,High Dose,2023-03-23,2023-05-18,6.24,4.74,112,88,95,None,None,No Change,0
2458,PT-02458,52,M,PGI Chandigarh,Phase III,ORX-606,Rheumatology,Placebo,2023-10-06,2023-12-01,7.96,7.98,129,90,45,None,None,Worsened,0
2459,PT-02459,46,F,AIIMS Delhi,Phase IV,ORX-404,Neurology,Placebo,2023-12-01,2024-02-29,5.95,6.59,125,82,56,None,None,Improved,0
2460,PT-02460,61,M,AIIMS Delhi,Phase IV,ORX-606,Rheumatology,Low Dose,2024-07-01,2024-07-29,7.95,8.05,113,72,81,None,None,Improved,0
2461,PT-02461,33,F,NIMHANS Bengaluru,Phase I,ORX-505,Infectious Disease,Low Dose,2023-12-05,2023-12-12,7.72,5.38,119,103,84,None,None,Improved,1
2462,PT-02462,47,F,Indore Medical Institute,Phase II,ORX-303,Cardiology,Placebo,2024-06-27,2024-07-04,9.58,7.08,113,77,90,None,None,No Change,0
2463,PT-02463,59,M,Bhopal Research Hospital,Phase III,ORX-101,Oncology,High Dose,2024-08-23,2024-08-30,6.16,6.66,120,96,63,Fever,None,No Change,0
2464,PT-02464,43,M,AIIMS Delhi,Phase III,ORX-303,Cardiology,Placebo,2024-09-14,2024-10-12,6.61,7.16,118,81,85,Headache,Mild,Improved,0
2465,PT-02465,53,F,Kolkata Clinical Center,Phase III,ORX-606,Rheumatology,Low Dose,2023-08-25,2023-09-01,8.26,8.05,120,77,78,Rash,Severe,No Change,0
2466,PT-02466,48,M,NIMHANS Bengaluru,Phase I,ORX-101,Oncology,Placebo,2024-04-19,2024-05-17,7.02,6.64,100,90,80,Dizziness,Moderate,Worsened,0
2467,PT-02467,61,F,Fortis Mumbai,Phase II,ORX-606,Rheumatology,Low Dose,2023-05-21,2023-05-28,7.2,5.24,121,79,88,Headache,Severe,Improved,1
2468,PT-02468,18,F,PGI Chandigarh,Phase III,ORX-202,Diabetes,Low Dose,2023-05-08,2023-08-06,7.25,7.31,116,82,69,Nausea,Mild,Improved,0
2469,PT-02469,33,F,PGI Chandigarh,Phase II,ORX-505,Infectious Disease,Placebo,2023-10-17,2023-11-14,6.71,5.67,140,73,65,None,None,Improved,1
2470,PT-02470,73,M,PGI Chandigarh,Phase III,ORX-202,Diabetes,Placebo,2024-09-23,2024-11-18,8.35,6.28,114,84,82,Headache,None,Improved,1
2471,PT-02471,21,M,NIMHANS Bengaluru,Phase IV,ORX-101,Oncology,High Dose,2023-05-23,2023-06-20,8.59,8.93,136,98,84,None,None,Improved,0
2472,PT-02472,52,M,AIIMS Delhi,Phase II,ORX-404,Neurology,High Dose,2024-02-20,2024-02-27,9.07,9.66,112,89,68,None,None,Improved,0
2473,PT-02473,53,M,PGI Chandigarh,Phase II,ORX-101,Oncology,Placebo,2023-07-23,2023-07-30,7.77,6.13,125,85,71,None,None,Improved,1
2474,PT-02474,50,M,Bhopal Research Hospital,Phase III,ORX-303,Cardiology,Low Dose,2023-12-22,2024-03-21,8.17,7.74,132,98,84,None,None,Improved,1
2475,PT-02475,48,M,Fortis Mumbai,Phase II,ORX-101,Oncology,Placebo,2024-08-27,2024-09-24,6.05,6.25,133,97,78,Nausea,None,Improved,0
2476,PT-02476,18,F,PGI Chandigarh,Phase IV,ORX-202,Diabetes,Placebo,2023-11-24,2024-01-19,5.16,5.42,117,87,79,None,None,No Change,0
2477,PT-02477,42,F,Bhopal Research Hospital,Phase I,ORX-606,Rheumatology,High Dose,2024-10-14,2025-01-12,7.08,5.91,127,74,72,None,None,Improved,1
2478,PT-02478,39,F,NIMHANS Bengaluru,Phase III,ORX-505,Infectious Disease,Placebo,2023-12-05,2024-01-30,6.93,7.36,125,94,99,Nausea,None,Worsened,0
2479,PT-02479,58,F,Kolkata Clinical Center,Phase III,ORX-303,Cardiology,Low Dose,2024-07-26,2024-09-20,7.84,7.74,143,83,91,Dizziness,None,Improved,1
2480,PT-02480,54,F,AIIMS Delhi,Phase I,ORX-202,Diabetes,High Dose,2024-05-04,2024-06-29,6.77,7.17,129,80,71,None,None,No Change,0
2481,PT-02481,47,F,Indore Medical Institute,Phase II,ORX-606,Rheumatology,Placebo,2023-07-10,2023-07-24,8.4,8.8,134,89,95,None,None,Improved,0
2482,PT-02482,42,F,Apollo Chennai,Phase II,ORX-202,Diabetes,High Dose,2024-09-10,2024-11-05,5.86,6.63,118,73,52,Headache,None,Improved,0
2483,PT-02483,54,F,Indore Medical Institute,Phase II,ORX-202,Diabetes,High Dose,2023-05-17,2023-06-14,5.25,4.18,138,90,68,None,None,Improved,1
2484,PT-02484,42,F,Kolkata Clinical Center,Phase IV,ORX-404,Neurology,Low Dose,2024-08-30,2024-09-13,6.15,5.26,132,75,74,None,None,Improved,1
2485,PT-02485,21,M,AIIMS Delhi,Phase III,ORX-202,Diabetes,High Dose,2023-12-13,2023-12-27,8.56,8.62,142,97,66,None,None,Improved,0
2486,PT-02486,39,M,Bhopal Research Hospital,Phase I,ORX-303,Cardiology,High Dose,2023-01-01,2023-01-08,4.93,7.35,125,94,60,None,None,Improved,0
2487,PT-02487,60,M,Fortis Mumbai,Phase III,ORX-202,Diabetes,Placebo,2023-11-01,2023-12-27,9.43,8.97,109,80,46,Nausea,None,No Change,0
2488,PT-02488,44,M,Kolkata Clinical Center,Phase III,ORX-303,Cardiology,High Dose,2023-03-28,2023-04-25,8.19,7.75,122,88,86,Headache,None,No Change,0
2489,PT-02489,18,F,Kolkata Clinical Center,Phase I,ORX-303,Cardiology,Low Dose,2024-09-15,2024-12-14,7.31,9.1,103,80,105,Nausea,None,Improved,0
2490,PT-02490,62,M,NIMHANS Bengaluru,Phase I,ORX-303,Cardiology,High Dose,2023-08-07,2023-08-21,6.58,6.37,127,73,76,Headache,Severe,Improved,1
2491,PT-02491,40,M,Kolkata Clinical Center,Phase IV,ORX-404,Neurology,Low Dose,2023-08-12,2023-08-26,7.34,6.26,105,81,102,None,None,Worsened,0
2492,PT-02492,46,M,NIMHANS Bengaluru,Phase IV,ORX-303,Cardiology,High Dose,2023-01-29,2023-03-26,6.8,7.08,125,104,77,Nausea,None,Improved,0
2493,PT-02493,56,F,PGI Chandigarh,Phase III,ORX-505,Infectious Disease,Low Dose,2024-09-30,2024-12-29,6.29,6.35,132,81,70,None,None,No Change,0
2494,PT-02494,34,F,Indore Medical Institute,Phase I,ORX-606,Rheumatology,Low Dose,2023-11-01,2023-11-08,7.54,7.7,125,85,77,None,None,Improved,0
2495,PT-02495,46,M,NIMHANS Bengaluru,Phase III,ORX-404,Neurology,High Dose,2024-01-11,2024-04-10,6.96,6.58,176,85,87,None,None,Improved,1
2496,PT-02496,52,M,Indore Medical Institute,Phase II,ORX-404,Neurology,High Dose,2023-01-15,2023-01-22,6.88,7.65,122,94,73,None,None,Improved,0
2497,PT-02497,29,F,NIMHANS Bengaluru,Phase III,ORX-303,Cardiology,High Dose,2023-03-14,2023-04-11,7.64,6.24,137,67,73,None,None,No Change,0
2498,PT-02498,22,F,Apollo Chennai,Phase III,ORX-101,Oncology,Low Dose,2023-08-11,2023-11-09,10.59,8.7,128,95,92,Nausea,None,No Change,0
2499,PT-02499,58,F,Bhopal Research Hospital,Phase III,ORX-303,Cardiology,Low Dose,2024-06-02,2024-07-28,6.82,7.64,144,84,81,Headache,Moderate,Improved,0
2500,PT-02500,40,F,Fortis Mumbai,Phase I,ORX-505,Infectious Disease,High Dose,2024-11-08,2024-11-22,6.11,6.82,151,71,75,None,None,Improved,0
2501,PT-02501,42,F,AIIMS Delhi,Phase II,ORX-202,Diabetes,High Dose,2024-08-27,2024-09-24,7.16,6.82,145,73,66,None,None,Worsened,0
2502,PT-02502,64,M,Bhopal Research Hospital,Phase II,ORX-606,Rheumatology,High Dose,2023-04-17,2023-05-15,6.64,5.11,119,78,99,Nausea,None,No Change,0
2503,PT-02503,59,F,Bhopal Research Hospital,Phase I,ORX-202,Diabetes,High Dose,2024-03-23,2024-04-06,8.58,8.92,145,73,75,None,None,Improved,0
2504,PT-02504,29,F,Fortis Mumbai,Phase IV,ORX-202,Diabetes,High Dose,2024-10-14,2024-10-28,6.95,7.16,130,97,62,Headache,Mild,Improved,0
2505,PT-02505,53,F,AIIMS Delhi,Phase I,ORX-202,Diabetes,Placebo,2024-06-22,2024-09-20,5.7,5.39,141,79,85,None,None,No Change,0
2506,PT-02506,29,F,Indore Medical Institute,Phase I,ORX-404,Neurology,High Dose,2023-07-24,2023-08-21,5.2,5.3,159,70,95,None,None,No Change,0
2507,PT-02507,45,F,Fortis Mumbai,Phase III,ORX-404,Neurology,Placebo,2024-11-26,2024-12-24,5.6,4.18,128,77,59,Headache,Mild,Improved,1
2508,PT-02508,18,F,Apollo Chennai,Phase II,ORX-101,Oncology,High Dose,2024-03-31,2024-04-14,6.18,5.96,127,75,80,Rash,None,Improved,1
2509,PT-02509,61,M,AIIMS Delhi,Phase III,ORX-404,Neurology,Placebo,2024-02-15,2024-02-29,7.67,7.16,144,70,74,None,None,Improved,1
2510,PT-02510,41,F,Kolkata Clinical Center,Phase IV,ORX-606,Rheumatology,Low Dose,2023-10-12,2023-11-09,5.72,4.94,90,104,64,Dizziness,Moderate,Improved,1
2511,PT-02511,70,F,PGI Chandigarh,Phase II,ORX-404,Neurology,Low Dose,2023-06-26,2023-07-24,7.25,7.35,119,84,87,None,None,Improved,0
2512,PT-02512,55,M,Kolkata Clinical Center,Phase I,ORX-303,Cardiology,Low Dose,2024-02-29,2024-05-29,8.13,7.4,119,62,85,None,None,Worsened,0
2513,PT-02513,62,M,NIMHANS Bengaluru,Phase II,ORX-404,Neurology,Low Dose,2023-11-29,2023-12-06,9.14,9.01,114,61,92,Fatigue,Moderate,Improved,1
2514,PT-02514,18,F,Kolkata Clinical Center,Phase I,ORX-303,Cardiology,Placebo,2023-07-26,2023-08-09,6.79,6.19,126,82,79,Fatigue,Severe,Improved,1
2515,PT-02515,18,M,Apollo Chennai,Phase III,ORX-303,Cardiology,High Dose,2023-02-12,2023-02-19,7.22,4.81,141,75,47,Dizziness,None,Improved,1
2516,PT-02516,31,M,Fortis Mumbai,Phase IV,ORX-303,Cardiology,Placebo,2023-08-06,2023-11-04,6.52,7.19,131,86,94,None,None,No Change,0
2517,PT-02517,43,M,PGI Chandigarh,Phase III,ORX-606,Rheumatology,Placebo,2024-09-18,2024-12-17,8.11,8.32,104,99,58,Fever,Mild,Improved,0
2518,PT-02518,59,F,Apollo Chennai,Phase III,ORX-303,Cardiology,High Dose,2023-01-13,2023-04-13,5.38,5.52,161,79,74,Nausea,Moderate,No Change,0
2519,PT-02519,54,F,Kolkata Clinical Center,Phase III,ORX-202,Diabetes,High Dose,2023-12-11,2023-12-25,6.8,8.04,131,78,70,None,None,No Change,0
2520,PT-02520,30,F,Fortis Mumbai,Phase II,ORX-505,Infectious Disease,Placebo,2023-11-22,2023-11-29,6.45,5.73,119,74,107,None,None,Improved,1
2521,PT-02521,28,F,Kolkata Clinical Center,Phase III,ORX-303,Cardiology,High Dose,2023-01-15,2023-04-15,7.38,7.51,139,81,74,Nausea,Severe,Improved,0
2522,PT-02522,52,F,PGI Chandigarh,Phase III,ORX-505,Infectious Disease,High Dose,2024-07-15,2024-07-22,7.52,6.89,99,76,61,Fever,None,Improved,1
2523,PT-02523,34,F,Indore Medical Institute,Phase II,ORX-202,Diabetes,High Dose,2023-12-29,2024-03-28,7.24,7.16,160,75,88,Headache,None,No Change,0
2524,PT-02524,49,F,Indore Medical Institute,Phase III,ORX-404,Neurology,Placebo,2023-11-16,2023-11-30,8.76,8.87,109,61,82,None,None,Improved,0
2525,PT-02525,36,F,Kolkata Clinical Center,Phase III,ORX-303,Cardiology,Low Dose,2024-04-16,2024-05-14,6.02,4.48,130,100,72,Dizziness,None,No Change,0
2526,PT-02526,54,F,NIMHANS Bengaluru,Phase I,ORX-606,Rheumatology,Placebo,2024-06-19,2024-07-03,7.08,5.52,141,68,78,None,None,Improved,1
2527,PT-02527,39,M,PGI Chandigarh,Phase III,ORX-606,Rheumatology,Low Dose,2024-02-10,2024-05-10,8.27,6.92,135,71,70,None,None,No Change,0
2528,PT-02528,18,F,Apollo Chennai,Phase II,ORX-202,Diabetes,High Dose,2024-03-15,2024-03-22,9.71,9.81,114,68,71,None,None,No Change,0
2529,PT-02529,56,F,Fortis Mumbai,Phase III,ORX-202,Diabetes,Low Dose,2024-05-07,2024-06-04,4.93,4.4,159,68,79,None,None,Worsened,0
2530,PT-02530,80,F,Indore Medical Institute,Phase II,ORX-404,Neurology,Low Dose,2024-08-27,2024-09-10,7.96,7.67,137,77,96,Nausea,Mild,No Change,0
2531,PT-02531,38,F,Bhopal Research Hospital,Phase I,ORX-404,Neurology,Low Dose,2023-06-03,2023-07-01,4.85,4.1,110,78,74,Fatigue,Moderate,No Change,0
2532,PT-02532,64,F,NIMHANS Bengaluru,Phase III,ORX-505,Infectious Disease,Low Dose,2023-01-24,2023-03-21,8.03,7.87,127,69,47,None,None,Worsened,0
2533,PT-02533,46,F,Apollo Chennai,Phase III,ORX-606,Rheumatology,Low Dose,2024-04-06,2024-07-05,8.15,7.66,118,87,76,Nausea,Severe,Improved,1
2534,PT-02534,71,M,Indore Medical Institute,Phase II,ORX-101,Oncology,High Dose,2024-03-14,2024-04-11,8.68,9.14,141,66,87,Fatigue,Mild,No Change,0
2535,PT-02535,51,F,Fortis Mumbai,Phase I,ORX-404,Neurology,High Dose,2024-08-17,2024-09-14,7.93,7.97,136,114,76,None,None,No Change,0
2536,PT-02536,59,F,PGI Chandigarh,Phase III,ORX-303,Cardiology,Placebo,2024-06-21,2024-06-28,6.63,6.95,144,86,101,Fatigue,None,Worsened,0
2537,PT-02537,30,M,Apollo Chennai,Phase III,ORX-404,Neurology,Low Dose,2023-12-28,2024-03-27,6.62,6.41,143,84,96,None,None,Improved,1
2538,PT-02538,34,M,Fortis Mumbai,Phase III,ORX-303,Cardiology,Low Dose,2024-09-15,2024-11-10,5.83,5.71,126,88,77,Rash,None,Improved,1
2539,PT-02539,39,F,Kolkata Clinical Center,Phase III,ORX-404,Neurology,Placebo,2023-01-24,2023-02-07,7.11,6.74,122,79,72,Headache,None,Worsened,0
2540,PT-02540,58,M,NIMHANS Bengaluru,Phase II,ORX-606,Rheumatology,Placebo,2023-04-28,2023-07-27,7.43,9.06,130,75,115,Rash,Mild,Improved,0
2541,PT-02541,51,M,NIMHANS Bengaluru,Phase II,ORX-606,Rheumatology,High Dose,2023-04-11,2023-07-10,8.39,8.52,139,88,62,Rash,None,No Change,0
2542,PT-02542,50,F,NIMHANS Bengaluru,Phase I,ORX-404,Neurology,High Dose,2024-09-02,2024-09-09,5.61,5.05,114,86,82,None,None,Worsened,0
2543,PT-02543,52,M,AIIMS Delhi,Phase II,ORX-505,Infectious Disease,Low Dose,2024-02-01,2024-05-01,7.54,6.6,123,93,92,None,None,No Change,0
2544,PT-02544,26,F,NIMHANS Bengaluru,Phase IV,ORX-606,Rheumatology,Low Dose,2024-04-10,2024-04-17,5.36,4.31,146,96,65,None,None,Improved,1
2545,PT-02545,49,F,Kolkata Clinical Center,Phase III,ORX-505,Infectious Disease,Low Dose,2024-06-15,2024-06-29,9.4,9.38,153,93,65,None,None,Worsened,0
2546,PT-02546,41,F,Indore Medical Institute,Phase III,ORX-404,Neurology,Low Dose,2023-04-14,2023-04-28,7.24,6.94,144,86,45,Nausea,Moderate,No Change,0
2547,PT-02547,23,M,PGI Chandigarh,Phase II,ORX-606,Rheumatology,Placebo,2023-11-22,2024-01-17,4.58,4.33,132,85,64,None,None,No Change,0
2548,PT-02548,55,M,Kolkata Clinical Center,Phase III,ORX-505,Infectious Disease,Low Dose,2023-08-16,2023-11-14,8.06,6.53,101,81,103,Rash,None,Improved,1
2549,PT-02549,72,F,Apollo Chennai,Phase II,ORX-101,Oncology,High Dose,2023-11-15,2023-11-22,7.88,6.82,143,76,67,None,None,Improved,1
2550,PT-02550,18,M,Bhopal Research Hospital,Phase III,ORX-202,Diabetes,High Dose,2024-10-25,2024-11-22,7.32,6.36,129,54,80,None,None,Worsened,0
2551,PT-02551,18,F,NIMHANS Bengaluru,Phase I,ORX-505,Infectious Disease,Low Dose,2023-02-08,2023-05-09,8.51,8.58,122,88,64,Fatigue,None,No Change,0
2552,PT-02552,46,F,AIIMS Delhi,Phase III,ORX-202,Diabetes,Low Dose,2023-11-06,2023-12-04,8.15,4.97,119,81,75,None,None,Improved,1
2553,PT-02553,68,F,Kolkata Clinical Center,Phase III,ORX-505,Infectious Disease,High Dose,2023-01-26,2023-02-09,5.85,4.89,93,100,74,None,None,No Change,0
2554,PT-02554,37,F,Indore Medical Institute,Phase IV,ORX-101,Oncology,Low Dose,2023-05-18,2023-08-16,7.14,7.31,134,113,84,None,None,Improved,0
2555,PT-02555,37,F,Apollo Chennai,Phase III,ORX-101,Oncology,Low Dose,2024-05-25,2024-06-22,6.53,5.77,100,82,88,Fatigue,Mild,Improved,1
2556,PT-02556,35,M,Apollo Chennai,Phase III,ORX-101,Oncology,Low Dose,2024-07-26,2024-08-09,6.23,7.2,102,57,61,None,None,No Change,0
2557,PT-02557,20,M,PGI Chandigarh,Phase II,ORX-606,Rheumatology,High Dose,2024-10-19,2024-11-02,7.66,6.94,124,95,68,None,None,Worsened,0
2558,PT-02558,57,M,NIMHANS Bengaluru,Phase II,ORX-606,Rheumatology,Low Dose,2024-07-17,2024-08-14,9.01,8.2,141,79,90,None,None,No Change,0
2559,PT-02559,19,M,NIMHANS Bengaluru,Phase III,ORX-101,Oncology,High Dose,2023-08-01,2023-08-29,5.23,4.47,111,75,74,None,None,Improved,1
2560,PT-02560,56,F,NIMHANS Bengaluru,Phase III,ORX-202,Diabetes,High Dose,2023-12-20,2024-03-19,6.71,5.57,121,72,64,None,None,Improved,1
2561,PT-02561,19,M,Kolkata Clinical Center,Phase IV,ORX-303,Cardiology,High Dose,2024-09-16,2024-09-23,7.28,6.37,145,64,70,None,None,Improved,1
2562,PT-02562,74,F,AIIMS Delhi,Phase I,ORX-202,Diabetes,Placebo,2024-11-11,2024-11-18,6.07,5.46,106,65,99,Nausea,Mild,Improved,1
2563,PT-02563,47,F,Bhopal Research Hospital,Phase IV,ORX-202,Diabetes,High Dose,2023-11-04,2023-12-02,7.36,5.43,134,95,94,None,None,No Change,0
2564,PT-02564,55,M,Fortis Mumbai,Phase III,ORX-505,Infectious Disease,Placebo,2024-05-13,2024-07-08,5.84,5.73,140,60,62,Headache,None,Improved,1
2565,PT-02565,59,M,Fortis Mumbai,Phase III,ORX-606,Rheumatology,Low Dose,2023-09-05,2023-09-19,8.25,6.46,142,83,88,None,None,No Change,0
2566,PT-02566,34,M,PGI Chandigarh,Phase III,ORX-606,Rheumatology,Placebo,2024-10-23,2025-01-21,7.97,8.33,121,82,68,Rash,None,Improved,0
2567,PT-02567,71,M,Kolkata Clinical Center,Phase III,ORX-404,Neurology,Placebo,2024-01-22,2024-03-18,7.06,5.83,115,83,88,Dizziness,None,Improved,1
2568,PT-02568,23,F,Apollo Chennai,Phase III,ORX-303,Cardiology,Placebo,2023-02-02,2023-02-16,9.42,9.29,136,80,78,Rash,None,No Change,0
2569,PT-02569,42,M,Indore Medical Institute,Phase II,ORX-101,Oncology,High Dose,2023-08-02,2023-09-27,8.42,8.01,141,76,80,Nausea,Moderate,Worsened,0
2570,PT-02570,32,F,Indore Medical Institute,Phase II,ORX-101,Oncology,Low Dose,2024-04-08,2024-07-07,8.66,7.51,122,78,73,None,None,Improved,1
2571,PT-02571,56,F,NIMHANS Bengaluru,Phase II,ORX-101,Oncology,Placebo,2023-01-28,2023-04-28,6.82,7.67,113,84,67,None,None,Improved,0
2572,PT-02572,51,F,Fortis Mumbai,Phase I,ORX-404,Neurology,High Dose,2024-03-20,2024-04-17,7.18,,149,74,86,Rash,Moderate,Improved,1
2573,PT-02573,32,M,Apollo Chennai,Phase III,ORX-404,Neurology,High Dose,2024-01-24,2024-02-07,7.34,5.86,116,81,103,Nausea,Mild,Improved,1
2574,PT-02574,46,F,PGI Chandigarh,Phase IV,ORX-303,Cardiology,Low Dose,2023-06-11,2023-06-25,9.19,8.98,121,100,84,None,None,Improved,1
2575,PT-02575,34,F,Fortis Mumbai,Phase III,ORX-505,Infectious Disease,Placebo,2023-08-10,2023-11-08,7.76,7.1,92,93,93,Fever,Mild,Improved,1
2576,PT-02576,74,F,Apollo Chennai,Phase II,ORX-303,Cardiology,High Dose,2024-11-30,2024-12-28,7.71,7.08,143,92,100,None,None,Worsened,0
2577,PT-02577,44,M,Apollo Chennai,Phase II,ORX-505,Infectious Disease,Placebo,2024-04-25,2024-05-09,7.0,5.96,137,63,88,None,None,Worsened,0
2578,PT-02578,54,F,Bhopal Research Hospital,Phase II,ORX-303,Cardiology,High Dose,2023-10-27,2024-01-25,7.9,7.63,155,92,69,None,None,No Change,0
2579,PT-02579,35,M,Kolkata Clinical Center,Phase I,ORX-505,Infectious Disease,Low Dose,2024-08-26,2024-09-23,6.14,6.24,109,95,96,None,None,Improved,0
2580,PT-02580,30,M,PGI Chandigarh,Phase II,ORX-303,Cardiology,Placebo,2024-05-22,2024-07-17,6.98,6.59,143,101,54,None,None,Improved,1
2581,PT-02581,39,M,PGI Chandigarh,Phase III,ORX-505,Infectious Disease,Placebo,2023-04-13,2023-07-12,6.88,5.22,119,87,74,None,None,Improved,1
2582,PT-02582,20,F,Bhopal Research Hospital,Phase II,ORX-303,Cardiology,Placebo,2023-03-08,2023-04-05,10.65,10.49,130,68,81,None,None,Improved,1
2583,PT-02583,42,F,Bhopal Research Hospital,Phase II,ORX-101,Oncology,Low Dose,2024-07-15,2024-07-22,4.93,3.57,142,105,83,None,None,Improved,1
2584,PT-02584,62,F,PGI Chandigarh,Phase III,ORX-404,Neurology,Low Dose,2023-12-05,2024-01-30,7.01,6.54,147,101,96,None,None,No Change,0
2585,PT-02585,27,M,NIMHANS Bengaluru,Phase I,ORX-505,Infectious Disease,High Dose,2023-09-08,2023-09-15,7.12,6.97,123,86,89,None,None,Improved,1
2586,PT-02586,61,M,Indore Medical Institute,Phase I,ORX-101,Oncology,Placebo,2023-02-25,2023-03-11,9.22,8.53,103,86,104,None,None,Worsened,0
2587,PT-02587,37,F,PGI Chandigarh,Phase IV,ORX-606,Rheumatology,Placebo,2023-12-01,2023-12-15,8.02,8.25,131,82,65,Headache,None,Improved,0
2588,PT-02588,18,M,NIMHANS Bengaluru,Phase I,ORX-404,Neurology,Placebo,2023-11-19,2023-11-26,5.87,5.11,147,80,70,Headache,Mild,Improved,1
2589,PT-02589,30,M,NIMHANS Bengaluru,Phase I,ORX-404,Neurology,High Dose,2023-07-30,2023-10-28,7.99,8.81,147,89,57,None,None,Improved,0
2590,PT-02590,39,M,Indore Medical Institute,Phase II,ORX-303,Cardiology,Placebo,2024-08-24,2024-09-07,9.54,10.15,100,81,83,None,None,Improved,0
2591,PT-02591,32,F,Indore Medical Institute,Phase II,ORX-101,Oncology,High Dose,2024-09-20,2024-09-27,4.43,4.12,113,72,73,None,None,Worsened,0
2592,PT-02592,42,M,Fortis Mumbai,Phase II,ORX-202,Diabetes,Placebo,2023-04-14,2023-04-28,7.19,5.99,124,60,82,None,None,Improved,1
2593,PT-02593,18,M,Bhopal Research Hospital,Phase III,ORX-202,Diabetes,Placebo,2024-09-04,2024-10-02,6.85,7.28,108,90,94,Fatigue,Mild,Improved,0
2594,PT-02594,18,F,Fortis Mumbai,Phase I,ORX-202,Diabetes,Low Dose,2023-11-02,2023-11-30,7.02,4.03,125,81,45,None,None,No Change,0
2595,PT-02595,75,M,NIMHANS Bengaluru,Phase II,ORX-404,Neurology,Placebo,2023-06-28,2023-07-05,7.54,6.38,154,60,60,Nausea,None,No Change,0
2596,PT-02596,18,F,Kolkata Clinical Center,Phase III,ORX-606,Rheumatology,High Dose,2023-09-06,2023-10-04,9.36,9.26,139,85,86,Nausea,Mild,No Change,0
2597,PT-02597,46,M,Apollo Chennai,Phase III,ORX-303,Cardiology,Low Dose,2023-04-05,2023-05-03,7.53,7.22,117,81,81,Fever,Severe,No Change,0
2598,PT-02598,46,F,PGI Chandigarh,Phase II,ORX-505,Infectious Disease,High Dose,2023-10-01,2023-11-26,5.43,3.82,147,78,86,None,None,No Change,0
2599,PT-02599,27,M,Apollo Chennai,Phase II,ORX-606,Rheumatology,Low Dose,2024-09-26,2024-11-21,5.43,4.27,123,74,96,None,None,Improved,1
2600,PT-02600,47,F,PGI Chandigarh,Phase III,ORX-202,Diabetes,Placebo,2024-08-18,2024-09-15,9.42,9.38,90,94,56,Fatigue,Mild,Improved,1
2601,PT-02601,48,F,NIMHANS Bengaluru,Phase IV,ORX-404,Neurology,High Dose,2024-11-13,2024-11-27,6.27,7.8,153,73,76,Nausea,Mild,Improved,0
2602,PT-02602,48,F,PGI Chandigarh,Phase I,ORX-606,Rheumatology,Placebo,2023-10-24,2023-11-07,8.24,7.86,109,73,77,Headache,Severe,Worsened,0
2603,PT-02603,64,F,AIIMS Delhi,Phase IV,ORX-303,Cardiology,Placebo,2024-05-01,2024-05-08,7.71,6.62,139,77,90,None,None,Improved,1
2604,PT-02604,85,F,Apollo Chennai,Phase IV,ORX-303,Cardiology,Placebo,2024-11-06,2024-12-04,6.77,7.09,114,80,78,None,None,Improved,0
2605,PT-02605,41,F,Indore Medical Institute,Phase II,ORX-404,Neurology,High Dose,2024-02-07,2024-05-07,10.16,,138,58,84,Nausea,Mild,Improved,1
2606,PT-02606,63,M,Bhopal Research Hospital,Phase III,ORX-404,Neurology,Placebo,2023-08-18,2023-11-16,6.57,3.91,127,82,88,None,None,Improved,1
2607,PT-02607,77,M,Bhopal Research Hospital,Phase III,ORX-101,Oncology,Placebo,2024-05-24,2024-06-07,6.74,5.57,106,84,84,None,None,Improved,1
2608,PT-02608,36,F,Indore Medical Institute,Phase III,ORX-101,Oncology,Placebo,2024-09-20,2024-11-15,8.13,8.15,128,71,71,Dizziness,Moderate,No Change,0
2609,PT-02609,18,M,AIIMS Delhi,Phase III,ORX-404,Neurology,High Dose,2024-08-10,2024-08-24,7.48,7.11,131,88,83,Fever,Severe,Improved,1
2610,PT-02610,43,F,Fortis Mumbai,Phase III,ORX-404,Neurology,Low Dose,2023-11-28,2023-12-26,7.26,5.59,117,82,67,Headache,Severe,No Change,0
2611,PT-02611,58,M,Fortis Mumbai,Phase II,ORX-303,Cardiology,High Dose,2023-07-30,2023-08-13,6.41,6.2,130,90,90,None,None,No Change,0
2612,PT-02612,56,F,NIMHANS Bengaluru,Phase I,ORX-505,Infectious Disease,Placebo,2024-11-11,2024-11-18,4.67,5.35,155,76,81,None,None,Worsened,0
2613,PT-02613,30,F,NIMHANS Bengaluru,Phase III,ORX-606,Rheumatology,Placebo,2024-04-16,2024-04-23,4.86,3.8,118,77,64,None,None,No Change,0
2614,PT-02614,33,M,Apollo Chennai,Phase III,ORX-202,Diabetes,Low Dose,2024-09-06,2024-09-13,7.19,6.09,137,90,111,Dizziness,None,Improved,1
2615,PT-02615,63,F,Indore Medical Institute,Phase III,ORX-101,Oncology,Low Dose,2023-09-10,2023-12-09,7.49,6.53,133,85,70,Headache,None,No Change,0
2616,PT-02616,57,M,Apollo Chennai,Phase II,ORX-303,Cardiology,High Dose,2023-08-09,2023-10-04,5.52,4.9,138,78,75,None,None,Worsened,0
2617,PT-02617,42,F,Apollo Chennai,Phase III,ORX-606,Rheumatology,Placebo,2023-04-13,2023-05-11,6.2,6.85,109,85,83,Nausea,Mild,Improved,0
2618,PT-02618,29,F,Indore Medical Institute,Phase I,ORX-101,Oncology,High Dose,2024-05-20,2024-08-18,7.29,6.07,153,68,68,None,None,Improved,1
2619,PT-02619,25,F,Bhopal Research Hospital,Phase IV,ORX-101,Oncology,Low Dose,2023-10-17,2024-01-15,5.57,6.6,137,83,68,Nausea,Mild,No Change,0
2620,PT-02620,59,M,Fortis Mumbai,Phase I,ORX-606,Rheumatology,High Dose,2023-06-15,2023-06-22,6.21,6.53,112,74,88,Nausea,Moderate,Improved,0
2621,PT-02621,58,F,NIMHANS Bengaluru,Phase IV,ORX-505,Infectious Disease,High Dose,2023-03-16,2023-06-14,7.92,6.57,119,83,66,None,None,No Change,0
2622,PT-02622,66,M,Apollo Chennai,Phase I,ORX-303,Cardiology,Low Dose,2023-12-04,2024-01-01,4.32,3.22,118,50,58,Fatigue,Severe,No Change,0
2623,PT-02623,55,M,Bhopal Research Hospital,Phase II,ORX-404,Neurology,Placebo,2024-05-04,2024-08-02,7.24,8.25,155,87,82,None,None,Worsened,0
2624,PT-02624,46,M,NIMHANS Bengaluru,Phase II,ORX-101,Oncology,Placebo,2024-05-07,2024-05-14,4.01,2.36,129,89,82,Fatigue,Mild,Worsened,0
2625,PT-02625,30,M,AIIMS Delhi,Phase II,ORX-606,Rheumatology,Placebo,2024-11-29,2024-12-27,8.32,9.26,144,93,70,Rash,Severe,Worsened,0
2626,PT-02626,62,F,Indore Medical Institute,Phase IV,ORX-202,Diabetes,High Dose,2024-06-17,2024-09-15,7.37,7.44,134,80,65,None,None,No Change,0
2627,PT-02627,43,M,Kolkata Clinical Center,Phase I,ORX-606,Rheumatology,Placebo,2023-05-20,2023-07-15,8.38,7.59,144,90,73,None,None,Worsened,0
2628,PT-02628,67,M,Kolkata Clinical Center,Phase IV,ORX-505,Infectious Disease,Low Dose,2024-01-25,2024-02-22,6.77,7.73,135,81,65,None,None,Worsened,0
2629,PT-02629,43,M,Bhopal Research Hospital,Phase II,ORX-101,Oncology,High Dose,2024-05-26,2024-06-23,6.96,5.42,124,72,86,None,None,No Change,0
2630,PT-02630,65,F,Fortis Mumbai,Phase I,ORX-202,Diabetes,Placebo,2023-06-05,2023-06-12,5.73,6.87,125,70,88,Fatigue,None,Improved,0
2631,PT-02631,37,M,PGI Chandigarh,Phase I,ORX-202,Diabetes,Low Dose,2024-02-25,2024-05-25,7.1,6.34,113,90,73,Fever,None,No Change,0
2632,PT-02632,22,M,Fortis Mumbai,Phase III,ORX-303,Cardiology,Low Dose,2023-11-27,2023-12-11,7.86,6.38,107,96,61,None,None,No Change,0
2633,PT-02633,18,F,Indore Medical Institute,Phase IV,ORX-202,Diabetes,Low Dose,2023-10-17,2023-12-12,7.95,7.27,124,78,81,None,None,No Change,0
2634,PT-02634,32,F,Fortis Mumbai,Phase III,ORX-505,Infectious Disease,Low Dose,2024-01-03,2024-02-28,8.97,7.24,136,89,67,None,None,Improved,1
2635,PT-02635,28,M,Indore Medical Institute,Phase IV,ORX-303,Cardiology,Placebo,2024-10-05,2024-11-02,8.42,7.13,117,92,78,None,None,Improved,1
2636,PT-02636,18,F,PGI Chandigarh,Phase II,ORX-505,Infectious Disease,Placebo,2023-05-30,2023-06-13,9.3,8.42,120,85,86,Headache,None,Improved,1
2637,PT-02637,76,F,PGI Chandigarh,Phase III,ORX-404,Neurology,Low Dose,2023-09-23,2023-11-18,5.21,5.55,141,80,89,None,None,Worsened,0
2638,PT-02638,59,M,Fortis Mumbai,Phase I,ORX-101,Oncology,High Dose,2023-01-06,2023-03-03,5.54,6.72,99,68,74,Dizziness,None,Improved,0
2639,PT-02639,75,M,Kolkata Clinical Center,Phase II,ORX-101,Oncology,High Dose,2023-01-04,2023-03-01,6.83,6.4,153,78,61,Nausea,Mild,Improved,1
2640,PT-02640,38,M,AIIMS Delhi,Phase III,ORX-101,Oncology,Low Dose,2023-06-22,2023-07-06,8.84,8.51,162,90,68,None,None,Improved,1
2641,PT-02641,45,F,AIIMS Delhi,Phase IV,ORX-202,Diabetes,Placebo,2024-07-19,2024-08-02,6.18,5.17,190,94,90,Nausea,None,Improved,1
2642,PT-02642,35,F,AIIMS Delhi,Phase III,ORX-505,Infectious Disease,Placebo,2024-09-12,2024-12-11,9.08,9.67,161,103,57,None,None,No Change,0
2643,PT-02643,27,F,Fortis Mumbai,Phase I,ORX-404,Neurology,Low Dose,2023-04-29,2023-05-13,6.0,4.75,133,75,107,Headache,Mild,Improved,1
2644,PT-02644,75,M,Indore Medical Institute,Phase II,ORX-303,Cardiology,Placebo,2024-03-29,2024-04-12,7.19,8.55,154,76,49,Nausea,Mild,Improved,0
2645,PT-02645,41,M,NIMHANS Bengaluru,Phase III,ORX-303,Cardiology,Placebo,2024-11-11,2024-12-09,6.43,6.21,129,82,85,Nausea,None,Worsened,0
2646,PT-02646,25,F,Indore Medical Institute,Phase III,ORX-202,Diabetes,High Dose,2023-01-18,2023-01-25,7.69,6.9,131,93,60,None,None,Improved,1
2647,PT-02647,40,F,PGI Chandigarh,Phase IV,ORX-202,Diabetes,Low Dose,2024-09-19,2024-10-17,7.06,6.19,144,73,70,None,None,Worsened,0
2648,PT-02648,33,M,Fortis Mumbai,Phase IV,ORX-303,Cardiology,Low Dose,2024-02-24,2024-04-20,8.51,7.67,136,105,76,Fatigue,None,Improved,1
2649,PT-02649,62,M,Apollo Chennai,Phase II,ORX-101,Oncology,Low Dose,2023-12-19,2024-02-13,9.21,9.73,127,89,59,Nausea,Mild,Worsened,0
2650,PT-02650,32,M,Apollo Chennai,Phase III,ORX-404,Neurology,Low Dose,2023-04-29,2023-05-13,6.47,8.09,113,72,63,Rash,Mild,Improved,0
2651,PT-02651,53,F,Apollo Chennai,Phase II,ORX-606,Rheumatology,Low Dose,2024-08-12,2024-08-19,7.37,7.95,140,65,66,None,None,Improved,0
2652,PT-02652,66,F,Kolkata Clinical Center,Phase IV,ORX-303,Cardiology,Low Dose,2023-11-10,2023-11-17,6.96,7.62,125,70,73,None,None,Improved,0
2653,PT-02653,29,M,NIMHANS Bengaluru,Phase III,ORX-505,Infectious Disease,Low Dose,2023-11-02,2023-11-30,6.52,6.3,137,62,77,None,None,Worsened,0
2654,PT-02654,35,F,Bhopal Research Hospital,Phase I,ORX-606,Rheumatology,Placebo,2023-12-06,2024-01-31,6.42,6.14,118,98,94,None,None,Improved,1
2655,PT-02655,63,F,Indore Medical Institute,Phase II,ORX-101,Oncology,Low Dose,2023-05-28,2023-07-23,6.61,5.34,129,80,69,Dizziness,None,Improved,1
2656,PT-02656,26,M,Indore Medical Institute,Phase II,ORX-202,Diabetes,Low Dose,2024-10-12,2024-10-19,7.15,6.39,140,89,93,None,None,Improved,1
2657,PT-02657,24,F,AIIMS Delhi,Phase III,ORX-606,Rheumatology,Low Dose,2024-02-12,2024-03-11,7.68,6.63,106,76,92,None,None,Improved,1
2658,PT-02658,39,F,AIIMS Delhi,Phase IV,ORX-303,Cardiology,High Dose,2023-01-10,2023-04-10,9.08,9.17,120,95,84,None,None,Improved,0
2659,PT-02659,30,M,AIIMS Delhi,Phase IV,ORX-202,Diabetes,Low Dose,2023-01-05,2023-01-12,9.43,9.26,128,71,94,None,None,Improved,1
2660,PT-02660,53,M,PGI Chandigarh,Phase II,ORX-303,Cardiology,Placebo,2024-02-12,2024-05-12,7.96,7.1,143,92,68,None,None,Improved,1
2661,PT-02661,22,F,Indore Medical Institute,Phase III,ORX-404,Neurology,Placebo,2024-05-25,2024-08-23,7.9,6.08,130,76,95,None,None,No Change,0
2662,PT-02662,38,F,Kolkata Clinical Center,Phase II,ORX-101,Oncology,Placebo,2023-08-07,2023-08-21,8.53,7.67,145,106,63,Nausea,None,No Change,0
2663,PT-02663,49,F,Apollo Chennai,Phase II,ORX-101,Oncology,Low Dose,2024-07-04,2024-07-18,10.5,10.16,129,91,78,None,None,Improved,1
2664,PT-02664,18,F,AIIMS Delhi,Phase I,ORX-505,Infectious Disease,Low Dose,2023-07-08,2023-10-06,8.56,6.36,120,96,73,None,None,No Change,0
2665,PT-02665,33,M,AIIMS Delhi,Phase III,ORX-505,Infectious Disease,Placebo,2023-05-15,2023-05-22,8.26,7.09,105,85,75,None,None,Improved,1
2666,PT-02666,25,M,PGI Chandigarh,Phase IV,ORX-606,Rheumatology,Placebo,2023-06-30,2023-08-25,7.96,7.98,121,78,84,None,None,Improved,0
2667,PT-02667,64,M,AIIMS Delhi,Phase II,ORX-303,Cardiology,High Dose,2023-08-09,2023-08-16,6.86,7.05,138,92,78,Nausea,None,No Change,0
2668,PT-02668,30,F,PGI Chandigarh,Phase III,ORX-101,Oncology,Placebo,2023-02-16,2023-04-13,6.65,6.55,160,76,89,Nausea,None,Improved,1
2669,PT-02669,39,M,Apollo Chennai,Phase III,ORX-303,Cardiology,Low Dose,2024-05-16,2024-08-14,7.33,8.3,141,67,69,Nausea,None,Improved,0
2670,PT-02670,65,M,PGI Chandigarh,Phase II,ORX-404,Neurology,Placebo,2023-05-30,2023-06-13,7.37,5.94,113,90,91,None,None,No Change,0
2671,PT-02671,45,F,Bhopal Research Hospital,Phase III,ORX-505,Infectious Disease,High Dose,2023-12-29,2024-03-28,10.17,10.51,123,72,64,Headache,Mild,Improved,0
2672,PT-02672,50,M,Fortis Mumbai,Phase II,ORX-303,Cardiology,High Dose,2023-08-11,2023-08-25,6.61,7.72,154,89,61,None,None,No Change,0
2673,PT-02673,34,F,Kolkata Clinical Center,Phase III,ORX-404,Neurology,High Dose,2024-07-01,2024-07-08,8.71,7.8,148,87,78,None,None,Improved,1
2674,PT-02674,33,F,Apollo Chennai,Phase III,ORX-404,Neurology,Placebo,2023-05-02,2023-07-31,7.09,6.86,146,71,74,Headache,None,Improved,1
2675,PT-02675,45,M,Kolkata Clinical Center,Phase IV,ORX-404,Neurology,Low Dose,2024-03-06,2024-05-01,8.0,,104,90,56,None,None,Improved,1
2676,PT-02676,65,F,NIMHANS Bengaluru,Phase III,ORX-101,Oncology,Placebo,2024-08-12,2024-08-26,7.01,5.22,119,86,70,Rash,Mild,No Change,0
2677,PT-02677,45,F,NIMHANS Bengaluru,Phase III,ORX-606,Rheumatology,Placebo,2024-10-01,2024-10-08,8.09,7.51,111,78,97,None,None,Improved,1
2678,PT-02678,71,M,Kolkata Clinical Center,Phase II,ORX-101,Oncology,Low Dose,2024-05-04,2024-06-29,4.78,5.36,132,93,70,None,None,Improved,0
2679,PT-02679,18,M,Kolkata Clinical Center,Phase II,ORX-101,Oncology,Low Dose,2024-08-22,2024-09-05,7.9,6.65,103,66,86,None,None,Improved,1
2680,PT-02680,47,F,PGI Chandigarh,Phase III,ORX-404,Neurology,Placebo,2024-05-24,2024-05-31,8.14,8.34,120,81,70,Rash,Mild,Improved,0
2681,PT-02681,41,M,Indore Medical Institute,Phase I,ORX-606,Rheumatology,Placebo,2023-12-11,2023-12-25,6.04,5.99,147,72,95,None,None,No Change,0
2682,PT-02682,46,M,Bhopal Research Hospital,Phase IV,ORX-202,Diabetes,Placebo,2024-03-23,2024-04-20,7.49,5.56,95,83,89,Nausea,Moderate,No Change,0
2683,PT-02683,34,F,AIIMS Delhi,Phase III,ORX-404,Neurology,High Dose,2024-07-02,2024-07-30,9.2,9.47,111,82,112,Nausea,None,Improved,0
2684,PT-02684,25,F,Bhopal Research Hospital,Phase III,ORX-303,Cardiology,High Dose,2024-06-20,2024-07-04,7.83,7.14,140,97,72,None,None,Improved,1
2685,PT-02685,62,F,Indore Medical Institute,Phase III,ORX-404,Neurology,High Dose,2023-06-17,2023-08-12,9.87,9.53,142,74,78,None,None,Improved,1
2686,PT-02686,42,F,Apollo Chennai,Phase IV,ORX-303,Cardiology,Placebo,2023-05-28,2023-07-23,8.16,8.84,126,100,99,None,None,Improved,0
2687,PT-02687,58,F,Apollo Chennai,Phase II,ORX-404,Neurology,High Dose,2024-01-10,2024-03-06,6.58,5.63,113,93,61,Headache,Mild,Improved,1
2688,PT-02688,55,F,Kolkata Clinical Center,Phase II,ORX-505,Infectious Disease,Placebo,2024-03-12,2024-03-26,5.9,6.24,128,98,93,Rash,Mild,Improved,0
2689,PT-02689,67,F,Indore Medical Institute,Phase III,ORX-303,Cardiology,Low Dose,2023-05-22,2023-06-19,8.95,8.68,107,69,48,None,None,Improved,1
2690,PT-02690,27,M,NIMHANS Bengaluru,Phase IV,ORX-303,Cardiology,Low Dose,2023-12-08,2023-12-15,7.28,6.38,124,87,73,Headache,Moderate,Improved,1
2691,PT-02691,27,M,NIMHANS Bengaluru,Phase III,ORX-606,Rheumatology,Low Dose,2024-09-03,2024-09-17,7.14,5.93,123,98,74,Headache,Mild,No Change,0
2692,PT-02692,73,M,Fortis Mumbai,Phase II,ORX-202,Diabetes,Placebo,2024-08-12,2024-08-19,8.92,8.0,107,81,94,Fatigue,Mild,Improved,1
2693,PT-02693,37,M,Apollo Chennai,Phase II,ORX-303,Cardiology,High Dose,2024-04-17,2024-07-16,8.29,8.98,114,73,87,Headache,Moderate,Worsened,0
2694,PT-02694,47,M,PGI Chandigarh,Phase II,ORX-404,Neurology,High Dose,2024-04-19,2024-05-03,6.38,5.66,126,63,88,Fatigue,None,Improved,1
2695,PT-02695,37,M,Apollo Chennai,Phase III,ORX-202,Diabetes,Low Dose,2024-06-26,2024-07-10,3.86,3.44,114,102,69,None,None,Improved,1
2696,PT-02696,27,M,Apollo Chennai,Phase III,ORX-404,Neurology,Low Dose,2023-06-09,2023-06-16,7.81,6.82,113,88,63,Headache,None,Worsened,0
2697,PT-02697,21,M,NIMHANS Bengaluru,Phase III,ORX-404,Neurology,Low Dose,2024-03-31,2024-04-07,9.27,9.39,123,81,85,None,None,Improved,0
2698,PT-02698,60,M,NIMHANS Bengaluru,Phase III,ORX-202,Diabetes,Placebo,2023-03-10,2023-03-24,6.29,6.22,118,79,80,Rash,None,Worsened,0
2699,PT-02699,44,M,Fortis Mumbai,Phase IV,ORX-505,Infectious Disease,High Dose,2023-05-10,2023-07-05,8.08,8.12,100,65,72,Headache,Moderate,No Change,0
2700,PT-02700,74,M,Apollo Chennai,Phase II,ORX-404,Neurology,High Dose,2024-11-22,2025-02-20,6.18,5.59,118,75,80,Dizziness,None,Improved,1
2701,PT-02701,67,F,Bhopal Research Hospital,Phase III,ORX-606,Rheumatology,Placebo,2023-01-09,2023-02-06,7.75,6.62,177,82,69,None,None,No Change,0
2702,PT-02702,67,F,AIIMS Delhi,Phase IV,ORX-101,Oncology,Low Dose,2024-01-15,2024-03-11,6.64,7.73,112,99,80,Headache,None,Improved,0
2703,PT-02703,65,M,PGI Chandigarh,Phase I,ORX-101,Oncology,High Dose,2023-08-09,2023-09-06,9.48,8.06,150,65,63,Nausea,Moderate,Improved,1
2704,PT-02704,32,M,PGI Chandigarh,Phase I,ORX-303,Cardiology,Low Dose,2024-05-01,2024-05-29,7.8,7.43,124,83,86,None,None,No Change,0
2705,PT-02705,55,M,Indore Medical Institute,Phase III,ORX-202,Diabetes,High Dose,2024-06-05,2024-09-03,8.51,9.75,127,75,86,Headache,None,No Change,0
2706,PT-02706,26,F,Indore Medical Institute,Phase III,ORX-303,Cardiology,Placebo,2023-09-05,2023-09-12,6.39,6.88,125,67,57,None,None,Improved,0
2707,PT-02707,45,F,Apollo Chennai,Phase I,ORX-303,Cardiology,Placebo,2024-10-11,2024-10-18,8.57,9.19,129,106,76,Nausea,None,Improved,0
2708,PT-02708,42,F,Indore Medical Institute,Phase II,ORX-202,Diabetes,Placebo,2024-10-16,2024-10-23,4.12,3.32,143,100,66,None,None,Improved,1
2709,PT-02709,52,F,Kolkata Clinical Center,Phase II,ORX-101,Oncology,Low Dose,2024-04-06,2024-07-05,8.46,8.07,90,84,88,None,None,Improved,1
2710,PT-02710,29,M,Kolkata Clinical Center,Phase II,ORX-606,Rheumatology,Placebo,2024-09-12,2024-12-11,6.9,5.46,90,94,77,Nausea,None,No Change,0
2711,PT-02711,70,M,Bhopal Research Hospital,Phase III,ORX-303,Cardiology,Low Dose,2024-02-03,2024-03-30,8.23,7.51,126,88,91,None,None,Worsened,0
2712,PT-02712,50,F,Kolkata Clinical Center,Phase I,ORX-404,Neurology,Low Dose,2024-08-16,2024-11-14,8.53,7.86,110,81,80,None,None,Improved,1
2713,PT-02713,25,F,Indore Medical Institute,Phase I,ORX-606,Rheumatology,Low Dose,2023-01-29,2023-02-26,5.6,5.6,120,80,72,None,None,Worsened,0
2714,PT-02714,69,F,PGI Chandigarh,Phase II,ORX-606,Rheumatology,Low Dose,2024-08-25,2024-09-22,8.71,7.2,118,92,86,None,None,Improved,1
2715,PT-02715,44,M,Apollo Chennai,Phase III,ORX-303,Cardiology,High Dose,2023-09-11,2023-12-10,5.83,4.82,118,85,101,Headache,None,No Change,0
2716,PT-02716,34,F,NIMHANS Bengaluru,Phase II,ORX-606,Rheumatology,Placebo,2024-04-24,2024-06-19,5.97,5.47,146,64,98,None,None,Improved,1
2717,PT-02717,42,F,Fortis Mumbai,Phase III,ORX-404,Neurology,Low Dose,2024-05-11,2024-08-09,6.32,4.48,140,79,80,None,None,Worsened,0
2718,PT-02718,30,M,PGI Chandigarh,Phase I,ORX-202,Diabetes,Placebo,2024-04-18,2024-05-02,6.82,,126,73,56,None,None,Improved,1
2719,PT-02719,85,M,Bhopal Research Hospital,Phase II,ORX-606,Rheumatology,Low Dose,2023-03-04,2023-03-18,5.56,5.33,96,58,79,Fatigue,None,Improved,1
2720,PT-02720,47,F,Apollo Chennai,Phase III,ORX-101,Oncology,High Dose,2024-04-23,2024-05-07,8.71,8.67,125,70,98,None,None,Worsened,0
2721,PT-02721,59,F,Indore Medical Institute,Phase I,ORX-606,Rheumatology,Low Dose,2023-08-18,2023-11-16,5.7,5.34,130,77,88,Rash,Severe,Worsened,0
2722,PT-02722,58,F,Bhopal Research Hospital,Phase III,ORX-101,Oncology,High Dose,2024-05-28,2024-06-25,6.97,6.32,154,93,79,None,None,Improved,1
2723,PT-02723,18,F,NIMHANS Bengaluru,Phase III,ORX-202,Diabetes,Placebo,2024-09-09,2024-09-16,7.61,7.84,90,85,72,Fatigue,None,Improved,0
2724,PT-02724,41,M,Fortis Mumbai,Phase III,ORX-202,Diabetes,Placebo,2024-11-22,2024-12-20,6.11,5.58,153,76,91,Fatigue,Severe,Improved,1
2725,PT-02725,32,F,Kolkata Clinical Center,Phase III,ORX-606,Rheumatology,High Dose,2024-04-25,2024-05-02,8.11,7.71,134,82,86,Rash,Mild,No Change,0
2726,PT-02726,18,F,Kolkata Clinical Center,Phase IV,ORX-101,Oncology,Low Dose,2024-09-16,2024-11-11,5.5,5.47,91,75,77,None,None,Improved,1
2727,PT-02727,31,F,Indore Medical Institute,Phase III,ORX-505,Infectious Disease,Low Dose,2024-11-28,2025-01-23,6.37,6.21,146,70,69,None,None,Improved,1
2728,PT-02728,33,F,Indore Medical Institute,Phase III,ORX-101,Oncology,Low Dose,2024-01-11,2024-01-25,4.29,4.02,144,94,65,Rash,None,Improved,1
2729,PT-02729,24,M,NIMHANS Bengaluru,Phase IV,ORX-606,Rheumatology,High Dose,2023-07-20,2023-09-14,7.23,7.57,130,85,93,Dizziness,None,No Change,0
2730,PT-02730,33,M,Fortis Mumbai,Phase III,ORX-202,Diabetes,High Dose,2023-01-14,2023-03-11,6.94,8.01,124,66,68,Headache,None,Improved,0
2731,PT-02731,29,M,Bhopal Research Hospital,Phase III,ORX-303,Cardiology,Low Dose,2024-10-17,2025-01-15,7.63,6.42,132,73,48,Fatigue,None,Improved,1
2732,PT-02732,49,M,NIMHANS Bengaluru,Phase I,ORX-606,Rheumatology,High Dose,2023-06-05,2023-07-31,7.38,7.44,115,72,83,None,None,Improved,0
2733,PT-02733,69,M,Apollo Chennai,Phase III,ORX-606,Rheumatology,Placebo,2024-04-24,2024-05-22,7.21,7.2,122,63,91,Fatigue,Moderate,No Change,0
2734,PT-02734,59,M,Fortis Mumbai,Phase II,ORX-505,Infectious Disease,Low Dose,2023-07-31,2023-08-28,8.05,7.49,138,92,100,None,None,Improved,1
2735,PT-02735,60,M,NIMHANS Bengaluru,Phase I,ORX-404,Neurology,Low Dose,2023-09-16,2023-11-11,7.28,5.7,130,85,87,Fatigue,None,Improved,1
2736,PT-02736,66,F,NIMHANS Bengaluru,Phase IV,ORX-303,Cardiology,High Dose,2023-09-03,2023-09-17,7.09,8.58,96,87,66,None,None,Improved,0
2737,PT-02737,18,F,NIMHANS Bengaluru,Phase III,ORX-404,Neurology,Low Dose,2024-06-14,2024-06-28,6.96,5.25,125,82,93,None,None,Improved,1
2738,PT-02738,20,F,AIIMS Delhi,Phase IV,ORX-606,Rheumatology,Low Dose,2023-05-12,2023-06-09,8.29,7.98,146,76,59,Rash,Mild,Improved,1
2739,PT-02739,25,M,NIMHANS Bengaluru,Phase I,ORX-606,Rheumatology,Placebo,2023-11-08,2024-01-03,5.65,5.68,154,75,86,None,None,No Change,0
2740,PT-02740,20,M,PGI Chandigarh,Phase III,ORX-303,Cardiology,Placebo,2023-05-27,2023-07-22,7.42,7.62,101,79,88,None,None,Worsened,0
2741,PT-02741,18,M,Apollo Chennai,Phase III,ORX-202,Diabetes,Low Dose,2024-03-06,2024-03-20,8.8,8.72,140,77,53,Headache,Moderate,Improved,1
2742,PT-02742,53,M,Bhopal Research Hospital,Phase III,ORX-101,Oncology,Placebo,2023-02-08,2023-05-09,7.1,6.73,147,91,104,Rash,Mild,Improved,1
2743,PT-02743,47,M,Bhopal Research Hospital,Phase III,ORX-606,Rheumatology,Placebo,2023-11-14,2024-02-12,6.37,5.8,135,94,57,None,None,Worsened,0
2744,PT-02744,45,M,Fortis Mumbai,Phase II,ORX-101,Oncology,Low Dose,2024-09-06,2024-09-20,9.13,8.52,144,87,91,None,None,No Change,0
2745,PT-02745,32,M,Fortis Mumbai,Phase I,ORX-606,Rheumatology,Placebo,2024-03-30,2024-05-25,6.23,5.85,100,78,81,None,None,Improved,1
2746,PT-02746,73,F,Indore Medical Institute,Phase II,ORX-505,Infectious Disease,High Dose,2023-03-26,2023-04-09,7.68,7.85,148,70,75,Headache,None,Worsened,0
2747,PT-02747,83,M,Fortis Mumbai,Phase II,ORX-404,Neurology,High Dose,2023-09-20,2023-11-15,7.11,7.71,145,64,82,Fatigue,Moderate,No Change,0
2748,PT-02748,47,M,Bhopal Research Hospital,Phase I,ORX-101,Oncology,High Dose,2024-11-28,2025-02-26,7.6,6.52,107,76,76,Headache,Mild,Worsened,0
2749,PT-02749,63,M,NIMHANS Bengaluru,Phase IV,ORX-404,Neurology,High Dose,2024-09-11,2024-11-06,9.38,10.24,143,69,72,None,None,No Change,0
2750,PT-02750,48,M,Bhopal Research Hospital,Phase I,ORX-606,Rheumatology,Low Dose,2024-11-14,2025-01-09,6.44,6.56,140,88,92,None,None,No Change,0
2751,PT-02751,30,F,PGI Chandigarh,Phase III,ORX-606,Rheumatology,Placebo,2023-04-17,2023-06-12,8.32,7.29,111,88,95,None,None,No Change,0
2752,PT-02752,52,M,Kolkata Clinical Center,Phase III,ORX-404,Neurology,High Dose,2023-05-09,2023-08-07,7.22,7.1,130,68,60,Dizziness,None,Improved,1
2753,PT-02753,43,M,PGI Chandigarh,Phase III,ORX-101,Oncology,Placebo,2024-11-01,2024-12-27,7.3,6.91,140,79,85,Headache,None,Worsened,0
2754,PT-02754,42,F,AIIMS Delhi,Phase II,ORX-202,Diabetes,Low Dose,2024-03-21,2024-05-16,9.39,9.06,170,86,75,Headache,None,Improved,1
2755,PT-02755,30,M,NIMHANS Bengaluru,Phase III,ORX-101,Oncology,High Dose,2023-11-29,2023-12-13,5.47,4.18,112,86,70,Fatigue,Mild,Improved,1
2756,PT-02756,47,M,Apollo Chennai,Phase III,ORX-303,Cardiology,Low Dose,2023-04-19,2023-05-03,8.74,8.26,165,67,75,Nausea,None,Improved,1
2757,PT-02757,36,M,Kolkata Clinical Center,Phase III,ORX-404,Neurology,Placebo,2024-07-16,2024-07-30,8.32,5.91,102,80,99,None,None,Worsened,0
2758,PT-02758,48,M,Bhopal Research Hospital,Phase II,ORX-606,Rheumatology,High Dose,2023-10-25,2023-11-01,5.58,4.1,158,74,64,None,None,No Change,0
2759,PT-02759,68,F,Apollo Chennai,Phase II,ORX-505,Infectious Disease,Placebo,2023-05-23,2023-08-21,8.41,9.16,110,63,79,Fatigue,Moderate,Worsened,0
2760,PT-02760,50,F,Kolkata Clinical Center,Phase III,ORX-101,Oncology,Low Dose,2023-11-12,2024-02-10,7.64,8.57,96,92,62,None,None,Improved,0
2761,PT-02761,58,F,Indore Medical Institute,Phase III,ORX-606,Rheumatology,Low Dose,2023-09-26,2023-10-24,6.63,5.5,117,64,78,Nausea,None,No Change,0
2762,PT-02762,32,F,Kolkata Clinical Center,Phase III,ORX-303,Cardiology,Low Dose,2023-02-20,2023-03-06,8.14,8.32,158,86,85,Headache,Mild,No Change,0
2763,PT-02763,67,M,AIIMS Delhi,Phase I,ORX-303,Cardiology,Low Dose,2023-03-07,2023-06-05,6.45,4.71,131,64,112,Nausea,None,Improved,1
2764,PT-02764,68,M,Indore Medical Institute,Phase III,ORX-404,Neurology,High Dose,2024-09-07,2024-10-05,9.8,9.45,137,76,90,None,None,Improved,1
2765,PT-02765,25,M,NIMHANS Bengaluru,Phase IV,ORX-505,Infectious Disease,Placebo,2023-05-02,2023-07-31,4.15,3.04,101,99,103,None,None,Improved,1
2766,PT-02766,22,M,Kolkata Clinical Center,Phase I,ORX-606,Rheumatology,Placebo,2023-05-20,2023-06-17,8.75,9.21,99,77,69,Fatigue,Mild,No Change,0
2767,PT-02767,56,F,Kolkata Clinical Center,Phase I,ORX-303,Cardiology,Placebo,2024-10-12,2024-11-09,5.73,5.24,115,87,74,Headache,None,Worsened,0
2768,PT-02768,36,M,Fortis Mumbai,Phase III,ORX-303,Cardiology,Low Dose,2024-11-10,2025-02-08,6.94,8.38,120,69,86,None,None,Improved,0
2769,PT-02769,42,F,NIMHANS Bengaluru,Phase II,ORX-505,Infectious Disease,High Dose,2023-08-02,2023-08-30,5.5,7.11,121,77,80,None,None,No Change,0
2770,PT-02770,72,F,PGI Chandigarh,Phase II,ORX-606,Rheumatology,Placebo,2024-01-25,2024-03-21,5.18,5.03,165,83,60,Fever,Mild,Worsened,0
2771,PT-02771,35,F,Apollo Chennai,Phase II,ORX-606,Rheumatology,High Dose,2023-10-02,2023-12-31,7.45,8.25,121,91,57,None,None,Improved,0
2772,PT-02772,21,M,PGI Chandigarh,Phase III,ORX-606,Rheumatology,Low Dose,2024-03-15,2024-03-29,6.62,7.51,129,85,81,Rash,None,Worsened,0
2773,PT-02773,62,F,PGI Chandigarh,Phase III,ORX-202,Diabetes,Placebo,2024-11-09,2025-01-04,6.47,6.69,113,105,66,None,None,Improved,0
2774,PT-02774,30,M,Fortis Mumbai,Phase IV,ORX-202,Diabetes,Placebo,2024-10-28,2024-12-23,7.86,7.53,133,84,62,Nausea,None,No Change,0
2775,PT-02775,70,F,NIMHANS Bengaluru,Phase II,ORX-505,Infectious Disease,High Dose,2024-07-02,2024-07-09,8.27,9.1,118,86,80,Headache,Mild,Improved,0
2776,PT-02776,63,F,PGI Chandigarh,Phase III,ORX-606,Rheumatology,Placebo,2023-06-29,2023-09-27,8.59,8.37,100,103,85,None,None,Improved,1
2777,PT-02777,35,M,Apollo Chennai,Phase I,ORX-303,Cardiology,Placebo,2024-09-09,2024-09-23,7.69,5.93,146,64,74,Headache,None,No Change,0
2778,PT-02778,48,F,PGI Chandigarh,Phase IV,ORX-303,Cardiology,Low Dose,2023-12-20,2023-12-27,8.45,8.14,139,81,77,Dizziness,None,Improved,1
2779,PT-02779,46,M,PGI Chandigarh,Phase II,ORX-101,Oncology,Low Dose,2024-11-23,2024-12-07,6.97,5.06,114,84,74,Nausea,None,No Change,0
2780,PT-02780,42,F,AIIMS Delhi,Phase I,ORX-505,Infectious Disease,Placebo,2023-08-03,2023-08-31,6.81,5.63,119,78,78,None,None,Improved,1
2781,PT-02781,51,F,Apollo Chennai,Phase III,ORX-202,Diabetes,High Dose,2024-09-27,2024-10-25,6.98,5.66,102,113,62,Rash,Mild,Improved,1
2782,PT-02782,36,M,Apollo Chennai,Phase I,ORX-606,Rheumatology,Low Dose,2023-01-30,2023-02-27,7.82,7.75,137,76,81,None,None,Worsened,0
2783,PT-02783,45,F,Kolkata Clinical Center,Phase II,ORX-303,Cardiology,Placebo,2024-03-20,2024-05-15,6.83,6.65,146,81,77,Rash,None,Worsened,0
2784,PT-02784,62,M,Kolkata Clinical Center,Phase III,ORX-202,Diabetes,Low Dose,2024-07-21,2024-08-18,8.35,9.38,96,92,86,None,None,Improved,0
2785,PT-02785,30,M,NIMHANS Bengaluru,Phase II,ORX-101,Oncology,High Dose,2024-10-02,2024-10-09,7.5,8.05,113,87,90,None,None,No Change,0
2786,PT-02786,27,M,Fortis Mumbai,Phase III,ORX-303,Cardiology,High Dose,2023-11-17,2023-12-01,7.03,,113,71,76,Headache,Moderate,No Change,0
2787,PT-02787,57,F,AIIMS Delhi,Phase I,ORX-505,Infectious Disease,High Dose,2024-03-01,2024-04-26,7.97,6.8,139,71,55,None,None,Improved,1
2788,PT-02788,39,F,AIIMS Delhi,Phase I,ORX-101,Oncology,High Dose,2024-05-02,2024-05-30,8.55,8.74,127,76,72,Headache,Mild,Worsened,0
2789,PT-02789,46,M,Fortis Mumbai,Phase III,ORX-101,Oncology,Placebo,2024-03-10,2024-03-17,5.92,5.2,124,65,66,None,None,Improved,1
2790,PT-02790,51,F,Indore Medical Institute,Phase II,ORX-505,Infectious Disease,Low Dose,2023-03-02,2023-04-27,7.21,6.53,111,100,66,None,None,No Change,0
2791,PT-02791,49,F,Apollo Chennai,Phase II,ORX-505,Infectious Disease,Low Dose,2023-03-17,2023-05-12,6.61,6.25,136,65,77,Dizziness,None,No Change,0
2792,PT-02792,64,M,AIIMS Delhi,Phase III,ORX-202,Diabetes,High Dose,2024-03-04,2024-04-29,9.31,8.8,128,108,93,Rash,Moderate,Improved,1
2793,PT-02793,35,M,Apollo Chennai,Phase II,ORX-505,Infectious Disease,High Dose,2024-06-27,2024-07-04,6.46,6.92,109,95,82,None,None,Improved,0
2794,PT-02794,53,M,AIIMS Delhi,Phase III,ORX-101,Oncology,Placebo,2024-09-14,2024-09-28,6.89,5.93,154,79,72,None,None,Improved,1
2795,PT-02795,43,M,Apollo Chennai,Phase III,ORX-101,Oncology,Placebo,2023-05-16,2023-07-11,7.43,6.1,117,74,89,None,None,Improved,1
2796,PT-02796,30,F,Bhopal Research Hospital,Phase III,ORX-101,Oncology,High Dose,2023-10-27,2024-01-25,5.09,2.92,101,98,78,None,None,Improved,1
2797,PT-02797,53,F,Bhopal Research Hospital,Phase II,ORX-505,Infectious Disease,High Dose,2023-07-27,2023-08-24,7.84,7.49,126,94,80,Fatigue,None,Improved,1
2798,PT-02798,67,M,AIIMS Delhi,Phase IV,ORX-606,Rheumatology,High Dose,2024-05-10,2024-07-05,7.94,6.99,119,73,95,Nausea,None,Improved,1
2799,PT-02799,38,F,Bhopal Research Hospital,Phase I,ORX-606,Rheumatology,High Dose,2024-09-11,2024-09-25,6.24,6.13,126,85,104,Headache,None,Improved,1
2800,PT-02800,59,M,Apollo Chennai,Phase IV,ORX-202,Diabetes,Low Dose,2024-03-13,2024-03-27,7.23,5.56,119,90,61,None,None,No Change,0
2801,PT-02801,79,M,Kolkata Clinical Center,Phase III,ORX-202,Diabetes,High Dose,2023-06-09,2023-06-23,7.22,6.86,116,87,61,None,None,Improved,1
2802,PT-02802,79,F,Bhopal Research Hospital,Phase III,ORX-303,Cardiology,Low Dose,2024-11-26,2025-01-21,8.78,9.27,102,84,94,None,None,Improved,0
2803,PT-02803,54,M,Kolkata Clinical Center,Phase II,ORX-404,Neurology,Placebo,2024-10-20,2024-11-17,6.0,5.01,119,74,99,Nausea,Mild,Improved,1
2804,PT-02804,18,M,Apollo Chennai,Phase II,ORX-101,Oncology,Placebo,2023-11-22,2023-11-29,7.99,6.42,110,57,70,Fever,None,Improved,1
2805,PT-02805,69,F,Apollo Chennai,Phase III,ORX-505,Infectious Disease,Low Dose,2024-09-19,2024-09-26,7.52,6.04,146,96,79,Headache,None,Worsened,0
2806,PT-02806,77,F,AIIMS Delhi,Phase IV,ORX-505,Infectious Disease,Low Dose,2024-02-14,2024-04-10,8.19,8.4,113,89,81,None,None,No Change,0
2807,PT-02807,53,M,Apollo Chennai,Phase II,ORX-303,Cardiology,Low Dose,2024-04-15,2024-05-13,6.38,6.09,113,56,91,None,None,Improved,1
2808,PT-02808,20,M,NIMHANS Bengaluru,Phase II,ORX-505,Infectious Disease,Low Dose,2023-02-15,2023-02-22,7.33,7.23,133,78,81,Rash,Mild,Worsened,0
2809,PT-02809,52,F,Indore Medical Institute,Phase II,ORX-303,Cardiology,Placebo,2023-09-08,2023-10-06,8.08,9.24,132,82,65,None,None,Improved,0
2810,PT-02810,51,F,Indore Medical Institute,Phase II,ORX-101,Oncology,Placebo,2024-11-04,2025-02-02,8.0,7.43,137,78,87,Rash,None,Improved,1
2811,PT-02811,59,M,Bhopal Research Hospital,Phase III,ORX-606,Rheumatology,Low Dose,2023-05-05,2023-06-30,8.28,7.98,109,74,86,Rash,None,Improved,1
2812,PT-02812,84,M,Kolkata Clinical Center,Phase III,ORX-202,Diabetes,High Dose,2024-09-06,2024-09-13,6.79,6.8,117,70,68,None,None,Improved,0
2813,PT-02813,18,F,NIMHANS Bengaluru,Phase III,ORX-404,Neurology,Placebo,2023-02-13,2023-02-20,8.82,6.42,123,67,65,None,None,Improved,1
2814,PT-02814,67,M,Kolkata Clinical Center,Phase III,ORX-101,Oncology,Low Dose,2024-03-20,2024-04-03,7.44,6.17,117,72,77,None,None,Improved,1
2815,PT-02815,47,M,PGI Chandigarh,Phase III,ORX-101,Oncology,Placebo,2024-04-14,2024-04-21,9.47,7.35,127,78,91,None,None,Improved,1
2816,PT-02816,50,M,Bhopal Research Hospital,Phase IV,ORX-505,Infectious Disease,Placebo,2024-10-20,2024-11-17,7.91,7.82,111,96,89,Dizziness,None,Improved,1
2817,PT-02817,59,F,NIMHANS Bengaluru,Phase I,ORX-303,Cardiology,Low Dose,2023-04-28,2023-07-27,8.72,8.69,154,86,74,None,None,Improved,1
2818,PT-02818,44,M,Kolkata Clinical Center,Phase II,ORX-606,Rheumatology,High Dose,2023-04-30,2023-07-29,7.17,6.3,157,85,79,Headache,Moderate,Improved,1
2819,PT-02819,51,M,NIMHANS Bengaluru,Phase III,ORX-101,Oncology,Placebo,2024-02-16,2024-04-12,10.78,9.36,112,65,74,None,None,Worsened,0
2820,PT-02820,48,M,PGI Chandigarh,Phase IV,ORX-303,Cardiology,Low Dose,2024-04-14,2024-04-21,6.64,5.76,130,75,82,Rash,None,Improved,1
2821,PT-02821,62,F,Indore Medical Institute,Phase III,ORX-202,Diabetes,High Dose,2023-08-11,2023-09-08,8.01,8.41,147,85,75,Fever,None,No Change,0
2822,PT-02822,32,F,AIIMS Delhi,Phase IV,ORX-404,Neurology,Low Dose,2023-08-12,2023-08-19,6.73,5.86,141,86,87,Headache,None,Improved,1
2823,PT-02823,26,F,Bhopal Research Hospital,Phase III,ORX-606,Rheumatology,Placebo,2024-10-03,2024-10-10,8.92,8.13,108,76,112,None,None,Improved,1
2824,PT-02824,38,M,NIMHANS Bengaluru,Phase I,ORX-505,Infectious Disease,High Dose,2023-08-01,2023-09-26,6.81,6.24,125,72,80,None,None,Improved,1
2825,PT-02825,62,F,NIMHANS Bengaluru,Phase II,ORX-505,Infectious Disease,High Dose,2024-02-01,2024-05-01,7.58,6.18,121,75,78,None,None,Improved,1
2826,PT-02826,66,M,Apollo Chennai,Phase II,ORX-101,Oncology,Placebo,2024-07-08,2024-07-22,7.02,6.54,159,92,86,Nausea,Mild,Improved,1
2827,PT-02827,76,F,Bhopal Research Hospital,Phase III,ORX-303,Cardiology,Low Dose,2023-07-05,2023-07-19,7.79,5.6,142,62,84,Headache,Moderate,No Change,0
2828,PT-02828,18,M,AIIMS Delhi,Phase III,ORX-404,Neurology,High Dose,2024-01-28,2024-02-25,6.64,5.91,114,77,92,None,None,No Change,0
2829,PT-02829,33,M,Indore Medical Institute,Phase IV,ORX-404,Neurology,High Dose,2023-05-29,2023-08-27,7.85,6.59,124,85,64,None,None,Improved,1
2830,PT-02830,24,M,AIIMS Delhi,Phase I,ORX-303,Cardiology,Low Dose,2024-06-15,2024-06-29,7.79,8.4,126,76,80,None,None,Improved,0
2831,PT-02831,45,F,NIMHANS Bengaluru,Phase III,ORX-606,Rheumatology,Placebo,2024-05-06,2024-06-03,7.49,4.82,108,71,80,None,None,No Change,0
2832,PT-02832,47,F,Kolkata Clinical Center,Phase III,ORX-303,Cardiology,Low Dose,2024-04-04,2024-07-03,7.96,7.8,104,99,95,None,None,No Change,0
2833,PT-02833,24,M,Bhopal Research Hospital,Phase I,ORX-101,Oncology,Placebo,2024-02-24,2024-03-23,7.6,6.66,130,94,107,None,None,Worsened,0
2834,PT-02834,57,M,Bhopal Research Hospital,Phase III,ORX-101,Oncology,Low Dose,2024-05-19,2024-06-02,7.55,6.85,131,98,77,Headache,Severe,No Change,0
2835,PT-02835,30,F,Apollo Chennai,Phase III,ORX-101,Oncology,High Dose,2023-07-24,2023-07-31,5.26,5.32,132,74,92,None,None,Improved,0
2836,PT-02836,38,F,Kolkata Clinical Center,Phase III,ORX-202,Diabetes,High Dose,2024-02-29,2024-03-07,7.04,6.62,121,84,94,None,None,Improved,1
2837,PT-02837,26,F,Bhopal Research Hospital,Phase II,ORX-101,Oncology,Low Dose,2023-08-05,2023-11-03,7.79,7.54,130,92,78,Headache,Mild,Worsened,0
2838,PT-02838,52,M,AIIMS Delhi,Phase II,ORX-606,Rheumatology,Placebo,2023-08-01,2023-08-08,8.06,7.21,133,78,76,None,None,Improved,1
2839,PT-02839,39,F,AIIMS Delhi,Phase II,ORX-101,Oncology,Low Dose,2023-07-19,2023-09-13,7.77,7.44,135,81,55,Rash,None,Worsened,0
2840,PT-02840,45,F,PGI Chandigarh,Phase III,ORX-303,Cardiology,Low Dose,2023-02-16,2023-03-16,7.28,7.09,117,67,86,Rash,None,No Change,0
2841,PT-02841,40,M,Fortis Mumbai,Phase III,ORX-303,Cardiology,Low Dose,2023-12-07,2024-03-06,7.41,6.75,127,76,64,Headache,Moderate,Improved,1
2842,PT-02842,52,M,Bhopal Research Hospital,Phase III,ORX-202,Diabetes,Low Dose,2023-10-13,2023-10-27,6.48,6.22,135,74,61,None,None,No Change,0
2843,PT-02843,83,F,PGI Chandigarh,Phase III,ORX-101,Oncology,Low Dose,2023-10-06,2023-10-13,6.57,6.73,162,91,73,Headache,None,No Change,0
2844,PT-02844,43,M,Fortis Mumbai,Phase III,ORX-404,Neurology,High Dose,2023-07-03,2023-07-10,6.2,6.59,138,75,63,Fever,Mild,No Change,0
2845,PT-02845,23,F,Bhopal Research Hospital,Phase III,ORX-606,Rheumatology,Low Dose,2023-08-27,2023-11-25,8.38,8.09,131,72,57,None,None,No Change,0
2846,PT-02846,60,M,Fortis Mumbai,Phase III,ORX-303,Cardiology,Placebo,2023-11-18,2024-01-13,7.25,7.67,121,79,87,None,None,Improved,0
2847,PT-02847,56,M,Kolkata Clinical Center,Phase I,ORX-505,Infectious Disease,Low Dose,2024-11-08,2024-12-06,8.16,7.49,139,95,76,Nausea,Mild,No Change,0
2848,PT-02848,36,F,Fortis Mumbai,Phase III,ORX-303,Cardiology,High Dose,2024-08-16,2024-11-14,8.81,7.82,139,81,52,Nausea,Moderate,Improved,1
2849,PT-02849,63,M,AIIMS Delhi,Phase III,ORX-606,Rheumatology,Placebo,2024-05-10,2024-05-24,3.89,1.7,137,88,69,Dizziness,Moderate,Improved,1
2850,PT-02850,47,F,Bhopal Research Hospital,Phase III,ORX-101,Oncology,High Dose,2023-08-09,2023-11-07,4.16,4.4,132,81,78,Dizziness,None,Improved,0
2851,PT-02851,52,F,Bhopal Research Hospital,Phase III,ORX-404,Neurology,High Dose,2023-10-28,2023-11-04,7.17,5.08,167,96,60,None,None,No Change,0
2852,PT-02852,39,M,AIIMS Delhi,Phase III,ORX-606,Rheumatology,High Dose,2023-10-04,2023-10-11,6.92,7.49,90,76,53,None,None,No Change,0
2853,PT-02853,40,M,Indore Medical Institute,Phase III,ORX-404,Neurology,High Dose,2023-09-09,2023-09-23,6.63,6.3,117,72,86,None,None,No Change,0
2854,PT-02854,52,F,Bhopal Research Hospital,Phase IV,ORX-505,Infectious Disease,Placebo,2023-11-14,2023-12-12,7.86,7.3,117,80,85,None,None,Improved,1
2855,PT-02855,18,F,Indore Medical Institute,Phase II,ORX-202,Diabetes,High Dose,2023-09-08,2023-10-06,7.67,7.55,129,80,45,Nausea,None,Improved,1
2856,PT-02856,37,F,Bhopal Research Hospital,Phase III,ORX-101,Oncology,High Dose,2024-06-11,2024-08-06,9.35,8.96,122,82,82,Fever,None,No Change,0
2857,PT-02857,55,F,Fortis Mumbai,Phase I,ORX-101,Oncology,Low Dose,2023-12-26,2024-01-09,6.93,6.91,158,94,110,Nausea,None,No Change,0
2858,PT-02858,34,M,PGI Chandigarh,Phase III,ORX-303,Cardiology,High Dose,2023-05-18,2023-06-15,9.21,8.1,134,90,70,Fever,Mild,No Change,0
2859,PT-02859,46,M,AIIMS Delhi,Phase III,ORX-404,Neurology,High Dose,2024-11-14,2024-11-21,8.29,7.25,158,65,105,None,None,Improved,1
2860,PT-02860,61,F,Fortis Mumbai,Phase II,ORX-202,Diabetes,High Dose,2024-08-30,2024-09-13,7.09,6.33,118,80,77,Dizziness,None,Improved,1
2861,PT-02861,65,F,NIMHANS Bengaluru,Phase III,ORX-505,Infectious Disease,High Dose,2024-03-09,2024-06-07,9.56,9.34,112,75,75,None,None,Improved,1
2862,PT-02862,28,F,NIMHANS Bengaluru,Phase II,ORX-101,Oncology,Low Dose,2023-04-06,2023-04-13,5.79,7.27,133,72,89,None,None,No Change,0
2863,PT-02863,26,M,Indore Medical Institute,Phase III,ORX-505,Infectious Disease,High Dose,2023-11-09,2023-11-23,5.88,4.76,157,78,45,Nausea,None,Improved,1
2864,PT-02864,64,M,AIIMS Delhi,Phase II,ORX-505,Infectious Disease,High Dose,2023-10-04,2023-11-29,6.83,4.77,122,88,83,Rash,Mild,Improved,1
2865,PT-02865,73,M,Fortis Mumbai,Phase IV,ORX-202,Diabetes,Low Dose,2023-04-15,2023-07-14,6.18,5.82,115,63,90,Fatigue,None,Improved,1
2866,PT-02866,52,M,PGI Chandigarh,Phase III,ORX-303,Cardiology,Placebo,2023-09-13,2023-12-12,7.54,7.52,115,69,78,Dizziness,Moderate,Improved,1
2867,PT-02867,63,F,Kolkata Clinical Center,Phase II,ORX-303,Cardiology,Placebo,2023-01-23,2023-04-23,9.13,9.45,128,85,78,None,None,Worsened,0
2868,PT-02868,28,F,Kolkata Clinical Center,Phase III,ORX-606,Rheumatology,High Dose,2023-09-12,2023-12-11,7.23,5.63,125,101,89,Fatigue,Moderate,Improved,1
2869,PT-02869,30,F,Apollo Chennai,Phase II,ORX-303,Cardiology,Low Dose,2024-04-26,2024-06-21,7.11,5.96,126,94,87,None,None,Improved,1
2870,PT-02870,84,M,Apollo Chennai,Phase III,ORX-101,Oncology,Placebo,2024-08-29,2024-11-27,8.63,8.41,140,79,62,None,None,Improved,1
2871,PT-02871,65,F,Fortis Mumbai,Phase II,ORX-303,Cardiology,High Dose,2024-09-17,2024-11-12,8.41,7.79,132,96,89,None,None,No Change,0
2872,PT-02872,21,F,Fortis Mumbai,Phase III,ORX-404,Neurology,Placebo,2023-04-20,2023-06-15,7.49,6.94,148,94,96,Fatigue,None,No Change,0
2873,PT-02873,27,F,Bhopal Research Hospital,Phase III,ORX-303,Cardiology,Low Dose,2023-03-26,2023-04-02,6.26,6.86,117,63,85,Headache,Mild,Improved,0
2874,PT-02874,36,F,Kolkata Clinical Center,Phase III,ORX-101,Oncology,Low Dose,2024-05-06,2024-06-03,9.35,9.21,130,77,100,Headache,None,Improved,1
2875,PT-02875,50,F,NIMHANS Bengaluru,Phase I,ORX-101,Oncology,High Dose,2024-01-29,2024-03-25,6.71,5.6,126,70,92,None,None,No Change,0
2876,PT-02876,18,M,Apollo Chennai,Phase II,ORX-303,Cardiology,Low Dose,2024-10-17,2024-12-12,7.03,7.18,134,73,87,None,None,No Change,0
2877,PT-02877,30,F,Indore Medical Institute,Phase II,ORX-606,Rheumatology,Low Dose,2024-02-23,2024-04-19,7.17,7.36,136,73,94,Nausea,Moderate,Worsened,0
2878,PT-02878,46,F,Indore Medical Institute,Phase II,ORX-202,Diabetes,High Dose,2023-09-28,2023-10-12,8.09,9.07,148,95,80,None,None,No Change,0
2879,PT-02879,57,F,AIIMS Delhi,Phase III,ORX-303,Cardiology,High Dose,2023-05-08,2023-06-05,7.46,5.97,133,85,86,Rash,None,Worsened,0
2880,PT-02880,42,M,Kolkata Clinical Center,Phase III,ORX-404,Neurology,High Dose,2024-01-21,2024-02-18,6.29,6.48,104,99,74,Headache,Mild,Improved,0
2881,PT-02881,48,M,Fortis Mumbai,Phase III,ORX-505,Infectious Disease,Placebo,2024-02-21,2024-05-21,7.87,8.0,102,91,82,Headache,None,Worsened,0
2882,PT-02882,34,F,Bhopal Research Hospital,Phase II,ORX-101,Oncology,High Dose,2023-05-25,2023-07-20,6.3,5.6,104,102,98,None,None,Improved,1
2883,PT-02883,52,F,Apollo Chennai,Phase I,ORX-101,Oncology,High Dose,2024-10-20,2025-01-18,6.93,6.35,141,103,70,None,None,Worsened,0
2884,PT-02884,27,F,NIMHANS Bengaluru,Phase III,ORX-404,Neurology,Placebo,2023-08-10,2023-10-05,9.06,7.05,109,79,56,None,None,Improved,1
2885,PT-02885,62,M,Apollo Chennai,Phase III,ORX-303,Cardiology,Low Dose,2023-10-16,2023-10-30,8.23,7.31,151,99,76,None,None,No Change,0
2886,PT-02886,37,F,Apollo Chennai,Phase III,ORX-202,Diabetes,Placebo,2023-03-15,2023-03-29,9.91,10.16,132,98,82,None,None,Improved,0
2887,PT-02887,36,F,Indore Medical Institute,Phase I,ORX-404,Neurology,High Dose,2023-05-08,2023-07-03,7.3,7.83,92,78,97,Fatigue,None,Improved,0
2888,PT-02888,36,F,NIMHANS Bengaluru,Phase II,ORX-202,Diabetes,Low Dose,2024-02-06,2024-04-02,9.06,9.93,126,75,73,Headache,None,Improved,0
2889,PT-02889,85,F,Fortis Mumbai,Phase III,ORX-404,Neurology,High Dose,2024-01-19,2024-04-18,9.45,9.16,117,83,81,None,None,Improved,1
2890,PT-02890,25,M,PGI Chandigarh,Phase IV,ORX-202,Diabetes,Low Dose,2023-07-14,2023-09-08,7.3,8.09,95,91,97,Headache,Moderate,No Change,0
2891,PT-02891,36,M,Apollo Chennai,Phase IV,ORX-404,Neurology,Low Dose,2024-03-05,2024-06-03,9.23,8.21,135,78,73,None,None,Improved,1
2892,PT-02892,35,M,Kolkata Clinical Center,Phase I,ORX-404,Neurology,Low Dose,2023-03-24,2023-04-21,8.04,8.4,126,65,83,None,None,No Change,0
2893,PT-02893,51,F,PGI Chandigarh,Phase I,ORX-404,Neurology,High Dose,2024-10-29,2024-11-12,6.94,8.22,99,55,67,Nausea,Mild,Improved,0
2894,PT-02894,56,M,Fortis Mumbai,Phase III,ORX-606,Rheumatology,Placebo,2024-02-23,2024-03-22,5.93,4.65,145,87,83,Headache,None,Improved,1
2895,PT-02895,57,F,PGI Chandigarh,Phase III,ORX-202,Diabetes,Low Dose,2023-12-08,2024-02-02,6.69,5.95,142,65,48,None,None,Improved,1
2896,PT-02896,38,M,AIIMS Delhi,Phase IV,ORX-404,Neurology,Low Dose,2023-02-02,2023-02-09,8.32,8.15,143,57,82,None,None,Worsened,0
2897,PT-02897,55,F,Bhopal Research Hospital,Phase I,ORX-101,Oncology,Placebo,2023-09-09,2023-10-07,5.58,5.95,125,118,47,Headache,None,No Change,0
2898,PT-02898,66,F,NIMHANS Bengaluru,Phase I,ORX-303,Cardiology,High Dose,2023-03-30,2023-06-28,6.73,4.87,118,85,92,Fatigue,None,Improved,1
2899,PT-02899,72,F,Fortis Mumbai,Phase III,ORX-404,Neurology,Low Dose,2023-11-16,2023-12-14,8.91,7.64,148,86,68,None,None,Improved,1
2900,PT-02900,41,M,NIMHANS Bengaluru,Phase III,ORX-505,Infectious Disease,Low Dose,2023-01-01,2023-01-29,6.35,5.98,114,69,84,Headache,None,No Change,0
2901,PT-02901,55,F,AIIMS Delhi,Phase III,ORX-606,Rheumatology,Low Dose,2024-01-17,2024-01-31,6.97,7.81,123,78,87,None,None,Improved,0
2902,PT-02902,42,F,Bhopal Research Hospital,Phase I,ORX-303,Cardiology,High Dose,2023-08-27,2023-09-10,7.3,4.63,128,60,60,None,None,Improved,1
2903,PT-02903,23,M,Fortis Mumbai,Phase III,ORX-101,Oncology,Low Dose,2024-05-07,2024-05-21,5.95,5.05,119,89,81,None,None,No Change,0
2904,PT-02904,18,M,Indore Medical Institute,Phase I,ORX-303,Cardiology,Placebo,2023-04-01,2023-06-30,7.3,7.19,122,81,80,None,None,Improved,1
2905,PT-02905,57,F,Apollo Chennai,Phase II,ORX-202,Diabetes,Low Dose,2023-04-03,2023-05-01,5.31,4.69,155,98,89,Headache,None,Improved,1
2906,PT-02906,53,F,Fortis Mumbai,Phase III,ORX-202,Diabetes,Placebo,2023-12-02,2024-03-01,9.19,10.51,125,70,74,None,None,Improved,0
2907,PT-02907,85,M,Apollo Chennai,Phase IV,ORX-505,Infectious Disease,Low Dose,2023-08-20,2023-09-17,5.32,4.49,102,83,61,None,None,Worsened,0
2908,PT-02908,43,F,Kolkata Clinical Center,Phase III,ORX-404,Neurology,Low Dose,2023-07-28,2023-08-04,4.86,5.02,150,77,76,Fatigue,None,Worsened,0
2909,PT-02909,42,M,PGI Chandigarh,Phase I,ORX-505,Infectious Disease,Low Dose,2023-10-01,2023-11-26,7.42,6.98,141,96,66,None,None,No Change,0
2910,PT-02910,40,M,PGI Chandigarh,Phase II,ORX-606,Rheumatology,Placebo,2023-05-02,2023-06-27,8.28,6.6,92,84,84,None,None,No Change,0
2911,PT-02911,33,M,Fortis Mumbai,Phase III,ORX-606,Rheumatology,High Dose,2023-03-19,2023-04-02,6.51,5.42,112,90,61,Nausea,None,Worsened,0
2912,PT-02912,40,F,Bhopal Research Hospital,Phase III,ORX-404,Neurology,Low Dose,2024-09-27,2024-10-11,6.11,4.4,143,75,80,None,None,Improved,1
2913,PT-02913,20,M,Fortis Mumbai,Phase III,ORX-505,Infectious Disease,High Dose,2024-08-08,2024-08-15,6.31,6.59,174,58,75,Headache,None,Improved,0
2914,PT-02914,51,M,Bhopal Research Hospital,Phase IV,ORX-303,Cardiology,High Dose,2023-07-13,2023-08-10,6.46,6.83,112,83,70,Nausea,Moderate,Improved,0
2915,PT-02915,64,F,Bhopal Research Hospital,Phase IV,ORX-606,Rheumatology,Low Dose,2024-01-14,2024-04-13,6.39,5.67,145,69,78,Rash,Severe,Improved,1
2916,PT-02916,18,M,Bhopal Research Hospital,Phase III,ORX-202,Diabetes,Placebo,2023-11-18,2023-12-02,5.89,5.84,110,75,84,None,None,Improved,1
2917,PT-02917,35,M,Fortis Mumbai,Phase IV,ORX-606,Rheumatology,Low Dose,2023-07-21,2023-08-04,8.19,7.98,135,96,82,Fatigue,None,Improved,1
2918,PT-02918,69,M,Bhopal Research Hospital,Phase III,ORX-303,Cardiology,Placebo,2023-07-14,2023-07-21,8.29,7.42,151,85,72,None,None,No Change,0
2919,PT-02919,49,F,Bhopal Research Hospital,Phase III,ORX-606,Rheumatology,High Dose,2023-02-18,2023-05-19,8.53,8.54,160,95,85,Headache,None,Worsened,0
2920,PT-02920,28,F,PGI Chandigarh,Phase III,ORX-303,Cardiology,Low Dose,2024-03-18,2024-04-01,6.98,6.65,140,89,80,None,None,No Change,0
2921,PT-02921,46,F,AIIMS Delhi,Phase I,ORX-505,Infectious Disease,Low Dose,2023-05-25,2023-07-20,8.06,6.89,158,57,98,Fatigue,Mild,Worsened,0
2922,PT-02922,44,F,NIMHANS Bengaluru,Phase II,ORX-303,Cardiology,High Dose,2024-09-24,2024-10-01,8.4,8.33,134,88,89,Fever,Moderate,Improved,1
2923,PT-02923,39,F,NIMHANS Bengaluru,Phase IV,ORX-606,Rheumatology,Low Dose,2023-01-18,2023-01-25,8.44,7.07,127,92,91,Fatigue,Moderate,Worsened,0
2924,PT-02924,52,M,Fortis Mumbai,Phase II,ORX-202,Diabetes,High Dose,2023-05-07,2023-07-02,6.73,7.13,115,103,76,None,None,Improved,0
2925,PT-02925,20,M,Bhopal Research Hospital,Phase II,ORX-606,Rheumatology,High Dose,2023-12-31,2024-02-25,5.77,5.41,130,105,63,Headache,Moderate,Improved,1
2926,PT-02926,45,F,Indore Medical Institute,Phase IV,ORX-505,Infectious Disease,Placebo,2023-10-05,2023-11-30,5.93,5.09,158,68,86,Dizziness,None,No Change,0
2927,PT-02927,51,M,Apollo Chennai,Phase I,ORX-202,Diabetes,High Dose,2024-10-11,2024-11-08,7.17,7.24,107,101,104,Headache,Mild,Improved,0
2928,PT-02928,45,F,Apollo Chennai,Phase I,ORX-202,Diabetes,Placebo,2023-02-17,2023-04-14,10.11,,135,99,71,None,None,Worsened,0
2929,PT-02929,22,F,AIIMS Delhi,Phase III,ORX-303,Cardiology,High Dose,2024-07-23,2024-09-17,5.27,6.72,118,79,62,None,None,Worsened,0
2930,PT-02930,60,F,PGI Chandigarh,Phase I,ORX-202,Diabetes,High Dose,2023-02-15,2023-03-15,6.26,5.42,133,69,75,None,None,No Change,0
2931,PT-02931,67,M,AIIMS Delhi,Phase III,ORX-606,Rheumatology,High Dose,2024-02-14,2024-02-21,7.71,7.43,131,77,105,None,None,No Change,0
2932,PT-02932,32,M,AIIMS Delhi,Phase II,ORX-303,Cardiology,Placebo,2024-01-03,2024-01-31,7.45,7.16,146,95,77,None,None,Worsened,0
2933,PT-02933,49,F,PGI Chandigarh,Phase III,ORX-101,Oncology,High Dose,2023-01-24,2023-02-21,7.59,5.15,99,74,70,Nausea,Severe,Worsened,0
2934,PT-02934,25,F,Fortis Mumbai,Phase III,ORX-202,Diabetes,Placebo,2024-02-03,2024-03-02,8.1,7.7,124,66,77,None,None,No Change,0
2935,PT-02935,18,M,Kolkata Clinical Center,Phase II,ORX-505,Infectious Disease,Low Dose,2024-06-06,2024-08-01,7.0,6.66,132,63,81,None,None,No Change,0
2936,PT-02936,28,F,Apollo Chennai,Phase III,ORX-101,Oncology,Placebo,2024-11-05,2024-11-12,6.23,6.47,164,82,66,None,None,Improved,0
2937,PT-02937,48,M,Indore Medical Institute,Phase III,ORX-101,Oncology,High Dose,2023-07-18,2023-10-16,8.33,8.49,177,73,81,Dizziness,None,Improved,0
2938,PT-02938,69,F,Kolkata Clinical Center,Phase III,ORX-101,Oncology,High Dose,2024-09-22,2024-09-29,8.98,6.83,127,99,118,None,None,Improved,1
2939,PT-02939,56,F,Fortis Mumbai,Phase I,ORX-505,Infectious Disease,Low Dose,2023-11-27,2023-12-11,6.76,5.45,167,90,66,Dizziness,Mild,No Change,0
2940,PT-02940,41,F,Bhopal Research Hospital,Phase I,ORX-303,Cardiology,Low Dose,2024-07-30,2024-08-06,7.57,7.66,111,74,54,None,None,Worsened,0
2941,PT-02941,61,F,Apollo Chennai,Phase I,ORX-505,Infectious Disease,Low Dose,2023-04-06,2023-06-01,6.79,6.81,153,84,76,Nausea,Moderate,Improved,0
2942,PT-02942,48,F,AIIMS Delhi,Phase III,ORX-606,Rheumatology,High Dose,2024-05-20,2024-05-27,7.28,8.0,133,75,92,None,None,No Change,0
2943,PT-02943,64,F,NIMHANS Bengaluru,Phase III,ORX-303,Cardiology,Low Dose,2024-11-07,2024-11-21,5.59,6.57,134,85,92,None,None,No Change,0
2944,PT-02944,35,M,AIIMS Delhi,Phase IV,ORX-505,Infectious Disease,High Dose,2024-07-03,2024-07-10,8.34,7.61,101,70,85,None,None,No Change,0
2945,PT-02945,29,M,PGI Chandigarh,Phase II,ORX-202,Diabetes,Placebo,2024-06-06,2024-09-04,9.13,9.8,152,83,81,None,None,Improved,0
2946,PT-02946,25,F,NIMHANS Bengaluru,Phase III,ORX-404,Neurology,High Dose,2024-10-16,2024-12-11,8.39,8.34,138,102,69,Nausea,None,Improved,1
2947,PT-02947,42,F,Apollo Chennai,Phase III,ORX-404,Neurology,High Dose,2023-10-15,2024-01-13,7.59,6.35,124,87,73,Nausea,None,Improved,1
2948,PT-02948,65,M,Apollo Chennai,Phase II,ORX-101,Oncology,High Dose,2023-11-27,2023-12-25,5.39,6.0,139,75,65,Headache,Mild,No Change,0
2949,PT-02949,18,M,Kolkata Clinical Center,Phase IV,ORX-303,Cardiology,Low Dose,2024-04-13,2024-05-11,6.25,6.79,126,95,69,Headache,Mild,Improved,0
2950,PT-02950,56,F,NIMHANS Bengaluru,Phase IV,ORX-606,Rheumatology,High Dose,2023-06-10,2023-08-05,6.34,5.07,126,74,56,Headache,Moderate,Improved,1
2951,PT-02951,42,M,Kolkata Clinical Center,Phase III,ORX-404,Neurology,Placebo,2023-08-18,2023-09-15,7.33,8.07,144,96,88,None,None,No Change,0
2952,PT-02952,50,F,PGI Chandigarh,Phase I,ORX-606,Rheumatology,Low Dose,2023-04-25,2023-07-24,5.73,5.46,138,99,87,None,None,Improved,1
2953,PT-02953,64,F,Indore Medical Institute,Phase II,ORX-101,Oncology,Low Dose,2023-07-31,2023-08-28,5.96,5.27,135,95,75,Rash,None,No Change,0
2954,PT-02954,43,M,Apollo Chennai,Phase II,ORX-101,Oncology,Placebo,2023-12-02,2024-03-01,8.02,6.61,156,71,51,Nausea,None,Improved,1
2955,PT-02955,45,F,Fortis Mumbai,Phase I,ORX-505,Infectious Disease,High Dose,2023-08-09,2023-09-06,9.24,9.37,141,82,75,Nausea,None,No Change,0
2956,PT-02956,20,F,Fortis Mumbai,Phase III,ORX-404,Neurology,High Dose,2023-02-20,2023-02-27,4.49,4.27,151,86,86,Fatigue,Severe,No Change,0
2957,PT-02957,70,F,Apollo Chennai,Phase I,ORX-202,Diabetes,High Dose,2024-07-20,2024-07-27,7.59,7.08,113,106,85,Fatigue,Moderate,Improved,1
2958,PT-02958,29,F,PGI Chandigarh,Phase III,ORX-505,Infectious Disease,Low Dose,2024-05-12,2024-05-19,5.79,6.52,109,104,45,None,None,Worsened,0
2959,PT-02959,67,F,Indore Medical Institute,Phase III,ORX-303,Cardiology,Placebo,2023-06-07,2023-08-02,7.78,7.49,124,104,87,Fatigue,None,Improved,1
2960,PT-02960,30,F,NIMHANS Bengaluru,Phase IV,ORX-606,Rheumatology,High Dose,2024-05-22,2024-06-05,5.14,4.9,127,63,77,None,None,Improved,1
2961,PT-02961,35,M,Fortis Mumbai,Phase II,ORX-505,Infectious Disease,Low Dose,2023-04-20,2023-07-19,7.21,7.46,154,92,67,Headache,Moderate,No Change,0
2962,PT-02962,50,F,AIIMS Delhi,Phase III,ORX-505,Infectious Disease,Low Dose,2023-02-13,2023-02-27,7.28,5.68,135,104,78,Fatigue,Moderate,Worsened,0
2963,PT-02963,19,F,Apollo Chennai,Phase III,ORX-505,Infectious Disease,Placebo,2023-01-21,2023-03-18,7.24,5.74,143,88,75,Fatigue,None,Improved,1
2964,PT-02964,39,M,NIMHANS Bengaluru,Phase IV,ORX-202,Diabetes,Low Dose,2023-08-11,2023-11-09,6.95,,114,65,93,None,None,Improved,1
2965,PT-02965,38,F,NIMHANS Bengaluru,Phase II,ORX-101,Oncology,Low Dose,2024-09-16,2024-09-23,7.4,7.26,133,67,54,Rash,None,No Change,0
2966,PT-02966,35,M,Bhopal Research Hospital,Phase III,ORX-404,Neurology,Low Dose,2024-01-15,2024-01-22,7.67,6.62,121,107,52,Headache,None,Improved,1
2967,PT-02967,32,M,AIIMS Delhi,Phase III,ORX-303,Cardiology,Placebo,2023-04-13,2023-06-08,9.48,9.04,115,96,78,Nausea,None,Worsened,0
2968,PT-02968,39,M,PGI Chandigarh,Phase III,ORX-606,Rheumatology,Low Dose,2023-10-06,2023-12-01,7.43,6.44,109,80,63,None,None,Improved,1
2969,PT-02969,45,F,Indore Medical Institute,Phase III,ORX-404,Neurology,Placebo,2023-11-30,2023-12-28,7.63,7.99,148,77,84,None,None,No Change,0
2970,PT-02970,52,M,Fortis Mumbai,Phase III,ORX-202,Diabetes,High Dose,2024-03-18,2024-06-16,7.59,6.76,109,88,54,None,None,Improved,1
2971,PT-02971,40,F,AIIMS Delhi,Phase IV,ORX-202,Diabetes,High Dose,2024-08-19,2024-09-16,4.14,2.53,112,95,87,Fatigue,None,No Change,0
2972,PT-02972,36,F,Apollo Chennai,Phase IV,ORX-303,Cardiology,High Dose,2023-12-21,2024-01-04,8.08,8.47,125,65,75,None,None,Improved,0
2973,PT-02973,43,M,Indore Medical Institute,Phase IV,ORX-101,Oncology,Placebo,2023-12-08,2024-01-05,5.72,5.65,133,87,81,Fatigue,Mild,Improved,1
2974,PT-02974,56,F,Bhopal Research Hospital,Phase II,ORX-606,Rheumatology,Placebo,2024-07-03,2024-08-28,6.98,6.77,120,74,96,None,None,Improved,1
2975,PT-02975,18,F,PGI Chandigarh,Phase III,ORX-404,Neurology,Placebo,2023-08-17,2023-09-14,8.25,7.29,114,85,57,Fever,Mild,Improved,1
2976,PT-02976,31,F,PGI Chandigarh,Phase I,ORX-606,Rheumatology,Low Dose,2023-08-08,2023-11-06,6.18,5.58,113,101,103,None,None,No Change,0
2977,PT-02977,18,M,PGI Chandigarh,Phase III,ORX-303,Cardiology,Low Dose,2024-11-21,2025-02-19,7.85,8.23,137,74,74,Rash,None,No Change,0
2978,PT-02978,33,F,PGI Chandigarh,Phase III,ORX-505,Infectious Disease,Placebo,2024-02-23,2024-04-19,6.7,5.21,125,63,75,Headache,Moderate,Improved,1
2979,PT-02979,25,F,Bhopal Research Hospital,Phase III,ORX-202,Diabetes,Low Dose,2023-09-02,2023-09-16,7.45,6.44,133,94,100,Nausea,Severe,No Change,0
2980,PT-02980,18,F,Fortis Mumbai,Phase III,ORX-101,Oncology,Low Dose,2023-09-15,2023-11-10,6.2,5.53,136,62,64,Fever,None,No Change,0
2981,PT-02981,47,M,Kolkata Clinical Center,Phase II,ORX-606,Rheumatology,Low Dose,2023-09-09,2023-10-07,7.3,7.24,135,86,80,None,None,Improved,1
2982,PT-02982,45,F,Indore Medical Institute,Phase III,ORX-505,Infectious Disease,High Dose,2024-05-26,2024-06-23,8.0,5.58,155,55,62,Headache,None,Improved,1
2983,PT-02983,41,F,NIMHANS Bengaluru,Phase I,ORX-101,Oncology,Placebo,2024-04-16,2024-05-14,8.01,4.91,127,91,91,None,None,No Change,0
2984,PT-02984,33,M,Kolkata Clinical Center,Phase III,ORX-606,Rheumatology,Placebo,2024-01-28,2024-03-24,6.84,5.88,120,69,65,Nausea,Mild,No Change,0
2985,PT-02985,51,F,AIIMS Delhi,Phase III,ORX-505,Infectious Disease,Low Dose,2024-11-27,2024-12-04,7.36,7.4,131,90,90,Headache,None,Improved,0
2986,PT-02986,18,F,Apollo Chennai,Phase III,ORX-606,Rheumatology,Low Dose,2024-08-22,2024-10-17,6.17,5.57,127,73,90,Headache,None,Improved,1
2987,PT-02987,76,M,Kolkata Clinical Center,Phase III,ORX-202,Diabetes,Low Dose,2024-11-20,2024-12-18,7.42,7.1,143,59,78,Nausea,None,No Change,0
2988,PT-02988,60,M,AIIMS Delhi,Phase III,ORX-505,Infectious Disease,Low Dose,2023-10-04,2023-10-11,6.43,4.92,124,81,65,None,None,Worsened,0
2989,PT-02989,78,F,Apollo Chennai,Phase III,ORX-505,Infectious Disease,Placebo,2023-10-06,2023-10-20,6.63,5.19,126,92,78,None,None,Improved,1
2990,PT-02990,52,F,Fortis Mumbai,Phase II,ORX-505,Infectious Disease,Placebo,2024-02-19,2024-03-04,6.15,7.09,138,94,83,Headache,Mild,Improved,0
2991,PT-02991,58,F,Bhopal Research Hospital,Phase III,ORX-606,Rheumatology,Placebo,2023-01-23,2023-02-06,6.15,5.31,152,100,61,Fatigue,Moderate,No Change,0
2992,PT-02992,48,M,Kolkata Clinical Center,Phase III,ORX-606,Rheumatology,High Dose,2024-01-08,2024-03-04,6.68,5.66,133,95,84,Nausea,None,No Change,0
2993,PT-02993,39,M,PGI Chandigarh,Phase III,ORX-202,Diabetes,High Dose,2024-11-16,2025-01-11,7.82,7.09,135,98,48,Headache,Moderate,Improved,1
2994,PT-02994,57,F,Bhopal Research Hospital,Phase III,ORX-202,Diabetes,High Dose,2024-06-19,2024-08-14,5.35,6.06,116,67,87,Nausea,None,Improved,0
2995,PT-02995,50,M,Apollo Chennai,Phase III,ORX-202,Diabetes,Placebo,2024-10-03,2024-10-17,6.0,4.47,124,67,63,None,None,Improved,1
2996,PT-02996,46,F,Bhopal Research Hospital,Phase I,ORX-505,Infectious Disease,Low Dose,2024-10-19,2025-01-17,6.04,6.02,154,80,79,Fever,Moderate,No Change,0
2997,PT-02997,77,F,PGI Chandigarh,Phase II,ORX-404,Neurology,High Dose,2024-10-06,2024-11-03,5.77,6.45,147,92,96,None,None,Improved,0
2998,PT-02998,49,M,PGI Chandigarh,Phase II,ORX-303,Cardiology,Placebo,2023-03-20,2023-03-27,6.5,7.09,148,95,78,Rash,Mild,Improved,0
2999,PT-02999,33,F,NIMHANS Bengaluru,Phase I,ORX-404,Neurology,Placebo,2023-01-19,2023-02-16,7.43,7.88,146,76,82,None,None,Improved,0
3000,PT-03000,24,M,Apollo Chennai,Phase III,ORX-404,Neurology,High Dose,2024-03-15,2024-06-13,8.38,7.28,142,68,92,None,None,Improved,1
3001,PT-03001,50,F,Bhopal Research Hospital,Phase IV,ORX-303,Cardiology,Low Dose,2023-05-18,2023-06-01,6.26,6.48,117,90,74,None,None,Improved,0
3002,PT-03002,18,M,PGI Chandigarh,Phase II,ORX-303,Cardiology,High Dose,2023-04-10,2023-04-17,6.02,5.23,152,92,100,None,None,Improved,1
3003,PT-03003,71,M,Indore Medical Institute,Phase IV,ORX-202,Diabetes,Placebo,2024-05-08,2024-07-03,6.56,5.99,120,73,52,None,None,Worsened,0
3004,PT-03004,44,F,Indore Medical Institute,Phase I,ORX-404,Neurology,High Dose,2024-05-09,2024-07-04,5.66,5.23,166,75,80,None,None,Improved,1
3005,PT-03005,59,F,PGI Chandigarh,Phase II,ORX-101,Oncology,Low Dose,2024-10-31,2024-12-26,7.54,7.4,121,79,64,None,None,No Change,0
3006,PT-03006,58,F,Bhopal Research Hospital,Phase II,ORX-404,Neurology,Placebo,2023-10-16,2024-01-14,5.11,5.58,102,93,73,None,None,Improved,0
3007,PT-03007,25,M,Bhopal Research Hospital,Phase III,ORX-505,Infectious Disease,Low Dose,2024-08-11,2024-08-25,7.9,8.33,120,90,46,Fatigue,Mild,Improved,0
3008,PT-03008,23,F,PGI Chandigarh,Phase III,ORX-404,Neurology,Placebo,2024-03-15,2024-05-10,8.75,8.15,94,73,65,Nausea,None,Improved,1
3009,PT-03009,42,M,Apollo Chennai,Phase II,ORX-505,Infectious Disease,High Dose,2024-02-01,2024-02-29,6.76,6.52,126,98,83,Nausea,Severe,No Change,0
3010,PT-03010,52,F,Apollo Chennai,Phase III,ORX-303,Cardiology,Placebo,2024-11-08,2024-11-15,8.6,7.85,105,96,79,Nausea,Mild,No Change,0
3011,PT-03011,47,M,PGI Chandigarh,Phase III,ORX-505,Infectious Disease,Low Dose,2023-07-12,2023-09-06,6.44,5.48,143,93,88,None,None,Worsened,0
3012,PT-03012,57,F,Indore Medical Institute,Phase III,ORX-404,Neurology,Placebo,2023-05-01,2023-05-29,7.88,7.6,124,96,72,None,None,Worsened,0
3013,PT-03013,50,M,NIMHANS Bengaluru,Phase III,ORX-606,Rheumatology,Placebo,2023-12-16,2023-12-30,6.24,5.24,123,72,89,None,None,Improved,1
3014,PT-03014,23,M,Indore Medical Institute,Phase I,ORX-505,Infectious Disease,High Dose,2024-04-11,2024-05-09,7.32,7.04,95,76,81,None,None,No Change,0
3015,PT-03015,51,M,Apollo Chennai,Phase IV,ORX-202,Diabetes,High Dose,2024-01-12,2024-04-11,6.95,7.16,126,82,81,None,None,Improved,0
3016,PT-03016,59,F,Bhopal Research Hospital,Phase II,ORX-101,Oncology,Low Dose,2024-04-04,2024-04-18,6.39,5.55,115,78,97,None,None,Worsened,0
3017,PT-03017,54,M,PGI Chandigarh,Phase III,ORX-303,Cardiology,Low Dose,2023-08-11,2023-09-08,5.84,4.9,134,71,67,Fatigue,Mild,Improved,1
3018,PT-03018,66,F,Bhopal Research Hospital,Phase I,ORX-202,Diabetes,High Dose,2023-09-08,2023-09-22,6.46,6.92,150,73,65,None,None,Improved,0
3019,PT-03019,40,F,Indore Medical Institute,Phase III,ORX-202,Diabetes,Low Dose,2024-09-09,2024-11-04,5.89,5.6,124,86,97,Dizziness,None,Improved,1
3020,PT-03020,58,F,Apollo Chennai,Phase III,ORX-101,Oncology,Low Dose,2024-05-27,2024-07-22,7.79,5.62,135,102,45,Fatigue,None,Worsened,0
3021,PT-03021,56,M,NIMHANS Bengaluru,Phase II,ORX-101,Oncology,Low Dose,2024-02-06,2024-03-05,7.01,5.84,142,102,88,None,None,Improved,1
3022,PT-03022,39,F,Kolkata Clinical Center,Phase II,ORX-404,Neurology,Low Dose,2023-04-29,2023-07-28,6.07,5.8,143,77,73,Rash,None,Improved,1
3023,PT-03023,85,F,Indore Medical Institute,Phase IV,ORX-404,Neurology,Placebo,2023-11-14,2023-12-12,8.49,9.13,101,73,79,Nausea,Mild,Worsened,0
3024,PT-03024,28,F,Apollo Chennai,Phase III,ORX-101,Oncology,Low Dose,2024-04-28,2024-05-12,9.12,9.99,118,103,77,None,None,Improved,0
3025,PT-03025,85,F,NIMHANS Bengaluru,Phase III,ORX-606,Rheumatology,High Dose,2024-04-07,2024-05-05,7.37,7.49,153,97,85,Fever,Moderate,Worsened,0
3026,PT-03026,42,F,PGI Chandigarh,Phase IV,ORX-101,Oncology,High Dose,2023-11-06,2024-02-04,7.82,6.68,130,68,53,None,None,Improved,1
3027,PT-03027,45,M,Kolkata Clinical Center,Phase III,ORX-606,Rheumatology,High Dose,2023-04-30,2023-07-29,8.71,9.15,126,102,70,None,None,Improved,0
3028,PT-03028,18,M,Fortis Mumbai,Phase IV,ORX-202,Diabetes,Low Dose,2024-04-10,2024-07-09,4.58,3.12,142,74,84,Nausea,Moderate,No Change,0
3029,PT-03029,71,F,NIMHANS Bengaluru,Phase III,ORX-101,Oncology,Placebo,2023-02-22,2023-04-19,5.88,5.91,137,71,96,Nausea,None,Worsened,0
3030,PT-03030,40,F,PGI Chandigarh,Phase II,ORX-404,Neurology,Low Dose,2023-06-03,2023-09-01,6.74,8.24,137,93,96,None,None,No Change,0
3031,PT-03031,34,M,Apollo Chennai,Phase II,ORX-303,Cardiology,Low Dose,2023-10-02,2023-10-09,8.7,7.85,118,78,69,Nausea,Mild,No Change,0
3032,PT-03032,58,F,NIMHANS Bengaluru,Phase IV,ORX-505,Infectious Disease,High Dose,2024-03-02,2024-03-09,7.52,6.68,140,78,73,None,None,No Change,0
3033,PT-03033,45,M,NIMHANS Bengaluru,Phase IV,ORX-101,Oncology,Placebo,2023-05-16,2023-07-11,7.76,7.71,121,92,74,None,None,No Change,0
3034,PT-03034,34,F,Kolkata Clinical Center,Phase IV,ORX-404,Neurology,Low Dose,2024-04-24,2024-05-01,5.44,5.92,128,84,92,None,None,No Change,0
3035,PT-03035,37,F,Apollo Chennai,Phase I,ORX-404,Neurology,Low Dose,2023-07-08,2023-09-02,5.55,5.21,133,78,98,Headache,None,Improved,1
3036,PT-03036,18,F,PGI Chandigarh,Phase III,ORX-101,Oncology,Placebo,2024-09-03,2024-10-29,8.54,8.86,136,50,95,Nausea,None,Improved,0
3037,PT-03037,28,M,AIIMS Delhi,Phase II,ORX-202,Diabetes,Placebo,2023-09-05,2023-09-12,6.59,6.04,135,89,90,None,None,No Change,0
3038,PT-03038,58,M,NIMHANS Bengaluru,Phase II,ORX-101,Oncology,High Dose,2023-01-29,2023-03-26,7.5,7.48,108,72,90,Fever,Mild,No Change,0
3039,PT-03039,58,M,PGI Chandigarh,Phase II,ORX-606,Rheumatology,Placebo,2023-12-16,2024-02-10,8.07,7.21,144,68,93,None,None,Improved,1
3040,PT-03040,40,M,Bhopal Research Hospital,Phase III,ORX-202,Diabetes,Low Dose,2023-09-06,2023-11-01,9.22,7.45,159,77,72,None,None,No Change,0
3041,PT-03041,48,F,Fortis Mumbai,Phase IV,ORX-303,Cardiology,Low Dose,2024-07-23,2024-08-20,6.36,5.9,114,73,84,None,None,Improved,1
3042,PT-03042,30,F,Bhopal Research Hospital,Phase II,ORX-505,Infectious Disease,Low Dose,2024-06-16,2024-06-23,6.28,4.64,118,97,66,None,None,Improved,1
3043,PT-03043,33,F,Indore Medical Institute,Phase IV,ORX-303,Cardiology,Placebo,2024-03-30,2024-05-25,7.43,6.7,168,80,82,None,None,No Change,0
3044,PT-03044,60,M,Indore Medical Institute,Phase II,ORX-404,Neurology,Low Dose,2024-03-10,2024-06-08,8.31,8.12,125,106,76,Fever,None,Improved,1
3045,PT-03045,37,M,Indore Medical Institute,Phase III,ORX-202,Diabetes,High Dose,2023-05-14,2023-05-28,6.42,4.47,142,53,77,Fatigue,Moderate,Improved,1
3046,PT-03046,41,M,Bhopal Research Hospital,Phase IV,ORX-505,Infectious Disease,High Dose,2023-11-30,2024-02-28,9.89,7.84,111,80,75,None,None,Improved,1
3047,PT-03047,36,M,AIIMS Delhi,Phase IV,ORX-505,Infectious Disease,High Dose,2024-08-02,2024-10-31,7.1,5.57,134,54,77,None,None,No Change,0
3048,PT-03048,35,F,Bhopal Research Hospital,Phase II,ORX-303,Cardiology,High Dose,2023-11-14,2024-02-12,8.42,9.6,122,98,73,None,None,Improved,0
3049,PT-03049,29,M,NIMHANS Bengaluru,Phase III,ORX-303,Cardiology,Low Dose,2024-03-13,2024-03-20,9.3,9.36,128,90,81,Headache,None,Improved,0
3050,PT-03050,43,M,Indore Medical Institute,Phase III,ORX-303,Cardiology,Placebo,2023-02-12,2023-02-26,5.61,4.96,139,80,90,None,None,Improved,1
3051,PT-03051,51,M,Indore Medical Institute,Phase II,ORX-202,Diabetes,High Dose,2024-11-02,2024-11-09,6.15,4.56,125,75,82,Fatigue,None,Improved,1
3052,PT-03052,33,F,Bhopal Research Hospital,Phase IV,ORX-404,Neurology,Placebo,2024-05-25,2024-08-23,6.46,7.01,130,73,78,Fatigue,None,Improved,0
3053,PT-03053,67,F,AIIMS Delhi,Phase III,ORX-404,Neurology,Low Dose,2023-01-19,2023-01-26,7.55,7.69,114,94,110,None,None,Improved,0
3054,PT-03054,32,F,AIIMS Delhi,Phase II,ORX-101,Oncology,Placebo,2024-02-12,2024-02-19,5.78,5.54,143,80,63,Fatigue,None,Improved,1
3055,PT-03055,43,M,PGI Chandigarh,Phase II,ORX-505,Infectious Disease,High Dose,2023-05-26,2023-06-09,7.92,7.15,138,95,81,None,None,No Change,0
3056,PT-03056,44,M,Bhopal Research Hospital,Phase III,ORX-303,Cardiology,Low Dose,2024-08-31,2024-09-14,8.2,7.02,110,78,71,None,None,Improved,1
3057,PT-03057,32,M,PGI Chandigarh,Phase II,ORX-505,Infectious Disease,High Dose,2024-09-27,2024-11-22,9.4,10.95,121,83,75,None,None,Improved,0
3058,PT-03058,62,M,Kolkata Clinical Center,Phase III,ORX-505,Infectious Disease,High Dose,2024-05-09,2024-05-23,8.77,6.77,136,66,102,None,None,Improved,1
3059,PT-03059,52,M,Indore Medical Institute,Phase III,ORX-101,Oncology,High Dose,2023-06-08,2023-09-06,6.21,5.59,122,88,92,None,None,No Change,0
3060,PT-03060,26,M,AIIMS Delhi,Phase II,ORX-505,Infectious Disease,Low Dose,2023-01-04,2023-02-01,9.41,10.45,112,82,101,Fatigue,Mild,No Change,0
3061,PT-03061,64,F,Bhopal Research Hospital,Phase III,ORX-303,Cardiology,Low Dose,2024-10-08,2024-11-05,6.8,7.13,181,83,69,Rash,None,Worsened,0
3062,PT-03062,47,M,Kolkata Clinical Center,Phase III,ORX-101,Oncology,Placebo,2023-06-18,2023-06-25,7.5,6.62,135,66,68,None,None,Worsened,0
3063,PT-03063,57,F,Bhopal Research Hospital,Phase II,ORX-303,Cardiology,High Dose,2023-11-03,2024-02-01,5.09,5.51,91,61,71,Rash,Mild,No Change,0
3064,PT-03064,49,M,PGI Chandigarh,Phase II,ORX-505,Infectious Disease,Placebo,2024-07-12,2024-07-26,8.79,8.44,123,88,65,None,None,No Change,0
3065,PT-03065,47,F,Apollo Chennai,Phase III,ORX-606,Rheumatology,Low Dose,2024-04-17,2024-06-12,5.76,5.43,125,72,80,Headache,None,Improved,1
3066,PT-03066,47,F,PGI Chandigarh,Phase II,ORX-303,Cardiology,Low Dose,2024-04-18,2024-07-17,8.61,6.77,126,72,90,Nausea,Moderate,Improved,1
3067,PT-03067,57,F,PGI Chandigarh,Phase III,ORX-404,Neurology,High Dose,2023-11-11,2023-11-25,7.81,6.78,143,63,53,Fatigue,Mild,Worsened,0
3068,PT-03068,24,M,Indore Medical Institute,Phase III,ORX-202,Diabetes,Placebo,2024-06-30,2024-07-07,7.16,7.37,90,97,79,None,None,No Change,0
3069,PT-03069,19,F,NIMHANS Bengaluru,Phase III,ORX-101,Oncology,Low Dose,2023-02-21,2023-05-22,7.32,7.9,138,95,58,Nausea,None,Improved,0
3070,PT-03070,38,F,Kolkata Clinical Center,Phase III,ORX-404,Neurology,Placebo,2023-06-21,2023-08-16,6.09,7.24,139,116,71,Headache,Mild,Improved,0
3071,PT-03071,33,M,Fortis Mumbai,Phase I,ORX-505,Infectious Disease,Placebo,2023-02-03,2023-02-17,7.03,7.87,121,83,79,Nausea,None,Improved,0
3072,PT-03072,45,M,Fortis Mumbai,Phase III,ORX-606,Rheumatology,High Dose,2023-04-13,2023-05-11,6.42,5.89,124,81,91,None,None,Improved,1
3073,PT-03073,73,M,AIIMS Delhi,Phase III,ORX-202,Diabetes,Low Dose,2023-03-09,2023-04-06,6.19,5.44,113,84,70,Fatigue,None,Improved,1
3074,PT-03074,48,M,Bhopal Research Hospital,Phase IV,ORX-505,Infectious Disease,Placebo,2024-09-17,2024-10-01,8.52,5.85,136,76,84,None,None,Improved,1
3075,PT-03075,30,F,Fortis Mumbai,Phase III,ORX-202,Diabetes,Placebo,2024-07-05,2024-07-19,8.64,9.06,138,91,67,Fever,Mild,No Change,0
3076,PT-03076,35,F,NIMHANS Bengaluru,Phase III,ORX-606,Rheumatology,Low Dose,2024-05-03,2024-05-10,8.1,7.01,154,78,85,None,None,Worsened,0
3077,PT-03077,78,M,AIIMS Delhi,Phase III,ORX-404,Neurology,High Dose,2023-06-17,2023-07-15,6.35,6.01,146,93,73,Headache,None,Improved,1
3078,PT-03078,36,M,Apollo Chennai,Phase I,ORX-202,Diabetes,Low Dose,2023-01-17,2023-04-17,6.92,7.82,122,82,72,Fever,None,Improved,0
3079,PT-03079,56,F,NIMHANS Bengaluru,Phase III,ORX-101,Oncology,High Dose,2024-10-22,2024-11-19,7.39,6.08,110,58,66,None,None,Improved,1
3080,PT-03080,57,F,PGI Chandigarh,Phase II,ORX-303,Cardiology,Placebo,2023-02-23,2023-03-23,8.79,9.01,137,80,88,None,None,Improved,0
3081,PT-03081,49,F,AIIMS Delhi,Phase III,ORX-606,Rheumatology,High Dose,2023-03-04,2023-04-29,9.37,8.88,152,92,88,None,None,Improved,1
3082,PT-03082,18,F,Apollo Chennai,Phase IV,ORX-505,Infectious Disease,Placebo,2023-08-25,2023-11-23,8.32,7.8,120,64,77,None,None,Improved,1
3083,PT-03083,45,F,AIIMS Delhi,Phase IV,ORX-606,Rheumatology,Low Dose,2024-06-09,2024-08-04,5.64,3.91,136,92,80,None,None,No Change,0
3084,PT-03084,63,F,Bhopal Research Hospital,Phase II,ORX-202,Diabetes,Placebo,2024-05-07,2024-05-21,7.1,6.65,111,63,103,None,None,Improved,1
3085,PT-03085,63,M,Apollo Chennai,Phase I,ORX-404,Neurology,Low Dose,2023-07-03,2023-07-17,5.53,5.27,126,78,72,None,None,Improved,1
3086,PT-03086,51,F,PGI Chandigarh,Phase I,ORX-202,Diabetes,High Dose,2024-04-14,2024-04-28,8.18,8.14,125,80,91,None,None,Improved,1
3087,PT-03087,52,M,Bhopal Research Hospital,Phase II,ORX-404,Neurology,Placebo,2023-09-12,2023-09-26,7.29,6.85,134,76,89,Rash,None,Improved,1
3088,PT-03088,27,M,PGI Chandigarh,Phase II,ORX-303,Cardiology,Low Dose,2024-05-25,2024-06-01,6.71,6.86,107,63,78,Dizziness,None,No Change,0
3089,PT-03089,18,M,AIIMS Delhi,Phase II,ORX-606,Rheumatology,High Dose,2024-11-22,2024-12-20,5.64,5.92,124,97,61,None,None,Worsened,0
3090,PT-03090,43,M,AIIMS Delhi,Phase I,ORX-303,Cardiology,High Dose,2023-03-31,2023-04-14,7.68,6.23,146,88,55,None,None,Improved,1
3091,PT-03091,44,M,Bhopal Research Hospital,Phase IV,ORX-505,Infectious Disease,Placebo,2023-09-13,2023-10-11,7.66,6.73,101,85,108,None,None,Worsened,0
3092,PT-03092,38,M,Fortis Mumbai,Phase III,ORX-505,Infectious Disease,High Dose,2023-03-12,2023-06-10,9.08,8.01,131,91,77,None,None,No Change,0
3093,PT-03093,40,F,PGI Chandigarh,Phase III,ORX-303,Cardiology,Low Dose,2023-05-05,2023-06-30,8.07,9.37,133,75,75,None,None,Improved,0
3094,PT-03094,85,M,NIMHANS Bengaluru,Phase IV,ORX-202,Diabetes,Placebo,2024-03-16,2024-03-23,7.36,6.43,107,60,83,None,None,No Change,0
3095,PT-03095,55,M,PGI Chandigarh,Phase III,ORX-606,Rheumatology,Low Dose,2023-11-20,2023-12-04,6.72,6.31,106,83,84,Headache,None,Improved,1
3096,PT-03096,36,M,Fortis Mumbai,Phase II,ORX-202,Diabetes,Placebo,2024-09-13,2024-12-12,9.23,8.08,133,92,76,None,None,No Change,0
3097,PT-03097,41,F,NIMHANS Bengaluru,Phase III,ORX-505,Infectious Disease,Low Dose,2023-03-21,2023-04-18,5.49,6.31,124,88,87,None,None,Improved,0
3098,PT-03098,34,F,Indore Medical Institute,Phase I,ORX-606,Rheumatology,High Dose,2023-02-08,2023-02-15,6.96,7.76,107,107,67,Fatigue,Mild,Improved,0
3099,PT-03099,26,F,Indore Medical Institute,Phase III,ORX-606,Rheumatology,Placebo,2023-06-02,2023-07-28,7.36,8.95,93,80,84,None,None,No Change,0
3100,PT-03100,45,M,Apollo Chennai,Phase III,ORX-101,Oncology,Placebo,2024-02-05,2024-02-12,7.66,6.61,117,80,62,None,None,Improved,1
3101,PT-03101,44,M,Kolkata Clinical Center,Phase III,ORX-606,Rheumatology,Low Dose,2023-12-27,2024-01-03,6.73,5.91,133,60,74,Headache,Moderate,Improved,1
3102,PT-03102,82,M,Indore Medical Institute,Phase IV,ORX-606,Rheumatology,Low Dose,2023-12-09,2024-02-03,5.9,6.65,128,74,59,None,None,No Change,0
3103,PT-03103,47,M,AIIMS Delhi,Phase II,ORX-505,Infectious Disease,Placebo,2024-05-05,2024-05-19,8.94,8.19,126,94,82,None,None,No Change,0
3104,PT-03104,19,M,Bhopal Research Hospital,Phase III,ORX-606,Rheumatology,High Dose,2023-10-25,2023-12-20,7.32,8.28,127,50,83,None,None,Improved,0
3105,PT-03105,41,M,Fortis Mumbai,Phase II,ORX-101,Oncology,Low Dose,2023-08-17,2023-08-24,5.01,3.09,145,73,65,None,None,Worsened,0
3106,PT-03106,44,F,PGI Chandigarh,Phase III,ORX-101,Oncology,Low Dose,2023-12-21,2024-01-18,6.43,6.12,124,67,70,None,None,No Change,0
3107,PT-03107,52,F,Fortis Mumbai,Phase IV,ORX-404,Neurology,Low Dose,2024-07-31,2024-08-07,7.25,6.78,162,90,89,None,None,Worsened,0
3108,PT-03108,42,F,Bhopal Research Hospital,Phase III,ORX-505,Infectious Disease,Low Dose,2024-05-18,2024-05-25,7.46,6.68,141,80,81,None,None,Improved,1
3109,PT-03109,47,F,PGI Chandigarh,Phase I,ORX-404,Neurology,Placebo,2023-11-07,2023-11-21,7.18,9.42,116,73,87,None,None,Worsened,0
3110,PT-03110,35,M,Kolkata Clinical Center,Phase IV,ORX-202,Diabetes,Low Dose,2023-05-31,2023-06-07,6.85,,136,88,73,None,None,No Change,0
3111,PT-03111,56,F,Apollo Chennai,Phase III,ORX-202,Diabetes,High Dose,2024-05-03,2024-06-28,4.97,3.93,124,67,53,None,None,No Change,0
3112,PT-03112,40,M,Kolkata Clinical Center,Phase I,ORX-606,Rheumatology,Low Dose,2023-04-21,2023-07-20,8.03,8.79,118,90,86,Rash,None,No Change,0
3113,PT-03113,64,F,AIIMS Delhi,Phase III,ORX-101,Oncology,High Dose,2023-05-28,2023-06-25,6.78,4.76,129,69,67,None,None,No Change,0
3114,PT-03114,40,F,Fortis Mumbai,Phase IV,ORX-303,Cardiology,Low Dose,2024-11-04,2024-11-11,6.79,6.52,140,77,83,None,None,Worsened,0
3115,PT-03115,45,M,Indore Medical Institute,Phase III,ORX-606,Rheumatology,Low Dose,2024-07-17,2024-07-31,8.32,7.75,126,77,75,None,None,No Change,0
3116,PT-03116,32,F,Kolkata Clinical Center,Phase II,ORX-202,Diabetes,Low Dose,2023-04-10,2023-06-05,6.14,6.44,108,78,92,None,None,Improved,0
3117,PT-03117,39,F,Apollo Chennai,Phase II,ORX-606,Rheumatology,Placebo,2023-01-31,2023-05-01,8.19,7.26,109,62,96,None,None,Improved,1
3118,PT-03118,26,M,Apollo Chennai,Phase III,ORX-101,Oncology,Low Dose,2023-10-12,2023-10-19,8.1,6.8,151,108,54,Nausea,Severe,Improved,1
3119,PT-03119,27,F,Fortis Mumbai,Phase II,ORX-404,Neurology,High Dose,2023-06-06,2023-09-04,8.13,8.19,141,75,105,Headache,None,No Change,0
3120,PT-03120,46,F,PGI Chandigarh,Phase II,ORX-202,Diabetes,Low Dose,2023-12-02,2024-01-27,5.74,5.11,106,101,68,None,None,Improved,1
3121,PT-03121,52,M,Apollo Chennai,Phase I,ORX-303,Cardiology,Placebo,2024-01-27,2024-03-23,6.64,5.68,93,89,96,Rash,Severe,Improved,1
3122,PT-03122,30,M,PGI Chandigarh,Phase II,ORX-505,Infectious Disease,Low Dose,2023-02-14,2023-03-14,5.35,5.67,98,96,65,None,None,Improved,0
3123,PT-03123,27,M,Indore Medical Institute,Phase III,ORX-303,Cardiology,Placebo,2024-02-17,2024-04-13,7.5,6.16,115,86,45,None,None,Improved,1
3124,PT-03124,71,M,Apollo Chennai,Phase III,ORX-505,Infectious Disease,Placebo,2024-06-23,2024-09-21,7.25,5.69,109,93,86,None,None,Improved,1
3125,PT-03125,67,M,NIMHANS Bengaluru,Phase III,ORX-202,Diabetes,Low Dose,2023-12-01,2023-12-15,6.38,6.25,135,90,93,Nausea,Moderate,Improved,1
3126,PT-03126,33,F,AIIMS Delhi,Phase II,ORX-101,Oncology,Placebo,2023-09-23,2023-12-22,7.06,6.11,127,90,54,None,None,Improved,1
3127,PT-03127,62,F,Bhopal Research Hospital,Phase II,ORX-202,Diabetes,High Dose,2023-08-29,2023-10-24,5.83,5.16,150,85,82,None,None,Improved,1
3128,PT-03128,26,M,Bhopal Research Hospital,Phase IV,ORX-505,Infectious Disease,Placebo,2023-06-06,2023-08-01,5.95,6.39,117,76,91,Nausea,Moderate,No Change,0
3129,PT-03129,28,F,Apollo Chennai,Phase III,ORX-606,Rheumatology,Low Dose,2023-01-07,2023-03-04,7.52,7.16,127,75,69,None,None,Improved,1
3130,PT-03130,27,M,Bhopal Research Hospital,Phase IV,ORX-101,Oncology,High Dose,2024-09-22,2024-10-06,7.78,6.78,145,79,63,Rash,None,No Change,0
3131,PT-03131,41,M,Kolkata Clinical Center,Phase IV,ORX-404,Neurology,Low Dose,2024-11-16,2024-11-30,6.71,7.22,121,78,97,Fever,None,Improved,0
3132,PT-03132,53,M,Apollo Chennai,Phase II,ORX-101,Oncology,Low Dose,2023-04-24,2023-07-23,9.2,9.93,112,93,99,None,None,No Change,0
3133,PT-03133,69,F,Apollo Chennai,Phase IV,ORX-202,Diabetes,Low Dose,2023-04-29,2023-06-24,8.39,8.86,122,71,73,Nausea,None,Worsened,0
3134,PT-03134,18,F,PGI Chandigarh,Phase I,ORX-404,Neurology,Placebo,2023-10-09,2023-10-16,8.81,8.16,151,67,93,Fatigue,None,No Change,0
3135,PT-03135,37,F,Kolkata Clinical Center,Phase III,ORX-505,Infectious Disease,Placebo,2023-01-23,2023-02-06,5.66,6.72,147,84,78,Rash,None,Improved,0
3136,PT-03136,52,F,Kolkata Clinical Center,Phase II,ORX-202,Diabetes,High Dose,2023-06-06,2023-08-01,7.43,6.32,120,105,115,Fever,Mild,Improved,1
3137,PT-03137,70,M,Fortis Mumbai,Phase III,ORX-101,Oncology,Placebo,2024-04-05,2024-05-03,7.77,7.07,113,73,70,Nausea,Mild,Improved,1
3138,PT-03138,79,F,Apollo Chennai,Phase I,ORX-202,Diabetes,Low Dose,2023-08-23,2023-10-18,9.37,9.64,110,92,74,Fever,None,No Change,0
3139,PT-03139,18,M,NIMHANS Bengaluru,Phase III,ORX-303,Cardiology,Placebo,2024-01-30,2024-02-06,7.54,6.39,113,78,71,None,None,Improved,1
3140,PT-03140,44,F,Bhopal Research Hospital,Phase II,ORX-606,Rheumatology,Low Dose,2023-02-16,2023-03-16,7.1,5.01,155,70,64,Dizziness,None,Improved,1
3141,PT-03141,39,M,NIMHANS Bengaluru,Phase I,ORX-606,Rheumatology,Low Dose,2024-02-21,2024-02-28,7.07,7.98,132,88,81,None,None,Improved,0
3142,PT-03142,48,M,Fortis Mumbai,Phase II,ORX-101,Oncology,Placebo,2024-03-27,2024-04-24,7.57,5.43,123,95,130,None,None,Worsened,0
3143,PT-03143,25,F,NIMHANS Bengaluru,Phase IV,ORX-606,Rheumatology,Low Dose,2024-06-15,2024-09-13,7.71,6.79,164,65,86,None,None,Improved,1
3144,PT-03144,22,M,Apollo Chennai,Phase III,ORX-404,Neurology,High Dose,2023-01-26,2023-02-02,6.82,6.39,147,69,87,None,None,Worsened,0
3145,PT-03145,45,F,Bhopal Research Hospital,Phase I,ORX-404,Neurology,Low Dose,2023-08-16,2023-10-11,7.53,7.99,104,91,70,Fatigue,Mild,Improved,0
3146,PT-03146,62,M,Indore Medical Institute,Phase III,ORX-404,Neurology,Low Dose,2023-04-24,2023-05-01,7.6,7.01,117,91,95,Nausea,Mild,Improved,1
3147,PT-03147,36,M,Fortis Mumbai,Phase IV,ORX-505,Infectious Disease,Placebo,2023-04-06,2023-05-04,5.84,6.07,101,66,63,None,None,Improved,0
3148,PT-03148,38,F,NIMHANS Bengaluru,Phase II,ORX-404,Neurology,Placebo,2023-08-26,2023-09-09,5.6,3.45,107,89,60,None,None,No Change,0
3149,PT-03149,39,F,PGI Chandigarh,Phase IV,ORX-303,Cardiology,High Dose,2023-08-23,2023-11-21,9.54,9.09,134,70,108,None,None,Worsened,0
3150,PT-03150,36,M,Apollo Chennai,Phase III,ORX-303,Cardiology,Placebo,2023-01-02,2023-01-09,6.93,7.71,124,82,74,Headache,Mild,Improved,0
3151,PT-03151,40,M,NIMHANS Bengaluru,Phase II,ORX-303,Cardiology,Placebo,2024-01-31,2024-02-07,7.64,7.74,116,72,69,Nausea,Mild,Worsened,0
3152,PT-03152,22,F,Kolkata Clinical Center,Phase II,ORX-202,Diabetes,High Dose,2023-11-07,2024-01-02,5.29,5.16,144,92,45,None,None,No Change,0
3153,PT-03153,41,F,AIIMS Delhi,Phase III,ORX-202,Diabetes,High Dose,2024-07-27,2024-08-24,5.88,,120,89,77,None,None,No Change,0
3154,PT-03154,18,F,Apollo Chennai,Phase IV,ORX-505,Infectious Disease,Placebo,2024-05-05,2024-06-30,6.04,5.64,129,65,56,Nausea,None,No Change,0
3155,PT-03155,45,M,Apollo Chennai,Phase IV,ORX-303,Cardiology,Low Dose,2023-05-08,2023-07-03,5.52,3.61,119,76,65,None,None,Worsened,0
3156,PT-03156,33,M,PGI Chandigarh,Phase III,ORX-303,Cardiology,Low Dose,2023-04-14,2023-06-09,7.22,6.17,129,77,80,Rash,None,Worsened,0
3157,PT-03157,59,M,Bhopal Research Hospital,Phase I,ORX-404,Neurology,Placebo,2023-01-26,2023-03-23,8.21,8.97,143,84,71,Nausea,Mild,No Change,0
3158,PT-03158,38,F,NIMHANS Bengaluru,Phase III,ORX-303,Cardiology,Low Dose,2024-08-29,2024-11-27,6.15,5.75,140,73,77,None,None,No Change,0
3159,PT-03159,34,M,PGI Chandigarh,Phase IV,ORX-303,Cardiology,Low Dose,2023-08-25,2023-11-23,7.45,6.56,114,73,85,None,None,No Change,0
3160,PT-03160,43,M,Bhopal Research Hospital,Phase III,ORX-606,Rheumatology,Low Dose,2024-02-09,2024-04-05,6.69,6.52,120,95,64,Nausea,None,Worsened,0
3161,PT-03161,42,F,Indore Medical Institute,Phase I,ORX-303,Cardiology,Placebo,2023-06-27,2023-08-22,5.51,4.8,97,90,88,None,None,Worsened,0
3162,PT-03162,57,M,Bhopal Research Hospital,Phase III,ORX-606,Rheumatology,High Dose,2023-02-26,2023-03-05,7.23,6.04,113,100,98,None,None,No Change,0
3163,PT-03163,46,F,Kolkata Clinical Center,Phase I,ORX-202,Diabetes,Low Dose,2023-09-16,2023-12-15,6.58,7.41,115,84,96,None,None,No Change,0
3164,PT-03164,31,M,Indore Medical Institute,Phase IV,ORX-101,Oncology,High Dose,2024-07-23,2024-10-21,8.2,,127,70,67,Headache,None,Improved,0
3165,PT-03165,49,F,NIMHANS Bengaluru,Phase III,ORX-505,Infectious Disease,Low Dose,2024-11-27,2025-02-25,5.49,5.21,137,93,58,None,None,Worsened,0
3166,PT-03166,66,M,Apollo Chennai,Phase III,ORX-101,Oncology,Placebo,2024-11-12,2024-12-10,9.23,9.2,109,78,77,None,None,Improved,1
3167,PT-03167,49,F,Apollo Chennai,Phase IV,ORX-606,Rheumatology,High Dose,2024-01-07,2024-02-04,7.23,7.08,126,85,71,None,None,No Change,0
3168,PT-03168,39,M,Bhopal Research Hospital,Phase I,ORX-505,Infectious Disease,Low Dose,2023-05-24,2023-05-31,6.51,7.83,154,88,96,Headache,None,Improved,0
3169,PT-03169,57,F,Bhopal Research Hospital,Phase III,ORX-404,Neurology,Low Dose,2024-10-15,2024-10-29,7.42,5.66,123,77,62,None,None,No Change,0
3170,PT-03170,21,F,Bhopal Research Hospital,Phase II,ORX-606,Rheumatology,Low Dose,2024-09-14,2024-09-28,7.79,7.68,106,73,94,None,None,Improved,1
3171,PT-03171,30,M,Kolkata Clinical Center,Phase III,ORX-404,Neurology,Placebo,2023-09-07,2023-09-21,7.4,6.83,137,71,79,Nausea,None,Improved,1
3172,PT-03172,47,M,PGI Chandigarh,Phase III,ORX-202,Diabetes,High Dose,2024-06-30,2024-07-14,7.48,7.15,134,108,113,Nausea,None,Worsened,0
3173,PT-03173,34,F,AIIMS Delhi,Phase IV,ORX-404,Neurology,High Dose,2023-09-04,2023-10-30,4.42,4.55,131,94,81,Nausea,Mild,No Change,0
3174,PT-03174,45,F,AIIMS Delhi,Phase III,ORX-202,Diabetes,Low Dose,2024-09-21,2024-11-16,8.55,9.3,103,72,76,None,None,No Change,0
3175,PT-03175,46,F,Apollo Chennai,Phase III,ORX-606,Rheumatology,Low Dose,2024-07-09,2024-09-03,6.93,6.92,145,102,86,Fatigue,Moderate,Improved,1
3176,PT-03176,31,M,Apollo Chennai,Phase II,ORX-202,Diabetes,Placebo,2023-09-21,2023-09-28,7.02,6.56,137,86,106,None,None,No Change,0
3177,PT-03177,37,F,Kolkata Clinical Center,Phase III,ORX-101,Oncology,High Dose,2023-11-21,2023-12-19,7.66,9.38,117,83,64,Nausea,Mild,No Change,0
3178,PT-03178,46,F,AIIMS Delhi,Phase III,ORX-404,Neurology,Low Dose,2024-09-16,2024-09-23,6.26,6.81,130,70,89,None,None,Improved,0
3179,PT-03179,47,M,Indore Medical Institute,Phase III,ORX-606,Rheumatology,High Dose,2024-02-04,2024-02-18,8.34,6.91,134,91,72,None,None,Improved,1
3180,PT-03180,24,M,NIMHANS Bengaluru,Phase IV,ORX-404,Neurology,High Dose,2023-08-10,2023-08-24,7.15,7.86,148,76,60,None,None,Improved,0
3181,PT-03181,38,M,Indore Medical Institute,Phase III,ORX-202,Diabetes,Low Dose,2023-12-19,2024-03-18,6.64,6.64,126,72,93,Dizziness,None,No Change,0
3182,PT-03182,47,M,Apollo Chennai,Phase III,ORX-505,Infectious Disease,High Dose,2024-05-15,2024-08-13,7.72,5.77,90,64,71,None,None,Improved,1
3183,PT-03183,54,M,Kolkata Clinical Center,Phase II,ORX-303,Cardiology,High Dose,2023-03-17,2023-03-24,4.39,5.42,131,98,65,None,None,Improved,0
3184,PT-03184,53,F,Kolkata Clinical Center,Phase IV,ORX-101,Oncology,Placebo,2024-06-24,2024-08-19,7.3,7.64,123,87,93,None,None,Improved,0
3185,PT-03185,34,F,Bhopal Research Hospital,Phase IV,ORX-101,Oncology,Placebo,2024-07-22,2024-08-19,7.49,5.39,140,105,60,None,None,No Change,0
3186,PT-03186,43,M,Indore Medical Institute,Phase I,ORX-505,Infectious Disease,Placebo,2024-02-12,2024-02-26,8.26,7.88,130,77,72,Dizziness,Mild,Improved,1
3187,PT-03187,43,M,AIIMS Delhi,Phase III,ORX-505,Infectious Disease,Low Dose,2023-06-25,2023-07-02,7.25,5.79,126,100,72,None,None,Improved,1
3188,PT-03188,25,M,Kolkata Clinical Center,Phase I,ORX-202,Diabetes,High Dose,2023-12-28,2024-01-25,7.02,5.98,103,83,68,None,None,Improved,1
3189,PT-03189,35,M,Indore Medical Institute,Phase III,ORX-101,Oncology,Low Dose,2023-01-24,2023-04-24,7.38,5.6,96,90,50,None,None,Improved,1
3190,PT-03190,29,F,Bhopal Research Hospital,Phase III,ORX-404,Neurology,High Dose,2023-06-14,2023-08-09,5.04,4.2,135,83,111,None,None,No Change,0
3191,PT-03191,62,M,PGI Chandigarh,Phase III,ORX-101,Oncology,Placebo,2023-12-02,2023-12-30,6.08,4.61,176,94,86,Headache,None,Improved,1
3192,PT-03192,46,F,Indore Medical Institute,Phase IV,ORX-505,Infectious Disease,Placebo,2023-11-07,2024-02-05,7.53,5.79,130,82,65,Headache,None,No Change,0
3193,PT-03193,36,M,Indore Medical Institute,Phase II,ORX-101,Oncology,Placebo,2023-01-11,2023-03-08,9.02,8.51,165,61,70,None,None,Improved,1
3194,PT-03194,20,M,Apollo Chennai,Phase II,ORX-101,Oncology,High Dose,2023-07-14,2023-08-11,5.75,4.6,133,85,68,Fatigue,Mild,No Change,0
3195,PT-03195,18,M,PGI Chandigarh,Phase IV,ORX-202,Diabetes,Low Dose,2024-03-21,2024-06-19,8.97,8.32,107,85,80,Dizziness,None,Improved,1
3196,PT-03196,39,M,NIMHANS Bengaluru,Phase IV,ORX-202,Diabetes,Placebo,2024-03-12,2024-06-10,7.38,5.94,141,70,69,Nausea,Mild,Improved,1
3197,PT-03197,55,F,Apollo Chennai,Phase I,ORX-101,Oncology,Placebo,2023-10-13,2023-11-10,8.64,9.67,147,78,56,None,None,Improved,0
3198,PT-03198,67,M,Fortis Mumbai,Phase III,ORX-505,Infectious Disease,Low Dose,2023-02-01,2023-05-02,8.84,7.84,144,78,99,Headache,None,Improved,1
3199,PT-03199,36,M,Bhopal Research Hospital,Phase I,ORX-404,Neurology,Low Dose,2023-05-27,2023-08-25,9.57,9.88,160,76,83,Rash,None,Worsened,0
3200,PT-03200,29,M,Fortis Mumbai,Phase III,ORX-101,Oncology,Placebo,2023-01-07,2023-02-04,8.21,8.62,171,87,88,Nausea,Severe,No Change,0
3201,PT-03201,37,F,NIMHANS Bengaluru,Phase III,ORX-101,Oncology,High Dose,2023-07-19,2023-07-26,7.85,7.11,130,84,73,None,None,Improved,1
3202,PT-03202,46,F,Apollo Chennai,Phase II,ORX-606,Rheumatology,Placebo,2024-11-07,2025-02-05,6.75,6.01,147,84,82,None,None,Worsened,0
3203,PT-03203,21,M,Kolkata Clinical Center,Phase IV,ORX-606,Rheumatology,Low Dose,2023-12-25,2024-01-22,7.71,7.79,120,107,45,Dizziness,Moderate,No Change,0
3204,PT-03204,57,F,NIMHANS Bengaluru,Phase III,ORX-202,Diabetes,High Dose,2024-11-23,2024-12-07,8.06,8.14,131,88,90,None,None,No Change,0
3205,PT-03205,33,M,PGI Chandigarh,Phase I,ORX-202,Diabetes,High Dose,2023-11-24,2024-02-22,7.56,6.99,108,90,70,Rash,None,No Change,0
3206,PT-03206,21,M,Apollo Chennai,Phase III,ORX-101,Oncology,High Dose,2023-10-10,2024-01-08,6.55,5.43,146,83,97,Fever,None,No Change,0
3207,PT-03207,34,F,Indore Medical Institute,Phase III,ORX-606,Rheumatology,High Dose,2024-04-27,2024-05-04,8.25,10.4,134,92,87,None,None,No Change,0
3208,PT-03208,22,F,AIIMS Delhi,Phase III,ORX-202,Diabetes,Low Dose,2023-08-14,2023-09-11,7.9,7.78,123,71,87,None,None,Worsened,0
3209,PT-03209,29,F,PGI Chandigarh,Phase III,ORX-505,Infectious Disease,High Dose,2023-02-16,2023-03-16,9.76,9.46,105,75,74,None,None,No Change,0
3210,PT-03210,83,F,Kolkata Clinical Center,Phase III,ORX-404,Neurology,Low Dose,2023-04-01,2023-04-08,6.14,5.63,118,87,70,Headache,Severe,No Change,0
3211,PT-03211,26,M,Fortis Mumbai,Phase I,ORX-303,Cardiology,Low Dose,2023-05-27,2023-07-22,6.97,6.3,117,75,94,None,None,Worsened,0
3212,PT-03212,39,M,NIMHANS Bengaluru,Phase I,ORX-101,Oncology,Low Dose,2024-01-01,2024-03-31,5.84,5.02,128,65,100,Fatigue,None,No Change,0
3213,PT-03213,58,M,AIIMS Delhi,Phase IV,ORX-202,Diabetes,Placebo,2023-07-30,2023-08-13,8.92,8.87,90,100,65,None,None,Improved,1
3214,PT-03214,32,F,Apollo Chennai,Phase I,ORX-303,Cardiology,Low Dose,2024-11-28,2024-12-05,7.39,8.23,146,92,73,None,None,Improved,0
3215,PT-03215,39,M,Kolkata Clinical Center,Phase I,ORX-303,Cardiology,Low Dose,2023-04-19,2023-04-26,7.62,7.1,144,91,86,Headache,Mild,No Change,0
3216,PT-03216,18,F,AIIMS Delhi,Phase III,ORX-404,Neurology,Placebo,2023-12-03,2024-01-28,7.35,6.86,131,72,59,Fatigue,Moderate,Worsened,0
3217,PT-03217,52,M,Kolkata Clinical Center,Phase II,ORX-606,Rheumatology,Low Dose,2024-06-15,2024-07-13,6.77,6.89,115,98,92,None,None,Worsened,0
3218,PT-03218,49,F,NIMHANS Bengaluru,Phase III,ORX-505,Infectious Disease,High Dose,2024-07-13,2024-08-10,6.94,7.31,135,84,92,Fever,None,No Change,0
3219,PT-03219,67,M,Indore Medical Institute,Phase I,ORX-606,Rheumatology,Placebo,2023-08-31,2023-10-26,5.7,4.35,113,63,77,Nausea,Severe,No Change,0
3220,PT-03220,54,F,PGI Chandigarh,Phase III,ORX-404,Neurology,High Dose,2024-10-19,2024-11-16,7.17,6.29,148,83,82,None,None,Worsened,0
3221,PT-03221,63,M,Indore Medical Institute,Phase III,ORX-404,Neurology,Low Dose,2023-06-24,2023-08-19,7.05,8.51,119,105,64,Nausea,Moderate,Improved,0
3222,PT-03222,53,F,Fortis Mumbai,Phase III,ORX-404,Neurology,High Dose,2024-08-04,2024-08-11,6.43,7.04,119,85,68,None,None,No Change,0
3223,PT-03223,59,F,Apollo Chennai,Phase II,ORX-505,Infectious Disease,Low Dose,2024-10-03,2025-01-01,6.41,7.53,110,65,91,None,None,No Change,0
3224,PT-03224,35,F,PGI Chandigarh,Phase II,ORX-404,Neurology,Low Dose,2023-08-17,2023-10-12,7.19,6.5,104,81,95,Nausea,Mild,Improved,1
3225,PT-03225,61,M,Fortis Mumbai,Phase II,ORX-202,Diabetes,High Dose,2024-11-24,2024-12-01,7.48,8.08,108,78,83,Dizziness,None,Improved,0
3226,PT-03226,42,F,Bhopal Research Hospital,Phase III,ORX-606,Rheumatology,High Dose,2024-04-21,2024-06-16,6.9,5.42,90,91,81,Dizziness,Mild,Improved,1
3227,PT-03227,59,M,Indore Medical Institute,Phase II,ORX-606,Rheumatology,Low Dose,2024-05-18,2024-08-16,6.68,5.63,128,92,74,None,None,Improved,1
3228,PT-03228,57,M,Apollo Chennai,Phase I,ORX-606,Rheumatology,High Dose,2023-11-26,2023-12-24,5.99,5.45,126,96,80,Fatigue,None,Improved,1
3229,PT-03229,72,F,PGI Chandigarh,Phase I,ORX-606,Rheumatology,High Dose,2023-07-11,2023-07-25,5.58,5.3,131,89,66,Fever,None,Improved,1
3230,PT-03230,71,F,AIIMS Delhi,Phase II,ORX-404,Neurology,Placebo,2024-11-18,2024-12-16,7.22,5.84,127,78,116,None,None,No Change,0
3231,PT-03231,61,F,Indore Medical Institute,Phase II,ORX-202,Diabetes,Placebo,2023-05-12,2023-05-26,7.26,6.76,145,93,45,None,None,Improved,1
3232,PT-03232,55,F,PGI Chandigarh,Phase III,ORX-101,Oncology,Low Dose,2024-01-01,2024-01-29,7.23,5.65,143,108,85,Headache,Severe,Improved,1
3233,PT-03233,62,M,AIIMS Delhi,Phase IV,ORX-101,Oncology,Placebo,2023-04-27,2023-06-22,9.36,8.22,94,89,74,None,None,Improved,1
3234,PT-03234,23,F,PGI Chandigarh,Phase II,ORX-505,Infectious Disease,Placebo,2024-04-26,2024-06-21,7.11,7.36,125,72,74,None,None,Improved,0
3235,PT-03235,44,M,Bhopal Research Hospital,Phase IV,ORX-606,Rheumatology,Placebo,2024-11-24,2024-12-01,4.88,4.36,103,89,56,None,None,No Change,0
3236,PT-03236,61,F,Bhopal Research Hospital,Phase III,ORX-202,Diabetes,Placebo,2023-06-03,2023-09-01,6.71,5.82,133,71,81,Nausea,Mild,No Change,0
3237,PT-03237,33,F,Fortis Mumbai,Phase II,ORX-404,Neurology,Low Dose,2023-12-28,2024-01-11,6.53,6.5,107,66,81,Dizziness,None,No Change,0
3238,PT-03238,44,F,PGI Chandigarh,Phase III,ORX-505,Infectious Disease,Low Dose,2023-05-10,2023-07-05,7.4,7.3,129,89,79,None,None,Improved,1
3239,PT-03239,18,M,Kolkata Clinical Center,Phase III,ORX-505,Infectious Disease,Low Dose,2024-11-19,2024-12-17,5.1,6.44,128,93,73,None,None,Worsened,0
3240,PT-03240,44,M,Apollo Chennai,Phase III,ORX-505,Infectious Disease,High Dose,2023-03-05,2023-04-02,6.66,8.48,132,75,54,None,None,No Change,0
3241,PT-03241,76,M,Apollo Chennai,Phase III,ORX-404,Neurology,Low Dose,2024-11-07,2024-11-21,7.0,7.27,143,76,87,None,None,Worsened,0
3242,PT-03242,35,M,AIIMS Delhi,Phase II,ORX-202,Diabetes,Placebo,2024-03-30,2024-04-27,6.01,6.66,125,88,83,Headache,None,Worsened,0
3243,PT-03243,55,F,Indore Medical Institute,Phase III,ORX-404,Neurology,Low Dose,2024-04-18,2024-04-25,5.33,4.41,122,72,84,None,None,Worsened,0
3244,PT-03244,63,F,AIIMS Delhi,Phase III,ORX-101,Oncology,Placebo,2024-08-21,2024-09-04,8.81,8.11,133,87,86,Nausea,None,Improved,1
3245,PT-03245,30,F,Bhopal Research Hospital,Phase IV,ORX-404,Neurology,Placebo,2023-03-17,2023-06-15,9.38,9.82,145,96,85,Headache,Mild,No Change,0
3246,PT-03246,28,M,Bhopal Research Hospital,Phase III,ORX-606,Rheumatology,Low Dose,2024-08-14,2024-10-09,7.03,5.15,135,79,77,Nausea,None,No Change,0
3247,PT-03247,64,F,Kolkata Clinical Center,Phase II,ORX-101,Oncology,Placebo,2024-03-03,2024-03-10,6.65,6.02,128,59,74,Fatigue,None,Worsened,0
3248,PT-03248,18,M,Kolkata Clinical Center,Phase III,ORX-404,Neurology,High Dose,2023-07-06,2023-08-31,6.5,6.87,136,74,78,None,None,No Change,0
3249,PT-03249,27,F,Kolkata Clinical Center,Phase III,ORX-202,Diabetes,High Dose,2023-05-29,2023-06-05,7.2,9.43,161,82,80,None,None,Improved,0
3250,PT-03250,29,M,AIIMS Delhi,Phase IV,ORX-404,Neurology,High Dose,2024-07-20,2024-07-27,6.24,6.16,118,92,99,None,None,Worsened,0
3251,PT-03251,50,F,PGI Chandigarh,Phase II,ORX-202,Diabetes,High Dose,2023-10-05,2023-11-30,7.32,5.41,141,68,72,Rash,None,Improved,1
3252,PT-03252,60,M,Fortis Mumbai,Phase III,ORX-404,Neurology,Placebo,2024-10-04,2024-11-01,8.44,7.62,120,73,61,Fever,None,Worsened,0
3253,PT-03253,34,F,Kolkata Clinical Center,Phase II,ORX-606,Rheumatology,Placebo,2024-05-21,2024-08-19,5.26,5.48,135,88,64,None,None,Worsened,0
3254,PT-03254,25,F,Fortis Mumbai,Phase I,ORX-404,Neurology,Low Dose,2024-04-24,2024-06-19,7.26,6.92,125,78,101,None,None,No Change,0
3255,PT-03255,51,F,Kolkata Clinical Center,Phase I,ORX-202,Diabetes,Low Dose,2023-06-08,2023-08-03,9.56,10.31,158,69,86,Rash,None,Improved,0
3256,PT-03256,38,M,Bhopal Research Hospital,Phase IV,ORX-606,Rheumatology,Low Dose,2024-01-22,2024-02-19,5.2,6.15,122,69,72,None,None,Improved,0
3257,PT-03257,32,F,Kolkata Clinical Center,Phase II,ORX-101,Oncology,Low Dose,2024-03-10,2024-03-17,6.37,5.77,159,74,101,Headache,None,Improved,1
3258,PT-03258,58,M,Bhopal Research Hospital,Phase III,ORX-606,Rheumatology,High Dose,2024-10-18,2024-12-13,7.68,7.95,128,97,85,Fever,Severe,Improved,0
3259,PT-03259,18,F,AIIMS Delhi,Phase III,ORX-404,Neurology,Low Dose,2023-07-15,2023-07-22,7.56,7.86,122,83,69,Headache,Severe,Worsened,0
3260,PT-03260,22,M,PGI Chandigarh,Phase III,ORX-202,Diabetes,High Dose,2024-11-19,2024-12-17,5.34,3.56,140,52,68,None,None,Improved,1
3261,PT-03261,32,M,Bhopal Research Hospital,Phase I,ORX-505,Infectious Disease,Low Dose,2023-09-25,2023-12-24,6.86,4.79,135,66,93,None,None,Improved,1
3262,PT-03262,35,M,NIMHANS Bengaluru,Phase III,ORX-404,Neurology,High Dose,2023-04-16,2023-05-14,7.09,6.69,132,82,72,None,None,Improved,1
3263,PT-03263,50,M,Indore Medical Institute,Phase III,ORX-404,Neurology,High Dose,2023-03-01,2023-03-29,7.76,6.67,135,96,87,None,None,Improved,1
3264,PT-03264,59,F,NIMHANS Bengaluru,Phase III,ORX-404,Neurology,High Dose,2024-10-25,2024-11-22,7.41,6.16,113,85,91,Nausea,None,Improved,1
3265,PT-03265,85,M,Indore Medical Institute,Phase I,ORX-101,Oncology,High Dose,2023-02-22,2023-03-01,8.38,6.92,114,109,74,Headache,None,Improved,1
3266,PT-03266,45,M,Indore Medical Institute,Phase I,ORX-202,Diabetes,Low Dose,2023-10-23,2024-01-21,6.05,7.06,137,72,64,Headache,Moderate,Improved,0
3267,PT-03267,49,M,AIIMS Delhi,Phase III,ORX-101,Oncology,Placebo,2024-11-21,2024-12-05,7.25,7.6,137,78,70,Fatigue,None,No Change,0
3268,PT-03268,42,F,Kolkata Clinical Center,Phase II,ORX-606,Rheumatology,High Dose,2024-11-10,2024-12-08,6.54,6.02,128,71,86,Fatigue,None,No Change,0
3269,PT-03269,39,F,Fortis Mumbai,Phase III,ORX-202,Diabetes,Low Dose,2024-01-28,2024-04-27,6.19,5.47,132,82,83,None,None,No Change,0
3270,PT-03270,59,M,Bhopal Research Hospital,Phase I,ORX-404,Neurology,Placebo,2023-12-24,2024-01-07,8.77,8.62,108,78,63,None,None,Improved,1
3271,PT-03271,72,F,Apollo Chennai,Phase I,ORX-202,Diabetes,Low Dose,2024-09-19,2024-10-03,9.58,9.77,143,85,83,Headache,Mild,Worsened,0
3272,PT-03272,19,F,Kolkata Clinical Center,Phase III,ORX-404,Neurology,Low Dose,2024-11-23,2025-01-18,7.11,5.92,133,81,105,None,None,No Change,0
3273,PT-03273,59,F,Bhopal Research Hospital,Phase II,ORX-404,Neurology,Low Dose,2024-11-04,2024-11-11,7.54,6.9,158,81,82,None,None,No Change,0
3274,PT-03274,45,F,Bhopal Research Hospital,Phase III,ORX-303,Cardiology,Placebo,2024-09-18,2024-09-25,6.72,6.35,92,63,82,None,None,Improved,1
3275,PT-03275,70,F,AIIMS Delhi,Phase III,ORX-303,Cardiology,High Dose,2024-11-21,2024-12-19,7.62,6.57,102,91,70,None,None,Improved,1
3276,PT-03276,55,M,NIMHANS Bengaluru,Phase III,ORX-202,Diabetes,Placebo,2024-01-18,2024-02-01,7.67,7.7,128,86,76,Fever,Mild,Improved,0
3277,PT-03277,34,M,Bhopal Research Hospital,Phase I,ORX-101,Oncology,High Dose,2023-02-28,2023-05-29,6.04,3.5,124,100,88,Headache,None,Improved,1
3278,PT-03278,48,F,NIMHANS Bengaluru,Phase III,ORX-505,Infectious Disease,Low Dose,2024-11-15,2024-12-13,6.32,6.82,125,100,64,Rash,None,No Change,0
3279,PT-03279,33,F,NIMHANS Bengaluru,Phase III,ORX-101,Oncology,Low Dose,2023-08-03,2023-08-10,6.18,4.45,111,83,68,None,None,No Change,0
3280,PT-03280,18,M,Indore Medical Institute,Phase III,ORX-101,Oncology,High Dose,2023-06-01,2023-07-27,8.49,6.57,138,82,107,None,None,Improved,1
3281,PT-03281,60,F,AIIMS Delhi,Phase III,ORX-101,Oncology,Low Dose,2023-12-06,2024-01-03,6.59,,155,64,80,None,None,Improved,1
3282,PT-03282,42,F,Bhopal Research Hospital,Phase IV,ORX-606,Rheumatology,Low Dose,2023-03-07,2023-04-04,6.79,6.71,131,87,79,Headache,Mild,Improved,1
3283,PT-03283,51,F,NIMHANS Bengaluru,Phase III,ORX-101,Oncology,Placebo,2024-08-20,2024-09-03,7.31,6.32,128,73,67,Dizziness,None,Worsened,0
3284,PT-03284,39,F,AIIMS Delhi,Phase III,ORX-101,Oncology,Placebo,2023-03-22,2023-05-17,7.06,6.69,144,76,80,None,None,Improved,1
3285,PT-03285,46,M,PGI Chandigarh,Phase III,ORX-202,Diabetes,Low Dose,2023-07-05,2023-08-30,6.47,6.14,146,84,81,Dizziness,None,Improved,1
3286,PT-03286,33,F,Kolkata Clinical Center,Phase III,ORX-404,Neurology,Low Dose,2023-10-13,2023-11-10,9.56,8.58,97,92,76,Fatigue,Mild,Improved,1
3287,PT-03287,40,M,Indore Medical Institute,Phase II,ORX-101,Oncology,High Dose,2023-05-20,2023-08-18,6.55,7.83,134,88,80,Fever,None,Worsened,0
3288,PT-03288,49,M,NIMHANS Bengaluru,Phase III,ORX-202,Diabetes,High Dose,2023-12-07,2023-12-14,8.88,8.25,101,92,84,Nausea,None,Worsened,0
3289,PT-03289,46,M,Indore Medical Institute,Phase III,ORX-101,Oncology,Placebo,2023-10-13,2024-01-11,7.76,7.03,128,80,69,None,None,Improved,1
3290,PT-03290,64,M,PGI Chandigarh,Phase III,ORX-404,Neurology,Placebo,2023-03-13,2023-04-10,5.51,7.23,143,60,74,Rash,None,Improved,0
3291,PT-03291,42,M,Apollo Chennai,Phase III,ORX-101,Oncology,High Dose,2024-04-21,2024-04-28,7.67,6.38,128,80,67,None,None,No Change,0
3292,PT-03292,30,F,PGI Chandigarh,Phase III,ORX-202,Diabetes,Placebo,2023-02-05,2023-02-19,8.3,6.38,136,91,74,None,None,No Change,0
3293,PT-03293,45,F,Indore Medical Institute,Phase II,ORX-202,Diabetes,High Dose,2024-11-22,2024-12-06,8.6,7.56,117,76,94,Fatigue,Mild,No Change,0
3294,PT-03294,65,F,NIMHANS Bengaluru,Phase I,ORX-606,Rheumatology,Low Dose,2023-10-19,2023-11-16,5.52,6.03,142,100,83,Fatigue,None,Improved,0
3295,PT-03295,44,M,Bhopal Research Hospital,Phase III,ORX-202,Diabetes,Low Dose,2023-08-03,2023-11-01,8.57,8.8,168,93,80,None,None,No Change,0
3296,PT-03296,26,M,Kolkata Clinical Center,Phase III,ORX-505,Infectious Disease,High Dose,2023-02-18,2023-04-15,6.5,4.81,124,93,77,None,None,Improved,1
3297,PT-03297,61,F,PGI Chandigarh,Phase II,ORX-505,Infectious Disease,Low Dose,2023-08-26,2023-09-23,7.61,,129,87,79,Headache,None,Improved,1
3298,PT-03298,47,M,AIIMS Delhi,Phase II,ORX-303,Cardiology,Placebo,2023-06-25,2023-09-23,6.28,5.49,168,96,57,None,None,No Change,0
3299,PT-03299,18,M,PGI Chandigarh,Phase IV,ORX-505,Infectious Disease,Placebo,2024-08-26,2024-11-24,7.29,7.7,118,94,78,None,None,Improved,0
3300,PT-03300,42,M,Fortis Mumbai,Phase IV,ORX-404,Neurology,High Dose,2023-12-03,2023-12-17,8.11,7.23,122,90,77,None,None,Improved,1
3301,PT-03301,75,M,AIIMS Delhi,Phase III,ORX-505,Infectious Disease,Low Dose,2024-04-16,2024-04-23,8.03,8.2,127,92,73,Headache,None,No Change,0
3302,PT-03302,49,M,Apollo Chennai,Phase IV,ORX-404,Neurology,High Dose,2024-06-19,2024-08-14,6.1,6.64,133,105,111,None,None,Worsened,0
3303,PT-03303,57,F,Kolkata Clinical Center,Phase IV,ORX-505,Infectious Disease,Low Dose,2024-03-13,2024-06-11,7.28,6.03,144,84,85,Headache,None,No Change,0
3304,PT-03304,72,M,NIMHANS Bengaluru,Phase III,ORX-101,Oncology,High Dose,2023-06-03,2023-06-10,6.21,4.98,123,91,85,Fatigue,None,Improved,1
3305,PT-03305,30,M,Kolkata Clinical Center,Phase III,ORX-101,Oncology,High Dose,2023-01-08,2023-03-05,8.11,6.63,112,80,70,None,None,Improved,1
3306,PT-03306,59,M,PGI Chandigarh,Phase II,ORX-606,Rheumatology,High Dose,2024-05-06,2024-05-20,7.54,8.73,123,80,94,None,None,Improved,0
3307,PT-03307,43,M,AIIMS Delhi,Phase IV,ORX-404,Neurology,Low Dose,2023-02-07,2023-02-14,8.99,9.08,90,96,90,None,None,Improved,0
3308,PT-03308,60,F,Kolkata Clinical Center,Phase III,ORX-202,Diabetes,Placebo,2023-05-09,2023-07-04,4.91,3.91,117,71,102,Nausea,Moderate,Improved,1
3309,PT-03309,44,M,Kolkata Clinical Center,Phase III,ORX-101,Oncology,Low Dose,2023-06-17,2023-07-15,7.16,7.25,138,50,68,Headache,None,Improved,0
3310,PT-03310,22,F,NIMHANS Bengaluru,Phase II,ORX-505,Infectious Disease,Low Dose,2024-12-01,2024-12-15,7.68,7.02,128,57,73,Rash,Moderate,Worsened,0
3311,PT-03311,62,F,Fortis Mumbai,Phase III,ORX-101,Oncology,Placebo,2024-05-03,2024-08-01,8.89,9.14,103,97,88,Dizziness,None,Improved,0
3312,PT-03312,43,F,Fortis Mumbai,Phase III,ORX-404,Neurology,High Dose,2024-04-16,2024-04-30,4.77,,117,86,78,Rash,Severe,Improved,0
3313,PT-03313,69,F,Indore Medical Institute,Phase II,ORX-303,Cardiology,High Dose,2023-10-13,2024-01-11,7.05,6.64,156,74,89,Fatigue,Mild,No Change,0
3314,PT-03314,41,F,Apollo Chennai,Phase III,ORX-202,Diabetes,Placebo,2023-07-02,2023-09-30,6.0,5.6,140,98,98,Fever,None,No Change,0
3315,PT-03315,40,F,Kolkata Clinical Center,Phase II,ORX-606,Rheumatology,Low Dose,2023-01-11,2023-03-08,6.02,5.33,106,79,73,None,None,Worsened,0
3316,PT-03316,56,F,Fortis Mumbai,Phase IV,ORX-202,Diabetes,Low Dose,2023-02-02,2023-03-30,4.55,3.49,114,96,62,Nausea,Mild,Improved,1
3317,PT-03317,48,M,AIIMS Delhi,Phase I,ORX-606,Rheumatology,Placebo,2023-09-08,2023-12-07,7.05,7.58,138,83,70,Headache,None,Improved,0
3318,PT-03318,18,F,NIMHANS Bengaluru,Phase I,ORX-202,Diabetes,Low Dose,2023-09-11,2023-10-09,7.5,7.57,99,67,81,Nausea,None,Improved,0
3319,PT-03319,50,M,Indore Medical Institute,Phase I,ORX-101,Oncology,Low Dose,2023-08-12,2023-08-26,6.01,5.09,94,98,59,Rash,None,Improved,1
3320,PT-03320,53,F,AIIMS Delhi,Phase III,ORX-606,Rheumatology,High Dose,2024-05-17,2024-05-31,7.16,7.92,113,82,54,None,None,Improved,0
3321,PT-03321,18,F,PGI Chandigarh,Phase IV,ORX-505,Infectious Disease,Low Dose,2024-09-27,2024-10-25,7.92,5.91,123,94,88,Fatigue,Mild,Improved,1
3322,PT-03322,34,F,Kolkata Clinical Center,Phase II,ORX-303,Cardiology,Low Dose,2024-09-18,2024-12-17,5.29,5.35,152,74,66,None,None,Improved,0
3323,PT-03323,36,F,Apollo Chennai,Phase II,ORX-606,Rheumatology,Low Dose,2023-05-18,2023-08-16,7.89,8.59,105,64,110,None,None,No Change,0
3324,PT-03324,42,M,PGI Chandigarh,Phase II,ORX-303,Cardiology,High Dose,2024-07-26,2024-08-09,7.5,6.48,136,93,82,Dizziness,Mild,No Change,0
3325,PT-03325,72,M,PGI Chandigarh,Phase III,ORX-202,Diabetes,High Dose,2023-03-05,2023-04-30,6.81,6.17,132,87,81,Headache,Mild,Worsened,0
3326,PT-03326,24,M,Bhopal Research Hospital,Phase III,ORX-404,Neurology,High Dose,2023-04-09,2023-04-16,7.58,6.84,117,82,64,Headache,None,No Change,0
3327,PT-03327,26,F,Fortis Mumbai,Phase III,ORX-303,Cardiology,Placebo,2023-07-29,2023-08-05,4.06,5.23,138,80,68,Nausea,None,No Change,0
3328,PT-03328,18,F,Fortis Mumbai,Phase III,ORX-404,Neurology,Placebo,2024-06-09,2024-09-07,6.33,6.57,144,89,80,Dizziness,None,Improved,0
3329,PT-03329,65,F,Apollo Chennai,Phase III,ORX-202,Diabetes,High Dose,2023-04-04,2023-04-18,6.81,7.38,121,71,63,None,None,No Change,0
3330,PT-03330,27,F,AIIMS Delhi,Phase I,ORX-505,Infectious Disease,Placebo,2024-03-22,2024-04-05,7.99,6.92,109,90,82,Rash,Mild,Improved,1
3331,PT-03331,60,F,Bhopal Research Hospital,Phase I,ORX-505,Infectious Disease,High Dose,2024-01-06,2024-01-20,7.82,6.74,129,83,65,Nausea,Mild,Improved,1
3332,PT-03332,27,M,Fortis Mumbai,Phase III,ORX-404,Neurology,Low Dose,2023-09-16,2023-09-23,6.38,7.82,120,96,71,Fatigue,None,Improved,0
3333,PT-03333,59,M,NIMHANS Bengaluru,Phase II,ORX-101,Oncology,Placebo,2024-08-31,2024-09-07,8.28,8.74,134,98,83,Headache,None,Worsened,0
3334,PT-03334,72,F,Apollo Chennai,Phase III,ORX-303,Cardiology,High Dose,2024-01-11,2024-03-07,5.26,5.17,133,70,86,None,None,Improved,1
3335,PT-03335,21,F,Kolkata Clinical Center,Phase III,ORX-404,Neurology,Low Dose,2023-03-31,2023-04-14,6.41,4.22,156,79,108,None,None,Improved,1
3336,PT-03336,57,M,Bhopal Research Hospital,Phase I,ORX-202,Diabetes,Placebo,2023-06-19,2023-09-17,7.74,6.81,109,88,76,Headache,None,Improved,1
3337,PT-03337,23,M,Indore Medical Institute,Phase IV,ORX-101,Oncology,Placebo,2023-11-09,2024-02-07,5.38,4.12,160,108,80,Nausea,Severe,Improved,1
3338,PT-03338,47,M,Bhopal Research Hospital,Phase III,ORX-505,Infectious Disease,Low Dose,2024-02-27,2024-03-26,6.8,5.56,152,104,65,None,None,No Change,0
3339,PT-03339,43,M,Bhopal Research Hospital,Phase III,ORX-606,Rheumatology,Low Dose,2024-08-27,2024-09-03,6.66,5.88,149,66,84,None,None,Improved,1
3340,PT-03340,56,M,NIMHANS Bengaluru,Phase II,ORX-505,Infectious Disease,High Dose,2023-07-31,2023-08-07,7.03,7.43,130,96,56,None,None,Improved,0
3341,PT-03341,39,F,NIMHANS Bengaluru,Phase IV,ORX-404,Neurology,Placebo,2023-11-04,2023-11-11,7.11,4.31,108,72,91,None,None,Worsened,0
3342,PT-03342,33,M,Bhopal Research Hospital,Phase III,ORX-505,Infectious Disease,Placebo,2024-06-02,2024-07-28,6.22,6.55,98,57,72,None,None,Improved,0
3343,PT-03343,21,M,Apollo Chennai,Phase I,ORX-202,Diabetes,Placebo,2023-09-12,2023-10-10,5.51,5.62,143,91,93,None,None,Worsened,0
3344,PT-03344,64,F,Kolkata Clinical Center,Phase III,ORX-101,Oncology,Placebo,2024-06-15,2024-08-10,4.65,4.65,118,73,85,None,None,No Change,0
3345,PT-03345,18,F,AIIMS Delhi,Phase III,ORX-303,Cardiology,High Dose,2024-10-30,2024-12-25,5.1,5.27,136,83,65,None,None,Improved,0
3346,PT-03346,56,F,Apollo Chennai,Phase III,ORX-101,Oncology,Low Dose,2023-07-20,2023-09-14,8.02,7.69,106,76,89,None,None,Worsened,0
3347,PT-03347,66,M,Indore Medical Institute,Phase I,ORX-303,Cardiology,High Dose,2024-03-26,2024-04-02,6.81,6.18,125,85,69,Headache,Mild,Worsened,0
3348,PT-03348,18,F,Apollo Chennai,Phase IV,ORX-101,Oncology,Low Dose,2024-04-17,2024-04-24,8.63,9.85,116,69,76,Nausea,None,Improved,0
3349,PT-03349,41,F,Apollo Chennai,Phase II,ORX-606,Rheumatology,Placebo,2023-09-11,2023-09-25,8.39,8.04,113,66,90,None,None,No Change,0
3350,PT-03350,54,F,PGI Chandigarh,Phase I,ORX-505,Infectious Disease,High Dose,2023-01-28,2023-04-28,8.47,7.2,161,61,87,Fatigue,None,Improved,1
3351,PT-03351,18,M,Apollo Chennai,Phase III,ORX-202,Diabetes,Placebo,2023-11-02,2023-11-16,6.25,7.26,142,75,70,Rash,None,No Change,0
3352,PT-03352,46,F,Apollo Chennai,Phase II,ORX-505,Infectious Disease,High Dose,2023-06-25,2023-07-09,7.82,8.54,119,62,80,Nausea,None,Improved,0
3353,PT-03353,37,F,PGI Chandigarh,Phase II,ORX-505,Infectious Disease,High Dose,2023-05-25,2023-06-22,5.64,5.51,124,85,65,None,None,No Change,0
3354,PT-03354,52,F,Bhopal Research Hospital,Phase II,ORX-202,Diabetes,Low Dose,2023-04-28,2023-07-27,5.62,4.47,123,102,88,Headache,Severe,Worsened,0
3355,PT-03355,62,F,AIIMS Delhi,Phase III,ORX-202,Diabetes,Low Dose,2024-07-09,2024-10-07,8.9,11.74,128,99,92,None,None,Worsened,0
3356,PT-03356,60,F,Apollo Chennai,Phase II,ORX-202,Diabetes,High Dose,2024-06-28,2024-07-05,9.33,8.55,119,85,75,Headache,None,Improved,1
3357,PT-03357,50,F,Fortis Mumbai,Phase II,ORX-404,Neurology,Low Dose,2023-10-08,2024-01-06,9.08,8.24,122,84,74,None,None,Improved,1
3358,PT-03358,18,F,Apollo Chennai,Phase I,ORX-404,Neurology,High Dose,2023-05-14,2023-05-21,6.5,6.72,153,68,61,None,None,Improved,0
3359,PT-03359,45,F,AIIMS Delhi,Phase II,ORX-505,Infectious Disease,Low Dose,2024-02-14,2024-02-21,4.71,3.91,96,98,67,None,None,Improved,1
3360,PT-03360,71,F,Bhopal Research Hospital,Phase I,ORX-101,Oncology,High Dose,2023-10-03,2023-10-31,8.54,7.55,108,79,76,None,None,No Change,0
3361,PT-03361,50,M,Fortis Mumbai,Phase III,ORX-606,Rheumatology,Placebo,2024-01-24,2024-01-31,6.27,6.54,132,77,68,None,None,Improved,0
3362,PT-03362,42,M,NIMHANS Bengaluru,Phase I,ORX-101,Oncology,High Dose,2024-01-20,2024-01-27,6.22,5.87,129,85,102,Nausea,None,Improved,1
3363,PT-03363,42,M,PGI Chandigarh,Phase III,ORX-303,Cardiology,High Dose,2023-10-04,2023-11-29,8.41,8.21,123,80,77,Fatigue,None,Worsened,0
3364,PT-03364,49,F,Apollo Chennai,Phase III,ORX-404,Neurology,Low Dose,2023-09-19,2023-10-03,6.05,4.33,139,92,88,None,None,Improved,1
3365,PT-03365,47,F,Apollo Chennai,Phase III,ORX-303,Cardiology,High Dose,2024-11-23,2024-12-21,8.12,8.36,142,71,62,None,None,No Change,0
3366,PT-03366,38,F,PGI Chandigarh,Phase III,ORX-606,Rheumatology,Low Dose,2024-03-10,2024-03-17,7.18,6.56,94,102,74,Fever,Moderate,Improved,1
3367,PT-03367,47,M,NIMHANS Bengaluru,Phase III,ORX-606,Rheumatology,High Dose,2023-06-05,2023-07-31,8.69,6.18,118,77,73,Dizziness,Severe,No Change,0
3368,PT-03368,42,F,Kolkata Clinical Center,Phase III,ORX-303,Cardiology,High Dose,2023-04-12,2023-06-07,8.94,9.14,145,82,58,Rash,None,No Change,0
3369,PT-03369,18,M,Indore Medical Institute,Phase III,ORX-505,Infectious Disease,Low Dose,2024-11-26,2025-01-21,5.36,5.29,128,79,72,Headache,None,Improved,1
3370,PT-03370,77,M,Bhopal Research Hospital,Phase III,ORX-404,Neurology,High Dose,2024-01-05,2024-01-12,6.21,6.65,128,81,94,None,None,Improved,0
3371,PT-03371,68,F,Fortis Mumbai,Phase III,ORX-101,Oncology,Placebo,2024-06-24,2024-07-22,6.91,7.23,134,82,80,None,None,No Change,0
3372,PT-03372,33,F,Indore Medical Institute,Phase III,ORX-101,Oncology,High Dose,2023-06-26,2023-08-21,6.83,,144,80,59,None,None,Worsened,0
3373,PT-03373,33,F,Bhopal Research Hospital,Phase IV,ORX-303,Cardiology,High Dose,2024-08-31,2024-09-28,3.5,2.65,128,80,105,Nausea,None,Improved,1
3374,PT-03374,54,F,Bhopal Research Hospital,Phase II,ORX-606,Rheumatology,High Dose,2024-05-02,2024-05-30,7.84,5.96,121,76,66,None,None,No Change,0
3375,PT-03375,32,F,Indore Medical Institute,Phase II,ORX-101,Oncology,Placebo,2023-03-10,2023-05-05,5.03,3.48,143,80,70,None,None,Improved,1
3376,PT-03376,44,F,PGI Chandigarh,Phase III,ORX-505,Infectious Disease,Placebo,2023-11-17,2023-11-24,8.6,8.2,137,71,69,Headache,Mild,No Change,0
3377,PT-03377,50,M,Kolkata Clinical Center,Phase III,ORX-606,Rheumatology,Placebo,2024-11-30,2024-12-07,9.47,10.36,138,83,97,None,None,Improved,0
3378,PT-03378,57,F,Bhopal Research Hospital,Phase III,ORX-202,Diabetes,High Dose,2024-09-29,2024-10-27,4.45,3.1,134,60,65,None,None,No Change,0
3379,PT-03379,33,F,Apollo Chennai,Phase IV,ORX-101,Oncology,High Dose,2024-08-02,2024-08-30,6.89,6.23,122,91,74,None,None,No Change,0
3380,PT-03380,38,F,Apollo Chennai,Phase II,ORX-303,Cardiology,High Dose,2023-06-03,2023-09-01,5.58,6.1,115,68,80,None,None,Improved,0
3381,PT-03381,32,M,Kolkata Clinical Center,Phase III,ORX-606,Rheumatology,Low Dose,2024-02-20,2024-04-16,6.57,6.4,122,109,76,Nausea,Mild,No Change,0
3382,PT-03382,54,M,NIMHANS Bengaluru,Phase IV,ORX-303,Cardiology,Low Dose,2024-10-14,2024-12-09,4.87,3.7,108,70,83,None,None,Worsened,0
3383,PT-03383,61,M,AIIMS Delhi,Phase II,ORX-606,Rheumatology,High Dose,2023-03-08,2023-06-06,7.61,7.01,116,95,106,Fever,Severe,Worsened,0
3384,PT-03384,47,F,Indore Medical Institute,Phase I,ORX-404,Neurology,High Dose,2023-05-04,2023-05-11,8.33,8.24,141,68,71,None,None,Worsened,0
3385,PT-03385,51,F,Fortis Mumbai,Phase IV,ORX-303,Cardiology,Low Dose,2024-10-27,2024-11-03,8.65,7.52,91,76,92,Fever,Moderate,Worsened,0
3386,PT-03386,19,M,Kolkata Clinical Center,Phase I,ORX-303,Cardiology,High Dose,2023-06-26,2023-07-24,5.79,5.53,125,89,60,None,None,Worsened,0
3387,PT-03387,39,F,AIIMS Delhi,Phase IV,ORX-202,Diabetes,Low Dose,2024-11-16,2025-01-11,8.63,7.16,154,69,89,Nausea,Moderate,Worsened,0
3388,PT-03388,39,F,Indore Medical Institute,Phase III,ORX-404,Neurology,Low Dose,2023-05-04,2023-05-18,5.83,4.98,137,81,93,None,None,Improved,1
3389,PT-03389,67,M,Indore Medical Institute,Phase II,ORX-505,Infectious Disease,High Dose,2023-06-19,2023-08-14,5.78,4.25,104,71,93,Fever,None,Improved,1
3390,PT-03390,53,F,NIMHANS Bengaluru,Phase III,ORX-606,Rheumatology,Placebo,2024-07-08,2024-09-02,6.55,6.14,153,104,81,Headache,None,Improved,1
3391,PT-03391,18,M,PGI Chandigarh,Phase III,ORX-404,Neurology,Placebo,2023-11-11,2024-01-06,7.56,8.0,132,90,82,Nausea,None,No Change,0
3392,PT-03392,25,M,Indore Medical Institute,Phase III,ORX-101,Oncology,Placebo,2024-04-28,2024-05-05,6.14,5.45,147,72,84,Headache,Moderate,No Change,0
3393,PT-03393,49,M,Apollo Chennai,Phase III,ORX-404,Neurology,Low Dose,2023-03-04,2023-06-02,9.1,8.67,96,89,107,Headache,None,No Change,0
3394,PT-03394,56,F,Apollo Chennai,Phase III,ORX-202,Diabetes,Placebo,2023-02-05,2023-05-06,6.25,4.88,110,106,73,Fatigue,None,Worsened,0
3395,PT-03395,34,F,NIMHANS Bengaluru,Phase III,ORX-404,Neurology,High Dose,2024-07-07,2024-09-01,7.01,6.32,156,69,94,Dizziness,None,Worsened,0
3396,PT-03396,46,F,Kolkata Clinical Center,Phase II,ORX-303,Cardiology,High Dose,2023-10-03,2023-10-31,8.65,9.67,129,78,78,None,None,Improved,0
3397,PT-03397,43,F,PGI Chandigarh,Phase III,ORX-606,Rheumatology,Placebo,2024-09-04,2024-12-03,5.21,6.21,132,68,49,None,None,Improved,0
3398,PT-03398,18,F,PGI Chandigarh,Phase III,ORX-101,Oncology,High Dose,2023-02-11,2023-02-25,8.12,7.17,119,87,70,Headache,Mild,Improved,1
3399,PT-03399,53,M,AIIMS Delhi,Phase II,ORX-404,Neurology,Low Dose,2023-08-20,2023-08-27,7.31,6.84,99,72,86,Rash,None,Improved,1
3400,PT-03400,34,F,PGI Chandigarh,Phase II,ORX-404,Neurology,Placebo,2023-01-11,2023-04-11,8.65,10.36,139,99,88,Headache,Severe,Worsened,0
3401,PT-03401,36,F,Fortis Mumbai,Phase III,ORX-101,Oncology,High Dose,2023-08-21,2023-09-18,7.44,8.85,118,69,62,None,None,Improved,0
3402,PT-03402,41,M,Fortis Mumbai,Phase III,ORX-404,Neurology,Low Dose,2024-05-05,2024-06-02,6.0,7.1,131,93,73,None,None,Improved,0
3403,PT-03403,26,M,Indore Medical Institute,Phase III,ORX-101,Oncology,High Dose,2024-01-02,2024-01-16,5.63,4.41,134,88,86,Dizziness,None,Improved,1
3404,PT-03404,21,M,Kolkata Clinical Center,Phase II,ORX-404,Neurology,Placebo,2023-09-22,2023-10-06,7.2,5.88,135,87,61,Dizziness,Mild,Improved,1
3405,PT-03405,60,M,Apollo Chennai,Phase III,ORX-404,Neurology,Placebo,2023-08-13,2023-10-08,10.01,10.36,125,78,75,None,None,No Change,0
3406,PT-03406,32,M,Apollo Chennai,Phase I,ORX-202,Diabetes,High Dose,2023-02-24,2023-03-03,7.5,6.08,93,84,78,Nausea,None,Improved,1
3407,PT-03407,35,M,Indore Medical Institute,Phase II,ORX-202,Diabetes,High Dose,2023-01-12,2023-02-09,5.66,5.52,110,80,102,None,None,Improved,1
3408,PT-03408,55,M,Apollo Chennai,Phase III,ORX-505,Infectious Disease,Placebo,2024-02-13,2024-02-20,5.56,4.01,130,65,49,Nausea,Moderate,Improved,1
3409,PT-03409,53,M,Apollo Chennai,Phase II,ORX-404,Neurology,Placebo,2024-06-20,2024-07-18,7.59,7.59,132,81,68,Headache,None,No Change,0
3410,PT-03410,53,F,NIMHANS Bengaluru,Phase III,ORX-505,Infectious Disease,Placebo,2024-10-30,2024-12-25,9.04,8.18,109,68,65,Rash,None,Improved,1
3411,PT-03411,48,F,AIIMS Delhi,Phase III,ORX-101,Oncology,Low Dose,2024-11-12,2025-02-10,4.63,4.63,139,60,64,None,None,No Change,0
3412,PT-03412,46,M,Indore Medical Institute,Phase III,ORX-303,Cardiology,Placebo,2023-05-29,2023-07-24,7.03,7.1,125,97,73,Fever,Severe,Improved,0
3413,PT-03413,29,F,PGI Chandigarh,Phase III,ORX-505,Infectious Disease,Placebo,2023-05-16,2023-08-14,5.92,6.19,128,89,86,None,None,Worsened,0
3414,PT-03414,18,M,Kolkata Clinical Center,Phase II,ORX-505,Infectious Disease,High Dose,2024-04-24,2024-07-23,5.83,4.51,113,76,91,Headache,None,Worsened,0
3415,PT-03415,64,F,AIIMS Delhi,Phase I,ORX-101,Oncology,Low Dose,2024-01-19,2024-04-18,6.85,6.22,115,83,80,None,None,No Change,0
3416,PT-03416,57,F,Bhopal Research Hospital,Phase III,ORX-606,Rheumatology,High Dose,2023-01-31,2023-02-14,8.16,5.69,125,98,71,None,None,Improved,1
3417,PT-03417,63,F,NIMHANS Bengaluru,Phase IV,ORX-606,Rheumatology,High Dose,2023-02-07,2023-04-04,6.83,6.59,107,68,88,None,None,No Change,0
3418,PT-03418,59,F,Kolkata Clinical Center,Phase III,ORX-101,Oncology,High Dose,2024-08-04,2024-11-02,7.23,5.73,128,97,102,None,None,No Change,0
3419,PT-03419,39,M,PGI Chandigarh,Phase III,ORX-606,Rheumatology,Low Dose,2023-01-01,2023-01-15,5.21,5.56,123,93,81,None,None,Improved,0
3420,PT-03420,30,M,NIMHANS Bengaluru,Phase IV,ORX-202,Diabetes,Placebo,2023-11-30,2023-12-28,7.27,8.05,125,69,55,None,None,No Change,0
3421,PT-03421,32,F,NIMHANS Bengaluru,Phase II,ORX-202,Diabetes,Low Dose,2023-09-21,2023-12-20,6.71,7.05,107,100,59,Nausea,None,Improved,0
3422,PT-03422,82,F,Fortis Mumbai,Phase II,ORX-404,Neurology,Low Dose,2024-11-09,2024-12-07,9.27,9.0,98,81,72,None,None,Improved,1
3423,PT-03423,24,F,Indore Medical Institute,Phase II,ORX-202,Diabetes,High Dose,2023-04-04,2023-04-11,7.55,6.41,115,79,69,Headache,Moderate,No Change,0
3424,PT-03424,78,M,NIMHANS Bengaluru,Phase II,ORX-202,Diabetes,High Dose,2023-06-21,2023-07-19,6.56,6.55,130,86,84,Nausea,None,No Change,0
3425,PT-03425,59,M,Apollo Chennai,Phase II,ORX-303,Cardiology,High Dose,2024-04-07,2024-05-05,7.52,7.32,129,80,65,Nausea,None,No Change,0
3426,PT-03426,44,F,Bhopal Research Hospital,Phase I,ORX-505,Infectious Disease,Placebo,2024-09-09,2024-09-16,7.49,7.45,131,79,77,None,None,Improved,1
3427,PT-03427,36,F,Indore Medical Institute,Phase III,ORX-606,Rheumatology,Low Dose,2023-06-07,2023-08-02,7.58,6.98,131,94,68,Dizziness,None,Improved,1
3428,PT-03428,54,M,PGI Chandigarh,Phase III,ORX-505,Infectious Disease,Low Dose,2023-10-14,2023-10-21,7.24,8.66,124,90,78,None,None,Improved,0
3429,PT-03429,22,M,Indore Medical Institute,Phase III,ORX-505,Infectious Disease,Placebo,2023-04-10,2023-06-05,6.58,6.97,120,55,77,Dizziness,Mild,Improved,0
3430,PT-03430,27,F,Bhopal Research Hospital,Phase III,ORX-101,Oncology,Placebo,2024-05-17,2024-05-31,7.36,8.35,141,100,70,None,None,No Change,0
3431,PT-03431,42,F,Kolkata Clinical Center,Phase II,ORX-202,Diabetes,High Dose,2023-08-28,2023-11-26,5.95,4.93,111,66,97,None,None,Improved,1
3432,PT-03432,18,M,PGI Chandigarh,Phase III,ORX-202,Diabetes,Low Dose,2024-08-09,2024-08-16,8.84,9.57,136,68,55,None,None,No Change,0
3433,PT-03433,36,F,Bhopal Research Hospital,Phase IV,ORX-505,Infectious Disease,Placebo,2024-07-09,2024-08-06,7.95,7.55,109,95,101,None,None,No Change,0
3434,PT-03434,41,M,Fortis Mumbai,Phase IV,ORX-202,Diabetes,High Dose,2023-12-30,2024-01-06,7.33,5.57,120,88,82,None,None,No Change,0
3435,PT-03435,36,F,Indore Medical Institute,Phase III,ORX-404,Neurology,Placebo,2023-11-28,2023-12-05,6.87,6.07,122,87,50,None,None,Improved,1
3436,PT-03436,43,F,AIIMS Delhi,Phase II,ORX-303,Cardiology,High Dose,2023-11-02,2023-11-16,7.62,6.71,119,76,71,None,None,Improved,1
3437,PT-03437,45,F,Bhopal Research Hospital,Phase II,ORX-202,Diabetes,High Dose,2023-12-31,2024-02-25,7.35,5.06,139,78,105,None,None,Improved,1
3438,PT-03438,25,F,Indore Medical Institute,Phase I,ORX-202,Diabetes,Low Dose,2023-11-14,2024-01-09,6.16,5.58,135,58,66,None,None,No Change,0
3439,PT-03439,54,M,Indore Medical Institute,Phase IV,ORX-202,Diabetes,Low Dose,2023-09-23,2023-11-18,6.06,6.9,119,71,86,None,None,Improved,0
3440,PT-03440,70,M,Bhopal Research Hospital,Phase III,ORX-404,Neurology,Placebo,2023-07-01,2023-07-08,7.7,8.43,158,70,91,None,None,No Change,0
3441,PT-03441,20,M,NIMHANS Bengaluru,Phase III,ORX-606,Rheumatology,Low Dose,2023-12-26,2024-03-25,7.71,7.25,150,96,85,Headache,Mild,No Change,0
3442,PT-03442,49,M,Indore Medical Institute,Phase III,ORX-101,Oncology,High Dose,2023-11-06,2023-11-13,7.81,7.47,126,99,99,Nausea,None,Improved,1
3443,PT-03443,42,F,NIMHANS Bengaluru,Phase I,ORX-606,Rheumatology,High Dose,2024-02-15,2024-02-22,7.49,7.16,98,77,100,None,None,Improved,1
3444,PT-03444,33,F,Indore Medical Institute,Phase II,ORX-101,Oncology,Placebo,2023-12-13,2024-02-07,9.74,10.39,135,88,65,None,None,Improved,0
3445,PT-03445,40,M,Indore Medical Institute,Phase IV,ORX-101,Oncology,Placebo,2023-10-29,2023-11-26,8.93,7.98,147,65,61,None,None,Worsened,0
3446,PT-03446,75,M,Indore Medical Institute,Phase IV,ORX-404,Neurology,High Dose,2024-10-31,2024-11-07,7.19,6.3,152,96,90,Nausea,Mild,No Change,0
3447,PT-03447,35,M,NIMHANS Bengaluru,Phase II,ORX-606,Rheumatology,High Dose,2024-01-18,2024-01-25,6.86,6.74,140,75,80,None,None,Worsened,0
3448,PT-03448,49,M,Apollo Chennai,Phase III,ORX-505,Infectious Disease,Low Dose,2024-03-24,2024-03-31,8.74,9.02,100,79,64,Rash,None,Improved,0
3449,PT-03449,54,F,Indore Medical Institute,Phase I,ORX-606,Rheumatology,Low Dose,2023-06-01,2023-08-30,8.31,8.0,123,82,80,Headache,Mild,Worsened,0
3450,PT-03450,34,F,Bhopal Research Hospital,Phase I,ORX-505,Infectious Disease,Low Dose,2023-06-07,2023-09-05,5.74,3.49,150,87,83,Rash,None,Improved,1
3451,PT-03451,65,M,PGI Chandigarh,Phase II,ORX-202,Diabetes,High Dose,2023-02-13,2023-05-14,5.69,3.73,134,85,53,Fatigue,Moderate,Worsened,0
3452,PT-03452,50,M,Apollo Chennai,Phase III,ORX-404,Neurology,High Dose,2023-03-16,2023-05-11,6.72,5.59,121,52,69,None,None,Improved,1
3453,PT-03453,33,F,Kolkata Clinical Center,Phase II,ORX-303,Cardiology,Low Dose,2024-02-02,2024-03-29,7.87,,139,51,66,Headache,Moderate,Improved,1
3454,PT-03454,53,M,AIIMS Delhi,Phase IV,ORX-606,Rheumatology,Placebo,2023-08-24,2023-08-31,6.83,7.19,95,90,69,Nausea,Moderate,Worsened,0
3455,PT-03455,33,M,Kolkata Clinical Center,Phase III,ORX-606,Rheumatology,Placebo,2023-04-23,2023-04-30,8.39,9.03,146,106,95,None,None,No Change,0
3456,PT-03456,32,M,Bhopal Research Hospital,Phase III,ORX-606,Rheumatology,High Dose,2024-11-15,2024-11-29,7.37,6.65,164,95,75,Nausea,Mild,Worsened,0
3457,PT-03457,59,M,AIIMS Delhi,Phase II,ORX-303,Cardiology,Low Dose,2024-06-04,2024-07-30,5.72,5.55,111,61,88,Fatigue,None,No Change,0
3458,PT-03458,59,M,Fortis Mumbai,Phase II,ORX-606,Rheumatology,Low Dose,2024-03-16,2024-06-14,7.75,7.18,105,68,64,None,None,No Change,0
3459,PT-03459,41,M,NIMHANS Bengaluru,Phase III,ORX-606,Rheumatology,Placebo,2024-02-19,2024-05-19,8.49,9.05,98,73,67,None,None,Improved,0
3460,PT-03460,18,M,Bhopal Research Hospital,Phase II,ORX-101,Oncology,Placebo,2023-02-20,2023-03-06,7.88,7.26,125,98,79,None,None,No Change,0
3461,PT-03461,38,M,Fortis Mumbai,Phase III,ORX-101,Oncology,High Dose,2024-07-24,2024-07-31,7.89,8.44,133,90,75,Headache,Moderate,Improved,0
3462,PT-03462,43,M,Bhopal Research Hospital,Phase IV,ORX-606,Rheumatology,Low Dose,2023-04-15,2023-05-13,7.34,6.26,117,98,106,Headache,Moderate,Improved,1
3463,PT-03463,70,F,PGI Chandigarh,Phase III,ORX-303,Cardiology,Placebo,2023-12-27,2024-01-03,5.61,3.93,106,83,45,None,None,No Change,0
3464,PT-03464,35,F,Indore Medical Institute,Phase III,ORX-404,Neurology,High Dose,2024-04-12,2024-05-10,8.89,9.37,118,76,85,None,None,Improved,0
3465,PT-03465,59,M,PGI Chandigarh,Phase III,ORX-505,Infectious Disease,High Dose,2024-05-13,2024-06-10,6.56,5.95,117,66,74,Fever,None,Improved,1
3466,PT-03466,40,M,Indore Medical Institute,Phase III,ORX-303,Cardiology,Low Dose,2024-04-10,2024-06-05,5.69,5.87,136,90,67,None,None,Worsened,0
3467,PT-03467,18,M,Fortis Mumbai,Phase III,ORX-404,Neurology,Low Dose,2024-02-04,2024-05-04,7.76,6.76,111,66,74,Nausea,None,Improved,1
3468,PT-03468,70,M,Fortis Mumbai,Phase I,ORX-404,Neurology,Placebo,2024-10-07,2024-12-02,6.59,5.21,139,84,48,Fever,Mild,Improved,1
3469,PT-03469,55,F,PGI Chandigarh,Phase IV,ORX-505,Infectious Disease,High Dose,2023-05-18,2023-07-13,9.75,7.01,105,50,76,Rash,Severe,Improved,1
3470,PT-03470,60,M,NIMHANS Bengaluru,Phase I,ORX-404,Neurology,Placebo,2024-07-07,2024-09-01,7.33,8.18,142,102,94,Headache,None,Improved,0
3471,PT-03471,38,M,NIMHANS Bengaluru,Phase II,ORX-505,Infectious Disease,Low Dose,2024-10-08,2024-12-03,7.28,6.1,123,82,76,None,None,Improved,1
3472,PT-03472,66,F,AIIMS Delhi,Phase II,ORX-404,Neurology,High Dose,2024-12-01,2024-12-29,6.8,5.56,112,89,58,None,None,Improved,1
3473,PT-03473,41,F,Kolkata Clinical Center,Phase III,ORX-202,Diabetes,Placebo,2023-06-01,2023-06-29,8.79,8.66,126,81,63,None,None,Improved,1
3474,PT-03474,31,M,PGI Chandigarh,Phase II,ORX-606,Rheumatology,Low Dose,2023-02-04,2023-02-11,6.97,6.81,145,83,96,Headache,None,Improved,1
3475,PT-03475,70,F,Bhopal Research Hospital,Phase III,ORX-404,Neurology,Placebo,2024-01-06,2024-01-13,8.15,8.86,110,68,85,None,None,Improved,0
3476,PT-03476,23,F,Apollo Chennai,Phase IV,ORX-303,Cardiology,Placebo,2023-03-31,2023-04-14,6.85,7.15,153,78,68,None,None,No Change,0
3477,PT-03477,50,F,Indore Medical Institute,Phase IV,ORX-303,Cardiology,Low Dose,2024-09-30,2024-10-14,5.91,5.36,127,81,79,None,None,Improved,1
3478,PT-03478,31,M,Bhopal Research Hospital,Phase I,ORX-101,Oncology,Low Dose,2023-05-31,2023-08-29,6.33,5.26,98,86,90,None,None,Improved,1
3479,PT-03479,57,M,Fortis Mumbai,Phase III,ORX-606,Rheumatology,Low Dose,2023-03-18,2023-04-15,6.89,5.76,141,89,81,Rash,None,Worsened,0
3480,PT-03480,72,F,Fortis Mumbai,Phase III,ORX-606,Rheumatology,High Dose,2023-07-21,2023-09-15,7.17,,120,63,87,None,None,Worsened,0
3481,PT-03481,43,M,Fortis Mumbai,Phase III,ORX-101,Oncology,High Dose,2023-04-09,2023-04-16,7.81,,120,53,84,None,None,Improved,0
3482,PT-03482,47,M,Kolkata Clinical Center,Phase I,ORX-505,Infectious Disease,High Dose,2024-11-28,2025-02-26,6.32,6.28,142,70,73,None,None,Improved,1
3483,PT-03483,68,M,NIMHANS Bengaluru,Phase IV,ORX-202,Diabetes,High Dose,2023-06-16,2023-08-11,6.33,5.99,90,64,80,None,None,Improved,1
3484,PT-03484,64,F,PGI Chandigarh,Phase III,ORX-303,Cardiology,Low Dose,2024-04-07,2024-05-05,5.57,5.23,121,93,60,Fatigue,Moderate,No Change,0
3485,PT-03485,51,F,Fortis Mumbai,Phase II,ORX-505,Infectious Disease,Low Dose,2024-06-29,2024-07-13,6.42,6.22,129,78,84,Headache,None,Improved,1
3486,PT-03486,45,M,Fortis Mumbai,Phase II,ORX-606,Rheumatology,Placebo,2024-10-16,2024-11-13,7.04,6.32,129,84,64,None,None,Improved,1
3487,PT-03487,39,F,AIIMS Delhi,Phase IV,ORX-505,Infectious Disease,Placebo,2023-02-17,2023-03-03,5.93,5.5,117,91,87,None,None,Improved,1
3488,PT-03488,30,M,Kolkata Clinical Center,Phase III,ORX-202,Diabetes,Placebo,2023-09-26,2023-11-21,7.2,7.37,124,73,62,None,None,Improved,0
3489,PT-03489,58,F,AIIMS Delhi,Phase III,ORX-505,Infectious Disease,Low Dose,2024-05-22,2024-06-19,8.28,7.7,141,50,96,Headache,None,Improved,1
3490,PT-03490,42,M,AIIMS Delhi,Phase III,ORX-101,Oncology,Low Dose,2023-11-17,2023-12-01,7.37,6.68,153,69,98,Rash,None,Improved,1
3491,PT-03491,51,F,Apollo Chennai,Phase III,ORX-101,Oncology,Low Dose,2023-05-20,2023-07-15,7.95,7.25,104,93,82,Nausea,None,Improved,1
3492,PT-03492,66,F,Bhopal Research Hospital,Phase III,ORX-303,Cardiology,High Dose,2023-09-27,2023-10-11,6.97,6.19,152,104,78,Rash,None,Improved,1
3493,PT-03493,32,F,Fortis Mumbai,Phase I,ORX-303,Cardiology,Placebo,2024-09-03,2024-10-29,8.17,7.54,138,78,99,None,None,Worsened,0
3494,PT-03494,33,F,Apollo Chennai,Phase II,ORX-202,Diabetes,Placebo,2024-09-19,2024-11-14,7.78,6.94,122,77,88,None,None,Improved,1
3495,PT-03495,59,F,Apollo Chennai,Phase II,ORX-303,Cardiology,High Dose,2024-04-06,2024-04-20,7.87,7.37,130,92,91,Rash,None,No Change,0
3496,PT-03496,18,M,Indore Medical Institute,Phase I,ORX-606,Rheumatology,Placebo,2024-10-10,2024-11-07,6.87,6.27,140,81,88,None,None,Improved,1
3497,PT-03497,27,F,PGI Chandigarh,Phase II,ORX-505,Infectious Disease,High Dose,2024-10-03,2024-10-10,7.51,7.92,101,112,94,None,None,No Change,0
3498,PT-03498,45,M,Kolkata Clinical Center,Phase III,ORX-505,Infectious Disease,Low Dose,2023-05-14,2023-05-21,6.21,5.65,129,87,99,Nausea,None,Improved,1
3499,PT-03499,37,F,NIMHANS Bengaluru,Phase II,ORX-202,Diabetes,Low Dose,2024-05-17,2024-06-14,7.88,6.31,120,86,87,None,None,No Change,0
3500,PT-03500,32,M,AIIMS Delhi,Phase II,ORX-202,Diabetes,Placebo,2024-09-08,2024-10-06,6.67,7.59,148,84,46,None,None,Improved,0
3501,PT-03501,85,F,Kolkata Clinical Center,Phase I,ORX-202,Diabetes,High Dose,2023-11-16,2024-02-14,7.18,6.49,118,86,83,None,None,Improved,1
3502,PT-03502,60,F,Kolkata Clinical Center,Phase II,ORX-606,Rheumatology,High Dose,2023-09-19,2023-09-26,6.09,5.41,164,84,75,None,None,Improved,1
3503,PT-03503,29,F,PGI Chandigarh,Phase III,ORX-404,Neurology,Placebo,2024-11-19,2025-01-14,7.81,8.34,143,78,83,Headache,None,Improved,0
3504,PT-03504,71,M,AIIMS Delhi,Phase I,ORX-606,Rheumatology,Low Dose,2023-05-11,2023-05-18,8.49,7.38,90,85,89,Dizziness,Moderate,No Change,0
3505,PT-03505,27,F,AIIMS Delhi,Phase IV,ORX-404,Neurology,Low Dose,2023-09-25,2023-11-20,7.19,6.55,129,75,96,None,None,Improved,1
3506,PT-03506,47,M,Apollo Chennai,Phase III,ORX-101,Oncology,High Dose,2024-01-04,2024-04-03,6.15,6.57,105,97,91,None,None,Worsened,0
3507,PT-03507,67,M,Indore Medical Institute,Phase III,ORX-404,Neurology,Low Dose,2024-02-11,2024-02-18,7.01,6.16,129,80,68,None,None,Worsened,0
3508,PT-03508,36,M,Apollo Chennai,Phase I,ORX-303,Cardiology,High Dose,2023-09-28,2023-10-12,6.76,5.31,140,81,73,None,None,Worsened,0
3509,PT-03509,27,F,Bhopal Research Hospital,Phase III,ORX-101,Oncology,High Dose,2024-11-04,2024-12-02,5.81,7.15,116,89,80,Rash,None,Worsened,0
3510,PT-03510,18,M,AIIMS Delhi,Phase IV,ORX-101,Oncology,Placebo,2024-02-03,2024-02-17,9.35,9.57,114,81,61,Headache,None,Improved,0
3511,PT-03511,74,M,Apollo Chennai,Phase II,ORX-404,Neurology,Placebo,2024-06-25,2024-07-02,6.11,5.24,114,82,97,None,None,Improved,1
3512,PT-03512,73,F,PGI Chandigarh,Phase III,ORX-606,Rheumatology,High Dose,2024-07-19,2024-08-16,6.72,6.66,129,70,111,None,None,No Change,0
3513,PT-03513,66,M,Kolkata Clinical Center,Phase III,ORX-505,Infectious Disease,High Dose,2023-04-17,2023-05-01,7.43,8.45,149,82,82,None,None,No Change,0
3514,PT-03514,69,F,Kolkata Clinical Center,Phase II,ORX-202,Diabetes,Low Dose,2024-04-17,2024-06-12,6.06,7.17,123,100,77,None,None,Improved,0
3515,PT-03515,50,F,PGI Chandigarh,Phase III,ORX-505,Infectious Disease,Low Dose,2023-08-02,2023-08-30,7.16,6.28,123,98,45,None,None,Improved,1
3516,PT-03516,25,M,Apollo Chennai,Phase III,ORX-505,Infectious Disease,Placebo,2024-07-14,2024-10-12,6.33,4.96,155,97,86,None,None,No Change,0
3517,PT-03517,34,F,Apollo Chennai,Phase IV,ORX-202,Diabetes,Low Dose,2023-01-14,2023-03-11,8.8,6.97,166,73,74,None,None,No Change,0
3518,PT-03518,38,M,Bhopal Research Hospital,Phase I,ORX-101,Oncology,Placebo,2023-04-19,2023-05-17,5.91,7.24,142,96,60,Fever,None,Improved,0
3519,PT-03519,47,M,NIMHANS Bengaluru,Phase III,ORX-303,Cardiology,Low Dose,2023-06-10,2023-06-17,7.83,7.67,107,94,79,Nausea,None,Improved,1
3520,PT-03520,29,M,NIMHANS Bengaluru,Phase IV,ORX-101,Oncology,High Dose,2024-01-29,2024-02-26,4.97,5.12,172,69,80,Headache,None,No Change,0
3521,PT-03521,62,M,Kolkata Clinical Center,Phase II,ORX-202,Diabetes,Low Dose,2023-01-28,2023-03-25,5.68,4.84,112,93,96,Dizziness,None,Improved,1
3522,PT-03522,47,M,AIIMS Delhi,Phase II,ORX-101,Oncology,Low Dose,2024-02-08,2024-02-15,6.19,5.39,116,70,76,None,None,Improved,1
3523,PT-03523,54,M,NIMHANS Bengaluru,Phase III,ORX-303,Cardiology,Placebo,2023-06-27,2023-07-04,7.79,7.38,129,81,59,Rash,Mild,Improved,1
3524,PT-03524,47,F,Fortis Mumbai,Phase IV,ORX-303,Cardiology,Low Dose,2024-04-25,2024-05-02,6.5,4.89,134,74,81,Headache,None,No Change,0
3525,PT-03525,58,F,AIIMS Delhi,Phase III,ORX-404,Neurology,Low Dose,2023-05-02,2023-05-09,6.06,5.74,95,100,58,None,None,No Change,0
3526,PT-03526,36,M,Kolkata Clinical Center,Phase III,ORX-606,Rheumatology,Low Dose,2024-10-02,2024-10-16,8.81,8.19,106,90,87,Fatigue,None,No Change,0
3527,PT-03527,34,F,NIMHANS Bengaluru,Phase III,ORX-505,Infectious Disease,Low Dose,2024-07-02,2024-09-30,6.57,5.78,124,59,75,None,None,Improved,1
3528,PT-03528,73,F,Kolkata Clinical Center,Phase III,ORX-202,Diabetes,High Dose,2024-05-27,2024-07-22,6.12,5.2,106,89,94,None,None,Worsened,0
3529,PT-03529,63,F,Apollo Chennai,Phase III,ORX-404,Neurology,Placebo,2024-05-23,2024-05-30,5.7,5.75,153,88,84,None,None,Improved,0
3530,PT-03530,37,F,Kolkata Clinical Center,Phase II,ORX-606,Rheumatology,Low Dose,2023-12-26,2024-03-25,7.46,8.18,133,67,71,Fatigue,None,Improved,0
3531,PT-03531,64,F,NIMHANS Bengaluru,Phase III,ORX-404,Neurology,Low Dose,2024-08-20,2024-09-17,7.59,7.3,118,96,101,Headache,None,Worsened,0
3532,PT-03532,65,M,Kolkata Clinical Center,Phase II,ORX-303,Cardiology,High Dose,2024-10-25,2024-11-01,8.93,8.21,118,80,78,None,None,No Change,0
3533,PT-03533,67,M,Apollo Chennai,Phase III,ORX-404,Neurology,Low Dose,2024-09-06,2024-09-13,8.6,8.68,102,61,81,None,None,No Change,0
3534,PT-03534,59,F,Apollo Chennai,Phase II,ORX-606,Rheumatology,Low Dose,2023-12-07,2023-12-14,7.1,8.43,108,67,68,Rash,None,Improved,0
3535,PT-03535,33,M,Kolkata Clinical Center,Phase III,ORX-505,Infectious Disease,Placebo,2023-08-24,2023-11-22,7.83,7.05,100,92,53,Headache,None,Improved,1
3536,PT-03536,27,F,AIIMS Delhi,Phase III,ORX-606,Rheumatology,Low Dose,2023-09-11,2023-11-06,5.25,5.04,131,104,90,None,None,No Change,0
3537,PT-03537,68,M,Fortis Mumbai,Phase III,ORX-101,Oncology,Low Dose,2024-04-14,2024-04-28,7.55,6.27,130,89,87,Rash,None,Improved,1
3538,PT-03538,37,F,NIMHANS Bengaluru,Phase I,ORX-202,Diabetes,Placebo,2023-09-21,2023-09-28,7.79,6.55,109,68,78,None,None,Improved,1
3539,PT-03539,26,M,Apollo Chennai,Phase III,ORX-505,Infectious Disease,Low Dose,2024-08-18,2024-10-13,6.69,7.1,109,75,79,Fatigue,Moderate,Improved,0
3540,PT-03540,48,F,NIMHANS Bengaluru,Phase II,ORX-303,Cardiology,High Dose,2024-02-08,2024-04-04,6.6,6.91,138,95,76,None,None,No Change,0
3541,PT-03541,36,M,Apollo Chennai,Phase IV,ORX-505,Infectious Disease,Low Dose,2023-09-28,2023-10-05,6.38,6.26,121,75,71,None,None,Improved,1
3542,PT-03542,34,M,Fortis Mumbai,Phase III,ORX-101,Oncology,Placebo,2023-04-01,2023-04-08,7.44,5.77,133,90,69,None,None,Improved,1
3543,PT-03543,75,M,Bhopal Research Hospital,Phase III,ORX-606,Rheumatology,High Dose,2023-12-02,2023-12-09,7.22,5.42,122,82,84,Fever,None,Improved,1
3544,PT-03544,40,F,Kolkata Clinical Center,Phase III,ORX-202,Diabetes,Low Dose,2023-08-30,2023-09-06,5.99,4.6,116,75,62,None,None,Improved,1
3545,PT-03545,33,M,Kolkata Clinical Center,Phase IV,ORX-606,Rheumatology,Low Dose,2024-04-29,2024-07-28,7.99,9.07,141,97,91,Fatigue,None,No Change,0
3546,PT-03546,58,F,AIIMS Delhi,Phase III,ORX-404,Neurology,Placebo,2024-04-23,2024-04-30,6.79,6.52,120,79,78,Fatigue,None,No Change,0
3547,PT-03547,56,F,Indore Medical Institute,Phase III,ORX-404,Neurology,Placebo,2024-07-08,2024-07-15,7.71,7.16,128,87,87,Nausea,None,Worsened,0
3548,PT-03548,20,F,Apollo Chennai,Phase IV,ORX-505,Infectious Disease,Placebo,2023-07-12,2023-09-06,5.91,6.5,126,76,74,None,None,Improved,0
3549,PT-03549,40,F,Bhopal Research Hospital,Phase IV,ORX-606,Rheumatology,High Dose,2023-08-01,2023-08-15,7.87,6.47,128,84,83,Dizziness,None,Improved,1
3550,PT-03550,48,F,Indore Medical Institute,Phase IV,ORX-404,Neurology,Low Dose,2023-02-15,2023-04-12,7.82,6.9,111,111,73,None,None,No Change,0
3551,PT-03551,42,M,Fortis Mumbai,Phase III,ORX-101,Oncology,Low Dose,2024-04-10,2024-07-09,8.01,9.05,118,70,60,None,None,Improved,0
3552,PT-03552,70,F,Fortis Mumbai,Phase III,ORX-505,Infectious Disease,High Dose,2023-01-11,2023-01-25,5.95,5.53,110,64,73,Rash,None,Improved,1
3553,PT-03553,29,M,PGI Chandigarh,Phase III,ORX-606,Rheumatology,Placebo,2024-11-25,2024-12-02,6.37,7.78,135,93,89,Fatigue,Mild,Worsened,0
3554,PT-03554,43,F,Indore Medical Institute,Phase II,ORX-505,Infectious Disease,Placebo,2023-05-01,2023-06-26,6.67,6.5,131,75,79,Rash,None,No Change,0
3555,PT-03555,33,F,Fortis Mumbai,Phase III,ORX-202,Diabetes,High Dose,2023-03-26,2023-05-21,6.99,6.29,105,53,64,None,None,Improved,1
3556,PT-03556,73,F,Fortis Mumbai,Phase IV,ORX-101,Oncology,Low Dose,2024-11-05,2025-02-03,6.83,7.13,90,69,59,Fever,Mild,Worsened,0
3557,PT-03557,41,M,AIIMS Delhi,Phase II,ORX-606,Rheumatology,Placebo,2024-10-03,2024-10-31,10.11,10.12,158,78,97,Rash,Moderate,Improved,0
3558,PT-03558,78,M,Indore Medical Institute,Phase III,ORX-101,Oncology,High Dose,2023-06-12,2023-06-26,7.07,6.18,104,78,79,Nausea,Moderate,No Change,0
3559,PT-03559,77,F,Apollo Chennai,Phase II,ORX-101,Oncology,High Dose,2023-06-19,2023-07-03,5.65,5.3,95,76,82,Fever,None,Improved,1
3560,PT-03560,53,M,Indore Medical Institute,Phase IV,ORX-404,Neurology,Low Dose,2024-08-30,2024-09-06,7.91,7.86,138,82,63,None,None,No Change,0
3561,PT-03561,18,M,Kolkata Clinical Center,Phase III,ORX-202,Diabetes,High Dose,2023-01-27,2023-02-03,6.54,6.02,150,80,75,Fever,Mild,Improved,1
3562,PT-03562,51,M,PGI Chandigarh,Phase I,ORX-101,Oncology,Placebo,2023-05-12,2023-05-26,6.88,7.21,163,108,79,Dizziness,None,Improved,0
3563,PT-03563,50,M,NIMHANS Bengaluru,Phase III,ORX-505,Infectious Disease,Placebo,2023-02-26,2023-03-26,9.09,8.56,140,68,73,None,None,Improved,1
3564,PT-03564,63,M,Indore Medical Institute,Phase III,ORX-303,Cardiology,Placebo,2023-10-22,2023-12-17,6.34,5.82,99,106,95,None,None,Improved,1
3565,PT-03565,48,F,Kolkata Clinical Center,Phase III,ORX-505,Infectious Disease,Low Dose,2023-07-29,2023-10-27,7.81,7.77,152,75,88,Dizziness,None,No Change,0
3566,PT-03566,62,F,PGI Chandigarh,Phase III,ORX-202,Diabetes,Low Dose,2023-04-18,2023-05-16,8.66,6.22,117,69,80,None,None,Worsened,0
3567,PT-03567,18,F,Apollo Chennai,Phase I,ORX-505,Infectious Disease,High Dose,2024-03-23,2024-04-20,4.75,6.3,139,83,83,Nausea,Moderate,Worsened,0
3568,PT-03568,47,M,AIIMS Delhi,Phase III,ORX-303,Cardiology,Low Dose,2024-04-23,2024-06-18,8.4,7.43,131,84,63,Headache,Mild,No Change,0
3569,PT-03569,65,M,PGI Chandigarh,Phase II,ORX-505,Infectious Disease,Placebo,2023-02-24,2023-05-25,6.67,7.18,130,101,63,None,None,Improved,0
3570,PT-03570,27,F,Fortis Mumbai,Phase III,ORX-606,Rheumatology,Low Dose,2024-02-01,2024-02-08,6.11,5.83,155,101,45,None,None,No Change,0
3571,PT-03571,48,F,Fortis Mumbai,Phase III,ORX-505,Infectious Disease,High Dose,2023-11-30,2023-12-07,3.5,3.82,148,81,79,None,None,Improved,0
3572,PT-03572,46,F,Fortis Mumbai,Phase II,ORX-101,Oncology,Placebo,2023-12-07,2023-12-14,6.26,6.25,123,93,76,Fatigue,Mild,Improved,1
3573,PT-03573,31,F,PGI Chandigarh,Phase II,ORX-505,Infectious Disease,High Dose,2023-08-04,2023-09-01,5.36,3.28,151,76,82,None,None,Worsened,0
3574,PT-03574,73,M,AIIMS Delhi,Phase IV,ORX-606,Rheumatology,Placebo,2024-03-25,2024-04-22,6.52,5.56,125,82,104,Headache,None,Improved,1
3575,PT-03575,70,F,Fortis Mumbai,Phase IV,ORX-303,Cardiology,Low Dose,2023-07-04,2023-08-01,7.95,8.85,124,85,73,Headache,None,Improved,0
3576,PT-03576,24,F,Fortis Mumbai,Phase I,ORX-606,Rheumatology,Low Dose,2023-09-12,2023-11-07,8.64,8.72,128,81,56,Nausea,None,No Change,0
3577,PT-03577,29,M,PGI Chandigarh,Phase III,ORX-303,Cardiology,Low Dose,2023-10-19,2024-01-17,7.6,6.73,124,80,68,Nausea,Mild,No Change,0
3578,PT-03578,29,F,Bhopal Research Hospital,Phase IV,ORX-404,Neurology,Low Dose,2023-07-22,2023-10-20,5.27,4.73,139,62,77,None,None,Improved,1
3579,PT-03579,49,F,PGI Chandigarh,Phase I,ORX-303,Cardiology,Low Dose,2023-12-18,2023-12-25,6.01,6.89,121,80,75,Headache,None,Worsened,0
3580,PT-03580,18,F,Indore Medical Institute,Phase III,ORX-404,Neurology,Low Dose,2023-06-08,2023-06-22,8.41,7.15,123,89,98,Headache,None,Improved,1
3581,PT-03581,27,M,Fortis Mumbai,Phase III,ORX-303,Cardiology,High Dose,2024-10-04,2024-10-18,6.66,7.51,136,90,63,None,None,Improved,0
3582,PT-03582,38,M,Fortis Mumbai,Phase I,ORX-303,Cardiology,Low Dose,2023-09-04,2023-10-02,7.0,5.83,97,75,96,Nausea,None,Improved,1
3583,PT-03583,45,F,AIIMS Delhi,Phase IV,ORX-101,Oncology,Low Dose,2024-07-25,2024-08-08,8.85,8.61,114,97,80,Rash,Moderate,Improved,1
3584,PT-03584,60,F,NIMHANS Bengaluru,Phase III,ORX-404,Neurology,Low Dose,2024-07-27,2024-10-25,5.92,6.45,147,85,66,None,None,Improved,0
3585,PT-03585,44,M,NIMHANS Bengaluru,Phase I,ORX-606,Rheumatology,Placebo,2023-07-25,2023-08-01,7.93,7.74,138,94,68,None,None,Improved,1
3586,PT-03586,26,F,PGI Chandigarh,Phase III,ORX-202,Diabetes,Placebo,2024-08-15,2024-10-10,7.15,,142,69,92,None,None,No Change,0
3587,PT-03587,66,F,Apollo Chennai,Phase IV,ORX-101,Oncology,High Dose,2024-03-06,2024-03-13,7.2,6.86,114,75,72,Dizziness,Moderate,Improved,1
3588,PT-03588,68,F,Indore Medical Institute,Phase III,ORX-101,Oncology,Placebo,2024-01-16,2024-04-15,7.11,5.52,132,91,77,None,None,Improved,1
3589,PT-03589,68,M,Apollo Chennai,Phase II,ORX-202,Diabetes,Placebo,2024-02-20,2024-03-19,8.13,6.79,118,84,54,Nausea,None,Improved,1
3590,PT-03590,50,M,NIMHANS Bengaluru,Phase III,ORX-202,Diabetes,Low Dose,2023-02-13,2023-02-27,5.09,5.61,144,88,68,Nausea,Moderate,Worsened,0
3591,PT-03591,47,F,Bhopal Research Hospital,Phase III,ORX-505,Infectious Disease,Low Dose,2023-08-05,2023-11-03,6.58,5.26,121,90,78,Dizziness,None,Improved,1
3592,PT-03592,68,M,NIMHANS Bengaluru,Phase III,ORX-404,Neurology,Low Dose,2023-09-12,2023-10-10,8.12,8.31,99,78,63,Rash,Mild,Worsened,0
3593,PT-03593,42,M,Bhopal Research Hospital,Phase II,ORX-202,Diabetes,Placebo,2024-02-19,2024-04-15,6.37,5.63,147,87,92,None,None,Improved,1
3594,PT-03594,19,F,Indore Medical Institute,Phase II,ORX-303,Cardiology,Low Dose,2024-07-26,2024-08-09,7.27,7.74,155,63,73,Headache,Mild,No Change,0
3595,PT-03595,61,F,Kolkata Clinical Center,Phase III,ORX-505,Infectious Disease,High Dose,2023-12-02,2024-03-01,6.97,5.75,100,70,54,Headache,None,Improved,1
3596,PT-03596,45,F,AIIMS Delhi,Phase II,ORX-303,Cardiology,Low Dose,2024-04-01,2024-04-08,8.28,6.74,132,92,77,Dizziness,None,Improved,1
3597,PT-03597,19,M,PGI Chandigarh,Phase IV,ORX-202,Diabetes,Placebo,2023-12-01,2023-12-29,7.66,7.21,125,75,79,None,None,No Change,0
3598,PT-03598,53,M,Fortis Mumbai,Phase II,ORX-101,Oncology,High Dose,2024-10-03,2024-11-28,10.07,9.77,155,86,76,Nausea,None,No Change,0
3599,PT-03599,47,F,NIMHANS Bengaluru,Phase II,ORX-404,Neurology,Low Dose,2024-06-15,2024-06-22,5.73,5.61,92,71,79,None,None,Worsened,0
3600,PT-03600,64,M,AIIMS Delhi,Phase III,ORX-202,Diabetes,High Dose,2024-10-27,2024-11-10,8.92,8.3,130,93,59,Nausea,None,Improved,1
3601,PT-03601,51,M,Apollo Chennai,Phase II,ORX-202,Diabetes,Low Dose,2024-07-25,2024-08-22,6.21,5.65,119,87,85,None,None,Improved,1
3602,PT-03602,59,M,NIMHANS Bengaluru,Phase II,ORX-404,Neurology,High Dose,2024-06-17,2024-07-15,7.62,7.37,161,63,101,None,None,Improved,1
3603,PT-03603,40,F,PGI Chandigarh,Phase III,ORX-505,Infectious Disease,Low Dose,2023-11-30,2024-01-25,7.89,7.19,115,87,92,Nausea,Mild,No Change,0
3604,PT-03604,52,F,Kolkata Clinical Center,Phase III,ORX-505,Infectious Disease,Low Dose,2024-11-24,2024-12-01,6.55,9.4,149,93,73,None,None,Improved,0
3605,PT-03605,34,M,AIIMS Delhi,Phase III,ORX-404,Neurology,Low Dose,2024-05-05,2024-06-30,6.86,7.44,110,69,85,None,None,Improved,0
3606,PT-03606,50,F,NIMHANS Bengaluru,Phase II,ORX-202,Diabetes,Placebo,2023-02-07,2023-03-07,6.28,4.89,153,86,58,None,None,Improved,1
3607,PT-03607,24,F,Fortis Mumbai,Phase II,ORX-303,Cardiology,Placebo,2023-03-04,2023-04-01,6.77,7.03,138,95,57,Fever,None,Improved,0
3608,PT-03608,48,F,Bhopal Research Hospital,Phase II,ORX-303,Cardiology,Placebo,2023-09-13,2023-10-11,8.91,9.71,134,110,86,Nausea,Mild,Improved,0
3609,PT-03609,61,F,Indore Medical Institute,Phase III,ORX-303,Cardiology,Low Dose,2024-10-04,2024-10-11,7.25,6.15,112,84,75,None,None,Improved,1
3610,PT-03610,18,F,Bhopal Research Hospital,Phase I,ORX-606,Rheumatology,Placebo,2023-07-12,2023-07-26,5.97,5.28,141,81,76,Headache,None,No Change,0
3611,PT-03611,29,F,NIMHANS Bengaluru,Phase IV,ORX-606,Rheumatology,High Dose,2023-07-10,2023-09-04,7.23,8.01,130,63,60,Headache,None,No Change,0
3612,PT-03612,54,F,Apollo Chennai,Phase I,ORX-505,Infectious Disease,Placebo,2024-02-16,2024-02-23,6.93,,116,88,73,Headache,None,Worsened,0
3613,PT-03613,42,M,Kolkata Clinical Center,Phase III,ORX-101,Oncology,Placebo,2023-06-04,2023-06-18,6.18,6.61,124,89,61,None,None,No Change,0
3614,PT-03614,72,F,Fortis Mumbai,Phase III,ORX-505,Infectious Disease,High Dose,2024-02-21,2024-03-20,8.73,6.61,113,87,59,None,None,No Change,0
3615,PT-03615,42,M,AIIMS Delhi,Phase III,ORX-303,Cardiology,Low Dose,2024-03-15,2024-03-22,7.71,7.15,137,73,46,Rash,None,Worsened,0
3616,PT-03616,60,M,Indore Medical Institute,Phase I,ORX-606,Rheumatology,Low Dose,2024-01-11,2024-01-18,8.37,10.22,90,91,50,None,None,Improved,0
3617,PT-03617,73,M,AIIMS Delhi,Phase III,ORX-202,Diabetes,Placebo,2024-07-16,2024-10-14,7.79,6.53,142,75,82,None,None,Improved,1
3618,PT-03618,48,M,Bhopal Research Hospital,Phase III,ORX-303,Cardiology,High Dose,2023-09-02,2023-09-16,9.29,10.53,117,94,82,None,None,Improved,0
3619,PT-03619,22,M,Apollo Chennai,Phase III,ORX-101,Oncology,Placebo,2024-03-11,2024-05-06,6.36,8.07,134,93,75,Fatigue,None,Improved,0
3620,PT-03620,36,M,NIMHANS Bengaluru,Phase III,ORX-303,Cardiology,Low Dose,2023-01-23,2023-03-20,7.23,6.59,101,69,87,None,None,No Change,0
3621,PT-03621,38,F,AIIMS Delhi,Phase II,ORX-404,Neurology,Low Dose,2023-05-23,2023-05-30,7.23,7.04,133,95,62,None,None,No Change,0
3622,PT-03622,54,F,AIIMS Delhi,Phase III,ORX-404,Neurology,High Dose,2023-04-26,2023-05-03,8.11,8.59,102,85,102,Fever,Moderate,Improved,0
3623,PT-03623,43,F,Indore Medical Institute,Phase III,ORX-404,Neurology,Low Dose,2023-11-23,2024-01-18,7.78,8.08,109,104,84,Headache,Severe,Worsened,0
3624,PT-03624,53,M,Bhopal Research Hospital,Phase III,ORX-404,Neurology,Low Dose,2024-09-05,2024-09-19,5.21,5.52,137,101,73,Fever,None,No Change,0
3625,PT-03625,29,M,Apollo Chennai,Phase III,ORX-606,Rheumatology,High Dose,2023-01-18,2023-02-15,6.38,5.53,107,97,96,None,None,Improved,1
3626,PT-03626,41,F,NIMHANS Bengaluru,Phase IV,ORX-303,Cardiology,Low Dose,2023-02-27,2023-04-24,6.73,4.69,140,101,69,None,None,No Change,0
3627,PT-03627,43,M,Apollo Chennai,Phase III,ORX-101,Oncology,Placebo,2023-06-30,2023-08-25,7.72,8.87,131,84,80,None,None,No Change,0
3628,PT-03628,22,F,PGI Chandigarh,Phase III,ORX-606,Rheumatology,Placebo,2023-01-26,2023-02-09,5.46,4.34,146,77,70,None,None,No Change,0
3629,PT-03629,36,M,Fortis Mumbai,Phase II,ORX-505,Infectious Disease,Low Dose,2023-11-20,2023-11-27,7.03,8.17,125,72,78,None,None,Improved,0
3630,PT-03630,73,F,PGI Chandigarh,Phase II,ORX-606,Rheumatology,Placebo,2024-03-02,2024-03-16,6.6,5.13,118,83,87,None,None,No Change,0
3631,PT-03631,61,F,PGI Chandigarh,Phase III,ORX-606,Rheumatology,Low Dose,2024-04-21,2024-04-28,5.95,4.69,122,90,60,Rash,Moderate,Improved,1
3632,PT-03632,35,M,Fortis Mumbai,Phase III,ORX-202,Diabetes,Low Dose,2024-04-04,2024-04-11,6.49,6.94,137,92,96,None,None,No Change,0
3633,PT-03633,40,F,Fortis Mumbai,Phase I,ORX-404,Neurology,Placebo,2023-07-08,2023-08-05,5.78,4.31,94,76,72,Fatigue,None,No Change,0
3634,PT-03634,57,M,Kolkata Clinical Center,Phase IV,ORX-101,Oncology,Low Dose,2024-07-06,2024-08-03,7.22,6.38,125,69,92,None,None,Improved,1
3635,PT-03635,32,F,PGI Chandigarh,Phase III,ORX-101,Oncology,Low Dose,2023-04-07,2023-06-02,5.83,6.17,138,61,89,None,None,Worsened,0
3636,PT-03636,33,M,Bhopal Research Hospital,Phase I,ORX-101,Oncology,High Dose,2024-01-07,2024-04-06,6.75,6.52,138,87,77,None,None,Improved,1
3637,PT-03637,38,M,Bhopal Research Hospital,Phase II,ORX-404,Neurology,Low Dose,2024-01-20,2024-02-17,7.69,7.19,160,89,65,None,None,No Change,0
3638,PT-03638,37,F,Indore Medical Institute,Phase III,ORX-404,Neurology,Low Dose,2024-10-06,2024-11-03,7.26,8.03,153,77,64,Fatigue,Moderate,Worsened,0
3639,PT-03639,28,F,PGI Chandigarh,Phase III,ORX-404,Neurology,Placebo,2024-05-24,2024-07-19,7.5,9.18,137,62,67,None,None,Worsened,0
3640,PT-03640,35,F,Indore Medical Institute,Phase II,ORX-404,Neurology,Low Dose,2024-10-25,2024-11-22,6.21,5.46,134,90,93,Nausea,Mild,Improved,1
3641,PT-03641,53,F,AIIMS Delhi,Phase I,ORX-404,Neurology,Placebo,2023-05-12,2023-07-07,4.86,3.5,125,83,90,Rash,None,No Change,0
3642,PT-03642,45,F,Indore Medical Institute,Phase III,ORX-606,Rheumatology,Placebo,2024-09-12,2024-09-26,7.26,7.07,123,83,93,None,None,Improved,1
3643,PT-03643,43,M,Indore Medical Institute,Phase III,ORX-505,Infectious Disease,Placebo,2024-04-23,2024-04-30,7.16,6.73,151,68,102,None,None,Improved,1
3644,PT-03644,26,M,NIMHANS Bengaluru,Phase III,ORX-606,Rheumatology,Placebo,2023-01-25,2023-02-22,6.41,6.69,146,65,62,Rash,Mild,Worsened,0
3645,PT-03645,49,F,Kolkata Clinical Center,Phase III,ORX-404,Neurology,High Dose,2023-03-28,2023-04-25,10.01,10.73,123,52,79,None,None,No Change,0
3646,PT-03646,50,F,Bhopal Research Hospital,Phase III,ORX-101,Oncology,Low Dose,2024-03-13,2024-06-11,6.74,5.58,130,70,104,None,None,Worsened,0
3647,PT-03647,69,M,Kolkata Clinical Center,Phase IV,ORX-202,Diabetes,Low Dose,2024-08-31,2024-09-28,7.99,,116,81,100,Rash,Mild,Improved,1
3648,PT-03648,58,M,PGI Chandigarh,Phase I,ORX-101,Oncology,High Dose,2024-01-13,2024-03-09,7.44,7.88,137,86,91,Dizziness,Moderate,Improved,0
3649,PT-03649,53,F,AIIMS Delhi,Phase III,ORX-303,Cardiology,Placebo,2024-05-22,2024-06-19,8.23,7.98,123,75,68,None,None,Improved,1
3650,PT-03650,19,F,NIMHANS Bengaluru,Phase IV,ORX-606,Rheumatology,Low Dose,2024-01-07,2024-04-06,6.11,4.86,118,100,75,None,None,Improved,1
3651,PT-03651,48,M,Kolkata Clinical Center,Phase III,ORX-303,Cardiology,Low Dose,2023-10-16,2023-12-11,7.53,8.56,117,79,76,None,None,Improved,0
3652,PT-03652,63,F,Fortis Mumbai,Phase III,ORX-202,Diabetes,Low Dose,2024-01-17,2024-03-13,8.81,8.84,150,84,75,Nausea,Mild,No Change,0
3653,PT-03653,63,M,Indore Medical Institute,Phase II,ORX-101,Oncology,Low Dose,2023-03-05,2023-04-30,7.79,6.72,145,79,73,None,None,Worsened,0
3654,PT-03654,59,M,Kolkata Clinical Center,Phase I,ORX-101,Oncology,Low Dose,2024-08-05,2024-09-30,7.09,7.04,139,72,83,Nausea,None,Worsened,0
3655,PT-03655,66,M,Apollo Chennai,Phase III,ORX-606,Rheumatology,Placebo,2024-07-22,2024-09-16,6.05,6.06,113,94,92,None,None,No Change,0
3656,PT-03656,39,F,Kolkata Clinical Center,Phase III,ORX-303,Cardiology,Placebo,2023-12-04,2024-01-01,9.85,10.45,140,89,91,Headache,None,Improved,0
3657,PT-03657,29,F,Kolkata Clinical Center,Phase III,ORX-303,Cardiology,Low Dose,2023-05-07,2023-05-14,7.43,7.38,120,87,95,None,None,Improved,1
3658,PT-03658,38,M,PGI Chandigarh,Phase II,ORX-101,Oncology,Low Dose,2024-08-07,2024-08-21,7.13,6.0,95,91,77,None,None,No Change,0
3659,PT-03659,45,M,Kolkata Clinical Center,Phase I,ORX-505,Infectious Disease,Low Dose,2023-01-09,2023-01-23,6.02,5.45,147,82,78,None,None,No Change,0
3660,PT-03660,48,F,Indore Medical Institute,Phase II,ORX-303,Cardiology,Low Dose,2024-05-08,2024-07-03,5.72,5.88,105,70,63,Headache,Mild,No Change,0
3661,PT-03661,42,F,Bhopal Research Hospital,Phase II,ORX-202,Diabetes,High Dose,2023-08-05,2023-09-02,6.78,6.38,111,94,89,None,None,No Change,0
3662,PT-03662,42,M,Bhopal Research Hospital,Phase III,ORX-101,Oncology,High Dose,2024-05-21,2024-06-18,6.63,5.7,122,65,64,Nausea,Moderate,Improved,1
3663,PT-03663,58,F,Fortis Mumbai,Phase II,ORX-505,Infectious Disease,Placebo,2023-07-12,2023-09-06,7.56,8.63,122,77,72,Fatigue,None,No Change,0
3664,PT-03664,39,F,AIIMS Delhi,Phase IV,ORX-505,Infectious Disease,Placebo,2023-07-24,2023-10-22,6.41,6.25,128,75,95,None,None,Improved,1
3665,PT-03665,75,F,PGI Chandigarh,Phase IV,ORX-303,Cardiology,Placebo,2024-08-09,2024-09-06,8.6,8.7,141,104,88,Dizziness,Mild,Improved,0
3666,PT-03666,35,F,Bhopal Research Hospital,Phase II,ORX-101,Oncology,High Dose,2023-03-11,2023-03-18,7.67,7.83,110,78,93,Fatigue,Mild,Improved,0
3667,PT-03667,18,F,Apollo Chennai,Phase II,ORX-303,Cardiology,Placebo,2024-08-21,2024-09-04,5.7,5.14,134,65,76,Dizziness,None,Improved,1
3668,PT-03668,63,M,NIMHANS Bengaluru,Phase III,ORX-505,Infectious Disease,High Dose,2024-09-29,2024-10-06,7.28,7.73,117,72,89,None,None,Improved,0
3669,PT-03669,50,M,PGI Chandigarh,Phase II,ORX-202,Diabetes,Low Dose,2024-05-29,2024-06-05,5.78,4.66,156,70,91,None,None,Improved,1
3670,PT-03670,37,F,Apollo Chennai,Phase I,ORX-303,Cardiology,Low Dose,2024-02-10,2024-02-17,7.2,7.06,90,64,79,Fatigue,Moderate,No Change,0
3671,PT-03671,33,F,AIIMS Delhi,Phase III,ORX-404,Neurology,Placebo,2023-12-09,2024-01-06,8.4,6.55,138,65,73,Fever,None,Improved,1
3672,PT-03672,27,M,Apollo Chennai,Phase IV,ORX-303,Cardiology,High Dose,2024-02-03,2024-05-03,9.48,7.88,125,61,100,None,None,No Change,0
3673,PT-03673,51,M,Indore Medical Institute,Phase III,ORX-404,Neurology,High Dose,2023-03-27,2023-05-22,7.36,8.29,130,84,79,None,None,Improved,0
3674,PT-03674,54,F,Indore Medical Institute,Phase II,ORX-505,Infectious Disease,High Dose,2023-09-23,2023-11-18,6.61,6.02,142,85,76,Headache,None,No Change,0
3675,PT-03675,22,M,Apollo Chennai,Phase III,ORX-505,Infectious Disease,Low Dose,2023-03-20,2023-03-27,9.0,8.0,145,84,59,Fever,None,Improved,1
3676,PT-03676,65,F,AIIMS Delhi,Phase II,ORX-101,Oncology,Placebo,2023-03-29,2023-04-12,7.51,8.31,124,90,53,None,None,Improved,0
3677,PT-03677,36,F,Kolkata Clinical Center,Phase III,ORX-303,Cardiology,Low Dose,2024-01-28,2024-04-27,5.67,4.94,136,74,90,Nausea,None,Improved,1
3678,PT-03678,31,M,PGI Chandigarh,Phase III,ORX-303,Cardiology,Placebo,2023-08-12,2023-08-26,8.26,9.04,146,77,48,None,None,Improved,0
3679,PT-03679,54,M,PGI Chandigarh,Phase I,ORX-505,Infectious Disease,High Dose,2023-03-10,2023-04-07,7.05,5.77,117,99,62,Headache,Moderate,Worsened,0
3680,PT-03680,52,M,Bhopal Research Hospital,Phase III,ORX-606,Rheumatology,Low Dose,2024-04-29,2024-07-28,7.46,6.74,139,101,73,None,None,Improved,1
3681,PT-03681,41,F,Fortis Mumbai,Phase II,ORX-505,Infectious Disease,Placebo,2023-03-29,2023-06-27,7.95,8.37,125,78,46,Nausea,None,Worsened,0
3682,PT-03682,32,F,Fortis Mumbai,Phase II,ORX-505,Infectious Disease,Placebo,2023-04-23,2023-05-21,5.83,6.05,123,78,77,None,None,Improved,0
3683,PT-03683,31,F,NIMHANS Bengaluru,Phase III,ORX-505,Infectious Disease,Low Dose,2024-08-17,2024-08-24,9.06,9.83,157,90,77,None,None,Improved,0
3684,PT-03684,70,F,Bhopal Research Hospital,Phase II,ORX-202,Diabetes,High Dose,2023-02-01,2023-02-08,6.38,5.2,117,88,67,Fatigue,None,Improved,1
3685,PT-03685,42,F,NIMHANS Bengaluru,Phase III,ORX-505,Infectious Disease,High Dose,2024-06-09,2024-09-07,5.28,5.31,100,70,95,None,None,Improved,0
3686,PT-03686,63,F,AIIMS Delhi,Phase III,ORX-404,Neurology,Placebo,2024-09-06,2024-09-13,7.65,7.5,118,72,72,None,None,Improved,1
3687,PT-03687,20,F,Bhopal Research Hospital,Phase IV,ORX-404,Neurology,Low Dose,2023-10-07,2024-01-05,7.5,7.15,111,100,86,Fatigue,None,Improved,1
3688,PT-03688,56,M,Indore Medical Institute,Phase III,ORX-101,Oncology,Placebo,2023-03-05,2023-06-03,6.62,6.21,139,83,100,None,None,Improved,1
3689,PT-03689,41,M,AIIMS Delhi,Phase II,ORX-202,Diabetes,Placebo,2024-07-10,2024-08-07,6.59,6.77,105,93,59,Fever,Mild,Worsened,0
3690,PT-03690,55,M,Fortis Mumbai,Phase IV,ORX-404,Neurology,Placebo,2024-02-07,2024-04-03,6.42,6.45,144,83,61,Nausea,Severe,No Change,0
3691,PT-03691,30,M,AIIMS Delhi,Phase I,ORX-303,Cardiology,Placebo,2023-09-17,2023-10-01,6.33,4.22,148,83,62,None,None,Improved,1
3692,PT-03692,68,M,Kolkata Clinical Center,Phase III,ORX-404,Neurology,Placebo,2023-05-18,2023-08-16,6.36,6.18,113,57,58,None,None,Worsened,0
3693,PT-03693,37,F,NIMHANS Bengaluru,Phase III,ORX-606,Rheumatology,Low Dose,2024-04-26,2024-05-24,8.28,8.19,130,57,95,None,None,Improved,1
3694,PT-03694,48,F,AIIMS Delhi,Phase III,ORX-101,Oncology,Placebo,2024-10-27,2024-11-24,7.06,7.68,150,95,74,None,None,Improved,0
3695,PT-03695,28,M,Apollo Chennai,Phase I,ORX-606,Rheumatology,Placebo,2024-01-15,2024-01-22,8.39,6.76,163,82,63,Headache,Moderate,Improved,1
3696,PT-03696,25,F,AIIMS Delhi,Phase IV,ORX-303,Cardiology,High Dose,2023-05-21,2023-06-18,5.67,5.39,127,67,73,None,None,Improved,1
3697,PT-03697,23,F,NIMHANS Bengaluru,Phase IV,ORX-606,Rheumatology,High Dose,2024-06-28,2024-09-26,7.91,7.46,121,66,73,Nausea,None,No Change,0
3698,PT-03698,38,F,Apollo Chennai,Phase III,ORX-505,Infectious Disease,Low Dose,2023-07-09,2023-07-23,7.58,7.33,142,76,51,None,None,No Change,0
3699,PT-03699,60,M,Apollo Chennai,Phase III,ORX-404,Neurology,Low Dose,2024-11-17,2024-12-01,6.08,4.68,127,85,70,None,None,No Change,0
3700,PT-03700,36,F,Kolkata Clinical Center,Phase III,ORX-606,Rheumatology,High Dose,2023-10-08,2023-10-22,6.73,7.61,127,70,64,None,None,No Change,0
3701,PT-03701,40,F,Apollo Chennai,Phase III,ORX-101,Oncology,Low Dose,2024-09-08,2024-10-06,7.49,7.52,130,71,72,None,None,No Change,0
3702,PT-03702,56,M,AIIMS Delhi,Phase III,ORX-606,Rheumatology,Placebo,2023-07-15,2023-08-12,5.82,5.01,138,92,75,Headache,Mild,Improved,1
3703,PT-03703,38,F,Kolkata Clinical Center,Phase I,ORX-606,Rheumatology,Placebo,2024-05-05,2024-06-02,5.61,5.69,151,112,83,Nausea,Moderate,Improved,0
3704,PT-03704,44,F,NIMHANS Bengaluru,Phase III,ORX-202,Diabetes,High Dose,2024-04-12,2024-06-07,6.1,4.01,131,110,95,Headache,None,Improved,1
3705,PT-03705,62,M,Indore Medical Institute,Phase II,ORX-303,Cardiology,High Dose,2024-01-03,2024-01-10,7.49,7.42,90,91,69,Rash,Mild,No Change,0
3706,PT-03706,33,F,AIIMS Delhi,Phase II,ORX-202,Diabetes,High Dose,2024-08-19,2024-09-16,6.81,6.09,115,82,70,None,None,Improved,1
3707,PT-03707,46,M,PGI Chandigarh,Phase III,ORX-505,Infectious Disease,Placebo,2023-10-29,2023-11-05,5.42,4.82,108,74,80,None,None,No Change,0
3708,PT-03708,19,F,Bhopal Research Hospital,Phase I,ORX-101,Oncology,Low Dose,2024-05-24,2024-06-21,6.21,6.33,102,103,94,Headache,Severe,Improved,0
3709,PT-03709,37,F,PGI Chandigarh,Phase II,ORX-606,Rheumatology,Low Dose,2023-12-10,2023-12-17,6.26,6.04,101,57,71,None,None,Improved,1
3710,PT-03710,42,F,AIIMS Delhi,Phase IV,ORX-202,Diabetes,Placebo,2023-05-18,2023-07-13,7.31,6.36,150,64,62,None,None,Worsened,0
3711,PT-03711,52,F,Indore Medical Institute,Phase IV,ORX-606,Rheumatology,Placebo,2024-11-25,2024-12-09,5.81,4.33,130,69,76,Rash,None,Improved,1
3712,PT-03712,33,M,Apollo Chennai,Phase III,ORX-303,Cardiology,High Dose,2023-11-11,2024-01-06,6.17,3.87,130,67,75,Fatigue,None,No Change,0
3713,PT-03713,36,M,Bhopal Research Hospital,Phase IV,ORX-101,Oncology,High Dose,2024-03-27,2024-04-24,6.95,6.42,131,73,95,None,None,Worsened,0
3714,PT-03714,18,F,Apollo Chennai,Phase IV,ORX-101,Oncology,Placebo,2024-09-12,2024-09-26,6.93,7.28,136,70,66,Fever,Moderate,Improved,0
3715,PT-03715,28,F,Apollo Chennai,Phase II,ORX-101,Oncology,High Dose,2023-12-09,2024-03-08,7.92,6.85,132,85,111,Headache,None,Worsened,0
3716,PT-03716,50,M,Bhopal Research Hospital,Phase III,ORX-505,Infectious Disease,High Dose,2023-09-07,2023-11-02,6.23,4.51,123,80,47,Dizziness,Mild,Improved,1
3717,PT-03717,33,M,AIIMS Delhi,Phase IV,ORX-101,Oncology,Low Dose,2023-11-08,2023-11-15,7.56,6.68,145,63,87,None,None,No Change,0
3718,PT-03718,59,M,AIIMS Delhi,Phase III,ORX-505,Infectious Disease,Placebo,2024-03-08,2024-03-15,8.35,6.54,133,73,58,Nausea,None,Improved,1
3719,PT-03719,38,M,Bhopal Research Hospital,Phase II,ORX-303,Cardiology,Low Dose,2024-08-10,2024-10-05,6.11,6.54,137,68,67,Fatigue,None,Worsened,0
3720,PT-03720,38,M,Fortis Mumbai,Phase IV,ORX-202,Diabetes,Low Dose,2024-11-11,2025-01-06,7.11,7.62,140,82,74,Headache,None,Improved,0
3721,PT-03721,18,M,NIMHANS Bengaluru,Phase I,ORX-303,Cardiology,Placebo,2023-02-16,2023-02-23,8.75,7.95,155,84,106,None,None,Improved,1
3722,PT-03722,54,M,Fortis Mumbai,Phase I,ORX-101,Oncology,Placebo,2023-08-29,2023-09-26,5.48,4.53,124,71,72,Fever,None,Improved,1
3723,PT-03723,23,F,Kolkata Clinical Center,Phase I,ORX-202,Diabetes,High Dose,2023-05-11,2023-05-25,7.21,7.02,109,105,78,None,None,No Change,0
3724,PT-03724,31,F,Bhopal Research Hospital,Phase I,ORX-404,Neurology,Low Dose,2023-03-20,2023-06-18,5.24,4.9,123,91,75,Nausea,Mild,No Change,0
3725,PT-03725,25,F,Kolkata Clinical Center,Phase III,ORX-404,Neurology,Low Dose,2024-03-24,2024-04-21,9.2,9.2,123,83,84,None,None,Worsened,0
3726,PT-03726,22,F,Bhopal Research Hospital,Phase III,ORX-202,Diabetes,High Dose,2024-09-13,2024-12-12,7.39,6.58,137,73,69,Fever,None,Improved,1
3727,PT-03727,71,F,AIIMS Delhi,Phase III,ORX-101,Oncology,Placebo,2024-05-02,2024-05-16,8.68,5.31,148,81,68,None,None,Improved,1
3728,PT-03728,28,F,NIMHANS Bengaluru,Phase II,ORX-505,Infectious Disease,High Dose,2023-03-28,2023-05-23,6.06,5.05,107,65,63,None,None,No Change,0
3729,PT-03729,50,M,Indore Medical Institute,Phase III,ORX-404,Neurology,High Dose,2024-08-15,2024-10-10,7.26,7.36,126,66,84,Headache,None,No Change,0
3730,PT-03730,28,M,Kolkata Clinical Center,Phase II,ORX-303,Cardiology,Low Dose,2024-09-26,2024-10-10,7.98,6.53,115,77,87,None,None,Worsened,0
3731,PT-03731,47,F,NIMHANS Bengaluru,Phase II,ORX-606,Rheumatology,Placebo,2024-01-06,2024-02-03,7.22,8.52,94,69,62,Nausea,Mild,No Change,0
3732,PT-03732,18,M,PGI Chandigarh,Phase III,ORX-303,Cardiology,Placebo,2024-02-25,2024-03-10,6.34,6.56,117,78,53,Rash,Moderate,Improved,0
3733,PT-03733,32,M,Indore Medical Institute,Phase I,ORX-606,Rheumatology,Low Dose,2024-10-12,2024-10-19,6.65,6.82,97,76,93,None,None,No Change,0
3734,PT-03734,37,F,PGI Chandigarh,Phase II,ORX-303,Cardiology,High Dose,2023-12-23,2024-01-20,4.66,5.41,141,92,53,Headache,None,No Change,0
3735,PT-03735,69,M,NIMHANS Bengaluru,Phase III,ORX-404,Neurology,Low Dose,2024-05-30,2024-08-28,6.27,5.41,115,93,75,Rash,Moderate,Improved,1
3736,PT-03736,52,M,AIIMS Delhi,Phase III,ORX-101,Oncology,High Dose,2023-02-02,2023-02-09,7.29,6.81,110,103,57,None,None,Improved,1
3737,PT-03737,51,M,Indore Medical Institute,Phase IV,ORX-505,Infectious Disease,Low Dose,2023-03-11,2023-03-18,7.65,8.29,152,80,85,None,None,No Change,0
3738,PT-03738,73,M,PGI Chandigarh,Phase III,ORX-606,Rheumatology,Low Dose,2023-01-16,2023-02-13,7.12,5.76,121,66,83,Fatigue,Severe,Improved,1
3739,PT-03739,62,F,NIMHANS Bengaluru,Phase III,ORX-404,Neurology,Placebo,2024-03-04,2024-04-01,7.05,5.2,146,60,56,None,None,Worsened,0
3740,PT-03740,42,F,Fortis Mumbai,Phase I,ORX-303,Cardiology,High Dose,2024-05-24,2024-05-31,7.5,7.48,126,103,78,Nausea,None,No Change,0
3741,PT-03741,61,M,Indore Medical Institute,Phase I,ORX-101,Oncology,Low Dose,2024-04-22,2024-04-29,8.14,6.58,124,107,70,None,None,Improved,1
3742,PT-03742,34,F,Fortis Mumbai,Phase III,ORX-606,Rheumatology,Placebo,2023-01-30,2023-03-27,7.4,6.58,113,76,98,None,None,Improved,1
3743,PT-03743,42,F,Kolkata Clinical Center,Phase III,ORX-606,Rheumatology,High Dose,2024-09-07,2024-09-14,5.61,3.85,167,79,84,Nausea,None,No Change,0
3744,PT-03744,32,M,Bhopal Research Hospital,Phase III,ORX-404,Neurology,Low Dose,2024-09-01,2024-11-30,7.59,8.5,116,87,58,Nausea,None,Worsened,0
3745,PT-03745,77,M,Indore Medical Institute,Phase II,ORX-303,Cardiology,High Dose,2023-05-05,2023-05-12,7.52,6.75,122,75,71,Headache,None,Worsened,0
3746,PT-03746,18,F,Fortis Mumbai,Phase III,ORX-202,Diabetes,Placebo,2023-03-27,2023-04-24,7.08,6.56,136,75,67,Headache,Moderate,Worsened,0
3747,PT-03747,44,M,Bhopal Research Hospital,Phase III,ORX-202,Diabetes,Low Dose,2024-08-31,2024-09-07,5.27,4.99,94,95,87,None,None,Worsened,0
3748,PT-03748,30,M,Apollo Chennai,Phase II,ORX-404,Neurology,Placebo,2023-06-08,2023-07-06,7.99,7.69,109,57,82,Rash,None,Worsened,0
3749,PT-03749,32,M,PGI Chandigarh,Phase IV,ORX-202,Diabetes,Low Dose,2023-11-19,2023-11-26,8.51,8.13,115,103,86,Headache,None,Worsened,0
3750,PT-03750,18,M,Fortis Mumbai,Phase III,ORX-101,Oncology,Low Dose,2023-04-27,2023-07-26,6.62,4.97,113,80,82,Fatigue,Mild,No Change,0
3751,PT-03751,49,M,Kolkata Clinical Center,Phase II,ORX-101,Oncology,Placebo,2024-02-16,2024-05-16,8.49,8.67,138,84,96,Headache,None,Improved,0
3752,PT-03752,39,M,Fortis Mumbai,Phase II,ORX-303,Cardiology,Placebo,2024-03-10,2024-05-05,6.85,4.74,147,81,119,Dizziness,Mild,No Change,0
3753,PT-03753,38,F,Fortis Mumbai,Phase III,ORX-606,Rheumatology,Placebo,2024-03-10,2024-03-17,7.31,7.4,108,86,78,None,None,Improved,0
3754,PT-03754,40,F,Fortis Mumbai,Phase III,ORX-303,Cardiology,High Dose,2024-02-28,2024-03-06,8.61,7.39,132,99,68,Fatigue,None,Improved,1
3755,PT-03755,40,M,PGI Chandigarh,Phase III,ORX-505,Infectious Disease,High Dose,2024-02-16,2024-05-16,10.01,10.04,118,91,70,Nausea,None,Improved,0
3756,PT-03756,19,M,Fortis Mumbai,Phase II,ORX-101,Oncology,Placebo,2023-07-16,2023-07-30,8.85,7.45,172,76,107,Nausea,Mild,Improved,1
3757,PT-03757,23,F,Apollo Chennai,Phase III,ORX-606,Rheumatology,High Dose,2024-10-05,2024-11-02,8.43,8.48,143,93,71,None,None,Worsened,0
3758,PT-03758,24,M,Kolkata Clinical Center,Phase II,ORX-303,Cardiology,Placebo,2024-05-24,2024-08-22,7.14,6.94,119,85,82,Headache,Moderate,Improved,1
3759,PT-03759,30,F,PGI Chandigarh,Phase III,ORX-303,Cardiology,High Dose,2023-10-29,2023-11-12,7.67,7.03,115,91,67,None,None,Improved,1
3760,PT-03760,37,F,Kolkata Clinical Center,Phase III,ORX-303,Cardiology,Placebo,2023-10-08,2024-01-06,7.29,8.12,131,88,73,Rash,None,Improved,0
3761,PT-03761,43,F,Indore Medical Institute,Phase III,ORX-101,Oncology,Low Dose,2024-01-31,2024-04-30,7.14,7.01,122,98,72,None,None,Improved,1
3762,PT-03762,18,M,NIMHANS Bengaluru,Phase II,ORX-202,Diabetes,High Dose,2024-11-18,2025-01-13,10.49,9.8,151,98,91,None,None,Improved,1
3763,PT-03763,41,M,Apollo Chennai,Phase III,ORX-505,Infectious Disease,Low Dose,2024-10-29,2024-11-26,7.54,6.0,163,71,74,None,None,No Change,0
3764,PT-03764,46,M,Indore Medical Institute,Phase I,ORX-303,Cardiology,Placebo,2023-06-10,2023-07-08,7.07,6.08,153,93,82,Fever,Mild,Improved,1
3765,PT-03765,38,F,NIMHANS Bengaluru,Phase I,ORX-101,Oncology,Low Dose,2024-09-21,2024-10-05,8.48,7.66,156,83,95,Nausea,None,Improved,1
3766,PT-03766,43,M,AIIMS Delhi,Phase III,ORX-404,Neurology,High Dose,2024-01-05,2024-01-12,7.29,7.99,167,100,90,None,None,No Change,0
3767,PT-03767,54,M,Indore Medical Institute,Phase III,ORX-202,Diabetes,Placebo,2023-03-02,2023-03-16,6.59,6.46,111,86,84,Fever,Mild,No Change,0
3768,PT-03768,18,F,Fortis Mumbai,Phase II,ORX-303,Cardiology,High Dose,2024-04-15,2024-07-14,7.25,7.22,126,86,59,None,None,No Change,0
3769,PT-03769,32,M,Kolkata Clinical Center,Phase III,ORX-505,Infectious Disease,High Dose,2024-08-06,2024-10-01,8.44,8.04,134,75,78,None,None,No Change,0
3770,PT-03770,18,F,PGI Chandigarh,Phase III,ORX-606,Rheumatology,Low Dose,2024-04-12,2024-07-11,8.22,9.44,108,70,84,None,None,Worsened,0
3771,PT-03771,68,M,Kolkata Clinical Center,Phase III,ORX-606,Rheumatology,High Dose,2024-11-28,2024-12-12,7.2,5.69,124,69,68,None,None,Improved,1
3772,PT-03772,40,M,AIIMS Delhi,Phase I,ORX-606,Rheumatology,Placebo,2023-01-25,2023-02-08,6.08,4.98,129,84,58,Fever,None,Improved,1
3773,PT-03773,51,M,Bhopal Research Hospital,Phase III,ORX-404,Neurology,Low Dose,2023-10-05,2023-10-12,6.74,6.99,142,75,86,None,None,No Change,0
3774,PT-03774,31,M,NIMHANS Bengaluru,Phase II,ORX-303,Cardiology,High Dose,2023-04-12,2023-04-19,8.79,7.67,134,79,63,None,None,Improved,1
3775,PT-03775,59,M,Indore Medical Institute,Phase IV,ORX-303,Cardiology,Placebo,2023-05-20,2023-06-03,6.46,4.53,90,71,97,Nausea,None,Improved,1
3776,PT-03776,65,F,PGI Chandigarh,Phase III,ORX-505,Infectious Disease,Low Dose,2024-06-22,2024-07-06,6.34,5.6,119,65,64,Dizziness,None,Improved,1
3777,PT-03777,60,F,AIIMS Delhi,Phase III,ORX-202,Diabetes,Low Dose,2023-11-22,2023-12-20,7.8,7.65,103,83,45,Headache,Moderate,Improved,1
3778,PT-03778,58,F,AIIMS Delhi,Phase II,ORX-606,Rheumatology,Low Dose,2023-08-10,2023-11-08,7.51,5.9,157,60,85,Headache,None,Improved,1
3779,PT-03779,53,F,Indore Medical Institute,Phase I,ORX-202,Diabetes,Low Dose,2024-05-16,2024-07-11,5.71,5.28,98,50,63,None,None,No Change,0
3780,PT-03780,35,M,Fortis Mumbai,Phase IV,ORX-606,Rheumatology,Low Dose,2024-08-05,2024-09-30,7.97,7.63,129,69,70,Dizziness,None,Worsened,0
3781,PT-03781,30,F,PGI Chandigarh,Phase I,ORX-404,Neurology,Placebo,2023-01-27,2023-02-24,5.73,4.8,129,75,73,Nausea,Mild,Improved,1
3782,PT-03782,56,M,Apollo Chennai,Phase III,ORX-101,Oncology,High Dose,2024-08-04,2024-09-01,6.6,5.0,138,85,82,Nausea,Moderate,Improved,1
3783,PT-03783,55,F,Apollo Chennai,Phase III,ORX-101,Oncology,High Dose,2024-09-18,2024-11-13,7.75,7.37,171,66,69,Fatigue,None,Worsened,0
3784,PT-03784,60,M,PGI Chandigarh,Phase III,ORX-101,Oncology,High Dose,2023-06-13,2023-08-08,7.37,7.65,131,98,63,Fever,Mild,No Change,0
3785,PT-03785,66,M,NIMHANS Bengaluru,Phase III,ORX-505,Infectious Disease,High Dose,2023-01-01,2023-04-01,8.61,7.12,139,81,69,None,None,Improved,1
3786,PT-03786,18,M,Kolkata Clinical Center,Phase III,ORX-101,Oncology,High Dose,2023-05-05,2023-08-03,5.99,6.22,142,79,89,Headache,None,No Change,0
3787,PT-03787,60,M,PGI Chandigarh,Phase II,ORX-505,Infectious Disease,Low Dose,2023-02-08,2023-02-22,7.39,6.34,135,87,87,None,None,Improved,1
3788,PT-03788,58,F,Kolkata Clinical Center,Phase III,ORX-303,Cardiology,Placebo,2024-01-05,2024-03-01,5.57,4.71,93,90,75,None,None,No Change,0
3789,PT-03789,51,M,Indore Medical Institute,Phase II,ORX-404,Neurology,High Dose,2024-09-11,2024-10-09,5.43,6.29,106,91,79,None,None,Worsened,0
3790,PT-03790,41,M,Fortis Mumbai,Phase II,ORX-101,Oncology,High Dose,2023-01-25,2023-02-01,6.88,5.9,151,82,60,Nausea,None,Improved,1
3791,PT-03791,38,F,Kolkata Clinical Center,Phase III,ORX-303,Cardiology,Low Dose,2024-07-08,2024-08-05,7.35,7.76,117,75,78,None,None,Worsened,0
3792,PT-03792,58,F,Bhopal Research Hospital,Phase III,ORX-303,Cardiology,Low Dose,2023-10-31,2024-01-29,5.56,5.61,119,78,106,None,None,No Change,0
3793,PT-03793,41,M,Fortis Mumbai,Phase II,ORX-606,Rheumatology,Low Dose,2024-04-01,2024-04-15,8.11,8.35,106,59,89,Dizziness,None,Improved,0
3794,PT-03794,27,M,AIIMS Delhi,Phase II,ORX-101,Oncology,Low Dose,2023-08-20,2023-11-18,5.2,5.73,109,72,105,Nausea,Moderate,Improved,0
3795,PT-03795,18,F,AIIMS Delhi,Phase IV,ORX-101,Oncology,Low Dose,2024-01-31,2024-02-28,5.69,4.88,123,71,61,Dizziness,Mild,No Change,0
3796,PT-03796,69,M,Fortis Mumbai,Phase IV,ORX-101,Oncology,Low Dose,2024-01-22,2024-03-18,7.52,7.64,125,85,91,None,None,Improved,0
3797,PT-03797,29,F,PGI Chandigarh,Phase III,ORX-505,Infectious Disease,Low Dose,2023-10-05,2024-01-03,7.52,7.74,155,105,78,Headache,None,Improved,0
3798,PT-03798,63,F,AIIMS Delhi,Phase III,ORX-404,Neurology,Placebo,2023-04-04,2023-07-03,4.0,4.99,114,79,84,None,None,Improved,0
3799,PT-03799,42,F,PGI Chandigarh,Phase III,ORX-202,Diabetes,Low Dose,2023-02-23,2023-03-02,7.44,8.46,121,68,103,None,None,Worsened,0
3800,PT-03800,53,M,Bhopal Research Hospital,Phase IV,ORX-404,Neurology,High Dose,2023-12-31,2024-03-30,9.51,9.88,104,89,64,None,None,Improved,0
3801,PT-03801,45,F,Kolkata Clinical Center,Phase IV,ORX-505,Infectious Disease,Placebo,2024-03-26,2024-04-02,7.11,5.25,113,108,81,None,None,Improved,1
3802,PT-03802,42,M,Bhopal Research Hospital,Phase II,ORX-505,Infectious Disease,High Dose,2024-01-18,2024-03-14,9.38,8.62,126,93,72,None,None,No Change,0
3803,PT-03803,33,F,AIIMS Delhi,Phase IV,ORX-101,Oncology,High Dose,2023-08-14,2023-08-28,4.5,3.25,110,83,69,None,None,Improved,1
3804,PT-03804,79,F,Bhopal Research Hospital,Phase III,ORX-202,Diabetes,Low Dose,2024-05-10,2024-05-24,5.93,6.79,131,91,88,None,None,Worsened,0
3805,PT-03805,18,M,PGI Chandigarh,Phase I,ORX-404,Neurology,High Dose,2024-08-12,2024-09-09,7.19,6.55,107,87,102,None,None,No Change,0
3806,PT-03806,18,M,Fortis Mumbai,Phase I,ORX-202,Diabetes,Low Dose,2024-02-02,2024-03-29,6.56,5.04,129,78,69,Nausea,Mild,Improved,1
3807,PT-03807,56,M,PGI Chandigarh,Phase IV,ORX-404,Neurology,High Dose,2023-08-06,2023-10-01,9.16,11.16,114,60,85,None,None,No Change,0
3808,PT-03808,70,M,Fortis Mumbai,Phase I,ORX-101,Oncology,High Dose,2023-09-09,2023-11-04,8.18,9.22,123,74,79,None,None,Improved,0
3809,PT-03809,39,F,Fortis Mumbai,Phase III,ORX-505,Infectious Disease,High Dose,2024-09-08,2024-11-03,8.0,8.47,146,88,81,Rash,Moderate,Worsened,0
3810,PT-03810,57,M,Indore Medical Institute,Phase III,ORX-404,Neurology,Placebo,2024-05-25,2024-06-22,4.84,4.63,128,84,76,None,None,Worsened,0
3811,PT-03811,51,F,Apollo Chennai,Phase III,ORX-404,Neurology,Placebo,2023-02-22,2023-03-22,6.51,7.13,136,83,68,None,None,No Change,0
3812,PT-03812,58,F,Fortis Mumbai,Phase IV,ORX-202,Diabetes,Low Dose,2024-03-24,2024-03-31,7.45,6.37,126,89,85,Nausea,Moderate,No Change,0
3813,PT-03813,52,F,Kolkata Clinical Center,Phase II,ORX-404,Neurology,Placebo,2023-03-23,2023-04-20,7.31,7.83,150,90,69,Headache,Mild,Worsened,0
3814,PT-03814,28,M,Fortis Mumbai,Phase III,ORX-303,Cardiology,High Dose,2024-03-23,2024-05-18,6.55,7.91,133,107,76,None,None,Improved,0
3815,PT-03815,40,F,Fortis Mumbai,Phase II,ORX-202,Diabetes,Low Dose,2024-01-06,2024-01-20,7.11,6.63,114,68,85,None,None,No Change,0
3816,PT-03816,61,F,Apollo Chennai,Phase II,ORX-606,Rheumatology,Placebo,2024-08-08,2024-08-22,10.13,9.34,121,72,93,None,None,Improved,1
3817,PT-03817,58,M,AIIMS Delhi,Phase III,ORX-101,Oncology,Low Dose,2023-01-25,2023-02-01,6.15,4.94,145,86,88,Rash,None,Improved,1
3818,PT-03818,30,M,Indore Medical Institute,Phase III,ORX-303,Cardiology,High Dose,2024-06-07,2024-07-05,4.95,3.76,140,107,71,None,None,Worsened,0
3819,PT-03819,81,F,Kolkata Clinical Center,Phase IV,ORX-101,Oncology,Low Dose,2024-11-13,2024-12-11,8.2,6.54,131,92,45,Dizziness,Mild,Improved,1
3820,PT-03820,55,F,Fortis Mumbai,Phase II,ORX-303,Cardiology,Low Dose,2024-08-26,2024-09-09,8.61,8.57,126,79,74,Fatigue,None,No Change,0
3821,PT-03821,26,F,NIMHANS Bengaluru,Phase II,ORX-404,Neurology,High Dose,2024-11-14,2025-01-09,6.37,5.6,130,75,65,None,None,No Change,0
3822,PT-03822,57,F,NIMHANS Bengaluru,Phase III,ORX-404,Neurology,Low Dose,2023-09-15,2023-11-10,7.64,6.76,137,76,78,None,None,Worsened,0
3823,PT-03823,60,F,PGI Chandigarh,Phase I,ORX-606,Rheumatology,Placebo,2024-03-22,2024-04-19,6.48,5.02,125,65,74,None,None,Improved,1
3824,PT-03824,40,M,PGI Chandigarh,Phase I,ORX-101,Oncology,Placebo,2024-09-30,2024-12-29,4.24,4.32,124,96,81,None,None,Improved,0
3825,PT-03825,56,F,Kolkata Clinical Center,Phase IV,ORX-303,Cardiology,Placebo,2023-10-10,2023-10-24,8.63,8.11,127,63,95,None,None,Improved,1
3826,PT-03826,42,F,NIMHANS Bengaluru,Phase III,ORX-505,Infectious Disease,Placebo,2024-07-03,2024-08-28,5.99,6.26,90,76,90,None,None,No Change,0
3827,PT-03827,37,F,Fortis Mumbai,Phase III,ORX-101,Oncology,Placebo,2024-05-05,2024-05-19,6.34,5.56,91,90,76,Fatigue,None,Improved,1
3828,PT-03828,40,M,Bhopal Research Hospital,Phase II,ORX-303,Cardiology,Placebo,2023-07-18,2023-07-25,6.88,6.49,139,81,58,None,None,Improved,1
3829,PT-03829,54,M,Indore Medical Institute,Phase II,ORX-101,Oncology,Placebo,2023-04-25,2023-07-24,7.8,7.58,147,82,93,None,None,Improved,1
3830,PT-03830,67,F,PGI Chandigarh,Phase II,ORX-303,Cardiology,Low Dose,2023-11-24,2023-12-22,7.9,6.83,125,96,57,None,None,Improved,1
3831,PT-03831,38,M,Bhopal Research Hospital,Phase III,ORX-303,Cardiology,Placebo,2023-07-17,2023-09-11,6.79,,143,86,68,Dizziness,None,No Change,0
3832,PT-03832,54,M,Kolkata Clinical Center,Phase II,ORX-505,Infectious Disease,High Dose,2023-07-24,2023-10-22,7.01,5.81,115,87,91,Dizziness,Mild,Improved,1
3833,PT-03833,37,F,NIMHANS Bengaluru,Phase II,ORX-404,Neurology,High Dose,2024-03-18,2024-04-01,7.85,8.88,105,86,89,None,None,No Change,0
3834,PT-03834,43,F,NIMHANS Bengaluru,Phase III,ORX-606,Rheumatology,Placebo,2024-04-20,2024-07-19,8.69,10.26,134,79,91,None,None,Worsened,0
3835,PT-03835,58,F,Bhopal Research Hospital,Phase IV,ORX-505,Infectious Disease,Low Dose,2024-08-20,2024-08-27,4.18,3.77,120,86,75,Fatigue,None,No Change,0
3836,PT-03836,43,F,Fortis Mumbai,Phase IV,ORX-606,Rheumatology,Low Dose,2023-06-22,2023-09-20,6.16,6.43,157,71,58,Rash,Mild,Improved,0
3837,PT-03837,45,F,PGI Chandigarh,Phase I,ORX-101,Oncology,Low Dose,2024-08-27,2024-10-22,7.17,7.82,105,75,47,None,None,Improved,0
3838,PT-03838,66,M,Indore Medical Institute,Phase I,ORX-202,Diabetes,High Dose,2024-05-21,2024-05-28,7.5,6.68,104,67,83,None,None,No Change,0
3839,PT-03839,27,F,AIIMS Delhi,Phase IV,ORX-101,Oncology,Placebo,2024-11-07,2025-01-02,7.32,8.76,121,70,83,Fatigue,None,Improved,0
3840,PT-03840,25,F,Indore Medical Institute,Phase III,ORX-606,Rheumatology,Placebo,2023-12-27,2024-02-21,9.26,10.13,125,71,72,None,None,Improved,0
3841,PT-03841,40,F,AIIMS Delhi,Phase III,ORX-202,Diabetes,Placebo,2024-02-05,2024-03-04,7.66,8.2,109,94,86,None,None,Improved,0
3842,PT-03842,36,M,PGI Chandigarh,Phase III,ORX-101,Oncology,Low Dose,2023-10-22,2023-11-05,5.9,5.6,108,94,62,None,None,No Change,0
3843,PT-03843,53,F,Bhopal Research Hospital,Phase II,ORX-303,Cardiology,Placebo,2023-02-24,2023-04-21,7.1,6.2,126,94,61,Dizziness,Mild,Improved,1
3844,PT-03844,38,F,Fortis Mumbai,Phase I,ORX-202,Diabetes,Placebo,2023-10-17,2024-01-15,6.3,5.86,115,60,63,Headache,None,Improved,1
3845,PT-03845,71,F,Indore Medical Institute,Phase II,ORX-606,Rheumatology,Low Dose,2023-09-10,2023-09-24,7.5,7.29,122,81,71,Fatigue,Mild,Improved,1
3846,PT-03846,53,F,Fortis Mumbai,Phase I,ORX-303,Cardiology,Placebo,2023-07-27,2023-08-03,7.32,5.87,132,52,83,Nausea,None,Improved,1
3847,PT-03847,22,M,AIIMS Delhi,Phase III,ORX-202,Diabetes,High Dose,2023-09-05,2023-09-19,7.08,5.61,128,88,99,None,None,No Change,0
3848,PT-03848,20,M,PGI Chandigarh,Phase III,ORX-303,Cardiology,Placebo,2024-02-12,2024-02-19,8.37,8.09,119,91,74,None,None,Improved,1
3849,PT-03849,56,F,PGI Chandigarh,Phase IV,ORX-303,Cardiology,Low Dose,2023-04-20,2023-05-18,6.01,5.04,144,99,77,None,None,Improved,1
3850,PT-03850,18,F,Bhopal Research Hospital,Phase III,ORX-303,Cardiology,High Dose,2023-09-10,2023-12-09,6.96,6.59,123,86,71,Headache,Mild,Improved,1
3851,PT-03851,58,M,AIIMS Delhi,Phase III,ORX-404,Neurology,High Dose,2023-05-23,2023-05-30,5.8,6.51,155,71,65,Dizziness,None,Improved,0
3852,PT-03852,51,F,Apollo Chennai,Phase III,ORX-606,Rheumatology,Placebo,2023-02-21,2023-04-18,5.78,4.93,147,90,105,Nausea,Mild,Improved,1
3853,PT-03853,47,F,Fortis Mumbai,Phase III,ORX-404,Neurology,Low Dose,2023-08-09,2023-11-07,6.47,6.11,125,80,77,None,None,Improved,1
3854,PT-03854,30,M,Bhopal Research Hospital,Phase II,ORX-606,Rheumatology,Low Dose,2023-06-01,2023-07-27,7.54,5.87,115,80,46,None,None,Improved,1
3855,PT-03855,57,F,Bhopal Research Hospital,Phase II,ORX-303,Cardiology,High Dose,2023-03-28,2023-04-04,4.74,4.94,104,77,85,Headache,Severe,Improved,0
3856,PT-03856,80,M,NIMHANS Bengaluru,Phase III,ORX-606,Rheumatology,High Dose,2023-11-30,2024-02-28,7.34,5.16,145,79,78,None,None,Improved,1
3857,PT-03857,53,F,Apollo Chennai,Phase III,ORX-404,Neurology,Placebo,2023-08-09,2023-10-04,4.53,4.14,120,96,88,None,None,Improved,1
3858,PT-03858,18,M,NIMHANS Bengaluru,Phase III,ORX-505,Infectious Disease,Placebo,2023-05-31,2023-06-14,8.72,8.72,100,82,92,Fever,Mild,No Change,0
3859,PT-03859,25,M,AIIMS Delhi,Phase III,ORX-202,Diabetes,High Dose,2024-03-28,2024-05-23,8.85,7.09,113,70,97,None,None,No Change,0
3860,PT-03860,37,M,Indore Medical Institute,Phase III,ORX-606,Rheumatology,Low Dose,2024-04-01,2024-06-30,5.8,5.81,139,90,74,None,None,Improved,0
3861,PT-03861,49,M,Apollo Chennai,Phase III,ORX-202,Diabetes,Low Dose,2024-01-17,2024-01-31,6.42,7.53,148,94,89,None,None,Improved,0
3862,PT-03862,53,M,NIMHANS Bengaluru,Phase IV,ORX-202,Diabetes,Low Dose,2023-05-24,2023-06-21,5.71,5.88,130,97,89,Fatigue,Mild,Improved,0
3863,PT-03863,53,F,PGI Chandigarh,Phase IV,ORX-303,Cardiology,Low Dose,2024-07-18,2024-09-12,5.18,4.7,117,85,72,None,None,Improved,1
3864,PT-03864,40,F,Indore Medical Institute,Phase IV,ORX-202,Diabetes,Placebo,2024-03-07,2024-03-21,7.75,6.96,130,63,66,Headache,Moderate,Improved,1
3865,PT-03865,55,F,NIMHANS Bengaluru,Phase III,ORX-505,Infectious Disease,Placebo,2023-03-08,2023-04-05,5.72,6.44,145,78,119,None,None,Improved,0
3866,PT-03866,64,M,Kolkata Clinical Center,Phase II,ORX-303,Cardiology,Low Dose,2023-11-18,2023-11-25,6.06,6.33,129,72,63,None,None,No Change,0
3867,PT-03867,60,M,Kolkata Clinical Center,Phase III,ORX-404,Neurology,Low Dose,2024-01-31,2024-02-28,6.48,5.99,111,73,76,Nausea,Moderate,No Change,0
3868,PT-03868,51,F,NIMHANS Bengaluru,Phase II,ORX-101,Oncology,Placebo,2024-10-17,2024-10-31,4.09,3.71,114,98,119,None,None,No Change,0
3869,PT-03869,39,F,NIMHANS Bengaluru,Phase II,ORX-606,Rheumatology,Placebo,2023-09-20,2023-10-04,5.13,4.84,124,105,101,Nausea,None,Improved,1
3870,PT-03870,58,M,Fortis Mumbai,Phase II,ORX-303,Cardiology,Low Dose,2024-08-24,2024-09-21,6.5,6.71,132,84,56,None,None,No Change,0
3871,PT-03871,61,M,NIMHANS Bengaluru,Phase II,ORX-404,Neurology,Placebo,2023-03-13,2023-04-10,7.33,6.84,117,72,82,None,None,Improved,1
3872,PT-03872,18,M,Kolkata Clinical Center,Phase I,ORX-101,Oncology,Low Dose,2023-08-14,2023-10-09,8.15,6.8,90,103,65,Nausea,None,Improved,1
3873,PT-03873,33,M,Apollo Chennai,Phase III,ORX-303,Cardiology,Low Dose,2023-06-02,2023-06-30,8.56,9.83,100,70,65,Headache,Mild,Worsened,0
3874,PT-03874,59,M,PGI Chandigarh,Phase III,ORX-101,Oncology,Placebo,2024-11-20,2024-12-18,9.17,7.79,153,73,82,Fatigue,Mild,No Change,0
3875,PT-03875,24,M,NIMHANS Bengaluru,Phase III,ORX-606,Rheumatology,Low Dose,2024-08-28,2024-09-25,7.05,6.55,122,86,63,None,None,Improved,1
3876,PT-03876,30,F,Apollo Chennai,Phase III,ORX-606,Rheumatology,High Dose,2023-10-29,2023-12-24,7.73,8.53,127,88,88,Headache,None,Improved,0
3877,PT-03877,58,F,Fortis Mumbai,Phase III,ORX-303,Cardiology,Low Dose,2024-02-06,2024-04-02,6.06,4.96,115,105,85,Headache,None,No Change,0
3878,PT-03878,52,M,Fortis Mumbai,Phase III,ORX-202,Diabetes,Low Dose,2024-06-01,2024-06-15,7.64,6.05,162,87,88,Headache,Moderate,Worsened,0
3879,PT-03879,18,M,PGI Chandigarh,Phase III,ORX-505,Infectious Disease,Placebo,2024-10-10,2024-12-05,8.14,7.41,104,70,60,None,None,Improved,1
3880,PT-03880,24,M,AIIMS Delhi,Phase II,ORX-202,Diabetes,High Dose,2023-05-27,2023-06-24,7.27,6.52,134,102,76,Rash,None,Improved,1
3881,PT-03881,18,F,NIMHANS Bengaluru,Phase III,ORX-505,Infectious Disease,High Dose,2024-09-12,2024-09-26,6.91,7.58,126,100,84,None,None,Improved,0
3882,PT-03882,18,F,Apollo Chennai,Phase III,ORX-606,Rheumatology,High Dose,2023-09-17,2023-10-15,7.33,7.2,147,103,90,Fever,None,Worsened,0
3883,PT-03883,52,M,Bhopal Research Hospital,Phase I,ORX-303,Cardiology,Low Dose,2024-01-31,2024-02-07,8.01,7.46,101,82,83,Fever,Moderate,Improved,1
3884,PT-03884,25,F,NIMHANS Bengaluru,Phase II,ORX-606,Rheumatology,High Dose,2024-06-18,2024-08-13,8.79,9.3,103,98,73,Nausea,None,Worsened,0
3885,PT-03885,32,F,Fortis Mumbai,Phase III,ORX-101,Oncology,High Dose,2024-11-27,2025-02-25,8.5,8.05,162,71,53,None,None,Improved,1
3886,PT-03886,40,F,PGI Chandigarh,Phase III,ORX-404,Neurology,High Dose,2023-08-24,2023-09-21,8.15,6.91,104,84,57,Fatigue,Severe,Improved,1
3887,PT-03887,49,M,Apollo Chennai,Phase III,ORX-101,Oncology,Low Dose,2024-07-11,2024-07-18,6.79,6.84,103,97,75,Nausea,None,Improved,0
3888,PT-03888,57,F,Bhopal Research Hospital,Phase III,ORX-202,Diabetes,Low Dose,2023-07-28,2023-09-22,8.35,6.91,143,64,58,Nausea,Mild,Worsened,0
3889,PT-03889,76,M,AIIMS Delhi,Phase I,ORX-202,Diabetes,High Dose,2023-01-29,2023-02-05,8.53,,121,83,85,None,None,Improved,0
3890,PT-03890,44,F,Indore Medical Institute,Phase II,ORX-606,Rheumatology,Placebo,2024-08-16,2024-08-23,6.3,5.1,131,69,62,None,None,Improved,1
3891,PT-03891,51,M,NIMHANS Bengaluru,Phase II,ORX-606,Rheumatology,High Dose,2023-08-11,2023-08-18,7.09,7.53,120,75,83,None,None,Improved,0
3892,PT-03892,32,M,Kolkata Clinical Center,Phase I,ORX-101,Oncology,Placebo,2023-05-06,2023-08-04,6.41,5.45,124,103,58,None,None,No Change,0
3893,PT-03893,65,M,Bhopal Research Hospital,Phase I,ORX-202,Diabetes,Low Dose,2024-09-10,2024-09-17,8.09,9.1,184,99,90,Dizziness,None,Worsened,0
3894,PT-03894,24,F,PGI Chandigarh,Phase III,ORX-404,Neurology,High Dose,2023-01-15,2023-01-22,5.78,5.7,97,89,48,Headache,Mild,No Change,0
3895,PT-03895,63,M,NIMHANS Bengaluru,Phase IV,ORX-303,Cardiology,High Dose,2023-08-06,2023-08-20,6.81,6.53,114,59,95,Rash,None,Worsened,0
3896,PT-03896,66,F,Kolkata Clinical Center,Phase IV,ORX-101,Oncology,Low Dose,2023-03-16,2023-04-13,6.78,6.97,120,85,88,None,None,Improved,0
3897,PT-03897,53,F,Bhopal Research Hospital,Phase III,ORX-404,Neurology,High Dose,2023-03-01,2023-05-30,8.81,8.88,128,72,71,None,None,Improved,0
3898,PT-03898,57,M,AIIMS Delhi,Phase III,ORX-101,Oncology,High Dose,2023-02-24,2023-03-03,5.4,5.99,122,72,62,Nausea,Mild,No Change,0
3899,PT-03899,55,M,Apollo Chennai,Phase IV,ORX-303,Cardiology,Low Dose,2024-08-04,2024-08-11,7.18,8.21,105,75,76,None,None,Improved,0
3900,PT-03900,32,M,Indore Medical Institute,Phase II,ORX-101,Oncology,Low Dose,2024-09-06,2024-09-20,7.21,7.09,136,100,59,Headache,None,Improved,1
3901,PT-03901,50,M,PGI Chandigarh,Phase III,ORX-202,Diabetes,High Dose,2024-01-29,2024-02-12,6.42,6.41,135,70,65,Nausea,None,Improved,1
3902,PT-03902,53,M,Bhopal Research Hospital,Phase I,ORX-101,Oncology,Low Dose,2024-07-31,2024-08-28,7.23,6.63,139,90,70,None,None,No Change,0
3903,PT-03903,31,M,NIMHANS Bengaluru,Phase II,ORX-404,Neurology,High Dose,2023-04-14,2023-04-21,5.69,5.32,102,83,95,None,None,Improved,1
3904,PT-03904,39,M,Kolkata Clinical Center,Phase III,ORX-606,Rheumatology,Low Dose,2023-05-19,2023-08-17,6.56,7.95,155,72,79,None,None,Improved,0
3905,PT-03905,50,F,NIMHANS Bengaluru,Phase II,ORX-303,Cardiology,High Dose,2024-03-18,2024-05-13,7.44,8.68,129,84,87,None,None,Improved,0
3906,PT-03906,64,M,Fortis Mumbai,Phase I,ORX-101,Oncology,Low Dose,2023-12-13,2023-12-27,8.32,8.41,99,76,89,None,None,No Change,0
3907,PT-03907,49,M,Apollo Chennai,Phase II,ORX-101,Oncology,Low Dose,2023-10-15,2023-10-22,8.19,9.49,106,95,73,None,None,Improved,0
3908,PT-03908,59,F,PGI Chandigarh,Phase II,ORX-101,Oncology,Low Dose,2024-05-28,2024-06-25,7.15,8.66,130,74,83,None,None,Improved,0
3909,PT-03909,50,F,Apollo Chennai,Phase III,ORX-404,Neurology,Low Dose,2024-03-22,2024-05-17,8.57,8.57,172,80,76,None,None,No Change,0
3910,PT-03910,35,M,Apollo Chennai,Phase III,ORX-101,Oncology,High Dose,2024-02-07,2024-03-06,7.3,7.11,133,82,69,Rash,None,No Change,0
3911,PT-03911,30,M,Indore Medical Institute,Phase II,ORX-101,Oncology,Low Dose,2023-06-17,2023-08-12,6.75,7.38,152,81,64,Nausea,Severe,Improved,0
3912,PT-03912,43,M,AIIMS Delhi,Phase IV,ORX-505,Infectious Disease,Placebo,2023-01-27,2023-02-03,9.71,10.21,137,93,99,None,None,No Change,0
3913,PT-03913,26,M,PGI Chandigarh,Phase I,ORX-101,Oncology,Placebo,2023-06-11,2023-06-18,6.73,5.85,138,83,88,None,None,No Change,0
3914,PT-03914,36,F,NIMHANS Bengaluru,Phase IV,ORX-505,Infectious Disease,Placebo,2024-09-24,2024-12-23,8.85,8.38,140,96,93,None,None,Improved,1
3915,PT-03915,50,F,PGI Chandigarh,Phase I,ORX-101,Oncology,Placebo,2024-04-25,2024-05-23,8.18,9.35,137,73,86,None,None,Worsened,0
3916,PT-03916,44,M,Kolkata Clinical Center,Phase III,ORX-101,Oncology,High Dose,2023-10-06,2024-01-04,4.38,4.4,130,95,67,Rash,None,Improved,0
3917,PT-03917,20,F,NIMHANS Bengaluru,Phase IV,ORX-202,Diabetes,Low Dose,2023-04-02,2023-04-16,7.4,7.34,129,82,63,Headache,None,Worsened,0
3918,PT-03918,42,M,Indore Medical Institute,Phase III,ORX-303,Cardiology,Low Dose,2024-07-10,2024-07-17,6.78,7.35,134,78,102,None,None,Worsened,0
3919,PT-03919,40,M,Bhopal Research Hospital,Phase III,ORX-101,Oncology,High Dose,2023-10-08,2023-11-05,7.87,,157,83,79,None,None,No Change,0
3920,PT-03920,42,F,NIMHANS Bengaluru,Phase III,ORX-101,Oncology,Low Dose,2023-12-13,2023-12-27,7.44,8.12,143,82,101,None,None,Improved,0
3921,PT-03921,58,M,Indore Medical Institute,Phase I,ORX-505,Infectious Disease,Placebo,2023-04-07,2023-06-02,6.67,5.03,120,86,86,None,None,Improved,1
3922,PT-03922,66,F,Kolkata Clinical Center,Phase IV,ORX-101,Oncology,Placebo,2023-06-06,2023-06-20,5.89,5.09,106,65,69,None,None,No Change,0
3923,PT-03923,50,F,Fortis Mumbai,Phase IV,ORX-404,Neurology,Low Dose,2023-06-16,2023-08-11,8.13,6.87,113,60,81,None,None,Improved,1
3924,PT-03924,33,M,Indore Medical Institute,Phase III,ORX-505,Infectious Disease,High Dose,2024-10-13,2025-01-11,9.2,9.16,124,74,57,None,None,No Change,0
3925,PT-03925,23,F,Kolkata Clinical Center,Phase III,ORX-202,Diabetes,Low Dose,2024-05-29,2024-07-24,6.45,5.42,110,86,85,None,None,Improved,1
3926,PT-03926,37,M,Apollo Chennai,Phase III,ORX-202,Diabetes,Low Dose,2023-12-14,2024-02-08,9.52,7.55,129,79,70,Nausea,None,Worsened,0
3927,PT-03927,33,F,Apollo Chennai,Phase I,ORX-505,Infectious Disease,Low Dose,2024-11-12,2025-01-07,7.19,6.59,120,66,55,Nausea,None,Improved,1
3928,PT-03928,40,F,Fortis Mumbai,Phase II,ORX-303,Cardiology,Placebo,2024-04-10,2024-04-24,6.72,6.14,126,75,75,None,None,No Change,0
3929,PT-03929,31,F,PGI Chandigarh,Phase III,ORX-202,Diabetes,High Dose,2024-09-09,2024-09-16,9.03,7.91,121,73,67,Nausea,Mild,No Change,0
3930,PT-03930,45,F,AIIMS Delhi,Phase II,ORX-404,Neurology,Placebo,2023-08-20,2023-09-03,7.08,6.26,122,73,83,Fatigue,Moderate,Worsened,0
3931,PT-03931,77,M,Bhopal Research Hospital,Phase I,ORX-404,Neurology,Low Dose,2023-09-09,2023-10-07,6.15,6.1,128,90,87,None,None,No Change,0
3932,PT-03932,48,M,NIMHANS Bengaluru,Phase I,ORX-606,Rheumatology,Placebo,2023-12-18,2024-01-01,7.15,6.36,114,80,60,None,None,Worsened,0
3933,PT-03933,35,F,NIMHANS Bengaluru,Phase II,ORX-202,Diabetes,High Dose,2023-07-19,2023-08-16,8.53,8.22,144,99,75,None,None,Improved,1
3934,PT-03934,48,F,Bhopal Research Hospital,Phase II,ORX-606,Rheumatology,High Dose,2024-10-30,2024-11-27,6.84,5.71,110,92,80,Fatigue,Moderate,Improved,1
3935,PT-03935,74,M,Kolkata Clinical Center,Phase I,ORX-303,Cardiology,Placebo,2024-08-12,2024-09-09,8.37,7.31,143,78,95,Nausea,None,Improved,1
3936,PT-03936,37,F,Bhopal Research Hospital,Phase II,ORX-606,Rheumatology,Low Dose,2023-11-03,2023-11-17,5.94,4.82,114,71,69,Headache,None,Worsened,0
3937,PT-03937,58,M,Bhopal Research Hospital,Phase IV,ORX-202,Diabetes,Low Dose,2023-05-06,2023-07-01,9.36,7.76,150,76,82,None,None,Improved,1
3938,PT-03938,18,M,NIMHANS Bengaluru,Phase IV,ORX-303,Cardiology,Placebo,2024-09-02,2024-12-01,7.83,5.62,133,85,80,None,None,Worsened,0
3939,PT-03939,33,F,PGI Chandigarh,Phase III,ORX-202,Diabetes,High Dose,2024-09-28,2024-12-27,7.86,7.81,124,90,76,None,None,Improved,1
3940,PT-03940,53,M,Indore Medical Institute,Phase II,ORX-101,Oncology,Low Dose,2023-05-03,2023-05-31,7.05,6.84,138,77,60,Dizziness,None,Improved,1
3941,PT-03941,49,M,Kolkata Clinical Center,Phase IV,ORX-505,Infectious Disease,Placebo,2023-08-29,2023-09-05,8.63,8.5,133,81,88,None,None,Improved,1
3942,PT-03942,42,M,Apollo Chennai,Phase II,ORX-101,Oncology,Placebo,2024-05-30,2024-06-06,6.66,7.25,118,92,93,None,None,Improved,0
3943,PT-03943,54,F,Apollo Chennai,Phase IV,ORX-606,Rheumatology,Low Dose,2024-10-17,2024-12-12,5.7,5.33,124,76,79,None,None,Worsened,0
3944,PT-03944,57,M,Bhopal Research Hospital,Phase IV,ORX-303,Cardiology,Low Dose,2023-01-14,2023-03-11,6.65,6.1,123,95,74,Headache,None,Improved,1
3945,PT-03945,25,M,NIMHANS Bengaluru,Phase II,ORX-202,Diabetes,High Dose,2023-11-13,2024-02-11,5.31,5.24,114,90,59,Rash,Mild,Improved,1
3946,PT-03946,36,M,Kolkata Clinical Center,Phase III,ORX-505,Infectious Disease,High Dose,2024-10-05,2024-10-12,5.6,5.59,139,86,62,None,None,Improved,1
3947,PT-03947,33,M,Fortis Mumbai,Phase III,ORX-404,Neurology,Placebo,2024-08-18,2024-08-25,7.48,5.56,123,100,75,Fatigue,None,Improved,1
3948,PT-03948,21,M,Apollo Chennai,Phase III,ORX-101,Oncology,Low Dose,2023-01-02,2023-01-30,6.47,5.5,166,101,88,None,None,No Change,0
3949,PT-03949,39,F,NIMHANS Bengaluru,Phase II,ORX-505,Infectious Disease,High Dose,2024-10-16,2024-10-30,8.64,7.22,147,93,75,None,None,Improved,1
3950,PT-03950,63,F,Fortis Mumbai,Phase IV,ORX-606,Rheumatology,High Dose,2024-07-15,2024-08-12,6.66,5.12,145,80,86,None,None,Improved,1
3951,PT-03951,74,F,NIMHANS Bengaluru,Phase III,ORX-505,Infectious Disease,Low Dose,2024-10-13,2024-12-08,6.33,5.8,156,90,68,None,None,Improved,1
3952,PT-03952,29,M,Bhopal Research Hospital,Phase IV,ORX-303,Cardiology,Placebo,2023-10-04,2023-10-18,6.57,5.5,132,82,81,None,None,Improved,1
3953,PT-03953,31,F,Kolkata Clinical Center,Phase II,ORX-202,Diabetes,Placebo,2024-06-30,2024-08-25,7.11,4.86,130,96,58,Fever,Mild,Improved,1
3954,PT-03954,52,M,PGI Chandigarh,Phase III,ORX-606,Rheumatology,Low Dose,2024-09-06,2024-10-04,6.47,6.79,130,86,78,None,None,Improved,0
3955,PT-03955,66,F,Apollo Chennai,Phase III,ORX-404,Neurology,High Dose,2024-09-15,2024-12-14,7.62,6.58,129,77,80,None,None,Improved,1
3956,PT-03956,38,F,Kolkata Clinical Center,Phase II,ORX-505,Infectious Disease,Low Dose,2024-09-07,2024-12-06,6.39,6.17,129,94,72,None,None,No Change,0
3957,PT-03957,18,F,Kolkata Clinical Center,Phase III,ORX-303,Cardiology,High Dose,2023-04-13,2023-04-20,6.76,4.9,135,61,64,None,None,Improved,1
3958,PT-03958,39,F,Bhopal Research Hospital,Phase III,ORX-303,Cardiology,Placebo,2023-10-15,2023-10-29,9.05,7.69,128,88,98,Fever,None,No Change,0
3959,PT-03959,57,F,AIIMS Delhi,Phase III,ORX-505,Infectious Disease,Low Dose,2024-07-18,2024-09-12,8.51,8.89,106,86,89,Fever,None,No Change,0
3960,PT-03960,29,M,NIMHANS Bengaluru,Phase IV,ORX-202,Diabetes,Low Dose,2024-11-23,2025-01-18,6.5,5.38,141,81,73,None,None,Worsened,0
3961,PT-03961,24,F,Bhopal Research Hospital,Phase II,ORX-202,Diabetes,Placebo,2023-04-01,2023-06-30,7.12,6.21,132,68,80,None,None,Improved,1
3962,PT-03962,37,M,Fortis Mumbai,Phase II,ORX-101,Oncology,Low Dose,2023-05-14,2023-06-11,5.7,4.11,106,79,79,None,None,Improved,1
3963,PT-03963,49,F,Apollo Chennai,Phase IV,ORX-303,Cardiology,Low Dose,2023-09-04,2023-10-02,7.57,6.49,147,76,84,None,None,Improved,1
3964,PT-03964,42,M,Kolkata Clinical Center,Phase III,ORX-606,Rheumatology,High Dose,2023-12-05,2023-12-12,7.65,7.06,135,81,89,Headache,None,No Change,0
3965,PT-03965,31,F,PGI Chandigarh,Phase III,ORX-404,Neurology,High Dose,2024-05-12,2024-06-09,5.08,3.8,147,80,79,Headache,Mild,No Change,0
3966,PT-03966,28,M,AIIMS Delhi,Phase II,ORX-202,Diabetes,High Dose,2024-07-18,2024-08-15,7.28,5.96,112,77,84,Rash,Moderate,Improved,1
3967,PT-03967,53,M,Kolkata Clinical Center,Phase I,ORX-303,Cardiology,High Dose,2023-06-11,2023-08-06,7.89,6.07,127,79,56,Nausea,None,No Change,0
3968,PT-03968,45,F,NIMHANS Bengaluru,Phase III,ORX-303,Cardiology,High Dose,2023-08-03,2023-11-01,6.9,6.96,129,75,90,None,None,Improved,0
3969,PT-03969,18,M,Apollo Chennai,Phase I,ORX-606,Rheumatology,Low Dose,2023-10-03,2023-10-10,7.12,5.14,111,88,60,None,None,Improved,1
3970,PT-03970,22,F,PGI Chandigarh,Phase III,ORX-505,Infectious Disease,High Dose,2023-05-12,2023-06-09,10.06,8.43,157,79,70,Nausea,None,Improved,1
3971,PT-03971,54,F,PGI Chandigarh,Phase II,ORX-101,Oncology,High Dose,2023-07-26,2023-10-24,8.8,7.37,118,92,82,None,None,Worsened,0
3972,PT-03972,62,M,Fortis Mumbai,Phase II,ORX-404,Neurology,Placebo,2023-05-14,2023-07-09,7.82,9.05,131,84,82,None,None,No Change,0
3973,PT-03973,42,M,AIIMS Delhi,Phase III,ORX-101,Oncology,Low Dose,2023-09-09,2023-09-23,8.22,8.03,142,93,83,None,None,Improved,1
3974,PT-03974,53,M,Kolkata Clinical Center,Phase III,ORX-505,Infectious Disease,Low Dose,2024-04-04,2024-04-18,5.99,5.09,143,99,50,Nausea,Moderate,Improved,1
3975,PT-03975,35,M,Indore Medical Institute,Phase III,ORX-303,Cardiology,Placebo,2024-09-19,2024-09-26,7.23,6.04,113,87,100,Rash,Moderate,Improved,1
3976,PT-03976,18,M,Apollo Chennai,Phase IV,ORX-606,Rheumatology,High Dose,2023-08-25,2023-09-01,7.0,7.01,142,85,102,None,None,Improved,0
3977,PT-03977,45,F,Fortis Mumbai,Phase I,ORX-202,Diabetes,Low Dose,2024-03-16,2024-03-23,8.77,7.79,129,67,90,Headache,Mild,No Change,0
3978,PT-03978,43,M,Kolkata Clinical Center,Phase I,ORX-505,Infectious Disease,Low Dose,2023-06-12,2023-06-19,7.63,6.95,138,86,64,None,None,Improved,1
3979,PT-03979,30,F,NIMHANS Bengaluru,Phase III,ORX-404,Neurology,High Dose,2024-04-19,2024-06-14,7.17,7.36,161,85,92,None,None,Improved,0
3980,PT-03980,19,F,PGI Chandigarh,Phase II,ORX-303,Cardiology,Placebo,2024-09-24,2024-10-01,9.62,9.76,127,80,62,Fatigue,None,Improved,0
3981,PT-03981,31,F,Fortis Mumbai,Phase III,ORX-202,Diabetes,Low Dose,2023-04-24,2023-05-01,9.49,8.2,109,73,61,None,None,Worsened,0
3982,PT-03982,45,M,PGI Chandigarh,Phase III,ORX-202,Diabetes,Placebo,2023-02-20,2023-05-21,8.51,7.56,103,85,77,Headache,None,No Change,0
3983,PT-03983,61,M,Bhopal Research Hospital,Phase II,ORX-202,Diabetes,Low Dose,2023-03-13,2023-04-10,6.65,6.02,125,83,72,None,None,Worsened,0
3984,PT-03984,36,F,Indore Medical Institute,Phase III,ORX-404,Neurology,Placebo,2024-01-21,2024-02-18,4.98,4.07,140,92,71,None,None,Improved,1
3985,PT-03985,65,F,Kolkata Clinical Center,Phase I,ORX-303,Cardiology,High Dose,2023-11-24,2023-12-01,7.17,5.56,98,96,72,None,None,No Change,0
3986,PT-03986,25,F,Bhopal Research Hospital,Phase III,ORX-404,Neurology,High Dose,2024-07-29,2024-08-12,4.49,3.73,135,73,63,None,None,No Change,0
3987,PT-03987,36,M,Kolkata Clinical Center,Phase III,ORX-202,Diabetes,Placebo,2024-08-20,2024-09-17,8.69,7.04,116,96,84,Nausea,Moderate,Improved,1
3988,PT-03988,47,M,Indore Medical Institute,Phase II,ORX-202,Diabetes,Placebo,2024-01-05,2024-04-04,6.42,6.05,118,71,62,None,None,No Change,0
3989,PT-03989,57,M,AIIMS Delhi,Phase II,ORX-505,Infectious Disease,Placebo,2024-07-26,2024-10-24,7.13,7.01,130,87,74,Nausea,Moderate,Worsened,0
3990,PT-03990,37,F,PGI Chandigarh,Phase III,ORX-101,Oncology,Low Dose,2023-12-08,2024-03-07,6.22,4.55,107,77,55,Headache,Mild,No Change,0
3991,PT-03991,22,F,NIMHANS Bengaluru,Phase II,ORX-606,Rheumatology,High Dose,2023-11-02,2023-12-28,8.45,8.25,119,109,54,None,None,Improved,1
3992,PT-03992,60,M,Indore Medical Institute,Phase III,ORX-101,Oncology,Placebo,2024-01-15,2024-01-29,7.07,7.37,129,59,79,None,None,Improved,0
3993,PT-03993,50,F,PGI Chandigarh,Phase III,ORX-303,Cardiology,Placebo,2023-01-10,2023-01-17,4.57,5.92,133,90,61,None,None,Improved,0
3994,PT-03994,56,F,PGI Chandigarh,Phase III,ORX-101,Oncology,Placebo,2023-11-05,2023-12-31,8.51,8.34,127,71,74,None,None,Improved,1
3995,PT-03995,36,M,AIIMS Delhi,Phase III,ORX-606,Rheumatology,High Dose,2023-02-15,2023-03-01,7.89,6.72,138,71,74,Headache,None,Worsened,0
3996,PT-03996,54,F,Kolkata Clinical Center,Phase III,ORX-404,Neurology,High Dose,2023-02-03,2023-03-31,6.36,6.54,137,78,94,Headache,None,Improved,0
3997,PT-03997,46,M,Bhopal Research Hospital,Phase I,ORX-202,Diabetes,High Dose,2023-01-13,2023-03-10,8.52,,123,89,69,None,None,No Change,0
3998,PT-03998,28,M,Fortis Mumbai,Phase II,ORX-303,Cardiology,Low Dose,2023-07-01,2023-08-26,6.97,5.34,111,89,70,Nausea,Mild,Improved,1
3999,PT-03999,56,M,NIMHANS Bengaluru,Phase IV,ORX-404,Neurology,High Dose,2024-05-29,2024-06-26,7.56,8.83,137,95,83,Dizziness,Mild,Worsened,0
4000,PT-04000,49,F,NIMHANS Bengaluru,Phase IV,ORX-505,Infectious Disease,High Dose,2023-03-13,2023-04-10,8.6,8.8,131,84,85,None,None,Improved,0
4001,PT-04001,34,F,NIMHANS Bengaluru,Phase II,ORX-606,Rheumatology,Low Dose,2024-03-07,2024-05-02,6.34,7.23,161,70,68,Nausea,None,No Change,0
4002,PT-04002,63,M,NIMHANS Bengaluru,Phase III,ORX-606,Rheumatology,Placebo,2023-09-14,2023-11-09,7.84,8.05,144,79,82,None,None,No Change,0
4003,PT-04003,49,F,NIMHANS Bengaluru,Phase II,ORX-101,Oncology,High Dose,2023-03-15,2023-03-29,6.17,6.05,150,77,80,None,None,Improved,1
4004,PT-04004,48,M,Fortis Mumbai,Phase II,ORX-303,Cardiology,High Dose,2024-06-07,2024-06-21,6.86,7.07,115,97,86,Nausea,None,Improved,0
4005,PT-04005,30,M,AIIMS Delhi,Phase I,ORX-606,Rheumatology,High Dose,2024-08-04,2024-09-29,9.24,8.99,114,95,84,Fatigue,Mild,No Change,0
4006,PT-04006,18,F,Fortis Mumbai,Phase III,ORX-505,Infectious Disease,Low Dose,2024-06-03,2024-09-01,6.57,6.42,90,83,80,Headache,None,Worsened,0
4007,PT-04007,26,F,Indore Medical Institute,Phase IV,ORX-303,Cardiology,Placebo,2024-10-04,2024-10-11,7.52,7.13,106,93,89,None,None,Improved,1
4008,PT-04008,40,M,PGI Chandigarh,Phase II,ORX-505,Infectious Disease,High Dose,2024-03-08,2024-04-05,6.96,7.22,124,58,84,None,None,Improved,0
4009,PT-04009,31,M,Fortis Mumbai,Phase I,ORX-404,Neurology,Low Dose,2023-01-11,2023-01-18,6.73,7.64,125,82,85,None,None,Improved,0
4010,PT-04010,53,M,Bhopal Research Hospital,Phase III,ORX-505,Infectious Disease,High Dose,2024-03-11,2024-03-25,6.1,5.64,128,85,82,Headache,None,Improved,1
4011,PT-04011,85,F,Apollo Chennai,Phase III,ORX-404,Neurology,Placebo,2023-06-03,2023-06-17,5.79,6.27,149,87,68,None,None,Improved,0
4012,PT-04012,71,F,Apollo Chennai,Phase III,ORX-606,Rheumatology,High Dose,2024-05-17,2024-07-12,4.57,3.55,149,77,100,Nausea,None,Improved,1
4013,PT-04013,20,F,Indore Medical Institute,Phase III,ORX-303,Cardiology,High Dose,2023-02-06,2023-02-20,5.87,4.99,135,79,71,None,None,Worsened,0
4014,PT-04014,67,M,AIIMS Delhi,Phase I,ORX-303,Cardiology,High Dose,2023-06-28,2023-08-23,9.02,8.24,97,56,81,Headache,None,Improved,1
4015,PT-04015,55,F,Apollo Chennai,Phase I,ORX-303,Cardiology,High Dose,2023-03-24,2023-03-31,7.28,6.81,113,89,101,Headache,None,No Change,0
4016,PT-04016,18,M,Indore Medical Institute,Phase III,ORX-606,Rheumatology,High Dose,2024-11-19,2025-02-17,7.11,5.83,101,68,83,Nausea,None,Improved,1
4017,PT-04017,51,M,PGI Chandigarh,Phase III,ORX-202,Diabetes,High Dose,2024-11-11,2024-11-18,8.95,8.56,96,79,58,None,None,No Change,0
4018,PT-04018,25,M,Bhopal Research Hospital,Phase III,ORX-404,Neurology,Low Dose,2024-09-09,2024-09-16,7.9,7.67,138,77,89,None,None,No Change,0
4019,PT-04019,38,F,NIMHANS Bengaluru,Phase III,ORX-202,Diabetes,Low Dose,2024-09-23,2024-10-21,8.54,8.45,124,84,77,None,None,Improved,1
4020,PT-04020,70,M,PGI Chandigarh,Phase II,ORX-505,Infectious Disease,Low Dose,2023-12-11,2023-12-18,7.49,7.09,123,92,87,Fever,None,Improved,1
4021,PT-04021,40,M,Fortis Mumbai,Phase III,ORX-101,Oncology,High Dose,2024-05-17,2024-06-14,5.81,4.6,124,98,74,Nausea,None,Improved,1
4022,PT-04022,35,M,AIIMS Delhi,Phase III,ORX-606,Rheumatology,Placebo,2023-12-18,2024-01-01,5.09,6.05,138,91,91,None,None,No Change,0
4023,PT-04023,42,F,Bhopal Research Hospital,Phase III,ORX-505,Infectious Disease,Low Dose,2023-02-18,2023-03-04,7.3,8.24,131,89,90,None,None,Improved,0
4024,PT-04024,55,F,Kolkata Clinical Center,Phase III,ORX-101,Oncology,Placebo,2024-02-12,2024-03-11,7.05,6.62,141,91,94,Rash,Mild,Improved,1
4025,PT-04025,53,M,AIIMS Delhi,Phase III,ORX-606,Rheumatology,Low Dose,2024-06-01,2024-06-15,7.92,7.11,117,91,69,Fatigue,Moderate,Improved,1
4026,PT-04026,44,M,Fortis Mumbai,Phase II,ORX-505,Infectious Disease,Low Dose,2024-05-23,2024-07-18,8.85,9.55,133,78,76,None,None,Improved,0
4027,PT-04027,58,F,NIMHANS Bengaluru,Phase III,ORX-303,Cardiology,Low Dose,2023-12-21,2024-01-04,7.16,6.25,149,84,69,Fever,Severe,Improved,1
4028,PT-04028,52,F,PGI Chandigarh,Phase I,ORX-606,Rheumatology,Placebo,2024-07-31,2024-08-07,8.37,7.06,124,79,84,Dizziness,Mild,Worsened,0
4029,PT-04029,55,F,Fortis Mumbai,Phase III,ORX-202,Diabetes,High Dose,2023-09-20,2023-10-18,6.54,4.79,146,68,81,Rash,Severe,Improved,1
4030,PT-04030,42,F,Apollo Chennai,Phase I,ORX-505,Infectious Disease,Low Dose,2024-03-23,2024-04-20,7.39,8.48,182,62,91,None,None,No Change,0
4031,PT-04031,42,M,Bhopal Research Hospital,Phase III,ORX-606,Rheumatology,Low Dose,2023-12-21,2024-02-15,8.46,8.92,153,85,65,None,None,No Change,0
4032,PT-04032,59,M,PGI Chandigarh,Phase IV,ORX-505,Infectious Disease,High Dose,2024-01-28,2024-02-04,7.34,6.73,119,94,100,Nausea,None,Worsened,0
4033,PT-04033,25,M,Indore Medical Institute,Phase III,ORX-404,Neurology,Low Dose,2024-07-29,2024-08-26,7.95,7.21,101,83,66,None,None,No Change,0
4034,PT-04034,19,F,Kolkata Clinical Center,Phase III,ORX-202,Diabetes,Placebo,2023-05-24,2023-05-31,6.26,4.94,116,66,72,Fatigue,Moderate,Worsened,0
4035,PT-04035,33,M,Bhopal Research Hospital,Phase III,ORX-101,Oncology,Placebo,2024-08-14,2024-11-12,7.65,7.78,132,79,74,Fatigue,None,Improved,0
4036,PT-04036,31,M,Indore Medical Institute,Phase III,ORX-202,Diabetes,Low Dose,2023-08-17,2023-09-14,6.22,6.46,96,81,73,None,None,No Change,0
4037,PT-04037,54,F,Kolkata Clinical Center,Phase II,ORX-101,Oncology,Low Dose,2023-04-14,2023-07-13,5.49,5.1,134,59,62,None,None,No Change,0
4038,PT-04038,43,F,PGI Chandigarh,Phase III,ORX-404,Neurology,High Dose,2023-07-18,2023-10-16,7.82,7.58,138,69,55,None,None,Improved,1
4039,PT-04039,46,F,Kolkata Clinical Center,Phase II,ORX-202,Diabetes,Low Dose,2023-03-19,2023-05-14,5.72,4.55,144,84,70,Nausea,Mild,Improved,1
4040,PT-04040,33,F,NIMHANS Bengaluru,Phase II,ORX-505,Infectious Disease,High Dose,2024-05-22,2024-06-05,7.95,7.74,106,58,104,None,None,No Change,0
4041,PT-04041,25,F,NIMHANS Bengaluru,Phase III,ORX-505,Infectious Disease,Placebo,2023-06-14,2023-07-12,7.83,8.79,130,74,58,None,None,Improved,0
4042,PT-04042,21,M,NIMHANS Bengaluru,Phase III,ORX-202,Diabetes,Low Dose,2024-05-22,2024-08-20,7.65,8.56,120,75,87,Headache,Mild,Worsened,0
4043,PT-04043,34,M,Bhopal Research Hospital,Phase II,ORX-303,Cardiology,Low Dose,2023-11-20,2024-02-18,7.53,7.17,120,81,102,Headache,None,No Change,0
4044,PT-04044,54,M,Indore Medical Institute,Phase I,ORX-101,Oncology,Low Dose,2024-06-15,2024-09-13,8.51,7.28,147,89,57,None,None,Worsened,0
4045,PT-04045,53,F,Apollo Chennai,Phase IV,ORX-606,Rheumatology,Low Dose,2024-05-23,2024-06-20,6.58,4.79,130,88,80,None,None,Improved,1
4046,PT-04046,43,M,Indore Medical Institute,Phase III,ORX-505,Infectious Disease,Low Dose,2023-04-18,2023-05-02,6.8,8.62,106,92,78,None,None,Improved,0
4047,PT-04047,31,F,Apollo Chennai,Phase III,ORX-202,Diabetes,Placebo,2023-01-14,2023-02-11,7.14,5.49,117,81,56,Dizziness,None,Improved,1
4048,PT-04048,53,F,AIIMS Delhi,Phase III,ORX-303,Cardiology,Low Dose,2023-04-17,2023-04-24,6.04,4.34,108,108,50,Nausea,None,Worsened,0
4049,PT-04049,51,F,Indore Medical Institute,Phase III,ORX-505,Infectious Disease,Placebo,2024-11-08,2025-02-06,6.3,5.58,138,88,68,Rash,None,Improved,1
4050,PT-04050,23,F,Indore Medical Institute,Phase III,ORX-606,Rheumatology,High Dose,2023-05-23,2023-06-06,7.95,8.04,122,87,71,Headache,Mild,No Change,0
4051,PT-04051,31,F,NIMHANS Bengaluru,Phase II,ORX-101,Oncology,High Dose,2024-02-01,2024-02-15,7.2,7.27,133,88,67,None,None,No Change,0
4052,PT-04052,70,F,Bhopal Research Hospital,Phase IV,ORX-202,Diabetes,High Dose,2023-11-14,2023-11-21,6.79,6.28,104,79,85,Nausea,Moderate,No Change,0
4053,PT-04053,57,F,Kolkata Clinical Center,Phase III,ORX-303,Cardiology,Placebo,2024-10-30,2024-11-13,9.07,9.14,132,76,68,None,None,Improved,0
4054,PT-04054,60,M,AIIMS Delhi,Phase III,ORX-606,Rheumatology,High Dose,2024-11-11,2024-11-25,8.34,6.97,141,89,62,Fatigue,Moderate,No Change,0
4055,PT-04055,53,M,NIMHANS Bengaluru,Phase II,ORX-202,Diabetes,Low Dose,2023-01-05,2023-03-02,5.94,3.35,125,85,76,Dizziness,Mild,Improved,1
4056,PT-04056,85,F,Apollo Chennai,Phase I,ORX-101,Oncology,Placebo,2024-04-26,2024-07-25,7.65,7.39,135,76,91,None,None,Improved,1
4057,PT-04057,50,F,Kolkata Clinical Center,Phase III,ORX-404,Neurology,Placebo,2023-05-20,2023-08-18,7.58,6.62,99,75,81,None,None,No Change,0
4058,PT-04058,37,M,Indore Medical Institute,Phase IV,ORX-202,Diabetes,Low Dose,2024-03-30,2024-04-27,7.55,6.94,135,70,80,None,None,No Change,0
4059,PT-04059,34,F,AIIMS Delhi,Phase III,ORX-202,Diabetes,High Dose,2023-01-14,2023-01-28,5.35,4.81,155,64,79,None,None,Improved,1
4060,PT-04060,57,F,Bhopal Research Hospital,Phase III,ORX-505,Infectious Disease,High Dose,2023-06-23,2023-07-21,9.96,9.12,116,67,93,None,None,No Change,0
4061,PT-04061,31,M,PGI Chandigarh,Phase II,ORX-404,Neurology,Placebo,2024-02-19,2024-03-18,6.76,4.69,143,95,89,None,None,No Change,0
4062,PT-04062,19,F,Bhopal Research Hospital,Phase III,ORX-606,Rheumatology,High Dose,2023-11-20,2023-12-04,7.93,6.02,129,84,82,Headache,None,Improved,1
4063,PT-04063,53,F,Fortis Mumbai,Phase IV,ORX-606,Rheumatology,High Dose,2024-06-14,2024-09-12,7.19,5.02,137,83,65,Fatigue,None,Improved,1
4064,PT-04064,19,F,Indore Medical Institute,Phase III,ORX-606,Rheumatology,Placebo,2024-06-17,2024-07-15,9.05,9.76,140,73,45,Headache,None,Worsened,0
4065,PT-04065,57,M,NIMHANS Bengaluru,Phase II,ORX-404,Neurology,High Dose,2023-08-26,2023-11-24,7.64,6.9,148,92,80,None,None,Worsened,0
4066,PT-04066,45,F,NIMHANS Bengaluru,Phase III,ORX-404,Neurology,High Dose,2024-10-26,2024-11-23,7.26,7.47,112,87,65,None,None,Improved,0
4067,PT-04067,66,M,Apollo Chennai,Phase IV,ORX-505,Infectious Disease,High Dose,2023-03-11,2023-06-09,7.84,6.82,129,71,99,None,None,Improved,1
4068,PT-04068,70,M,Kolkata Clinical Center,Phase II,ORX-303,Cardiology,Low Dose,2024-03-14,2024-03-21,8.04,9.04,130,91,95,Nausea,Mild,Improved,0
4069,PT-04069,44,F,Apollo Chennai,Phase II,ORX-202,Diabetes,High Dose,2024-08-14,2024-08-28,7.29,7.73,139,72,47,Nausea,Moderate,Improved,0
4070,PT-04070,42,M,PGI Chandigarh,Phase II,ORX-404,Neurology,Placebo,2023-03-20,2023-04-17,4.68,3.39,112,75,89,Fatigue,Mild,Worsened,0
4071,PT-04071,61,M,Indore Medical Institute,Phase III,ORX-606,Rheumatology,Placebo,2023-06-20,2023-07-18,7.81,7.98,139,52,78,Headache,Moderate,Worsened,0
4072,PT-04072,18,F,Bhopal Research Hospital,Phase I,ORX-606,Rheumatology,Low Dose,2024-11-18,2025-01-13,7.81,5.53,124,88,62,Headache,Mild,No Change,0
4073,PT-04073,60,F,Kolkata Clinical Center,Phase III,ORX-606,Rheumatology,Placebo,2024-03-03,2024-03-17,7.81,7.75,140,77,80,Fever,Mild,Worsened,0
4074,PT-04074,45,M,PGI Chandigarh,Phase II,ORX-606,Rheumatology,High Dose,2024-04-25,2024-07-24,7.18,6.18,105,77,72,Headache,Mild,No Change,0
4075,PT-04075,33,F,Apollo Chennai,Phase III,ORX-101,Oncology,High Dose,2023-06-08,2023-06-22,8.22,6.77,124,95,90,Dizziness,None,No Change,0
4076,PT-04076,64,M,Apollo Chennai,Phase IV,ORX-202,Diabetes,Low Dose,2023-01-01,2023-02-26,6.49,6.8,108,78,75,None,None,Improved,0
4077,PT-04077,35,F,Bhopal Research Hospital,Phase IV,ORX-505,Infectious Disease,Low Dose,2023-12-16,2024-01-13,6.77,5.92,110,92,75,Rash,Mild,Improved,1
4078,PT-04078,48,F,Apollo Chennai,Phase III,ORX-101,Oncology,Placebo,2023-01-04,2023-01-11,7.4,7.05,129,78,97,None,None,Worsened,0
4079,PT-04079,57,M,AIIMS Delhi,Phase I,ORX-505,Infectious Disease,Placebo,2024-05-01,2024-05-15,7.22,6.42,125,87,98,None,None,Improved,1
4080,PT-04080,23,M,Kolkata Clinical Center,Phase II,ORX-505,Infectious Disease,High Dose,2024-07-13,2024-09-07,7.99,8.61,101,79,63,None,None,Improved,0
4081,PT-04081,51,F,Bhopal Research Hospital,Phase III,ORX-202,Diabetes,Placebo,2024-01-11,2024-01-18,6.77,6.25,120,90,81,None,None,Improved,1
4082,PT-04082,48,F,PGI Chandigarh,Phase IV,ORX-404,Neurology,Placebo,2024-10-02,2024-10-16,7.39,7.51,123,102,60,None,None,Improved,0
4083,PT-04083,18,M,AIIMS Delhi,Phase II,ORX-303,Cardiology,Low Dose,2023-07-01,2023-09-29,5.03,2.76,140,88,94,Nausea,None,No Change,0
4084,PT-04084,28,F,Apollo Chennai,Phase IV,ORX-404,Neurology,Placebo,2024-02-11,2024-02-25,8.09,7.75,130,89,67,Fatigue,None,Improved,1
4085,PT-04085,85,M,AIIMS Delhi,Phase I,ORX-606,Rheumatology,Low Dose,2023-06-05,2023-09-03,8.8,7.92,108,80,80,None,None,No Change,0
4086,PT-04086,62,M,NIMHANS Bengaluru,Phase III,ORX-303,Cardiology,Low Dose,2024-06-11,2024-07-09,5.8,5.65,100,87,76,Nausea,None,No Change,0
4087,PT-04087,75,M,NIMHANS Bengaluru,Phase III,ORX-202,Diabetes,Placebo,2024-10-29,2024-11-12,5.34,6.18,97,66,54,Headache,None,Worsened,0
4088,PT-04088,49,M,Bhopal Research Hospital,Phase I,ORX-404,Neurology,Low Dose,2024-01-20,2024-03-16,5.79,4.18,131,87,78,Headache,None,Improved,1
4089,PT-04089,42,F,PGI Chandigarh,Phase II,ORX-303,Cardiology,Placebo,2023-01-03,2023-04-03,9.39,9.13,142,83,62,None,None,No Change,0
4090,PT-04090,53,F,PGI Chandigarh,Phase II,ORX-101,Oncology,High Dose,2023-04-17,2023-04-24,6.41,5.93,133,58,55,None,None,Improved,1
4091,PT-04091,59,M,NIMHANS Bengaluru,Phase I,ORX-606,Rheumatology,Placebo,2024-11-06,2024-11-13,6.4,5.45,130,77,83,None,None,Improved,1
4092,PT-04092,44,M,Indore Medical Institute,Phase II,ORX-606,Rheumatology,Placebo,2023-09-26,2023-12-25,7.44,6.41,131,95,70,None,None,No Change,0
4093,PT-04093,59,M,NIMHANS Bengaluru,Phase IV,ORX-202,Diabetes,High Dose,2023-10-12,2023-10-19,7.14,7.4,130,81,82,None,None,Worsened,0
4094,PT-04094,64,F,Fortis Mumbai,Phase III,ORX-303,Cardiology,High Dose,2023-08-15,2023-08-29,7.48,7.51,121,100,86,None,None,Worsened,0
4095,PT-04095,46,M,Fortis Mumbai,Phase IV,ORX-202,Diabetes,High Dose,2024-06-21,2024-09-19,7.05,7.53,117,60,79,None,None,Improved,0
4096,PT-04096,64,F,Indore Medical Institute,Phase III,ORX-404,Neurology,Placebo,2023-03-11,2023-03-18,9.11,8.61,128,88,74,Headache,Mild,No Change,0
4097,PT-04097,53,F,Apollo Chennai,Phase I,ORX-606,Rheumatology,High Dose,2023-12-21,2023-12-28,7.1,7.61,141,91,75,None,None,No Change,0
4098,PT-04098,75,M,PGI Chandigarh,Phase II,ORX-202,Diabetes,High Dose,2024-11-03,2024-11-17,7.78,7.6,114,80,79,None,None,No Change,0
4099,PT-04099,32,M,PGI Chandigarh,Phase II,ORX-303,Cardiology,Placebo,2023-03-09,2023-03-23,6.85,6.3,129,60,76,Rash,Mild,No Change,0
4100,PT-04100,38,M,AIIMS Delhi,Phase II,ORX-202,Diabetes,Placebo,2023-07-04,2023-10-02,7.17,7.71,164,90,60,Fatigue,None,Worsened,0
4101,PT-04101,39,M,PGI Chandigarh,Phase I,ORX-202,Diabetes,Placebo,2024-03-27,2024-05-22,7.92,7.95,145,80,72,None,None,Improved,0
4102,PT-04102,73,M,NIMHANS Bengaluru,Phase III,ORX-202,Diabetes,Low Dose,2023-02-16,2023-03-16,7.27,5.96,154,64,45,None,None,No Change,0
4103,PT-04103,57,M,AIIMS Delhi,Phase IV,ORX-303,Cardiology,High Dose,2024-09-06,2024-09-13,8.29,8.27,104,81,74,Nausea,None,Improved,1
4104,PT-04104,36,M,AIIMS Delhi,Phase III,ORX-303,Cardiology,Placebo,2023-06-22,2023-08-17,8.89,7.55,133,96,83,None,None,Improved,1
4105,PT-04105,64,M,Apollo Chennai,Phase III,ORX-505,Infectious Disease,Placebo,2023-10-16,2023-11-13,7.88,7.86,134,89,72,Fatigue,Moderate,Improved,1
4106,PT-04106,24,M,NIMHANS Bengaluru,Phase III,ORX-303,Cardiology,Placebo,2024-09-02,2024-12-01,8.34,8.99,132,75,56,None,None,No Change,0
4107,PT-04107,46,F,Indore Medical Institute,Phase III,ORX-202,Diabetes,Placebo,2023-01-27,2023-04-27,5.58,3.84,127,72,82,None,None,Improved,1
4108,PT-04108,42,M,NIMHANS Bengaluru,Phase II,ORX-606,Rheumatology,Placebo,2023-05-12,2023-08-10,6.47,4.54,112,72,60,None,None,No Change,0
4109,PT-04109,39,M,Indore Medical Institute,Phase II,ORX-303,Cardiology,High Dose,2024-06-07,2024-08-02,5.82,5.28,132,72,83,None,None,No Change,0
4110,PT-04110,23,M,Bhopal Research Hospital,Phase III,ORX-505,Infectious Disease,Placebo,2023-08-05,2023-09-30,5.87,5.36,140,92,100,None,None,Improved,1
4111,PT-04111,38,M,Fortis Mumbai,Phase III,ORX-303,Cardiology,Low Dose,2023-08-26,2023-11-24,7.05,5.72,105,84,67,None,None,Improved,1
4112,PT-04112,64,M,Fortis Mumbai,Phase III,ORX-606,Rheumatology,Placebo,2023-07-25,2023-08-22,5.45,5.48,109,72,85,None,None,Improved,0
4113,PT-04113,34,F,NIMHANS Bengaluru,Phase IV,ORX-303,Cardiology,High Dose,2024-05-13,2024-05-27,6.58,5.45,160,74,78,Headache,Mild,Improved,1
4114,PT-04114,41,F,Indore Medical Institute,Phase II,ORX-404,Neurology,Placebo,2024-02-08,2024-04-04,7.47,6.51,124,86,65,Headache,Moderate,No Change,0
4115,PT-04115,62,F,AIIMS Delhi,Phase II,ORX-101,Oncology,Low Dose,2024-07-10,2024-07-17,8.62,8.77,129,50,83,None,None,Improved,0
4116,PT-04116,38,M,AIIMS Delhi,Phase III,ORX-303,Cardiology,High Dose,2023-05-16,2023-08-14,6.9,4.8,136,64,79,Nausea,None,No Change,0
4117,PT-04117,59,F,Apollo Chennai,Phase II,ORX-303,Cardiology,Placebo,2023-01-19,2023-02-02,6.64,7.33,114,89,59,Headache,None,Improved,0
4118,PT-04118,61,F,NIMHANS Bengaluru,Phase II,ORX-404,Neurology,Low Dose,2024-07-26,2024-08-02,8.25,8.27,120,65,72,Headache,None,Improved,0
4119,PT-04119,62,F,Bhopal Research Hospital,Phase III,ORX-404,Neurology,Low Dose,2023-09-25,2023-12-24,7.36,5.56,107,97,84,None,None,Improved,1
4120,PT-04120,25,F,Fortis Mumbai,Phase II,ORX-202,Diabetes,Low Dose,2024-06-11,2024-06-25,5.08,4.12,94,80,112,None,None,No Change,0
4121,PT-04121,19,M,PGI Chandigarh,Phase IV,ORX-202,Diabetes,Low Dose,2023-05-19,2023-07-14,6.98,7.76,141,80,75,Nausea,Severe,Improved,0
4122,PT-04122,26,M,Kolkata Clinical Center,Phase II,ORX-202,Diabetes,Placebo,2023-01-31,2023-02-07,6.88,6.7,147,74,75,Nausea,Mild,Improved,1
4123,PT-04123,29,F,PGI Chandigarh,Phase III,ORX-303,Cardiology,High Dose,2023-07-26,2023-09-20,7.47,7.78,139,67,80,None,None,Worsened,0
4124,PT-04124,34,M,NIMHANS Bengaluru,Phase III,ORX-404,Neurology,Low Dose,2024-09-09,2024-10-07,8.41,7.87,100,79,84,Rash,Severe,Improved,1
4125,PT-04125,48,F,Kolkata Clinical Center,Phase III,ORX-202,Diabetes,Low Dose,2023-04-07,2023-04-14,6.59,5.66,110,77,66,Headache,None,No Change,0
4126,PT-04126,60,F,NIMHANS Bengaluru,Phase III,ORX-505,Infectious Disease,High Dose,2024-08-17,2024-08-24,6.12,5.83,128,93,93,None,None,Worsened,0
4127,PT-04127,56,M,Bhopal Research Hospital,Phase II,ORX-606,Rheumatology,High Dose,2023-11-18,2024-01-13,7.62,6.28,108,71,88,None,None,No Change,0
4128,PT-04128,46,M,AIIMS Delhi,Phase I,ORX-101,Oncology,High Dose,2024-05-29,2024-08-27,8.24,8.74,114,82,77,None,None,Improved,0
4129,PT-04129,39,M,NIMHANS Bengaluru,Phase III,ORX-505,Infectious Disease,Low Dose,2024-02-01,2024-02-29,6.56,7.22,128,82,66,None,None,Improved,0
4130,PT-04130,55,F,Bhopal Research Hospital,Phase II,ORX-101,Oncology,Placebo,2024-07-04,2024-08-01,5.99,6.0,136,77,82,Nausea,Mild,Improved,0
4131,PT-04131,47,F,Bhopal Research Hospital,Phase IV,ORX-202,Diabetes,Low Dose,2024-05-03,2024-05-17,7.15,6.76,129,83,78,None,None,Improved,1
4132,PT-04132,27,M,Bhopal Research Hospital,Phase III,ORX-202,Diabetes,High Dose,2024-07-29,2024-10-27,7.02,6.86,129,93,86,None,None,No Change,0
4133,PT-04133,31,F,AIIMS Delhi,Phase IV,ORX-303,Cardiology,Low Dose,2024-11-20,2025-02-18,7.0,6.32,127,81,86,Fatigue,None,Improved,1
4134,PT-04134,47,F,PGI Chandigarh,Phase I,ORX-606,Rheumatology,High Dose,2023-12-09,2024-01-06,8.68,8.49,113,76,86,Headache,None,Improved,1
4135,PT-04135,19,F,NIMHANS Bengaluru,Phase II,ORX-202,Diabetes,Placebo,2023-11-25,2023-12-23,5.58,5.19,145,97,74,Fever,None,No Change,0
4136,PT-04136,61,M,Fortis Mumbai,Phase III,ORX-303,Cardiology,Low Dose,2023-04-08,2023-05-06,7.29,5.51,127,74,90,None,None,No Change,0
4137,PT-04137,44,M,Fortis Mumbai,Phase III,ORX-101,Oncology,High Dose,2024-01-14,2024-03-10,5.67,3.92,127,52,70,None,None,Improved,1
4138,PT-04138,48,M,NIMHANS Bengaluru,Phase I,ORX-303,Cardiology,High Dose,2023-02-11,2023-04-08,5.93,6.43,149,69,73,Nausea,None,No Change,0
4139,PT-04139,60,F,AIIMS Delhi,Phase III,ORX-202,Diabetes,High Dose,2024-05-30,2024-06-27,7.2,5.54,125,71,93,None,None,No Change,0
4140,PT-04140,54,F,Fortis Mumbai,Phase IV,ORX-303,Cardiology,High Dose,2024-05-12,2024-08-10,6.82,6.55,104,72,99,Nausea,Moderate,No Change,0
4141,PT-04141,45,F,Kolkata Clinical Center,Phase I,ORX-606,Rheumatology,Placebo,2024-02-25,2024-04-21,8.32,8.12,151,58,75,Fatigue,Severe,No Change,0
4142,PT-04142,71,F,PGI Chandigarh,Phase III,ORX-505,Infectious Disease,High Dose,2024-04-17,2024-07-16,8.35,9.14,127,75,63,Dizziness,Severe,No Change,0
4143,PT-04143,27,M,Kolkata Clinical Center,Phase IV,ORX-101,Oncology,High Dose,2023-11-27,2023-12-11,8.17,8.23,126,88,79,Headache,None,Worsened,0
4144,PT-04144,60,M,Kolkata Clinical Center,Phase III,ORX-404,Neurology,Placebo,2023-11-28,2023-12-12,8.34,6.98,132,61,79,None,None,No Change,0
4145,PT-04145,54,M,Apollo Chennai,Phase III,ORX-606,Rheumatology,Placebo,2023-03-04,2023-03-18,5.62,4.85,128,84,74,Dizziness,None,Improved,1
4146,PT-04146,26,F,Bhopal Research Hospital,Phase I,ORX-404,Neurology,High Dose,2024-05-21,2024-07-16,7.14,5.25,123,76,76,None,None,Improved,1
4147,PT-04147,36,M,AIIMS Delhi,Phase III,ORX-404,Neurology,Low Dose,2024-04-24,2024-05-01,5.39,4.66,144,97,112,None,None,Improved,1
4148,PT-04148,72,F,Fortis Mumbai,Phase I,ORX-202,Diabetes,High Dose,2024-04-14,2024-04-28,5.76,5.0,127,80,78,Nausea,None,No Change,0
4149,PT-04149,83,F,Bhopal Research Hospital,Phase II,ORX-404,Neurology,High Dose,2024-02-21,2024-04-17,5.9,4.86,157,74,83,Dizziness,None,Improved,1
4150,PT-04150,61,F,PGI Chandigarh,Phase I,ORX-303,Cardiology,Placebo,2023-03-15,2023-05-10,7.78,7.56,144,71,71,Fever,Mild,No Change,0
4151,PT-04151,53,F,NIMHANS Bengaluru,Phase III,ORX-303,Cardiology,High Dose,2023-05-10,2023-06-07,4.72,5.59,133,83,55,Rash,None,Improved,0
4152,PT-04152,24,F,AIIMS Delhi,Phase IV,ORX-606,Rheumatology,Placebo,2023-07-29,2023-09-23,6.72,,90,91,72,None,None,No Change,0
4153,PT-04153,41,M,PGI Chandigarh,Phase II,ORX-101,Oncology,High Dose,2023-07-09,2023-09-03,7.5,7.35,115,89,45,None,None,Worsened,0
4154,PT-04154,37,M,Kolkata Clinical Center,Phase III,ORX-202,Diabetes,Placebo,2023-05-19,2023-06-02,7.38,6.67,95,91,60,Headache,Moderate,No Change,0
4155,PT-04155,43,F,NIMHANS Bengaluru,Phase II,ORX-404,Neurology,High Dose,2023-10-21,2023-10-28,7.38,7.0,149,81,83,Headache,None,Improved,1
4156,PT-04156,44,M,Bhopal Research Hospital,Phase III,ORX-606,Rheumatology,High Dose,2024-08-01,2024-08-29,7.94,8.79,130,91,98,None,None,Improved,0
4157,PT-04157,66,M,NIMHANS Bengaluru,Phase IV,ORX-101,Oncology,Low Dose,2024-11-12,2024-11-19,6.74,7.27,132,95,85,Fatigue,None,Improved,0
4158,PT-04158,49,M,Kolkata Clinical Center,Phase IV,ORX-202,Diabetes,Placebo,2023-08-17,2023-10-12,7.72,7.55,133,80,74,None,None,No Change,0
4159,PT-04159,73,F,PGI Chandigarh,Phase II,ORX-303,Cardiology,Placebo,2023-04-23,2023-05-21,7.77,6.86,123,94,67,None,None,Improved,1
4160,PT-04160,21,F,Kolkata Clinical Center,Phase III,ORX-101,Oncology,Low Dose,2023-06-10,2023-09-08,5.51,3.55,104,67,97,None,None,Worsened,0
4161,PT-04161,44,F,Fortis Mumbai,Phase III,ORX-303,Cardiology,Placebo,2023-07-15,2023-08-12,6.76,5.07,125,61,72,Nausea,Moderate,Worsened,0
4162,PT-04162,78,F,PGI Chandigarh,Phase III,ORX-505,Infectious Disease,Low Dose,2023-06-04,2023-07-30,8.0,7.41,140,75,66,None,None,Improved,1
4163,PT-04163,72,M,AIIMS Delhi,Phase II,ORX-303,Cardiology,High Dose,2023-03-06,2023-04-03,5.83,5.11,133,70,87,Rash,Severe,Improved,1
4164,PT-04164,40,F,PGI Chandigarh,Phase III,ORX-101,Oncology,High Dose,2023-07-25,2023-09-19,8.0,8.12,123,102,68,None,None,Worsened,0
4165,PT-04165,66,F,AIIMS Delhi,Phase II,ORX-404,Neurology,High Dose,2023-10-01,2023-10-29,8.61,9.8,131,72,107,None,None,No Change,0
4166,PT-04166,39,M,Kolkata Clinical Center,Phase III,ORX-404,Neurology,High Dose,2023-04-25,2023-05-09,6.22,5.65,110,88,69,None,None,Worsened,0
4167,PT-04167,40,M,NIMHANS Bengaluru,Phase II,ORX-101,Oncology,Low Dose,2024-03-17,2024-04-14,8.36,8.52,128,84,78,Rash,None,Improved,0
4168,PT-04168,38,F,Kolkata Clinical Center,Phase IV,ORX-101,Oncology,High Dose,2024-06-06,2024-06-13,7.2,7.24,125,87,66,None,None,Worsened,0
4169,PT-04169,35,F,Bhopal Research Hospital,Phase III,ORX-202,Diabetes,Low Dose,2024-03-29,2024-04-05,6.32,5.41,151,90,62,None,None,No Change,0
4170,PT-04170,51,M,Fortis Mumbai,Phase III,ORX-202,Diabetes,Low Dose,2023-11-06,2024-02-04,6.73,5.72,101,93,58,Fatigue,Mild,No Change,0
4171,PT-04171,44,M,NIMHANS Bengaluru,Phase III,ORX-505,Infectious Disease,Placebo,2024-09-07,2024-09-21,6.06,6.36,121,80,76,None,None,Improved,0
4172,PT-04172,49,M,Indore Medical Institute,Phase II,ORX-303,Cardiology,High Dose,2024-06-04,2024-06-11,7.22,6.78,118,63,62,None,None,Improved,1
4173,PT-04173,56,M,Indore Medical Institute,Phase II,ORX-303,Cardiology,High Dose,2024-07-20,2024-07-27,6.83,5.84,102,61,68,Fatigue,None,No Change,0
4174,PT-04174,59,M,NIMHANS Bengaluru,Phase II,ORX-505,Infectious Disease,Low Dose,2024-10-11,2024-10-25,6.53,6.49,117,89,73,Headache,Severe,Worsened,0
4175,PT-04175,25,M,NIMHANS Bengaluru,Phase III,ORX-505,Infectious Disease,Low Dose,2023-01-23,2023-02-06,6.88,8.13,160,87,76,None,None,Worsened,0
4176,PT-04176,49,F,Kolkata Clinical Center,Phase IV,ORX-404,Neurology,High Dose,2023-05-28,2023-08-26,7.58,7.14,135,84,73,Headache,Mild,Improved,1
4177,PT-04177,25,F,Apollo Chennai,Phase III,ORX-404,Neurology,High Dose,2023-02-22,2023-04-19,6.65,6.97,127,85,74,None,None,No Change,0
4178,PT-04178,28,F,PGI Chandigarh,Phase III,ORX-505,Infectious Disease,Placebo,2023-06-26,2023-08-21,6.91,5.59,108,96,72,Nausea,None,Improved,1
4179,PT-04179,33,M,Fortis Mumbai,Phase I,ORX-606,Rheumatology,Low Dose,2024-03-03,2024-03-31,9.14,9.48,121,87,74,Fatigue,None,Improved,0
4180,PT-04180,33,F,Kolkata Clinical Center,Phase II,ORX-505,Infectious Disease,Low Dose,2023-08-05,2023-08-12,7.77,7.08,129,94,90,Nausea,None,Improved,1
4181,PT-04181,36,M,NIMHANS Bengaluru,Phase II,ORX-303,Cardiology,Low Dose,2024-02-12,2024-03-11,7.78,6.37,136,83,83,None,None,Improved,1
4182,PT-04182,40,M,PGI Chandigarh,Phase IV,ORX-202,Diabetes,High Dose,2023-05-14,2023-05-28,9.7,8.49,145,69,85,None,None,No Change,0
4183,PT-04183,54,M,Kolkata Clinical Center,Phase IV,ORX-404,Neurology,Placebo,2023-07-10,2023-09-04,7.27,6.42,130,85,103,None,None,Improved,1
4184,PT-04184,31,F,PGI Chandigarh,Phase III,ORX-404,Neurology,Placebo,2024-07-11,2024-09-05,6.53,6.39,123,80,92,Headache,Mild,Improved,1
4185,PT-04185,18,M,Fortis Mumbai,Phase III,ORX-101,Oncology,Low Dose,2024-01-13,2024-02-10,6.48,4.51,106,110,86,Dizziness,Moderate,No Change,0
4186,PT-04186,60,F,PGI Chandigarh,Phase III,ORX-505,Infectious Disease,Low Dose,2024-06-06,2024-06-13,7.1,7.39,96,94,66,None,None,No Change,0
4187,PT-04187,36,F,Apollo Chennai,Phase II,ORX-202,Diabetes,Low Dose,2024-09-04,2024-10-30,7.81,7.69,129,65,79,Dizziness,None,No Change,0
4188,PT-04188,60,M,NIMHANS Bengaluru,Phase I,ORX-505,Infectious Disease,Placebo,2023-06-28,2023-08-23,6.56,7.34,112,82,99,Fatigue,None,Improved,0
4189,PT-04189,34,M,PGI Chandigarh,Phase III,ORX-303,Cardiology,Low Dose,2024-04-26,2024-07-25,8.46,9.84,131,75,67,Headache,None,No Change,0
4190,PT-04190,65,M,Indore Medical Institute,Phase IV,ORX-101,Oncology,High Dose,2024-05-24,2024-05-31,8.73,9.64,127,94,77,None,None,No Change,0
4191,PT-04191,30,M,PGI Chandigarh,Phase III,ORX-101,Oncology,Placebo,2024-01-31,2024-04-30,8.55,9.62,109,69,78,None,None,Improved,0
4192,PT-04192,60,F,Fortis Mumbai,Phase III,ORX-101,Oncology,High Dose,2024-10-19,2024-11-16,5.84,5.64,117,90,66,Nausea,None,No Change,0
4193,PT-04193,57,M,Apollo Chennai,Phase II,ORX-606,Rheumatology,High Dose,2024-06-25,2024-08-20,7.01,5.77,129,58,70,Headache,Severe,No Change,0
4194,PT-04194,50,M,NIMHANS Bengaluru,Phase IV,ORX-606,Rheumatology,Low Dose,2023-09-21,2023-11-16,5.07,2.36,90,97,76,Nausea,Mild,Improved,1
4195,PT-04195,36,M,Indore Medical Institute,Phase I,ORX-303,Cardiology,Placebo,2023-08-24,2023-11-22,8.33,7.57,132,82,71,Headache,Moderate,Improved,1
4196,PT-04196,49,M,Bhopal Research Hospital,Phase II,ORX-606,Rheumatology,Low Dose,2024-04-25,2024-06-20,8.13,7.56,119,77,45,Headache,Mild,No Change,0
4197,PT-04197,49,M,Fortis Mumbai,Phase IV,ORX-202,Diabetes,Placebo,2023-08-05,2023-11-03,5.75,5.92,126,83,87,Nausea,None,Improved,0
4198,PT-04198,30,M,Kolkata Clinical Center,Phase II,ORX-404,Neurology,Low Dose,2023-07-05,2023-08-30,7.64,7.48,124,70,86,None,None,Improved,1
4199,PT-04199,56,F,Bhopal Research Hospital,Phase I,ORX-606,Rheumatology,High Dose,2024-06-22,2024-07-20,7.34,5.97,118,81,87,None,None,Improved,1
4200,PT-04200,19,F,NIMHANS Bengaluru,Phase III,ORX-101,Oncology,Placebo,2024-01-23,2024-02-06,6.52,5.76,126,66,74,Nausea,None,Improved,1
4201,PT-04201,40,F,Fortis Mumbai,Phase III,ORX-202,Diabetes,High Dose,2023-01-17,2023-02-14,5.95,5.45,118,87,65,Fatigue,Mild,Improved,1
4202,PT-04202,46,M,Fortis Mumbai,Phase II,ORX-404,Neurology,High Dose,2023-02-27,2023-04-24,6.23,5.29,133,84,72,Dizziness,Moderate,No Change,0
4203,PT-04203,40,M,Apollo Chennai,Phase III,ORX-202,Diabetes,Low Dose,2023-02-25,2023-03-11,5.46,6.32,140,89,55,Dizziness,None,Worsened,0
4204,PT-04204,35,M,Kolkata Clinical Center,Phase IV,ORX-505,Infectious Disease,High Dose,2024-02-26,2024-04-22,6.8,4.66,144,99,106,None,None,No Change,0
4205,PT-04205,28,M,NIMHANS Bengaluru,Phase III,ORX-202,Diabetes,High Dose,2023-03-22,2023-04-05,7.34,8.13,123,75,51,None,None,Worsened,0
4206,PT-04206,63,F,PGI Chandigarh,Phase III,ORX-505,Infectious Disease,Placebo,2023-03-08,2023-03-15,7.18,6.12,133,83,80,None,None,No Change,0
4207,PT-04207,41,F,PGI Chandigarh,Phase II,ORX-606,Rheumatology,Placebo,2024-09-25,2024-10-23,9.15,8.63,157,88,82,None,None,Improved,1
4208,PT-04208,43,F,Apollo Chennai,Phase I,ORX-505,Infectious Disease,High Dose,2024-08-20,2024-10-15,8.37,8.07,111,70,83,None,None,Worsened,0
4209,PT-04209,30,F,Bhopal Research Hospital,Phase III,ORX-606,Rheumatology,Low Dose,2024-10-04,2024-10-18,7.13,7.68,133,73,97,Rash,None,No Change,0
4210,PT-04210,53,M,Indore Medical Institute,Phase I,ORX-101,Oncology,High Dose,2023-07-02,2023-09-30,8.42,5.98,133,92,101,Nausea,Mild,No Change,0
4211,PT-04211,21,F,Bhopal Research Hospital,Phase II,ORX-303,Cardiology,Low Dose,2024-08-23,2024-09-20,8.65,9.73,91,87,86,Fatigue,Mild,Improved,0
4212,PT-04212,39,M,NIMHANS Bengaluru,Phase III,ORX-404,Neurology,Placebo,2024-11-17,2024-11-24,6.61,6.81,116,79,89,None,None,No Change,0
4213,PT-04213,73,F,PGI Chandigarh,Phase III,ORX-505,Infectious Disease,High Dose,2023-07-07,2023-08-04,7.85,7.57,118,69,93,None,None,Improved,1
4214,PT-04214,42,F,NIMHANS Bengaluru,Phase IV,ORX-404,Neurology,Low Dose,2024-11-06,2024-11-20,8.58,7.88,116,87,76,Rash,None,No Change,0
4215,PT-04215,25,M,PGI Chandigarh,Phase IV,ORX-101,Oncology,Low Dose,2024-08-23,2024-10-18,9.38,8.42,144,92,60,None,None,Improved,1
4216,PT-04216,28,M,Fortis Mumbai,Phase III,ORX-202,Diabetes,High Dose,2023-08-29,2023-09-26,6.84,5.66,159,79,90,None,None,Improved,1
4217,PT-04217,53,F,Kolkata Clinical Center,Phase III,ORX-404,Neurology,Low Dose,2023-09-14,2023-09-28,7.52,7.15,150,72,102,Rash,None,Improved,1
4218,PT-04218,24,F,Apollo Chennai,Phase II,ORX-606,Rheumatology,Placebo,2023-11-03,2024-02-01,8.14,6.47,122,83,71,None,None,Improved,1
4219,PT-04219,42,M,Kolkata Clinical Center,Phase III,ORX-101,Oncology,Low Dose,2024-10-04,2024-10-18,5.54,4.25,136,82,68,None,None,Worsened,0
4220,PT-04220,66,F,Indore Medical Institute,Phase I,ORX-404,Neurology,High Dose,2024-02-08,2024-04-04,5.74,5.01,118,89,78,Fever,Mild,Worsened,0
4221,PT-04221,43,F,Fortis Mumbai,Phase III,ORX-404,Neurology,Placebo,2023-04-03,2023-05-29,4.99,5.37,124,83,67,Dizziness,None,Improved,0
4222,PT-04222,30,M,NIMHANS Bengaluru,Phase II,ORX-505,Infectious Disease,High Dose,2023-09-08,2023-09-15,9.0,7.0,109,99,86,None,None,Improved,1
4223,PT-04223,39,M,PGI Chandigarh,Phase II,ORX-606,Rheumatology,Placebo,2024-01-07,2024-02-04,8.7,8.7,132,84,84,Headache,Moderate,Improved,0
4224,PT-04224,53,F,Indore Medical Institute,Phase II,ORX-404,Neurology,High Dose,2023-04-06,2023-04-13,9.84,9.26,125,67,77,None,None,No Change,0
4225,PT-04225,74,M,Fortis Mumbai,Phase III,ORX-404,Neurology,High Dose,2023-10-02,2023-11-27,8.38,7.49,128,66,64,Fever,None,No Change,0
4226,PT-04226,47,F,Apollo Chennai,Phase I,ORX-606,Rheumatology,Low Dose,2023-08-31,2023-09-07,6.61,5.27,136,81,56,None,None,No Change,0
4227,PT-04227,18,F,Fortis Mumbai,Phase II,ORX-303,Cardiology,Placebo,2023-02-09,2023-05-10,6.52,4.69,94,95,76,Nausea,Moderate,Improved,1
4228,PT-04228,40,F,NIMHANS Bengaluru,Phase IV,ORX-202,Diabetes,High Dose,2023-03-05,2023-04-30,6.97,5.55,135,80,67,None,None,Improved,1
4229,PT-04229,35,M,Indore Medical Institute,Phase III,ORX-303,Cardiology,High Dose,2024-02-03,2024-03-02,5.73,4.96,123,76,78,None,None,Improved,1
4230,PT-04230,43,M,Bhopal Research Hospital,Phase IV,ORX-101,Oncology,Placebo,2024-10-31,2024-11-28,7.48,7.93,138,93,66,Fatigue,None,No Change,0
4231,PT-04231,36,F,Apollo Chennai,Phase III,ORX-505,Infectious Disease,Low Dose,2023-06-13,2023-08-08,7.98,8.19,115,89,64,Fatigue,Mild,Worsened,0
4232,PT-04232,52,F,NIMHANS Bengaluru,Phase III,ORX-404,Neurology,Low Dose,2023-03-04,2023-04-01,7.17,5.52,120,108,80,None,None,Improved,1
4233,PT-04233,81,M,AIIMS Delhi,Phase III,ORX-606,Rheumatology,Low Dose,2024-09-11,2024-11-06,5.47,5.74,90,81,86,Nausea,None,No Change,0
4234,PT-04234,58,F,AIIMS Delhi,Phase III,ORX-404,Neurology,Placebo,2024-11-03,2024-11-17,6.24,6.78,118,80,71,None,None,No Change,0
4235,PT-04235,26,M,AIIMS Delhi,Phase II,ORX-404,Neurology,Low Dose,2023-07-19,2023-09-13,9.08,8.73,147,94,64,None,None,No Change,0
4236,PT-04236,64,M,NIMHANS Bengaluru,Phase I,ORX-505,Infectious Disease,High Dose,2023-10-22,2023-10-29,7.8,6.47,136,69,100,None,None,Improved,1
4237,PT-04237,58,M,Bhopal Research Hospital,Phase III,ORX-505,Infectious Disease,Placebo,2024-10-02,2024-10-30,7.11,7.85,99,73,74,Nausea,Mild,Improved,0
4238,PT-04238,80,M,PGI Chandigarh,Phase III,ORX-303,Cardiology,Low Dose,2023-06-10,2023-06-24,5.92,3.98,102,92,69,None,None,Improved,1
4239,PT-04239,42,M,PGI Chandigarh,Phase III,ORX-505,Infectious Disease,Low Dose,2023-01-27,2023-03-24,8.12,7.57,131,88,71,Headache,None,Improved,1
4240,PT-04240,42,M,AIIMS Delhi,Phase III,ORX-505,Infectious Disease,High Dose,2023-08-30,2023-09-27,7.49,7.87,113,50,87,None,None,Worsened,0
4241,PT-04241,59,F,Kolkata Clinical Center,Phase III,ORX-101,Oncology,Low Dose,2023-07-18,2023-08-15,7.44,7.28,117,88,89,Nausea,None,No Change,0
4242,PT-04242,45,F,NIMHANS Bengaluru,Phase IV,ORX-505,Infectious Disease,High Dose,2024-05-25,2024-06-22,10.19,8.38,130,67,90,Headache,None,Improved,1
4243,PT-04243,19,F,Apollo Chennai,Phase III,ORX-101,Oncology,High Dose,2023-05-06,2023-08-04,5.6,4.63,132,74,69,Headache,None,Worsened,0
4244,PT-04244,42,M,Kolkata Clinical Center,Phase IV,ORX-303,Cardiology,Low Dose,2023-11-14,2023-12-12,6.91,7.85,140,78,107,Headache,None,No Change,0
4245,PT-04245,52,M,PGI Chandigarh,Phase III,ORX-505,Infectious Disease,Placebo,2023-01-02,2023-04-02,6.04,5.87,137,73,63,Nausea,Mild,Worsened,0
4246,PT-04246,46,F,Kolkata Clinical Center,Phase III,ORX-303,Cardiology,Placebo,2024-03-21,2024-03-28,6.77,7.7,141,74,83,None,None,No Change,0
4247,PT-04247,65,F,NIMHANS Bengaluru,Phase II,ORX-606,Rheumatology,Placebo,2023-12-05,2023-12-19,5.53,4.21,127,82,77,None,None,Worsened,0
4248,PT-04248,40,F,NIMHANS Bengaluru,Phase III,ORX-202,Diabetes,Placebo,2024-05-06,2024-08-04,6.81,6.75,148,76,112,None,None,Worsened,0
4249,PT-04249,76,F,AIIMS Delhi,Phase IV,ORX-505,Infectious Disease,Placebo,2023-03-18,2023-04-15,8.8,8.96,164,78,66,None,None,Improved,0
4250,PT-04250,36,F,Kolkata Clinical Center,Phase II,ORX-202,Diabetes,Placebo,2023-11-17,2023-11-24,6.0,5.71,133,84,77,None,None,Improved,1
4251,PT-04251,47,F,Indore Medical Institute,Phase I,ORX-303,Cardiology,Low Dose,2024-03-02,2024-03-09,9.28,9.44,144,84,55,Fatigue,Mild,No Change,0
4252,PT-04252,18,F,Bhopal Research Hospital,Phase II,ORX-303,Cardiology,Low Dose,2024-08-24,2024-10-19,9.7,8.82,116,84,85,Fever,None,Improved,1
4253,PT-04253,55,M,PGI Chandigarh,Phase III,ORX-505,Infectious Disease,Placebo,2024-07-24,2024-07-31,9.33,10.28,113,93,72,None,None,Improved,0
4254,PT-04254,42,M,PGI Chandigarh,Phase II,ORX-202,Diabetes,Low Dose,2024-10-23,2025-01-21,5.89,3.96,127,70,90,None,None,Improved,1
4255,PT-04255,40,F,PGI Chandigarh,Phase III,ORX-606,Rheumatology,High Dose,2024-04-08,2024-04-15,7.57,8.4,101,73,80,Rash,Mild,Improved,0
4256,PT-04256,50,F,Fortis Mumbai,Phase IV,ORX-606,Rheumatology,Low Dose,2024-02-04,2024-02-11,8.52,8.9,129,85,82,None,None,Worsened,0
4257,PT-04257,21,F,Kolkata Clinical Center,Phase II,ORX-303,Cardiology,Low Dose,2024-05-09,2024-06-06,7.01,6.84,136,70,60,Nausea,None,Improved,1
4258,PT-04258,41,M,Kolkata Clinical Center,Phase III,ORX-404,Neurology,Low Dose,2023-03-16,2023-06-14,9.56,8.42,149,101,78,None,None,Improved,1
4259,PT-04259,34,F,Kolkata Clinical Center,Phase II,ORX-505,Infectious Disease,High Dose,2024-07-04,2024-07-18,7.82,7.59,112,74,84,None,None,Improved,1
4260,PT-04260,59,M,Indore Medical Institute,Phase III,ORX-101,Oncology,Low Dose,2023-01-13,2023-02-10,6.81,6.35,140,79,73,Headache,None,Improved,1
4261,PT-04261,32,F,PGI Chandigarh,Phase II,ORX-303,Cardiology,Placebo,2024-08-03,2024-08-10,6.27,8.27,124,98,101,None,None,No Change,0
4262,PT-04262,42,M,AIIMS Delhi,Phase II,ORX-606,Rheumatology,High Dose,2024-04-25,2024-05-02,7.64,7.33,98,63,78,None,None,Worsened,0
4263,PT-04263,38,M,Indore Medical Institute,Phase II,ORX-404,Neurology,Low Dose,2023-07-27,2023-08-24,9.47,8.86,163,76,104,None,None,Worsened,0
4264,PT-04264,53,F,Kolkata Clinical Center,Phase III,ORX-303,Cardiology,High Dose,2024-08-22,2024-11-20,7.88,7.02,138,102,75,None,None,Improved,1
4265,PT-04265,39,M,Bhopal Research Hospital,Phase III,ORX-505,Infectious Disease,Low Dose,2023-01-01,2023-04-01,6.9,7.96,143,99,82,None,None,Improved,0
4266,PT-04266,45,F,AIIMS Delhi,Phase III,ORX-606,Rheumatology,High Dose,2023-07-14,2023-09-08,7.71,,123,98,83,None,None,Worsened,0
4267,PT-04267,18,M,Kolkata Clinical Center,Phase III,ORX-404,Neurology,Placebo,2024-10-18,2025-01-16,8.26,6.72,143,92,82,Fatigue,Moderate,No Change,0
4268,PT-04268,53,F,Kolkata Clinical Center,Phase I,ORX-606,Rheumatology,Low Dose,2024-05-25,2024-08-23,8.52,7.67,142,95,102,Dizziness,Severe,No Change,0
4269,PT-04269,27,M,Fortis Mumbai,Phase III,ORX-303,Cardiology,High Dose,2024-11-08,2024-11-15,7.69,6.42,109,86,79,None,None,Improved,1
4270,PT-04270,63,F,Indore Medical Institute,Phase II,ORX-606,Rheumatology,Placebo,2024-03-28,2024-06-26,6.78,6.26,131,71,67,None,None,Improved,1
4271,PT-04271,62,M,AIIMS Delhi,Phase III,ORX-404,Neurology,Low Dose,2023-12-20,2024-01-17,6.54,7.21,138,63,85,None,None,Improved,0
4272,PT-04272,53,F,PGI Chandigarh,Phase III,ORX-404,Neurology,Low Dose,2023-03-11,2023-05-06,7.71,7.18,111,98,76,None,None,Improved,1
4273,PT-04273,30,F,PGI Chandigarh,Phase II,ORX-505,Infectious Disease,Placebo,2024-08-27,2024-11-25,7.75,6.68,110,77,68,None,None,Improved,1
4274,PT-04274,30,F,PGI Chandigarh,Phase I,ORX-606,Rheumatology,Low Dose,2023-07-25,2023-10-23,8.17,7.67,150,71,53,None,None,No Change,0
4275,PT-04275,47,F,Kolkata Clinical Center,Phase II,ORX-202,Diabetes,Low Dose,2023-08-11,2023-11-09,9.43,9.51,185,85,81,None,None,Worsened,0
4276,PT-04276,18,F,Indore Medical Institute,Phase III,ORX-303,Cardiology,Placebo,2023-07-14,2023-07-21,7.71,7.47,120,80,77,None,None,Improved,1
4277,PT-04277,42,M,AIIMS Delhi,Phase I,ORX-505,Infectious Disease,Placebo,2024-02-02,2024-05-02,9.71,8.97,131,77,88,None,None,Improved,1
4278,PT-04278,47,M,AIIMS Delhi,Phase III,ORX-404,Neurology,High Dose,2024-06-17,2024-07-15,6.86,4.73,132,78,77,Nausea,Moderate,Improved,1
4279,PT-04279,26,M,AIIMS Delhi,Phase I,ORX-303,Cardiology,Placebo,2024-04-29,2024-05-06,8.92,9.29,153,95,86,None,None,Improved,0
4280,PT-04280,26,F,Indore Medical Institute,Phase III,ORX-505,Infectious Disease,Low Dose,2023-08-09,2023-08-16,9.41,8.18,123,90,88,None,None,Improved,1
4281,PT-04281,54,M,NIMHANS Bengaluru,Phase IV,ORX-505,Infectious Disease,High Dose,2024-03-09,2024-05-04,6.72,5.77,173,81,75,None,None,Improved,1
4282,PT-04282,33,F,NIMHANS Bengaluru,Phase II,ORX-101,Oncology,High Dose,2024-05-01,2024-06-26,7.49,7.27,127,86,102,Dizziness,Mild,Improved,1
4283,PT-04283,35,F,PGI Chandigarh,Phase III,ORX-303,Cardiology,Placebo,2023-01-04,2023-02-01,7.25,6.27,133,75,70,Headache,Mild,Worsened,0
4284,PT-04284,21,F,AIIMS Delhi,Phase III,ORX-303,Cardiology,High Dose,2023-10-28,2023-11-04,7.32,7.3,161,87,71,Headache,Moderate,Improved,1
4285,PT-04285,23,M,PGI Chandigarh,Phase I,ORX-303,Cardiology,Low Dose,2023-06-04,2023-06-18,5.73,4.17,161,85,69,None,None,Improved,1
4286,PT-04286,29,F,AIIMS Delhi,Phase III,ORX-101,Oncology,Low Dose,2023-06-06,2023-07-04,6.17,5.22,151,81,57,None,None,Worsened,0
4287,PT-04287,81,F,Indore Medical Institute,Phase I,ORX-404,Neurology,High Dose,2023-11-07,2024-02-05,5.83,4.9,151,86,71,None,None,Improved,1
4288,PT-04288,25,M,Bhopal Research Hospital,Phase III,ORX-404,Neurology,High Dose,2023-04-28,2023-05-05,6.04,4.82,128,84,75,None,None,Improved,1
4289,PT-04289,44,F,Bhopal Research Hospital,Phase IV,ORX-202,Diabetes,Low Dose,2023-01-18,2023-02-15,5.94,5.8,151,80,75,Nausea,None,Improved,1
4290,PT-04290,46,M,Fortis Mumbai,Phase IV,ORX-303,Cardiology,Low Dose,2023-02-04,2023-05-05,8.54,7.34,154,87,78,None,None,No Change,0
4291,PT-04291,64,F,Indore Medical Institute,Phase I,ORX-606,Rheumatology,Low Dose,2024-09-13,2024-10-11,5.78,5.85,135,70,84,None,None,No Change,0
4292,PT-04292,49,F,Indore Medical Institute,Phase III,ORX-606,Rheumatology,Placebo,2024-11-02,2024-12-28,6.99,7.36,117,85,76,None,None,Improved,0
4293,PT-04293,35,F,AIIMS Delhi,Phase III,ORX-303,Cardiology,Low Dose,2024-06-06,2024-06-13,7.8,7.22,101,60,89,None,None,Improved,1
4294,PT-04294,25,M,Bhopal Research Hospital,Phase II,ORX-303,Cardiology,High Dose,2024-11-14,2024-11-28,7.54,7.18,121,105,80,Nausea,Moderate,Improved,1
4295,PT-04295,57,F,Apollo Chennai,Phase III,ORX-606,Rheumatology,Low Dose,2023-02-11,2023-02-18,7.54,6.93,127,99,93,None,None,Improved,1
4296,PT-04296,76,M,NIMHANS Bengaluru,Phase II,ORX-404,Neurology,Low Dose,2023-11-20,2023-11-27,7.47,6.28,120,67,88,Headache,None,Improved,1
4297,PT-04297,35,F,Kolkata Clinical Center,Phase I,ORX-202,Diabetes,Placebo,2023-01-15,2023-04-15,3.53,5.35,117,75,101,None,None,Improved,0
4298,PT-04298,25,F,Bhopal Research Hospital,Phase IV,ORX-202,Diabetes,High Dose,2023-08-24,2023-11-22,8.56,7.64,104,102,90,Nausea,Mild,Improved,1
4299,PT-04299,59,M,Bhopal Research Hospital,Phase II,ORX-404,Neurology,Placebo,2023-09-25,2023-11-20,7.64,7.78,105,83,64,None,None,Improved,0
4300,PT-04300,22,F,AIIMS Delhi,Phase II,ORX-303,Cardiology,Placebo,2023-04-21,2023-05-05,7.69,8.34,121,79,62,Nausea,None,Improved,0
4301,PT-04301,45,M,AIIMS Delhi,Phase III,ORX-505,Infectious Disease,Low Dose,2024-05-25,2024-08-23,8.11,8.42,137,74,68,None,None,Worsened,0
4302,PT-04302,57,F,Indore Medical Institute,Phase I,ORX-606,Rheumatology,Low Dose,2024-06-01,2024-08-30,8.17,7.62,120,96,72,None,None,No Change,0
4303,PT-04303,56,M,Bhopal Research Hospital,Phase III,ORX-303,Cardiology,High Dose,2023-04-07,2023-06-02,7.04,5.69,157,83,68,None,None,Improved,1
4304,PT-04304,22,F,Bhopal Research Hospital,Phase IV,ORX-303,Cardiology,High Dose,2023-09-16,2023-11-11,5.65,4.92,162,74,98,None,None,Improved,1
4305,PT-04305,42,M,Fortis Mumbai,Phase III,ORX-101,Oncology,Low Dose,2024-03-16,2024-04-13,5.78,4.96,104,71,65,None,None,Improved,1
4306,PT-04306,18,M,NIMHANS Bengaluru,Phase III,ORX-606,Rheumatology,Low Dose,2024-01-13,2024-02-10,9.02,8.81,115,84,66,Headache,Mild,Improved,1
4307,PT-04307,18,M,Kolkata Clinical Center,Phase III,ORX-505,Infectious Disease,Placebo,2024-09-01,2024-11-30,10.75,10.52,117,58,57,None,None,Improved,1
4308,PT-04308,71,M,Apollo Chennai,Phase III,ORX-404,Neurology,Placebo,2024-02-06,2024-03-05,9.0,9.28,107,100,84,None,None,No Change,0
4309,PT-04309,55,M,NIMHANS Bengaluru,Phase III,ORX-101,Oncology,High Dose,2024-05-12,2024-06-09,7.74,5.98,106,75,87,None,None,No Change,0
4310,PT-04310,22,F,Fortis Mumbai,Phase II,ORX-101,Oncology,High Dose,2024-03-21,2024-03-28,6.99,6.43,142,90,63,None,None,Improved,1
4311,PT-04311,68,M,PGI Chandigarh,Phase II,ORX-404,Neurology,Placebo,2023-07-22,2023-08-05,5.8,6.39,118,83,81,None,None,No Change,0
4312,PT-04312,48,M,Apollo Chennai,Phase III,ORX-505,Infectious Disease,Placebo,2023-05-06,2023-06-03,8.01,7.96,142,87,60,Rash,Mild,Improved,1
4313,PT-04313,49,F,AIIMS Delhi,Phase II,ORX-606,Rheumatology,Low Dose,2023-05-25,2023-07-20,6.52,5.13,122,84,81,None,None,Improved,1
4314,PT-04314,61,M,Fortis Mumbai,Phase III,ORX-606,Rheumatology,High Dose,2023-06-26,2023-07-03,8.77,8.67,137,83,88,None,None,Improved,1
4315,PT-04315,52,M,Apollo Chennai,Phase II,ORX-303,Cardiology,Placebo,2024-11-10,2024-11-24,7.13,8.67,118,99,59,None,None,No Change,0
4316,PT-04316,58,M,Apollo Chennai,Phase III,ORX-202,Diabetes,Low Dose,2023-06-12,2023-08-07,8.92,6.81,130,90,81,None,None,Improved,1
4317,PT-04317,51,F,Kolkata Clinical Center,Phase I,ORX-606,Rheumatology,Low Dose,2023-10-26,2023-12-21,7.36,5.98,170,75,84,None,None,Worsened,0
4318,PT-04318,34,M,Fortis Mumbai,Phase III,ORX-404,Neurology,Low Dose,2024-04-02,2024-05-28,4.47,3.24,101,95,69,Nausea,None,No Change,0
4319,PT-04319,36,F,Apollo Chennai,Phase II,ORX-101,Oncology,Placebo,2024-05-15,2024-06-12,5.92,5.61,115,93,82,None,None,No Change,0
4320,PT-04320,35,F,Fortis Mumbai,Phase III,ORX-606,Rheumatology,High Dose,2023-01-05,2023-02-02,8.22,7.83,128,64,77,Nausea,Moderate,Improved,1
4321,PT-04321,50,M,Indore Medical Institute,Phase III,ORX-202,Diabetes,Placebo,2023-05-07,2023-05-21,8.8,7.72,169,88,56,None,None,Worsened,0
4322,PT-04322,31,M,Fortis Mumbai,Phase II,ORX-101,Oncology,High Dose,2024-07-21,2024-10-19,8.91,9.62,128,83,61,None,None,Improved,0
4323,PT-04323,66,F,Bhopal Research Hospital,Phase III,ORX-505,Infectious Disease,Placebo,2024-02-12,2024-04-08,6.01,6.37,152,82,91,Rash,None,Improved,0
4324,PT-04324,74,F,Indore Medical Institute,Phase I,ORX-101,Oncology,High Dose,2023-08-16,2023-11-14,7.52,6.96,126,73,67,Headache,Moderate,Improved,1
4325,PT-04325,52,F,Bhopal Research Hospital,Phase IV,ORX-101,Oncology,Low Dose,2024-11-15,2024-11-29,7.0,6.9,101,80,92,None,None,No Change,0
4326,PT-04326,27,M,Apollo Chennai,Phase II,ORX-303,Cardiology,High Dose,2023-11-22,2024-02-20,7.22,5.15,104,91,73,None,None,No Change,0
4327,PT-04327,74,F,Indore Medical Institute,Phase III,ORX-505,Infectious Disease,Low Dose,2023-07-07,2023-07-21,7.72,7.8,108,77,67,None,None,No Change,0
4328,PT-04328,27,F,AIIMS Delhi,Phase II,ORX-404,Neurology,High Dose,2024-10-30,2024-11-13,8.0,8.37,135,72,82,None,None,No Change,0
4329,PT-04329,18,F,AIIMS Delhi,Phase III,ORX-202,Diabetes,High Dose,2023-12-11,2023-12-18,8.79,7.22,107,83,80,Nausea,Mild,No Change,0
4330,PT-04330,43,F,Bhopal Research Hospital,Phase IV,ORX-202,Diabetes,Low Dose,2024-03-01,2024-03-15,5.87,6.49,97,64,76,None,None,Improved,0
4331,PT-04331,24,M,Kolkata Clinical Center,Phase I,ORX-505,Infectious Disease,High Dose,2024-05-23,2024-05-30,8.67,7.21,156,94,95,Headache,Moderate,Improved,1
4332,PT-04332,75,M,Kolkata Clinical Center,Phase I,ORX-606,Rheumatology,Low Dose,2024-03-08,2024-06-06,7.3,5.99,126,75,68,Dizziness,None,Improved,1
4333,PT-04333,47,M,Bhopal Research Hospital,Phase III,ORX-404,Neurology,Low Dose,2024-11-20,2024-12-04,6.83,5.75,123,88,91,None,None,Improved,1
4334,PT-04334,19,M,Apollo Chennai,Phase III,ORX-101,Oncology,Low Dose,2024-04-09,2024-04-16,6.84,6.31,106,80,80,Headache,Mild,Worsened,0
4335,PT-04335,53,M,AIIMS Delhi,Phase III,ORX-101,Oncology,High Dose,2023-12-16,2024-02-10,7.29,6.1,164,91,85,Rash,None,Improved,1
4336,PT-04336,61,M,Fortis Mumbai,Phase IV,ORX-404,Neurology,Placebo,2023-12-01,2024-01-26,7.49,8.25,129,82,86,Headache,Moderate,No Change,0
4337,PT-04337,70,M,AIIMS Delhi,Phase I,ORX-404,Neurology,Placebo,2023-05-01,2023-05-29,9.01,9.15,137,90,91,None,None,Worsened,0
4338,PT-04338,65,M,Kolkata Clinical Center,Phase II,ORX-606,Rheumatology,High Dose,2023-12-02,2023-12-30,6.92,7.7,134,89,97,None,None,Improved,0
4339,PT-04339,56,M,Fortis Mumbai,Phase III,ORX-404,Neurology,High Dose,2024-01-12,2024-02-09,8.3,7.55,154,90,79,None,None,Improved,1
4340,PT-04340,62,F,PGI Chandigarh,Phase III,ORX-505,Infectious Disease,Placebo,2024-07-13,2024-07-20,10.31,8.85,113,114,83,Rash,Moderate,Improved,1
4341,PT-04341,48,M,Fortis Mumbai,Phase III,ORX-404,Neurology,Placebo,2024-02-25,2024-05-25,7.06,7.75,175,74,76,None,None,No Change,0
4342,PT-04342,39,F,PGI Chandigarh,Phase II,ORX-606,Rheumatology,Placebo,2023-12-11,2024-03-10,8.08,8.78,157,91,113,None,None,Improved,0
4343,PT-04343,35,M,Kolkata Clinical Center,Phase I,ORX-606,Rheumatology,Low Dose,2023-02-02,2023-05-03,6.2,7.12,130,65,73,Headache,None,No Change,0
4344,PT-04344,49,M,Bhopal Research Hospital,Phase I,ORX-202,Diabetes,High Dose,2024-08-24,2024-11-22,6.42,5.11,124,69,86,None,None,Improved,1
4345,PT-04345,18,M,PGI Chandigarh,Phase I,ORX-606,Rheumatology,Low Dose,2024-03-06,2024-04-03,7.31,7.38,126,95,58,None,None,Improved,0
4346,PT-04346,33,F,Bhopal Research Hospital,Phase III,ORX-505,Infectious Disease,High Dose,2023-08-02,2023-08-30,6.8,7.05,131,107,66,Rash,None,Improved,0
4347,PT-04347,22,M,NIMHANS Bengaluru,Phase III,ORX-101,Oncology,High Dose,2023-08-01,2023-08-08,9.35,7.66,140,70,49,Headache,None,Worsened,0
4348,PT-04348,39,F,Apollo Chennai,Phase II,ORX-202,Diabetes,Placebo,2023-04-07,2023-05-05,8.28,6.78,138,91,60,None,None,Improved,1
4349,PT-04349,41,M,Indore Medical Institute,Phase II,ORX-101,Oncology,Low Dose,2024-04-04,2024-04-11,9.09,9.28,123,86,68,Nausea,None,No Change,0
4350,PT-04350,62,F,Bhopal Research Hospital,Phase I,ORX-505,Infectious Disease,High Dose,2024-08-09,2024-09-06,8.54,8.24,132,70,59,None,None,Improved,1
4351,PT-04351,38,M,PGI Chandigarh,Phase I,ORX-404,Neurology,High Dose,2023-08-27,2023-09-24,7.1,7.65,144,84,94,None,None,Improved,0
4352,PT-04352,29,M,PGI Chandigarh,Phase II,ORX-101,Oncology,Low Dose,2024-03-18,2024-04-01,8.49,7.38,150,81,50,None,None,Improved,1
4353,PT-04353,56,M,Indore Medical Institute,Phase III,ORX-202,Diabetes,High Dose,2024-06-23,2024-08-18,8.17,7.36,121,80,51,None,None,Improved,1
4354,PT-04354,18,F,NIMHANS Bengaluru,Phase III,ORX-101,Oncology,Placebo,2024-08-18,2024-09-01,8.76,7.62,161,98,99,None,None,Worsened,0
4355,PT-04355,34,F,Fortis Mumbai,Phase III,ORX-101,Oncology,High Dose,2024-08-16,2024-08-23,5.27,3.89,119,53,71,None,None,Improved,1
4356,PT-04356,41,F,AIIMS Delhi,Phase II,ORX-606,Rheumatology,Low Dose,2024-11-29,2025-02-27,5.65,4.31,124,86,65,Rash,None,Worsened,0
4357,PT-04357,49,F,Bhopal Research Hospital,Phase II,ORX-303,Cardiology,Low Dose,2024-06-19,2024-09-17,7.36,7.01,116,65,101,Rash,None,No Change,0
4358,PT-04358,55,M,Apollo Chennai,Phase III,ORX-101,Oncology,Low Dose,2023-04-19,2023-05-17,8.41,7.93,125,87,52,None,None,Worsened,0
4359,PT-04359,27,M,Fortis Mumbai,Phase II,ORX-101,Oncology,Placebo,2024-05-27,2024-06-24,6.24,5.43,112,85,79,Fatigue,Severe,Worsened,0
4360,PT-04360,67,F,Apollo Chennai,Phase II,ORX-404,Neurology,Placebo,2024-04-26,2024-05-24,10.17,8.63,130,83,77,Fatigue,None,Improved,1
4361,PT-04361,27,F,PGI Chandigarh,Phase III,ORX-303,Cardiology,High Dose,2023-11-22,2023-11-29,6.1,5.92,110,83,74,None,None,Improved,1
4362,PT-04362,47,M,Indore Medical Institute,Phase II,ORX-101,Oncology,Low Dose,2023-04-03,2023-05-29,6.06,5.8,112,83,96,Fatigue,None,Improved,1
4363,PT-04363,49,F,Indore Medical Institute,Phase I,ORX-101,Oncology,Placebo,2023-05-09,2023-07-04,7.59,7.92,102,102,63,None,None,Improved,0
4364,PT-04364,59,M,Bhopal Research Hospital,Phase III,ORX-404,Neurology,Placebo,2023-09-08,2023-10-06,8.1,6.88,146,87,104,None,None,Improved,1
4365,PT-04365,48,F,Indore Medical Institute,Phase II,ORX-101,Oncology,Low Dose,2024-11-12,2024-12-10,7.07,6.21,96,78,74,None,None,Improved,1
4366,PT-04366,49,F,Kolkata Clinical Center,Phase III,ORX-505,Infectious Disease,High Dose,2023-06-02,2023-06-30,5.49,4.88,138,90,51,None,None,Improved,1
4367,PT-04367,56,F,AIIMS Delhi,Phase II,ORX-303,Cardiology,High Dose,2023-03-13,2023-03-20,6.9,6.34,90,99,80,Fever,None,Improved,1
4368,PT-04368,20,F,NIMHANS Bengaluru,Phase III,ORX-202,Diabetes,Placebo,2024-06-24,2024-07-08,7.65,7.56,150,78,78,Dizziness,None,Improved,1
4369,PT-04369,34,F,Fortis Mumbai,Phase IV,ORX-202,Diabetes,High Dose,2023-03-23,2023-05-18,7.92,6.81,111,81,60,None,None,Worsened,0
4370,PT-04370,70,M,PGI Chandigarh,Phase II,ORX-101,Oncology,Low Dose,2023-12-13,2024-03-12,9.51,8.7,103,86,71,None,None,Improved,1
4371,PT-04371,63,F,AIIMS Delhi,Phase II,ORX-101,Oncology,High Dose,2024-05-22,2024-06-19,6.26,6.35,130,73,81,None,None,Improved,0
4372,PT-04372,59,M,NIMHANS Bengaluru,Phase I,ORX-303,Cardiology,Low Dose,2023-11-19,2023-11-26,7.3,6.99,112,95,92,Headache,Mild,Improved,1
4373,PT-04373,38,F,Apollo Chennai,Phase I,ORX-404,Neurology,High Dose,2024-10-30,2024-11-06,7.05,7.92,107,89,70,Nausea,None,Worsened,0
4374,PT-04374,73,F,Apollo Chennai,Phase III,ORX-606,Rheumatology,Placebo,2024-12-01,2024-12-08,7.28,8.01,114,67,74,None,None,Worsened,0
4375,PT-04375,49,M,NIMHANS Bengaluru,Phase III,ORX-505,Infectious Disease,High Dose,2023-11-25,2024-01-20,6.59,6.87,124,57,85,None,None,No Change,0
4376,PT-04376,30,M,Fortis Mumbai,Phase IV,ORX-101,Oncology,High Dose,2023-11-27,2023-12-25,6.77,7.76,159,75,86,None,None,No Change,0
4377,PT-04377,36,F,Fortis Mumbai,Phase II,ORX-606,Rheumatology,Placebo,2024-11-01,2025-01-30,6.86,5.91,96,83,82,None,None,Improved,1
4378,PT-04378,34,F,NIMHANS Bengaluru,Phase I,ORX-505,Infectious Disease,High Dose,2023-06-09,2023-07-07,8.51,7.71,116,88,56,None,None,No Change,0
4379,PT-04379,59,F,PGI Chandigarh,Phase III,ORX-101,Oncology,Placebo,2023-01-05,2023-04-05,6.72,7.21,151,89,66,None,None,Improved,0
4380,PT-04380,24,M,NIMHANS Bengaluru,Phase III,ORX-505,Infectious Disease,Low Dose,2024-04-03,2024-05-01,5.48,6.07,125,74,76,Headache,None,No Change,0
4381,PT-04381,62,M,PGI Chandigarh,Phase II,ORX-101,Oncology,Low Dose,2024-05-09,2024-08-07,8.13,8.13,139,84,82,None,None,Improved,1
4382,PT-04382,48,F,AIIMS Delhi,Phase III,ORX-404,Neurology,Low Dose,2023-02-20,2023-04-17,7.2,7.48,134,71,85,Headache,Mild,Worsened,0
4383,PT-04383,48,M,NIMHANS Bengaluru,Phase II,ORX-606,Rheumatology,Placebo,2024-09-03,2024-10-01,7.93,7.44,142,81,88,None,None,Worsened,0
4384,PT-04384,37,F,Kolkata Clinical Center,Phase II,ORX-505,Infectious Disease,Low Dose,2024-09-18,2024-09-25,6.74,6.88,122,108,85,None,None,Improved,0
4385,PT-04385,45,M,Apollo Chennai,Phase II,ORX-101,Oncology,High Dose,2023-06-03,2023-06-10,8.18,7.35,144,92,95,Nausea,Mild,Improved,1
4386,PT-04386,37,M,AIIMS Delhi,Phase III,ORX-202,Diabetes,Placebo,2023-03-25,2023-04-08,5.73,4.78,122,102,108,None,None,Improved,1
4387,PT-04387,50,M,Apollo Chennai,Phase II,ORX-505,Infectious Disease,High Dose,2024-03-15,2024-03-22,7.21,6.5,142,108,103,Headache,Mild,Improved,1
4388,PT-04388,63,F,Fortis Mumbai,Phase I,ORX-202,Diabetes,Low Dose,2024-05-21,2024-06-04,8.55,8.9,127,73,77,None,None,Improved,0
4389,PT-04389,51,F,Kolkata Clinical Center,Phase II,ORX-303,Cardiology,Placebo,2023-04-14,2023-05-12,5.46,4.92,113,94,70,None,None,No Change,0
4390,PT-04390,50,F,Kolkata Clinical Center,Phase II,ORX-505,Infectious Disease,Placebo,2024-05-07,2024-06-04,6.36,7.4,97,87,60,Nausea,None,Improved,0
4391,PT-04391,36,F,Indore Medical Institute,Phase I,ORX-606,Rheumatology,Low Dose,2024-08-03,2024-08-17,7.45,7.28,132,83,69,Rash,None,No Change,0
4392,PT-04392,42,M,PGI Chandigarh,Phase IV,ORX-303,Cardiology,High Dose,2024-12-01,2025-03-01,7.24,7.01,126,90,79,Nausea,Severe,Improved,1
4393,PT-04393,48,M,AIIMS Delhi,Phase II,ORX-404,Neurology,Placebo,2024-08-22,2024-09-19,6.74,5.39,130,96,84,None,None,Improved,1
4394,PT-04394,31,M,Bhopal Research Hospital,Phase III,ORX-202,Diabetes,Low Dose,2023-03-29,2023-04-12,8.18,7.48,140,77,82,None,None,Improved,1
4395,PT-04395,36,M,Apollo Chennai,Phase II,ORX-101,Oncology,Placebo,2024-05-01,2024-05-29,6.61,4.8,137,86,83,Dizziness,Mild,Improved,1
4396,PT-04396,49,M,NIMHANS Bengaluru,Phase IV,ORX-505,Infectious Disease,Placebo,2024-06-21,2024-07-19,6.29,6.75,145,72,85,Fatigue,None,No Change,0
4397,PT-04397,58,M,AIIMS Delhi,Phase III,ORX-202,Diabetes,Placebo,2023-06-24,2023-07-01,6.64,5.97,137,63,62,Headache,None,No Change,0
4398,PT-04398,29,F,Kolkata Clinical Center,Phase IV,ORX-101,Oncology,High Dose,2024-08-12,2024-09-09,5.04,5.62,92,86,89,Rash,None,Improved,0
4399,PT-04399,40,F,PGI Chandigarh,Phase I,ORX-505,Infectious Disease,High Dose,2024-06-15,2024-06-29,6.4,6.21,128,94,45,None,None,Improved,1
4400,PT-04400,30,M,Bhopal Research Hospital,Phase IV,ORX-404,Neurology,High Dose,2024-07-21,2024-08-04,7.87,7.52,141,85,76,Nausea,None,Improved,1
4401,PT-04401,40,M,PGI Chandigarh,Phase III,ORX-101,Oncology,Low Dose,2023-03-18,2023-05-13,9.99,10.97,136,82,85,None,None,No Change,0
4402,PT-04402,58,M,Apollo Chennai,Phase III,ORX-404,Neurology,Low Dose,2024-10-27,2024-12-22,7.7,6.63,160,84,106,Rash,None,Worsened,0
4403,PT-04403,47,M,Apollo Chennai,Phase II,ORX-404,Neurology,Placebo,2023-09-14,2023-12-13,6.91,7.75,133,83,61,None,None,Improved,0
4404,PT-04404,55,F,Indore Medical Institute,Phase II,ORX-404,Neurology,High Dose,2023-01-16,2023-01-23,6.61,5.81,119,87,56,None,None,Improved,1
4405,PT-04405,41,F,AIIMS Delhi,Phase II,ORX-202,Diabetes,High Dose,2024-07-19,2024-07-26,8.38,6.86,131,74,72,Headache,None,No Change,0
4406,PT-04406,71,M,Apollo Chennai,Phase III,ORX-505,Infectious Disease,High Dose,2023-03-01,2023-03-15,5.22,5.51,119,75,62,None,None,No Change,0
4407,PT-04407,57,F,AIIMS Delhi,Phase III,ORX-303,Cardiology,Low Dose,2023-12-29,2024-01-12,6.97,6.28,129,79,49,Fever,None,Improved,1
4408,PT-04408,37,F,Apollo Chennai,Phase I,ORX-202,Diabetes,High Dose,2024-04-01,2024-04-08,8.27,6.52,108,76,67,None,None,Improved,1
4409,PT-04409,44,F,NIMHANS Bengaluru,Phase I,ORX-202,Diabetes,High Dose,2023-08-27,2023-09-03,5.89,,127,89,95,Headache,None,Improved,1
4410,PT-04410,40,F,Bhopal Research Hospital,Phase III,ORX-505,Infectious Disease,Low Dose,2023-08-14,2023-08-21,9.47,8.9,142,105,79,None,None,No Change,0
4411,PT-04411,23,M,Fortis Mumbai,Phase III,ORX-606,Rheumatology,Placebo,2024-05-14,2024-07-09,7.31,6.36,123,105,60,Fever,None,No Change,0
4412,PT-04412,49,M,Apollo Chennai,Phase III,ORX-101,Oncology,Low Dose,2024-07-05,2024-10-03,6.15,5.47,141,85,74,None,None,Improved,1
4413,PT-04413,34,M,PGI Chandigarh,Phase II,ORX-505,Infectious Disease,Placebo,2024-05-03,2024-05-17,7.58,8.72,111,104,94,None,None,No Change,0
4414,PT-04414,66,F,Fortis Mumbai,Phase III,ORX-202,Diabetes,Placebo,2024-07-26,2024-08-23,7.57,8.22,109,73,88,None,None,Worsened,0
4415,PT-04415,49,F,PGI Chandigarh,Phase IV,ORX-101,Oncology,High Dose,2023-12-03,2023-12-17,7.02,4.37,120,67,84,Nausea,None,No Change,0
4416,PT-04416,41,M,Kolkata Clinical Center,Phase II,ORX-505,Infectious Disease,Low Dose,2023-05-13,2023-05-20,6.45,8.42,146,94,108,Fever,Moderate,No Change,0
4417,PT-04417,57,M,Kolkata Clinical Center,Phase III,ORX-505,Infectious Disease,High Dose,2024-09-11,2024-09-18,6.27,5.08,145,57,76,None,None,No Change,0
4418,PT-04418,18,F,Bhopal Research Hospital,Phase I,ORX-505,Infectious Disease,Low Dose,2024-02-29,2024-05-29,7.32,7.69,133,93,105,Dizziness,Mild,Worsened,0
4419,PT-04419,42,F,PGI Chandigarh,Phase II,ORX-606,Rheumatology,Low Dose,2024-07-05,2024-07-12,10.57,10.36,145,74,100,None,None,No Change,0
4420,PT-04420,61,F,Indore Medical Institute,Phase IV,ORX-303,Cardiology,Placebo,2024-10-13,2024-11-10,8.97,8.61,105,87,54,Fever,Moderate,Worsened,0
4421,PT-04421,39,F,Fortis Mumbai,Phase III,ORX-101,Oncology,Low Dose,2023-06-28,2023-07-05,7.43,9.17,133,83,77,None,None,Improved,0
4422,PT-04422,23,F,Apollo Chennai,Phase III,ORX-101,Oncology,High Dose,2023-01-25,2023-02-01,7.3,7.0,110,67,71,None,None,Improved,1
4423,PT-04423,46,M,Indore Medical Institute,Phase II,ORX-303,Cardiology,High Dose,2024-07-05,2024-07-12,6.65,5.31,133,88,79,None,None,Improved,1
4424,PT-04424,35,M,Fortis Mumbai,Phase III,ORX-404,Neurology,Low Dose,2024-06-15,2024-07-13,7.91,7.34,106,94,82,None,None,Improved,1
4425,PT-04425,43,M,Indore Medical Institute,Phase IV,ORX-101,Oncology,Placebo,2024-02-27,2024-03-26,5.31,4.24,164,63,74,None,None,No Change,0
4426,PT-04426,44,F,Apollo Chennai,Phase II,ORX-303,Cardiology,High Dose,2024-07-02,2024-08-27,7.58,5.84,131,61,79,None,None,Improved,1
4427,PT-04427,34,M,AIIMS Delhi,Phase II,ORX-303,Cardiology,Low Dose,2023-05-18,2023-06-15,6.16,6.51,123,87,85,None,None,Improved,0
4428,PT-04428,65,M,Kolkata Clinical Center,Phase III,ORX-505,Infectious Disease,Low Dose,2023-03-23,2023-03-30,5.75,6.18,128,77,61,None,None,Worsened,0
4429,PT-04429,54,M,NIMHANS Bengaluru,Phase III,ORX-303,Cardiology,Placebo,2024-11-04,2024-12-02,6.09,6.16,162,93,97,Headache,None,Improved,0
4430,PT-04430,33,F,Fortis Mumbai,Phase III,ORX-202,Diabetes,Placebo,2023-01-23,2023-03-20,8.12,6.69,123,102,69,Dizziness,None,Worsened,0
4431,PT-04431,62,F,NIMHANS Bengaluru,Phase II,ORX-606,Rheumatology,Placebo,2024-05-10,2024-07-05,8.42,8.99,105,88,75,Rash,Moderate,Worsened,0
4432,PT-04432,62,M,Apollo Chennai,Phase III,ORX-202,Diabetes,High Dose,2023-05-05,2023-08-03,5.21,5.15,132,58,65,None,None,Improved,1
4433,PT-04433,18,M,NIMHANS Bengaluru,Phase II,ORX-101,Oncology,Low Dose,2023-09-18,2023-10-16,6.33,6.42,131,84,63,Nausea,None,Improved,0
4434,PT-04434,62,M,Fortis Mumbai,Phase II,ORX-101,Oncology,High Dose,2024-07-09,2024-07-23,7.18,6.81,144,70,81,Fatigue,None,Improved,1
4435,PT-04435,51,M,Apollo Chennai,Phase IV,ORX-404,Neurology,Low Dose,2023-10-06,2023-11-03,6.55,6.73,136,80,76,Dizziness,Mild,No Change,0
4436,PT-04436,53,M,Kolkata Clinical Center,Phase III,ORX-606,Rheumatology,High Dose,2024-08-11,2024-08-18,8.15,7.8,148,89,52,None,None,No Change,0
4437,PT-04437,22,F,Fortis Mumbai,Phase IV,ORX-101,Oncology,High Dose,2024-08-11,2024-09-08,8.62,8.0,130,95,77,Fatigue,Moderate,Improved,1
4438,PT-04438,45,F,Apollo Chennai,Phase IV,ORX-505,Infectious Disease,Placebo,2023-10-24,2024-01-22,6.16,6.09,138,75,65,Rash,None,No Change,0
4439,PT-04439,85,M,Kolkata Clinical Center,Phase III,ORX-202,Diabetes,Low Dose,2024-11-13,2025-01-08,7.09,6.07,140,81,62,None,None,Improved,1
4440,PT-04440,52,F,Kolkata Clinical Center,Phase IV,ORX-505,Infectious Disease,Placebo,2023-09-12,2023-10-10,6.18,7.2,136,78,79,None,None,Worsened,0
4441,PT-04441,59,M,Kolkata Clinical Center,Phase IV,ORX-101,Oncology,Low Dose,2024-07-05,2024-10-03,7.42,8.93,148,87,64,None,None,Improved,0
4442,PT-04442,42,F,NIMHANS Bengaluru,Phase III,ORX-101,Oncology,High Dose,2023-03-25,2023-06-23,7.77,6.63,151,70,69,None,None,Improved,1
4443,PT-04443,36,F,Fortis Mumbai,Phase II,ORX-202,Diabetes,Low Dose,2024-11-04,2025-02-02,8.09,,95,95,71,None,None,Improved,1
4444,PT-04444,27,F,Indore Medical Institute,Phase III,ORX-505,Infectious Disease,High Dose,2024-03-06,2024-05-01,6.29,7.44,116,80,71,None,None,Improved,0
4445,PT-04445,25,F,NIMHANS Bengaluru,Phase III,ORX-606,Rheumatology,High Dose,2024-08-28,2024-10-23,6.31,4.74,145,83,112,Nausea,Moderate,Improved,1
4446,PT-04446,33,F,Kolkata Clinical Center,Phase III,ORX-101,Oncology,Placebo,2023-12-30,2024-02-24,6.17,7.15,147,86,62,None,None,No Change,0
4447,PT-04447,72,M,PGI Chandigarh,Phase I,ORX-606,Rheumatology,Placebo,2023-03-29,2023-04-26,7.11,6.33,148,81,61,None,None,Improved,1
4448,PT-04448,45,F,PGI Chandigarh,Phase I,ORX-404,Neurology,High Dose,2023-05-16,2023-06-13,6.26,3.15,112,75,61,Nausea,None,Improved,1
4449,PT-04449,54,F,Fortis Mumbai,Phase IV,ORX-303,Cardiology,Low Dose,2023-12-11,2024-02-05,6.27,6.3,105,92,60,Rash,Mild,Improved,0
4450,PT-04450,18,F,PGI Chandigarh,Phase II,ORX-606,Rheumatology,Placebo,2023-07-08,2023-07-15,8.68,7.51,159,88,89,Fever,None,No Change,0
4451,PT-04451,61,F,Indore Medical Institute,Phase IV,ORX-606,Rheumatology,Low Dose,2024-04-26,2024-06-21,7.34,7.05,151,83,67,Nausea,Mild,Improved,1
4452,PT-04452,54,M,PGI Chandigarh,Phase III,ORX-606,Rheumatology,Low Dose,2024-07-23,2024-09-17,4.66,5.45,152,96,94,Headache,Mild,Improved,0
4453,PT-04453,43,F,AIIMS Delhi,Phase III,ORX-606,Rheumatology,High Dose,2024-03-12,2024-05-07,7.07,5.57,159,76,82,None,None,Improved,1
4454,PT-04454,49,F,Indore Medical Institute,Phase III,ORX-606,Rheumatology,Placebo,2024-04-20,2024-06-15,5.59,3.62,128,76,76,None,None,No Change,0
4455,PT-04455,62,M,Fortis Mumbai,Phase III,ORX-202,Diabetes,High Dose,2023-02-17,2023-02-24,7.47,7.75,136,78,63,Nausea,None,Worsened,0
4456,PT-04456,49,M,Apollo Chennai,Phase III,ORX-404,Neurology,Low Dose,2024-04-23,2024-07-22,7.3,7.72,125,78,74,None,None,Improved,0
4457,PT-04457,30,M,Fortis Mumbai,Phase III,ORX-505,Infectious Disease,High Dose,2024-08-23,2024-08-30,8.94,9.56,106,91,52,Dizziness,None,Improved,0
4458,PT-04458,60,F,Kolkata Clinical Center,Phase I,ORX-202,Diabetes,Low Dose,2023-06-30,2023-07-28,6.36,6.29,93,67,84,None,None,Improved,1
4459,PT-04459,33,M,Kolkata Clinical Center,Phase II,ORX-505,Infectious Disease,Placebo,2024-10-01,2024-12-30,6.19,7.05,167,93,62,None,None,Improved,0
4460,PT-04460,73,M,Bhopal Research Hospital,Phase I,ORX-202,Diabetes,Placebo,2023-11-12,2024-02-10,5.33,4.65,128,105,90,None,None,Improved,1
4461,PT-04461,37,F,AIIMS Delhi,Phase II,ORX-404,Neurology,Low Dose,2023-06-29,2023-07-27,6.07,6.57,118,84,58,None,None,No Change,0
4462,PT-04462,54,M,NIMHANS Bengaluru,Phase I,ORX-606,Rheumatology,Low Dose,2023-12-27,2024-03-26,7.79,6.27,146,88,88,None,None,No Change,0
4463,PT-04463,38,M,Fortis Mumbai,Phase III,ORX-404,Neurology,High Dose,2023-02-10,2023-02-24,7.41,7.07,125,84,95,None,None,Improved,1
4464,PT-04464,62,M,Bhopal Research Hospital,Phase III,ORX-303,Cardiology,Low Dose,2024-01-01,2024-03-31,5.78,6.27,149,80,85,Fever,Mild,Improved,0
4465,PT-04465,52,M,Apollo Chennai,Phase III,ORX-505,Infectious Disease,High Dose,2023-03-02,2023-03-30,6.18,5.44,141,76,91,None,None,No Change,0
4466,PT-04466,65,F,Fortis Mumbai,Phase III,ORX-202,Diabetes,Placebo,2023-10-25,2023-11-08,8.57,9.95,126,84,82,None,None,No Change,0
4467,PT-04467,44,F,Fortis Mumbai,Phase II,ORX-202,Diabetes,Low Dose,2023-11-04,2023-12-30,7.85,5.91,131,65,64,Headache,None,Improved,1
4468,PT-04468,56,F,Apollo Chennai,Phase I,ORX-101,Oncology,High Dose,2023-07-03,2023-08-28,6.96,7.19,124,95,74,None,None,Improved,0
4469,PT-04469,18,M,Apollo Chennai,Phase IV,ORX-101,Oncology,Low Dose,2024-01-02,2024-01-09,7.47,5.12,101,71,63,None,None,Worsened,0
4470,PT-04470,36,M,Kolkata Clinical Center,Phase II,ORX-505,Infectious Disease,Low Dose,2023-10-12,2023-11-09,5.95,4.28,155,73,46,Headache,None,No Change,0
4471,PT-04471,39,F,Kolkata Clinical Center,Phase I,ORX-606,Rheumatology,Low Dose,2023-09-04,2023-12-03,5.85,4.65,140,76,61,None,None,Worsened,0
4472,PT-04472,52,F,Bhopal Research Hospital,Phase IV,ORX-202,Diabetes,High Dose,2024-03-22,2024-05-17,8.58,8.66,90,68,78,None,None,Improved,0
4473,PT-04473,41,F,NIMHANS Bengaluru,Phase III,ORX-505,Infectious Disease,Placebo,2023-10-29,2023-11-05,6.81,5.52,102,106,78,Headache,Moderate,Improved,1
4474,PT-04474,55,M,NIMHANS Bengaluru,Phase III,ORX-303,Cardiology,Placebo,2023-10-16,2023-10-23,7.21,6.85,126,68,56,None,None,No Change,0
4475,PT-04475,51,M,Indore Medical Institute,Phase III,ORX-202,Diabetes,Placebo,2023-01-21,2023-02-18,7.43,7.87,141,72,93,Fatigue,None,Improved,0
4476,PT-04476,57,M,AIIMS Delhi,Phase III,ORX-505,Infectious Disease,High Dose,2023-10-14,2023-10-28,8.03,9.65,164,90,85,None,None,No Change,0
4477,PT-04477,62,M,AIIMS Delhi,Phase IV,ORX-404,Neurology,Low Dose,2024-06-25,2024-07-02,6.5,5.59,140,71,86,None,None,Improved,1
4478,PT-04478,47,F,Bhopal Research Hospital,Phase II,ORX-505,Infectious Disease,Placebo,2023-08-03,2023-08-10,6.17,5.8,151,82,79,None,None,No Change,0
4479,PT-04479,50,M,Fortis Mumbai,Phase III,ORX-303,Cardiology,Low Dose,2023-08-19,2023-08-26,7.75,7.05,134,69,66,None,None,No Change,0
4480,PT-04480,34,M,Bhopal Research Hospital,Phase III,ORX-606,Rheumatology,High Dose,2023-10-09,2024-01-07,7.76,7.51,125,90,83,Fatigue,None,Improved,1
4481,PT-04481,40,F,Kolkata Clinical Center,Phase IV,ORX-202,Diabetes,Placebo,2023-04-17,2023-06-12,5.96,4.82,101,83,65,None,None,Improved,1
4482,PT-04482,37,F,Indore Medical Institute,Phase III,ORX-101,Oncology,High Dose,2023-01-06,2023-01-13,7.05,7.59,144,81,95,Dizziness,Mild,No Change,0
4483,PT-04483,18,F,AIIMS Delhi,Phase II,ORX-202,Diabetes,High Dose,2024-11-24,2024-12-22,9.45,9.68,129,71,71,None,None,Improved,0
4484,PT-04484,54,M,NIMHANS Bengaluru,Phase II,ORX-303,Cardiology,Placebo,2024-08-30,2024-10-25,7.96,8.16,114,70,80,None,None,Worsened,0
4485,PT-04485,57,F,Fortis Mumbai,Phase IV,ORX-202,Diabetes,Low Dose,2023-02-12,2023-03-12,7.2,8.14,128,81,87,None,None,No Change,0
4486,PT-04486,64,M,Indore Medical Institute,Phase IV,ORX-303,Cardiology,Low Dose,2023-03-26,2023-04-23,5.58,4.17,122,119,74,Dizziness,Mild,No Change,0
4487,PT-04487,43,F,NIMHANS Bengaluru,Phase III,ORX-101,Oncology,High Dose,2023-06-04,2023-07-30,7.94,8.42,131,95,61,Headache,Mild,Improved,0
4488,PT-04488,32,F,Kolkata Clinical Center,Phase III,ORX-404,Neurology,Low Dose,2024-03-03,2024-03-10,8.59,8.2,105,66,66,None,None,No Change,0
4489,PT-04489,45,F,PGI Chandigarh,Phase II,ORX-404,Neurology,Low Dose,2023-10-07,2023-10-21,7.76,7.06,134,76,95,None,None,Improved,1
4490,PT-04490,85,F,NIMHANS Bengaluru,Phase III,ORX-505,Infectious Disease,High Dose,2024-11-09,2025-02-07,6.73,6.76,135,83,87,None,None,Improved,0
4491,PT-04491,52,F,Fortis Mumbai,Phase II,ORX-101,Oncology,High Dose,2023-06-13,2023-08-08,6.63,7.42,131,77,112,None,None,No Change,0
4492,PT-04492,43,M,Bhopal Research Hospital,Phase II,ORX-404,Neurology,Placebo,2024-07-23,2024-07-30,7.51,7.26,125,87,66,Nausea,Mild,Worsened,0
4493,PT-04493,54,F,Kolkata Clinical Center,Phase II,ORX-101,Oncology,Low Dose,2024-02-16,2024-04-12,5.09,3.52,160,66,50,None,None,No Change,0
4494,PT-04494,25,F,Fortis Mumbai,Phase IV,ORX-303,Cardiology,High Dose,2023-04-04,2023-05-02,9.29,7.28,110,64,74,None,None,Worsened,0
4495,PT-04495,38,M,Fortis Mumbai,Phase III,ORX-202,Diabetes,High Dose,2024-05-20,2024-05-27,6.62,7.89,106,80,82,None,None,Improved,0
4496,PT-04496,29,F,Bhopal Research Hospital,Phase III,ORX-303,Cardiology,High Dose,2023-08-21,2023-10-16,7.78,7.02,134,80,49,Nausea,Severe,No Change,0
4497,PT-04497,65,M,Fortis Mumbai,Phase III,ORX-505,Infectious Disease,High Dose,2024-03-30,2024-04-06,9.68,9.13,111,100,104,None,None,Improved,1
4498,PT-04498,42,F,Bhopal Research Hospital,Phase III,ORX-303,Cardiology,Placebo,2023-01-06,2023-03-03,6.94,6.47,97,78,102,Nausea,None,Worsened,0
4499,PT-04499,42,M,Bhopal Research Hospital,Phase I,ORX-303,Cardiology,Placebo,2024-01-04,2024-04-03,5.95,6.0,115,81,60,Headache,None,Improved,0
4500,PT-04500,28,F,Bhopal Research Hospital,Phase II,ORX-606,Rheumatology,Placebo,2023-09-15,2023-09-22,8.09,7.79,114,83,69,Headache,None,Worsened,0
4501,PT-04501,32,M,NIMHANS Bengaluru,Phase III,ORX-101,Oncology,Placebo,2024-04-13,2024-05-11,8.6,8.9,127,83,77,None,None,No Change,0
4502,PT-04502,52,M,Kolkata Clinical Center,Phase I,ORX-404,Neurology,Low Dose,2023-07-03,2023-10-01,6.24,6.62,134,78,71,None,None,Improved,0
4503,PT-04503,58,F,NIMHANS Bengaluru,Phase III,ORX-404,Neurology,Low Dose,2023-02-16,2023-04-13,7.02,5.99,121,91,55,None,None,Improved,1
4504,PT-04504,39,M,AIIMS Delhi,Phase III,ORX-202,Diabetes,Low Dose,2023-08-27,2023-09-24,8.48,7.93,132,95,90,None,None,No Change,0
4505,PT-04505,37,M,AIIMS Delhi,Phase I,ORX-101,Oncology,Low Dose,2024-04-08,2024-04-22,7.04,7.46,144,80,77,Nausea,None,No Change,0
4506,PT-04506,49,M,Kolkata Clinical Center,Phase III,ORX-303,Cardiology,High Dose,2023-02-25,2023-05-26,8.84,9.4,140,69,74,None,None,No Change,0
4507,PT-04507,41,M,Fortis Mumbai,Phase II,ORX-303,Cardiology,High Dose,2024-10-05,2024-11-30,8.9,8.29,150,75,71,Rash,Severe,No Change,0
4508,PT-04508,52,M,AIIMS Delhi,Phase I,ORX-303,Cardiology,High Dose,2023-05-13,2023-05-20,9.08,8.49,90,63,82,None,None,Improved,1
4509,PT-04509,21,M,Indore Medical Institute,Phase IV,ORX-202,Diabetes,Low Dose,2024-11-04,2024-11-11,6.16,5.77,90,77,61,Rash,Moderate,No Change,0
4510,PT-04510,21,M,NIMHANS Bengaluru,Phase III,ORX-606,Rheumatology,Placebo,2023-03-05,2023-03-19,6.24,4.88,136,96,72,Dizziness,Mild,Worsened,0
4511,PT-04511,35,M,NIMHANS Bengaluru,Phase II,ORX-404,Neurology,High Dose,2023-03-20,2023-05-15,6.7,5.31,104,62,59,None,None,No Change,0
4512,PT-04512,71,F,PGI Chandigarh,Phase IV,ORX-505,Infectious Disease,High Dose,2023-07-17,2023-09-11,6.37,3.32,117,62,78,None,None,Worsened,0
4513,PT-04513,44,F,NIMHANS Bengaluru,Phase II,ORX-505,Infectious Disease,Low Dose,2023-05-28,2023-06-04,7.27,6.83,121,64,76,None,None,No Change,0
4514,PT-04514,61,F,Indore Medical Institute,Phase II,ORX-404,Neurology,Low Dose,2023-01-19,2023-04-19,9.38,8.76,125,88,98,Rash,None,Improved,1
4515,PT-04515,37,M,Kolkata Clinical Center,Phase III,ORX-101,Oncology,High Dose,2024-07-02,2024-07-16,8.03,6.89,133,93,59,None,None,No Change,0
4516,PT-04516,36,M,Indore Medical Institute,Phase III,ORX-606,Rheumatology,Placebo,2024-02-03,2024-03-02,8.35,8.5,146,92,73,None,None,Improved,0
4517,PT-04517,80,M,Apollo Chennai,Phase IV,ORX-101,Oncology,High Dose,2023-10-11,2023-12-06,7.36,4.21,122,76,89,Headache,None,Improved,1
4518,PT-04518,37,F,Kolkata Clinical Center,Phase I,ORX-101,Oncology,Low Dose,2024-08-01,2024-08-15,8.52,8.62,109,80,67,Nausea,None,Improved,0
4519,PT-04519,47,F,Indore Medical Institute,Phase III,ORX-606,Rheumatology,High Dose,2023-11-19,2024-02-17,6.26,5.93,123,80,106,None,None,No Change,0
4520,PT-04520,39,F,Kolkata Clinical Center,Phase I,ORX-606,Rheumatology,Low Dose,2023-01-25,2023-02-08,4.88,5.39,146,58,68,None,None,No Change,0
4521,PT-04521,51,F,Apollo Chennai,Phase I,ORX-101,Oncology,High Dose,2023-02-18,2023-03-18,7.83,7.42,128,70,45,Rash,Moderate,Worsened,0
4522,PT-04522,77,M,PGI Chandigarh,Phase IV,ORX-404,Neurology,Low Dose,2024-05-08,2024-05-22,6.04,5.8,125,92,79,None,None,Worsened,0
4523,PT-04523,47,M,AIIMS Delhi,Phase III,ORX-404,Neurology,Low Dose,2024-01-27,2024-02-10,4.04,2.89,141,89,64,None,None,Improved,1
4524,PT-04524,19,M,PGI Chandigarh,Phase III,ORX-303,Cardiology,Placebo,2023-01-14,2023-02-11,7.35,4.34,107,103,98,Fever,None,No Change,0
4525,PT-04525,52,F,Indore Medical Institute,Phase III,ORX-101,Oncology,Placebo,2023-06-10,2023-07-08,7.57,5.41,114,78,67,None,None,Improved,1
4526,PT-04526,39,F,Kolkata Clinical Center,Phase III,ORX-606,Rheumatology,High Dose,2023-12-20,2023-12-27,8.76,7.87,121,90,58,None,None,No Change,0
4527,PT-04527,31,M,Fortis Mumbai,Phase IV,ORX-101,Oncology,Low Dose,2024-01-03,2024-01-10,6.31,5.96,121,78,68,None,None,No Change,0
4528,PT-04528,27,M,Indore Medical Institute,Phase IV,ORX-404,Neurology,Placebo,2023-02-12,2023-03-12,7.93,7.23,139,68,68,None,None,No Change,0
4529,PT-04529,41,F,Apollo Chennai,Phase III,ORX-202,Diabetes,High Dose,2023-06-07,2023-08-02,7.05,7.33,120,90,83,Nausea,Mild,Improved,0
4530,PT-04530,43,F,Fortis Mumbai,Phase III,ORX-404,Neurology,Placebo,2024-04-21,2024-07-20,6.06,6.34,111,81,77,Nausea,None,Improved,0
4531,PT-04531,41,F,Apollo Chennai,Phase II,ORX-505,Infectious Disease,Placebo,2023-02-22,2023-03-22,6.73,5.59,98,98,71,None,None,Improved,1
4532,PT-04532,42,M,AIIMS Delhi,Phase III,ORX-303,Cardiology,High Dose,2023-05-07,2023-05-21,7.04,7.62,162,83,75,Nausea,None,Improved,0
4533,PT-04533,27,M,PGI Chandigarh,Phase I,ORX-505,Infectious Disease,High Dose,2023-03-13,2023-06-11,5.47,3.47,113,56,93,None,None,Improved,1
4534,PT-04534,51,F,NIMHANS Bengaluru,Phase IV,ORX-303,Cardiology,Placebo,2024-03-13,2024-04-10,6.9,7.5,108,72,50,None,None,No Change,0
4535,PT-04535,57,F,PGI Chandigarh,Phase IV,ORX-606,Rheumatology,High Dose,2023-10-14,2023-11-11,6.23,5.84,146,98,77,Nausea,None,Worsened,0
4536,PT-04536,51,M,PGI Chandigarh,Phase III,ORX-101,Oncology,High Dose,2024-01-26,2024-02-09,6.12,7.23,125,82,72,Dizziness,None,No Change,0
4537,PT-04537,64,F,Kolkata Clinical Center,Phase III,ORX-404,Neurology,High Dose,2023-09-03,2023-09-10,7.44,7.72,134,79,91,None,None,Improved,0
4538,PT-04538,50,M,Apollo Chennai,Phase III,ORX-202,Diabetes,High Dose,2024-06-14,2024-09-12,6.05,4.76,130,92,100,None,None,No Change,0
4539,PT-04539,18,F,AIIMS Delhi,Phase I,ORX-303,Cardiology,Placebo,2024-11-05,2024-11-19,7.23,7.27,133,94,87,None,None,Improved,0
4540,PT-04540,29,M,Apollo Chennai,Phase III,ORX-505,Infectious Disease,High Dose,2024-01-24,2024-03-20,5.98,5.86,145,83,55,None,None,Improved,1
4541,PT-04541,28,F,NIMHANS Bengaluru,Phase III,ORX-101,Oncology,High Dose,2024-04-20,2024-05-18,8.03,7.32,130,94,61,None,None,Improved,1
4542,PT-04542,38,F,Apollo Chennai,Phase IV,ORX-404,Neurology,Low Dose,2024-01-01,2024-01-15,6.57,6.49,141,64,77,None,None,Worsened,0
4543,PT-04543,58,M,AIIMS Delhi,Phase III,ORX-202,Diabetes,Placebo,2023-02-14,2023-05-15,4.97,4.52,106,74,45,None,None,Improved,1
4544,PT-04544,67,M,Kolkata Clinical Center,Phase II,ORX-101,Oncology,Low Dose,2024-04-22,2024-05-20,6.77,5.65,133,69,62,Headache,None,Improved,1
4545,PT-04545,69,M,NIMHANS Bengaluru,Phase I,ORX-202,Diabetes,Low Dose,2024-06-24,2024-07-08,9.37,8.44,147,86,58,Nausea,Moderate,Improved,1
4546,PT-04546,30,F,NIMHANS Bengaluru,Phase I,ORX-404,Neurology,High Dose,2024-05-31,2024-08-29,9.06,7.38,169,75,100,Fatigue,None,Improved,1
4547,PT-04547,40,M,AIIMS Delhi,Phase II,ORX-303,Cardiology,Placebo,2024-11-19,2024-12-17,8.16,,153,74,65,None,None,Improved,0
4548,PT-04548,43,M,Bhopal Research Hospital,Phase III,ORX-606,Rheumatology,Low Dose,2023-05-18,2023-06-01,5.64,5.45,113,94,70,None,None,No Change,0
4549,PT-04549,18,F,Kolkata Clinical Center,Phase IV,ORX-101,Oncology,Placebo,2023-02-12,2023-05-13,8.88,8.65,128,95,90,None,None,Improved,1
4550,PT-04550,32,M,PGI Chandigarh,Phase III,ORX-606,Rheumatology,Placebo,2024-06-27,2024-08-22,6.66,5.26,101,88,83,None,None,No Change,0
4551,PT-04551,57,F,Apollo Chennai,Phase IV,ORX-202,Diabetes,Placebo,2023-11-22,2024-02-20,8.74,9.03,143,57,73,Headache,Moderate,Improved,0
4552,PT-04552,60,M,AIIMS Delhi,Phase II,ORX-101,Oncology,Placebo,2024-11-17,2025-02-15,5.8,5.48,137,87,83,None,None,No Change,0
4553,PT-04553,54,F,NIMHANS Bengaluru,Phase III,ORX-303,Cardiology,Placebo,2024-10-17,2025-01-15,7.42,5.7,137,85,57,None,None,Worsened,0
4554,PT-04554,67,F,Indore Medical Institute,Phase II,ORX-505,Infectious Disease,Low Dose,2024-07-23,2024-07-30,7.84,6.2,113,75,70,None,None,No Change,0
4555,PT-04555,49,M,PGI Chandigarh,Phase IV,ORX-606,Rheumatology,High Dose,2023-09-04,2023-10-30,6.03,6.64,146,89,78,None,None,Improved,0
4556,PT-04556,59,F,Bhopal Research Hospital,Phase I,ORX-303,Cardiology,High Dose,2023-11-24,2024-01-19,6.87,5.82,149,85,68,Nausea,None,Improved,1
4557,PT-04557,38,F,Bhopal Research Hospital,Phase II,ORX-303,Cardiology,High Dose,2023-05-03,2023-06-28,6.32,7.74,128,83,88,None,None,No Change,0
4558,PT-04558,25,M,Fortis Mumbai,Phase II,ORX-606,Rheumatology,Placebo,2023-07-21,2023-07-28,8.52,7.57,160,78,92,None,None,Improved,1
4559,PT-04559,18,F,Indore Medical Institute,Phase II,ORX-303,Cardiology,Low Dose,2024-09-23,2024-11-18,5.79,5.13,91,89,82,None,None,Improved,1
4560,PT-04560,29,F,Kolkata Clinical Center,Phase III,ORX-505,Infectious Disease,Placebo,2024-02-15,2024-03-14,7.18,7.51,90,66,73,Headache,None,Worsened,0
4561,PT-04561,45,F,NIMHANS Bengaluru,Phase II,ORX-202,Diabetes,Placebo,2024-09-21,2024-11-16,7.13,7.53,136,90,58,None,None,Improved,0
4562,PT-04562,47,F,AIIMS Delhi,Phase II,ORX-303,Cardiology,High Dose,2024-11-10,2024-12-08,6.83,7.75,131,73,89,None,None,Improved,0
4563,PT-04563,54,F,AIIMS Delhi,Phase III,ORX-505,Infectious Disease,Placebo,2024-09-13,2024-09-20,6.21,5.5,122,96,80,None,None,Worsened,0
4564,PT-04564,56,F,Fortis Mumbai,Phase III,ORX-101,Oncology,Low Dose,2023-01-25,2023-02-01,6.61,6.51,151,77,79,Headache,None,Improved,1
4565,PT-04565,23,M,Apollo Chennai,Phase III,ORX-505,Infectious Disease,Low Dose,2024-07-04,2024-10-02,6.28,5.58,108,97,66,None,None,Improved,1
4566,PT-04566,57,M,NIMHANS Bengaluru,Phase III,ORX-202,Diabetes,Placebo,2024-10-24,2024-11-21,7.42,7.05,154,54,75,None,None,Improved,1
4567,PT-04567,27,F,NIMHANS Bengaluru,Phase II,ORX-404,Neurology,High Dose,2023-03-03,2023-03-17,4.85,3.37,128,73,90,None,None,Improved,1
4568,PT-04568,41,F,Indore Medical Institute,Phase III,ORX-505,Infectious Disease,High Dose,2023-07-25,2023-09-19,6.81,,126,76,66,None,None,No Change,0
4569,PT-04569,60,F,AIIMS Delhi,Phase III,ORX-404,Neurology,Placebo,2023-08-26,2023-09-23,6.45,5.71,135,85,65,None,None,Improved,1
4570,PT-04570,57,M,AIIMS Delhi,Phase III,ORX-404,Neurology,Low Dose,2023-10-20,2023-12-15,7.85,7.61,120,77,75,None,None,No Change,0
4571,PT-04571,25,F,Indore Medical Institute,Phase I,ORX-505,Infectious Disease,High Dose,2023-03-27,2023-04-03,7.15,7.56,143,77,92,None,None,Improved,0
4572,PT-04572,75,F,PGI Chandigarh,Phase II,ORX-303,Cardiology,Low Dose,2023-11-15,2023-11-29,6.82,7.04,90,66,79,None,None,Improved,0
4573,PT-04573,28,F,AIIMS Delhi,Phase IV,ORX-606,Rheumatology,High Dose,2024-05-17,2024-06-14,9.65,9.79,145,81,63,Nausea,None,Worsened,0
4574,PT-04574,36,M,PGI Chandigarh,Phase IV,ORX-202,Diabetes,High Dose,2023-05-14,2023-06-11,7.51,6.53,140,90,78,None,None,No Change,0
4575,PT-04575,18,F,Apollo Chennai,Phase III,ORX-101,Oncology,Low Dose,2023-07-23,2023-08-06,9.26,8.67,176,89,75,Fever,None,Improved,1
4576,PT-04576,52,F,Bhopal Research Hospital,Phase III,ORX-101,Oncology,High Dose,2023-03-02,2023-05-31,4.78,5.3,174,56,73,None,None,No Change,0
4577,PT-04577,43,M,Kolkata Clinical Center,Phase IV,ORX-101,Oncology,Placebo,2023-09-16,2023-09-23,8.25,9.75,134,107,80,None,None,No Change,0
4578,PT-04578,52,M,AIIMS Delhi,Phase III,ORX-202,Diabetes,High Dose,2024-03-06,2024-04-03,7.59,8.29,120,91,60,Rash,Mild,Improved,0
4579,PT-04579,40,F,NIMHANS Bengaluru,Phase II,ORX-606,Rheumatology,High Dose,2023-12-31,2024-01-07,6.44,6.12,122,95,65,Fever,None,No Change,0
4580,PT-04580,18,F,Fortis Mumbai,Phase III,ORX-101,Oncology,Placebo,2024-02-26,2024-03-04,5.57,6.07,110,86,73,None,None,Improved,0
4581,PT-04581,58,F,Kolkata Clinical Center,Phase II,ORX-303,Cardiology,Low Dose,2024-10-16,2025-01-14,6.92,9.01,162,78,71,None,None,Improved,0
4582,PT-04582,85,M,Bhopal Research Hospital,Phase I,ORX-606,Rheumatology,Low Dose,2023-11-27,2023-12-11,5.91,5.46,128,81,53,Fever,Mild,Worsened,0
4583,PT-04583,52,M,Indore Medical Institute,Phase III,ORX-101,Oncology,Low Dose,2023-10-08,2023-10-22,6.04,6.93,101,82,46,Nausea,Mild,Improved,0
4584,PT-04584,18,M,Kolkata Clinical Center,Phase III,ORX-404,Neurology,High Dose,2023-10-29,2023-11-26,6.19,5.16,154,81,96,Headache,Severe,Improved,1
4585,PT-04585,38,F,Kolkata Clinical Center,Phase II,ORX-505,Infectious Disease,Low Dose,2024-05-25,2024-06-22,7.93,6.87,113,60,82,None,None,Worsened,0
4586,PT-04586,49,F,AIIMS Delhi,Phase IV,ORX-303,Cardiology,Low Dose,2024-02-07,2024-03-06,8.13,7.93,164,84,91,None,None,Worsened,0
4587,PT-04587,39,M,Fortis Mumbai,Phase III,ORX-101,Oncology,Low Dose,2023-01-11,2023-03-08,6.11,6.36,126,91,82,Fatigue,Mild,Improved,0
4588,PT-04588,32,M,Kolkata Clinical Center,Phase I,ORX-505,Infectious Disease,Placebo,2023-06-27,2023-09-25,8.49,7.31,139,97,72,Nausea,None,Improved,1
4589,PT-04589,63,F,AIIMS Delhi,Phase III,ORX-101,Oncology,Placebo,2023-05-10,2023-07-05,7.68,8.04,112,84,58,None,None,Improved,0
4590,PT-04590,72,F,Indore Medical Institute,Phase IV,ORX-202,Diabetes,Placebo,2024-08-29,2024-09-05,4.78,4.06,111,90,104,Nausea,None,Improved,1
4591,PT-04591,55,M,Fortis Mumbai,Phase II,ORX-202,Diabetes,Placebo,2023-12-26,2024-02-20,10.75,9.11,104,71,79,None,None,Improved,1
4592,PT-04592,28,M,Apollo Chennai,Phase IV,ORX-303,Cardiology,Placebo,2023-09-29,2023-10-27,6.3,6.46,105,68,72,Fatigue,Mild,Improved,0
4593,PT-04593,40,M,Apollo Chennai,Phase III,ORX-101,Oncology,High Dose,2023-09-03,2023-12-02,8.41,7.2,115,88,89,Nausea,None,Improved,1
4594,PT-04594,67,F,Fortis Mumbai,Phase III,ORX-303,Cardiology,Low Dose,2024-04-28,2024-05-12,7.76,7.48,138,78,74,Headache,None,Worsened,0
4595,PT-04595,18,M,Bhopal Research Hospital,Phase I,ORX-101,Oncology,Placebo,2023-11-12,2023-11-26,8.27,8.06,141,50,77,Nausea,None,Improved,1
4596,PT-04596,31,F,Kolkata Clinical Center,Phase II,ORX-505,Infectious Disease,Low Dose,2023-08-11,2023-10-06,9.0,9.15,132,76,83,None,None,No Change,0
4597,PT-04597,30,F,Indore Medical Institute,Phase I,ORX-404,Neurology,Placebo,2024-01-15,2024-01-22,7.08,6.16,168,99,92,Dizziness,None,No Change,0
4598,PT-04598,21,M,NIMHANS Bengaluru,Phase II,ORX-202,Diabetes,High Dose,2024-11-03,2024-11-17,8.24,8.01,150,85,77,None,None,Improved,1
4599,PT-04599,48,M,Kolkata Clinical Center,Phase I,ORX-505,Infectious Disease,Low Dose,2023-09-19,2023-11-14,5.03,3.94,134,95,70,None,None,Improved,1
4600,PT-04600,44,M,Kolkata Clinical Center,Phase III,ORX-404,Neurology,High Dose,2023-06-16,2023-06-30,5.28,6.19,148,89,83,Nausea,Moderate,No Change,0
4601,PT-04601,69,M,Bhopal Research Hospital,Phase II,ORX-505,Infectious Disease,Low Dose,2023-10-11,2023-11-08,6.23,5.01,147,93,61,Headache,Mild,Improved,1
4602,PT-04602,36,M,PGI Chandigarh,Phase IV,ORX-404,Neurology,High Dose,2024-08-05,2024-08-19,9.23,9.2,142,68,87,None,None,Improved,1
4603,PT-04603,22,M,Indore Medical Institute,Phase III,ORX-101,Oncology,Low Dose,2023-12-27,2024-01-03,4.82,5.08,153,78,70,Headache,None,Improved,0
4604,PT-04604,72,F,Kolkata Clinical Center,Phase IV,ORX-505,Infectious Disease,High Dose,2024-05-20,2024-05-27,6.97,6.51,158,77,68,None,None,Improved,1
4605,PT-04605,58,M,Apollo Chennai,Phase II,ORX-101,Oncology,High Dose,2024-04-01,2024-06-30,6.35,5.82,104,84,78,None,None,Worsened,0
4606,PT-04606,60,M,Kolkata Clinical Center,Phase III,ORX-303,Cardiology,High Dose,2023-03-07,2023-06-05,8.23,8.33,135,81,86,Headache,Moderate,No Change,0
4607,PT-04607,27,F,Indore Medical Institute,Phase II,ORX-202,Diabetes,Placebo,2023-01-21,2023-01-28,4.38,5.03,140,80,93,None,None,No Change,0
4608,PT-04608,33,F,PGI Chandigarh,Phase II,ORX-505,Infectious Disease,High Dose,2024-04-20,2024-04-27,6.35,5.19,138,63,67,None,None,No Change,0
4609,PT-04609,49,M,Apollo Chennai,Phase IV,ORX-505,Infectious Disease,High Dose,2023-02-24,2023-04-21,5.76,4.76,90,89,68,Nausea,None,Improved,1
4610,PT-04610,27,M,NIMHANS Bengaluru,Phase IV,ORX-505,Infectious Disease,Placebo,2024-07-23,2024-09-17,5.65,4.87,99,105,45,Fatigue,Mild,No Change,0
4611,PT-04611,37,F,NIMHANS Bengaluru,Phase II,ORX-202,Diabetes,Placebo,2024-06-11,2024-09-09,7.33,6.23,131,72,99,None,None,Improved,1
4612,PT-04612,27,M,PGI Chandigarh,Phase III,ORX-202,Diabetes,High Dose,2023-07-31,2023-10-29,4.38,2.81,134,80,88,Fatigue,None,Improved,1
4613,PT-04613,53,F,Apollo Chennai,Phase III,ORX-606,Rheumatology,Placebo,2024-10-28,2024-11-25,6.44,5.6,121,104,87,Nausea,Moderate,Improved,1
4614,PT-04614,75,M,NIMHANS Bengaluru,Phase III,ORX-606,Rheumatology,Placebo,2024-11-25,2025-02-23,8.21,7.75,109,84,77,Headache,Mild,Worsened,0
4615,PT-04615,43,M,Apollo Chennai,Phase III,ORX-505,Infectious Disease,Placebo,2024-08-11,2024-08-25,6.95,4.7,150,81,58,None,None,No Change,0
4616,PT-04616,52,M,Kolkata Clinical Center,Phase III,ORX-202,Diabetes,High Dose,2024-02-28,2024-05-28,6.17,6.28,143,94,75,Nausea,None,Improved,0
4617,PT-04617,38,M,AIIMS Delhi,Phase IV,ORX-303,Cardiology,Placebo,2023-05-02,2023-05-09,6.45,5.4,127,79,66,None,None,Worsened,0
4618,PT-04618,26,F,Indore Medical Institute,Phase III,ORX-404,Neurology,Low Dose,2023-04-18,2023-05-16,7.07,6.28,107,91,102,Headache,None,Improved,1
4619,PT-04619,60,M,NIMHANS Bengaluru,Phase III,ORX-606,Rheumatology,Low Dose,2024-01-21,2024-01-28,6.34,5.89,155,67,88,Headache,None,Worsened,0
4620,PT-04620,21,F,Indore Medical Institute,Phase II,ORX-101,Oncology,Placebo,2023-07-09,2023-09-03,9.22,8.43,168,102,76,None,None,No Change,0
4621,PT-04621,33,F,Kolkata Clinical Center,Phase III,ORX-303,Cardiology,Low Dose,2024-10-19,2024-12-14,7.43,6.87,120,62,70,None,None,Improved,1
4622,PT-04622,27,M,Kolkata Clinical Center,Phase III,ORX-404,Neurology,High Dose,2023-03-27,2023-04-03,7.86,8.35,141,86,66,None,None,Improved,0
4623,PT-04623,48,F,AIIMS Delhi,Phase III,ORX-202,Diabetes,Placebo,2024-09-18,2024-10-16,8.15,7.22,130,80,101,None,None,Worsened,0
4624,PT-04624,58,M,Kolkata Clinical Center,Phase I,ORX-606,Rheumatology,Placebo,2024-03-04,2024-03-11,7.93,5.99,131,80,75,Dizziness,None,No Change,0
4625,PT-04625,19,F,Indore Medical Institute,Phase II,ORX-303,Cardiology,Placebo,2023-10-31,2023-11-14,5.89,5.43,148,74,72,None,None,Improved,1
4626,PT-04626,73,F,Bhopal Research Hospital,Phase III,ORX-606,Rheumatology,High Dose,2024-03-03,2024-03-17,6.84,6.33,125,65,86,None,None,No Change,0
4627,PT-04627,34,F,Indore Medical Institute,Phase I,ORX-404,Neurology,Placebo,2023-02-21,2023-04-18,7.16,7.16,162,66,90,None,None,Improved,1
4628,PT-04628,58,M,Kolkata Clinical Center,Phase II,ORX-101,Oncology,Low Dose,2023-03-02,2023-03-30,6.43,6.57,157,72,81,None,None,Improved,0
4629,PT-04629,51,F,NIMHANS Bengaluru,Phase III,ORX-606,Rheumatology,Placebo,2024-08-31,2024-11-29,7.84,8.13,130,88,65,None,None,Worsened,0
4630,PT-04630,47,M,NIMHANS Bengaluru,Phase III,ORX-606,Rheumatology,Placebo,2024-04-17,2024-05-15,6.63,5.12,118,85,84,Rash,Moderate,No Change,0
4631,PT-04631,24,M,Apollo Chennai,Phase III,ORX-101,Oncology,Low Dose,2024-05-16,2024-08-14,6.07,6.33,137,92,97,Headache,None,Improved,0
4632,PT-04632,53,M,Apollo Chennai,Phase II,ORX-404,Neurology,Low Dose,2024-02-17,2024-05-17,6.7,6.41,157,115,84,None,None,No Change,0
4633,PT-04633,53,F,Kolkata Clinical Center,Phase IV,ORX-303,Cardiology,High Dose,2023-07-11,2023-07-25,8.07,7.69,148,94,82,Headache,None,Improved,1
4634,PT-04634,39,F,PGI Chandigarh,Phase I,ORX-303,Cardiology,Low Dose,2023-12-07,2024-03-06,5.38,5.63,131,73,62,None,None,Worsened,0
4635,PT-04635,55,M,Apollo Chennai,Phase IV,ORX-404,Neurology,Low Dose,2023-06-05,2023-06-12,5.28,5.15,143,88,72,None,None,Improved,1
4636,PT-04636,25,F,Bhopal Research Hospital,Phase III,ORX-303,Cardiology,Placebo,2023-06-13,2023-09-11,7.9,8.58,117,88,100,None,None,Improved,0
4637,PT-04637,50,F,Bhopal Research Hospital,Phase II,ORX-606,Rheumatology,Placebo,2023-03-23,2023-05-18,6.72,7.26,114,66,89,None,None,No Change,0
4638,PT-04638,38,F,AIIMS Delhi,Phase III,ORX-606,Rheumatology,High Dose,2023-08-10,2023-08-17,6.82,5.86,119,98,101,Nausea,Mild,Improved,1
4639,PT-04639,73,F,Bhopal Research Hospital,Phase IV,ORX-202,Diabetes,Placebo,2024-10-31,2025-01-29,8.51,8.53,102,79,108,None,None,Improved,0
4640,PT-04640,38,M,NIMHANS Bengaluru,Phase III,ORX-505,Infectious Disease,High Dose,2023-01-27,2023-02-24,9.02,8.67,90,89,95,Nausea,None,Worsened,0
4641,PT-04641,44,F,Fortis Mumbai,Phase II,ORX-101,Oncology,High Dose,2024-11-29,2025-02-27,8.68,6.78,103,84,84,None,None,Improved,1
4642,PT-04642,66,M,AIIMS Delhi,Phase III,ORX-404,Neurology,Low Dose,2023-04-06,2023-04-13,7.97,6.49,131,89,51,Headache,None,No Change,0
4643,PT-04643,44,M,NIMHANS Bengaluru,Phase I,ORX-606,Rheumatology,Placebo,2024-03-08,2024-06-06,6.8,5.81,136,68,83,Fever,None,Improved,1
4644,PT-04644,53,M,NIMHANS Bengaluru,Phase III,ORX-606,Rheumatology,Low Dose,2023-04-16,2023-06-11,8.5,7.09,100,85,73,Headache,Moderate,No Change,0
4645,PT-04645,85,F,Indore Medical Institute,Phase II,ORX-404,Neurology,High Dose,2024-04-25,2024-05-02,7.75,7.4,124,67,85,None,None,No Change,0
4646,PT-04646,43,F,Fortis Mumbai,Phase III,ORX-606,Rheumatology,Placebo,2024-09-30,2024-11-25,7.11,6.79,131,61,89,Headache,Severe,Improved,1
4647,PT-04647,31,F,AIIMS Delhi,Phase III,ORX-303,Cardiology,High Dose,2023-02-04,2023-02-18,7.03,7.79,160,61,78,None,None,Improved,0
4648,PT-04648,49,M,NIMHANS Bengaluru,Phase III,ORX-101,Oncology,Low Dose,2024-08-26,2024-11-24,5.39,5.71,130,84,65,None,None,No Change,0
4649,PT-04649,51,M,Fortis Mumbai,Phase III,ORX-606,Rheumatology,High Dose,2024-03-05,2024-04-02,8.21,7.92,118,76,81,None,None,No Change,0
4650,PT-04650,45,F,PGI Chandigarh,Phase III,ORX-505,Infectious Disease,High Dose,2023-07-05,2023-08-02,8.29,7.45,106,86,71,Nausea,None,Improved,1
4651,PT-04651,57,M,NIMHANS Bengaluru,Phase IV,ORX-202,Diabetes,Placebo,2024-09-29,2024-10-13,7.21,7.4,109,83,68,None,None,Worsened,0
4652,PT-04652,25,F,Kolkata Clinical Center,Phase III,ORX-101,Oncology,Low Dose,2024-08-14,2024-09-11,6.17,5.28,150,75,60,None,None,Worsened,0
4653,PT-04653,47,M,PGI Chandigarh,Phase II,ORX-606,Rheumatology,Low Dose,2023-07-23,2023-08-20,7.24,6.39,125,93,87,Headache,None,Improved,1
4654,PT-04654,54,M,PGI Chandigarh,Phase I,ORX-606,Rheumatology,High Dose,2024-05-03,2024-06-28,5.78,7.98,146,88,61,Headache,Mild,No Change,0
4655,PT-04655,60,F,Bhopal Research Hospital,Phase IV,ORX-202,Diabetes,Low Dose,2024-01-07,2024-02-04,6.6,6.02,97,67,84,None,None,No Change,0
4656,PT-04656,61,M,Indore Medical Institute,Phase III,ORX-505,Infectious Disease,High Dose,2024-09-16,2024-11-11,8.02,,126,77,82,None,None,Improved,0
4657,PT-04657,58,M,AIIMS Delhi,Phase III,ORX-606,Rheumatology,High Dose,2023-08-14,2023-08-28,7.21,7.9,124,70,77,None,None,Improved,0
4658,PT-04658,46,M,Apollo Chennai,Phase I,ORX-505,Infectious Disease,Low Dose,2024-05-09,2024-08-07,7.1,7.85,142,64,99,None,None,Worsened,0
4659,PT-04659,18,F,Indore Medical Institute,Phase II,ORX-404,Neurology,Placebo,2023-08-17,2023-09-14,9.78,9.12,124,81,83,None,None,Improved,1
4660,PT-04660,44,F,PGI Chandigarh,Phase IV,ORX-303,Cardiology,High Dose,2023-02-15,2023-03-15,7.04,7.82,138,70,88,None,None,No Change,0
4661,PT-04661,53,F,AIIMS Delhi,Phase I,ORX-505,Infectious Disease,Low Dose,2024-01-10,2024-02-07,6.55,6.86,125,79,74,Headache,Mild,Improved,0
4662,PT-04662,18,F,NIMHANS Bengaluru,Phase I,ORX-202,Diabetes,Low Dose,2024-01-05,2024-04-04,6.57,6.81,127,66,91,Headache,None,Worsened,0
4663,PT-04663,40,M,AIIMS Delhi,Phase II,ORX-606,Rheumatology,Placebo,2023-05-28,2023-06-11,5.73,7.32,109,92,67,Nausea,Severe,Worsened,0
4664,PT-04664,47,F,Indore Medical Institute,Phase II,ORX-101,Oncology,Placebo,2023-07-22,2023-08-05,6.12,4.6,137,86,94,None,None,No Change,0
4665,PT-04665,44,M,Apollo Chennai,Phase IV,ORX-303,Cardiology,High Dose,2023-10-20,2023-12-15,9.86,9.71,138,65,69,None,None,Improved,1
4666,PT-04666,53,F,NIMHANS Bengaluru,Phase IV,ORX-202,Diabetes,High Dose,2023-04-02,2023-04-16,7.1,6.87,113,83,79,Fever,Mild,Worsened,0
4667,PT-04667,26,F,Indore Medical Institute,Phase I,ORX-606,Rheumatology,High Dose,2023-12-07,2023-12-21,7.97,6.04,131,103,87,None,None,Improved,1
4668,PT-04668,55,M,AIIMS Delhi,Phase III,ORX-606,Rheumatology,High Dose,2023-08-17,2023-11-15,6.12,7.32,152,71,71,Rash,None,Improved,0
4669,PT-04669,65,F,Kolkata Clinical Center,Phase III,ORX-404,Neurology,Placebo,2023-10-23,2023-11-20,9.36,7.82,109,80,47,Nausea,Moderate,Improved,1
4670,PT-04670,45,M,AIIMS Delhi,Phase IV,ORX-101,Oncology,Low Dose,2024-11-03,2024-11-17,8.62,6.93,130,75,100,Headache,Moderate,No Change,0
4671,PT-04671,35,F,AIIMS Delhi,Phase III,ORX-505,Infectious Disease,Low Dose,2024-01-31,2024-02-07,9.02,8.09,141,85,76,None,None,Improved,1
4672,PT-04672,32,M,NIMHANS Bengaluru,Phase III,ORX-101,Oncology,High Dose,2024-03-18,2024-06-16,7.59,6.79,115,99,85,Nausea,Mild,No Change,0
4673,PT-04673,55,F,Indore Medical Institute,Phase II,ORX-404,Neurology,High Dose,2024-06-25,2024-07-09,6.73,6.16,123,86,86,None,None,Improved,1
4674,PT-04674,44,M,AIIMS Delhi,Phase I,ORX-505,Infectious Disease,Low Dose,2024-01-22,2024-01-29,6.25,6.53,128,64,48,None,None,Improved,0
4675,PT-04675,49,F,Bhopal Research Hospital,Phase III,ORX-101,Oncology,Placebo,2024-10-28,2024-11-11,6.2,6.19,114,83,72,None,None,No Change,0
4676,PT-04676,73,F,NIMHANS Bengaluru,Phase III,ORX-202,Diabetes,Low Dose,2023-02-05,2023-05-06,8.34,9.15,128,91,79,None,None,Improved,0
4677,PT-04677,68,M,AIIMS Delhi,Phase II,ORX-505,Infectious Disease,Low Dose,2024-09-21,2024-12-20,7.11,5.46,92,102,84,Rash,Mild,No Change,0
4678,PT-04678,53,F,Bhopal Research Hospital,Phase III,ORX-101,Oncology,High Dose,2023-01-04,2023-03-01,8.99,7.1,121,79,88,Nausea,None,Improved,1
4679,PT-04679,33,M,Indore Medical Institute,Phase III,ORX-202,Diabetes,High Dose,2024-02-28,2024-05-28,5.76,4.27,148,73,70,Nausea,Severe,Improved,1
4680,PT-04680,55,F,Fortis Mumbai,Phase II,ORX-202,Diabetes,High Dose,2024-05-14,2024-05-28,6.36,4.43,99,81,84,Rash,None,No Change,0
4681,PT-04681,41,F,NIMHANS Bengaluru,Phase IV,ORX-202,Diabetes,High Dose,2023-08-18,2023-08-25,7.72,5.86,100,109,95,None,None,No Change,0
4682,PT-04682,57,M,Apollo Chennai,Phase III,ORX-505,Infectious Disease,High Dose,2023-09-04,2023-09-11,6.41,5.79,127,97,83,Fever,Mild,No Change,0
4683,PT-04683,53,F,NIMHANS Bengaluru,Phase II,ORX-505,Infectious Disease,High Dose,2023-09-25,2023-10-09,7.0,7.31,133,82,67,None,None,Improved,0
4684,PT-04684,43,M,Kolkata Clinical Center,Phase I,ORX-303,Cardiology,Low Dose,2024-09-04,2024-09-11,5.9,5.47,129,53,74,Headache,None,No Change,0
4685,PT-04685,26,M,NIMHANS Bengaluru,Phase II,ORX-303,Cardiology,Low Dose,2024-03-27,2024-04-24,7.8,7.97,120,88,86,None,None,Improved,0
4686,PT-04686,41,M,Bhopal Research Hospital,Phase III,ORX-202,Diabetes,Placebo,2024-06-24,2024-07-01,9.04,7.99,154,79,66,Headache,None,Improved,1
4687,PT-04687,39,M,Kolkata Clinical Center,Phase IV,ORX-303,Cardiology,Low Dose,2024-07-18,2024-07-25,5.88,6.19,99,98,64,None,None,Worsened,0
4688,PT-04688,58,M,Apollo Chennai,Phase I,ORX-101,Oncology,High Dose,2023-04-30,2023-06-25,7.23,7.07,117,86,79,Fatigue,None,Improved,1
4689,PT-04689,21,F,Bhopal Research Hospital,Phase I,ORX-101,Oncology,Low Dose,2023-08-19,2023-08-26,6.04,5.16,114,97,78,None,None,Worsened,0
4690,PT-04690,32,M,AIIMS Delhi,Phase III,ORX-303,Cardiology,Placebo,2024-02-11,2024-02-25,6.61,5.76,122,69,66,None,None,Improved,1
4691,PT-04691,57,M,Kolkata Clinical Center,Phase I,ORX-101,Oncology,Placebo,2024-08-02,2024-10-31,7.42,6.89,128,81,75,None,None,Worsened,0
4692,PT-04692,53,F,Fortis Mumbai,Phase I,ORX-404,Neurology,Low Dose,2023-03-26,2023-04-09,7.73,5.92,125,63,86,None,None,No Change,0
4693,PT-04693,57,F,Kolkata Clinical Center,Phase III,ORX-202,Diabetes,Placebo,2023-10-17,2023-11-14,6.47,5.96,90,93,87,Headache,Severe,Improved,1
4694,PT-04694,63,M,Apollo Chennai,Phase III,ORX-606,Rheumatology,High Dose,2023-12-26,2024-01-09,8.98,7.48,143,99,57,None,None,Improved,1
4695,PT-04695,42,M,NIMHANS Bengaluru,Phase I,ORX-606,Rheumatology,Placebo,2023-05-16,2023-06-13,6.76,7.13,90,103,76,None,None,Worsened,0
4696,PT-04696,59,F,Bhopal Research Hospital,Phase II,ORX-404,Neurology,Placebo,2024-01-07,2024-01-14,7.13,7.17,90,77,89,Dizziness,None,No Change,0
4697,PT-04697,49,M,Indore Medical Institute,Phase III,ORX-505,Infectious Disease,Low Dose,2023-07-27,2023-08-03,5.24,4.89,113,71,56,Dizziness,Moderate,Worsened,0
4698,PT-04698,54,M,Indore Medical Institute,Phase II,ORX-404,Neurology,Low Dose,2024-10-15,2024-10-29,8.54,10.04,101,91,89,Nausea,None,Improved,0
4699,PT-04699,35,F,Indore Medical Institute,Phase II,ORX-202,Diabetes,High Dose,2023-08-19,2023-11-17,6.1,4.72,118,84,97,None,None,Worsened,0
4700,PT-04700,62,F,Bhopal Research Hospital,Phase II,ORX-505,Infectious Disease,Low Dose,2024-05-31,2024-06-07,5.26,4.15,151,73,77,None,None,No Change,0
4701,PT-04701,18,F,AIIMS Delhi,Phase I,ORX-606,Rheumatology,Low Dose,2024-01-05,2024-01-12,8.58,6.46,98,94,104,None,None,Improved,1
4702,PT-04702,40,M,Fortis Mumbai,Phase III,ORX-404,Neurology,Low Dose,2023-01-19,2023-02-02,7.14,7.56,133,77,71,Headache,Moderate,No Change,0
4703,PT-04703,19,F,PGI Chandigarh,Phase IV,ORX-505,Infectious Disease,High Dose,2023-10-25,2023-12-20,7.48,7.0,120,69,65,None,None,Worsened,0
4704,PT-04704,54,M,Bhopal Research Hospital,Phase I,ORX-606,Rheumatology,High Dose,2023-01-22,2023-02-05,8.26,7.56,120,71,91,None,None,Improved,1
4705,PT-04705,45,F,Bhopal Research Hospital,Phase IV,ORX-505,Infectious Disease,Low Dose,2024-09-10,2024-09-17,7.64,7.56,122,68,64,None,None,Improved,1
4706,PT-04706,63,M,PGI Chandigarh,Phase IV,ORX-101,Oncology,Low Dose,2023-12-18,2023-12-25,6.33,5.56,107,67,67,Headache,Moderate,Worsened,0
4707,PT-04707,72,F,Kolkata Clinical Center,Phase III,ORX-404,Neurology,Low Dose,2023-01-22,2023-02-19,7.99,7.12,147,80,96,Fatigue,Mild,Improved,1
4708,PT-04708,80,M,Fortis Mumbai,Phase III,ORX-202,Diabetes,High Dose,2024-11-21,2025-01-16,8.43,8.12,140,82,52,None,None,Improved,1
4709,PT-04709,34,F,AIIMS Delhi,Phase III,ORX-101,Oncology,Placebo,2023-01-04,2023-02-01,6.06,5.05,160,95,84,Dizziness,Severe,No Change,0
4710,PT-04710,57,M,Apollo Chennai,Phase IV,ORX-404,Neurology,High Dose,2023-12-14,2023-12-28,4.93,5.18,144,55,88,None,None,Improved,0
4711,PT-04711,22,F,Fortis Mumbai,Phase I,ORX-202,Diabetes,High Dose,2024-04-25,2024-05-02,4.84,5.63,109,73,91,Nausea,None,No Change,0
4712,PT-04712,40,F,Bhopal Research Hospital,Phase II,ORX-303,Cardiology,Low Dose,2024-01-13,2024-02-10,6.98,6.4,134,79,79,Nausea,None,Improved,1
4713,PT-04713,36,M,Indore Medical Institute,Phase III,ORX-404,Neurology,High Dose,2023-12-25,2024-01-22,7.62,7.5,162,77,75,Fever,None,Improved,1
4714,PT-04714,48,F,Kolkata Clinical Center,Phase I,ORX-606,Rheumatology,Placebo,2023-09-18,2023-10-02,8.36,6.97,129,51,74,None,None,Improved,1
4715,PT-04715,62,M,AIIMS Delhi,Phase III,ORX-303,Cardiology,Low Dose,2024-10-22,2025-01-20,6.33,6.09,118,71,91,Headache,Mild,Improved,1
4716,PT-04716,28,F,Apollo Chennai,Phase I,ORX-404,Neurology,Placebo,2023-10-30,2023-11-06,7.55,7.43,112,83,64,Headache,None,Improved,1
4717,PT-04717,53,M,PGI Chandigarh,Phase II,ORX-303,Cardiology,High Dose,2023-07-27,2023-08-03,5.62,4.92,123,95,79,Headache,None,Improved,1
4718,PT-04718,60,M,Indore Medical Institute,Phase IV,ORX-505,Infectious Disease,Low Dose,2023-03-12,2023-05-07,7.87,7.96,122,94,73,Headache,None,Improved,0
4719,PT-04719,18,M,Kolkata Clinical Center,Phase IV,ORX-505,Infectious Disease,Placebo,2024-07-16,2024-08-13,6.94,6.95,99,71,60,Nausea,None,No Change,0
4720,PT-04720,57,M,NIMHANS Bengaluru,Phase II,ORX-505,Infectious Disease,Low Dose,2023-04-16,2023-04-23,9.21,8.62,137,88,99,Dizziness,Moderate,No Change,0
4721,PT-04721,34,M,NIMHANS Bengaluru,Phase III,ORX-606,Rheumatology,High Dose,2023-12-29,2024-02-23,6.94,6.23,129,112,78,None,None,Worsened,0
4722,PT-04722,31,M,NIMHANS Bengaluru,Phase III,ORX-303,Cardiology,Low Dose,2024-02-23,2024-04-19,5.81,6.54,112,89,68,None,None,Improved,0
4723,PT-04723,24,F,PGI Chandigarh,Phase II,ORX-101,Oncology,Low Dose,2023-12-28,2024-01-04,7.93,6.96,135,87,85,None,None,No Change,0
4724,PT-04724,40,F,AIIMS Delhi,Phase II,ORX-303,Cardiology,Low Dose,2023-01-16,2023-04-16,8.02,6.79,90,90,80,None,None,No Change,0
4725,PT-04725,35,F,AIIMS Delhi,Phase I,ORX-505,Infectious Disease,Low Dose,2023-12-09,2023-12-16,5.43,3.2,128,101,76,None,None,Improved,1
4726,PT-04726,39,M,PGI Chandigarh,Phase II,ORX-202,Diabetes,Placebo,2023-07-10,2023-10-08,7.17,8.73,141,70,78,None,None,No Change,0
4727,PT-04727,50,M,Bhopal Research Hospital,Phase III,ORX-505,Infectious Disease,High Dose,2024-06-25,2024-07-02,5.93,6.22,113,63,79,None,None,No Change,0
4728,PT-04728,43,M,Indore Medical Institute,Phase III,ORX-303,Cardiology,Placebo,2024-03-19,2024-05-14,7.2,6.11,116,95,84,None,None,Improved,1
4729,PT-04729,29,M,Apollo Chennai,Phase III,ORX-505,Infectious Disease,High Dose,2023-10-24,2023-10-31,4.86,3.64,130,74,68,None,None,Improved,1
4730,PT-04730,35,F,NIMHANS Bengaluru,Phase III,ORX-505,Infectious Disease,Placebo,2023-03-08,2023-06-06,7.11,7.42,127,82,74,None,None,Worsened,0
4731,PT-04731,37,M,Kolkata Clinical Center,Phase II,ORX-101,Oncology,Low Dose,2023-02-05,2023-05-06,8.27,8.54,164,89,71,None,None,Improved,0
4732,PT-04732,30,F,Fortis Mumbai,Phase II,ORX-101,Oncology,High Dose,2024-08-28,2024-09-04,8.34,7.21,142,72,82,None,None,Worsened,0
4733,PT-04733,28,F,Kolkata Clinical Center,Phase III,ORX-202,Diabetes,Low Dose,2023-11-09,2023-11-23,8.14,6.63,132,79,79,Headache,Mild,Improved,1
4734,PT-04734,38,F,NIMHANS Bengaluru,Phase III,ORX-505,Infectious Disease,Low Dose,2024-04-17,2024-07-16,6.7,6.44,109,69,72,None,None,Improved,1
4735,PT-04735,38,F,Kolkata Clinical Center,Phase II,ORX-202,Diabetes,Placebo,2023-09-28,2023-10-12,5.99,6.43,121,79,59,None,None,Improved,0
4736,PT-04736,78,M,Indore Medical Institute,Phase III,ORX-303,Cardiology,Low Dose,2023-11-25,2023-12-02,10.11,9.01,150,80,100,None,None,Worsened,0
4737,PT-04737,50,M,Indore Medical Institute,Phase II,ORX-404,Neurology,Low Dose,2024-10-29,2024-11-12,7.32,4.67,112,82,80,Nausea,None,Improved,1
4738,PT-04738,25,F,Bhopal Research Hospital,Phase III,ORX-606,Rheumatology,Low Dose,2024-03-17,2024-03-24,6.33,6.42,103,83,95,Rash,Mild,Worsened,0
4739,PT-04739,51,M,Indore Medical Institute,Phase III,ORX-202,Diabetes,High Dose,2023-07-10,2023-07-24,7.6,5.38,113,106,69,None,None,Improved,1
4740,PT-04740,65,F,Apollo Chennai,Phase III,ORX-404,Neurology,Placebo,2023-02-16,2023-02-23,6.47,5.82,137,83,83,None,None,Improved,1
4741,PT-04741,31,F,Bhopal Research Hospital,Phase II,ORX-202,Diabetes,Low Dose,2024-11-21,2025-01-16,5.84,4.64,118,79,92,Rash,Mild,No Change,0
4742,PT-04742,46,M,Bhopal Research Hospital,Phase III,ORX-101,Oncology,High Dose,2023-10-21,2023-12-16,7.78,7.51,107,82,79,Fatigue,None,Improved,1
4743,PT-04743,57,M,Kolkata Clinical Center,Phase II,ORX-202,Diabetes,High Dose,2023-11-16,2023-11-23,5.92,3.68,131,86,75,Fever,Moderate,Improved,1
4744,PT-04744,45,F,Kolkata Clinical Center,Phase IV,ORX-202,Diabetes,Placebo,2023-04-11,2023-06-06,8.25,7.44,122,82,60,None,None,Improved,1
4745,PT-04745,42,M,Apollo Chennai,Phase III,ORX-404,Neurology,Low Dose,2023-01-20,2023-01-27,7.12,8.2,122,84,90,Nausea,Moderate,Improved,0
4746,PT-04746,31,F,Apollo Chennai,Phase II,ORX-101,Oncology,Placebo,2024-07-14,2024-08-11,8.85,10.04,127,75,100,Headache,Moderate,Improved,0
4747,PT-04747,57,F,NIMHANS Bengaluru,Phase II,ORX-101,Oncology,Low Dose,2023-02-18,2023-03-18,7.3,8.18,151,77,81,None,None,Worsened,0
4748,PT-04748,54,M,AIIMS Delhi,Phase III,ORX-303,Cardiology,Placebo,2024-02-16,2024-03-01,7.23,5.58,111,65,84,Headache,None,No Change,0
4749,PT-04749,26,F,NIMHANS Bengaluru,Phase II,ORX-101,Oncology,High Dose,2024-07-12,2024-09-06,7.43,8.68,153,59,60,Rash,Moderate,Improved,0
4750,PT-04750,32,M,Apollo Chennai,Phase II,ORX-606,Rheumatology,Placebo,2023-03-29,2023-04-12,5.8,3.91,127,90,91,None,None,Improved,1
4751,PT-04751,37,M,Apollo Chennai,Phase III,ORX-505,Infectious Disease,High Dose,2023-01-08,2023-02-05,6.87,6.79,126,91,84,Nausea,None,Improved,1
4752,PT-04752,38,M,Bhopal Research Hospital,Phase II,ORX-606,Rheumatology,Placebo,2023-10-21,2023-12-16,4.97,5.92,115,86,51,Nausea,Mild,Improved,0
4753,PT-04753,44,M,NIMHANS Bengaluru,Phase III,ORX-505,Infectious Disease,High Dose,2023-07-28,2023-08-11,7.32,7.05,182,74,89,None,None,Worsened,0
4754,PT-04754,53,M,AIIMS Delhi,Phase IV,ORX-606,Rheumatology,Low Dose,2024-07-25,2024-08-01,6.39,6.71,125,92,105,None,None,No Change,0
4755,PT-04755,47,M,AIIMS Delhi,Phase III,ORX-303,Cardiology,High Dose,2024-07-01,2024-07-15,6.86,7.41,153,71,71,None,None,Improved,0
4756,PT-04756,55,M,Bhopal Research Hospital,Phase II,ORX-404,Neurology,Placebo,2023-09-02,2023-09-16,7.04,5.78,137,90,73,None,None,Improved,1
4757,PT-04757,45,F,Kolkata Clinical Center,Phase III,ORX-404,Neurology,Placebo,2024-06-07,2024-08-02,6.51,5.12,119,82,57,Fever,None,Improved,1
4758,PT-04758,38,F,Fortis Mumbai,Phase IV,ORX-505,Infectious Disease,Low Dose,2023-01-04,2023-02-01,7.31,7.98,122,67,75,None,None,No Change,0
4759,PT-04759,35,M,Bhopal Research Hospital,Phase III,ORX-202,Diabetes,Low Dose,2024-11-16,2024-11-30,7.86,7.16,90,120,79,Nausea,Mild,Improved,1
4760,PT-04760,46,F,Apollo Chennai,Phase IV,ORX-101,Oncology,High Dose,2023-06-08,2023-06-22,5.35,3.63,126,86,87,Nausea,None,No Change,0
4761,PT-04761,48,F,PGI Chandigarh,Phase III,ORX-202,Diabetes,Low Dose,2023-09-08,2023-11-03,5.78,3.12,126,75,60,Headache,None,No Change,0
4762,PT-04762,58,M,AIIMS Delhi,Phase I,ORX-606,Rheumatology,Low Dose,2024-06-07,2024-08-02,5.31,5.46,102,83,91,Headache,None,Improved,0
4763,PT-04763,39,M,Indore Medical Institute,Phase II,ORX-606,Rheumatology,Low Dose,2024-07-19,2024-07-26,9.23,10.55,132,88,92,Nausea,None,Improved,0
4764,PT-04764,53,M,Fortis Mumbai,Phase IV,ORX-606,Rheumatology,High Dose,2023-06-04,2023-09-02,7.72,6.85,97,65,111,None,None,Worsened,0
4765,PT-04765,50,F,AIIMS Delhi,Phase III,ORX-101,Oncology,High Dose,2023-07-26,2023-09-20,6.91,7.64,114,88,79,None,None,Improved,0
4766,PT-04766,52,F,NIMHANS Bengaluru,Phase III,ORX-202,Diabetes,Placebo,2024-04-04,2024-07-03,6.8,5.53,113,72,77,Nausea,Mild,No Change,0
4767,PT-04767,20,F,AIIMS Delhi,Phase IV,ORX-404,Neurology,Low Dose,2024-02-22,2024-02-29,5.7,5.43,125,84,77,Fever,None,No Change,0
4768,PT-04768,85,F,Apollo Chennai,Phase III,ORX-404,Neurology,Low Dose,2024-08-19,2024-08-26,7.35,6.61,129,94,77,Headache,None,Improved,1
4769,PT-04769,55,F,Fortis Mumbai,Phase III,ORX-606,Rheumatology,Placebo,2024-03-01,2024-04-26,7.68,7.01,129,101,81,None,None,Worsened,0
4770,PT-04770,29,M,PGI Chandigarh,Phase III,ORX-404,Neurology,High Dose,2024-06-03,2024-07-01,6.82,4.51,130,97,59,None,None,Improved,1
4771,PT-04771,47,F,Kolkata Clinical Center,Phase III,ORX-505,Infectious Disease,Low Dose,2023-05-22,2023-08-20,8.38,8.96,151,59,85,None,None,Improved,0
4772,PT-04772,20,M,Apollo Chennai,Phase III,ORX-404,Neurology,Placebo,2024-07-08,2024-10-06,6.0,6.34,130,90,64,None,None,Worsened,0
4773,PT-04773,68,F,AIIMS Delhi,Phase I,ORX-303,Cardiology,Placebo,2023-01-05,2023-01-19,8.03,8.43,108,96,73,Rash,None,Improved,0
4774,PT-04774,35,M,Kolkata Clinical Center,Phase II,ORX-505,Infectious Disease,Placebo,2023-12-07,2024-03-06,7.95,8.08,112,106,103,Fatigue,Moderate,No Change,0
4775,PT-04775,54,M,Apollo Chennai,Phase III,ORX-404,Neurology,High Dose,2023-08-02,2023-08-16,7.72,7.61,100,83,79,None,None,No Change,0
4776,PT-04776,35,M,Kolkata Clinical Center,Phase II,ORX-303,Cardiology,Placebo,2023-06-10,2023-08-05,6.83,4.29,108,93,102,Rash,Moderate,No Change,0
4777,PT-04777,29,F,Bhopal Research Hospital,Phase II,ORX-101,Oncology,Low Dose,2023-04-15,2023-07-14,7.42,8.01,118,90,77,None,None,No Change,0
4778,PT-04778,64,M,Apollo Chennai,Phase IV,ORX-505,Infectious Disease,High Dose,2024-11-25,2024-12-02,5.66,4.27,133,83,77,Nausea,None,Improved,1
4779,PT-04779,54,F,Fortis Mumbai,Phase III,ORX-202,Diabetes,Low Dose,2023-02-13,2023-02-20,6.08,4.45,118,77,74,None,None,Worsened,0
4780,PT-04780,65,F,PGI Chandigarh,Phase II,ORX-404,Neurology,Low Dose,2024-01-23,2024-02-06,8.12,8.2,131,76,66,Nausea,Severe,No Change,0
4781,PT-04781,25,F,Indore Medical Institute,Phase III,ORX-303,Cardiology,Low Dose,2023-12-12,2024-01-09,6.37,5.93,107,84,75,None,None,Improved,1
4782,PT-04782,38,F,NIMHANS Bengaluru,Phase I,ORX-101,Oncology,High Dose,2024-03-17,2024-05-12,8.59,5.98,121,53,81,None,None,No Change,0
4783,PT-04783,57,M,Apollo Chennai,Phase III,ORX-101,Oncology,Low Dose,2024-02-20,2024-02-27,5.58,4.08,97,82,73,None,None,No Change,0
4784,PT-04784,40,F,NIMHANS Bengaluru,Phase III,ORX-505,Infectious Disease,Low Dose,2024-08-27,2024-09-03,6.76,5.48,148,85,61,None,None,Improved,1
4785,PT-04785,33,M,NIMHANS Bengaluru,Phase III,ORX-505,Infectious Disease,High Dose,2023-12-03,2024-01-28,6.15,7.02,140,80,101,Rash,None,Improved,0
4786,PT-04786,68,M,Apollo Chennai,Phase II,ORX-303,Cardiology,High Dose,2023-07-04,2023-08-29,6.92,6.15,121,70,102,None,None,Improved,1
4787,PT-04787,28,M,Fortis Mumbai,Phase III,ORX-505,Infectious Disease,High Dose,2024-03-21,2024-06-19,8.24,8.46,122,103,56,Headache,None,Improved,0
4788,PT-04788,43,M,PGI Chandigarh,Phase III,ORX-505,Infectious Disease,Low Dose,2023-10-23,2023-10-30,6.61,7.08,134,61,95,None,None,Improved,0
4789,PT-04789,52,F,Fortis Mumbai,Phase IV,ORX-505,Infectious Disease,Low Dose,2023-12-08,2023-12-15,5.96,5.24,104,79,80,Headache,None,Improved,1
4790,PT-04790,39,M,Indore Medical Institute,Phase IV,ORX-202,Diabetes,Placebo,2024-09-13,2024-09-27,6.66,4.81,134,58,78,Nausea,Mild,Worsened,0
4791,PT-04791,18,F,Bhopal Research Hospital,Phase II,ORX-606,Rheumatology,Placebo,2023-07-22,2023-08-19,7.26,6.86,135,92,92,Headache,None,Worsened,0
4792,PT-04792,19,F,Indore Medical Institute,Phase III,ORX-101,Oncology,Low Dose,2023-12-17,2024-02-11,7.13,8.54,130,72,76,Fatigue,Mild,Improved,0
4793,PT-04793,38,F,Apollo Chennai,Phase I,ORX-101,Oncology,Low Dose,2023-08-03,2023-09-28,5.79,6.17,138,65,76,Fatigue,Severe,Improved,0
4794,PT-04794,35,F,PGI Chandigarh,Phase III,ORX-101,Oncology,High Dose,2023-02-23,2023-03-23,5.28,3.6,105,81,71,None,None,Improved,1
4795,PT-04795,29,F,NIMHANS Bengaluru,Phase III,ORX-404,Neurology,Low Dose,2024-08-16,2024-08-30,6.73,7.0,134,94,74,Headache,None,No Change,0
4796,PT-04796,70,F,Kolkata Clinical Center,Phase III,ORX-101,Oncology,Low Dose,2024-04-27,2024-05-25,7.62,6.78,129,67,73,None,None,Improved,1
4797,PT-04797,51,M,Indore Medical Institute,Phase III,ORX-505,Infectious Disease,Low Dose,2023-09-28,2023-10-05,7.93,7.16,177,79,54,None,None,Worsened,0
4798,PT-04798,64,F,Apollo Chennai,Phase IV,ORX-505,Infectious Disease,High Dose,2024-06-25,2024-07-09,7.93,7.74,119,86,100,Nausea,None,Improved,1
4799,PT-04799,48,F,Apollo Chennai,Phase IV,ORX-606,Rheumatology,Low Dose,2024-05-13,2024-06-10,5.44,1.93,134,70,76,None,None,No Change,0
4800,PT-04800,32,F,Indore Medical Institute,Phase III,ORX-505,Infectious Disease,High Dose,2024-06-14,2024-08-09,6.14,5.05,115,91,86,Fatigue,Severe,Improved,1
4801,PT-04801,25,F,Apollo Chennai,Phase I,ORX-303,Cardiology,Low Dose,2024-09-30,2024-10-28,5.91,5.86,146,94,63,Headache,Mild,No Change,0
4802,PT-04802,60,F,AIIMS Delhi,Phase III,ORX-404,Neurology,Placebo,2023-05-22,2023-06-19,5.07,4.49,136,57,107,None,None,Improved,1
4803,PT-04803,66,M,NIMHANS Bengaluru,Phase III,ORX-101,Oncology,Placebo,2023-12-09,2024-01-06,7.98,6.71,126,91,62,Nausea,None,Improved,1
4804,PT-04804,42,F,Kolkata Clinical Center,Phase IV,ORX-303,Cardiology,High Dose,2024-09-20,2024-10-04,8.29,6.55,133,60,64,Dizziness,None,No Change,0
4805,PT-04805,36,M,AIIMS Delhi,Phase II,ORX-505,Infectious Disease,High Dose,2023-02-01,2023-02-15,7.82,6.79,130,73,70,None,None,Improved,1
4806,PT-04806,65,M,Indore Medical Institute,Phase III,ORX-505,Infectious Disease,High Dose,2024-01-17,2024-04-16,5.82,6.1,127,75,60,None,None,Improved,0
4807,PT-04807,26,F,Bhopal Research Hospital,Phase II,ORX-202,Diabetes,Low Dose,2024-11-19,2025-02-17,6.31,5.78,138,78,74,Rash,Mild,Improved,1
4808,PT-04808,43,F,Kolkata Clinical Center,Phase II,ORX-505,Infectious Disease,High Dose,2024-05-04,2024-06-01,7.77,7.95,103,78,95,Rash,Moderate,No Change,0
4809,PT-04809,23,M,Kolkata Clinical Center,Phase III,ORX-404,Neurology,Placebo,2024-02-17,2024-03-02,7.29,6.74,117,101,78,Headache,Mild,Improved,1
4810,PT-04810,69,F,Apollo Chennai,Phase I,ORX-202,Diabetes,High Dose,2024-02-06,2024-02-20,7.21,7.22,117,75,83,None,None,No Change,0
4811,PT-04811,51,M,AIIMS Delhi,Phase IV,ORX-606,Rheumatology,High Dose,2023-05-13,2023-06-10,7.92,7.86,103,72,89,Nausea,None,No Change,0
4812,PT-04812,18,M,NIMHANS Bengaluru,Phase III,ORX-404,Neurology,Low Dose,2023-10-11,2024-01-09,7.55,7.05,143,86,68,None,None,Improved,1
4813,PT-04813,33,F,Fortis Mumbai,Phase II,ORX-303,Cardiology,High Dose,2023-09-12,2023-10-10,6.57,6.69,90,83,65,Nausea,None,Worsened,0
4814,PT-04814,48,M,Kolkata Clinical Center,Phase I,ORX-404,Neurology,Placebo,2024-07-07,2024-07-14,7.61,5.72,123,83,79,Headache,Moderate,No Change,0
4815,PT-04815,43,M,AIIMS Delhi,Phase IV,ORX-505,Infectious Disease,Placebo,2023-01-25,2023-04-25,5.73,4.37,103,88,76,None,None,Improved,1
4816,PT-04816,44,M,PGI Chandigarh,Phase IV,ORX-101,Oncology,Placebo,2023-12-30,2024-02-24,5.15,4.72,139,59,70,Nausea,Mild,Improved,1
4817,PT-04817,19,M,AIIMS Delhi,Phase IV,ORX-202,Diabetes,Placebo,2023-11-20,2023-12-04,6.7,5.48,134,84,96,None,None,No Change,0
4818,PT-04818,44,F,Bhopal Research Hospital,Phase IV,ORX-303,Cardiology,Low Dose,2023-12-01,2024-02-29,7.61,6.7,108,92,95,Headache,None,No Change,0
4819,PT-04819,56,F,Bhopal Research Hospital,Phase III,ORX-606,Rheumatology,High Dose,2024-05-06,2024-07-01,7.36,6.08,148,88,106,Headache,Moderate,No Change,0
4820,PT-04820,26,M,Apollo Chennai,Phase III,ORX-202,Diabetes,High Dose,2024-03-22,2024-06-20,8.24,8.33,121,98,83,None,None,Improved,0
4821,PT-04821,30,M,Fortis Mumbai,Phase III,ORX-303,Cardiology,Low Dose,2024-01-23,2024-01-30,7.06,5.8,119,90,91,Rash,Mild,Improved,1
4822,PT-04822,48,M,PGI Chandigarh,Phase IV,ORX-101,Oncology,High Dose,2023-10-16,2023-10-23,6.3,6.24,141,58,79,None,None,Improved,1
4823,PT-04823,41,F,Kolkata Clinical Center,Phase I,ORX-202,Diabetes,High Dose,2024-10-15,2024-12-10,8.34,8.29,136,76,78,None,None,Improved,1
4824,PT-04824,60,F,NIMHANS Bengaluru,Phase III,ORX-303,Cardiology,High Dose,2024-01-06,2024-02-03,7.12,6.88,100,81,49,None,None,Improved,1
4825,PT-04825,36,M,Fortis Mumbai,Phase II,ORX-606,Rheumatology,High Dose,2024-04-10,2024-04-24,7.28,7.57,110,86,98,None,None,Improved,0
4826,PT-04826,34,M,AIIMS Delhi,Phase I,ORX-606,Rheumatology,High Dose,2024-09-08,2024-09-15,5.34,5.2,106,72,90,Headache,Moderate,Worsened,0
4827,PT-04827,75,M,Fortis Mumbai,Phase II,ORX-202,Diabetes,Low Dose,2024-03-16,2024-03-30,6.0,4.94,120,75,105,None,None,No Change,0
4828,PT-04828,36,F,Indore Medical Institute,Phase III,ORX-404,Neurology,High Dose,2024-06-07,2024-06-14,6.73,7.79,138,93,65,None,None,No Change,0
4829,PT-04829,36,F,Kolkata Clinical Center,Phase IV,ORX-303,Cardiology,High Dose,2023-09-08,2023-10-06,5.95,6.27,150,74,72,None,None,No Change,0
4830,PT-04830,39,F,PGI Chandigarh,Phase III,ORX-101,Oncology,Low Dose,2024-07-02,2024-07-16,5.34,4.34,141,71,79,None,None,No Change,0
4831,PT-04831,24,F,PGI Chandigarh,Phase III,ORX-303,Cardiology,Low Dose,2023-12-26,2024-01-02,7.03,6.12,106,91,89,None,None,Improved,1
4832,PT-04832,29,M,NIMHANS Bengaluru,Phase III,ORX-101,Oncology,Placebo,2023-12-24,2024-03-23,6.94,6.58,95,65,96,Nausea,None,Improved,1
4833,PT-04833,27,M,Apollo Chennai,Phase III,ORX-101,Oncology,Low Dose,2023-10-07,2023-12-02,8.71,7.1,139,78,75,Fever,Mild,Improved,1
4834,PT-04834,74,F,AIIMS Delhi,Phase II,ORX-505,Infectious Disease,Placebo,2023-11-25,2023-12-23,5.69,5.83,137,120,62,None,None,No Change,0
4835,PT-04835,34,M,Apollo Chennai,Phase III,ORX-101,Oncology,Low Dose,2023-02-18,2023-04-15,8.18,7.6,119,93,74,None,None,No Change,0
4836,PT-04836,30,F,Indore Medical Institute,Phase III,ORX-101,Oncology,Placebo,2023-10-06,2023-10-20,8.07,8.01,122,77,65,Headache,None,Worsened,0
4837,PT-04837,56,F,PGI Chandigarh,Phase I,ORX-606,Rheumatology,Low Dose,2024-01-12,2024-02-09,6.77,5.68,104,86,70,Headache,None,Worsened,0
4838,PT-04838,18,M,Fortis Mumbai,Phase IV,ORX-505,Infectious Disease,Low Dose,2024-01-29,2024-02-26,5.76,5.15,124,79,72,None,None,No Change,0
4839,PT-04839,21,M,Apollo Chennai,Phase III,ORX-505,Infectious Disease,Placebo,2024-08-17,2024-09-14,6.15,6.82,146,88,84,None,None,Improved,0
4840,PT-04840,59,F,PGI Chandigarh,Phase I,ORX-404,Neurology,Low Dose,2024-06-27,2024-07-11,5.86,5.48,107,68,83,None,None,No Change,0
4841,PT-04841,60,M,PGI Chandigarh,Phase III,ORX-404,Neurology,Placebo,2024-06-05,2024-06-19,6.97,8.05,131,72,62,None,None,No Change,0
4842,PT-04842,61,M,Bhopal Research Hospital,Phase III,ORX-505,Infectious Disease,Low Dose,2024-03-18,2024-04-15,7.35,7.56,90,84,70,Nausea,Mild,No Change,0
4843,PT-04843,22,F,Indore Medical Institute,Phase III,ORX-404,Neurology,High Dose,2023-12-16,2024-02-10,7.12,7.71,168,84,68,None,None,Improved,0
4844,PT-04844,32,F,Indore Medical Institute,Phase III,ORX-202,Diabetes,High Dose,2024-04-03,2024-04-10,8.36,7.06,139,85,80,Rash,None,Worsened,0
4845,PT-04845,19,F,PGI Chandigarh,Phase III,ORX-101,Oncology,High Dose,2024-07-19,2024-07-26,6.77,5.06,117,93,95,None,None,No Change,0
4846,PT-04846,48,F,AIIMS Delhi,Phase IV,ORX-101,Oncology,Placebo,2024-08-22,2024-08-29,6.52,7.54,117,68,87,Fever,None,Worsened,0
4847,PT-04847,52,M,Fortis Mumbai,Phase III,ORX-505,Infectious Disease,Placebo,2024-05-21,2024-06-04,6.55,6.24,135,84,84,None,None,No Change,0
4848,PT-04848,36,F,Fortis Mumbai,Phase III,ORX-303,Cardiology,Placebo,2024-05-04,2024-05-18,7.83,7.45,119,79,76,Nausea,None,No Change,0
4849,PT-04849,21,M,AIIMS Delhi,Phase I,ORX-101,Oncology,High Dose,2024-02-12,2024-04-08,6.44,6.09,103,74,111,Nausea,Severe,Worsened,0
4850,PT-04850,26,M,Fortis Mumbai,Phase III,ORX-202,Diabetes,High Dose,2023-03-26,2023-05-21,6.74,5.59,125,72,74,None,None,Improved,1
4851,PT-04851,33,F,Indore Medical Institute,Phase I,ORX-404,Neurology,High Dose,2023-08-14,2023-09-11,8.47,8.14,109,92,64,None,None,Improved,1
4852,PT-04852,19,F,Indore Medical Institute,Phase I,ORX-505,Infectious Disease,Placebo,2023-07-17,2023-07-24,7.2,8.51,95,66,88,None,None,No Change,0
4853,PT-04853,34,F,Apollo Chennai,Phase I,ORX-202,Diabetes,Placebo,2023-06-12,2023-09-10,7.93,6.78,130,102,61,None,None,Worsened,0
4854,PT-04854,61,F,NIMHANS Bengaluru,Phase II,ORX-404,Neurology,High Dose,2023-10-02,2023-10-16,8.02,6.28,138,82,79,None,None,Worsened,0
4855,PT-04855,50,M,AIIMS Delhi,Phase III,ORX-505,Infectious Disease,High Dose,2023-08-29,2023-09-05,6.78,6.44,132,90,56,None,None,Improved,1
4856,PT-04856,65,M,Fortis Mumbai,Phase IV,ORX-404,Neurology,High Dose,2023-09-16,2023-10-14,5.81,6.1,129,66,85,None,None,Improved,0
4857,PT-04857,29,M,Indore Medical Institute,Phase III,ORX-404,Neurology,Low Dose,2024-10-21,2024-11-04,8.48,7.44,101,100,80,None,None,Improved,1
4858,PT-04858,58,M,Bhopal Research Hospital,Phase I,ORX-505,Infectious Disease,Placebo,2023-03-03,2023-04-28,6.18,4.08,158,81,84,Nausea,None,Improved,1
4859,PT-04859,55,F,Indore Medical Institute,Phase III,ORX-606,Rheumatology,Placebo,2023-04-08,2023-06-03,6.8,6.6,156,81,91,None,None,Improved,1
4860,PT-04860,18,F,NIMHANS Bengaluru,Phase II,ORX-606,Rheumatology,Low Dose,2024-10-06,2024-11-03,8.55,6.78,146,86,76,None,None,Improved,1
4861,PT-04861,43,M,Apollo Chennai,Phase IV,ORX-404,Neurology,Low Dose,2023-11-24,2024-02-22,6.9,5.76,124,108,96,Dizziness,Mild,No Change,0
4862,PT-04862,31,M,Indore Medical Institute,Phase III,ORX-505,Infectious Disease,High Dose,2024-09-25,2024-12-24,7.52,7.21,125,69,84,None,None,No Change,0
4863,PT-04863,58,F,NIMHANS Bengaluru,Phase III,ORX-303,Cardiology,Placebo,2023-02-14,2023-05-15,6.2,7.56,155,88,60,None,None,Improved,0
4864,PT-04864,51,M,Apollo Chennai,Phase II,ORX-101,Oncology,Placebo,2024-07-11,2024-07-25,7.54,7.6,156,79,106,None,None,Improved,0
4865,PT-04865,51,M,AIIMS Delhi,Phase I,ORX-404,Neurology,High Dose,2024-04-24,2024-05-22,6.85,8.61,142,76,79,None,None,Improved,0
4866,PT-04866,55,M,NIMHANS Bengaluru,Phase III,ORX-303,Cardiology,High Dose,2023-04-02,2023-05-28,7.02,6.74,113,61,79,None,None,Improved,1
4867,PT-04867,47,M,AIIMS Delhi,Phase I,ORX-606,Rheumatology,Placebo,2023-07-17,2023-08-14,7.83,,103,70,92,None,None,Improved,1
4868,PT-04868,34,M,Apollo Chennai,Phase IV,ORX-606,Rheumatology,Placebo,2023-01-30,2023-04-30,6.67,5.99,116,73,65,None,None,No Change,0
4869,PT-04869,67,F,Indore Medical Institute,Phase III,ORX-505,Infectious Disease,High Dose,2024-06-11,2024-08-06,8.02,8.74,154,53,82,None,None,Worsened,0
4870,PT-04870,35,M,Indore Medical Institute,Phase III,ORX-303,Cardiology,Low Dose,2023-08-26,2023-09-02,8.54,7.47,109,64,73,None,None,Improved,1
4871,PT-04871,59,F,AIIMS Delhi,Phase IV,ORX-101,Oncology,Placebo,2024-03-31,2024-04-07,7.51,6.03,166,89,88,None,None,No Change,0
4872,PT-04872,65,M,Bhopal Research Hospital,Phase III,ORX-606,Rheumatology,High Dose,2024-03-01,2024-04-26,5.23,4.01,142,72,74,Fatigue,None,Worsened,0
4873,PT-04873,43,F,NIMHANS Bengaluru,Phase II,ORX-404,Neurology,Placebo,2024-10-31,2024-12-26,5.67,4.94,144,90,93,None,None,Improved,1
4874,PT-04874,61,M,NIMHANS Bengaluru,Phase IV,ORX-505,Infectious Disease,Low Dose,2023-10-08,2023-12-03,7.69,7.58,132,74,63,Rash,None,Worsened,0
4875,PT-04875,33,F,PGI Chandigarh,Phase IV,ORX-505,Infectious Disease,High Dose,2024-03-13,2024-06-11,6.81,5.82,135,84,82,None,None,No Change,0
4876,PT-04876,50,F,AIIMS Delhi,Phase II,ORX-303,Cardiology,Placebo,2024-04-15,2024-06-10,8.63,8.23,146,88,93,None,None,Worsened,0
4877,PT-04877,70,F,Apollo Chennai,Phase III,ORX-606,Rheumatology,High Dose,2024-01-18,2024-01-25,7.89,7.59,129,76,70,Fatigue,None,Improved,1
4878,PT-04878,59,M,Apollo Chennai,Phase IV,ORX-606,Rheumatology,Low Dose,2023-01-31,2023-02-07,6.04,7.1,125,116,68,Headache,Moderate,Improved,0
4879,PT-04879,49,F,Indore Medical Institute,Phase III,ORX-606,Rheumatology,Low Dose,2024-10-23,2024-10-30,6.78,5.66,147,68,68,Fever,None,Improved,1
4880,PT-04880,54,F,Apollo Chennai,Phase III,ORX-202,Diabetes,Placebo,2024-10-28,2024-11-25,8.09,6.44,138,83,65,None,None,Improved,1
4881,PT-04881,32,F,NIMHANS Bengaluru,Phase III,ORX-101,Oncology,High Dose,2024-01-06,2024-04-05,4.76,5.91,146,66,89,None,None,Worsened,0
4882,PT-04882,35,M,Fortis Mumbai,Phase II,ORX-101,Oncology,Low Dose,2024-11-30,2025-02-28,8.3,7.45,121,78,68,Fatigue,Mild,No Change,0
4883,PT-04883,67,F,Bhopal Research Hospital,Phase II,ORX-303,Cardiology,High Dose,2024-02-23,2024-04-19,8.28,7.98,146,62,60,Rash,Moderate,Improved,1
4884,PT-04884,52,M,Indore Medical Institute,Phase IV,ORX-303,Cardiology,High Dose,2024-10-16,2025-01-14,8.08,7.93,94,69,83,Dizziness,None,Improved,1
4885,PT-04885,83,M,PGI Chandigarh,Phase III,ORX-404,Neurology,Low Dose,2024-06-18,2024-08-13,8.66,9.68,134,85,63,Nausea,Mild,Improved,0
4886,PT-04886,60,M,AIIMS Delhi,Phase II,ORX-303,Cardiology,High Dose,2023-09-24,2023-10-01,7.11,7.34,128,85,76,None,None,No Change,0
4887,PT-04887,48,M,Kolkata Clinical Center,Phase I,ORX-606,Rheumatology,Placebo,2023-01-22,2023-04-22,8.4,6.86,101,87,98,None,None,Improved,1
4888,PT-04888,72,M,Apollo Chennai,Phase III,ORX-202,Diabetes,Low Dose,2023-08-30,2023-09-27,5.73,4.97,101,75,93,None,None,Improved,1
4889,PT-04889,44,M,PGI Chandigarh,Phase III,ORX-101,Oncology,Low Dose,2023-06-22,2023-09-20,6.75,6.84,113,101,78,None,None,No Change,0
4890,PT-04890,38,F,AIIMS Delhi,Phase II,ORX-404,Neurology,Placebo,2024-05-03,2024-05-17,7.9,8.35,156,79,93,Fatigue,None,Improved,0
4891,PT-04891,46,M,Kolkata Clinical Center,Phase I,ORX-404,Neurology,High Dose,2023-08-17,2023-09-14,6.47,5.37,108,73,93,Rash,Mild,Improved,1
4892,PT-04892,56,F,Kolkata Clinical Center,Phase II,ORX-404,Neurology,Low Dose,2023-07-06,2023-07-20,5.71,3.74,107,72,73,Rash,None,Improved,1
4893,PT-04893,63,F,Bhopal Research Hospital,Phase IV,ORX-404,Neurology,Low Dose,2023-03-10,2023-05-05,6.54,7.66,97,77,88,None,None,Improved,0
4894,PT-04894,58,M,AIIMS Delhi,Phase II,ORX-606,Rheumatology,Low Dose,2023-12-02,2023-12-30,6.8,7.3,142,73,82,None,None,No Change,0
4895,PT-04895,56,F,Indore Medical Institute,Phase I,ORX-303,Cardiology,High Dose,2024-03-26,2024-04-23,6.47,7.59,112,83,60,Headache,Severe,No Change,0
4896,PT-04896,46,F,Fortis Mumbai,Phase III,ORX-505,Infectious Disease,Low Dose,2023-11-02,2023-11-09,5.92,5.25,99,91,82,Nausea,None,Improved,1
4897,PT-04897,62,F,Kolkata Clinical Center,Phase III,ORX-505,Infectious Disease,High Dose,2023-07-21,2023-08-18,6.78,7.4,128,83,107,None,None,No Change,0
4898,PT-04898,37,M,PGI Chandigarh,Phase IV,ORX-202,Diabetes,Placebo,2024-07-08,2024-10-06,8.67,8.7,117,66,63,Fatigue,Mild,Improved,0
4899,PT-04899,63,F,Fortis Mumbai,Phase III,ORX-101,Oncology,Low Dose,2023-12-28,2024-01-25,9.28,8.96,130,91,79,Rash,None,Improved,1
4900,PT-04900,62,M,Bhopal Research Hospital,Phase I,ORX-303,Cardiology,High Dose,2024-04-18,2024-05-02,7.55,7.27,115,70,45,Nausea,Moderate,No Change,0
4901,PT-04901,64,M,Apollo Chennai,Phase III,ORX-303,Cardiology,Low Dose,2023-10-16,2024-01-14,7.02,6.26,92,74,67,Headache,Mild,Worsened,0
4902,PT-04902,32,M,Bhopal Research Hospital,Phase III,ORX-202,Diabetes,High Dose,2024-05-16,2024-05-23,7.6,7.31,103,66,59,None,None,Worsened,0
4903,PT-04903,73,F,Indore Medical Institute,Phase II,ORX-505,Infectious Disease,Placebo,2024-04-06,2024-05-04,8.99,7.82,92,83,78,Nausea,Moderate,Improved,1
4904,PT-04904,50,M,Indore Medical Institute,Phase IV,ORX-606,Rheumatology,Placebo,2024-07-04,2024-10-02,8.09,8.1,107,85,89,None,None,No Change,0
4905,PT-04905,33,M,Fortis Mumbai,Phase IV,ORX-101,Oncology,Low Dose,2024-02-03,2024-03-02,7.56,6.66,163,66,94,None,None,No Change,0
4906,PT-04906,18,M,Apollo Chennai,Phase III,ORX-404,Neurology,Low Dose,2023-11-26,2023-12-10,9.35,7.92,131,62,59,Nausea,Mild,No Change,0
4907,PT-04907,59,M,AIIMS Delhi,Phase III,ORX-202,Diabetes,Low Dose,2024-01-30,2024-02-27,8.43,8.25,141,94,68,Fever,None,Improved,1
4908,PT-04908,22,M,PGI Chandigarh,Phase III,ORX-505,Infectious Disease,Low Dose,2024-11-16,2024-11-23,7.18,6.26,134,88,68,Headache,None,Worsened,0
4909,PT-04909,56,M,Indore Medical Institute,Phase III,ORX-101,Oncology,Low Dose,2023-07-19,2023-09-13,7.98,8.24,120,91,85,None,None,Improved,0
4910,PT-04910,55,F,Kolkata Clinical Center,Phase IV,ORX-606,Rheumatology,Placebo,2024-11-02,2024-11-16,9.21,9.11,117,68,93,Headache,None,Improved,1
4911,PT-04911,50,F,Bhopal Research Hospital,Phase I,ORX-404,Neurology,Low Dose,2023-06-24,2023-07-08,9.2,6.98,144,78,73,Headache,None,Improved,1
4912,PT-04912,32,F,PGI Chandigarh,Phase II,ORX-303,Cardiology,Placebo,2023-03-11,2023-06-09,8.28,8.43,107,83,87,None,None,Worsened,0
4913,PT-04913,47,M,AIIMS Delhi,Phase III,ORX-404,Neurology,High Dose,2024-09-26,2024-10-10,8.53,7.87,90,84,80,Headache,None,No Change,0
4914,PT-04914,49,M,NIMHANS Bengaluru,Phase III,ORX-202,Diabetes,Low Dose,2023-09-01,2023-09-29,8.53,6.37,123,70,61,Headache,None,No Change,0
4915,PT-04915,43,F,Fortis Mumbai,Phase III,ORX-505,Infectious Disease,Low Dose,2024-09-15,2024-09-22,8.04,7.91,115,80,91,None,None,Improved,1
4916,PT-04916,55,M,PGI Chandigarh,Phase IV,ORX-303,Cardiology,High Dose,2024-05-31,2024-06-28,6.54,5.58,97,76,53,Fever,Moderate,Improved,1
4917,PT-04917,78,M,Apollo Chennai,Phase II,ORX-606,Rheumatology,Low Dose,2024-09-15,2024-09-22,6.17,6.77,160,84,76,None,None,Worsened,0
4918,PT-04918,23,M,Kolkata Clinical Center,Phase II,ORX-303,Cardiology,Placebo,2024-10-13,2024-10-27,6.59,7.64,134,82,96,None,None,No Change,0
4919,PT-04919,56,M,Fortis Mumbai,Phase IV,ORX-101,Oncology,Low Dose,2024-08-02,2024-08-30,7.02,6.82,114,75,75,None,None,No Change,0
4920,PT-04920,53,M,Bhopal Research Hospital,Phase II,ORX-303,Cardiology,Low Dose,2023-09-27,2023-12-26,5.7,5.37,120,71,72,None,None,Improved,1
4921,PT-04921,18,M,AIIMS Delhi,Phase III,ORX-505,Infectious Disease,Placebo,2024-06-12,2024-07-10,6.29,4.9,122,54,80,None,None,Improved,1
4922,PT-04922,59,F,Indore Medical Institute,Phase I,ORX-505,Infectious Disease,High Dose,2024-03-06,2024-03-20,7.06,7.11,118,63,78,Headache,Severe,No Change,0
4923,PT-04923,55,F,Indore Medical Institute,Phase III,ORX-404,Neurology,High Dose,2023-01-22,2023-01-29,5.61,4.79,123,116,81,Nausea,None,No Change,0
4924,PT-04924,18,M,Kolkata Clinical Center,Phase I,ORX-303,Cardiology,High Dose,2024-11-04,2024-12-02,4.62,4.87,172,78,73,Headache,Mild,Improved,0
4925,PT-04925,51,M,PGI Chandigarh,Phase II,ORX-606,Rheumatology,Low Dose,2023-01-26,2023-04-26,6.24,3.55,146,74,92,Rash,Mild,Improved,1
4926,PT-04926,32,M,Bhopal Research Hospital,Phase I,ORX-202,Diabetes,High Dose,2024-01-25,2024-02-08,7.35,7.72,147,84,80,None,None,Improved,0
4927,PT-04927,54,F,Indore Medical Institute,Phase III,ORX-101,Oncology,Placebo,2023-12-20,2023-12-27,7.76,6.19,105,56,88,None,None,No Change,0
4928,PT-04928,38,F,Fortis Mumbai,Phase IV,ORX-606,Rheumatology,Placebo,2024-03-11,2024-03-18,8.18,8.15,109,80,71,None,None,No Change,0
4929,PT-04929,35,F,AIIMS Delhi,Phase III,ORX-303,Cardiology,Low Dose,2024-05-11,2024-06-08,8.3,10.16,148,81,95,None,None,Improved,0
4930,PT-04930,72,M,Apollo Chennai,Phase IV,ORX-303,Cardiology,Low Dose,2024-11-16,2025-02-14,5.53,6.23,141,96,89,Dizziness,None,No Change,0
4931,PT-04931,41,M,NIMHANS Bengaluru,Phase I,ORX-202,Diabetes,Placebo,2024-04-16,2024-05-14,9.64,9.55,120,88,91,Headache,None,No Change,0
4932,PT-04932,46,F,AIIMS Delhi,Phase IV,ORX-101,Oncology,High Dose,2023-06-10,2023-06-24,7.67,7.35,116,72,58,Headache,Mild,Improved,1
4933,PT-04933,69,F,Apollo Chennai,Phase III,ORX-404,Neurology,High Dose,2024-10-30,2024-11-13,6.93,3.45,135,86,51,Rash,None,Worsened,0
4934,PT-04934,31,F,PGI Chandigarh,Phase II,ORX-303,Cardiology,Placebo,2024-06-05,2024-07-31,6.15,5.08,149,80,72,Dizziness,Moderate,No Change,0
4935,PT-04935,62,F,NIMHANS Bengaluru,Phase I,ORX-404,Neurology,Placebo,2024-05-27,2024-07-22,7.79,5.83,116,85,64,Nausea,None,Improved,1
4936,PT-04936,77,F,Indore Medical Institute,Phase I,ORX-101,Oncology,Placebo,2023-12-18,2024-01-15,7.34,6.26,107,93,68,Nausea,None,Improved,1
4937,PT-04937,51,M,Kolkata Clinical Center,Phase II,ORX-505,Infectious Disease,Low Dose,2023-05-20,2023-08-18,5.82,5.48,116,78,66,Nausea,None,Improved,1
4938,PT-04938,61,F,Fortis Mumbai,Phase III,ORX-101,Oncology,High Dose,2023-11-15,2023-12-13,6.61,6.08,126,101,90,Nausea,None,Improved,1
4939,PT-04939,57,M,NIMHANS Bengaluru,Phase III,ORX-505,Infectious Disease,High Dose,2024-10-26,2024-11-02,5.31,4.32,149,67,79,None,None,Worsened,0
4940,PT-04940,27,F,Apollo Chennai,Phase III,ORX-505,Infectious Disease,Low Dose,2024-01-08,2024-04-07,6.04,7.15,140,93,88,Nausea,None,Improved,0
4941,PT-04941,42,M,Apollo Chennai,Phase III,ORX-606,Rheumatology,Placebo,2023-03-20,2023-06-18,6.37,5.61,124,103,59,None,None,No Change,0
4942,PT-04942,36,F,Bhopal Research Hospital,Phase III,ORX-505,Infectious Disease,Placebo,2023-04-21,2023-06-16,6.1,6.66,161,85,83,Headache,None,Improved,0
4943,PT-04943,46,M,Fortis Mumbai,Phase II,ORX-505,Infectious Disease,Low Dose,2023-01-03,2023-04-03,7.72,8.02,135,87,88,Nausea,None,Improved,0
4944,PT-04944,18,F,NIMHANS Bengaluru,Phase II,ORX-505,Infectious Disease,High Dose,2024-04-26,2024-05-24,7.2,7.08,135,79,80,None,None,Worsened,0
4945,PT-04945,33,F,NIMHANS Bengaluru,Phase III,ORX-606,Rheumatology,High Dose,2024-06-30,2024-09-28,5.07,5.56,107,80,67,None,None,Improved,0
4946,PT-04946,70,M,Bhopal Research Hospital,Phase II,ORX-606,Rheumatology,High Dose,2024-11-12,2025-01-07,7.1,6.43,141,107,83,None,None,No Change,0
4947,PT-04947,38,F,Indore Medical Institute,Phase III,ORX-505,Infectious Disease,Placebo,2023-03-25,2023-06-23,8.04,6.22,128,105,80,None,None,Improved,1
4948,PT-04948,46,M,Kolkata Clinical Center,Phase IV,ORX-505,Infectious Disease,High Dose,2024-10-17,2024-10-24,7.22,6.47,133,91,73,None,None,Worsened,0
4949,PT-04949,18,M,NIMHANS Bengaluru,Phase I,ORX-101,Oncology,Low Dose,2024-05-16,2024-06-13,7.76,9.28,121,64,87,Fatigue,Severe,Improved,0
4950,PT-04950,72,F,PGI Chandigarh,Phase IV,ORX-505,Infectious Disease,High Dose,2024-03-28,2024-05-23,7.84,8.99,142,90,70,None,None,No Change,0
4951,PT-04951,49,M,NIMHANS Bengaluru,Phase III,ORX-505,Infectious Disease,Placebo,2023-02-05,2023-04-02,7.16,6.71,123,84,59,None,None,Improved,1
4952,PT-04952,57,M,Apollo Chennai,Phase I,ORX-303,Cardiology,Low Dose,2023-11-11,2023-11-18,6.15,5.52,133,70,50,None,None,Improved,1
4953,PT-04953,38,F,AIIMS Delhi,Phase II,ORX-202,Diabetes,Placebo,2024-01-14,2024-04-13,5.48,5.72,107,99,77,Headache,None,Improved,0
4954,PT-04954,45,F,Bhopal Research Hospital,Phase III,ORX-101,Oncology,High Dose,2023-07-03,2023-08-28,4.82,4.55,126,66,79,None,None,Improved,1
4955,PT-04955,38,M,Fortis Mumbai,Phase IV,ORX-505,Infectious Disease,Placebo,2024-02-26,2024-03-11,6.94,6.56,119,84,76,Headache,None,Improved,1
4956,PT-04956,52,M,Indore Medical Institute,Phase III,ORX-202,Diabetes,Low Dose,2023-03-18,2023-03-25,6.57,5.21,115,99,91,None,None,Worsened,0
4957,PT-04957,64,F,Fortis Mumbai,Phase II,ORX-303,Cardiology,Placebo,2023-10-14,2023-12-09,8.74,7.92,133,82,87,Nausea,Severe,Improved,1
4958,PT-04958,40,F,Apollo Chennai,Phase IV,ORX-202,Diabetes,High Dose,2024-02-12,2024-03-11,7.31,6.98,137,89,79,None,None,Improved,1
4959,PT-04959,46,M,Kolkata Clinical Center,Phase III,ORX-101,Oncology,High Dose,2023-12-05,2023-12-19,7.47,8.55,96,70,87,Headache,Moderate,Improved,0
4960,PT-04960,49,F,Apollo Chennai,Phase III,ORX-303,Cardiology,High Dose,2023-04-08,2023-06-03,7.52,7.72,131,75,86,None,None,Improved,0
4961,PT-04961,45,F,PGI Chandigarh,Phase IV,ORX-101,Oncology,Placebo,2024-11-05,2024-12-03,6.66,6.88,139,84,102,None,None,Improved,0
4962,PT-04962,66,M,AIIMS Delhi,Phase III,ORX-606,Rheumatology,High Dose,2023-12-08,2024-01-05,8.4,10.31,125,76,90,None,None,No Change,0
4963,PT-04963,40,M,PGI Chandigarh,Phase II,ORX-606,Rheumatology,High Dose,2023-08-31,2023-09-07,7.21,5.93,138,64,76,Fatigue,Severe,No Change,0
4964,PT-04964,44,M,Indore Medical Institute,Phase III,ORX-303,Cardiology,Low Dose,2024-06-27,2024-09-25,6.68,4.7,96,73,85,None,None,Improved,1
4965,PT-04965,49,M,Indore Medical Institute,Phase II,ORX-505,Infectious Disease,Low Dose,2024-01-19,2024-03-15,7.18,5.98,134,60,45,Fatigue,Severe,No Change,0
4966,PT-04966,41,M,PGI Chandigarh,Phase II,ORX-303,Cardiology,Low Dose,2024-06-05,2024-07-03,6.54,7.06,130,101,70,None,None,No Change,0
4967,PT-04967,52,M,Apollo Chennai,Phase III,ORX-505,Infectious Disease,Low Dose,2024-03-25,2024-04-22,6.9,7.74,124,92,62,None,None,Improved,0
4968,PT-04968,38,M,PGI Chandigarh,Phase I,ORX-606,Rheumatology,Low Dose,2023-08-02,2023-08-16,7.1,7.84,90,78,72,None,None,Worsened,0
4969,PT-04969,18,M,NIMHANS Bengaluru,Phase III,ORX-101,Oncology,Low Dose,2023-10-23,2023-10-30,6.64,4.86,90,78,73,None,None,Improved,1
4970,PT-04970,41,F,Kolkata Clinical Center,Phase I,ORX-303,Cardiology,Placebo,2024-02-27,2024-04-23,7.5,6.31,160,81,96,None,None,Improved,1
4971,PT-04971,18,M,PGI Chandigarh,Phase III,ORX-505,Infectious Disease,High Dose,2024-08-27,2024-10-22,6.2,6.42,123,69,52,Headache,Mild,Worsened,0
4972,PT-04972,56,M,Fortis Mumbai,Phase II,ORX-202,Diabetes,Placebo,2023-09-03,2023-09-10,7.98,7.8,119,68,77,None,None,Improved,1
4973,PT-04973,23,M,Indore Medical Institute,Phase III,ORX-404,Neurology,High Dose,2024-04-25,2024-05-02,6.3,7.03,94,90,98,None,None,No Change,0
4974,PT-04974,58,M,Bhopal Research Hospital,Phase II,ORX-606,Rheumatology,High Dose,2023-04-04,2023-05-02,7.68,6.86,116,55,78,None,None,Worsened,0
4975,PT-04975,38,M,AIIMS Delhi,Phase IV,ORX-505,Infectious Disease,Low Dose,2023-05-17,2023-05-31,6.36,5.94,129,74,100,Nausea,Mild,Improved,1
4976,PT-04976,56,M,AIIMS Delhi,Phase II,ORX-606,Rheumatology,Placebo,2023-12-04,2024-01-01,8.28,7.78,137,71,87,None,None,Improved,1
4977,PT-04977,41,M,Apollo Chennai,Phase II,ORX-101,Oncology,Placebo,2023-05-15,2023-05-22,5.97,5.55,122,109,84,None,None,Improved,1
4978,PT-04978,70,M,AIIMS Delhi,Phase III,ORX-505,Infectious Disease,High Dose,2023-06-14,2023-07-12,8.56,8.19,120,61,65,None,None,No Change,0
4979,PT-04979,55,F,Apollo Chennai,Phase III,ORX-303,Cardiology,Placebo,2023-06-15,2023-09-13,6.84,6.78,91,87,93,None,None,Improved,1
4980,PT-04980,18,F,AIIMS Delhi,Phase IV,ORX-505,Infectious Disease,Placebo,2024-06-15,2024-07-13,7.65,8.46,158,75,88,None,None,Improved,0
4981,PT-04981,67,F,Kolkata Clinical Center,Phase II,ORX-404,Neurology,Low Dose,2024-01-07,2024-01-21,7.68,8.44,127,86,69,Fatigue,None,Improved,0
4982,PT-04982,42,M,Kolkata Clinical Center,Phase I,ORX-101,Oncology,Low Dose,2024-02-06,2024-02-20,7.72,6.69,123,91,106,None,None,Worsened,0
4983,PT-04983,18,M,Apollo Chennai,Phase I,ORX-101,Oncology,High Dose,2023-12-09,2024-02-03,9.57,8.94,145,95,99,Headache,None,Improved,1
4984,PT-04984,33,F,Apollo Chennai,Phase III,ORX-404,Neurology,Placebo,2023-05-30,2023-06-27,6.93,6.48,121,97,76,Nausea,None,Improved,1
4985,PT-04985,19,F,Kolkata Clinical Center,Phase III,ORX-202,Diabetes,Low Dose,2023-07-06,2023-08-03,6.44,4.62,123,90,68,None,None,Improved,1
4986,PT-04986,38,M,AIIMS Delhi,Phase II,ORX-505,Infectious Disease,Placebo,2023-07-10,2023-07-24,6.87,6.6,137,91,109,Fatigue,None,Worsened,0
4987,PT-04987,46,M,PGI Chandigarh,Phase II,ORX-202,Diabetes,High Dose,2023-08-11,2023-09-08,8.08,6.25,121,78,63,None,None,No Change,0
4988,PT-04988,36,M,Indore Medical Institute,Phase III,ORX-505,Infectious Disease,High Dose,2023-10-26,2023-11-02,7.07,6.22,174,88,106,Headache,Severe,Worsened,0
4989,PT-04989,68,F,Fortis Mumbai,Phase I,ORX-303,Cardiology,High Dose,2023-07-09,2023-10-07,6.43,6.07,120,80,64,None,None,Worsened,0
4990,PT-04990,37,F,Indore Medical Institute,Phase II,ORX-505,Infectious Disease,High Dose,2024-10-22,2025-01-20,7.63,7.53,132,81,90,Headache,Moderate,Improved,1
4991,PT-04991,40,F,NIMHANS Bengaluru,Phase I,ORX-202,Diabetes,High Dose,2024-09-20,2024-10-04,8.87,6.81,139,87,68,Dizziness,None,Improved,1
4992,PT-04992,39,F,PGI Chandigarh,Phase IV,ORX-505,Infectious Disease,High Dose,2023-08-28,2023-09-11,7.76,8.18,96,89,71,None,None,No Change,0
4993,PT-04993,63,F,Bhopal Research Hospital,Phase III,ORX-606,Rheumatology,High Dose,2024-09-16,2024-09-23,4.99,6.79,112,99,77,Headache,Mild,Improved,0
4994,PT-04994,31,F,Kolkata Clinical Center,Phase II,ORX-303,Cardiology,Low Dose,2023-03-02,2023-05-31,7.52,8.04,100,90,77,None,None,No Change,0
4995,PT-04995,54,F,AIIMS Delhi,Phase I,ORX-606,Rheumatology,High Dose,2023-07-15,2023-07-22,7.21,6.3,107,90,87,None,None,Improved,1
4996,PT-04996,55,F,Bhopal Research Hospital,Phase IV,ORX-505,Infectious Disease,Low Dose,2023-11-07,2024-02-05,7.71,8.16,153,59,45,None,None,No Change,0
4997,PT-04997,72,F,PGI Chandigarh,Phase II,ORX-202,Diabetes,High Dose,2023-04-11,2023-05-09,5.59,4.21,122,62,72,Headache,Severe,Improved,1
4998,PT-04998,29,F,Indore Medical Institute,Phase IV,ORX-505,Infectious Disease,Low Dose,2024-01-26,2024-04-25,6.92,6.77,121,77,81,Rash,None,Improved,1
4999,PT-04999,61,M,PGI Chandigarh,Phase III,ORX-202,Diabetes,High Dose,2024-01-13,2024-02-10,9.12,8.53,160,92,60,None,None,Worsened,0
5000,PT-05000,24,M,Indore Medical Institute,Phase III,ORX-303,Cardiology,Low Dose,2024-02-25,2024-03-10,6.51,7.41,118,59,74,Fever,None,No Change,0
5001,PT-05001,18,F,Indore Medical Institute,Phase III,ORX-606,Rheumatology,High Dose,2023-09-29,2023-10-06,5.93,5.01,130,94,87,Nausea,None,No Change,0
5002,PT-05002,26,M,NIMHANS Bengaluru,Phase II,ORX-303,Cardiology,Placebo,2023-10-23,2023-11-20,6.75,6.42,123,78,53,Fever,None,No Change,0
5003,PT-05003,26,F,Apollo Chennai,Phase II,ORX-202,Diabetes,High Dose,2024-10-11,2024-10-18,6.72,3.53,139,65,87,None,None,Improved,1
5004,PT-05004,54,M,Apollo Chennai,Phase III,ORX-404,Neurology,Placebo,2023-06-02,2023-06-30,6.55,7.05,141,78,72,None,None,Improved,0
5005,PT-05005,62,M,NIMHANS Bengaluru,Phase II,ORX-505,Infectious Disease,Placebo,2023-01-31,2023-05-01,7.48,8.02,90,83,55,Headache,None,Worsened,0
5006,PT-05006,44,M,AIIMS Delhi,Phase III,ORX-202,Diabetes,High Dose,2023-06-17,2023-08-12,8.06,9.22,111,75,76,None,None,Improved,0
5007,PT-05007,29,F,Indore Medical Institute,Phase III,ORX-404,Neurology,Low Dose,2024-10-03,2024-11-28,8.37,7.91,130,89,76,None,None,Improved,1
5008,PT-05008,31,F,Apollo Chennai,Phase III,ORX-101,Oncology,Low Dose,2024-11-05,2024-11-12,7.12,5.95,129,93,61,None,None,Improved,1
5009,PT-05009,20,M,Indore Medical Institute,Phase III,ORX-101,Oncology,Placebo,2023-10-24,2024-01-22,7.26,6.17,128,85,47,None,None,No Change,0
5010,PT-05010,56,F,Bhopal Research Hospital,Phase IV,ORX-101,Oncology,High Dose,2024-05-08,2024-06-05,5.8,5.38,116,75,101,Nausea,None,No Change,0
5011,PT-05011,50,F,Indore Medical Institute,Phase III,ORX-606,Rheumatology,High Dose,2023-03-05,2023-04-30,8.29,8.02,139,87,81,None,None,Improved,1
5012,PT-05012,62,M,Fortis Mumbai,Phase III,ORX-505,Infectious Disease,Placebo,2023-02-01,2023-03-01,7.39,9.04,145,68,75,None,None,No Change,0
5013,PT-05013,51,F,Fortis Mumbai,Phase II,ORX-101,Oncology,Placebo,2023-03-02,2023-04-27,7.25,7.47,142,65,95,Rash,Mild,Improved,0
5014,PT-05014,37,M,PGI Chandigarh,Phase I,ORX-303,Cardiology,High Dose,2023-08-11,2023-08-18,6.48,5.55,142,78,68,None,None,Improved,1
5015,PT-05015,38,F,Indore Medical Institute,Phase III,ORX-404,Neurology,Low Dose,2024-03-16,2024-05-11,5.05,3.89,105,78,87,None,None,Worsened,0
5016,PT-05016,53,M,Fortis Mumbai,Phase II,ORX-505,Infectious Disease,Placebo,2023-03-15,2023-04-12,8.71,9.24,118,82,77,Nausea,None,Improved,0
5017,PT-05017,18,M,Kolkata Clinical Center,Phase IV,ORX-101,Oncology,High Dose,2023-03-08,2023-04-05,5.74,5.19,124,88,84,None,None,No Change,0
5018,PT-05018,18,M,PGI Chandigarh,Phase I,ORX-101,Oncology,Placebo,2024-03-20,2024-04-03,7.82,7.58,139,94,75,None,None,Worsened,0
5019,PT-05019,64,M,PGI Chandigarh,Phase II,ORX-505,Infectious Disease,Placebo,2023-04-25,2023-05-02,6.13,4.88,135,77,81,Nausea,None,Improved,1
5020,PT-05020,76,F,Fortis Mumbai,Phase I,ORX-606,Rheumatology,High Dose,2023-07-11,2023-08-08,7.67,7.46,112,61,76,None,None,Improved,1
5021,PT-05021,62,M,Kolkata Clinical Center,Phase III,ORX-101,Oncology,Placebo,2023-01-08,2023-03-05,6.81,6.77,153,98,84,Headache,None,Improved,1
5022,PT-05022,47,F,AIIMS Delhi,Phase II,ORX-303,Cardiology,High Dose,2024-07-15,2024-10-13,5.38,4.41,122,71,81,Rash,Mild,Improved,1
5023,PT-05023,75,F,AIIMS Delhi,Phase III,ORX-303,Cardiology,High Dose,2023-08-24,2023-09-07,9.02,8.84,142,73,98,None,None,Improved,1
5024,PT-05024,20,M,Apollo Chennai,Phase IV,ORX-101,Oncology,High Dose,2024-08-27,2024-09-03,8.3,8.34,114,79,62,Headache,None,Worsened,0
5025,PT-05025,27,M,Bhopal Research Hospital,Phase I,ORX-202,Diabetes,High Dose,2024-10-01,2024-11-26,5.29,5.58,149,56,103,None,None,Worsened,0
5026,PT-05026,44,M,AIIMS Delhi,Phase III,ORX-505,Infectious Disease,Low Dose,2023-11-10,2023-11-17,7.55,5.82,151,84,93,Nausea,Moderate,Improved,1
5027,PT-05027,64,M,Fortis Mumbai,Phase III,ORX-606,Rheumatology,Placebo,2023-12-05,2023-12-12,8.8,7.82,124,74,90,None,None,Improved,1
5028,PT-05028,50,M,NIMHANS Bengaluru,Phase III,ORX-606,Rheumatology,Low Dose,2024-02-08,2024-04-04,8.48,9.08,96,98,91,None,None,Worsened,0
5029,PT-05029,39,M,Bhopal Research Hospital,Phase I,ORX-202,Diabetes,Low Dose,2023-05-19,2023-07-14,7.62,7.11,139,77,84,None,None,Improved,1
5030,PT-05030,46,M,Kolkata Clinical Center,Phase III,ORX-404,Neurology,Low Dose,2024-06-13,2024-06-27,6.68,6.45,176,73,74,None,None,No Change,0
5031,PT-05031,34,M,Indore Medical Institute,Phase I,ORX-505,Infectious Disease,High Dose,2023-05-18,2023-06-15,6.52,6.86,140,81,92,None,None,Worsened,0
5032,PT-05032,57,M,Bhopal Research Hospital,Phase III,ORX-606,Rheumatology,High Dose,2023-08-13,2023-08-27,7.01,5.22,142,84,78,None,None,No Change,0
5033,PT-05033,37,F,AIIMS Delhi,Phase III,ORX-101,Oncology,Low Dose,2024-11-18,2024-12-02,8.09,8.01,123,67,92,None,None,No Change,0
5034,PT-05034,54,F,Indore Medical Institute,Phase III,ORX-101,Oncology,Low Dose,2023-06-04,2023-09-02,7.51,4.72,127,79,69,None,None,No Change,0
5035,PT-05035,57,M,NIMHANS Bengaluru,Phase III,ORX-606,Rheumatology,High Dose,2024-02-15,2024-02-22,8.06,8.05,146,69,71,Nausea,Moderate,Worsened,0
5036,PT-05036,46,F,Bhopal Research Hospital,Phase III,ORX-101,Oncology,Low Dose,2023-01-02,2023-01-16,6.45,6.71,118,97,64,Headache,None,No Change,0
5037,PT-05037,79,F,Kolkata Clinical Center,Phase II,ORX-202,Diabetes,High Dose,2023-01-22,2023-04-22,9.64,9.15,148,77,92,Fatigue,None,Improved,1
5038,PT-05038,42,F,NIMHANS Bengaluru,Phase I,ORX-606,Rheumatology,Low Dose,2024-05-20,2024-07-15,5.66,2.08,123,85,96,Headache,None,Improved,1
5039,PT-05039,45,M,PGI Chandigarh,Phase III,ORX-101,Oncology,High Dose,2023-02-24,2023-05-25,8.4,7.59,121,94,45,None,None,Improved,1
5040,PT-05040,45,M,Indore Medical Institute,Phase II,ORX-303,Cardiology,High Dose,2024-01-15,2024-03-11,6.72,7.54,118,88,90,None,None,Worsened,0
5041,PT-05041,21,M,Fortis Mumbai,Phase III,ORX-101,Oncology,High Dose,2023-09-25,2023-10-09,7.03,6.24,145,90,74,None,None,Improved,1
5042,PT-05042,28,F,AIIMS Delhi,Phase I,ORX-505,Infectious Disease,Low Dose,2024-08-21,2024-11-19,8.45,7.98,98,63,84,None,None,Worsened,0
5043,PT-05043,24,M,Bhopal Research Hospital,Phase III,ORX-606,Rheumatology,High Dose,2023-11-14,2024-02-12,9.43,8.19,127,83,67,None,None,Worsened,0
5044,PT-05044,18,F,Indore Medical Institute,Phase III,ORX-202,Diabetes,Placebo,2023-04-06,2023-06-01,7.43,6.35,130,80,81,Nausea,Severe,Improved,1
5045,PT-05045,69,M,Kolkata Clinical Center,Phase IV,ORX-404,Neurology,Low Dose,2024-01-16,2024-01-23,6.54,5.72,98,79,83,Fever,Mild,Worsened,0
5046,PT-05046,37,F,Kolkata Clinical Center,Phase II,ORX-303,Cardiology,Low Dose,2023-07-23,2023-07-30,7.7,7.14,104,85,75,None,None,Improved,1
5047,PT-05047,46,M,PGI Chandigarh,Phase IV,ORX-101,Oncology,High Dose,2023-09-11,2023-12-10,6.52,5.53,130,79,102,Fatigue,Moderate,Improved,1
5048,PT-05048,57,M,Kolkata Clinical Center,Phase II,ORX-303,Cardiology,Low Dose,2024-03-28,2024-04-25,7.85,7.29,91,72,68,None,None,Worsened,0
5049,PT-05049,40,F,PGI Chandigarh,Phase IV,ORX-101,Oncology,High Dose,2023-09-12,2023-10-10,7.16,7.35,132,95,73,Fever,None,No Change,0
5050,PT-05050,49,M,AIIMS Delhi,Phase III,ORX-404,Neurology,Placebo,2023-04-18,2023-05-02,7.61,7.43,151,91,59,None,None,Improved,1
5051,PT-05051,43,M,Bhopal Research Hospital,Phase II,ORX-101,Oncology,Placebo,2023-09-13,2023-09-27,7.18,8.72,122,70,84,None,None,No Change,0
5052,PT-05052,52,M,Fortis Mumbai,Phase III,ORX-101,Oncology,High Dose,2024-02-19,2024-02-26,7.11,6.51,145,71,73,Nausea,Mild,No Change,0
5053,PT-05053,36,F,PGI Chandigarh,Phase III,ORX-101,Oncology,High Dose,2024-02-13,2024-02-20,8.51,8.37,108,70,104,None,None,No Change,0
5054,PT-05054,62,F,Fortis Mumbai,Phase II,ORX-505,Infectious Disease,Placebo,2023-08-17,2023-11-15,8.21,7.82,155,68,88,Headache,Moderate,Improved,1
5055,PT-05055,37,F,NIMHANS Bengaluru,Phase III,ORX-606,Rheumatology,Placebo,2023-06-22,2023-08-17,6.9,7.15,125,76,71,Fatigue,None,No Change,0
5056,PT-05056,18,M,Fortis Mumbai,Phase I,ORX-606,Rheumatology,High Dose,2023-02-08,2023-02-22,8.12,6.81,161,78,96,None,None,No Change,0
5057,PT-05057,18,M,Fortis Mumbai,Phase III,ORX-404,Neurology,Low Dose,2023-12-06,2024-03-05,8.08,8.57,151,63,68,None,None,Improved,0
5058,PT-05058,54,F,NIMHANS Bengaluru,Phase II,ORX-303,Cardiology,High Dose,2024-10-01,2024-12-30,7.38,7.24,121,100,114,Rash,Mild,Worsened,0
5059,PT-05059,46,F,PGI Chandigarh,Phase IV,ORX-202,Diabetes,High Dose,2023-03-06,2023-06-04,7.74,7.39,151,91,63,None,None,Improved,1
5060,PT-05060,35,F,NIMHANS Bengaluru,Phase III,ORX-101,Oncology,High Dose,2023-11-08,2023-12-06,5.99,8.01,139,74,68,Headache,Moderate,Improved,0
5061,PT-05061,57,F,NIMHANS Bengaluru,Phase IV,ORX-606,Rheumatology,Low Dose,2024-09-27,2024-10-04,8.29,8.6,120,85,79,None,None,Improved,0
5062,PT-05062,30,M,Kolkata Clinical Center,Phase III,ORX-505,Infectious Disease,Low Dose,2024-02-06,2024-02-20,6.09,6.06,131,88,89,Headache,Mild,Improved,1
5063,PT-05063,68,M,Indore Medical Institute,Phase III,ORX-101,Oncology,Placebo,2024-08-30,2024-09-13,6.27,6.44,141,78,79,None,None,No Change,0
5064,PT-05064,40,F,Apollo Chennai,Phase II,ORX-303,Cardiology,Low Dose,2024-11-05,2024-11-12,9.73,9.42,136,78,71,Headache,Moderate,Improved,1
5065,PT-05065,24,M,NIMHANS Bengaluru,Phase I,ORX-404,Neurology,Low Dose,2023-01-05,2023-04-05,8.52,8.81,122,71,80,None,None,Worsened,0
5066,PT-05066,37,M,NIMHANS Bengaluru,Phase I,ORX-303,Cardiology,Low Dose,2024-09-28,2024-11-23,6.93,5.4,131,84,93,None,None,Improved,1
5067,PT-05067,42,F,PGI Chandigarh,Phase I,ORX-404,Neurology,Low Dose,2023-05-14,2023-08-12,6.8,5.0,147,92,78,Rash,None,Improved,1
5068,PT-05068,23,M,Fortis Mumbai,Phase III,ORX-606,Rheumatology,Placebo,2023-12-11,2023-12-18,5.74,4.85,145,85,57,Fatigue,Mild,No Change,0
5069,PT-05069,51,M,Apollo Chennai,Phase III,ORX-606,Rheumatology,Placebo,2024-02-04,2024-05-04,6.19,5.32,145,91,93,None,None,No Change,0
5070,PT-05070,44,F,NIMHANS Bengaluru,Phase II,ORX-101,Oncology,Placebo,2024-02-19,2024-03-18,8.26,7.33,123,78,78,None,None,Worsened,0
5071,PT-05071,24,M,PGI Chandigarh,Phase IV,ORX-606,Rheumatology,High Dose,2023-01-23,2023-03-20,6.93,7.84,108,66,60,Fatigue,Mild,Improved,0
5072,PT-05072,85,M,Fortis Mumbai,Phase III,ORX-606,Rheumatology,Low Dose,2024-05-23,2024-08-21,7.76,7.11,129,84,69,None,None,Improved,1
5073,PT-05073,36,F,Apollo Chennai,Phase I,ORX-202,Diabetes,High Dose,2023-10-11,2023-11-08,7.01,5.96,120,86,64,Nausea,None,Improved,1
5074,PT-05074,85,F,Bhopal Research Hospital,Phase II,ORX-505,Infectious Disease,Placebo,2024-05-23,2024-08-21,8.1,6.56,90,73,87,None,None,Improved,1
5075,PT-05075,52,F,Fortis Mumbai,Phase III,ORX-202,Diabetes,High Dose,2023-01-25,2023-03-22,7.07,6.13,111,77,63,None,None,No Change,0
5076,PT-05076,38,M,Apollo Chennai,Phase I,ORX-505,Infectious Disease,Low Dose,2024-11-20,2024-11-27,8.8,7.7,138,91,62,Rash,None,No Change,0
5077,PT-05077,31,F,PGI Chandigarh,Phase III,ORX-303,Cardiology,Placebo,2023-11-25,2023-12-09,8.48,7.25,126,106,91,None,None,Worsened,0
5078,PT-05078,46,F,Apollo Chennai,Phase III,ORX-404,Neurology,High Dose,2023-08-02,2023-08-16,8.21,7.76,146,57,76,None,None,Worsened,0
5079,PT-05079,18,M,Kolkata Clinical Center,Phase IV,ORX-303,Cardiology,Placebo,2023-12-31,2024-01-07,7.39,6.78,152,90,70,Headache,None,No Change,0
5080,PT-05080,38,F,Bhopal Research Hospital,Phase III,ORX-606,Rheumatology,Placebo,2023-06-10,2023-07-08,7.66,6.74,127,97,66,None,None,No Change,0
5081,PT-05081,37,F,AIIMS Delhi,Phase I,ORX-606,Rheumatology,Low Dose,2024-01-06,2024-03-02,6.83,9.27,138,95,88,None,None,Improved,0
5082,PT-05082,58,F,NIMHANS Bengaluru,Phase I,ORX-101,Oncology,Placebo,2024-11-16,2024-12-14,7.77,7.7,101,86,76,Nausea,None,No Change,0
5083,PT-05083,53,M,AIIMS Delhi,Phase I,ORX-303,Cardiology,Low Dose,2024-06-07,2024-06-21,7.11,7.4,144,50,71,Headache,Moderate,Worsened,0
5084,PT-05084,18,F,Kolkata Clinical Center,Phase III,ORX-505,Infectious Disease,Placebo,2024-07-24,2024-09-18,7.49,6.82,152,84,71,None,None,Improved,1
5085,PT-05085,60,F,Apollo Chennai,Phase I,ORX-303,Cardiology,High Dose,2024-04-27,2024-05-04,6.82,5.97,135,101,89,None,None,Improved,1
5086,PT-05086,54,M,Indore Medical Institute,Phase III,ORX-202,Diabetes,Low Dose,2023-06-17,2023-08-12,10.5,9.44,114,83,99,Rash,Mild,No Change,0
5087,PT-05087,29,F,AIIMS Delhi,Phase IV,ORX-505,Infectious Disease,Placebo,2024-11-14,2025-01-09,9.31,7.61,125,84,65,None,None,Improved,1
5088,PT-05088,35,F,Fortis Mumbai,Phase II,ORX-303,Cardiology,High Dose,2023-09-22,2023-09-29,8.16,9.05,90,84,76,None,None,Improved,0
5089,PT-05089,46,M,PGI Chandigarh,Phase III,ORX-505,Infectious Disease,Low Dose,2023-08-31,2023-10-26,6.82,5.26,155,95,76,Nausea,None,No Change,0
5090,PT-05090,37,M,Fortis Mumbai,Phase IV,ORX-404,Neurology,Placebo,2023-09-21,2023-10-19,6.47,3.74,134,91,79,None,None,Improved,1
5091,PT-05091,43,M,Indore Medical Institute,Phase III,ORX-101,Oncology,High Dose,2024-11-01,2024-12-27,7.36,6.19,119,80,87,Headache,Mild,Improved,1
5092,PT-05092,67,F,Apollo Chennai,Phase I,ORX-505,Infectious Disease,Low Dose,2023-05-31,2023-08-29,6.93,5.58,128,106,64,Fatigue,None,Improved,1
5093,PT-05093,59,M,Fortis Mumbai,Phase II,ORX-202,Diabetes,Placebo,2024-08-19,2024-11-17,8.8,8.08,115,88,82,None,None,No Change,0
5094,PT-05094,56,M,Fortis Mumbai,Phase III,ORX-303,Cardiology,High Dose,2023-06-30,2023-07-28,9.69,9.44,106,82,81,Nausea,Severe,Improved,1
5095,PT-05095,65,F,Indore Medical Institute,Phase III,ORX-303,Cardiology,High Dose,2024-06-11,2024-09-09,6.96,6.2,103,88,124,Headache,Mild,Improved,1
5096,PT-05096,41,M,Kolkata Clinical Center,Phase III,ORX-404,Neurology,Placebo,2023-09-19,2023-10-03,7.74,6.85,104,87,78,None,None,Improved,1
5097,PT-05097,18,F,PGI Chandigarh,Phase I,ORX-404,Neurology,Low Dose,2023-07-18,2023-09-12,9.13,9.11,129,76,83,None,None,No Change,0
5098,PT-05098,52,F,Bhopal Research Hospital,Phase IV,ORX-404,Neurology,Placebo,2024-05-15,2024-05-29,7.68,8.24,151,106,66,None,None,Improved,0
5099,PT-05099,35,M,Kolkata Clinical Center,Phase II,ORX-202,Diabetes,Placebo,2023-01-21,2023-02-04,7.63,6.53,116,87,90,Nausea,Moderate,Worsened,0
5100,PT-05100,65,F,Bhopal Research Hospital,Phase III,ORX-404,Neurology,Placebo,2024-11-21,2025-01-16,6.97,6.99,132,82,66,None,None,No Change,0
5101,PT-05101,29,F,NIMHANS Bengaluru,Phase III,ORX-202,Diabetes,High Dose,2023-03-19,2023-06-17,8.0,6.85,96,81,98,None,None,Improved,1
5102,PT-05102,18,M,Kolkata Clinical Center,Phase I,ORX-404,Neurology,High Dose,2024-07-19,2024-09-13,6.85,7.06,95,79,62,Fever,None,Improved,0
5103,PT-05103,28,F,Bhopal Research Hospital,Phase III,ORX-606,Rheumatology,Placebo,2024-11-12,2025-02-10,6.72,5.31,106,81,109,Nausea,None,Improved,1
5104,PT-05104,57,F,Apollo Chennai,Phase III,ORX-303,Cardiology,High Dose,2024-09-03,2024-12-02,8.41,8.73,115,85,93,Fever,Mild,Improved,0
5105,PT-05105,58,M,Bhopal Research Hospital,Phase II,ORX-202,Diabetes,High Dose,2023-09-02,2023-09-30,7.43,7.5,172,92,73,None,None,Improved,0
5106,PT-05106,43,F,Bhopal Research Hospital,Phase III,ORX-101,Oncology,Low Dose,2023-11-19,2024-02-17,5.94,7.65,156,82,108,Fatigue,Moderate,Worsened,0
5107,PT-05107,55,M,PGI Chandigarh,Phase III,ORX-101,Oncology,Low Dose,2024-09-10,2024-09-17,6.68,7.1,135,92,58,None,None,Improved,0
5108,PT-05108,32,F,NIMHANS Bengaluru,Phase III,ORX-606,Rheumatology,Low Dose,2023-04-30,2023-05-14,8.99,10.11,153,108,86,Rash,Moderate,Improved,0
5109,PT-05109,53,F,Apollo Chennai,Phase II,ORX-202,Diabetes,Low Dose,2023-10-31,2023-11-14,6.1,5.18,92,78,49,Fever,Moderate,Improved,1
5110,PT-05110,62,F,AIIMS Delhi,Phase II,ORX-606,Rheumatology,Placebo,2023-04-13,2023-04-27,7.67,5.44,124,105,76,None,None,Improved,1
5111,PT-05111,29,F,Bhopal Research Hospital,Phase III,ORX-303,Cardiology,Low Dose,2024-11-15,2025-02-13,5.06,3.08,137,76,73,Nausea,Moderate,Improved,1
5112,PT-05112,38,F,Apollo Chennai,Phase III,ORX-101,Oncology,High Dose,2024-05-06,2024-05-13,7.03,5.53,133,64,67,None,None,Improved,1
5113,PT-05113,61,M,Apollo Chennai,Phase II,ORX-202,Diabetes,Placebo,2023-09-30,2023-10-14,7.65,7.87,166,81,78,None,None,Improved,0
5114,PT-05114,40,M,Kolkata Clinical Center,Phase III,ORX-505,Infectious Disease,Low Dose,2023-08-24,2023-10-19,6.67,5.36,129,86,83,None,None,Improved,1
5115,PT-05115,46,F,Fortis Mumbai,Phase IV,ORX-606,Rheumatology,Low Dose,2024-08-16,2024-11-14,8.31,7.94,120,70,56,None,None,Worsened,0
5116,PT-05116,68,F,Apollo Chennai,Phase IV,ORX-202,Diabetes,High Dose,2024-04-04,2024-04-18,6.36,5.13,120,78,100,Nausea,None,No Change,0
5117,PT-05117,39,M,Fortis Mumbai,Phase II,ORX-202,Diabetes,Low Dose,2023-05-24,2023-05-31,10.36,10.02,165,92,83,Rash,None,Improved,1
5118,PT-05118,70,F,PGI Chandigarh,Phase IV,ORX-101,Oncology,Low Dose,2024-11-10,2025-01-05,8.55,8.72,169,76,64,None,None,Improved,0
5119,PT-05119,34,M,AIIMS Delhi,Phase III,ORX-101,Oncology,Placebo,2023-01-19,2023-02-02,9.3,10.21,118,53,75,Headache,Mild,Improved,0
5120,PT-05120,28,M,Indore Medical Institute,Phase III,ORX-101,Oncology,Low Dose,2023-01-03,2023-01-31,6.61,5.26,99,104,68,Dizziness,None,No Change,0
5121,PT-05121,67,F,Indore Medical Institute,Phase I,ORX-606,Rheumatology,Low Dose,2024-02-02,2024-05-02,6.93,5.52,137,77,75,None,None,Improved,1
5122,PT-05122,47,F,Indore Medical Institute,Phase III,ORX-101,Oncology,High Dose,2023-12-01,2023-12-29,6.23,4.37,127,93,65,None,None,Worsened,0
5123,PT-05123,47,M,Apollo Chennai,Phase III,ORX-101,Oncology,High Dose,2023-10-08,2023-10-22,9.01,8.53,129,82,68,None,None,Worsened,0
5124,PT-05124,29,F,Apollo Chennai,Phase III,ORX-202,Diabetes,Placebo,2023-04-21,2023-04-28,6.01,5.94,141,91,72,None,None,Worsened,0
5125,PT-05125,62,F,AIIMS Delhi,Phase III,ORX-505,Infectious Disease,Placebo,2024-11-30,2025-01-25,7.57,7.23,90,72,56,Fever,Mild,No Change,0
5126,PT-05126,55,M,Bhopal Research Hospital,Phase III,ORX-202,Diabetes,Low Dose,2023-03-09,2023-05-04,7.31,5.95,133,64,63,None,None,No Change,0
5127,PT-05127,33,M,PGI Chandigarh,Phase I,ORX-505,Infectious Disease,Low Dose,2024-10-11,2024-10-25,7.85,8.71,117,97,78,None,None,No Change,0
5128,PT-05128,48,M,Bhopal Research Hospital,Phase IV,ORX-404,Neurology,High Dose,2023-01-14,2023-01-21,7.12,6.55,135,90,65,None,None,No Change,0
5129,PT-05129,41,M,NIMHANS Bengaluru,Phase IV,ORX-101,Oncology,Low Dose,2023-10-26,2023-11-09,9.2,8.96,133,96,70,None,None,No Change,0
5130,PT-05130,44,M,Kolkata Clinical Center,Phase III,ORX-202,Diabetes,Placebo,2023-01-04,2023-04-04,8.18,8.9,90,73,64,Dizziness,None,Improved,0
5131,PT-05131,43,F,Indore Medical Institute,Phase II,ORX-303,Cardiology,Placebo,2023-12-19,2024-02-13,6.09,6.29,131,92,91,Dizziness,Mild,No Change,0
5132,PT-05132,55,M,Fortis Mumbai,Phase IV,ORX-505,Infectious Disease,Low Dose,2023-09-29,2023-11-24,6.8,6.49,119,65,91,Fatigue,None,Improved,1
5133,PT-05133,43,F,Bhopal Research Hospital,Phase IV,ORX-606,Rheumatology,Low Dose,2023-08-04,2023-08-18,5.4,5.48,123,57,58,None,None,No Change,0
5134,PT-05134,33,F,Kolkata Clinical Center,Phase IV,ORX-606,Rheumatology,High Dose,2023-10-24,2023-10-31,7.45,7.76,141,89,77,Nausea,None,Improved,0
5135,PT-05135,72,M,Indore Medical Institute,Phase III,ORX-202,Diabetes,Low Dose,2024-08-16,2024-08-23,8.04,7.84,138,77,77,Rash,None,No Change,0
5136,PT-05136,18,F,PGI Chandigarh,Phase III,ORX-202,Diabetes,Placebo,2024-06-03,2024-07-01,6.74,7.92,130,83,91,Fatigue,None,No Change,0
5137,PT-05137,50,M,Apollo Chennai,Phase II,ORX-505,Infectious Disease,Placebo,2024-08-27,2024-09-03,6.26,5.88,107,84,66,Rash,Mild,Improved,1
5138,PT-05138,59,M,PGI Chandigarh,Phase II,ORX-404,Neurology,Low Dose,2023-07-24,2023-10-22,6.59,5.45,125,86,61,Fever,None,No Change,0
5139,PT-05139,36,F,Kolkata Clinical Center,Phase I,ORX-404,Neurology,Placebo,2023-03-26,2023-04-09,7.33,8.13,90,89,72,Fever,Mild,Improved,0
5140,PT-05140,37,F,Fortis Mumbai,Phase III,ORX-505,Infectious Disease,Low Dose,2023-03-05,2023-04-30,6.38,5.66,139,75,101,None,None,Improved,1
5141,PT-05141,54,M,Fortis Mumbai,Phase III,ORX-101,Oncology,High Dose,2023-12-24,2023-12-31,7.44,6.89,149,98,61,None,None,Worsened,0
5142,PT-05142,33,M,Bhopal Research Hospital,Phase III,ORX-202,Diabetes,High Dose,2024-01-31,2024-02-07,7.96,8.4,122,73,79,None,None,Improved,0
5143,PT-05143,68,M,PGI Chandigarh,Phase IV,ORX-303,Cardiology,High Dose,2023-04-22,2023-05-06,7.25,5.71,129,91,76,Nausea,None,No Change,0
5144,PT-05144,65,M,Fortis Mumbai,Phase I,ORX-606,Rheumatology,Low Dose,2023-11-22,2023-12-20,8.24,7.78,128,59,94,Headache,None,Worsened,0
5145,PT-05145,39,F,NIMHANS Bengaluru,Phase III,ORX-101,Oncology,Placebo,2023-04-14,2023-04-28,6.72,5.83,136,68,64,Headache,Mild,No Change,0
5146,PT-05146,44,F,Indore Medical Institute,Phase I,ORX-505,Infectious Disease,Placebo,2023-05-13,2023-05-20,6.45,6.35,117,101,87,Nausea,None,Improved,1
5147,PT-05147,55,F,Bhopal Research Hospital,Phase I,ORX-303,Cardiology,Low Dose,2023-08-28,2023-09-11,6.47,8.24,120,73,87,Headache,Mild,Improved,0
5148,PT-05148,48,F,AIIMS Delhi,Phase IV,ORX-606,Rheumatology,Low Dose,2023-03-20,2023-04-03,6.22,7.79,145,82,111,Rash,None,Improved,0
5149,PT-05149,57,F,Indore Medical Institute,Phase III,ORX-101,Oncology,Placebo,2023-06-18,2023-07-02,7.19,8.84,139,89,72,Headache,None,Improved,0
5150,PT-05150,45,F,NIMHANS Bengaluru,Phase III,ORX-303,Cardiology,High Dose,2024-10-02,2024-11-27,6.71,7.6,99,98,65,Fatigue,None,No Change,0
5151,PT-05151,44,M,Fortis Mumbai,Phase II,ORX-101,Oncology,Placebo,2023-11-11,2023-12-09,6.85,5.98,140,81,68,None,None,Improved,1
5152,PT-05152,47,M,Fortis Mumbai,Phase III,ORX-606,Rheumatology,Low Dose,2023-02-27,2023-03-27,6.36,5.48,101,76,84,None,None,Worsened,0
5153,PT-05153,45,M,PGI Chandigarh,Phase II,ORX-101,Oncology,Low Dose,2023-10-04,2023-10-18,9.38,11.33,119,72,93,None,None,Improved,0
5154,PT-05154,50,M,PGI Chandigarh,Phase II,ORX-404,Neurology,Low Dose,2023-03-29,2023-04-05,8.56,8.52,124,79,84,None,None,No Change,0
5155,PT-05155,41,F,Bhopal Research Hospital,Phase II,ORX-101,Oncology,High Dose,2024-01-17,2024-04-16,8.66,7.09,149,59,80,Dizziness,None,Improved,1
5156,PT-05156,39,F,Bhopal Research Hospital,Phase IV,ORX-303,Cardiology,Low Dose,2023-04-04,2023-07-03,5.38,3.13,108,82,69,None,None,Improved,1
5157,PT-05157,28,F,NIMHANS Bengaluru,Phase II,ORX-303,Cardiology,Placebo,2023-11-22,2023-12-06,8.82,7.31,140,71,62,None,None,Improved,1
5158,PT-05158,35,M,AIIMS Delhi,Phase III,ORX-303,Cardiology,High Dose,2024-05-06,2024-05-20,7.94,6.31,133,70,67,None,None,No Change,0
5159,PT-05159,51,M,AIIMS Delhi,Phase I,ORX-505,Infectious Disease,Placebo,2024-04-14,2024-04-28,9.81,8.59,140,78,71,Headache,Mild,Improved,1
5160,PT-05160,62,M,AIIMS Delhi,Phase III,ORX-101,Oncology,Low Dose,2023-12-10,2024-02-04,6.19,4.75,136,101,88,None,None,Improved,1
5161,PT-05161,22,M,PGI Chandigarh,Phase I,ORX-404,Neurology,Placebo,2024-01-17,2024-01-31,6.46,6.94,156,84,69,None,None,Improved,0
5162,PT-05162,71,M,Bhopal Research Hospital,Phase II,ORX-202,Diabetes,Placebo,2023-04-29,2023-05-06,7.11,6.17,114,67,117,None,None,Improved,1
5163,PT-05163,67,F,AIIMS Delhi,Phase III,ORX-101,Oncology,Placebo,2024-04-21,2024-06-16,6.41,7.57,137,87,67,Fatigue,None,Improved,0
5164,PT-05164,36,F,AIIMS Delhi,Phase II,ORX-606,Rheumatology,Placebo,2024-05-04,2024-06-29,7.15,4.98,119,82,96,Nausea,None,Improved,1
5165,PT-05165,35,F,NIMHANS Bengaluru,Phase III,ORX-505,Infectious Disease,High Dose,2024-04-29,2024-07-28,8.17,5.92,149,71,79,Fever,Moderate,No Change,0
5166,PT-05166,51,M,NIMHANS Bengaluru,Phase II,ORX-606,Rheumatology,High Dose,2023-03-21,2023-03-28,7.45,6.96,105,71,91,None,None,Improved,1
5167,PT-05167,35,F,Fortis Mumbai,Phase III,ORX-505,Infectious Disease,Low Dose,2024-04-07,2024-04-21,7.08,5.33,143,66,90,Headache,None,No Change,0
5168,PT-05168,27,F,Indore Medical Institute,Phase III,ORX-404,Neurology,Placebo,2023-04-19,2023-07-18,8.42,8.03,117,101,77,None,None,Worsened,0
5169,PT-05169,39,M,PGI Chandigarh,Phase III,ORX-606,Rheumatology,Placebo,2023-02-16,2023-02-23,8.29,6.56,90,95,66,Fatigue,Mild,Improved,1
5170,PT-05170,58,F,Indore Medical Institute,Phase III,ORX-606,Rheumatology,Placebo,2023-05-12,2023-06-09,7.26,5.81,138,77,62,Headache,None,Worsened,0
5171,PT-05171,28,M,Bhopal Research Hospital,Phase II,ORX-303,Cardiology,Placebo,2023-04-25,2023-06-20,5.12,5.08,111,81,75,Dizziness,None,Worsened,0
5172,PT-05172,29,F,Kolkata Clinical Center,Phase III,ORX-303,Cardiology,High Dose,2024-02-28,2024-05-28,5.37,7.25,127,103,94,None,None,Improved,0
5173,PT-05173,39,M,PGI Chandigarh,Phase III,ORX-101,Oncology,High Dose,2023-05-01,2023-05-29,7.42,7.15,161,91,66,Fatigue,None,Improved,1
5174,PT-05174,50,M,Kolkata Clinical Center,Phase IV,ORX-101,Oncology,Low Dose,2024-01-13,2024-04-12,8.17,6.71,136,98,65,None,None,Improved,1
5175,PT-05175,33,F,NIMHANS Bengaluru,Phase I,ORX-202,Diabetes,High Dose,2023-11-06,2023-12-04,8.59,7.87,110,92,86,None,None,No Change,0
5176,PT-05176,46,F,Apollo Chennai,Phase III,ORX-404,Neurology,Placebo,2023-10-15,2023-12-10,8.55,9.23,126,105,100,None,None,No Change,0
5177,PT-05177,18,M,Indore Medical Institute,Phase III,ORX-303,Cardiology,Low Dose,2024-04-15,2024-04-22,5.96,3.53,122,67,66,Fever,Moderate,Improved,1
5178,PT-05178,62,F,Fortis Mumbai,Phase III,ORX-101,Oncology,Placebo,2024-05-14,2024-06-11,5.09,4.81,130,81,79,Nausea,None,No Change,0
5179,PT-05179,18,F,Kolkata Clinical Center,Phase IV,ORX-505,Infectious Disease,High Dose,2024-02-20,2024-04-16,6.23,7.22,106,101,58,None,None,Improved,0
5180,PT-05180,20,F,NIMHANS Bengaluru,Phase III,ORX-606,Rheumatology,Low Dose,2023-05-03,2023-08-01,6.06,6.67,118,86,79,None,None,Improved,0
5181,PT-05181,44,M,Kolkata Clinical Center,Phase III,ORX-606,Rheumatology,Placebo,2024-04-01,2024-05-27,8.73,9.02,107,78,102,None,None,Improved,0
5182,PT-05182,50,F,AIIMS Delhi,Phase II,ORX-404,Neurology,High Dose,2023-09-06,2023-09-13,5.39,3.7,144,90,65,Rash,Moderate,No Change,0
5183,PT-05183,56,M,Kolkata Clinical Center,Phase II,ORX-303,Cardiology,High Dose,2023-05-04,2023-05-18,9.12,10.03,156,88,75,None,None,No Change,0
5184,PT-05184,38,F,Kolkata Clinical Center,Phase II,ORX-505,Infectious Disease,Low Dose,2023-01-31,2023-03-28,7.18,5.99,121,97,55,Headache,None,No Change,0
5185,PT-05185,20,F,Fortis Mumbai,Phase III,ORX-606,Rheumatology,Low Dose,2023-12-12,2023-12-26,8.2,7.48,93,81,75,None,None,Improved,1
5186,PT-05186,38,F,Fortis Mumbai,Phase II,ORX-101,Oncology,Placebo,2023-06-26,2023-07-24,8.02,6.42,128,79,78,None,None,No Change,0
5187,PT-05187,18,M,PGI Chandigarh,Phase III,ORX-404,Neurology,Low Dose,2023-05-11,2023-06-08,6.57,6.19,137,104,89,None,None,Improved,1
5188,PT-05188,52,M,Bhopal Research Hospital,Phase II,ORX-404,Neurology,Low Dose,2024-10-11,2025-01-09,8.73,8.05,155,95,71,None,None,Improved,1
5189,PT-05189,75,F,AIIMS Delhi,Phase II,ORX-606,Rheumatology,Placebo,2024-03-24,2024-04-21,7.74,9.31,133,75,67,Headache,Mild,Improved,0
5190,PT-05190,39,M,Indore Medical Institute,Phase II,ORX-303,Cardiology,Placebo,2024-03-04,2024-04-01,6.51,7.26,127,62,80,None,None,Worsened,0
5191,PT-05191,47,F,PGI Chandigarh,Phase II,ORX-202,Diabetes,High Dose,2023-04-20,2023-05-18,6.64,6.48,127,89,86,None,None,Improved,1
5192,PT-05192,50,F,Apollo Chennai,Phase III,ORX-404,Neurology,Placebo,2023-02-04,2023-02-11,5.64,7.15,99,80,62,Fever,Severe,No Change,0
5193,PT-05193,51,F,Apollo Chennai,Phase II,ORX-202,Diabetes,Placebo,2023-01-02,2023-02-27,7.37,6.81,155,95,73,None,None,No Change,0
5194,PT-05194,57,F,Bhopal Research Hospital,Phase IV,ORX-606,Rheumatology,High Dose,2023-12-10,2024-03-09,9.08,9.67,125,62,82,None,None,Improved,0
5195,PT-05195,55,F,NIMHANS Bengaluru,Phase I,ORX-303,Cardiology,Low Dose,2023-09-28,2023-10-05,6.28,5.9,126,98,103,Headache,Moderate,Improved,1
5196,PT-05196,63,M,NIMHANS Bengaluru,Phase I,ORX-404,Neurology,Low Dose,2023-02-04,2023-03-04,7.1,7.73,139,81,107,Headache,None,Improved,0
5197,PT-05197,33,M,PGI Chandigarh,Phase I,ORX-101,Oncology,High Dose,2024-04-22,2024-05-20,7.92,8.28,122,88,91,None,None,Improved,0
5198,PT-05198,48,M,NIMHANS Bengaluru,Phase IV,ORX-101,Oncology,Low Dose,2024-03-16,2024-04-13,7.77,7.46,142,79,73,Dizziness,Mild,Improved,1
5199,PT-05199,45,M,AIIMS Delhi,Phase II,ORX-202,Diabetes,Placebo,2023-02-17,2023-03-17,8.62,6.65,111,109,81,Rash,None,Improved,1
5200,PT-05200,38,F,AIIMS Delhi,Phase III,ORX-202,Diabetes,Low Dose,2023-09-17,2023-12-16,8.15,7.05,90,86,67,Nausea,None,Worsened,0
5201,PT-05201,46,M,Kolkata Clinical Center,Phase III,ORX-303,Cardiology,Placebo,2024-02-12,2024-02-19,7.6,7.32,97,82,84,Headache,Severe,Improved,1
5202,PT-05202,22,F,Kolkata Clinical Center,Phase III,ORX-202,Diabetes,High Dose,2024-06-12,2024-06-19,5.38,4.01,141,58,89,None,None,Improved,1
5203,PT-05203,51,M,PGI Chandigarh,Phase I,ORX-202,Diabetes,High Dose,2024-08-17,2024-08-31,6.89,5.16,113,91,95,None,None,Worsened,0
5204,PT-05204,28,F,AIIMS Delhi,Phase IV,ORX-202,Diabetes,Placebo,2024-05-20,2024-06-17,8.57,8.79,127,73,69,None,None,Improved,0
5205,PT-05205,74,M,Apollo Chennai,Phase II,ORX-606,Rheumatology,Placebo,2023-10-13,2024-01-11,7.41,8.21,132,76,86,None,None,No Change,0
5206,PT-05206,79,F,Fortis Mumbai,Phase III,ORX-101,Oncology,High Dose,2023-06-23,2023-08-18,6.43,6.85,131,64,57,Headache,None,Improved,0
5207,PT-05207,37,F,Apollo Chennai,Phase I,ORX-202,Diabetes,High Dose,2024-08-07,2024-10-02,7.62,8.01,99,89,76,None,None,Improved,0
5208,PT-05208,45,F,Bhopal Research Hospital,Phase III,ORX-606,Rheumatology,Low Dose,2023-02-05,2023-03-05,7.91,9.08,133,65,75,None,None,Improved,0
5209,PT-05209,58,M,NIMHANS Bengaluru,Phase I,ORX-606,Rheumatology,High Dose,2024-10-26,2024-11-23,8.26,8.46,118,65,86,None,None,Improved,0
5210,PT-05210,25,M,Fortis Mumbai,Phase III,ORX-202,Diabetes,Low Dose,2023-02-03,2023-02-17,8.03,8.26,119,80,80,None,None,No Change,0
5211,PT-05211,35,M,Apollo Chennai,Phase II,ORX-303,Cardiology,Low Dose,2023-06-22,2023-07-06,5.54,5.11,129,98,67,Rash,Severe,Worsened,0
5212,PT-05212,62,F,Fortis Mumbai,Phase II,ORX-303,Cardiology,High Dose,2024-02-11,2024-02-18,5.82,4.21,122,70,58,Headache,Moderate,Improved,1
5213,PT-05213,76,M,Indore Medical Institute,Phase I,ORX-404,Neurology,Low Dose,2024-02-07,2024-02-21,6.66,8.34,110,61,96,None,None,Improved,0
5214,PT-05214,33,F,Bhopal Research Hospital,Phase III,ORX-101,Oncology,Placebo,2024-05-18,2024-08-16,7.37,5.75,127,65,76,None,None,Improved,1
5215,PT-05215,37,M,AIIMS Delhi,Phase III,ORX-505,Infectious Disease,Placebo,2024-09-03,2024-10-01,7.48,7.64,132,87,76,Headache,None,Worsened,0
5216,PT-05216,38,M,Apollo Chennai,Phase IV,ORX-505,Infectious Disease,Placebo,2024-07-19,2024-09-13,7.76,7.26,126,86,63,Fatigue,Severe,Improved,1
5217,PT-05217,67,F,NIMHANS Bengaluru,Phase I,ORX-303,Cardiology,High Dose,2023-06-15,2023-06-29,6.9,6.61,127,89,82,Fatigue,Moderate,No Change,0
5218,PT-05218,44,M,Indore Medical Institute,Phase III,ORX-404,Neurology,Low Dose,2023-08-10,2023-08-24,8.94,5.66,150,93,52,None,None,Worsened,0
5219,PT-05219,59,M,Apollo Chennai,Phase III,ORX-404,Neurology,Low Dose,2024-02-06,2024-02-13,8.47,8.58,99,90,92,Nausea,None,Improved,0
5220,PT-05220,35,F,NIMHANS Bengaluru,Phase III,ORX-404,Neurology,Low Dose,2023-01-25,2023-04-25,7.73,7.01,143,78,69,None,None,Worsened,0
5221,PT-05221,44,F,Apollo Chennai,Phase III,ORX-101,Oncology,Placebo,2023-07-10,2023-07-24,5.59,5.07,134,92,81,None,None,Improved,1
5222,PT-05222,22,M,Indore Medical Institute,Phase III,ORX-303,Cardiology,Low Dose,2023-01-06,2023-04-06,8.82,9.72,130,72,70,None,None,Improved,0
5223,PT-05223,41,M,Bhopal Research Hospital,Phase III,ORX-303,Cardiology,Placebo,2023-04-25,2023-05-09,7.53,6.86,112,94,81,None,None,No Change,0
5224,PT-05224,28,M,Apollo Chennai,Phase III,ORX-505,Infectious Disease,Placebo,2023-05-28,2023-07-23,7.55,7.3,115,96,79,Headache,Mild,Worsened,0
5225,PT-05225,41,F,Kolkata Clinical Center,Phase II,ORX-404,Neurology,High Dose,2023-05-09,2023-08-07,7.1,7.1,126,81,92,Headache,None,Improved,1
5226,PT-05226,22,F,Apollo Chennai,Phase III,ORX-202,Diabetes,High Dose,2023-01-31,2023-03-28,5.7,6.0,171,92,104,Fatigue,None,Improved,0
5227,PT-05227,38,F,Bhopal Research Hospital,Phase III,ORX-606,Rheumatology,High Dose,2024-03-02,2024-03-09,6.44,6.45,145,66,75,None,None,No Change,0
5228,PT-05228,44,M,Indore Medical Institute,Phase III,ORX-303,Cardiology,Placebo,2023-08-01,2023-08-15,6.39,5.48,143,87,89,None,None,Improved,1
5229,PT-05229,50,M,Fortis Mumbai,Phase IV,ORX-303,Cardiology,High Dose,2023-07-10,2023-09-04,6.15,6.13,110,78,63,None,None,Improved,1
5230,PT-05230,35,F,AIIMS Delhi,Phase III,ORX-606,Rheumatology,High Dose,2024-05-10,2024-05-24,7.31,6.5,112,95,76,None,None,Improved,1
5231,PT-05231,36,F,Apollo Chennai,Phase IV,ORX-202,Diabetes,Low Dose,2023-04-09,2023-06-04,5.9,3.82,124,65,87,Nausea,Mild,No Change,0
5232,PT-05232,45,M,Kolkata Clinical Center,Phase III,ORX-303,Cardiology,Low Dose,2023-03-29,2023-05-24,9.07,8.87,114,59,89,Headache,Mild,Improved,1
5233,PT-05233,24,M,NIMHANS Bengaluru,Phase III,ORX-202,Diabetes,High Dose,2023-10-31,2024-01-29,6.71,7.82,138,86,91,Fatigue,None,No Change,0
5234,PT-05234,59,F,Indore Medical Institute,Phase III,ORX-606,Rheumatology,High Dose,2024-04-20,2024-05-18,9.1,8.16,121,70,77,Nausea,None,No Change,0
5235,PT-05235,42,F,Kolkata Clinical Center,Phase IV,ORX-101,Oncology,High Dose,2023-04-06,2023-07-05,5.09,4.11,153,84,88,Fatigue,None,Improved,1
5236,PT-05236,43,M,Apollo Chennai,Phase III,ORX-606,Rheumatology,Low Dose,2024-08-19,2024-08-26,4.94,4.42,146,67,88,Fever,None,Improved,1
5237,PT-05237,18,F,NIMHANS Bengaluru,Phase IV,ORX-202,Diabetes,Low Dose,2024-11-11,2025-02-09,7.22,7.31,122,111,71,Fatigue,None,Improved,0
5238,PT-05238,35,F,NIMHANS Bengaluru,Phase III,ORX-606,Rheumatology,High Dose,2023-12-30,2024-03-29,7.45,6.37,102,68,88,Headache,None,No Change,0
5239,PT-05239,40,F,NIMHANS Bengaluru,Phase IV,ORX-505,Infectious Disease,Low Dose,2023-03-04,2023-03-18,9.24,,140,88,71,None,None,Improved,1
5240,PT-05240,30,F,PGI Chandigarh,Phase III,ORX-606,Rheumatology,Placebo,2023-10-24,2023-11-07,5.12,5.22,149,62,72,None,None,Improved,0
5241,PT-05241,34,F,Fortis Mumbai,Phase II,ORX-202,Diabetes,Placebo,2023-04-17,2023-06-12,7.86,7.17,151,77,60,None,None,Improved,1
5242,PT-05242,37,F,Fortis Mumbai,Phase III,ORX-606,Rheumatology,High Dose,2023-06-01,2023-06-15,6.77,6.84,121,87,66,Fatigue,Mild,Improved,0
5243,PT-05243,40,M,Bhopal Research Hospital,Phase IV,ORX-606,Rheumatology,High Dose,2024-05-06,2024-05-20,6.26,5.1,150,73,73,None,None,Worsened,0
5244,PT-05244,61,M,Fortis Mumbai,Phase IV,ORX-404,Neurology,Placebo,2024-04-09,2024-05-07,8.1,9.18,136,74,106,Nausea,Mild,Improved,0
5245,PT-05245,54,F,PGI Chandigarh,Phase III,ORX-101,Oncology,Low Dose,2023-07-30,2023-08-13,7.01,6.67,131,79,58,None,None,Improved,1
5246,PT-05246,71,F,PGI Chandigarh,Phase II,ORX-101,Oncology,High Dose,2023-11-22,2024-01-17,7.17,6.94,165,73,87,Fever,Mild,No Change,0
5247,PT-05247,32,M,Kolkata Clinical Center,Phase I,ORX-101,Oncology,Low Dose,2024-10-09,2024-10-16,7.59,7.37,142,96,69,None,None,Worsened,0
5248,PT-05248,67,M,Fortis Mumbai,Phase III,ORX-404,Neurology,Low Dose,2024-01-03,2024-01-31,8.98,8.36,127,76,73,None,None,Worsened,0
5249,PT-05249,25,M,Bhopal Research Hospital,Phase II,ORX-404,Neurology,High Dose,2024-07-11,2024-10-09,8.13,5.89,115,81,96,Headache,None,Worsened,0
5250,PT-05250,36,F,AIIMS Delhi,Phase IV,ORX-505,Infectious Disease,High Dose,2024-08-29,2024-09-26,7.71,7.24,145,86,89,Nausea,None,Improved,1
5251,PT-05251,36,F,Bhopal Research Hospital,Phase II,ORX-606,Rheumatology,Low Dose,2024-08-09,2024-08-16,5.98,5.91,119,82,82,Nausea,None,No Change,0
5252,PT-05252,64,M,AIIMS Delhi,Phase III,ORX-303,Cardiology,High Dose,2024-09-03,2024-12-02,8.14,7.13,107,102,55,Dizziness,None,Improved,1
5253,PT-05253,37,F,Apollo Chennai,Phase II,ORX-202,Diabetes,High Dose,2024-03-20,2024-03-27,7.97,9.05,124,82,65,None,None,No Change,0
5254,PT-05254,47,F,Bhopal Research Hospital,Phase III,ORX-404,Neurology,Placebo,2023-01-12,2023-02-09,5.82,4.74,141,76,90,None,None,Improved,1
5255,PT-05255,42,M,Apollo Chennai,Phase III,ORX-404,Neurology,Low Dose,2023-05-11,2023-07-06,5.56,6.21,104,74,75,None,None,No Change,0
5256,PT-05256,61,F,PGI Chandigarh,Phase III,ORX-202,Diabetes,High Dose,2023-06-28,2023-07-05,6.57,5.33,130,79,71,None,None,Improved,1
5257,PT-05257,48,F,NIMHANS Bengaluru,Phase IV,ORX-505,Infectious Disease,High Dose,2023-05-24,2023-08-22,5.76,3.81,166,83,80,Fever,Moderate,Improved,1
5258,PT-05258,32,F,NIMHANS Bengaluru,Phase I,ORX-202,Diabetes,Low Dose,2023-03-08,2023-06-06,8.28,7.4,90,75,74,None,None,No Change,0
5259,PT-05259,42,F,Kolkata Clinical Center,Phase IV,ORX-303,Cardiology,High Dose,2024-07-25,2024-09-19,6.96,5.98,114,78,54,None,None,No Change,0
5260,PT-05260,18,F,Bhopal Research Hospital,Phase I,ORX-505,Infectious Disease,High Dose,2024-10-15,2024-11-12,7.32,7.02,143,78,61,Fatigue,None,Improved,1
5261,PT-05261,18,F,Indore Medical Institute,Phase II,ORX-303,Cardiology,Low Dose,2023-04-16,2023-06-11,6.13,6.11,153,82,61,Headache,None,Improved,1
5262,PT-05262,30,F,Kolkata Clinical Center,Phase I,ORX-202,Diabetes,High Dose,2024-05-03,2024-05-31,6.18,5.42,148,96,75,None,None,Improved,1
5263,PT-05263,47,M,Bhopal Research Hospital,Phase III,ORX-303,Cardiology,Placebo,2024-11-06,2024-11-13,6.24,4.3,160,54,52,None,None,No Change,0
5264,PT-05264,73,F,Indore Medical Institute,Phase III,ORX-202,Diabetes,Low Dose,2024-10-23,2024-11-20,7.22,5.81,140,91,59,Headache,None,Improved,1
5265,PT-05265,36,M,AIIMS Delhi,Phase IV,ORX-505,Infectious Disease,Low Dose,2024-03-13,2024-05-08,8.25,7.12,133,99,45,Fatigue,Moderate,Improved,1
5266,PT-05266,39,M,PGI Chandigarh,Phase IV,ORX-505,Infectious Disease,Low Dose,2024-09-13,2024-11-08,7.51,5.5,118,94,68,None,None,Worsened,0
5267,PT-05267,21,M,NIMHANS Bengaluru,Phase III,ORX-606,Rheumatology,High Dose,2024-08-12,2024-08-26,8.56,8.56,126,80,92,Headache,Mild,Improved,0
5268,PT-05268,49,F,NIMHANS Bengaluru,Phase II,ORX-202,Diabetes,Low Dose,2023-06-30,2023-09-28,7.97,6.95,93,89,93,None,None,Improved,1
5269,PT-05269,41,M,NIMHANS Bengaluru,Phase IV,ORX-303,Cardiology,High Dose,2024-10-14,2024-11-11,8.27,7.56,126,103,73,None,None,No Change,0
5270,PT-05270,39,M,PGI Chandigarh,Phase III,ORX-101,Oncology,Low Dose,2024-08-04,2024-11-02,4.96,5.18,115,83,73,None,None,No Change,0
5271,PT-05271,37,M,NIMHANS Bengaluru,Phase III,ORX-202,Diabetes,High Dose,2023-03-04,2023-06-02,7.06,6.62,149,100,87,None,None,No Change,0
5272,PT-05272,65,M,PGI Chandigarh,Phase III,ORX-606,Rheumatology,Low Dose,2023-05-05,2023-06-30,8.22,8.27,154,66,68,Headache,Mild,No Change,0
5273,PT-05273,31,F,Bhopal Research Hospital,Phase IV,ORX-303,Cardiology,High Dose,2023-05-02,2023-05-30,6.84,7.06,107,88,69,None,None,Improved,0
5274,PT-05274,39,F,Indore Medical Institute,Phase II,ORX-505,Infectious Disease,Low Dose,2024-02-03,2024-02-17,7.44,8.55,115,81,62,None,None,Improved,0
5275,PT-05275,33,F,Indore Medical Institute,Phase III,ORX-303,Cardiology,Placebo,2024-01-14,2024-01-28,5.9,5.72,135,90,67,Headache,Mild,No Change,0
5276,PT-05276,53,F,Indore Medical Institute,Phase IV,ORX-202,Diabetes,Low Dose,2024-04-17,2024-06-12,7.34,6.88,105,83,80,Rash,Moderate,Improved,1
5277,PT-05277,46,M,Kolkata Clinical Center,Phase IV,ORX-505,Infectious Disease,High Dose,2024-05-15,2024-06-12,7.68,7.91,108,79,85,Nausea,Mild,Improved,0
5278,PT-05278,40,F,PGI Chandigarh,Phase III,ORX-101,Oncology,Low Dose,2023-10-17,2023-10-24,8.35,8.03,92,92,76,Rash,Severe,Improved,1
5279,PT-05279,18,F,NIMHANS Bengaluru,Phase IV,ORX-101,Oncology,Low Dose,2023-02-12,2023-03-12,6.9,5.36,141,81,65,Headache,None,Improved,1
5280,PT-05280,57,M,AIIMS Delhi,Phase III,ORX-101,Oncology,Low Dose,2023-11-22,2023-11-29,7.75,7.14,105,71,65,None,None,No Change,0
5281,PT-05281,56,M,PGI Chandigarh,Phase I,ORX-101,Oncology,Placebo,2023-04-06,2023-05-04,5.18,4.74,123,94,81,Fatigue,Moderate,Improved,1
5282,PT-05282,53,F,Indore Medical Institute,Phase II,ORX-606,Rheumatology,Low Dose,2024-01-15,2024-02-12,6.57,5.06,122,91,88,None,None,Improved,1
5283,PT-05283,38,M,Indore Medical Institute,Phase III,ORX-303,Cardiology,Low Dose,2024-05-21,2024-06-18,6.17,4.82,125,83,98,Headache,None,Improved,1
5284,PT-05284,46,F,NIMHANS Bengaluru,Phase II,ORX-202,Diabetes,Placebo,2023-09-09,2023-12-08,7.94,6.83,128,83,76,None,None,Improved,1
5285,PT-05285,44,F,Indore Medical Institute,Phase II,ORX-202,Diabetes,High Dose,2024-07-28,2024-08-11,7.35,7.38,149,54,93,Nausea,None,No Change,0
5286,PT-05286,18,M,NIMHANS Bengaluru,Phase I,ORX-101,Oncology,Low Dose,2023-09-18,2023-10-16,7.57,9.29,127,84,73,None,None,No Change,0
5287,PT-05287,55,F,Apollo Chennai,Phase III,ORX-303,Cardiology,High Dose,2023-05-02,2023-06-27,7.63,6.63,125,68,76,Headache,Mild,No Change,0
5288,PT-05288,38,M,Apollo Chennai,Phase II,ORX-606,Rheumatology,Low Dose,2024-04-09,2024-04-16,7.36,6.32,124,82,79,Rash,Moderate,Improved,1
5289,PT-05289,49,M,AIIMS Delhi,Phase III,ORX-101,Oncology,High Dose,2024-11-17,2024-11-24,6.99,5.88,129,79,92,Nausea,Mild,Worsened,0
5290,PT-05290,63,M,NIMHANS Bengaluru,Phase I,ORX-404,Neurology,High Dose,2024-11-12,2025-02-10,5.55,5.71,142,65,86,None,None,Improved,0
5291,PT-05291,59,M,Indore Medical Institute,Phase III,ORX-202,Diabetes,High Dose,2023-08-30,2023-11-28,6.06,5.45,131,88,64,Fatigue,Severe,No Change,0
5292,PT-05292,63,F,AIIMS Delhi,Phase IV,ORX-606,Rheumatology,High Dose,2024-04-05,2024-07-04,4.76,5.56,137,74,90,None,None,Worsened,0
5293,PT-05293,28,F,Fortis Mumbai,Phase III,ORX-606,Rheumatology,Placebo,2023-03-13,2023-06-11,7.34,7.15,132,71,71,None,None,No Change,0
5294,PT-05294,47,F,Kolkata Clinical Center,Phase IV,ORX-606,Rheumatology,Placebo,2024-02-05,2024-02-19,6.33,6.17,116,94,99,Nausea,None,No Change,0
5295,PT-05295,40,F,AIIMS Delhi,Phase III,ORX-202,Diabetes,Low Dose,2023-09-26,2023-12-25,8.3,7.71,111,76,79,None,None,Improved,1
5296,PT-05296,18,F,Bhopal Research Hospital,Phase III,ORX-303,Cardiology,Low Dose,2024-09-13,2024-09-20,7.95,7.63,146,89,79,None,None,No Change,0
5297,PT-05297,39,M,PGI Chandigarh,Phase III,ORX-404,Neurology,Placebo,2024-01-21,2024-04-20,9.03,10.58,121,94,68,None,None,Improved,0
5298,PT-05298,35,M,Kolkata Clinical Center,Phase I,ORX-202,Diabetes,Placebo,2024-06-16,2024-06-30,6.74,6.95,108,100,91,Fever,None,Improved,0
5299,PT-05299,55,M,Fortis Mumbai,Phase IV,ORX-505,Infectious Disease,High Dose,2023-07-02,2023-07-30,6.85,7.19,90,87,80,None,None,No Change,0
5300,PT-05300,18,M,PGI Chandigarh,Phase II,ORX-505,Infectious Disease,Low Dose,2023-12-06,2023-12-20,7.69,7.82,94,67,106,None,None,Improved,0
5301,PT-05301,42,M,PGI Chandigarh,Phase IV,ORX-606,Rheumatology,Low Dose,2023-11-12,2024-02-10,8.37,8.98,135,94,48,None,None,No Change,0
5302,PT-05302,41,M,Fortis Mumbai,Phase I,ORX-101,Oncology,Low Dose,2024-07-16,2024-09-10,3.5,1.53,118,74,78,None,None,Improved,1
5303,PT-05303,44,M,Kolkata Clinical Center,Phase II,ORX-404,Neurology,Low Dose,2024-09-18,2024-09-25,7.36,7.12,133,70,67,Headache,Mild,Improved,1
5304,PT-05304,44,M,Indore Medical Institute,Phase III,ORX-202,Diabetes,Placebo,2023-10-08,2023-10-15,7.17,5.8,147,90,65,None,None,No Change,0
5305,PT-05305,41,F,Bhopal Research Hospital,Phase I,ORX-101,Oncology,High Dose,2024-09-03,2024-10-29,9.61,9.36,135,74,73,None,None,Improved,1
5306,PT-05306,69,F,PGI Chandigarh,Phase II,ORX-101,Oncology,Placebo,2023-08-08,2023-10-03,7.34,6.87,128,112,78,None,None,Improved,1
5307,PT-05307,31,F,Apollo Chennai,Phase III,ORX-202,Diabetes,High Dose,2023-07-05,2023-07-19,6.41,6.72,102,87,67,None,None,Improved,0
5308,PT-05308,18,F,AIIMS Delhi,Phase III,ORX-101,Oncology,High Dose,2024-05-15,2024-06-12,6.02,5.65,153,92,73,None,None,Improved,1
5309,PT-05309,60,M,PGI Chandigarh,Phase II,ORX-505,Infectious Disease,High Dose,2023-12-22,2024-03-21,6.77,5.05,128,63,89,Nausea,None,Improved,1
5310,PT-05310,57,F,NIMHANS Bengaluru,Phase IV,ORX-202,Diabetes,Placebo,2023-06-25,2023-09-23,6.14,5.88,130,92,60,None,None,Worsened,0
5311,PT-05311,54,M,Fortis Mumbai,Phase III,ORX-303,Cardiology,Placebo,2023-11-02,2023-12-28,5.62,5.92,147,73,95,None,None,Improved,0
5312,PT-05312,19,F,Apollo Chennai,Phase III,ORX-404,Neurology,High Dose,2023-06-29,2023-07-27,8.52,9.41,134,79,82,Dizziness,Mild,Worsened,0
5313,PT-05313,35,F,Fortis Mumbai,Phase III,ORX-404,Neurology,Low Dose,2024-08-20,2024-09-17,10.35,9.42,151,73,100,None,None,Worsened,0
5314,PT-05314,77,F,Indore Medical Institute,Phase III,ORX-303,Cardiology,Placebo,2024-02-21,2024-03-20,7.66,7.52,110,69,82,None,None,Worsened,0
5315,PT-05315,68,F,NIMHANS Bengaluru,Phase III,ORX-303,Cardiology,High Dose,2023-03-10,2023-03-17,6.54,8.13,117,84,81,Nausea,None,Improved,0
5316,PT-05316,43,M,PGI Chandigarh,Phase IV,ORX-404,Neurology,Low Dose,2023-01-03,2023-01-31,4.75,3.79,131,80,86,None,None,Worsened,0
5317,PT-05317,57,F,Kolkata Clinical Center,Phase IV,ORX-505,Infectious Disease,Low Dose,2024-07-12,2024-07-19,6.91,5.65,155,65,69,None,None,No Change,0
5318,PT-05318,31,F,Indore Medical Institute,Phase III,ORX-606,Rheumatology,High Dose,2024-02-04,2024-02-18,8.1,8.88,124,84,84,Headache,Moderate,Improved,0
5319,PT-05319,73,F,Fortis Mumbai,Phase I,ORX-101,Oncology,Low Dose,2024-04-20,2024-05-18,5.07,5.34,134,77,82,Rash,Mild,Improved,0
5320,PT-05320,56,M,AIIMS Delhi,Phase III,ORX-202,Diabetes,Low Dose,2023-04-23,2023-05-07,7.9,9.44,130,82,75,Rash,Mild,No Change,0
5321,PT-05321,53,M,Fortis Mumbai,Phase III,ORX-303,Cardiology,High Dose,2024-01-27,2024-02-10,7.16,6.77,128,80,69,None,None,Worsened,0
5322,PT-05322,51,F,Bhopal Research Hospital,Phase IV,ORX-303,Cardiology,Low Dose,2023-09-27,2023-12-26,6.86,7.01,129,77,99,Nausea,None,Worsened,0
5323,PT-05323,43,M,PGI Chandigarh,Phase I,ORX-303,Cardiology,Low Dose,2024-07-27,2024-10-25,7.95,6.92,91,75,48,Fever,None,Improved,1
5324,PT-05324,41,M,Fortis Mumbai,Phase II,ORX-505,Infectious Disease,Low Dose,2024-09-09,2024-12-08,8.96,7.75,90,100,71,None,None,No Change,0
5325,PT-05325,44,F,PGI Chandigarh,Phase II,ORX-606,Rheumatology,Low Dose,2023-12-14,2023-12-28,8.15,8.22,141,92,53,Headache,Mild,Improved,0
5326,PT-05326,22,F,Indore Medical Institute,Phase I,ORX-505,Infectious Disease,High Dose,2023-03-09,2023-06-07,8.61,7.5,115,66,72,Nausea,Mild,Improved,1
5327,PT-05327,39,F,Bhopal Research Hospital,Phase II,ORX-101,Oncology,Placebo,2024-09-13,2024-11-08,6.08,4.73,133,72,69,None,None,Improved,1
5328,PT-05328,18,M,Bhopal Research Hospital,Phase III,ORX-101,Oncology,Low Dose,2023-01-03,2023-01-31,9.53,9.97,119,71,78,Headache,Mild,No Change,0
5329,PT-05329,44,F,Bhopal Research Hospital,Phase III,ORX-505,Infectious Disease,High Dose,2024-10-26,2024-11-23,5.67,2.97,118,63,80,Rash,None,Improved,1
5330,PT-05330,47,F,Apollo Chennai,Phase II,ORX-303,Cardiology,High Dose,2023-10-25,2023-11-22,6.03,5.15,159,91,71,None,None,No Change,0
5331,PT-05331,81,M,Fortis Mumbai,Phase I,ORX-202,Diabetes,Placebo,2024-06-05,2024-07-03,5.76,4.63,126,63,103,Fatigue,None,No Change,0
5332,PT-05332,47,F,Indore Medical Institute,Phase II,ORX-404,Neurology,Low Dose,2023-06-28,2023-07-26,6.25,6.26,130,78,61,Headache,None,Improved,0
5333,PT-05333,22,F,Bhopal Research Hospital,Phase IV,ORX-505,Infectious Disease,Placebo,2023-07-29,2023-09-23,9.82,8.21,158,71,89,None,None,Improved,1
5334,PT-05334,52,F,Kolkata Clinical Center,Phase IV,ORX-505,Infectious Disease,High Dose,2024-11-04,2024-11-11,8.0,8.26,98,73,58,Headache,None,Worsened,0
5335,PT-05335,48,F,Bhopal Research Hospital,Phase III,ORX-202,Diabetes,High Dose,2023-04-13,2023-04-27,5.61,3.43,123,55,81,None,None,No Change,0
5336,PT-05336,24,M,PGI Chandigarh,Phase II,ORX-303,Cardiology,Low Dose,2024-01-09,2024-04-08,6.19,3.74,157,64,72,None,None,Worsened,0
5337,PT-05337,18,M,AIIMS Delhi,Phase III,ORX-202,Diabetes,Low Dose,2024-11-03,2024-11-10,6.2,7.37,133,73,77,None,None,No Change,0
5338,PT-05338,36,F,NIMHANS Bengaluru,Phase III,ORX-101,Oncology,High Dose,2024-10-22,2024-11-05,7.09,7.36,122,84,81,None,None,Improved,0
5339,PT-05339,39,M,Apollo Chennai,Phase II,ORX-303,Cardiology,High Dose,2024-11-04,2024-11-18,6.32,5.44,140,91,62,Nausea,Moderate,Improved,1
5340,PT-05340,40,F,NIMHANS Bengaluru,Phase IV,ORX-505,Infectious Disease,Placebo,2024-04-25,2024-05-09,6.3,6.62,119,108,81,Nausea,Moderate,No Change,0
5341,PT-05341,63,F,NIMHANS Bengaluru,Phase IV,ORX-202,Diabetes,Placebo,2024-01-03,2024-04-02,5.98,5.59,139,69,78,Headache,None,Worsened,0
5342,PT-05342,61,M,Kolkata Clinical Center,Phase II,ORX-606,Rheumatology,Low Dose,2023-01-03,2023-01-10,6.81,5.64,160,67,80,None,None,No Change,0
5343,PT-05343,33,M,Apollo Chennai,Phase I,ORX-202,Diabetes,High Dose,2024-09-16,2024-10-14,6.08,6.34,124,86,46,Dizziness,None,Worsened,0
5344,PT-05344,53,M,AIIMS Delhi,Phase II,ORX-303,Cardiology,Placebo,2024-03-28,2024-04-04,6.34,4.24,161,89,81,Fatigue,Mild,No Change,0
5345,PT-05345,64,M,Kolkata Clinical Center,Phase III,ORX-505,Infectious Disease,Low Dose,2023-09-09,2023-12-08,7.5,6.38,124,73,70,Rash,Mild,Improved,1
5346,PT-05346,24,M,AIIMS Delhi,Phase II,ORX-202,Diabetes,High Dose,2024-06-03,2024-06-17,6.04,6.44,133,75,63,None,None,Improved,0
5347,PT-05347,38,F,Apollo Chennai,Phase III,ORX-303,Cardiology,Placebo,2024-05-17,2024-08-15,5.18,4.89,145,110,62,Headache,None,No Change,0
5348,PT-05348,59,F,Kolkata Clinical Center,Phase III,ORX-101,Oncology,High Dose,2023-02-05,2023-03-05,6.35,4.94,107,83,64,Nausea,None,Worsened,0
5349,PT-05349,35,M,AIIMS Delhi,Phase I,ORX-505,Infectious Disease,Placebo,2023-05-17,2023-06-14,6.67,5.61,113,52,79,None,None,No Change,0
5350,PT-05350,46,M,Apollo Chennai,Phase III,ORX-606,Rheumatology,High Dose,2023-09-02,2023-10-28,6.24,6.17,153,82,96,None,None,Improved,1
5351,PT-05351,80,F,Indore Medical Institute,Phase I,ORX-303,Cardiology,High Dose,2024-04-29,2024-07-28,10.24,8.77,106,76,79,Headache,Mild,Improved,1
5352,PT-05352,70,F,Apollo Chennai,Phase II,ORX-303,Cardiology,Low Dose,2023-08-27,2023-10-22,7.95,6.47,116,81,57,Headache,None,Improved,1
5353,PT-05353,45,F,Kolkata Clinical Center,Phase IV,ORX-505,Infectious Disease,Low Dose,2024-01-12,2024-02-09,5.77,3.89,110,86,83,None,None,Improved,1
5354,PT-05354,46,F,Indore Medical Institute,Phase IV,ORX-606,Rheumatology,Placebo,2023-06-18,2023-06-25,8.39,8.79,131,82,79,Dizziness,Moderate,Improved,0
5355,PT-05355,42,F,NIMHANS Bengaluru,Phase I,ORX-404,Neurology,Placebo,2024-10-13,2024-11-10,4.59,5.21,135,67,97,None,None,No Change,0
5356,PT-05356,35,M,AIIMS Delhi,Phase III,ORX-101,Oncology,High Dose,2023-09-09,2023-10-07,7.07,7.59,131,98,73,Fatigue,None,Improved,0
5357,PT-05357,72,F,NIMHANS Bengaluru,Phase II,ORX-505,Infectious Disease,High Dose,2024-08-16,2024-09-13,6.27,7.05,90,68,82,None,None,Improved,0
5358,PT-05358,38,M,Fortis Mumbai,Phase III,ORX-505,Infectious Disease,High Dose,2024-08-30,2024-09-27,7.11,6.75,106,68,81,Nausea,Mild,Improved,1
5359,PT-05359,34,F,Kolkata Clinical Center,Phase III,ORX-202,Diabetes,Low Dose,2024-04-22,2024-05-06,8.81,8.24,140,87,69,Headache,None,No Change,0
5360,PT-05360,18,F,Fortis Mumbai,Phase III,ORX-202,Diabetes,High Dose,2024-04-03,2024-05-01,8.62,7.34,120,80,77,Nausea,Mild,Improved,1
5361,PT-05361,60,F,PGI Chandigarh,Phase III,ORX-101,Oncology,High Dose,2023-11-05,2023-12-03,7.21,6.69,146,89,67,Headache,None,Improved,1
5362,PT-05362,26,F,Fortis Mumbai,Phase III,ORX-606,Rheumatology,Low Dose,2023-11-21,2023-12-05,6.21,5.77,105,83,76,None,None,No Change,0
5363,PT-05363,18,F,PGI Chandigarh,Phase II,ORX-101,Oncology,High Dose,2024-09-17,2024-10-01,5.51,2.52,121,94,51,None,None,Worsened,0
5364,PT-05364,23,M,Fortis Mumbai,Phase III,ORX-202,Diabetes,Placebo,2024-09-02,2024-09-09,7.0,5.65,108,88,71,None,None,Improved,1
5365,PT-05365,21,F,Apollo Chennai,Phase II,ORX-505,Infectious Disease,Placebo,2024-05-11,2024-07-06,4.69,6.28,148,76,79,None,None,Worsened,0
5366,PT-05366,37,F,PGI Chandigarh,Phase III,ORX-303,Cardiology,High Dose,2023-06-17,2023-07-15,7.81,6.64,118,87,98,Fever,Severe,Improved,1
5367,PT-05367,56,M,Apollo Chennai,Phase III,ORX-303,Cardiology,High Dose,2023-07-10,2023-08-07,8.68,8.0,116,58,79,None,None,Improved,1
5368,PT-05368,51,F,Indore Medical Institute,Phase IV,ORX-404,Neurology,Placebo,2023-03-12,2023-06-10,6.84,5.74,150,89,96,None,None,Improved,1
5369,PT-05369,29,F,Indore Medical Institute,Phase I,ORX-404,Neurology,Placebo,2023-08-29,2023-11-27,6.35,7.03,127,75,71,Nausea,Mild,Worsened,0
5370,PT-05370,44,F,Apollo Chennai,Phase IV,ORX-202,Diabetes,High Dose,2023-06-13,2023-06-20,8.4,7.86,142,87,65,None,None,Worsened,0
5371,PT-05371,30,M,Kolkata Clinical Center,Phase IV,ORX-303,Cardiology,Low Dose,2024-07-13,2024-07-27,6.66,5.06,118,100,77,Dizziness,None,Worsened,0
5372,PT-05372,32,M,Fortis Mumbai,Phase III,ORX-303,Cardiology,High Dose,2023-03-04,2023-06-02,9.5,8.26,110,96,87,Headache,Mild,Improved,1
5373,PT-05373,42,M,Bhopal Research Hospital,Phase III,ORX-505,Infectious Disease,Low Dose,2023-07-05,2023-10-03,8.2,8.07,106,53,70,Rash,Mild,Improved,1
5374,PT-05374,62,M,Indore Medical Institute,Phase II,ORX-404,Neurology,Placebo,2023-07-25,2023-10-23,6.69,6.7,131,61,72,Fatigue,None,No Change,0
5375,PT-05375,50,M,Apollo Chennai,Phase III,ORX-202,Diabetes,Placebo,2024-11-24,2025-01-19,6.26,5.53,135,82,92,Headache,None,No Change,0
5376,PT-05376,51,M,Apollo Chennai,Phase II,ORX-202,Diabetes,Placebo,2023-10-11,2023-10-25,6.05,5.22,128,98,71,Fever,Moderate,No Change,0
5377,PT-05377,18,M,Bhopal Research Hospital,Phase IV,ORX-606,Rheumatology,High Dose,2024-04-15,2024-04-29,7.73,6.65,104,82,91,None,None,Improved,1
5378,PT-05378,35,M,Apollo Chennai,Phase II,ORX-101,Oncology,High Dose,2024-11-02,2024-12-28,7.8,8.01,142,73,62,None,None,No Change,0
5379,PT-05379,29,F,Apollo Chennai,Phase III,ORX-505,Infectious Disease,High Dose,2024-05-12,2024-05-19,8.15,8.35,110,107,62,None,None,Worsened,0
5380,PT-05380,60,M,NIMHANS Bengaluru,Phase II,ORX-505,Infectious Disease,High Dose,2023-02-21,2023-03-07,9.02,8.72,114,73,74,None,None,Improved,1
5381,PT-05381,62,M,AIIMS Delhi,Phase III,ORX-303,Cardiology,Placebo,2024-09-30,2024-10-28,5.76,3.71,134,88,105,None,None,Improved,1
5382,PT-05382,22,F,Bhopal Research Hospital,Phase III,ORX-303,Cardiology,Placebo,2024-07-07,2024-07-21,7.04,7.68,130,79,89,Dizziness,Mild,Improved,0
5383,PT-05383,35,F,PGI Chandigarh,Phase III,ORX-101,Oncology,Low Dose,2024-01-02,2024-01-09,8.22,6.69,100,78,45,Fatigue,None,Worsened,0
5384,PT-05384,46,F,Indore Medical Institute,Phase II,ORX-202,Diabetes,Low Dose,2024-02-04,2024-02-11,5.12,4.98,131,81,84,Fatigue,None,Improved,1
5385,PT-05385,48,F,Kolkata Clinical Center,Phase I,ORX-303,Cardiology,Placebo,2023-02-04,2023-02-11,6.85,8.1,135,91,93,Fatigue,Mild,Improved,0
5386,PT-05386,55,F,Fortis Mumbai,Phase III,ORX-202,Diabetes,Low Dose,2024-05-01,2024-05-15,9.68,9.42,127,74,74,Fatigue,None,Improved,1
5387,PT-05387,33,M,Fortis Mumbai,Phase III,ORX-303,Cardiology,Low Dose,2024-02-02,2024-02-16,8.01,6.79,129,88,80,Dizziness,None,Worsened,0
5388,PT-05388,30,M,Apollo Chennai,Phase III,ORX-404,Neurology,Placebo,2024-04-30,2024-05-14,8.04,,90,70,97,None,None,Improved,1
5389,PT-05389,68,M,Indore Medical Institute,Phase III,ORX-606,Rheumatology,High Dose,2023-03-30,2023-04-06,7.83,8.14,113,78,95,None,None,Improved,0
5390,PT-05390,51,F,Indore Medical Institute,Phase I,ORX-404,Neurology,High Dose,2024-11-20,2024-12-18,7.28,6.71,149,95,87,Dizziness,Mild,No Change,0
5391,PT-05391,46,M,AIIMS Delhi,Phase IV,ORX-505,Infectious Disease,Placebo,2023-10-16,2023-12-11,6.77,7.0,108,71,57,Rash,Mild,Improved,0
5392,PT-05392,64,F,Apollo Chennai,Phase III,ORX-101,Oncology,Low Dose,2023-04-05,2023-05-03,6.34,6.3,125,116,84,Fatigue,Severe,Improved,1
5393,PT-05393,18,M,PGI Chandigarh,Phase II,ORX-202,Diabetes,Low Dose,2023-10-16,2023-10-30,8.61,7.86,124,73,80,None,None,No Change,0
5394,PT-05394,47,M,Fortis Mumbai,Phase IV,ORX-404,Neurology,Low Dose,2024-01-29,2024-02-12,6.43,5.57,129,53,57,Fatigue,None,Improved,1
5395,PT-05395,71,M,Kolkata Clinical Center,Phase III,ORX-505,Infectious Disease,Placebo,2023-12-31,2024-01-28,7.59,6.72,97,81,91,Headache,None,Worsened,0
5396,PT-05396,85,M,PGI Chandigarh,Phase III,ORX-505,Infectious Disease,High Dose,2023-09-24,2023-10-08,9.47,8.27,119,64,66,Nausea,None,Improved,1
5397,PT-05397,41,F,Kolkata Clinical Center,Phase II,ORX-101,Oncology,Low Dose,2024-11-01,2024-12-27,6.76,8.21,104,81,49,Nausea,None,Improved,0
5398,PT-05398,50,F,Apollo Chennai,Phase IV,ORX-101,Oncology,Placebo,2023-02-17,2023-02-24,5.59,6.18,122,65,48,Rash,None,Improved,0
5399,PT-05399,29,F,Bhopal Research Hospital,Phase II,ORX-101,Oncology,High Dose,2024-10-16,2024-11-13,7.49,7.47,119,93,62,None,None,Improved,1
5400,PT-05400,18,M,Indore Medical Institute,Phase I,ORX-606,Rheumatology,High Dose,2023-08-07,2023-10-02,7.54,8.3,151,66,70,Headache,Mild,No Change,0
5401,PT-05401,56,F,Indore Medical Institute,Phase III,ORX-505,Infectious Disease,High Dose,2023-09-04,2023-10-02,6.45,6.14,115,68,65,Headache,Moderate,Improved,1
5402,PT-05402,60,M,PGI Chandigarh,Phase III,ORX-303,Cardiology,Low Dose,2024-04-04,2024-05-02,7.22,7.96,137,101,89,None,None,No Change,0
5403,PT-05403,57,F,PGI Chandigarh,Phase II,ORX-606,Rheumatology,Placebo,2023-06-15,2023-09-13,7.06,9.36,130,58,81,None,None,No Change,0
5404,PT-05404,29,F,AIIMS Delhi,Phase II,ORX-404,Neurology,Low Dose,2024-06-11,2024-07-09,8.42,8.67,124,71,80,None,None,No Change,0
5405,PT-05405,34,F,Kolkata Clinical Center,Phase I,ORX-505,Infectious Disease,High Dose,2024-03-17,2024-05-12,8.15,8.25,180,76,73,Headache,None,Worsened,0
5406,PT-05406,42,M,Indore Medical Institute,Phase II,ORX-505,Infectious Disease,High Dose,2024-03-25,2024-06-23,7.07,7.59,123,105,86,Dizziness,Mild,No Change,0
5407,PT-05407,37,F,Apollo Chennai,Phase I,ORX-606,Rheumatology,High Dose,2023-06-12,2023-07-10,6.31,6.85,128,82,69,None,None,Improved,0
5408,PT-05408,44,M,AIIMS Delhi,Phase III,ORX-202,Diabetes,Low Dose,2023-04-19,2023-04-26,6.43,7.26,140,79,75,Headache,Mild,Worsened,0
5409,PT-05409,46,F,NIMHANS Bengaluru,Phase IV,ORX-202,Diabetes,Low Dose,2024-07-26,2024-09-20,7.19,5.93,93,72,76,None,None,Improved,1
5410,PT-05410,33,M,Indore Medical Institute,Phase III,ORX-505,Infectious Disease,High Dose,2024-01-21,2024-01-28,8.18,7.58,161,75,79,Nausea,None,Improved,1
5411,PT-05411,40,F,Fortis Mumbai,Phase III,ORX-101,Oncology,Low Dose,2024-05-08,2024-05-22,7.73,8.29,138,57,84,Rash,Mild,No Change,0
5412,PT-05412,28,M,Apollo Chennai,Phase III,ORX-404,Neurology,Low Dose,2024-06-27,2024-07-04,6.83,7.05,107,95,73,Headache,None,Improved,0
5413,PT-05413,79,F,Bhopal Research Hospital,Phase I,ORX-404,Neurology,Placebo,2023-07-14,2023-07-21,7.28,8.42,149,74,59,Dizziness,None,No Change,0
5414,PT-05414,46,F,Fortis Mumbai,Phase I,ORX-404,Neurology,High Dose,2024-08-28,2024-09-04,6.5,7.52,123,78,58,None,None,No Change,0
5415,PT-05415,51,M,Bhopal Research Hospital,Phase III,ORX-404,Neurology,High Dose,2023-05-27,2023-07-22,5.79,5.79,138,73,91,None,None,Improved,1
5416,PT-05416,40,F,Indore Medical Institute,Phase III,ORX-101,Oncology,Placebo,2024-02-14,2024-05-14,5.43,6.43,111,88,83,Rash,None,Worsened,0
5417,PT-05417,51,M,Kolkata Clinical Center,Phase I,ORX-101,Oncology,Placebo,2023-08-09,2023-08-23,7.65,6.37,158,93,84,Headache,Mild,Improved,1
5418,PT-05418,23,F,Bhopal Research Hospital,Phase III,ORX-505,Infectious Disease,Placebo,2023-04-07,2023-04-14,6.03,6.22,91,86,59,None,None,Improved,0
5419,PT-05419,31,M,Indore Medical Institute,Phase III,ORX-101,Oncology,Low Dose,2023-01-22,2023-01-29,5.51,5.33,148,86,84,None,None,Improved,1
5420,PT-05420,47,M,Bhopal Research Hospital,Phase I,ORX-202,Diabetes,High Dose,2024-07-27,2024-08-10,8.02,8.04,90,92,89,Dizziness,None,Worsened,0
5421,PT-05421,39,M,Indore Medical Institute,Phase III,ORX-101,Oncology,High Dose,2023-03-20,2023-06-18,4.83,4.65,133,76,80,Headache,Mild,Worsened,0
5422,PT-05422,62,F,Bhopal Research Hospital,Phase III,ORX-101,Oncology,High Dose,2024-04-19,2024-06-14,10.08,9.81,134,72,70,Fatigue,Moderate,No Change,0
5423,PT-05423,42,M,Bhopal Research Hospital,Phase III,ORX-303,Cardiology,Low Dose,2023-03-23,2023-03-30,8.61,8.95,162,64,59,Dizziness,Severe,No Change,0
5424,PT-05424,62,M,AIIMS Delhi,Phase III,ORX-606,Rheumatology,Placebo,2023-04-25,2023-07-24,8.94,8.57,90,73,82,Headache,Moderate,Improved,1
5425,PT-05425,30,F,NIMHANS Bengaluru,Phase III,ORX-101,Oncology,Low Dose,2023-05-30,2023-06-06,7.42,8.73,153,91,77,Fatigue,None,Improved,0
5426,PT-05426,37,M,Fortis Mumbai,Phase III,ORX-303,Cardiology,High Dose,2024-09-01,2024-10-27,8.11,7.73,129,63,67,None,None,Improved,1
5427,PT-05427,57,M,AIIMS Delhi,Phase III,ORX-606,Rheumatology,Placebo,2024-06-14,2024-06-28,5.88,5.72,135,87,85,Rash,None,Worsened,0
5428,PT-05428,55,M,Kolkata Clinical Center,Phase II,ORX-303,Cardiology,Low Dose,2023-12-03,2023-12-10,6.45,4.73,112,90,61,None,None,Worsened,0
5429,PT-05429,28,M,AIIMS Delhi,Phase IV,ORX-404,Neurology,Placebo,2024-01-19,2024-02-02,5.94,3.88,107,94,67,Nausea,Mild,Improved,1
5430,PT-05430,18,F,Kolkata Clinical Center,Phase III,ORX-101,Oncology,High Dose,2023-07-18,2023-08-01,6.59,6.65,95,93,57,None,None,Improved,0
5431,PT-05431,38,M,AIIMS Delhi,Phase III,ORX-101,Oncology,Placebo,2024-06-20,2024-08-15,6.71,5.8,126,91,77,Rash,Mild,Improved,1
5432,PT-05432,35,F,AIIMS Delhi,Phase II,ORX-202,Diabetes,Low Dose,2024-05-15,2024-08-13,7.75,7.54,115,82,67,Fatigue,Mild,Improved,1
5433,PT-05433,31,M,Fortis Mumbai,Phase IV,ORX-505,Infectious Disease,Low Dose,2023-02-02,2023-05-03,8.17,8.17,141,89,65,None,None,Worsened,0
5434,PT-05434,61,F,NIMHANS Bengaluru,Phase III,ORX-202,Diabetes,Low Dose,2023-02-02,2023-02-16,6.84,7.28,125,85,82,Headache,Moderate,Worsened,0
5435,PT-05435,58,F,Bhopal Research Hospital,Phase III,ORX-606,Rheumatology,Placebo,2024-05-19,2024-05-26,5.24,3.42,140,86,67,None,None,Worsened,0
5436,PT-05436,50,F,PGI Chandigarh,Phase IV,ORX-606,Rheumatology,Low Dose,2023-09-29,2023-10-27,5.51,8.05,151,89,79,None,None,Worsened,0
5437,PT-05437,35,F,Bhopal Research Hospital,Phase III,ORX-202,Diabetes,High Dose,2024-10-10,2024-12-05,5.63,5.13,112,72,58,None,None,Improved,1
5438,PT-05438,48,M,Apollo Chennai,Phase III,ORX-606,Rheumatology,High Dose,2024-06-17,2024-08-12,6.75,6.83,136,84,115,None,None,No Change,0
5439,PT-05439,58,M,NIMHANS Bengaluru,Phase III,ORX-404,Neurology,High Dose,2023-09-21,2023-12-20,5.69,5.7,127,65,58,None,None,No Change,0
5440,PT-05440,52,F,Fortis Mumbai,Phase III,ORX-404,Neurology,High Dose,2023-12-17,2024-01-14,8.04,6.7,145,85,94,None,None,No Change,0
5441,PT-05441,62,M,AIIMS Delhi,Phase III,ORX-606,Rheumatology,Placebo,2023-11-04,2023-11-18,7.01,8.08,107,110,65,None,None,Improved,0
5442,PT-05442,44,F,Apollo Chennai,Phase II,ORX-505,Infectious Disease,High Dose,2023-06-26,2023-07-10,6.52,5.78,180,76,89,None,None,Improved,1
5443,PT-05443,41,F,Apollo Chennai,Phase III,ORX-303,Cardiology,Low Dose,2024-06-11,2024-06-25,8.32,7.43,132,89,67,Headache,None,Worsened,0
5444,PT-05444,85,F,Kolkata Clinical Center,Phase III,ORX-606,Rheumatology,Low Dose,2024-09-11,2024-09-25,8.02,7.41,115,83,60,Fever,Severe,No Change,0
5445,PT-05445,73,M,Apollo Chennai,Phase I,ORX-606,Rheumatology,Low Dose,2024-02-11,2024-02-18,7.72,7.24,146,73,61,None,None,No Change,0
5446,PT-05446,42,F,Kolkata Clinical Center,Phase III,ORX-101,Oncology,Placebo,2023-11-15,2023-11-22,7.35,7.43,101,76,45,None,None,Improved,0
5447,PT-05447,26,M,AIIMS Delhi,Phase III,ORX-202,Diabetes,Placebo,2023-09-07,2023-12-06,8.06,8.52,107,78,78,None,None,Improved,0
5448,PT-05448,62,M,Kolkata Clinical Center,Phase II,ORX-606,Rheumatology,High Dose,2023-12-12,2023-12-19,9.03,8.77,123,64,79,None,None,No Change,0
5449,PT-05449,78,M,Kolkata Clinical Center,Phase IV,ORX-606,Rheumatology,Low Dose,2024-01-13,2024-03-09,8.75,8.51,133,73,73,Nausea,Mild,No Change,0
5450,PT-05450,47,M,PGI Chandigarh,Phase I,ORX-101,Oncology,Placebo,2024-09-10,2024-12-09,7.38,7.89,145,88,64,None,None,No Change,0
5451,PT-05451,29,F,Indore Medical Institute,Phase II,ORX-101,Oncology,Placebo,2024-05-14,2024-05-28,6.13,5.95,91,81,97,None,None,Improved,1
5452,PT-05452,55,F,Fortis Mumbai,Phase II,ORX-202,Diabetes,Low Dose,2024-02-27,2024-03-12,6.78,5.75,142,85,74,Rash,None,No Change,0
5453,PT-05453,35,F,AIIMS Delhi,Phase IV,ORX-404,Neurology,High Dose,2024-03-03,2024-03-17,7.29,6.62,142,96,58,None,None,No Change,0
5454,PT-05454,25,F,Indore Medical Institute,Phase II,ORX-404,Neurology,Low Dose,2024-09-03,2024-12-02,8.82,8.57,107,93,82,Fatigue,None,Worsened,0
5455,PT-05455,80,M,Fortis Mumbai,Phase II,ORX-202,Diabetes,Low Dose,2023-10-26,2023-11-09,6.92,7.52,101,98,91,None,None,No Change,0
5456,PT-05456,70,F,Fortis Mumbai,Phase III,ORX-606,Rheumatology,Low Dose,2023-04-25,2023-05-23,8.53,8.04,106,74,53,None,None,Worsened,0
5457,PT-05457,30,M,Bhopal Research Hospital,Phase III,ORX-404,Neurology,Low Dose,2023-05-18,2023-08-16,7.71,7.27,123,72,53,Rash,Moderate,No Change,0
5458,PT-05458,47,M,Fortis Mumbai,Phase II,ORX-606,Rheumatology,Low Dose,2023-09-10,2023-12-09,7.65,6.36,118,100,94,None,None,No Change,0
5459,PT-05459,21,F,Kolkata Clinical Center,Phase I,ORX-202,Diabetes,High Dose,2023-12-08,2024-03-07,7.1,8.01,124,78,93,Nausea,Moderate,Improved,0
5460,PT-05460,60,M,Fortis Mumbai,Phase II,ORX-303,Cardiology,Low Dose,2023-10-30,2023-11-06,8.32,7.69,139,99,77,Dizziness,None,No Change,0
5461,PT-05461,38,M,Fortis Mumbai,Phase I,ORX-606,Rheumatology,Low Dose,2024-02-14,2024-02-21,8.68,10.12,166,77,74,Rash,None,Improved,0
5462,PT-05462,28,F,PGI Chandigarh,Phase III,ORX-202,Diabetes,Low Dose,2024-10-26,2024-11-02,7.34,5.97,118,90,83,None,None,No Change,0
5463,PT-05463,18,F,AIIMS Delhi,Phase II,ORX-606,Rheumatology,Low Dose,2023-06-30,2023-07-14,9.08,7.71,110,67,68,None,None,Improved,1
5464,PT-05464,30,M,Indore Medical Institute,Phase IV,ORX-101,Oncology,High Dose,2024-10-05,2024-10-19,6.15,3.54,130,84,109,Headache,Moderate,No Change,0
5465,PT-05465,52,F,AIIMS Delhi,Phase IV,ORX-606,Rheumatology,Low Dose,2023-07-31,2023-09-25,6.6,5.12,126,87,70,None,None,No Change,0
5466,PT-05466,45,M,PGI Chandigarh,Phase I,ORX-202,Diabetes,Low Dose,2024-06-27,2024-08-22,9.48,8.73,94,92,82,None,None,No Change,0
5467,PT-05467,18,M,Bhopal Research Hospital,Phase III,ORX-101,Oncology,Low Dose,2023-05-05,2023-06-30,7.71,6.42,135,104,75,None,None,Improved,1
5468,PT-05468,62,M,Fortis Mumbai,Phase III,ORX-505,Infectious Disease,Low Dose,2023-05-08,2023-06-05,5.73,3.96,164,85,86,None,None,Improved,1
5469,PT-05469,63,F,Kolkata Clinical Center,Phase II,ORX-505,Infectious Disease,Low Dose,2024-04-13,2024-04-20,6.57,6.91,140,66,99,Dizziness,Moderate,Improved,0
5470,PT-05470,65,M,Bhopal Research Hospital,Phase II,ORX-101,Oncology,High Dose,2023-10-13,2024-01-11,5.66,5.44,123,99,58,Headache,None,Worsened,0
5471,PT-05471,85,F,Kolkata Clinical Center,Phase II,ORX-202,Diabetes,Low Dose,2023-10-15,2023-10-29,6.99,7.26,152,79,76,None,None,No Change,0
5472,PT-05472,36,M,AIIMS Delhi,Phase III,ORX-101,Oncology,Low Dose,2024-09-23,2024-10-07,6.14,5.98,125,75,71,None,None,Worsened,0
5473,PT-05473,54,F,AIIMS Delhi,Phase III,ORX-606,Rheumatology,High Dose,2024-05-07,2024-06-04,6.24,5.62,144,84,63,None,None,Improved,1
5474,PT-05474,44,F,Indore Medical Institute,Phase III,ORX-606,Rheumatology,Low Dose,2023-12-29,2024-01-05,7.72,8.21,114,75,68,None,None,No Change,0
5475,PT-05475,34,M,AIIMS Delhi,Phase III,ORX-606,Rheumatology,Low Dose,2024-02-10,2024-05-10,7.69,7.82,146,80,58,Fatigue,None,Improved,0
5476,PT-05476,55,F,Apollo Chennai,Phase II,ORX-202,Diabetes,Placebo,2023-03-27,2023-04-03,7.39,7.04,104,79,61,Headache,Mild,Improved,1
5477,PT-05477,52,F,Indore Medical Institute,Phase II,ORX-202,Diabetes,Low Dose,2023-05-09,2023-05-16,6.68,5.82,100,94,74,None,None,Improved,1
5478,PT-05478,46,M,NIMHANS Bengaluru,Phase III,ORX-202,Diabetes,Placebo,2024-01-14,2024-01-21,6.32,4.43,118,77,82,Fatigue,None,Improved,1
5479,PT-05479,39,M,PGI Chandigarh,Phase III,ORX-404,Neurology,Placebo,2023-03-05,2023-04-30,6.34,4.58,128,72,96,None,None,No Change,0
5480,PT-05480,47,F,Fortis Mumbai,Phase I,ORX-505,Infectious Disease,Placebo,2023-11-26,2023-12-24,7.87,7.25,131,71,61,Fatigue,None,Improved,1
5481,PT-05481,45,F,PGI Chandigarh,Phase III,ORX-606,Rheumatology,High Dose,2024-04-06,2024-06-01,7.88,5.73,119,104,84,None,None,Improved,1
5482,PT-05482,69,F,PGI Chandigarh,Phase IV,ORX-101,Oncology,Low Dose,2023-04-10,2023-06-05,6.44,5.63,145,89,76,Headache,Moderate,Improved,1
5483,PT-05483,24,M,Apollo Chennai,Phase IV,ORX-606,Rheumatology,Low Dose,2023-02-10,2023-03-10,8.59,,99,98,71,None,None,Improved,0
5484,PT-05484,39,F,Indore Medical Institute,Phase III,ORX-404,Neurology,High Dose,2023-07-11,2023-08-08,7.52,6.04,127,62,84,Headache,None,Improved,1
5485,PT-05485,80,F,NIMHANS Bengaluru,Phase I,ORX-505,Infectious Disease,Low Dose,2024-01-01,2024-01-08,6.43,5.88,125,93,83,None,None,Improved,1
5486,PT-05486,59,M,Indore Medical Institute,Phase III,ORX-404,Neurology,Low Dose,2024-02-24,2024-03-23,6.59,6.58,90,90,60,Rash,None,Improved,1
5487,PT-05487,39,F,Fortis Mumbai,Phase III,ORX-404,Neurology,Placebo,2023-04-20,2023-05-18,8.09,6.31,147,80,98,Headache,None,Improved,1
5488,PT-05488,30,F,NIMHANS Bengaluru,Phase II,ORX-505,Infectious Disease,Placebo,2023-08-04,2023-09-01,5.02,4.6,138,90,62,Headache,None,No Change,0
5489,PT-05489,19,M,AIIMS Delhi,Phase IV,ORX-101,Oncology,High Dose,2024-05-14,2024-05-21,6.83,6.89,136,100,72,None,None,Improved,0
5490,PT-05490,18,M,AIIMS Delhi,Phase III,ORX-404,Neurology,Placebo,2023-04-08,2023-07-07,8.64,8.41,133,91,95,Rash,Mild,No Change,0
5491,PT-05491,44,M,Kolkata Clinical Center,Phase IV,ORX-505,Infectious Disease,Placebo,2024-02-28,2024-03-27,8.61,8.71,116,79,86,Rash,Severe,Improved,0
5492,PT-05492,33,F,Kolkata Clinical Center,Phase III,ORX-404,Neurology,High Dose,2023-04-16,2023-07-15,8.26,8.01,134,99,82,None,None,Improved,1
5493,PT-05493,46,F,PGI Chandigarh,Phase III,ORX-606,Rheumatology,Placebo,2024-02-26,2024-03-11,7.1,6.58,133,98,69,Headache,None,Improved,1
5494,PT-05494,34,M,Bhopal Research Hospital,Phase II,ORX-404,Neurology,High Dose,2023-12-12,2023-12-19,8.74,7.83,131,74,54,None,None,Improved,1
5495,PT-05495,48,M,Kolkata Clinical Center,Phase II,ORX-303,Cardiology,Low Dose,2023-04-29,2023-05-13,8.54,8.08,101,83,67,Headache,Mild,Improved,1
5496,PT-05496,18,F,NIMHANS Bengaluru,Phase III,ORX-202,Diabetes,High Dose,2023-12-19,2024-01-16,7.1,7.17,149,103,87,Dizziness,None,No Change,0
5497,PT-05497,59,F,AIIMS Delhi,Phase I,ORX-303,Cardiology,Low Dose,2024-03-10,2024-04-07,5.66,6.72,150,77,87,None,None,Improved,0
5498,PT-05498,54,M,Kolkata Clinical Center,Phase III,ORX-101,Oncology,High Dose,2023-09-15,2023-12-14,8.96,8.43,114,76,90,None,None,No Change,0
5499,PT-05499,18,M,Apollo Chennai,Phase IV,ORX-303,Cardiology,Placebo,2023-12-08,2023-12-15,3.6,4.01,132,82,59,None,None,Improved,0
5500,PT-05500,18,M,Fortis Mumbai,Phase III,ORX-505,Infectious Disease,Low Dose,2024-10-11,2025-01-09,6.44,6.36,117,92,64,None,None,Improved,1
5501,PT-05501,36,F,PGI Chandigarh,Phase III,ORX-303,Cardiology,High Dose,2024-07-05,2024-07-19,8.04,7.3,122,74,66,Rash,Moderate,Improved,1
5502,PT-05502,50,F,AIIMS Delhi,Phase II,ORX-101,Oncology,High Dose,2023-12-04,2024-01-01,7.78,7.58,116,79,100,Dizziness,Severe,Improved,1
5503,PT-05503,22,F,PGI Chandigarh,Phase III,ORX-101,Oncology,Placebo,2023-03-08,2023-04-05,9.46,9.15,124,93,49,None,None,Improved,1
5504,PT-05504,67,F,NIMHANS Bengaluru,Phase II,ORX-303,Cardiology,High Dose,2024-09-26,2024-12-25,9.43,10.01,90,91,101,Headache,None,Worsened,0
5505,PT-05505,69,F,Fortis Mumbai,Phase III,ORX-404,Neurology,High Dose,2023-03-22,2023-04-05,5.51,6.03,160,82,57,None,None,Improved,0
5506,PT-05506,58,M,Apollo Chennai,Phase III,ORX-303,Cardiology,High Dose,2023-03-31,2023-04-07,8.46,7.94,106,93,67,Headache,Moderate,Improved,1
5507,PT-05507,51,M,Kolkata Clinical Center,Phase III,ORX-404,Neurology,High Dose,2024-01-11,2024-03-07,9.07,7.18,144,79,75,Dizziness,Mild,No Change,0
5508,PT-05508,53,F,Indore Medical Institute,Phase III,ORX-202,Diabetes,High Dose,2023-08-27,2023-09-10,6.27,4.82,95,96,72,None,None,Worsened,0
5509,PT-05509,54,F,Fortis Mumbai,Phase III,ORX-101,Oncology,Placebo,2024-12-01,2025-03-01,6.62,5.17,139,85,74,Nausea,Moderate,Improved,1
5510,PT-05510,49,M,Indore Medical Institute,Phase III,ORX-101,Oncology,Placebo,2023-10-09,2023-10-16,6.05,6.6,151,91,72,None,None,No Change,0
5511,PT-05511,45,M,Bhopal Research Hospital,Phase III,ORX-404,Neurology,Placebo,2023-05-19,2023-05-26,9.08,9.84,163,72,65,Nausea,None,Improved,0
5512,PT-05512,47,F,NIMHANS Bengaluru,Phase II,ORX-606,Rheumatology,Low Dose,2024-05-28,2024-06-25,7.69,7.16,120,97,76,Rash,None,Improved,1
5513,PT-05513,25,F,Fortis Mumbai,Phase III,ORX-303,Cardiology,High Dose,2024-10-02,2024-11-27,5.88,5.7,182,70,73,Fatigue,None,No Change,0
5514,PT-05514,83,F,Fortis Mumbai,Phase I,ORX-505,Infectious Disease,Placebo,2024-09-08,2024-10-06,6.62,6.63,161,70,73,Nausea,Mild,Improved,0
5515,PT-05515,37,F,AIIMS Delhi,Phase III,ORX-202,Diabetes,Low Dose,2024-08-07,2024-09-04,5.38,6.39,117,71,71,None,None,Improved,0
5516,PT-05516,59,M,Kolkata Clinical Center,Phase IV,ORX-606,Rheumatology,Low Dose,2024-02-12,2024-04-08,7.34,6.22,135,91,77,None,None,Improved,1
5517,PT-05517,41,F,Indore Medical Institute,Phase I,ORX-202,Diabetes,Placebo,2024-01-30,2024-02-27,8.42,7.86,156,72,67,None,None,Improved,1
5518,PT-05518,30,M,AIIMS Delhi,Phase IV,ORX-303,Cardiology,Placebo,2023-10-07,2023-10-21,6.91,6.52,104,83,85,None,None,Improved,1
5519,PT-05519,21,F,Bhopal Research Hospital,Phase II,ORX-202,Diabetes,Placebo,2023-07-02,2023-09-30,6.57,6.69,108,78,93,None,None,Improved,0
5520,PT-05520,73,F,NIMHANS Bengaluru,Phase I,ORX-606,Rheumatology,Placebo,2023-02-01,2023-05-02,7.73,7.18,118,92,93,Fever,Mild,Improved,1
5521,PT-05521,26,M,Kolkata Clinical Center,Phase III,ORX-101,Oncology,Low Dose,2023-11-21,2023-12-05,8.29,7.35,112,80,91,None,None,Improved,1
5522,PT-05522,49,F,AIIMS Delhi,Phase II,ORX-606,Rheumatology,High Dose,2024-04-04,2024-05-30,7.54,7.46,136,80,86,None,None,Improved,1
5523,PT-05523,34,M,PGI Chandigarh,Phase II,ORX-404,Neurology,High Dose,2023-10-15,2023-10-29,7.98,8.35,140,91,84,None,None,Worsened,0
5524,PT-05524,63,M,Apollo Chennai,Phase IV,ORX-606,Rheumatology,High Dose,2024-07-25,2024-10-23,4.47,4.84,163,74,67,Headache,None,Worsened,0
5525,PT-05525,65,M,Indore Medical Institute,Phase II,ORX-101,Oncology,Low Dose,2023-12-06,2024-03-05,6.09,5.09,131,72,90,None,None,Worsened,0
5526,PT-05526,32,M,Fortis Mumbai,Phase IV,ORX-101,Oncology,High Dose,2024-04-06,2024-04-13,7.63,7.49,157,95,70,Headache,None,Improved,1
5527,PT-05527,24,M,Apollo Chennai,Phase III,ORX-202,Diabetes,Placebo,2023-11-03,2023-11-17,8.21,7.22,121,69,87,None,None,Improved,1
5528,PT-05528,34,F,Kolkata Clinical Center,Phase I,ORX-404,Neurology,Placebo,2023-03-18,2023-05-13,7.16,6.74,131,89,74,None,None,No Change,0
5529,PT-05529,33,F,AIIMS Delhi,Phase III,ORX-101,Oncology,Placebo,2023-04-17,2023-06-12,4.97,4.66,125,73,78,Fatigue,None,Improved,1
5530,PT-05530,58,M,PGI Chandigarh,Phase I,ORX-101,Oncology,High Dose,2023-12-12,2023-12-19,8.53,6.75,121,93,100,None,None,No Change,0
5531,PT-05531,31,F,Apollo Chennai,Phase II,ORX-202,Diabetes,Placebo,2023-03-03,2023-03-31,8.85,7.24,148,78,99,Rash,Mild,No Change,0
5532,PT-05532,37,F,PGI Chandigarh,Phase III,ORX-101,Oncology,Low Dose,2024-02-06,2024-02-20,6.83,6.31,100,60,85,None,None,Improved,1
5533,PT-05533,60,F,NIMHANS Bengaluru,Phase I,ORX-303,Cardiology,High Dose,2024-06-28,2024-08-23,7.93,6.4,136,70,83,None,None,No Change,0
5534,PT-05534,63,M,PGI Chandigarh,Phase III,ORX-606,Rheumatology,High Dose,2024-04-18,2024-04-25,7.64,8.56,125,79,78,Fever,None,No Change,0
5535,PT-05535,23,M,Apollo Chennai,Phase III,ORX-606,Rheumatology,High Dose,2024-09-11,2024-09-18,6.72,6.03,122,85,57,Headache,None,Improved,1
5536,PT-05536,26,F,Indore Medical Institute,Phase III,ORX-202,Diabetes,Placebo,2024-03-25,2024-06-23,8.56,6.35,139,77,80,Headache,Mild,Worsened,0
5537,PT-05537,69,F,Kolkata Clinical Center,Phase II,ORX-505,Infectious Disease,High Dose,2023-10-25,2023-11-08,7.04,7.21,129,80,74,Fever,None,Improved,0
5538,PT-05538,56,F,Indore Medical Institute,Phase III,ORX-404,Neurology,High Dose,2023-10-21,2023-12-16,6.32,4.9,129,84,52,None,None,Worsened,0
5539,PT-05539,44,F,Bhopal Research Hospital,Phase III,ORX-606,Rheumatology,High Dose,2024-07-07,2024-09-01,5.73,5.89,95,105,73,Headache,Moderate,Improved,0
5540,PT-05540,31,F,Apollo Chennai,Phase III,ORX-606,Rheumatology,Placebo,2023-08-03,2023-11-01,6.86,6.96,144,78,57,None,None,Improved,0
5541,PT-05541,25,F,Indore Medical Institute,Phase III,ORX-606,Rheumatology,High Dose,2024-04-26,2024-05-24,7.54,8.03,148,84,91,Fever,Mild,Improved,0
5542,PT-05542,75,F,Fortis Mumbai,Phase III,ORX-303,Cardiology,Low Dose,2024-01-31,2024-02-28,8.63,9.06,113,93,84,Nausea,None,Improved,0
5543,PT-05543,55,F,Indore Medical Institute,Phase II,ORX-505,Infectious Disease,Placebo,2023-05-13,2023-05-27,8.71,8.64,126,69,73,Fever,None,Improved,1
5544,PT-05544,48,F,AIIMS Delhi,Phase I,ORX-404,Neurology,Low Dose,2023-09-02,2023-09-30,7.53,7.35,145,92,77,None,None,No Change,0
5545,PT-05545,31,F,PGI Chandigarh,Phase III,ORX-303,Cardiology,High Dose,2024-10-24,2024-12-19,7.66,9.28,133,78,85,None,None,Improved,0
5546,PT-05546,54,M,NIMHANS Bengaluru,Phase III,ORX-404,Neurology,Placebo,2024-11-04,2024-12-02,7.9,8.74,134,97,81,None,None,Improved,0
5547,PT-05547,69,M,AIIMS Delhi,Phase IV,ORX-606,Rheumatology,High Dose,2023-03-02,2023-04-27,8.65,9.08,142,109,93,None,None,Worsened,0
5548,PT-05548,31,M,NIMHANS Bengaluru,Phase II,ORX-303,Cardiology,Placebo,2024-04-15,2024-07-14,7.5,6.86,165,97,106,Nausea,None,Improved,1
5549,PT-05549,32,F,Apollo Chennai,Phase III,ORX-505,Infectious Disease,High Dose,2023-09-09,2023-12-08,8.52,6.89,99,77,99,None,None,Improved,1
5550,PT-05550,29,F,Apollo Chennai,Phase III,ORX-505,Infectious Disease,High Dose,2024-02-13,2024-05-13,7.18,7.85,143,108,78,None,None,No Change,0
5551,PT-05551,37,F,Kolkata Clinical Center,Phase III,ORX-202,Diabetes,Low Dose,2024-03-20,2024-06-18,5.89,5.16,108,60,105,Fever,None,Improved,1
5552,PT-05552,45,M,Indore Medical Institute,Phase II,ORX-404,Neurology,High Dose,2024-10-12,2025-01-10,10.31,9.15,120,72,69,Nausea,None,No Change,0
5553,PT-05553,58,F,PGI Chandigarh,Phase II,ORX-202,Diabetes,Placebo,2024-09-10,2024-12-09,7.88,8.27,152,95,63,Dizziness,None,Improved,0
5554,PT-05554,36,F,Apollo Chennai,Phase I,ORX-202,Diabetes,High Dose,2023-06-30,2023-09-28,7.35,10.3,141,83,87,Headache,Mild,Worsened,0
5555,PT-05555,35,M,Kolkata Clinical Center,Phase III,ORX-202,Diabetes,High Dose,2023-06-07,2023-08-02,7.51,7.97,127,72,76,None,None,No Change,0
5556,PT-05556,39,M,Kolkata Clinical Center,Phase IV,ORX-404,Neurology,Low Dose,2024-03-30,2024-06-28,5.57,4.66,102,67,62,Fever,Mild,Worsened,0
5557,PT-05557,60,M,Kolkata Clinical Center,Phase III,ORX-101,Oncology,Low Dose,2023-03-11,2023-06-09,8.99,7.2,156,68,88,Nausea,None,Improved,1
5558,PT-05558,49,F,Apollo Chennai,Phase III,ORX-202,Diabetes,Placebo,2023-08-09,2023-10-04,7.96,6.51,95,72,83,Nausea,None,Improved,1
5559,PT-05559,76,F,Bhopal Research Hospital,Phase I,ORX-101,Oncology,High Dose,2023-09-05,2023-09-19,5.96,5.48,114,81,50,Nausea,None,Improved,1
5560,PT-05560,68,M,Bhopal Research Hospital,Phase II,ORX-505,Infectious Disease,Low Dose,2024-09-12,2024-09-19,7.23,7.65,123,84,93,Rash,Mild,No Change,0
5561,PT-05561,47,M,Fortis Mumbai,Phase II,ORX-101,Oncology,Low Dose,2024-01-09,2024-03-05,7.4,6.29,118,69,67,None,None,Improved,1
5562,PT-05562,65,M,PGI Chandigarh,Phase III,ORX-404,Neurology,High Dose,2024-02-11,2024-05-11,9.37,7.85,135,78,97,None,None,Improved,1
5563,PT-05563,47,M,Fortis Mumbai,Phase III,ORX-202,Diabetes,Low Dose,2023-12-30,2024-03-29,7.19,6.12,100,91,82,Rash,None,No Change,0
5564,PT-05564,51,F,AIIMS Delhi,Phase III,ORX-606,Rheumatology,High Dose,2024-10-22,2024-11-19,6.48,5.95,142,93,61,Dizziness,None,No Change,0
5565,PT-05565,34,F,Fortis Mumbai,Phase III,ORX-505,Infectious Disease,High Dose,2023-08-17,2023-09-14,5.53,5.31,143,78,68,None,None,No Change,0
5566,PT-05566,39,F,Fortis Mumbai,Phase II,ORX-303,Cardiology,Placebo,2024-01-26,2024-02-23,9.97,,141,85,77,None,None,No Change,0
5567,PT-05567,30,M,Kolkata Clinical Center,Phase III,ORX-404,Neurology,Placebo,2023-06-14,2023-06-28,5.93,5.01,110,74,76,None,None,No Change,0
5568,PT-05568,44,F,Bhopal Research Hospital,Phase III,ORX-303,Cardiology,High Dose,2023-08-31,2023-09-07,6.46,6.5,124,84,67,None,None,Improved,0
5569,PT-05569,56,M,PGI Chandigarh,Phase III,ORX-606,Rheumatology,Placebo,2024-05-02,2024-06-27,6.56,7.61,123,80,86,Fever,Mild,No Change,0
5570,PT-05570,57,F,Apollo Chennai,Phase III,ORX-505,Infectious Disease,High Dose,2023-11-23,2023-11-30,8.3,9.5,139,81,70,None,None,Improved,0
5571,PT-05571,42,F,Indore Medical Institute,Phase III,ORX-101,Oncology,High Dose,2024-06-12,2024-06-19,8.98,7.33,113,79,66,Dizziness,None,Improved,1
5572,PT-05572,38,F,Indore Medical Institute,Phase IV,ORX-101,Oncology,Low Dose,2024-09-24,2024-10-01,9.37,8.7,135,62,62,None,None,Worsened,0
5573,PT-05573,59,F,Apollo Chennai,Phase IV,ORX-505,Infectious Disease,High Dose,2023-06-10,2023-06-24,9.2,9.0,122,87,45,None,None,Worsened,0
5574,PT-05574,48,F,PGI Chandigarh,Phase IV,ORX-202,Diabetes,Placebo,2023-05-11,2023-05-18,5.94,6.26,90,74,77,Fever,Severe,Improved,0
5575,PT-05575,32,F,Bhopal Research Hospital,Phase II,ORX-202,Diabetes,Low Dose,2024-08-08,2024-11-06,6.75,7.16,127,70,91,None,None,Improved,0
5576,PT-05576,49,F,Apollo Chennai,Phase III,ORX-202,Diabetes,High Dose,2023-09-02,2023-12-01,7.55,6.35,90,71,63,None,None,Improved,1
5577,PT-05577,35,F,Indore Medical Institute,Phase III,ORX-404,Neurology,Placebo,2024-11-06,2025-01-01,6.19,5.89,143,94,89,Headache,None,No Change,0
5578,PT-05578,30,F,Apollo Chennai,Phase III,ORX-404,Neurology,High Dose,2024-10-28,2024-11-04,7.27,8.28,99,98,64,None,None,No Change,0
5579,PT-05579,49,F,Bhopal Research Hospital,Phase II,ORX-101,Oncology,Low Dose,2023-07-15,2023-07-22,7.7,7.47,168,78,55,Nausea,Mild,No Change,0
5580,PT-05580,50,M,PGI Chandigarh,Phase I,ORX-202,Diabetes,Low Dose,2024-06-15,2024-09-13,7.0,7.1,143,81,84,Nausea,Mild,No Change,0
5581,PT-05581,47,M,Apollo Chennai,Phase III,ORX-101,Oncology,High Dose,2023-07-11,2023-10-09,9.35,8.62,115,92,64,None,None,Improved,1
5582,PT-05582,51,M,Indore Medical Institute,Phase III,ORX-303,Cardiology,Low Dose,2023-02-23,2023-05-24,7.0,6.51,171,96,92,Headache,Mild,Worsened,0
5583,PT-05583,53,M,Indore Medical Institute,Phase III,ORX-303,Cardiology,High Dose,2024-07-13,2024-08-10,6.37,6.21,138,84,79,None,None,No Change,0
5584,PT-05584,38,F,Bhopal Research Hospital,Phase II,ORX-505,Infectious Disease,High Dose,2023-10-06,2023-10-13,7.53,6.66,140,57,97,None,None,No Change,0
5585,PT-05585,24,F,Fortis Mumbai,Phase II,ORX-404,Neurology,Placebo,2023-07-11,2023-09-05,5.92,5.89,137,106,82,Dizziness,Mild,No Change,0
5586,PT-05586,44,F,Kolkata Clinical Center,Phase II,ORX-303,Cardiology,Low Dose,2023-02-07,2023-03-07,7.43,8.46,171,79,85,None,None,Improved,0
5587,PT-05587,43,M,Indore Medical Institute,Phase IV,ORX-303,Cardiology,Low Dose,2023-01-07,2023-04-07,7.09,8.38,111,53,82,None,None,No Change,0
5588,PT-05588,64,F,PGI Chandigarh,Phase IV,ORX-101,Oncology,High Dose,2023-05-22,2023-06-05,7.46,7.52,141,83,85,None,None,Worsened,0
5589,PT-05589,53,F,NIMHANS Bengaluru,Phase III,ORX-404,Neurology,High Dose,2024-01-04,2024-01-11,4.85,4.55,99,81,71,Nausea,Moderate,Worsened,0
5590,PT-05590,61,F,Kolkata Clinical Center,Phase III,ORX-404,Neurology,Low Dose,2024-07-04,2024-10-02,7.49,7.52,124,94,55,Rash,Mild,Improved,0
5591,PT-05591,30,M,Fortis Mumbai,Phase III,ORX-404,Neurology,Placebo,2024-04-17,2024-05-01,8.74,7.95,90,99,93,Rash,None,Worsened,0
5592,PT-05592,56,M,AIIMS Delhi,Phase II,ORX-101,Oncology,High Dose,2024-08-03,2024-09-28,7.31,8.41,150,100,87,None,None,No Change,0
5593,PT-05593,46,M,Kolkata Clinical Center,Phase I,ORX-404,Neurology,High Dose,2023-10-06,2023-12-01,6.72,5.18,137,89,73,Headache,Moderate,Improved,1
5594,PT-05594,54,M,Apollo Chennai,Phase II,ORX-202,Diabetes,Placebo,2023-03-18,2023-06-16,6.8,7.18,112,69,74,None,None,Improved,0
5595,PT-05595,58,F,AIIMS Delhi,Phase III,ORX-202,Diabetes,Low Dose,2023-07-16,2023-10-14,5.81,6.35,98,79,58,None,None,Improved,0
5596,PT-05596,18,M,Apollo Chennai,Phase I,ORX-101,Oncology,High Dose,2024-01-14,2024-01-28,7.64,7.08,102,75,84,None,None,Improved,1
5597,PT-05597,39,M,NIMHANS Bengaluru,Phase II,ORX-202,Diabetes,High Dose,2023-07-05,2023-10-03,6.96,6.2,117,74,69,Nausea,Moderate,Improved,1
5598,PT-05598,32,F,NIMHANS Bengaluru,Phase II,ORX-404,Neurology,High Dose,2023-02-04,2023-03-04,5.98,5.24,116,69,88,None,None,Worsened,0
5599,PT-05599,64,M,PGI Chandigarh,Phase III,ORX-606,Rheumatology,High Dose,2024-07-11,2024-07-18,7.2,6.86,115,94,102,Rash,Moderate,Improved,1
5600,PT-05600,42,M,PGI Chandigarh,Phase IV,ORX-303,Cardiology,Placebo,2024-07-10,2024-08-07,6.57,6.48,130,75,84,None,None,Improved,1
5601,PT-05601,60,M,Kolkata Clinical Center,Phase IV,ORX-505,Infectious Disease,High Dose,2023-10-08,2024-01-06,6.26,8.14,100,71,81,Fatigue,Mild,Worsened,0
5602,PT-05602,80,M,Bhopal Research Hospital,Phase II,ORX-303,Cardiology,Placebo,2024-02-21,2024-02-28,6.52,5.17,137,79,87,Nausea,None,Worsened,0
5603,PT-05603,43,M,Indore Medical Institute,Phase III,ORX-101,Oncology,High Dose,2024-02-21,2024-03-20,6.17,7.89,90,103,91,None,None,Improved,0
5604,PT-05604,33,F,PGI Chandigarh,Phase II,ORX-303,Cardiology,High Dose,2023-11-18,2023-12-16,9.45,7.81,146,57,61,Fatigue,Mild,Improved,1
5605,PT-05605,26,M,Kolkata Clinical Center,Phase III,ORX-404,Neurology,Low Dose,2024-09-10,2024-12-09,6.3,5.91,113,57,84,Nausea,None,Worsened,0
5606,PT-05606,45,M,AIIMS Delhi,Phase II,ORX-202,Diabetes,High Dose,2024-07-28,2024-08-04,7.69,7.45,145,81,92,None,None,No Change,0
5607,PT-05607,32,F,Fortis Mumbai,Phase III,ORX-505,Infectious Disease,High Dose,2024-09-20,2024-09-27,6.34,7.18,152,88,65,None,None,Improved,0
5608,PT-05608,29,F,AIIMS Delhi,Phase II,ORX-505,Infectious Disease,Low Dose,2024-02-18,2024-03-03,8.79,9.54,126,110,84,None,None,No Change,0
5609,PT-05609,27,M,Apollo Chennai,Phase III,ORX-202,Diabetes,Placebo,2024-01-05,2024-01-12,6.87,6.47,129,97,64,None,None,No Change,0
5610,PT-05610,23,M,Bhopal Research Hospital,Phase II,ORX-101,Oncology,High Dose,2023-01-05,2023-01-19,7.92,7.07,171,93,70,None,None,Improved,1
5611,PT-05611,64,M,Kolkata Clinical Center,Phase II,ORX-505,Infectious Disease,High Dose,2024-04-01,2024-04-15,8.08,8.25,125,87,48,None,None,No Change,0
5612,PT-05612,66,M,NIMHANS Bengaluru,Phase III,ORX-101,Oncology,Low Dose,2024-02-22,2024-05-22,3.5,2.7,99,75,76,None,None,Improved,1
5613,PT-05613,25,F,Fortis Mumbai,Phase III,ORX-606,Rheumatology,Placebo,2023-08-09,2023-09-06,3.87,3.66,165,77,91,Headache,None,No Change,0
5614,PT-05614,69,F,Fortis Mumbai,Phase II,ORX-101,Oncology,High Dose,2023-07-19,2023-10-17,4.92,4.11,105,72,101,Nausea,None,Improved,1
5615,PT-05615,48,F,PGI Chandigarh,Phase II,ORX-404,Neurology,Low Dose,2024-08-08,2024-08-15,8.15,7.71,106,90,95,None,None,Improved,1
5616,PT-05616,50,M,Fortis Mumbai,Phase III,ORX-202,Diabetes,Low Dose,2023-03-30,2023-06-28,7.79,6.28,140,98,83,None,None,Improved,1
5617,PT-05617,18,F,AIIMS Delhi,Phase II,ORX-303,Cardiology,Placebo,2023-05-13,2023-08-11,9.16,7.91,134,93,93,None,None,Worsened,0
5618,PT-05618,18,F,NIMHANS Bengaluru,Phase I,ORX-101,Oncology,High Dose,2023-02-19,2023-04-16,7.34,6.99,153,87,98,Fatigue,None,Improved,1
5619,PT-05619,53,F,Apollo Chennai,Phase II,ORX-404,Neurology,High Dose,2023-12-24,2024-01-07,7.11,6.89,155,66,90,Rash,None,Improved,1
5620,PT-05620,34,M,Bhopal Research Hospital,Phase II,ORX-404,Neurology,High Dose,2023-11-02,2023-11-09,6.19,6.71,112,86,71,None,None,Improved,0
5621,PT-05621,18,M,Fortis Mumbai,Phase III,ORX-101,Oncology,High Dose,2023-04-01,2023-04-15,7.77,7.49,93,73,52,Nausea,None,Improved,1
5622,PT-05622,56,M,Kolkata Clinical Center,Phase III,ORX-101,Oncology,Low Dose,2024-05-08,2024-05-15,8.87,9.23,145,75,85,None,None,No Change,0
5623,PT-05623,44,F,PGI Chandigarh,Phase I,ORX-101,Oncology,Placebo,2024-10-29,2024-11-26,7.42,7.88,149,77,58,Headache,None,Improved,0
5624,PT-05624,42,M,Indore Medical Institute,Phase II,ORX-404,Neurology,Placebo,2024-02-08,2024-04-04,6.94,6.79,142,59,68,Rash,None,No Change,0
5625,PT-05625,29,F,Bhopal Research Hospital,Phase II,ORX-404,Neurology,High Dose,2023-11-15,2024-02-13,8.7,8.11,118,88,69,None,None,Improved,1
5626,PT-05626,44,M,Indore Medical Institute,Phase IV,ORX-505,Infectious Disease,Low Dose,2024-04-11,2024-04-18,9.38,10.58,120,79,69,Headache,None,No Change,0
5627,PT-05627,18,F,Apollo Chennai,Phase II,ORX-101,Oncology,High Dose,2024-01-22,2024-01-29,8.44,10.22,120,72,74,Headache,None,Improved,0
5628,PT-05628,46,M,Kolkata Clinical Center,Phase III,ORX-202,Diabetes,Placebo,2023-01-30,2023-02-13,5.84,5.02,146,83,95,Rash,None,Improved,1
5629,PT-05629,50,M,Kolkata Clinical Center,Phase III,ORX-202,Diabetes,Placebo,2024-05-23,2024-06-06,5.89,4.97,132,68,60,Nausea,None,No Change,0
5630,PT-05630,25,F,AIIMS Delhi,Phase III,ORX-606,Rheumatology,Low Dose,2023-02-15,2023-03-15,7.82,7.09,149,71,45,None,None,No Change,0
5631,PT-05631,42,M,PGI Chandigarh,Phase II,ORX-202,Diabetes,Placebo,2024-11-03,2024-12-01,9.18,8.81,103,62,94,None,None,Improved,1
5632,PT-05632,32,F,Kolkata Clinical Center,Phase IV,ORX-202,Diabetes,High Dose,2024-01-14,2024-01-21,9.05,9.24,114,96,65,Nausea,Moderate,Improved,0
5633,PT-05633,21,F,NIMHANS Bengaluru,Phase II,ORX-101,Oncology,Low Dose,2023-03-05,2023-03-12,6.16,6.45,148,77,51,Nausea,None,No Change,0
5634,PT-05634,20,F,Indore Medical Institute,Phase II,ORX-606,Rheumatology,Low Dose,2023-09-22,2023-10-06,5.92,4.35,132,105,89,Fatigue,None,Improved,1
5635,PT-05635,26,M,Bhopal Research Hospital,Phase III,ORX-606,Rheumatology,Placebo,2024-01-11,2024-03-07,6.37,5.52,135,100,71,None,None,Improved,1
5636,PT-05636,69,M,Fortis Mumbai,Phase III,ORX-202,Diabetes,Low Dose,2023-02-13,2023-04-10,9.72,9.01,121,77,78,Headache,Mild,Improved,1
5637,PT-05637,39,M,Fortis Mumbai,Phase II,ORX-202,Diabetes,Low Dose,2024-04-18,2024-07-17,8.26,6.47,118,85,90,None,None,Worsened,0
5638,PT-05638,80,F,Fortis Mumbai,Phase IV,ORX-303,Cardiology,High Dose,2024-07-29,2024-10-27,5.65,4.67,90,68,53,None,None,Improved,1
5639,PT-05639,36,F,Kolkata Clinical Center,Phase II,ORX-303,Cardiology,Placebo,2023-10-05,2024-01-03,6.93,6.95,122,87,79,None,None,Improved,0
5640,PT-05640,28,F,AIIMS Delhi,Phase II,ORX-505,Infectious Disease,High Dose,2024-06-09,2024-09-07,5.18,5.3,157,112,91,Fever,None,No Change,0
5641,PT-05641,68,M,NIMHANS Bengaluru,Phase III,ORX-404,Neurology,Low Dose,2024-04-09,2024-04-16,7.75,7.63,129,80,86,Headache,None,Improved,1
5642,PT-05642,36,M,Apollo Chennai,Phase III,ORX-202,Diabetes,Low Dose,2024-06-12,2024-08-07,7.02,5.56,136,70,78,None,None,Improved,1
5643,PT-05643,53,F,Fortis Mumbai,Phase II,ORX-303,Cardiology,High Dose,2023-08-08,2023-09-05,7.9,8.2,124,87,71,Headache,None,Improved,0
5644,PT-05644,18,F,Apollo Chennai,Phase II,ORX-505,Infectious Disease,Low Dose,2024-06-16,2024-06-30,7.84,7.71,146,81,55,None,None,No Change,0
5645,PT-05645,43,M,Fortis Mumbai,Phase II,ORX-202,Diabetes,Placebo,2023-07-16,2023-08-13,8.26,8.29,125,62,63,Dizziness,None,No Change,0
5646,PT-05646,52,M,Kolkata Clinical Center,Phase II,ORX-202,Diabetes,High Dose,2023-10-21,2023-12-16,5.2,4.52,128,95,86,Rash,Moderate,Improved,1
5647,PT-05647,60,F,AIIMS Delhi,Phase IV,ORX-606,Rheumatology,Placebo,2023-04-15,2023-05-13,7.56,6.4,116,70,86,None,None,Improved,1
5648,PT-05648,33,M,Indore Medical Institute,Phase I,ORX-606,Rheumatology,High Dose,2023-02-09,2023-02-23,6.73,6.35,157,89,67,None,None,No Change,0
5649,PT-05649,47,M,Apollo Chennai,Phase III,ORX-505,Infectious Disease,Low Dose,2024-01-08,2024-01-15,9.18,9.34,99,71,64,Fatigue,None,Improved,0
5650,PT-05650,68,M,AIIMS Delhi,Phase I,ORX-505,Infectious Disease,Low Dose,2023-09-23,2023-09-30,8.71,7.75,116,82,79,None,None,Improved,1
5651,PT-05651,29,M,Apollo Chennai,Phase III,ORX-606,Rheumatology,Placebo,2023-05-11,2023-05-18,6.9,5.19,150,60,53,None,None,Improved,1
5652,PT-05652,51,F,Indore Medical Institute,Phase I,ORX-303,Cardiology,Low Dose,2024-09-24,2024-11-19,5.72,4.86,129,90,74,Fatigue,None,Improved,1
5653,PT-05653,73,M,Bhopal Research Hospital,Phase III,ORX-606,Rheumatology,Placebo,2023-12-28,2024-03-27,7.2,7.87,133,107,92,None,None,Improved,0
5654,PT-05654,45,F,AIIMS Delhi,Phase II,ORX-606,Rheumatology,High Dose,2023-07-14,2023-08-11,7.95,7.32,123,66,66,None,None,Improved,1
5655,PT-05655,77,M,NIMHANS Bengaluru,Phase II,ORX-606,Rheumatology,Low Dose,2023-07-12,2023-07-19,5.76,4.77,126,81,83,Fatigue,None,Improved,1
5656,PT-05656,37,M,Apollo Chennai,Phase III,ORX-202,Diabetes,Placebo,2024-07-15,2024-07-22,7.73,8.36,150,78,86,None,None,Improved,0
5657,PT-05657,26,M,Kolkata Clinical Center,Phase III,ORX-404,Neurology,Low Dose,2023-06-15,2023-08-10,6.33,4.88,127,71,56,None,None,Improved,1
5658,PT-05658,38,M,Fortis Mumbai,Phase II,ORX-101,Oncology,High Dose,2024-08-20,2024-09-03,5.13,5.92,117,93,71,Nausea,Mild,Improved,0
5659,PT-05659,25,F,Bhopal Research Hospital,Phase III,ORX-505,Infectious Disease,High Dose,2023-01-13,2023-03-10,8.61,8.29,161,76,71,None,None,No Change,0
5660,PT-05660,61,F,Apollo Chennai,Phase III,ORX-606,Rheumatology,Low Dose,2023-04-21,2023-07-20,8.41,8.15,188,78,60,None,None,Worsened,0
5661,PT-05661,28,F,Kolkata Clinical Center,Phase III,ORX-303,Cardiology,Low Dose,2023-06-27,2023-07-11,6.87,7.84,124,100,84,None,None,Worsened,0
5662,PT-05662,62,M,Fortis Mumbai,Phase I,ORX-101,Oncology,Low Dose,2023-04-26,2023-06-21,7.66,7.61,141,75,70,None,None,No Change,0
5663,PT-05663,50,F,Kolkata Clinical Center,Phase IV,ORX-202,Diabetes,Low Dose,2023-07-27,2023-08-10,9.53,7.74,91,78,92,None,None,Worsened,0
5664,PT-05664,45,F,NIMHANS Bengaluru,Phase III,ORX-505,Infectious Disease,Low Dose,2024-06-29,2024-07-27,5.8,5.47,96,89,73,Rash,None,No Change,0
5665,PT-05665,43,M,AIIMS Delhi,Phase I,ORX-101,Oncology,Placebo,2024-11-18,2025-01-13,7.71,7.5,118,94,89,Rash,None,Improved,1
5666,PT-05666,18,F,Apollo Chennai,Phase III,ORX-505,Infectious Disease,High Dose,2024-01-08,2024-02-05,6.92,5.55,105,88,72,None,None,No Change,0
5667,PT-05667,42,F,Kolkata Clinical Center,Phase II,ORX-101,Oncology,High Dose,2023-07-29,2023-08-05,6.4,6.33,140,108,75,Headache,None,Worsened,0
5668,PT-05668,21,F,PGI Chandigarh,Phase I,ORX-505,Infectious Disease,Low Dose,2024-04-07,2024-07-06,6.6,6.96,114,64,67,None,None,Improved,0
5669,PT-05669,36,F,AIIMS Delhi,Phase II,ORX-202,Diabetes,Placebo,2024-08-03,2024-08-31,5.9,5.7,126,91,71,None,None,No Change,0
5670,PT-05670,53,M,NIMHANS Bengaluru,Phase II,ORX-101,Oncology,Low Dose,2024-10-20,2024-10-27,6.61,5.19,118,62,103,Fatigue,None,No Change,0
5671,PT-05671,47,M,Indore Medical Institute,Phase III,ORX-606,Rheumatology,Low Dose,2024-09-25,2024-12-24,6.25,5.51,90,99,96,None,None,Improved,1
5672,PT-05672,46,F,Fortis Mumbai,Phase III,ORX-101,Oncology,Low Dose,2023-03-03,2023-06-01,7.58,6.04,106,61,75,Nausea,Mild,Improved,1
5673,PT-05673,61,F,Fortis Mumbai,Phase III,ORX-606,Rheumatology,Placebo,2024-09-07,2024-11-02,6.74,6.65,145,62,103,Headache,None,Worsened,0
5674,PT-05674,63,M,NIMHANS Bengaluru,Phase II,ORX-303,Cardiology,Low Dose,2023-11-24,2023-12-22,7.82,8.25,145,85,97,Headache,Mild,No Change,0
5675,PT-05675,37,M,Apollo Chennai,Phase II,ORX-505,Infectious Disease,High Dose,2024-02-12,2024-02-19,7.75,8.54,90,87,88,None,None,No Change,0
5676,PT-05676,18,M,Bhopal Research Hospital,Phase III,ORX-404,Neurology,Placebo,2024-10-06,2024-11-03,7.54,6.42,135,80,64,Headache,Moderate,Improved,1
5677,PT-05677,62,F,PGI Chandigarh,Phase III,ORX-606,Rheumatology,Placebo,2024-03-18,2024-06-16,6.7,6.54,151,70,78,None,None,Worsened,0
5678,PT-05678,37,M,Bhopal Research Hospital,Phase III,ORX-202,Diabetes,Placebo,2024-01-29,2024-03-25,6.87,8.41,136,85,85,None,None,Improved,0
5679,PT-05679,51,M,Indore Medical Institute,Phase III,ORX-505,Infectious Disease,High Dose,2023-01-02,2023-01-16,5.01,6.68,101,102,86,Headache,None,Improved,0
5680,PT-05680,47,M,Apollo Chennai,Phase III,ORX-303,Cardiology,High Dose,2023-04-14,2023-05-12,6.83,8.78,138,82,70,None,None,No Change,0
5681,PT-05681,34,F,Apollo Chennai,Phase III,ORX-101,Oncology,Low Dose,2023-05-19,2023-06-16,7.26,6.02,140,74,92,None,None,Worsened,0
5682,PT-05682,60,F,NIMHANS Bengaluru,Phase I,ORX-101,Oncology,Low Dose,2024-10-24,2024-11-07,7.13,7.26,139,64,102,None,None,Improved,0
5683,PT-05683,40,F,AIIMS Delhi,Phase III,ORX-303,Cardiology,Placebo,2023-03-30,2023-05-25,8.03,8.29,90,74,89,Headache,None,Improved,0
5684,PT-05684,45,M,Indore Medical Institute,Phase II,ORX-202,Diabetes,High Dose,2023-07-10,2023-08-07,8.03,7.71,150,83,97,Nausea,Moderate,Worsened,0
5685,PT-05685,29,F,Fortis Mumbai,Phase III,ORX-101,Oncology,Placebo,2023-08-30,2023-09-06,7.05,6.11,134,78,74,None,None,Worsened,0
5686,PT-05686,33,F,Fortis Mumbai,Phase III,ORX-505,Infectious Disease,High Dose,2023-11-05,2023-11-19,6.65,6.24,91,54,78,Nausea,None,Improved,1
5687,PT-05687,18,F,Apollo Chennai,Phase II,ORX-101,Oncology,Low Dose,2024-09-21,2024-09-28,6.97,6.23,137,73,99,Nausea,Mild,Worsened,0
5688,PT-05688,58,F,Bhopal Research Hospital,Phase III,ORX-202,Diabetes,Placebo,2024-01-26,2024-02-23,5.39,4.73,155,73,77,Rash,None,Improved,1
5689,PT-05689,67,F,NIMHANS Bengaluru,Phase I,ORX-303,Cardiology,Low Dose,2023-07-20,2023-08-17,6.55,7.16,111,50,95,Dizziness,None,Improved,0
5690,PT-05690,52,M,AIIMS Delhi,Phase III,ORX-202,Diabetes,Placebo,2023-11-29,2023-12-13,7.81,6.42,109,95,81,None,None,No Change,0
5691,PT-05691,43,F,Kolkata Clinical Center,Phase III,ORX-505,Infectious Disease,Low Dose,2023-09-19,2023-12-18,7.47,8.42,141,76,58,None,None,No Change,0
5692,PT-05692,54,F,Apollo Chennai,Phase III,ORX-606,Rheumatology,Placebo,2023-06-30,2023-07-07,6.09,4.63,151,92,83,None,None,No Change,0
5693,PT-05693,25,F,NIMHANS Bengaluru,Phase II,ORX-303,Cardiology,Placebo,2023-07-20,2023-07-27,9.35,9.87,122,75,79,None,None,Improved,0
5694,PT-05694,37,F,Kolkata Clinical Center,Phase II,ORX-505,Infectious Disease,Placebo,2024-04-08,2024-05-06,9.85,9.11,108,101,70,None,None,Improved,1
5695,PT-05695,57,M,Indore Medical Institute,Phase III,ORX-202,Diabetes,High Dose,2024-08-07,2024-08-14,8.01,7.56,110,81,61,Fatigue,Mild,Improved,1
5696,PT-05696,44,M,NIMHANS Bengaluru,Phase II,ORX-202,Diabetes,High Dose,2024-02-28,2024-03-27,8.13,9.27,108,78,70,Dizziness,Mild,Improved,0
5697,PT-05697,49,M,NIMHANS Bengaluru,Phase IV,ORX-303,Cardiology,High Dose,2023-10-19,2023-11-02,5.37,4.14,97,64,68,None,None,Improved,1
5698,PT-05698,71,F,NIMHANS Bengaluru,Phase III,ORX-404,Neurology,High Dose,2024-02-04,2024-03-31,7.62,7.28,152,86,84,Dizziness,None,No Change,0
5699,PT-05699,37,F,Indore Medical Institute,Phase III,ORX-101,Oncology,High Dose,2023-07-31,2023-08-14,6.44,4.86,117,78,82,Nausea,Mild,Improved,1
5700,PT-05700,44,M,Kolkata Clinical Center,Phase III,ORX-101,Oncology,Placebo,2024-03-03,2024-04-28,6.76,5.54,135,76,82,Nausea,None,Improved,1
5701,PT-05701,18,F,PGI Chandigarh,Phase III,ORX-101,Oncology,Low Dose,2024-04-15,2024-05-13,7.6,7.88,139,79,90,None,None,Improved,0
5702,PT-05702,24,F,Apollo Chennai,Phase III,ORX-505,Infectious Disease,Placebo,2023-12-01,2023-12-15,7.09,6.52,146,57,63,Rash,None,Improved,1
5703,PT-05703,72,M,Kolkata Clinical Center,Phase III,ORX-505,Infectious Disease,Low Dose,2024-02-18,2024-02-25,4.28,4.62,115,85,97,None,None,Improved,0
5704,PT-05704,49,M,NIMHANS Bengaluru,Phase III,ORX-404,Neurology,Placebo,2024-01-13,2024-04-12,8.92,8.08,121,91,71,Fatigue,None,Improved,1
5705,PT-05705,54,F,Kolkata Clinical Center,Phase IV,ORX-505,Infectious Disease,Low Dose,2024-07-14,2024-10-12,8.62,9.0,99,77,81,Fatigue,None,Improved,0
5706,PT-05706,41,M,Apollo Chennai,Phase II,ORX-303,Cardiology,High Dose,2024-05-09,2024-05-16,7.3,7.16,118,79,61,None,None,Improved,1
5707,PT-05707,37,F,AIIMS Delhi,Phase II,ORX-202,Diabetes,High Dose,2024-10-02,2024-10-30,5.37,5.07,124,71,102,Rash,Mild,No Change,0
5708,PT-05708,41,M,AIIMS Delhi,Phase III,ORX-505,Infectious Disease,Low Dose,2023-02-06,2023-04-03,7.54,6.57,120,85,73,None,None,Improved,1
5709,PT-05709,45,M,AIIMS Delhi,Phase II,ORX-202,Diabetes,Placebo,2024-07-07,2024-10-05,8.17,7.3,104,63,98,None,None,No Change,0
5710,PT-05710,59,M,Kolkata Clinical Center,Phase IV,ORX-606,Rheumatology,Low Dose,2023-09-07,2023-12-06,7.99,7.19,104,78,76,None,None,No Change,0
5711,PT-05711,26,M,Kolkata Clinical Center,Phase III,ORX-404,Neurology,High Dose,2024-06-30,2024-07-14,5.44,3.48,139,67,82,None,None,Improved,1
5712,PT-05712,38,F,NIMHANS Bengaluru,Phase II,ORX-404,Neurology,Low Dose,2023-11-08,2023-12-06,7.91,7.81,123,83,76,Rash,None,No Change,0
5713,PT-05713,35,F,Indore Medical Institute,Phase II,ORX-404,Neurology,Placebo,2023-01-24,2023-03-21,8.38,7.6,126,65,81,None,None,Improved,1
5714,PT-05714,35,F,Bhopal Research Hospital,Phase III,ORX-505,Infectious Disease,Low Dose,2024-03-25,2024-04-08,6.63,5.47,125,57,87,Rash,None,Improved,1
5715,PT-05715,44,M,Indore Medical Institute,Phase II,ORX-505,Infectious Disease,Placebo,2024-10-24,2024-11-07,6.64,4.85,135,74,96,Fever,Moderate,No Change,0
5716,PT-05716,52,M,Bhopal Research Hospital,Phase III,ORX-606,Rheumatology,High Dose,2024-03-24,2024-06-22,9.04,8.76,147,87,71,Fatigue,None,Improved,1
5717,PT-05717,47,F,Kolkata Clinical Center,Phase IV,ORX-303,Cardiology,Low Dose,2023-12-14,2023-12-21,6.2,7.66,126,82,83,None,None,Worsened,0
5718,PT-05718,27,M,AIIMS Delhi,Phase III,ORX-505,Infectious Disease,Low Dose,2024-10-27,2024-11-03,8.79,7.46,105,80,60,None,None,Improved,1
5719,PT-05719,69,F,Bhopal Research Hospital,Phase III,ORX-404,Neurology,Placebo,2024-01-22,2024-04-21,6.92,3.62,131,88,72,Headache,None,Improved,1
5720,PT-05720,23,M,Indore Medical Institute,Phase II,ORX-505,Infectious Disease,High Dose,2023-12-05,2023-12-12,7.08,6.24,110,69,80,Nausea,None,Worsened,0
5721,PT-05721,59,M,Bhopal Research Hospital,Phase II,ORX-202,Diabetes,Low Dose,2023-11-24,2024-01-19,7.75,5.8,139,91,97,None,None,No Change,0
5722,PT-05722,29,M,NIMHANS Bengaluru,Phase II,ORX-202,Diabetes,Placebo,2023-12-09,2024-03-08,7.13,7.24,118,88,77,Headache,None,Improved,0
5723,PT-05723,31,M,Bhopal Research Hospital,Phase III,ORX-404,Neurology,Placebo,2024-05-19,2024-08-17,6.29,7.01,110,67,82,Rash,None,Improved,0
5724,PT-05724,44,F,NIMHANS Bengaluru,Phase III,ORX-505,Infectious Disease,Placebo,2024-05-05,2024-05-12,5.63,4.76,113,74,113,None,None,No Change,0
5725,PT-05725,40,M,Bhopal Research Hospital,Phase III,ORX-101,Oncology,High Dose,2024-09-10,2024-09-17,6.14,7.56,143,90,66,None,None,Worsened,0
5726,PT-05726,64,F,Bhopal Research Hospital,Phase III,ORX-505,Infectious Disease,Low Dose,2023-03-25,2023-04-01,8.18,7.91,97,81,102,None,None,No Change,0
5727,PT-05727,48,F,AIIMS Delhi,Phase II,ORX-202,Diabetes,High Dose,2024-01-15,2024-01-29,6.75,6.14,125,72,77,Nausea,Mild,Worsened,0
5728,PT-05728,68,F,Indore Medical Institute,Phase III,ORX-101,Oncology,High Dose,2023-02-19,2023-05-20,8.8,7.72,150,91,86,None,None,Improved,1
5729,PT-05729,51,M,Apollo Chennai,Phase II,ORX-101,Oncology,Low Dose,2024-01-27,2024-03-23,6.08,5.32,142,67,63,None,None,Improved,1
5730,PT-05730,49,F,AIIMS Delhi,Phase III,ORX-404,Neurology,Low Dose,2024-10-10,2025-01-08,6.25,6.59,114,84,82,Fatigue,None,No Change,0
5731,PT-05731,37,F,Bhopal Research Hospital,Phase IV,ORX-505,Infectious Disease,Placebo,2024-06-28,2024-07-12,6.91,5.9,127,70,74,Nausea,None,Improved,1
5732,PT-05732,56,M,Bhopal Research Hospital,Phase II,ORX-101,Oncology,Low Dose,2023-09-19,2023-11-14,5.84,5.0,137,57,103,None,None,Improved,1
5733,PT-05733,61,M,AIIMS Delhi,Phase II,ORX-101,Oncology,Placebo,2023-03-22,2023-04-19,5.35,3.06,128,68,91,None,None,No Change,0
5734,PT-05734,51,M,Fortis Mumbai,Phase III,ORX-606,Rheumatology,Placebo,2023-10-08,2023-11-05,7.35,6.43,156,91,86,Nausea,None,Improved,1
5735,PT-05735,64,F,PGI Chandigarh,Phase I,ORX-505,Infectious Disease,Low Dose,2023-11-04,2024-02-02,5.98,6.73,123,86,75,Headache,Mild,Worsened,0
5736,PT-05736,18,M,NIMHANS Bengaluru,Phase III,ORX-505,Infectious Disease,High Dose,2024-09-15,2024-09-29,8.35,6.31,110,76,50,None,None,Improved,1
5737,PT-05737,27,M,PGI Chandigarh,Phase II,ORX-101,Oncology,High Dose,2023-07-22,2023-07-29,7.49,6.78,123,71,78,None,None,Improved,1
5738,PT-05738,39,F,Bhopal Research Hospital,Phase IV,ORX-404,Neurology,Placebo,2023-04-19,2023-06-14,5.23,4.65,105,92,72,None,None,No Change,0
5739,PT-05739,85,F,Fortis Mumbai,Phase IV,ORX-606,Rheumatology,Low Dose,2023-05-19,2023-05-26,8.36,7.84,138,56,91,None,None,Worsened,0
5740,PT-05740,31,M,Bhopal Research Hospital,Phase III,ORX-505,Infectious Disease,Placebo,2024-02-03,2024-05-03,7.31,6.25,116,79,79,None,None,Improved,1
5741,PT-05741,44,F,Fortis Mumbai,Phase II,ORX-101,Oncology,Low Dose,2024-03-26,2024-04-09,7.2,5.33,169,84,84,None,None,Worsened,0
5742,PT-05742,39,F,Apollo Chennai,Phase II,ORX-505,Infectious Disease,Low Dose,2023-07-20,2023-09-14,6.15,5.89,133,97,107,Headache,Mild,Improved,1
5743,PT-05743,68,F,Fortis Mumbai,Phase I,ORX-505,Infectious Disease,High Dose,2023-10-29,2023-11-05,5.08,4.27,134,77,77,Headache,Moderate,Improved,1
5744,PT-05744,18,M,Indore Medical Institute,Phase IV,ORX-101,Oncology,Low Dose,2024-02-04,2024-03-31,8.3,6.21,99,69,76,None,None,Worsened,0
5745,PT-05745,19,F,Kolkata Clinical Center,Phase II,ORX-202,Diabetes,Placebo,2024-07-12,2024-08-09,5.93,6.56,125,87,60,Nausea,Moderate,No Change,0
5746,PT-05746,44,F,Indore Medical Institute,Phase III,ORX-303,Cardiology,Low Dose,2024-01-10,2024-03-06,7.04,5.92,127,59,84,Fatigue,None,Improved,1
5747,PT-05747,38,F,PGI Chandigarh,Phase II,ORX-404,Neurology,High Dose,2023-10-12,2023-10-19,6.89,7.26,135,78,62,None,None,No Change,0
5748,PT-05748,66,F,Bhopal Research Hospital,Phase III,ORX-303,Cardiology,Low Dose,2023-04-25,2023-05-02,5.59,5.76,99,93,92,None,None,No Change,0
5749,PT-05749,18,F,Indore Medical Institute,Phase I,ORX-606,Rheumatology,Low Dose,2024-06-23,2024-09-21,7.74,7.67,140,86,64,None,None,Improved,1
5750,PT-05750,41,F,AIIMS Delhi,Phase III,ORX-404,Neurology,Placebo,2023-12-14,2023-12-28,9.2,7.8,133,95,64,None,None,Improved,1
5751,PT-05751,22,F,Apollo Chennai,Phase I,ORX-202,Diabetes,Low Dose,2024-09-13,2024-12-12,5.68,5.64,105,80,97,None,None,No Change,0
5752,PT-05752,44,F,NIMHANS Bengaluru,Phase I,ORX-606,Rheumatology,High Dose,2024-10-12,2025-01-10,6.27,5.98,126,87,100,None,None,No Change,0
5753,PT-05753,51,M,Apollo Chennai,Phase III,ORX-303,Cardiology,High Dose,2023-06-14,2023-09-12,9.64,9.65,114,109,76,Nausea,None,No Change,0
5754,PT-05754,28,F,Bhopal Research Hospital,Phase II,ORX-606,Rheumatology,High Dose,2023-03-08,2023-03-22,9.99,8.93,114,75,80,Nausea,Mild,Improved,1
5755,PT-05755,59,M,Indore Medical Institute,Phase I,ORX-303,Cardiology,Placebo,2023-09-11,2023-11-06,4.02,4.46,118,77,102,Fatigue,None,Worsened,0
5756,PT-05756,48,F,Indore Medical Institute,Phase III,ORX-101,Oncology,High Dose,2023-02-13,2023-03-13,7.74,7.29,141,101,45,Headache,None,Improved,1
5757,PT-05757,62,F,Kolkata Clinical Center,Phase III,ORX-101,Oncology,High Dose,2024-09-04,2024-09-11,9.06,9.11,115,68,111,Nausea,None,No Change,0
5758,PT-05758,30,F,Indore Medical Institute,Phase III,ORX-303,Cardiology,Low Dose,2024-02-09,2024-05-09,9.02,8.97,164,78,55,Headache,Mild,Worsened,0
5759,PT-05759,45,M,Apollo Chennai,Phase III,ORX-505,Infectious Disease,Low Dose,2023-10-01,2023-12-30,5.42,7.43,139,91,88,None,None,No Change,0
5760,PT-05760,33,M,NIMHANS Bengaluru,Phase III,ORX-101,Oncology,Low Dose,2023-07-18,2023-09-12,7.04,6.74,162,68,67,Headache,None,Worsened,0
5761,PT-05761,39,M,Kolkata Clinical Center,Phase III,ORX-303,Cardiology,Placebo,2024-02-25,2024-05-25,6.39,4.68,90,60,93,Dizziness,Mild,No Change,0
5762,PT-05762,44,F,PGI Chandigarh,Phase III,ORX-303,Cardiology,High Dose,2024-10-09,2025-01-07,8.2,7.28,126,101,99,None,None,Improved,1
5763,PT-05763,60,M,Fortis Mumbai,Phase III,ORX-101,Oncology,High Dose,2023-09-22,2023-10-20,7.44,7.51,134,79,72,Rash,Mild,No Change,0
5764,PT-05764,62,F,Indore Medical Institute,Phase I,ORX-505,Infectious Disease,High Dose,2024-04-28,2024-05-26,5.65,6.58,123,66,70,None,None,Worsened,0
5765,PT-05765,31,F,Fortis Mumbai,Phase II,ORX-505,Infectious Disease,Placebo,2024-07-03,2024-10-01,6.51,5.57,116,78,77,Fatigue,None,No Change,0
5766,PT-05766,57,F,Bhopal Research Hospital,Phase IV,ORX-202,Diabetes,High Dose,2023-04-26,2023-07-25,6.91,6.8,128,88,78,None,None,Improved,1
5767,PT-05767,34,F,Bhopal Research Hospital,Phase IV,ORX-303,Cardiology,High Dose,2023-01-23,2023-01-30,6.1,5.89,150,79,68,Rash,Moderate,Improved,1
5768,PT-05768,40,F,AIIMS Delhi,Phase II,ORX-505,Infectious Disease,High Dose,2023-03-18,2023-04-15,6.53,5.53,102,79,81,None,None,Improved,1
5769,PT-05769,27,F,NIMHANS Bengaluru,Phase III,ORX-606,Rheumatology,High Dose,2024-01-02,2024-02-27,6.15,4.89,103,70,75,None,None,Worsened,0
5770,PT-05770,23,F,Kolkata Clinical Center,Phase III,ORX-202,Diabetes,Placebo,2024-05-28,2024-08-26,7.03,6.0,111,86,69,None,None,Improved,1
5771,PT-05771,37,F,Fortis Mumbai,Phase II,ORX-202,Diabetes,High Dose,2023-07-02,2023-07-09,8.76,7.53,156,77,62,Dizziness,None,Worsened,0
5772,PT-05772,36,F,NIMHANS Bengaluru,Phase II,ORX-505,Infectious Disease,Low Dose,2024-05-13,2024-07-08,7.28,8.01,142,82,95,Nausea,None,No Change,0
5773,PT-05773,18,F,Indore Medical Institute,Phase III,ORX-505,Infectious Disease,Low Dose,2024-08-07,2024-11-05,7.5,7.38,133,62,63,Fever,Mild,No Change,0
5774,PT-05774,42,F,NIMHANS Bengaluru,Phase II,ORX-101,Oncology,Low Dose,2024-09-03,2024-12-02,8.54,9.86,116,66,89,None,None,Improved,0
5775,PT-05775,85,M,PGI Chandigarh,Phase II,ORX-404,Neurology,High Dose,2023-06-16,2023-07-14,8.53,7.45,179,90,66,None,None,Improved,1
5776,PT-05776,75,M,Indore Medical Institute,Phase I,ORX-202,Diabetes,Low Dose,2023-12-21,2024-02-15,6.16,5.2,141,81,78,Fatigue,Severe,No Change,0
5777,PT-05777,45,F,Indore Medical Institute,Phase II,ORX-101,Oncology,High Dose,2023-11-01,2023-11-29,8.54,6.05,133,78,67,None,None,Improved,1
5778,PT-05778,32,F,Indore Medical Institute,Phase III,ORX-303,Cardiology,High Dose,2023-06-10,2023-08-05,4.04,2.92,151,91,75,None,None,Improved,1
5779,PT-05779,22,M,Bhopal Research Hospital,Phase I,ORX-404,Neurology,Low Dose,2024-08-04,2024-08-18,8.19,8.97,146,70,65,Nausea,Mild,No Change,0
5780,PT-05780,71,M,Kolkata Clinical Center,Phase II,ORX-101,Oncology,Placebo,2023-08-21,2023-10-16,5.75,5.78,96,78,86,Headache,None,No Change,0
5781,PT-05781,44,F,Apollo Chennai,Phase II,ORX-202,Diabetes,High Dose,2023-10-13,2024-01-11,7.83,6.33,113,87,87,None,None,Worsened,0
5782,PT-05782,48,M,Kolkata Clinical Center,Phase II,ORX-404,Neurology,High Dose,2024-03-06,2024-05-01,8.34,6.44,119,103,95,Dizziness,Moderate,Improved,1
5783,PT-05783,55,F,PGI Chandigarh,Phase IV,ORX-202,Diabetes,High Dose,2023-10-11,2023-10-18,7.01,7.54,135,63,91,None,None,Worsened,0
5784,PT-05784,31,F,Indore Medical Institute,Phase II,ORX-404,Neurology,Low Dose,2024-05-02,2024-05-30,8.11,6.26,156,78,62,None,None,Improved,1
5785,PT-05785,33,F,Kolkata Clinical Center,Phase III,ORX-505,Infectious Disease,Low Dose,2023-11-03,2023-12-01,6.8,6.39,151,82,47,Headache,None,Improved,1
5786,PT-05786,25,M,Apollo Chennai,Phase III,ORX-303,Cardiology,Low Dose,2024-11-28,2024-12-12,10.51,10.23,145,78,63,Nausea,Mild,No Change,0
5787,PT-05787,37,F,PGI Chandigarh,Phase I,ORX-202,Diabetes,Placebo,2024-06-17,2024-08-12,7.35,6.54,162,74,63,None,None,Worsened,0
5788,PT-05788,57,M,Kolkata Clinical Center,Phase I,ORX-404,Neurology,Low Dose,2023-09-04,2023-10-02,8.32,7.95,117,59,95,None,None,Worsened,0
5789,PT-05789,58,F,Kolkata Clinical Center,Phase III,ORX-606,Rheumatology,Low Dose,2023-11-04,2023-12-30,6.67,6.33,123,101,63,Headache,Mild,Worsened,0
5790,PT-05790,35,M,Indore Medical Institute,Phase IV,ORX-202,Diabetes,Placebo,2024-07-03,2024-08-28,6.34,6.22,129,84,65,Fever,Severe,Worsened,0
5791,PT-05791,68,M,NIMHANS Bengaluru,Phase III,ORX-101,Oncology,High Dose,2024-11-14,2025-02-12,6.66,7.32,184,71,82,None,None,Improved,0
5792,PT-05792,42,F,Fortis Mumbai,Phase III,ORX-606,Rheumatology,High Dose,2023-01-10,2023-02-07,9.64,8.98,132,84,76,None,None,No Change,0
5793,PT-05793,57,F,Fortis Mumbai,Phase III,ORX-404,Neurology,Placebo,2023-03-13,2023-05-08,7.31,7.35,131,74,74,Headache,None,Improved,0
5794,PT-05794,53,F,Bhopal Research Hospital,Phase IV,ORX-303,Cardiology,Placebo,2023-05-16,2023-05-23,7.86,8.58,161,75,79,None,None,Improved,0
5795,PT-05795,41,M,AIIMS Delhi,Phase III,ORX-606,Rheumatology,Low Dose,2024-10-19,2024-12-14,5.87,5.98,142,69,72,None,None,No Change,0
5796,PT-05796,37,F,NIMHANS Bengaluru,Phase III,ORX-303,Cardiology,High Dose,2024-10-16,2024-11-13,5.39,4.96,107,83,81,None,None,Improved,1
5797,PT-05797,51,M,Bhopal Research Hospital,Phase III,ORX-404,Neurology,Placebo,2023-12-25,2024-03-24,7.73,8.71,113,72,87,None,None,Improved,0
5798,PT-05798,42,M,PGI Chandigarh,Phase I,ORX-303,Cardiology,High Dose,2023-06-18,2023-07-02,8.55,8.66,162,80,57,None,None,Improved,0
5799,PT-05799,50,M,NIMHANS Bengaluru,Phase II,ORX-303,Cardiology,Low Dose,2024-11-04,2025-02-02,7.11,7.2,139,75,63,None,None,Improved,0
5800,PT-05800,42,F,Apollo Chennai,Phase IV,ORX-303,Cardiology,Placebo,2024-07-10,2024-07-24,4.34,4.02,120,92,50,Dizziness,None,Improved,1
5801,PT-05801,45,F,Bhopal Research Hospital,Phase III,ORX-202,Diabetes,High Dose,2024-05-27,2024-06-03,9.09,9.3,145,86,54,None,None,Improved,0
5802,PT-05802,47,F,Indore Medical Institute,Phase III,ORX-101,Oncology,High Dose,2024-06-30,2024-07-28,7.69,6.32,125,50,73,Headache,Moderate,Improved,1
5803,PT-05803,38,F,Kolkata Clinical Center,Phase II,ORX-202,Diabetes,Placebo,2024-10-22,2024-11-05,8.88,7.94,123,81,69,None,None,Improved,1
5804,PT-05804,56,M,Bhopal Research Hospital,Phase II,ORX-505,Infectious Disease,High Dose,2024-10-11,2024-10-25,4.81,5.43,127,97,45,Nausea,Mild,Improved,0
5805,PT-05805,18,F,Apollo Chennai,Phase III,ORX-303,Cardiology,Low Dose,2024-10-18,2024-10-25,6.85,6.9,118,89,91,None,None,Improved,0
5806,PT-05806,55,F,Kolkata Clinical Center,Phase II,ORX-303,Cardiology,Low Dose,2023-12-09,2024-02-03,7.32,7.01,116,81,63,None,None,Improved,1
5807,PT-05807,32,M,AIIMS Delhi,Phase III,ORX-303,Cardiology,High Dose,2024-02-06,2024-05-06,7.82,7.0,114,87,83,None,None,Improved,1
5808,PT-05808,41,M,NIMHANS Bengaluru,Phase III,ORX-404,Neurology,High Dose,2023-01-29,2023-04-29,7.02,7.0,145,84,61,None,None,Improved,1
5809,PT-05809,41,M,AIIMS Delhi,Phase III,ORX-404,Neurology,Placebo,2023-12-06,2024-03-05,6.71,5.36,136,88,88,Dizziness,Mild,Worsened,0
5810,PT-05810,29,F,Fortis Mumbai,Phase II,ORX-303,Cardiology,High Dose,2024-02-03,2024-02-17,7.39,6.98,133,83,77,Headache,Mild,Improved,1
5811,PT-05811,42,M,Indore Medical Institute,Phase III,ORX-505,Infectious Disease,High Dose,2024-04-14,2024-05-12,8.53,7.35,124,94,66,Headache,Moderate,No Change,0
5812,PT-05812,32,M,AIIMS Delhi,Phase III,ORX-202,Diabetes,Placebo,2023-03-17,2023-04-14,8.08,6.4,139,76,83,Fever,Mild,No Change,0
5813,PT-05813,25,F,NIMHANS Bengaluru,Phase I,ORX-505,Infectious Disease,Placebo,2023-11-29,2023-12-27,8.62,7.13,141,67,103,Headache,Mild,No Change,0
5814,PT-05814,43,M,Kolkata Clinical Center,Phase IV,ORX-101,Oncology,Placebo,2024-07-04,2024-08-29,9.54,8.4,120,96,58,None,None,Improved,1
5815,PT-05815,33,M,Apollo Chennai,Phase III,ORX-202,Diabetes,Placebo,2024-03-17,2024-03-24,7.79,6.48,137,84,56,None,None,Improved,1
5816,PT-05816,60,F,Fortis Mumbai,Phase III,ORX-202,Diabetes,Placebo,2024-04-23,2024-05-21,5.69,5.98,130,76,62,None,None,Worsened,0
5817,PT-05817,50,F,Apollo Chennai,Phase IV,ORX-101,Oncology,High Dose,2023-08-02,2023-08-16,6.15,6.84,150,101,81,None,None,Improved,0
5818,PT-05818,38,F,Apollo Chennai,Phase III,ORX-404,Neurology,High Dose,2024-05-07,2024-05-21,6.84,6.11,132,87,95,None,None,Improved,1
5819,PT-05819,45,F,Bhopal Research Hospital,Phase III,ORX-505,Infectious Disease,Low Dose,2023-10-12,2023-11-09,5.52,4.75,156,63,88,Nausea,None,No Change,0
5820,PT-05820,38,M,Bhopal Research Hospital,Phase II,ORX-202,Diabetes,High Dose,2023-03-23,2023-04-06,6.14,6.1,156,86,74,Fever,Moderate,Improved,1
5821,PT-05821,24,M,AIIMS Delhi,Phase III,ORX-606,Rheumatology,Placebo,2024-05-03,2024-08-01,7.08,5.48,122,81,45,None,None,Improved,1
5822,PT-05822,67,F,NIMHANS Bengaluru,Phase III,ORX-404,Neurology,High Dose,2024-04-13,2024-06-08,5.71,5.15,137,97,66,Headache,Mild,No Change,0
5823,PT-05823,18,M,Fortis Mumbai,Phase III,ORX-303,Cardiology,High Dose,2023-12-18,2024-01-15,8.49,6.97,134,87,45,Dizziness,None,No Change,0
5824,PT-05824,19,F,Apollo Chennai,Phase I,ORX-101,Oncology,Low Dose,2024-03-01,2024-05-30,6.65,3.92,103,83,76,None,None,No Change,0
5825,PT-05825,49,M,AIIMS Delhi,Phase I,ORX-404,Neurology,High Dose,2023-11-21,2024-02-19,7.74,,104,91,99,None,None,No Change,0
5826,PT-05826,29,M,Fortis Mumbai,Phase III,ORX-404,Neurology,Low Dose,2024-01-16,2024-04-15,7.51,7.84,132,79,69,None,None,Improved,0
5827,PT-05827,76,M,Indore Medical Institute,Phase III,ORX-202,Diabetes,High Dose,2024-07-22,2024-08-19,7.32,7.27,133,72,78,None,None,Improved,1
5828,PT-05828,39,F,AIIMS Delhi,Phase II,ORX-606,Rheumatology,High Dose,2023-12-25,2024-01-01,6.79,6.68,111,67,85,None,None,No Change,0
5829,PT-05829,36,M,NIMHANS Bengaluru,Phase III,ORX-303,Cardiology,Placebo,2023-01-07,2023-01-21,6.79,4.65,145,88,87,Headache,Moderate,Improved,1
5830,PT-05830,51,M,NIMHANS Bengaluru,Phase III,ORX-404,Neurology,High Dose,2024-10-14,2024-11-11,5.38,5.19,117,70,85,None,None,No Change,0
5831,PT-05831,71,F,PGI Chandigarh,Phase III,ORX-505,Infectious Disease,High Dose,2023-01-03,2023-01-10,8.99,9.15,127,79,65,None,None,No Change,0
5832,PT-05832,40,F,Apollo Chennai,Phase II,ORX-303,Cardiology,Low Dose,2023-07-13,2023-10-11,8.29,9.53,113,58,70,None,None,Improved,0
5833,PT-05833,59,M,Bhopal Research Hospital,Phase IV,ORX-505,Infectious Disease,Low Dose,2023-02-15,2023-02-22,9.69,10.47,151,71,66,Fatigue,None,Improved,0
5834,PT-05834,23,M,AIIMS Delhi,Phase II,ORX-606,Rheumatology,Placebo,2024-07-08,2024-10-06,6.4,6.82,157,86,74,Headache,None,Improved,0
5835,PT-05835,27,M,Indore Medical Institute,Phase III,ORX-303,Cardiology,Low Dose,2023-03-14,2023-05-09,7.06,6.85,101,93,72,Rash,Moderate,Improved,1
5836,PT-05836,58,F,AIIMS Delhi,Phase III,ORX-303,Cardiology,High Dose,2023-12-27,2024-03-26,7.19,7.05,115,77,86,None,None,No Change,0
5837,PT-05837,42,M,Apollo Chennai,Phase IV,ORX-505,Infectious Disease,Placebo,2024-02-06,2024-04-02,5.87,5.57,134,98,94,Headache,None,Improved,1
5838,PT-05838,43,F,NIMHANS Bengaluru,Phase III,ORX-101,Oncology,Placebo,2023-07-21,2023-07-28,6.54,5.94,118,88,92,None,None,Improved,1
5839,PT-05839,64,F,Fortis Mumbai,Phase I,ORX-303,Cardiology,Placebo,2023-07-24,2023-08-07,6.71,5.84,120,58,61,Headache,Severe,No Change,0
5840,PT-05840,44,F,Fortis Mumbai,Phase II,ORX-101,Oncology,High Dose,2024-03-13,2024-06-11,7.66,7.7,113,76,74,Headache,Mild,No Change,0
5841,PT-05841,38,F,Fortis Mumbai,Phase III,ORX-404,Neurology,Low Dose,2024-01-23,2024-03-19,8.03,6.45,107,78,58,Nausea,Mild,Improved,1
5842,PT-05842,18,F,Bhopal Research Hospital,Phase III,ORX-303,Cardiology,Placebo,2024-06-01,2024-06-29,5.41,4.79,139,89,100,None,None,Improved,1
5843,PT-05843,46,M,Bhopal Research Hospital,Phase III,ORX-202,Diabetes,High Dose,2024-03-30,2024-04-27,7.48,6.86,124,106,81,None,None,Improved,1
5844,PT-05844,50,F,Indore Medical Institute,Phase III,ORX-404,Neurology,Placebo,2023-07-02,2023-07-16,5.83,5.8,139,95,86,None,None,Worsened,0
5845,PT-05845,42,M,NIMHANS Bengaluru,Phase II,ORX-202,Diabetes,Low Dose,2023-05-25,2023-06-08,7.0,6.53,129,97,93,None,None,No Change,0
5846,PT-05846,57,M,Fortis Mumbai,Phase I,ORX-101,Oncology,Low Dose,2024-02-19,2024-03-18,9.64,6.84,119,81,68,Fever,Severe,Improved,1
5847,PT-05847,30,F,Indore Medical Institute,Phase I,ORX-101,Oncology,Placebo,2023-12-26,2024-03-25,5.14,4.46,144,91,67,Fever,None,Improved,1
5848,PT-05848,48,F,Fortis Mumbai,Phase II,ORX-404,Neurology,Low Dose,2023-09-02,2023-12-01,8.83,7.06,125,85,78,Dizziness,Severe,Improved,1
5849,PT-05849,58,M,AIIMS Delhi,Phase II,ORX-404,Neurology,High Dose,2024-10-19,2024-12-14,5.4,4.1,140,61,89,Fatigue,None,Worsened,0
5850,PT-05850,52,F,PGI Chandigarh,Phase IV,ORX-606,Rheumatology,Low Dose,2024-06-22,2024-06-29,8.09,7.27,137,67,72,None,None,No Change,0
5851,PT-05851,45,F,PGI Chandigarh,Phase III,ORX-404,Neurology,Low Dose,2023-08-06,2023-08-13,6.12,5.92,107,85,102,Headache,Mild,Improved,1
5852,PT-05852,24,M,Kolkata Clinical Center,Phase IV,ORX-101,Oncology,High Dose,2024-07-04,2024-08-01,7.17,5.32,113,90,71,None,None,Improved,1
5853,PT-05853,56,F,Apollo Chennai,Phase I,ORX-606,Rheumatology,Low Dose,2023-09-08,2023-12-07,7.63,7.17,109,90,82,Fever,Mild,Improved,1
5854,PT-05854,20,M,Fortis Mumbai,Phase III,ORX-202,Diabetes,Low Dose,2023-06-14,2023-08-09,6.04,3.15,103,78,63,Fever,None,No Change,0
5855,PT-05855,31,M,Kolkata Clinical Center,Phase III,ORX-202,Diabetes,Placebo,2024-05-13,2024-05-20,8.87,9.39,115,91,95,None,None,Improved,0
5856,PT-05856,54,M,PGI Chandigarh,Phase III,ORX-303,Cardiology,High Dose,2024-08-01,2024-09-26,7.56,8.15,141,67,75,None,None,Improved,0
5857,PT-05857,36,M,Indore Medical Institute,Phase I,ORX-505,Infectious Disease,Placebo,2024-02-02,2024-02-16,8.58,7.66,114,94,81,None,None,No Change,0
5858,PT-05858,78,F,Indore Medical Institute,Phase III,ORX-404,Neurology,High Dose,2023-11-04,2023-11-11,6.17,5.3,148,66,96,Nausea,None,Improved,1
5859,PT-05859,25,F,Bhopal Research Hospital,Phase II,ORX-101,Oncology,High Dose,2024-07-23,2024-08-06,7.93,5.87,128,65,104,None,None,No Change,0
5860,PT-05860,27,M,Kolkata Clinical Center,Phase III,ORX-303,Cardiology,Low Dose,2023-11-08,2023-11-22,6.21,6.29,117,90,68,Rash,None,Improved,0
5861,PT-05861,32,F,Apollo Chennai,Phase II,ORX-606,Rheumatology,Low Dose,2023-04-26,2023-05-24,7.17,5.67,135,92,85,Fever,None,No Change,0
5862,PT-05862,55,F,Bhopal Research Hospital,Phase IV,ORX-505,Infectious Disease,High Dose,2023-05-03,2023-06-28,4.89,4.07,123,99,69,None,None,Improved,1
5863,PT-05863,18,F,PGI Chandigarh,Phase II,ORX-606,Rheumatology,Placebo,2024-08-28,2024-10-23,6.0,5.0,90,93,56,Nausea,None,Worsened,0
5864,PT-05864,52,M,AIIMS Delhi,Phase III,ORX-303,Cardiology,High Dose,2024-06-25,2024-07-09,5.89,6.85,123,76,85,None,None,Improved,0
5865,PT-05865,28,F,Kolkata Clinical Center,Phase III,ORX-303,Cardiology,Low Dose,2023-09-09,2023-10-07,7.89,7.06,117,80,62,Nausea,Mild,No Change,0
5866,PT-05866,41,M,PGI Chandigarh,Phase III,ORX-202,Diabetes,Placebo,2024-07-24,2024-10-22,7.61,5.13,147,91,52,None,None,Improved,1
5867,PT-05867,18,M,AIIMS Delhi,Phase III,ORX-404,Neurology,High Dose,2024-03-29,2024-06-27,8.21,8.5,139,64,103,None,None,No Change,0
5868,PT-05868,32,F,Apollo Chennai,Phase III,ORX-202,Diabetes,High Dose,2024-05-28,2024-06-04,7.49,7.31,156,83,83,None,None,Worsened,0
5869,PT-05869,43,F,Kolkata Clinical Center,Phase I,ORX-404,Neurology,High Dose,2023-05-03,2023-05-10,5.76,3.28,128,65,82,None,None,Improved,1
5870,PT-05870,47,M,Kolkata Clinical Center,Phase IV,ORX-202,Diabetes,Low Dose,2024-05-25,2024-06-22,7.35,6.0,146,87,61,Headache,None,Improved,1
5871,PT-05871,78,F,Bhopal Research Hospital,Phase III,ORX-505,Infectious Disease,Placebo,2024-06-25,2024-07-02,6.95,5.35,114,63,97,None,None,Improved,1
5872,PT-05872,62,M,Bhopal Research Hospital,Phase IV,ORX-202,Diabetes,Placebo,2024-10-15,2024-10-29,8.09,8.18,150,79,83,None,None,No Change,0
5873,PT-05873,32,M,Indore Medical Institute,Phase II,ORX-101,Oncology,Placebo,2023-09-11,2023-12-10,7.02,7.02,90,74,80,None,None,Improved,0
5874,PT-05874,43,M,Kolkata Clinical Center,Phase III,ORX-404,Neurology,High Dose,2023-09-30,2023-10-28,6.66,6.79,115,67,94,None,None,Improved,0
5875,PT-05875,61,F,PGI Chandigarh,Phase IV,ORX-404,Neurology,Placebo,2023-11-14,2024-01-09,6.48,6.02,143,82,85,Fatigue,None,No Change,0
5876,PT-05876,52,M,NIMHANS Bengaluru,Phase II,ORX-303,Cardiology,Low Dose,2024-03-29,2024-04-26,6.82,6.88,110,86,76,None,None,Improved,0
5877,PT-05877,39,M,Kolkata Clinical Center,Phase II,ORX-606,Rheumatology,High Dose,2023-05-02,2023-07-31,5.7,5.42,128,71,55,Headache,Mild,Improved,1
5878,PT-05878,18,M,AIIMS Delhi,Phase II,ORX-606,Rheumatology,Low Dose,2024-03-08,2024-03-15,6.9,6.77,161,81,55,None,None,No Change,0
5879,PT-05879,41,F,Bhopal Research Hospital,Phase III,ORX-202,Diabetes,Low Dose,2024-02-26,2024-05-26,8.7,7.69,148,84,87,None,None,No Change,0
5880,PT-05880,74,M,Kolkata Clinical Center,Phase III,ORX-404,Neurology,High Dose,2024-11-22,2025-02-20,5.0,5.4,126,70,76,None,None,No Change,0
5881,PT-05881,72,F,Fortis Mumbai,Phase II,ORX-505,Infectious Disease,High Dose,2024-01-16,2024-04-15,8.8,6.6,114,93,77,Nausea,None,Improved,1
5882,PT-05882,44,F,Kolkata Clinical Center,Phase III,ORX-202,Diabetes,High Dose,2024-10-03,2025-01-01,5.32,4.25,103,62,60,Fatigue,None,Improved,1
5883,PT-05883,30,F,Apollo Chennai,Phase III,ORX-606,Rheumatology,High Dose,2024-05-01,2024-05-15,6.29,5.13,146,71,97,None,None,No Change,0
5884,PT-05884,37,M,Fortis Mumbai,Phase II,ORX-606,Rheumatology,Placebo,2024-11-11,2024-11-25,7.73,7.75,111,78,70,Nausea,None,Improved,0
5885,PT-05885,50,F,Kolkata Clinical Center,Phase III,ORX-202,Diabetes,Low Dose,2024-07-11,2024-08-08,7.05,5.97,130,86,103,None,None,Improved,1
5886,PT-05886,46,F,Kolkata Clinical Center,Phase II,ORX-202,Diabetes,Placebo,2023-09-12,2023-09-26,7.21,7.2,110,61,73,None,None,Improved,1
5887,PT-05887,62,F,AIIMS Delhi,Phase III,ORX-606,Rheumatology,Low Dose,2023-01-16,2023-01-30,8.68,6.59,139,55,84,Headache,Moderate,Worsened,0
5888,PT-05888,51,F,Kolkata Clinical Center,Phase II,ORX-404,Neurology,Low Dose,2023-08-12,2023-08-19,5.13,5.63,159,81,79,None,None,Improved,0
5889,PT-05889,68,F,Indore Medical Institute,Phase III,ORX-404,Neurology,Low Dose,2024-08-19,2024-08-26,5.85,4.46,112,82,78,Headache,Mild,No Change,0
5890,PT-05890,36,M,Apollo Chennai,Phase III,ORX-606,Rheumatology,High Dose,2023-03-27,2023-04-24,6.84,5.95,119,72,67,None,None,No Change,0
5891,PT-05891,18,F,Bhopal Research Hospital,Phase II,ORX-505,Infectious Disease,High Dose,2023-11-14,2024-01-09,6.93,4.77,141,75,76,None,None,Improved,1
5892,PT-05892,39,F,NIMHANS Bengaluru,Phase III,ORX-404,Neurology,Placebo,2024-03-26,2024-04-09,6.91,7.64,103,62,79,None,None,Improved,0
5893,PT-05893,37,F,NIMHANS Bengaluru,Phase III,ORX-202,Diabetes,Placebo,2024-03-08,2024-04-05,7.63,7.88,108,89,63,Fever,Moderate,No Change,0
5894,PT-05894,46,F,AIIMS Delhi,Phase I,ORX-606,Rheumatology,High Dose,2024-02-06,2024-04-02,5.72,5.43,127,68,58,None,None,Improved,1
5895,PT-05895,57,F,Kolkata Clinical Center,Phase II,ORX-101,Oncology,Placebo,2023-09-10,2023-09-24,6.66,7.17,118,97,64,None,None,No Change,0
5896,PT-05896,68,F,Indore Medical Institute,Phase III,ORX-101,Oncology,High Dose,2024-09-26,2024-10-03,7.41,7.37,109,90,88,None,None,Improved,1
5897,PT-05897,39,M,PGI Chandigarh,Phase I,ORX-606,Rheumatology,Low Dose,2024-09-04,2024-09-18,4.64,3.24,107,87,71,None,None,No Change,0
5898,PT-05898,37,M,Indore Medical Institute,Phase IV,ORX-202,Diabetes,Placebo,2023-09-06,2023-09-13,6.52,7.44,128,84,69,Nausea,None,Worsened,0
5899,PT-05899,44,F,Fortis Mumbai,Phase I,ORX-404,Neurology,Placebo,2024-10-11,2024-10-18,6.03,5.94,107,90,67,None,None,Improved,1
5900,PT-05900,60,F,Fortis Mumbai,Phase IV,ORX-101,Oncology,Placebo,2023-12-20,2024-01-17,9.49,9.09,151,91,57,None,None,Improved,1
5901,PT-05901,46,M,Apollo Chennai,Phase IV,ORX-303,Cardiology,Low Dose,2023-03-18,2023-05-13,7.8,7.94,131,83,78,Headache,Mild,No Change,0
5902,PT-05902,47,M,NIMHANS Bengaluru,Phase II,ORX-404,Neurology,Placebo,2023-07-21,2023-09-15,5.73,5.12,101,76,69,None,None,Improved,1
5903,PT-05903,34,F,PGI Chandigarh,Phase III,ORX-101,Oncology,Placebo,2023-10-29,2023-11-26,5.94,5.78,122,76,58,None,None,Improved,1
5904,PT-05904,40,F,Indore Medical Institute,Phase III,ORX-101,Oncology,High Dose,2023-03-31,2023-05-26,8.57,9.22,134,78,85,None,None,Improved,0
5905,PT-05905,34,F,NIMHANS Bengaluru,Phase I,ORX-606,Rheumatology,Low Dose,2024-03-13,2024-05-08,6.84,5.77,144,91,77,Nausea,Moderate,Improved,1
5906,PT-05906,72,M,Fortis Mumbai,Phase II,ORX-303,Cardiology,Placebo,2023-10-10,2024-01-08,7.7,7.62,132,66,65,None,None,Worsened,0
5907,PT-05907,44,M,PGI Chandigarh,Phase III,ORX-202,Diabetes,Low Dose,2023-01-26,2023-04-26,7.14,7.28,115,82,79,None,None,Improved,0
5908,PT-05908,47,F,Bhopal Research Hospital,Phase III,ORX-505,Infectious Disease,Placebo,2024-01-23,2024-02-06,7.22,5.56,90,70,70,Nausea,None,No Change,0
5909,PT-05909,26,F,Apollo Chennai,Phase II,ORX-202,Diabetes,High Dose,2023-03-29,2023-04-05,7.13,7.71,141,87,91,Nausea,Mild,Improved,0
5910,PT-05910,30,M,Fortis Mumbai,Phase III,ORX-202,Diabetes,High Dose,2023-09-29,2023-11-24,6.65,6.81,119,76,104,Headache,Mild,No Change,0
5911,PT-05911,46,M,PGI Chandigarh,Phase III,ORX-101,Oncology,High Dose,2023-04-08,2023-06-03,9.32,7.28,116,86,79,None,None,Worsened,0
5912,PT-05912,18,M,NIMHANS Bengaluru,Phase III,ORX-202,Diabetes,Low Dose,2023-08-14,2023-08-28,6.92,8.75,132,89,68,None,None,Worsened,0
5913,PT-05913,48,F,Bhopal Research Hospital,Phase III,ORX-101,Oncology,High Dose,2024-09-14,2024-09-28,7.19,7.79,147,86,78,Fever,Mild,No Change,0
5914,PT-05914,18,M,Apollo Chennai,Phase III,ORX-101,Oncology,High Dose,2024-03-13,2024-03-27,5.14,4.82,143,97,65,Headache,None,Worsened,0
5915,PT-05915,20,M,AIIMS Delhi,Phase IV,ORX-303,Cardiology,Low Dose,2024-02-29,2024-04-25,8.32,7.19,99,76,70,None,None,No Change,0
5916,PT-05916,66,F,NIMHANS Bengaluru,Phase I,ORX-101,Oncology,Low Dose,2023-03-29,2023-04-05,8.24,7.18,153,83,92,Nausea,Moderate,Improved,1
5917,PT-05917,66,M,PGI Chandigarh,Phase II,ORX-505,Infectious Disease,Placebo,2023-08-03,2023-08-31,6.88,7.0,120,93,79,Fatigue,None,Improved,0
5918,PT-05918,60,F,Kolkata Clinical Center,Phase II,ORX-606,Rheumatology,Placebo,2023-11-15,2023-12-13,9.03,9.12,126,81,45,Nausea,Mild,No Change,0
5919,PT-05919,33,M,Bhopal Research Hospital,Phase III,ORX-303,Cardiology,High Dose,2024-11-12,2025-01-07,8.32,8.79,114,83,75,Rash,Mild,Improved,0
5920,PT-05920,56,M,AIIMS Delhi,Phase I,ORX-303,Cardiology,Placebo,2024-07-14,2024-07-28,9.85,10.09,115,81,97,None,None,No Change,0
5921,PT-05921,22,M,Kolkata Clinical Center,Phase II,ORX-101,Oncology,Placebo,2024-03-17,2024-04-14,6.46,6.7,151,89,69,Headache,Severe,No Change,0
5922,PT-05922,53,F,AIIMS Delhi,Phase IV,ORX-606,Rheumatology,Placebo,2023-05-23,2023-06-06,7.7,7.61,126,82,65,Fatigue,None,Improved,1
5923,PT-05923,84,M,Bhopal Research Hospital,Phase II,ORX-202,Diabetes,Low Dose,2023-04-17,2023-05-15,7.39,7.48,124,92,59,None,None,Improved,0
5924,PT-05924,18,F,Fortis Mumbai,Phase IV,ORX-404,Neurology,Low Dose,2023-01-08,2023-02-05,7.16,8.61,149,72,85,None,None,Improved,0
5925,PT-05925,34,M,Fortis Mumbai,Phase III,ORX-202,Diabetes,Placebo,2023-03-21,2023-03-28,7.71,7.77,144,63,60,Nausea,Mild,Improved,0
5926,PT-05926,43,M,PGI Chandigarh,Phase II,ORX-202,Diabetes,High Dose,2023-08-11,2023-08-25,5.96,4.56,132,71,109,Nausea,None,No Change,0
5927,PT-05927,36,F,Apollo Chennai,Phase III,ORX-303,Cardiology,High Dose,2023-05-02,2023-07-31,6.88,6.74,100,88,82,None,None,Worsened,0
5928,PT-05928,39,M,Kolkata Clinical Center,Phase III,ORX-404,Neurology,Low Dose,2023-09-28,2023-11-23,7.53,7.51,153,112,63,None,None,Improved,1
5929,PT-05929,24,M,Kolkata Clinical Center,Phase III,ORX-101,Oncology,High Dose,2024-03-09,2024-03-23,7.32,5.05,139,83,83,Headache,None,Improved,1
5930,PT-05930,40,F,AIIMS Delhi,Phase IV,ORX-101,Oncology,Low Dose,2024-11-06,2025-01-01,7.51,7.53,131,65,80,None,None,Improved,0
5931,PT-05931,74,F,Kolkata Clinical Center,Phase III,ORX-202,Diabetes,Placebo,2023-09-14,2023-12-13,7.49,7.21,156,73,90,None,None,Worsened,0
5932,PT-05932,36,F,Apollo Chennai,Phase II,ORX-101,Oncology,Low Dose,2024-03-11,2024-06-09,8.5,8.82,120,78,91,None,None,Improved,0
5933,PT-05933,18,M,Indore Medical Institute,Phase III,ORX-606,Rheumatology,Low Dose,2024-05-29,2024-06-05,6.67,6.83,122,83,49,None,None,No Change,0
5934,PT-05934,31,M,Indore Medical Institute,Phase II,ORX-505,Infectious Disease,High Dose,2023-12-31,2024-01-14,8.02,6.94,104,94,85,None,None,No Change,0
5935,PT-05935,27,F,Apollo Chennai,Phase III,ORX-606,Rheumatology,Low Dose,2023-09-23,2023-11-18,7.37,6.02,125,84,66,None,None,No Change,0
5936,PT-05936,56,M,AIIMS Delhi,Phase III,ORX-505,Infectious Disease,High Dose,2024-08-17,2024-08-24,8.28,8.11,135,64,97,None,None,Improved,1
5937,PT-05937,43,M,AIIMS Delhi,Phase III,ORX-202,Diabetes,Low Dose,2024-07-28,2024-08-11,6.08,5.81,141,88,62,Rash,Mild,No Change,0
5938,PT-05938,57,M,Fortis Mumbai,Phase II,ORX-202,Diabetes,Placebo,2023-02-04,2023-02-18,7.13,7.18,113,94,80,None,None,Improved,0
5939,PT-05939,64,M,Kolkata Clinical Center,Phase III,ORX-404,Neurology,Low Dose,2023-01-13,2023-01-27,5.36,3.7,123,99,105,None,None,Improved,1
5940,PT-05940,30,F,PGI Chandigarh,Phase I,ORX-101,Oncology,High Dose,2024-07-09,2024-08-06,7.26,7.0,140,92,62,None,None,Improved,1
5941,PT-05941,46,F,AIIMS Delhi,Phase III,ORX-606,Rheumatology,Placebo,2023-12-01,2023-12-08,4.79,5.12,121,67,82,None,None,Worsened,0
5942,PT-05942,39,M,NIMHANS Bengaluru,Phase I,ORX-404,Neurology,High Dose,2023-01-23,2023-04-23,8.71,7.51,168,92,96,Headache,Severe,No Change,0
5943,PT-05943,28,F,Bhopal Research Hospital,Phase III,ORX-101,Oncology,High Dose,2023-04-23,2023-05-21,9.35,7.85,124,97,85,Fatigue,None,Worsened,0
5944,PT-05944,25,F,Kolkata Clinical Center,Phase III,ORX-202,Diabetes,Low Dose,2023-12-19,2024-03-18,8.56,8.47,120,63,84,Nausea,None,No Change,0
5945,PT-05945,42,M,NIMHANS Bengaluru,Phase I,ORX-505,Infectious Disease,Placebo,2023-07-28,2023-08-25,7.39,5.56,120,87,104,Headache,Severe,No Change,0
5946,PT-05946,41,F,NIMHANS Bengaluru,Phase III,ORX-606,Rheumatology,Low Dose,2023-12-10,2024-01-07,8.93,9.24,132,69,64,Fever,Moderate,Worsened,0
5947,PT-05947,54,F,PGI Chandigarh,Phase III,ORX-404,Neurology,Placebo,2024-08-18,2024-09-15,6.57,5.61,124,80,90,Fatigue,None,Improved,1
5948,PT-05948,36,M,Bhopal Research Hospital,Phase III,ORX-505,Infectious Disease,High Dose,2024-10-21,2024-10-28,8.16,8.16,97,85,45,None,None,Improved,1
5949,PT-05949,30,F,PGI Chandigarh,Phase III,ORX-505,Infectious Disease,Placebo,2024-10-02,2024-11-27,7.76,7.35,96,68,45,None,None,Improved,1
5950,PT-05950,23,F,Bhopal Research Hospital,Phase III,ORX-303,Cardiology,Low Dose,2024-07-10,2024-09-04,7.89,6.99,131,82,78,Rash,None,Improved,1
5951,PT-05951,61,F,Kolkata Clinical Center,Phase III,ORX-101,Oncology,Low Dose,2023-03-07,2023-04-04,6.96,7.38,90,95,59,Fatigue,Severe,Improved,0
5952,PT-05952,27,M,PGI Chandigarh,Phase III,ORX-505,Infectious Disease,Placebo,2023-04-28,2023-07-27,6.35,6.93,111,74,64,Headache,None,Improved,0
5953,PT-05953,49,F,Apollo Chennai,Phase I,ORX-202,Diabetes,Low Dose,2024-02-04,2024-03-31,8.09,9.23,171,89,83,None,None,Improved,0
5954,PT-05954,25,M,Kolkata Clinical Center,Phase I,ORX-303,Cardiology,Placebo,2023-01-01,2023-01-08,9.49,9.29,122,86,69,None,None,No Change,0
5955,PT-05955,18,M,Indore Medical Institute,Phase III,ORX-404,Neurology,Placebo,2023-06-18,2023-07-02,7.89,8.69,138,81,78,None,None,Improved,0
5956,PT-05956,47,M,Fortis Mumbai,Phase II,ORX-505,Infectious Disease,High Dose,2023-11-18,2023-11-25,7.37,6.92,128,100,84,Nausea,Mild,No Change,0
5957,PT-05957,46,M,Kolkata Clinical Center,Phase III,ORX-505,Infectious Disease,High Dose,2023-12-05,2024-01-02,7.99,8.18,145,72,71,None,None,Improved,0
5958,PT-05958,31,M,Apollo Chennai,Phase II,ORX-404,Neurology,Low Dose,2023-02-11,2023-02-25,8.12,8.37,105,86,97,Nausea,None,Improved,0
5959,PT-05959,41,M,Fortis Mumbai,Phase I,ORX-505,Infectious Disease,Placebo,2024-06-21,2024-06-28,7.58,7.83,104,83,95,None,None,No Change,0
5960,PT-05960,35,M,PGI Chandigarh,Phase III,ORX-404,Neurology,Low Dose,2023-04-06,2023-07-05,8.2,7.82,115,80,70,None,None,Improved,1
5961,PT-05961,30,M,Kolkata Clinical Center,Phase I,ORX-505,Infectious Disease,High Dose,2023-06-22,2023-08-17,6.89,6.56,125,78,81,None,None,No Change,0
5962,PT-05962,53,M,Kolkata Clinical Center,Phase III,ORX-303,Cardiology,Placebo,2024-07-31,2024-10-29,5.83,5.2,92,80,80,Nausea,None,No Change,0
5963,PT-05963,54,M,Indore Medical Institute,Phase III,ORX-404,Neurology,Low Dose,2023-02-28,2023-05-29,7.38,7.48,129,73,62,Nausea,None,Improved,0
5964,PT-05964,40,M,PGI Chandigarh,Phase III,ORX-505,Infectious Disease,Placebo,2023-01-27,2023-04-27,6.28,5.77,119,87,78,None,None,Improved,1
5965,PT-05965,52,F,Fortis Mumbai,Phase II,ORX-303,Cardiology,High Dose,2024-06-29,2024-07-13,7.73,7.17,125,88,112,None,None,No Change,0
5966,PT-05966,29,F,NIMHANS Bengaluru,Phase IV,ORX-404,Neurology,High Dose,2023-12-07,2024-01-04,7.25,5.77,127,73,76,Fever,None,Worsened,0
5967,PT-05967,47,F,Bhopal Research Hospital,Phase IV,ORX-202,Diabetes,High Dose,2024-02-25,2024-05-25,6.61,4.61,153,92,76,Headache,None,Improved,1
5968,PT-05968,30,F,Apollo Chennai,Phase IV,ORX-202,Diabetes,Placebo,2024-09-04,2024-10-30,7.3,7.23,141,92,92,Rash,None,Improved,1
5969,PT-05969,18,M,NIMHANS Bengaluru,Phase III,ORX-202,Diabetes,Placebo,2023-06-26,2023-07-24,6.83,7.33,111,96,103,None,None,Improved,0
5970,PT-05970,64,M,Bhopal Research Hospital,Phase I,ORX-202,Diabetes,High Dose,2024-04-19,2024-06-14,7.99,7.19,133,65,67,None,None,Improved,1
5971,PT-05971,33,M,Kolkata Clinical Center,Phase III,ORX-505,Infectious Disease,High Dose,2023-11-15,2023-11-29,7.27,6.52,132,92,68,None,None,Improved,1
5972,PT-05972,47,M,AIIMS Delhi,Phase I,ORX-303,Cardiology,Low Dose,2024-02-26,2024-03-25,6.7,6.47,140,93,87,None,None,Improved,1
5973,PT-05973,51,F,PGI Chandigarh,Phase II,ORX-505,Infectious Disease,Low Dose,2024-03-27,2024-06-25,5.5,4.12,113,86,59,Rash,None,No Change,0
5974,PT-05974,50,F,Indore Medical Institute,Phase I,ORX-101,Oncology,High Dose,2024-11-06,2024-12-04,7.52,5.38,108,94,87,Fatigue,Severe,Improved,1
5975,PT-05975,31,F,Fortis Mumbai,Phase II,ORX-303,Cardiology,High Dose,2024-03-08,2024-03-22,5.96,3.35,154,82,104,Dizziness,None,No Change,0
5976,PT-05976,41,M,Apollo Chennai,Phase III,ORX-505,Infectious Disease,High Dose,2024-09-21,2024-11-16,7.54,7.94,157,88,78,Dizziness,Mild,No Change,0
5977,PT-05977,45,M,NIMHANS Bengaluru,Phase III,ORX-404,Neurology,High Dose,2024-05-12,2024-06-09,5.94,5.2,128,98,71,Rash,Mild,No Change,0
5978,PT-05978,62,M,Apollo Chennai,Phase I,ORX-101,Oncology,High Dose,2023-11-25,2024-01-20,7.1,7.82,140,89,91,None,None,No Change,0
5979,PT-05979,58,F,PGI Chandigarh,Phase IV,ORX-505,Infectious Disease,Placebo,2023-05-15,2023-06-12,8.48,10.0,157,87,71,None,None,Improved,0
5980,PT-05980,50,F,Apollo Chennai,Phase III,ORX-404,Neurology,Placebo,2023-02-13,2023-05-14,4.89,5.23,108,95,105,None,None,Improved,0
5981,PT-05981,21,M,AIIMS Delhi,Phase III,ORX-404,Neurology,Placebo,2024-03-04,2024-04-29,7.14,5.78,96,80,86,Fatigue,Mild,Improved,1
5982,PT-05982,57,M,NIMHANS Bengaluru,Phase II,ORX-101,Oncology,Placebo,2024-10-06,2024-12-01,7.38,5.49,130,64,58,None,None,Improved,1
5983,PT-05983,29,F,Apollo Chennai,Phase III,ORX-202,Diabetes,High Dose,2024-03-21,2024-03-28,8.46,8.55,133,71,72,Nausea,None,Improved,0
5984,PT-05984,23,M,Indore Medical Institute,Phase III,ORX-101,Oncology,High Dose,2024-07-18,2024-08-01,8.84,10.41,138,90,75,Nausea,Moderate,Improved,0
5985,PT-05985,19,M,PGI Chandigarh,Phase I,ORX-606,Rheumatology,Placebo,2023-10-10,2023-12-05,6.19,5.37,121,74,78,None,None,Improved,1
5986,PT-05986,31,F,PGI Chandigarh,Phase I,ORX-202,Diabetes,Placebo,2023-03-21,2023-04-18,9.8,8.17,143,78,84,Headache,None,Improved,1
5987,PT-05987,53,F,Kolkata Clinical Center,Phase II,ORX-303,Cardiology,Placebo,2023-04-20,2023-07-19,7.39,5.97,122,84,79,Dizziness,Moderate,Improved,1
5988,PT-05988,28,M,AIIMS Delhi,Phase II,ORX-101,Oncology,Low Dose,2024-08-24,2024-10-19,8.75,6.11,123,70,80,Dizziness,None,Improved,1
5989,PT-05989,61,M,Apollo Chennai,Phase II,ORX-606,Rheumatology,Low Dose,2023-02-18,2023-03-04,5.51,7.23,131,86,57,None,None,Worsened,0
5990,PT-05990,44,F,Indore Medical Institute,Phase III,ORX-404,Neurology,Placebo,2024-06-08,2024-06-22,8.37,8.15,130,81,58,None,None,Worsened,0
5991,PT-05991,22,F,Fortis Mumbai,Phase II,ORX-606,Rheumatology,Placebo,2023-05-18,2023-06-15,8.6,9.0,146,72,75,None,None,Improved,0
5992,PT-05992,64,M,Apollo Chennai,Phase IV,ORX-303,Cardiology,Placebo,2024-10-29,2024-11-05,5.73,6.34,117,71,77,Headache,Mild,Improved,0
5993,PT-05993,27,F,PGI Chandigarh,Phase II,ORX-606,Rheumatology,Low Dose,2024-04-29,2024-06-24,4.92,4.59,137,96,86,Dizziness,Mild,No Change,0
5994,PT-05994,76,F,Apollo Chennai,Phase II,ORX-404,Neurology,Low Dose,2023-04-16,2023-04-23,8.83,9.1,136,96,47,Headache,None,Improved,0
5995,PT-05995,37,F,Kolkata Clinical Center,Phase IV,ORX-606,Rheumatology,Placebo,2024-10-09,2024-12-04,4.97,5.17,114,118,70,None,None,Improved,0
5996,PT-05996,46,M,Indore Medical Institute,Phase II,ORX-101,Oncology,High Dose,2023-07-09,2023-08-06,6.72,5.88,105,66,47,None,None,Worsened,0
5997,PT-05997,53,F,NIMHANS Bengaluru,Phase I,ORX-303,Cardiology,Placebo,2023-08-11,2023-08-25,6.69,8.03,105,99,100,Fatigue,Mild,No Change,0
5998,PT-05998,65,M,Kolkata Clinical Center,Phase III,ORX-606,Rheumatology,High Dose,2023-03-09,2023-03-16,7.48,6.78,150,72,81,None,None,Improved,1
5999,PT-05999,44,M,Indore Medical Institute,Phase III,ORX-505,Infectious Disease,High Dose,2024-08-15,2024-08-29,6.13,5.98,141,70,84,None,None,No Change,0
6000,PT-06000,18,F,Fortis Mumbai,Phase III,ORX-202,Diabetes,Placebo,2023-04-30,2023-05-07,5.94,5.13,134,92,79,Headache,Mild,Improved,1
6001,PT-06001,54,M,Bhopal Research Hospital,Phase I,ORX-101,Oncology,Low Dose,2023-04-28,2023-05-05,7.01,6.97,134,75,73,Headache,None,Worsened,0
6002,PT-06002,54,M,AIIMS Delhi,Phase III,ORX-606,Rheumatology,High Dose,2023-11-15,2024-02-13,9.37,10.06,107,68,70,None,None,Improved,0
6003,PT-06003,46,F,NIMHANS Bengaluru,Phase III,ORX-606,Rheumatology,Low Dose,2023-01-22,2023-02-05,7.26,7.97,151,82,74,Nausea,None,Improved,0
6004,PT-06004,53,M,Apollo Chennai,Phase I,ORX-505,Infectious Disease,High Dose,2024-09-06,2024-09-13,8.48,8.57,120,74,62,Headache,None,Improved,0
6005,PT-06005,48,F,Indore Medical Institute,Phase III,ORX-404,Neurology,High Dose,2024-02-24,2024-05-24,7.95,8.21,148,99,58,Headache,None,No Change,0
6006,PT-06006,51,F,PGI Chandigarh,Phase III,ORX-303,Cardiology,Placebo,2023-12-27,2024-03-26,7.73,7.26,113,99,69,Nausea,None,Worsened,0
6007,PT-06007,18,F,Bhopal Research Hospital,Phase II,ORX-202,Diabetes,High Dose,2023-10-30,2023-11-27,7.22,6.61,161,87,73,None,None,No Change,0
6008,PT-06008,41,F,Bhopal Research Hospital,Phase III,ORX-101,Oncology,Low Dose,2024-06-05,2024-07-03,6.95,8.55,140,65,74,None,None,No Change,0
6009,PT-06009,44,M,AIIMS Delhi,Phase III,ORX-202,Diabetes,Placebo,2023-09-30,2023-10-28,5.87,3.87,138,72,95,Rash,None,No Change,0
6010,PT-06010,45,F,PGI Chandigarh,Phase III,ORX-606,Rheumatology,Low Dose,2024-09-26,2024-10-24,6.63,4.06,150,85,71,None,None,Improved,1
6011,PT-06011,30,F,PGI Chandigarh,Phase II,ORX-404,Neurology,Placebo,2024-08-23,2024-08-30,9.12,7.76,121,88,98,None,None,Improved,1
6012,PT-06012,41,M,Apollo Chennai,Phase III,ORX-202,Diabetes,High Dose,2023-03-29,2023-04-26,6.32,5.82,144,95,58,None,None,Improved,1
6013,PT-06013,46,F,Fortis Mumbai,Phase III,ORX-606,Rheumatology,Low Dose,2023-05-16,2023-05-30,5.48,5.87,135,70,99,None,None,No Change,0
6014,PT-06014,50,F,AIIMS Delhi,Phase II,ORX-303,Cardiology,High Dose,2023-04-25,2023-05-09,7.47,6.91,127,77,67,Rash,None,Improved,1
6015,PT-06015,64,F,Kolkata Clinical Center,Phase III,ORX-606,Rheumatology,High Dose,2023-08-11,2023-08-18,6.61,5.73,125,99,93,Fever,None,Worsened,0
6016,PT-06016,38,M,Apollo Chennai,Phase II,ORX-303,Cardiology,Low Dose,2024-02-09,2024-02-23,8.67,8.37,112,76,97,None,None,Improved,1
6017,PT-06017,78,M,Bhopal Research Hospital,Phase III,ORX-606,Rheumatology,High Dose,2024-08-19,2024-09-02,7.58,6.67,125,72,69,None,None,Improved,1
6018,PT-06018,33,M,Apollo Chennai,Phase III,ORX-606,Rheumatology,Low Dose,2024-03-29,2024-04-12,7.1,6.81,125,79,88,None,None,No Change,0
6019,PT-06019,41,F,PGI Chandigarh,Phase II,ORX-101,Oncology,Low Dose,2023-05-02,2023-05-30,7.0,6.44,155,76,86,None,None,Improved,1
6020,PT-06020,33,F,PGI Chandigarh,Phase I,ORX-404,Neurology,High Dose,2024-10-11,2024-12-06,7.62,7.71,147,77,62,None,None,Improved,0
6021,PT-06021,32,F,Kolkata Clinical Center,Phase IV,ORX-606,Rheumatology,Placebo,2023-08-24,2023-11-22,8.36,9.83,143,66,89,Dizziness,None,No Change,0
6022,PT-06022,29,F,PGI Chandigarh,Phase III,ORX-101,Oncology,High Dose,2023-10-02,2023-12-31,6.78,6.55,134,82,69,None,None,No Change,0
6023,PT-06023,61,M,Fortis Mumbai,Phase I,ORX-404,Neurology,High Dose,2023-09-07,2023-12-06,6.57,7.3,103,84,60,None,None,Improved,0
6024,PT-06024,31,F,Bhopal Research Hospital,Phase III,ORX-202,Diabetes,High Dose,2023-05-24,2023-05-31,6.58,7.55,151,92,78,Fever,Mild,Worsened,0
6025,PT-06025,48,F,Apollo Chennai,Phase III,ORX-101,Oncology,Placebo,2023-02-24,2023-03-24,8.72,8.95,128,99,89,None,None,Worsened,0
6026,PT-06026,48,M,AIIMS Delhi,Phase I,ORX-606,Rheumatology,High Dose,2023-06-05,2023-06-12,6.65,5.75,121,87,89,Dizziness,None,Improved,1
6027,PT-06027,21,M,NIMHANS Bengaluru,Phase III,ORX-404,Neurology,High Dose,2024-08-29,2024-10-24,4.86,3.61,120,96,74,Rash,Moderate,Improved,1
6028,PT-06028,49,F,Apollo Chennai,Phase IV,ORX-606,Rheumatology,Low Dose,2024-07-19,2024-08-02,7.7,6.38,154,74,99,None,None,Improved,1
6029,PT-06029,42,F,Indore Medical Institute,Phase I,ORX-606,Rheumatology,Placebo,2024-11-10,2025-01-05,6.79,5.4,131,109,83,None,None,Improved,1
6030,PT-06030,49,F,NIMHANS Bengaluru,Phase III,ORX-202,Diabetes,Low Dose,2024-09-04,2024-10-02,6.4,6.53,130,81,84,Headache,None,No Change,0
6031,PT-06031,18,M,Apollo Chennai,Phase II,ORX-101,Oncology,Placebo,2023-12-13,2023-12-27,7.08,5.6,128,73,68,Fever,None,Improved,1
6032,PT-06032,23,F,Apollo Chennai,Phase II,ORX-404,Neurology,Placebo,2024-05-01,2024-05-29,8.54,7.53,116,100,85,None,None,Worsened,0
6033,PT-06033,18,M,Bhopal Research Hospital,Phase II,ORX-303,Cardiology,Low Dose,2023-07-07,2023-07-14,8.86,9.95,155,90,62,Headache,Moderate,Improved,0
6034,PT-06034,44,F,Kolkata Clinical Center,Phase IV,ORX-202,Diabetes,Placebo,2023-12-22,2024-01-19,5.46,4.28,108,74,80,None,None,Improved,1
6035,PT-06035,37,M,PGI Chandigarh,Phase II,ORX-303,Cardiology,Low Dose,2023-06-07,2023-08-02,6.61,5.95,154,107,71,Nausea,Mild,No Change,0
6036,PT-06036,50,M,Apollo Chennai,Phase II,ORX-606,Rheumatology,Low Dose,2024-04-18,2024-05-02,6.19,6.48,119,73,106,Nausea,None,Improved,0
6037,PT-06037,23,M,AIIMS Delhi,Phase IV,ORX-606,Rheumatology,High Dose,2024-10-11,2025-01-09,4.26,4.52,121,74,116,Headache,Moderate,No Change,0
6038,PT-06038,56,M,NIMHANS Bengaluru,Phase I,ORX-606,Rheumatology,High Dose,2023-07-04,2023-10-02,7.13,6.09,136,61,70,Dizziness,Mild,Improved,1
6039,PT-06039,44,M,Apollo Chennai,Phase II,ORX-606,Rheumatology,High Dose,2023-04-16,2023-05-14,7.46,6.93,115,93,54,Headache,None,Worsened,0
6040,PT-06040,40,M,Indore Medical Institute,Phase III,ORX-404,Neurology,Low Dose,2024-05-23,2024-06-20,6.58,7.09,119,87,82,Fatigue,None,No Change,0
6041,PT-06041,18,F,Fortis Mumbai,Phase I,ORX-101,Oncology,High Dose,2024-03-29,2024-06-27,7.12,5.15,134,73,94,None,None,No Change,0
6042,PT-06042,42,F,Bhopal Research Hospital,Phase III,ORX-101,Oncology,High Dose,2024-06-04,2024-07-02,6.28,6.96,112,92,84,Dizziness,Mild,No Change,0
6043,PT-06043,39,M,Fortis Mumbai,Phase III,ORX-202,Diabetes,High Dose,2023-10-31,2024-01-29,5.6,6.31,137,72,81,None,None,No Change,0
6044,PT-06044,61,M,Fortis Mumbai,Phase II,ORX-404,Neurology,High Dose,2023-09-24,2023-10-01,7.33,7.15,146,100,76,Fatigue,Moderate,No Change,0
6045,PT-06045,23,F,PGI Chandigarh,Phase III,ORX-101,Oncology,Low Dose,2024-02-15,2024-05-15,5.64,4.62,111,61,103,None,None,No Change,0
6046,PT-06046,53,M,Apollo Chennai,Phase IV,ORX-404,Neurology,Low Dose,2024-08-19,2024-08-26,6.57,6.14,95,95,50,None,None,No Change,0
6047,PT-06047,53,F,Fortis Mumbai,Phase III,ORX-606,Rheumatology,Low Dose,2024-02-18,2024-03-03,4.99,4.22,150,62,75,Headache,Mild,Improved,1
6048,PT-06048,55,F,Bhopal Research Hospital,Phase III,ORX-303,Cardiology,Placebo,2023-11-18,2024-02-16,7.76,7.42,136,74,105,Dizziness,None,Improved,1
6049,PT-06049,19,M,NIMHANS Bengaluru,Phase III,ORX-404,Neurology,High Dose,2024-04-12,2024-05-10,8.59,8.37,139,91,85,None,None,Improved,1
6050,PT-06050,32,F,NIMHANS Bengaluru,Phase II,ORX-606,Rheumatology,Low Dose,2024-03-27,2024-06-25,6.86,5.15,122,85,86,None,None,Improved,1
6051,PT-06051,51,F,Fortis Mumbai,Phase I,ORX-202,Diabetes,Low Dose,2024-10-30,2024-11-06,5.09,4.19,116,66,66,None,None,Improved,1
6052,PT-06052,45,F,PGI Chandigarh,Phase III,ORX-202,Diabetes,Low Dose,2024-05-21,2024-05-28,8.9,7.64,107,74,82,None,None,Improved,1
6053,PT-06053,64,F,PGI Chandigarh,Phase III,ORX-404,Neurology,Low Dose,2023-10-07,2023-10-21,7.1,5.39,105,84,91,None,None,Improved,1
6054,PT-06054,74,M,Indore Medical Institute,Phase IV,ORX-202,Diabetes,High Dose,2024-07-24,2024-10-22,5.78,5.51,109,71,64,None,None,Improved,1
6055,PT-06055,39,F,Bhopal Research Hospital,Phase III,ORX-303,Cardiology,Placebo,2023-03-28,2023-04-04,6.14,7.97,119,93,68,None,None,No Change,0
6056,PT-06056,80,M,Fortis Mumbai,Phase III,ORX-404,Neurology,Placebo,2024-07-27,2024-08-03,7.61,7.96,117,93,82,Headache,Mild,Worsened,0
6057,PT-06057,38,M,Fortis Mumbai,Phase IV,ORX-202,Diabetes,Placebo,2024-05-27,2024-06-03,5.9,5.29,122,92,74,None,None,Improved,1
6058,PT-06058,18,F,AIIMS Delhi,Phase II,ORX-303,Cardiology,High Dose,2024-05-04,2024-05-11,7.98,8.74,98,103,97,None,None,Improved,0
6059,PT-06059,34,F,AIIMS Delhi,Phase I,ORX-404,Neurology,Low Dose,2024-01-07,2024-03-03,5.86,6.41,103,73,59,None,None,Improved,0
6060,PT-06060,45,F,Fortis Mumbai,Phase II,ORX-202,Diabetes,High Dose,2024-11-26,2025-01-21,8.96,8.9,146,77,79,None,None,Improved,1
6061,PT-06061,25,M,Fortis Mumbai,Phase III,ORX-404,Neurology,Low Dose,2024-09-13,2024-09-27,7.08,6.01,125,79,73,None,None,Worsened,0
6062,PT-06062,78,M,AIIMS Delhi,Phase III,ORX-202,Diabetes,High Dose,2023-08-30,2023-09-06,9.32,10.2,160,99,77,None,None,No Change,0
6063,PT-06063,43,F,NIMHANS Bengaluru,Phase IV,ORX-606,Rheumatology,Placebo,2023-11-06,2023-12-04,7.48,6.89,109,85,56,Nausea,Moderate,Improved,1
6064,PT-06064,47,M,Indore Medical Institute,Phase III,ORX-606,Rheumatology,Placebo,2024-06-09,2024-07-07,6.01,5.53,131,77,55,Fatigue,None,Improved,1
6065,PT-06065,25,M,Fortis Mumbai,Phase III,ORX-101,Oncology,High Dose,2023-06-07,2023-08-02,7.75,6.85,138,82,75,None,None,Improved,1
6066,PT-06066,50,M,Fortis Mumbai,Phase III,ORX-505,Infectious Disease,High Dose,2023-04-22,2023-05-20,6.39,6.35,120,112,62,None,None,No Change,0
6067,PT-06067,39,M,Kolkata Clinical Center,Phase II,ORX-303,Cardiology,Placebo,2023-08-29,2023-10-24,6.82,5.2,141,76,45,None,None,No Change,0
6068,PT-06068,56,M,NIMHANS Bengaluru,Phase III,ORX-101,Oncology,High Dose,2023-05-13,2023-05-27,6.44,5.94,140,77,72,None,None,No Change,0
6069,PT-06069,84,M,AIIMS Delhi,Phase I,ORX-505,Infectious Disease,Low Dose,2023-01-09,2023-03-06,4.62,3.06,108,103,68,Headache,Mild,No Change,0
6070,PT-06070,48,F,PGI Chandigarh,Phase III,ORX-202,Diabetes,Placebo,2023-05-31,2023-06-14,6.63,6.77,127,85,96,None,None,Improved,0
6071,PT-06071,52,M,Bhopal Research Hospital,Phase III,ORX-404,Neurology,Low Dose,2023-07-29,2023-08-26,6.32,6.2,171,88,80,Rash,Mild,No Change,0
6072,PT-06072,23,M,AIIMS Delhi,Phase III,ORX-202,Diabetes,Placebo,2023-05-28,2023-06-11,8.07,8.45,133,83,117,None,None,Improved,0
6073,PT-06073,58,M,NIMHANS Bengaluru,Phase IV,ORX-101,Oncology,Low Dose,2024-07-23,2024-10-21,8.69,8.35,125,89,76,Nausea,None,Worsened,0
6074,PT-06074,44,F,AIIMS Delhi,Phase III,ORX-606,Rheumatology,Placebo,2023-07-16,2023-07-30,7.76,6.89,131,82,91,Dizziness,None,Improved,1
6075,PT-06075,35,F,Kolkata Clinical Center,Phase I,ORX-101,Oncology,Placebo,2023-04-07,2023-07-06,4.8,4.12,135,93,68,None,None,Improved,1
6076,PT-06076,53,M,Apollo Chennai,Phase II,ORX-404,Neurology,High Dose,2023-11-22,2023-12-06,8.56,8.84,113,73,84,None,None,Improved,0
6077,PT-06077,71,F,Fortis Mumbai,Phase III,ORX-404,Neurology,Placebo,2024-05-04,2024-05-11,7.22,6.67,103,77,67,Fatigue,Severe,No Change,0
6078,PT-06078,45,F,Fortis Mumbai,Phase III,ORX-202,Diabetes,High Dose,2024-11-04,2024-12-02,5.38,4.69,109,93,65,Fatigue,None,No Change,0
6079,PT-06079,35,M,PGI Chandigarh,Phase III,ORX-606,Rheumatology,Placebo,2023-08-06,2023-10-01,7.54,6.73,170,93,78,Rash,None,No Change,0
6080,PT-06080,50,M,Indore Medical Institute,Phase III,ORX-404,Neurology,High Dose,2024-10-25,2025-01-23,4.37,5.08,137,81,85,Nausea,None,Improved,0
6081,PT-06081,56,M,NIMHANS Bengaluru,Phase IV,ORX-404,Neurology,High Dose,2024-06-03,2024-07-01,6.7,6.64,146,87,74,None,None,No Change,0
6082,PT-06082,49,F,PGI Chandigarh,Phase IV,ORX-404,Neurology,High Dose,2023-08-20,2023-09-03,8.86,9.16,107,89,84,None,None,Improved,0
6083,PT-06083,63,M,Indore Medical Institute,Phase III,ORX-202,Diabetes,Placebo,2024-08-29,2024-09-26,7.24,6.51,103,73,94,None,None,No Change,0
6084,PT-06084,48,F,Fortis Mumbai,Phase III,ORX-606,Rheumatology,High Dose,2024-01-24,2024-01-31,7.08,7.85,147,73,94,None,None,Worsened,0
6085,PT-06085,18,M,Indore Medical Institute,Phase II,ORX-404,Neurology,Low Dose,2024-02-15,2024-02-29,7.75,7.66,148,86,74,None,None,Improved,1
6086,PT-06086,42,F,Fortis Mumbai,Phase II,ORX-606,Rheumatology,Placebo,2024-04-10,2024-05-08,10.43,10.11,138,57,66,Fatigue,Mild,Improved,1
6087,PT-06087,53,F,Bhopal Research Hospital,Phase II,ORX-404,Neurology,High Dose,2023-01-24,2023-01-31,5.26,5.36,114,69,67,None,None,Improved,0
6088,PT-06088,69,F,NIMHANS Bengaluru,Phase II,ORX-404,Neurology,Low Dose,2023-10-29,2023-12-24,7.6,6.38,141,91,72,None,None,Improved,1
6089,PT-06089,60,F,Fortis Mumbai,Phase III,ORX-303,Cardiology,Placebo,2024-09-11,2024-12-10,8.41,8.77,115,67,54,Nausea,None,No Change,0
6090,PT-06090,34,F,NIMHANS Bengaluru,Phase IV,ORX-404,Neurology,Low Dose,2024-06-15,2024-09-13,6.76,6.1,127,102,73,None,None,Improved,1
6091,PT-06091,44,M,AIIMS Delhi,Phase IV,ORX-202,Diabetes,High Dose,2023-01-02,2023-01-09,5.02,6.62,104,73,87,None,None,No Change,0
6092,PT-06092,48,M,Kolkata Clinical Center,Phase IV,ORX-101,Oncology,High Dose,2023-11-17,2023-11-24,9.17,9.42,126,94,94,None,None,Worsened,0
6093,PT-06093,34,M,Apollo Chennai,Phase I,ORX-505,Infectious Disease,High Dose,2023-01-11,2023-01-25,8.36,7.76,126,83,72,None,None,No Change,0
6094,PT-06094,38,M,Apollo Chennai,Phase III,ORX-404,Neurology,High Dose,2023-04-22,2023-05-06,8.38,6.61,108,90,76,Nausea,Mild,Worsened,0
6095,PT-06095,60,M,Fortis Mumbai,Phase III,ORX-505,Infectious Disease,High Dose,2024-10-03,2025-01-01,7.63,6.03,129,88,81,Nausea,None,Improved,1
6096,PT-06096,37,F,Kolkata Clinical Center,Phase III,ORX-202,Diabetes,Placebo,2023-07-01,2023-09-29,6.87,5.97,104,64,83,Rash,None,Improved,1
6097,PT-06097,31,M,Apollo Chennai,Phase IV,ORX-606,Rheumatology,High Dose,2024-07-06,2024-08-31,7.89,6.96,104,77,107,Nausea,Mild,Improved,1
6098,PT-06098,43,F,Fortis Mumbai,Phase II,ORX-404,Neurology,High Dose,2024-07-29,2024-09-23,7.98,7.73,102,99,74,Fatigue,Mild,Worsened,0
6099,PT-06099,24,M,Bhopal Research Hospital,Phase IV,ORX-505,Infectious Disease,High Dose,2024-07-12,2024-09-06,6.59,6.0,141,73,114,None,None,Improved,1
6100,PT-06100,30,F,NIMHANS Bengaluru,Phase III,ORX-303,Cardiology,Placebo,2023-10-08,2024-01-06,7.93,5.76,125,86,62,None,None,Improved,1
6101,PT-06101,68,M,PGI Chandigarh,Phase I,ORX-303,Cardiology,High Dose,2024-03-26,2024-04-09,7.72,7.04,135,74,95,Fatigue,None,Improved,1
6102,PT-06102,61,M,Indore Medical Institute,Phase IV,ORX-505,Infectious Disease,Low Dose,2023-12-12,2024-03-11,7.65,7.8,101,99,76,Fatigue,None,Improved,0
6103,PT-06103,61,M,Kolkata Clinical Center,Phase III,ORX-202,Diabetes,Low Dose,2024-01-17,2024-01-31,8.1,8.61,109,70,109,None,None,Improved,0
6104,PT-06104,20,M,AIIMS Delhi,Phase III,ORX-202,Diabetes,Placebo,2023-05-04,2023-06-01,5.88,5.52,128,75,86,None,None,Improved,1
6105,PT-06105,59,F,Apollo Chennai,Phase II,ORX-505,Infectious Disease,Placebo,2024-04-18,2024-06-13,7.18,6.54,127,76,54,Rash,None,No Change,0
6106,PT-06106,49,F,Bhopal Research Hospital,Phase III,ORX-606,Rheumatology,Low Dose,2023-10-09,2023-12-04,8.12,7.58,90,75,90,None,None,Improved,1
6107,PT-06107,21,F,PGI Chandigarh,Phase IV,ORX-606,Rheumatology,High Dose,2023-10-21,2023-10-28,8.04,7.23,127,73,62,Rash,None,No Change,0
6108,PT-06108,67,F,Kolkata Clinical Center,Phase III,ORX-101,Oncology,Low Dose,2023-10-25,2023-12-20,8.18,8.36,144,88,91,Nausea,Mild,No Change,0
6109,PT-06109,34,F,Apollo Chennai,Phase III,ORX-404,Neurology,High Dose,2023-11-30,2023-12-14,8.85,9.61,134,78,60,Nausea,Moderate,No Change,0
6110,PT-06110,48,M,Indore Medical Institute,Phase I,ORX-101,Oncology,Placebo,2024-04-27,2024-07-26,9.22,7.78,146,76,72,Fatigue,Severe,Improved,1
6111,PT-06111,26,M,Apollo Chennai,Phase III,ORX-404,Neurology,Low Dose,2023-03-14,2023-06-12,6.3,6.48,141,84,70,Headache,None,Improved,0
6112,PT-06112,27,M,Indore Medical Institute,Phase II,ORX-606,Rheumatology,Low Dose,2024-10-01,2024-10-15,7.27,6.55,131,78,73,Headache,None,Improved,1
6113,PT-06113,47,F,PGI Chandigarh,Phase III,ORX-303,Cardiology,High Dose,2023-12-25,2024-01-22,7.62,8.32,121,88,103,Fatigue,Moderate,No Change,0
6114,PT-06114,54,F,Kolkata Clinical Center,Phase III,ORX-606,Rheumatology,Low Dose,2023-06-28,2023-07-26,8.6,7.64,115,80,77,None,None,Improved,1
6115,PT-06115,62,F,Bhopal Research Hospital,Phase IV,ORX-404,Neurology,Low Dose,2024-02-22,2024-04-18,6.32,5.84,147,84,77,None,None,No Change,0
6116,PT-06116,48,F,Indore Medical Institute,Phase I,ORX-606,Rheumatology,High Dose,2023-05-04,2023-05-18,5.85,4.42,99,84,90,Nausea,None,Improved,1
6117,PT-06117,57,M,NIMHANS Bengaluru,Phase II,ORX-101,Oncology,High Dose,2023-05-15,2023-06-12,8.57,9.48,130,81,98,Nausea,Moderate,Worsened,0
6118,PT-06118,33,M,Kolkata Clinical Center,Phase IV,ORX-505,Infectious Disease,High Dose,2024-05-20,2024-08-18,5.79,5.08,119,82,66,None,None,Improved,1
6119,PT-06119,50,M,Bhopal Research Hospital,Phase II,ORX-202,Diabetes,High Dose,2023-08-11,2023-09-08,6.52,7.22,106,80,73,Fever,Mild,No Change,0
6120,PT-06120,48,M,Kolkata Clinical Center,Phase II,ORX-101,Oncology,Placebo,2024-02-03,2024-02-17,8.31,8.15,125,90,89,None,None,Improved,1
6121,PT-06121,49,M,Apollo Chennai,Phase III,ORX-303,Cardiology,Low Dose,2024-06-03,2024-07-01,7.67,7.85,98,77,83,None,None,Improved,0
6122,PT-06122,40,M,AIIMS Delhi,Phase III,ORX-505,Infectious Disease,Placebo,2023-04-12,2023-04-26,6.85,6.79,135,87,66,Headache,None,Improved,1
6123,PT-06123,22,F,Indore Medical Institute,Phase II,ORX-505,Infectious Disease,High Dose,2024-07-07,2024-07-21,8.17,7.1,113,71,94,Nausea,None,Improved,1
6124,PT-06124,48,F,NIMHANS Bengaluru,Phase IV,ORX-606,Rheumatology,Low Dose,2024-11-07,2025-01-02,7.61,7.83,127,94,61,None,None,Improved,0
6125,PT-06125,27,M,Fortis Mumbai,Phase III,ORX-101,Oncology,Low Dose,2023-08-10,2023-10-05,5.83,5.81,137,76,74,None,None,Improved,1
6126,PT-06126,65,F,Fortis Mumbai,Phase IV,ORX-505,Infectious Disease,Placebo,2024-10-30,2024-11-06,6.37,6.23,115,95,86,Headache,None,No Change,0
6127,PT-06127,22,M,PGI Chandigarh,Phase III,ORX-101,Oncology,Low Dose,2023-01-03,2023-04-03,6.89,4.62,144,106,47,None,None,No Change,0
6128,PT-06128,22,F,PGI Chandigarh,Phase II,ORX-101,Oncology,High Dose,2023-09-26,2023-10-03,7.4,6.98,120,61,82,None,None,Improved,1
6129,PT-06129,59,F,PGI Chandigarh,Phase III,ORX-606,Rheumatology,High Dose,2024-08-18,2024-09-01,10.62,11.39,104,81,86,None,None,No Change,0
6130,PT-06130,33,M,Kolkata Clinical Center,Phase I,ORX-303,Cardiology,High Dose,2024-07-15,2024-09-09,8.14,8.37,150,91,81,Fever,Mild,No Change,0
6131,PT-06131,34,M,PGI Chandigarh,Phase I,ORX-404,Neurology,High Dose,2024-11-05,2024-12-03,5.65,5.45,120,78,93,Fatigue,None,Improved,1
6132,PT-06132,66,M,Bhopal Research Hospital,Phase IV,ORX-606,Rheumatology,Placebo,2023-07-09,2023-09-03,5.72,5.13,120,85,46,None,None,Improved,1
6133,PT-06133,21,F,PGI Chandigarh,Phase III,ORX-303,Cardiology,Low Dose,2023-09-11,2023-09-18,7.06,7.37,129,90,80,None,None,Improved,0
6134,PT-06134,65,M,NIMHANS Bengaluru,Phase II,ORX-404,Neurology,High Dose,2023-06-02,2023-06-16,8.98,7.9,143,88,113,None,None,No Change,0
6135,PT-06135,32,F,Indore Medical Institute,Phase III,ORX-404,Neurology,Low Dose,2023-03-24,2023-05-19,7.06,5.73,110,86,80,None,None,Improved,1
6136,PT-06136,53,F,Kolkata Clinical Center,Phase II,ORX-505,Infectious Disease,High Dose,2023-01-14,2023-04-14,7.82,7.21,123,70,68,Rash,Severe,No Change,0
6137,PT-06137,44,F,AIIMS Delhi,Phase II,ORX-202,Diabetes,Low Dose,2023-04-25,2023-06-20,7.44,7.68,138,100,64,None,None,Improved,0
6138,PT-06138,41,M,Fortis Mumbai,Phase II,ORX-606,Rheumatology,High Dose,2023-12-31,2024-01-28,6.14,6.89,118,95,98,Headache,None,Improved,0
6139,PT-06139,51,M,PGI Chandigarh,Phase IV,ORX-404,Neurology,Low Dose,2024-11-12,2024-12-10,7.55,7.19,122,76,75,None,None,No Change,0
6140,PT-06140,74,F,Fortis Mumbai,Phase I,ORX-505,Infectious Disease,Placebo,2023-05-10,2023-08-08,5.95,5.73,140,78,83,None,None,Improved,1
6141,PT-06141,20,F,AIIMS Delhi,Phase I,ORX-202,Diabetes,High Dose,2023-08-28,2023-09-25,8.79,9.41,126,71,89,None,None,Worsened,0
6142,PT-06142,26,F,NIMHANS Bengaluru,Phase III,ORX-202,Diabetes,Low Dose,2023-09-06,2023-12-05,5.99,5.55,155,89,68,None,None,No Change,0
6143,PT-06143,18,F,Indore Medical Institute,Phase II,ORX-404,Neurology,Placebo,2023-09-27,2023-10-11,7.25,7.08,126,103,76,Headache,None,Improved,1
6144,PT-06144,18,M,AIIMS Delhi,Phase I,ORX-404,Neurology,High Dose,2023-03-09,2023-03-16,6.71,6.72,134,79,73,Rash,None,Improved,0
6145,PT-06145,18,M,Bhopal Research Hospital,Phase IV,ORX-303,Cardiology,Low Dose,2024-08-28,2024-10-23,7.3,6.6,132,87,95,None,None,Improved,1
6146,PT-06146,29,F,Kolkata Clinical Center,Phase I,ORX-303,Cardiology,High Dose,2024-06-01,2024-06-29,5.65,4.73,114,72,98,None,None,Improved,1
6147,PT-06147,47,F,Bhopal Research Hospital,Phase IV,ORX-404,Neurology,High Dose,2024-06-11,2024-06-18,9.57,9.16,106,72,92,None,None,No Change,0
6148,PT-06148,26,M,Kolkata Clinical Center,Phase III,ORX-303,Cardiology,Low Dose,2024-05-01,2024-05-15,7.87,7.15,111,98,69,None,None,No Change,0
6149,PT-06149,31,F,PGI Chandigarh,Phase IV,ORX-303,Cardiology,Low Dose,2023-10-20,2023-12-15,7.11,6.25,167,94,69,None,None,Worsened,0
6150,PT-06150,37,F,PGI Chandigarh,Phase I,ORX-606,Rheumatology,Low Dose,2024-06-03,2024-06-17,4.78,4.5,114,83,50,Rash,Moderate,Improved,1
6151,PT-06151,44,F,Apollo Chennai,Phase III,ORX-202,Diabetes,High Dose,2024-01-09,2024-02-06,9.24,8.89,114,81,77,Dizziness,Mild,Improved,1
6152,PT-06152,80,F,AIIMS Delhi,Phase III,ORX-404,Neurology,Low Dose,2023-03-28,2023-04-25,6.8,5.32,128,84,85,Fever,None,No Change,0
6153,PT-06153,57,F,Bhopal Research Hospital,Phase IV,ORX-505,Infectious Disease,Placebo,2024-01-12,2024-01-26,9.55,8.61,115,59,87,Rash,None,Improved,1
6154,PT-06154,30,M,Fortis Mumbai,Phase III,ORX-404,Neurology,Placebo,2023-04-15,2023-06-10,8.27,7.43,159,64,92,Headache,Moderate,No Change,0
6155,PT-06155,59,F,NIMHANS Bengaluru,Phase I,ORX-606,Rheumatology,Low Dose,2023-07-25,2023-08-08,7.83,6.43,137,83,52,None,None,Improved,1
6156,PT-06156,69,M,Apollo Chennai,Phase III,ORX-606,Rheumatology,High Dose,2023-08-21,2023-08-28,6.79,7.72,126,93,65,None,None,Improved,0
6157,PT-06157,48,M,Fortis Mumbai,Phase II,ORX-505,Infectious Disease,Low Dose,2024-08-14,2024-08-28,7.37,6.68,112,50,66,Dizziness,Mild,Improved,1
6158,PT-06158,56,M,NIMHANS Bengaluru,Phase IV,ORX-404,Neurology,Low Dose,2023-08-01,2023-08-29,5.53,4.06,102,84,65,None,None,Improved,1
6159,PT-06159,64,M,Indore Medical Institute,Phase I,ORX-101,Oncology,Placebo,2024-07-03,2024-07-10,8.08,7.86,133,72,67,None,None,Improved,1
6160,PT-06160,56,M,NIMHANS Bengaluru,Phase III,ORX-404,Neurology,High Dose,2024-04-22,2024-07-21,8.3,8.53,119,77,64,Headache,Moderate,Improved,0
6161,PT-06161,57,F,Bhopal Research Hospital,Phase II,ORX-404,Neurology,High Dose,2023-05-28,2023-07-23,4.85,2.46,91,56,96,Headache,None,No Change,0
6162,PT-06162,57,M,Fortis Mumbai,Phase IV,ORX-202,Diabetes,Low Dose,2023-03-29,2023-04-12,5.76,5.27,154,88,107,Fatigue,None,Improved,1
6163,PT-06163,43,M,Kolkata Clinical Center,Phase II,ORX-303,Cardiology,High Dose,2023-06-10,2023-08-05,6.41,5.04,128,93,79,Nausea,Moderate,Improved,1
6164,PT-06164,39,F,NIMHANS Bengaluru,Phase IV,ORX-202,Diabetes,Placebo,2024-09-12,2024-09-26,8.71,8.78,125,72,74,None,None,Improved,0
6165,PT-06165,52,M,Kolkata Clinical Center,Phase III,ORX-606,Rheumatology,Placebo,2024-03-25,2024-05-20,6.26,4.75,119,81,97,Fatigue,None,No Change,0
6166,PT-06166,26,M,Fortis Mumbai,Phase III,ORX-505,Infectious Disease,High Dose,2023-09-29,2023-12-28,7.47,6.82,123,100,79,Headache,None,Improved,1
6167,PT-06167,30,M,AIIMS Delhi,Phase I,ORX-202,Diabetes,Placebo,2023-11-23,2023-12-07,8.27,8.6,109,67,83,None,None,Improved,0
6168,PT-06168,44,M,Kolkata Clinical Center,Phase I,ORX-303,Cardiology,Placebo,2023-01-31,2023-02-14,6.64,7.19,117,87,94,None,None,Improved,0
6169,PT-06169,39,M,NIMHANS Bengaluru,Phase II,ORX-606,Rheumatology,Low Dose,2024-08-14,2024-11-12,5.01,4.24,131,94,70,Dizziness,Mild,Improved,1
6170,PT-06170,72,F,Apollo Chennai,Phase III,ORX-606,Rheumatology,Placebo,2024-06-25,2024-08-20,5.64,5.39,123,98,57,Rash,None,Improved,1
6171,PT-06171,51,F,PGI Chandigarh,Phase II,ORX-303,Cardiology,High Dose,2024-11-02,2024-11-09,6.91,7.88,113,86,66,None,None,Improved,0
6172,PT-06172,48,M,PGI Chandigarh,Phase II,ORX-202,Diabetes,Low Dose,2023-12-11,2024-03-10,6.76,6.01,92,86,62,Dizziness,None,Improved,1
6173,PT-06173,27,F,Kolkata Clinical Center,Phase II,ORX-101,Oncology,Low Dose,2024-09-30,2024-10-28,5.33,3.98,137,87,87,None,None,Worsened,0
6174,PT-06174,28,M,AIIMS Delhi,Phase II,ORX-101,Oncology,Placebo,2023-02-08,2023-02-22,7.46,6.5,145,87,68,Nausea,None,Improved,1
6175,PT-06175,61,F,NIMHANS Bengaluru,Phase I,ORX-101,Oncology,High Dose,2023-05-15,2023-05-22,7.81,6.16,97,65,101,Fatigue,Moderate,Improved,1
6176,PT-06176,28,M,NIMHANS Bengaluru,Phase I,ORX-505,Infectious Disease,Low Dose,2024-04-27,2024-05-25,9.45,8.09,106,92,90,None,None,Improved,1
6177,PT-06177,53,M,NIMHANS Bengaluru,Phase III,ORX-303,Cardiology,Placebo,2023-12-22,2024-01-19,8.01,6.89,142,84,72,Dizziness,None,No Change,0
6178,PT-06178,46,M,Indore Medical Institute,Phase II,ORX-606,Rheumatology,Low Dose,2023-09-30,2023-10-28,8.47,8.43,90,92,89,None,None,No Change,0
6179,PT-06179,38,M,NIMHANS Bengaluru,Phase II,ORX-404,Neurology,Placebo,2023-05-28,2023-08-26,7.34,7.04,92,77,72,Fatigue,Mild,Improved,1
6180,PT-06180,42,M,Indore Medical Institute,Phase III,ORX-404,Neurology,Placebo,2024-06-12,2024-08-07,6.57,6.77,113,92,86,None,None,Improved,0
6181,PT-06181,66,M,PGI Chandigarh,Phase IV,ORX-101,Oncology,Low Dose,2024-01-09,2024-01-23,9.28,10.45,106,86,67,None,None,Improved,0
6182,PT-06182,85,M,Apollo Chennai,Phase I,ORX-606,Rheumatology,Placebo,2024-04-02,2024-05-28,7.94,8.81,135,50,67,Fatigue,Moderate,Improved,0
6183,PT-06183,34,F,AIIMS Delhi,Phase II,ORX-404,Neurology,High Dose,2023-11-11,2023-11-25,6.73,6.66,137,50,74,None,None,No Change,0
6184,PT-06184,37,F,AIIMS Delhi,Phase III,ORX-202,Diabetes,Low Dose,2024-03-11,2024-03-25,8.86,8.99,124,84,54,None,None,Improved,0
6185,PT-06185,55,M,AIIMS Delhi,Phase IV,ORX-202,Diabetes,High Dose,2023-03-15,2023-04-12,6.73,5.6,151,85,68,None,None,Worsened,0
6186,PT-06186,35,F,Indore Medical Institute,Phase III,ORX-202,Diabetes,Low Dose,2024-09-08,2024-10-06,7.64,7.5,128,67,63,Fatigue,None,No Change,0
6187,PT-06187,33,F,Indore Medical Institute,Phase III,ORX-202,Diabetes,Low Dose,2023-04-18,2023-04-25,6.96,6.53,125,80,104,None,None,No Change,0
6188,PT-06188,58,M,Fortis Mumbai,Phase II,ORX-202,Diabetes,Placebo,2024-01-08,2024-01-15,8.63,8.64,129,86,81,None,None,No Change,0
6189,PT-06189,57,M,Indore Medical Institute,Phase III,ORX-606,Rheumatology,Low Dose,2024-02-23,2024-03-01,6.03,6.28,131,60,79,None,None,Improved,0
6190,PT-06190,24,F,NIMHANS Bengaluru,Phase IV,ORX-505,Infectious Disease,Placebo,2024-06-23,2024-08-18,6.56,6.01,100,81,78,None,None,Improved,1
6191,PT-06191,57,F,PGI Chandigarh,Phase II,ORX-202,Diabetes,High Dose,2024-03-26,2024-05-21,6.66,6.5,126,76,54,None,None,Improved,1
6192,PT-06192,43,F,Fortis Mumbai,Phase III,ORX-303,Cardiology,High Dose,2024-08-18,2024-09-01,8.09,6.85,124,81,93,None,None,Improved,1
6193,PT-06193,45,M,AIIMS Delhi,Phase III,ORX-303,Cardiology,Placebo,2024-02-22,2024-04-18,7.55,7.14,119,68,74,None,None,Improved,1
6194,PT-06194,51,M,AIIMS Delhi,Phase III,ORX-101,Oncology,Low Dose,2023-03-01,2023-05-30,7.35,8.28,145,96,49,None,None,Worsened,0
6195,PT-06195,70,M,Bhopal Research Hospital,Phase III,ORX-303,Cardiology,Low Dose,2024-04-05,2024-04-12,7.52,7.49,144,82,63,None,None,No Change,0
6196,PT-06196,68,M,Apollo Chennai,Phase III,ORX-606,Rheumatology,Low Dose,2024-05-25,2024-07-20,6.28,4.99,123,77,78,None,None,No Change,0
6197,PT-06197,43,F,Apollo Chennai,Phase I,ORX-505,Infectious Disease,Low Dose,2023-08-07,2023-10-02,8.82,8.83,112,73,72,None,None,Improved,0
6198,PT-06198,38,M,PGI Chandigarh,Phase IV,ORX-606,Rheumatology,Low Dose,2023-08-12,2023-10-07,6.58,5.19,133,76,64,None,None,Improved,1
6199,PT-06199,52,F,NIMHANS Bengaluru,Phase IV,ORX-202,Diabetes,Placebo,2024-03-20,2024-04-17,8.22,7.6,160,108,84,None,None,Worsened,0
6200,PT-06200,37,M,NIMHANS Bengaluru,Phase III,ORX-303,Cardiology,Low Dose,2024-10-06,2024-12-01,7.52,6.02,112,61,69,Fatigue,Mild,Worsened,0
6201,PT-06201,25,M,Kolkata Clinical Center,Phase II,ORX-202,Diabetes,Low Dose,2024-10-17,2024-10-31,7.95,6.87,132,90,94,Headache,Moderate,No Change,0
6202,PT-06202,39,M,Fortis Mumbai,Phase IV,ORX-606,Rheumatology,High Dose,2024-08-03,2024-11-01,7.57,7.48,150,91,96,None,None,Worsened,0
6203,PT-06203,18,F,Indore Medical Institute,Phase III,ORX-404,Neurology,Low Dose,2023-11-21,2024-01-16,6.4,6.93,138,80,71,Dizziness,None,Improved,0
6204,PT-06204,57,F,Bhopal Research Hospital,Phase II,ORX-101,Oncology,Low Dose,2023-11-03,2024-02-01,4.82,5.14,129,76,85,None,None,No Change,0
6205,PT-06205,38,F,NIMHANS Bengaluru,Phase III,ORX-101,Oncology,Placebo,2024-07-22,2024-10-20,7.23,,141,83,51,None,None,No Change,0
6206,PT-06206,22,M,Kolkata Clinical Center,Phase III,ORX-202,Diabetes,Low Dose,2023-01-09,2023-01-16,5.9,5.91,138,102,63,Fatigue,None,No Change,0
6207,PT-06207,65,M,NIMHANS Bengaluru,Phase II,ORX-202,Diabetes,Low Dose,2023-09-25,2023-10-09,4.87,4.49,132,84,73,None,None,Improved,1
6208,PT-06208,46,M,NIMHANS Bengaluru,Phase III,ORX-505,Infectious Disease,High Dose,2024-05-08,2024-07-03,5.72,6.1,132,86,74,None,None,No Change,0
6209,PT-06209,39,M,AIIMS Delhi,Phase II,ORX-404,Neurology,High Dose,2023-05-09,2023-05-16,7.83,8.86,102,64,81,Fatigue,Mild,No Change,0
6210,PT-06210,39,M,Indore Medical Institute,Phase III,ORX-606,Rheumatology,Placebo,2023-09-11,2023-09-25,7.35,6.93,139,78,61,None,None,Improved,1
6211,PT-06211,32,F,AIIMS Delhi,Phase III,ORX-303,Cardiology,High Dose,2024-01-10,2024-04-09,7.01,5.48,127,82,72,None,None,No Change,0
6212,PT-06212,48,M,Indore Medical Institute,Phase II,ORX-202,Diabetes,High Dose,2024-06-04,2024-09-02,5.26,4.0,107,92,110,Rash,None,No Change,0
6213,PT-06213,30,F,Apollo Chennai,Phase III,ORX-101,Oncology,Low Dose,2023-03-22,2023-03-29,6.92,5.89,131,74,81,None,None,No Change,0
6214,PT-06214,55,F,Bhopal Research Hospital,Phase II,ORX-101,Oncology,Low Dose,2024-01-31,2024-03-27,5.73,5.58,95,78,73,Nausea,Mild,Worsened,0
6215,PT-06215,41,F,Apollo Chennai,Phase III,ORX-303,Cardiology,Placebo,2023-11-24,2023-12-22,6.83,5.98,123,84,81,None,None,Worsened,0
6216,PT-06216,46,M,Bhopal Research Hospital,Phase I,ORX-202,Diabetes,High Dose,2023-06-02,2023-06-30,6.51,7.08,155,66,80,None,None,Improved,0
6217,PT-06217,37,F,Bhopal Research Hospital,Phase II,ORX-202,Diabetes,Low Dose,2023-01-22,2023-02-19,8.31,7.9,128,87,73,None,None,Improved,1
6218,PT-06218,71,F,Kolkata Clinical Center,Phase II,ORX-101,Oncology,Low Dose,2024-11-29,2025-01-24,7.81,8.25,124,80,89,Nausea,None,No Change,0
6219,PT-06219,56,F,Bhopal Research Hospital,Phase III,ORX-202,Diabetes,Placebo,2023-12-08,2023-12-22,5.7,5.42,136,80,83,None,None,No Change,0
6220,PT-06220,43,M,AIIMS Delhi,Phase III,ORX-101,Oncology,High Dose,2024-03-27,2024-06-25,4.5,2.92,145,79,80,Headache,None,Worsened,0
6221,PT-06221,44,F,Fortis Mumbai,Phase II,ORX-101,Oncology,Placebo,2023-06-15,2023-08-10,6.21,5.39,133,87,108,Fever,Mild,No Change,0
6222,PT-06222,37,M,Indore Medical Institute,Phase I,ORX-404,Neurology,High Dose,2024-05-11,2024-05-25,9.2,8.03,136,84,76,None,None,Improved,1
6223,PT-06223,44,M,Fortis Mumbai,Phase III,ORX-303,Cardiology,High Dose,2023-12-26,2024-01-02,6.45,6.87,112,85,88,Nausea,None,No Change,0
6224,PT-06224,67,F,AIIMS Delhi,Phase II,ORX-101,Oncology,High Dose,2023-01-08,2023-04-08,8.37,8.48,116,72,62,None,None,Improved,0
6225,PT-06225,25,F,Kolkata Clinical Center,Phase II,ORX-101,Oncology,Placebo,2024-11-17,2025-02-15,7.2,6.14,149,75,79,None,None,Improved,1
6226,PT-06226,40,F,AIIMS Delhi,Phase IV,ORX-202,Diabetes,Low Dose,2023-09-02,2023-09-30,5.52,6.1,140,91,86,None,None,Improved,0
6227,PT-06227,32,F,Fortis Mumbai,Phase I,ORX-505,Infectious Disease,Low Dose,2024-09-25,2024-12-24,6.31,6.32,155,86,91,Nausea,Mild,No Change,0
6228,PT-06228,36,M,PGI Chandigarh,Phase II,ORX-202,Diabetes,Low Dose,2023-07-08,2023-07-22,8.52,7.74,132,77,90,None,None,Improved,1
6229,PT-06229,59,F,Indore Medical Institute,Phase III,ORX-202,Diabetes,Placebo,2023-09-18,2023-11-13,5.43,6.22,170,77,76,None,None,Worsened,0
6230,PT-06230,64,F,PGI Chandigarh,Phase IV,ORX-505,Infectious Disease,High Dose,2024-05-17,2024-06-14,7.28,6.88,162,65,66,None,None,Improved,1
6231,PT-06231,51,M,AIIMS Delhi,Phase III,ORX-606,Rheumatology,High Dose,2023-02-04,2023-03-04,5.26,4.52,121,93,87,None,None,Improved,1
6232,PT-06232,18,F,Indore Medical Institute,Phase I,ORX-202,Diabetes,Placebo,2024-07-12,2024-09-06,6.37,5.35,124,68,84,Nausea,None,No Change,0
6233,PT-06233,33,M,Indore Medical Institute,Phase II,ORX-101,Oncology,Placebo,2023-11-18,2024-01-13,7.91,7.5,110,98,97,None,None,Improved,1
6234,PT-06234,49,F,Fortis Mumbai,Phase III,ORX-606,Rheumatology,High Dose,2024-02-21,2024-03-20,6.91,5.56,147,91,66,Headache,Moderate,Improved,1
6235,PT-06235,34,M,Kolkata Clinical Center,Phase III,ORX-505,Infectious Disease,High Dose,2023-11-25,2023-12-02,7.75,6.29,116,69,63,Headache,Moderate,No Change,0
6236,PT-06236,33,F,PGI Chandigarh,Phase III,ORX-202,Diabetes,High Dose,2024-09-02,2024-10-28,8.29,6.31,135,85,91,None,None,Improved,1
6237,PT-06237,49,F,AIIMS Delhi,Phase III,ORX-505,Infectious Disease,Placebo,2024-05-30,2024-08-28,6.75,5.61,145,87,71,None,None,Improved,1
6238,PT-06238,59,F,NIMHANS Bengaluru,Phase IV,ORX-202,Diabetes,Placebo,2023-11-03,2023-11-17,6.66,6.26,117,88,64,Rash,Mild,No Change,0
6239,PT-06239,40,M,Bhopal Research Hospital,Phase II,ORX-404,Neurology,Low Dose,2023-10-30,2024-01-28,6.41,6.25,134,68,83,None,None,No Change,0
6240,PT-06240,21,F,Fortis Mumbai,Phase III,ORX-606,Rheumatology,Low Dose,2023-03-14,2023-04-11,9.83,8.97,146,84,81,Dizziness,None,Worsened,0
6241,PT-06241,26,F,NIMHANS Bengaluru,Phase IV,ORX-303,Cardiology,Placebo,2023-07-05,2023-08-30,8.21,7.86,136,80,79,Nausea,Mild,Improved,1
6242,PT-06242,30,F,Indore Medical Institute,Phase IV,ORX-404,Neurology,Low Dose,2023-08-20,2023-09-17,7.02,6.24,115,83,83,None,None,Improved,1
6243,PT-06243,49,F,NIMHANS Bengaluru,Phase IV,ORX-202,Diabetes,High Dose,2023-08-10,2023-08-24,7.08,7.05,132,83,80,Nausea,None,Improved,1
6244,PT-06244,63,F,AIIMS Delhi,Phase I,ORX-202,Diabetes,High Dose,2023-08-07,2023-08-14,5.75,5.07,134,63,97,Fever,None,No Change,0
6245,PT-06245,49,M,NIMHANS Bengaluru,Phase II,ORX-404,Neurology,Low Dose,2024-01-08,2024-03-04,8.35,8.96,135,55,80,None,None,Improved,0
6246,PT-06246,48,M,Fortis Mumbai,Phase II,ORX-303,Cardiology,Placebo,2024-01-27,2024-03-23,5.9,3.89,136,67,106,Rash,Mild,No Change,0
6247,PT-06247,49,M,AIIMS Delhi,Phase III,ORX-303,Cardiology,High Dose,2024-09-21,2024-09-28,8.82,8.45,141,82,92,Nausea,None,No Change,0
6248,PT-06248,18,F,PGI Chandigarh,Phase IV,ORX-606,Rheumatology,High Dose,2023-06-13,2023-09-11,8.27,8.47,125,77,73,Dizziness,None,Improved,0
6249,PT-06249,49,M,NIMHANS Bengaluru,Phase III,ORX-404,Neurology,High Dose,2023-09-27,2023-11-22,8.66,7.78,97,111,87,None,None,Improved,1
6250,PT-06250,38,F,Indore Medical Institute,Phase II,ORX-404,Neurology,Placebo,2023-03-30,2023-04-06,8.63,9.07,136,76,87,None,None,Improved,0
6251,PT-06251,62,M,AIIMS Delhi,Phase III,ORX-404,Neurology,High Dose,2024-05-25,2024-06-01,5.14,4.94,133,85,78,Headache,Mild,Improved,1
6252,PT-06252,63,M,Kolkata Clinical Center,Phase II,ORX-303,Cardiology,High Dose,2023-01-22,2023-02-19,6.95,6.54,133,79,58,None,None,No Change,0
6253,PT-06253,48,M,Fortis Mumbai,Phase III,ORX-606,Rheumatology,High Dose,2024-09-08,2024-12-07,7.47,6.74,125,50,94,Nausea,None,No Change,0
6254,PT-06254,59,M,Fortis Mumbai,Phase IV,ORX-202,Diabetes,Low Dose,2023-11-15,2023-11-29,5.59,4.59,154,68,84,None,None,Improved,1
6255,PT-06255,37,M,Bhopal Research Hospital,Phase II,ORX-202,Diabetes,High Dose,2024-06-20,2024-07-18,7.69,7.34,122,86,71,Rash,None,Worsened,0
6256,PT-06256,18,M,Indore Medical Institute,Phase III,ORX-505,Infectious Disease,Placebo,2023-08-30,2023-09-27,6.09,4.74,99,86,75,None,None,Improved,1
6257,PT-06257,50,M,Bhopal Research Hospital,Phase III,ORX-101,Oncology,Placebo,2024-10-23,2025-01-21,7.82,8.11,135,70,86,None,None,Worsened,0
6258,PT-06258,48,M,Bhopal Research Hospital,Phase III,ORX-202,Diabetes,Low Dose,2024-01-03,2024-01-31,9.83,9.44,134,80,78,Nausea,Mild,No Change,0
6259,PT-06259,44,F,NIMHANS Bengaluru,Phase IV,ORX-202,Diabetes,Placebo,2023-12-09,2023-12-16,6.68,6.44,139,76,89,None,None,Improved,1
6260,PT-06260,56,F,Indore Medical Institute,Phase III,ORX-303,Cardiology,High Dose,2023-05-13,2023-08-11,6.14,4.88,136,74,63,Headache,Mild,Improved,1
6261,PT-06261,72,M,Indore Medical Institute,Phase II,ORX-404,Neurology,Placebo,2024-10-30,2025-01-28,6.04,,113,84,79,Fatigue,Mild,Improved,1
6262,PT-06262,75,F,Kolkata Clinical Center,Phase III,ORX-404,Neurology,High Dose,2024-11-09,2024-11-16,6.28,6.09,148,74,87,Rash,None,Improved,1
6263,PT-06263,18,F,AIIMS Delhi,Phase I,ORX-101,Oncology,Placebo,2023-10-16,2024-01-14,9.31,9.81,115,91,96,None,None,Improved,0
6264,PT-06264,24,M,Indore Medical Institute,Phase III,ORX-606,Rheumatology,Low Dose,2024-04-19,2024-05-03,6.48,7.29,129,87,78,None,None,Improved,0
6265,PT-06265,59,F,Apollo Chennai,Phase III,ORX-404,Neurology,Placebo,2023-09-09,2023-12-08,7.82,7.51,90,89,88,None,None,No Change,0
6266,PT-06266,25,M,Kolkata Clinical Center,Phase III,ORX-101,Oncology,High Dose,2024-03-18,2024-04-01,5.79,5.86,131,58,66,None,None,No Change,0
6267,PT-06267,50,F,Fortis Mumbai,Phase III,ORX-505,Infectious Disease,Low Dose,2023-02-15,2023-02-22,8.01,7.09,125,71,96,None,None,No Change,0
6268,PT-06268,47,M,Fortis Mumbai,Phase II,ORX-505,Infectious Disease,Placebo,2024-06-08,2024-07-06,6.4,4.96,105,103,75,None,None,Improved,1
6269,PT-06269,38,F,PGI Chandigarh,Phase III,ORX-505,Infectious Disease,High Dose,2024-02-28,2024-04-24,6.94,5.98,126,82,78,None,None,Worsened,0
6270,PT-06270,24,F,AIIMS Delhi,Phase II,ORX-303,Cardiology,Low Dose,2023-12-11,2023-12-25,8.27,7.37,116,73,63,None,None,No Change,0
6271,PT-06271,49,F,Apollo Chennai,Phase IV,ORX-202,Diabetes,Low Dose,2023-01-23,2023-02-06,8.27,7.22,94,69,71,Dizziness,Mild,No Change,0
6272,PT-06272,25,F,PGI Chandigarh,Phase IV,ORX-606,Rheumatology,Low Dose,2024-10-19,2024-11-16,6.48,5.59,127,64,86,Fatigue,Moderate,Worsened,0
6273,PT-06273,71,M,Apollo Chennai,Phase IV,ORX-404,Neurology,High Dose,2023-01-09,2023-01-23,8.91,7.99,140,88,77,None,None,Improved,1
6274,PT-06274,47,F,Indore Medical Institute,Phase II,ORX-404,Neurology,Placebo,2024-02-17,2024-02-24,8.02,8.41,113,90,101,None,None,No Change,0
6275,PT-06275,59,F,PGI Chandigarh,Phase II,ORX-404,Neurology,Low Dose,2024-02-04,2024-02-18,9.04,6.32,138,85,92,Headache,None,No Change,0
6276,PT-06276,26,M,Bhopal Research Hospital,Phase IV,ORX-202,Diabetes,High Dose,2023-05-27,2023-06-10,6.59,7.0,108,84,77,None,None,Worsened,0
6277,PT-06277,41,M,AIIMS Delhi,Phase IV,ORX-101,Oncology,Placebo,2024-05-18,2024-08-16,7.89,6.48,113,80,61,Fever,None,No Change,0
6278,PT-06278,64,M,Fortis Mumbai,Phase IV,ORX-606,Rheumatology,Low Dose,2024-07-30,2024-08-13,6.24,6.55,112,90,55,None,None,Improved,0
6279,PT-06279,67,M,Apollo Chennai,Phase II,ORX-303,Cardiology,High Dose,2024-08-05,2024-08-19,8.56,7.66,113,87,56,Nausea,Mild,No Change,0
6280,PT-06280,45,F,Bhopal Research Hospital,Phase III,ORX-202,Diabetes,Low Dose,2024-08-26,2024-11-24,6.23,5.6,116,72,101,None,None,Improved,1
6281,PT-06281,57,M,Apollo Chennai,Phase I,ORX-404,Neurology,Placebo,2023-10-20,2023-11-17,5.42,4.24,143,93,58,Fatigue,Mild,Worsened,0
6282,PT-06282,56,F,Kolkata Clinical Center,Phase I,ORX-606,Rheumatology,Placebo,2024-10-15,2024-10-22,7.52,5.37,120,80,78,None,None,Worsened,0
6283,PT-06283,23,M,AIIMS Delhi,Phase III,ORX-202,Diabetes,High Dose,2024-02-26,2024-05-26,6.28,5.32,118,75,76,None,None,Improved,1
6284,PT-06284,49,M,AIIMS Delhi,Phase III,ORX-404,Neurology,Low Dose,2023-03-31,2023-04-14,9.33,9.71,151,76,63,Headache,Mild,Improved,0
6285,PT-06285,57,M,Apollo Chennai,Phase IV,ORX-202,Diabetes,High Dose,2024-04-11,2024-04-25,7.18,7.44,112,89,75,None,None,Worsened,0
6286,PT-06286,37,F,Indore Medical Institute,Phase III,ORX-303,Cardiology,Low Dose,2024-02-28,2024-03-06,6.76,6.8,141,77,82,Fatigue,Moderate,No Change,0
6287,PT-06287,50,F,PGI Chandigarh,Phase I,ORX-505,Infectious Disease,Placebo,2023-04-24,2023-05-01,8.09,8.57,160,76,98,Headache,Mild,Improved,0
6288,PT-06288,46,F,AIIMS Delhi,Phase III,ORX-505,Infectious Disease,Placebo,2023-08-30,2023-09-06,5.89,4.9,136,90,63,None,None,No Change,0
6289,PT-06289,32,F,Apollo Chennai,Phase III,ORX-606,Rheumatology,Low Dose,2023-02-12,2023-02-19,6.56,5.38,94,55,72,None,None,Worsened,0
6290,PT-06290,49,M,Kolkata Clinical Center,Phase IV,ORX-202,Diabetes,Placebo,2023-05-26,2023-07-21,7.99,6.36,103,75,78,Headache,None,Improved,1
6291,PT-06291,61,M,Fortis Mumbai,Phase I,ORX-303,Cardiology,Placebo,2024-06-05,2024-09-03,8.06,7.33,134,71,79,Headache,None,Improved,1
6292,PT-06292,44,M,Kolkata Clinical Center,Phase II,ORX-303,Cardiology,Placebo,2024-09-04,2024-10-02,8.89,8.93,114,72,73,None,None,Improved,0
6293,PT-06293,19,F,Kolkata Clinical Center,Phase III,ORX-606,Rheumatology,Low Dose,2023-06-09,2023-06-23,6.92,6.39,136,89,79,None,None,No Change,0
6294,PT-06294,18,M,Bhopal Research Hospital,Phase I,ORX-303,Cardiology,Low Dose,2023-03-12,2023-06-10,5.73,4.79,139,89,74,None,None,Worsened,0
6295,PT-06295,82,M,Kolkata Clinical Center,Phase III,ORX-505,Infectious Disease,High Dose,2023-06-29,2023-07-13,9.07,9.79,140,87,83,Fatigue,None,Worsened,0
6296,PT-06296,18,M,Fortis Mumbai,Phase IV,ORX-202,Diabetes,Low Dose,2023-11-26,2024-02-24,5.94,5.34,130,80,81,None,None,No Change,0
6297,PT-06297,18,M,AIIMS Delhi,Phase IV,ORX-404,Neurology,High Dose,2023-10-28,2023-11-25,7.81,7.46,124,93,63,Dizziness,None,Worsened,0
6298,PT-06298,41,F,NIMHANS Bengaluru,Phase III,ORX-101,Oncology,High Dose,2024-03-13,2024-06-11,7.54,6.37,91,68,77,None,None,Improved,1
6299,PT-06299,41,F,Indore Medical Institute,Phase I,ORX-303,Cardiology,Placebo,2024-08-23,2024-10-18,7.18,6.18,104,83,75,Headache,Mild,Improved,1
6300,PT-06300,55,M,Fortis Mumbai,Phase IV,ORX-101,Oncology,Placebo,2023-01-30,2023-04-30,6.3,4.08,90,77,79,None,None,No Change,0
6301,PT-06301,41,M,NIMHANS Bengaluru,Phase II,ORX-303,Cardiology,Placebo,2024-05-05,2024-06-30,6.52,4.69,93,86,74,Rash,None,No Change,0
6302,PT-06302,39,M,AIIMS Delhi,Phase II,ORX-505,Infectious Disease,Low Dose,2023-02-13,2023-03-13,5.35,4.08,128,85,75,None,None,No Change,0
6303,PT-06303,67,M,Fortis Mumbai,Phase III,ORX-404,Neurology,Low Dose,2024-01-18,2024-01-25,6.51,7.27,131,83,91,Nausea,Mild,Improved,0
6304,PT-06304,35,F,Bhopal Research Hospital,Phase III,ORX-404,Neurology,High Dose,2023-01-15,2023-02-12,6.8,5.3,144,86,93,None,None,Improved,1
6305,PT-06305,48,F,Indore Medical Institute,Phase III,ORX-505,Infectious Disease,High Dose,2024-07-26,2024-10-24,8.52,7.45,145,77,78,None,None,No Change,0
6306,PT-06306,56,M,AIIMS Delhi,Phase II,ORX-202,Diabetes,High Dose,2024-06-18,2024-07-16,9.99,10.33,144,75,80,None,None,Improved,0
6307,PT-06307,43,M,Indore Medical Institute,Phase II,ORX-202,Diabetes,High Dose,2023-03-17,2023-03-24,8.89,8.36,151,66,97,Headache,None,Improved,1
6308,PT-06308,31,M,Apollo Chennai,Phase II,ORX-303,Cardiology,Low Dose,2023-07-23,2023-08-20,8.22,7.05,139,70,92,Fatigue,None,No Change,0
6309,PT-06309,58,F,Bhopal Research Hospital,Phase II,ORX-606,Rheumatology,High Dose,2024-01-14,2024-03-10,6.48,6.6,145,70,63,Fatigue,Moderate,Worsened,0
6310,PT-06310,27,M,NIMHANS Bengaluru,Phase II,ORX-101,Oncology,Placebo,2024-01-25,2024-02-01,5.74,4.38,144,88,54,None,None,Improved,1
6311,PT-06311,36,F,Fortis Mumbai,Phase II,ORX-505,Infectious Disease,High Dose,2024-10-25,2025-01-23,5.81,6.19,119,63,80,Rash,Moderate,No Change,0
6312,PT-06312,54,F,Fortis Mumbai,Phase III,ORX-606,Rheumatology,Low Dose,2023-10-30,2023-11-13,6.06,5.42,111,96,71,None,None,Improved,1
6313,PT-06313,33,F,Apollo Chennai,Phase III,ORX-101,Oncology,High Dose,2023-12-14,2024-03-13,7.14,,140,96,95,None,None,No Change,0
6314,PT-06314,38,F,PGI Chandigarh,Phase III,ORX-202,Diabetes,Low Dose,2024-03-16,2024-03-30,7.57,8.51,155,71,86,None,None,No Change,0
6315,PT-06315,51,M,Fortis Mumbai,Phase III,ORX-505,Infectious Disease,Placebo,2024-08-06,2024-09-03,8.31,9.03,109,73,90,None,None,No Change,0
6316,PT-06316,47,M,Bhopal Research Hospital,Phase II,ORX-202,Diabetes,High Dose,2024-09-21,2024-10-05,4.53,2.63,139,92,59,None,None,No Change,0
6317,PT-06317,62,F,PGI Chandigarh,Phase II,ORX-606,Rheumatology,Placebo,2023-06-10,2023-06-24,6.96,5.64,117,67,69,None,None,Improved,1
6318,PT-06318,18,F,Fortis Mumbai,Phase II,ORX-404,Neurology,High Dose,2024-11-21,2025-02-19,7.11,7.24,103,82,66,None,None,Worsened,0
6319,PT-06319,55,F,AIIMS Delhi,Phase I,ORX-606,Rheumatology,Placebo,2023-11-30,2023-12-07,4.42,4.66,95,79,68,Headache,Moderate,Improved,0
6320,PT-06320,39,M,Bhopal Research Hospital,Phase II,ORX-606,Rheumatology,Placebo,2023-04-28,2023-05-26,5.36,6.46,104,67,103,None,None,Improved,0
6321,PT-06321,50,M,Indore Medical Institute,Phase II,ORX-404,Neurology,High Dose,2023-03-19,2023-05-14,5.69,5.18,123,61,67,None,None,No Change,0
6322,PT-06322,44,M,Apollo Chennai,Phase III,ORX-101,Oncology,High Dose,2024-03-27,2024-04-10,8.72,8.15,125,72,93,Nausea,Mild,Improved,1
6323,PT-06323,59,M,PGI Chandigarh,Phase II,ORX-303,Cardiology,Placebo,2023-09-04,2023-12-03,8.15,7.85,99,95,78,Fatigue,None,No Change,0
6324,PT-06324,40,M,PGI Chandigarh,Phase III,ORX-202,Diabetes,High Dose,2024-07-13,2024-09-07,7.74,7.54,108,78,51,None,None,Improved,1
6325,PT-06325,46,M,Indore Medical Institute,Phase II,ORX-606,Rheumatology,High Dose,2023-02-03,2023-02-17,8.8,6.78,130,90,89,None,None,Improved,1
6326,PT-06326,33,F,Bhopal Research Hospital,Phase IV,ORX-505,Infectious Disease,Placebo,2023-02-09,2023-02-16,5.88,4.95,149,61,60,Nausea,Severe,Improved,1
6327,PT-06327,37,F,Kolkata Clinical Center,Phase I,ORX-303,Cardiology,High Dose,2024-05-14,2024-08-12,6.03,5.59,153,67,75,Fatigue,Moderate,No Change,0
6328,PT-06328,44,F,Indore Medical Institute,Phase I,ORX-606,Rheumatology,High Dose,2024-03-20,2024-04-17,6.8,4.98,116,74,86,Nausea,Mild,Improved,1
6329,PT-06329,51,F,Apollo Chennai,Phase I,ORX-606,Rheumatology,Placebo,2023-10-20,2023-12-15,5.34,4.59,118,105,82,Nausea,None,Improved,1
6330,PT-06330,27,F,Apollo Chennai,Phase III,ORX-505,Infectious Disease,High Dose,2023-06-04,2023-06-11,6.27,5.53,134,87,80,Rash,Moderate,Improved,1
6331,PT-06331,41,F,Kolkata Clinical Center,Phase III,ORX-101,Oncology,High Dose,2023-12-30,2024-01-13,7.04,6.52,95,81,69,None,None,No Change,0
6332,PT-06332,18,F,Fortis Mumbai,Phase II,ORX-505,Infectious Disease,Placebo,2024-08-03,2024-11-01,10.1,9.98,128,77,88,Rash,Mild,Worsened,0
6333,PT-06333,26,F,Apollo Chennai,Phase II,ORX-202,Diabetes,High Dose,2023-07-31,2023-08-07,6.82,5.57,140,72,93,Nausea,None,Worsened,0
6334,PT-06334,43,M,Indore Medical Institute,Phase II,ORX-101,Oncology,Low Dose,2023-01-08,2023-01-22,8.13,8.09,147,70,90,None,None,No Change,0
6335,PT-06335,18,F,PGI Chandigarh,Phase I,ORX-303,Cardiology,High Dose,2024-04-24,2024-07-23,7.25,6.36,102,71,69,None,None,No Change,0
6336,PT-06336,41,F,Fortis Mumbai,Phase IV,ORX-505,Infectious Disease,Low Dose,2023-10-22,2023-11-05,6.57,6.24,113,76,73,None,None,Worsened,0
6337,PT-06337,47,F,Kolkata Clinical Center,Phase IV,ORX-303,Cardiology,High Dose,2023-01-22,2023-04-22,8.22,8.59,132,87,82,None,None,Improved,0
6338,PT-06338,39,M,Bhopal Research Hospital,Phase III,ORX-404,Neurology,Placebo,2024-04-13,2024-04-20,8.28,7.06,91,69,97,None,None,No Change,0
6339,PT-06339,40,M,AIIMS Delhi,Phase III,ORX-404,Neurology,Placebo,2024-01-25,2024-02-08,7.53,6.88,138,82,77,None,None,Improved,1
6340,PT-06340,54,F,NIMHANS Bengaluru,Phase III,ORX-202,Diabetes,High Dose,2024-10-08,2025-01-06,6.64,6.58,124,80,66,None,None,Improved,1
6341,PT-06341,41,M,Apollo Chennai,Phase II,ORX-202,Diabetes,High Dose,2024-05-08,2024-05-15,6.55,7.17,97,92,53,None,None,Improved,0
6342,PT-06342,53,M,Fortis Mumbai,Phase III,ORX-101,Oncology,Placebo,2023-12-28,2024-01-25,6.19,6.3,125,64,97,Nausea,None,Improved,0
6343,PT-06343,57,M,Apollo Chennai,Phase II,ORX-101,Oncology,Placebo,2023-04-12,2023-07-11,7.8,6.83,142,66,46,None,None,Improved,1
6344,PT-06344,20,M,Bhopal Research Hospital,Phase III,ORX-303,Cardiology,Placebo,2024-06-12,2024-09-10,6.09,5.01,120,77,68,None,None,No Change,0
6345,PT-06345,18,F,Fortis Mumbai,Phase III,ORX-505,Infectious Disease,Placebo,2024-08-09,2024-09-06,7.43,6.79,115,98,74,None,None,No Change,0
6346,PT-06346,45,M,Bhopal Research Hospital,Phase III,ORX-606,Rheumatology,Placebo,2023-05-28,2023-06-25,8.16,6.41,127,91,76,None,None,No Change,0
6347,PT-06347,24,M,NIMHANS Bengaluru,Phase III,ORX-101,Oncology,Placebo,2023-12-26,2024-01-23,6.62,6.39,90,65,105,Rash,None,Improved,1
6348,PT-06348,52,M,PGI Chandigarh,Phase II,ORX-303,Cardiology,Low Dose,2024-02-05,2024-02-19,8.98,9.36,135,78,83,None,None,Improved,0
6349,PT-06349,68,F,PGI Chandigarh,Phase I,ORX-404,Neurology,High Dose,2024-11-11,2024-11-18,8.19,7.94,124,87,70,None,None,Worsened,0
6350,PT-06350,52,F,AIIMS Delhi,Phase IV,ORX-202,Diabetes,High Dose,2024-10-23,2024-11-06,6.36,5.64,109,76,68,None,None,No Change,0
6351,PT-06351,72,F,PGI Chandigarh,Phase I,ORX-606,Rheumatology,Placebo,2023-09-23,2023-09-30,6.13,6.07,110,82,82,None,None,No Change,0
6352,PT-06352,18,M,Kolkata Clinical Center,Phase III,ORX-303,Cardiology,Low Dose,2024-04-08,2024-05-06,5.52,4.26,104,83,81,None,None,Improved,1
6353,PT-06353,27,M,Indore Medical Institute,Phase IV,ORX-404,Neurology,Low Dose,2023-07-14,2023-07-28,7.35,6.57,126,74,84,Headache,None,Improved,1
6354,PT-06354,71,F,Apollo Chennai,Phase III,ORX-303,Cardiology,High Dose,2023-08-25,2023-10-20,8.13,8.98,102,73,85,None,None,Improved,0
6355,PT-06355,69,F,Kolkata Clinical Center,Phase II,ORX-101,Oncology,Low Dose,2023-03-01,2023-05-30,7.98,6.66,120,86,75,None,None,Worsened,0
6356,PT-06356,32,M,NIMHANS Bengaluru,Phase II,ORX-202,Diabetes,Placebo,2023-03-09,2023-03-16,6.85,6.44,108,93,71,None,None,Improved,1
6357,PT-06357,43,F,Kolkata Clinical Center,Phase IV,ORX-303,Cardiology,Low Dose,2024-11-30,2024-12-28,8.44,7.93,145,69,84,None,None,No Change,0
6358,PT-06358,58,F,AIIMS Delhi,Phase II,ORX-101,Oncology,Low Dose,2024-06-16,2024-06-30,6.2,5.64,125,84,84,None,None,Improved,1
6359,PT-06359,30,F,Indore Medical Institute,Phase III,ORX-505,Infectious Disease,Placebo,2024-08-22,2024-09-05,7.13,8.16,146,91,75,Dizziness,Mild,Improved,0
6360,PT-06360,79,F,Apollo Chennai,Phase II,ORX-303,Cardiology,Placebo,2023-12-11,2024-02-05,8.44,8.07,131,76,83,None,None,Improved,1
6361,PT-06361,54,F,NIMHANS Bengaluru,Phase II,ORX-202,Diabetes,High Dose,2024-04-10,2024-04-17,8.04,7.48,101,84,87,None,None,Worsened,0
6362,PT-06362,29,M,Kolkata Clinical Center,Phase IV,ORX-101,Oncology,Placebo,2024-03-17,2024-03-24,7.09,7.9,106,78,98,None,None,No Change,0
6363,PT-06363,47,F,AIIMS Delhi,Phase II,ORX-101,Oncology,High Dose,2024-10-20,2024-12-15,6.57,6.16,142,79,86,Fatigue,Severe,No Change,0
6364,PT-06364,48,F,Fortis Mumbai,Phase III,ORX-303,Cardiology,Low Dose,2023-07-02,2023-07-09,7.58,7.78,122,70,84,None,None,No Change,0
6365,PT-06365,42,M,Kolkata Clinical Center,Phase IV,ORX-606,Rheumatology,High Dose,2024-08-25,2024-10-20,6.66,6.74,150,80,78,Headache,None,No Change,0
6366,PT-06366,26,F,Fortis Mumbai,Phase II,ORX-202,Diabetes,Low Dose,2024-11-05,2024-11-12,6.93,6.73,127,77,88,None,None,No Change,0
6367,PT-06367,45,M,AIIMS Delhi,Phase IV,ORX-202,Diabetes,High Dose,2024-10-16,2025-01-14,10.31,10.09,90,68,85,None,None,No Change,0
6368,PT-06368,34,F,PGI Chandigarh,Phase III,ORX-404,Neurology,Placebo,2023-07-09,2023-07-16,6.5,4.99,119,84,83,Dizziness,Mild,Improved,1
6369,PT-06369,28,M,AIIMS Delhi,Phase III,ORX-404,Neurology,Low Dose,2024-08-10,2024-11-08,8.17,6.69,135,86,64,None,None,Improved,1
6370,PT-06370,28,M,PGI Chandigarh,Phase IV,ORX-606,Rheumatology,High Dose,2024-10-14,2025-01-12,7.66,6.75,124,90,84,None,None,Improved,1
6371,PT-06371,30,F,Indore Medical Institute,Phase III,ORX-101,Oncology,Low Dose,2024-04-04,2024-07-03,7.14,5.89,143,100,66,None,None,No Change,0
6372,PT-06372,44,M,NIMHANS Bengaluru,Phase III,ORX-606,Rheumatology,Placebo,2024-02-26,2024-03-11,8.3,7.92,138,82,63,Headache,Mild,Worsened,0
6373,PT-06373,46,M,AIIMS Delhi,Phase III,ORX-505,Infectious Disease,Low Dose,2024-01-28,2024-02-11,8.55,8.44,157,60,83,Fatigue,Mild,No Change,0
6374,PT-06374,34,F,NIMHANS Bengaluru,Phase III,ORX-202,Diabetes,Low Dose,2024-01-30,2024-02-13,6.15,6.95,123,77,82,None,None,Worsened,0
6375,PT-06375,18,M,Indore Medical Institute,Phase III,ORX-404,Neurology,Low Dose,2023-01-12,2023-02-09,8.83,10.14,144,86,74,Nausea,None,Improved,0
6376,PT-06376,27,M,Apollo Chennai,Phase IV,ORX-505,Infectious Disease,Low Dose,2023-04-11,2023-04-18,8.63,9.06,136,86,82,Fatigue,Mild,Improved,0
6377,PT-06377,36,M,Kolkata Clinical Center,Phase I,ORX-505,Infectious Disease,Placebo,2024-05-24,2024-07-19,10.2,9.54,120,95,77,Fatigue,Mild,Worsened,0
6378,PT-06378,44,F,AIIMS Delhi,Phase I,ORX-303,Cardiology,Low Dose,2023-03-12,2023-05-07,8.9,9.11,141,64,83,None,None,Improved,0
6379,PT-06379,28,M,Indore Medical Institute,Phase III,ORX-202,Diabetes,High Dose,2024-07-28,2024-08-04,6.65,6.41,127,89,88,Fatigue,None,Improved,1
6380,PT-06380,58,F,NIMHANS Bengaluru,Phase II,ORX-404,Neurology,Placebo,2024-02-28,2024-03-27,5.59,7.31,127,96,45,Headache,None,Improved,0
6381,PT-06381,40,F,AIIMS Delhi,Phase II,ORX-404,Neurology,Low Dose,2024-05-24,2024-05-31,5.45,4.27,128,77,96,None,None,Improved,1
6382,PT-06382,73,M,AIIMS Delhi,Phase II,ORX-202,Diabetes,High Dose,2024-11-20,2025-02-18,6.04,5.2,109,95,80,Nausea,Mild,Improved,1
6383,PT-06383,45,M,Bhopal Research Hospital,Phase III,ORX-404,Neurology,Low Dose,2023-09-18,2023-12-17,7.57,6.89,112,82,74,None,None,No Change,0
6384,PT-06384,50,F,Apollo Chennai,Phase II,ORX-303,Cardiology,Low Dose,2023-09-26,2023-10-03,5.24,5.01,115,83,90,Headache,Moderate,No Change,0
6385,PT-06385,36,M,PGI Chandigarh,Phase III,ORX-303,Cardiology,Low Dose,2023-02-19,2023-05-20,8.64,6.67,155,96,65,None,None,Improved,1
6386,PT-06386,30,F,AIIMS Delhi,Phase III,ORX-505,Infectious Disease,High Dose,2024-04-15,2024-07-14,5.41,5.84,122,77,62,Fatigue,None,No Change,0
6387,PT-06387,73,M,NIMHANS Bengaluru,Phase III,ORX-505,Infectious Disease,Placebo,2023-08-26,2023-09-02,6.03,5.65,131,77,69,None,None,No Change,0
6388,PT-06388,39,M,Kolkata Clinical Center,Phase IV,ORX-404,Neurology,Low Dose,2024-11-15,2024-11-22,7.88,7.17,157,72,88,None,None,Improved,1
6389,PT-06389,18,M,Apollo Chennai,Phase III,ORX-606,Rheumatology,High Dose,2023-11-12,2023-11-26,6.27,5.13,108,85,76,None,None,Improved,1
6390,PT-06390,18,M,AIIMS Delhi,Phase II,ORX-202,Diabetes,Placebo,2023-11-15,2023-11-22,9.59,9.35,128,97,91,None,None,Improved,1
6391,PT-06391,40,F,NIMHANS Bengaluru,Phase III,ORX-202,Diabetes,Low Dose,2023-04-22,2023-05-06,4.86,4.96,110,96,67,Fatigue,None,No Change,0
6392,PT-06392,37,F,Indore Medical Institute,Phase IV,ORX-505,Infectious Disease,Placebo,2023-03-23,2023-04-06,5.59,4.05,126,79,71,None,None,No Change,0
6393,PT-06393,77,F,PGI Chandigarh,Phase II,ORX-606,Rheumatology,Low Dose,2024-03-31,2024-05-26,7.92,7.53,90,91,119,Headache,Mild,Improved,1
6394,PT-06394,41,F,PGI Chandigarh,Phase II,ORX-101,Oncology,High Dose,2024-11-01,2024-11-15,6.23,5.97,102,87,99,None,None,Improved,1
6395,PT-06395,34,F,Kolkata Clinical Center,Phase II,ORX-202,Diabetes,Placebo,2024-11-10,2024-11-24,6.43,5.96,118,63,72,None,None,No Change,0
6396,PT-06396,35,M,NIMHANS Bengaluru,Phase IV,ORX-101,Oncology,Placebo,2023-07-01,2023-09-29,8.84,9.48,153,91,80,None,None,Improved,0
6397,PT-06397,31,F,Indore Medical Institute,Phase III,ORX-404,Neurology,Low Dose,2024-07-14,2024-07-21,8.79,8.7,105,71,60,None,None,No Change,0
6398,PT-06398,18,F,Fortis Mumbai,Phase I,ORX-303,Cardiology,Low Dose,2024-05-21,2024-05-28,7.67,6.15,114,82,75,None,None,No Change,0
6399,PT-06399,33,F,Indore Medical Institute,Phase II,ORX-404,Neurology,High Dose,2024-06-24,2024-08-19,9.02,7.25,101,87,69,None,None,Improved,1
6400,PT-06400,34,M,Bhopal Research Hospital,Phase II,ORX-202,Diabetes,Low Dose,2024-04-16,2024-06-11,5.91,5.81,132,83,69,None,None,No Change,0
6401,PT-06401,32,M,Kolkata Clinical Center,Phase IV,ORX-303,Cardiology,Placebo,2024-06-03,2024-09-01,7.0,7.47,156,95,85,Headache,None,Improved,0
6402,PT-06402,60,M,Kolkata Clinical Center,Phase IV,ORX-606,Rheumatology,High Dose,2023-08-24,2023-11-22,5.78,4.74,137,80,82,None,None,No Change,0
6403,PT-06403,60,F,Indore Medical Institute,Phase II,ORX-101,Oncology,Placebo,2023-04-03,2023-05-01,8.19,6.81,128,70,67,Rash,None,No Change,0
6404,PT-06404,18,F,Fortis Mumbai,Phase III,ORX-606,Rheumatology,Low Dose,2023-01-09,2023-02-06,7.36,5.35,135,98,85,Dizziness,Moderate,No Change,0
6405,PT-06405,45,M,NIMHANS Bengaluru,Phase I,ORX-303,Cardiology,Low Dose,2023-06-28,2023-07-12,9.04,8.94,112,83,105,None,None,Worsened,0
6406,PT-06406,27,F,Apollo Chennai,Phase III,ORX-303,Cardiology,High Dose,2023-04-06,2023-04-13,5.54,5.7,123,75,60,None,None,Worsened,0
6407,PT-06407,18,F,PGI Chandigarh,Phase II,ORX-404,Neurology,Placebo,2023-11-21,2023-11-28,5.45,6.51,127,58,94,None,None,No Change,0
6408,PT-06408,64,F,Bhopal Research Hospital,Phase IV,ORX-404,Neurology,High Dose,2023-03-30,2023-04-13,8.68,7.89,123,83,97,None,None,Improved,1
6409,PT-06409,36,F,AIIMS Delhi,Phase III,ORX-303,Cardiology,High Dose,2024-02-13,2024-02-20,6.29,6.52,149,81,87,None,None,Improved,0
6410,PT-06410,46,F,Apollo Chennai,Phase III,ORX-606,Rheumatology,Placebo,2023-12-07,2024-02-01,6.9,5.75,107,74,64,None,None,Improved,1
6411,PT-06411,49,F,Apollo Chennai,Phase II,ORX-303,Cardiology,Placebo,2024-08-01,2024-09-26,8.66,8.44,111,92,82,None,None,No Change,0
6412,PT-06412,52,M,AIIMS Delhi,Phase IV,ORX-404,Neurology,Placebo,2023-01-06,2023-01-13,6.58,7.2,148,79,88,Rash,Moderate,No Change,0
6413,PT-06413,62,M,Apollo Chennai,Phase I,ORX-101,Oncology,Low Dose,2023-05-29,2023-06-05,6.64,6.17,129,68,84,None,None,No Change,0
6414,PT-06414,61,F,PGI Chandigarh,Phase I,ORX-606,Rheumatology,Placebo,2024-10-25,2025-01-23,7.03,6.93,153,77,83,None,None,Improved,1
6415,PT-06415,35,M,Apollo Chennai,Phase III,ORX-101,Oncology,Low Dose,2024-05-30,2024-07-25,6.48,6.39,132,88,79,None,None,Improved,1
6416,PT-06416,52,M,PGI Chandigarh,Phase I,ORX-101,Oncology,Low Dose,2024-11-21,2024-12-05,9.2,9.75,134,88,73,None,None,Improved,0
6417,PT-06417,42,F,Apollo Chennai,Phase III,ORX-101,Oncology,Low Dose,2023-02-10,2023-02-24,7.79,7.47,142,97,76,None,None,Improved,1
6418,PT-06418,18,F,Kolkata Clinical Center,Phase III,ORX-404,Neurology,High Dose,2024-01-06,2024-03-02,9.64,8.65,131,90,97,Headache,None,Worsened,0
6419,PT-06419,73,M,NIMHANS Bengaluru,Phase IV,ORX-505,Infectious Disease,High Dose,2023-12-23,2024-01-20,6.76,7.43,131,114,93,None,None,No Change,0
6420,PT-06420,42,M,PGI Chandigarh,Phase I,ORX-202,Diabetes,Placebo,2023-04-23,2023-05-21,6.25,3.48,140,94,88,None,None,Improved,1
6421,PT-06421,18,F,Bhopal Research Hospital,Phase III,ORX-202,Diabetes,Placebo,2023-04-27,2023-05-11,5.69,5.72,160,81,93,Nausea,Mild,No Change,0
6422,PT-06422,28,M,AIIMS Delhi,Phase I,ORX-202,Diabetes,Low Dose,2024-11-17,2024-12-15,7.45,6.8,149,75,101,None,None,No Change,0
6423,PT-06423,40,F,PGI Chandigarh,Phase II,ORX-303,Cardiology,High Dose,2023-02-14,2023-05-15,5.92,4.58,116,86,69,None,None,Improved,1
6424,PT-06424,31,F,Indore Medical Institute,Phase III,ORX-404,Neurology,Low Dose,2023-11-10,2023-11-24,8.27,4.98,120,65,65,None,None,No Change,0
6425,PT-06425,48,F,Fortis Mumbai,Phase III,ORX-303,Cardiology,High Dose,2024-02-10,2024-02-17,6.95,6.29,149,81,103,None,None,Improved,1
6426,PT-06426,56,M,PGI Chandigarh,Phase III,ORX-505,Infectious Disease,Low Dose,2023-12-20,2024-01-03,6.04,7.38,133,104,74,Nausea,Mild,Improved,0
6427,PT-06427,49,M,Indore Medical Institute,Phase II,ORX-404,Neurology,Low Dose,2023-07-18,2023-07-25,7.72,7.17,150,105,45,Fatigue,Moderate,Improved,1
6428,PT-06428,58,F,AIIMS Delhi,Phase II,ORX-505,Infectious Disease,Placebo,2023-07-27,2023-09-21,6.13,3.39,137,88,87,None,None,No Change,0
6429,PT-06429,50,M,Kolkata Clinical Center,Phase II,ORX-505,Infectious Disease,Placebo,2023-08-28,2023-11-26,8.25,7.31,132,90,96,Headache,None,Improved,1
6430,PT-06430,45,F,Bhopal Research Hospital,Phase III,ORX-202,Diabetes,Placebo,2023-08-14,2023-08-28,6.94,6.49,106,91,57,None,None,Improved,1
6431,PT-06431,51,F,Indore Medical Institute,Phase III,ORX-303,Cardiology,High Dose,2024-03-08,2024-03-22,7.3,5.51,101,71,73,None,None,Improved,1
6432,PT-06432,68,M,Bhopal Research Hospital,Phase I,ORX-101,Oncology,High Dose,2023-11-30,2023-12-28,7.07,7.16,150,94,77,None,None,No Change,0
6433,PT-06433,33,F,Fortis Mumbai,Phase I,ORX-404,Neurology,High Dose,2023-01-19,2023-01-26,7.8,6.78,160,92,80,None,None,Improved,1
6434,PT-06434,53,M,Apollo Chennai,Phase III,ORX-404,Neurology,Low Dose,2024-08-17,2024-10-12,7.41,6.68,136,79,105,Dizziness,Mild,Improved,1
6435,PT-06435,33,F,Fortis Mumbai,Phase IV,ORX-606,Rheumatology,High Dose,2024-02-08,2024-02-15,7.81,6.71,113,60,83,Fatigue,None,Improved,1
6436,PT-06436,36,F,AIIMS Delhi,Phase I,ORX-606,Rheumatology,High Dose,2023-01-10,2023-02-07,8.5,8.47,130,65,86,None,None,Improved,1
6437,PT-06437,34,M,PGI Chandigarh,Phase I,ORX-404,Neurology,High Dose,2024-10-17,2024-10-31,5.48,5.47,105,56,96,Headache,None,Worsened,0
6438,PT-06438,36,M,PGI Chandigarh,Phase II,ORX-101,Oncology,Placebo,2024-09-06,2024-09-13,5.11,3.84,115,95,54,None,None,Improved,1
6439,PT-06439,23,M,NIMHANS Bengaluru,Phase III,ORX-505,Infectious Disease,High Dose,2024-03-14,2024-05-09,8.38,7.57,132,76,106,None,None,Improved,1
6440,PT-06440,24,F,Apollo Chennai,Phase IV,ORX-404,Neurology,Placebo,2023-06-04,2023-06-11,7.54,8.49,121,72,88,None,None,No Change,0
6441,PT-06441,61,M,PGI Chandigarh,Phase III,ORX-202,Diabetes,Placebo,2024-08-19,2024-11-17,6.24,7.16,128,88,98,None,None,No Change,0
6442,PT-06442,57,F,Indore Medical Institute,Phase IV,ORX-101,Oncology,High Dose,2024-01-25,2024-02-01,7.2,6.2,176,72,82,None,None,Worsened,0
6443,PT-06443,53,M,AIIMS Delhi,Phase III,ORX-404,Neurology,High Dose,2023-08-22,2023-11-20,7.87,9.38,128,80,99,Rash,None,Improved,0
6444,PT-06444,42,M,NIMHANS Bengaluru,Phase I,ORX-303,Cardiology,Placebo,2023-01-30,2023-04-30,8.25,8.03,144,90,72,Headache,None,No Change,0
6445,PT-06445,18,F,NIMHANS Bengaluru,Phase III,ORX-505,Infectious Disease,Low Dose,2024-10-03,2024-10-31,5.19,3.13,126,53,75,Headache,Mild,Worsened,0
6446,PT-06446,47,F,AIIMS Delhi,Phase II,ORX-202,Diabetes,Low Dose,2023-09-19,2023-12-18,8.23,8.28,144,86,73,None,None,No Change,0
6447,PT-06447,43,M,Apollo Chennai,Phase III,ORX-202,Diabetes,Placebo,2023-01-06,2023-03-03,6.18,5.98,99,94,64,None,None,Improved,1
6448,PT-06448,47,F,PGI Chandigarh,Phase III,ORX-404,Neurology,Low Dose,2023-06-03,2023-07-29,7.59,8.23,97,78,85,None,None,Improved,0
6449,PT-06449,73,F,NIMHANS Bengaluru,Phase III,ORX-505,Infectious Disease,Low Dose,2024-06-20,2024-07-04,7.15,6.22,164,91,97,Fatigue,Moderate,Improved,1
6450,PT-06450,25,M,Apollo Chennai,Phase II,ORX-606,Rheumatology,High Dose,2024-11-22,2024-11-29,7.83,6.45,104,88,87,None,None,Improved,1
6451,PT-06451,37,M,NIMHANS Bengaluru,Phase II,ORX-202,Diabetes,Placebo,2024-03-29,2024-04-26,8.92,8.19,123,81,74,None,None,Improved,1
6452,PT-06452,65,F,AIIMS Delhi,Phase I,ORX-303,Cardiology,Placebo,2023-05-30,2023-07-25,5.95,4.87,106,104,73,None,None,Improved,1
6453,PT-06453,32,M,Indore Medical Institute,Phase IV,ORX-303,Cardiology,Low Dose,2023-09-10,2023-09-17,6.86,7.22,139,75,72,None,None,Worsened,0
6454,PT-06454,21,M,NIMHANS Bengaluru,Phase II,ORX-404,Neurology,High Dose,2023-01-11,2023-02-08,7.37,8.12,117,89,69,None,None,No Change,0
6455,PT-06455,27,M,Kolkata Clinical Center,Phase III,ORX-505,Infectious Disease,Placebo,2023-10-18,2023-12-13,8.02,9.73,137,77,73,Rash,Mild,Improved,0
6456,PT-06456,75,M,Kolkata Clinical Center,Phase III,ORX-202,Diabetes,Low Dose,2023-06-30,2023-07-28,7.57,6.48,126,84,84,None,None,Improved,1
6457,PT-06457,69,M,Kolkata Clinical Center,Phase II,ORX-606,Rheumatology,Low Dose,2023-04-19,2023-05-03,8.73,8.51,127,86,69,None,None,No Change,0
6458,PT-06458,60,F,AIIMS Delhi,Phase IV,ORX-303,Cardiology,High Dose,2024-08-20,2024-11-18,6.96,7.0,158,88,81,Nausea,None,Worsened,0
6459,PT-06459,36,F,Bhopal Research Hospital,Phase III,ORX-505,Infectious Disease,Low Dose,2023-02-08,2023-04-05,7.11,5.68,137,56,91,None,None,No Change,0
6460,PT-06460,56,F,Bhopal Research Hospital,Phase II,ORX-606,Rheumatology,Placebo,2023-02-07,2023-05-08,7.32,6.44,127,60,89,Rash,None,Improved,1
6461,PT-06461,42,F,NIMHANS Bengaluru,Phase III,ORX-505,Infectious Disease,High Dose,2024-06-17,2024-06-24,9.02,8.97,132,86,64,Fatigue,None,Improved,1
6462,PT-06462,37,M,NIMHANS Bengaluru,Phase IV,ORX-303,Cardiology,High Dose,2024-09-22,2024-10-06,7.36,6.69,117,78,78,Headache,Mild,No Change,0
6463,PT-06463,82,F,Bhopal Research Hospital,Phase IV,ORX-202,Diabetes,Placebo,2023-09-27,2023-10-04,6.81,5.8,125,100,100,None,None,Improved,1
6464,PT-06464,76,M,NIMHANS Bengaluru,Phase III,ORX-303,Cardiology,Low Dose,2024-05-10,2024-05-17,7.27,7.45,109,77,62,Dizziness,None,Improved,0
6465,PT-06465,52,M,AIIMS Delhi,Phase IV,ORX-606,Rheumatology,Placebo,2024-01-25,2024-02-08,7.25,7.05,112,92,45,None,None,Improved,1
6466,PT-06466,40,F,Bhopal Research Hospital,Phase III,ORX-202,Diabetes,High Dose,2024-07-07,2024-10-05,7.07,4.85,134,79,85,None,None,Improved,1
6467,PT-06467,76,M,PGI Chandigarh,Phase IV,ORX-303,Cardiology,High Dose,2024-01-10,2024-01-17,7.59,8.06,152,87,65,Fever,None,Improved,0
6468,PT-06468,18,F,PGI Chandigarh,Phase II,ORX-505,Infectious Disease,High Dose,2023-05-22,2023-06-19,7.65,6.89,151,76,77,None,None,No Change,0
6469,PT-06469,26,M,PGI Chandigarh,Phase I,ORX-101,Oncology,High Dose,2023-01-23,2023-03-20,6.79,5.54,112,81,69,Headache,None,No Change,0
6470,PT-06470,85,M,AIIMS Delhi,Phase III,ORX-606,Rheumatology,Placebo,2024-08-16,2024-11-14,8.2,8.78,126,83,71,Fever,Mild,Improved,0
6471,PT-06471,85,M,PGI Chandigarh,Phase II,ORX-404,Neurology,Placebo,2023-04-24,2023-05-01,7.07,6.13,114,86,97,Headache,None,Improved,1
6472,PT-06472,62,M,AIIMS Delhi,Phase II,ORX-505,Infectious Disease,High Dose,2023-04-06,2023-05-04,6.29,5.19,150,107,75,Nausea,Moderate,No Change,0
6473,PT-06473,64,F,Bhopal Research Hospital,Phase IV,ORX-606,Rheumatology,Low Dose,2023-04-24,2023-05-22,5.44,4.28,109,86,75,Headache,Mild,Worsened,0
6474,PT-06474,48,M,Bhopal Research Hospital,Phase IV,ORX-606,Rheumatology,High Dose,2023-11-20,2023-12-04,8.66,7.68,129,65,94,None,None,No Change,0
6475,PT-06475,62,F,Fortis Mumbai,Phase II,ORX-303,Cardiology,Low Dose,2023-10-17,2023-12-12,7.63,7.34,118,65,82,None,None,No Change,0
6476,PT-06476,57,M,AIIMS Delhi,Phase II,ORX-404,Neurology,High Dose,2024-04-21,2024-07-20,9.62,8.87,132,95,94,None,None,No Change,0
6477,PT-06477,35,F,NIMHANS Bengaluru,Phase III,ORX-606,Rheumatology,High Dose,2023-03-08,2023-03-15,6.87,5.99,111,99,78,Dizziness,None,No Change,0
6478,PT-06478,43,M,Indore Medical Institute,Phase IV,ORX-505,Infectious Disease,High Dose,2023-11-11,2023-11-18,7.5,7.15,124,72,99,None,None,Improved,1
6479,PT-06479,35,F,Bhopal Research Hospital,Phase III,ORX-404,Neurology,High Dose,2023-06-11,2023-09-09,6.08,5.61,166,72,87,None,None,Improved,1
6480,PT-06480,41,F,Kolkata Clinical Center,Phase III,ORX-202,Diabetes,Placebo,2023-10-27,2024-01-25,7.49,7.92,97,71,90,None,None,No Change,0
6481,PT-06481,46,F,AIIMS Delhi,Phase III,ORX-404,Neurology,Placebo,2023-04-25,2023-07-24,7.45,7.69,111,94,89,None,None,Worsened,0
6482,PT-06482,48,F,PGI Chandigarh,Phase II,ORX-202,Diabetes,Placebo,2023-10-27,2023-11-24,7.76,8.41,117,89,102,None,None,No Change,0
6483,PT-06483,55,F,NIMHANS Bengaluru,Phase II,ORX-505,Infectious Disease,Placebo,2023-11-07,2023-11-21,6.93,8.62,132,98,72,None,None,No Change,0
6484,PT-06484,62,F,Fortis Mumbai,Phase IV,ORX-101,Oncology,High Dose,2024-01-18,2024-03-14,6.54,6.44,117,104,74,None,None,Worsened,0
6485,PT-06485,27,F,Kolkata Clinical Center,Phase IV,ORX-202,Diabetes,Low Dose,2023-03-09,2023-04-06,7.31,7.4,127,72,92,Headache,Mild,No Change,0
6486,PT-06486,65,F,Bhopal Research Hospital,Phase III,ORX-303,Cardiology,High Dose,2023-03-27,2023-04-10,5.22,4.03,125,75,85,None,None,No Change,0
6487,PT-06487,74,M,Kolkata Clinical Center,Phase IV,ORX-404,Neurology,Placebo,2023-04-03,2023-05-29,6.74,7.76,101,87,69,Headache,None,No Change,0
6488,PT-06488,52,F,Kolkata Clinical Center,Phase II,ORX-404,Neurology,Low Dose,2024-11-27,2025-01-22,5.09,3.53,136,74,73,Fatigue,None,Improved,1
6489,PT-06489,74,F,Bhopal Research Hospital,Phase I,ORX-606,Rheumatology,High Dose,2023-12-31,2024-01-14,7.37,7.78,114,65,76,Nausea,None,Improved,0
6490,PT-06490,21,F,PGI Chandigarh,Phase III,ORX-101,Oncology,Placebo,2024-05-12,2024-06-09,6.36,6.18,125,86,86,None,None,Improved,1
6491,PT-06491,25,F,Indore Medical Institute,Phase III,ORX-404,Neurology,Placebo,2023-05-01,2023-05-08,6.07,3.71,121,90,98,Fatigue,Moderate,No Change,0
6492,PT-06492,48,M,NIMHANS Bengaluru,Phase III,ORX-505,Infectious Disease,High Dose,2024-05-06,2024-05-20,8.85,8.79,129,74,45,None,None,No Change,0
6493,PT-06493,64,M,AIIMS Delhi,Phase II,ORX-404,Neurology,High Dose,2024-05-18,2024-06-01,7.14,7.99,110,111,74,None,None,Improved,0
6494,PT-06494,33,M,NIMHANS Bengaluru,Phase II,ORX-505,Infectious Disease,Low Dose,2023-03-15,2023-03-29,6.94,6.7,126,75,52,None,None,Worsened,0
6495,PT-06495,32,F,Kolkata Clinical Center,Phase III,ORX-202,Diabetes,Low Dose,2023-05-04,2023-06-01,8.49,7.3,97,69,76,Nausea,Mild,Worsened,0
6496,PT-06496,32,F,Indore Medical Institute,Phase III,ORX-101,Oncology,Placebo,2024-07-10,2024-07-24,6.86,5.75,146,87,109,Headache,Mild,Worsened,0
6497,PT-06497,38,F,Fortis Mumbai,Phase III,ORX-101,Oncology,High Dose,2024-01-27,2024-02-24,6.86,7.52,135,70,85,None,None,Improved,0
6498,PT-06498,51,M,Indore Medical Institute,Phase II,ORX-404,Neurology,Low Dose,2024-11-25,2025-01-20,5.05,4.06,131,99,87,None,None,Improved,1
6499,PT-06499,35,F,Indore Medical Institute,Phase IV,ORX-101,Oncology,Placebo,2024-01-19,2024-03-15,6.35,6.67,90,72,97,None,None,No Change,0
6500,PT-06500,49,F,PGI Chandigarh,Phase III,ORX-505,Infectious Disease,Placebo,2023-06-05,2023-06-19,6.29,4.81,143,82,74,Fever,None,Worsened,0
6501,PT-06501,50,F,PGI Chandigarh,Phase IV,ORX-606,Rheumatology,High Dose,2024-05-04,2024-06-29,7.4,7.08,104,69,88,None,None,Improved,1
6502,PT-06502,53,F,Indore Medical Institute,Phase I,ORX-101,Oncology,Low Dose,2023-01-03,2023-01-17,7.66,6.73,141,77,96,Dizziness,None,Worsened,0
6503,PT-06503,33,F,Kolkata Clinical Center,Phase IV,ORX-202,Diabetes,Placebo,2024-05-26,2024-06-02,6.57,6.03,143,81,78,Headache,None,Improved,1
6504,PT-06504,38,F,Indore Medical Institute,Phase III,ORX-606,Rheumatology,High Dose,2024-11-17,2025-02-15,7.52,7.06,113,83,80,None,None,Improved,1
6505,PT-06505,82,F,Bhopal Research Hospital,Phase I,ORX-404,Neurology,Low Dose,2023-05-31,2023-06-14,6.47,5.31,133,70,62,None,None,Improved,1
6506,PT-06506,22,F,NIMHANS Bengaluru,Phase III,ORX-303,Cardiology,Low Dose,2024-07-06,2024-07-13,6.27,5.2,104,78,45,Headache,Mild,No Change,0
6507,PT-06507,52,F,PGI Chandigarh,Phase III,ORX-505,Infectious Disease,High Dose,2023-04-15,2023-04-29,6.53,5.76,138,86,69,None,None,Improved,1
6508,PT-06508,52,M,AIIMS Delhi,Phase II,ORX-101,Oncology,Low Dose,2023-03-06,2023-03-13,9.06,7.75,141,68,94,None,None,Improved,1
6509,PT-06509,33,M,PGI Chandigarh,Phase III,ORX-101,Oncology,High Dose,2024-01-26,2024-02-09,6.3,6.93,140,73,79,None,None,No Change,0
6510,PT-06510,33,M,Bhopal Research Hospital,Phase IV,ORX-606,Rheumatology,Placebo,2023-01-07,2023-04-07,5.29,5.06,121,70,96,Headache,None,Improved,1
6511,PT-06511,30,F,Fortis Mumbai,Phase III,ORX-202,Diabetes,Low Dose,2023-10-19,2023-10-26,7.37,7.94,123,73,82,None,None,No Change,0
6512,PT-06512,52,F,NIMHANS Bengaluru,Phase II,ORX-101,Oncology,High Dose,2024-09-06,2024-11-01,8.25,9.54,119,84,60,None,None,Improved,0
6513,PT-06513,55,M,AIIMS Delhi,Phase III,ORX-505,Infectious Disease,Low Dose,2023-04-28,2023-07-27,7.42,6.86,116,77,81,None,None,Improved,1
6514,PT-06514,29,M,AIIMS Delhi,Phase III,ORX-101,Oncology,Low Dose,2024-05-29,2024-06-05,6.83,6.45,100,69,68,None,None,Worsened,0
6515,PT-06515,70,F,Indore Medical Institute,Phase III,ORX-606,Rheumatology,Low Dose,2023-03-19,2023-03-26,6.2,5.75,109,72,57,Rash,None,No Change,0
6516,PT-06516,55,M,Fortis Mumbai,Phase III,ORX-303,Cardiology,Low Dose,2023-03-31,2023-05-26,5.61,6.03,136,81,91,None,None,No Change,0
6517,PT-06517,85,M,Bhopal Research Hospital,Phase III,ORX-505,Infectious Disease,High Dose,2023-01-11,2023-02-08,7.77,6.36,154,84,107,Fever,None,Improved,1
6518,PT-06518,36,F,PGI Chandigarh,Phase III,ORX-202,Diabetes,Low Dose,2023-04-24,2023-05-01,8.74,8.34,175,78,120,None,None,No Change,0
6519,PT-06519,52,F,NIMHANS Bengaluru,Phase II,ORX-404,Neurology,High Dose,2023-07-10,2023-08-07,8.22,9.35,113,93,73,None,None,Improved,0
6520,PT-06520,47,F,Apollo Chennai,Phase III,ORX-505,Infectious Disease,Low Dose,2023-02-25,2023-03-04,7.3,7.41,137,75,79,Nausea,Moderate,Worsened,0
6521,PT-06521,18,M,Fortis Mumbai,Phase II,ORX-505,Infectious Disease,Placebo,2023-10-05,2023-11-02,8.39,9.51,131,62,88,None,None,No Change,0
6522,PT-06522,32,F,Bhopal Research Hospital,Phase III,ORX-303,Cardiology,Low Dose,2023-07-01,2023-07-15,7.42,7.64,137,94,80,Fatigue,None,Improved,0
6523,PT-06523,47,F,Fortis Mumbai,Phase III,ORX-505,Infectious Disease,Low Dose,2024-07-18,2024-08-01,8.08,7.62,115,87,62,Nausea,None,No Change,0
6524,PT-06524,43,F,Bhopal Research Hospital,Phase III,ORX-303,Cardiology,Placebo,2023-03-18,2023-03-25,5.55,4.65,118,70,93,None,None,No Change,0
6525,PT-06525,61,F,Indore Medical Institute,Phase II,ORX-303,Cardiology,Placebo,2023-06-29,2023-07-06,8.78,8.21,120,91,79,None,None,Improved,1
6526,PT-06526,46,F,Kolkata Clinical Center,Phase I,ORX-505,Infectious Disease,Placebo,2024-05-21,2024-05-28,4.15,4.43,139,81,89,None,None,Improved,0
6527,PT-06527,54,F,Apollo Chennai,Phase III,ORX-202,Diabetes,High Dose,2023-06-08,2023-06-15,6.36,5.77,109,99,91,Headache,None,Worsened,0
6528,PT-06528,31,M,NIMHANS Bengaluru,Phase III,ORX-303,Cardiology,Low Dose,2024-01-19,2024-04-18,7.94,7.79,115,83,90,None,None,Improved,1
6529,PT-06529,60,F,Kolkata Clinical Center,Phase III,ORX-606,Rheumatology,High Dose,2023-06-10,2023-09-08,10.0,9.68,123,88,75,None,None,Improved,1
6530,PT-06530,35,F,Bhopal Research Hospital,Phase III,ORX-101,Oncology,High Dose,2023-05-27,2023-06-03,6.09,2.6,141,62,65,None,None,No Change,0
6531,PT-06531,49,M,NIMHANS Bengaluru,Phase II,ORX-606,Rheumatology,Placebo,2024-05-15,2024-05-22,6.81,8.35,100,108,97,Headache,None,Improved,0
6532,PT-06532,59,F,AIIMS Delhi,Phase I,ORX-606,Rheumatology,Placebo,2023-02-08,2023-02-22,8.93,8.89,97,88,57,None,None,Improved,1
6533,PT-06533,36,M,Apollo Chennai,Phase I,ORX-202,Diabetes,Placebo,2024-08-15,2024-08-22,7.11,5.89,145,79,83,None,None,Improved,1
6534,PT-06534,44,M,Apollo Chennai,Phase III,ORX-505,Infectious Disease,High Dose,2023-09-19,2023-09-26,7.35,6.15,106,80,64,Rash,None,No Change,0
6535,PT-06535,67,M,AIIMS Delhi,Phase III,ORX-202,Diabetes,Placebo,2023-08-25,2023-09-01,5.55,7.25,133,82,70,None,None,Improved,0
6536,PT-06536,55,F,Kolkata Clinical Center,Phase III,ORX-404,Neurology,Placebo,2023-02-11,2023-03-11,6.95,6.83,143,90,95,None,None,Improved,1
6537,PT-06537,53,F,Indore Medical Institute,Phase III,ORX-606,Rheumatology,Low Dose,2023-01-15,2023-03-12,6.06,3.79,131,84,104,Headache,Mild,No Change,0
6538,PT-06538,43,F,Kolkata Clinical Center,Phase II,ORX-404,Neurology,High Dose,2024-09-12,2024-11-07,7.65,7.95,137,92,66,None,None,Improved,0
6539,PT-06539,29,F,Bhopal Research Hospital,Phase II,ORX-202,Diabetes,High Dose,2023-11-27,2023-12-25,6.86,4.51,127,74,82,None,None,Worsened,0
6540,PT-06540,40,F,Fortis Mumbai,Phase III,ORX-303,Cardiology,Low Dose,2024-10-21,2024-11-18,5.98,6.76,129,92,80,None,None,No Change,0
6541,PT-06541,52,F,AIIMS Delhi,Phase II,ORX-606,Rheumatology,Placebo,2023-09-24,2023-10-22,5.57,6.32,143,81,82,None,None,Improved,0
6542,PT-06542,61,F,Bhopal Research Hospital,Phase III,ORX-101,Oncology,Low Dose,2024-09-12,2024-09-26,6.75,4.93,121,83,77,None,None,No Change,0
6543,PT-06543,66,M,Kolkata Clinical Center,Phase IV,ORX-303,Cardiology,Low Dose,2023-09-07,2023-09-14,6.05,4.9,108,87,56,Rash,Mild,Improved,1
6544,PT-06544,56,F,NIMHANS Bengaluru,Phase II,ORX-606,Rheumatology,Placebo,2024-04-04,2024-04-18,6.08,4.98,159,96,79,None,None,No Change,0
6545,PT-06545,24,F,Kolkata Clinical Center,Phase IV,ORX-303,Cardiology,Placebo,2024-06-07,2024-09-05,9.62,9.04,132,92,50,None,None,Improved,1
6546,PT-06546,34,F,PGI Chandigarh,Phase III,ORX-202,Diabetes,Placebo,2024-04-27,2024-07-26,7.12,6.84,104,85,78,Rash,None,Improved,1
6547,PT-06547,71,M,AIIMS Delhi,Phase III,ORX-101,Oncology,High Dose,2024-06-16,2024-09-14,8.4,7.76,124,94,81,None,None,Worsened,0
6548,PT-06548,23,F,Apollo Chennai,Phase III,ORX-101,Oncology,Low Dose,2023-04-01,2023-04-29,9.71,8.42,172,87,69,None,None,No Change,0
6549,PT-06549,18,F,Indore Medical Institute,Phase III,ORX-404,Neurology,Placebo,2023-10-05,2023-11-02,8.13,6.34,134,105,62,Nausea,None,Improved,1
6550,PT-06550,56,M,Indore Medical Institute,Phase II,ORX-404,Neurology,High Dose,2024-03-11,2024-03-18,6.23,6.85,129,81,94,Dizziness,None,Worsened,0
6551,PT-06551,55,F,Fortis Mumbai,Phase III,ORX-202,Diabetes,High Dose,2023-06-15,2023-07-13,6.23,7.44,100,85,66,Rash,Moderate,Worsened,0
6552,PT-06552,21,M,Indore Medical Institute,Phase III,ORX-404,Neurology,High Dose,2024-10-28,2024-11-25,5.84,5.39,134,94,98,None,None,No Change,0
6553,PT-06553,49,M,Indore Medical Institute,Phase III,ORX-505,Infectious Disease,Low Dose,2023-07-17,2023-08-14,6.67,7.2,116,62,91,Nausea,None,Improved,0
6554,PT-06554,66,F,PGI Chandigarh,Phase IV,ORX-606,Rheumatology,Low Dose,2024-01-05,2024-01-12,6.21,7.58,138,87,70,None,None,Improved,0
6555,PT-06555,61,F,PGI Chandigarh,Phase III,ORX-303,Cardiology,Placebo,2023-09-08,2023-09-22,5.37,4.66,114,66,90,Nausea,None,Improved,1
6556,PT-06556,50,M,Kolkata Clinical Center,Phase III,ORX-505,Infectious Disease,Low Dose,2023-07-19,2023-09-13,8.17,7.52,145,82,71,None,None,No Change,0
6557,PT-06557,34,M,Fortis Mumbai,Phase III,ORX-202,Diabetes,High Dose,2024-05-24,2024-05-31,4.82,5.47,146,117,73,None,None,Improved,0
6558,PT-06558,34,F,Bhopal Research Hospital,Phase I,ORX-606,Rheumatology,Low Dose,2024-10-01,2024-11-26,5.16,5.62,141,100,65,None,None,Improved,0
6559,PT-06559,56,F,Apollo Chennai,Phase II,ORX-505,Infectious Disease,High Dose,2023-06-16,2023-09-14,6.57,7.38,137,63,76,Fatigue,Moderate,Improved,0
6560,PT-06560,18,F,NIMHANS Bengaluru,Phase III,ORX-303,Cardiology,High Dose,2023-09-30,2023-10-28,5.8,4.41,116,78,80,None,None,Improved,1
6561,PT-06561,46,F,Apollo Chennai,Phase I,ORX-202,Diabetes,Low Dose,2024-02-11,2024-05-11,7.17,7.07,105,82,98,Fatigue,Moderate,Improved,1
6562,PT-06562,42,M,Kolkata Clinical Center,Phase I,ORX-202,Diabetes,Placebo,2023-07-14,2023-10-12,7.79,7.76,143,85,89,None,None,Improved,1
6563,PT-06563,53,M,Indore Medical Institute,Phase IV,ORX-606,Rheumatology,Placebo,2023-12-29,2024-02-23,7.99,7.99,109,67,73,None,None,No Change,0
6564,PT-06564,69,M,NIMHANS Bengaluru,Phase III,ORX-606,Rheumatology,Placebo,2023-02-18,2023-02-25,6.99,6.87,92,84,79,None,None,Improved,1
6565,PT-06565,18,M,Apollo Chennai,Phase IV,ORX-606,Rheumatology,High Dose,2024-03-17,2024-04-14,7.55,5.66,114,93,80,Headache,Mild,Worsened,0
6566,PT-06566,37,M,PGI Chandigarh,Phase III,ORX-606,Rheumatology,High Dose,2024-06-08,2024-07-06,6.56,5.78,130,67,93,Nausea,Moderate,Improved,1
6567,PT-06567,26,M,Apollo Chennai,Phase II,ORX-101,Oncology,Low Dose,2024-06-25,2024-07-23,5.13,5.62,120,82,87,Rash,None,No Change,0
6568,PT-06568,33,M,PGI Chandigarh,Phase II,ORX-303,Cardiology,Low Dose,2023-08-17,2023-08-31,7.36,7.55,157,75,71,Rash,Moderate,Improved,0
6569,PT-06569,54,M,AIIMS Delhi,Phase IV,ORX-202,Diabetes,Low Dose,2023-04-05,2023-05-31,7.45,6.93,156,61,58,Nausea,Severe,No Change,0
6570,PT-06570,18,M,AIIMS Delhi,Phase I,ORX-505,Infectious Disease,Low Dose,2023-09-11,2023-09-18,8.64,8.71,103,80,77,None,None,No Change,0
6571,PT-06571,18,M,Bhopal Research Hospital,Phase II,ORX-505,Infectious Disease,Placebo,2024-10-18,2025-01-16,7.43,5.97,140,68,81,None,None,Improved,1
6572,PT-06572,65,F,PGI Chandigarh,Phase III,ORX-404,Neurology,Placebo,2023-08-11,2023-08-18,8.37,8.43,126,63,71,None,None,No Change,0
6573,PT-06573,41,F,PGI Chandigarh,Phase III,ORX-606,Rheumatology,Placebo,2023-09-25,2023-11-20,6.84,5.06,135,67,99,Rash,None,No Change,0
6574,PT-06574,47,M,Fortis Mumbai,Phase III,ORX-404,Neurology,High Dose,2024-05-03,2024-05-17,8.38,8.84,165,84,72,Dizziness,None,Improved,0
6575,PT-06575,39,M,Bhopal Research Hospital,Phase II,ORX-404,Neurology,High Dose,2023-06-05,2023-06-19,9.0,7.41,112,84,75,Nausea,None,Improved,1
6576,PT-06576,60,M,AIIMS Delhi,Phase IV,ORX-606,Rheumatology,Low Dose,2024-10-06,2024-10-13,5.59,5.13,124,69,90,None,None,No Change,0
6577,PT-06577,43,M,AIIMS Delhi,Phase I,ORX-505,Infectious Disease,Low Dose,2023-02-22,2023-04-19,7.04,5.9,121,69,90,None,None,No Change,0
6578,PT-06578,61,F,Fortis Mumbai,Phase III,ORX-101,Oncology,Low Dose,2023-12-23,2024-02-17,9.22,9.21,121,76,84,Nausea,None,No Change,0
6579,PT-06579,48,F,Fortis Mumbai,Phase I,ORX-606,Rheumatology,Placebo,2024-11-06,2025-01-01,6.99,6.36,149,76,96,Dizziness,Mild,Improved,1
6580,PT-06580,47,M,PGI Chandigarh,Phase II,ORX-202,Diabetes,High Dose,2023-12-26,2024-01-23,6.76,5.65,125,88,72,None,None,Improved,1
6581,PT-06581,58,M,Fortis Mumbai,Phase III,ORX-404,Neurology,High Dose,2024-02-19,2024-04-15,6.69,6.18,104,88,74,Nausea,None,Improved,1
6582,PT-06582,70,M,Bhopal Research Hospital,Phase III,ORX-606,Rheumatology,Placebo,2023-04-21,2023-07-20,8.05,7.72,150,86,92,Nausea,None,Improved,1
6583,PT-06583,31,F,PGI Chandigarh,Phase I,ORX-505,Infectious Disease,High Dose,2023-11-01,2023-11-08,7.75,7.81,100,100,61,Dizziness,Severe,Improved,0
6584,PT-06584,24,F,Indore Medical Institute,Phase II,ORX-505,Infectious Disease,Placebo,2024-07-30,2024-08-27,3.78,3.81,98,75,89,None,None,Improved,0
6585,PT-06585,48,F,Kolkata Clinical Center,Phase IV,ORX-404,Neurology,Low Dose,2024-03-14,2024-03-21,6.45,4.62,126,92,87,None,None,Improved,1
6586,PT-06586,73,M,PGI Chandigarh,Phase IV,ORX-202,Diabetes,Placebo,2023-01-27,2023-02-24,6.42,4.83,133,84,77,None,None,Improved,1
6587,PT-06587,33,M,AIIMS Delhi,Phase III,ORX-505,Infectious Disease,High Dose,2023-10-04,2023-10-18,4.02,2.71,138,85,91,None,None,Improved,1
6588,PT-06588,50,M,AIIMS Delhi,Phase III,ORX-101,Oncology,Low Dose,2023-08-16,2023-09-13,8.08,8.37,128,82,45,None,None,Improved,0
6589,PT-06589,34,M,Bhopal Research Hospital,Phase II,ORX-606,Rheumatology,Low Dose,2024-10-31,2024-11-28,6.46,5.97,111,93,65,Headache,None,Improved,1
6590,PT-06590,62,F,Apollo Chennai,Phase I,ORX-404,Neurology,Placebo,2023-02-10,2023-04-07,6.05,5.1,115,76,94,None,None,Improved,1
6591,PT-06591,39,M,Bhopal Research Hospital,Phase II,ORX-505,Infectious Disease,Low Dose,2023-09-18,2023-12-17,6.84,5.77,123,84,74,Fatigue,Mild,Improved,1
6592,PT-06592,42,M,PGI Chandigarh,Phase III,ORX-202,Diabetes,Low Dose,2023-11-23,2023-12-07,8.42,8.27,107,80,70,None,None,No Change,0
6593,PT-06593,53,F,Fortis Mumbai,Phase I,ORX-101,Oncology,High Dose,2023-09-12,2023-11-07,7.32,7.94,114,79,63,None,None,Worsened,0
6594,PT-06594,44,F,Fortis Mumbai,Phase I,ORX-202,Diabetes,Placebo,2024-07-07,2024-10-05,5.36,5.25,127,83,89,Headache,Mild,Improved,1
6595,PT-06595,48,F,Bhopal Research Hospital,Phase IV,ORX-303,Cardiology,Low Dose,2023-06-07,2023-07-05,5.67,4.77,126,78,75,Fatigue,None,No Change,0
6596,PT-06596,70,F,Apollo Chennai,Phase III,ORX-404,Neurology,Low Dose,2024-05-12,2024-08-10,7.32,7.26,91,90,117,None,None,No Change,0
6597,PT-06597,66,F,Indore Medical Institute,Phase IV,ORX-404,Neurology,Placebo,2023-12-14,2024-03-13,6.67,8.32,128,85,74,None,None,Improved,0
6598,PT-06598,40,M,AIIMS Delhi,Phase III,ORX-505,Infectious Disease,Low Dose,2023-09-02,2023-10-28,4.5,4.81,122,79,81,Fatigue,None,Improved,0
6599,PT-06599,38,F,Indore Medical Institute,Phase III,ORX-505,Infectious Disease,Low Dose,2024-02-10,2024-05-10,7.52,8.2,135,80,76,None,None,Improved,0
6600,PT-06600,48,F,Apollo Chennai,Phase I,ORX-303,Cardiology,Low Dose,2023-01-31,2023-02-14,6.2,5.99,140,83,72,None,None,Improved,1
6601,PT-06601,40,F,Bhopal Research Hospital,Phase III,ORX-303,Cardiology,Placebo,2024-08-26,2024-09-23,7.98,6.59,113,62,78,Nausea,None,Improved,1
6602,PT-06602,58,M,Apollo Chennai,Phase II,ORX-303,Cardiology,Placebo,2023-04-16,2023-04-23,8.8,9.79,115,85,72,None,None,Improved,0
6603,PT-06603,71,M,Fortis Mumbai,Phase III,ORX-404,Neurology,Placebo,2024-01-04,2024-01-18,8.76,8.52,116,50,57,Nausea,None,Worsened,0
6604,PT-06604,18,F,NIMHANS Bengaluru,Phase III,ORX-202,Diabetes,Low Dose,2023-05-08,2023-07-03,5.46,6.76,104,69,65,None,None,Improved,0
6605,PT-06605,85,F,Apollo Chennai,Phase III,ORX-606,Rheumatology,Low Dose,2023-09-25,2023-10-23,7.13,,131,58,99,None,None,Improved,0
6606,PT-06606,51,F,Apollo Chennai,Phase IV,ORX-202,Diabetes,Placebo,2024-10-03,2024-10-17,7.05,8.24,121,80,73,None,None,Improved,0
6607,PT-06607,62,M,Bhopal Research Hospital,Phase III,ORX-101,Oncology,High Dose,2023-02-11,2023-02-25,8.18,8.03,109,77,63,None,None,Improved,1
6608,PT-06608,63,M,Kolkata Clinical Center,Phase IV,ORX-606,Rheumatology,Low Dose,2024-07-26,2024-10-24,5.31,6.35,151,70,72,None,None,No Change,0
6609,PT-06609,33,F,Kolkata Clinical Center,Phase III,ORX-101,Oncology,High Dose,2024-03-02,2024-04-27,7.72,8.59,149,76,95,None,None,Worsened,0
6610,PT-06610,63,F,Apollo Chennai,Phase IV,ORX-101,Oncology,Low Dose,2023-02-03,2023-05-04,6.97,6.56,155,94,95,None,None,Improved,1
6611,PT-06611,85,M,Kolkata Clinical Center,Phase III,ORX-202,Diabetes,High Dose,2024-09-12,2024-09-19,7.86,7.75,152,105,69,Fatigue,None,Improved,1
6612,PT-06612,41,F,Apollo Chennai,Phase II,ORX-303,Cardiology,Low Dose,2024-09-28,2024-12-27,5.98,5.89,144,70,93,None,None,No Change,0
6613,PT-06613,37,M,Fortis Mumbai,Phase III,ORX-202,Diabetes,Low Dose,2023-08-08,2023-10-03,6.56,7.18,116,65,88,None,None,Improved,0
6614,PT-06614,42,M,PGI Chandigarh,Phase I,ORX-202,Diabetes,High Dose,2024-01-13,2024-04-12,8.64,8.99,96,97,104,None,None,Improved,0
6615,PT-06615,61,M,AIIMS Delhi,Phase I,ORX-202,Diabetes,Placebo,2023-01-12,2023-01-19,8.49,7.87,119,84,90,Nausea,None,Worsened,0
6616,PT-06616,59,F,Bhopal Research Hospital,Phase I,ORX-404,Neurology,Placebo,2023-12-30,2024-01-27,6.67,5.79,101,89,72,None,None,No Change,0
6617,PT-06617,40,M,Bhopal Research Hospital,Phase II,ORX-606,Rheumatology,High Dose,2024-04-22,2024-06-17,9.27,9.41,133,91,97,None,None,Worsened,0
6618,PT-06618,19,M,NIMHANS Bengaluru,Phase II,ORX-202,Diabetes,Placebo,2023-08-21,2023-10-16,6.52,5.91,110,78,56,Headache,None,Improved,1
6619,PT-06619,59,F,Bhopal Research Hospital,Phase III,ORX-101,Oncology,Placebo,2023-02-11,2023-02-18,6.58,6.36,128,88,45,None,None,No Change,0
6620,PT-06620,52,F,Bhopal Research Hospital,Phase IV,ORX-202,Diabetes,High Dose,2024-11-03,2025-02-01,6.87,6.84,106,86,96,Rash,Severe,Improved,1
6621,PT-06621,48,F,Fortis Mumbai,Phase IV,ORX-202,Diabetes,Low Dose,2024-05-18,2024-06-15,6.34,5.33,138,88,82,None,None,No Change,0
6622,PT-06622,44,F,Bhopal Research Hospital,Phase III,ORX-101,Oncology,Low Dose,2023-08-25,2023-10-20,7.44,6.99,121,91,82,None,None,Improved,1
6623,PT-06623,65,F,Apollo Chennai,Phase II,ORX-404,Neurology,Placebo,2023-09-21,2023-10-05,8.54,8.39,138,70,76,None,None,No Change,0
6624,PT-06624,50,M,Indore Medical Institute,Phase III,ORX-101,Oncology,High Dose,2023-06-22,2023-07-20,5.3,5.29,110,71,70,Fatigue,None,Improved,1
6625,PT-06625,44,M,NIMHANS Bengaluru,Phase III,ORX-101,Oncology,Low Dose,2024-02-12,2024-02-26,5.61,5.98,131,105,82,Nausea,Severe,Improved,0
6626,PT-06626,54,F,Fortis Mumbai,Phase III,ORX-303,Cardiology,Placebo,2023-05-13,2023-08-11,6.18,4.71,139,68,86,None,None,Improved,1
6627,PT-06627,72,M,AIIMS Delhi,Phase III,ORX-404,Neurology,Placebo,2024-10-08,2024-10-22,8.33,8.45,132,77,76,Headache,None,Improved,0
6628,PT-06628,35,F,Kolkata Clinical Center,Phase IV,ORX-505,Infectious Disease,High Dose,2024-11-18,2024-11-25,5.62,5.25,147,66,97,None,None,Improved,1
6629,PT-06629,64,F,NIMHANS Bengaluru,Phase I,ORX-505,Infectious Disease,High Dose,2024-08-25,2024-11-23,7.68,7.64,124,82,71,Fatigue,Mild,No Change,0
6630,PT-06630,45,M,NIMHANS Bengaluru,Phase III,ORX-202,Diabetes,High Dose,2023-05-10,2023-07-05,7.37,8.66,138,79,76,None,None,Worsened,0
6631,PT-06631,33,F,PGI Chandigarh,Phase II,ORX-101,Oncology,Low Dose,2023-09-02,2023-09-16,6.54,6.96,119,74,69,None,None,Improved,0
6632,PT-06632,33,F,AIIMS Delhi,Phase I,ORX-606,Rheumatology,Placebo,2023-06-24,2023-09-22,8.55,8.28,122,82,81,Headache,None,Improved,1
6633,PT-06633,33,F,Apollo Chennai,Phase III,ORX-303,Cardiology,Low Dose,2023-11-10,2024-01-05,5.53,6.34,145,86,90,Rash,None,Worsened,0
6634,PT-06634,75,F,NIMHANS Bengaluru,Phase III,ORX-303,Cardiology,Low Dose,2023-09-13,2023-09-20,6.56,5.15,139,64,78,None,None,Improved,1
6635,PT-06635,40,F,AIIMS Delhi,Phase I,ORX-606,Rheumatology,Placebo,2024-10-02,2024-12-31,8.01,7.17,149,73,87,Fatigue,Mild,Improved,1
6636,PT-06636,34,M,NIMHANS Bengaluru,Phase II,ORX-606,Rheumatology,Low Dose,2024-02-26,2024-04-22,7.86,6.54,127,97,79,Nausea,Severe,Improved,1
6637,PT-06637,63,M,PGI Chandigarh,Phase I,ORX-101,Oncology,Placebo,2024-11-03,2025-02-01,7.17,6.31,131,89,51,None,None,Improved,1
6638,PT-06638,53,F,Fortis Mumbai,Phase III,ORX-303,Cardiology,Low Dose,2023-08-03,2023-08-10,6.07,4.6,137,98,81,None,None,Improved,1
6639,PT-06639,23,M,Bhopal Research Hospital,Phase I,ORX-606,Rheumatology,Placebo,2023-06-12,2023-07-10,6.4,5.62,131,81,84,Rash,None,Improved,1
6640,PT-06640,60,M,Fortis Mumbai,Phase II,ORX-202,Diabetes,High Dose,2024-03-25,2024-04-22,7.61,8.02,123,120,85,None,None,Improved,0
6641,PT-06641,55,F,PGI Chandigarh,Phase III,ORX-606,Rheumatology,Placebo,2024-03-28,2024-04-11,9.31,8.99,116,97,97,None,None,No Change,0
6642,PT-06642,47,M,Fortis Mumbai,Phase III,ORX-505,Infectious Disease,Low Dose,2024-01-13,2024-03-09,9.31,8.84,144,100,79,Dizziness,None,Improved,1
6643,PT-06643,52,M,PGI Chandigarh,Phase III,ORX-303,Cardiology,Low Dose,2023-04-06,2023-06-01,8.43,7.7,113,97,82,Nausea,None,Improved,1
6644,PT-06644,36,M,NIMHANS Bengaluru,Phase III,ORX-101,Oncology,High Dose,2024-05-06,2024-05-13,7.31,7.37,99,90,83,None,None,Improved,0
6645,PT-06645,71,M,AIIMS Delhi,Phase IV,ORX-606,Rheumatology,Placebo,2023-10-18,2023-11-15,6.94,7.78,127,83,81,None,None,Improved,0
6646,PT-06646,78,F,PGI Chandigarh,Phase III,ORX-101,Oncology,Low Dose,2023-10-25,2023-11-01,5.71,5.76,128,81,86,None,None,Improved,0
6647,PT-06647,62,F,Indore Medical Institute,Phase II,ORX-101,Oncology,Low Dose,2023-08-19,2023-11-17,7.84,8.55,123,81,63,Rash,Mild,No Change,0
6648,PT-06648,76,F,Indore Medical Institute,Phase III,ORX-404,Neurology,High Dose,2024-02-12,2024-02-19,6.98,6.31,138,95,68,Nausea,Moderate,No Change,0
6649,PT-06649,63,F,NIMHANS Bengaluru,Phase III,ORX-303,Cardiology,High Dose,2023-03-23,2023-04-06,6.84,7.72,118,90,78,Nausea,None,Improved,0
6650,PT-06650,26,F,Bhopal Research Hospital,Phase III,ORX-303,Cardiology,Low Dose,2023-09-25,2023-12-24,5.5,4.43,145,58,82,None,None,Worsened,0
6651,PT-06651,48,F,PGI Chandigarh,Phase I,ORX-404,Neurology,Low Dose,2024-11-22,2025-02-20,5.18,4.06,113,82,98,None,None,Improved,1
6652,PT-06652,62,F,PGI Chandigarh,Phase III,ORX-101,Oncology,High Dose,2024-07-17,2024-07-31,6.77,5.62,99,77,65,Fever,Severe,Improved,1
6653,PT-06653,44,F,PGI Chandigarh,Phase I,ORX-404,Neurology,Low Dose,2023-03-03,2023-03-10,7.2,6.37,119,73,70,None,None,Worsened,0
6654,PT-06654,67,F,Bhopal Research Hospital,Phase IV,ORX-606,Rheumatology,Low Dose,2023-01-19,2023-03-16,7.82,7.9,146,93,97,Nausea,None,Improved,0
6655,PT-06655,54,M,Bhopal Research Hospital,Phase III,ORX-101,Oncology,Low Dose,2024-05-16,2024-08-14,7.45,6.51,113,92,76,None,None,Improved,1
6656,PT-06656,23,M,PGI Chandigarh,Phase III,ORX-101,Oncology,High Dose,2024-09-21,2024-11-16,4.69,6.22,110,73,95,None,None,Worsened,0
6657,PT-06657,25,F,NIMHANS Bengaluru,Phase III,ORX-505,Infectious Disease,Low Dose,2023-01-25,2023-02-08,7.84,9.08,166,76,77,Fever,Severe,Improved,0
6658,PT-06658,38,F,NIMHANS Bengaluru,Phase IV,ORX-505,Infectious Disease,Placebo,2024-10-31,2024-12-26,7.18,7.95,102,89,75,None,None,No Change,0
6659,PT-06659,66,M,PGI Chandigarh,Phase IV,ORX-404,Neurology,Placebo,2023-04-19,2023-06-14,8.78,8.01,126,92,91,None,None,Improved,1
6660,PT-06660,18,M,AIIMS Delhi,Phase III,ORX-606,Rheumatology,Placebo,2024-10-07,2024-10-14,8.27,9.35,132,93,95,None,None,Improved,0
6661,PT-06661,48,F,Apollo Chennai,Phase III,ORX-101,Oncology,Placebo,2023-04-29,2023-05-27,8.18,7.79,127,74,80,None,None,No Change,0
6662,PT-06662,75,M,NIMHANS Bengaluru,Phase II,ORX-606,Rheumatology,High Dose,2024-03-08,2024-03-22,6.12,6.27,133,99,101,Fever,None,Worsened,0
6663,PT-06663,30,F,NIMHANS Bengaluru,Phase II,ORX-202,Diabetes,Placebo,2023-01-06,2023-04-06,6.51,5.64,119,77,82,None,None,Improved,1
6664,PT-06664,31,M,AIIMS Delhi,Phase III,ORX-404,Neurology,High Dose,2023-02-11,2023-04-08,6.35,5.24,136,81,74,None,None,Improved,1
6665,PT-06665,31,F,Indore Medical Institute,Phase IV,ORX-303,Cardiology,High Dose,2024-05-24,2024-06-07,5.28,6.34,122,114,88,None,None,Worsened,0
6666,PT-06666,74,F,Kolkata Clinical Center,Phase III,ORX-303,Cardiology,Low Dose,2023-03-04,2023-06-02,8.39,8.13,117,70,93,None,None,No Change,0
6667,PT-06667,49,M,AIIMS Delhi,Phase III,ORX-505,Infectious Disease,Placebo,2023-05-06,2023-07-01,7.94,8.27,134,76,92,None,None,Worsened,0
6668,PT-06668,41,F,Fortis Mumbai,Phase III,ORX-202,Diabetes,Low Dose,2024-09-26,2024-10-03,7.31,7.55,126,60,92,Dizziness,None,Worsened,0
6669,PT-06669,65,M,Indore Medical Institute,Phase III,ORX-101,Oncology,Placebo,2024-04-03,2024-04-17,5.0,3.66,164,84,78,Headache,None,Improved,1
6670,PT-06670,38,M,Kolkata Clinical Center,Phase IV,ORX-505,Infectious Disease,High Dose,2024-05-14,2024-05-21,5.96,5.39,145,81,86,Dizziness,None,No Change,0
6671,PT-06671,73,M,PGI Chandigarh,Phase IV,ORX-606,Rheumatology,Placebo,2023-11-04,2023-11-18,6.5,6.38,146,70,80,None,None,Worsened,0
6672,PT-06672,74,M,AIIMS Delhi,Phase I,ORX-505,Infectious Disease,Low Dose,2023-05-27,2023-06-03,6.79,7.35,125,103,54,None,None,Improved,0
6673,PT-06673,46,F,Fortis Mumbai,Phase III,ORX-101,Oncology,Placebo,2023-07-08,2023-08-05,5.43,4.39,115,78,61,Nausea,None,No Change,0
6674,PT-06674,43,F,Apollo Chennai,Phase I,ORX-101,Oncology,High Dose,2024-06-10,2024-06-17,7.75,5.97,116,112,82,None,None,Worsened,0
6675,PT-06675,18,F,Kolkata Clinical Center,Phase II,ORX-101,Oncology,Low Dose,2024-07-08,2024-10-06,5.52,5.32,129,74,108,Fatigue,Moderate,No Change,0
6676,PT-06676,85,F,AIIMS Delhi,Phase II,ORX-404,Neurology,Low Dose,2024-09-05,2024-12-04,6.88,7.27,144,94,69,None,None,No Change,0
6677,PT-06677,76,F,Bhopal Research Hospital,Phase IV,ORX-505,Infectious Disease,High Dose,2023-10-14,2024-01-12,7.12,7.1,128,80,81,Headache,None,No Change,0
6678,PT-06678,26,F,AIIMS Delhi,Phase II,ORX-202,Diabetes,Placebo,2024-07-04,2024-08-29,4.83,4.24,112,88,84,None,None,Worsened,0
6679,PT-06679,45,F,NIMHANS Bengaluru,Phase I,ORX-303,Cardiology,High Dose,2023-04-06,2023-06-01,8.98,8.57,101,79,94,None,None,Improved,1
6680,PT-06680,18,F,NIMHANS Bengaluru,Phase IV,ORX-404,Neurology,High Dose,2023-06-03,2023-07-01,7.09,7.21,175,96,79,None,None,Improved,0
6681,PT-06681,53,F,Bhopal Research Hospital,Phase III,ORX-202,Diabetes,High Dose,2023-10-04,2023-10-11,4.92,3.58,139,83,82,None,None,No Change,0
6682,PT-06682,45,F,NIMHANS Bengaluru,Phase I,ORX-202,Diabetes,High Dose,2023-01-24,2023-04-24,7.19,6.89,108,79,60,None,None,Worsened,0
6683,PT-06683,35,M,AIIMS Delhi,Phase III,ORX-101,Oncology,Low Dose,2023-10-05,2023-11-30,8.64,8.07,138,83,72,None,None,Improved,1
6684,PT-06684,28,M,Bhopal Research Hospital,Phase II,ORX-303,Cardiology,Placebo,2023-02-05,2023-05-06,6.72,6.48,138,83,87,None,None,Improved,1
6685,PT-06685,20,M,Fortis Mumbai,Phase III,ORX-101,Oncology,High Dose,2024-03-22,2024-06-20,8.24,6.82,145,88,51,None,None,No Change,0
6686,PT-06686,56,F,Kolkata Clinical Center,Phase III,ORX-202,Diabetes,High Dose,2024-04-13,2024-04-27,8.39,9.13,114,84,87,Headache,None,No Change,0
6687,PT-06687,56,F,Indore Medical Institute,Phase I,ORX-303,Cardiology,Placebo,2023-05-26,2023-06-02,7.69,6.91,145,93,75,None,None,Improved,1
6688,PT-06688,32,F,Kolkata Clinical Center,Phase III,ORX-101,Oncology,Low Dose,2023-03-20,2023-05-15,6.33,7.15,145,81,75,None,None,No Change,0
6689,PT-06689,18,M,Bhopal Research Hospital,Phase IV,ORX-303,Cardiology,Placebo,2023-04-04,2023-04-11,7.1,5.63,130,96,64,None,None,Improved,1
6690,PT-06690,48,M,NIMHANS Bengaluru,Phase IV,ORX-606,Rheumatology,Low Dose,2023-11-16,2024-02-14,8.4,8.2,118,82,91,Nausea,None,Improved,1
6691,PT-06691,49,M,Apollo Chennai,Phase III,ORX-505,Infectious Disease,Placebo,2024-04-18,2024-04-25,7.2,7.84,137,67,86,None,None,Worsened,0
6692,PT-06692,60,F,Kolkata Clinical Center,Phase I,ORX-101,Oncology,Low Dose,2023-11-01,2024-01-30,5.72,3.27,109,80,92,Rash,None,Improved,1
6693,PT-06693,30,F,Bhopal Research Hospital,Phase III,ORX-404,Neurology,High Dose,2023-10-25,2023-11-01,7.87,4.86,131,77,107,None,None,No Change,0
6694,PT-06694,18,F,Fortis Mumbai,Phase III,ORX-101,Oncology,Placebo,2024-10-14,2024-11-11,7.18,5.07,118,61,110,Fatigue,Mild,No Change,0
6695,PT-06695,39,F,NIMHANS Bengaluru,Phase III,ORX-404,Neurology,Placebo,2024-05-07,2024-05-14,6.95,6.51,107,94,86,None,None,No Change,0
6696,PT-06696,59,M,Indore Medical Institute,Phase I,ORX-404,Neurology,Placebo,2023-12-29,2024-02-23,5.74,6.36,146,79,90,Nausea,Mild,Improved,0
6697,PT-06697,49,F,PGI Chandigarh,Phase III,ORX-404,Neurology,Low Dose,2024-03-04,2024-04-01,5.29,4.72,119,83,92,None,None,Improved,1
6698,PT-06698,18,F,Kolkata Clinical Center,Phase II,ORX-303,Cardiology,High Dose,2023-04-06,2023-04-20,6.67,5.53,113,72,78,None,None,Improved,1
6699,PT-06699,53,F,Fortis Mumbai,Phase IV,ORX-101,Oncology,Placebo,2023-11-05,2023-11-19,7.62,7.39,139,110,79,None,None,Improved,1
6700,PT-06700,61,F,Apollo Chennai,Phase III,ORX-606,Rheumatology,Placebo,2024-11-26,2024-12-24,8.36,9.56,138,71,82,None,None,No Change,0
6701,PT-06701,49,M,NIMHANS Bengaluru,Phase I,ORX-101,Oncology,Placebo,2023-10-18,2024-01-16,8.18,6.99,150,82,89,None,None,Improved,1
6702,PT-06702,49,M,PGI Chandigarh,Phase III,ORX-505,Infectious Disease,Placebo,2024-09-24,2024-12-23,7.35,7.16,140,105,49,None,None,Improved,1
6703,PT-06703,53,F,Indore Medical Institute,Phase III,ORX-303,Cardiology,Low Dose,2023-03-29,2023-06-27,7.25,6.69,90,88,76,None,None,Worsened,0
6704,PT-06704,31,F,Kolkata Clinical Center,Phase II,ORX-505,Infectious Disease,High Dose,2023-02-07,2023-03-07,7.25,6.59,96,83,86,None,None,Improved,1
6705,PT-06705,36,F,Indore Medical Institute,Phase I,ORX-404,Neurology,Low Dose,2024-08-27,2024-09-24,7.51,7.21,146,80,89,Dizziness,None,Improved,1
6706,PT-06706,39,F,PGI Chandigarh,Phase II,ORX-101,Oncology,Placebo,2024-03-16,2024-04-13,9.56,8.77,115,80,67,Headache,Mild,Improved,1
6707,PT-06707,25,F,AIIMS Delhi,Phase II,ORX-606,Rheumatology,High Dose,2024-11-12,2025-02-10,8.07,4.92,115,65,79,None,None,Improved,1
6708,PT-06708,18,M,Bhopal Research Hospital,Phase IV,ORX-202,Diabetes,High Dose,2023-04-10,2023-05-08,7.86,8.05,98,84,85,Nausea,Mild,Improved,0
6709,PT-06709,60,F,AIIMS Delhi,Phase III,ORX-303,Cardiology,Placebo,2024-03-25,2024-04-01,5.44,3.59,155,72,70,None,None,Improved,1
6710,PT-06710,55,M,Indore Medical Institute,Phase II,ORX-101,Oncology,Low Dose,2023-04-22,2023-06-17,5.8,5.16,144,64,70,None,None,No Change,0
6711,PT-06711,26,M,AIIMS Delhi,Phase III,ORX-606,Rheumatology,Low Dose,2024-07-04,2024-07-18,6.27,6.94,153,85,85,Fatigue,None,Improved,0
6712,PT-06712,53,M,AIIMS Delhi,Phase III,ORX-101,Oncology,High Dose,2023-12-13,2023-12-20,6.39,6.21,104,70,76,Fatigue,None,Improved,1
6713,PT-06713,28,M,Fortis Mumbai,Phase I,ORX-404,Neurology,Low Dose,2023-07-02,2023-08-27,5.67,4.63,148,100,77,None,None,Improved,1
6714,PT-06714,54,F,Bhopal Research Hospital,Phase I,ORX-303,Cardiology,Placebo,2023-09-21,2023-10-19,6.52,4.26,111,78,79,None,None,Improved,1
6715,PT-06715,43,F,NIMHANS Bengaluru,Phase III,ORX-404,Neurology,Placebo,2023-07-23,2023-07-30,6.86,5.94,134,65,89,None,None,Improved,1
6716,PT-06716,35,M,AIIMS Delhi,Phase IV,ORX-303,Cardiology,Placebo,2024-11-13,2025-01-08,9.68,9.0,119,75,71,None,None,Improved,1
6717,PT-06717,54,M,NIMHANS Bengaluru,Phase IV,ORX-202,Diabetes,Placebo,2023-08-21,2023-11-19,7.15,7.64,136,82,83,Fatigue,None,Improved,0
6718,PT-06718,64,F,Fortis Mumbai,Phase I,ORX-404,Neurology,High Dose,2023-05-15,2023-05-22,7.99,7.84,135,68,114,Fever,None,Improved,1
6719,PT-06719,53,F,Kolkata Clinical Center,Phase II,ORX-303,Cardiology,Placebo,2023-07-24,2023-09-18,7.95,7.53,90,78,79,None,None,Worsened,0
6720,PT-06720,31,F,Apollo Chennai,Phase III,ORX-606,Rheumatology,Placebo,2023-08-30,2023-09-13,6.2,5.5,141,97,80,None,None,Worsened,0
6721,PT-06721,35,F,Fortis Mumbai,Phase IV,ORX-101,Oncology,High Dose,2023-12-25,2024-01-01,6.77,6.45,131,87,71,Headache,None,Improved,1
6722,PT-06722,53,F,AIIMS Delhi,Phase II,ORX-303,Cardiology,High Dose,2023-09-25,2023-12-24,7.74,6.98,97,71,99,None,None,No Change,0
6723,PT-06723,18,F,Apollo Chennai,Phase I,ORX-606,Rheumatology,Low Dose,2024-06-17,2024-08-12,8.78,6.83,114,77,102,Dizziness,None,No Change,0
6724,PT-06724,45,M,Indore Medical Institute,Phase I,ORX-404,Neurology,High Dose,2024-08-02,2024-08-30,6.94,5.7,137,75,74,Headache,None,Worsened,0
6725,PT-06725,39,M,NIMHANS Bengaluru,Phase II,ORX-404,Neurology,Placebo,2023-08-07,2023-11-05,8.06,8.35,111,74,67,Headache,Mild,No Change,0
6726,PT-06726,47,F,Kolkata Clinical Center,Phase II,ORX-303,Cardiology,Low Dose,2023-01-24,2023-01-31,8.29,8.07,90,91,59,None,None,No Change,0
6727,PT-06727,33,F,PGI Chandigarh,Phase II,ORX-505,Infectious Disease,High Dose,2023-07-15,2023-10-13,7.44,6.96,143,74,64,None,None,Improved,1
6728,PT-06728,40,F,AIIMS Delhi,Phase IV,ORX-505,Infectious Disease,High Dose,2023-05-04,2023-06-01,8.37,8.54,129,97,94,None,None,Worsened,0
6729,PT-06729,57,F,Indore Medical Institute,Phase I,ORX-202,Diabetes,Low Dose,2024-04-20,2024-05-18,5.79,6.09,124,77,68,None,None,Improved,0
6730,PT-06730,42,M,Bhopal Research Hospital,Phase II,ORX-202,Diabetes,Placebo,2024-05-26,2024-08-24,6.45,6.2,124,84,85,None,None,Worsened,0
6731,PT-06731,40,M,Fortis Mumbai,Phase II,ORX-202,Diabetes,Placebo,2023-11-29,2023-12-06,6.32,4.11,141,82,75,None,None,Improved,1
6732,PT-06732,63,M,Apollo Chennai,Phase III,ORX-505,Infectious Disease,High Dose,2024-11-13,2025-02-11,5.65,5.3,110,89,46,None,None,Improved,1
6733,PT-06733,57,M,Apollo Chennai,Phase IV,ORX-505,Infectious Disease,High Dose,2023-08-24,2023-11-22,8.12,6.88,129,71,83,None,None,Improved,1
6734,PT-06734,58,F,Kolkata Clinical Center,Phase III,ORX-303,Cardiology,Low Dose,2023-09-20,2023-10-18,5.99,4.43,147,105,84,Headache,Moderate,Improved,1
6735,PT-06735,54,M,NIMHANS Bengaluru,Phase III,ORX-505,Infectious Disease,High Dose,2024-01-30,2024-02-27,6.8,6.56,134,79,96,None,None,No Change,0
6736,PT-06736,47,F,Bhopal Research Hospital,Phase IV,ORX-606,Rheumatology,Placebo,2024-10-18,2024-12-13,7.57,7.02,126,96,80,Fever,None,Improved,1
6737,PT-06737,47,M,Bhopal Research Hospital,Phase III,ORX-505,Infectious Disease,High Dose,2023-12-22,2024-03-21,7.42,6.69,102,100,92,Nausea,Mild,Improved,1
6738,PT-06738,64,F,Apollo Chennai,Phase I,ORX-404,Neurology,Placebo,2024-11-26,2025-01-21,5.91,6.81,163,94,101,Nausea,None,Improved,0
6739,PT-06739,57,F,Indore Medical Institute,Phase IV,ORX-606,Rheumatology,High Dose,2023-09-19,2023-11-14,6.18,6.24,109,74,82,None,None,No Change,0
6740,PT-06740,47,M,Bhopal Research Hospital,Phase IV,ORX-606,Rheumatology,Low Dose,2024-01-22,2024-01-29,7.76,5.74,125,88,88,None,None,Improved,1
6741,PT-06741,58,M,Fortis Mumbai,Phase III,ORX-606,Rheumatology,Placebo,2023-06-24,2023-08-19,7.5,6.76,137,78,90,Nausea,None,Worsened,0
6742,PT-06742,51,M,PGI Chandigarh,Phase II,ORX-505,Infectious Disease,High Dose,2023-06-29,2023-09-27,7.13,6.03,148,88,107,Nausea,None,Worsened,0
6743,PT-06743,53,M,Kolkata Clinical Center,Phase I,ORX-303,Cardiology,High Dose,2024-10-15,2024-11-12,7.93,6.21,133,78,89,Dizziness,Severe,No Change,0
6744,PT-06744,50,M,Bhopal Research Hospital,Phase II,ORX-505,Infectious Disease,Placebo,2024-04-25,2024-05-02,8.38,9.9,113,93,87,None,None,Improved,0
6745,PT-06745,76,M,Kolkata Clinical Center,Phase II,ORX-101,Oncology,High Dose,2023-06-16,2023-07-14,8.05,8.19,143,93,98,Headache,None,Improved,0
6746,PT-06746,31,M,Apollo Chennai,Phase I,ORX-303,Cardiology,Low Dose,2023-09-04,2023-12-03,6.73,7.89,92,80,80,None,None,No Change,0
6747,PT-06747,42,F,NIMHANS Bengaluru,Phase I,ORX-606,Rheumatology,Placebo,2023-09-28,2023-10-26,9.1,9.13,121,74,81,None,None,Improved,0
6748,PT-06748,63,F,Kolkata Clinical Center,Phase III,ORX-202,Diabetes,Placebo,2024-01-07,2024-04-06,7.37,6.85,115,86,82,Dizziness,Severe,Improved,1
6749,PT-06749,33,F,PGI Chandigarh,Phase III,ORX-202,Diabetes,High Dose,2024-09-06,2024-09-20,8.43,9.57,128,85,62,None,None,No Change,0
6750,PT-06750,56,M,Fortis Mumbai,Phase II,ORX-303,Cardiology,Low Dose,2023-11-24,2023-12-22,7.76,7.06,114,104,83,None,None,No Change,0
6751,PT-06751,30,M,Kolkata Clinical Center,Phase II,ORX-202,Diabetes,High Dose,2024-08-14,2024-08-21,8.23,8.03,129,93,45,None,None,Improved,1
6752,PT-06752,18,F,Apollo Chennai,Phase III,ORX-606,Rheumatology,Low Dose,2023-08-30,2023-10-25,8.86,8.34,120,65,80,Nausea,Mild,Improved,1
6753,PT-06753,50,M,Indore Medical Institute,Phase II,ORX-606,Rheumatology,Placebo,2023-03-29,2023-06-27,8.93,8.86,122,86,93,Headache,Severe,Worsened,0
6754,PT-06754,59,F,Kolkata Clinical Center,Phase IV,ORX-404,Neurology,Placebo,2024-09-01,2024-09-29,7.95,7.79,117,69,61,None,None,No Change,0
6755,PT-06755,51,F,PGI Chandigarh,Phase I,ORX-606,Rheumatology,Low Dose,2024-04-29,2024-05-27,7.8,8.38,138,94,76,Headache,None,No Change,0
6756,PT-06756,57,F,Indore Medical Institute,Phase III,ORX-202,Diabetes,Low Dose,2023-08-06,2023-10-01,6.0,5.54,95,82,95,Dizziness,None,Improved,1
6757,PT-06757,46,M,Kolkata Clinical Center,Phase I,ORX-101,Oncology,High Dose,2023-12-08,2024-03-07,8.07,7.91,117,79,94,Fever,None,Improved,1
6758,PT-06758,56,M,NIMHANS Bengaluru,Phase III,ORX-303,Cardiology,Low Dose,2023-07-06,2023-07-20,6.46,,131,75,75,Nausea,None,Improved,1
6759,PT-06759,21,M,Kolkata Clinical Center,Phase III,ORX-303,Cardiology,High Dose,2023-03-01,2023-03-08,8.45,7.96,128,72,74,None,None,Improved,1
6760,PT-06760,46,M,AIIMS Delhi,Phase III,ORX-505,Infectious Disease,Low Dose,2023-08-30,2023-09-27,6.46,5.87,152,60,80,None,None,Improved,1
6761,PT-06761,32,F,Kolkata Clinical Center,Phase III,ORX-303,Cardiology,Low Dose,2023-01-21,2023-04-21,8.8,8.24,109,79,82,None,None,Improved,1
6762,PT-06762,85,F,Kolkata Clinical Center,Phase I,ORX-606,Rheumatology,High Dose,2024-10-17,2024-10-31,4.67,3.19,151,63,78,None,None,No Change,0
6763,PT-06763,37,F,Bhopal Research Hospital,Phase IV,ORX-101,Oncology,Low Dose,2023-12-03,2023-12-31,6.43,5.88,122,94,96,Fatigue,Mild,Improved,1
6764,PT-06764,51,M,AIIMS Delhi,Phase IV,ORX-101,Oncology,Placebo,2024-07-19,2024-07-26,6.92,6.75,142,94,83,Dizziness,Moderate,Improved,1
6765,PT-06765,69,M,Apollo Chennai,Phase III,ORX-101,Oncology,Placebo,2024-03-20,2024-06-18,6.46,7.09,140,74,81,Headache,Moderate,Improved,0
6766,PT-06766,49,F,AIIMS Delhi,Phase III,ORX-202,Diabetes,Placebo,2023-02-26,2023-05-27,7.03,6.49,100,73,74,None,None,No Change,0
6767,PT-06767,35,F,Apollo Chennai,Phase III,ORX-404,Neurology,High Dose,2024-01-28,2024-03-24,6.17,6.73,126,108,81,None,None,No Change,0
6768,PT-06768,61,M,Indore Medical Institute,Phase II,ORX-404,Neurology,Placebo,2023-12-18,2023-12-25,6.95,5.95,132,97,76,None,None,No Change,0
6769,PT-06769,52,F,Apollo Chennai,Phase I,ORX-202,Diabetes,Low Dose,2023-10-10,2023-10-17,7.51,7.02,127,70,77,Headache,Mild,No Change,0
6770,PT-06770,55,F,Indore Medical Institute,Phase I,ORX-303,Cardiology,Placebo,2024-06-12,2024-09-10,7.55,7.32,141,84,78,Rash,None,Worsened,0
6771,PT-06771,56,M,AIIMS Delhi,Phase III,ORX-303,Cardiology,Low Dose,2023-12-26,2024-01-23,7.36,6.75,136,81,74,None,None,Improved,1
6772,PT-06772,47,M,Fortis Mumbai,Phase I,ORX-101,Oncology,Placebo,2024-07-19,2024-07-26,7.4,6.01,133,104,64,Headache,Mild,Improved,1
6773,PT-06773,36,F,Apollo Chennai,Phase II,ORX-303,Cardiology,High Dose,2023-06-28,2023-08-23,10.54,9.4,151,79,78,None,None,Improved,1
6774,PT-06774,42,F,PGI Chandigarh,Phase III,ORX-404,Neurology,Placebo,2024-02-24,2024-05-24,7.71,5.89,131,77,51,Headache,None,Improved,1
6775,PT-06775,62,F,Apollo Chennai,Phase III,ORX-101,Oncology,Low Dose,2024-05-18,2024-08-16,4.67,6.2,139,65,96,None,None,No Change,0
6776,PT-06776,32,M,Apollo Chennai,Phase II,ORX-505,Infectious Disease,High Dose,2023-09-20,2023-12-19,6.35,4.33,112,73,89,None,None,Improved,1
6777,PT-06777,63,F,Fortis Mumbai,Phase III,ORX-303,Cardiology,Low Dose,2024-05-29,2024-06-26,5.71,5.55,94,85,108,Nausea,None,Improved,1
6778,PT-06778,18,M,Apollo Chennai,Phase III,ORX-101,Oncology,Low Dose,2024-04-30,2024-05-07,5.98,6.24,143,70,98,Headache,Mild,Worsened,0
6779,PT-06779,31,F,Indore Medical Institute,Phase IV,ORX-606,Rheumatology,High Dose,2023-06-03,2023-09-01,9.21,9.23,150,86,87,Rash,Severe,Improved,0
6780,PT-06780,56,M,Bhopal Research Hospital,Phase III,ORX-101,Oncology,Low Dose,2024-07-13,2024-10-11,8.57,8.14,111,81,68,Headache,Mild,Improved,1
6781,PT-06781,35,F,Bhopal Research Hospital,Phase III,ORX-101,Oncology,Placebo,2024-04-15,2024-04-22,9.19,9.35,138,94,86,Nausea,None,Improved,0
6782,PT-06782,74,F,Apollo Chennai,Phase II,ORX-606,Rheumatology,Placebo,2024-02-20,2024-04-16,4.69,3.39,115,65,79,Fever,Moderate,Improved,1
6783,PT-06783,47,M,PGI Chandigarh,Phase III,ORX-101,Oncology,High Dose,2023-03-30,2023-04-06,9.57,9.98,118,87,52,None,None,No Change,0
6784,PT-06784,47,M,AIIMS Delhi,Phase III,ORX-101,Oncology,Low Dose,2024-01-01,2024-01-08,7.31,6.09,124,73,64,None,None,Improved,1
6785,PT-06785,55,M,Indore Medical Institute,Phase IV,ORX-505,Infectious Disease,High Dose,2024-07-09,2024-10-07,8.44,8.5,120,74,72,Fatigue,Mild,No Change,0
6786,PT-06786,41,F,Bhopal Research Hospital,Phase III,ORX-303,Cardiology,Placebo,2024-03-31,2024-04-14,6.15,6.7,124,91,58,None,None,Improved,0
6787,PT-06787,33,F,NIMHANS Bengaluru,Phase IV,ORX-505,Infectious Disease,High Dose,2023-07-14,2023-07-21,8.23,8.62,106,85,82,None,None,No Change,0
6788,PT-06788,33,M,Bhopal Research Hospital,Phase II,ORX-606,Rheumatology,Placebo,2024-05-19,2024-06-02,7.63,5.81,111,89,78,None,None,Improved,1
6789,PT-06789,46,M,Indore Medical Institute,Phase III,ORX-202,Diabetes,Low Dose,2024-04-27,2024-06-22,6.99,7.07,138,91,79,None,None,Improved,0
6790,PT-06790,38,M,PGI Chandigarh,Phase III,ORX-606,Rheumatology,High Dose,2024-04-10,2024-05-08,6.53,5.18,120,74,100,Nausea,None,Worsened,0
6791,PT-06791,28,F,PGI Chandigarh,Phase I,ORX-606,Rheumatology,Placebo,2023-10-30,2024-01-28,8.44,7.8,124,86,58,Nausea,None,Improved,1
6792,PT-06792,32,F,Kolkata Clinical Center,Phase IV,ORX-202,Diabetes,Placebo,2024-04-14,2024-07-13,5.71,4.97,111,97,69,Dizziness,None,No Change,0
6793,PT-06793,18,M,AIIMS Delhi,Phase I,ORX-101,Oncology,High Dose,2023-02-18,2023-04-15,6.8,7.13,157,79,70,Headache,Mild,Improved,0
6794,PT-06794,44,F,PGI Chandigarh,Phase III,ORX-303,Cardiology,Low Dose,2024-10-10,2024-12-05,7.7,6.28,123,81,78,None,None,Worsened,0
6795,PT-06795,42,M,Kolkata Clinical Center,Phase II,ORX-404,Neurology,Low Dose,2024-02-21,2024-04-17,6.08,5.98,127,81,62,None,None,No Change,0
6796,PT-06796,55,F,NIMHANS Bengaluru,Phase IV,ORX-404,Neurology,Placebo,2024-05-12,2024-05-19,6.06,7.12,106,91,51,Nausea,None,Improved,0
6797,PT-06797,18,F,Apollo Chennai,Phase III,ORX-505,Infectious Disease,Placebo,2024-04-11,2024-04-18,6.53,4.1,141,81,97,None,None,Worsened,0
6798,PT-06798,42,F,NIMHANS Bengaluru,Phase II,ORX-606,Rheumatology,High Dose,2024-06-18,2024-07-02,7.49,6.85,112,77,61,None,None,Improved,1
6799,PT-06799,51,M,Fortis Mumbai,Phase III,ORX-202,Diabetes,Low Dose,2023-11-29,2023-12-27,6.83,6.34,178,77,82,Rash,Mild,Improved,1
6800,PT-06800,44,F,PGI Chandigarh,Phase IV,ORX-505,Infectious Disease,High Dose,2024-09-15,2024-09-29,8.59,,123,109,65,None,None,Worsened,0
6801,PT-06801,41,M,Apollo Chennai,Phase III,ORX-202,Diabetes,High Dose,2023-10-12,2023-11-09,8.3,7.16,141,76,92,None,None,Improved,1
6802,PT-06802,60,F,Fortis Mumbai,Phase IV,ORX-606,Rheumatology,Low Dose,2023-12-21,2024-02-15,7.09,5.79,120,81,90,None,None,Improved,1
6803,PT-06803,50,M,NIMHANS Bengaluru,Phase II,ORX-202,Diabetes,Placebo,2023-11-13,2023-12-11,7.85,7.76,143,79,80,None,None,Worsened,0
6804,PT-06804,45,M,NIMHANS Bengaluru,Phase I,ORX-303,Cardiology,High Dose,2024-05-13,2024-05-20,6.67,7.18,145,96,67,None,None,Improved,0
6805,PT-06805,50,F,Fortis Mumbai,Phase III,ORX-404,Neurology,Placebo,2023-05-09,2023-05-16,8.51,9.46,100,81,75,Fatigue,None,Improved,0
6806,PT-06806,70,F,Indore Medical Institute,Phase I,ORX-606,Rheumatology,High Dose,2023-11-30,2024-01-25,4.55,3.21,153,76,59,None,None,No Change,0
6807,PT-06807,69,M,Bhopal Research Hospital,Phase III,ORX-606,Rheumatology,Low Dose,2024-05-27,2024-08-25,5.48,6.0,99,64,80,None,None,Improved,0
6808,PT-06808,31,M,Indore Medical Institute,Phase II,ORX-404,Neurology,Low Dose,2023-01-19,2023-04-19,7.53,8.75,125,101,82,None,None,Worsened,0
6809,PT-06809,60,F,NIMHANS Bengaluru,Phase I,ORX-505,Infectious Disease,Low Dose,2024-02-05,2024-04-01,4.38,4.55,136,77,104,Nausea,Moderate,Improved,0
6810,PT-06810,37,F,Bhopal Research Hospital,Phase IV,ORX-606,Rheumatology,Low Dose,2023-02-06,2023-02-13,5.27,5.57,102,82,96,Headache,None,Improved,0
6811,PT-06811,52,F,Fortis Mumbai,Phase III,ORX-606,Rheumatology,Low Dose,2023-03-11,2023-05-06,6.9,6.19,150,67,88,Headache,Mild,Worsened,0
6812,PT-06812,80,M,Bhopal Research Hospital,Phase I,ORX-606,Rheumatology,Low Dose,2023-11-24,2023-12-08,7.85,7.24,125,76,68,None,None,Improved,1
6813,PT-06813,46,F,NIMHANS Bengaluru,Phase III,ORX-505,Infectious Disease,Placebo,2024-04-30,2024-05-14,8.02,9.07,92,52,100,Fever,Mild,Worsened,0
6814,PT-06814,45,F,PGI Chandigarh,Phase III,ORX-303,Cardiology,Low Dose,2023-09-10,2023-09-24,7.33,7.38,124,105,84,None,None,Improved,0
6815,PT-06815,37,M,NIMHANS Bengaluru,Phase III,ORX-202,Diabetes,Placebo,2023-04-03,2023-04-17,6.77,6.24,114,102,79,None,None,Improved,1
6816,PT-06816,26,M,AIIMS Delhi,Phase IV,ORX-303,Cardiology,Low Dose,2024-02-05,2024-05-05,7.69,8.58,147,72,62,None,None,Improved,0
6817,PT-06817,67,M,Bhopal Research Hospital,Phase I,ORX-505,Infectious Disease,Low Dose,2024-01-25,2024-02-08,5.25,5.18,117,97,63,None,None,Worsened,0
6818,PT-06818,32,F,Indore Medical Institute,Phase II,ORX-101,Oncology,Placebo,2023-03-08,2023-06-06,7.94,8.26,152,87,82,None,None,Improved,0
6819,PT-06819,61,M,Bhopal Research Hospital,Phase III,ORX-505,Infectious Disease,Low Dose,2023-06-02,2023-08-31,5.56,4.36,104,50,89,None,None,No Change,0
6820,PT-06820,67,M,NIMHANS Bengaluru,Phase IV,ORX-101,Oncology,Placebo,2023-01-18,2023-01-25,7.87,7.81,129,82,101,Nausea,Mild,No Change,0
6821,PT-06821,69,M,Kolkata Clinical Center,Phase IV,ORX-303,Cardiology,High Dose,2023-07-27,2023-09-21,6.5,7.1,150,89,83,None,None,No Change,0
6822,PT-06822,50,M,NIMHANS Bengaluru,Phase II,ORX-101,Oncology,High Dose,2024-06-22,2024-09-20,5.42,3.61,142,68,58,None,None,No Change,0
6823,PT-06823,18,M,AIIMS Delhi,Phase II,ORX-101,Oncology,Placebo,2024-10-30,2025-01-28,6.63,6.57,136,92,72,Rash,None,Improved,1
6824,PT-06824,46,M,NIMHANS Bengaluru,Phase I,ORX-101,Oncology,High Dose,2024-10-27,2024-11-10,8.21,8.23,117,85,50,Rash,Mild,No Change,0
6825,PT-06825,45,F,Apollo Chennai,Phase IV,ORX-404,Neurology,High Dose,2024-04-17,2024-05-15,6.46,7.42,110,83,71,Headache,Mild,Improved,0
6826,PT-06826,36,F,Indore Medical Institute,Phase III,ORX-505,Infectious Disease,Low Dose,2023-11-12,2023-12-10,7.65,6.88,161,58,86,None,None,Improved,1
6827,PT-06827,43,F,Fortis Mumbai,Phase III,ORX-606,Rheumatology,Placebo,2024-05-22,2024-07-17,7.14,7.01,145,85,92,None,None,Improved,1
6828,PT-06828,45,M,Apollo Chennai,Phase II,ORX-101,Oncology,High Dose,2024-06-08,2024-07-06,5.96,5.48,148,77,62,None,None,No Change,0
6829,PT-06829,54,M,PGI Chandigarh,Phase III,ORX-303,Cardiology,High Dose,2024-09-28,2024-10-26,7.6,6.51,123,79,78,None,None,No Change,0
6830,PT-06830,55,F,Bhopal Research Hospital,Phase IV,ORX-303,Cardiology,Placebo,2023-08-29,2023-10-24,6.71,6.94,118,101,101,None,None,No Change,0
6831,PT-06831,31,F,NIMHANS Bengaluru,Phase III,ORX-101,Oncology,Placebo,2023-07-14,2023-07-28,5.73,6.21,132,88,68,None,None,Improved,0
6832,PT-06832,42,M,Bhopal Research Hospital,Phase I,ORX-606,Rheumatology,High Dose,2023-09-07,2023-11-02,6.79,6.66,105,80,60,None,None,Improved,1
6833,PT-06833,36,F,Indore Medical Institute,Phase III,ORX-505,Infectious Disease,Placebo,2023-05-08,2023-05-22,7.08,7.14,138,91,57,None,None,No Change,0
6834,PT-06834,65,M,AIIMS Delhi,Phase III,ORX-101,Oncology,High Dose,2023-03-20,2023-03-27,6.43,5.51,132,77,83,None,None,Improved,1
6835,PT-06835,53,M,Indore Medical Institute,Phase III,ORX-505,Infectious Disease,Low Dose,2024-08-06,2024-08-20,6.28,5.72,125,93,71,None,None,Worsened,0
6836,PT-06836,36,M,Bhopal Research Hospital,Phase II,ORX-606,Rheumatology,Low Dose,2024-07-29,2024-09-23,5.97,4.76,103,73,100,None,None,No Change,0
6837,PT-06837,56,M,AIIMS Delhi,Phase IV,ORX-505,Infectious Disease,Low Dose,2024-11-03,2025-02-01,8.73,7.48,92,85,103,None,None,No Change,0
6838,PT-06838,37,F,PGI Chandigarh,Phase II,ORX-606,Rheumatology,High Dose,2024-06-15,2024-08-10,7.32,5.51,128,80,48,None,None,Improved,1
6839,PT-06839,28,F,Indore Medical Institute,Phase III,ORX-303,Cardiology,High Dose,2024-06-21,2024-08-16,5.86,4.04,114,88,69,Dizziness,Mild,Improved,1
6840,PT-06840,63,M,Kolkata Clinical Center,Phase III,ORX-505,Infectious Disease,Placebo,2023-10-14,2023-11-11,6.76,6.66,136,100,67,None,None,Improved,1
6841,PT-06841,52,M,NIMHANS Bengaluru,Phase III,ORX-303,Cardiology,Low Dose,2023-01-29,2023-04-29,6.06,7.21,109,86,99,Headache,None,Improved,0
6842,PT-06842,25,M,Kolkata Clinical Center,Phase III,ORX-303,Cardiology,Placebo,2023-05-29,2023-06-12,7.91,6.62,169,59,56,Nausea,Mild,Worsened,0
6843,PT-06843,27,M,Kolkata Clinical Center,Phase I,ORX-404,Neurology,Low Dose,2024-07-17,2024-07-31,5.89,5.96,160,95,81,None,None,No Change,0
6844,PT-06844,45,M,NIMHANS Bengaluru,Phase II,ORX-303,Cardiology,High Dose,2024-01-20,2024-03-16,6.47,6.42,124,84,67,Headache,None,No Change,0
6845,PT-06845,25,M,Fortis Mumbai,Phase III,ORX-505,Infectious Disease,High Dose,2023-12-15,2024-01-12,7.23,6.83,117,72,85,None,None,Improved,1
6846,PT-06846,52,M,AIIMS Delhi,Phase III,ORX-404,Neurology,Placebo,2023-09-24,2023-10-22,9.45,10.29,106,79,58,None,None,No Change,0
6847,PT-06847,18,M,Kolkata Clinical Center,Phase I,ORX-303,Cardiology,High Dose,2024-08-30,2024-10-25,9.83,10.77,116,96,97,None,None,Improved,0
6848,PT-06848,18,F,NIMHANS Bengaluru,Phase II,ORX-404,Neurology,Low Dose,2024-11-14,2024-12-12,8.22,7.38,134,118,100,None,None,Worsened,0
6849,PT-06849,42,F,Indore Medical Institute,Phase III,ORX-404,Neurology,Placebo,2023-04-30,2023-05-07,8.91,6.78,137,88,87,None,None,Improved,1
6850,PT-06850,36,M,Apollo Chennai,Phase II,ORX-606,Rheumatology,Low Dose,2024-08-26,2024-10-21,7.66,8.03,90,78,65,Dizziness,None,Improved,0
6851,PT-06851,55,F,PGI Chandigarh,Phase II,ORX-101,Oncology,Low Dose,2023-11-05,2023-12-03,8.85,7.9,108,83,61,None,None,Improved,1
6852,PT-06852,41,F,Fortis Mumbai,Phase III,ORX-505,Infectious Disease,High Dose,2024-11-26,2025-01-21,6.8,6.92,133,83,100,None,None,No Change,0
6853,PT-06853,49,M,PGI Chandigarh,Phase III,ORX-404,Neurology,High Dose,2024-03-27,2024-05-22,6.7,6.03,114,69,58,None,None,Improved,1
6854,PT-06854,63,M,Indore Medical Institute,Phase III,ORX-606,Rheumatology,Placebo,2024-06-03,2024-09-01,6.34,6.22,122,81,94,Dizziness,Severe,No Change,0
6855,PT-06855,47,M,PGI Chandigarh,Phase II,ORX-505,Infectious Disease,High Dose,2023-02-05,2023-04-02,6.09,5.19,143,87,90,None,None,Improved,1
6856,PT-06856,41,F,Fortis Mumbai,Phase II,ORX-101,Oncology,Low Dose,2024-11-29,2025-01-24,5.52,5.58,132,85,58,None,None,Improved,0
6857,PT-06857,34,M,Apollo Chennai,Phase I,ORX-202,Diabetes,Placebo,2023-10-25,2023-11-08,6.07,6.03,135,81,91,Fever,None,No Change,0
6858,PT-06858,68,M,Kolkata Clinical Center,Phase IV,ORX-606,Rheumatology,Placebo,2024-03-08,2024-03-22,7.62,7.83,118,73,92,Fever,None,Improved,0
6859,PT-06859,31,F,AIIMS Delhi,Phase I,ORX-404,Neurology,High Dose,2024-11-25,2024-12-02,8.04,9.18,139,81,59,Headache,Moderate,Improved,0
6860,PT-06860,47,M,AIIMS Delhi,Phase II,ORX-202,Diabetes,High Dose,2023-02-17,2023-04-14,8.41,7.85,146,86,82,Rash,Moderate,No Change,0
6861,PT-06861,39,F,Fortis Mumbai,Phase III,ORX-404,Neurology,Placebo,2023-02-02,2023-03-02,5.45,4.67,120,88,77,None,None,No Change,0
6862,PT-06862,62,M,NIMHANS Bengaluru,Phase I,ORX-404,Neurology,High Dose,2023-06-27,2023-08-22,7.54,6.68,113,74,80,None,None,Improved,1
6863,PT-06863,39,F,Bhopal Research Hospital,Phase I,ORX-303,Cardiology,Low Dose,2024-03-26,2024-04-23,5.91,6.41,130,85,66,Fatigue,Moderate,Improved,0
6864,PT-06864,28,M,PGI Chandigarh,Phase III,ORX-606,Rheumatology,High Dose,2023-07-18,2023-07-25,7.01,4.78,142,73,74,None,None,No Change,0
6865,PT-06865,51,M,Apollo Chennai,Phase III,ORX-303,Cardiology,Placebo,2024-09-02,2024-09-30,6.93,5.48,155,63,46,None,None,Improved,1
6866,PT-06866,58,M,NIMHANS Bengaluru,Phase III,ORX-606,Rheumatology,Low Dose,2023-07-21,2023-08-18,5.45,6.18,134,85,70,None,None,Worsened,0
6867,PT-06867,31,M,Fortis Mumbai,Phase III,ORX-303,Cardiology,Low Dose,2023-11-15,2024-01-10,6.75,5.56,149,73,85,None,None,Improved,1
6868,PT-06868,61,F,Apollo Chennai,Phase III,ORX-101,Oncology,High Dose,2024-10-28,2025-01-26,6.14,6.08,111,79,71,None,None,Improved,1
6869,PT-06869,33,M,NIMHANS Bengaluru,Phase II,ORX-404,Neurology,Low Dose,2024-12-01,2024-12-15,7.39,5.9,144,69,60,None,None,No Change,0
6870,PT-06870,40,F,AIIMS Delhi,Phase IV,ORX-202,Diabetes,Low Dose,2024-08-26,2024-11-24,6.75,6.67,129,62,91,Nausea,Moderate,Improved,1
6871,PT-06871,40,F,Fortis Mumbai,Phase III,ORX-606,Rheumatology,Low Dose,2024-07-07,2024-10-05,7.49,9.07,151,84,58,None,None,Worsened,0
6872,PT-06872,23,F,AIIMS Delhi,Phase II,ORX-202,Diabetes,Low Dose,2023-02-03,2023-03-31,8.59,7.83,124,68,84,Fatigue,None,Improved,1
6873,PT-06873,63,F,Fortis Mumbai,Phase III,ORX-606,Rheumatology,High Dose,2023-10-20,2023-10-27,9.03,8.22,139,80,90,None,None,No Change,0
6874,PT-06874,44,M,Kolkata Clinical Center,Phase III,ORX-505,Infectious Disease,High Dose,2024-06-14,2024-07-12,6.21,7.0,129,77,80,Headache,None,Improved,0
6875,PT-06875,33,F,NIMHANS Bengaluru,Phase III,ORX-606,Rheumatology,Low Dose,2023-07-29,2023-10-27,7.7,7.12,113,110,63,None,None,No Change,0
6876,PT-06876,50,M,Indore Medical Institute,Phase II,ORX-606,Rheumatology,High Dose,2024-05-20,2024-08-18,7.27,5.95,121,65,106,None,None,Improved,1
6877,PT-06877,40,F,AIIMS Delhi,Phase III,ORX-101,Oncology,Low Dose,2024-08-13,2024-11-11,6.98,8.33,113,97,86,Dizziness,Mild,Worsened,0
6878,PT-06878,18,M,Bhopal Research Hospital,Phase IV,ORX-202,Diabetes,Low Dose,2023-05-14,2023-06-11,6.75,6.75,128,82,69,Headache,None,Improved,1
6879,PT-06879,33,F,AIIMS Delhi,Phase III,ORX-606,Rheumatology,High Dose,2024-01-23,2024-02-20,6.83,8.2,111,76,78,None,None,No Change,0
6880,PT-06880,21,F,NIMHANS Bengaluru,Phase IV,ORX-606,Rheumatology,High Dose,2023-07-02,2023-07-16,7.72,6.16,108,68,55,Fatigue,None,Worsened,0
6881,PT-06881,65,F,NIMHANS Bengaluru,Phase II,ORX-404,Neurology,High Dose,2024-06-17,2024-07-15,7.83,8.26,142,79,77,Nausea,Moderate,Improved,0
6882,PT-06882,61,M,PGI Chandigarh,Phase III,ORX-505,Infectious Disease,Low Dose,2024-05-05,2024-06-02,9.17,7.63,173,66,71,None,None,Improved,1
6883,PT-06883,46,M,Apollo Chennai,Phase II,ORX-606,Rheumatology,Low Dose,2023-04-07,2023-05-05,7.4,8.77,146,86,92,Fatigue,None,Worsened,0
6884,PT-06884,50,M,Apollo Chennai,Phase III,ORX-606,Rheumatology,Low Dose,2023-07-02,2023-07-30,6.39,6.43,129,71,95,None,None,No Change,0
6885,PT-06885,44,F,NIMHANS Bengaluru,Phase III,ORX-505,Infectious Disease,High Dose,2023-11-21,2024-01-16,5.86,4.59,137,94,84,Headache,None,Improved,1
6886,PT-06886,52,F,Bhopal Research Hospital,Phase II,ORX-202,Diabetes,High Dose,2023-01-13,2023-03-10,6.23,5.91,122,79,76,Rash,None,Improved,1
6887,PT-06887,34,M,Indore Medical Institute,Phase II,ORX-202,Diabetes,High Dose,2023-06-03,2023-07-01,8.1,6.79,104,72,90,None,None,Improved,1
6888,PT-06888,50,M,Bhopal Research Hospital,Phase III,ORX-202,Diabetes,High Dose,2023-07-15,2023-09-09,5.06,5.2,127,76,74,Fatigue,None,Improved,0
6889,PT-06889,23,F,NIMHANS Bengaluru,Phase I,ORX-303,Cardiology,High Dose,2023-06-01,2023-08-30,7.41,5.87,121,77,88,Nausea,Moderate,No Change,0
6890,PT-06890,45,F,Kolkata Clinical Center,Phase II,ORX-606,Rheumatology,Low Dose,2023-06-29,2023-07-06,8.05,6.57,126,88,95,Headache,None,Improved,1
6891,PT-06891,26,M,Fortis Mumbai,Phase III,ORX-303,Cardiology,High Dose,2024-08-29,2024-09-05,6.19,6.25,157,85,62,Nausea,Moderate,Improved,0
6892,PT-06892,27,M,PGI Chandigarh,Phase III,ORX-606,Rheumatology,High Dose,2023-02-26,2023-03-26,7.36,7.28,124,69,93,None,None,Improved,1
6893,PT-06893,39,F,NIMHANS Bengaluru,Phase I,ORX-303,Cardiology,High Dose,2024-01-19,2024-01-26,7.83,5.84,149,73,96,None,None,Worsened,0
6894,PT-06894,54,M,Fortis Mumbai,Phase II,ORX-101,Oncology,Placebo,2023-06-19,2023-09-17,5.49,5.31,157,74,101,None,None,Improved,1
6895,PT-06895,51,M,Apollo Chennai,Phase II,ORX-606,Rheumatology,Placebo,2023-05-04,2023-05-18,8.81,8.55,125,104,88,Nausea,None,No Change,0
6896,PT-06896,41,F,Bhopal Research Hospital,Phase IV,ORX-303,Cardiology,High Dose,2024-05-21,2024-06-04,7.71,6.8,129,96,75,None,None,Improved,1
6897,PT-06897,31,M,Bhopal Research Hospital,Phase III,ORX-404,Neurology,High Dose,2023-02-23,2023-03-02,6.04,5.71,113,64,61,Rash,None,No Change,0
6898,PT-06898,63,M,Indore Medical Institute,Phase IV,ORX-303,Cardiology,Low Dose,2024-05-29,2024-06-26,7.03,6.68,110,75,69,Rash,Moderate,Worsened,0
6899,PT-06899,40,M,Apollo Chennai,Phase III,ORX-606,Rheumatology,Low Dose,2023-05-04,2023-08-02,5.21,5.79,127,84,90,Headache,None,No Change,0
6900,PT-06900,58,F,Bhopal Research Hospital,Phase IV,ORX-404,Neurology,Low Dose,2023-01-23,2023-01-30,6.51,6.65,138,85,92,Nausea,Moderate,No Change,0
6901,PT-06901,57,M,Fortis Mumbai,Phase I,ORX-202,Diabetes,High Dose,2024-03-21,2024-05-16,8.07,8.9,128,82,89,None,None,Worsened,0
6902,PT-06902,42,F,Indore Medical Institute,Phase I,ORX-303,Cardiology,High Dose,2024-07-27,2024-10-25,7.78,6.87,90,89,56,None,None,Improved,1
6903,PT-06903,33,F,NIMHANS Bengaluru,Phase III,ORX-202,Diabetes,Low Dose,2023-01-31,2023-02-07,8.18,8.53,149,57,82,None,None,No Change,0
6904,PT-06904,40,M,Apollo Chennai,Phase III,ORX-404,Neurology,High Dose,2023-05-29,2023-08-27,8.39,9.31,104,82,89,Nausea,None,Worsened,0
6905,PT-06905,39,M,PGI Chandigarh,Phase I,ORX-404,Neurology,Low Dose,2024-04-20,2024-07-19,9.29,8.53,122,69,80,Fatigue,None,No Change,0
6906,PT-06906,18,M,AIIMS Delhi,Phase IV,ORX-404,Neurology,High Dose,2024-09-23,2024-10-21,6.9,7.64,102,62,93,Headache,None,No Change,0
6907,PT-06907,65,M,Kolkata Clinical Center,Phase II,ORX-202,Diabetes,Low Dose,2023-07-26,2023-08-09,5.57,6.73,135,94,66,None,None,No Change,0
6908,PT-06908,68,F,Kolkata Clinical Center,Phase III,ORX-606,Rheumatology,Placebo,2024-02-10,2024-05-10,6.88,6.2,136,77,56,None,None,Improved,1
6909,PT-06909,47,F,NIMHANS Bengaluru,Phase IV,ORX-101,Oncology,Low Dose,2023-03-04,2023-03-18,6.82,5.73,150,110,65,None,None,No Change,0
6910,PT-06910,48,F,Fortis Mumbai,Phase II,ORX-101,Oncology,Placebo,2023-04-05,2023-05-31,6.72,8.38,136,93,94,Headache,None,Worsened,0
6911,PT-06911,47,F,Indore Medical Institute,Phase II,ORX-101,Oncology,Low Dose,2024-03-18,2024-04-01,6.98,7.94,142,71,67,Rash,None,Improved,0
6912,PT-06912,38,M,Indore Medical Institute,Phase III,ORX-404,Neurology,Placebo,2023-12-07,2024-03-06,8.59,9.52,166,73,79,Headache,None,Improved,0
6913,PT-06913,38,F,Indore Medical Institute,Phase IV,ORX-303,Cardiology,High Dose,2024-03-20,2024-04-17,6.98,7.42,127,97,70,None,None,No Change,0
6914,PT-06914,56,M,AIIMS Delhi,Phase III,ORX-505,Infectious Disease,Placebo,2024-02-14,2024-05-14,6.67,4.62,109,83,104,None,None,Improved,1
6915,PT-06915,37,M,PGI Chandigarh,Phase II,ORX-202,Diabetes,Placebo,2023-11-01,2023-11-15,7.0,7.04,117,76,79,Nausea,None,Improved,0
6916,PT-06916,38,F,Apollo Chennai,Phase III,ORX-202,Diabetes,Placebo,2023-06-30,2023-07-07,5.06,4.08,139,89,96,Headache,None,Improved,1
6917,PT-06917,65,F,PGI Chandigarh,Phase III,ORX-505,Infectious Disease,Low Dose,2023-07-13,2023-08-10,6.12,5.05,115,80,69,None,None,Improved,1
6918,PT-06918,42,F,PGI Chandigarh,Phase III,ORX-101,Oncology,Low Dose,2024-04-27,2024-05-25,6.15,6.46,110,70,85,Headache,Mild,No Change,0
6919,PT-06919,56,M,Fortis Mumbai,Phase II,ORX-606,Rheumatology,High Dose,2024-10-13,2024-11-10,6.93,7.31,142,104,88,Headache,Mild,Worsened,0
6920,PT-06920,72,M,Indore Medical Institute,Phase III,ORX-505,Infectious Disease,Low Dose,2023-11-24,2023-12-22,7.27,8.13,153,80,68,Nausea,None,Improved,0
6921,PT-06921,36,M,Bhopal Research Hospital,Phase I,ORX-404,Neurology,High Dose,2024-08-07,2024-09-04,7.7,6.26,119,96,87,Nausea,Moderate,Worsened,0
6922,PT-06922,18,M,Apollo Chennai,Phase II,ORX-202,Diabetes,Low Dose,2024-08-10,2024-09-07,5.6,7.14,149,75,57,Fatigue,Severe,No Change,0
6923,PT-06923,25,F,NIMHANS Bengaluru,Phase II,ORX-606,Rheumatology,Placebo,2023-10-12,2024-01-10,7.81,9.19,162,63,73,Rash,None,Worsened,0
6924,PT-06924,31,F,NIMHANS Bengaluru,Phase IV,ORX-606,Rheumatology,Placebo,2024-03-20,2024-04-03,7.36,5.77,118,71,85,Rash,None,Improved,1
6925,PT-06925,36,M,PGI Chandigarh,Phase I,ORX-606,Rheumatology,High Dose,2023-06-14,2023-07-12,6.75,6.81,157,107,84,None,None,Improved,0
6926,PT-06926,43,F,Apollo Chennai,Phase II,ORX-101,Oncology,High Dose,2024-03-20,2024-05-15,8.78,9.43,143,63,94,Fatigue,None,Improved,0
6927,PT-06927,50,M,NIMHANS Bengaluru,Phase IV,ORX-202,Diabetes,Placebo,2024-11-27,2024-12-25,6.13,5.12,138,51,76,Rash,None,No Change,0
6928,PT-06928,34,M,NIMHANS Bengaluru,Phase I,ORX-303,Cardiology,Placebo,2024-11-13,2024-12-11,6.29,5.48,101,94,48,Headache,Mild,No Change,0
6929,PT-06929,47,F,Fortis Mumbai,Phase III,ORX-404,Neurology,High Dose,2024-03-29,2024-04-12,6.18,7.57,128,56,85,Dizziness,None,Improved,0
6930,PT-06930,27,M,NIMHANS Bengaluru,Phase III,ORX-202,Diabetes,Low Dose,2024-04-30,2024-06-25,8.38,8.54,154,84,89,None,None,Improved,0
6931,PT-06931,45,F,NIMHANS Bengaluru,Phase I,ORX-303,Cardiology,Low Dose,2024-02-07,2024-03-06,6.49,7.05,105,81,70,None,None,Worsened,0
6932,PT-06932,58,M,Apollo Chennai,Phase II,ORX-404,Neurology,Low Dose,2024-06-04,2024-07-30,6.06,5.3,128,99,70,None,None,Improved,1
6933,PT-06933,38,M,NIMHANS Bengaluru,Phase III,ORX-404,Neurology,Low Dose,2024-09-05,2024-09-19,5.58,4.3,135,82,78,Fever,None,No Change,0
6934,PT-06934,72,F,Apollo Chennai,Phase IV,ORX-303,Cardiology,Placebo,2024-03-09,2024-06-07,5.19,6.88,149,78,83,None,None,Worsened,0
6935,PT-06935,34,F,NIMHANS Bengaluru,Phase I,ORX-202,Diabetes,High Dose,2023-07-31,2023-09-25,7.58,9.12,116,79,67,None,None,No Change,0
6936,PT-06936,35,F,Bhopal Research Hospital,Phase III,ORX-404,Neurology,High Dose,2023-08-17,2023-08-31,6.72,5.33,123,82,72,Dizziness,None,Improved,1
6937,PT-06937,18,F,NIMHANS Bengaluru,Phase IV,ORX-404,Neurology,Low Dose,2024-11-30,2024-12-07,7.01,6.57,162,82,91,None,None,Improved,1
6938,PT-06938,38,F,PGI Chandigarh,Phase I,ORX-505,Infectious Disease,High Dose,2023-04-13,2023-06-08,8.76,7.51,137,92,87,Rash,Mild,No Change,0
6939,PT-06939,79,F,Indore Medical Institute,Phase III,ORX-606,Rheumatology,High Dose,2023-04-22,2023-07-21,6.5,7.37,148,82,103,None,None,No Change,0
6940,PT-06940,42,F,PGI Chandigarh,Phase II,ORX-404,Neurology,High Dose,2023-11-10,2024-01-05,7.23,6.82,105,91,86,None,None,No Change,0
6941,PT-06941,43,F,Apollo Chennai,Phase IV,ORX-606,Rheumatology,Placebo,2023-10-17,2023-10-31,9.32,8.52,96,104,92,None,None,Improved,1
6942,PT-06942,55,M,Bhopal Research Hospital,Phase I,ORX-505,Infectious Disease,High Dose,2023-05-26,2023-06-02,6.79,6.7,105,79,65,None,None,Improved,1
6943,PT-06943,49,F,NIMHANS Bengaluru,Phase IV,ORX-404,Neurology,Placebo,2024-09-13,2024-09-20,8.31,6.97,141,84,87,Headache,Moderate,Improved,1
6944,PT-06944,41,F,Kolkata Clinical Center,Phase IV,ORX-606,Rheumatology,Low Dose,2023-06-17,2023-07-01,8.04,7.02,97,64,70,Headache,None,Improved,1
6945,PT-06945,19,F,NIMHANS Bengaluru,Phase III,ORX-404,Neurology,Low Dose,2024-04-25,2024-05-02,9.06,8.59,144,91,78,None,None,Improved,1
6946,PT-06946,85,M,Bhopal Research Hospital,Phase II,ORX-606,Rheumatology,High Dose,2023-05-11,2023-05-25,10.71,11.57,111,99,53,Fatigue,Mild,Improved,0
6947,PT-06947,67,F,AIIMS Delhi,Phase III,ORX-303,Cardiology,High Dose,2024-08-31,2024-09-07,4.13,3.45,149,86,57,None,None,Improved,1
6948,PT-06948,47,M,Fortis Mumbai,Phase III,ORX-505,Infectious Disease,Low Dose,2023-01-27,2023-04-27,7.66,7.45,120,92,94,Dizziness,Moderate,No Change,0
6949,PT-06949,42,F,Bhopal Research Hospital,Phase III,ORX-505,Infectious Disease,Placebo,2024-06-15,2024-06-22,9.02,8.48,119,98,96,None,None,Improved,1
6950,PT-06950,35,M,PGI Chandigarh,Phase III,ORX-404,Neurology,High Dose,2024-05-09,2024-05-16,6.28,7.47,126,82,74,Rash,Mild,Improved,0
6951,PT-06951,66,M,PGI Chandigarh,Phase III,ORX-101,Oncology,Low Dose,2023-07-24,2023-10-22,9.77,9.44,171,75,74,None,None,No Change,0
6952,PT-06952,55,F,Fortis Mumbai,Phase III,ORX-505,Infectious Disease,Low Dose,2024-09-11,2024-10-09,6.22,6.41,118,63,53,Nausea,None,Improved,0
6953,PT-06953,39,M,Kolkata Clinical Center,Phase I,ORX-303,Cardiology,Low Dose,2023-08-07,2023-11-05,7.7,6.08,131,84,75,Headache,Moderate,No Change,0
6954,PT-06954,30,M,Fortis Mumbai,Phase III,ORX-101,Oncology,High Dose,2023-03-18,2023-05-13,7.49,6.96,145,66,79,Nausea,Mild,Improved,1
6955,PT-06955,24,M,NIMHANS Bengaluru,Phase III,ORX-202,Diabetes,Low Dose,2024-06-22,2024-07-20,6.92,5.53,111,81,70,Dizziness,None,Improved,1
6956,PT-06956,68,M,Indore Medical Institute,Phase II,ORX-505,Infectious Disease,Low Dose,2023-01-07,2023-02-04,8.61,8.94,142,83,96,None,None,No Change,0
6957,PT-06957,40,F,Kolkata Clinical Center,Phase IV,ORX-303,Cardiology,Low Dose,2023-09-17,2023-09-24,9.74,8.5,107,65,60,Headache,None,Improved,1
6958,PT-06958,18,F,Apollo Chennai,Phase I,ORX-505,Infectious Disease,Low Dose,2023-05-26,2023-07-21,7.46,7.83,128,65,71,None,None,No Change,0
6959,PT-06959,58,F,Fortis Mumbai,Phase III,ORX-606,Rheumatology,Placebo,2024-07-08,2024-10-06,6.79,5.67,100,76,68,Fatigue,None,Improved,1
6960,PT-06960,43,M,Bhopal Research Hospital,Phase III,ORX-505,Infectious Disease,High Dose,2023-11-27,2023-12-11,7.77,7.12,131,87,60,Headache,Mild,Improved,1
6961,PT-06961,75,F,AIIMS Delhi,Phase III,ORX-303,Cardiology,Low Dose,2024-10-17,2024-12-12,6.31,6.38,107,83,80,None,None,Improved,0
6962,PT-06962,71,M,AIIMS Delhi,Phase II,ORX-505,Infectious Disease,High Dose,2024-02-26,2024-03-11,6.92,7.69,133,104,53,Nausea,None,No Change,0
6963,PT-06963,52,M,Apollo Chennai,Phase IV,ORX-202,Diabetes,High Dose,2023-07-23,2023-10-21,3.99,3.54,146,99,88,None,None,No Change,0
6964,PT-06964,40,M,PGI Chandigarh,Phase II,ORX-404,Neurology,Placebo,2024-10-09,2024-10-16,7.85,9.72,129,93,71,None,None,No Change,0
6965,PT-06965,62,M,Apollo Chennai,Phase III,ORX-303,Cardiology,Placebo,2024-03-14,2024-03-28,8.29,7.34,141,91,88,None,None,No Change,0
6966,PT-06966,44,F,Bhopal Research Hospital,Phase III,ORX-202,Diabetes,Placebo,2023-07-19,2023-08-02,8.67,7.43,128,83,94,None,None,Improved,1
6967,PT-06967,29,M,PGI Chandigarh,Phase I,ORX-404,Neurology,Low Dose,2023-05-12,2023-05-19,7.49,6.65,129,86,60,None,None,Improved,1
6968,PT-06968,65,M,AIIMS Delhi,Phase II,ORX-505,Infectious Disease,Low Dose,2023-05-17,2023-08-15,7.71,6.54,121,99,83,None,None,Improved,1
6969,PT-06969,29,F,Fortis Mumbai,Phase II,ORX-606,Rheumatology,Low Dose,2023-08-27,2023-09-03,6.26,6.42,141,86,73,None,None,No Change,0
6970,PT-06970,57,F,Indore Medical Institute,Phase III,ORX-404,Neurology,Placebo,2024-11-20,2025-02-18,6.83,5.66,156,87,67,None,None,Improved,1
6971,PT-06971,47,F,Fortis Mumbai,Phase III,ORX-202,Diabetes,Low Dose,2023-11-27,2024-02-25,7.23,6.52,132,70,90,None,None,No Change,0
6972,PT-06972,44,F,NIMHANS Bengaluru,Phase IV,ORX-606,Rheumatology,High Dose,2024-01-07,2024-03-03,5.27,4.66,116,50,75,None,None,Improved,1
6973,PT-06973,61,F,Bhopal Research Hospital,Phase III,ORX-101,Oncology,High Dose,2024-11-19,2024-11-26,7.07,7.31,128,76,67,Headache,None,No Change,0
6974,PT-06974,24,M,Apollo Chennai,Phase II,ORX-404,Neurology,Low Dose,2024-03-13,2024-06-11,8.31,8.57,122,57,84,None,None,Improved,0
6975,PT-06975,30,M,NIMHANS Bengaluru,Phase III,ORX-505,Infectious Disease,High Dose,2023-07-22,2023-08-19,7.37,5.59,129,80,45,Headache,None,Improved,1
6976,PT-06976,70,M,AIIMS Delhi,Phase I,ORX-505,Infectious Disease,High Dose,2023-12-18,2024-03-17,6.81,6.18,137,81,83,None,None,No Change,0
6977,PT-06977,26,F,PGI Chandigarh,Phase IV,ORX-101,Oncology,Low Dose,2024-11-06,2025-01-01,7.03,4.91,123,99,56,Nausea,None,Improved,1
6978,PT-06978,39,M,Bhopal Research Hospital,Phase I,ORX-303,Cardiology,High Dose,2024-10-10,2024-12-05,4.65,4.26,136,86,69,None,None,Improved,1
6979,PT-06979,18,F,Fortis Mumbai,Phase II,ORX-404,Neurology,Low Dose,2024-05-09,2024-07-04,5.71,6.44,143,80,80,None,None,Worsened,0
6980,PT-06980,28,M,Indore Medical Institute,Phase III,ORX-101,Oncology,High Dose,2023-08-02,2023-09-27,8.75,7.7,135,66,75,Fatigue,Severe,Improved,1
6981,PT-06981,64,F,NIMHANS Bengaluru,Phase II,ORX-303,Cardiology,Placebo,2024-11-10,2024-12-08,6.06,6.34,108,71,77,None,None,Improved,0
6982,PT-06982,60,M,Kolkata Clinical Center,Phase II,ORX-101,Oncology,Placebo,2023-12-12,2024-01-09,6.84,7.0,148,72,56,Nausea,None,Improved,0
6983,PT-06983,39,F,AIIMS Delhi,Phase III,ORX-101,Oncology,Placebo,2023-09-30,2023-10-14,8.73,7.6,146,78,102,None,None,Worsened,0
6984,PT-06984,80,F,Kolkata Clinical Center,Phase III,ORX-505,Infectious Disease,Low Dose,2023-09-28,2023-12-27,8.44,6.56,90,82,90,None,None,No Change,0
6985,PT-06985,53,M,NIMHANS Bengaluru,Phase III,ORX-101,Oncology,High Dose,2023-01-30,2023-03-27,6.33,4.59,144,104,68,Headache,None,Improved,1
6986,PT-06986,58,M,PGI Chandigarh,Phase III,ORX-404,Neurology,Low Dose,2024-03-09,2024-03-16,10.32,9.75,124,88,74,Fatigue,Mild,Worsened,0
6987,PT-06987,66,M,Apollo Chennai,Phase III,ORX-505,Infectious Disease,High Dose,2023-12-10,2024-01-07,6.72,6.29,102,79,63,Fatigue,Moderate,No Change,0
6988,PT-06988,50,F,Apollo Chennai,Phase III,ORX-505,Infectious Disease,Low Dose,2023-01-09,2023-02-06,5.2,5.68,112,103,97,Fatigue,None,Improved,0
6989,PT-06989,53,F,Bhopal Research Hospital,Phase III,ORX-606,Rheumatology,Low Dose,2024-05-29,2024-06-05,5.35,4.39,111,72,100,Rash,Moderate,Improved,1
6990,PT-06990,42,F,Indore Medical Institute,Phase III,ORX-303,Cardiology,Low Dose,2023-11-14,2023-12-12,6.41,5.34,118,88,55,None,None,Improved,1
6991,PT-06991,46,M,AIIMS Delhi,Phase II,ORX-303,Cardiology,Low Dose,2023-10-21,2024-01-19,7.71,5.75,102,81,98,None,None,Improved,1
6992,PT-06992,64,F,Bhopal Research Hospital,Phase III,ORX-606,Rheumatology,Low Dose,2023-07-27,2023-08-03,6.47,7.34,122,78,79,None,None,No Change,0
6993,PT-06993,58,F,NIMHANS Bengaluru,Phase II,ORX-505,Infectious Disease,High Dose,2024-01-25,2024-02-01,6.47,5.71,105,86,91,None,None,Improved,1
6994,PT-06994,60,M,Kolkata Clinical Center,Phase II,ORX-101,Oncology,Placebo,2024-11-08,2025-01-03,5.56,4.82,150,84,78,Headache,Mild,Worsened,0
6995,PT-06995,45,M,NIMHANS Bengaluru,Phase I,ORX-404,Neurology,Placebo,2023-05-13,2023-07-08,7.85,7.71,117,92,61,Rash,None,Worsened,0
6996,PT-06996,66,M,PGI Chandigarh,Phase II,ORX-606,Rheumatology,High Dose,2024-05-19,2024-08-17,6.12,6.22,125,76,97,None,None,No Change,0
6997,PT-06997,56,M,NIMHANS Bengaluru,Phase II,ORX-404,Neurology,Low Dose,2023-08-07,2023-10-02,7.13,8.3,145,72,46,None,None,No Change,0
6998,PT-06998,46,M,Bhopal Research Hospital,Phase IV,ORX-606,Rheumatology,High Dose,2023-06-20,2023-07-18,8.86,9.01,156,74,76,None,None,Improved,0
6999,PT-06999,43,F,Kolkata Clinical Center,Phase IV,ORX-505,Infectious Disease,Low Dose,2024-06-03,2024-07-01,7.49,7.78,157,104,101,Headache,None,Worsened,0
7000,PT-07000,55,F,NIMHANS Bengaluru,Phase I,ORX-505,Infectious Disease,Placebo,2023-06-12,2023-08-07,6.79,6.59,139,83,65,Dizziness,Mild,No Change,0
7001,PT-07001,37,M,Apollo Chennai,Phase III,ORX-404,Neurology,Placebo,2024-01-18,2024-04-17,8.24,7.62,128,81,65,Fever,None,Improved,1
7002,PT-07002,42,M,Apollo Chennai,Phase II,ORX-202,Diabetes,High Dose,2023-07-07,2023-07-21,6.65,5.63,108,80,86,Headache,Mild,Improved,1
7003,PT-07003,62,F,Bhopal Research Hospital,Phase IV,ORX-101,Oncology,Low Dose,2023-12-19,2024-03-18,5.53,6.57,133,68,72,Headache,Moderate,Improved,0
7004,PT-07004,18,F,PGI Chandigarh,Phase IV,ORX-101,Oncology,Placebo,2024-11-16,2025-01-11,5.25,6.4,115,88,76,Rash,None,Improved,0
7005,PT-07005,45,M,Apollo Chennai,Phase III,ORX-505,Infectious Disease,Placebo,2024-02-16,2024-03-01,7.64,5.37,151,80,70,Fatigue,None,No Change,0
7006,PT-07006,52,F,Bhopal Research Hospital,Phase IV,ORX-101,Oncology,Low Dose,2024-08-10,2024-08-17,6.33,6.12,125,90,75,Nausea,Mild,No Change,0
7007,PT-07007,28,F,Fortis Mumbai,Phase III,ORX-101,Oncology,High Dose,2024-03-20,2024-03-27,7.63,6.99,95,84,70,Fatigue,None,No Change,0
7008,PT-07008,50,F,Apollo Chennai,Phase II,ORX-303,Cardiology,Low Dose,2023-03-04,2023-06-02,6.17,4.69,149,92,77,Headache,None,No Change,0
7009,PT-07009,52,M,Fortis Mumbai,Phase III,ORX-505,Infectious Disease,High Dose,2024-10-05,2024-11-02,8.17,7.76,106,85,92,None,None,Worsened,0
7010,PT-07010,54,F,Kolkata Clinical Center,Phase II,ORX-606,Rheumatology,Low Dose,2024-04-07,2024-05-05,7.27,7.38,123,94,96,None,None,Improved,0
7011,PT-07011,24,F,Bhopal Research Hospital,Phase III,ORX-303,Cardiology,High Dose,2024-10-22,2024-11-05,8.54,10.15,137,93,68,Rash,Mild,No Change,0
7012,PT-07012,36,M,Apollo Chennai,Phase IV,ORX-606,Rheumatology,High Dose,2024-05-15,2024-05-29,6.95,6.19,104,79,89,None,None,Improved,1
7013,PT-07013,24,F,Indore Medical Institute,Phase III,ORX-505,Infectious Disease,Placebo,2024-10-12,2024-11-09,7.41,7.15,122,87,83,Nausea,Severe,Improved,1
7014,PT-07014,39,M,Fortis Mumbai,Phase I,ORX-202,Diabetes,High Dose,2023-08-28,2023-09-25,8.47,8.58,156,81,73,None,None,No Change,0
7015,PT-07015,41,M,Kolkata Clinical Center,Phase I,ORX-606,Rheumatology,Low Dose,2023-09-21,2023-10-19,8.61,8.08,126,105,59,Rash,None,No Change,0
7016,PT-07016,50,F,AIIMS Delhi,Phase I,ORX-101,Oncology,High Dose,2023-11-17,2023-12-01,7.13,6.5,110,74,72,None,None,No Change,0
7017,PT-07017,52,M,Indore Medical Institute,Phase I,ORX-404,Neurology,Placebo,2023-10-20,2023-12-15,8.22,6.22,106,88,86,None,None,Worsened,0
7018,PT-07018,21,M,AIIMS Delhi,Phase III,ORX-202,Diabetes,Low Dose,2023-06-07,2023-07-05,8.25,7.84,141,71,58,None,None,Improved,1
7019,PT-07019,40,M,AIIMS Delhi,Phase III,ORX-606,Rheumatology,High Dose,2023-02-08,2023-04-05,6.88,6.19,120,102,54,None,None,Improved,1
7020,PT-07020,31,F,NIMHANS Bengaluru,Phase IV,ORX-404,Neurology,Placebo,2023-07-14,2023-09-08,6.7,6.32,140,92,93,None,None,Worsened,0
7021,PT-07021,52,M,PGI Chandigarh,Phase III,ORX-606,Rheumatology,High Dose,2024-05-10,2024-06-07,5.12,3.23,148,94,86,None,None,Improved,1
7022,PT-07022,31,M,Kolkata Clinical Center,Phase IV,ORX-505,Infectious Disease,Placebo,2023-07-30,2023-09-24,6.81,6.05,109,85,108,None,None,Improved,1
7023,PT-07023,37,M,PGI Chandigarh,Phase III,ORX-606,Rheumatology,Low Dose,2024-09-24,2024-10-01,8.76,7.56,100,93,74,Headache,None,No Change,0
7024,PT-07024,65,M,Kolkata Clinical Center,Phase III,ORX-303,Cardiology,High Dose,2024-06-01,2024-06-08,8.97,8.31,152,71,65,Nausea,None,Improved,1
7025,PT-07025,62,F,Apollo Chennai,Phase I,ORX-404,Neurology,Low Dose,2023-02-28,2023-05-29,5.34,4.94,150,97,71,None,None,No Change,0
7026,PT-07026,61,F,PGI Chandigarh,Phase III,ORX-404,Neurology,High Dose,2023-07-01,2023-07-08,5.85,4.85,132,86,63,None,None,Improved,1
7027,PT-07027,74,M,Kolkata Clinical Center,Phase II,ORX-606,Rheumatology,High Dose,2024-08-07,2024-09-04,4.95,4.6,131,61,96,Nausea,Moderate,Improved,1
7028,PT-07028,33,F,Indore Medical Institute,Phase III,ORX-101,Oncology,Placebo,2024-03-30,2024-04-06,7.32,7.21,101,69,99,Dizziness,Severe,Worsened,0
7029,PT-07029,43,M,Fortis Mumbai,Phase IV,ORX-404,Neurology,High Dose,2024-08-26,2024-09-02,3.96,3.29,127,84,50,Rash,None,Improved,1
7030,PT-07030,44,F,Kolkata Clinical Center,Phase II,ORX-505,Infectious Disease,Placebo,2024-10-26,2024-12-21,6.2,6.0,137,86,97,None,None,Improved,1
7031,PT-07031,80,F,Bhopal Research Hospital,Phase III,ORX-202,Diabetes,Low Dose,2023-01-19,2023-02-16,5.84,5.1,141,80,45,Fatigue,Mild,Worsened,0
7032,PT-07032,41,M,AIIMS Delhi,Phase IV,ORX-404,Neurology,Low Dose,2023-06-16,2023-06-30,8.68,7.03,131,59,90,None,None,Improved,1
7033,PT-07033,48,M,Apollo Chennai,Phase IV,ORX-303,Cardiology,Placebo,2023-04-15,2023-05-13,6.52,5.74,101,94,66,Rash,None,No Change,0
7034,PT-07034,53,M,NIMHANS Bengaluru,Phase I,ORX-202,Diabetes,High Dose,2023-04-23,2023-04-30,6.05,7.62,156,106,108,None,None,No Change,0
7035,PT-07035,34,F,PGI Chandigarh,Phase III,ORX-202,Diabetes,Low Dose,2023-03-12,2023-03-26,6.14,7.56,125,91,69,Dizziness,None,No Change,0
7036,PT-07036,35,F,Fortis Mumbai,Phase II,ORX-404,Neurology,Low Dose,2024-06-19,2024-09-17,8.2,6.02,142,88,70,None,None,Worsened,0
7037,PT-07037,45,M,Kolkata Clinical Center,Phase III,ORX-505,Infectious Disease,Placebo,2023-08-10,2023-08-24,7.42,7.23,140,72,115,Headache,None,No Change,0
7038,PT-07038,41,M,AIIMS Delhi,Phase III,ORX-606,Rheumatology,High Dose,2024-09-25,2024-10-09,7.04,8.39,95,105,79,Rash,None,No Change,0
7039,PT-07039,36,M,Kolkata Clinical Center,Phase III,ORX-101,Oncology,Low Dose,2023-11-23,2023-12-21,5.86,4.31,121,85,86,None,None,No Change,0
7040,PT-07040,49,F,Kolkata Clinical Center,Phase III,ORX-303,Cardiology,Low Dose,2023-07-07,2023-08-04,6.59,7.39,176,99,72,Dizziness,None,Worsened,0
7041,PT-07041,53,M,Indore Medical Institute,Phase III,ORX-202,Diabetes,High Dose,2023-11-03,2024-02-01,7.88,8.92,121,70,93,None,None,No Change,0
7042,PT-07042,51,M,Kolkata Clinical Center,Phase I,ORX-101,Oncology,Low Dose,2024-07-18,2024-09-12,5.87,6.1,161,73,65,None,None,Improved,0
7043,PT-07043,45,F,NIMHANS Bengaluru,Phase III,ORX-101,Oncology,Placebo,2023-11-17,2023-12-15,8.02,7.55,148,85,92,Nausea,None,Improved,1
7044,PT-07044,33,F,Apollo Chennai,Phase II,ORX-404,Neurology,Placebo,2024-02-11,2024-05-11,5.73,5.02,103,86,49,None,None,Worsened,0
7045,PT-07045,37,M,Fortis Mumbai,Phase II,ORX-505,Infectious Disease,High Dose,2023-05-04,2023-05-18,6.86,5.51,122,82,95,None,None,Worsened,0
7046,PT-07046,28,F,Fortis Mumbai,Phase IV,ORX-606,Rheumatology,High Dose,2023-09-05,2023-10-31,7.63,7.73,127,76,62,Dizziness,None,No Change,0
7047,PT-07047,75,M,PGI Chandigarh,Phase III,ORX-606,Rheumatology,High Dose,2024-01-18,2024-02-01,7.29,6.6,166,84,113,Headache,None,Worsened,0
7048,PT-07048,22,F,PGI Chandigarh,Phase IV,ORX-202,Diabetes,Low Dose,2024-09-15,2024-11-10,6.92,5.28,125,80,71,None,None,Improved,1
7049,PT-07049,45,F,Apollo Chennai,Phase I,ORX-404,Neurology,Placebo,2024-08-11,2024-10-06,6.71,6.21,114,99,62,Nausea,None,No Change,0
7050,PT-07050,48,M,NIMHANS Bengaluru,Phase IV,ORX-505,Infectious Disease,Placebo,2024-02-12,2024-02-19,5.77,4.62,114,80,80,Headache,Mild,Improved,1
7051,PT-07051,27,M,Indore Medical Institute,Phase I,ORX-303,Cardiology,High Dose,2024-05-11,2024-08-09,6.7,5.41,109,95,58,None,None,Improved,1
7052,PT-07052,46,M,PGI Chandigarh,Phase III,ORX-101,Oncology,Low Dose,2023-10-07,2024-01-05,9.24,9.92,135,81,88,Headache,None,Improved,0
7053,PT-07053,50,F,AIIMS Delhi,Phase III,ORX-404,Neurology,High Dose,2024-01-30,2024-02-06,8.91,8.39,146,78,104,None,None,Improved,1
7054,PT-07054,42,M,Bhopal Research Hospital,Phase IV,ORX-404,Neurology,High Dose,2024-09-26,2024-10-24,5.26,4.93,141,101,64,None,None,Improved,1
7055,PT-07055,18,M,Fortis Mumbai,Phase III,ORX-101,Oncology,Low Dose,2024-07-25,2024-10-23,7.8,7.82,102,78,74,Nausea,None,Improved,0
7056,PT-07056,58,M,Bhopal Research Hospital,Phase I,ORX-303,Cardiology,High Dose,2023-10-25,2023-11-22,6.7,,130,65,104,Headache,None,Worsened,0
7057,PT-07057,59,M,AIIMS Delhi,Phase III,ORX-505,Infectious Disease,Low Dose,2024-01-31,2024-03-27,6.36,4.95,109,89,63,None,None,Worsened,0
7058,PT-07058,41,F,Bhopal Research Hospital,Phase II,ORX-505,Infectious Disease,Low Dose,2024-07-18,2024-08-01,5.17,5.26,138,79,80,Headache,Mild,No Change,0
7059,PT-07059,57,F,Kolkata Clinical Center,Phase III,ORX-101,Oncology,Low Dose,2024-07-08,2024-10-06,7.4,7.7,106,86,80,None,None,Improved,0
7060,PT-07060,64,M,Kolkata Clinical Center,Phase I,ORX-303,Cardiology,High Dose,2023-12-22,2024-02-16,7.24,6.75,117,99,45,None,None,No Change,0
7061,PT-07061,53,M,Fortis Mumbai,Phase II,ORX-101,Oncology,High Dose,2023-07-21,2023-07-28,7.18,6.61,122,81,84,Rash,None,Improved,1
7062,PT-07062,32,M,NIMHANS Bengaluru,Phase II,ORX-303,Cardiology,Low Dose,2023-01-23,2023-03-20,7.36,7.28,110,88,83,None,None,No Change,0
7063,PT-07063,32,M,Bhopal Research Hospital,Phase III,ORX-505,Infectious Disease,Low Dose,2023-03-26,2023-04-02,5.77,4.64,130,81,97,None,None,Improved,1
7064,PT-07064,39,M,Apollo Chennai,Phase III,ORX-606,Rheumatology,High Dose,2023-01-05,2023-01-19,6.13,6.32,110,72,67,Headache,Moderate,Improved,0
7065,PT-07065,18,M,Indore Medical Institute,Phase III,ORX-202,Diabetes,Placebo,2023-04-20,2023-05-04,7.88,8.33,144,104,99,None,None,Improved,0
7066,PT-07066,39,M,Kolkata Clinical Center,Phase III,ORX-404,Neurology,Placebo,2024-10-22,2024-11-05,8.53,8.04,120,72,74,None,None,Improved,1
7067,PT-07067,50,F,NIMHANS Bengaluru,Phase II,ORX-505,Infectious Disease,Placebo,2023-08-16,2023-08-23,9.1,9.35,114,69,85,None,None,Improved,0
7068,PT-07068,59,F,Indore Medical Institute,Phase I,ORX-101,Oncology,Placebo,2023-04-01,2023-06-30,8.67,8.03,136,92,59,Fatigue,Moderate,No Change,0
7069,PT-07069,49,M,Kolkata Clinical Center,Phase IV,ORX-202,Diabetes,Low Dose,2024-07-28,2024-08-04,8.29,8.34,126,113,105,None,None,Worsened,0
7070,PT-07070,45,M,AIIMS Delhi,Phase II,ORX-303,Cardiology,Low Dose,2024-11-29,2025-01-24,6.97,7.2,126,97,60,None,None,Improved,0
7071,PT-07071,41,M,Indore Medical Institute,Phase I,ORX-404,Neurology,High Dose,2023-10-07,2023-11-04,8.02,8.53,101,70,54,Fatigue,Mild,Improved,0
7072,PT-07072,31,M,Bhopal Research Hospital,Phase I,ORX-101,Oncology,Low Dose,2024-04-17,2024-04-24,5.67,5.75,132,80,78,None,None,Improved,0
7073,PT-07073,64,F,Bhopal Research Hospital,Phase III,ORX-606,Rheumatology,Placebo,2023-11-27,2023-12-04,5.95,3.81,140,77,63,None,None,No Change,0
7074,PT-07074,53,M,PGI Chandigarh,Phase III,ORX-101,Oncology,High Dose,2023-04-27,2023-05-11,4.84,3.67,90,85,100,None,None,Worsened,0
7075,PT-07075,35,F,AIIMS Delhi,Phase I,ORX-404,Neurology,Low Dose,2023-02-12,2023-02-26,6.25,7.46,139,110,80,Nausea,None,No Change,0
7076,PT-07076,48,M,Bhopal Research Hospital,Phase III,ORX-303,Cardiology,Low Dose,2023-09-04,2023-10-30,8.93,8.4,132,52,102,Fever,Mild,Worsened,0
7077,PT-07077,51,M,Bhopal Research Hospital,Phase II,ORX-303,Cardiology,Placebo,2024-01-26,2024-04-25,7.07,7.49,106,75,85,Fever,Mild,Improved,0
7078,PT-07078,45,F,Bhopal Research Hospital,Phase III,ORX-101,Oncology,Low Dose,2024-07-22,2024-08-05,7.74,7.56,139,66,95,None,None,No Change,0
7079,PT-07079,37,M,Bhopal Research Hospital,Phase II,ORX-202,Diabetes,Low Dose,2023-08-22,2023-10-17,7.27,6.33,122,84,88,None,None,No Change,0
7080,PT-07080,59,F,Indore Medical Institute,Phase III,ORX-303,Cardiology,Placebo,2023-08-24,2023-09-07,7.72,6.78,134,84,78,Nausea,None,Worsened,0
7081,PT-07081,53,F,Bhopal Research Hospital,Phase I,ORX-404,Neurology,Low Dose,2023-12-31,2024-02-25,5.67,3.44,149,80,83,Nausea,Moderate,Improved,1
7082,PT-07082,31,F,PGI Chandigarh,Phase III,ORX-505,Infectious Disease,High Dose,2024-06-02,2024-08-31,8.71,8.63,124,85,53,None,None,Improved,1
7083,PT-07083,50,F,Bhopal Research Hospital,Phase III,ORX-404,Neurology,High Dose,2024-03-29,2024-05-24,8.98,8.87,131,78,93,None,None,Improved,1
7084,PT-07084,64,F,Kolkata Clinical Center,Phase IV,ORX-101,Oncology,Placebo,2024-02-04,2024-02-11,6.68,6.6,132,86,67,None,None,Worsened,0
7085,PT-07085,63,M,Kolkata Clinical Center,Phase II,ORX-202,Diabetes,High Dose,2023-12-24,2024-01-07,7.88,8.56,107,69,106,None,None,No Change,0
7086,PT-07086,63,M,Kolkata Clinical Center,Phase II,ORX-505,Infectious Disease,Placebo,2024-04-23,2024-07-22,6.22,6.6,119,61,48,None,None,Improved,0
7087,PT-07087,44,F,Indore Medical Institute,Phase III,ORX-505,Infectious Disease,Low Dose,2023-09-24,2023-11-19,9.07,10.04,150,91,82,None,None,Improved,0
7088,PT-07088,63,F,Bhopal Research Hospital,Phase II,ORX-303,Cardiology,Placebo,2023-11-10,2023-11-24,4.79,5.28,107,71,87,None,None,No Change,0
7089,PT-07089,59,F,AIIMS Delhi,Phase III,ORX-404,Neurology,Low Dose,2024-02-29,2024-03-14,6.47,6.65,138,78,80,None,None,No Change,0
7090,PT-07090,78,M,Apollo Chennai,Phase III,ORX-505,Infectious Disease,High Dose,2023-08-27,2023-09-10,6.86,6.24,130,79,89,Headache,Mild,Improved,1
7091,PT-07091,68,F,PGI Chandigarh,Phase IV,ORX-303,Cardiology,High Dose,2024-08-10,2024-11-08,6.9,5.73,163,83,54,None,None,Improved,1
7092,PT-07092,74,F,PGI Chandigarh,Phase I,ORX-505,Infectious Disease,Low Dose,2024-10-24,2024-12-19,8.55,9.59,153,113,63,Rash,None,Improved,0
7093,PT-07093,32,M,Bhopal Research Hospital,Phase II,ORX-202,Diabetes,High Dose,2024-11-20,2025-01-15,6.61,5.74,130,76,61,None,None,Improved,1
7094,PT-07094,31,F,Kolkata Clinical Center,Phase III,ORX-606,Rheumatology,High Dose,2024-10-18,2025-01-16,6.85,7.48,117,91,59,Fatigue,None,Improved,0
7095,PT-07095,18,M,Kolkata Clinical Center,Phase IV,ORX-404,Neurology,Placebo,2023-11-24,2024-02-22,7.04,6.09,112,70,68,Rash,None,Improved,1
7096,PT-07096,29,M,AIIMS Delhi,Phase IV,ORX-606,Rheumatology,Low Dose,2024-08-22,2024-09-19,6.12,4.5,90,55,112,None,None,Improved,1
7097,PT-07097,43,F,Indore Medical Institute,Phase I,ORX-404,Neurology,Low Dose,2023-01-27,2023-02-10,9.03,8.47,125,85,86,Headache,Mild,No Change,0
7098,PT-07098,25,F,Fortis Mumbai,Phase II,ORX-101,Oncology,Low Dose,2023-01-12,2023-02-09,6.74,6.62,93,97,92,Nausea,None,Worsened,0
7099,PT-07099,18,F,NIMHANS Bengaluru,Phase III,ORX-606,Rheumatology,High Dose,2023-04-17,2023-06-12,6.15,5.84,143,100,69,None,None,Improved,1
7100,PT-07100,82,F,Kolkata Clinical Center,Phase III,ORX-202,Diabetes,Placebo,2023-01-16,2023-02-13,7.14,6.54,138,85,81,Rash,None,Worsened,0
7101,PT-07101,76,M,AIIMS Delhi,Phase I,ORX-303,Cardiology,Placebo,2024-06-23,2024-08-18,7.5,6.21,112,99,87,None,None,Improved,1
7102,PT-07102,20,F,PGI Chandigarh,Phase III,ORX-101,Oncology,Placebo,2023-03-26,2023-04-09,5.27,,139,73,54,Fever,Mild,No Change,0
7103,PT-07103,26,F,Kolkata Clinical Center,Phase III,ORX-101,Oncology,High Dose,2024-01-23,2024-02-20,9.17,9.22,146,95,69,Rash,None,Improved,0
7104,PT-07104,39,M,Fortis Mumbai,Phase I,ORX-505,Infectious Disease,Low Dose,2024-06-06,2024-06-20,7.0,6.97,147,104,89,None,None,Improved,1
7105,PT-07105,58,M,Indore Medical Institute,Phase I,ORX-202,Diabetes,High Dose,2023-04-21,2023-05-19,9.51,8.93,149,88,86,None,None,No Change,0
7106,PT-07106,41,M,NIMHANS Bengaluru,Phase I,ORX-606,Rheumatology,Low Dose,2024-01-09,2024-03-05,5.53,5.44,134,75,76,None,None,Improved,1
7107,PT-07107,30,F,Kolkata Clinical Center,Phase IV,ORX-202,Diabetes,Low Dose,2023-01-28,2023-03-25,6.15,5.32,104,74,87,None,None,No Change,0
7108,PT-07108,68,F,Kolkata Clinical Center,Phase II,ORX-606,Rheumatology,Low Dose,2024-08-19,2024-09-16,9.69,8.93,149,86,74,None,None,No Change,0
7109,PT-07109,51,M,PGI Chandigarh,Phase I,ORX-101,Oncology,Placebo,2024-10-10,2025-01-08,8.52,7.67,118,77,69,None,None,Improved,1
7110,PT-07110,64,M,Apollo Chennai,Phase I,ORX-303,Cardiology,High Dose,2023-03-14,2023-06-12,6.28,5.35,133,84,72,Headache,Mild,Improved,1
7111,PT-07111,71,F,Bhopal Research Hospital,Phase III,ORX-404,Neurology,High Dose,2024-01-05,2024-04-04,6.44,5.89,93,78,59,None,None,Worsened,0
7112,PT-07112,30,M,NIMHANS Bengaluru,Phase III,ORX-101,Oncology,Low Dose,2024-10-27,2024-12-22,4.85,3.65,126,79,72,Dizziness,None,Improved,1
7113,PT-07113,39,M,PGI Chandigarh,Phase IV,ORX-505,Infectious Disease,Placebo,2023-07-20,2023-10-18,6.59,6.16,126,85,75,Headache,Severe,Improved,1
7114,PT-07114,38,M,NIMHANS Bengaluru,Phase III,ORX-303,Cardiology,High Dose,2024-07-14,2024-07-28,8.13,8.28,127,96,79,Nausea,None,Improved,0
7115,PT-07115,42,F,PGI Chandigarh,Phase I,ORX-606,Rheumatology,High Dose,2023-11-17,2024-02-15,7.12,6.87,111,59,81,None,None,No Change,0
7116,PT-07116,58,F,Kolkata Clinical Center,Phase III,ORX-303,Cardiology,High Dose,2024-01-22,2024-02-05,6.0,6.56,98,75,101,Nausea,Moderate,Improved,0
7117,PT-07117,50,M,Apollo Chennai,Phase III,ORX-202,Diabetes,Placebo,2024-04-23,2024-05-07,6.84,6.66,149,64,96,Headache,None,No Change,0
7118,PT-07118,37,F,Indore Medical Institute,Phase II,ORX-101,Oncology,Placebo,2024-02-08,2024-05-08,8.05,7.1,158,81,59,None,None,No Change,0
7119,PT-07119,52,F,AIIMS Delhi,Phase III,ORX-303,Cardiology,Low Dose,2024-03-31,2024-05-26,8.76,9.43,129,91,72,Nausea,Mild,Improved,0
7120,PT-07120,54,F,Kolkata Clinical Center,Phase III,ORX-404,Neurology,Low Dose,2024-01-26,2024-02-02,7.64,4.63,109,84,80,None,None,Improved,1
7121,PT-07121,44,F,PGI Chandigarh,Phase I,ORX-202,Diabetes,Placebo,2023-05-07,2023-06-04,7.31,7.99,134,54,105,None,None,No Change,0
7122,PT-07122,18,M,PGI Chandigarh,Phase III,ORX-202,Diabetes,Placebo,2024-04-11,2024-04-18,8.35,6.54,153,78,83,None,None,No Change,0
7123,PT-07123,18,F,NIMHANS Bengaluru,Phase III,ORX-303,Cardiology,High Dose,2024-01-10,2024-04-09,8.08,,139,93,80,None,None,Improved,1
7124,PT-07124,41,M,Apollo Chennai,Phase III,ORX-404,Neurology,Placebo,2024-04-07,2024-04-21,6.23,5.43,149,71,52,None,None,Improved,1
7125,PT-07125,29,F,AIIMS Delhi,Phase IV,ORX-101,Oncology,High Dose,2023-11-03,2024-02-01,7.93,7.25,138,57,45,Fatigue,None,No Change,0
7126,PT-07126,49,F,PGI Chandigarh,Phase I,ORX-404,Neurology,High Dose,2024-11-16,2024-11-30,8.41,6.47,137,96,77,None,None,Improved,1
7127,PT-07127,59,M,Bhopal Research Hospital,Phase III,ORX-202,Diabetes,Low Dose,2024-01-23,2024-04-22,7.43,6.79,142,104,70,Rash,Moderate,Worsened,0
7128,PT-07128,43,M,AIIMS Delhi,Phase II,ORX-505,Infectious Disease,Low Dose,2024-05-12,2024-05-26,6.01,5.75,125,95,97,None,None,Improved,1
7129,PT-07129,57,M,Bhopal Research Hospital,Phase III,ORX-202,Diabetes,High Dose,2023-01-29,2023-02-12,8.46,7.42,110,87,78,None,None,Improved,1
7130,PT-07130,76,F,Fortis Mumbai,Phase III,ORX-505,Infectious Disease,Placebo,2024-07-27,2024-08-10,4.89,5.05,138,72,64,None,None,Improved,0
7131,PT-07131,39,F,AIIMS Delhi,Phase III,ORX-303,Cardiology,Low Dose,2023-04-28,2023-07-27,5.23,6.14,176,77,69,Dizziness,None,Worsened,0
7132,PT-07132,24,F,Kolkata Clinical Center,Phase III,ORX-202,Diabetes,High Dose,2024-02-16,2024-02-23,5.88,4.95,149,120,67,Fatigue,None,Improved,1
7133,PT-07133,30,M,Bhopal Research Hospital,Phase III,ORX-404,Neurology,Placebo,2024-08-22,2024-11-20,5.8,5.8,134,83,71,Rash,None,Worsened,0
7134,PT-07134,66,M,Apollo Chennai,Phase III,ORX-505,Infectious Disease,Low Dose,2023-06-27,2023-07-25,8.12,8.37,134,79,67,Fatigue,None,Improved,0
7135,PT-07135,53,F,Fortis Mumbai,Phase IV,ORX-404,Neurology,High Dose,2023-06-19,2023-06-26,7.71,7.82,99,86,73,None,None,Improved,0
7136,PT-07136,30,M,Indore Medical Institute,Phase II,ORX-505,Infectious Disease,Placebo,2024-07-28,2024-08-11,8.07,7.83,170,87,73,None,None,Improved,1
7137,PT-07137,43,F,NIMHANS Bengaluru,Phase III,ORX-606,Rheumatology,Low Dose,2023-11-24,2023-12-08,5.79,6.5,133,85,63,Nausea,Mild,Improved,0
7138,PT-07138,57,M,Kolkata Clinical Center,Phase III,ORX-606,Rheumatology,High Dose,2024-09-13,2024-12-12,6.08,5.18,130,75,66,None,None,Improved,1
7139,PT-07139,44,F,Fortis Mumbai,Phase IV,ORX-505,Infectious Disease,Placebo,2024-03-03,2024-03-31,8.41,8.82,140,87,71,Fatigue,None,No Change,0
7140,PT-07140,62,M,Fortis Mumbai,Phase III,ORX-404,Neurology,Low Dose,2023-01-19,2023-03-16,5.12,5.11,143,80,67,None,None,Improved,1
7141,PT-07141,44,M,Fortis Mumbai,Phase III,ORX-404,Neurology,Placebo,2023-03-16,2023-03-23,6.29,6.35,145,87,83,None,None,No Change,0
7142,PT-07142,57,F,Kolkata Clinical Center,Phase III,ORX-202,Diabetes,Placebo,2024-01-17,2024-01-24,8.25,7.15,100,85,90,None,None,No Change,0
7143,PT-07143,19,M,Fortis Mumbai,Phase II,ORX-101,Oncology,Low Dose,2024-02-04,2024-03-03,7.28,7.9,125,100,96,Fever,Severe,No Change,0
7144,PT-07144,42,M,Kolkata Clinical Center,Phase III,ORX-303,Cardiology,High Dose,2023-11-13,2023-11-20,6.76,6.04,130,67,58,None,None,No Change,0
7145,PT-07145,18,F,Indore Medical Institute,Phase II,ORX-303,Cardiology,Low Dose,2023-09-01,2023-09-29,7.17,8.61,92,79,75,None,None,Improved,0
7146,PT-07146,42,M,Kolkata Clinical Center,Phase II,ORX-404,Neurology,Placebo,2024-01-05,2024-01-19,8.71,7.51,92,75,68,Fatigue,None,Improved,1
7147,PT-07147,18,M,Apollo Chennai,Phase III,ORX-505,Infectious Disease,Placebo,2023-05-08,2023-05-22,7.49,6.03,126,77,62,None,None,No Change,0
7148,PT-07148,59,M,Bhopal Research Hospital,Phase III,ORX-606,Rheumatology,Low Dose,2024-05-17,2024-06-14,6.86,6.51,138,85,80,Rash,None,Worsened,0
7149,PT-07149,31,F,AIIMS Delhi,Phase II,ORX-404,Neurology,Placebo,2024-10-07,2024-11-04,5.87,5.61,110,91,76,Dizziness,Mild,Improved,1
7150,PT-07150,55,F,Apollo Chennai,Phase I,ORX-303,Cardiology,Low Dose,2023-05-22,2023-08-20,6.02,4.59,158,80,90,Fatigue,None,Improved,1
7151,PT-07151,22,F,AIIMS Delhi,Phase II,ORX-202,Diabetes,High Dose,2023-10-21,2023-12-16,6.86,7.63,99,109,80,Fatigue,Mild,Improved,0
7152,PT-07152,31,M,Apollo Chennai,Phase II,ORX-202,Diabetes,Low Dose,2023-02-15,2023-03-01,7.62,8.22,113,73,81,None,None,Improved,0
7153,PT-07153,52,F,Bhopal Research Hospital,Phase II,ORX-404,Neurology,High Dose,2023-12-29,2024-03-28,6.96,6.92,143,84,68,Headache,Mild,Improved,1
7154,PT-07154,44,M,Apollo Chennai,Phase III,ORX-101,Oncology,Low Dose,2024-06-03,2024-06-10,9.31,9.21,150,75,81,None,None,No Change,0
7155,PT-07155,57,M,AIIMS Delhi,Phase III,ORX-303,Cardiology,High Dose,2024-11-06,2024-11-20,9.0,9.7,107,95,101,Rash,None,Improved,0
7156,PT-07156,35,F,PGI Chandigarh,Phase IV,ORX-505,Infectious Disease,Low Dose,2023-06-14,2023-06-28,6.13,5.7,131,77,61,None,None,Improved,1
7157,PT-07157,68,M,Apollo Chennai,Phase I,ORX-505,Infectious Disease,Low Dose,2023-09-26,2023-12-25,6.17,5.31,129,64,56,Rash,Moderate,Improved,1
7158,PT-07158,38,M,NIMHANS Bengaluru,Phase III,ORX-404,Neurology,Low Dose,2024-01-12,2024-01-19,8.19,7.96,90,98,89,None,None,Improved,1
7159,PT-07159,48,F,Fortis Mumbai,Phase III,ORX-303,Cardiology,Placebo,2023-11-10,2023-11-24,7.4,7.6,169,92,82,Nausea,Mild,No Change,0
7160,PT-07160,25,M,NIMHANS Bengaluru,Phase III,ORX-505,Infectious Disease,Placebo,2023-08-25,2023-09-08,7.4,7.69,125,75,85,None,None,Worsened,0
7161,PT-07161,29,M,PGI Chandigarh,Phase II,ORX-303,Cardiology,High Dose,2024-04-03,2024-04-17,8.24,7.45,90,76,77,None,None,Improved,1
7162,PT-07162,53,M,Apollo Chennai,Phase IV,ORX-101,Oncology,Placebo,2024-02-03,2024-03-02,7.72,6.16,130,75,72,None,None,Improved,1
7163,PT-07163,29,F,NIMHANS Bengaluru,Phase II,ORX-606,Rheumatology,High Dose,2024-01-23,2024-03-19,7.14,9.56,161,70,78,Rash,None,Worsened,0
7164,PT-07164,39,F,Kolkata Clinical Center,Phase I,ORX-101,Oncology,Low Dose,2024-10-23,2024-10-30,7.37,7.8,125,73,94,None,None,No Change,0
7165,PT-07165,25,M,Apollo Chennai,Phase III,ORX-202,Diabetes,Low Dose,2023-06-20,2023-07-18,7.43,5.69,109,90,68,None,None,Improved,1
7166,PT-07166,18,F,Fortis Mumbai,Phase III,ORX-101,Oncology,High Dose,2023-02-26,2023-03-12,6.33,5.19,105,88,56,None,None,No Change,0
7167,PT-07167,35,M,AIIMS Delhi,Phase III,ORX-101,Oncology,High Dose,2024-10-12,2024-10-26,7.36,6.65,120,73,60,None,None,Improved,1
7168,PT-07168,34,F,AIIMS Delhi,Phase II,ORX-202,Diabetes,Low Dose,2023-02-10,2023-04-07,7.99,7.2,131,95,86,Nausea,Moderate,Improved,1
7169,PT-07169,24,F,Indore Medical Institute,Phase III,ORX-404,Neurology,Placebo,2024-09-29,2024-11-24,7.74,8.28,117,62,71,None,None,No Change,0
7170,PT-07170,48,F,Kolkata Clinical Center,Phase III,ORX-303,Cardiology,High Dose,2024-07-28,2024-08-04,7.91,7.04,91,66,83,Nausea,Mild,No Change,0
7171,PT-07171,76,M,Indore Medical Institute,Phase I,ORX-202,Diabetes,Low Dose,2024-06-22,2024-07-20,7.17,7.96,108,74,45,None,None,No Change,0
7172,PT-07172,50,M,Apollo Chennai,Phase II,ORX-202,Diabetes,High Dose,2024-01-13,2024-01-27,6.13,6.27,118,106,103,Headache,Mild,Improved,0
7173,PT-07173,18,F,AIIMS Delhi,Phase II,ORX-101,Oncology,High Dose,2023-03-25,2023-04-08,7.91,6.84,139,65,98,Headache,Moderate,No Change,0
7174,PT-07174,61,F,Apollo Chennai,Phase III,ORX-202,Diabetes,Placebo,2024-02-06,2024-05-06,5.5,4.94,130,90,77,None,None,Improved,1
7175,PT-07175,57,F,Bhopal Research Hospital,Phase II,ORX-101,Oncology,Low Dose,2024-01-30,2024-02-27,7.12,7.27,103,81,94,Headache,Moderate,No Change,0
7176,PT-07176,67,F,AIIMS Delhi,Phase III,ORX-202,Diabetes,Low Dose,2024-01-19,2024-04-18,7.41,6.92,152,80,94,None,None,Improved,1
7177,PT-07177,43,M,Indore Medical Institute,Phase I,ORX-101,Oncology,Placebo,2023-01-04,2023-01-18,7.25,5.85,105,93,102,None,None,Improved,1
7178,PT-07178,46,M,Fortis Mumbai,Phase III,ORX-606,Rheumatology,Placebo,2024-07-30,2024-08-06,7.0,7.52,134,53,91,Fever,Mild,Improved,0
7179,PT-07179,23,M,Indore Medical Institute,Phase I,ORX-303,Cardiology,Placebo,2024-06-14,2024-09-12,7.19,6.39,116,82,90,Nausea,None,No Change,0
7180,PT-07180,45,M,Indore Medical Institute,Phase III,ORX-303,Cardiology,High Dose,2023-10-06,2023-10-20,8.89,9.87,155,81,71,Rash,None,Improved,0
7181,PT-07181,44,F,Indore Medical Institute,Phase I,ORX-101,Oncology,Placebo,2024-09-28,2024-11-23,8.55,9.11,90,85,45,Fever,Mild,Improved,0
7182,PT-07182,44,M,AIIMS Delhi,Phase III,ORX-101,Oncology,Placebo,2024-10-17,2024-10-24,6.57,5.41,143,74,77,Fever,Mild,Improved,1
7183,PT-07183,30,M,Indore Medical Institute,Phase IV,ORX-606,Rheumatology,Low Dose,2024-06-11,2024-07-09,7.29,7.75,112,89,78,Headache,None,No Change,0
7184,PT-07184,45,M,Kolkata Clinical Center,Phase III,ORX-606,Rheumatology,High Dose,2024-04-13,2024-06-08,6.78,7.08,140,80,80,None,None,No Change,0
7185,PT-07185,56,M,Indore Medical Institute,Phase I,ORX-101,Oncology,Low Dose,2023-11-14,2023-12-12,7.85,7.17,148,92,107,Nausea,Moderate,Improved,1
7186,PT-07186,19,F,Apollo Chennai,Phase I,ORX-404,Neurology,Low Dose,2023-09-02,2023-09-16,8.04,8.68,146,78,58,None,None,Improved,0
7187,PT-07187,69,F,AIIMS Delhi,Phase III,ORX-606,Rheumatology,High Dose,2023-01-14,2023-03-11,6.62,5.96,165,66,89,Rash,None,Worsened,0
7188,PT-07188,32,M,Kolkata Clinical Center,Phase IV,ORX-303,Cardiology,Placebo,2024-11-09,2024-12-07,6.27,6.02,140,93,93,Rash,Moderate,Worsened,0
7189,PT-07189,33,M,Fortis Mumbai,Phase I,ORX-606,Rheumatology,Low Dose,2023-08-08,2023-10-03,5.83,5.12,134,79,45,Fever,None,Improved,1
7190,PT-07190,18,F,Kolkata Clinical Center,Phase III,ORX-606,Rheumatology,High Dose,2024-01-28,2024-02-11,6.91,7.28,111,90,57,Dizziness,None,No Change,0
7191,PT-07191,49,M,PGI Chandigarh,Phase II,ORX-404,Neurology,Low Dose,2023-09-25,2023-12-24,7.52,7.54,109,63,88,None,None,Improved,0
7192,PT-07192,20,M,Indore Medical Institute,Phase III,ORX-101,Oncology,High Dose,2024-06-09,2024-09-07,6.27,7.13,131,86,86,None,None,No Change,0
7193,PT-07193,54,M,Kolkata Clinical Center,Phase III,ORX-505,Infectious Disease,Low Dose,2023-06-27,2023-07-11,7.17,,176,78,82,None,None,Worsened,0
7194,PT-07194,52,F,AIIMS Delhi,Phase III,ORX-202,Diabetes,Placebo,2023-05-26,2023-06-09,6.56,5.78,154,73,83,None,None,Improved,1
7195,PT-07195,59,M,Fortis Mumbai,Phase I,ORX-101,Oncology,Placebo,2023-09-22,2023-10-20,6.94,,145,80,48,None,None,Worsened,0
7196,PT-07196,69,M,NIMHANS Bengaluru,Phase II,ORX-303,Cardiology,High Dose,2024-04-07,2024-06-02,6.03,5.82,104,75,71,Headache,None,Improved,1
7197,PT-07197,47,M,Bhopal Research Hospital,Phase II,ORX-404,Neurology,Placebo,2023-11-06,2023-11-20,6.15,7.53,128,92,77,None,None,Improved,0
7198,PT-07198,60,M,Apollo Chennai,Phase IV,ORX-606,Rheumatology,High Dose,2023-01-28,2023-02-11,4.68,3.64,118,75,85,None,None,No Change,0
7199,PT-07199,54,F,NIMHANS Bengaluru,Phase II,ORX-505,Infectious Disease,Placebo,2023-06-03,2023-07-29,7.11,6.67,171,85,46,Headache,None,No Change,0
7200,PT-07200,57,F,Bhopal Research Hospital,Phase I,ORX-404,Neurology,High Dose,2024-03-10,2024-05-05,7.87,,138,71,90,None,None,Improved,0
7201,PT-07201,46,F,PGI Chandigarh,Phase IV,ORX-606,Rheumatology,Low Dose,2024-01-23,2024-03-19,8.46,9.45,125,92,92,None,None,Improved,0
7202,PT-07202,47,M,PGI Chandigarh,Phase IV,ORX-505,Infectious Disease,High Dose,2024-10-15,2024-10-22,9.55,10.09,117,85,90,Dizziness,None,Improved,0
7203,PT-07203,75,F,NIMHANS Bengaluru,Phase III,ORX-505,Infectious Disease,High Dose,2023-10-12,2024-01-10,7.95,7.81,150,79,64,Headache,Moderate,Improved,1
7204,PT-07204,56,F,Fortis Mumbai,Phase II,ORX-303,Cardiology,High Dose,2024-11-15,2025-02-13,6.75,8.79,132,90,69,None,None,Worsened,0
7205,PT-07205,65,M,NIMHANS Bengaluru,Phase II,ORX-505,Infectious Disease,Placebo,2023-06-13,2023-09-11,7.17,6.66,126,66,74,None,None,Improved,1
7206,PT-07206,53,F,Indore Medical Institute,Phase II,ORX-303,Cardiology,Low Dose,2024-01-11,2024-01-25,5.35,5.87,123,84,46,None,None,Worsened,0
7207,PT-07207,48,M,Indore Medical Institute,Phase III,ORX-303,Cardiology,High Dose,2024-05-01,2024-05-15,5.95,5.23,99,71,75,None,None,Improved,1
7208,PT-07208,40,M,Indore Medical Institute,Phase IV,ORX-202,Diabetes,High Dose,2023-02-20,2023-03-06,8.26,6.18,127,80,71,None,None,Improved,1
7209,PT-07209,30,M,Kolkata Clinical Center,Phase IV,ORX-404,Neurology,Low Dose,2023-01-19,2023-01-26,8.52,9.97,97,70,63,None,None,No Change,0
7210,PT-07210,40,M,Apollo Chennai,Phase III,ORX-202,Diabetes,Placebo,2024-07-10,2024-08-07,8.71,8.78,125,82,73,Nausea,None,Improved,0
7211,PT-07211,56,F,NIMHANS Bengaluru,Phase I,ORX-202,Diabetes,Low Dose,2024-07-24,2024-07-31,8.23,8.36,90,82,75,None,None,Improved,0
7212,PT-07212,60,F,Indore Medical Institute,Phase II,ORX-404,Neurology,Low Dose,2024-01-26,2024-02-23,7.49,7.59,119,93,95,None,None,No Change,0
7213,PT-07213,18,M,NIMHANS Bengaluru,Phase III,ORX-303,Cardiology,Placebo,2023-12-23,2023-12-30,5.64,5.93,124,94,81,None,None,Improved,0
7214,PT-07214,56,F,Apollo Chennai,Phase IV,ORX-404,Neurology,Placebo,2023-06-18,2023-06-25,6.3,6.21,134,73,92,None,None,No Change,0
7215,PT-07215,18,M,Kolkata Clinical Center,Phase II,ORX-404,Neurology,High Dose,2024-06-25,2024-08-20,7.45,5.88,109,93,62,Headache,None,No Change,0
7216,PT-07216,26,F,PGI Chandigarh,Phase II,ORX-101,Oncology,Low Dose,2024-09-03,2024-09-17,7.9,6.5,146,89,67,Nausea,None,No Change,0
7217,PT-07217,60,M,Bhopal Research Hospital,Phase III,ORX-202,Diabetes,Placebo,2023-11-28,2023-12-26,4.87,4.9,105,75,71,Dizziness,Severe,Worsened,0
7218,PT-07218,65,M,NIMHANS Bengaluru,Phase III,ORX-202,Diabetes,Placebo,2024-05-20,2024-07-15,6.6,6.13,120,70,63,Nausea,None,Improved,1
7219,PT-07219,49,F,Apollo Chennai,Phase I,ORX-404,Neurology,Placebo,2024-02-10,2024-04-06,7.17,7.45,123,79,88,None,None,No Change,0
7220,PT-07220,39,M,Kolkata Clinical Center,Phase III,ORX-404,Neurology,Placebo,2024-09-12,2024-09-19,5.47,5.84,115,82,69,None,None,Improved,0
7221,PT-07221,29,F,PGI Chandigarh,Phase I,ORX-303,Cardiology,Low Dose,2023-08-31,2023-09-07,4.92,4.83,90,97,92,None,None,No Change,0
7222,PT-07222,30,M,Fortis Mumbai,Phase IV,ORX-505,Infectious Disease,High Dose,2023-03-11,2023-05-06,9.11,10.56,123,86,79,Nausea,None,Improved,0
7223,PT-07223,69,F,AIIMS Delhi,Phase III,ORX-404,Neurology,High Dose,2023-05-23,2023-06-20,5.53,4.92,144,91,77,None,None,Improved,1
7224,PT-07224,67,F,Bhopal Research Hospital,Phase IV,ORX-505,Infectious Disease,High Dose,2023-12-20,2023-12-27,7.48,7.18,140,81,78,Dizziness,None,Improved,1
7225,PT-07225,32,F,NIMHANS Bengaluru,Phase I,ORX-202,Diabetes,Placebo,2024-08-19,2024-08-26,10.72,9.89,141,104,59,None,None,No Change,0
7226,PT-07226,54,M,Apollo Chennai,Phase IV,ORX-101,Oncology,Placebo,2023-07-22,2023-08-05,7.23,8.44,111,72,77,None,None,Improved,0
7227,PT-07227,37,M,Fortis Mumbai,Phase III,ORX-606,Rheumatology,Placebo,2023-07-02,2023-08-27,6.65,8.07,130,72,72,None,None,Improved,0
7228,PT-07228,51,F,Bhopal Research Hospital,Phase III,ORX-404,Neurology,Low Dose,2023-10-07,2023-12-02,7.6,6.69,98,81,76,Rash,Moderate,Worsened,0
7229,PT-07229,34,F,PGI Chandigarh,Phase III,ORX-505,Infectious Disease,Placebo,2024-02-27,2024-04-23,8.74,8.85,130,77,102,Headache,Mild,Improved,0
7230,PT-07230,26,F,Kolkata Clinical Center,Phase III,ORX-606,Rheumatology,High Dose,2024-09-17,2024-09-24,6.6,5.8,133,89,59,Nausea,Severe,Improved,1
7231,PT-07231,34,M,Kolkata Clinical Center,Phase I,ORX-101,Oncology,Low Dose,2023-06-09,2023-09-07,7.74,6.74,120,84,64,None,None,Improved,1
7232,PT-07232,49,M,Kolkata Clinical Center,Phase II,ORX-101,Oncology,Low Dose,2023-02-22,2023-04-19,7.94,7.57,153,90,77,Nausea,Moderate,Improved,1
7233,PT-07233,39,M,Indore Medical Institute,Phase IV,ORX-606,Rheumatology,High Dose,2023-07-06,2023-07-13,9.31,8.31,123,77,83,Headache,Mild,No Change,0
7234,PT-07234,81,F,Kolkata Clinical Center,Phase II,ORX-101,Oncology,High Dose,2024-07-24,2024-09-18,7.5,6.81,131,66,75,None,None,No Change,0
7235,PT-07235,72,F,AIIMS Delhi,Phase II,ORX-303,Cardiology,Low Dose,2023-05-18,2023-06-15,7.99,8.7,146,73,104,Nausea,None,Improved,0
7236,PT-07236,18,F,AIIMS Delhi,Phase I,ORX-505,Infectious Disease,High Dose,2023-01-31,2023-02-14,7.6,5.35,97,93,68,None,None,Improved,1
7237,PT-07237,64,F,AIIMS Delhi,Phase II,ORX-505,Infectious Disease,High Dose,2024-11-09,2024-12-07,4.59,4.11,106,78,99,None,None,Improved,1
7238,PT-07238,73,F,Bhopal Research Hospital,Phase III,ORX-202,Diabetes,Low Dose,2024-06-24,2024-07-01,7.82,5.98,106,83,66,Fatigue,None,No Change,0
7239,PT-07239,55,F,NIMHANS Bengaluru,Phase II,ORX-202,Diabetes,High Dose,2024-07-17,2024-07-24,9.21,7.93,111,67,74,Headache,Mild,No Change,0
7240,PT-07240,45,F,AIIMS Delhi,Phase IV,ORX-505,Infectious Disease,Placebo,2023-04-15,2023-05-13,7.23,7.63,135,81,78,None,None,Improved,0
7241,PT-07241,46,M,PGI Chandigarh,Phase III,ORX-505,Infectious Disease,Low Dose,2024-05-30,2024-06-27,7.13,6.12,106,83,71,Fever,Severe,Improved,1
7242,PT-07242,53,M,Apollo Chennai,Phase II,ORX-101,Oncology,High Dose,2023-11-05,2024-02-03,7.29,6.9,145,65,102,None,None,Improved,1
7243,PT-07243,18,M,AIIMS Delhi,Phase III,ORX-505,Infectious Disease,Low Dose,2023-05-12,2023-05-19,8.94,8.72,118,64,69,Nausea,None,Worsened,0
7244,PT-07244,42,F,AIIMS Delhi,Phase II,ORX-505,Infectious Disease,Placebo,2023-03-09,2023-04-06,7.43,8.33,129,85,82,Rash,None,Worsened,0
7245,PT-07245,39,F,Fortis Mumbai,Phase IV,ORX-404,Neurology,High Dose,2024-08-18,2024-10-13,6.97,6.47,139,71,70,Fatigue,None,No Change,0
7246,PT-07246,50,M,AIIMS Delhi,Phase I,ORX-101,Oncology,Low Dose,2023-02-06,2023-03-06,5.91,5.61,118,88,97,Nausea,Moderate,No Change,0
7247,PT-07247,36,F,AIIMS Delhi,Phase II,ORX-505,Infectious Disease,Placebo,2024-10-21,2024-10-28,8.11,7.89,121,82,96,Rash,Mild,Worsened,0
7248,PT-07248,42,M,Fortis Mumbai,Phase III,ORX-202,Diabetes,Placebo,2024-03-24,2024-04-21,8.77,8.26,102,80,57,None,None,No Change,0
7249,PT-07249,39,F,Fortis Mumbai,Phase III,ORX-202,Diabetes,Low Dose,2023-01-05,2023-01-12,6.77,8.01,156,83,94,None,None,No Change,0
7250,PT-07250,38,M,Kolkata Clinical Center,Phase III,ORX-101,Oncology,High Dose,2024-03-04,2024-06-02,5.49,5.56,134,70,65,None,None,No Change,0
7251,PT-07251,60,M,AIIMS Delhi,Phase III,ORX-303,Cardiology,Placebo,2023-04-28,2023-06-23,5.18,5.28,122,88,91,None,None,Improved,0
7252,PT-07252,31,M,NIMHANS Bengaluru,Phase I,ORX-505,Infectious Disease,High Dose,2024-04-20,2024-05-04,5.83,6.75,126,85,90,Fatigue,None,Worsened,0
7253,PT-07253,29,F,Indore Medical Institute,Phase IV,ORX-404,Neurology,Low Dose,2023-03-17,2023-06-15,8.28,8.46,154,99,78,Nausea,Severe,Worsened,0
7254,PT-07254,57,F,PGI Chandigarh,Phase III,ORX-606,Rheumatology,Placebo,2023-12-09,2024-02-03,7.25,6.98,107,79,52,None,None,Improved,1
7255,PT-07255,42,F,Indore Medical Institute,Phase IV,ORX-101,Oncology,High Dose,2024-03-21,2024-05-16,8.78,9.08,130,79,70,None,None,Improved,0
7256,PT-07256,30,M,Kolkata Clinical Center,Phase III,ORX-303,Cardiology,Placebo,2024-09-17,2024-12-16,8.18,6.4,99,92,80,None,None,Worsened,0
7257,PT-07257,45,M,NIMHANS Bengaluru,Phase III,ORX-101,Oncology,High Dose,2024-07-06,2024-08-31,7.45,8.86,129,85,106,None,None,No Change,0
7258,PT-07258,43,F,AIIMS Delhi,Phase III,ORX-606,Rheumatology,High Dose,2024-06-03,2024-07-01,9.27,6.98,107,73,86,Nausea,None,No Change,0
7259,PT-07259,73,M,Fortis Mumbai,Phase IV,ORX-505,Infectious Disease,Placebo,2024-08-18,2024-09-15,6.49,6.97,168,100,72,Fatigue,Mild,Improved,0
7260,PT-07260,58,F,NIMHANS Bengaluru,Phase III,ORX-404,Neurology,High Dose,2023-04-30,2023-07-29,7.61,6.61,135,76,79,None,None,Improved,1
7261,PT-07261,22,M,Indore Medical Institute,Phase I,ORX-505,Infectious Disease,Placebo,2024-05-01,2024-05-15,5.08,4.43,133,68,85,Fatigue,None,Improved,1
7262,PT-07262,45,F,Kolkata Clinical Center,Phase II,ORX-101,Oncology,Low Dose,2023-12-06,2024-01-31,7.98,8.43,152,89,73,None,None,Improved,0
7263,PT-07263,48,F,Apollo Chennai,Phase I,ORX-505,Infectious Disease,Low Dose,2023-11-18,2023-11-25,10.0,10.48,129,80,69,Fever,Severe,Improved,0
7264,PT-07264,26,M,AIIMS Delhi,Phase III,ORX-404,Neurology,Placebo,2024-08-26,2024-09-02,9.25,9.28,105,80,95,None,None,Improved,0
7265,PT-07265,37,M,Bhopal Research Hospital,Phase I,ORX-606,Rheumatology,Low Dose,2024-11-09,2024-11-16,6.22,6.14,139,76,69,Nausea,Mild,Improved,1
7266,PT-07266,52,M,AIIMS Delhi,Phase III,ORX-606,Rheumatology,High Dose,2024-06-19,2024-08-14,5.85,4.97,125,90,72,Headache,None,Improved,1
7267,PT-07267,54,M,Indore Medical Institute,Phase IV,ORX-404,Neurology,Low Dose,2023-03-29,2023-04-05,8.6,7.74,186,99,81,None,None,Worsened,0
7268,PT-07268,42,M,Fortis Mumbai,Phase IV,ORX-606,Rheumatology,Low Dose,2024-11-19,2025-02-17,6.53,7.63,131,64,54,None,None,Improved,0
7269,PT-07269,46,F,NIMHANS Bengaluru,Phase III,ORX-202,Diabetes,Low Dose,2023-11-06,2023-12-04,7.36,6.14,100,58,67,Headache,Moderate,Improved,1
7270,PT-07270,39,M,NIMHANS Bengaluru,Phase III,ORX-202,Diabetes,High Dose,2024-11-26,2024-12-03,8.03,7.51,147,89,85,Fatigue,None,Improved,1
7271,PT-07271,60,M,PGI Chandigarh,Phase III,ORX-404,Neurology,High Dose,2023-02-06,2023-05-07,5.54,4.65,171,59,73,None,None,Improved,1
7272,PT-07272,52,M,Kolkata Clinical Center,Phase IV,ORX-404,Neurology,High Dose,2024-07-07,2024-07-21,4.95,3.87,163,84,69,None,None,Improved,1
7273,PT-07273,48,M,Fortis Mumbai,Phase III,ORX-606,Rheumatology,High Dose,2023-11-07,2024-01-02,6.51,7.65,110,75,57,Headache,None,Improved,0
7274,PT-07274,40,F,Apollo Chennai,Phase III,ORX-101,Oncology,Placebo,2023-02-14,2023-02-28,6.99,7.67,109,87,79,Fatigue,Severe,Worsened,0
7275,PT-07275,18,F,AIIMS Delhi,Phase II,ORX-404,Neurology,Low Dose,2023-03-14,2023-04-11,6.33,5.24,158,88,80,Fever,None,Improved,1
7276,PT-07276,18,F,Bhopal Research Hospital,Phase II,ORX-606,Rheumatology,Low Dose,2023-07-27,2023-10-25,4.91,5.17,142,73,78,Nausea,None,No Change,0
7277,PT-07277,44,F,PGI Chandigarh,Phase I,ORX-505,Infectious Disease,Low Dose,2024-03-03,2024-06-01,7.4,6.67,142,95,64,None,None,Worsened,0
7278,PT-07278,25,M,AIIMS Delhi,Phase III,ORX-303,Cardiology,Placebo,2023-06-23,2023-09-21,6.24,5.89,134,91,91,Rash,Moderate,Improved,1
7279,PT-07279,50,M,AIIMS Delhi,Phase II,ORX-202,Diabetes,Placebo,2024-06-17,2024-09-15,7.48,8.56,128,89,82,Headache,None,Worsened,0
7280,PT-07280,42,F,Kolkata Clinical Center,Phase II,ORX-101,Oncology,High Dose,2023-11-17,2023-11-24,7.0,7.79,126,77,67,None,None,Improved,0
7281,PT-07281,51,M,Bhopal Research Hospital,Phase III,ORX-303,Cardiology,High Dose,2024-11-19,2025-02-17,6.59,6.48,131,76,58,Fatigue,None,Improved,1
7282,PT-07282,28,M,Kolkata Clinical Center,Phase III,ORX-606,Rheumatology,Placebo,2024-10-11,2024-10-18,6.15,4.85,136,107,70,Dizziness,None,No Change,0
7283,PT-07283,38,F,Bhopal Research Hospital,Phase III,ORX-101,Oncology,Placebo,2024-03-12,2024-05-07,6.5,6.87,135,81,61,Rash,Moderate,Improved,0
7284,PT-07284,29,M,NIMHANS Bengaluru,Phase I,ORX-505,Infectious Disease,High Dose,2023-08-17,2023-09-14,7.41,7.21,127,89,60,Nausea,Mild,No Change,0
7285,PT-07285,49,F,Kolkata Clinical Center,Phase III,ORX-303,Cardiology,High Dose,2024-02-03,2024-03-30,7.5,6.24,117,90,62,Fatigue,Mild,No Change,0
7286,PT-07286,84,F,Kolkata Clinical Center,Phase I,ORX-505,Infectious Disease,Placebo,2024-10-25,2025-01-23,7.87,7.42,123,91,72,Dizziness,None,No Change,0
7287,PT-07287,39,M,Indore Medical Institute,Phase III,ORX-404,Neurology,High Dose,2024-10-28,2024-11-25,8.94,8.12,130,72,81,None,None,Worsened,0
7288,PT-07288,54,M,Apollo Chennai,Phase III,ORX-303,Cardiology,Low Dose,2024-03-28,2024-05-23,9.22,7.98,101,78,69,Fever,None,Improved,1
7289,PT-07289,44,F,Bhopal Research Hospital,Phase II,ORX-101,Oncology,High Dose,2024-01-10,2024-02-07,7.83,9.46,119,55,74,None,None,No Change,0
7290,PT-07290,50,F,PGI Chandigarh,Phase III,ORX-404,Neurology,High Dose,2023-10-25,2023-11-22,6.04,5.85,130,85,89,None,None,Worsened,0
7291,PT-07291,43,M,Bhopal Research Hospital,Phase IV,ORX-606,Rheumatology,Low Dose,2024-01-31,2024-02-07,7.86,5.84,110,77,63,None,None,Improved,1
7292,PT-07292,45,M,AIIMS Delhi,Phase IV,ORX-505,Infectious Disease,High Dose,2023-10-26,2023-12-21,6.79,5.98,143,83,62,None,None,Improved,1
7293,PT-07293,35,F,Kolkata Clinical Center,Phase II,ORX-303,Cardiology,Placebo,2023-05-17,2023-06-14,8.1,7.88,149,92,72,None,None,No Change,0
7294,PT-07294,67,M,Bhopal Research Hospital,Phase III,ORX-505,Infectious Disease,Low Dose,2024-09-28,2024-12-27,9.02,7.01,128,75,74,Headache,None,Improved,1
7295,PT-07295,31,M,Fortis Mumbai,Phase III,ORX-505,Infectious Disease,Placebo,2023-06-13,2023-08-08,6.07,6.48,106,83,59,None,None,Improved,0
7296,PT-07296,65,F,AIIMS Delhi,Phase III,ORX-404,Neurology,Low Dose,2023-01-15,2023-03-12,7.24,7.51,131,78,78,Dizziness,Severe,No Change,0
7297,PT-07297,69,F,Apollo Chennai,Phase I,ORX-202,Diabetes,Placebo,2023-02-28,2023-04-25,6.12,3.43,113,67,91,Headache,Moderate,No Change,0
7298,PT-07298,42,M,Bhopal Research Hospital,Phase II,ORX-606,Rheumatology,High Dose,2024-08-18,2024-10-13,8.19,7.82,128,83,98,Dizziness,None,No Change,0
7299,PT-07299,47,M,Apollo Chennai,Phase III,ORX-101,Oncology,Low Dose,2024-03-06,2024-05-01,8.53,9.07,125,81,72,Headache,Mild,Improved,0
7300,PT-07300,65,F,Bhopal Research Hospital,Phase III,ORX-505,Infectious Disease,Low Dose,2024-03-17,2024-06-15,6.07,5.02,123,68,69,None,None,Improved,1
7301,PT-07301,63,M,Kolkata Clinical Center,Phase III,ORX-101,Oncology,High Dose,2023-03-07,2023-05-02,7.98,7.2,142,106,82,None,None,No Change,0
7302,PT-07302,67,F,Indore Medical Institute,Phase III,ORX-101,Oncology,Low Dose,2023-06-15,2023-06-22,8.22,7.56,131,88,67,None,None,Worsened,0
7303,PT-07303,18,M,AIIMS Delhi,Phase III,ORX-101,Oncology,High Dose,2023-05-07,2023-08-05,6.2,3.86,114,61,90,Fatigue,Severe,No Change,0
7304,PT-07304,26,F,Kolkata Clinical Center,Phase III,ORX-202,Diabetes,Placebo,2024-03-15,2024-05-10,7.85,8.14,140,59,93,None,None,Improved,0
7305,PT-07305,51,M,Fortis Mumbai,Phase III,ORX-202,Diabetes,Low Dose,2024-06-16,2024-08-11,8.17,9.41,142,67,87,Rash,None,No Change,0
7306,PT-07306,20,F,Fortis Mumbai,Phase I,ORX-505,Infectious Disease,Low Dose,2024-10-27,2024-11-03,7.12,6.27,128,63,58,None,None,Improved,1
7307,PT-07307,37,M,Kolkata Clinical Center,Phase III,ORX-202,Diabetes,Low Dose,2023-04-19,2023-05-17,6.93,6.15,154,87,83,Headache,Severe,Improved,1
7308,PT-07308,38,F,PGI Chandigarh,Phase III,ORX-505,Infectious Disease,Low Dose,2024-09-14,2024-09-28,5.53,5.13,160,84,93,Fatigue,Severe,No Change,0
7309,PT-07309,64,M,AIIMS Delhi,Phase IV,ORX-606,Rheumatology,Low Dose,2024-06-02,2024-06-16,7.87,7.67,110,79,72,Fever,Mild,Improved,1
7310,PT-07310,50,M,Apollo Chennai,Phase III,ORX-404,Neurology,Low Dose,2023-09-30,2023-10-14,5.5,4.62,135,73,65,None,None,Improved,1
7311,PT-07311,32,M,NIMHANS Bengaluru,Phase III,ORX-101,Oncology,High Dose,2024-08-24,2024-08-31,6.87,4.33,114,93,82,None,None,No Change,0
7312,PT-07312,51,M,PGI Chandigarh,Phase III,ORX-404,Neurology,High Dose,2023-12-26,2024-01-09,5.01,4.23,125,87,93,Rash,Mild,No Change,0
7313,PT-07313,60,F,Kolkata Clinical Center,Phase III,ORX-202,Diabetes,High Dose,2023-06-10,2023-08-05,6.5,5.59,153,77,62,Rash,Severe,No Change,0
7314,PT-07314,41,M,NIMHANS Bengaluru,Phase III,ORX-404,Neurology,Low Dose,2023-01-29,2023-02-05,8.82,7.6,120,71,91,None,None,Improved,1
7315,PT-07315,49,M,AIIMS Delhi,Phase II,ORX-404,Neurology,High Dose,2024-11-21,2024-12-19,8.31,9.32,100,72,71,None,None,Improved,0
7316,PT-07316,46,F,NIMHANS Bengaluru,Phase I,ORX-202,Diabetes,High Dose,2024-05-11,2024-07-06,7.81,6.96,115,93,85,None,None,Improved,1
7317,PT-07317,50,F,Indore Medical Institute,Phase III,ORX-606,Rheumatology,Low Dose,2023-09-14,2023-09-21,4.63,5.31,131,80,66,Headache,None,Improved,0
7318,PT-07318,34,F,Indore Medical Institute,Phase IV,ORX-606,Rheumatology,Placebo,2024-05-22,2024-06-05,6.13,3.93,113,62,77,None,None,No Change,0
7319,PT-07319,26,M,PGI Chandigarh,Phase IV,ORX-404,Neurology,Placebo,2024-08-29,2024-09-05,8.08,6.18,149,92,63,None,None,Improved,1
7320,PT-07320,43,M,Bhopal Research Hospital,Phase III,ORX-101,Oncology,High Dose,2024-10-03,2024-10-31,6.17,6.3,160,96,68,Rash,None,Worsened,0
7321,PT-07321,46,M,NIMHANS Bengaluru,Phase IV,ORX-202,Diabetes,High Dose,2023-05-31,2023-07-26,9.03,9.1,146,89,79,None,None,Improved,0
7322,PT-07322,43,F,Fortis Mumbai,Phase I,ORX-202,Diabetes,Placebo,2023-07-09,2023-09-03,5.75,4.66,111,77,79,None,None,Improved,1
7323,PT-07323,43,F,AIIMS Delhi,Phase IV,ORX-303,Cardiology,High Dose,2024-01-20,2024-04-19,7.46,7.66,120,90,93,None,None,Improved,0
7324,PT-07324,51,F,Fortis Mumbai,Phase III,ORX-606,Rheumatology,Low Dose,2024-05-09,2024-05-16,6.55,7.0,136,89,99,None,None,No Change,0
7325,PT-07325,56,M,Bhopal Research Hospital,Phase III,ORX-101,Oncology,High Dose,2024-01-21,2024-02-18,9.09,8.56,120,95,64,None,None,Improved,1
7326,PT-07326,75,F,Bhopal Research Hospital,Phase IV,ORX-303,Cardiology,Low Dose,2024-05-22,2024-08-20,8.76,8.44,149,89,59,None,None,Improved,1
7327,PT-07327,31,M,Kolkata Clinical Center,Phase III,ORX-606,Rheumatology,Placebo,2023-04-12,2023-05-10,7.54,7.29,151,85,60,Nausea,Moderate,No Change,0
7328,PT-07328,36,F,Indore Medical Institute,Phase IV,ORX-404,Neurology,Low Dose,2024-02-29,2024-03-28,8.09,,102,77,90,None,None,Improved,1
7329,PT-07329,41,M,AIIMS Delhi,Phase IV,ORX-101,Oncology,Low Dose,2023-05-03,2023-08-01,7.75,7.36,125,74,89,None,None,Improved,1
7330,PT-07330,24,F,Indore Medical Institute,Phase III,ORX-303,Cardiology,High Dose,2024-02-15,2024-03-14,6.92,7.55,114,63,48,None,None,Improved,0
7331,PT-07331,55,M,NIMHANS Bengaluru,Phase III,ORX-101,Oncology,Placebo,2023-07-01,2023-07-15,8.08,7.37,105,80,94,Headache,Severe,Improved,1
7332,PT-07332,24,F,AIIMS Delhi,Phase III,ORX-404,Neurology,Low Dose,2023-11-06,2023-11-20,8.47,6.54,107,83,91,Fatigue,Mild,Worsened,0
7333,PT-07333,68,M,Bhopal Research Hospital,Phase IV,ORX-303,Cardiology,Low Dose,2023-02-13,2023-05-14,8.39,9.39,131,74,94,Dizziness,None,No Change,0
7334,PT-07334,66,F,NIMHANS Bengaluru,Phase I,ORX-505,Infectious Disease,Placebo,2023-04-30,2023-05-07,8.32,8.47,153,86,77,None,None,No Change,0
7335,PT-07335,56,F,PGI Chandigarh,Phase III,ORX-404,Neurology,Placebo,2023-04-03,2023-04-17,7.77,8.17,125,92,90,Headache,None,Worsened,0
7336,PT-07336,48,F,Fortis Mumbai,Phase I,ORX-303,Cardiology,Low Dose,2024-04-30,2024-05-07,6.3,7.02,106,70,80,Nausea,Mild,Improved,0
7337,PT-07337,18,M,Indore Medical Institute,Phase IV,ORX-303,Cardiology,Placebo,2023-02-23,2023-05-24,9.05,8.66,155,103,75,None,None,Worsened,0
7338,PT-07338,66,M,PGI Chandigarh,Phase II,ORX-606,Rheumatology,Low Dose,2023-10-16,2023-10-30,5.93,5.92,119,90,90,Nausea,Moderate,Improved,1
7339,PT-07339,42,M,Bhopal Research Hospital,Phase III,ORX-202,Diabetes,Low Dose,2024-11-02,2025-01-31,7.85,8.3,131,112,76,None,None,No Change,0
7340,PT-07340,71,F,AIIMS Delhi,Phase II,ORX-606,Rheumatology,High Dose,2023-05-03,2023-05-17,8.57,6.5,154,94,79,None,None,Worsened,0
7341,PT-07341,50,M,Indore Medical Institute,Phase IV,ORX-404,Neurology,Low Dose,2023-12-01,2024-01-26,7.79,8.63,120,101,62,Headache,Mild,Improved,0
7342,PT-07342,18,M,PGI Chandigarh,Phase III,ORX-303,Cardiology,Placebo,2023-03-20,2023-03-27,7.91,8.65,124,54,57,None,None,No Change,0
7343,PT-07343,51,F,NIMHANS Bengaluru,Phase I,ORX-101,Oncology,High Dose,2023-12-10,2024-01-07,7.19,7.94,129,73,82,None,None,Worsened,0
7344,PT-07344,61,M,Kolkata Clinical Center,Phase III,ORX-606,Rheumatology,High Dose,2024-10-23,2024-11-20,8.82,8.32,129,91,67,None,None,Improved,1
7345,PT-07345,56,F,Kolkata Clinical Center,Phase I,ORX-404,Neurology,Placebo,2024-03-18,2024-06-16,6.92,6.45,128,83,104,None,None,Worsened,0
7346,PT-07346,37,M,Fortis Mumbai,Phase III,ORX-505,Infectious Disease,High Dose,2023-06-09,2023-08-04,6.7,7.6,136,91,63,Headache,None,Improved,0
7347,PT-07347,48,F,NIMHANS Bengaluru,Phase III,ORX-303,Cardiology,High Dose,2023-07-26,2023-09-20,8.17,7.17,139,79,68,Headache,None,Improved,1
7348,PT-07348,61,M,Bhopal Research Hospital,Phase II,ORX-303,Cardiology,Placebo,2024-06-30,2024-08-25,8.57,8.28,136,97,72,None,None,Worsened,0
7349,PT-07349,50,M,PGI Chandigarh,Phase II,ORX-303,Cardiology,Placebo,2024-07-11,2024-08-08,6.74,5.42,120,68,83,Fever,Mild,No Change,0
7350,PT-07350,32,F,AIIMS Delhi,Phase II,ORX-404,Neurology,Low Dose,2024-05-15,2024-05-22,5.52,5.79,140,78,87,None,None,No Change,0
7351,PT-07351,32,M,Fortis Mumbai,Phase III,ORX-303,Cardiology,High Dose,2023-07-17,2023-07-31,6.75,6.72,146,77,69,None,None,No Change,0
7352,PT-07352,60,M,NIMHANS Bengaluru,Phase III,ORX-101,Oncology,High Dose,2024-09-01,2024-10-27,7.94,7.67,149,105,83,Headache,Mild,Improved,1
7353,PT-07353,35,F,NIMHANS Bengaluru,Phase III,ORX-101,Oncology,Placebo,2023-04-06,2023-05-04,7.8,6.66,150,73,75,None,None,No Change,0
7354,PT-07354,31,M,Fortis Mumbai,Phase II,ORX-606,Rheumatology,Low Dose,2024-08-08,2024-08-22,7.42,7.21,141,83,78,None,None,Improved,1
7355,PT-07355,35,M,NIMHANS Bengaluru,Phase III,ORX-101,Oncology,Placebo,2024-05-23,2024-07-18,6.86,5.2,153,80,100,None,None,No Change,0
7356,PT-07356,43,M,PGI Chandigarh,Phase II,ORX-404,Neurology,Placebo,2023-07-12,2023-10-10,4.92,4.11,127,82,87,None,None,No Change,0
7357,PT-07357,47,F,Bhopal Research Hospital,Phase IV,ORX-606,Rheumatology,Placebo,2023-12-12,2024-02-06,6.8,5.57,120,89,90,None,None,Improved,1
7358,PT-07358,34,M,Bhopal Research Hospital,Phase III,ORX-505,Infectious Disease,High Dose,2023-01-30,2023-04-30,8.41,8.52,112,84,83,Nausea,Severe,Improved,0
7359,PT-07359,27,F,Apollo Chennai,Phase II,ORX-202,Diabetes,Low Dose,2024-02-20,2024-03-05,5.57,5.6,119,100,102,None,None,No Change,0
7360,PT-07360,52,M,Bhopal Research Hospital,Phase I,ORX-303,Cardiology,High Dose,2023-01-26,2023-04-26,8.34,7.02,104,80,59,None,None,Improved,1
7361,PT-07361,49,M,AIIMS Delhi,Phase I,ORX-303,Cardiology,Low Dose,2024-05-06,2024-07-01,6.26,6.03,124,89,82,Headache,Mild,No Change,0
7362,PT-07362,38,F,NIMHANS Bengaluru,Phase III,ORX-303,Cardiology,Placebo,2024-06-04,2024-06-11,5.56,5.3,96,96,85,Nausea,Moderate,Worsened,0
7363,PT-07363,58,M,AIIMS Delhi,Phase III,ORX-505,Infectious Disease,Low Dose,2024-03-20,2024-05-15,6.04,5.96,116,83,64,None,None,Improved,1
7364,PT-07364,43,F,PGI Chandigarh,Phase II,ORX-606,Rheumatology,Low Dose,2023-07-27,2023-08-24,5.55,5.0,98,102,80,None,None,Improved,1
7365,PT-07365,45,M,Bhopal Research Hospital,Phase III,ORX-606,Rheumatology,Placebo,2023-08-27,2023-09-24,8.01,6.44,113,88,80,Fever,None,No Change,0
7366,PT-07366,33,M,Fortis Mumbai,Phase III,ORX-505,Infectious Disease,High Dose,2023-09-08,2023-11-03,7.98,7.85,137,86,68,None,None,Improved,1
7367,PT-07367,43,F,PGI Chandigarh,Phase II,ORX-202,Diabetes,Low Dose,2023-07-08,2023-10-06,4.97,4.11,123,89,85,None,None,Improved,1
7368,PT-07368,32,M,Bhopal Research Hospital,Phase II,ORX-101,Oncology,High Dose,2023-05-21,2023-06-18,6.27,7.05,122,83,88,Rash,Mild,Improved,0
7369,PT-07369,43,F,NIMHANS Bengaluru,Phase IV,ORX-303,Cardiology,Placebo,2023-08-21,2023-08-28,7.02,6.33,118,83,52,None,None,Improved,1
7370,PT-07370,39,F,PGI Chandigarh,Phase III,ORX-101,Oncology,Placebo,2023-05-25,2023-07-20,7.85,7.83,153,92,83,Nausea,None,Worsened,0
7371,PT-07371,45,F,Apollo Chennai,Phase III,ORX-505,Infectious Disease,Placebo,2023-03-05,2023-06-03,6.65,6.71,133,77,65,None,None,No Change,0
7372,PT-07372,44,M,Bhopal Research Hospital,Phase II,ORX-101,Oncology,Low Dose,2023-05-02,2023-05-30,8.59,8.29,128,87,84,None,None,Improved,1
7373,PT-07373,48,F,Kolkata Clinical Center,Phase II,ORX-303,Cardiology,High Dose,2023-03-09,2023-03-16,7.15,6.29,146,76,100,None,None,Improved,1
7374,PT-07374,47,M,Apollo Chennai,Phase III,ORX-404,Neurology,Placebo,2024-08-24,2024-10-19,7.26,7.55,116,88,79,None,None,Improved,0
7375,PT-07375,51,F,Apollo Chennai,Phase II,ORX-101,Oncology,Placebo,2023-09-04,2023-12-03,6.38,5.36,95,76,70,Headache,None,Improved,1
7376,PT-07376,34,F,Fortis Mumbai,Phase II,ORX-101,Oncology,Placebo,2023-01-10,2023-03-07,7.06,6.72,136,88,87,None,None,Worsened,0
7377,PT-07377,56,F,Apollo Chennai,Phase II,ORX-404,Neurology,High Dose,2024-05-16,2024-05-23,7.53,7.18,144,90,57,None,None,No Change,0
7378,PT-07378,42,M,NIMHANS Bengaluru,Phase I,ORX-202,Diabetes,Low Dose,2024-01-08,2024-01-15,5.04,3.0,118,80,72,Dizziness,None,Improved,1
7379,PT-07379,18,M,Bhopal Research Hospital,Phase III,ORX-303,Cardiology,Placebo,2023-07-16,2023-10-14,8.13,7.09,136,73,71,None,None,Worsened,0
7380,PT-07380,51,F,AIIMS Delhi,Phase I,ORX-404,Neurology,High Dose,2023-04-16,2023-05-14,6.78,6.53,132,64,84,None,None,Improved,1
7381,PT-07381,29,M,AIIMS Delhi,Phase II,ORX-202,Diabetes,Low Dose,2024-09-30,2024-10-14,5.87,4.81,142,62,87,None,None,Worsened,0
7382,PT-07382,50,F,Bhopal Research Hospital,Phase II,ORX-303,Cardiology,High Dose,2024-01-30,2024-02-13,7.29,7.11,122,90,72,Nausea,None,No Change,0
7383,PT-07383,19,M,Fortis Mumbai,Phase IV,ORX-303,Cardiology,Placebo,2023-04-29,2023-05-13,7.11,7.43,136,103,74,Headache,Moderate,No Change,0
7384,PT-07384,42,F,Indore Medical Institute,Phase III,ORX-303,Cardiology,High Dose,2023-01-29,2023-04-29,6.92,5.82,119,69,45,Fatigue,Mild,No Change,0
7385,PT-07385,35,F,Kolkata Clinical Center,Phase I,ORX-202,Diabetes,Placebo,2024-01-12,2024-01-19,7.23,7.4,117,75,92,None,None,Improved,0
7386,PT-07386,23,F,Fortis Mumbai,Phase IV,ORX-303,Cardiology,High Dose,2023-03-05,2023-03-12,7.0,7.47,115,63,101,Headache,None,Improved,0
7387,PT-07387,57,M,AIIMS Delhi,Phase IV,ORX-202,Diabetes,Placebo,2024-03-03,2024-03-31,8.2,7.72,139,52,71,None,None,No Change,0
7388,PT-07388,60,M,Fortis Mumbai,Phase III,ORX-606,Rheumatology,Low Dose,2024-10-10,2024-11-07,5.52,4.82,133,72,78,Fatigue,None,Worsened,0
7389,PT-07389,51,M,NIMHANS Bengaluru,Phase II,ORX-606,Rheumatology,Placebo,2024-09-28,2024-12-27,7.56,6.8,113,86,82,Headache,None,Improved,1
7390,PT-07390,49,F,Kolkata Clinical Center,Phase II,ORX-404,Neurology,Low Dose,2023-07-04,2023-07-18,7.34,7.24,143,85,79,Headache,None,No Change,0
7391,PT-07391,36,F,Apollo Chennai,Phase III,ORX-303,Cardiology,Placebo,2024-01-03,2024-01-31,8.86,7.45,124,75,52,None,None,No Change,0
7392,PT-07392,50,F,PGI Chandigarh,Phase I,ORX-202,Diabetes,Low Dose,2024-01-07,2024-02-04,6.96,6.58,124,91,90,None,None,Improved,1
7393,PT-07393,27,M,Indore Medical Institute,Phase III,ORX-202,Diabetes,High Dose,2024-04-28,2024-06-23,9.32,8.7,138,84,79,None,None,No Change,0
7394,PT-07394,53,F,PGI Chandigarh,Phase III,ORX-202,Diabetes,High Dose,2023-04-18,2023-04-25,8.78,9.08,123,80,70,Rash,None,No Change,0
7395,PT-07395,56,M,Apollo Chennai,Phase III,ORX-202,Diabetes,High Dose,2023-03-25,2023-04-08,7.91,7.2,151,94,103,Rash,None,Improved,1
7396,PT-07396,32,F,PGI Chandigarh,Phase III,ORX-101,Oncology,High Dose,2024-08-11,2024-10-06,7.08,6.5,174,82,95,Headache,Mild,Improved,1
7397,PT-07397,61,M,Apollo Chennai,Phase III,ORX-202,Diabetes,High Dose,2023-05-27,2023-07-22,7.1,6.75,137,97,75,Rash,Mild,Improved,1
7398,PT-07398,36,M,Indore Medical Institute,Phase I,ORX-404,Neurology,Placebo,2024-09-17,2024-12-16,8.32,6.89,132,94,84,Nausea,None,Improved,1
7399,PT-07399,35,M,Fortis Mumbai,Phase II,ORX-101,Oncology,Placebo,2023-09-09,2023-12-08,6.0,6.67,124,71,93,None,None,Worsened,0
7400,PT-07400,57,F,PGI Chandigarh,Phase III,ORX-505,Infectious Disease,High Dose,2023-03-21,2023-04-18,5.94,7.8,118,91,105,Nausea,Severe,No Change,0
7401,PT-07401,59,F,Apollo Chennai,Phase II,ORX-202,Diabetes,High Dose,2023-08-04,2023-09-29,7.51,5.82,164,92,58,None,None,Improved,1
7402,PT-07402,69,F,Fortis Mumbai,Phase II,ORX-404,Neurology,High Dose,2024-07-30,2024-08-13,7.27,6.62,117,84,89,None,None,Improved,1
7403,PT-07403,37,F,Apollo Chennai,Phase I,ORX-202,Diabetes,Low Dose,2024-09-07,2024-09-14,7.35,10.0,136,93,64,Nausea,Mild,Improved,0
7404,PT-07404,23,M,Kolkata Clinical Center,Phase IV,ORX-202,Diabetes,Low Dose,2023-05-12,2023-06-09,8.96,9.62,158,81,95,Dizziness,None,Improved,0
7405,PT-07405,18,F,Kolkata Clinical Center,Phase III,ORX-202,Diabetes,Low Dose,2023-02-04,2023-04-01,7.85,8.38,115,94,75,None,None,Improved,0
7406,PT-07406,43,M,Fortis Mumbai,Phase I,ORX-101,Oncology,Low Dose,2024-06-15,2024-09-13,6.89,7.91,119,75,65,None,None,Improved,0
7407,PT-07407,39,M,PGI Chandigarh,Phase III,ORX-505,Infectious Disease,Low Dose,2023-03-06,2023-05-01,7.43,7.61,114,86,86,None,None,Improved,0
7408,PT-07408,30,F,Kolkata Clinical Center,Phase III,ORX-202,Diabetes,Placebo,2023-12-26,2024-01-09,7.28,6.8,129,75,76,Fatigue,Severe,Improved,1
7409,PT-07409,45,F,Indore Medical Institute,Phase III,ORX-606,Rheumatology,Placebo,2024-05-07,2024-05-21,9.44,9.08,152,98,59,Rash,Moderate,Improved,1
7410,PT-07410,40,M,Indore Medical Institute,Phase III,ORX-202,Diabetes,Low Dose,2023-05-06,2023-08-04,8.9,8.66,125,91,92,Nausea,Mild,Worsened,0
7411,PT-07411,44,F,Bhopal Research Hospital,Phase III,ORX-202,Diabetes,Placebo,2023-12-11,2024-02-05,6.87,4.34,128,77,63,Dizziness,None,Improved,1
7412,PT-07412,41,F,Kolkata Clinical Center,Phase IV,ORX-101,Oncology,High Dose,2023-08-14,2023-09-11,6.7,6.45,122,87,80,None,None,Improved,1
7413,PT-07413,65,M,Apollo Chennai,Phase III,ORX-404,Neurology,Low Dose,2023-03-16,2023-04-13,6.56,7.76,147,99,81,None,None,Improved,0
7414,PT-07414,40,F,Fortis Mumbai,Phase III,ORX-303,Cardiology,Low Dose,2024-08-02,2024-08-30,6.55,7.73,147,69,91,None,None,Improved,0
7415,PT-07415,31,F,Indore Medical Institute,Phase III,ORX-505,Infectious Disease,Low Dose,2024-06-22,2024-09-20,7.59,7.93,154,84,76,Headache,Mild,Worsened,0
7416,PT-07416,45,M,Kolkata Clinical Center,Phase II,ORX-505,Infectious Disease,Low Dose,2023-10-27,2024-01-25,8.48,8.79,127,59,45,None,None,No Change,0
7417,PT-07417,48,F,PGI Chandigarh,Phase IV,ORX-202,Diabetes,High Dose,2023-08-24,2023-11-22,5.78,4.91,123,106,79,Nausea,Mild,Worsened,0
7418,PT-07418,56,F,PGI Chandigarh,Phase II,ORX-101,Oncology,High Dose,2023-07-17,2023-07-24,7.81,5.23,120,67,102,Headache,None,Improved,1
7419,PT-07419,18,M,Kolkata Clinical Center,Phase IV,ORX-404,Neurology,Placebo,2023-06-28,2023-08-23,6.7,6.06,110,83,77,None,None,Worsened,0
7420,PT-07420,47,M,Apollo Chennai,Phase IV,ORX-202,Diabetes,High Dose,2023-04-27,2023-05-25,7.8,7.62,134,95,54,None,None,Worsened,0
7421,PT-07421,56,M,Apollo Chennai,Phase III,ORX-101,Oncology,Placebo,2024-09-30,2024-10-14,5.95,4.97,130,86,85,None,None,Improved,1
7422,PT-07422,29,F,Fortis Mumbai,Phase III,ORX-202,Diabetes,High Dose,2024-01-29,2024-02-05,9.16,8.38,115,66,58,Headache,None,Improved,1
7423,PT-07423,22,M,AIIMS Delhi,Phase II,ORX-606,Rheumatology,Low Dose,2024-10-26,2024-11-02,7.58,7.72,112,68,75,None,None,Worsened,0
7424,PT-07424,46,F,Indore Medical Institute,Phase I,ORX-606,Rheumatology,Low Dose,2024-04-20,2024-04-27,7.52,6.25,124,100,61,None,None,Improved,1
7425,PT-07425,44,M,NIMHANS Bengaluru,Phase III,ORX-606,Rheumatology,Low Dose,2023-12-20,2023-12-27,7.8,,139,65,86,None,None,No Change,0
7426,PT-07426,45,M,Fortis Mumbai,Phase IV,ORX-202,Diabetes,Low Dose,2024-04-03,2024-04-17,5.5,5.72,111,80,86,None,None,No Change,0
7427,PT-07427,29,F,NIMHANS Bengaluru,Phase III,ORX-606,Rheumatology,Placebo,2024-01-22,2024-02-19,6.57,7.18,90,99,57,None,None,Improved,0
7428,PT-07428,33,F,Bhopal Research Hospital,Phase III,ORX-202,Diabetes,Low Dose,2024-09-07,2024-10-05,7.54,7.68,133,82,71,None,None,No Change,0
7429,PT-07429,69,F,PGI Chandigarh,Phase IV,ORX-505,Infectious Disease,High Dose,2024-07-19,2024-10-17,8.13,8.79,120,54,92,Fatigue,None,Improved,0
7430,PT-07430,50,M,Fortis Mumbai,Phase III,ORX-505,Infectious Disease,Placebo,2024-10-18,2024-10-25,7.42,6.51,121,74,78,Headache,None,Improved,1
7431,PT-07431,26,M,Apollo Chennai,Phase II,ORX-505,Infectious Disease,High Dose,2024-11-21,2024-12-05,8.12,9.55,117,62,76,None,None,Improved,0
7432,PT-07432,50,M,Kolkata Clinical Center,Phase I,ORX-202,Diabetes,High Dose,2024-11-27,2024-12-25,7.74,8.79,142,60,60,Fatigue,Mild,No Change,0
7433,PT-07433,51,F,PGI Chandigarh,Phase I,ORX-101,Oncology,Placebo,2024-05-15,2024-06-12,6.66,7.62,111,93,68,None,None,Improved,0
7434,PT-07434,49,M,Apollo Chennai,Phase III,ORX-303,Cardiology,Low Dose,2023-06-23,2023-06-30,6.21,6.31,147,85,104,Fatigue,Mild,Worsened,0
7435,PT-07435,33,M,Apollo Chennai,Phase IV,ORX-505,Infectious Disease,High Dose,2024-11-05,2024-11-19,7.32,7.68,110,82,87,Rash,None,Improved,0
7436,PT-07436,59,M,Apollo Chennai,Phase I,ORX-606,Rheumatology,Low Dose,2024-10-19,2024-12-14,8.57,7.39,133,66,67,None,None,No Change,0
7437,PT-07437,42,F,NIMHANS Bengaluru,Phase III,ORX-101,Oncology,Placebo,2023-12-28,2024-02-22,8.57,8.65,128,87,85,None,None,No Change,0
7438,PT-07438,50,M,AIIMS Delhi,Phase III,ORX-202,Diabetes,Placebo,2023-05-01,2023-06-26,6.51,5.25,123,72,86,Rash,None,Worsened,0
7439,PT-07439,69,M,PGI Chandigarh,Phase III,ORX-404,Neurology,Placebo,2024-11-23,2024-11-30,7.88,5.85,116,82,57,None,None,Worsened,0
7440,PT-07440,45,M,Bhopal Research Hospital,Phase IV,ORX-303,Cardiology,Placebo,2023-02-21,2023-05-22,7.76,8.63,160,67,76,Rash,None,No Change,0
7441,PT-07441,43,F,Bhopal Research Hospital,Phase III,ORX-404,Neurology,High Dose,2024-07-12,2024-07-19,6.34,6.03,126,89,96,Headache,None,Improved,1
7442,PT-07442,47,M,Apollo Chennai,Phase II,ORX-303,Cardiology,High Dose,2023-09-20,2023-10-04,6.61,5.29,164,92,83,Headache,None,No Change,0
7443,PT-07443,42,M,Kolkata Clinical Center,Phase III,ORX-505,Infectious Disease,Placebo,2024-02-02,2024-02-16,9.13,8.59,97,85,60,Headache,Severe,No Change,0
7444,PT-07444,49,F,NIMHANS Bengaluru,Phase III,ORX-303,Cardiology,Low Dose,2023-01-23,2023-03-20,8.81,6.91,111,92,71,None,None,Improved,1
7445,PT-07445,51,F,NIMHANS Bengaluru,Phase IV,ORX-202,Diabetes,High Dose,2023-02-26,2023-03-12,7.7,8.1,116,51,83,None,None,Improved,0
7446,PT-07446,19,M,Bhopal Research Hospital,Phase II,ORX-101,Oncology,High Dose,2023-03-12,2023-03-19,8.32,7.88,122,90,53,None,None,No Change,0
7447,PT-07447,41,F,AIIMS Delhi,Phase II,ORX-101,Oncology,Placebo,2024-08-09,2024-09-06,7.74,7.57,119,76,99,Headache,Mild,No Change,0
7448,PT-07448,59,F,NIMHANS Bengaluru,Phase II,ORX-101,Oncology,High Dose,2023-11-11,2024-01-06,6.4,7.22,141,87,85,Headache,None,Improved,0
7449,PT-07449,26,M,Kolkata Clinical Center,Phase II,ORX-505,Infectious Disease,High Dose,2023-08-29,2023-09-12,9.01,9.46,132,84,76,None,None,No Change,0
7450,PT-07450,35,M,Kolkata Clinical Center,Phase III,ORX-404,Neurology,High Dose,2024-09-03,2024-12-02,7.84,6.73,130,83,83,None,None,No Change,0
7451,PT-07451,60,F,PGI Chandigarh,Phase IV,ORX-606,Rheumatology,High Dose,2024-05-23,2024-05-30,7.68,7.91,93,87,79,Rash,None,Improved,0
7452,PT-07452,50,M,Bhopal Research Hospital,Phase III,ORX-303,Cardiology,Low Dose,2023-12-25,2024-01-08,6.57,7.2,132,73,70,Nausea,None,Improved,0
7453,PT-07453,59,M,Kolkata Clinical Center,Phase IV,ORX-101,Oncology,Placebo,2023-04-15,2023-06-10,7.1,6.69,124,94,84,Nausea,Severe,Improved,1
7454,PT-07454,26,F,Bhopal Research Hospital,Phase III,ORX-101,Oncology,High Dose,2023-07-05,2023-07-12,6.03,5.63,116,56,67,None,None,No Change,0
7455,PT-07455,40,M,Indore Medical Institute,Phase III,ORX-404,Neurology,High Dose,2023-02-19,2023-03-05,6.72,6.97,90,72,89,Headache,None,No Change,0
7456,PT-07456,34,F,Kolkata Clinical Center,Phase IV,ORX-404,Neurology,Low Dose,2023-07-18,2023-08-15,5.75,4.73,136,78,67,None,None,No Change,0
7457,PT-07457,52,F,Apollo Chennai,Phase III,ORX-606,Rheumatology,High Dose,2024-07-10,2024-07-24,7.65,6.11,129,66,94,None,None,Improved,1
7458,PT-07458,64,M,Kolkata Clinical Center,Phase III,ORX-303,Cardiology,High Dose,2024-05-14,2024-05-21,6.85,7.41,114,80,69,None,None,Improved,0
7459,PT-07459,44,F,NIMHANS Bengaluru,Phase III,ORX-303,Cardiology,Placebo,2023-06-04,2023-07-02,7.28,6.88,126,83,95,Nausea,None,No Change,0
7460,PT-07460,18,M,NIMHANS Bengaluru,Phase II,ORX-101,Oncology,Low Dose,2023-07-21,2023-08-04,9.51,8.79,126,97,86,None,None,Improved,1
7461,PT-07461,53,M,NIMHANS Bengaluru,Phase III,ORX-202,Diabetes,Placebo,2023-10-17,2024-01-15,8.69,8.15,144,66,83,None,None,Improved,1
7462,PT-07462,53,F,Kolkata Clinical Center,Phase I,ORX-202,Diabetes,Low Dose,2023-02-21,2023-02-28,8.58,8.81,131,78,73,Rash,Severe,No Change,0
7463,PT-07463,39,M,AIIMS Delhi,Phase III,ORX-303,Cardiology,High Dose,2023-04-11,2023-05-09,5.64,6.81,145,85,89,None,None,No Change,0
7464,PT-07464,57,F,Apollo Chennai,Phase III,ORX-505,Infectious Disease,Placebo,2023-04-16,2023-06-11,6.01,6.18,150,73,56,Headache,Moderate,No Change,0
7465,PT-07465,26,M,PGI Chandigarh,Phase IV,ORX-606,Rheumatology,High Dose,2023-09-14,2023-09-21,7.08,5.59,124,74,77,Rash,None,Improved,1
7466,PT-07466,36,M,PGI Chandigarh,Phase III,ORX-606,Rheumatology,Low Dose,2023-08-06,2023-09-03,7.16,7.3,110,85,66,Fever,Mild,Improved,0
7467,PT-07467,44,F,PGI Chandigarh,Phase III,ORX-606,Rheumatology,Low Dose,2024-08-31,2024-10-26,7.1,7.02,131,96,77,Fever,Mild,Improved,1
7468,PT-07468,34,F,AIIMS Delhi,Phase IV,ORX-606,Rheumatology,Low Dose,2023-02-10,2023-05-11,8.32,8.21,143,80,59,Headache,None,Worsened,0
7469,PT-07469,80,F,AIIMS Delhi,Phase III,ORX-101,Oncology,High Dose,2023-02-18,2023-03-18,6.48,5.03,140,70,72,None,None,No Change,0
7470,PT-07470,46,M,NIMHANS Bengaluru,Phase III,ORX-303,Cardiology,Placebo,2023-09-09,2023-12-08,7.03,6.3,156,80,65,None,None,Improved,1
7471,PT-07471,60,F,Kolkata Clinical Center,Phase III,ORX-606,Rheumatology,Placebo,2024-08-08,2024-09-05,6.33,5.83,111,84,78,Fever,Mild,Worsened,0
7472,PT-07472,44,M,Indore Medical Institute,Phase II,ORX-505,Infectious Disease,Placebo,2024-05-20,2024-05-27,7.38,7.72,140,69,68,None,None,No Change,0
7473,PT-07473,59,F,Indore Medical Institute,Phase III,ORX-404,Neurology,Low Dose,2023-06-04,2023-07-30,6.26,6.3,143,62,72,Dizziness,None,Improved,0
7474,PT-07474,58,M,NIMHANS Bengaluru,Phase III,ORX-404,Neurology,Placebo,2023-01-14,2023-03-11,7.02,6.26,142,95,68,None,None,Improved,1
7475,PT-07475,73,M,PGI Chandigarh,Phase IV,ORX-202,Diabetes,Low Dose,2023-12-22,2024-01-19,5.06,3.3,119,77,73,Nausea,Moderate,Improved,1
7476,PT-07476,36,F,Bhopal Research Hospital,Phase III,ORX-101,Oncology,Placebo,2023-01-08,2023-01-15,6.33,5.73,117,90,78,None,None,Worsened,0
7477,PT-07477,41,F,PGI Chandigarh,Phase III,ORX-202,Diabetes,Placebo,2024-11-11,2024-12-09,7.11,,119,66,64,Rash,None,Improved,0
7478,PT-07478,41,M,AIIMS Delhi,Phase III,ORX-606,Rheumatology,Low Dose,2023-01-10,2023-03-07,7.78,8.17,157,90,65,None,None,No Change,0
7479,PT-07479,41,M,AIIMS Delhi,Phase II,ORX-303,Cardiology,Placebo,2024-07-25,2024-08-22,4.6,3.92,117,54,107,Fatigue,None,Improved,1
7480,PT-07480,38,M,Indore Medical Institute,Phase III,ORX-101,Oncology,High Dose,2023-03-06,2023-03-13,4.67,4.02,157,104,78,None,None,Improved,1
7481,PT-07481,46,M,Bhopal Research Hospital,Phase III,ORX-505,Infectious Disease,Low Dose,2024-08-24,2024-09-07,8.67,8.14,136,92,62,Nausea,Mild,Improved,1
7482,PT-07482,69,F,Apollo Chennai,Phase III,ORX-303,Cardiology,Low Dose,2024-05-26,2024-06-02,6.14,5.17,129,93,87,Nausea,None,Improved,1
7483,PT-07483,44,M,Fortis Mumbai,Phase III,ORX-101,Oncology,High Dose,2024-07-19,2024-10-17,7.54,8.11,128,72,69,None,None,Improved,0
7484,PT-07484,59,M,Bhopal Research Hospital,Phase III,ORX-505,Infectious Disease,High Dose,2023-08-13,2023-08-27,6.23,4.42,122,81,90,None,None,Improved,1
7485,PT-07485,21,M,PGI Chandigarh,Phase III,ORX-101,Oncology,Low Dose,2023-05-24,2023-06-07,7.62,8.25,113,82,47,None,None,No Change,0
7486,PT-07486,58,M,Apollo Chennai,Phase III,ORX-505,Infectious Disease,High Dose,2024-07-11,2024-07-25,8.15,7.74,104,90,74,None,None,Improved,1
7487,PT-07487,18,F,Kolkata Clinical Center,Phase III,ORX-202,Diabetes,High Dose,2023-08-24,2023-09-21,8.13,8.78,152,66,51,None,None,No Change,0
7488,PT-07488,38,M,PGI Chandigarh,Phase III,ORX-505,Infectious Disease,High Dose,2023-03-11,2023-04-08,7.82,,99,90,73,None,None,Worsened,0
7489,PT-07489,54,F,PGI Chandigarh,Phase IV,ORX-101,Oncology,Low Dose,2024-02-25,2024-04-21,7.22,6.67,126,77,71,None,None,Improved,1
7490,PT-07490,27,M,Indore Medical Institute,Phase III,ORX-101,Oncology,Low Dose,2024-02-05,2024-03-04,7.78,8.5,118,104,83,None,None,Improved,0
7491,PT-07491,49,F,AIIMS Delhi,Phase I,ORX-505,Infectious Disease,High Dose,2023-02-15,2023-03-15,7.99,8.46,119,88,92,None,None,Worsened,0
7492,PT-07492,38,M,Fortis Mumbai,Phase III,ORX-606,Rheumatology,Placebo,2024-03-08,2024-03-22,7.21,6.12,119,77,65,Nausea,None,Improved,1
7493,PT-07493,43,M,Fortis Mumbai,Phase III,ORX-404,Neurology,High Dose,2023-04-27,2023-05-11,7.6,,113,74,89,None,None,No Change,0
7494,PT-07494,35,F,Indore Medical Institute,Phase III,ORX-303,Cardiology,Low Dose,2024-08-23,2024-08-30,8.19,7.13,134,91,45,Nausea,None,No Change,0
7495,PT-07495,58,F,Kolkata Clinical Center,Phase III,ORX-202,Diabetes,Placebo,2024-05-31,2024-06-07,8.76,8.09,134,71,83,None,None,No Change,0
7496,PT-07496,84,M,NIMHANS Bengaluru,Phase IV,ORX-202,Diabetes,High Dose,2023-07-06,2023-08-03,4.56,3.71,142,97,58,None,None,Improved,1
7497,PT-07497,34,M,Indore Medical Institute,Phase IV,ORX-202,Diabetes,Placebo,2023-05-18,2023-05-25,6.5,5.52,125,64,74,Rash,None,Improved,1
7498,PT-07498,30,F,Bhopal Research Hospital,Phase III,ORX-505,Infectious Disease,Low Dose,2023-01-31,2023-03-28,7.12,6.08,124,69,91,Rash,None,Improved,1
7499,PT-07499,39,F,Kolkata Clinical Center,Phase IV,ORX-202,Diabetes,High Dose,2023-04-01,2023-05-27,7.22,6.69,128,82,89,Headache,Severe,No Change,0
7500,PT-07500,40,F,Apollo Chennai,Phase II,ORX-606,Rheumatology,Low Dose,2024-06-04,2024-06-11,6.34,5.97,116,81,63,Fever,None,No Change,0
7501,PT-07501,61,F,Apollo Chennai,Phase I,ORX-303,Cardiology,Low Dose,2023-10-20,2024-01-18,6.26,6.94,126,92,67,Rash,Moderate,Improved,0
7502,PT-07502,18,M,Bhopal Research Hospital,Phase I,ORX-101,Oncology,Low Dose,2024-09-29,2024-12-28,5.22,7.07,117,95,59,Rash,None,Worsened,0
7503,PT-07503,47,F,Apollo Chennai,Phase II,ORX-505,Infectious Disease,High Dose,2024-04-25,2024-05-09,7.62,9.77,122,73,82,Rash,Moderate,Improved,0
7504,PT-07504,30,F,Apollo Chennai,Phase III,ORX-505,Infectious Disease,Low Dose,2023-11-21,2024-02-19,7.69,7.24,114,87,79,None,None,No Change,0
7505,PT-07505,57,M,AIIMS Delhi,Phase III,ORX-404,Neurology,Placebo,2023-07-10,2023-07-24,9.18,8.33,120,65,85,None,None,Improved,1
7506,PT-07506,34,M,NIMHANS Bengaluru,Phase III,ORX-202,Diabetes,High Dose,2024-06-24,2024-08-19,7.61,8.26,115,76,92,Fever,None,Improved,0
7507,PT-07507,56,M,Apollo Chennai,Phase II,ORX-303,Cardiology,Low Dose,2024-05-19,2024-08-17,7.92,7.17,102,73,63,Headache,None,Improved,1
7508,PT-07508,54,F,PGI Chandigarh,Phase I,ORX-404,Neurology,High Dose,2024-07-02,2024-07-16,7.54,6.6,120,87,73,None,None,Improved,1
7509,PT-07509,35,M,Apollo Chennai,Phase IV,ORX-606,Rheumatology,High Dose,2023-12-13,2024-02-07,9.57,8.68,140,86,56,None,None,No Change,0
7510,PT-07510,34,F,Fortis Mumbai,Phase IV,ORX-101,Oncology,Placebo,2024-04-13,2024-07-12,8.18,7.66,101,86,69,Nausea,None,No Change,0
7511,PT-07511,51,M,AIIMS Delhi,Phase IV,ORX-202,Diabetes,Low Dose,2024-09-28,2024-10-05,10.43,10.37,139,78,62,Headache,None,Improved,1
7512,PT-07512,61,F,Indore Medical Institute,Phase II,ORX-404,Neurology,Low Dose,2023-08-31,2023-09-07,6.47,5.87,160,77,95,Dizziness,None,Improved,1
7513,PT-07513,51,F,NIMHANS Bengaluru,Phase III,ORX-303,Cardiology,High Dose,2023-07-13,2023-07-27,6.54,6.44,115,92,95,None,None,Improved,1
7514,PT-07514,45,M,AIIMS Delhi,Phase III,ORX-202,Diabetes,High Dose,2024-04-21,2024-04-28,8.81,8.56,144,117,112,None,None,Improved,1
7515,PT-07515,42,F,PGI Chandigarh,Phase III,ORX-101,Oncology,High Dose,2023-07-25,2023-09-19,7.55,6.2,142,86,67,None,None,Improved,1
7516,PT-07516,63,M,Apollo Chennai,Phase III,ORX-202,Diabetes,High Dose,2023-01-23,2023-04-23,6.88,6.01,135,76,77,Headache,Mild,Improved,1
7517,PT-07517,72,F,Bhopal Research Hospital,Phase II,ORX-505,Infectious Disease,Placebo,2024-01-28,2024-04-27,6.46,6.67,117,70,76,Nausea,None,Improved,0
7518,PT-07518,85,M,Bhopal Research Hospital,Phase I,ORX-606,Rheumatology,High Dose,2023-05-18,2023-05-25,8.14,8.15,118,77,57,None,None,No Change,0
7519,PT-07519,73,F,Apollo Chennai,Phase IV,ORX-606,Rheumatology,Low Dose,2023-04-27,2023-06-22,7.52,7.29,131,107,82,Headache,None,Worsened,0
7520,PT-07520,41,M,Kolkata Clinical Center,Phase III,ORX-505,Infectious Disease,Placebo,2024-07-23,2024-08-06,9.36,8.84,97,63,75,None,None,Improved,1
7521,PT-07521,49,M,AIIMS Delhi,Phase III,ORX-404,Neurology,Low Dose,2023-01-10,2023-01-17,8.19,6.96,123,72,93,None,None,Improved,1
7522,PT-07522,65,F,Fortis Mumbai,Phase III,ORX-404,Neurology,High Dose,2023-02-03,2023-02-17,9.55,9.47,161,73,81,Fever,Moderate,No Change,0
7523,PT-07523,28,M,Apollo Chennai,Phase II,ORX-404,Neurology,Low Dose,2023-01-15,2023-04-15,7.89,7.74,90,95,89,Nausea,None,No Change,0
7524,PT-07524,36,M,Indore Medical Institute,Phase I,ORX-505,Infectious Disease,High Dose,2023-05-05,2023-08-03,7.54,5.79,114,102,61,None,None,Improved,1
7525,PT-07525,45,F,PGI Chandigarh,Phase III,ORX-505,Infectious Disease,Low Dose,2023-10-23,2023-10-30,5.52,5.43,138,90,84,Nausea,None,No Change,0
7526,PT-07526,67,M,Kolkata Clinical Center,Phase II,ORX-202,Diabetes,Placebo,2024-08-10,2024-08-24,6.54,5.18,117,65,79,Fatigue,Mild,Improved,1
7527,PT-07527,42,M,Fortis Mumbai,Phase III,ORX-505,Infectious Disease,Placebo,2024-02-22,2024-02-29,7.77,5.92,127,96,86,None,None,No Change,0
7528,PT-07528,18,M,Kolkata Clinical Center,Phase I,ORX-202,Diabetes,High Dose,2023-11-09,2023-11-23,7.19,6.13,128,77,102,None,None,Improved,1
7529,PT-07529,46,F,Fortis Mumbai,Phase II,ORX-202,Diabetes,High Dose,2024-05-12,2024-07-07,7.58,7.14,136,79,88,None,None,No Change,0
7530,PT-07530,38,F,Apollo Chennai,Phase I,ORX-505,Infectious Disease,Placebo,2023-10-16,2023-12-11,8.85,8.9,125,92,84,None,None,Improved,0
7531,PT-07531,58,M,PGI Chandigarh,Phase III,ORX-303,Cardiology,High Dose,2023-12-29,2024-01-26,7.3,6.69,130,75,91,Rash,None,Improved,1
7532,PT-07532,68,M,PGI Chandigarh,Phase III,ORX-606,Rheumatology,High Dose,2023-03-15,2023-03-29,7.89,8.77,148,78,89,Rash,Severe,No Change,0
7533,PT-07533,24,F,Fortis Mumbai,Phase III,ORX-303,Cardiology,Placebo,2024-08-07,2024-10-02,7.42,5.96,126,64,93,Headache,None,No Change,0
7534,PT-07534,38,M,Bhopal Research Hospital,Phase IV,ORX-202,Diabetes,Placebo,2024-04-08,2024-04-15,8.29,7.82,94,76,70,None,None,No Change,0
7535,PT-07535,44,M,Kolkata Clinical Center,Phase III,ORX-101,Oncology,High Dose,2024-11-22,2025-01-17,9.01,10.12,123,66,67,Nausea,None,Improved,0
7536,PT-07536,52,F,Bhopal Research Hospital,Phase III,ORX-101,Oncology,High Dose,2024-06-20,2024-07-18,7.07,5.25,118,97,82,None,None,Improved,1
7537,PT-07537,45,F,Kolkata Clinical Center,Phase III,ORX-404,Neurology,High Dose,2024-04-18,2024-05-16,6.73,5.92,137,83,88,None,None,Improved,1
7538,PT-07538,53,F,Kolkata Clinical Center,Phase II,ORX-404,Neurology,Placebo,2024-02-17,2024-03-16,7.22,7.17,117,81,96,None,None,Improved,1
7539,PT-07539,45,F,Kolkata Clinical Center,Phase III,ORX-202,Diabetes,High Dose,2024-06-11,2024-06-18,6.94,6.73,107,84,101,None,None,No Change,0
7540,PT-07540,32,M,Bhopal Research Hospital,Phase II,ORX-404,Neurology,High Dose,2023-10-29,2023-11-12,7.52,7.1,127,81,88,Nausea,None,No Change,0
7541,PT-07541,27,F,Bhopal Research Hospital,Phase III,ORX-505,Infectious Disease,High Dose,2024-06-19,2024-06-26,8.03,7.69,96,86,79,None,None,No Change,0
7542,PT-07542,31,F,PGI Chandigarh,Phase II,ORX-606,Rheumatology,Placebo,2024-04-05,2024-05-03,7.39,,115,82,54,None,None,No Change,0
7543,PT-07543,26,M,Fortis Mumbai,Phase IV,ORX-101,Oncology,High Dose,2023-06-27,2023-07-11,6.0,5.67,135,71,64,None,None,Improved,1
7544,PT-07544,47,M,Fortis Mumbai,Phase III,ORX-101,Oncology,Placebo,2024-09-10,2024-09-24,7.33,6.3,160,84,75,Nausea,None,Improved,1
7545,PT-07545,38,M,Bhopal Research Hospital,Phase III,ORX-606,Rheumatology,Placebo,2024-11-07,2025-01-02,8.41,8.5,96,73,71,Nausea,Moderate,No Change,0
7546,PT-07546,44,F,Kolkata Clinical Center,Phase III,ORX-101,Oncology,Low Dose,2024-06-15,2024-09-13,7.95,6.59,126,102,78,Nausea,None,Improved,1
7547,PT-07547,33,M,Bhopal Research Hospital,Phase I,ORX-505,Infectious Disease,Low Dose,2023-12-28,2024-01-25,5.6,4.76,108,77,85,Headache,Mild,Improved,1
7548,PT-07548,45,F,Indore Medical Institute,Phase III,ORX-202,Diabetes,High Dose,2023-03-29,2023-05-24,6.62,4.61,142,77,79,Rash,None,Improved,1
7549,PT-07549,30,M,Kolkata Clinical Center,Phase III,ORX-505,Infectious Disease,Placebo,2023-05-26,2023-08-24,6.71,5.79,103,71,77,None,None,Improved,1
7550,PT-07550,49,F,AIIMS Delhi,Phase II,ORX-202,Diabetes,Placebo,2023-12-05,2024-01-30,6.38,4.9,121,91,64,Dizziness,Mild,Improved,1
7551,PT-07551,45,M,Kolkata Clinical Center,Phase III,ORX-202,Diabetes,Low Dose,2024-02-21,2024-05-21,6.41,7.02,118,89,92,Fatigue,Mild,Improved,0
7552,PT-07552,69,F,Bhopal Research Hospital,Phase II,ORX-505,Infectious Disease,Low Dose,2024-01-14,2024-01-28,5.58,3.92,148,94,69,Dizziness,None,No Change,0
7553,PT-07553,18,F,Kolkata Clinical Center,Phase IV,ORX-303,Cardiology,Placebo,2023-09-18,2023-10-02,7.3,5.53,113,84,82,Nausea,Mild,No Change,0
7554,PT-07554,70,M,AIIMS Delhi,Phase III,ORX-404,Neurology,High Dose,2024-08-21,2024-09-04,6.75,5.47,144,86,72,Fatigue,None,Improved,1
7555,PT-07555,45,F,Indore Medical Institute,Phase III,ORX-303,Cardiology,Placebo,2023-01-19,2023-02-16,6.75,6.97,158,73,83,None,None,Worsened,0
7556,PT-07556,20,F,Apollo Chennai,Phase I,ORX-606,Rheumatology,Low Dose,2023-06-23,2023-09-21,5.91,6.02,126,68,78,None,None,Improved,0
7557,PT-07557,59,F,Indore Medical Institute,Phase III,ORX-404,Neurology,Placebo,2023-12-13,2024-02-07,5.46,6.64,138,89,77,None,None,No Change,0
7558,PT-07558,72,M,Indore Medical Institute,Phase III,ORX-404,Neurology,High Dose,2023-11-28,2023-12-05,8.35,7.62,141,73,74,None,None,Improved,1
7559,PT-07559,68,M,Bhopal Research Hospital,Phase I,ORX-303,Cardiology,High Dose,2024-11-28,2024-12-26,7.67,7.86,149,88,66,None,None,No Change,0
7560,PT-07560,71,M,NIMHANS Bengaluru,Phase IV,ORX-303,Cardiology,High Dose,2024-08-10,2024-10-05,7.82,7.95,129,95,104,Headache,None,Worsened,0
7561,PT-07561,38,M,Fortis Mumbai,Phase III,ORX-202,Diabetes,High Dose,2023-10-05,2023-11-30,8.48,8.11,92,65,83,None,None,Worsened,0
7562,PT-07562,61,F,Apollo Chennai,Phase III,ORX-404,Neurology,High Dose,2024-08-05,2024-09-30,7.93,8.22,174,88,74,None,None,Improved,0
7563,PT-07563,42,F,Indore Medical Institute,Phase I,ORX-303,Cardiology,High Dose,2024-09-29,2024-11-24,9.16,7.62,150,82,66,None,None,Improved,1
7564,PT-07564,21,F,PGI Chandigarh,Phase I,ORX-101,Oncology,Low Dose,2024-10-20,2025-01-18,8.98,7.81,129,70,105,Rash,Mild,Improved,1
7565,PT-07565,46,M,PGI Chandigarh,Phase I,ORX-404,Neurology,Low Dose,2023-07-01,2023-09-29,5.58,4.8,153,70,72,None,None,Worsened,0
7566,PT-07566,63,M,NIMHANS Bengaluru,Phase III,ORX-202,Diabetes,Placebo,2024-07-16,2024-07-23,7.61,6.11,132,80,78,None,None,No Change,0
7567,PT-07567,60,F,Apollo Chennai,Phase III,ORX-202,Diabetes,Low Dose,2024-08-20,2024-09-17,7.49,7.01,125,94,67,None,None,No Change,0
7568,PT-07568,18,F,AIIMS Delhi,Phase III,ORX-606,Rheumatology,High Dose,2023-07-26,2023-08-02,6.93,6.87,120,75,72,None,None,Improved,1
7569,PT-07569,44,F,Indore Medical Institute,Phase III,ORX-202,Diabetes,High Dose,2024-09-12,2024-11-07,5.64,5.84,90,88,82,Rash,None,Improved,0
7570,PT-07570,52,M,Bhopal Research Hospital,Phase II,ORX-101,Oncology,High Dose,2023-01-25,2023-03-22,4.89,4.75,118,101,83,None,None,Improved,1
7571,PT-07571,26,F,AIIMS Delhi,Phase III,ORX-606,Rheumatology,Placebo,2024-10-19,2024-11-16,5.17,4.22,142,95,80,None,None,Worsened,0
7572,PT-07572,46,M,PGI Chandigarh,Phase I,ORX-505,Infectious Disease,High Dose,2024-08-21,2024-10-16,6.8,6.38,149,77,87,None,None,No Change,0
7573,PT-07573,36,F,Bhopal Research Hospital,Phase I,ORX-101,Oncology,High Dose,2024-01-01,2024-01-15,8.42,8.54,145,104,45,None,None,Improved,0
7574,PT-07574,57,F,NIMHANS Bengaluru,Phase III,ORX-404,Neurology,Low Dose,2023-04-14,2023-07-13,7.76,7.77,132,84,82,Headache,None,Improved,0
7575,PT-07575,59,F,Apollo Chennai,Phase II,ORX-404,Neurology,Placebo,2023-05-06,2023-05-13,8.19,7.77,124,82,72,Rash,Moderate,No Change,0
7576,PT-07576,73,F,Apollo Chennai,Phase II,ORX-101,Oncology,Placebo,2024-03-30,2024-05-25,5.68,5.95,141,75,82,None,None,Improved,0
7577,PT-07577,65,M,Fortis Mumbai,Phase III,ORX-101,Oncology,Placebo,2023-11-13,2023-11-20,6.8,7.58,148,73,62,Rash,None,Improved,0
7578,PT-07578,47,M,AIIMS Delhi,Phase II,ORX-101,Oncology,Low Dose,2024-12-01,2024-12-15,5.71,2.7,119,108,71,Fatigue,None,Improved,1
7579,PT-07579,51,M,Kolkata Clinical Center,Phase IV,ORX-303,Cardiology,Low Dose,2024-02-14,2024-04-10,8.04,7.6,121,96,78,None,None,Worsened,0
7580,PT-07580,43,F,Kolkata Clinical Center,Phase III,ORX-101,Oncology,High Dose,2023-04-12,2023-04-26,8.16,6.83,105,62,85,None,None,No Change,0
7581,PT-07581,42,F,Fortis Mumbai,Phase I,ORX-101,Oncology,High Dose,2023-05-04,2023-06-29,8.19,7.84,103,77,90,None,None,Improved,1
7582,PT-07582,40,M,Apollo Chennai,Phase I,ORX-101,Oncology,Placebo,2023-07-18,2023-08-15,8.62,7.82,140,60,74,Headache,None,No Change,0
7583,PT-07583,38,F,Indore Medical Institute,Phase IV,ORX-101,Oncology,High Dose,2023-12-01,2024-01-26,5.52,6.12,116,73,96,None,None,Worsened,0
7584,PT-07584,47,F,Fortis Mumbai,Phase II,ORX-101,Oncology,Low Dose,2024-01-29,2024-02-12,8.14,6.2,113,107,89,None,None,Worsened,0
7585,PT-07585,27,M,Fortis Mumbai,Phase III,ORX-303,Cardiology,Low Dose,2024-02-03,2024-05-03,7.47,6.17,153,54,81,None,None,Improved,1
7586,PT-07586,49,M,Bhopal Research Hospital,Phase II,ORX-505,Infectious Disease,Placebo,2023-11-27,2024-01-22,5.86,5.22,134,60,60,None,None,Improved,1
7587,PT-07587,42,F,Apollo Chennai,Phase II,ORX-202,Diabetes,Low Dose,2023-05-10,2023-06-07,6.2,5.38,127,71,77,None,None,Improved,1
7588,PT-07588,49,F,NIMHANS Bengaluru,Phase IV,ORX-202,Diabetes,Placebo,2024-10-27,2025-01-25,8.13,6.61,116,89,57,None,None,Worsened,0
7589,PT-07589,46,F,PGI Chandigarh,Phase III,ORX-404,Neurology,Low Dose,2024-08-05,2024-09-30,7.23,4.51,119,85,75,None,None,Worsened,0
7590,PT-07590,37,M,PGI Chandigarh,Phase III,ORX-404,Neurology,Low Dose,2023-02-03,2023-05-04,7.39,7.88,137,72,57,Headache,Mild,Improved,0
7591,PT-07591,53,F,AIIMS Delhi,Phase III,ORX-101,Oncology,High Dose,2023-08-12,2023-09-09,5.79,4.91,131,95,96,Nausea,Moderate,Improved,1
7592,PT-07592,45,F,Indore Medical Institute,Phase IV,ORX-101,Oncology,Placebo,2023-04-30,2023-05-07,6.59,5.11,163,78,87,Rash,None,Improved,1
7593,PT-07593,48,F,Bhopal Research Hospital,Phase IV,ORX-606,Rheumatology,Placebo,2023-05-30,2023-06-06,6.61,5.72,103,95,76,None,None,Improved,1
7594,PT-07594,67,F,Indore Medical Institute,Phase III,ORX-606,Rheumatology,Low Dose,2023-12-21,2024-01-04,6.66,5.99,107,78,60,None,None,Improved,1
7595,PT-07595,51,F,AIIMS Delhi,Phase II,ORX-404,Neurology,Low Dose,2023-01-17,2023-03-14,7.33,8.26,101,96,64,None,None,No Change,0
7596,PT-07596,50,F,Indore Medical Institute,Phase I,ORX-505,Infectious Disease,Placebo,2024-11-17,2025-01-12,5.83,5.61,90,73,79,Nausea,Moderate,No Change,0
7597,PT-07597,73,M,Indore Medical Institute,Phase I,ORX-505,Infectious Disease,High Dose,2024-03-23,2024-03-30,4.65,4.24,118,59,62,Nausea,Mild,No Change,0
7598,PT-07598,37,M,Apollo Chennai,Phase II,ORX-404,Neurology,Low Dose,2023-09-03,2023-10-29,7.76,7.44,104,59,83,Headache,Mild,No Change,0
7599,PT-07599,41,M,Kolkata Clinical Center,Phase I,ORX-202,Diabetes,Placebo,2023-04-02,2023-04-16,9.13,8.42,148,88,89,Headache,Moderate,Improved,1
7600,PT-07600,51,M,NIMHANS Bengaluru,Phase II,ORX-202,Diabetes,High Dose,2024-05-15,2024-06-12,7.75,5.28,123,74,95,Nausea,Mild,No Change,0
7601,PT-07601,28,M,AIIMS Delhi,Phase IV,ORX-606,Rheumatology,Low Dose,2023-08-18,2023-09-15,6.86,7.18,133,84,93,None,None,Worsened,0
7602,PT-07602,49,F,Apollo Chennai,Phase III,ORX-303,Cardiology,Placebo,2024-08-22,2024-09-05,6.55,4.98,136,72,74,None,None,Improved,1
7603,PT-07603,62,F,AIIMS Delhi,Phase I,ORX-505,Infectious Disease,High Dose,2024-03-10,2024-05-05,6.93,6.13,122,78,64,Nausea,Moderate,No Change,0
7604,PT-07604,71,F,NIMHANS Bengaluru,Phase II,ORX-404,Neurology,Placebo,2024-05-28,2024-08-26,6.54,6.85,109,88,80,None,None,Improved,0
7605,PT-07605,45,M,Apollo Chennai,Phase I,ORX-606,Rheumatology,Low Dose,2024-10-09,2024-12-04,7.41,7.38,123,79,86,Rash,Severe,Improved,1
7606,PT-07606,26,M,Bhopal Research Hospital,Phase I,ORX-404,Neurology,High Dose,2023-09-12,2023-11-07,5.64,5.41,91,61,103,None,None,Improved,1
7607,PT-07607,69,M,Bhopal Research Hospital,Phase II,ORX-505,Infectious Disease,Low Dose,2023-12-18,2024-01-15,6.52,7.01,146,87,76,Fatigue,Moderate,No Change,0
7608,PT-07608,55,F,PGI Chandigarh,Phase III,ORX-202,Diabetes,Placebo,2024-06-26,2024-07-24,8.16,8.34,100,106,111,None,None,No Change,0
7609,PT-07609,18,F,NIMHANS Bengaluru,Phase I,ORX-404,Neurology,High Dose,2023-08-19,2023-09-02,7.81,9.25,146,94,57,Headache,None,Improved,0
7610,PT-07610,57,M,Apollo Chennai,Phase III,ORX-101,Oncology,Placebo,2024-02-05,2024-03-04,7.49,7.79,109,69,76,None,None,Improved,0
7611,PT-07611,38,M,PGI Chandigarh,Phase III,ORX-606,Rheumatology,High Dose,2023-08-15,2023-11-13,7.01,6.18,124,74,77,Nausea,Moderate,Worsened,0
7612,PT-07612,22,M,NIMHANS Bengaluru,Phase III,ORX-303,Cardiology,Placebo,2024-09-20,2024-09-27,7.82,7.65,105,97,66,Fever,None,Improved,1
7613,PT-07613,64,F,Apollo Chennai,Phase III,ORX-606,Rheumatology,Low Dose,2023-12-08,2024-03-07,7.6,8.1,131,88,91,None,None,Worsened,0
7614,PT-07614,75,M,NIMHANS Bengaluru,Phase III,ORX-404,Neurology,High Dose,2024-08-12,2024-11-10,8.49,8.49,103,53,76,Fatigue,None,Improved,0
7615,PT-07615,33,F,Indore Medical Institute,Phase III,ORX-404,Neurology,Low Dose,2023-01-29,2023-03-26,6.39,5.91,139,74,90,None,None,Improved,1
7616,PT-07616,45,M,Kolkata Clinical Center,Phase III,ORX-303,Cardiology,Low Dose,2024-02-27,2024-04-23,7.25,8.53,131,81,85,None,None,Improved,0
7617,PT-07617,73,M,Kolkata Clinical Center,Phase IV,ORX-404,Neurology,Placebo,2023-12-13,2023-12-27,7.14,7.14,126,80,71,None,None,Improved,1
7618,PT-07618,36,F,Kolkata Clinical Center,Phase III,ORX-202,Diabetes,High Dose,2023-11-03,2023-11-17,9.24,8.34,100,83,92,Fatigue,None,Improved,1
7619,PT-07619,64,M,AIIMS Delhi,Phase I,ORX-202,Diabetes,High Dose,2024-08-13,2024-11-11,5.77,6.37,165,73,75,None,None,No Change,0
7620,PT-07620,25,F,Indore Medical Institute,Phase I,ORX-303,Cardiology,Low Dose,2024-05-29,2024-06-05,9.42,7.68,120,91,68,None,None,Worsened,0
7621,PT-07621,29,F,AIIMS Delhi,Phase III,ORX-404,Neurology,Low Dose,2024-02-02,2024-03-01,7.14,8.89,123,79,62,Nausea,Moderate,Worsened,0
7622,PT-07622,51,M,Indore Medical Institute,Phase II,ORX-202,Diabetes,Low Dose,2023-01-10,2023-01-17,8.26,7.31,137,74,51,Nausea,Moderate,Worsened,0
7623,PT-07623,52,M,PGI Chandigarh,Phase III,ORX-101,Oncology,Placebo,2023-01-24,2023-01-31,9.69,8.21,131,97,76,Headache,None,Worsened,0
7624,PT-07624,22,M,Kolkata Clinical Center,Phase III,ORX-202,Diabetes,Low Dose,2024-03-04,2024-03-18,7.25,8.2,118,84,63,None,None,Improved,0
7625,PT-07625,43,F,AIIMS Delhi,Phase II,ORX-101,Oncology,Low Dose,2023-09-08,2023-10-06,7.66,7.38,120,87,87,None,None,No Change,0
7626,PT-07626,56,F,Apollo Chennai,Phase III,ORX-505,Infectious Disease,Low Dose,2023-07-09,2023-08-06,6.85,5.89,163,83,74,Fever,None,No Change,0
7627,PT-07627,21,F,Bhopal Research Hospital,Phase III,ORX-505,Infectious Disease,High Dose,2023-11-20,2024-02-18,6.08,5.1,135,77,78,None,None,Worsened,0
7628,PT-07628,22,F,PGI Chandigarh,Phase III,ORX-101,Oncology,Low Dose,2023-10-31,2023-12-26,8.89,7.82,132,75,73,None,None,No Change,0
7629,PT-07629,32,M,Bhopal Research Hospital,Phase IV,ORX-404,Neurology,Placebo,2023-07-28,2023-08-11,7.56,6.27,133,80,86,Nausea,None,No Change,0
7630,PT-07630,56,F,Kolkata Clinical Center,Phase III,ORX-505,Infectious Disease,High Dose,2024-09-18,2024-10-16,6.82,6.75,119,97,72,Fatigue,None,Improved,1
7631,PT-07631,41,F,PGI Chandigarh,Phase III,ORX-202,Diabetes,Low Dose,2023-05-21,2023-08-19,6.64,5.58,164,87,78,Headache,None,Improved,1
7632,PT-07632,37,M,Apollo Chennai,Phase I,ORX-606,Rheumatology,High Dose,2023-02-09,2023-02-23,8.54,7.64,130,108,64,None,None,Improved,1
7633,PT-07633,53,M,Indore Medical Institute,Phase III,ORX-303,Cardiology,Placebo,2024-02-29,2024-05-29,7.55,7.62,122,74,81,None,None,No Change,0
7634,PT-07634,37,F,PGI Chandigarh,Phase III,ORX-202,Diabetes,Placebo,2024-05-22,2024-05-29,4.4,3.26,122,69,80,Dizziness,Moderate,No Change,0
7635,PT-07635,32,F,NIMHANS Bengaluru,Phase III,ORX-101,Oncology,Low Dose,2023-09-13,2023-09-20,7.15,8.7,150,89,103,Dizziness,None,No Change,0
7636,PT-07636,43,M,AIIMS Delhi,Phase III,ORX-404,Neurology,Low Dose,2024-02-17,2024-05-17,7.13,5.78,151,105,90,None,None,Improved,1
7637,PT-07637,67,M,Apollo Chennai,Phase II,ORX-202,Diabetes,High Dose,2024-06-26,2024-07-24,3.92,5.62,126,110,102,None,None,Improved,0
7638,PT-07638,57,M,PGI Chandigarh,Phase I,ORX-303,Cardiology,Low Dose,2024-01-12,2024-03-08,6.79,6.53,93,93,45,Headache,Moderate,No Change,0
7639,PT-07639,40,F,Fortis Mumbai,Phase III,ORX-505,Infectious Disease,High Dose,2024-10-21,2024-11-18,9.05,9.3,100,65,69,None,None,No Change,0
7640,PT-07640,46,M,Bhopal Research Hospital,Phase II,ORX-303,Cardiology,Low Dose,2023-03-15,2023-06-13,8.25,8.4,108,89,88,None,None,Worsened,0
7641,PT-07641,52,M,Bhopal Research Hospital,Phase II,ORX-606,Rheumatology,Low Dose,2024-04-29,2024-05-06,10.17,10.43,145,104,89,Nausea,Moderate,Improved,0
7642,PT-07642,36,F,Indore Medical Institute,Phase III,ORX-101,Oncology,High Dose,2023-05-11,2023-07-06,8.69,7.93,110,71,95,Dizziness,None,Improved,1
7643,PT-07643,54,F,Fortis Mumbai,Phase I,ORX-606,Rheumatology,High Dose,2023-02-28,2023-04-25,8.47,8.64,131,85,86,Fever,None,Improved,0
7644,PT-07644,35,F,PGI Chandigarh,Phase IV,ORX-101,Oncology,High Dose,2023-05-18,2023-08-16,5.65,4.82,137,74,107,Fever,Mild,Worsened,0
7645,PT-07645,52,M,AIIMS Delhi,Phase III,ORX-505,Infectious Disease,Low Dose,2023-03-19,2023-03-26,7.34,6.4,144,67,82,Dizziness,None,No Change,0
7646,PT-07646,38,F,Kolkata Clinical Center,Phase III,ORX-202,Diabetes,High Dose,2024-06-21,2024-07-05,7.35,7.38,107,61,64,None,None,No Change,0
7647,PT-07647,59,F,PGI Chandigarh,Phase III,ORX-505,Infectious Disease,Placebo,2023-08-13,2023-08-27,7.65,6.89,163,97,92,None,None,Worsened,0
7648,PT-07648,33,M,PGI Chandigarh,Phase II,ORX-505,Infectious Disease,Placebo,2023-08-01,2023-10-30,8.44,8.35,114,80,63,None,None,Improved,1
7649,PT-07649,33,M,Fortis Mumbai,Phase II,ORX-404,Neurology,High Dose,2023-12-19,2024-02-13,5.83,6.29,126,70,85,Headache,Mild,No Change,0
7650,PT-07650,45,M,AIIMS Delhi,Phase III,ORX-303,Cardiology,Low Dose,2024-04-12,2024-06-07,8.46,8.18,102,76,61,None,None,Improved,1
7651,PT-07651,54,F,Kolkata Clinical Center,Phase III,ORX-303,Cardiology,High Dose,2023-03-16,2023-03-30,8.5,6.71,125,95,56,Headache,None,Improved,1
7652,PT-07652,38,F,NIMHANS Bengaluru,Phase III,ORX-202,Diabetes,Placebo,2024-03-20,2024-03-27,7.2,7.76,137,90,86,Nausea,Moderate,Improved,0
7653,PT-07653,39,F,Kolkata Clinical Center,Phase IV,ORX-606,Rheumatology,High Dose,2024-05-25,2024-06-08,9.17,8.17,90,60,76,None,None,Improved,1
7654,PT-07654,39,F,Kolkata Clinical Center,Phase II,ORX-303,Cardiology,Placebo,2024-10-01,2024-10-29,6.56,6.29,149,87,87,Fatigue,Mild,Improved,1
7655,PT-07655,27,M,Apollo Chennai,Phase II,ORX-505,Infectious Disease,Low Dose,2024-03-17,2024-03-24,6.58,6.81,129,87,86,None,None,Worsened,0
7656,PT-07656,47,F,PGI Chandigarh,Phase III,ORX-606,Rheumatology,High Dose,2024-08-10,2024-10-05,9.1,8.22,113,60,88,Rash,Mild,Improved,1
7657,PT-07657,35,F,PGI Chandigarh,Phase II,ORX-606,Rheumatology,Low Dose,2023-03-22,2023-04-19,8.72,8.54,121,69,89,Nausea,Moderate,Improved,1
7658,PT-07658,44,F,Bhopal Research Hospital,Phase III,ORX-505,Infectious Disease,Placebo,2023-05-26,2023-07-21,7.52,7.67,132,71,85,None,None,Improved,0
7659,PT-07659,58,M,AIIMS Delhi,Phase IV,ORX-505,Infectious Disease,Placebo,2023-06-28,2023-07-12,7.63,7.8,141,77,71,None,None,Worsened,0
7660,PT-07660,80,F,Indore Medical Institute,Phase II,ORX-303,Cardiology,High Dose,2023-07-04,2023-07-11,8.79,8.35,140,70,69,None,None,Improved,1
7661,PT-07661,25,M,NIMHANS Bengaluru,Phase I,ORX-101,Oncology,High Dose,2024-09-24,2024-10-01,7.54,7.41,147,79,92,Rash,Mild,Improved,1
7662,PT-07662,55,M,Fortis Mumbai,Phase III,ORX-303,Cardiology,Low Dose,2023-06-20,2023-08-15,10.15,11.25,154,92,65,Nausea,None,No Change,0
7663,PT-07663,49,M,Fortis Mumbai,Phase II,ORX-404,Neurology,Placebo,2024-03-01,2024-05-30,9.9,9.95,113,86,64,Fever,Moderate,Improved,0
7664,PT-07664,31,M,NIMHANS Bengaluru,Phase III,ORX-606,Rheumatology,Placebo,2023-12-20,2024-02-14,7.7,7.96,113,75,58,None,None,No Change,0
7665,PT-07665,42,F,Indore Medical Institute,Phase IV,ORX-505,Infectious Disease,Low Dose,2023-05-31,2023-08-29,4.86,4.2,129,60,63,None,None,Worsened,0
7666,PT-07666,44,M,AIIMS Delhi,Phase III,ORX-404,Neurology,Placebo,2023-01-21,2023-04-21,6.96,6.43,133,61,87,None,None,Improved,1
7667,PT-07667,39,M,Fortis Mumbai,Phase II,ORX-101,Oncology,Low Dose,2023-09-16,2023-12-15,6.48,4.41,123,88,79,Fever,Mild,Worsened,0
7668,PT-07668,47,M,NIMHANS Bengaluru,Phase IV,ORX-505,Infectious Disease,Placebo,2023-01-11,2023-02-08,6.79,6.34,108,81,71,Rash,None,Improved,1
7669,PT-07669,27,F,Bhopal Research Hospital,Phase III,ORX-404,Neurology,High Dose,2023-10-31,2023-11-14,8.11,6.29,137,89,70,None,None,No Change,0
7670,PT-07670,61,F,Kolkata Clinical Center,Phase II,ORX-202,Diabetes,Placebo,2024-04-17,2024-05-15,6.54,5.59,106,81,64,None,None,Improved,1
7671,PT-07671,32,M,PGI Chandigarh,Phase III,ORX-101,Oncology,High Dose,2024-07-13,2024-07-20,7.12,6.7,150,93,85,Dizziness,Mild,No Change,0
7672,PT-07672,42,M,Fortis Mumbai,Phase I,ORX-404,Neurology,Placebo,2024-09-17,2024-10-15,6.72,6.29,117,73,76,Nausea,Moderate,Improved,1
7673,PT-07673,30,F,Fortis Mumbai,Phase II,ORX-101,Oncology,Low Dose,2024-10-08,2024-10-22,6.22,6.68,103,69,95,Nausea,None,Improved,0
7674,PT-07674,38,M,Bhopal Research Hospital,Phase I,ORX-606,Rheumatology,High Dose,2023-03-31,2023-04-07,8.85,7.4,129,91,65,None,None,Improved,1
7675,PT-07675,71,M,Indore Medical Institute,Phase III,ORX-202,Diabetes,Placebo,2024-08-05,2024-09-30,6.73,6.79,115,99,82,Fever,Mild,Improved,0
7676,PT-07676,78,M,Kolkata Clinical Center,Phase II,ORX-505,Infectious Disease,Placebo,2024-06-10,2024-09-08,8.61,8.97,110,83,73,None,None,Worsened,0
7677,PT-07677,45,M,NIMHANS Bengaluru,Phase III,ORX-404,Neurology,Low Dose,2024-06-21,2024-06-28,7.38,6.17,125,80,63,Headache,Moderate,Improved,1
7678,PT-07678,57,M,Bhopal Research Hospital,Phase III,ORX-606,Rheumatology,High Dose,2024-09-18,2024-11-13,7.47,7.8,136,61,66,None,None,No Change,0
7679,PT-07679,71,F,Kolkata Clinical Center,Phase III,ORX-303,Cardiology,High Dose,2023-09-13,2023-09-27,8.14,6.28,136,72,48,None,None,Improved,1
7680,PT-07680,71,M,AIIMS Delhi,Phase IV,ORX-202,Diabetes,Low Dose,2024-02-13,2024-05-13,7.29,7.09,105,68,55,None,None,Worsened,0
7681,PT-07681,67,F,Fortis Mumbai,Phase II,ORX-202,Diabetes,Low Dose,2024-06-01,2024-06-29,5.23,6.28,110,67,77,None,None,Worsened,0
7682,PT-07682,34,F,AIIMS Delhi,Phase I,ORX-202,Diabetes,Low Dose,2023-04-02,2023-04-09,7.32,6.13,122,72,90,None,None,No Change,0
7683,PT-07683,53,F,NIMHANS Bengaluru,Phase III,ORX-606,Rheumatology,Placebo,2023-01-20,2023-01-27,7.5,8.05,132,84,76,None,None,Worsened,0
7684,PT-07684,33,F,AIIMS Delhi,Phase II,ORX-101,Oncology,Placebo,2024-08-23,2024-08-30,6.34,6.08,146,88,85,Nausea,None,No Change,0
7685,PT-07685,27,F,Apollo Chennai,Phase III,ORX-101,Oncology,High Dose,2023-09-24,2023-10-01,7.83,7.07,131,88,61,Nausea,Moderate,No Change,0
7686,PT-07686,47,M,PGI Chandigarh,Phase III,ORX-606,Rheumatology,Placebo,2024-06-28,2024-07-26,7.48,7.98,118,81,80,Dizziness,None,No Change,0
7687,PT-07687,36,M,Apollo Chennai,Phase I,ORX-101,Oncology,Low Dose,2024-10-23,2024-11-06,6.56,5.64,125,102,76,Headache,Mild,Improved,1
7688,PT-07688,52,M,NIMHANS Bengaluru,Phase III,ORX-101,Oncology,Placebo,2024-09-18,2024-10-02,7.24,6.56,127,91,77,None,None,Improved,1
7689,PT-07689,42,F,PGI Chandigarh,Phase III,ORX-606,Rheumatology,High Dose,2024-04-30,2024-05-14,6.92,5.62,146,76,98,Nausea,None,Improved,1
7690,PT-07690,48,F,Kolkata Clinical Center,Phase III,ORX-202,Diabetes,Low Dose,2023-04-16,2023-06-11,8.89,8.31,114,94,70,Nausea,Moderate,No Change,0
7691,PT-07691,65,F,Fortis Mumbai,Phase II,ORX-303,Cardiology,Placebo,2023-01-08,2023-02-05,7.89,8.81,110,93,67,None,None,Improved,0
7692,PT-07692,18,F,Bhopal Research Hospital,Phase III,ORX-303,Cardiology,Placebo,2023-01-09,2023-04-09,8.28,7.87,145,83,78,Headache,Mild,Improved,1
7693,PT-07693,68,M,Kolkata Clinical Center,Phase III,ORX-202,Diabetes,Low Dose,2024-08-02,2024-09-27,7.34,6.51,126,83,45,None,None,Improved,1
7694,PT-07694,52,M,Fortis Mumbai,Phase II,ORX-606,Rheumatology,High Dose,2024-05-07,2024-05-14,8.83,8.39,120,86,102,None,None,Improved,1
7695,PT-07695,52,M,Apollo Chennai,Phase III,ORX-202,Diabetes,Low Dose,2023-09-07,2023-09-14,7.46,6.71,108,82,78,None,None,No Change,0
7696,PT-07696,18,F,Fortis Mumbai,Phase III,ORX-606,Rheumatology,Placebo,2023-01-14,2023-01-21,6.33,6.97,123,52,100,Headache,Mild,No Change,0
7697,PT-07697,30,F,NIMHANS Bengaluru,Phase III,ORX-404,Neurology,Low Dose,2024-01-10,2024-01-24,6.64,7.19,114,58,81,None,None,Improved,0
7698,PT-07698,57,F,AIIMS Delhi,Phase IV,ORX-303,Cardiology,High Dose,2023-02-24,2023-05-25,6.64,6.13,106,70,73,Headache,None,Worsened,0
7699,PT-07699,55,M,PGI Chandigarh,Phase IV,ORX-404,Neurology,Placebo,2023-11-01,2023-12-27,7.32,7.84,157,92,55,None,None,Improved,0
7700,PT-07700,40,M,Fortis Mumbai,Phase III,ORX-606,Rheumatology,High Dose,2024-04-12,2024-04-19,8.25,7.74,98,75,46,None,None,Improved,1
7701,PT-07701,40,F,AIIMS Delhi,Phase III,ORX-404,Neurology,Placebo,2024-02-16,2024-02-23,6.38,5.65,149,66,67,None,None,Worsened,0
7702,PT-07702,26,F,Kolkata Clinical Center,Phase II,ORX-606,Rheumatology,High Dose,2024-04-09,2024-05-07,8.49,9.1,134,85,61,Dizziness,None,No Change,0
7703,PT-07703,48,M,Indore Medical Institute,Phase III,ORX-404,Neurology,Low Dose,2024-03-30,2024-04-27,5.85,5.49,121,74,78,None,None,Worsened,0
7704,PT-07704,55,M,Bhopal Research Hospital,Phase I,ORX-404,Neurology,Placebo,2024-11-16,2025-01-11,9.33,9.43,169,84,102,Dizziness,None,Improved,0
7705,PT-07705,51,F,Apollo Chennai,Phase IV,ORX-202,Diabetes,Low Dose,2024-07-14,2024-10-12,7.49,6.94,133,87,58,None,None,Improved,1
7706,PT-07706,56,F,NIMHANS Bengaluru,Phase IV,ORX-303,Cardiology,Low Dose,2024-04-21,2024-05-05,5.42,5.65,138,99,65,Rash,None,Improved,0
7707,PT-07707,29,F,Fortis Mumbai,Phase III,ORX-404,Neurology,Low Dose,2024-11-21,2024-12-05,8.53,7.16,106,84,77,None,None,Improved,1
7708,PT-07708,47,F,Fortis Mumbai,Phase I,ORX-404,Neurology,Placebo,2024-03-12,2024-05-07,7.85,7.93,126,82,77,None,None,No Change,0
7709,PT-07709,45,F,Fortis Mumbai,Phase IV,ORX-101,Oncology,Low Dose,2023-09-27,2023-11-22,5.54,5.82,146,89,85,Fatigue,Mild,Improved,0
7710,PT-07710,29,M,Apollo Chennai,Phase II,ORX-404,Neurology,High Dose,2023-05-29,2023-06-12,5.5,5.85,128,84,81,Fatigue,Mild,Improved,0
7711,PT-07711,49,F,Indore Medical Institute,Phase III,ORX-101,Oncology,Placebo,2023-11-01,2023-12-27,7.98,7.49,93,90,86,Rash,Moderate,Improved,1
7712,PT-07712,24,F,Apollo Chennai,Phase III,ORX-505,Infectious Disease,High Dose,2024-03-08,2024-05-03,5.8,6.2,148,50,84,None,None,Improved,0
7713,PT-07713,41,F,Kolkata Clinical Center,Phase II,ORX-404,Neurology,High Dose,2023-01-26,2023-02-09,7.29,7.01,114,89,68,Fatigue,Moderate,Worsened,0
7714,PT-07714,56,F,Bhopal Research Hospital,Phase II,ORX-303,Cardiology,Placebo,2024-07-11,2024-07-25,8.36,7.18,112,83,99,None,None,No Change,0
7715,PT-07715,35,F,PGI Chandigarh,Phase III,ORX-202,Diabetes,Placebo,2024-10-02,2024-10-16,6.72,6.61,139,88,78,None,None,Improved,1
7716,PT-07716,40,M,Fortis Mumbai,Phase IV,ORX-404,Neurology,High Dose,2024-05-16,2024-05-23,7.6,4.32,161,79,80,None,None,Improved,1
7717,PT-07717,78,M,Indore Medical Institute,Phase IV,ORX-202,Diabetes,Placebo,2023-06-23,2023-07-21,6.31,8.01,141,87,87,Nausea,None,No Change,0
7718,PT-07718,31,M,Apollo Chennai,Phase II,ORX-404,Neurology,Placebo,2024-01-14,2024-03-10,5.22,3.76,147,70,54,None,None,No Change,0
7719,PT-07719,43,M,Fortis Mumbai,Phase III,ORX-101,Oncology,Low Dose,2024-08-07,2024-08-21,7.89,7.52,138,95,85,Fever,Mild,Improved,1
7720,PT-07720,42,F,AIIMS Delhi,Phase III,ORX-404,Neurology,Low Dose,2024-08-30,2024-09-27,6.55,6.84,132,71,96,None,None,Worsened,0
7721,PT-07721,49,M,Kolkata Clinical Center,Phase III,ORX-606,Rheumatology,High Dose,2023-02-23,2023-03-02,7.98,7.23,148,62,101,None,None,Worsened,0
7722,PT-07722,18,F,PGI Chandigarh,Phase III,ORX-404,Neurology,High Dose,2024-10-07,2024-12-02,5.55,5.37,118,78,70,None,None,Improved,1
7723,PT-07723,32,M,PGI Chandigarh,Phase III,ORX-101,Oncology,High Dose,2023-02-01,2023-05-02,7.58,7.14,143,82,72,None,None,Improved,1
7724,PT-07724,57,F,Bhopal Research Hospital,Phase I,ORX-404,Neurology,Placebo,2024-11-27,2025-01-22,5.0,2.28,99,77,83,None,None,Improved,1
7725,PT-07725,18,M,Bhopal Research Hospital,Phase II,ORX-404,Neurology,Low Dose,2023-10-09,2023-11-06,7.19,6.47,130,59,114,Headache,None,Improved,1
7726,PT-07726,45,F,AIIMS Delhi,Phase II,ORX-606,Rheumatology,Low Dose,2024-10-22,2024-12-17,5.74,5.46,154,66,57,None,None,Improved,1
7727,PT-07727,43,F,Apollo Chennai,Phase II,ORX-505,Infectious Disease,High Dose,2024-07-21,2024-09-15,7.16,7.4,154,91,58,Nausea,Mild,No Change,0
7728,PT-07728,27,M,AIIMS Delhi,Phase I,ORX-505,Infectious Disease,Placebo,2024-05-09,2024-08-07,6.24,6.54,138,97,85,Rash,None,Worsened,0
7729,PT-07729,34,F,PGI Chandigarh,Phase III,ORX-101,Oncology,Low Dose,2023-01-27,2023-02-03,6.96,5.25,139,74,95,None,None,Worsened,0
7730,PT-07730,54,F,NIMHANS Bengaluru,Phase II,ORX-303,Cardiology,Placebo,2023-12-21,2023-12-28,9.53,9.5,135,79,72,None,None,Improved,1
7731,PT-07731,40,M,Indore Medical Institute,Phase III,ORX-606,Rheumatology,High Dose,2024-11-20,2024-11-27,8.4,6.79,129,62,83,Nausea,None,Improved,1
7732,PT-07732,37,F,AIIMS Delhi,Phase III,ORX-606,Rheumatology,Placebo,2024-03-22,2024-03-29,7.8,6.74,123,89,79,Rash,Mild,Improved,1
7733,PT-07733,69,M,Indore Medical Institute,Phase III,ORX-606,Rheumatology,Low Dose,2023-09-09,2023-12-08,6.62,5.71,150,77,72,None,None,No Change,0
7734,PT-07734,51,M,Apollo Chennai,Phase III,ORX-404,Neurology,Low Dose,2023-04-27,2023-05-04,7.0,6.32,115,98,75,Nausea,Moderate,No Change,0
7735,PT-07735,36,F,Bhopal Research Hospital,Phase II,ORX-505,Infectious Disease,Placebo,2024-01-28,2024-02-11,6.84,6.76,154,79,65,Headache,Mild,No Change,0
7736,PT-07736,75,M,Bhopal Research Hospital,Phase III,ORX-404,Neurology,Low Dose,2023-02-01,2023-03-01,7.36,6.87,129,67,77,None,None,No Change,0
7737,PT-07737,57,F,Kolkata Clinical Center,Phase II,ORX-606,Rheumatology,Placebo,2024-09-19,2024-10-03,8.66,7.94,131,96,78,None,None,Improved,1
7738,PT-07738,56,M,Indore Medical Institute,Phase III,ORX-202,Diabetes,Placebo,2024-11-07,2024-12-05,7.71,6.71,111,94,45,Dizziness,None,Worsened,0
7739,PT-07739,34,M,Kolkata Clinical Center,Phase III,ORX-505,Infectious Disease,Low Dose,2023-02-28,2023-03-28,5.53,6.08,152,73,116,Nausea,Mild,Worsened,0
7740,PT-07740,67,M,PGI Chandigarh,Phase II,ORX-303,Cardiology,High Dose,2023-07-26,2023-08-09,7.44,8.39,116,78,84,None,None,Improved,0
7741,PT-07741,33,M,Bhopal Research Hospital,Phase II,ORX-202,Diabetes,High Dose,2023-07-23,2023-07-30,5.66,4.41,124,87,73,None,None,Improved,1
7742,PT-07742,18,M,Indore Medical Institute,Phase II,ORX-202,Diabetes,Low Dose,2023-03-16,2023-03-30,7.76,8.51,116,101,90,Fever,Moderate,Improved,0
7743,PT-07743,28,M,Kolkata Clinical Center,Phase IV,ORX-606,Rheumatology,Placebo,2024-05-23,2024-06-06,6.42,5.74,124,52,67,Nausea,None,Improved,1
7744,PT-07744,36,M,Kolkata Clinical Center,Phase III,ORX-606,Rheumatology,High Dose,2023-01-14,2023-04-14,9.47,,113,76,83,Rash,None,Improved,1
7745,PT-07745,38,F,Apollo Chennai,Phase II,ORX-303,Cardiology,Low Dose,2023-07-15,2023-07-29,6.5,5.6,136,65,62,Headache,None,Improved,1
7746,PT-07746,30,M,Bhopal Research Hospital,Phase III,ORX-606,Rheumatology,Placebo,2024-11-30,2024-12-07,5.88,4.73,144,94,81,Headache,None,Improved,1
7747,PT-07747,48,M,Apollo Chennai,Phase II,ORX-404,Neurology,High Dose,2023-12-01,2023-12-08,6.4,4.12,130,85,68,None,None,Improved,1
7748,PT-07748,27,M,PGI Chandigarh,Phase II,ORX-101,Oncology,High Dose,2023-04-26,2023-06-21,5.67,5.42,129,96,66,Fever,Mild,Improved,1
7749,PT-07749,40,F,Fortis Mumbai,Phase III,ORX-303,Cardiology,High Dose,2024-04-06,2024-04-20,7.22,6.33,143,96,62,Fatigue,None,Improved,1
7750,PT-07750,37,M,Fortis Mumbai,Phase I,ORX-606,Rheumatology,High Dose,2024-03-19,2024-03-26,8.79,8.68,130,86,87,Rash,None,Improved,1
7751,PT-07751,51,M,AIIMS Delhi,Phase III,ORX-404,Neurology,Placebo,2024-06-13,2024-08-08,7.46,7.06,152,78,78,None,None,Improved,1
7752,PT-07752,69,F,Indore Medical Institute,Phase III,ORX-505,Infectious Disease,High Dose,2023-12-05,2023-12-12,7.59,7.13,139,84,67,None,None,No Change,0
7753,PT-07753,48,M,Fortis Mumbai,Phase III,ORX-101,Oncology,Low Dose,2024-08-12,2024-10-07,6.23,7.47,132,70,72,None,None,Improved,0
7754,PT-07754,57,F,Fortis Mumbai,Phase III,ORX-606,Rheumatology,Low Dose,2024-11-21,2025-02-19,5.89,7.94,101,93,71,Headache,None,No Change,0
7755,PT-07755,32,M,Indore Medical Institute,Phase IV,ORX-202,Diabetes,Placebo,2024-08-30,2024-09-13,7.85,7.04,156,65,85,None,None,No Change,0
7756,PT-07756,40,M,Bhopal Research Hospital,Phase III,ORX-202,Diabetes,Low Dose,2023-07-28,2023-08-11,7.56,7.62,96,84,93,Headache,Moderate,Improved,0
7757,PT-07757,52,M,Indore Medical Institute,Phase III,ORX-606,Rheumatology,Placebo,2023-06-19,2023-09-17,6.76,5.09,137,104,87,None,None,Improved,1
7758,PT-07758,63,M,Apollo Chennai,Phase III,ORX-606,Rheumatology,Placebo,2023-12-13,2024-03-12,8.32,7.57,129,92,55,None,None,Improved,1
7759,PT-07759,55,M,Kolkata Clinical Center,Phase I,ORX-303,Cardiology,Placebo,2023-01-21,2023-02-04,8.71,8.26,142,75,78,None,None,Improved,1
7760,PT-07760,40,M,NIMHANS Bengaluru,Phase I,ORX-101,Oncology,Low Dose,2023-06-15,2023-06-29,7.75,7.26,97,73,105,Headache,None,No Change,0
7761,PT-07761,54,F,Apollo Chennai,Phase II,ORX-404,Neurology,High Dose,2023-01-08,2023-02-05,4.68,5.37,107,92,96,None,None,Improved,0
7762,PT-07762,46,F,Kolkata Clinical Center,Phase I,ORX-404,Neurology,Placebo,2023-02-05,2023-05-06,6.0,4.96,139,68,69,None,None,Worsened,0
7763,PT-07763,53,M,AIIMS Delhi,Phase IV,ORX-303,Cardiology,Placebo,2024-11-03,2024-11-17,6.42,7.3,109,50,67,Fatigue,None,No Change,0
7764,PT-07764,49,F,Bhopal Research Hospital,Phase III,ORX-202,Diabetes,High Dose,2023-04-07,2023-05-05,8.24,7.47,123,81,102,None,None,Improved,1
7765,PT-07765,51,F,NIMHANS Bengaluru,Phase II,ORX-505,Infectious Disease,High Dose,2023-03-06,2023-04-03,6.61,8.06,128,57,58,Rash,None,Improved,0
7766,PT-07766,53,M,Kolkata Clinical Center,Phase III,ORX-606,Rheumatology,Low Dose,2023-06-15,2023-09-13,5.07,5.12,113,96,80,Headache,None,Improved,0
7767,PT-07767,18,F,Fortis Mumbai,Phase I,ORX-202,Diabetes,Low Dose,2023-10-16,2023-10-23,8.3,9.12,105,72,85,Headache,None,No Change,0
7768,PT-07768,55,F,Apollo Chennai,Phase III,ORX-505,Infectious Disease,Placebo,2024-11-05,2025-02-03,10.02,10.43,171,82,83,None,None,No Change,0
7769,PT-07769,35,M,Indore Medical Institute,Phase III,ORX-303,Cardiology,Low Dose,2024-02-18,2024-03-17,6.57,6.31,117,51,68,Fatigue,Mild,Worsened,0
7770,PT-07770,62,M,PGI Chandigarh,Phase IV,ORX-303,Cardiology,Low Dose,2024-02-20,2024-03-19,7.29,6.96,114,85,101,None,None,Improved,1
7771,PT-07771,67,M,AIIMS Delhi,Phase II,ORX-101,Oncology,Low Dose,2023-01-16,2023-01-30,7.64,6.47,159,94,57,Headache,Mild,No Change,0
7772,PT-07772,18,F,Apollo Chennai,Phase II,ORX-606,Rheumatology,High Dose,2024-09-24,2024-10-22,5.49,4.65,144,92,82,Headache,None,Improved,1
7773,PT-07773,42,M,Bhopal Research Hospital,Phase IV,ORX-202,Diabetes,Low Dose,2024-02-03,2024-02-17,10.05,9.68,126,75,108,Fever,Moderate,No Change,0
7774,PT-07774,56,M,Fortis Mumbai,Phase II,ORX-404,Neurology,High Dose,2024-03-15,2024-04-12,5.96,4.52,97,80,57,None,None,Improved,1
7775,PT-07775,26,F,AIIMS Delhi,Phase III,ORX-202,Diabetes,Low Dose,2023-12-19,2023-12-26,8.48,8.88,154,64,63,None,None,Worsened,0
7776,PT-07776,34,F,Fortis Mumbai,Phase IV,ORX-404,Neurology,High Dose,2024-11-29,2024-12-13,9.17,8.82,160,89,76,Fatigue,Mild,Improved,1
7777,PT-07777,54,F,Fortis Mumbai,Phase IV,ORX-404,Neurology,Placebo,2023-08-18,2023-09-15,5.12,2.88,132,82,105,None,None,Improved,1
7778,PT-07778,22,F,Kolkata Clinical Center,Phase IV,ORX-606,Rheumatology,High Dose,2024-03-08,2024-05-03,7.65,7.87,134,95,69,Nausea,None,Improved,0
7779,PT-07779,58,M,AIIMS Delhi,Phase II,ORX-606,Rheumatology,Low Dose,2024-10-15,2024-10-22,7.87,8.52,118,67,69,Fever,None,Improved,0
7780,PT-07780,27,M,NIMHANS Bengaluru,Phase I,ORX-303,Cardiology,Low Dose,2023-05-29,2023-06-12,6.52,5.82,111,82,61,None,None,Improved,1
7781,PT-07781,43,F,Indore Medical Institute,Phase III,ORX-101,Oncology,High Dose,2024-07-02,2024-07-09,6.61,6.1,135,76,67,None,None,Improved,1
7782,PT-07782,34,F,PGI Chandigarh,Phase II,ORX-303,Cardiology,Placebo,2023-03-11,2023-03-25,8.43,9.18,118,80,54,Headache,Severe,Improved,0
7783,PT-07783,42,F,Indore Medical Institute,Phase IV,ORX-404,Neurology,High Dose,2023-03-26,2023-04-09,5.46,4.62,147,63,65,None,None,No Change,0
7784,PT-07784,30,M,AIIMS Delhi,Phase III,ORX-606,Rheumatology,High Dose,2023-11-17,2023-12-01,5.2,5.57,132,103,64,Nausea,None,No Change,0
7785,PT-07785,18,M,NIMHANS Bengaluru,Phase II,ORX-404,Neurology,Low Dose,2024-04-10,2024-06-05,8.33,7.6,119,99,80,Nausea,Mild,No Change,0
7786,PT-07786,59,F,Kolkata Clinical Center,Phase II,ORX-606,Rheumatology,High Dose,2023-12-24,2024-01-21,6.45,5.4,121,90,78,None,None,No Change,0
7787,PT-07787,52,M,Bhopal Research Hospital,Phase IV,ORX-505,Infectious Disease,Low Dose,2024-05-07,2024-05-21,4.08,1.98,90,77,58,None,None,Improved,1
7788,PT-07788,72,M,Kolkata Clinical Center,Phase III,ORX-101,Oncology,High Dose,2023-07-23,2023-08-06,7.17,6.97,108,68,99,None,None,Improved,1
7789,PT-07789,73,F,Kolkata Clinical Center,Phase II,ORX-202,Diabetes,High Dose,2024-03-29,2024-04-12,7.7,5.47,120,85,74,None,None,Improved,1
7790,PT-07790,18,M,Bhopal Research Hospital,Phase II,ORX-303,Cardiology,High Dose,2024-09-22,2024-10-06,9.42,8.27,103,81,94,None,None,Improved,1
7791,PT-07791,53,F,AIIMS Delhi,Phase I,ORX-606,Rheumatology,Low Dose,2023-01-30,2023-03-27,5.62,3.89,90,78,71,Fever,Severe,Improved,1
7792,PT-07792,53,F,NIMHANS Bengaluru,Phase III,ORX-202,Diabetes,High Dose,2023-10-13,2023-10-20,6.38,6.85,139,73,83,Dizziness,None,No Change,0
7793,PT-07793,66,F,Bhopal Research Hospital,Phase III,ORX-606,Rheumatology,Placebo,2024-11-24,2024-12-01,6.05,5.46,123,77,89,Headache,None,Improved,1
7794,PT-07794,59,M,AIIMS Delhi,Phase III,ORX-303,Cardiology,High Dose,2023-09-19,2023-10-17,7.69,7.61,117,85,60,Headache,None,No Change,0
7795,PT-07795,84,M,AIIMS Delhi,Phase II,ORX-303,Cardiology,Placebo,2024-06-23,2024-08-18,8.82,9.28,135,86,54,Nausea,Mild,Worsened,0
7796,PT-07796,24,M,PGI Chandigarh,Phase IV,ORX-101,Oncology,Placebo,2023-09-15,2023-09-22,5.84,5.49,122,91,64,None,None,Improved,1
7797,PT-07797,61,M,Apollo Chennai,Phase III,ORX-303,Cardiology,Low Dose,2023-06-05,2023-09-03,6.22,5.44,144,88,60,Rash,Severe,Improved,1
7798,PT-07798,62,M,NIMHANS Bengaluru,Phase III,ORX-101,Oncology,Low Dose,2024-10-24,2024-10-31,7.31,4.98,112,77,61,Rash,None,Improved,1
7799,PT-07799,66,M,Bhopal Research Hospital,Phase II,ORX-404,Neurology,High Dose,2024-10-20,2024-10-27,6.75,6.76,131,90,101,Fatigue,None,Improved,0
7800,PT-07800,55,M,Bhopal Research Hospital,Phase II,ORX-404,Neurology,High Dose,2024-04-13,2024-07-12,9.29,9.52,130,85,45,Fever,None,Worsened,0
7801,PT-07801,37,M,Bhopal Research Hospital,Phase IV,ORX-404,Neurology,Placebo,2024-01-09,2024-01-23,7.03,7.02,127,86,59,Fatigue,None,Improved,1
7802,PT-07802,19,M,Kolkata Clinical Center,Phase I,ORX-101,Oncology,Low Dose,2023-02-08,2023-05-09,5.78,,105,72,79,None,None,No Change,0
7803,PT-07803,19,M,Indore Medical Institute,Phase II,ORX-606,Rheumatology,High Dose,2023-10-05,2023-10-19,6.15,6.36,120,102,54,None,None,Worsened,0
7804,PT-07804,39,M,Kolkata Clinical Center,Phase I,ORX-101,Oncology,Low Dose,2024-06-19,2024-08-14,6.67,6.27,105,75,89,None,None,No Change,0
7805,PT-07805,40,F,Bhopal Research Hospital,Phase III,ORX-303,Cardiology,Low Dose,2024-03-08,2024-06-06,5.92,7.39,128,89,88,None,None,Improved,0
7806,PT-07806,43,F,PGI Chandigarh,Phase III,ORX-606,Rheumatology,Placebo,2023-11-28,2024-01-23,6.25,6.03,115,86,75,None,None,No Change,0
7807,PT-07807,61,F,AIIMS Delhi,Phase IV,ORX-505,Infectious Disease,Low Dose,2024-01-31,2024-03-27,5.83,6.08,139,79,88,Nausea,Mild,No Change,0
7808,PT-07808,51,M,Kolkata Clinical Center,Phase III,ORX-101,Oncology,High Dose,2023-03-17,2023-03-31,8.0,8.14,128,74,69,None,None,Worsened,0
7809,PT-07809,41,F,Apollo Chennai,Phase III,ORX-101,Oncology,Placebo,2023-05-01,2023-05-08,8.21,8.38,146,95,74,Headache,None,No Change,0
7810,PT-07810,76,M,Fortis Mumbai,Phase III,ORX-303,Cardiology,Low Dose,2024-06-25,2024-07-09,7.08,6.23,133,87,67,Nausea,Mild,Worsened,0
7811,PT-07811,42,M,Kolkata Clinical Center,Phase II,ORX-505,Infectious Disease,High Dose,2023-01-19,2023-02-02,6.66,6.39,142,78,86,None,None,Improved,1
7812,PT-07812,22,F,Bhopal Research Hospital,Phase III,ORX-404,Neurology,Placebo,2024-06-09,2024-07-07,8.27,7.46,119,86,84,None,None,No Change,0
7813,PT-07813,43,F,Indore Medical Institute,Phase II,ORX-404,Neurology,Placebo,2023-01-07,2023-04-07,6.13,5.3,129,87,66,None,None,Improved,1
7814,PT-07814,34,F,NIMHANS Bengaluru,Phase III,ORX-606,Rheumatology,Low Dose,2023-10-25,2023-11-01,7.52,7.04,130,50,73,Headache,None,Improved,1
7815,PT-07815,58,M,AIIMS Delhi,Phase II,ORX-505,Infectious Disease,Low Dose,2023-12-22,2024-02-16,6.46,6.5,106,63,83,Rash,None,Improved,0
7816,PT-07816,44,F,Fortis Mumbai,Phase I,ORX-303,Cardiology,Placebo,2023-03-18,2023-04-01,6.8,7.16,122,74,67,None,None,Worsened,0
7817,PT-07817,29,M,AIIMS Delhi,Phase II,ORX-606,Rheumatology,Placebo,2024-11-07,2024-12-05,7.76,7.08,148,50,90,None,None,Improved,1
7818,PT-07818,50,F,Indore Medical Institute,Phase II,ORX-404,Neurology,High Dose,2024-05-22,2024-07-17,7.09,5.53,98,91,81,None,None,No Change,0
7819,PT-07819,48,M,Apollo Chennai,Phase II,ORX-505,Infectious Disease,High Dose,2023-02-24,2023-03-03,7.08,7.44,117,77,75,None,None,Improved,0
7820,PT-07820,41,F,PGI Chandigarh,Phase IV,ORX-101,Oncology,Low Dose,2024-02-17,2024-02-24,8.8,7.27,92,64,87,Headache,None,Improved,1
7821,PT-07821,43,F,NIMHANS Bengaluru,Phase I,ORX-505,Infectious Disease,Placebo,2023-09-05,2023-09-19,5.28,4.97,122,88,89,Rash,None,No Change,0
7822,PT-07822,85,M,Bhopal Research Hospital,Phase I,ORX-101,Oncology,Placebo,2024-06-22,2024-09-20,5.78,3.7,138,93,60,Headache,Mild,Improved,1
7823,PT-07823,24,M,Fortis Mumbai,Phase III,ORX-404,Neurology,Low Dose,2024-09-20,2024-12-19,7.61,8.76,112,83,51,None,None,No Change,0
7824,PT-07824,41,F,Fortis Mumbai,Phase IV,ORX-404,Neurology,Low Dose,2024-10-05,2024-11-30,7.06,7.98,115,90,67,None,None,No Change,0
7825,PT-07825,46,F,Apollo Chennai,Phase I,ORX-505,Infectious Disease,High Dose,2023-06-01,2023-06-15,9.69,10.91,163,86,75,Headache,None,No Change,0
7826,PT-07826,49,F,PGI Chandigarh,Phase II,ORX-303,Cardiology,High Dose,2023-05-20,2023-07-15,7.76,7.71,115,72,69,None,None,No Change,0
7827,PT-07827,62,M,PGI Chandigarh,Phase III,ORX-101,Oncology,High Dose,2024-07-10,2024-10-08,8.61,11.08,135,72,71,None,None,Improved,0
7828,PT-07828,42,F,Kolkata Clinical Center,Phase II,ORX-404,Neurology,Low Dose,2024-04-21,2024-07-20,9.01,9.27,103,81,57,None,None,Worsened,0
7829,PT-07829,54,M,Indore Medical Institute,Phase II,ORX-505,Infectious Disease,Low Dose,2024-05-29,2024-06-12,6.35,,94,91,94,None,None,No Change,0
7830,PT-07830,33,M,NIMHANS Bengaluru,Phase II,ORX-202,Diabetes,Placebo,2023-12-09,2024-02-03,7.01,6.17,124,72,62,None,None,Improved,1
7831,PT-07831,66,F,Fortis Mumbai,Phase II,ORX-505,Infectious Disease,High Dose,2024-08-23,2024-09-06,4.03,4.09,133,101,74,Fatigue,Mild,Improved,0
7832,PT-07832,39,F,Kolkata Clinical Center,Phase III,ORX-303,Cardiology,Placebo,2023-08-11,2023-11-09,6.23,6.15,115,68,67,Headache,None,Improved,1
7833,PT-07833,29,M,Indore Medical Institute,Phase II,ORX-101,Oncology,Low Dose,2023-07-29,2023-08-05,5.99,5.67,124,88,80,Fatigue,None,Improved,1
7834,PT-07834,25,F,Apollo Chennai,Phase III,ORX-303,Cardiology,High Dose,2023-11-06,2024-02-04,4.65,3.3,141,90,91,Fatigue,None,Improved,1
7835,PT-07835,58,M,NIMHANS Bengaluru,Phase II,ORX-101,Oncology,Placebo,2023-03-06,2023-05-01,8.5,8.47,160,85,105,None,None,Worsened,0
7836,PT-07836,34,F,Bhopal Research Hospital,Phase II,ORX-505,Infectious Disease,High Dose,2023-07-22,2023-08-05,6.42,5.84,127,78,85,None,None,No Change,0
7837,PT-07837,43,M,NIMHANS Bengaluru,Phase IV,ORX-505,Infectious Disease,Low Dose,2024-11-14,2024-11-28,6.47,5.71,149,85,54,None,None,No Change,0
7838,PT-07838,69,F,NIMHANS Bengaluru,Phase III,ORX-505,Infectious Disease,Placebo,2024-03-13,2024-03-20,7.72,7.9,144,93,65,Headache,None,Improved,0
7839,PT-07839,27,M,Indore Medical Institute,Phase II,ORX-101,Oncology,Low Dose,2023-09-05,2023-12-04,10.08,9.05,134,101,71,Headache,Mild,No Change,0
7840,PT-07840,39,M,Fortis Mumbai,Phase III,ORX-202,Diabetes,High Dose,2023-10-14,2023-11-11,8.31,8.1,136,81,70,None,None,Worsened,0
7841,PT-07841,39,F,Fortis Mumbai,Phase III,ORX-606,Rheumatology,Placebo,2024-08-28,2024-09-25,8.63,7.97,135,70,106,None,None,No Change,0
7842,PT-07842,50,M,PGI Chandigarh,Phase III,ORX-202,Diabetes,Low Dose,2023-08-16,2023-11-14,7.61,8.04,119,96,56,Fever,None,Improved,0
7843,PT-07843,35,F,PGI Chandigarh,Phase III,ORX-202,Diabetes,Placebo,2023-02-13,2023-02-20,6.24,4.15,118,81,62,None,None,No Change,0
7844,PT-07844,25,M,AIIMS Delhi,Phase I,ORX-606,Rheumatology,High Dose,2023-12-27,2024-02-21,7.25,6.78,123,66,72,Headache,None,Improved,1
7845,PT-07845,34,M,AIIMS Delhi,Phase III,ORX-202,Diabetes,Placebo,2023-08-03,2023-08-10,7.3,6.4,127,66,58,None,None,Improved,1
7846,PT-07846,53,F,PGI Chandigarh,Phase III,ORX-303,Cardiology,High Dose,2023-08-02,2023-10-31,8.12,7.36,128,76,93,Nausea,None,No Change,0
7847,PT-07847,41,F,PGI Chandigarh,Phase I,ORX-303,Cardiology,Placebo,2024-11-10,2025-01-05,6.6,7.07,114,83,63,Rash,Mild,Improved,0
7848,PT-07848,55,M,Apollo Chennai,Phase II,ORX-303,Cardiology,Placebo,2024-08-08,2024-09-05,8.18,6.62,101,85,105,Rash,None,Worsened,0
7849,PT-07849,59,M,AIIMS Delhi,Phase III,ORX-101,Oncology,Low Dose,2023-09-11,2023-11-06,6.95,5.78,106,90,90,Nausea,Moderate,No Change,0
7850,PT-07850,34,M,NIMHANS Bengaluru,Phase III,ORX-202,Diabetes,High Dose,2023-02-19,2023-02-26,6.9,6.55,160,82,64,Nausea,None,Improved,1
7851,PT-07851,26,F,Kolkata Clinical Center,Phase IV,ORX-303,Cardiology,High Dose,2023-04-06,2023-04-13,6.11,6.84,137,77,45,None,None,Improved,0
7852,PT-07852,31,F,Indore Medical Institute,Phase III,ORX-303,Cardiology,Placebo,2023-04-14,2023-07-13,7.61,7.53,134,65,80,None,None,No Change,0
7853,PT-07853,29,M,AIIMS Delhi,Phase I,ORX-303,Cardiology,High Dose,2024-06-12,2024-08-07,7.2,6.11,147,86,75,None,None,Improved,1
7854,PT-07854,67,F,Bhopal Research Hospital,Phase II,ORX-202,Diabetes,Placebo,2023-06-10,2023-06-17,6.75,5.08,147,85,73,None,None,Worsened,0
7855,PT-07855,34,M,PGI Chandigarh,Phase IV,ORX-303,Cardiology,Placebo,2024-01-10,2024-01-24,7.81,8.15,114,88,81,Headache,Mild,Improved,0
7856,PT-07856,31,M,Bhopal Research Hospital,Phase III,ORX-404,Neurology,Placebo,2024-04-16,2024-07-15,7.2,6.31,150,74,99,Nausea,Moderate,No Change,0
7857,PT-07857,47,F,Apollo Chennai,Phase IV,ORX-202,Diabetes,Low Dose,2024-09-27,2024-12-26,5.11,2.75,124,98,95,None,None,Improved,1
7858,PT-07858,47,F,AIIMS Delhi,Phase I,ORX-606,Rheumatology,High Dose,2023-03-13,2023-04-10,6.32,5.54,131,95,85,None,None,Improved,1
7859,PT-07859,60,M,Apollo Chennai,Phase III,ORX-202,Diabetes,High Dose,2023-06-20,2023-06-27,7.97,8.42,90,71,62,None,None,No Change,0
7860,PT-07860,25,M,PGI Chandigarh,Phase II,ORX-101,Oncology,Placebo,2023-03-22,2023-05-17,7.21,5.5,111,80,55,Dizziness,Mild,Improved,1
7861,PT-07861,37,F,Fortis Mumbai,Phase I,ORX-404,Neurology,Low Dose,2023-02-02,2023-02-09,7.97,6.46,142,72,81,None,None,Worsened,0
7862,PT-07862,27,M,Indore Medical Institute,Phase II,ORX-101,Oncology,High Dose,2024-05-20,2024-06-17,7.74,7.07,136,75,85,None,None,No Change,0
7863,PT-07863,58,F,Indore Medical Institute,Phase III,ORX-505,Infectious Disease,High Dose,2023-07-23,2023-10-21,7.34,6.51,123,66,80,None,None,No Change,0
7864,PT-07864,54,M,Fortis Mumbai,Phase III,ORX-404,Neurology,Placebo,2024-10-07,2024-10-14,9.08,9.86,110,84,76,None,None,Improved,0
7865,PT-07865,64,F,NIMHANS Bengaluru,Phase III,ORX-303,Cardiology,Placebo,2023-07-30,2023-10-28,6.35,6.74,110,80,65,Rash,Moderate,No Change,0
7866,PT-07866,18,M,Bhopal Research Hospital,Phase IV,ORX-202,Diabetes,High Dose,2023-11-30,2024-02-28,6.11,5.48,153,68,69,None,None,Improved,1
7867,PT-07867,21,M,Kolkata Clinical Center,Phase III,ORX-101,Oncology,Placebo,2023-06-09,2023-07-07,8.59,7.77,121,77,50,None,None,No Change,0
7868,PT-07868,21,M,NIMHANS Bengaluru,Phase II,ORX-101,Oncology,Placebo,2023-01-15,2023-01-29,6.06,6.21,90,88,82,Rash,Mild,Improved,0
7869,PT-07869,18,F,Apollo Chennai,Phase III,ORX-101,Oncology,Low Dose,2023-02-15,2023-03-01,6.82,7.47,108,75,116,Nausea,Mild,Worsened,0
7870,PT-07870,50,M,Bhopal Research Hospital,Phase III,ORX-505,Infectious Disease,Placebo,2024-01-25,2024-02-22,6.89,6.06,134,90,47,Nausea,Moderate,Improved,1
7871,PT-07871,18,M,Indore Medical Institute,Phase III,ORX-505,Infectious Disease,High Dose,2023-05-15,2023-07-10,6.0,5.46,129,61,75,None,None,No Change,0
7872,PT-07872,43,F,AIIMS Delhi,Phase I,ORX-303,Cardiology,Placebo,2024-09-01,2024-09-15,6.18,5.3,114,87,78,Fever,Mild,Improved,1
7873,PT-07873,26,M,NIMHANS Bengaluru,Phase I,ORX-505,Infectious Disease,Placebo,2023-05-26,2023-06-02,8.35,6.72,97,79,74,Headache,Severe,Improved,1
7874,PT-07874,46,F,AIIMS Delhi,Phase II,ORX-505,Infectious Disease,Placebo,2023-09-14,2023-12-13,5.78,6.19,158,81,82,None,None,Improved,0
7875,PT-07875,18,F,AIIMS Delhi,Phase IV,ORX-202,Diabetes,Placebo,2024-01-21,2024-01-28,6.68,5.65,112,74,70,None,None,Worsened,0
7876,PT-07876,21,M,NIMHANS Bengaluru,Phase I,ORX-202,Diabetes,Placebo,2023-11-24,2023-12-01,6.62,5.28,142,85,82,None,None,No Change,0
7877,PT-07877,60,F,Indore Medical Institute,Phase I,ORX-505,Infectious Disease,High Dose,2024-08-23,2024-11-21,6.21,6.05,147,71,49,None,None,Improved,1
7878,PT-07878,33,F,NIMHANS Bengaluru,Phase II,ORX-303,Cardiology,Low Dose,2024-05-25,2024-07-20,8.35,7.09,119,72,75,None,None,Improved,1
7879,PT-07879,28,F,AIIMS Delhi,Phase II,ORX-101,Oncology,Low Dose,2023-12-05,2023-12-19,5.42,4.62,123,95,78,None,None,Improved,1
7880,PT-07880,26,M,Bhopal Research Hospital,Phase II,ORX-505,Infectious Disease,High Dose,2024-05-11,2024-06-08,6.32,6.56,120,68,79,Headache,None,No Change,0
7881,PT-07881,32,M,Fortis Mumbai,Phase II,ORX-505,Infectious Disease,Placebo,2023-11-26,2023-12-24,7.77,7.7,107,103,76,None,None,No Change,0
7882,PT-07882,18,M,Fortis Mumbai,Phase III,ORX-101,Oncology,High Dose,2024-05-28,2024-08-26,7.66,4.92,146,82,75,None,None,Improved,1
7883,PT-07883,43,M,Bhopal Research Hospital,Phase IV,ORX-505,Infectious Disease,High Dose,2024-03-30,2024-04-06,7.8,6.89,126,82,45,None,None,No Change,0
7884,PT-07884,53,M,Bhopal Research Hospital,Phase I,ORX-505,Infectious Disease,Placebo,2023-02-03,2023-02-17,8.01,7.94,133,100,76,None,None,Improved,1
7885,PT-07885,43,F,PGI Chandigarh,Phase III,ORX-202,Diabetes,Placebo,2024-02-25,2024-03-10,6.32,4.12,134,74,49,Rash,None,Improved,1
7886,PT-07886,42,F,Fortis Mumbai,Phase III,ORX-303,Cardiology,High Dose,2023-01-30,2023-03-27,6.97,6.29,128,62,90,None,None,Improved,1
7887,PT-07887,50,F,Bhopal Research Hospital,Phase III,ORX-303,Cardiology,High Dose,2024-09-30,2024-10-14,8.59,7.61,134,58,65,Nausea,None,No Change,0
7888,PT-07888,21,F,Bhopal Research Hospital,Phase IV,ORX-303,Cardiology,Placebo,2024-05-27,2024-06-03,7.41,5.94,118,80,71,None,None,Improved,1
7889,PT-07889,22,M,Indore Medical Institute,Phase I,ORX-202,Diabetes,High Dose,2024-04-25,2024-05-09,9.07,8.7,156,68,71,None,None,No Change,0
7890,PT-07890,45,M,AIIMS Delhi,Phase II,ORX-202,Diabetes,Placebo,2023-05-15,2023-08-13,8.94,9.94,118,72,76,None,None,Improved,0
7891,PT-07891,62,M,Bhopal Research Hospital,Phase II,ORX-404,Neurology,Low Dose,2024-08-09,2024-09-06,7.26,7.07,147,93,91,None,None,Improved,1
7892,PT-07892,54,M,Bhopal Research Hospital,Phase IV,ORX-606,Rheumatology,Low Dose,2024-02-25,2024-04-21,8.82,7.33,168,94,75,None,None,Improved,1
7893,PT-07893,62,F,Fortis Mumbai,Phase I,ORX-505,Infectious Disease,Placebo,2023-08-02,2023-08-16,6.78,6.81,138,92,71,Fever,None,Worsened,0
7894,PT-07894,59,M,Indore Medical Institute,Phase IV,ORX-303,Cardiology,High Dose,2023-06-01,2023-06-08,6.67,6.93,127,60,67,None,None,No Change,0
7895,PT-07895,58,M,NIMHANS Bengaluru,Phase II,ORX-404,Neurology,High Dose,2024-02-27,2024-03-12,6.84,7.53,106,90,77,None,None,Worsened,0
7896,PT-07896,41,F,AIIMS Delhi,Phase II,ORX-404,Neurology,Placebo,2023-01-27,2023-02-03,5.79,5.58,109,74,76,Fatigue,None,No Change,0
7897,PT-07897,39,M,Apollo Chennai,Phase I,ORX-505,Infectious Disease,Low Dose,2024-08-17,2024-09-14,8.43,5.7,124,77,77,None,None,Improved,1
7898,PT-07898,36,F,PGI Chandigarh,Phase I,ORX-303,Cardiology,High Dose,2024-01-02,2024-01-30,8.43,7.8,130,92,78,Rash,Mild,Improved,1
7899,PT-07899,24,M,AIIMS Delhi,Phase IV,ORX-202,Diabetes,Low Dose,2024-08-15,2024-08-22,6.69,6.18,98,73,77,None,None,No Change,0
7900,PT-07900,77,M,Indore Medical Institute,Phase II,ORX-505,Infectious Disease,High Dose,2024-07-31,2024-08-07,7.65,7.39,158,89,88,Headache,None,Improved,1
7901,PT-07901,38,M,Kolkata Clinical Center,Phase III,ORX-606,Rheumatology,High Dose,2023-04-29,2023-06-24,5.68,5.52,160,100,87,None,None,No Change,0
7902,PT-07902,34,F,Kolkata Clinical Center,Phase IV,ORX-404,Neurology,Low Dose,2023-06-08,2023-06-15,5.34,4.2,131,76,92,None,None,No Change,0
7903,PT-07903,21,F,Fortis Mumbai,Phase IV,ORX-303,Cardiology,Placebo,2024-01-22,2024-02-19,7.05,5.96,145,88,66,None,None,Improved,1
7904,PT-07904,58,F,PGI Chandigarh,Phase IV,ORX-505,Infectious Disease,Low Dose,2023-10-28,2024-01-26,5.25,3.24,112,58,76,None,None,Improved,1
7905,PT-07905,43,M,Indore Medical Institute,Phase III,ORX-101,Oncology,High Dose,2024-09-22,2024-10-20,6.71,6.8,114,66,66,None,None,Improved,0
7906,PT-07906,25,F,Apollo Chennai,Phase II,ORX-303,Cardiology,Placebo,2023-09-27,2023-10-04,6.47,6.6,96,77,91,None,None,No Change,0
7907,PT-07907,62,F,Bhopal Research Hospital,Phase IV,ORX-202,Diabetes,Placebo,2023-09-29,2023-11-24,6.38,7.97,109,79,61,None,None,Worsened,0
7908,PT-07908,51,F,Fortis Mumbai,Phase II,ORX-303,Cardiology,Low Dose,2023-11-25,2023-12-23,10.56,11.82,143,74,75,None,None,No Change,0
7909,PT-07909,62,M,Apollo Chennai,Phase III,ORX-505,Infectious Disease,High Dose,2024-03-08,2024-04-05,8.1,7.77,130,94,96,Headache,None,Improved,1
7910,PT-07910,20,M,AIIMS Delhi,Phase III,ORX-404,Neurology,High Dose,2023-07-19,2023-09-13,7.47,7.59,118,97,73,Nausea,Moderate,Improved,0
7911,PT-07911,65,F,Apollo Chennai,Phase I,ORX-606,Rheumatology,Low Dose,2023-03-27,2023-04-10,6.76,6.59,132,101,88,None,None,No Change,0
7912,PT-07912,37,F,Fortis Mumbai,Phase I,ORX-202,Diabetes,Low Dose,2023-03-28,2023-04-04,6.87,6.22,128,70,76,None,None,Worsened,0
7913,PT-07913,66,F,AIIMS Delhi,Phase III,ORX-202,Diabetes,Placebo,2024-07-27,2024-08-24,8.79,6.98,96,74,53,Fever,Moderate,Improved,1
7914,PT-07914,24,M,Kolkata Clinical Center,Phase II,ORX-303,Cardiology,Low Dose,2023-07-24,2023-08-21,7.62,7.19,97,96,72,None,None,Worsened,0
7915,PT-07915,36,F,Bhopal Research Hospital,Phase IV,ORX-303,Cardiology,High Dose,2024-01-14,2024-02-11,8.42,8.39,127,76,85,None,None,Improved,1
7916,PT-07916,38,F,Fortis Mumbai,Phase IV,ORX-505,Infectious Disease,High Dose,2023-04-19,2023-07-18,6.93,5.47,148,100,80,None,None,Improved,1
7917,PT-07917,37,F,Kolkata Clinical Center,Phase I,ORX-404,Neurology,Placebo,2024-06-04,2024-07-02,8.32,8.45,120,95,72,Headache,None,No Change,0
7918,PT-07918,24,M,NIMHANS Bengaluru,Phase III,ORX-101,Oncology,Low Dose,2024-11-12,2024-12-10,7.12,7.7,129,67,72,Rash,None,No Change,0
7919,PT-07919,64,M,Fortis Mumbai,Phase III,ORX-202,Diabetes,High Dose,2023-02-21,2023-02-28,7.53,7.11,125,94,92,Fatigue,None,Improved,1
7920,PT-07920,22,M,Bhopal Research Hospital,Phase I,ORX-101,Oncology,High Dose,2023-04-14,2023-06-09,8.33,8.39,156,81,93,None,None,Improved,0
7921,PT-07921,52,F,Kolkata Clinical Center,Phase III,ORX-202,Diabetes,Low Dose,2024-06-06,2024-06-13,5.86,6.38,142,74,82,None,None,Improved,0
7922,PT-07922,78,F,AIIMS Delhi,Phase III,ORX-101,Oncology,Low Dose,2023-09-05,2023-12-04,6.62,6.87,108,75,89,Headache,None,No Change,0
7923,PT-07923,49,M,Apollo Chennai,Phase III,ORX-101,Oncology,Low Dose,2024-08-15,2024-09-12,6.96,8.09,111,80,84,None,None,Improved,0
7924,PT-07924,31,M,Kolkata Clinical Center,Phase III,ORX-404,Neurology,Placebo,2024-02-10,2024-04-06,7.81,8.38,125,73,73,Fatigue,Moderate,Improved,0
7925,PT-07925,18,M,NIMHANS Bengaluru,Phase III,ORX-101,Oncology,Low Dose,2024-07-15,2024-08-12,8.41,8.25,124,61,93,Fever,Moderate,Worsened,0
7926,PT-07926,37,F,Fortis Mumbai,Phase III,ORX-303,Cardiology,High Dose,2023-10-21,2023-11-18,7.88,7.47,98,97,93,None,None,Improved,1
7927,PT-07927,57,F,PGI Chandigarh,Phase II,ORX-202,Diabetes,Low Dose,2024-07-26,2024-08-23,7.58,6.1,143,108,79,None,None,Improved,1
7928,PT-07928,47,F,Kolkata Clinical Center,Phase IV,ORX-404,Neurology,Low Dose,2024-03-31,2024-04-14,5.88,3.61,121,99,96,None,None,Worsened,0
7929,PT-07929,43,M,Fortis Mumbai,Phase II,ORX-101,Oncology,High Dose,2024-07-06,2024-07-20,7.72,6.22,130,75,78,None,None,Worsened,0
7930,PT-07930,40,M,Bhopal Research Hospital,Phase II,ORX-505,Infectious Disease,Low Dose,2024-01-15,2024-01-22,6.85,7.35,163,79,97,None,None,No Change,0
7931,PT-07931,25,F,PGI Chandigarh,Phase II,ORX-404,Neurology,High Dose,2024-08-27,2024-10-22,7.09,5.52,122,90,93,None,None,Worsened,0
7932,PT-07932,32,F,NIMHANS Bengaluru,Phase II,ORX-505,Infectious Disease,High Dose,2024-07-21,2024-08-04,7.75,8.46,147,85,69,Headache,None,Improved,0
7933,PT-07933,33,F,PGI Chandigarh,Phase II,ORX-505,Infectious Disease,Placebo,2024-06-16,2024-08-11,6.19,5.76,113,90,81,None,None,Improved,1
7934,PT-07934,47,M,Apollo Chennai,Phase II,ORX-404,Neurology,Placebo,2023-06-30,2023-07-28,4.99,4.62,119,107,60,Fatigue,None,Improved,1
7935,PT-07935,41,M,Fortis Mumbai,Phase I,ORX-101,Oncology,High Dose,2023-10-07,2024-01-05,7.66,6.38,162,105,65,None,None,Improved,1
7936,PT-07936,35,M,Fortis Mumbai,Phase II,ORX-404,Neurology,Placebo,2023-06-24,2023-07-01,9.78,10.63,121,87,58,None,None,No Change,0
7937,PT-07937,80,M,Kolkata Clinical Center,Phase III,ORX-606,Rheumatology,Placebo,2023-07-08,2023-07-15,7.29,7.41,111,68,84,None,None,Improved,0
7938,PT-07938,75,M,PGI Chandigarh,Phase III,ORX-202,Diabetes,Low Dose,2024-11-14,2025-01-09,6.55,5.27,133,101,69,Fever,Mild,No Change,0
7939,PT-07939,41,M,Apollo Chennai,Phase II,ORX-202,Diabetes,Low Dose,2024-01-03,2024-01-17,8.2,8.65,122,95,85,Fatigue,Mild,Improved,0
7940,PT-07940,45,F,Apollo Chennai,Phase III,ORX-505,Infectious Disease,Placebo,2024-11-12,2025-02-10,8.28,8.57,109,99,82,None,None,Improved,0
7941,PT-07941,67,F,Bhopal Research Hospital,Phase III,ORX-404,Neurology,High Dose,2024-09-17,2024-12-16,7.26,7.09,135,88,99,None,None,No Change,0
7942,PT-07942,52,F,Apollo Chennai,Phase III,ORX-505,Infectious Disease,Low Dose,2023-02-22,2023-03-22,7.17,7.67,135,117,82,None,None,Improved,0
7943,PT-07943,64,M,Indore Medical Institute,Phase IV,ORX-303,Cardiology,Placebo,2023-05-21,2023-06-18,8.26,6.01,114,76,57,None,None,Worsened,0
7944,PT-07944,38,F,Apollo Chennai,Phase III,ORX-202,Diabetes,Placebo,2023-12-13,2024-02-07,5.55,4.16,132,105,58,Dizziness,None,Improved,1
7945,PT-07945,25,F,Fortis Mumbai,Phase II,ORX-505,Infectious Disease,Low Dose,2023-10-04,2023-10-11,6.56,6.03,100,73,66,Fatigue,Mild,Improved,1
7946,PT-07946,50,F,Kolkata Clinical Center,Phase IV,ORX-505,Infectious Disease,High Dose,2023-06-07,2023-09-05,7.71,7.17,121,73,78,Fatigue,None,Improved,1
7947,PT-07947,29,F,Bhopal Research Hospital,Phase III,ORX-303,Cardiology,Placebo,2023-01-25,2023-02-22,9.06,7.31,116,92,72,Dizziness,None,No Change,0
7948,PT-07948,55,F,Bhopal Research Hospital,Phase III,ORX-404,Neurology,Placebo,2023-04-23,2023-07-22,9.26,9.61,106,68,75,None,None,Worsened,0
7949,PT-07949,52,F,AIIMS Delhi,Phase III,ORX-303,Cardiology,High Dose,2023-06-15,2023-06-22,8.65,7.54,119,78,74,Fatigue,Mild,Improved,1
7950,PT-07950,68,M,Indore Medical Institute,Phase I,ORX-505,Infectious Disease,Placebo,2024-11-01,2025-01-30,7.08,6.81,144,101,77,Nausea,Moderate,Improved,1
7951,PT-07951,65,F,Bhopal Research Hospital,Phase I,ORX-606,Rheumatology,Placebo,2024-01-09,2024-04-08,9.39,8.89,117,108,93,Headache,None,Worsened,0
7952,PT-07952,45,M,Kolkata Clinical Center,Phase III,ORX-505,Infectious Disease,High Dose,2023-09-16,2023-09-30,7.98,6.64,147,60,92,None,None,Improved,1
7953,PT-07953,33,M,Kolkata Clinical Center,Phase I,ORX-101,Oncology,High Dose,2024-09-28,2024-10-05,5.22,3.01,119,90,58,None,None,No Change,0
7954,PT-07954,25,M,Kolkata Clinical Center,Phase IV,ORX-101,Oncology,High Dose,2024-09-05,2024-09-19,6.61,6.93,144,83,91,Nausea,Mild,Improved,0
7955,PT-07955,56,F,Bhopal Research Hospital,Phase III,ORX-303,Cardiology,Low Dose,2023-08-10,2023-10-05,6.7,7.12,104,87,61,None,None,Improved,0
7956,PT-07956,47,F,Indore Medical Institute,Phase III,ORX-303,Cardiology,Low Dose,2023-12-15,2023-12-29,8.66,8.45,127,84,87,None,None,Improved,1
7957,PT-07957,79,M,Bhopal Research Hospital,Phase II,ORX-202,Diabetes,High Dose,2024-07-03,2024-07-31,7.98,7.13,124,71,60,Rash,None,Improved,1
7958,PT-07958,18,M,Apollo Chennai,Phase III,ORX-606,Rheumatology,Placebo,2023-09-10,2023-10-08,6.65,4.98,129,75,62,None,None,Worsened,0
7959,PT-07959,18,M,Kolkata Clinical Center,Phase III,ORX-606,Rheumatology,Placebo,2024-10-11,2024-12-06,6.78,4.8,140,85,74,None,None,No Change,0
7960,PT-07960,68,F,Fortis Mumbai,Phase III,ORX-303,Cardiology,High Dose,2024-08-31,2024-09-14,7.21,7.16,140,75,70,None,None,Improved,1
7961,PT-07961,45,M,NIMHANS Bengaluru,Phase II,ORX-505,Infectious Disease,Low Dose,2024-02-21,2024-05-21,5.58,6.79,130,79,107,None,None,Improved,0
7962,PT-07962,27,M,Kolkata Clinical Center,Phase III,ORX-404,Neurology,Placebo,2024-01-07,2024-01-21,9.04,9.38,148,79,78,Headache,Moderate,Improved,0
7963,PT-07963,39,F,PGI Chandigarh,Phase III,ORX-505,Infectious Disease,Low Dose,2024-11-18,2025-01-13,8.4,8.35,117,75,77,Rash,None,Improved,1
7964,PT-07964,39,M,AIIMS Delhi,Phase IV,ORX-505,Infectious Disease,High Dose,2023-10-22,2023-11-05,8.93,9.26,142,84,66,None,None,No Change,0
7965,PT-07965,56,M,AIIMS Delhi,Phase III,ORX-404,Neurology,High Dose,2024-03-02,2024-05-31,4.68,4.44,113,71,71,None,None,Improved,1
7966,PT-07966,43,M,Bhopal Research Hospital,Phase II,ORX-202,Diabetes,Low Dose,2024-01-24,2024-04-23,7.17,7.48,124,80,58,None,None,No Change,0
7967,PT-07967,24,M,NIMHANS Bengaluru,Phase III,ORX-101,Oncology,Low Dose,2023-08-11,2023-11-09,7.54,7.71,123,93,58,None,None,Improved,0
7968,PT-07968,51,M,AIIMS Delhi,Phase III,ORX-303,Cardiology,Placebo,2023-11-29,2024-01-24,6.18,4.94,114,81,84,None,None,Improved,1
7969,PT-07969,50,F,AIIMS Delhi,Phase III,ORX-303,Cardiology,Low Dose,2023-02-23,2023-04-20,6.85,7.02,158,80,79,Nausea,None,Worsened,0
7970,PT-07970,35,M,PGI Chandigarh,Phase III,ORX-303,Cardiology,Placebo,2024-02-05,2024-02-12,6.73,7.45,150,79,84,Nausea,None,No Change,0
7971,PT-07971,59,F,Kolkata Clinical Center,Phase I,ORX-505,Infectious Disease,Low Dose,2023-09-22,2023-12-21,6.66,5.09,140,92,88,None,None,No Change,0
7972,PT-07972,39,M,Kolkata Clinical Center,Phase III,ORX-404,Neurology,Placebo,2023-07-29,2023-10-27,9.03,8.88,107,62,73,None,None,Improved,1
7973,PT-07973,48,M,Fortis Mumbai,Phase I,ORX-505,Infectious Disease,High Dose,2023-12-14,2024-02-08,6.85,8.25,135,70,46,Headache,Mild,No Change,0
7974,PT-07974,48,M,Indore Medical Institute,Phase II,ORX-202,Diabetes,Placebo,2023-01-04,2023-01-11,8.39,9.66,124,102,58,Headache,Mild,Improved,0
7975,PT-07975,39,F,PGI Chandigarh,Phase III,ORX-606,Rheumatology,Low Dose,2023-03-08,2023-03-22,5.98,6.3,104,86,60,None,None,Improved,0
7976,PT-07976,73,F,Indore Medical Institute,Phase I,ORX-505,Infectious Disease,Placebo,2023-11-04,2023-11-18,6.75,6.69,95,64,67,None,None,Improved,1
7977,PT-07977,58,F,PGI Chandigarh,Phase I,ORX-505,Infectious Disease,Low Dose,2023-08-18,2023-10-13,7.99,8.57,100,88,70,Fatigue,None,Worsened,0
7978,PT-07978,32,M,PGI Chandigarh,Phase II,ORX-101,Oncology,High Dose,2023-02-07,2023-02-14,6.56,6.05,139,95,85,None,None,Improved,1
7979,PT-07979,55,F,Kolkata Clinical Center,Phase II,ORX-505,Infectious Disease,Placebo,2023-06-24,2023-07-08,9.39,9.62,124,88,101,None,None,Improved,0
7980,PT-07980,31,F,AIIMS Delhi,Phase I,ORX-505,Infectious Disease,High Dose,2024-03-01,2024-05-30,6.68,7.59,122,91,96,None,None,Improved,0
7981,PT-07981,24,F,Bhopal Research Hospital,Phase II,ORX-303,Cardiology,Placebo,2023-05-13,2023-05-27,6.71,,125,57,70,Rash,Moderate,Improved,0
7982,PT-07982,57,M,Indore Medical Institute,Phase II,ORX-202,Diabetes,Placebo,2024-10-11,2024-10-25,8.73,8.38,136,77,90,Rash,Moderate,Improved,1
7983,PT-07983,67,F,NIMHANS Bengaluru,Phase II,ORX-505,Infectious Disease,High Dose,2024-05-06,2024-08-04,8.12,7.62,135,93,78,None,None,Improved,1
7984,PT-07984,57,F,Bhopal Research Hospital,Phase II,ORX-202,Diabetes,Low Dose,2023-08-02,2023-08-30,7.64,8.52,140,76,97,Headache,None,No Change,0
7985,PT-07985,52,F,Indore Medical Institute,Phase IV,ORX-505,Infectious Disease,Low Dose,2024-10-11,2024-11-08,7.03,5.41,132,104,45,None,None,Improved,1
7986,PT-07986,18,F,Kolkata Clinical Center,Phase IV,ORX-505,Infectious Disease,Low Dose,2023-08-18,2023-11-16,8.12,7.93,140,75,48,None,None,No Change,0
7987,PT-07987,31,M,PGI Chandigarh,Phase III,ORX-404,Neurology,Placebo,2023-05-15,2023-05-22,9.07,8.27,120,50,52,None,None,Improved,1
7988,PT-07988,62,M,Bhopal Research Hospital,Phase I,ORX-101,Oncology,High Dose,2023-09-23,2023-11-18,6.89,7.38,114,64,74,None,None,Improved,0
7989,PT-07989,35,M,Apollo Chennai,Phase II,ORX-505,Infectious Disease,Low Dose,2024-11-06,2024-12-04,6.2,5.07,125,76,64,None,None,No Change,0
7990,PT-07990,73,F,AIIMS Delhi,Phase III,ORX-606,Rheumatology,Placebo,2023-07-21,2023-09-15,7.75,,126,89,85,None,None,No Change,0
7991,PT-07991,28,F,NIMHANS Bengaluru,Phase I,ORX-202,Diabetes,High Dose,2024-07-23,2024-08-20,5.36,2.91,160,76,86,Fatigue,Severe,No Change,0
7992,PT-07992,48,M,Indore Medical Institute,Phase II,ORX-101,Oncology,Low Dose,2023-02-12,2023-03-12,8.3,7.84,104,69,73,Fever,Mild,Improved,1
7993,PT-07993,19,F,Bhopal Research Hospital,Phase I,ORX-505,Infectious Disease,High Dose,2023-01-21,2023-03-18,6.17,,122,76,79,None,None,No Change,0
7994,PT-07994,58,M,AIIMS Delhi,Phase I,ORX-101,Oncology,Low Dose,2024-08-13,2024-08-20,6.91,5.16,91,83,68,None,None,Improved,1
7995,PT-07995,42,F,Bhopal Research Hospital,Phase IV,ORX-505,Infectious Disease,Low Dose,2023-01-22,2023-01-29,7.6,8.49,96,69,76,None,None,No Change,0
7996,PT-07996,26,F,Bhopal Research Hospital,Phase III,ORX-303,Cardiology,High Dose,2023-01-19,2023-04-19,5.41,6.19,109,66,61,Dizziness,Mild,No Change,0
7997,PT-07997,62,F,Bhopal Research Hospital,Phase II,ORX-101,Oncology,Low Dose,2023-09-16,2023-09-30,6.37,4.72,112,81,90,None,None,Improved,1
7998,PT-07998,57,M,Bhopal Research Hospital,Phase III,ORX-303,Cardiology,Low Dose,2024-09-11,2024-09-25,6.27,5.39,165,93,74,None,None,Worsened,0
7999,PT-07999,18,M,Apollo Chennai,Phase III,ORX-303,Cardiology,High Dose,2024-02-16,2024-03-01,6.65,5.06,112,70,74,Headache,Moderate,Improved,1
8000,PT-08000,46,M,NIMHANS Bengaluru,Phase III,ORX-202,Diabetes,High Dose,2024-03-31,2024-04-07,6.32,4.77,124,76,51,Headache,None,Worsened,0
8001,PT-08001,54,M,AIIMS Delhi,Phase III,ORX-404,Neurology,High Dose,2024-03-28,2024-04-11,6.33,5.68,124,81,80,None,None,Improved,1
8002,PT-08002,24,M,Indore Medical Institute,Phase III,ORX-202,Diabetes,Low Dose,2024-06-21,2024-06-28,7.57,6.87,147,91,96,Headache,Mild,Improved,1
8003,PT-08003,29,F,Fortis Mumbai,Phase III,ORX-101,Oncology,Low Dose,2023-10-03,2023-11-28,8.74,8.43,140,90,84,None,None,No Change,0
8004,PT-08004,27,F,Kolkata Clinical Center,Phase IV,ORX-202,Diabetes,Low Dose,2024-05-26,2024-06-23,8.35,8.26,101,76,61,None,None,No Change,0
8005,PT-08005,22,M,Apollo Chennai,Phase IV,ORX-606,Rheumatology,Low Dose,2023-12-07,2024-02-01,8.22,6.49,104,105,71,None,None,Improved,1
8006,PT-08006,55,M,Bhopal Research Hospital,Phase I,ORX-606,Rheumatology,High Dose,2024-09-23,2024-09-30,8.55,8.85,130,81,85,Nausea,None,Improved,0
8007,PT-08007,41,M,AIIMS Delhi,Phase II,ORX-202,Diabetes,High Dose,2024-06-03,2024-06-17,8.03,7.4,125,104,71,None,None,No Change,0
8008,PT-08008,45,F,PGI Chandigarh,Phase IV,ORX-404,Neurology,Low Dose,2023-01-24,2023-04-24,7.72,7.76,133,66,80,Fatigue,None,No Change,0
8009,PT-08009,48,F,Indore Medical Institute,Phase III,ORX-606,Rheumatology,Placebo,2024-09-18,2024-10-16,8.57,8.83,149,69,64,None,None,Improved,0
8010,PT-08010,50,F,Fortis Mumbai,Phase III,ORX-303,Cardiology,Low Dose,2024-01-13,2024-01-20,8.56,7.98,114,62,83,None,None,Improved,1
8011,PT-08011,43,M,Indore Medical Institute,Phase III,ORX-101,Oncology,High Dose,2024-06-22,2024-09-20,6.68,7.09,126,82,90,Rash,Mild,Improved,0
8012,PT-08012,80,M,Fortis Mumbai,Phase IV,ORX-303,Cardiology,Low Dose,2023-02-12,2023-04-09,6.67,5.48,110,87,62,Nausea,None,Improved,1
8013,PT-08013,39,M,Indore Medical Institute,Phase IV,ORX-202,Diabetes,High Dose,2024-08-17,2024-09-14,6.86,7.86,149,63,100,Fever,None,Improved,0
8014,PT-08014,25,M,PGI Chandigarh,Phase IV,ORX-404,Neurology,Low Dose,2024-08-13,2024-10-08,7.39,6.24,121,70,101,None,None,Improved,1
8015,PT-08015,42,F,NIMHANS Bengaluru,Phase III,ORX-303,Cardiology,Low Dose,2024-11-16,2024-11-30,7.47,6.11,102,76,85,None,None,No Change,0
8016,PT-08016,43,F,AIIMS Delhi,Phase III,ORX-606,Rheumatology,Low Dose,2024-07-31,2024-09-25,8.37,8.08,128,88,79,None,None,No Change,0
8017,PT-08017,60,M,PGI Chandigarh,Phase III,ORX-505,Infectious Disease,Low Dose,2023-07-12,2023-08-09,7.87,8.29,140,98,89,None,None,Improved,0
8018,PT-08018,72,M,PGI Chandigarh,Phase III,ORX-202,Diabetes,High Dose,2024-11-19,2025-01-14,6.55,6.9,103,93,78,Headache,None,Improved,0
8019,PT-08019,59,F,PGI Chandigarh,Phase III,ORX-404,Neurology,Low Dose,2023-05-03,2023-05-10,9.22,9.54,120,68,85,Headache,None,Improved,0
8020,PT-08020,40,F,AIIMS Delhi,Phase II,ORX-303,Cardiology,High Dose,2024-05-17,2024-05-31,8.0,7.14,111,79,85,Nausea,None,Improved,1
8021,PT-08021,46,M,AIIMS Delhi,Phase III,ORX-101,Oncology,High Dose,2023-08-17,2023-08-31,6.22,7.44,125,54,91,None,None,Worsened,0
8022,PT-08022,44,M,NIMHANS Bengaluru,Phase III,ORX-606,Rheumatology,Placebo,2024-06-23,2024-07-07,7.0,6.42,124,102,84,Nausea,Moderate,No Change,0
8023,PT-08023,49,F,Bhopal Research Hospital,Phase III,ORX-303,Cardiology,High Dose,2024-01-05,2024-03-01,6.88,8.04,143,93,81,None,None,Improved,0
8024,PT-08024,60,M,AIIMS Delhi,Phase II,ORX-404,Neurology,High Dose,2023-04-03,2023-05-29,7.67,6.94,134,107,80,None,None,Worsened,0
8025,PT-08025,65,F,Apollo Chennai,Phase III,ORX-202,Diabetes,Placebo,2024-09-20,2024-12-19,8.63,8.74,157,55,52,None,None,No Change,0
8026,PT-08026,72,F,Fortis Mumbai,Phase I,ORX-505,Infectious Disease,Placebo,2024-09-27,2024-10-04,6.42,6.12,159,84,101,None,None,No Change,0
8027,PT-08027,38,F,NIMHANS Bengaluru,Phase III,ORX-606,Rheumatology,High Dose,2023-05-28,2023-07-23,7.94,7.59,154,78,64,None,None,Improved,1
8028,PT-08028,37,M,Apollo Chennai,Phase I,ORX-606,Rheumatology,High Dose,2023-10-25,2024-01-23,6.69,5.71,115,95,97,Headache,None,Improved,1
8029,PT-08029,51,F,Apollo Chennai,Phase III,ORX-606,Rheumatology,Low Dose,2023-02-19,2023-05-20,6.42,5.5,90,86,68,None,None,Improved,1
8030,PT-08030,68,F,Apollo Chennai,Phase I,ORX-202,Diabetes,Low Dose,2023-01-12,2023-01-26,5.55,4.61,126,87,103,None,None,Worsened,0
8031,PT-08031,23,F,Kolkata Clinical Center,Phase III,ORX-303,Cardiology,Placebo,2023-03-29,2023-06-27,6.84,5.15,142,74,76,Dizziness,Mild,Improved,1
8032,PT-08032,42,F,PGI Chandigarh,Phase III,ORX-101,Oncology,Low Dose,2023-03-04,2023-03-18,7.34,6.8,110,83,66,None,None,Improved,1
8033,PT-08033,58,F,AIIMS Delhi,Phase IV,ORX-101,Oncology,Low Dose,2023-04-30,2023-05-28,7.27,5.93,171,101,112,None,None,Improved,1
8034,PT-08034,39,M,Bhopal Research Hospital,Phase III,ORX-505,Infectious Disease,High Dose,2023-01-28,2023-04-28,6.2,6.52,147,84,48,Fatigue,Mild,Improved,0
8035,PT-08035,29,M,Apollo Chennai,Phase IV,ORX-202,Diabetes,High Dose,2023-08-16,2023-09-13,7.71,6.71,103,78,45,Nausea,Mild,Improved,1
8036,PT-08036,35,M,AIIMS Delhi,Phase III,ORX-101,Oncology,High Dose,2023-11-29,2024-01-24,6.69,6.57,137,86,90,Nausea,Mild,Improved,1
8037,PT-08037,42,F,Indore Medical Institute,Phase III,ORX-505,Infectious Disease,Placebo,2023-05-26,2023-06-23,5.45,5.09,112,65,86,Rash,Mild,No Change,0
8038,PT-08038,22,F,Indore Medical Institute,Phase III,ORX-404,Neurology,High Dose,2023-03-30,2023-04-06,8.02,6.45,122,75,93,Rash,Moderate,Improved,1
8039,PT-08039,54,M,Indore Medical Institute,Phase III,ORX-202,Diabetes,Placebo,2023-08-05,2023-08-19,6.21,5.67,151,99,58,Headache,None,Improved,1
8040,PT-08040,66,F,Fortis Mumbai,Phase III,ORX-303,Cardiology,Placebo,2024-03-16,2024-04-13,8.69,8.45,126,75,60,Rash,None,Improved,1
8041,PT-08041,50,F,AIIMS Delhi,Phase IV,ORX-101,Oncology,High Dose,2023-08-14,2023-11-12,7.0,6.99,136,112,94,None,None,Improved,1
8042,PT-08042,53,F,AIIMS Delhi,Phase IV,ORX-202,Diabetes,High Dose,2024-10-13,2024-12-08,4.64,4.59,156,76,108,Headache,None,Improved,1
8043,PT-08043,53,F,NIMHANS Bengaluru,Phase II,ORX-606,Rheumatology,High Dose,2023-02-20,2023-05-21,7.55,6.26,155,72,70,None,None,Worsened,0
8044,PT-08044,18,M,Apollo Chennai,Phase III,ORX-505,Infectious Disease,High Dose,2023-01-05,2023-02-02,8.28,8.4,128,90,87,None,None,Worsened,0
8045,PT-08045,39,M,Bhopal Research Hospital,Phase III,ORX-606,Rheumatology,High Dose,2024-06-27,2024-07-04,6.26,4.31,124,66,80,Rash,None,Improved,1
8046,PT-08046,42,F,PGI Chandigarh,Phase III,ORX-606,Rheumatology,High Dose,2024-01-09,2024-01-23,6.72,7.26,110,59,74,None,None,No Change,0
8047,PT-08047,33,M,PGI Chandigarh,Phase III,ORX-202,Diabetes,Placebo,2024-10-28,2024-11-25,7.35,6.12,135,70,64,None,None,No Change,0
8048,PT-08048,54,M,AIIMS Delhi,Phase II,ORX-606,Rheumatology,High Dose,2024-06-29,2024-07-06,7.14,5.68,110,77,61,Rash,None,Improved,1
8049,PT-08049,40,F,PGI Chandigarh,Phase I,ORX-404,Neurology,High Dose,2024-08-26,2024-11-24,6.9,5.67,139,69,95,Fatigue,None,Improved,1
8050,PT-08050,41,F,NIMHANS Bengaluru,Phase III,ORX-606,Rheumatology,Placebo,2023-06-24,2023-09-22,6.41,6.49,128,91,49,None,None,Worsened,0
8051,PT-08051,53,F,Bhopal Research Hospital,Phase III,ORX-202,Diabetes,High Dose,2024-01-22,2024-04-21,6.58,6.21,126,98,51,None,None,No Change,0
8052,PT-08052,70,M,Fortis Mumbai,Phase I,ORX-404,Neurology,Low Dose,2023-06-22,2023-07-20,8.05,7.78,102,61,70,None,None,No Change,0
8053,PT-08053,55,M,Bhopal Research Hospital,Phase III,ORX-505,Infectious Disease,High Dose,2023-06-08,2023-07-06,7.19,7.31,101,82,93,Rash,None,Improved,0
8054,PT-08054,68,M,AIIMS Delhi,Phase III,ORX-404,Neurology,Placebo,2024-04-14,2024-04-28,5.7,4.98,121,74,90,None,None,Improved,1
8055,PT-08055,85,M,NIMHANS Bengaluru,Phase III,ORX-101,Oncology,Placebo,2023-05-13,2023-08-11,5.86,5.85,133,85,96,None,None,Improved,1
8056,PT-08056,50,F,Bhopal Research Hospital,Phase III,ORX-606,Rheumatology,Placebo,2023-03-03,2023-03-31,4.64,2.94,108,73,76,None,None,Worsened,0
8057,PT-08057,41,M,Bhopal Research Hospital,Phase II,ORX-404,Neurology,Low Dose,2024-11-11,2025-02-09,5.01,3.16,90,63,91,None,None,Improved,1
8058,PT-08058,40,F,Apollo Chennai,Phase III,ORX-505,Infectious Disease,Low Dose,2023-01-23,2023-02-20,6.06,3.93,109,89,84,None,None,Improved,1
8059,PT-08059,40,M,NIMHANS Bengaluru,Phase I,ORX-404,Neurology,High Dose,2024-05-20,2024-08-18,6.88,4.89,114,88,68,None,None,Improved,1
8060,PT-08060,70,F,Bhopal Research Hospital,Phase II,ORX-202,Diabetes,Placebo,2024-09-10,2024-10-08,8.65,7.84,123,108,89,None,None,Improved,1
8061,PT-08061,46,F,Apollo Chennai,Phase II,ORX-101,Oncology,Low Dose,2023-01-14,2023-02-11,7.42,7.16,127,69,72,Nausea,Moderate,No Change,0
8062,PT-08062,22,M,NIMHANS Bengaluru,Phase I,ORX-202,Diabetes,High Dose,2024-09-27,2024-10-11,8.07,7.55,141,66,97,None,None,Improved,1
8063,PT-08063,65,M,Fortis Mumbai,Phase III,ORX-606,Rheumatology,Placebo,2024-10-26,2024-12-21,5.31,4.46,120,64,74,None,None,Improved,1
8064,PT-08064,53,M,Bhopal Research Hospital,Phase II,ORX-404,Neurology,Placebo,2023-09-06,2023-09-20,6.64,4.7,141,72,68,Headache,None,Improved,1
8065,PT-08065,71,F,Indore Medical Institute,Phase II,ORX-202,Diabetes,Low Dose,2023-07-21,2023-08-04,7.68,6.55,106,93,90,None,None,Improved,1
8066,PT-08066,36,M,AIIMS Delhi,Phase IV,ORX-101,Oncology,Low Dose,2024-02-25,2024-03-24,5.69,5.64,138,77,62,None,None,Improved,1
8067,PT-08067,45,F,PGI Chandigarh,Phase IV,ORX-303,Cardiology,High Dose,2023-05-23,2023-08-21,7.75,6.92,132,86,94,None,None,No Change,0
8068,PT-08068,38,M,Indore Medical Institute,Phase IV,ORX-303,Cardiology,Low Dose,2023-09-08,2023-09-15,5.83,5.37,158,60,45,None,None,No Change,0
8069,PT-08069,43,M,Fortis Mumbai,Phase III,ORX-404,Neurology,Placebo,2023-11-20,2023-11-27,6.74,6.16,123,94,77,None,None,Improved,1
8070,PT-08070,58,M,PGI Chandigarh,Phase III,ORX-505,Infectious Disease,Placebo,2024-04-24,2024-06-19,4.23,3.35,113,54,79,None,None,Improved,1
8071,PT-08071,43,F,PGI Chandigarh,Phase III,ORX-606,Rheumatology,High Dose,2023-09-07,2023-09-21,6.64,6.13,129,94,86,Nausea,Mild,Worsened,0
8072,PT-08072,50,M,Apollo Chennai,Phase IV,ORX-606,Rheumatology,Low Dose,2023-01-20,2023-03-17,9.97,8.93,103,96,104,None,None,No Change,0
8073,PT-08073,34,F,Apollo Chennai,Phase IV,ORX-202,Diabetes,High Dose,2024-09-26,2024-10-03,8.85,7.97,138,89,69,Fatigue,None,Improved,1
8074,PT-08074,74,M,AIIMS Delhi,Phase III,ORX-404,Neurology,High Dose,2023-01-05,2023-03-02,9.55,8.23,131,92,51,Headache,Mild,Improved,1
8075,PT-08075,45,F,NIMHANS Bengaluru,Phase III,ORX-505,Infectious Disease,Low Dose,2024-02-12,2024-05-12,5.22,5.42,129,77,56,None,None,Improved,0
8076,PT-08076,35,M,Indore Medical Institute,Phase III,ORX-606,Rheumatology,Placebo,2024-06-24,2024-07-08,7.82,7.39,149,95,93,None,None,Improved,1
8077,PT-08077,36,M,Kolkata Clinical Center,Phase III,ORX-101,Oncology,High Dose,2024-11-01,2024-11-29,7.55,6.29,105,96,61,None,None,Improved,1
8078,PT-08078,24,F,Fortis Mumbai,Phase I,ORX-606,Rheumatology,Placebo,2023-10-12,2023-10-26,7.33,6.68,124,109,64,Headache,None,Worsened,0
8079,PT-08079,52,M,PGI Chandigarh,Phase IV,ORX-101,Oncology,Low Dose,2023-05-08,2023-05-22,7.3,7.81,113,79,79,Nausea,None,No Change,0
8080,PT-08080,22,F,Bhopal Research Hospital,Phase III,ORX-303,Cardiology,High Dose,2023-03-28,2023-04-04,5.03,4.61,152,77,74,Headache,Mild,Worsened,0
8081,PT-08081,63,F,Fortis Mumbai,Phase I,ORX-606,Rheumatology,Low Dose,2023-06-24,2023-09-22,7.02,7.32,175,75,75,None,None,Improved,0
8082,PT-08082,51,F,Indore Medical Institute,Phase III,ORX-606,Rheumatology,High Dose,2023-04-22,2023-04-29,8.99,8.49,141,86,76,None,None,No Change,0
8083,PT-08083,38,M,PGI Chandigarh,Phase IV,ORX-101,Oncology,Low Dose,2023-05-27,2023-07-22,6.47,8.83,100,64,81,Headache,None,Improved,0
8084,PT-08084,48,F,AIIMS Delhi,Phase II,ORX-303,Cardiology,Low Dose,2024-07-24,2024-08-07,7.71,6.52,109,78,90,Rash,Moderate,No Change,0
8085,PT-08085,28,F,Kolkata Clinical Center,Phase II,ORX-202,Diabetes,Placebo,2024-01-15,2024-01-22,7.38,6.52,100,66,90,None,None,Improved,1
8086,PT-08086,35,M,AIIMS Delhi,Phase I,ORX-404,Neurology,Low Dose,2024-11-21,2025-02-19,8.69,8.26,103,87,66,None,None,Improved,1
8087,PT-08087,38,F,Bhopal Research Hospital,Phase III,ORX-505,Infectious Disease,Placebo,2023-05-16,2023-08-14,8.56,7.0,119,68,61,None,None,No Change,0
8088,PT-08088,37,F,PGI Chandigarh,Phase III,ORX-303,Cardiology,High Dose,2024-03-29,2024-06-27,6.17,5.52,139,72,57,Headache,None,Worsened,0
8089,PT-08089,55,M,NIMHANS Bengaluru,Phase IV,ORX-404,Neurology,High Dose,2023-04-04,2023-05-30,6.29,7.54,120,80,45,None,None,Improved,0
8090,PT-08090,26,F,Apollo Chennai,Phase II,ORX-505,Infectious Disease,Low Dose,2024-08-11,2024-08-18,4.47,4.33,126,89,89,Nausea,None,Improved,1
8091,PT-08091,60,F,Apollo Chennai,Phase II,ORX-606,Rheumatology,Low Dose,2023-05-15,2023-07-10,6.93,6.61,138,72,64,None,None,Improved,1
8092,PT-08092,69,M,PGI Chandigarh,Phase III,ORX-505,Infectious Disease,High Dose,2023-05-27,2023-06-03,5.03,5.08,134,68,68,Fever,Moderate,Improved,0
8093,PT-08093,39,F,Kolkata Clinical Center,Phase III,ORX-606,Rheumatology,Low Dose,2023-11-03,2023-11-10,7.46,7.38,127,84,87,None,None,Improved,1
8094,PT-08094,54,F,Apollo Chennai,Phase II,ORX-303,Cardiology,Placebo,2023-07-09,2023-07-23,9.04,9.58,128,89,83,None,None,Worsened,0
8095,PT-08095,47,F,PGI Chandigarh,Phase III,ORX-101,Oncology,Low Dose,2024-02-13,2024-04-09,6.16,5.9,90,94,82,Headache,None,No Change,0
8096,PT-08096,42,F,Indore Medical Institute,Phase III,ORX-606,Rheumatology,Low Dose,2023-01-17,2023-01-31,6.7,6.88,161,86,104,None,None,Improved,0
8097,PT-08097,57,F,PGI Chandigarh,Phase I,ORX-404,Neurology,High Dose,2023-10-12,2023-12-07,6.23,6.27,135,72,72,None,None,Improved,0
8098,PT-08098,38,M,AIIMS Delhi,Phase IV,ORX-202,Diabetes,Low Dose,2023-06-30,2023-09-28,7.32,6.67,132,87,95,None,None,Improved,1
8099,PT-08099,53,F,PGI Chandigarh,Phase III,ORX-404,Neurology,Placebo,2024-09-30,2024-11-25,6.36,7.86,115,77,86,Headache,Mild,Improved,0
8100,PT-08100,85,M,Fortis Mumbai,Phase III,ORX-404,Neurology,Placebo,2024-03-25,2024-04-22,7.68,6.7,98,61,78,None,None,Worsened,0
8101,PT-08101,53,F,Fortis Mumbai,Phase III,ORX-505,Infectious Disease,Low Dose,2024-02-08,2024-02-15,5.5,5.3,104,70,86,Dizziness,Moderate,No Change,0
8102,PT-08102,33,F,Indore Medical Institute,Phase I,ORX-303,Cardiology,Placebo,2023-07-28,2023-08-25,8.77,7.85,147,109,67,None,None,No Change,0
8103,PT-08103,84,F,Bhopal Research Hospital,Phase III,ORX-101,Oncology,Placebo,2024-11-16,2025-01-11,7.22,6.25,122,77,97,Dizziness,None,Improved,1
8104,PT-08104,66,F,Fortis Mumbai,Phase I,ORX-303,Cardiology,Placebo,2023-02-02,2023-03-30,8.77,7.2,131,63,92,None,None,No Change,0
8105,PT-08105,37,F,Fortis Mumbai,Phase II,ORX-606,Rheumatology,Placebo,2023-03-29,2023-04-12,7.8,6.95,96,92,91,None,None,Improved,1
8106,PT-08106,47,M,Fortis Mumbai,Phase III,ORX-202,Diabetes,High Dose,2024-06-22,2024-06-29,4.67,4.94,114,88,71,None,None,Improved,0
8107,PT-08107,38,M,Kolkata Clinical Center,Phase III,ORX-606,Rheumatology,Low Dose,2023-07-13,2023-09-07,7.8,6.66,124,88,108,None,None,Worsened,0
8108,PT-08108,43,M,Indore Medical Institute,Phase III,ORX-101,Oncology,High Dose,2024-03-09,2024-05-04,8.21,6.75,158,72,76,Headache,None,Improved,1
8109,PT-08109,53,M,Fortis Mumbai,Phase III,ORX-202,Diabetes,High Dose,2024-01-28,2024-02-11,6.26,6.84,116,91,92,None,None,Worsened,0
8110,PT-08110,54,F,Indore Medical Institute,Phase III,ORX-202,Diabetes,High Dose,2023-05-27,2023-06-24,8.05,9.93,135,83,82,Headache,None,Worsened,0
8111,PT-08111,65,F,Indore Medical Institute,Phase I,ORX-303,Cardiology,Placebo,2024-07-05,2024-08-02,10.0,9.45,111,95,58,None,None,No Change,0
8112,PT-08112,49,M,PGI Chandigarh,Phase II,ORX-101,Oncology,Low Dose,2023-04-29,2023-06-24,7.57,7.07,127,62,65,Headache,Mild,No Change,0
8113,PT-08113,59,F,AIIMS Delhi,Phase III,ORX-202,Diabetes,Low Dose,2024-11-03,2024-12-01,4.75,4.27,122,58,101,None,None,Worsened,0
8114,PT-08114,28,F,Kolkata Clinical Center,Phase III,ORX-101,Oncology,High Dose,2023-03-21,2023-04-04,7.86,7.04,112,79,73,None,None,Improved,1
8115,PT-08115,42,F,NIMHANS Bengaluru,Phase I,ORX-202,Diabetes,Low Dose,2024-04-17,2024-06-12,6.26,4.94,146,82,77,None,None,Improved,1
8116,PT-08116,30,F,Kolkata Clinical Center,Phase IV,ORX-404,Neurology,Placebo,2024-03-11,2024-06-09,9.09,8.61,93,85,67,Headache,Moderate,No Change,0
8117,PT-08117,59,F,Apollo Chennai,Phase IV,ORX-404,Neurology,Placebo,2024-11-26,2024-12-10,8.45,8.88,119,80,81,Nausea,None,Improved,0
8118,PT-08118,59,M,Fortis Mumbai,Phase III,ORX-202,Diabetes,Placebo,2024-03-07,2024-04-04,5.95,5.64,161,75,77,None,None,No Change,0
8119,PT-08119,85,M,AIIMS Delhi,Phase III,ORX-303,Cardiology,Low Dose,2023-10-27,2023-11-24,6.91,5.13,126,102,92,Dizziness,None,No Change,0
8120,PT-08120,29,M,Indore Medical Institute,Phase III,ORX-505,Infectious Disease,Placebo,2023-04-22,2023-04-29,7.7,7.14,142,74,84,None,None,Improved,1
8121,PT-08121,75,M,Bhopal Research Hospital,Phase I,ORX-505,Infectious Disease,Low Dose,2024-04-03,2024-04-17,4.07,4.2,151,63,67,None,None,No Change,0
8122,PT-08122,38,M,Apollo Chennai,Phase II,ORX-505,Infectious Disease,Placebo,2024-11-24,2024-12-01,6.32,5.2,121,92,98,None,None,Improved,1
8123,PT-08123,65,M,Kolkata Clinical Center,Phase IV,ORX-202,Diabetes,High Dose,2024-09-01,2024-10-27,8.39,9.64,164,83,98,None,None,Improved,0
8124,PT-08124,51,M,AIIMS Delhi,Phase III,ORX-606,Rheumatology,Placebo,2023-09-14,2023-10-12,6.94,6.5,146,99,86,Headache,Mild,Worsened,0
8125,PT-08125,38,M,Kolkata Clinical Center,Phase III,ORX-303,Cardiology,Placebo,2023-11-29,2024-01-24,6.61,4.54,134,85,63,Fever,None,Improved,1
8126,PT-08126,52,M,AIIMS Delhi,Phase II,ORX-101,Oncology,Placebo,2023-07-29,2023-10-27,7.75,6.01,122,98,69,Rash,None,Improved,1
8127,PT-08127,45,M,Indore Medical Institute,Phase II,ORX-101,Oncology,High Dose,2023-08-12,2023-11-10,7.39,6.97,140,93,95,Fatigue,Mild,No Change,0
8128,PT-08128,39,M,Kolkata Clinical Center,Phase I,ORX-202,Diabetes,Placebo,2024-03-06,2024-03-13,7.83,8.18,125,73,80,Fatigue,None,Improved,0
8129,PT-08129,35,M,PGI Chandigarh,Phase II,ORX-404,Neurology,Placebo,2024-04-03,2024-07-02,6.35,6.15,124,84,56,None,None,Improved,1
8130,PT-08130,42,F,Apollo Chennai,Phase IV,ORX-101,Oncology,High Dose,2024-10-18,2024-11-15,4.49,3.15,126,96,85,None,None,Improved,1
8131,PT-08131,46,F,Fortis Mumbai,Phase III,ORX-505,Infectious Disease,Low Dose,2023-12-10,2024-02-04,6.75,6.12,151,68,67,None,None,Improved,1
8132,PT-08132,62,M,NIMHANS Bengaluru,Phase III,ORX-505,Infectious Disease,Low Dose,2023-03-01,2023-03-08,6.79,8.13,140,95,55,None,None,Worsened,0
8133,PT-08133,61,M,NIMHANS Bengaluru,Phase I,ORX-505,Infectious Disease,Low Dose,2023-09-24,2023-10-01,6.18,6.42,121,84,62,Dizziness,None,Improved,0
8134,PT-08134,18,M,Fortis Mumbai,Phase II,ORX-101,Oncology,Placebo,2023-02-04,2023-04-01,7.38,6.72,111,61,45,Rash,Moderate,Improved,1
8135,PT-08135,53,M,Indore Medical Institute,Phase III,ORX-303,Cardiology,Low Dose,2023-12-05,2023-12-12,6.89,5.95,131,94,81,None,None,Improved,1
8136,PT-08136,37,M,Kolkata Clinical Center,Phase III,ORX-606,Rheumatology,Low Dose,2023-06-02,2023-06-16,9.76,8.79,102,83,74,None,None,No Change,0
8137,PT-08137,60,M,PGI Chandigarh,Phase III,ORX-606,Rheumatology,Low Dose,2023-11-28,2024-02-26,6.57,6.02,112,91,80,Nausea,None,No Change,0
8138,PT-08138,40,M,AIIMS Delhi,Phase III,ORX-101,Oncology,High Dose,2024-04-18,2024-06-13,7.02,6.6,102,95,93,Fever,Moderate,Worsened,0
8139,PT-08139,45,M,Apollo Chennai,Phase IV,ORX-505,Infectious Disease,High Dose,2023-09-25,2023-11-20,7.12,5.82,159,99,83,None,None,Worsened,0
8140,PT-08140,58,M,NIMHANS Bengaluru,Phase III,ORX-101,Oncology,High Dose,2023-05-02,2023-05-30,8.68,9.2,112,78,84,None,None,No Change,0
8141,PT-08141,48,F,Indore Medical Institute,Phase I,ORX-202,Diabetes,Low Dose,2023-02-05,2023-05-06,8.1,8.28,132,50,94,Nausea,None,Improved,0
8142,PT-08142,58,F,Bhopal Research Hospital,Phase I,ORX-606,Rheumatology,High Dose,2023-09-19,2023-09-26,9.68,8.85,94,79,84,None,None,No Change,0
8143,PT-08143,37,M,Kolkata Clinical Center,Phase II,ORX-101,Oncology,Placebo,2023-05-15,2023-07-10,8.85,7.85,126,79,116,None,None,Worsened,0
8144,PT-08144,30,F,Fortis Mumbai,Phase III,ORX-404,Neurology,Placebo,2024-11-09,2024-12-07,7.9,6.42,134,70,93,None,None,Improved,1
8145,PT-08145,59,F,Bhopal Research Hospital,Phase III,ORX-505,Infectious Disease,Low Dose,2024-08-10,2024-08-24,7.53,5.87,127,78,89,None,None,Worsened,0
8146,PT-08146,30,M,PGI Chandigarh,Phase III,ORX-505,Infectious Disease,Placebo,2023-03-18,2023-05-13,8.59,9.06,103,79,77,None,None,Improved,0
8147,PT-08147,61,F,Bhopal Research Hospital,Phase I,ORX-505,Infectious Disease,Low Dose,2024-01-06,2024-03-02,6.38,6.16,147,85,51,None,None,Improved,1
8148,PT-08148,37,M,Indore Medical Institute,Phase II,ORX-202,Diabetes,Placebo,2024-07-03,2024-08-28,8.29,8.59,90,84,91,Nausea,None,Improved,0
8149,PT-08149,53,M,Indore Medical Institute,Phase III,ORX-101,Oncology,Low Dose,2024-01-30,2024-02-06,7.98,9.44,127,85,64,None,None,Worsened,0
8150,PT-08150,34,M,NIMHANS Bengaluru,Phase III,ORX-101,Oncology,Low Dose,2023-02-07,2023-05-08,6.8,7.17,114,96,62,Fatigue,None,Improved,0
8151,PT-08151,55,M,Apollo Chennai,Phase I,ORX-303,Cardiology,Low Dose,2023-03-01,2023-03-08,7.86,7.69,145,73,71,None,None,Improved,1
8152,PT-08152,29,F,Apollo Chennai,Phase II,ORX-101,Oncology,Low Dose,2023-11-14,2023-11-28,7.21,6.7,143,86,87,None,None,Improved,1
8153,PT-08153,41,M,Kolkata Clinical Center,Phase I,ORX-505,Infectious Disease,High Dose,2023-07-23,2023-09-17,7.69,8.92,103,59,86,None,None,No Change,0
8154,PT-08154,31,F,Kolkata Clinical Center,Phase II,ORX-505,Infectious Disease,Placebo,2024-07-07,2024-07-14,5.54,5.62,109,100,80,None,None,Improved,0
8155,PT-08155,41,F,AIIMS Delhi,Phase III,ORX-303,Cardiology,Low Dose,2024-05-19,2024-06-02,6.21,6.01,99,52,56,None,None,No Change,0
8156,PT-08156,63,M,PGI Chandigarh,Phase I,ORX-606,Rheumatology,Low Dose,2023-06-22,2023-07-20,6.09,4.4,126,108,93,None,None,Improved,1
8157,PT-08157,32,M,AIIMS Delhi,Phase II,ORX-101,Oncology,High Dose,2023-05-01,2023-05-15,6.22,5.1,111,88,73,None,None,Improved,1
8158,PT-08158,27,M,AIIMS Delhi,Phase III,ORX-505,Infectious Disease,Placebo,2023-12-25,2024-01-22,5.6,7.27,141,71,94,None,None,Worsened,0
8159,PT-08159,26,F,Fortis Mumbai,Phase IV,ORX-202,Diabetes,Placebo,2023-04-06,2023-04-20,7.04,6.41,131,70,79,Headache,Mild,Improved,1
8160,PT-08160,18,F,Fortis Mumbai,Phase II,ORX-303,Cardiology,High Dose,2024-09-16,2024-09-30,6.75,7.55,146,73,56,Fever,None,Improved,0
8161,PT-08161,18,M,PGI Chandigarh,Phase III,ORX-606,Rheumatology,High Dose,2024-07-15,2024-10-13,7.94,7.79,134,102,80,Nausea,Mild,No Change,0
8162,PT-08162,48,M,Bhopal Research Hospital,Phase III,ORX-404,Neurology,Low Dose,2024-04-17,2024-05-01,5.52,,125,72,80,Headache,None,Improved,0
8163,PT-08163,77,M,Indore Medical Institute,Phase II,ORX-404,Neurology,Placebo,2024-01-18,2024-01-25,9.76,8.49,149,86,91,Fever,None,Improved,1
8164,PT-08164,49,M,Kolkata Clinical Center,Phase II,ORX-505,Infectious Disease,Placebo,2023-12-20,2024-01-17,7.94,8.73,96,86,61,None,None,Worsened,0
8165,PT-08165,37,F,Kolkata Clinical Center,Phase III,ORX-303,Cardiology,Low Dose,2024-02-24,2024-03-09,7.2,5.89,117,65,69,Nausea,None,No Change,0
8166,PT-08166,53,F,PGI Chandigarh,Phase IV,ORX-101,Oncology,Placebo,2023-01-09,2023-01-16,8.24,7.15,151,88,98,None,None,Improved,1
8167,PT-08167,18,F,Bhopal Research Hospital,Phase III,ORX-202,Diabetes,High Dose,2024-08-24,2024-11-22,7.57,7.72,97,110,69,Rash,Mild,Improved,0
8168,PT-08168,53,M,NIMHANS Bengaluru,Phase III,ORX-101,Oncology,Low Dose,2023-04-24,2023-05-22,8.31,8.0,152,105,62,None,None,Improved,1
8169,PT-08169,46,F,AIIMS Delhi,Phase IV,ORX-202,Diabetes,Low Dose,2024-05-28,2024-06-25,8.3,6.43,147,102,95,Fatigue,Mild,Improved,1
8170,PT-08170,52,F,PGI Chandigarh,Phase III,ORX-202,Diabetes,Placebo,2023-01-10,2023-01-24,9.05,8.97,104,75,74,Headache,None,No Change,0
8171,PT-08171,43,M,Apollo Chennai,Phase I,ORX-202,Diabetes,Low Dose,2023-02-21,2023-02-28,7.09,6.38,131,100,80,Headache,Moderate,No Change,0
8172,PT-08172,55,M,PGI Chandigarh,Phase II,ORX-606,Rheumatology,Low Dose,2023-06-04,2023-06-18,4.57,4.28,147,96,94,None,None,Improved,1
8173,PT-08173,49,M,PGI Chandigarh,Phase III,ORX-101,Oncology,Placebo,2024-07-18,2024-10-16,7.7,6.69,143,73,87,None,None,Worsened,0
8174,PT-08174,45,F,NIMHANS Bengaluru,Phase IV,ORX-404,Neurology,High Dose,2024-09-07,2024-09-21,7.22,7.72,138,85,71,Rash,Mild,Improved,0
8175,PT-08175,70,M,Bhopal Research Hospital,Phase I,ORX-303,Cardiology,High Dose,2023-05-13,2023-08-11,7.6,7.87,129,73,82,None,None,Improved,0
8176,PT-08176,35,M,Kolkata Clinical Center,Phase III,ORX-606,Rheumatology,Low Dose,2024-05-18,2024-05-25,7.73,4.39,120,81,64,None,None,Worsened,0
8177,PT-08177,50,F,Fortis Mumbai,Phase II,ORX-505,Infectious Disease,High Dose,2023-09-28,2023-12-27,6.69,6.29,118,93,85,Nausea,None,No Change,0
8178,PT-08178,49,M,NIMHANS Bengaluru,Phase III,ORX-101,Oncology,Placebo,2024-02-09,2024-05-09,7.27,9.15,125,73,61,Headache,None,Improved,0
8179,PT-08179,59,F,Bhopal Research Hospital,Phase I,ORX-303,Cardiology,Placebo,2024-09-27,2024-10-25,9.16,7.99,122,77,76,Rash,None,Improved,1
8180,PT-08180,18,F,NIMHANS Bengaluru,Phase II,ORX-404,Neurology,Low Dose,2024-10-07,2024-11-04,8.17,8.84,93,103,100,None,None,Improved,0
8181,PT-08181,18,F,PGI Chandigarh,Phase II,ORX-606,Rheumatology,Low Dose,2024-11-28,2024-12-05,4.59,4.07,151,85,78,Nausea,None,No Change,0
8182,PT-08182,54,M,Apollo Chennai,Phase III,ORX-202,Diabetes,Low Dose,2024-07-03,2024-07-31,6.23,6.98,126,62,66,None,None,Improved,0
8183,PT-08183,50,F,Bhopal Research Hospital,Phase II,ORX-404,Neurology,Placebo,2024-10-01,2024-12-30,6.85,6.1,131,86,60,Fatigue,None,Improved,1
8184,PT-08184,64,F,Indore Medical Institute,Phase III,ORX-303,Cardiology,High Dose,2024-07-31,2024-10-29,7.04,7.02,129,77,90,None,None,No Change,0
8185,PT-08185,46,M,Fortis Mumbai,Phase III,ORX-404,Neurology,Low Dose,2024-02-08,2024-02-22,7.29,4.65,142,79,88,None,None,Worsened,0
8186,PT-08186,71,F,Indore Medical Institute,Phase III,ORX-202,Diabetes,High Dose,2024-03-30,2024-05-25,8.19,7.84,122,112,84,Headache,None,Improved,1
8187,PT-08187,48,F,Bhopal Research Hospital,Phase III,ORX-202,Diabetes,Low Dose,2023-04-30,2023-05-07,6.98,5.77,92,100,67,None,None,Improved,1
8188,PT-08188,41,F,Indore Medical Institute,Phase III,ORX-202,Diabetes,High Dose,2024-08-26,2024-11-24,7.07,,114,85,85,None,None,Improved,0
8189,PT-08189,22,M,Apollo Chennai,Phase I,ORX-101,Oncology,Low Dose,2024-06-28,2024-07-26,5.43,4.38,132,83,76,Fatigue,Mild,Improved,1
8190,PT-08190,55,F,AIIMS Delhi,Phase III,ORX-202,Diabetes,Placebo,2024-10-17,2024-12-12,6.17,5.62,125,72,110,Rash,None,Improved,1
8191,PT-08191,18,F,NIMHANS Bengaluru,Phase III,ORX-101,Oncology,Placebo,2024-02-21,2024-03-06,8.69,9.01,142,83,96,None,None,Improved,0
8192,PT-08192,37,M,NIMHANS Bengaluru,Phase I,ORX-505,Infectious Disease,Placebo,2024-09-14,2024-11-09,7.67,7.34,123,83,64,None,None,Improved,1
8193,PT-08193,34,M,PGI Chandigarh,Phase III,ORX-303,Cardiology,High Dose,2024-05-19,2024-07-14,9.1,11.29,137,92,81,None,None,No Change,0
8194,PT-08194,52,F,Indore Medical Institute,Phase III,ORX-505,Infectious Disease,Low Dose,2023-07-04,2023-10-02,7.85,8.38,155,71,117,Fever,None,Improved,0
8195,PT-08195,47,F,Indore Medical Institute,Phase I,ORX-404,Neurology,Low Dose,2024-03-20,2024-06-18,7.37,6.59,120,89,86,Headache,Moderate,Improved,1
8196,PT-08196,54,F,AIIMS Delhi,Phase III,ORX-303,Cardiology,Placebo,2024-10-01,2024-11-26,6.65,3.82,95,82,82,Rash,None,Improved,1
8197,PT-08197,38,M,Kolkata Clinical Center,Phase II,ORX-505,Infectious Disease,High Dose,2023-06-15,2023-07-13,6.37,6.24,126,76,55,None,None,No Change,0
8198,PT-08198,31,F,Fortis Mumbai,Phase III,ORX-101,Oncology,High Dose,2024-01-02,2024-01-30,8.32,7.05,139,98,66,Nausea,None,Worsened,0
8199,PT-08199,37,F,NIMHANS Bengaluru,Phase III,ORX-505,Infectious Disease,Low Dose,2023-06-29,2023-09-27,8.38,9.09,116,62,95,None,None,Worsened,0
8200,PT-08200,54,F,PGI Chandigarh,Phase III,ORX-303,Cardiology,High Dose,2023-03-09,2023-04-06,7.68,8.1,106,86,74,None,None,Improved,0
8201,PT-08201,54,M,Apollo Chennai,Phase I,ORX-101,Oncology,Low Dose,2024-08-31,2024-09-28,8.16,8.64,138,85,81,None,None,Improved,0
8202,PT-08202,50,M,PGI Chandigarh,Phase I,ORX-606,Rheumatology,Placebo,2023-12-01,2024-02-29,6.45,5.72,135,89,68,None,None,No Change,0
8203,PT-08203,27,F,Apollo Chennai,Phase II,ORX-202,Diabetes,High Dose,2024-07-29,2024-08-05,5.19,3.65,118,76,74,None,None,Improved,1
8204,PT-08204,25,M,AIIMS Delhi,Phase III,ORX-303,Cardiology,High Dose,2024-06-09,2024-08-04,5.02,4.74,130,89,89,Headache,Mild,No Change,0
8205,PT-08205,51,F,Kolkata Clinical Center,Phase III,ORX-101,Oncology,High Dose,2024-04-07,2024-05-05,7.34,7.73,153,73,88,None,None,Worsened,0
8206,PT-08206,35,M,PGI Chandigarh,Phase III,ORX-505,Infectious Disease,Low Dose,2023-09-10,2023-12-09,7.46,8.03,123,70,71,Dizziness,None,Improved,0
8207,PT-08207,29,F,Indore Medical Institute,Phase III,ORX-101,Oncology,Placebo,2023-03-07,2023-06-05,5.91,6.6,137,73,64,Nausea,None,No Change,0
8208,PT-08208,30,F,Indore Medical Institute,Phase I,ORX-404,Neurology,High Dose,2024-11-02,2025-01-31,6.34,6.97,126,107,77,None,None,Improved,0
8209,PT-08209,35,F,Fortis Mumbai,Phase II,ORX-505,Infectious Disease,Low Dose,2023-11-27,2024-01-22,8.31,6.41,131,67,47,None,None,Improved,1
8210,PT-08210,43,F,Apollo Chennai,Phase III,ORX-303,Cardiology,High Dose,2024-10-05,2024-11-02,8.2,7.99,129,50,75,Nausea,Mild,No Change,0
8211,PT-08211,42,F,Kolkata Clinical Center,Phase I,ORX-101,Oncology,Low Dose,2024-04-26,2024-05-03,7.95,6.59,142,75,73,Nausea,Moderate,Improved,1
8212,PT-08212,53,M,Bhopal Research Hospital,Phase II,ORX-505,Infectious Disease,Placebo,2024-02-01,2024-02-08,5.77,6.11,103,89,74,None,None,Improved,0
8213,PT-08213,42,F,Bhopal Research Hospital,Phase III,ORX-404,Neurology,Low Dose,2024-03-05,2024-04-02,3.52,2.59,124,100,77,Nausea,None,No Change,0
8214,PT-08214,34,F,Fortis Mumbai,Phase IV,ORX-202,Diabetes,Placebo,2023-02-03,2023-02-10,8.2,7.35,146,85,65,Fatigue,Severe,Improved,1
8215,PT-08215,60,M,AIIMS Delhi,Phase III,ORX-404,Neurology,High Dose,2024-02-13,2024-02-27,7.92,8.33,124,89,104,None,None,Improved,0
8216,PT-08216,47,M,Kolkata Clinical Center,Phase III,ORX-101,Oncology,High Dose,2024-09-13,2024-09-20,6.72,7.71,140,76,102,Rash,None,No Change,0
8217,PT-08217,25,M,NIMHANS Bengaluru,Phase IV,ORX-202,Diabetes,High Dose,2023-12-24,2024-02-18,7.83,8.47,147,71,60,None,None,Improved,0
8218,PT-08218,48,F,Kolkata Clinical Center,Phase III,ORX-505,Infectious Disease,High Dose,2023-05-31,2023-06-28,8.05,6.68,133,64,92,None,None,No Change,0
8219,PT-08219,35,M,Apollo Chennai,Phase II,ORX-505,Infectious Disease,Low Dose,2023-12-01,2023-12-15,7.0,7.38,141,87,92,Rash,Moderate,Improved,0
8220,PT-08220,51,M,Apollo Chennai,Phase II,ORX-202,Diabetes,Low Dose,2023-05-06,2023-08-04,8.94,7.0,126,80,74,Rash,Mild,No Change,0
8221,PT-08221,52,F,PGI Chandigarh,Phase I,ORX-404,Neurology,High Dose,2024-05-06,2024-06-03,7.46,7.8,106,109,72,Nausea,Moderate,Improved,0
8222,PT-08222,49,F,Fortis Mumbai,Phase II,ORX-606,Rheumatology,Low Dose,2024-07-31,2024-10-29,6.95,6.63,118,84,86,Nausea,Moderate,Improved,1
8223,PT-08223,18,F,Bhopal Research Hospital,Phase III,ORX-404,Neurology,Low Dose,2024-10-24,2025-01-22,6.81,6.08,169,92,99,None,None,No Change,0
8224,PT-08224,53,M,PGI Chandigarh,Phase III,ORX-404,Neurology,Low Dose,2023-06-24,2023-08-19,7.3,7.23,148,103,82,Headache,Moderate,Improved,1
8225,PT-08225,35,F,PGI Chandigarh,Phase III,ORX-303,Cardiology,High Dose,2023-03-30,2023-04-27,8.31,7.14,135,90,76,None,None,Improved,1
8226,PT-08226,30,M,Indore Medical Institute,Phase II,ORX-101,Oncology,Low Dose,2023-07-14,2023-07-28,6.65,5.97,109,77,57,Nausea,None,Improved,1
8227,PT-08227,54,M,NIMHANS Bengaluru,Phase III,ORX-606,Rheumatology,Placebo,2023-05-03,2023-08-01,7.6,7.44,121,78,66,Nausea,None,Improved,1
8228,PT-08228,53,M,Indore Medical Institute,Phase I,ORX-101,Oncology,Low Dose,2024-11-07,2025-02-05,5.57,5.25,116,103,85,Headache,None,No Change,0
8229,PT-08229,44,F,PGI Chandigarh,Phase IV,ORX-606,Rheumatology,Placebo,2023-05-21,2023-06-18,5.87,4.25,136,103,83,None,None,Improved,1
8230,PT-08230,47,F,NIMHANS Bengaluru,Phase II,ORX-303,Cardiology,Low Dose,2024-08-22,2024-11-20,7.43,7.12,131,73,64,Nausea,None,Worsened,0
8231,PT-08231,46,F,Indore Medical Institute,Phase I,ORX-606,Rheumatology,Low Dose,2023-11-21,2024-02-19,8.99,9.29,105,78,88,Nausea,None,No Change,0
8232,PT-08232,69,M,Fortis Mumbai,Phase III,ORX-505,Infectious Disease,High Dose,2024-10-21,2024-12-16,9.35,8.76,142,84,76,None,None,Improved,1
8233,PT-08233,45,M,Kolkata Clinical Center,Phase III,ORX-404,Neurology,Placebo,2023-12-14,2023-12-21,7.29,7.95,102,87,99,Fatigue,None,Worsened,0
8234,PT-08234,67,F,Bhopal Research Hospital,Phase II,ORX-101,Oncology,Placebo,2024-02-02,2024-02-16,7.88,6.8,141,97,70,Headache,None,No Change,0
8235,PT-08235,50,M,Fortis Mumbai,Phase II,ORX-505,Infectious Disease,Low Dose,2024-05-12,2024-05-19,6.95,6.0,122,83,65,Fatigue,None,Improved,1
8236,PT-08236,27,M,AIIMS Delhi,Phase III,ORX-202,Diabetes,Placebo,2023-10-06,2023-10-13,6.13,6.03,101,55,97,None,None,No Change,0
8237,PT-08237,28,F,Kolkata Clinical Center,Phase IV,ORX-303,Cardiology,High Dose,2024-06-22,2024-07-06,6.97,7.4,102,64,69,None,None,Improved,0
8238,PT-08238,60,M,Kolkata Clinical Center,Phase III,ORX-404,Neurology,Low Dose,2023-02-15,2023-04-12,7.17,6.77,122,88,98,Headache,None,No Change,0
8239,PT-08239,85,F,Apollo Chennai,Phase I,ORX-101,Oncology,Low Dose,2024-08-19,2024-09-02,7.02,8.0,145,85,47,Nausea,None,No Change,0
8240,PT-08240,38,F,Apollo Chennai,Phase III,ORX-303,Cardiology,Low Dose,2024-05-12,2024-05-26,6.79,6.72,124,75,106,Headache,Mild,Improved,1
8241,PT-08241,65,M,Fortis Mumbai,Phase III,ORX-606,Rheumatology,High Dose,2024-07-11,2024-07-18,4.77,4.12,139,97,72,Nausea,Moderate,Improved,1
8242,PT-08242,41,F,Kolkata Clinical Center,Phase II,ORX-202,Diabetes,High Dose,2024-02-23,2024-05-23,7.31,7.51,100,57,95,None,None,Improved,0
8243,PT-08243,29,F,Bhopal Research Hospital,Phase II,ORX-101,Oncology,Low Dose,2023-10-28,2023-12-23,9.75,8.57,124,86,48,Fever,Mild,No Change,0
8244,PT-08244,85,M,Indore Medical Institute,Phase III,ORX-606,Rheumatology,Placebo,2023-07-23,2023-07-30,6.73,5.57,107,86,82,None,None,Worsened,0
8245,PT-08245,26,M,Kolkata Clinical Center,Phase IV,ORX-303,Cardiology,High Dose,2024-04-19,2024-05-03,5.55,6.1,116,61,75,None,None,Improved,0
8246,PT-08246,38,F,Kolkata Clinical Center,Phase III,ORX-606,Rheumatology,Low Dose,2023-09-03,2023-10-29,9.54,8.67,122,84,70,Fever,Mild,Worsened,0
8247,PT-08247,52,M,Fortis Mumbai,Phase IV,ORX-606,Rheumatology,Low Dose,2024-01-13,2024-02-10,5.98,5.36,135,95,69,None,None,No Change,0
8248,PT-08248,35,M,NIMHANS Bengaluru,Phase II,ORX-606,Rheumatology,Placebo,2023-06-21,2023-08-16,9.05,8.15,126,102,78,Nausea,None,Improved,1
8249,PT-08249,41,F,AIIMS Delhi,Phase III,ORX-101,Oncology,Low Dose,2023-05-15,2023-08-13,6.99,5.93,136,70,88,None,None,Improved,1
8250,PT-08250,45,F,Fortis Mumbai,Phase III,ORX-303,Cardiology,Low Dose,2024-08-22,2024-09-19,7.48,8.64,101,82,86,None,None,No Change,0
8251,PT-08251,35,M,AIIMS Delhi,Phase II,ORX-202,Diabetes,Placebo,2023-06-29,2023-07-27,8.34,7.45,133,80,80,Nausea,None,Worsened,0
8252,PT-08252,46,M,Fortis Mumbai,Phase IV,ORX-202,Diabetes,Low Dose,2024-06-06,2024-07-04,7.16,6.34,116,85,78,None,None,Improved,1
8253,PT-08253,33,M,Kolkata Clinical Center,Phase III,ORX-606,Rheumatology,High Dose,2023-09-29,2023-10-13,7.61,6.8,155,111,97,Headache,None,Worsened,0
8254,PT-08254,66,M,PGI Chandigarh,Phase IV,ORX-101,Oncology,Placebo,2023-02-26,2023-05-27,8.18,7.59,93,69,68,None,None,No Change,0
8255,PT-08255,64,M,Fortis Mumbai,Phase III,ORX-303,Cardiology,Placebo,2024-04-07,2024-04-21,7.51,6.51,94,109,85,Nausea,Moderate,Improved,1
8256,PT-08256,59,F,AIIMS Delhi,Phase IV,ORX-303,Cardiology,High Dose,2024-10-23,2024-11-06,6.56,6.03,121,82,103,None,None,Improved,1
8257,PT-08257,25,M,Fortis Mumbai,Phase II,ORX-101,Oncology,Low Dose,2024-07-11,2024-07-25,7.15,7.08,125,93,53,None,None,Worsened,0
8258,PT-08258,75,F,AIIMS Delhi,Phase I,ORX-101,Oncology,High Dose,2024-03-15,2024-03-22,5.56,4.14,119,74,83,Nausea,Mild,Improved,1
8259,PT-08259,49,M,Apollo Chennai,Phase II,ORX-505,Infectious Disease,High Dose,2024-03-30,2024-04-27,7.34,5.66,125,82,95,Headache,None,Worsened,0
8260,PT-08260,48,M,AIIMS Delhi,Phase IV,ORX-202,Diabetes,Low Dose,2024-10-28,2024-11-04,7.66,9.03,107,77,62,Rash,Moderate,Worsened,0
8261,PT-08261,70,F,Kolkata Clinical Center,Phase III,ORX-606,Rheumatology,Low Dose,2023-10-23,2023-11-06,9.21,10.19,137,86,71,Fatigue,None,No Change,0
8262,PT-08262,57,F,PGI Chandigarh,Phase I,ORX-606,Rheumatology,Low Dose,2023-06-09,2023-06-23,5.66,4.11,120,104,70,None,None,Worsened,0
8263,PT-08263,38,F,NIMHANS Bengaluru,Phase I,ORX-606,Rheumatology,High Dose,2023-01-03,2023-01-31,7.55,7.95,150,68,76,None,None,Improved,0
8264,PT-08264,48,M,AIIMS Delhi,Phase IV,ORX-404,Neurology,High Dose,2023-12-28,2024-02-22,7.59,7.97,142,82,94,None,None,Improved,0
8265,PT-08265,60,F,Kolkata Clinical Center,Phase II,ORX-303,Cardiology,Low Dose,2023-11-30,2023-12-28,8.27,7.39,140,96,70,None,None,Improved,1
8266,PT-08266,47,M,Apollo Chennai,Phase III,ORX-303,Cardiology,Placebo,2023-10-11,2024-01-09,9.08,9.03,126,99,71,None,None,Improved,1
8267,PT-08267,18,M,PGI Chandigarh,Phase IV,ORX-606,Rheumatology,High Dose,2023-03-06,2023-03-13,6.26,6.89,137,82,92,Rash,Moderate,Improved,0
8268,PT-08268,47,F,PGI Chandigarh,Phase III,ORX-606,Rheumatology,High Dose,2023-10-31,2023-12-26,6.93,7.28,121,87,66,Fatigue,None,Worsened,0
8269,PT-08269,28,M,AIIMS Delhi,Phase II,ORX-202,Diabetes,High Dose,2024-07-29,2024-08-05,6.16,5.74,116,74,75,Headache,None,No Change,0
8270,PT-08270,43,M,Fortis Mumbai,Phase III,ORX-505,Infectious Disease,Placebo,2023-11-27,2024-01-22,5.34,2.67,135,83,58,Headache,Moderate,No Change,0
8271,PT-08271,51,F,Apollo Chennai,Phase III,ORX-202,Diabetes,High Dose,2023-06-16,2023-06-23,7.72,7.05,163,97,72,Nausea,None,Improved,1
8272,PT-08272,38,M,Kolkata Clinical Center,Phase I,ORX-404,Neurology,High Dose,2023-02-09,2023-02-23,5.45,6.15,132,91,48,Fatigue,None,No Change,0
8273,PT-08273,57,F,Bhopal Research Hospital,Phase II,ORX-505,Infectious Disease,High Dose,2024-08-15,2024-11-13,6.59,6.71,137,81,68,Rash,None,Improved,0
8274,PT-08274,51,M,AIIMS Delhi,Phase III,ORX-101,Oncology,Placebo,2024-02-14,2024-05-14,6.2,6.74,115,82,67,Nausea,Mild,Improved,0
8275,PT-08275,47,F,PGI Chandigarh,Phase II,ORX-101,Oncology,Placebo,2024-11-16,2025-02-14,5.96,4.83,169,92,83,None,None,Improved,1
8276,PT-08276,53,F,Indore Medical Institute,Phase III,ORX-505,Infectious Disease,High Dose,2023-01-07,2023-02-04,7.57,7.09,141,72,100,None,None,Improved,1
8277,PT-08277,46,M,Kolkata Clinical Center,Phase II,ORX-202,Diabetes,High Dose,2023-10-12,2023-12-07,8.16,9.18,136,72,95,None,None,Improved,0
8278,PT-08278,72,M,NIMHANS Bengaluru,Phase I,ORX-404,Neurology,Placebo,2024-10-08,2024-10-15,4.86,4.37,133,78,60,Rash,None,Worsened,0
8279,PT-08279,30,F,PGI Chandigarh,Phase III,ORX-404,Neurology,High Dose,2024-10-24,2024-11-07,4.98,5.44,152,98,77,Headache,Moderate,Worsened,0
8280,PT-08280,49,M,Bhopal Research Hospital,Phase III,ORX-202,Diabetes,Placebo,2023-04-17,2023-05-15,8.48,7.87,110,75,80,None,None,Improved,1
8281,PT-08281,33,F,Fortis Mumbai,Phase II,ORX-404,Neurology,Placebo,2023-12-06,2024-03-05,7.77,6.15,123,86,79,None,None,Improved,1
8282,PT-08282,33,F,Kolkata Clinical Center,Phase II,ORX-606,Rheumatology,High Dose,2024-04-11,2024-04-25,8.08,7.92,90,87,72,None,None,No Change,0
8283,PT-08283,36,M,Bhopal Research Hospital,Phase IV,ORX-202,Diabetes,Low Dose,2024-03-31,2024-04-28,6.2,,131,88,80,Nausea,None,Improved,1
8284,PT-08284,60,M,Bhopal Research Hospital,Phase III,ORX-404,Neurology,Placebo,2023-12-20,2024-03-19,7.9,5.69,111,96,60,None,None,No Change,0
8285,PT-08285,18,F,AIIMS Delhi,Phase III,ORX-101,Oncology,Low Dose,2023-10-23,2023-10-30,9.4,9.26,115,71,86,None,None,Worsened,0
8286,PT-08286,52,F,PGI Chandigarh,Phase IV,ORX-505,Infectious Disease,Low Dose,2023-09-19,2023-10-17,7.59,7.02,104,81,92,Nausea,None,Improved,1
8287,PT-08287,36,M,Apollo Chennai,Phase III,ORX-404,Neurology,Placebo,2024-08-12,2024-09-09,7.92,7.16,142,70,78,None,None,Worsened,0
8288,PT-08288,52,F,Apollo Chennai,Phase III,ORX-404,Neurology,High Dose,2023-01-18,2023-01-25,6.39,6.32,127,81,68,Dizziness,Mild,Improved,1
8289,PT-08289,60,M,AIIMS Delhi,Phase IV,ORX-404,Neurology,Placebo,2024-11-29,2024-12-13,6.07,5.92,112,81,87,None,None,Improved,1
8290,PT-08290,40,F,Kolkata Clinical Center,Phase II,ORX-404,Neurology,Placebo,2024-10-06,2024-10-13,3.51,1.9,90,82,77,None,None,Improved,1
8291,PT-08291,39,F,Kolkata Clinical Center,Phase II,ORX-303,Cardiology,Low Dose,2023-07-21,2023-08-18,6.45,6.25,101,93,79,None,None,Improved,1
8292,PT-08292,29,M,AIIMS Delhi,Phase I,ORX-404,Neurology,High Dose,2023-01-12,2023-03-09,6.7,6.18,103,90,91,None,None,Improved,1
8293,PT-08293,46,M,Apollo Chennai,Phase II,ORX-505,Infectious Disease,Low Dose,2024-07-19,2024-08-16,8.33,10.31,94,82,59,None,None,Improved,0
8294,PT-08294,69,F,PGI Chandigarh,Phase IV,ORX-505,Infectious Disease,Low Dose,2023-10-18,2023-11-15,7.5,6.47,123,98,84,None,None,Improved,1
8295,PT-08295,54,M,Apollo Chennai,Phase II,ORX-101,Oncology,Placebo,2024-10-11,2025-01-09,8.99,9.44,148,80,46,Fatigue,Mild,Worsened,0
8296,PT-08296,46,M,AIIMS Delhi,Phase III,ORX-404,Neurology,Placebo,2024-11-27,2024-12-25,6.4,6.71,96,91,80,None,None,Improved,0
8297,PT-08297,50,F,PGI Chandigarh,Phase II,ORX-606,Rheumatology,Low Dose,2024-05-08,2024-05-22,7.94,7.52,122,95,86,None,None,Improved,1
8298,PT-08298,56,F,Apollo Chennai,Phase I,ORX-505,Infectious Disease,High Dose,2023-06-21,2023-07-19,7.1,6.8,127,61,58,Fatigue,Moderate,Improved,1
8299,PT-08299,43,F,Indore Medical Institute,Phase III,ORX-101,Oncology,Low Dose,2024-02-09,2024-04-05,4.95,4.45,111,81,80,None,None,Improved,1
8300,PT-08300,18,F,AIIMS Delhi,Phase IV,ORX-303,Cardiology,Placebo,2023-05-11,2023-08-09,7.59,6.79,90,76,83,Rash,Mild,Improved,1
8301,PT-08301,38,M,AIIMS Delhi,Phase I,ORX-404,Neurology,Placebo,2024-06-17,2024-07-15,6.64,6.38,119,78,59,Fatigue,Moderate,Improved,1
8302,PT-08302,36,F,AIIMS Delhi,Phase III,ORX-606,Rheumatology,High Dose,2024-11-24,2025-01-19,9.46,9.22,132,74,72,None,None,Improved,1
8303,PT-08303,41,F,Bhopal Research Hospital,Phase III,ORX-303,Cardiology,Low Dose,2023-08-26,2023-09-02,8.25,8.93,119,81,74,None,None,Worsened,0
8304,PT-08304,57,F,Kolkata Clinical Center,Phase II,ORX-505,Infectious Disease,High Dose,2024-11-02,2025-01-31,7.76,7.28,146,88,67,None,None,Improved,1
8305,PT-08305,45,F,NIMHANS Bengaluru,Phase II,ORX-505,Infectious Disease,Placebo,2024-08-21,2024-11-19,6.99,5.7,123,95,93,Fever,None,No Change,0
8306,PT-08306,59,M,Kolkata Clinical Center,Phase III,ORX-101,Oncology,Low Dose,2023-08-01,2023-08-08,8.13,7.92,117,88,54,None,None,Improved,1
8307,PT-08307,34,F,Fortis Mumbai,Phase II,ORX-101,Oncology,Low Dose,2024-08-31,2024-10-26,8.53,,139,77,85,Dizziness,None,Improved,1
8308,PT-08308,20,F,Kolkata Clinical Center,Phase III,ORX-303,Cardiology,High Dose,2024-07-03,2024-07-17,8.73,7.32,103,96,77,Headache,Severe,Worsened,0
8309,PT-08309,40,M,Apollo Chennai,Phase IV,ORX-606,Rheumatology,Low Dose,2023-05-13,2023-05-20,9.08,9.34,119,80,93,None,None,Improved,0
8310,PT-08310,29,M,Indore Medical Institute,Phase IV,ORX-505,Infectious Disease,High Dose,2024-02-25,2024-03-03,8.93,8.13,112,95,88,None,None,Worsened,0
8311,PT-08311,18,M,Kolkata Clinical Center,Phase I,ORX-505,Infectious Disease,Placebo,2023-08-27,2023-09-03,7.07,5.68,142,102,85,Fatigue,Mild,Worsened,0
8312,PT-08312,32,M,Fortis Mumbai,Phase I,ORX-505,Infectious Disease,High Dose,2024-02-21,2024-02-28,8.27,7.82,126,76,79,None,None,Improved,1
8313,PT-08313,43,M,PGI Chandigarh,Phase III,ORX-404,Neurology,High Dose,2023-03-05,2023-03-12,4.31,3.94,125,86,49,Headache,Mild,Improved,1
8314,PT-08314,53,F,NIMHANS Bengaluru,Phase III,ORX-303,Cardiology,Placebo,2024-03-19,2024-04-02,7.23,7.28,98,67,51,None,None,Worsened,0
8315,PT-08315,47,F,NIMHANS Bengaluru,Phase IV,ORX-505,Infectious Disease,Low Dose,2023-07-29,2023-08-12,6.79,6.26,102,67,45,None,None,No Change,0
8316,PT-08316,23,M,NIMHANS Bengaluru,Phase III,ORX-404,Neurology,Low Dose,2024-08-12,2024-08-19,6.42,5.48,126,91,68,None,None,No Change,0
8317,PT-08317,52,F,AIIMS Delhi,Phase I,ORX-505,Infectious Disease,High Dose,2024-08-23,2024-08-30,8.13,8.77,136,82,62,None,None,No Change,0
8318,PT-08318,49,F,PGI Chandigarh,Phase III,ORX-101,Oncology,High Dose,2023-06-29,2023-07-13,6.75,7.59,129,80,97,None,None,No Change,0
8319,PT-08319,37,F,Apollo Chennai,Phase III,ORX-101,Oncology,Placebo,2023-05-14,2023-06-11,7.2,8.6,132,95,99,None,None,No Change,0
8320,PT-08320,36,F,AIIMS Delhi,Phase II,ORX-303,Cardiology,Placebo,2024-07-14,2024-07-28,8.29,7.59,164,99,88,None,None,No Change,0
8321,PT-08321,61,F,Indore Medical Institute,Phase III,ORX-404,Neurology,High Dose,2024-11-29,2024-12-06,6.37,7.51,111,86,68,Nausea,None,No Change,0
8322,PT-08322,58,F,Fortis Mumbai,Phase II,ORX-606,Rheumatology,High Dose,2024-04-23,2024-05-07,9.29,9.3,133,80,79,None,None,Worsened,0
8323,PT-08323,39,F,Indore Medical Institute,Phase III,ORX-505,Infectious Disease,Placebo,2023-04-18,2023-05-16,9.16,9.47,121,82,118,None,None,No Change,0
8324,PT-08324,49,F,NIMHANS Bengaluru,Phase III,ORX-202,Diabetes,Placebo,2024-02-22,2024-05-22,8.94,8.02,136,74,70,None,None,Worsened,0
8325,PT-08325,57,F,Apollo Chennai,Phase IV,ORX-606,Rheumatology,Low Dose,2023-09-30,2023-10-07,6.13,4.65,140,76,74,None,None,No Change,0
8326,PT-08326,18,F,AIIMS Delhi,Phase III,ORX-606,Rheumatology,High Dose,2023-03-05,2023-03-19,5.68,5.48,123,92,65,Nausea,None,Worsened,0
8327,PT-08327,42,F,NIMHANS Bengaluru,Phase III,ORX-303,Cardiology,High Dose,2024-01-07,2024-01-14,7.26,6.67,138,68,85,None,None,Improved,1
8328,PT-08328,63,M,Fortis Mumbai,Phase II,ORX-202,Diabetes,High Dose,2024-03-16,2024-05-11,6.21,6.17,134,89,78,None,None,No Change,0
8329,PT-08329,67,F,PGI Chandigarh,Phase III,ORX-606,Rheumatology,Placebo,2023-09-04,2023-10-02,9.73,9.89,133,82,59,None,None,Improved,0
8330,PT-08330,22,M,Bhopal Research Hospital,Phase III,ORX-303,Cardiology,High Dose,2024-04-03,2024-05-29,5.82,5.65,124,100,45,Nausea,None,Improved,1
8331,PT-08331,45,M,PGI Chandigarh,Phase I,ORX-606,Rheumatology,Low Dose,2024-02-23,2024-05-23,7.72,8.13,130,86,80,Fever,Moderate,No Change,0
8332,PT-08332,52,F,AIIMS Delhi,Phase IV,ORX-202,Diabetes,Low Dose,2023-05-06,2023-08-04,7.18,8.68,138,84,67,Headache,None,Improved,0
8333,PT-08333,39,F,Apollo Chennai,Phase IV,ORX-606,Rheumatology,High Dose,2023-08-12,2023-08-26,9.01,6.38,129,81,85,Headache,None,No Change,0
8334,PT-08334,49,M,Indore Medical Institute,Phase III,ORX-404,Neurology,Placebo,2023-08-17,2023-10-12,9.02,8.71,126,93,99,Nausea,None,No Change,0
8335,PT-08335,55,M,Kolkata Clinical Center,Phase II,ORX-505,Infectious Disease,High Dose,2024-10-18,2024-10-25,8.41,7.82,130,99,85,Rash,None,Improved,1
8336,PT-08336,41,F,Apollo Chennai,Phase III,ORX-303,Cardiology,Low Dose,2023-02-26,2023-03-26,7.24,7.77,148,71,83,None,None,Worsened,0
8337,PT-08337,44,F,AIIMS Delhi,Phase III,ORX-303,Cardiology,Placebo,2024-04-06,2024-05-04,7.12,7.92,123,75,66,Dizziness,Mild,Improved,0
8338,PT-08338,42,F,Kolkata Clinical Center,Phase II,ORX-101,Oncology,High Dose,2024-11-16,2024-11-23,6.32,5.14,111,72,67,Rash,Moderate,Improved,1
8339,PT-08339,51,F,NIMHANS Bengaluru,Phase III,ORX-404,Neurology,High Dose,2023-04-26,2023-05-24,4.85,3.82,126,95,74,None,None,No Change,0
8340,PT-08340,42,M,Bhopal Research Hospital,Phase III,ORX-404,Neurology,Low Dose,2024-09-04,2024-09-11,7.09,5.05,139,89,89,None,None,Worsened,0
8341,PT-08341,85,F,Indore Medical Institute,Phase III,ORX-101,Oncology,High Dose,2024-01-13,2024-01-20,5.64,3.9,140,77,64,Nausea,None,Worsened,0
8342,PT-08342,40,M,NIMHANS Bengaluru,Phase IV,ORX-101,Oncology,Placebo,2023-11-30,2023-12-14,6.46,7.61,168,62,57,None,None,Improved,0
8343,PT-08343,32,M,AIIMS Delhi,Phase IV,ORX-202,Diabetes,Placebo,2023-08-18,2023-11-16,6.37,5.27,124,76,59,None,None,Improved,1
8344,PT-08344,28,M,Apollo Chennai,Phase I,ORX-404,Neurology,Placebo,2024-09-03,2024-12-02,9.06,8.33,120,63,71,Dizziness,Moderate,Worsened,0
8345,PT-08345,60,M,Apollo Chennai,Phase II,ORX-202,Diabetes,High Dose,2023-02-23,2023-03-02,7.91,8.24,106,67,93,None,None,Improved,0
8346,PT-08346,58,F,AIIMS Delhi,Phase II,ORX-303,Cardiology,Placebo,2024-02-03,2024-02-17,6.89,7.26,106,67,55,None,None,Improved,0
8347,PT-08347,50,F,NIMHANS Bengaluru,Phase III,ORX-101,Oncology,Placebo,2023-10-03,2024-01-01,7.46,6.59,113,110,74,None,None,No Change,0
8348,PT-08348,67,M,NIMHANS Bengaluru,Phase II,ORX-505,Infectious Disease,Placebo,2023-06-23,2023-09-21,7.02,6.17,153,91,77,Headache,None,Improved,1
8349,PT-08349,63,M,Fortis Mumbai,Phase III,ORX-303,Cardiology,Placebo,2024-07-25,2024-08-08,10.22,9.17,136,77,64,Nausea,None,Improved,1
8350,PT-08350,29,F,AIIMS Delhi,Phase III,ORX-404,Neurology,Low Dose,2024-11-27,2025-02-25,9.11,7.07,137,72,102,Fatigue,Moderate,Improved,1
8351,PT-08351,40,M,Apollo Chennai,Phase III,ORX-606,Rheumatology,High Dose,2023-10-24,2023-11-21,6.76,7.78,143,88,89,None,None,Improved,0
8352,PT-08352,27,M,NIMHANS Bengaluru,Phase III,ORX-505,Infectious Disease,Placebo,2024-09-19,2024-09-26,8.09,7.51,134,87,62,Fatigue,None,Worsened,0
8353,PT-08353,54,F,AIIMS Delhi,Phase II,ORX-606,Rheumatology,Placebo,2023-12-06,2024-03-05,6.98,5.46,125,82,86,None,None,Worsened,0
8354,PT-08354,18,M,Apollo Chennai,Phase IV,ORX-505,Infectious Disease,High Dose,2023-07-01,2023-08-26,7.67,6.81,142,81,73,None,None,No Change,0
8355,PT-08355,42,F,Fortis Mumbai,Phase IV,ORX-303,Cardiology,Low Dose,2023-09-27,2023-12-26,7.6,8.02,111,77,98,None,None,No Change,0
8356,PT-08356,39,M,AIIMS Delhi,Phase III,ORX-202,Diabetes,Low Dose,2023-03-15,2023-05-10,7.64,6.13,97,69,68,None,None,Improved,1
8357,PT-08357,61,M,Bhopal Research Hospital,Phase I,ORX-505,Infectious Disease,High Dose,2023-08-11,2023-08-25,8.58,6.45,118,90,76,Nausea,Mild,Worsened,0
8358,PT-08358,69,F,Indore Medical Institute,Phase I,ORX-303,Cardiology,Low Dose,2023-06-01,2023-06-29,8.01,7.37,124,81,66,Fever,None,Improved,1
8359,PT-08359,60,F,Apollo Chennai,Phase III,ORX-505,Infectious Disease,Low Dose,2024-06-06,2024-09-04,8.09,8.1,132,69,85,Nausea,Mild,Worsened,0
8360,PT-08360,47,M,Kolkata Clinical Center,Phase II,ORX-606,Rheumatology,Low Dose,2024-11-06,2025-02-04,9.6,8.04,114,62,74,Headache,None,Improved,1
8361,PT-08361,18,M,Indore Medical Institute,Phase III,ORX-606,Rheumatology,Placebo,2024-03-20,2024-05-15,8.62,9.21,125,69,56,Nausea,None,No Change,0
8362,PT-08362,33,F,Kolkata Clinical Center,Phase I,ORX-606,Rheumatology,High Dose,2023-01-02,2023-01-30,7.95,6.84,162,99,78,Headache,None,Improved,1
8363,PT-08363,37,M,Apollo Chennai,Phase III,ORX-505,Infectious Disease,High Dose,2023-03-02,2023-03-09,6.52,7.56,116,93,78,None,None,Improved,0
8364,PT-08364,56,M,Bhopal Research Hospital,Phase III,ORX-101,Oncology,Low Dose,2023-02-21,2023-05-22,6.22,5.52,127,74,95,Rash,Moderate,Worsened,0
8365,PT-08365,32,M,Indore Medical Institute,Phase III,ORX-202,Diabetes,High Dose,2024-07-10,2024-10-08,6.51,7.33,148,101,51,None,None,Improved,0
8366,PT-08366,48,M,Bhopal Research Hospital,Phase IV,ORX-404,Neurology,Low Dose,2023-06-14,2023-08-09,7.31,6.4,133,78,80,Fever,Mild,Improved,1
8367,PT-08367,85,F,Fortis Mumbai,Phase II,ORX-202,Diabetes,Low Dose,2024-11-23,2024-12-21,7.58,7.5,142,84,62,None,None,Improved,1
8368,PT-08368,18,F,Kolkata Clinical Center,Phase I,ORX-505,Infectious Disease,Placebo,2024-11-09,2024-12-07,7.16,6.52,92,101,79,Dizziness,Moderate,Improved,1
8369,PT-08369,68,M,Apollo Chennai,Phase II,ORX-202,Diabetes,High Dose,2023-08-21,2023-10-16,4.52,5.43,119,97,81,None,None,Improved,0
8370,PT-08370,52,F,Fortis Mumbai,Phase II,ORX-505,Infectious Disease,Low Dose,2023-07-05,2023-08-02,7.75,6.96,116,77,57,Fever,Moderate,No Change,0
8371,PT-08371,37,F,Fortis Mumbai,Phase III,ORX-404,Neurology,Placebo,2023-09-20,2023-12-19,6.36,4.62,136,82,81,None,None,Improved,1
8372,PT-08372,56,M,Indore Medical Institute,Phase III,ORX-101,Oncology,Placebo,2023-10-26,2023-11-09,6.91,5.67,133,50,76,None,None,No Change,0
8373,PT-08373,57,M,NIMHANS Bengaluru,Phase IV,ORX-606,Rheumatology,Placebo,2024-03-28,2024-04-04,8.46,7.58,90,50,86,None,None,No Change,0
8374,PT-08374,39,M,Apollo Chennai,Phase II,ORX-101,Oncology,Placebo,2023-04-22,2023-07-21,9.62,7.95,134,101,80,None,None,Improved,1
8375,PT-08375,19,M,AIIMS Delhi,Phase II,ORX-202,Diabetes,Placebo,2023-12-25,2024-02-19,10.53,11.55,123,91,89,None,None,Improved,0
8376,PT-08376,55,M,Fortis Mumbai,Phase III,ORX-202,Diabetes,High Dose,2024-10-16,2025-01-14,5.54,5.43,154,88,83,None,None,Improved,1
8377,PT-08377,36,F,Apollo Chennai,Phase III,ORX-505,Infectious Disease,High Dose,2024-08-12,2024-08-19,6.12,4.3,141,79,59,None,None,Improved,1
8378,PT-08378,60,M,PGI Chandigarh,Phase III,ORX-404,Neurology,Placebo,2024-05-09,2024-07-04,6.5,5.32,119,79,84,Nausea,None,No Change,0
8379,PT-08379,30,M,AIIMS Delhi,Phase III,ORX-404,Neurology,Placebo,2023-07-23,2023-09-17,8.41,8.45,118,80,72,None,None,Improved,0
8380,PT-08380,46,F,Bhopal Research Hospital,Phase III,ORX-404,Neurology,High Dose,2024-11-17,2024-12-01,9.02,8.23,131,73,85,Nausea,Mild,No Change,0
8381,PT-08381,49,M,Fortis Mumbai,Phase III,ORX-303,Cardiology,High Dose,2023-01-29,2023-02-26,8.8,7.65,140,97,71,None,None,No Change,0
8382,PT-08382,42,F,AIIMS Delhi,Phase II,ORX-101,Oncology,Low Dose,2024-03-30,2024-04-06,7.43,6.82,131,90,76,Headache,Mild,Improved,1
8383,PT-08383,43,M,NIMHANS Bengaluru,Phase III,ORX-101,Oncology,High Dose,2024-07-25,2024-08-22,7.52,6.76,121,71,77,None,None,Improved,1
8384,PT-08384,52,M,Kolkata Clinical Center,Phase III,ORX-505,Infectious Disease,Low Dose,2024-08-20,2024-11-18,6.88,5.78,126,86,79,Headache,None,No Change,0
8385,PT-08385,80,F,Fortis Mumbai,Phase III,ORX-202,Diabetes,Placebo,2024-09-25,2024-12-24,6.41,5.88,142,73,104,Fatigue,None,No Change,0
8386,PT-08386,45,F,AIIMS Delhi,Phase III,ORX-303,Cardiology,High Dose,2024-07-23,2024-10-21,7.87,7.49,146,69,100,Nausea,None,Improved,1
8387,PT-08387,48,M,PGI Chandigarh,Phase II,ORX-606,Rheumatology,Low Dose,2024-07-24,2024-07-31,7.99,6.93,134,70,94,Headache,Mild,Worsened,0
8388,PT-08388,24,M,PGI Chandigarh,Phase III,ORX-202,Diabetes,Placebo,2023-07-19,2023-07-26,7.39,6.64,99,70,84,Rash,None,Improved,1
8389,PT-08389,30,F,PGI Chandigarh,Phase III,ORX-101,Oncology,Low Dose,2023-08-29,2023-09-05,6.4,6.33,144,89,77,None,None,No Change,0
8390,PT-08390,48,F,Kolkata Clinical Center,Phase I,ORX-606,Rheumatology,High Dose,2023-04-18,2023-05-16,7.34,6.01,133,69,86,None,None,Improved,1
8391,PT-08391,47,F,PGI Chandigarh,Phase II,ORX-505,Infectious Disease,High Dose,2024-02-07,2024-02-14,4.6,5.08,118,74,91,Nausea,Moderate,No Change,0
8392,PT-08392,42,F,Bhopal Research Hospital,Phase IV,ORX-101,Oncology,Low Dose,2024-07-05,2024-07-12,7.92,6.93,142,84,83,None,None,No Change,0
8393,PT-08393,42,F,PGI Chandigarh,Phase IV,ORX-303,Cardiology,Low Dose,2024-07-12,2024-09-06,9.16,10.44,90,93,62,Fever,Mild,Improved,0
8394,PT-08394,53,F,PGI Chandigarh,Phase I,ORX-303,Cardiology,Placebo,2023-02-20,2023-05-21,5.07,5.03,112,76,71,Fatigue,None,Worsened,0
8395,PT-08395,33,F,PGI Chandigarh,Phase III,ORX-303,Cardiology,Low Dose,2023-03-04,2023-04-01,6.35,5.59,125,85,104,None,None,Improved,1
8396,PT-08396,29,M,Kolkata Clinical Center,Phase II,ORX-101,Oncology,Placebo,2023-04-24,2023-05-01,7.35,7.65,115,54,51,Nausea,Mild,Worsened,0
8397,PT-08397,18,F,Indore Medical Institute,Phase I,ORX-202,Diabetes,Low Dose,2024-01-30,2024-03-26,9.05,9.2,141,93,69,None,None,Worsened,0
8398,PT-08398,81,M,Kolkata Clinical Center,Phase II,ORX-505,Infectious Disease,Low Dose,2023-03-08,2023-04-05,7.6,7.14,147,90,96,Headache,Mild,No Change,0
8399,PT-08399,67,F,Indore Medical Institute,Phase IV,ORX-404,Neurology,Low Dose,2023-12-14,2024-01-11,6.78,6.54,111,62,89,Headache,Mild,No Change,0
8400,PT-08400,60,M,Fortis Mumbai,Phase II,ORX-202,Diabetes,Low Dose,2023-11-18,2023-11-25,4.82,3.78,129,83,106,None,None,No Change,0
8401,PT-08401,34,M,NIMHANS Bengaluru,Phase II,ORX-303,Cardiology,Placebo,2023-08-15,2023-08-22,6.99,7.18,121,75,69,None,None,Improved,0
8402,PT-08402,48,M,Indore Medical Institute,Phase III,ORX-101,Oncology,Low Dose,2023-12-26,2024-01-09,6.99,7.2,134,50,53,None,None,Worsened,0
8403,PT-08403,36,M,Indore Medical Institute,Phase II,ORX-505,Infectious Disease,Low Dose,2024-07-01,2024-09-29,8.38,7.39,134,89,85,None,None,No Change,0
8404,PT-08404,36,M,Fortis Mumbai,Phase I,ORX-505,Infectious Disease,Low Dose,2024-06-05,2024-07-31,5.82,4.24,181,87,103,None,None,Improved,1
8405,PT-08405,31,F,AIIMS Delhi,Phase II,ORX-101,Oncology,High Dose,2023-03-10,2023-05-05,8.7,7.87,127,78,65,None,None,No Change,0
8406,PT-08406,31,M,Kolkata Clinical Center,Phase III,ORX-505,Infectious Disease,High Dose,2023-11-12,2023-11-26,7.15,6.22,130,71,87,None,None,Worsened,0
8407,PT-08407,37,M,Indore Medical Institute,Phase II,ORX-101,Oncology,High Dose,2023-08-05,2023-11-03,9.16,8.72,126,101,71,Nausea,None,Improved,1
8408,PT-08408,38,F,Fortis Mumbai,Phase I,ORX-606,Rheumatology,Placebo,2023-09-11,2023-12-10,6.36,6.14,114,91,77,None,None,No Change,0
8409,PT-08409,58,M,PGI Chandigarh,Phase I,ORX-505,Infectious Disease,Low Dose,2023-01-14,2023-01-21,8.07,7.21,114,78,78,None,None,Improved,1
8410,PT-08410,50,F,Apollo Chennai,Phase IV,ORX-404,Neurology,Placebo,2023-05-26,2023-06-23,7.73,7.31,115,74,85,None,None,Improved,1
8411,PT-08411,34,M,Bhopal Research Hospital,Phase III,ORX-404,Neurology,Placebo,2023-09-13,2023-09-27,7.87,8.01,155,76,73,Fatigue,Severe,Improved,0
8412,PT-08412,18,F,Fortis Mumbai,Phase III,ORX-101,Oncology,Low Dose,2023-10-14,2023-10-28,6.07,4.81,137,103,86,Headache,Mild,Worsened,0
8413,PT-08413,60,F,Fortis Mumbai,Phase III,ORX-505,Infectious Disease,Placebo,2023-01-29,2023-03-26,6.35,4.87,123,74,65,None,None,No Change,0
8414,PT-08414,48,F,Apollo Chennai,Phase III,ORX-101,Oncology,High Dose,2024-10-11,2025-01-09,5.78,6.12,120,81,79,None,None,Improved,0
8415,PT-08415,37,F,PGI Chandigarh,Phase II,ORX-404,Neurology,High Dose,2024-04-05,2024-05-31,8.72,6.87,151,77,90,None,None,Worsened,0
8416,PT-08416,48,M,Apollo Chennai,Phase III,ORX-202,Diabetes,High Dose,2023-10-04,2023-10-18,8.22,7.71,132,95,79,Headache,None,No Change,0
8417,PT-08417,66,F,AIIMS Delhi,Phase II,ORX-606,Rheumatology,High Dose,2023-12-22,2023-12-29,7.62,6.56,121,92,60,None,None,No Change,0
8418,PT-08418,57,F,Bhopal Research Hospital,Phase II,ORX-303,Cardiology,Low Dose,2023-04-24,2023-06-19,6.76,5.2,131,73,69,Nausea,None,Worsened,0
8419,PT-08419,34,M,AIIMS Delhi,Phase III,ORX-303,Cardiology,High Dose,2024-02-26,2024-03-04,7.34,6.59,135,94,85,None,None,Worsened,0
8420,PT-08420,73,M,AIIMS Delhi,Phase IV,ORX-606,Rheumatology,Low Dose,2024-06-29,2024-08-24,9.66,9.0,107,78,79,None,None,Improved,1
8421,PT-08421,80,M,AIIMS Delhi,Phase III,ORX-404,Neurology,Low Dose,2024-11-15,2025-02-13,6.75,6.6,115,77,60,None,None,Improved,1
8422,PT-08422,21,M,Fortis Mumbai,Phase IV,ORX-606,Rheumatology,Low Dose,2023-04-21,2023-04-28,8.83,9.39,121,94,59,None,None,Improved,0
8423,PT-08423,42,F,Apollo Chennai,Phase III,ORX-101,Oncology,High Dose,2023-10-16,2024-01-14,7.41,8.15,131,88,71,None,None,Worsened,0
8424,PT-08424,49,M,Kolkata Clinical Center,Phase I,ORX-606,Rheumatology,Low Dose,2023-03-18,2023-04-01,8.72,6.86,148,79,58,None,None,Improved,1
8425,PT-08425,40,M,Bhopal Research Hospital,Phase IV,ORX-606,Rheumatology,Placebo,2024-02-20,2024-05-20,8.75,7.91,133,62,52,None,None,No Change,0
8426,PT-08426,27,M,NIMHANS Bengaluru,Phase III,ORX-202,Diabetes,Low Dose,2023-11-08,2023-12-06,8.42,7.97,147,95,67,None,None,Improved,1
8427,PT-08427,70,M,Indore Medical Institute,Phase III,ORX-404,Neurology,High Dose,2024-05-13,2024-05-20,6.55,7.05,145,82,78,Nausea,None,No Change,0
8428,PT-08428,50,M,Fortis Mumbai,Phase II,ORX-505,Infectious Disease,Placebo,2024-07-27,2024-08-03,7.34,6.59,119,77,95,Fever,Moderate,Improved,1
8429,PT-08429,19,F,Fortis Mumbai,Phase III,ORX-404,Neurology,Placebo,2023-05-13,2023-05-20,6.6,5.91,123,85,59,None,None,Improved,1
8430,PT-08430,61,M,Indore Medical Institute,Phase III,ORX-303,Cardiology,Low Dose,2024-02-08,2024-05-08,8.26,8.47,124,73,73,Nausea,None,Improved,0
8431,PT-08431,45,F,Indore Medical Institute,Phase III,ORX-404,Neurology,High Dose,2023-04-29,2023-06-24,8.0,7.53,134,76,82,Rash,Moderate,Worsened,0
8432,PT-08432,41,F,PGI Chandigarh,Phase III,ORX-202,Diabetes,Placebo,2023-10-02,2023-10-16,7.52,5.53,136,88,85,None,None,No Change,0
8433,PT-08433,29,F,Indore Medical Institute,Phase II,ORX-404,Neurology,Placebo,2024-10-22,2025-01-20,6.35,5.17,133,89,68,Fever,None,Improved,1
8434,PT-08434,66,M,Kolkata Clinical Center,Phase IV,ORX-303,Cardiology,Placebo,2023-09-08,2023-09-22,8.76,8.49,134,61,70,None,None,No Change,0
8435,PT-08435,24,F,Indore Medical Institute,Phase IV,ORX-505,Infectious Disease,Placebo,2024-08-17,2024-08-31,6.11,6.17,141,91,81,Fever,None,No Change,0
8436,PT-08436,53,M,PGI Chandigarh,Phase III,ORX-505,Infectious Disease,Placebo,2023-09-19,2023-11-14,5.29,3.73,124,89,71,Fatigue,None,No Change,0
8437,PT-08437,23,F,Bhopal Research Hospital,Phase II,ORX-606,Rheumatology,Low Dose,2023-02-21,2023-02-28,6.37,5.13,96,108,95,None,None,No Change,0
8438,PT-08438,18,M,Apollo Chennai,Phase IV,ORX-606,Rheumatology,Placebo,2023-04-07,2023-07-06,4.89,3.77,101,110,66,Headache,None,No Change,0
8439,PT-08439,50,F,Bhopal Research Hospital,Phase III,ORX-505,Infectious Disease,Low Dose,2023-07-29,2023-08-26,6.59,5.14,146,89,77,None,None,Worsened,0
8440,PT-08440,83,M,Bhopal Research Hospital,Phase III,ORX-404,Neurology,High Dose,2024-05-13,2024-06-10,7.48,6.67,162,86,100,Headache,None,Improved,1
8441,PT-08441,44,F,NIMHANS Bengaluru,Phase IV,ORX-505,Infectious Disease,High Dose,2024-07-15,2024-07-22,3.58,1.78,147,74,81,None,None,Improved,1
8442,PT-08442,63,M,Indore Medical Institute,Phase III,ORX-101,Oncology,High Dose,2024-10-07,2024-10-21,7.42,6.24,127,83,72,Headache,None,No Change,0
8443,PT-08443,22,F,Kolkata Clinical Center,Phase III,ORX-101,Oncology,Low Dose,2023-04-03,2023-04-17,6.77,6.29,102,70,67,None,None,No Change,0
8444,PT-08444,18,F,PGI Chandigarh,Phase I,ORX-505,Infectious Disease,High Dose,2024-02-03,2024-03-30,7.35,7.17,118,65,83,None,None,No Change,0
8445,PT-08445,53,F,Kolkata Clinical Center,Phase IV,ORX-505,Infectious Disease,High Dose,2024-11-16,2025-02-14,7.32,6.96,138,80,65,None,None,Improved,1
8446,PT-08446,43,M,Fortis Mumbai,Phase II,ORX-505,Infectious Disease,Placebo,2024-11-13,2024-11-27,6.73,6.27,143,67,80,Dizziness,Mild,No Change,0
8447,PT-08447,24,F,Fortis Mumbai,Phase III,ORX-606,Rheumatology,Placebo,2024-11-08,2024-11-15,6.1,,136,83,54,None,None,Improved,0
8448,PT-08448,41,M,AIIMS Delhi,Phase I,ORX-101,Oncology,Placebo,2023-09-04,2023-09-11,4.71,4.35,105,88,80,None,None,No Change,0
8449,PT-08449,25,F,Fortis Mumbai,Phase II,ORX-101,Oncology,Placebo,2024-11-08,2024-12-06,7.66,9.14,124,92,48,Nausea,Moderate,Improved,0
8450,PT-08450,52,F,Apollo Chennai,Phase III,ORX-202,Diabetes,Placebo,2023-06-11,2023-06-18,6.52,5.87,138,79,55,None,None,Improved,1
8451,PT-08451,69,F,Fortis Mumbai,Phase III,ORX-404,Neurology,Placebo,2023-05-03,2023-05-31,5.46,4.3,130,83,83,None,None,Improved,1
8452,PT-08452,47,M,Apollo Chennai,Phase I,ORX-404,Neurology,High Dose,2023-08-07,2023-08-14,8.58,8.62,106,50,80,Headache,None,Improved,0
8453,PT-08453,68,F,Kolkata Clinical Center,Phase I,ORX-404,Neurology,Placebo,2023-10-10,2023-10-24,5.7,4.35,134,87,93,None,None,Worsened,0
8454,PT-08454,71,M,AIIMS Delhi,Phase II,ORX-606,Rheumatology,Low Dose,2023-03-03,2023-04-28,7.48,6.25,111,75,92,Headache,Mild,Improved,1
8455,PT-08455,36,F,Fortis Mumbai,Phase III,ORX-606,Rheumatology,Placebo,2023-05-04,2023-08-02,8.35,6.58,133,72,85,None,None,No Change,0
8456,PT-08456,40,M,AIIMS Delhi,Phase II,ORX-505,Infectious Disease,Placebo,2024-10-23,2024-12-18,8.16,7.37,127,91,76,None,None,Improved,1
8457,PT-08457,45,F,Indore Medical Institute,Phase II,ORX-101,Oncology,High Dose,2023-07-03,2023-10-01,8.11,7.64,99,75,51,Headache,Moderate,Improved,1
8458,PT-08458,41,M,Apollo Chennai,Phase II,ORX-303,Cardiology,High Dose,2023-08-06,2023-09-03,7.77,7.48,153,97,81,None,None,Improved,1
8459,PT-08459,18,F,Kolkata Clinical Center,Phase III,ORX-404,Neurology,Low Dose,2024-09-15,2024-09-29,8.01,6.91,143,85,87,Headache,Mild,Worsened,0
8460,PT-08460,53,M,PGI Chandigarh,Phase IV,ORX-202,Diabetes,Placebo,2024-06-26,2024-07-24,10.07,10.14,104,94,71,Fatigue,Moderate,Improved,0
8461,PT-08461,66,F,Fortis Mumbai,Phase III,ORX-101,Oncology,Low Dose,2023-11-03,2023-12-29,9.05,9.21,105,76,96,Nausea,None,Worsened,0
8462,PT-08462,76,F,Bhopal Research Hospital,Phase IV,ORX-505,Infectious Disease,Placebo,2023-07-01,2023-09-29,7.27,6.63,106,67,81,None,None,Improved,1
8463,PT-08463,56,M,Fortis Mumbai,Phase II,ORX-202,Diabetes,High Dose,2024-03-30,2024-04-27,5.42,5.76,152,89,101,None,None,Improved,0
8464,PT-08464,50,F,AIIMS Delhi,Phase III,ORX-101,Oncology,Low Dose,2023-11-18,2023-12-02,7.64,7.55,152,88,70,Fatigue,Mild,Improved,1
8465,PT-08465,51,F,Indore Medical Institute,Phase III,ORX-404,Neurology,Low Dose,2023-02-06,2023-02-13,7.72,7.13,146,83,87,None,None,No Change,0
8466,PT-08466,53,M,Apollo Chennai,Phase III,ORX-505,Infectious Disease,Low Dose,2024-06-23,2024-06-30,6.33,5.05,115,81,100,Rash,Moderate,Improved,1
8467,PT-08467,44,M,Kolkata Clinical Center,Phase III,ORX-505,Infectious Disease,High Dose,2024-10-15,2025-01-13,7.65,8.03,121,77,92,Headache,Severe,No Change,0
8468,PT-08468,54,M,PGI Chandigarh,Phase II,ORX-202,Diabetes,Low Dose,2024-07-04,2024-07-11,6.52,5.75,129,85,95,Fatigue,None,Improved,1
8469,PT-08469,53,M,Bhopal Research Hospital,Phase III,ORX-606,Rheumatology,Placebo,2023-07-03,2023-07-17,6.02,4.91,133,83,66,Nausea,None,No Change,0
8470,PT-08470,61,F,Fortis Mumbai,Phase III,ORX-202,Diabetes,Placebo,2023-10-26,2023-11-23,4.5,4.4,100,92,74,Headache,None,No Change,0
8471,PT-08471,56,M,Apollo Chennai,Phase III,ORX-202,Diabetes,Low Dose,2024-09-16,2024-11-11,6.73,7.52,94,92,69,Headache,None,No Change,0
8472,PT-08472,51,F,Bhopal Research Hospital,Phase II,ORX-101,Oncology,Placebo,2024-07-01,2024-07-08,7.7,6.05,145,86,79,None,None,No Change,0
8473,PT-08473,51,F,Indore Medical Institute,Phase III,ORX-606,Rheumatology,High Dose,2024-08-06,2024-11-04,7.35,7.7,119,92,86,Nausea,Severe,Worsened,0
8474,PT-08474,42,M,AIIMS Delhi,Phase III,ORX-505,Infectious Disease,Placebo,2024-05-10,2024-05-17,9.42,9.42,131,88,76,Nausea,None,Improved,0
8475,PT-08475,64,M,Bhopal Research Hospital,Phase I,ORX-303,Cardiology,High Dose,2023-10-18,2023-10-25,7.17,7.51,108,60,83,Fatigue,Mild,Worsened,0
8476,PT-08476,38,M,PGI Chandigarh,Phase II,ORX-505,Infectious Disease,High Dose,2024-08-20,2024-08-27,6.97,4.46,158,83,96,Fatigue,None,Improved,1
8477,PT-08477,22,F,NIMHANS Bengaluru,Phase II,ORX-202,Diabetes,High Dose,2024-04-02,2024-04-09,7.32,7.29,130,84,58,Nausea,None,No Change,0
8478,PT-08478,50,M,Kolkata Clinical Center,Phase I,ORX-404,Neurology,Low Dose,2024-02-20,2024-02-27,6.19,5.23,128,77,73,None,None,No Change,0
8479,PT-08479,62,M,Kolkata Clinical Center,Phase IV,ORX-606,Rheumatology,Low Dose,2023-09-09,2023-11-04,7.01,6.26,125,68,80,Headache,None,No Change,0
8480,PT-08480,56,F,NIMHANS Bengaluru,Phase III,ORX-606,Rheumatology,Placebo,2024-02-17,2024-05-17,7.58,7.21,138,75,78,Rash,None,Improved,1
8481,PT-08481,67,M,PGI Chandigarh,Phase III,ORX-505,Infectious Disease,Low Dose,2023-08-12,2023-08-19,6.85,6.99,139,72,87,None,None,Improved,0
8482,PT-08482,35,M,Kolkata Clinical Center,Phase IV,ORX-404,Neurology,Low Dose,2023-02-04,2023-02-18,7.71,6.75,133,83,79,Fatigue,None,No Change,0
8483,PT-08483,49,M,Fortis Mumbai,Phase III,ORX-606,Rheumatology,Low Dose,2023-03-24,2023-03-31,6.56,5.11,129,95,86,None,None,Worsened,0
8484,PT-08484,52,F,Bhopal Research Hospital,Phase II,ORX-404,Neurology,Placebo,2024-04-03,2024-04-17,6.59,6.35,113,76,82,None,None,Improved,1
8485,PT-08485,18,M,Fortis Mumbai,Phase III,ORX-303,Cardiology,High Dose,2024-08-14,2024-10-09,9.28,7.67,161,71,66,None,None,Improved,1
8486,PT-08486,38,M,Indore Medical Institute,Phase I,ORX-404,Neurology,Placebo,2024-07-10,2024-07-17,6.67,5.73,121,83,65,Fever,None,Improved,1
8487,PT-08487,58,M,PGI Chandigarh,Phase I,ORX-101,Oncology,Placebo,2024-04-18,2024-05-02,8.89,6.74,161,91,81,Rash,None,Worsened,0
8488,PT-08488,35,F,Kolkata Clinical Center,Phase III,ORX-202,Diabetes,Low Dose,2024-09-11,2024-10-09,7.4,7.81,174,108,56,None,None,Improved,0
8489,PT-08489,41,M,Bhopal Research Hospital,Phase IV,ORX-606,Rheumatology,Placebo,2024-05-23,2024-06-06,7.29,8.1,126,72,78,Nausea,Mild,Worsened,0
8490,PT-08490,38,M,Fortis Mumbai,Phase II,ORX-505,Infectious Disease,High Dose,2023-05-27,2023-08-25,8.38,10.13,144,93,95,None,None,Worsened,0
8491,PT-08491,52,F,AIIMS Delhi,Phase III,ORX-606,Rheumatology,High Dose,2024-01-30,2024-02-13,6.72,6.05,147,85,64,None,None,Improved,1
8492,PT-08492,65,M,PGI Chandigarh,Phase III,ORX-101,Oncology,Placebo,2024-06-30,2024-07-28,6.27,4.86,112,85,91,Fatigue,Mild,Worsened,0
8493,PT-08493,49,M,NIMHANS Bengaluru,Phase II,ORX-505,Infectious Disease,High Dose,2024-10-04,2024-10-11,6.53,5.4,141,80,82,None,None,Improved,1
8494,PT-08494,42,M,Kolkata Clinical Center,Phase II,ORX-202,Diabetes,High Dose,2024-05-30,2024-08-28,7.56,7.51,171,86,72,None,None,Improved,1
8495,PT-08495,47,F,Apollo Chennai,Phase II,ORX-404,Neurology,High Dose,2023-06-26,2023-09-24,6.06,4.8,150,85,93,None,None,Improved,1
8496,PT-08496,19,F,Fortis Mumbai,Phase I,ORX-202,Diabetes,Placebo,2024-02-16,2024-05-16,6.03,5.9,113,64,62,Rash,None,Improved,1
8497,PT-08497,39,M,NIMHANS Bengaluru,Phase I,ORX-505,Infectious Disease,Placebo,2024-12-01,2024-12-08,7.7,8.84,109,69,57,None,None,No Change,0
8498,PT-08498,54,M,Bhopal Research Hospital,Phase III,ORX-202,Diabetes,Placebo,2023-04-19,2023-05-03,7.35,,113,80,77,Fever,Mild,Improved,1
8499,PT-08499,28,F,Apollo Chennai,Phase III,ORX-505,Infectious Disease,Low Dose,2023-11-15,2024-02-13,7.41,5.77,128,79,83,None,None,Worsened,0
8500,PT-08500,64,M,NIMHANS Bengaluru,Phase III,ORX-505,Infectious Disease,High Dose,2023-01-16,2023-01-30,6.76,6.36,92,105,51,Fever,Mild,Improved,1
8501,PT-08501,43,M,Kolkata Clinical Center,Phase II,ORX-606,Rheumatology,High Dose,2023-04-04,2023-04-18,4.14,,159,95,91,None,None,Improved,1
8502,PT-08502,41,M,Bhopal Research Hospital,Phase II,ORX-303,Cardiology,High Dose,2023-01-24,2023-04-24,9.18,9.01,140,113,93,None,None,No Change,0
8503,PT-08503,43,M,Fortis Mumbai,Phase I,ORX-404,Neurology,High Dose,2023-12-18,2024-03-17,7.81,8.68,139,91,96,Nausea,None,Improved,0
8504,PT-08504,85,M,Fortis Mumbai,Phase I,ORX-303,Cardiology,High Dose,2024-05-12,2024-07-07,6.08,6.31,136,77,68,Rash,None,No Change,0
8505,PT-08505,71,F,Fortis Mumbai,Phase III,ORX-202,Diabetes,Placebo,2023-12-22,2023-12-29,5.97,4.31,117,60,66,Rash,Mild,Improved,1
8506,PT-08506,28,F,Bhopal Research Hospital,Phase IV,ORX-505,Infectious Disease,Low Dose,2024-11-24,2024-12-22,7.3,8.2,117,92,88,None,None,Improved,0
8507,PT-08507,18,F,PGI Chandigarh,Phase III,ORX-202,Diabetes,Placebo,2024-01-15,2024-04-14,6.54,5.8,134,88,82,None,None,No Change,0
8508,PT-08508,30,F,PGI Chandigarh,Phase II,ORX-303,Cardiology,High Dose,2023-10-15,2023-10-22,6.44,4.69,129,77,85,None,None,Improved,1
8509,PT-08509,56,M,Indore Medical Institute,Phase II,ORX-505,Infectious Disease,Low Dose,2023-06-26,2023-09-24,6.8,6.65,124,68,66,Headache,None,Worsened,0
8510,PT-08510,18,F,Kolkata Clinical Center,Phase II,ORX-202,Diabetes,Low Dose,2023-10-29,2024-01-27,6.73,5.79,108,91,85,None,None,Improved,1
8511,PT-08511,53,F,PGI Chandigarh,Phase III,ORX-404,Neurology,Placebo,2023-08-01,2023-08-29,8.03,7.63,127,91,87,None,None,Improved,1
8512,PT-08512,61,F,Indore Medical Institute,Phase III,ORX-202,Diabetes,Placebo,2023-02-01,2023-05-02,7.15,5.86,132,75,87,None,None,No Change,0
8513,PT-08513,49,M,NIMHANS Bengaluru,Phase III,ORX-606,Rheumatology,Low Dose,2024-07-05,2024-07-19,7.26,6.51,146,93,70,None,None,Improved,1
8514,PT-08514,25,M,PGI Chandigarh,Phase IV,ORX-505,Infectious Disease,Placebo,2023-02-12,2023-04-09,7.42,8.08,105,87,66,Nausea,None,Improved,0
8515,PT-08515,28,M,Bhopal Research Hospital,Phase III,ORX-101,Oncology,High Dose,2023-08-28,2023-09-04,8.32,8.5,125,91,87,Nausea,None,Improved,0
8516,PT-08516,21,M,Apollo Chennai,Phase III,ORX-202,Diabetes,Low Dose,2023-09-05,2023-09-19,7.3,8.17,136,50,63,Nausea,None,No Change,0
8517,PT-08517,60,F,NIMHANS Bengaluru,Phase III,ORX-404,Neurology,Placebo,2023-10-10,2024-01-08,6.53,7.14,164,79,69,None,None,Improved,0
8518,PT-08518,28,M,Bhopal Research Hospital,Phase IV,ORX-202,Diabetes,Placebo,2023-03-25,2023-06-23,8.11,7.17,120,68,71,None,None,Improved,1
8519,PT-08519,33,F,PGI Chandigarh,Phase I,ORX-404,Neurology,Low Dose,2023-10-02,2023-10-16,4.82,3.67,141,98,76,Fatigue,None,Improved,1
8520,PT-08520,45,F,NIMHANS Bengaluru,Phase II,ORX-505,Infectious Disease,Placebo,2023-05-21,2023-05-28,7.54,8.91,109,66,77,None,None,No Change,0
8521,PT-08521,51,F,Indore Medical Institute,Phase I,ORX-303,Cardiology,Placebo,2023-02-08,2023-02-22,7.16,5.53,143,80,85,Headache,Mild,Improved,1
8522,PT-08522,69,M,Bhopal Research Hospital,Phase IV,ORX-606,Rheumatology,High Dose,2024-04-17,2024-04-24,5.44,3.5,138,57,72,None,None,Improved,1
8523,PT-08523,35,F,NIMHANS Bengaluru,Phase II,ORX-303,Cardiology,High Dose,2024-02-15,2024-02-29,7.63,6.63,136,69,60,Nausea,None,Improved,1
8524,PT-08524,45,F,Bhopal Research Hospital,Phase I,ORX-303,Cardiology,High Dose,2024-10-06,2025-01-04,7.33,7.19,154,97,84,None,None,Worsened,0
8525,PT-08525,57,M,PGI Chandigarh,Phase III,ORX-606,Rheumatology,Low Dose,2024-10-19,2024-11-02,7.51,8.18,134,75,67,None,None,Improved,0
8526,PT-08526,63,F,Apollo Chennai,Phase I,ORX-101,Oncology,Low Dose,2023-06-13,2023-08-08,6.98,8.31,108,97,72,None,None,Worsened,0
8527,PT-08527,51,M,AIIMS Delhi,Phase III,ORX-101,Oncology,Low Dose,2024-09-17,2024-09-24,5.64,3.58,154,76,91,None,None,No Change,0
8528,PT-08528,34,F,NIMHANS Bengaluru,Phase IV,ORX-606,Rheumatology,Low Dose,2023-10-20,2024-01-18,8.38,7.6,106,89,91,Nausea,Mild,Worsened,0
8529,PT-08529,55,F,Indore Medical Institute,Phase III,ORX-202,Diabetes,High Dose,2023-08-28,2023-09-04,7.03,5.05,108,73,74,Fatigue,None,Worsened,0
8530,PT-08530,63,F,Bhopal Research Hospital,Phase III,ORX-202,Diabetes,High Dose,2023-04-13,2023-04-27,7.06,4.76,90,73,70,None,None,Improved,1
8531,PT-08531,50,F,PGI Chandigarh,Phase II,ORX-404,Neurology,Placebo,2023-03-08,2023-03-22,5.46,3.81,136,98,50,None,None,Improved,1
8532,PT-08532,32,M,NIMHANS Bengaluru,Phase III,ORX-505,Infectious Disease,Placebo,2024-07-10,2024-08-07,8.53,8.97,111,95,78,Fever,None,Improved,0
8533,PT-08533,55,F,NIMHANS Bengaluru,Phase I,ORX-505,Infectious Disease,Low Dose,2023-01-07,2023-01-21,6.36,6.22,107,75,73,None,None,Improved,1
8534,PT-08534,47,M,Kolkata Clinical Center,Phase III,ORX-101,Oncology,Low Dose,2023-09-06,2023-09-20,10.09,11.99,121,99,62,Nausea,Mild,Improved,0
8535,PT-08535,51,F,Bhopal Research Hospital,Phase III,ORX-101,Oncology,High Dose,2023-05-12,2023-08-10,6.38,5.57,175,77,68,None,None,No Change,0
8536,PT-08536,28,F,Bhopal Research Hospital,Phase III,ORX-505,Infectious Disease,High Dose,2023-12-31,2024-01-28,6.28,4.6,132,84,82,None,None,Improved,1
8537,PT-08537,44,F,Kolkata Clinical Center,Phase II,ORX-505,Infectious Disease,Low Dose,2024-11-07,2024-11-14,6.52,5.53,130,81,69,Headache,Moderate,Improved,1
8538,PT-08538,40,M,NIMHANS Bengaluru,Phase IV,ORX-606,Rheumatology,High Dose,2024-01-25,2024-04-24,9.05,10.42,124,73,77,None,None,Worsened,0
8539,PT-08539,63,F,Indore Medical Institute,Phase II,ORX-606,Rheumatology,High Dose,2023-11-21,2023-12-05,7.15,7.07,116,67,88,None,None,No Change,0
8540,PT-08540,48,F,NIMHANS Bengaluru,Phase III,ORX-505,Infectious Disease,High Dose,2024-04-01,2024-05-27,7.99,6.05,160,85,52,Nausea,Mild,Improved,1
8541,PT-08541,60,M,Kolkata Clinical Center,Phase I,ORX-505,Infectious Disease,Placebo,2023-05-02,2023-06-27,6.75,6.38,119,80,77,None,None,No Change,0
8542,PT-08542,18,M,Kolkata Clinical Center,Phase III,ORX-505,Infectious Disease,High Dose,2024-10-19,2024-12-14,8.24,7.94,136,91,79,None,None,Improved,1
8543,PT-08543,50,F,Apollo Chennai,Phase I,ORX-303,Cardiology,Placebo,2023-09-02,2023-09-09,5.44,4.29,129,84,83,None,None,Worsened,0
8544,PT-08544,67,F,Kolkata Clinical Center,Phase III,ORX-101,Oncology,Placebo,2023-08-16,2023-08-23,7.09,7.01,129,79,75,Nausea,None,Worsened,0
8545,PT-08545,32,M,Fortis Mumbai,Phase III,ORX-303,Cardiology,Low Dose,2024-12-01,2025-03-01,7.06,6.46,125,61,76,None,None,Improved,1
8546,PT-08546,30,M,Apollo Chennai,Phase I,ORX-101,Oncology,Placebo,2023-05-12,2023-05-26,7.13,5.74,128,78,69,Nausea,Mild,No Change,0
8547,PT-08547,49,F,PGI Chandigarh,Phase I,ORX-404,Neurology,Placebo,2023-07-23,2023-10-21,7.65,7.21,138,77,83,Fatigue,None,Improved,1
8548,PT-08548,44,F,AIIMS Delhi,Phase III,ORX-101,Oncology,Low Dose,2024-10-27,2024-11-24,6.0,4.88,148,100,87,Rash,Mild,Worsened,0
8549,PT-08549,35,M,Bhopal Research Hospital,Phase III,ORX-303,Cardiology,High Dose,2023-10-22,2024-01-20,8.91,9.06,134,104,65,Headache,None,Improved,0
8550,PT-08550,57,F,NIMHANS Bengaluru,Phase III,ORX-404,Neurology,Placebo,2023-04-03,2023-04-17,6.22,5.28,174,88,103,None,None,Improved,1
8551,PT-08551,53,F,Apollo Chennai,Phase III,ORX-303,Cardiology,Low Dose,2023-10-31,2024-01-29,7.68,6.72,145,82,79,None,None,Improved,1
8552,PT-08552,40,F,Indore Medical Institute,Phase III,ORX-101,Oncology,Low Dose,2024-06-05,2024-06-19,7.08,6.7,130,81,56,Nausea,None,Improved,1
8553,PT-08553,53,M,NIMHANS Bengaluru,Phase III,ORX-202,Diabetes,High Dose,2023-03-02,2023-03-09,7.05,3.67,99,76,95,Fatigue,None,Improved,1
8554,PT-08554,54,M,Bhopal Research Hospital,Phase III,ORX-606,Rheumatology,Placebo,2023-12-11,2024-03-10,6.38,5.8,147,74,62,Nausea,None,Improved,1
8555,PT-08555,59,M,PGI Chandigarh,Phase II,ORX-505,Infectious Disease,High Dose,2024-01-20,2024-04-19,8.54,7.59,136,81,69,None,None,Improved,1
8556,PT-08556,63,M,Bhopal Research Hospital,Phase I,ORX-606,Rheumatology,Placebo,2024-01-29,2024-02-26,6.4,6.68,129,79,70,Nausea,None,Improved,0
8557,PT-08557,29,M,AIIMS Delhi,Phase IV,ORX-202,Diabetes,Low Dose,2024-09-21,2024-10-05,6.9,6.04,129,67,75,None,None,Improved,1
8558,PT-08558,51,M,NIMHANS Bengaluru,Phase III,ORX-101,Oncology,Low Dose,2023-02-04,2023-03-04,6.39,6.66,143,67,67,None,None,Improved,0
8559,PT-08559,23,F,Kolkata Clinical Center,Phase I,ORX-606,Rheumatology,Low Dose,2023-07-17,2023-10-15,7.71,7.42,99,74,82,None,None,Improved,1
8560,PT-08560,46,F,Indore Medical Institute,Phase III,ORX-505,Infectious Disease,Placebo,2024-06-11,2024-08-06,8.65,7.22,127,69,79,None,None,Worsened,0
8561,PT-08561,42,M,Bhopal Research Hospital,Phase III,ORX-606,Rheumatology,Low Dose,2023-01-07,2023-03-04,7.53,6.76,141,73,63,None,None,Worsened,0
8562,PT-08562,48,F,Indore Medical Institute,Phase II,ORX-606,Rheumatology,High Dose,2024-03-13,2024-03-20,9.42,7.66,107,84,93,None,None,Worsened,0
8563,PT-08563,49,M,Apollo Chennai,Phase IV,ORX-404,Neurology,Low Dose,2023-05-31,2023-06-14,6.47,6.45,137,73,89,None,None,Improved,1
8564,PT-08564,44,F,Bhopal Research Hospital,Phase III,ORX-202,Diabetes,Low Dose,2024-10-23,2024-12-18,5.1,4.58,117,97,59,Headache,None,Improved,1
8565,PT-08565,37,F,Fortis Mumbai,Phase II,ORX-202,Diabetes,High Dose,2023-06-25,2023-07-09,7.51,9.29,163,81,82,Dizziness,None,Improved,0
8566,PT-08566,54,M,Fortis Mumbai,Phase III,ORX-101,Oncology,Placebo,2023-02-07,2023-02-14,5.99,5.59,152,83,105,Rash,None,No Change,0
8567,PT-08567,37,F,Kolkata Clinical Center,Phase IV,ORX-202,Diabetes,Low Dose,2023-06-02,2023-06-30,7.09,6.62,104,95,73,Rash,None,Worsened,0
8568,PT-08568,49,M,Fortis Mumbai,Phase I,ORX-606,Rheumatology,Placebo,2024-07-09,2024-07-16,6.48,7.63,150,82,60,None,None,Improved,0
8569,PT-08569,56,M,AIIMS Delhi,Phase III,ORX-303,Cardiology,Low Dose,2023-10-30,2023-12-25,8.5,7.26,125,82,93,Headache,None,Improved,1
8570,PT-08570,42,M,Apollo Chennai,Phase III,ORX-303,Cardiology,Low Dose,2023-03-11,2023-06-09,8.35,7.26,109,103,59,Fever,Moderate,Worsened,0
8571,PT-08571,32,M,Fortis Mumbai,Phase III,ORX-404,Neurology,High Dose,2023-05-28,2023-07-23,8.14,7.26,117,79,47,Dizziness,None,Improved,1
8572,PT-08572,62,M,Bhopal Research Hospital,Phase III,ORX-505,Infectious Disease,High Dose,2024-05-13,2024-08-11,7.41,6.28,97,65,55,Rash,None,No Change,0
8573,PT-08573,48,M,PGI Chandigarh,Phase III,ORX-606,Rheumatology,Low Dose,2024-04-06,2024-06-01,7.48,7.64,141,89,99,None,None,Improved,0
8574,PT-08574,64,M,Indore Medical Institute,Phase III,ORX-606,Rheumatology,High Dose,2023-05-13,2023-07-08,8.35,8.16,140,77,74,None,None,No Change,0
8575,PT-08575,72,F,Indore Medical Institute,Phase III,ORX-101,Oncology,Placebo,2023-06-26,2023-09-24,6.53,5.56,121,75,71,None,None,Improved,1
8576,PT-08576,48,F,Kolkata Clinical Center,Phase III,ORX-202,Diabetes,High Dose,2023-10-05,2024-01-03,7.53,7.95,167,77,77,Nausea,None,Improved,0
8577,PT-08577,18,M,NIMHANS Bengaluru,Phase I,ORX-505,Infectious Disease,Placebo,2023-11-06,2023-11-13,5.65,5.12,136,87,86,Headache,Mild,Improved,1
8578,PT-08578,65,F,NIMHANS Bengaluru,Phase I,ORX-101,Oncology,Low Dose,2024-02-10,2024-03-09,9.25,8.63,113,89,91,Fatigue,Moderate,Worsened,0
8579,PT-08579,47,M,PGI Chandigarh,Phase I,ORX-101,Oncology,High Dose,2023-03-12,2023-04-09,6.99,6.13,127,90,68,None,None,Improved,1
8580,PT-08580,32,F,NIMHANS Bengaluru,Phase I,ORX-606,Rheumatology,Placebo,2024-11-13,2025-01-08,7.92,6.76,130,83,78,Nausea,Moderate,Improved,1
8581,PT-08581,34,M,PGI Chandigarh,Phase II,ORX-202,Diabetes,Low Dose,2023-11-24,2023-12-08,9.28,9.24,118,85,103,None,None,Improved,1
8582,PT-08582,46,F,Fortis Mumbai,Phase III,ORX-202,Diabetes,High Dose,2024-08-08,2024-09-05,9.04,7.61,112,56,105,None,None,Improved,1
8583,PT-08583,18,F,AIIMS Delhi,Phase IV,ORX-101,Oncology,Placebo,2023-07-11,2023-08-08,7.41,8.57,145,86,95,Headache,Mild,Improved,0
8584,PT-08584,34,F,Apollo Chennai,Phase II,ORX-101,Oncology,High Dose,2024-11-16,2025-02-14,7.82,7.32,125,84,94,Rash,None,Worsened,0
8585,PT-08585,70,M,AIIMS Delhi,Phase III,ORX-606,Rheumatology,Low Dose,2024-07-09,2024-07-16,6.88,5.5,113,105,98,None,None,Improved,1
8586,PT-08586,27,F,Kolkata Clinical Center,Phase III,ORX-202,Diabetes,Low Dose,2023-08-27,2023-09-10,9.19,8.15,139,73,108,Nausea,None,Worsened,0
8587,PT-08587,35,M,PGI Chandigarh,Phase IV,ORX-303,Cardiology,Low Dose,2024-04-11,2024-04-25,5.94,5.13,175,85,63,None,None,No Change,0
8588,PT-08588,32,M,AIIMS Delhi,Phase I,ORX-404,Neurology,Low Dose,2024-07-24,2024-09-18,5.1,5.19,105,95,89,Nausea,Severe,No Change,0
8589,PT-08589,43,F,Fortis Mumbai,Phase II,ORX-404,Neurology,Placebo,2024-11-10,2025-01-05,8.68,9.12,130,72,83,Headache,None,No Change,0
8590,PT-08590,51,M,Bhopal Research Hospital,Phase III,ORX-505,Infectious Disease,Placebo,2023-01-11,2023-02-08,7.79,7.46,133,85,97,Fatigue,Severe,Improved,1
8591,PT-08591,24,M,AIIMS Delhi,Phase II,ORX-303,Cardiology,High Dose,2024-04-14,2024-04-21,6.0,5.67,114,84,62,None,None,No Change,0
8592,PT-08592,29,F,PGI Chandigarh,Phase III,ORX-606,Rheumatology,High Dose,2023-06-01,2023-07-27,9.67,9.07,106,80,92,Fatigue,None,Worsened,0
8593,PT-08593,64,M,Fortis Mumbai,Phase IV,ORX-202,Diabetes,Placebo,2023-05-15,2023-05-29,5.45,4.36,132,81,55,None,None,No Change,0
8594,PT-08594,21,M,Apollo Chennai,Phase III,ORX-101,Oncology,Placebo,2024-05-21,2024-06-04,5.92,3.93,119,96,68,Headache,None,Improved,1
8595,PT-08595,62,F,Indore Medical Institute,Phase I,ORX-101,Oncology,Placebo,2023-08-10,2023-09-07,7.24,6.67,98,96,79,None,None,Improved,1
8596,PT-08596,19,M,Kolkata Clinical Center,Phase III,ORX-606,Rheumatology,High Dose,2024-09-10,2024-09-24,7.66,6.73,129,84,95,None,None,Improved,1
8597,PT-08597,26,F,Apollo Chennai,Phase II,ORX-202,Diabetes,Placebo,2024-04-03,2024-04-17,7.89,8.68,173,94,83,None,None,No Change,0
8598,PT-08598,49,F,Kolkata Clinical Center,Phase II,ORX-404,Neurology,High Dose,2023-05-30,2023-08-28,9.06,8.4,142,108,76,None,None,No Change,0
8599,PT-08599,18,F,Fortis Mumbai,Phase III,ORX-505,Infectious Disease,Placebo,2023-06-16,2023-08-11,6.17,6.03,112,77,73,None,None,Improved,1
8600,PT-08600,53,F,Kolkata Clinical Center,Phase III,ORX-404,Neurology,High Dose,2024-10-08,2025-01-06,6.06,5.14,153,76,88,None,None,Improved,1
8601,PT-08601,45,M,Indore Medical Institute,Phase IV,ORX-505,Infectious Disease,High Dose,2024-11-27,2025-01-22,7.17,7.44,94,87,85,None,None,Improved,0
8602,PT-08602,58,M,Bhopal Research Hospital,Phase II,ORX-404,Neurology,Low Dose,2023-04-21,2023-07-20,6.75,6.35,90,73,80,Fatigue,Mild,Improved,1
8603,PT-08603,68,F,NIMHANS Bengaluru,Phase III,ORX-606,Rheumatology,Placebo,2023-11-26,2024-01-21,9.41,8.71,143,80,55,None,None,Worsened,0
8604,PT-08604,54,F,NIMHANS Bengaluru,Phase III,ORX-101,Oncology,Placebo,2023-01-29,2023-03-26,9.4,8.65,111,82,76,None,None,Improved,1
8605,PT-08605,85,F,Apollo Chennai,Phase I,ORX-606,Rheumatology,Placebo,2024-02-22,2024-02-29,8.41,8.12,90,80,103,None,None,Worsened,0
8606,PT-08606,46,M,PGI Chandigarh,Phase II,ORX-404,Neurology,High Dose,2024-11-03,2024-12-01,8.19,8.14,119,102,80,None,None,Worsened,0
8607,PT-08607,33,F,AIIMS Delhi,Phase III,ORX-404,Neurology,Low Dose,2023-10-11,2024-01-09,7.23,8.11,101,85,79,None,None,No Change,0
8608,PT-08608,20,M,PGI Chandigarh,Phase II,ORX-303,Cardiology,Low Dose,2023-03-26,2023-04-23,8.12,7.95,143,95,77,None,None,Improved,1
8609,PT-08609,36,M,Indore Medical Institute,Phase II,ORX-202,Diabetes,Placebo,2024-09-02,2024-09-30,5.49,4.51,128,70,86,None,None,Improved,1
8610,PT-08610,30,F,Kolkata Clinical Center,Phase III,ORX-404,Neurology,Low Dose,2023-03-18,2023-05-13,5.08,4.16,131,66,65,None,None,No Change,0
8611,PT-08611,34,M,Indore Medical Institute,Phase II,ORX-505,Infectious Disease,Low Dose,2024-09-11,2024-12-10,6.6,6.47,139,76,63,None,None,Improved,1
8612,PT-08612,47,F,Indore Medical Institute,Phase III,ORX-101,Oncology,Low Dose,2024-05-31,2024-07-26,7.82,8.87,148,66,76,Fever,None,Worsened,0
8613,PT-08613,52,M,AIIMS Delhi,Phase IV,ORX-404,Neurology,High Dose,2024-06-10,2024-06-24,6.18,5.46,140,84,78,Nausea,Mild,Improved,1
8614,PT-08614,34,M,Kolkata Clinical Center,Phase II,ORX-303,Cardiology,High Dose,2024-04-05,2024-07-04,5.47,4.78,126,64,78,None,None,Improved,1
8615,PT-08615,51,M,Bhopal Research Hospital,Phase III,ORX-303,Cardiology,Low Dose,2023-11-20,2024-01-15,6.37,6.33,132,78,72,Nausea,Mild,Improved,1
8616,PT-08616,39,M,AIIMS Delhi,Phase III,ORX-505,Infectious Disease,Low Dose,2023-05-19,2023-05-26,6.17,6.08,112,72,84,None,None,Improved,1
8617,PT-08617,41,F,AIIMS Delhi,Phase I,ORX-404,Neurology,High Dose,2024-05-21,2024-06-18,7.27,5.33,118,102,53,Nausea,Mild,No Change,0
8618,PT-08618,72,M,Fortis Mumbai,Phase IV,ORX-404,Neurology,Low Dose,2024-01-07,2024-04-06,7.51,6.63,124,96,46,None,None,No Change,0
8619,PT-08619,67,F,PGI Chandigarh,Phase IV,ORX-101,Oncology,High Dose,2023-11-26,2024-01-21,7.52,8.03,96,79,45,Headache,Mild,Improved,0
8620,PT-08620,64,F,AIIMS Delhi,Phase III,ORX-505,Infectious Disease,High Dose,2023-03-26,2023-06-24,6.02,4.72,93,87,79,Nausea,Mild,Improved,1
8621,PT-08621,33,M,Indore Medical Institute,Phase III,ORX-303,Cardiology,Placebo,2023-09-15,2023-11-10,7.52,6.41,96,77,101,Fatigue,Mild,No Change,0
8622,PT-08622,60,M,Apollo Chennai,Phase III,ORX-303,Cardiology,Low Dose,2024-01-10,2024-04-09,7.75,7.57,121,90,85,None,None,Worsened,0
8623,PT-08623,43,F,AIIMS Delhi,Phase III,ORX-606,Rheumatology,High Dose,2023-11-22,2023-12-20,7.44,5.59,119,67,61,None,None,Worsened,0
8624,PT-08624,52,M,Fortis Mumbai,Phase III,ORX-202,Diabetes,High Dose,2023-04-06,2023-06-01,5.68,5.97,146,81,69,Headache,None,No Change,0
8625,PT-08625,61,F,Kolkata Clinical Center,Phase II,ORX-303,Cardiology,Placebo,2024-02-26,2024-05-26,7.86,8.54,108,78,74,Headache,None,Worsened,0
8626,PT-08626,48,M,Bhopal Research Hospital,Phase III,ORX-202,Diabetes,High Dose,2023-11-06,2023-11-20,7.95,7.67,152,77,63,None,None,No Change,0
8627,PT-08627,34,F,Fortis Mumbai,Phase III,ORX-303,Cardiology,High Dose,2023-01-26,2023-02-23,6.25,5.44,123,79,81,Headache,Severe,Improved,1
8628,PT-08628,37,F,Indore Medical Institute,Phase I,ORX-202,Diabetes,Placebo,2024-10-27,2024-11-03,8.46,6.31,90,94,90,None,None,Worsened,0
8629,PT-08629,64,M,NIMHANS Bengaluru,Phase IV,ORX-606,Rheumatology,Placebo,2024-09-03,2024-10-29,7.96,7.57,123,62,80,Nausea,None,Improved,1
8630,PT-08630,22,M,Indore Medical Institute,Phase IV,ORX-101,Oncology,Placebo,2024-07-08,2024-10-06,10.16,8.83,126,100,72,None,None,Improved,1
8631,PT-08631,39,M,AIIMS Delhi,Phase III,ORX-404,Neurology,Placebo,2024-01-21,2024-01-28,4.1,2.52,138,102,65,Nausea,Mild,Improved,1
8632,PT-08632,48,F,Indore Medical Institute,Phase IV,ORX-303,Cardiology,Placebo,2024-04-06,2024-04-13,10.45,10.56,145,72,99,Headache,None,Improved,0
8633,PT-08633,33,M,Indore Medical Institute,Phase III,ORX-101,Oncology,Low Dose,2023-10-06,2024-01-04,6.16,7.09,116,81,100,None,None,No Change,0
8634,PT-08634,30,F,Indore Medical Institute,Phase I,ORX-606,Rheumatology,High Dose,2024-01-09,2024-01-16,6.92,5.97,122,82,96,Headache,None,No Change,0
8635,PT-08635,71,M,PGI Chandigarh,Phase II,ORX-404,Neurology,Low Dose,2023-10-18,2024-01-16,7.39,6.33,140,82,78,None,None,Improved,1
8636,PT-08636,28,F,NIMHANS Bengaluru,Phase III,ORX-606,Rheumatology,High Dose,2024-08-16,2024-08-23,5.26,4.84,108,75,98,Nausea,Mild,Improved,1
8637,PT-08637,43,M,Fortis Mumbai,Phase III,ORX-404,Neurology,Low Dose,2024-11-17,2024-12-01,8.53,8.4,138,75,94,None,None,Improved,1
8638,PT-08638,49,M,AIIMS Delhi,Phase III,ORX-505,Infectious Disease,High Dose,2024-05-30,2024-07-25,6.88,6.76,115,78,77,Headache,None,Improved,1
8639,PT-08639,36,F,Fortis Mumbai,Phase III,ORX-505,Infectious Disease,High Dose,2023-03-30,2023-05-25,9.07,8.3,165,82,74,None,None,Improved,1
8640,PT-08640,36,F,Kolkata Clinical Center,Phase II,ORX-303,Cardiology,Placebo,2024-06-06,2024-07-04,7.71,8.11,90,82,50,None,None,Improved,0
8641,PT-08641,60,F,Bhopal Research Hospital,Phase IV,ORX-404,Neurology,High Dose,2023-07-21,2023-08-04,8.4,8.04,131,64,70,None,None,Improved,1
8642,PT-08642,35,M,Fortis Mumbai,Phase III,ORX-404,Neurology,Placebo,2023-09-01,2023-11-30,6.66,7.05,151,89,73,None,None,Improved,0
8643,PT-08643,33,F,PGI Chandigarh,Phase I,ORX-303,Cardiology,Placebo,2023-01-09,2023-01-23,7.31,7.18,124,74,86,None,None,Improved,1
8644,PT-08644,56,M,AIIMS Delhi,Phase IV,ORX-303,Cardiology,Placebo,2023-01-07,2023-02-04,5.63,4.88,142,93,78,Nausea,None,Improved,1
8645,PT-08645,50,F,Indore Medical Institute,Phase III,ORX-606,Rheumatology,Placebo,2023-06-03,2023-07-29,7.5,7.96,108,85,65,Fatigue,None,Worsened,0
8646,PT-08646,62,M,Kolkata Clinical Center,Phase II,ORX-404,Neurology,High Dose,2023-11-11,2024-02-09,5.93,5.9,112,91,84,Fatigue,None,Improved,1
8647,PT-08647,48,M,PGI Chandigarh,Phase III,ORX-505,Infectious Disease,Placebo,2023-04-08,2023-04-22,9.55,8.52,144,96,90,None,None,Improved,1
8648,PT-08648,34,M,NIMHANS Bengaluru,Phase III,ORX-505,Infectious Disease,Low Dose,2024-08-06,2024-10-01,6.92,5.97,122,71,72,None,None,Improved,1
8649,PT-08649,68,M,Kolkata Clinical Center,Phase III,ORX-606,Rheumatology,Low Dose,2023-01-18,2023-01-25,6.82,6.51,114,81,89,None,None,Improved,1
8650,PT-08650,52,M,Apollo Chennai,Phase II,ORX-505,Infectious Disease,Placebo,2023-09-09,2023-09-16,8.9,7.41,114,77,99,Rash,None,Improved,1
8651,PT-08651,49,F,Indore Medical Institute,Phase III,ORX-202,Diabetes,High Dose,2023-11-05,2024-02-03,5.5,6.08,129,92,100,Dizziness,Mild,Improved,0
8652,PT-08652,29,M,Apollo Chennai,Phase III,ORX-303,Cardiology,Placebo,2023-01-21,2023-03-18,9.1,8.63,120,83,61,None,None,Improved,1
8653,PT-08653,44,M,Indore Medical Institute,Phase I,ORX-505,Infectious Disease,Low Dose,2023-12-13,2024-03-12,6.91,5.66,116,95,75,Nausea,Mild,Improved,1
8654,PT-08654,29,F,AIIMS Delhi,Phase II,ORX-505,Infectious Disease,Placebo,2024-01-18,2024-02-01,7.74,8.03,127,67,45,Headache,None,No Change,0
8655,PT-08655,30,M,Bhopal Research Hospital,Phase III,ORX-505,Infectious Disease,High Dose,2024-05-10,2024-05-24,8.47,8.93,113,79,87,None,None,Improved,0
8656,PT-08656,42,M,Bhopal Research Hospital,Phase II,ORX-404,Neurology,Low Dose,2023-03-13,2023-03-27,8.32,7.84,136,78,67,None,None,Improved,1
8657,PT-08657,63,M,NIMHANS Bengaluru,Phase I,ORX-606,Rheumatology,Low Dose,2023-12-24,2024-01-21,5.4,4.46,126,92,65,Fatigue,Mild,Worsened,0
8658,PT-08658,47,F,PGI Chandigarh,Phase III,ORX-303,Cardiology,Low Dose,2023-08-30,2023-09-27,5.54,5.53,160,58,67,Headache,None,Improved,1
8659,PT-08659,58,M,NIMHANS Bengaluru,Phase I,ORX-303,Cardiology,Placebo,2023-06-26,2023-07-10,10.73,10.86,114,80,60,Nausea,Severe,Improved,0
8660,PT-08660,57,M,PGI Chandigarh,Phase III,ORX-606,Rheumatology,High Dose,2024-04-18,2024-05-16,8.46,9.32,122,72,98,None,None,Improved,0
8661,PT-08661,67,F,Apollo Chennai,Phase I,ORX-404,Neurology,Low Dose,2024-08-02,2024-08-09,6.01,5.28,142,78,78,None,None,Worsened,0
8662,PT-08662,21,F,Bhopal Research Hospital,Phase III,ORX-404,Neurology,Low Dose,2023-05-13,2023-07-08,5.85,5.37,115,68,73,None,None,Improved,1
8663,PT-08663,30,M,Kolkata Clinical Center,Phase I,ORX-606,Rheumatology,Low Dose,2024-11-01,2024-12-27,7.23,7.73,122,76,93,None,None,No Change,0
8664,PT-08664,56,F,AIIMS Delhi,Phase III,ORX-404,Neurology,Low Dose,2023-02-18,2023-03-04,8.16,5.49,119,75,66,None,None,Improved,1
8665,PT-08665,61,M,Fortis Mumbai,Phase II,ORX-505,Infectious Disease,High Dose,2023-08-25,2023-10-20,6.55,4.9,132,81,65,None,None,Improved,1
8666,PT-08666,61,F,Apollo Chennai,Phase III,ORX-202,Diabetes,High Dose,2024-08-25,2024-09-22,7.84,7.91,136,95,75,None,None,Improved,0
8667,PT-08667,25,F,PGI Chandigarh,Phase II,ORX-202,Diabetes,Placebo,2024-08-29,2024-09-12,6.95,5.06,108,101,62,None,None,Worsened,0
8668,PT-08668,26,M,PGI Chandigarh,Phase IV,ORX-606,Rheumatology,Placebo,2023-12-10,2023-12-17,8.0,8.38,98,84,70,Fever,Mild,No Change,0
8669,PT-08669,50,M,Bhopal Research Hospital,Phase II,ORX-101,Oncology,High Dose,2024-08-15,2024-08-22,6.84,5.21,119,89,105,None,None,No Change,0
8670,PT-08670,51,M,PGI Chandigarh,Phase IV,ORX-101,Oncology,Placebo,2023-02-20,2023-03-06,6.73,5.27,125,77,82,Rash,Mild,Improved,1
8671,PT-08671,44,M,Apollo Chennai,Phase III,ORX-202,Diabetes,High Dose,2023-08-26,2023-10-21,7.78,7.05,158,89,68,None,None,Improved,1
8672,PT-08672,61,M,Fortis Mumbai,Phase II,ORX-505,Infectious Disease,High Dose,2023-03-15,2023-03-29,5.81,4.64,113,97,75,Rash,None,Improved,1
8673,PT-08673,34,M,Apollo Chennai,Phase IV,ORX-606,Rheumatology,Placebo,2023-10-27,2023-12-22,7.4,7.48,156,64,95,Nausea,Mild,No Change,0
8674,PT-08674,18,M,Apollo Chennai,Phase I,ORX-101,Oncology,Low Dose,2023-09-04,2023-10-30,8.29,8.93,149,88,63,Rash,Mild,No Change,0
8675,PT-08675,56,M,NIMHANS Bengaluru,Phase II,ORX-101,Oncology,Placebo,2024-08-11,2024-08-18,5.92,4.67,119,77,81,Fatigue,Mild,Worsened,0
8676,PT-08676,33,M,AIIMS Delhi,Phase II,ORX-101,Oncology,Placebo,2023-08-04,2023-08-11,7.6,5.96,128,78,92,Fatigue,Mild,No Change,0
8677,PT-08677,62,F,Indore Medical Institute,Phase III,ORX-303,Cardiology,Low Dose,2023-02-17,2023-02-24,7.0,4.83,101,95,75,Fatigue,None,Improved,1
8678,PT-08678,72,M,Bhopal Research Hospital,Phase I,ORX-606,Rheumatology,High Dose,2024-05-13,2024-05-20,8.28,8.11,130,68,69,Fatigue,None,No Change,0
8679,PT-08679,51,M,PGI Chandigarh,Phase I,ORX-202,Diabetes,High Dose,2023-07-22,2023-08-19,6.79,6.81,146,79,71,Fever,Mild,No Change,0
8680,PT-08680,30,M,NIMHANS Bengaluru,Phase III,ORX-303,Cardiology,High Dose,2024-05-05,2024-06-02,8.2,8.48,167,84,76,None,None,Improved,0
8681,PT-08681,52,M,AIIMS Delhi,Phase I,ORX-404,Neurology,High Dose,2023-11-14,2023-11-28,6.85,5.66,129,87,85,None,None,Improved,1
8682,PT-08682,52,F,NIMHANS Bengaluru,Phase IV,ORX-101,Oncology,Low Dose,2023-10-29,2023-12-24,8.48,8.55,132,66,81,Headache,None,Improved,0
8683,PT-08683,42,F,Apollo Chennai,Phase IV,ORX-606,Rheumatology,Placebo,2024-03-12,2024-03-19,5.85,5.9,137,87,85,Dizziness,Moderate,Worsened,0
8684,PT-08684,46,M,NIMHANS Bengaluru,Phase II,ORX-202,Diabetes,High Dose,2023-03-23,2023-03-30,6.9,8.1,130,51,45,Rash,None,No Change,0
8685,PT-08685,64,M,AIIMS Delhi,Phase III,ORX-202,Diabetes,Placebo,2023-05-01,2023-06-26,5.0,4.11,106,78,83,None,None,Improved,1
8686,PT-08686,34,F,Apollo Chennai,Phase IV,ORX-101,Oncology,Placebo,2023-11-19,2024-01-14,6.22,6.48,175,88,65,None,None,Improved,0
8687,PT-08687,58,M,Fortis Mumbai,Phase III,ORX-202,Diabetes,High Dose,2023-01-23,2023-02-06,9.29,9.85,100,88,71,Rash,None,No Change,0
8688,PT-08688,45,M,AIIMS Delhi,Phase III,ORX-303,Cardiology,High Dose,2023-10-09,2023-10-16,6.75,7.02,121,99,77,Fatigue,Mild,Improved,0
8689,PT-08689,41,M,AIIMS Delhi,Phase I,ORX-101,Oncology,Placebo,2023-12-05,2024-01-02,7.89,7.81,138,80,96,Dizziness,Moderate,Improved,1
8690,PT-08690,60,F,Kolkata Clinical Center,Phase I,ORX-505,Infectious Disease,High Dose,2024-04-30,2024-06-25,7.19,7.53,123,88,89,None,None,Improved,0
8691,PT-08691,48,M,Bhopal Research Hospital,Phase III,ORX-202,Diabetes,Placebo,2024-03-01,2024-03-15,6.22,4.74,133,73,92,None,None,Improved,1
8692,PT-08692,20,F,Fortis Mumbai,Phase II,ORX-101,Oncology,High Dose,2024-01-13,2024-01-20,8.78,8.43,112,76,75,Nausea,None,Improved,1
8693,PT-08693,52,F,AIIMS Delhi,Phase III,ORX-505,Infectious Disease,Placebo,2023-05-07,2023-07-02,5.73,4.47,122,81,88,Dizziness,None,No Change,0
8694,PT-08694,49,F,Fortis Mumbai,Phase I,ORX-404,Neurology,Placebo,2024-04-07,2024-07-06,6.73,6.55,130,78,79,None,None,Improved,1
8695,PT-08695,18,F,AIIMS Delhi,Phase III,ORX-101,Oncology,Low Dose,2024-04-28,2024-05-05,8.32,8.41,154,72,86,Nausea,Mild,Improved,0
8696,PT-08696,18,F,Apollo Chennai,Phase III,ORX-606,Rheumatology,High Dose,2023-03-24,2023-04-21,5.08,4.47,117,94,94,None,None,Improved,1
8697,PT-08697,65,F,Bhopal Research Hospital,Phase III,ORX-404,Neurology,High Dose,2023-10-12,2024-01-10,7.92,8.09,104,98,95,Headache,None,Improved,0
8698,PT-08698,22,F,AIIMS Delhi,Phase II,ORX-101,Oncology,High Dose,2023-07-04,2023-08-29,7.76,6.87,161,70,79,Nausea,None,Improved,1
8699,PT-08699,47,M,Kolkata Clinical Center,Phase IV,ORX-303,Cardiology,High Dose,2024-10-22,2024-10-29,7.14,8.67,158,62,84,Nausea,Severe,Improved,0
8700,PT-08700,44,M,NIMHANS Bengaluru,Phase IV,ORX-606,Rheumatology,High Dose,2024-04-17,2024-05-15,8.2,7.99,113,69,72,None,None,No Change,0
8701,PT-08701,43,M,PGI Chandigarh,Phase II,ORX-303,Cardiology,High Dose,2024-01-18,2024-03-14,7.43,6.52,158,88,90,None,None,No Change,0
8702,PT-08702,42,F,AIIMS Delhi,Phase III,ORX-202,Diabetes,Placebo,2024-07-14,2024-07-28,5.95,6.35,110,57,85,None,None,Improved,0
8703,PT-08703,32,F,AIIMS Delhi,Phase IV,ORX-202,Diabetes,High Dose,2023-08-24,2023-09-21,6.8,7.02,111,62,95,None,None,No Change,0
8704,PT-08704,44,M,AIIMS Delhi,Phase IV,ORX-606,Rheumatology,Low Dose,2024-07-02,2024-08-27,8.71,8.87,139,83,80,Nausea,None,No Change,0
8705,PT-08705,63,M,NIMHANS Bengaluru,Phase II,ORX-101,Oncology,Low Dose,2023-09-06,2023-12-05,8.18,7.25,136,74,73,None,None,Improved,1
8706,PT-08706,54,F,Apollo Chennai,Phase III,ORX-303,Cardiology,Placebo,2023-06-05,2023-09-03,6.44,6.17,134,77,88,Fatigue,None,Improved,1
8707,PT-08707,37,F,Fortis Mumbai,Phase III,ORX-303,Cardiology,Placebo,2024-04-09,2024-07-08,8.33,8.05,131,71,74,None,None,Improved,1
8708,PT-08708,48,M,Fortis Mumbai,Phase II,ORX-505,Infectious Disease,Low Dose,2024-08-02,2024-08-30,8.43,7.74,146,72,82,None,None,Improved,1
8709,PT-08709,36,F,Apollo Chennai,Phase I,ORX-404,Neurology,High Dose,2024-03-28,2024-05-23,9.05,9.88,133,75,56,Fatigue,None,No Change,0
8710,PT-08710,51,F,Indore Medical Institute,Phase IV,ORX-404,Neurology,Low Dose,2023-11-30,2024-02-28,7.45,7.82,101,83,84,None,None,Improved,0
8711,PT-08711,30,M,Bhopal Research Hospital,Phase III,ORX-303,Cardiology,High Dose,2023-05-30,2023-06-27,7.34,6.29,113,75,74,None,None,Improved,1
8712,PT-08712,64,F,Fortis Mumbai,Phase II,ORX-404,Neurology,Placebo,2024-09-03,2024-12-02,6.81,5.65,142,94,89,Nausea,None,Worsened,0
8713,PT-08713,66,M,Kolkata Clinical Center,Phase I,ORX-101,Oncology,High Dose,2023-10-15,2023-12-10,7.43,7.17,115,98,76,None,None,Improved,1
8714,PT-08714,40,F,AIIMS Delhi,Phase III,ORX-606,Rheumatology,High Dose,2023-04-15,2023-04-29,6.73,6.9,129,84,73,None,None,No Change,0
8715,PT-08715,41,M,Indore Medical Institute,Phase IV,ORX-303,Cardiology,Placebo,2024-02-09,2024-03-08,7.02,7.9,95,87,93,Dizziness,Severe,No Change,0
8716,PT-08716,18,M,Bhopal Research Hospital,Phase III,ORX-606,Rheumatology,High Dose,2024-04-06,2024-04-13,7.11,7.6,114,85,64,Nausea,None,Improved,0
8717,PT-08717,45,M,Indore Medical Institute,Phase III,ORX-202,Diabetes,High Dose,2023-03-31,2023-04-07,8.73,9.86,132,66,73,None,None,Improved,0
8718,PT-08718,18,M,Bhopal Research Hospital,Phase II,ORX-404,Neurology,Low Dose,2023-07-18,2023-10-16,6.85,7.32,103,79,66,Nausea,Mild,Improved,0
8719,PT-08719,73,F,Fortis Mumbai,Phase I,ORX-505,Infectious Disease,High Dose,2023-07-19,2023-08-16,7.68,8.04,133,91,93,Dizziness,None,Improved,0
8720,PT-08720,45,F,NIMHANS Bengaluru,Phase I,ORX-101,Oncology,High Dose,2024-08-21,2024-09-04,6.56,5.32,159,91,46,None,None,Improved,1
8721,PT-08721,41,F,AIIMS Delhi,Phase II,ORX-303,Cardiology,Low Dose,2024-07-11,2024-09-05,7.7,8.8,108,87,72,Nausea,None,Improved,0
8722,PT-08722,25,M,Kolkata Clinical Center,Phase III,ORX-606,Rheumatology,High Dose,2024-08-29,2024-10-24,8.81,7.55,145,62,71,None,None,No Change,0
8723,PT-08723,54,F,Kolkata Clinical Center,Phase I,ORX-101,Oncology,High Dose,2024-09-10,2024-09-17,8.06,8.05,145,78,97,None,None,Improved,1
8724,PT-08724,50,F,AIIMS Delhi,Phase III,ORX-606,Rheumatology,Low Dose,2023-11-14,2024-02-12,8.08,8.01,136,69,64,Fever,Moderate,Improved,1
8725,PT-08725,36,M,Apollo Chennai,Phase II,ORX-404,Neurology,Low Dose,2024-10-20,2024-11-17,7.82,6.89,122,81,97,None,None,No Change,0
8726,PT-08726,54,F,Bhopal Research Hospital,Phase III,ORX-606,Rheumatology,Placebo,2023-01-11,2023-01-18,5.45,5.19,122,79,78,Nausea,None,Improved,1
8727,PT-08727,63,F,AIIMS Delhi,Phase III,ORX-404,Neurology,Low Dose,2023-01-18,2023-02-15,6.22,6.01,133,79,69,Headache,None,Worsened,0
8728,PT-08728,32,M,AIIMS Delhi,Phase III,ORX-404,Neurology,High Dose,2024-01-27,2024-03-23,6.7,6.96,121,80,61,None,None,Worsened,0
8729,PT-08729,37,M,Apollo Chennai,Phase III,ORX-404,Neurology,High Dose,2023-07-15,2023-10-13,7.48,5.57,146,74,102,Headache,Mild,Improved,1
8730,PT-08730,51,M,PGI Chandigarh,Phase III,ORX-303,Cardiology,Low Dose,2024-05-22,2024-05-29,5.0,4.85,122,85,100,None,None,Improved,1
8731,PT-08731,56,F,Fortis Mumbai,Phase III,ORX-101,Oncology,Placebo,2023-06-06,2023-09-04,6.93,5.27,143,88,94,None,None,Improved,1
8732,PT-08732,42,M,Indore Medical Institute,Phase III,ORX-404,Neurology,Placebo,2023-04-03,2023-07-02,7.55,6.93,129,63,82,None,None,Worsened,0
8733,PT-08733,51,M,Kolkata Clinical Center,Phase III,ORX-505,Infectious Disease,Low Dose,2023-12-13,2024-01-10,6.6,6.74,143,98,63,None,None,Improved,0
8734,PT-08734,55,M,AIIMS Delhi,Phase IV,ORX-303,Cardiology,Placebo,2024-06-16,2024-06-30,8.81,8.09,153,73,78,Nausea,Mild,No Change,0
8735,PT-08735,18,M,Fortis Mumbai,Phase III,ORX-101,Oncology,Low Dose,2024-05-25,2024-06-01,4.96,3.16,153,72,67,None,None,Improved,1
8736,PT-08736,51,F,Bhopal Research Hospital,Phase IV,ORX-606,Rheumatology,Low Dose,2023-01-24,2023-03-21,6.31,6.99,161,55,85,Dizziness,Moderate,No Change,0
8737,PT-08737,18,F,PGI Chandigarh,Phase III,ORX-606,Rheumatology,Low Dose,2024-08-24,2024-09-21,5.57,5.6,111,85,78,Fatigue,None,Worsened,0
8738,PT-08738,18,M,Indore Medical Institute,Phase II,ORX-101,Oncology,High Dose,2024-08-31,2024-09-28,7.99,7.86,128,74,83,None,None,No Change,0
8739,PT-08739,24,F,Kolkata Clinical Center,Phase III,ORX-303,Cardiology,Placebo,2023-12-20,2024-01-17,5.99,5.88,146,76,84,None,None,No Change,0
8740,PT-08740,48,M,NIMHANS Bengaluru,Phase II,ORX-101,Oncology,Low Dose,2024-08-29,2024-09-26,7.7,6.67,125,81,98,None,None,Improved,1
8741,PT-08741,27,M,NIMHANS Bengaluru,Phase III,ORX-505,Infectious Disease,High Dose,2023-08-13,2023-08-27,5.52,7.81,133,88,86,Fatigue,None,Worsened,0
8742,PT-08742,57,F,NIMHANS Bengaluru,Phase III,ORX-101,Oncology,High Dose,2024-04-07,2024-04-14,8.28,8.58,148,84,93,None,None,Worsened,0
8743,PT-08743,75,F,Bhopal Research Hospital,Phase III,ORX-505,Infectious Disease,Low Dose,2024-03-18,2024-04-15,7.44,7.47,117,80,82,Nausea,Mild,No Change,0
8744,PT-08744,38,M,Fortis Mumbai,Phase IV,ORX-101,Oncology,High Dose,2024-01-15,2024-02-12,7.31,7.22,155,71,83,None,None,Improved,1
8745,PT-08745,35,M,Apollo Chennai,Phase II,ORX-303,Cardiology,Low Dose,2023-10-20,2023-10-27,8.12,8.48,158,76,80,Headache,None,No Change,0
8746,PT-08746,57,M,Fortis Mumbai,Phase III,ORX-202,Diabetes,Low Dose,2024-03-22,2024-05-17,7.99,5.35,115,88,75,None,None,Improved,1
8747,PT-08747,57,M,Kolkata Clinical Center,Phase II,ORX-101,Oncology,High Dose,2024-08-16,2024-11-14,8.45,7.86,138,99,92,None,None,Improved,1
8748,PT-08748,32,M,PGI Chandigarh,Phase III,ORX-404,Neurology,High Dose,2024-04-27,2024-05-04,6.98,6.6,111,94,68,Headache,None,Improved,1
8749,PT-08749,43,M,Kolkata Clinical Center,Phase III,ORX-505,Infectious Disease,Low Dose,2024-05-20,2024-06-03,8.49,7.68,121,86,72,None,None,No Change,0
8750,PT-08750,69,M,PGI Chandigarh,Phase III,ORX-202,Diabetes,High Dose,2023-03-17,2023-05-12,6.1,3.64,143,77,66,None,None,Improved,1
8751,PT-08751,51,M,AIIMS Delhi,Phase III,ORX-202,Diabetes,Placebo,2023-09-11,2023-09-18,7.7,6.62,149,92,105,None,None,Improved,1
8752,PT-08752,37,M,Indore Medical Institute,Phase II,ORX-101,Oncology,Placebo,2023-04-18,2023-07-17,7.39,7.2,122,86,84,Fatigue,None,Improved,1
8753,PT-08753,52,M,Kolkata Clinical Center,Phase III,ORX-303,Cardiology,Low Dose,2023-02-01,2023-02-15,6.81,6.22,117,72,77,None,None,Improved,1
8754,PT-08754,69,M,Kolkata Clinical Center,Phase II,ORX-202,Diabetes,Low Dose,2023-10-01,2023-10-08,9.65,10.43,119,86,49,None,None,Worsened,0
8755,PT-08755,42,M,PGI Chandigarh,Phase II,ORX-404,Neurology,High Dose,2023-06-29,2023-07-06,6.73,8.02,132,82,77,Fever,Moderate,No Change,0
8756,PT-08756,40,F,Indore Medical Institute,Phase I,ORX-202,Diabetes,Low Dose,2023-06-02,2023-06-16,7.84,6.84,137,99,79,None,None,No Change,0
8757,PT-08757,39,F,Kolkata Clinical Center,Phase II,ORX-202,Diabetes,High Dose,2023-03-17,2023-06-15,7.11,7.79,130,74,89,Dizziness,None,Improved,0
8758,PT-08758,33,F,Kolkata Clinical Center,Phase IV,ORX-303,Cardiology,High Dose,2023-02-04,2023-05-05,6.92,6.73,113,60,84,None,None,No Change,0
8759,PT-08759,18,M,NIMHANS Bengaluru,Phase II,ORX-505,Infectious Disease,Placebo,2023-06-02,2023-06-09,6.09,6.39,135,80,65,Fatigue,None,No Change,0
8760,PT-08760,38,M,NIMHANS Bengaluru,Phase II,ORX-505,Infectious Disease,Low Dose,2023-09-01,2023-09-15,7.89,7.37,105,71,71,Fatigue,None,Improved,1
8761,PT-08761,50,F,NIMHANS Bengaluru,Phase II,ORX-606,Rheumatology,Low Dose,2024-03-08,2024-03-22,7.33,5.8,152,73,84,None,None,Improved,1
8762,PT-08762,29,F,Indore Medical Institute,Phase IV,ORX-303,Cardiology,High Dose,2023-03-22,2023-03-29,10.18,10.97,114,83,63,None,None,Improved,0
8763,PT-08763,39,F,PGI Chandigarh,Phase III,ORX-202,Diabetes,Low Dose,2023-03-29,2023-06-27,7.71,8.07,105,73,91,Headache,Mild,Improved,0
8764,PT-08764,66,F,Fortis Mumbai,Phase III,ORX-606,Rheumatology,Low Dose,2024-11-06,2025-02-04,6.27,6.73,105,78,61,Fever,Moderate,Improved,0
8765,PT-08765,38,M,Kolkata Clinical Center,Phase III,ORX-404,Neurology,Placebo,2024-08-14,2024-11-12,9.49,9.04,122,75,73,Nausea,Moderate,Worsened,0
8766,PT-08766,32,M,AIIMS Delhi,Phase II,ORX-101,Oncology,Low Dose,2023-01-07,2023-01-21,7.36,6.93,119,75,80,Fever,Moderate,Improved,1
8767,PT-08767,33,M,Fortis Mumbai,Phase II,ORX-101,Oncology,Low Dose,2023-04-22,2023-07-21,6.91,6.11,90,92,52,Fatigue,None,Improved,1
8768,PT-08768,18,F,Kolkata Clinical Center,Phase IV,ORX-404,Neurology,Low Dose,2024-06-11,2024-07-09,8.27,6.88,90,98,69,None,None,Improved,1
8769,PT-08769,64,F,Apollo Chennai,Phase III,ORX-202,Diabetes,Placebo,2024-02-09,2024-02-16,6.1,4.22,122,67,83,Fatigue,None,Worsened,0
8770,PT-08770,55,F,Kolkata Clinical Center,Phase III,ORX-101,Oncology,High Dose,2024-04-08,2024-07-07,8.32,7.64,152,70,79,Headache,None,No Change,0
8771,PT-08771,42,F,NIMHANS Bengaluru,Phase III,ORX-606,Rheumatology,Placebo,2023-10-17,2023-10-24,9.57,10.25,128,84,99,Headache,Mild,No Change,0
8772,PT-08772,32,M,Apollo Chennai,Phase III,ORX-202,Diabetes,Placebo,2023-08-21,2023-11-19,4.76,3.49,120,98,92,None,None,Improved,1
8773,PT-08773,44,M,Indore Medical Institute,Phase III,ORX-101,Oncology,Low Dose,2024-03-14,2024-05-09,7.76,6.72,165,96,78,Rash,Mild,Improved,1
8774,PT-08774,43,M,PGI Chandigarh,Phase II,ORX-404,Neurology,Low Dose,2024-11-11,2024-11-18,8.04,7.59,95,100,94,None,None,No Change,0
8775,PT-08775,50,F,Fortis Mumbai,Phase III,ORX-505,Infectious Disease,High Dose,2024-09-26,2024-10-03,6.7,6.31,90,68,102,None,None,Worsened,0
8776,PT-08776,53,F,AIIMS Delhi,Phase III,ORX-606,Rheumatology,Low Dose,2024-02-10,2024-02-24,4.86,3.72,93,72,75,None,None,Improved,1
8777,PT-08777,70,F,Kolkata Clinical Center,Phase III,ORX-202,Diabetes,Placebo,2023-07-28,2023-09-22,8.14,7.47,123,72,93,Headache,Severe,Improved,1
8778,PT-08778,64,F,Fortis Mumbai,Phase II,ORX-303,Cardiology,High Dose,2023-08-05,2023-08-12,5.59,3.65,122,79,81,Headache,None,Worsened,0
8779,PT-08779,18,F,Indore Medical Institute,Phase III,ORX-505,Infectious Disease,Placebo,2023-07-29,2023-08-05,6.34,5.87,113,92,104,None,None,Worsened,0
8780,PT-08780,36,M,AIIMS Delhi,Phase IV,ORX-505,Infectious Disease,Placebo,2024-04-12,2024-05-10,8.27,7.55,111,73,88,None,None,Improved,1
8781,PT-08781,34,M,AIIMS Delhi,Phase III,ORX-606,Rheumatology,Low Dose,2023-11-06,2024-02-04,6.66,5.24,139,87,98,Headache,None,Improved,1
8782,PT-08782,54,M,PGI Chandigarh,Phase I,ORX-404,Neurology,Low Dose,2024-08-19,2024-11-17,7.7,7.82,123,83,91,Nausea,Mild,Improved,0
8783,PT-08783,31,F,Bhopal Research Hospital,Phase II,ORX-101,Oncology,Low Dose,2024-03-07,2024-05-02,9.24,9.42,164,67,61,None,None,Improved,0
8784,PT-08784,50,F,Bhopal Research Hospital,Phase III,ORX-505,Infectious Disease,High Dose,2024-01-12,2024-02-09,7.35,6.54,105,78,81,Rash,None,Improved,1
8785,PT-08785,24,M,AIIMS Delhi,Phase II,ORX-202,Diabetes,High Dose,2024-06-21,2024-07-19,6.71,6.65,142,78,66,None,None,Improved,1
8786,PT-08786,46,M,Bhopal Research Hospital,Phase I,ORX-101,Oncology,High Dose,2024-01-13,2024-02-10,6.95,5.23,119,74,78,None,None,No Change,0
8787,PT-08787,33,F,Apollo Chennai,Phase II,ORX-303,Cardiology,Placebo,2023-05-30,2023-06-27,6.54,5.98,139,83,115,Headache,None,Improved,1
8788,PT-08788,24,M,Bhopal Research Hospital,Phase II,ORX-505,Infectious Disease,Low Dose,2023-11-27,2023-12-25,8.29,7.82,102,77,56,Headache,Severe,Improved,1
8789,PT-08789,46,M,NIMHANS Bengaluru,Phase II,ORX-101,Oncology,Low Dose,2023-07-17,2023-10-15,6.83,5.82,108,94,75,None,None,No Change,0
8790,PT-08790,48,F,NIMHANS Bengaluru,Phase I,ORX-606,Rheumatology,Low Dose,2024-11-11,2024-12-09,7.41,7.11,122,100,109,None,None,Improved,1
8791,PT-08791,68,F,Fortis Mumbai,Phase IV,ORX-505,Infectious Disease,Placebo,2023-01-03,2023-01-10,7.23,6.78,147,72,101,None,None,Improved,1
8792,PT-08792,57,F,Kolkata Clinical Center,Phase II,ORX-101,Oncology,Placebo,2024-02-26,2024-05-26,6.86,6.72,139,76,92,None,None,No Change,0
8793,PT-08793,65,M,AIIMS Delhi,Phase IV,ORX-606,Rheumatology,Low Dose,2024-04-18,2024-04-25,6.88,6.06,126,68,54,None,None,Worsened,0
8794,PT-08794,38,M,Kolkata Clinical Center,Phase II,ORX-505,Infectious Disease,Low Dose,2023-08-07,2023-08-14,6.05,7.24,119,87,69,Rash,Mild,No Change,0
8795,PT-08795,73,F,PGI Chandigarh,Phase I,ORX-101,Oncology,Placebo,2023-08-12,2023-08-26,6.97,5.45,140,85,94,None,None,Improved,1
8796,PT-08796,42,F,Apollo Chennai,Phase IV,ORX-404,Neurology,Placebo,2024-01-20,2024-02-03,7.33,5.57,143,82,76,None,None,Improved,1
8797,PT-08797,41,M,NIMHANS Bengaluru,Phase III,ORX-101,Oncology,Placebo,2023-04-15,2023-07-14,6.86,7.23,111,90,55,None,None,Improved,0
8798,PT-08798,18,F,Bhopal Research Hospital,Phase III,ORX-404,Neurology,Low Dose,2023-10-05,2023-11-30,8.89,7.57,129,78,82,None,None,No Change,0
8799,PT-08799,45,M,Apollo Chennai,Phase II,ORX-202,Diabetes,Placebo,2023-03-25,2023-05-20,8.45,6.77,140,81,56,None,None,Worsened,0
8800,PT-08800,36,F,Kolkata Clinical Center,Phase III,ORX-606,Rheumatology,Placebo,2024-01-19,2024-02-02,5.28,3.37,120,96,82,Headache,None,No Change,0
8801,PT-08801,65,F,Fortis Mumbai,Phase III,ORX-606,Rheumatology,Low Dose,2024-06-19,2024-06-26,7.29,8.29,154,70,78,None,None,No Change,0
8802,PT-08802,33,F,Apollo Chennai,Phase II,ORX-505,Infectious Disease,Placebo,2024-02-09,2024-04-05,7.03,8.12,116,67,62,None,None,No Change,0
8803,PT-08803,38,M,Fortis Mumbai,Phase IV,ORX-505,Infectious Disease,Low Dose,2023-12-28,2024-02-22,11.69,12.62,90,81,69,None,None,Worsened,0
8804,PT-08804,60,F,NIMHANS Bengaluru,Phase II,ORX-303,Cardiology,High Dose,2024-01-13,2024-02-10,5.79,4.45,117,73,87,Rash,Severe,Improved,1
8805,PT-08805,39,M,AIIMS Delhi,Phase II,ORX-303,Cardiology,Placebo,2024-08-21,2024-08-28,8.4,7.27,143,68,86,Headache,Moderate,Worsened,0
8806,PT-08806,37,M,Apollo Chennai,Phase III,ORX-101,Oncology,High Dose,2024-10-09,2024-10-23,8.27,5.67,113,96,75,Fatigue,None,No Change,0
8807,PT-08807,18,M,Bhopal Research Hospital,Phase II,ORX-202,Diabetes,High Dose,2024-09-21,2024-09-28,6.35,6.3,113,95,93,None,None,Improved,1
8808,PT-08808,55,F,PGI Chandigarh,Phase III,ORX-101,Oncology,Low Dose,2024-01-09,2024-04-08,8.44,7.57,154,94,76,None,None,No Change,0
8809,PT-08809,18,F,Indore Medical Institute,Phase IV,ORX-101,Oncology,Low Dose,2024-06-03,2024-06-10,4.36,4.85,99,70,84,None,None,Improved,0
8810,PT-08810,24,M,Bhopal Research Hospital,Phase I,ORX-101,Oncology,High Dose,2023-07-02,2023-08-27,10.12,9.93,154,94,45,Headache,None,No Change,0
8811,PT-08811,56,M,Fortis Mumbai,Phase III,ORX-303,Cardiology,Low Dose,2024-06-19,2024-08-14,7.18,6.72,127,94,101,Nausea,Mild,Improved,1
8812,PT-08812,25,M,PGI Chandigarh,Phase III,ORX-505,Infectious Disease,High Dose,2023-10-02,2023-10-30,7.29,8.15,124,84,81,Fatigue,None,No Change,0
8813,PT-08813,78,M,NIMHANS Bengaluru,Phase III,ORX-202,Diabetes,High Dose,2024-05-10,2024-05-24,8.1,9.56,159,79,82,Nausea,Mild,Improved,0
8814,PT-08814,77,F,PGI Chandigarh,Phase III,ORX-101,Oncology,Placebo,2023-06-30,2023-07-28,5.83,6.11,141,78,72,None,None,No Change,0
8815,PT-08815,41,F,AIIMS Delhi,Phase III,ORX-606,Rheumatology,Placebo,2023-04-03,2023-04-10,8.04,8.97,141,66,99,Fatigue,None,No Change,0
8816,PT-08816,64,F,Indore Medical Institute,Phase I,ORX-101,Oncology,High Dose,2024-10-03,2024-10-31,6.91,5.92,111,94,51,None,None,Improved,1
8817,PT-08817,62,M,Indore Medical Institute,Phase III,ORX-606,Rheumatology,High Dose,2023-12-23,2024-02-17,6.66,6.51,90,60,68,Nausea,None,Worsened,0
8818,PT-08818,30,M,AIIMS Delhi,Phase III,ORX-505,Infectious Disease,High Dose,2023-07-12,2023-07-19,8.11,7.98,162,88,68,None,None,No Change,0
8819,PT-08819,64,F,Apollo Chennai,Phase II,ORX-202,Diabetes,Low Dose,2023-09-08,2023-09-15,6.64,,128,101,92,None,None,No Change,0
8820,PT-08820,61,M,Fortis Mumbai,Phase III,ORX-303,Cardiology,Placebo,2023-07-26,2023-09-20,9.55,10.05,105,88,100,Fatigue,None,Improved,0
8821,PT-08821,20,F,Bhopal Research Hospital,Phase III,ORX-606,Rheumatology,Low Dose,2023-06-27,2023-09-25,7.18,5.82,130,95,96,None,None,Improved,1
8822,PT-08822,42,F,AIIMS Delhi,Phase II,ORX-303,Cardiology,High Dose,2024-09-06,2024-11-01,7.99,6.24,96,95,45,Nausea,None,Improved,1
8823,PT-08823,34,F,Fortis Mumbai,Phase II,ORX-101,Oncology,Placebo,2023-02-02,2023-05-03,8.01,7.81,90,88,65,Headache,None,Improved,1
8824,PT-08824,46,M,Bhopal Research Hospital,Phase I,ORX-101,Oncology,High Dose,2023-12-07,2024-03-06,6.45,5.43,95,77,95,Headache,Mild,No Change,0
8825,PT-08825,38,M,Fortis Mumbai,Phase IV,ORX-303,Cardiology,High Dose,2023-11-03,2023-11-17,6.75,5.71,104,70,81,Nausea,None,Improved,1
8826,PT-08826,84,F,Bhopal Research Hospital,Phase III,ORX-202,Diabetes,High Dose,2023-11-12,2024-01-07,8.37,8.53,163,87,93,Nausea,None,Improved,0
8827,PT-08827,48,F,PGI Chandigarh,Phase II,ORX-606,Rheumatology,Low Dose,2024-07-31,2024-08-07,7.74,6.07,122,75,69,Headache,Severe,No Change,0
8828,PT-08828,34,F,Indore Medical Institute,Phase III,ORX-303,Cardiology,High Dose,2023-03-15,2023-03-29,8.92,8.19,125,109,88,Dizziness,None,Improved,1
8829,PT-08829,45,M,Kolkata Clinical Center,Phase III,ORX-303,Cardiology,Placebo,2024-06-05,2024-09-03,8.47,7.47,120,77,81,None,None,Worsened,0
8830,PT-08830,52,M,Kolkata Clinical Center,Phase III,ORX-303,Cardiology,Low Dose,2024-09-23,2024-12-22,6.06,6.03,138,76,75,None,None,Worsened,0
8831,PT-08831,26,M,PGI Chandigarh,Phase IV,ORX-404,Neurology,Low Dose,2024-04-06,2024-06-01,5.39,3.96,140,88,104,Fever,None,No Change,0
8832,PT-08832,45,F,Apollo Chennai,Phase III,ORX-202,Diabetes,High Dose,2023-06-01,2023-07-27,7.26,7.17,108,92,83,None,None,Improved,1
8833,PT-08833,29,M,Indore Medical Institute,Phase III,ORX-101,Oncology,Placebo,2023-03-08,2023-05-03,7.65,7.93,104,94,71,None,None,No Change,0
8834,PT-08834,18,M,Kolkata Clinical Center,Phase II,ORX-606,Rheumatology,Low Dose,2023-05-30,2023-07-25,8.37,9.17,107,61,96,Headache,Moderate,Improved,0
8835,PT-08835,35,F,Bhopal Research Hospital,Phase I,ORX-303,Cardiology,Placebo,2024-05-11,2024-05-25,8.81,6.8,153,94,85,Nausea,Moderate,Improved,1
8836,PT-08836,18,M,Kolkata Clinical Center,Phase II,ORX-202,Diabetes,Placebo,2023-05-16,2023-08-14,6.77,7.27,97,75,83,Fever,None,Improved,0
8837,PT-08837,26,M,Indore Medical Institute,Phase III,ORX-404,Neurology,Placebo,2023-05-29,2023-06-12,8.76,9.35,132,87,70,Headache,None,Improved,0
8838,PT-08838,54,M,Kolkata Clinical Center,Phase IV,ORX-202,Diabetes,Placebo,2023-05-31,2023-06-28,6.48,5.91,119,99,94,Nausea,None,Worsened,0
8839,PT-08839,28,F,PGI Chandigarh,Phase II,ORX-101,Oncology,Placebo,2024-04-03,2024-05-01,8.81,7.69,161,100,108,None,None,No Change,0
8840,PT-08840,49,M,Fortis Mumbai,Phase II,ORX-505,Infectious Disease,Placebo,2024-01-02,2024-02-27,6.86,6.19,134,69,45,Fatigue,Mild,No Change,0
8841,PT-08841,38,F,Apollo Chennai,Phase II,ORX-101,Oncology,High Dose,2024-08-06,2024-11-04,7.25,7.35,135,83,94,Rash,None,No Change,0
8842,PT-08842,31,M,PGI Chandigarh,Phase IV,ORX-202,Diabetes,High Dose,2023-06-21,2023-09-19,6.39,7.89,90,95,85,None,None,Worsened,0
8843,PT-08843,44,M,Indore Medical Institute,Phase II,ORX-101,Oncology,Low Dose,2023-04-21,2023-06-16,8.28,8.52,101,70,71,Nausea,None,Improved,0
8844,PT-08844,18,F,Indore Medical Institute,Phase I,ORX-404,Neurology,Low Dose,2023-05-10,2023-05-17,7.19,7.36,148,82,67,None,None,Worsened,0
8845,PT-08845,48,F,Indore Medical Institute,Phase III,ORX-303,Cardiology,Placebo,2023-06-21,2023-08-16,7.11,7.41,127,92,74,Nausea,None,Improved,0
8846,PT-08846,65,M,Apollo Chennai,Phase III,ORX-505,Infectious Disease,High Dose,2024-09-23,2024-10-21,7.41,6.47,122,90,60,None,None,Worsened,0
8847,PT-08847,42,M,Kolkata Clinical Center,Phase I,ORX-606,Rheumatology,High Dose,2024-04-11,2024-04-18,8.48,8.55,107,85,59,Nausea,None,Worsened,0
8848,PT-08848,47,F,NIMHANS Bengaluru,Phase III,ORX-101,Oncology,High Dose,2023-08-08,2023-08-22,8.86,8.52,107,79,80,Fatigue,None,No Change,0
8849,PT-08849,62,M,Indore Medical Institute,Phase II,ORX-404,Neurology,Low Dose,2023-01-15,2023-01-29,8.5,7.12,122,86,69,None,None,Improved,1
8850,PT-08850,52,F,Indore Medical Institute,Phase III,ORX-505,Infectious Disease,Placebo,2023-11-25,2023-12-09,5.58,5.42,146,82,80,Fatigue,None,Improved,1
8851,PT-08851,58,M,NIMHANS Bengaluru,Phase I,ORX-303,Cardiology,Placebo,2023-06-11,2023-06-18,6.67,6.83,127,71,90,Dizziness,None,No Change,0
8852,PT-08852,67,F,Fortis Mumbai,Phase II,ORX-404,Neurology,Placebo,2023-08-22,2023-09-19,8.59,9.0,137,86,76,None,None,Improved,0
8853,PT-08853,34,M,NIMHANS Bengaluru,Phase III,ORX-505,Infectious Disease,High Dose,2023-02-22,2023-04-19,4.72,2.91,128,66,83,Rash,Severe,Improved,1
8854,PT-08854,72,M,Bhopal Research Hospital,Phase III,ORX-505,Infectious Disease,Placebo,2024-04-08,2024-07-07,3.5,2.22,167,92,76,None,None,No Change,0
8855,PT-08855,36,F,Bhopal Research Hospital,Phase III,ORX-101,Oncology,High Dose,2023-02-15,2023-05-16,7.9,8.38,105,99,83,None,None,Improved,0
8856,PT-08856,60,M,Kolkata Clinical Center,Phase I,ORX-606,Rheumatology,Low Dose,2023-07-04,2023-08-01,8.43,8.31,136,88,73,None,None,No Change,0
8857,PT-08857,55,F,NIMHANS Bengaluru,Phase III,ORX-202,Diabetes,Low Dose,2024-07-30,2024-08-06,6.89,6.49,156,81,83,Fever,None,Worsened,0
8858,PT-08858,42,M,Bhopal Research Hospital,Phase III,ORX-101,Oncology,High Dose,2023-08-30,2023-10-25,6.76,8.1,101,82,61,Rash,Moderate,Improved,0
8859,PT-08859,65,M,AIIMS Delhi,Phase III,ORX-404,Neurology,Placebo,2024-05-16,2024-07-11,7.13,6.3,94,100,59,Headache,None,No Change,0
8860,PT-08860,52,M,PGI Chandigarh,Phase I,ORX-505,Infectious Disease,High Dose,2023-07-14,2023-09-08,8.32,9.87,118,71,72,None,None,Improved,0
8861,PT-08861,35,F,PGI Chandigarh,Phase III,ORX-505,Infectious Disease,High Dose,2023-08-22,2023-09-05,4.94,6.01,120,80,86,None,None,Improved,0
8862,PT-08862,67,F,Kolkata Clinical Center,Phase II,ORX-606,Rheumatology,High Dose,2023-07-14,2023-08-11,5.81,5.73,106,86,82,Headache,None,No Change,0
8863,PT-08863,37,M,Bhopal Research Hospital,Phase IV,ORX-101,Oncology,Low Dose,2024-03-07,2024-06-05,7.48,7.31,126,79,58,None,None,Worsened,0
8864,PT-08864,27,M,Apollo Chennai,Phase I,ORX-404,Neurology,Low Dose,2024-03-14,2024-04-11,6.46,5.16,117,81,79,None,None,Improved,1
8865,PT-08865,53,M,Kolkata Clinical Center,Phase I,ORX-505,Infectious Disease,High Dose,2024-11-06,2024-11-20,7.39,7.1,137,70,66,None,None,Improved,1
8866,PT-08866,39,M,NIMHANS Bengaluru,Phase III,ORX-606,Rheumatology,Low Dose,2024-01-09,2024-02-06,6.36,4.39,138,70,103,None,None,No Change,0
8867,PT-08867,47,M,Indore Medical Institute,Phase IV,ORX-202,Diabetes,High Dose,2023-01-15,2023-01-22,5.4,5.6,128,85,71,Dizziness,Mild,Improved,0
8868,PT-08868,30,F,Fortis Mumbai,Phase III,ORX-404,Neurology,High Dose,2023-07-24,2023-07-31,5.45,3.89,103,77,77,None,None,Improved,1
8869,PT-08869,20,F,AIIMS Delhi,Phase III,ORX-404,Neurology,High Dose,2023-02-17,2023-03-03,8.28,8.01,171,77,109,Nausea,Mild,Improved,1
8870,PT-08870,56,M,Apollo Chennai,Phase II,ORX-505,Infectious Disease,High Dose,2023-02-13,2023-04-10,4.85,3.38,133,61,65,Rash,None,No Change,0
8871,PT-08871,19,M,PGI Chandigarh,Phase IV,ORX-101,Oncology,Low Dose,2023-07-29,2023-10-27,9.77,10.36,121,100,95,None,None,Improved,0
8872,PT-08872,65,M,Apollo Chennai,Phase IV,ORX-505,Infectious Disease,Low Dose,2024-08-06,2024-08-20,6.53,5.85,108,80,66,Headache,None,No Change,0
8873,PT-08873,27,M,Apollo Chennai,Phase III,ORX-303,Cardiology,Placebo,2024-07-09,2024-10-07,8.56,8.76,112,93,82,Headache,None,No Change,0
8874,PT-08874,39,M,Apollo Chennai,Phase III,ORX-202,Diabetes,Low Dose,2024-01-29,2024-02-26,9.11,,159,88,87,Nausea,Mild,Improved,1
8875,PT-08875,27,F,Fortis Mumbai,Phase III,ORX-303,Cardiology,Low Dose,2024-08-30,2024-11-28,6.53,7.44,148,77,59,None,None,No Change,0
8876,PT-08876,71,M,PGI Chandigarh,Phase II,ORX-303,Cardiology,Low Dose,2023-05-08,2023-06-05,8.48,7.05,107,104,70,None,None,Improved,1
8877,PT-08877,37,F,PGI Chandigarh,Phase III,ORX-404,Neurology,Placebo,2023-09-09,2023-09-23,6.38,6.3,102,84,58,None,None,Improved,1
8878,PT-08878,22,F,Apollo Chennai,Phase I,ORX-202,Diabetes,Placebo,2024-03-09,2024-03-16,5.56,3.97,141,90,75,None,None,No Change,0
8879,PT-08879,34,F,Fortis Mumbai,Phase III,ORX-202,Diabetes,Low Dose,2024-03-07,2024-04-04,8.86,9.08,106,86,82,Dizziness,None,Improved,0
8880,PT-08880,56,M,AIIMS Delhi,Phase III,ORX-303,Cardiology,High Dose,2024-10-27,2024-12-22,10.5,9.36,137,99,102,None,None,Improved,1
8881,PT-08881,47,F,Kolkata Clinical Center,Phase III,ORX-404,Neurology,Low Dose,2023-04-12,2023-06-07,5.63,3.62,142,86,79,None,None,No Change,0
8882,PT-08882,49,F,Indore Medical Institute,Phase II,ORX-606,Rheumatology,High Dose,2024-05-12,2024-06-09,8.37,8.47,134,74,92,Fever,None,Worsened,0
8883,PT-08883,35,M,Kolkata Clinical Center,Phase III,ORX-404,Neurology,Low Dose,2023-11-10,2023-11-24,8.36,7.61,138,103,87,None,None,Improved,1
8884,PT-08884,67,M,Kolkata Clinical Center,Phase III,ORX-505,Infectious Disease,Low Dose,2023-03-10,2023-06-08,6.75,6.44,121,62,92,Fatigue,None,Improved,1
8885,PT-08885,54,F,Kolkata Clinical Center,Phase IV,ORX-303,Cardiology,High Dose,2023-03-22,2023-05-17,7.8,8.51,107,65,95,Dizziness,None,Improved,0
8886,PT-08886,43,F,NIMHANS Bengaluru,Phase I,ORX-505,Infectious Disease,Low Dose,2024-01-14,2024-02-11,7.46,5.74,154,90,69,Headache,None,Improved,1
8887,PT-08887,78,M,AIIMS Delhi,Phase III,ORX-404,Neurology,Placebo,2024-04-09,2024-05-07,5.56,4.87,145,95,57,None,None,Improved,1
8888,PT-08888,40,F,Indore Medical Institute,Phase III,ORX-202,Diabetes,Low Dose,2024-09-28,2024-10-26,8.09,9.02,153,90,79,Headache,Moderate,Improved,0
8889,PT-08889,42,F,Bhopal Research Hospital,Phase II,ORX-101,Oncology,High Dose,2024-05-13,2024-06-10,7.8,8.69,124,78,94,Nausea,None,Improved,0
8890,PT-08890,61,M,PGI Chandigarh,Phase I,ORX-404,Neurology,Placebo,2024-01-05,2024-03-01,6.6,5.01,97,83,62,Fatigue,Mild,Improved,1
8891,PT-08891,59,F,Kolkata Clinical Center,Phase IV,ORX-202,Diabetes,Placebo,2023-01-04,2023-04-04,5.14,6.19,121,72,70,None,None,Improved,0
8892,PT-08892,31,F,NIMHANS Bengaluru,Phase II,ORX-303,Cardiology,High Dose,2024-08-20,2024-09-03,9.02,9.22,129,67,77,Fever,Mild,Improved,0
8893,PT-08893,32,F,Kolkata Clinical Center,Phase III,ORX-606,Rheumatology,High Dose,2024-03-15,2024-06-13,4.04,3.02,138,76,75,None,None,Improved,1
8894,PT-08894,61,F,Bhopal Research Hospital,Phase III,ORX-404,Neurology,Low Dose,2023-05-04,2023-06-01,8.23,9.6,90,71,90,Rash,Mild,Improved,0
8895,PT-08895,51,M,Fortis Mumbai,Phase IV,ORX-505,Infectious Disease,Placebo,2023-09-13,2023-09-27,7.32,6.38,132,84,52,Fever,Mild,Improved,1
8896,PT-08896,48,F,NIMHANS Bengaluru,Phase I,ORX-303,Cardiology,Low Dose,2024-05-16,2024-08-14,6.58,6.94,134,105,77,None,None,Worsened,0
8897,PT-08897,27,M,NIMHANS Bengaluru,Phase III,ORX-404,Neurology,Low Dose,2023-04-17,2023-06-12,4.21,2.97,134,89,69,None,None,Improved,1
8898,PT-08898,38,M,Bhopal Research Hospital,Phase II,ORX-505,Infectious Disease,Placebo,2023-02-16,2023-03-02,7.28,7.23,146,74,67,Dizziness,Mild,Improved,1
8899,PT-08899,77,F,Bhopal Research Hospital,Phase II,ORX-404,Neurology,Placebo,2023-11-01,2023-11-29,9.34,8.46,148,108,96,Rash,Mild,Improved,1
8900,PT-08900,32,M,AIIMS Delhi,Phase III,ORX-303,Cardiology,Low Dose,2023-11-06,2023-11-20,7.33,5.35,110,81,81,None,None,No Change,0
8901,PT-08901,33,F,NIMHANS Bengaluru,Phase III,ORX-606,Rheumatology,High Dose,2023-01-21,2023-02-18,3.9,3.67,141,91,75,None,None,No Change,0
8902,PT-08902,42,M,Indore Medical Institute,Phase III,ORX-101,Oncology,Low Dose,2024-08-04,2024-11-02,7.5,7.46,126,54,97,None,None,Improved,1
8903,PT-08903,37,F,PGI Chandigarh,Phase II,ORX-303,Cardiology,Low Dose,2023-09-17,2023-10-01,5.73,4.98,130,74,70,None,None,Improved,1
8904,PT-08904,39,M,Kolkata Clinical Center,Phase IV,ORX-303,Cardiology,High Dose,2024-04-17,2024-04-24,7.63,6.52,134,65,106,Rash,Moderate,Worsened,0
8905,PT-08905,62,M,Fortis Mumbai,Phase III,ORX-404,Neurology,Low Dose,2023-11-03,2024-02-01,6.87,6.77,106,88,89,None,None,No Change,0
8906,PT-08906,49,M,Fortis Mumbai,Phase IV,ORX-505,Infectious Disease,High Dose,2024-06-03,2024-06-17,8.28,7.88,126,74,85,None,None,Worsened,0
8907,PT-08907,31,M,Indore Medical Institute,Phase IV,ORX-606,Rheumatology,High Dose,2023-07-11,2023-09-05,7.7,7.57,152,89,53,Rash,None,Improved,1
8908,PT-08908,34,M,Fortis Mumbai,Phase III,ORX-101,Oncology,Low Dose,2024-08-02,2024-08-30,6.37,5.31,145,55,97,Fever,None,Improved,1
8909,PT-08909,60,F,Bhopal Research Hospital,Phase IV,ORX-202,Diabetes,Placebo,2023-12-14,2023-12-21,7.42,7.34,129,83,93,None,None,Improved,1
8910,PT-08910,41,F,AIIMS Delhi,Phase II,ORX-505,Infectious Disease,Low Dose,2024-05-01,2024-06-26,7.92,6.74,137,78,83,Nausea,None,Improved,1
8911,PT-08911,31,M,NIMHANS Bengaluru,Phase IV,ORX-505,Infectious Disease,Placebo,2024-04-02,2024-07-01,7.74,7.3,156,85,84,None,None,No Change,0
8912,PT-08912,37,F,Fortis Mumbai,Phase I,ORX-404,Neurology,Placebo,2023-02-25,2023-03-25,7.57,7.6,121,76,66,None,None,Worsened,0
8913,PT-08913,43,M,Kolkata Clinical Center,Phase III,ORX-303,Cardiology,Low Dose,2024-07-06,2024-08-31,6.42,6.28,113,80,64,Nausea,None,Improved,1
8914,PT-08914,63,F,Fortis Mumbai,Phase III,ORX-606,Rheumatology,Placebo,2023-04-22,2023-05-06,7.23,6.84,138,103,79,None,None,Improved,1
8915,PT-08915,21,F,Indore Medical Institute,Phase III,ORX-606,Rheumatology,Placebo,2024-02-13,2024-04-09,8.62,7.0,119,96,73,Nausea,None,Improved,1
8916,PT-08916,35,F,PGI Chandigarh,Phase I,ORX-202,Diabetes,Low Dose,2023-09-14,2023-09-28,7.54,7.15,115,92,95,Fever,None,Improved,1
8917,PT-08917,67,F,Bhopal Research Hospital,Phase II,ORX-505,Infectious Disease,High Dose,2023-09-06,2023-10-04,7.86,6.83,105,54,92,Headache,Mild,Improved,1
8918,PT-08918,48,F,NIMHANS Bengaluru,Phase II,ORX-101,Oncology,Low Dose,2024-03-02,2024-03-16,6.7,4.56,106,60,98,Rash,None,Worsened,0
8919,PT-08919,55,M,AIIMS Delhi,Phase II,ORX-404,Neurology,Low Dose,2024-11-16,2024-12-14,5.63,6.7,115,86,82,None,None,Improved,0
8920,PT-08920,43,F,Indore Medical Institute,Phase I,ORX-404,Neurology,High Dose,2024-10-20,2024-11-17,6.84,6.47,122,84,82,Fever,None,Improved,1
8921,PT-08921,36,F,PGI Chandigarh,Phase I,ORX-404,Neurology,Placebo,2023-01-01,2023-04-01,8.52,7.37,135,77,65,None,None,Improved,1
8922,PT-08922,40,F,Apollo Chennai,Phase I,ORX-303,Cardiology,Low Dose,2024-11-03,2024-11-10,6.41,6.6,126,98,64,None,None,Improved,0
8923,PT-08923,18,M,Fortis Mumbai,Phase IV,ORX-303,Cardiology,Placebo,2023-11-03,2024-02-01,7.67,8.82,136,70,63,None,None,No Change,0
8924,PT-08924,77,M,Indore Medical Institute,Phase IV,ORX-101,Oncology,Placebo,2023-12-14,2024-03-13,6.74,5.43,149,80,49,Nausea,None,No Change,0
8925,PT-08925,78,F,Fortis Mumbai,Phase III,ORX-505,Infectious Disease,High Dose,2023-01-14,2023-04-14,7.9,6.14,153,69,62,None,None,No Change,0
8926,PT-08926,30,M,AIIMS Delhi,Phase IV,ORX-505,Infectious Disease,High Dose,2023-11-05,2024-02-03,9.53,10.97,118,102,45,Nausea,Moderate,Improved,0
8927,PT-08927,59,M,AIIMS Delhi,Phase II,ORX-606,Rheumatology,Low Dose,2024-10-21,2024-11-04,8.84,9.79,129,88,67,Nausea,Mild,Improved,0
8928,PT-08928,45,M,Fortis Mumbai,Phase I,ORX-606,Rheumatology,High Dose,2023-02-02,2023-03-30,7.0,6.4,148,84,101,Dizziness,Moderate,Improved,1
8929,PT-08929,48,M,Indore Medical Institute,Phase I,ORX-404,Neurology,Low Dose,2023-10-19,2023-12-14,9.83,10.53,126,84,66,Rash,Mild,No Change,0
8930,PT-08930,47,M,AIIMS Delhi,Phase IV,ORX-101,Oncology,High Dose,2023-04-21,2023-04-28,6.02,6.82,121,86,46,Fatigue,Mild,No Change,0
8931,PT-08931,40,M,AIIMS Delhi,Phase III,ORX-606,Rheumatology,Placebo,2023-12-23,2024-01-20,6.75,7.18,137,94,84,None,None,No Change,0
8932,PT-08932,64,M,Apollo Chennai,Phase III,ORX-505,Infectious Disease,High Dose,2024-11-23,2025-01-18,7.7,6.06,126,81,45,Headache,Mild,Improved,1
8933,PT-08933,28,M,AIIMS Delhi,Phase IV,ORX-202,Diabetes,Placebo,2023-12-03,2024-01-28,9.65,9.0,126,55,59,None,None,Improved,1
8934,PT-08934,52,F,AIIMS Delhi,Phase III,ORX-303,Cardiology,High Dose,2024-05-11,2024-05-18,6.64,5.24,151,73,59,None,None,Improved,1
8935,PT-08935,45,F,Fortis Mumbai,Phase III,ORX-303,Cardiology,Low Dose,2024-11-12,2024-12-10,6.22,5.09,126,74,54,None,None,Improved,1
8936,PT-08936,53,M,Indore Medical Institute,Phase IV,ORX-505,Infectious Disease,High Dose,2024-10-04,2024-11-01,8.24,7.61,139,77,51,None,None,No Change,0
8937,PT-08937,59,M,Bhopal Research Hospital,Phase III,ORX-505,Infectious Disease,Low Dose,2023-01-04,2023-02-01,7.08,6.82,126,79,79,None,None,No Change,0
8938,PT-08938,47,F,Apollo Chennai,Phase I,ORX-303,Cardiology,Placebo,2023-11-23,2023-11-30,8.72,8.71,149,100,55,Dizziness,Moderate,No Change,0
8939,PT-08939,65,M,Fortis Mumbai,Phase III,ORX-101,Oncology,Placebo,2023-01-27,2023-02-03,7.98,8.02,145,78,86,None,None,Worsened,0
8940,PT-08940,28,M,Bhopal Research Hospital,Phase III,ORX-404,Neurology,Low Dose,2023-06-18,2023-07-16,5.51,5.58,126,81,66,Headache,None,Improved,0
8941,PT-08941,51,F,Kolkata Clinical Center,Phase III,ORX-505,Infectious Disease,High Dose,2024-01-19,2024-02-16,6.69,6.25,119,72,75,Nausea,None,Improved,1
8942,PT-08942,63,F,Bhopal Research Hospital,Phase I,ORX-404,Neurology,Low Dose,2024-03-16,2024-05-11,6.63,6.12,123,74,95,None,None,Worsened,0
8943,PT-08943,23,M,Kolkata Clinical Center,Phase IV,ORX-505,Infectious Disease,High Dose,2023-12-29,2024-01-05,7.1,5.94,138,83,94,Headache,None,Improved,1
8944,PT-08944,56,M,Kolkata Clinical Center,Phase I,ORX-101,Oncology,Low Dose,2024-02-15,2024-03-14,7.3,7.57,143,71,88,None,None,Improved,0
8945,PT-08945,49,M,NIMHANS Bengaluru,Phase II,ORX-101,Oncology,Placebo,2024-02-24,2024-03-02,7.79,7.02,112,69,45,None,None,Worsened,0
8946,PT-08946,33,M,Kolkata Clinical Center,Phase II,ORX-303,Cardiology,High Dose,2023-12-21,2024-02-15,10.13,10.47,133,93,74,Rash,None,Improved,0
8947,PT-08947,38,M,Apollo Chennai,Phase III,ORX-303,Cardiology,Low Dose,2024-03-30,2024-04-13,6.85,5.79,116,81,78,None,None,Worsened,0
8948,PT-08948,66,M,Kolkata Clinical Center,Phase IV,ORX-505,Infectious Disease,Low Dose,2024-03-13,2024-06-11,8.43,6.69,122,68,45,None,None,No Change,0
8949,PT-08949,46,M,PGI Chandigarh,Phase II,ORX-101,Oncology,Low Dose,2023-05-24,2023-08-22,7.89,7.56,135,77,63,None,None,Improved,1
8950,PT-08950,39,M,AIIMS Delhi,Phase IV,ORX-202,Diabetes,High Dose,2024-08-30,2024-09-06,8.84,8.78,100,83,95,Nausea,Moderate,No Change,0
8951,PT-08951,57,F,Kolkata Clinical Center,Phase I,ORX-606,Rheumatology,Low Dose,2023-02-01,2023-02-15,8.74,7.0,130,77,86,None,None,No Change,0
8952,PT-08952,31,M,AIIMS Delhi,Phase III,ORX-202,Diabetes,High Dose,2023-07-15,2023-07-22,6.16,5.76,111,85,49,Rash,Moderate,Worsened,0
8953,PT-08953,63,M,Indore Medical Institute,Phase I,ORX-404,Neurology,Low Dose,2023-12-22,2024-01-05,3.86,4.27,117,64,80,None,None,Improved,0
8954,PT-08954,59,F,Fortis Mumbai,Phase III,ORX-404,Neurology,Low Dose,2024-10-06,2024-12-01,8.59,9.2,112,84,53,Headache,None,Improved,0
8955,PT-08955,46,M,Apollo Chennai,Phase II,ORX-606,Rheumatology,High Dose,2024-09-16,2024-10-14,7.61,6.87,94,74,104,Rash,None,Improved,1
8956,PT-08956,51,F,Indore Medical Institute,Phase II,ORX-303,Cardiology,Placebo,2023-09-15,2023-11-10,6.62,6.08,134,63,57,Nausea,Moderate,Improved,1
8957,PT-08957,33,M,Apollo Chennai,Phase II,ORX-404,Neurology,Placebo,2023-08-10,2023-09-07,6.59,7.8,129,75,78,None,None,No Change,0
8958,PT-08958,18,F,NIMHANS Bengaluru,Phase III,ORX-404,Neurology,Placebo,2023-04-06,2023-05-04,6.12,5.04,109,96,87,None,None,Improved,1
8959,PT-08959,25,F,Indore Medical Institute,Phase IV,ORX-202,Diabetes,Placebo,2023-03-08,2023-05-03,5.68,4.15,124,84,83,Fatigue,None,Improved,1
8960,PT-08960,28,M,Indore Medical Institute,Phase III,ORX-505,Infectious Disease,Low Dose,2023-02-08,2023-02-15,6.99,6.54,149,91,57,None,None,No Change,0
8961,PT-08961,18,F,AIIMS Delhi,Phase II,ORX-404,Neurology,Placebo,2023-09-25,2023-10-02,7.07,6.09,110,72,86,None,None,No Change,0
8962,PT-08962,20,M,Apollo Chennai,Phase I,ORX-404,Neurology,Placebo,2023-09-22,2023-12-21,9.42,8.37,139,73,56,None,None,Improved,1
8963,PT-08963,42,F,PGI Chandigarh,Phase III,ORX-404,Neurology,Placebo,2024-08-19,2024-10-14,5.7,5.43,127,73,80,Headache,Mild,No Change,0
8964,PT-08964,61,F,AIIMS Delhi,Phase III,ORX-303,Cardiology,Placebo,2024-02-21,2024-02-28,7.07,6.01,135,87,74,None,None,Worsened,0
8965,PT-08965,66,M,Kolkata Clinical Center,Phase II,ORX-101,Oncology,High Dose,2024-05-18,2024-05-25,6.84,7.78,116,92,74,None,None,Improved,0
8966,PT-08966,49,M,Indore Medical Institute,Phase IV,ORX-404,Neurology,Low Dose,2023-02-21,2023-04-18,4.77,6.32,133,94,58,Fatigue,None,No Change,0
8967,PT-08967,47,M,AIIMS Delhi,Phase II,ORX-101,Oncology,High Dose,2024-08-17,2024-11-15,6.98,5.63,151,83,77,None,None,No Change,0
8968,PT-08968,54,F,NIMHANS Bengaluru,Phase III,ORX-505,Infectious Disease,Placebo,2023-04-15,2023-06-10,6.17,5.92,129,83,92,Headache,Moderate,Improved,1
8969,PT-08969,38,F,NIMHANS Bengaluru,Phase III,ORX-606,Rheumatology,Placebo,2024-08-11,2024-08-25,6.56,5.61,116,95,77,None,None,Improved,1
8970,PT-08970,61,M,Indore Medical Institute,Phase I,ORX-404,Neurology,High Dose,2023-12-22,2024-03-21,7.53,6.34,100,64,65,None,None,No Change,0
8971,PT-08971,61,M,Indore Medical Institute,Phase IV,ORX-101,Oncology,Low Dose,2023-10-03,2023-11-28,8.76,8.44,144,75,69,Fatigue,None,Improved,1
8972,PT-08972,57,F,PGI Chandigarh,Phase IV,ORX-303,Cardiology,Low Dose,2024-11-10,2025-01-05,7.4,7.66,128,77,74,None,None,Worsened,0
8973,PT-08973,49,F,Bhopal Research Hospital,Phase III,ORX-303,Cardiology,High Dose,2024-08-06,2024-08-13,7.49,6.25,125,63,73,Nausea,Mild,No Change,0
8974,PT-08974,30,M,Indore Medical Institute,Phase I,ORX-202,Diabetes,High Dose,2023-01-13,2023-04-13,3.54,5.13,114,70,100,Headache,None,No Change,0
8975,PT-08975,26,F,Apollo Chennai,Phase III,ORX-606,Rheumatology,High Dose,2023-12-13,2024-02-07,5.46,4.87,119,74,65,None,None,Improved,1
8976,PT-08976,41,F,Fortis Mumbai,Phase II,ORX-202,Diabetes,Placebo,2023-12-01,2024-02-29,9.16,7.31,143,100,69,None,None,No Change,0
8977,PT-08977,51,F,PGI Chandigarh,Phase III,ORX-101,Oncology,High Dose,2023-11-07,2023-12-05,7.05,5.11,149,82,70,None,None,Improved,1
8978,PT-08978,20,F,Bhopal Research Hospital,Phase III,ORX-606,Rheumatology,Low Dose,2023-05-28,2023-08-26,7.83,7.56,138,88,66,Fatigue,Mild,No Change,0
8979,PT-08979,18,F,Fortis Mumbai,Phase IV,ORX-505,Infectious Disease,High Dose,2023-03-15,2023-05-10,7.07,6.51,130,100,77,None,None,Worsened,0
8980,PT-08980,56,F,Fortis Mumbai,Phase III,ORX-303,Cardiology,Placebo,2024-06-23,2024-08-18,7.65,6.01,104,95,65,None,None,Improved,1
8981,PT-08981,50,F,Fortis Mumbai,Phase II,ORX-505,Infectious Disease,Low Dose,2024-06-06,2024-07-04,5.97,6.24,132,78,87,None,None,Improved,0
8982,PT-08982,49,M,AIIMS Delhi,Phase III,ORX-303,Cardiology,Placebo,2024-08-17,2024-08-24,6.33,5.94,140,95,76,Rash,Moderate,Improved,1
8983,PT-08983,73,F,Bhopal Research Hospital,Phase II,ORX-505,Infectious Disease,High Dose,2023-07-22,2023-08-05,6.31,4.51,102,81,78,Dizziness,None,Improved,1
8984,PT-08984,47,F,Kolkata Clinical Center,Phase IV,ORX-303,Cardiology,High Dose,2023-12-26,2024-01-09,6.4,8.0,155,68,76,Nausea,Mild,Improved,0
8985,PT-08985,45,M,Kolkata Clinical Center,Phase I,ORX-606,Rheumatology,Placebo,2024-10-06,2024-10-13,8.02,6.25,97,67,99,Nausea,Moderate,Improved,1
8986,PT-08986,34,M,PGI Chandigarh,Phase III,ORX-505,Infectious Disease,Low Dose,2023-06-16,2023-09-14,8.17,8.3,124,91,60,None,None,No Change,0
8987,PT-08987,37,F,Fortis Mumbai,Phase III,ORX-404,Neurology,High Dose,2024-09-11,2024-09-25,4.54,4.23,113,108,78,None,None,Improved,1
8988,PT-08988,58,F,Kolkata Clinical Center,Phase III,ORX-303,Cardiology,Placebo,2024-10-26,2024-11-02,7.98,7.51,145,82,84,Headache,Mild,Worsened,0
8989,PT-08989,82,M,PGI Chandigarh,Phase III,ORX-505,Infectious Disease,Low Dose,2024-06-11,2024-06-18,7.43,6.56,115,81,79,None,None,Worsened,0
8990,PT-08990,45,F,Fortis Mumbai,Phase II,ORX-505,Infectious Disease,Low Dose,2024-01-05,2024-01-19,5.3,2.86,110,82,78,None,None,Improved,1
8991,PT-08991,52,F,Kolkata Clinical Center,Phase III,ORX-202,Diabetes,Placebo,2023-02-24,2023-03-03,7.64,6.79,109,88,81,None,None,Improved,1
8992,PT-08992,27,F,NIMHANS Bengaluru,Phase II,ORX-404,Neurology,Placebo,2023-07-11,2023-10-09,7.95,8.41,142,93,67,None,None,No Change,0
8993,PT-08993,58,F,AIIMS Delhi,Phase II,ORX-505,Infectious Disease,High Dose,2024-07-08,2024-08-05,7.01,8.45,144,87,102,None,None,Improved,0
8994,PT-08994,36,F,Apollo Chennai,Phase II,ORX-404,Neurology,Placebo,2023-06-23,2023-09-21,7.86,,142,83,74,Nausea,Mild,Worsened,0
8995,PT-08995,29,F,Kolkata Clinical Center,Phase III,ORX-505,Infectious Disease,High Dose,2023-07-23,2023-08-20,6.85,5.72,123,80,91,None,None,No Change,0
8996,PT-08996,38,F,Apollo Chennai,Phase III,ORX-303,Cardiology,Placebo,2024-11-15,2024-12-13,6.48,6.88,140,79,86,None,None,Worsened,0
8997,PT-08997,40,F,NIMHANS Bengaluru,Phase III,ORX-202,Diabetes,High Dose,2024-03-12,2024-05-07,6.94,7.94,125,77,78,None,None,Improved,0
8998,PT-08998,18,F,NIMHANS Bengaluru,Phase III,ORX-303,Cardiology,Low Dose,2024-06-26,2024-09-24,7.0,6.83,163,83,84,Headache,Severe,Improved,1
8999,PT-08999,50,F,NIMHANS Bengaluru,Phase III,ORX-404,Neurology,High Dose,2024-10-06,2024-12-01,9.92,10.42,101,96,64,None,None,No Change,0
9000,PT-09000,34,F,Apollo Chennai,Phase III,ORX-101,Oncology,Low Dose,2024-03-25,2024-04-22,5.64,6.88,149,96,92,None,None,No Change,0
9001,PT-09001,56,F,Kolkata Clinical Center,Phase IV,ORX-404,Neurology,Low Dose,2024-01-28,2024-03-24,6.82,6.6,118,71,69,None,None,No Change,0
9002,PT-09002,82,M,Indore Medical Institute,Phase III,ORX-202,Diabetes,Low Dose,2023-04-08,2023-04-22,6.74,7.24,165,91,66,Headache,Mild,Improved,0
9003,PT-09003,33,M,PGI Chandigarh,Phase IV,ORX-303,Cardiology,Low Dose,2024-04-25,2024-07-24,7.34,8.97,153,88,75,Fatigue,Moderate,No Change,0
9004,PT-09004,51,M,Indore Medical Institute,Phase II,ORX-202,Diabetes,High Dose,2023-03-28,2023-04-04,7.43,7.19,112,71,82,Dizziness,None,No Change,0
9005,PT-09005,26,F,NIMHANS Bengaluru,Phase II,ORX-505,Infectious Disease,High Dose,2024-03-25,2024-05-20,6.45,6.08,133,95,60,None,None,No Change,0
9006,PT-09006,24,F,Kolkata Clinical Center,Phase III,ORX-303,Cardiology,High Dose,2023-06-16,2023-06-23,8.77,9.88,109,71,85,None,None,Worsened,0
9007,PT-09007,45,M,AIIMS Delhi,Phase III,ORX-404,Neurology,High Dose,2024-01-22,2024-04-21,7.27,6.17,140,79,74,Nausea,Moderate,No Change,0
9008,PT-09008,26,M,Bhopal Research Hospital,Phase III,ORX-606,Rheumatology,Low Dose,2024-05-05,2024-06-30,8.15,7.42,127,96,63,None,None,Improved,1
9009,PT-09009,43,F,Fortis Mumbai,Phase II,ORX-404,Neurology,Low Dose,2024-07-18,2024-07-25,5.33,4.46,151,63,81,None,None,Improved,1
9010,PT-09010,70,M,Bhopal Research Hospital,Phase IV,ORX-606,Rheumatology,Low Dose,2024-08-18,2024-09-15,7.86,6.93,107,58,99,None,None,No Change,0
9011,PT-09011,38,F,Indore Medical Institute,Phase IV,ORX-606,Rheumatology,Placebo,2024-10-11,2024-10-18,5.04,3.72,108,76,111,None,None,Improved,1
9012,PT-09012,59,F,Bhopal Research Hospital,Phase III,ORX-606,Rheumatology,Low Dose,2024-04-14,2024-04-21,7.78,8.46,161,88,98,None,None,Improved,0
9013,PT-09013,34,M,Bhopal Research Hospital,Phase I,ORX-101,Oncology,Placebo,2024-03-30,2024-04-13,6.16,4.84,133,50,96,None,None,No Change,0
9014,PT-09014,37,M,Fortis Mumbai,Phase III,ORX-303,Cardiology,High Dose,2023-05-27,2023-07-22,8.19,6.54,148,98,79,None,None,No Change,0
9015,PT-09015,53,F,Apollo Chennai,Phase IV,ORX-606,Rheumatology,Low Dose,2024-07-02,2024-07-16,5.97,5.61,145,78,99,Nausea,None,Improved,1
9016,PT-09016,18,F,Fortis Mumbai,Phase III,ORX-101,Oncology,Low Dose,2024-02-01,2024-03-28,6.81,4.68,133,79,75,Headache,Mild,No Change,0
9017,PT-09017,56,M,Fortis Mumbai,Phase III,ORX-404,Neurology,Low Dose,2023-12-14,2024-03-13,6.86,8.99,142,82,68,None,None,No Change,0
9018,PT-09018,30,M,NIMHANS Bengaluru,Phase II,ORX-606,Rheumatology,Placebo,2024-04-24,2024-07-23,7.72,6.85,145,81,76,Fatigue,None,No Change,0
9019,PT-09019,46,M,AIIMS Delhi,Phase IV,ORX-101,Oncology,Placebo,2024-07-01,2024-08-26,7.02,6.87,165,88,83,Dizziness,None,Improved,1
9020,PT-09020,57,F,Kolkata Clinical Center,Phase III,ORX-101,Oncology,Low Dose,2024-08-08,2024-08-22,7.07,5.8,90,57,88,None,None,Improved,1
9021,PT-09021,50,F,NIMHANS Bengaluru,Phase III,ORX-202,Diabetes,Low Dose,2023-10-04,2023-11-29,7.02,8.75,127,53,88,None,None,No Change,0
9022,PT-09022,63,F,PGI Chandigarh,Phase III,ORX-101,Oncology,High Dose,2023-08-18,2023-08-25,8.06,8.72,96,83,66,Nausea,None,Improved,0
9023,PT-09023,53,M,AIIMS Delhi,Phase II,ORX-505,Infectious Disease,Placebo,2024-09-14,2024-09-21,9.02,8.29,139,71,77,None,None,Improved,1
9024,PT-09024,36,F,AIIMS Delhi,Phase III,ORX-505,Infectious Disease,High Dose,2023-04-18,2023-05-16,9.36,7.99,129,98,50,Headache,None,No Change,0
9025,PT-09025,51,F,AIIMS Delhi,Phase II,ORX-505,Infectious Disease,Low Dose,2024-06-14,2024-09-12,7.33,6.32,149,102,87,None,None,Worsened,0
9026,PT-09026,40,M,Bhopal Research Hospital,Phase III,ORX-606,Rheumatology,Low Dose,2023-04-14,2023-04-21,5.46,5.23,125,80,71,Headache,Mild,No Change,0
9027,PT-09027,35,F,Fortis Mumbai,Phase I,ORX-505,Infectious Disease,High Dose,2023-10-24,2023-11-07,7.23,5.73,146,72,79,None,None,Worsened,0
9028,PT-09028,39,F,Fortis Mumbai,Phase III,ORX-101,Oncology,Low Dose,2024-05-15,2024-05-22,7.98,8.12,137,67,75,Nausea,None,Improved,0
9029,PT-09029,70,M,Kolkata Clinical Center,Phase IV,ORX-505,Infectious Disease,Low Dose,2024-06-28,2024-08-23,6.79,7.33,127,78,80,Nausea,Mild,Improved,0
9030,PT-09030,31,F,Kolkata Clinical Center,Phase II,ORX-202,Diabetes,Low Dose,2024-10-16,2024-10-30,8.28,7.11,137,94,83,None,None,Improved,1
9031,PT-09031,35,F,PGI Chandigarh,Phase I,ORX-404,Neurology,Placebo,2024-04-23,2024-04-30,7.42,6.36,124,75,67,Nausea,Moderate,Improved,1
9032,PT-09032,55,F,PGI Chandigarh,Phase II,ORX-606,Rheumatology,Low Dose,2023-03-18,2023-04-01,8.38,8.93,132,99,68,Nausea,None,No Change,0
9033,PT-09033,65,M,Bhopal Research Hospital,Phase II,ORX-505,Infectious Disease,Low Dose,2023-08-23,2023-09-20,8.29,7.93,132,94,87,None,None,Worsened,0
9034,PT-09034,49,F,AIIMS Delhi,Phase III,ORX-101,Oncology,Low Dose,2023-04-19,2023-06-14,6.66,5.43,129,68,88,None,None,No Change,0
9035,PT-09035,18,F,Fortis Mumbai,Phase III,ORX-505,Infectious Disease,Placebo,2024-08-03,2024-09-28,7.57,6.92,120,78,45,None,None,Improved,1
9036,PT-09036,37,M,AIIMS Delhi,Phase I,ORX-202,Diabetes,High Dose,2023-09-24,2023-11-19,6.16,4.99,184,65,83,None,None,No Change,0
9037,PT-09037,32,F,Apollo Chennai,Phase IV,ORX-404,Neurology,High Dose,2023-03-15,2023-03-29,6.11,4.49,148,96,69,None,None,Improved,1
9038,PT-09038,59,M,Bhopal Research Hospital,Phase IV,ORX-101,Oncology,High Dose,2024-06-05,2024-06-19,5.96,5.2,140,69,67,None,None,No Change,0
9039,PT-09039,45,M,Kolkata Clinical Center,Phase I,ORX-505,Infectious Disease,Low Dose,2023-09-17,2023-10-15,7.24,5.87,168,71,91,None,None,Improved,1
9040,PT-09040,54,F,NIMHANS Bengaluru,Phase III,ORX-404,Neurology,High Dose,2024-11-01,2024-11-29,6.23,6.25,112,82,89,None,None,Improved,0
9041,PT-09041,36,F,Apollo Chennai,Phase III,ORX-404,Neurology,Low Dose,2023-09-13,2023-09-20,7.69,6.78,131,83,72,Rash,None,Improved,1
9042,PT-09042,18,F,Apollo Chennai,Phase I,ORX-606,Rheumatology,Low Dose,2024-02-24,2024-05-24,8.14,9.53,130,74,80,Fatigue,Moderate,No Change,0
9043,PT-09043,63,M,NIMHANS Bengaluru,Phase III,ORX-606,Rheumatology,High Dose,2023-09-26,2023-10-24,8.74,9.16,136,90,79,Headache,None,No Change,0
9044,PT-09044,29,F,PGI Chandigarh,Phase II,ORX-303,Cardiology,Low Dose,2024-11-16,2024-11-23,6.75,6.06,133,60,85,None,None,Improved,1
9045,PT-09045,18,F,Bhopal Research Hospital,Phase III,ORX-101,Oncology,Low Dose,2023-06-16,2023-09-14,7.69,8.35,144,71,86,Dizziness,None,Improved,0
9046,PT-09046,56,M,PGI Chandigarh,Phase II,ORX-505,Infectious Disease,Placebo,2023-10-02,2023-11-27,9.25,9.18,146,76,66,Fatigue,Moderate,Improved,1
9047,PT-09047,58,F,AIIMS Delhi,Phase II,ORX-606,Rheumatology,Low Dose,2024-01-18,2024-04-17,8.25,7.28,106,83,78,None,None,No Change,0
9048,PT-09048,48,F,AIIMS Delhi,Phase III,ORX-101,Oncology,High Dose,2024-11-04,2024-12-02,8.26,8.79,128,70,67,Rash,None,Improved,0
9049,PT-09049,35,F,Fortis Mumbai,Phase I,ORX-505,Infectious Disease,High Dose,2023-02-18,2023-05-19,7.06,6.19,123,82,68,None,None,Improved,1
9050,PT-09050,50,M,AIIMS Delhi,Phase II,ORX-606,Rheumatology,High Dose,2024-02-29,2024-05-29,9.39,8.84,115,85,66,None,None,Improved,1
9051,PT-09051,42,F,Apollo Chennai,Phase III,ORX-404,Neurology,High Dose,2024-08-12,2024-09-09,6.39,5.02,112,74,63,Headache,None,Improved,1
9052,PT-09052,65,F,Kolkata Clinical Center,Phase I,ORX-202,Diabetes,Low Dose,2023-12-28,2024-01-11,7.72,8.17,103,78,83,Nausea,Moderate,Worsened,0
9053,PT-09053,71,F,PGI Chandigarh,Phase II,ORX-606,Rheumatology,High Dose,2023-08-06,2023-10-01,6.3,4.74,131,73,101,None,None,Improved,1
9054,PT-09054,53,M,Fortis Mumbai,Phase III,ORX-606,Rheumatology,Placebo,2024-07-26,2024-08-02,6.86,6.2,125,60,78,Nausea,Mild,Improved,1
9055,PT-09055,37,M,Bhopal Research Hospital,Phase II,ORX-101,Oncology,Low Dose,2024-03-02,2024-03-16,7.96,6.75,140,88,80,None,None,Worsened,0
9056,PT-09056,65,M,Indore Medical Institute,Phase IV,ORX-303,Cardiology,Placebo,2024-09-07,2024-09-21,4.94,4.94,127,81,64,None,None,Improved,1
9057,PT-09057,22,M,PGI Chandigarh,Phase I,ORX-202,Diabetes,Low Dose,2024-01-03,2024-01-17,8.27,8.58,160,105,56,None,None,No Change,0
9058,PT-09058,42,M,Bhopal Research Hospital,Phase III,ORX-202,Diabetes,Low Dose,2023-05-17,2023-08-15,7.5,7.97,153,69,70,None,None,No Change,0
9059,PT-09059,66,M,PGI Chandigarh,Phase III,ORX-303,Cardiology,High Dose,2024-10-26,2024-12-21,5.19,3.82,135,106,54,None,None,No Change,0
9060,PT-09060,45,F,Indore Medical Institute,Phase III,ORX-202,Diabetes,High Dose,2023-12-29,2024-03-28,7.87,8.79,136,59,59,None,None,Improved,0
9061,PT-09061,66,F,Indore Medical Institute,Phase I,ORX-101,Oncology,Placebo,2024-11-11,2025-01-06,7.73,6.32,136,85,45,None,None,Worsened,0
9062,PT-09062,18,M,Bhopal Research Hospital,Phase III,ORX-606,Rheumatology,Low Dose,2024-04-12,2024-06-07,7.57,9.0,132,52,55,Headache,Mild,Improved,0
9063,PT-09063,55,M,PGI Chandigarh,Phase III,ORX-404,Neurology,Placebo,2023-04-25,2023-07-24,8.08,7.51,119,91,93,None,None,Improved,1
9064,PT-09064,56,M,Indore Medical Institute,Phase III,ORX-404,Neurology,High Dose,2023-12-23,2023-12-30,6.06,6.46,121,74,69,None,None,Improved,0
9065,PT-09065,45,M,AIIMS Delhi,Phase I,ORX-606,Rheumatology,Low Dose,2023-01-02,2023-01-09,7.88,5.67,114,76,92,Nausea,Mild,Improved,1
9066,PT-09066,31,F,NIMHANS Bengaluru,Phase IV,ORX-303,Cardiology,Placebo,2024-09-04,2024-10-02,6.8,7.13,128,100,75,None,None,Improved,0
9067,PT-09067,75,F,AIIMS Delhi,Phase I,ORX-202,Diabetes,High Dose,2024-04-09,2024-07-08,9.68,9.69,135,88,89,None,None,No Change,0
9068,PT-09068,46,M,Apollo Chennai,Phase III,ORX-606,Rheumatology,Placebo,2024-07-12,2024-10-10,8.6,8.65,152,64,81,Rash,None,No Change,0
9069,PT-09069,61,M,AIIMS Delhi,Phase III,ORX-404,Neurology,Placebo,2024-11-11,2024-12-09,5.83,5.82,138,102,73,Fatigue,Mild,No Change,0
9070,PT-09070,48,F,Bhopal Research Hospital,Phase I,ORX-101,Oncology,High Dose,2023-08-10,2023-10-05,6.53,6.01,157,81,68,Fever,None,Worsened,0
9071,PT-09071,42,M,Indore Medical Institute,Phase II,ORX-202,Diabetes,Placebo,2024-09-30,2024-12-29,6.58,5.78,118,76,61,Headache,Mild,Improved,1
9072,PT-09072,46,F,Fortis Mumbai,Phase II,ORX-303,Cardiology,Placebo,2023-05-11,2023-06-08,6.03,6.65,122,86,83,None,None,Improved,0
9073,PT-09073,18,F,Apollo Chennai,Phase II,ORX-202,Diabetes,High Dose,2024-11-12,2024-11-19,6.88,8.03,114,109,85,None,None,Improved,0
9074,PT-09074,53,M,Indore Medical Institute,Phase III,ORX-202,Diabetes,Placebo,2024-01-06,2024-01-20,7.49,8.03,147,81,71,Nausea,None,Improved,0
9075,PT-09075,22,F,Apollo Chennai,Phase II,ORX-606,Rheumatology,High Dose,2023-06-25,2023-07-02,8.18,7.84,112,75,77,Nausea,None,Improved,1
9076,PT-09076,29,M,Bhopal Research Hospital,Phase I,ORX-404,Neurology,High Dose,2024-11-03,2024-11-17,7.26,5.4,118,68,80,None,None,Worsened,0
9077,PT-09077,29,M,Indore Medical Institute,Phase III,ORX-606,Rheumatology,High Dose,2024-10-15,2024-10-22,6.53,8.16,143,89,96,None,None,Improved,0
9078,PT-09078,53,M,PGI Chandigarh,Phase III,ORX-303,Cardiology,Low Dose,2023-04-23,2023-05-07,5.51,3.93,90,84,63,Fatigue,None,Improved,1
9079,PT-09079,35,F,Fortis Mumbai,Phase III,ORX-202,Diabetes,High Dose,2023-06-06,2023-06-13,6.82,5.87,127,78,72,Fever,Moderate,No Change,0
9080,PT-09080,20,F,NIMHANS Bengaluru,Phase II,ORX-404,Neurology,High Dose,2024-08-24,2024-09-21,7.49,9.05,132,109,70,Fever,Mild,Worsened,0
9081,PT-09081,40,M,NIMHANS Bengaluru,Phase IV,ORX-303,Cardiology,High Dose,2024-02-26,2024-03-25,7.18,6.62,148,55,71,None,None,Improved,1
9082,PT-09082,71,M,NIMHANS Bengaluru,Phase I,ORX-505,Infectious Disease,Low Dose,2023-06-18,2023-09-16,6.6,7.04,138,81,82,None,None,Improved,0
9083,PT-09083,43,F,Apollo Chennai,Phase III,ORX-404,Neurology,High Dose,2024-08-27,2024-09-10,4.65,4.66,116,65,83,Headache,None,Improved,0
9084,PT-09084,50,M,PGI Chandigarh,Phase III,ORX-606,Rheumatology,High Dose,2024-05-01,2024-07-30,8.38,7.74,143,82,82,None,None,Improved,1
9085,PT-09085,51,M,NIMHANS Bengaluru,Phase II,ORX-404,Neurology,High Dose,2024-08-31,2024-10-26,5.6,5.54,129,78,79,Nausea,None,No Change,0
9086,PT-09086,85,M,NIMHANS Bengaluru,Phase III,ORX-404,Neurology,Placebo,2024-02-06,2024-02-20,4.9,4.38,142,67,83,None,None,Improved,1
9087,PT-09087,49,F,Indore Medical Institute,Phase I,ORX-606,Rheumatology,High Dose,2024-04-23,2024-07-22,5.29,4.37,160,62,71,None,None,Worsened,0
9088,PT-09088,42,M,Fortis Mumbai,Phase IV,ORX-505,Infectious Disease,High Dose,2024-01-14,2024-03-10,7.21,6.43,129,81,87,None,None,No Change,0
9089,PT-09089,58,F,AIIMS Delhi,Phase III,ORX-202,Diabetes,High Dose,2023-01-26,2023-02-09,7.73,7.54,99,83,93,None,None,Improved,1
9090,PT-09090,19,F,Bhopal Research Hospital,Phase IV,ORX-404,Neurology,Low Dose,2024-02-18,2024-03-03,5.62,6.56,101,80,70,Nausea,None,Improved,0
9091,PT-09091,67,F,Kolkata Clinical Center,Phase III,ORX-303,Cardiology,Low Dose,2023-02-26,2023-03-12,7.56,7.88,129,105,67,None,None,Worsened,0
9092,PT-09092,50,F,Bhopal Research Hospital,Phase IV,ORX-505,Infectious Disease,High Dose,2023-09-14,2023-09-28,8.71,9.64,123,57,72,Nausea,Moderate,Improved,0
9093,PT-09093,72,M,Fortis Mumbai,Phase III,ORX-606,Rheumatology,High Dose,2024-03-12,2024-05-07,6.28,6.15,122,81,96,None,None,Improved,1
9094,PT-09094,49,F,Apollo Chennai,Phase III,ORX-505,Infectious Disease,Low Dose,2023-09-29,2023-12-28,9.65,10.13,130,80,82,Headache,Severe,Improved,0
9095,PT-09095,25,M,Bhopal Research Hospital,Phase IV,ORX-101,Oncology,Low Dose,2023-05-05,2023-06-02,5.93,6.21,144,66,90,None,None,Improved,0
9096,PT-09096,42,F,Kolkata Clinical Center,Phase I,ORX-505,Infectious Disease,Low Dose,2023-09-12,2023-10-10,6.2,5.52,143,89,82,Fatigue,None,No Change,0
9097,PT-09097,51,F,AIIMS Delhi,Phase III,ORX-303,Cardiology,Low Dose,2024-08-27,2024-09-10,5.83,5.92,119,106,72,None,None,No Change,0
9098,PT-09098,80,F,Apollo Chennai,Phase III,ORX-101,Oncology,Low Dose,2024-08-15,2024-11-13,7.01,6.52,122,66,96,Dizziness,None,Improved,1
9099,PT-09099,46,M,Apollo Chennai,Phase III,ORX-606,Rheumatology,High Dose,2024-11-23,2025-02-21,7.95,9.01,125,80,80,Fatigue,Mild,Improved,0
9100,PT-09100,24,M,PGI Chandigarh,Phase III,ORX-303,Cardiology,High Dose,2023-06-15,2023-08-10,5.01,3.25,150,78,88,None,None,Improved,1
9101,PT-09101,40,M,Indore Medical Institute,Phase II,ORX-202,Diabetes,High Dose,2023-04-04,2023-07-03,5.31,5.69,111,88,90,Headache,Severe,Improved,0
9102,PT-09102,44,F,Kolkata Clinical Center,Phase I,ORX-404,Neurology,Low Dose,2023-11-20,2024-02-18,7.77,6.09,180,87,88,Fatigue,Moderate,Improved,1
9103,PT-09103,59,F,Kolkata Clinical Center,Phase III,ORX-303,Cardiology,High Dose,2023-09-15,2023-10-13,7.03,6.7,147,77,83,None,None,Improved,1
9104,PT-09104,52,F,Fortis Mumbai,Phase III,ORX-303,Cardiology,Low Dose,2023-09-15,2023-10-13,6.32,6.32,97,93,99,None,None,Worsened,0
9105,PT-09105,59,M,Bhopal Research Hospital,Phase II,ORX-404,Neurology,Low Dose,2023-10-09,2023-10-16,9.0,7.91,123,83,79,None,None,Improved,1
9106,PT-09106,38,F,PGI Chandigarh,Phase II,ORX-606,Rheumatology,Low Dose,2024-02-21,2024-02-28,6.1,7.26,113,101,84,Dizziness,Mild,Improved,0
9107,PT-09107,48,F,Kolkata Clinical Center,Phase III,ORX-202,Diabetes,Placebo,2023-05-17,2023-08-15,7.85,8.82,90,86,80,Fatigue,Mild,Improved,0
9108,PT-09108,47,F,Kolkata Clinical Center,Phase III,ORX-202,Diabetes,Low Dose,2023-09-28,2023-10-12,8.33,7.38,107,65,65,None,None,Improved,1
9109,PT-09109,55,F,Kolkata Clinical Center,Phase I,ORX-303,Cardiology,High Dose,2023-06-14,2023-06-28,7.81,8.2,119,77,101,Nausea,None,Improved,0
9110,PT-09110,61,M,NIMHANS Bengaluru,Phase IV,ORX-505,Infectious Disease,Placebo,2024-01-28,2024-02-25,8.1,6.06,163,80,80,None,None,Worsened,0
9111,PT-09111,52,F,Kolkata Clinical Center,Phase III,ORX-202,Diabetes,Placebo,2023-05-18,2023-06-01,7.4,6.84,130,89,89,None,None,Worsened,0
9112,PT-09112,64,M,PGI Chandigarh,Phase II,ORX-505,Infectious Disease,Placebo,2024-01-25,2024-02-08,5.88,4.99,143,63,80,None,None,Improved,1
9113,PT-09113,32,M,Fortis Mumbai,Phase III,ORX-606,Rheumatology,Placebo,2023-11-19,2024-02-17,7.86,6.7,121,78,81,None,None,Improved,1
9114,PT-09114,60,M,Bhopal Research Hospital,Phase III,ORX-505,Infectious Disease,Placebo,2024-06-02,2024-06-09,8.44,8.22,108,112,76,Headache,Mild,Worsened,0
9115,PT-09115,49,F,NIMHANS Bengaluru,Phase III,ORX-606,Rheumatology,Placebo,2023-08-19,2023-11-17,7.49,7.41,112,87,103,None,None,Improved,1
9116,PT-09116,18,F,AIIMS Delhi,Phase II,ORX-202,Diabetes,Placebo,2024-02-23,2024-05-23,7.24,5.83,145,95,76,None,None,Worsened,0
9117,PT-09117,45,F,Apollo Chennai,Phase II,ORX-404,Neurology,High Dose,2023-09-30,2023-10-14,6.14,3.62,123,79,78,None,None,Improved,1
9118,PT-09118,18,F,NIMHANS Bengaluru,Phase II,ORX-505,Infectious Disease,Low Dose,2023-06-07,2023-07-05,5.13,3.39,129,89,61,Headache,None,Improved,1
9119,PT-09119,40,F,Bhopal Research Hospital,Phase III,ORX-202,Diabetes,High Dose,2024-08-19,2024-09-16,6.51,7.93,121,76,66,Fever,None,No Change,0
9120,PT-09120,18,F,Apollo Chennai,Phase III,ORX-101,Oncology,Low Dose,2023-07-09,2023-09-03,7.98,7.34,121,84,55,Nausea,Mild,No Change,0
9121,PT-09121,73,M,AIIMS Delhi,Phase III,ORX-101,Oncology,Low Dose,2023-10-20,2024-01-18,5.02,6.21,127,77,87,Nausea,None,Improved,0
9122,PT-09122,39,F,AIIMS Delhi,Phase III,ORX-606,Rheumatology,Placebo,2023-05-24,2023-05-31,8.32,8.2,140,94,75,None,None,No Change,0
9123,PT-09123,60,F,Indore Medical Institute,Phase II,ORX-101,Oncology,Placebo,2023-05-21,2023-08-19,7.82,8.62,121,98,67,None,None,Improved,0
9124,PT-09124,18,M,Indore Medical Institute,Phase I,ORX-505,Infectious Disease,High Dose,2023-09-28,2023-11-23,5.56,4.86,132,82,89,None,None,No Change,0
9125,PT-09125,25,F,Fortis Mumbai,Phase II,ORX-404,Neurology,High Dose,2023-05-18,2023-06-01,9.27,10.08,144,97,56,None,None,Improved,0
9126,PT-09126,56,M,Kolkata Clinical Center,Phase I,ORX-202,Diabetes,High Dose,2024-09-19,2024-11-14,8.09,8.56,143,87,83,None,None,No Change,0
9127,PT-09127,64,F,NIMHANS Bengaluru,Phase III,ORX-101,Oncology,High Dose,2024-02-20,2024-02-27,6.45,6.38,118,80,45,None,None,Worsened,0
9128,PT-09128,31,F,NIMHANS Bengaluru,Phase II,ORX-505,Infectious Disease,Placebo,2023-03-24,2023-03-31,6.68,5.9,121,67,73,Nausea,Mild,Improved,1
9129,PT-09129,62,M,Kolkata Clinical Center,Phase III,ORX-606,Rheumatology,Placebo,2023-12-12,2023-12-26,6.84,7.61,150,74,85,Headache,None,Improved,0
9130,PT-09130,23,M,Fortis Mumbai,Phase II,ORX-303,Cardiology,Placebo,2023-09-25,2023-11-20,5.94,5.64,137,101,75,None,None,Improved,1
9131,PT-09131,47,F,Apollo Chennai,Phase II,ORX-404,Neurology,High Dose,2023-09-02,2023-12-01,7.32,8.53,152,86,89,Headache,None,Improved,0
9132,PT-09132,50,F,Apollo Chennai,Phase I,ORX-404,Neurology,High Dose,2024-11-26,2025-02-24,8.49,8.87,122,83,80,Fatigue,Moderate,Improved,0
9133,PT-09133,47,F,Apollo Chennai,Phase I,ORX-303,Cardiology,High Dose,2023-09-23,2023-12-22,6.59,6.49,118,74,76,Fatigue,Mild,Worsened,0
9134,PT-09134,49,F,Bhopal Research Hospital,Phase III,ORX-101,Oncology,Low Dose,2024-10-26,2025-01-24,8.67,8.91,147,103,69,Headache,Moderate,No Change,0
9135,PT-09135,56,F,PGI Chandigarh,Phase III,ORX-101,Oncology,Placebo,2023-06-19,2023-07-17,8.1,7.93,144,83,87,Nausea,None,No Change,0
9136,PT-09136,22,M,AIIMS Delhi,Phase II,ORX-606,Rheumatology,High Dose,2023-05-29,2023-06-05,7.2,7.44,146,71,76,None,None,Improved,0
9137,PT-09137,27,M,AIIMS Delhi,Phase III,ORX-606,Rheumatology,Placebo,2024-07-24,2024-07-31,6.73,6.62,146,92,81,None,None,Improved,1
9138,PT-09138,34,M,Fortis Mumbai,Phase IV,ORX-404,Neurology,High Dose,2024-03-30,2024-04-27,7.03,8.92,102,67,80,None,None,No Change,0
9139,PT-09139,56,F,Apollo Chennai,Phase III,ORX-505,Infectious Disease,Low Dose,2024-11-17,2025-01-12,8.24,8.1,100,79,53,None,None,No Change,0
9140,PT-09140,51,F,AIIMS Delhi,Phase III,ORX-505,Infectious Disease,Placebo,2024-07-23,2024-10-21,7.75,7.23,106,72,55,None,None,Improved,1
9141,PT-09141,44,M,Bhopal Research Hospital,Phase IV,ORX-505,Infectious Disease,High Dose,2023-11-30,2023-12-07,11.0,10.51,120,84,61,Fatigue,Mild,No Change,0
9142,PT-09142,27,F,PGI Chandigarh,Phase III,ORX-505,Infectious Disease,Placebo,2023-01-16,2023-02-13,6.46,6.85,134,80,88,Nausea,None,No Change,0
9143,PT-09143,72,M,AIIMS Delhi,Phase III,ORX-606,Rheumatology,Low Dose,2024-07-13,2024-07-27,8.08,6.77,94,61,90,None,None,No Change,0
9144,PT-09144,32,F,Apollo Chennai,Phase II,ORX-505,Infectious Disease,Placebo,2023-04-08,2023-04-15,8.18,7.37,134,90,67,None,None,No Change,0
9145,PT-09145,58,M,NIMHANS Bengaluru,Phase III,ORX-303,Cardiology,Placebo,2023-02-06,2023-04-03,6.41,5.38,142,89,84,Fatigue,None,No Change,0
9146,PT-09146,27,F,Kolkata Clinical Center,Phase III,ORX-303,Cardiology,Placebo,2023-09-23,2023-10-07,6.74,6.96,169,103,71,Headache,Moderate,Improved,0
9147,PT-09147,34,F,Indore Medical Institute,Phase III,ORX-404,Neurology,Low Dose,2024-02-28,2024-03-13,9.28,9.42,119,83,60,Headache,None,Worsened,0
9148,PT-09148,61,M,Indore Medical Institute,Phase IV,ORX-202,Diabetes,High Dose,2023-08-01,2023-09-26,8.88,9.87,148,78,90,Nausea,Mild,No Change,0
9149,PT-09149,68,F,PGI Chandigarh,Phase IV,ORX-303,Cardiology,High Dose,2024-08-26,2024-09-23,8.33,8.7,131,71,103,None,None,Improved,0
9150,PT-09150,44,F,NIMHANS Bengaluru,Phase III,ORX-404,Neurology,High Dose,2024-10-27,2024-11-24,8.66,10.49,144,96,64,None,None,Improved,0
9151,PT-09151,33,F,AIIMS Delhi,Phase IV,ORX-404,Neurology,Low Dose,2023-12-24,2023-12-31,8.72,7.82,103,62,74,Nausea,Mild,Improved,1
9152,PT-09152,41,F,AIIMS Delhi,Phase IV,ORX-505,Infectious Disease,Low Dose,2023-06-20,2023-09-18,8.4,7.11,152,67,61,Headache,None,No Change,0
9153,PT-09153,47,M,NIMHANS Bengaluru,Phase III,ORX-505,Infectious Disease,Placebo,2023-05-04,2023-06-01,7.26,7.39,106,86,54,Headache,Mild,No Change,0
9154,PT-09154,18,F,Indore Medical Institute,Phase II,ORX-404,Neurology,High Dose,2024-03-15,2024-05-10,9.39,9.94,127,57,71,Rash,None,Worsened,0
9155,PT-09155,52,M,Kolkata Clinical Center,Phase III,ORX-505,Infectious Disease,Placebo,2024-11-03,2024-12-29,6.65,7.65,139,70,55,None,None,Worsened,0
9156,PT-09156,58,F,Bhopal Research Hospital,Phase III,ORX-202,Diabetes,High Dose,2024-03-30,2024-04-13,8.21,8.49,158,87,79,None,None,Worsened,0
9157,PT-09157,57,F,AIIMS Delhi,Phase IV,ORX-606,Rheumatology,Low Dose,2024-07-25,2024-08-08,8.68,8.9,128,93,79,None,None,Improved,0
9158,PT-09158,37,F,Fortis Mumbai,Phase III,ORX-303,Cardiology,High Dose,2024-02-06,2024-03-05,7.35,6.66,126,71,91,None,None,Improved,1
9159,PT-09159,48,M,AIIMS Delhi,Phase II,ORX-101,Oncology,Low Dose,2023-07-28,2023-09-22,8.05,8.09,111,97,74,Headache,Mild,Improved,0
9160,PT-09160,39,F,Indore Medical Institute,Phase I,ORX-404,Neurology,Placebo,2024-05-07,2024-07-02,7.46,7.27,174,89,71,None,None,Improved,1
9161,PT-09161,75,M,NIMHANS Bengaluru,Phase I,ORX-303,Cardiology,High Dose,2023-02-13,2023-05-14,5.24,4.41,117,81,82,Fever,Mild,Improved,1
9162,PT-09162,51,M,Bhopal Research Hospital,Phase IV,ORX-606,Rheumatology,High Dose,2023-06-22,2023-08-17,7.7,7.87,126,97,55,None,None,Improved,0
9163,PT-09163,18,F,PGI Chandigarh,Phase II,ORX-202,Diabetes,Low Dose,2024-10-17,2024-10-31,8.09,7.39,158,94,86,None,None,Improved,1
9164,PT-09164,37,M,Indore Medical Institute,Phase IV,ORX-202,Diabetes,High Dose,2024-08-04,2024-08-18,8.01,7.25,129,78,81,Nausea,Moderate,No Change,0
9165,PT-09165,40,F,Bhopal Research Hospital,Phase III,ORX-101,Oncology,Low Dose,2024-06-12,2024-09-10,8.4,8.41,118,76,60,Fatigue,Mild,Improved,0
9166,PT-09166,18,M,Fortis Mumbai,Phase III,ORX-202,Diabetes,Placebo,2023-05-26,2023-07-21,8.32,7.6,106,87,67,None,None,No Change,0
9167,PT-09167,43,M,AIIMS Delhi,Phase II,ORX-303,Cardiology,Low Dose,2023-12-22,2024-01-05,5.65,5.83,129,87,72,None,None,Worsened,0
9168,PT-09168,48,M,AIIMS Delhi,Phase III,ORX-101,Oncology,Low Dose,2023-12-07,2024-02-01,5.45,7.1,135,102,74,Nausea,Mild,Improved,0
9169,PT-09169,28,M,Bhopal Research Hospital,Phase IV,ORX-202,Diabetes,Placebo,2023-11-11,2023-12-09,6.61,6.17,125,104,66,None,None,Improved,1
9170,PT-09170,35,F,Apollo Chennai,Phase II,ORX-505,Infectious Disease,Low Dose,2024-07-01,2024-09-29,8.06,6.23,127,83,84,Headache,None,Improved,1
9171,PT-09171,50,F,Fortis Mumbai,Phase II,ORX-505,Infectious Disease,Low Dose,2023-07-20,2023-09-14,9.59,8.39,116,89,81,None,None,No Change,0
9172,PT-09172,50,F,Bhopal Research Hospital,Phase I,ORX-202,Diabetes,Placebo,2023-01-15,2023-02-12,5.51,7.08,136,63,86,None,None,Improved,0
9173,PT-09173,27,F,PGI Chandigarh,Phase II,ORX-505,Infectious Disease,Placebo,2024-06-20,2024-07-04,8.31,6.73,146,67,64,None,None,No Change,0
9174,PT-09174,47,F,Apollo Chennai,Phase I,ORX-606,Rheumatology,Placebo,2024-08-15,2024-08-29,6.47,5.57,100,78,90,Rash,None,No Change,0
9175,PT-09175,75,F,Indore Medical Institute,Phase II,ORX-505,Infectious Disease,High Dose,2024-09-26,2024-10-03,8.19,8.41,97,81,68,None,None,Improved,0
9176,PT-09176,20,F,AIIMS Delhi,Phase III,ORX-101,Oncology,Placebo,2024-02-20,2024-04-16,5.67,5.87,117,64,69,Headache,None,No Change,0
9177,PT-09177,49,M,PGI Chandigarh,Phase III,ORX-202,Diabetes,Low Dose,2024-04-27,2024-05-04,6.39,4.9,111,92,48,Rash,Severe,Improved,1
9178,PT-09178,40,F,Apollo Chennai,Phase II,ORX-303,Cardiology,Low Dose,2023-03-03,2023-03-17,7.06,5.98,110,93,91,None,None,No Change,0
9179,PT-09179,46,F,Fortis Mumbai,Phase II,ORX-606,Rheumatology,Low Dose,2024-05-07,2024-06-04,6.55,6.25,135,80,84,Fatigue,Mild,Improved,1
9180,PT-09180,39,M,Bhopal Research Hospital,Phase III,ORX-101,Oncology,High Dose,2023-07-20,2023-09-14,3.5,2.93,140,82,82,None,None,No Change,0
9181,PT-09181,40,M,Bhopal Research Hospital,Phase II,ORX-606,Rheumatology,High Dose,2024-02-24,2024-03-23,6.97,6.72,162,92,87,None,None,Improved,1
9182,PT-09182,48,F,Fortis Mumbai,Phase III,ORX-606,Rheumatology,High Dose,2024-07-14,2024-07-21,5.6,6.31,144,86,77,Fever,Mild,No Change,0
9183,PT-09183,53,F,Indore Medical Institute,Phase III,ORX-303,Cardiology,High Dose,2023-08-12,2023-08-26,6.92,7.18,112,59,61,Dizziness,Moderate,Worsened,0
9184,PT-09184,47,F,NIMHANS Bengaluru,Phase II,ORX-101,Oncology,High Dose,2023-01-01,2023-01-15,6.84,6.3,104,85,63,Dizziness,Mild,Worsened,0
9185,PT-09185,52,M,Kolkata Clinical Center,Phase IV,ORX-101,Oncology,Low Dose,2023-11-01,2024-01-30,5.5,4.35,110,88,71,Rash,None,Improved,1
9186,PT-09186,51,M,Bhopal Research Hospital,Phase III,ORX-303,Cardiology,Placebo,2023-09-03,2023-12-02,8.57,9.77,132,68,95,None,None,No Change,0
9187,PT-09187,69,M,AIIMS Delhi,Phase II,ORX-202,Diabetes,Low Dose,2023-11-27,2023-12-11,7.13,7.91,133,62,69,Nausea,Mild,Improved,0
9188,PT-09188,36,F,Kolkata Clinical Center,Phase II,ORX-303,Cardiology,High Dose,2024-11-09,2024-12-07,6.76,5.52,110,98,53,None,None,No Change,0
9189,PT-09189,33,M,AIIMS Delhi,Phase II,ORX-303,Cardiology,High Dose,2023-08-18,2023-09-01,7.95,7.04,135,77,84,None,None,No Change,0
9190,PT-09190,28,F,Bhopal Research Hospital,Phase III,ORX-404,Neurology,Low Dose,2023-08-19,2023-09-02,4.97,4.21,95,81,62,None,None,Improved,1
9191,PT-09191,27,F,Bhopal Research Hospital,Phase I,ORX-303,Cardiology,Placebo,2024-05-10,2024-05-24,8.97,8.81,100,81,75,Headache,Mild,No Change,0
9192,PT-09192,18,F,Fortis Mumbai,Phase III,ORX-202,Diabetes,Low Dose,2024-08-17,2024-10-12,7.62,8.07,120,78,70,Fatigue,None,No Change,0
9193,PT-09193,51,F,Indore Medical Institute,Phase III,ORX-101,Oncology,Low Dose,2023-04-11,2023-04-18,6.9,6.31,113,106,74,None,None,Improved,1
9194,PT-09194,56,M,Bhopal Research Hospital,Phase I,ORX-505,Infectious Disease,Placebo,2024-10-25,2024-12-20,7.52,4.81,121,68,91,Fatigue,Mild,Improved,1
9195,PT-09195,24,F,Apollo Chennai,Phase I,ORX-606,Rheumatology,Low Dose,2023-07-21,2023-07-28,7.79,8.29,133,82,72,Nausea,None,Improved,0
9196,PT-09196,43,F,Apollo Chennai,Phase III,ORX-606,Rheumatology,Low Dose,2024-03-10,2024-03-24,5.59,5.35,146,71,78,Nausea,Mild,Improved,1
9197,PT-09197,43,F,Indore Medical Institute,Phase III,ORX-101,Oncology,Placebo,2024-04-13,2024-05-11,7.58,6.69,100,68,45,None,None,Improved,1
9198,PT-09198,57,M,Bhopal Research Hospital,Phase I,ORX-505,Infectious Disease,Low Dose,2023-11-13,2023-11-20,7.68,7.26,115,80,77,Fever,None,Improved,1
9199,PT-09199,36,F,Apollo Chennai,Phase IV,ORX-101,Oncology,Placebo,2024-08-09,2024-08-16,6.62,7.4,105,93,55,None,None,Improved,0
9200,PT-09200,70,M,AIIMS Delhi,Phase IV,ORX-101,Oncology,Low Dose,2023-12-24,2023-12-31,4.33,4.35,116,79,76,None,None,Worsened,0
9201,PT-09201,54,M,AIIMS Delhi,Phase III,ORX-606,Rheumatology,High Dose,2023-11-11,2023-12-09,4.85,,131,74,76,Nausea,Moderate,Improved,1
9202,PT-09202,34,F,PGI Chandigarh,Phase III,ORX-505,Infectious Disease,Placebo,2024-02-11,2024-04-07,7.87,7.79,131,89,95,Fatigue,None,Improved,1
9203,PT-09203,29,M,Indore Medical Institute,Phase III,ORX-505,Infectious Disease,High Dose,2023-11-18,2024-02-16,9.87,9.82,118,109,72,Rash,None,Improved,1
9204,PT-09204,25,M,Kolkata Clinical Center,Phase II,ORX-101,Oncology,Low Dose,2023-07-05,2023-10-03,6.59,5.69,147,80,79,Rash,None,Improved,1
9205,PT-09205,46,M,Bhopal Research Hospital,Phase IV,ORX-101,Oncology,High Dose,2024-08-21,2024-11-19,8.6,7.91,124,73,72,Fatigue,None,Improved,1
9206,PT-09206,53,F,Indore Medical Institute,Phase III,ORX-202,Diabetes,Placebo,2023-06-08,2023-08-03,8.07,9.2,126,78,83,None,None,Improved,0
9207,PT-09207,37,F,Fortis Mumbai,Phase I,ORX-202,Diabetes,High Dose,2023-01-20,2023-02-17,6.43,6.32,120,78,86,Fatigue,Mild,Improved,1
9208,PT-09208,49,F,Apollo Chennai,Phase III,ORX-505,Infectious Disease,High Dose,2024-06-05,2024-06-19,9.6,10.03,114,77,58,None,None,Improved,0
9209,PT-09209,29,M,Apollo Chennai,Phase IV,ORX-303,Cardiology,Low Dose,2024-05-13,2024-05-27,8.71,8.06,103,58,57,Dizziness,None,Improved,1
9210,PT-09210,32,M,PGI Chandigarh,Phase III,ORX-303,Cardiology,Low Dose,2024-01-26,2024-02-02,7.2,6.45,140,70,95,Fatigue,None,No Change,0
9211,PT-09211,42,F,Fortis Mumbai,Phase II,ORX-202,Diabetes,High Dose,2024-07-15,2024-09-09,7.75,6.88,146,66,60,None,None,No Change,0
9212,PT-09212,29,M,PGI Chandigarh,Phase II,ORX-606,Rheumatology,High Dose,2024-03-01,2024-03-15,8.61,8.0,110,79,80,Fatigue,None,Improved,1
9213,PT-09213,27,M,Bhopal Research Hospital,Phase IV,ORX-505,Infectious Disease,Placebo,2023-11-04,2023-12-02,7.39,6.87,118,66,90,Dizziness,None,Worsened,0
9214,PT-09214,37,F,AIIMS Delhi,Phase II,ORX-101,Oncology,High Dose,2024-09-15,2024-09-29,3.68,3.6,134,93,83,Headache,Mild,Worsened,0
9215,PT-09215,47,F,PGI Chandigarh,Phase III,ORX-202,Diabetes,Low Dose,2024-05-26,2024-06-02,6.62,5.78,140,80,57,Nausea,None,Improved,1
9216,PT-09216,39,M,PGI Chandigarh,Phase II,ORX-505,Infectious Disease,High Dose,2023-06-18,2023-07-02,7.13,,141,82,58,Nausea,None,Worsened,0
9217,PT-09217,40,F,PGI Chandigarh,Phase I,ORX-303,Cardiology,Low Dose,2024-03-07,2024-04-04,7.08,7.53,144,94,83,None,None,Worsened,0
9218,PT-09218,34,F,Indore Medical Institute,Phase III,ORX-505,Infectious Disease,High Dose,2024-05-17,2024-05-31,6.11,5.08,126,81,92,None,None,Improved,1
9219,PT-09219,40,M,AIIMS Delhi,Phase III,ORX-505,Infectious Disease,Placebo,2023-01-20,2023-01-27,4.77,3.3,110,70,45,None,None,No Change,0
9220,PT-09220,70,M,Indore Medical Institute,Phase II,ORX-303,Cardiology,Low Dose,2023-01-16,2023-03-13,4.58,3.66,139,89,57,None,None,Improved,1
9221,PT-09221,64,F,Fortis Mumbai,Phase II,ORX-101,Oncology,Placebo,2024-07-03,2024-10-01,8.47,7.91,128,71,81,Fatigue,None,Improved,1
9222,PT-09222,48,F,Kolkata Clinical Center,Phase II,ORX-303,Cardiology,High Dose,2024-05-09,2024-05-23,6.62,6.8,133,120,65,Headache,None,Worsened,0
9223,PT-09223,66,F,Apollo Chennai,Phase III,ORX-505,Infectious Disease,Placebo,2024-04-28,2024-05-12,6.18,6.25,90,75,84,None,None,Improved,0
9224,PT-09224,48,F,AIIMS Delhi,Phase II,ORX-606,Rheumatology,High Dose,2024-11-02,2025-01-31,4.79,4.02,154,94,91,None,None,No Change,0
9225,PT-09225,82,F,PGI Chandigarh,Phase III,ORX-505,Infectious Disease,Placebo,2024-07-31,2024-09-25,5.11,4.35,128,73,79,None,None,No Change,0
9226,PT-09226,65,F,NIMHANS Bengaluru,Phase I,ORX-505,Infectious Disease,High Dose,2023-03-17,2023-05-12,7.33,4.95,140,81,47,None,None,Improved,1
9227,PT-09227,35,F,Fortis Mumbai,Phase IV,ORX-606,Rheumatology,Placebo,2024-06-12,2024-07-10,5.12,4.46,118,63,81,None,None,No Change,0
9228,PT-09228,27,M,Fortis Mumbai,Phase III,ORX-505,Infectious Disease,High Dose,2024-10-01,2024-11-26,8.79,8.54,123,97,81,None,None,No Change,0
9229,PT-09229,50,M,Bhopal Research Hospital,Phase III,ORX-101,Oncology,Placebo,2024-03-24,2024-05-19,7.12,6.44,135,100,45,Dizziness,None,Worsened,0
9230,PT-09230,74,M,Indore Medical Institute,Phase III,ORX-101,Oncology,High Dose,2024-10-06,2024-11-03,5.99,5.76,97,99,58,Headache,None,Improved,1
9231,PT-09231,62,M,Bhopal Research Hospital,Phase II,ORX-505,Infectious Disease,Placebo,2023-09-20,2023-10-04,6.91,6.36,105,96,75,None,None,No Change,0
9232,PT-09232,56,F,Kolkata Clinical Center,Phase II,ORX-404,Neurology,Low Dose,2023-11-04,2023-11-18,4.72,3.52,132,63,83,Nausea,None,Improved,1
9233,PT-09233,34,F,PGI Chandigarh,Phase III,ORX-101,Oncology,Low Dose,2024-05-21,2024-06-04,6.27,6.33,131,68,93,None,None,Improved,0
9234,PT-09234,53,M,AIIMS Delhi,Phase II,ORX-101,Oncology,Placebo,2024-11-19,2024-11-26,4.78,4.11,134,80,45,None,None,No Change,0
9235,PT-09235,46,M,Fortis Mumbai,Phase II,ORX-303,Cardiology,Placebo,2023-04-02,2023-07-01,8.11,7.64,128,94,55,None,None,Improved,1
9236,PT-09236,56,F,AIIMS Delhi,Phase III,ORX-303,Cardiology,Placebo,2024-06-16,2024-07-14,7.61,5.75,140,103,82,Nausea,Mild,No Change,0
9237,PT-09237,53,M,PGI Chandigarh,Phase III,ORX-202,Diabetes,High Dose,2023-09-17,2023-11-12,5.92,4.96,109,86,70,None,None,Improved,1
9238,PT-09238,35,M,Kolkata Clinical Center,Phase II,ORX-404,Neurology,Placebo,2023-12-06,2023-12-20,8.04,9.15,126,63,78,Headache,None,Improved,0
9239,PT-09239,48,F,Kolkata Clinical Center,Phase III,ORX-404,Neurology,Low Dose,2023-01-18,2023-04-18,8.2,7.51,143,90,73,None,None,No Change,0
9240,PT-09240,58,M,Indore Medical Institute,Phase IV,ORX-505,Infectious Disease,Low Dose,2024-08-09,2024-09-06,8.32,6.93,145,80,74,Headache,Moderate,Improved,1
9241,PT-09241,43,F,Fortis Mumbai,Phase I,ORX-505,Infectious Disease,Placebo,2024-01-14,2024-02-11,8.69,9.4,136,85,76,Headache,None,Worsened,0
9242,PT-09242,85,M,NIMHANS Bengaluru,Phase III,ORX-101,Oncology,Low Dose,2024-11-08,2024-11-15,6.38,5.58,133,71,92,Nausea,None,Improved,1
9243,PT-09243,21,F,Kolkata Clinical Center,Phase I,ORX-404,Neurology,Low Dose,2023-11-02,2023-11-16,6.34,5.58,109,94,59,Rash,Mild,Improved,1
9244,PT-09244,29,M,Apollo Chennai,Phase IV,ORX-606,Rheumatology,Low Dose,2023-12-19,2024-03-18,6.39,6.75,154,88,59,None,None,Worsened,0
9245,PT-09245,35,F,Apollo Chennai,Phase III,ORX-202,Diabetes,Placebo,2023-10-02,2023-10-30,9.09,8.71,101,108,70,Nausea,None,No Change,0
9246,PT-09246,43,M,Indore Medical Institute,Phase III,ORX-606,Rheumatology,High Dose,2024-05-04,2024-05-11,6.38,5.12,151,84,82,None,None,Improved,1
9247,PT-09247,24,F,Fortis Mumbai,Phase III,ORX-101,Oncology,Low Dose,2023-11-27,2023-12-04,6.84,5.88,113,87,73,Nausea,Moderate,Improved,1
9248,PT-09248,56,M,Fortis Mumbai,Phase III,ORX-303,Cardiology,High Dose,2024-07-25,2024-08-08,8.06,7.27,136,76,66,None,None,Improved,1
9249,PT-09249,28,F,NIMHANS Bengaluru,Phase I,ORX-303,Cardiology,High Dose,2023-03-31,2023-04-14,7.3,6.24,152,101,84,None,None,Improved,1
9250,PT-09250,48,F,NIMHANS Bengaluru,Phase I,ORX-404,Neurology,Low Dose,2024-08-06,2024-08-13,7.22,8.96,163,79,75,Fatigue,None,Improved,0
9251,PT-09251,50,M,Apollo Chennai,Phase II,ORX-404,Neurology,High Dose,2023-05-08,2023-07-03,5.78,3.76,103,78,64,None,None,Improved,1
9252,PT-09252,68,M,AIIMS Delhi,Phase I,ORX-303,Cardiology,Low Dose,2023-09-01,2023-10-27,5.44,3.83,94,74,72,Headache,None,Worsened,0
9253,PT-09253,43,M,Indore Medical Institute,Phase III,ORX-404,Neurology,High Dose,2023-08-03,2023-11-01,7.16,6.2,109,87,65,Rash,Mild,No Change,0
9254,PT-09254,57,F,Kolkata Clinical Center,Phase I,ORX-303,Cardiology,High Dose,2024-01-05,2024-01-19,5.42,4.35,164,108,58,None,None,Improved,1
9255,PT-09255,64,F,Kolkata Clinical Center,Phase III,ORX-606,Rheumatology,Low Dose,2023-10-18,2023-11-01,9.14,9.69,126,58,79,Headache,None,Improved,0
9256,PT-09256,51,F,NIMHANS Bengaluru,Phase III,ORX-101,Oncology,Low Dose,2023-01-22,2023-03-19,7.49,7.52,113,76,45,Headache,None,No Change,0
9257,PT-09257,59,M,Fortis Mumbai,Phase II,ORX-606,Rheumatology,Placebo,2024-07-05,2024-07-12,6.12,5.5,132,75,62,Headache,None,No Change,0
9258,PT-09258,49,M,PGI Chandigarh,Phase III,ORX-202,Diabetes,Low Dose,2024-10-10,2024-10-24,5.06,5.35,139,75,71,Dizziness,Moderate,Improved,0
9259,PT-09259,29,M,AIIMS Delhi,Phase III,ORX-202,Diabetes,High Dose,2023-05-15,2023-07-10,6.74,6.16,122,99,53,None,None,Improved,1
9260,PT-09260,30,F,NIMHANS Bengaluru,Phase III,ORX-404,Neurology,Placebo,2024-08-04,2024-11-02,8.08,9.53,112,94,61,None,None,Improved,0
9261,PT-09261,38,F,Kolkata Clinical Center,Phase III,ORX-606,Rheumatology,High Dose,2023-07-20,2023-10-18,7.21,6.19,120,65,87,None,None,Improved,1
9262,PT-09262,30,F,Kolkata Clinical Center,Phase II,ORX-404,Neurology,High Dose,2023-02-05,2023-02-19,6.4,5.3,114,83,78,None,None,Improved,1
9263,PT-09263,85,M,NIMHANS Bengaluru,Phase IV,ORX-505,Infectious Disease,High Dose,2023-06-17,2023-07-15,6.91,6.42,152,84,76,None,None,No Change,0
9264,PT-09264,42,M,Fortis Mumbai,Phase III,ORX-101,Oncology,Placebo,2023-10-01,2023-12-30,7.43,7.91,152,94,84,Fatigue,Mild,No Change,0
9265,PT-09265,48,M,Indore Medical Institute,Phase III,ORX-606,Rheumatology,Placebo,2024-07-26,2024-09-20,9.65,8.82,140,96,92,None,None,No Change,0
9266,PT-09266,32,M,AIIMS Delhi,Phase IV,ORX-606,Rheumatology,Placebo,2024-03-12,2024-05-07,10.58,11.68,147,69,91,None,None,No Change,0
9267,PT-09267,18,F,Kolkata Clinical Center,Phase IV,ORX-606,Rheumatology,High Dose,2023-07-16,2023-07-23,6.92,6.62,119,100,79,None,None,Improved,1
9268,PT-09268,29,M,AIIMS Delhi,Phase III,ORX-101,Oncology,Placebo,2024-05-21,2024-06-18,8.1,8.06,96,98,79,Fever,None,Worsened,0
9269,PT-09269,60,F,NIMHANS Bengaluru,Phase IV,ORX-202,Diabetes,High Dose,2023-07-09,2023-07-23,7.69,6.99,135,80,82,Dizziness,Severe,Worsened,0
9270,PT-09270,54,M,Indore Medical Institute,Phase III,ORX-404,Neurology,High Dose,2024-04-16,2024-07-15,7.38,7.39,121,75,88,None,None,Improved,0
9271,PT-09271,68,F,NIMHANS Bengaluru,Phase I,ORX-303,Cardiology,Placebo,2024-06-18,2024-08-13,6.58,6.46,102,103,94,None,None,No Change,0
9272,PT-09272,35,M,NIMHANS Bengaluru,Phase I,ORX-404,Neurology,Low Dose,2023-03-04,2023-03-11,6.78,7.46,131,89,64,Dizziness,None,Improved,0
9273,PT-09273,54,M,Fortis Mumbai,Phase III,ORX-404,Neurology,High Dose,2023-05-22,2023-06-05,7.02,6.89,120,79,79,None,None,Improved,1
9274,PT-09274,35,F,Bhopal Research Hospital,Phase III,ORX-606,Rheumatology,High Dose,2024-01-02,2024-01-16,9.92,8.57,136,85,88,None,None,Improved,1
9275,PT-09275,18,M,NIMHANS Bengaluru,Phase II,ORX-404,Neurology,High Dose,2023-08-13,2023-11-11,5.18,4.28,144,78,73,None,None,Worsened,0
9276,PT-09276,45,F,PGI Chandigarh,Phase II,ORX-303,Cardiology,High Dose,2024-06-12,2024-06-26,6.19,6.21,131,88,99,Fatigue,None,Worsened,0
9277,PT-09277,41,F,Kolkata Clinical Center,Phase III,ORX-101,Oncology,High Dose,2024-07-29,2024-08-26,7.33,6.05,105,81,79,None,None,No Change,0
9278,PT-09278,56,F,Indore Medical Institute,Phase IV,ORX-101,Oncology,Placebo,2024-07-23,2024-08-20,7.89,7.72,158,78,75,None,None,Improved,1
9279,PT-09279,49,F,Indore Medical Institute,Phase IV,ORX-202,Diabetes,Low Dose,2024-03-24,2024-05-19,5.78,6.0,129,83,85,None,None,Improved,0
9280,PT-09280,51,F,PGI Chandigarh,Phase IV,ORX-505,Infectious Disease,Low Dose,2023-11-15,2023-11-29,7.69,6.94,156,64,68,None,None,Improved,1
9281,PT-09281,36,M,NIMHANS Bengaluru,Phase IV,ORX-101,Oncology,High Dose,2024-06-26,2024-07-03,6.34,4.36,157,89,69,Headache,None,Worsened,0
9282,PT-09282,56,M,Indore Medical Institute,Phase I,ORX-606,Rheumatology,Placebo,2024-02-15,2024-05-15,7.01,6.35,110,82,69,None,None,Improved,1
9283,PT-09283,29,M,Kolkata Clinical Center,Phase I,ORX-101,Oncology,High Dose,2024-05-19,2024-06-02,8.35,7.21,153,73,56,Headache,Mild,No Change,0
9284,PT-09284,53,F,Indore Medical Institute,Phase III,ORX-202,Diabetes,Placebo,2023-09-05,2023-09-19,6.66,4.84,132,66,50,Fatigue,None,Improved,1
9285,PT-09285,55,F,Bhopal Research Hospital,Phase III,ORX-202,Diabetes,High Dose,2023-02-18,2023-05-19,8.99,8.23,149,91,87,Nausea,None,Worsened,0
9286,PT-09286,42,F,Kolkata Clinical Center,Phase IV,ORX-606,Rheumatology,High Dose,2023-06-03,2023-07-01,6.48,,139,66,73,Nausea,Moderate,Worsened,0
9287,PT-09287,41,F,AIIMS Delhi,Phase II,ORX-606,Rheumatology,High Dose,2023-11-21,2023-12-19,6.86,5.85,104,78,74,None,None,No Change,0
9288,PT-09288,37,M,AIIMS Delhi,Phase I,ORX-101,Oncology,High Dose,2023-04-27,2023-05-11,7.98,6.35,133,60,77,None,None,No Change,0
9289,PT-09289,18,M,Bhopal Research Hospital,Phase III,ORX-303,Cardiology,High Dose,2024-03-15,2024-05-10,6.13,5.71,102,64,91,Dizziness,None,Improved,1
9290,PT-09290,19,M,Fortis Mumbai,Phase IV,ORX-505,Infectious Disease,Low Dose,2024-01-09,2024-01-23,7.06,7.99,130,82,68,Nausea,Moderate,Worsened,0
9291,PT-09291,33,F,Kolkata Clinical Center,Phase III,ORX-606,Rheumatology,High Dose,2024-08-18,2024-11-16,7.0,4.8,146,84,53,None,None,Improved,1
9292,PT-09292,61,M,NIMHANS Bengaluru,Phase III,ORX-404,Neurology,High Dose,2023-06-26,2023-09-24,8.02,8.01,168,83,99,Nausea,None,Worsened,0
9293,PT-09293,45,M,Fortis Mumbai,Phase IV,ORX-303,Cardiology,Placebo,2024-03-30,2024-04-27,7.74,6.84,94,60,76,Fever,Severe,Improved,1
9294,PT-09294,41,F,Kolkata Clinical Center,Phase IV,ORX-303,Cardiology,Placebo,2023-05-22,2023-05-29,5.78,5.13,136,97,68,None,None,No Change,0
9295,PT-09295,51,F,PGI Chandigarh,Phase II,ORX-505,Infectious Disease,High Dose,2023-03-03,2023-04-28,9.29,9.56,114,83,80,Nausea,None,No Change,0
9296,PT-09296,55,F,NIMHANS Bengaluru,Phase IV,ORX-404,Neurology,High Dose,2024-10-04,2024-10-11,7.25,7.28,146,69,59,None,None,Worsened,0
9297,PT-09297,54,F,Bhopal Research Hospital,Phase I,ORX-303,Cardiology,Low Dose,2023-09-23,2023-10-21,7.02,7.39,147,59,66,Rash,Moderate,Worsened,0
9298,PT-09298,42,F,AIIMS Delhi,Phase III,ORX-202,Diabetes,High Dose,2024-11-03,2024-12-29,5.97,5.15,104,76,64,Nausea,None,No Change,0
9299,PT-09299,50,F,Kolkata Clinical Center,Phase IV,ORX-303,Cardiology,Placebo,2023-03-31,2023-05-26,8.28,8.25,174,93,90,None,None,Improved,1
9300,PT-09300,43,M,Kolkata Clinical Center,Phase IV,ORX-404,Neurology,High Dose,2024-11-28,2025-01-23,6.83,7.58,123,82,75,None,None,No Change,0
9301,PT-09301,53,F,AIIMS Delhi,Phase III,ORX-505,Infectious Disease,Low Dose,2023-02-22,2023-05-23,8.27,8.83,122,84,82,Headache,Moderate,Improved,0
9302,PT-09302,68,M,Indore Medical Institute,Phase III,ORX-101,Oncology,Low Dose,2023-08-15,2023-08-22,5.06,4.67,116,75,66,Rash,None,Improved,1
9303,PT-09303,53,M,Fortis Mumbai,Phase II,ORX-505,Infectious Disease,Placebo,2023-06-18,2023-07-16,4.26,3.73,95,73,75,Fatigue,Mild,Improved,1
9304,PT-09304,38,F,NIMHANS Bengaluru,Phase III,ORX-606,Rheumatology,Low Dose,2024-02-19,2024-03-18,8.02,8.74,163,81,94,None,None,Improved,0
9305,PT-09305,68,F,NIMHANS Bengaluru,Phase II,ORX-404,Neurology,Placebo,2023-01-12,2023-01-19,6.63,7.34,90,85,100,None,None,Improved,0
9306,PT-09306,46,F,Kolkata Clinical Center,Phase II,ORX-505,Infectious Disease,Placebo,2024-04-08,2024-06-03,6.97,6.4,154,62,72,Nausea,None,Improved,1
9307,PT-09307,58,M,Bhopal Research Hospital,Phase II,ORX-202,Diabetes,Low Dose,2024-06-06,2024-07-04,7.58,8.25,140,76,86,None,None,Worsened,0
9308,PT-09308,23,F,Apollo Chennai,Phase IV,ORX-505,Infectious Disease,Low Dose,2024-10-02,2024-11-27,4.78,3.83,129,72,80,Fatigue,None,Worsened,0
9309,PT-09309,45,M,PGI Chandigarh,Phase III,ORX-303,Cardiology,Placebo,2023-02-28,2023-03-28,4.97,4.08,144,87,68,Nausea,None,Improved,1
9310,PT-09310,54,M,PGI Chandigarh,Phase II,ORX-606,Rheumatology,Low Dose,2024-06-08,2024-06-15,9.31,8.52,141,89,71,None,None,Worsened,0
9311,PT-09311,26,F,Kolkata Clinical Center,Phase III,ORX-606,Rheumatology,Placebo,2024-07-14,2024-10-12,9.18,9.76,122,96,85,None,None,Worsened,0
9312,PT-09312,64,M,PGI Chandigarh,Phase III,ORX-101,Oncology,High Dose,2023-01-02,2023-01-16,5.05,4.28,156,113,72,None,None,Improved,1
9313,PT-09313,38,M,PGI Chandigarh,Phase IV,ORX-202,Diabetes,Low Dose,2023-03-04,2023-03-11,8.02,7.93,137,56,74,Rash,Mild,Improved,1
9314,PT-09314,57,M,Indore Medical Institute,Phase I,ORX-101,Oncology,Low Dose,2024-10-12,2024-12-07,4.37,2.52,96,89,64,Headache,Moderate,Improved,1
9315,PT-09315,25,F,PGI Chandigarh,Phase III,ORX-505,Infectious Disease,Placebo,2024-04-08,2024-04-22,7.27,5.75,136,110,72,None,None,No Change,0
9316,PT-09316,18,M,Apollo Chennai,Phase I,ORX-505,Infectious Disease,Placebo,2024-02-13,2024-02-20,6.66,6.7,135,92,69,None,None,No Change,0
9317,PT-09317,40,F,Bhopal Research Hospital,Phase II,ORX-505,Infectious Disease,Placebo,2023-11-03,2023-12-01,4.26,4.41,104,84,65,Fever,Mild,Worsened,0
9318,PT-09318,43,M,AIIMS Delhi,Phase II,ORX-202,Diabetes,Placebo,2023-10-31,2023-12-26,8.35,7.56,114,82,69,Nausea,None,Improved,1
9319,PT-09319,29,M,PGI Chandigarh,Phase II,ORX-606,Rheumatology,Placebo,2024-06-09,2024-07-07,9.44,7.37,139,80,66,Headache,Severe,Improved,1
9320,PT-09320,50,F,Bhopal Research Hospital,Phase III,ORX-505,Infectious Disease,High Dose,2024-02-24,2024-05-24,7.24,8.03,107,75,92,None,None,No Change,0
9321,PT-09321,41,M,NIMHANS Bengaluru,Phase IV,ORX-505,Infectious Disease,Low Dose,2023-03-13,2023-03-20,7.86,8.55,138,74,73,Headache,Mild,Worsened,0
9322,PT-09322,64,M,Kolkata Clinical Center,Phase III,ORX-303,Cardiology,Placebo,2024-05-17,2024-05-24,7.39,6.8,134,66,74,Headache,Severe,Improved,1
9323,PT-09323,43,M,Fortis Mumbai,Phase II,ORX-101,Oncology,Low Dose,2023-06-29,2023-08-24,7.09,6.33,122,80,98,None,None,Improved,1
9324,PT-09324,18,M,Fortis Mumbai,Phase III,ORX-303,Cardiology,Placebo,2024-10-16,2024-12-11,8.04,7.56,126,77,85,Nausea,None,Improved,1
9325,PT-09325,60,M,Bhopal Research Hospital,Phase II,ORX-606,Rheumatology,Placebo,2023-02-18,2023-03-18,4.92,6.41,130,83,58,Nausea,None,Improved,0
9326,PT-09326,35,M,Apollo Chennai,Phase II,ORX-101,Oncology,Placebo,2024-02-08,2024-04-04,8.83,8.49,135,76,105,None,None,Improved,1
9327,PT-09327,42,M,NIMHANS Bengaluru,Phase III,ORX-101,Oncology,High Dose,2023-03-18,2023-04-15,8.56,8.02,134,86,90,None,None,No Change,0
9328,PT-09328,56,M,NIMHANS Bengaluru,Phase III,ORX-404,Neurology,Placebo,2023-09-07,2023-09-14,6.63,7.27,110,67,73,Headache,None,No Change,0
9329,PT-09329,51,M,Apollo Chennai,Phase III,ORX-606,Rheumatology,Low Dose,2023-04-18,2023-07-17,5.97,5.5,103,78,91,Dizziness,None,Improved,1
9330,PT-09330,31,F,Fortis Mumbai,Phase IV,ORX-202,Diabetes,Low Dose,2023-09-17,2023-09-24,5.73,5.67,113,111,80,None,None,Worsened,0
9331,PT-09331,61,M,NIMHANS Bengaluru,Phase II,ORX-202,Diabetes,Placebo,2024-10-03,2024-11-28,5.62,5.63,109,79,67,None,None,Worsened,0
9332,PT-09332,61,F,NIMHANS Bengaluru,Phase III,ORX-202,Diabetes,High Dose,2024-10-04,2024-10-18,7.59,7.29,152,82,92,None,None,Improved,1
9333,PT-09333,73,M,Kolkata Clinical Center,Phase III,ORX-303,Cardiology,High Dose,2023-02-08,2023-04-05,7.37,7.2,145,99,79,None,None,Improved,1
9334,PT-09334,34,M,NIMHANS Bengaluru,Phase IV,ORX-303,Cardiology,High Dose,2023-12-30,2024-03-29,8.24,8.35,143,90,80,Fatigue,None,Improved,0
9335,PT-09335,49,F,Bhopal Research Hospital,Phase III,ORX-404,Neurology,High Dose,2023-11-01,2023-11-15,8.04,6.34,151,87,66,Headache,None,Worsened,0
9336,PT-09336,47,F,Fortis Mumbai,Phase II,ORX-505,Infectious Disease,High Dose,2024-07-12,2024-09-06,8.78,8.64,114,66,112,None,None,Improved,1
9337,PT-09337,18,M,PGI Chandigarh,Phase III,ORX-505,Infectious Disease,Placebo,2024-07-04,2024-07-18,7.6,6.68,146,67,100,Dizziness,Moderate,Worsened,0
9338,PT-09338,42,F,Indore Medical Institute,Phase III,ORX-505,Infectious Disease,Low Dose,2023-04-25,2023-05-09,6.94,6.25,117,77,88,Nausea,None,Improved,1
9339,PT-09339,18,F,Indore Medical Institute,Phase III,ORX-202,Diabetes,High Dose,2023-01-01,2023-04-01,6.3,7.25,126,75,60,Fatigue,Mild,Improved,0
9340,PT-09340,26,F,Indore Medical Institute,Phase II,ORX-202,Diabetes,Low Dose,2024-06-15,2024-06-29,8.38,7.24,142,70,76,None,None,Improved,1
9341,PT-09341,43,F,Bhopal Research Hospital,Phase I,ORX-303,Cardiology,High Dose,2024-06-19,2024-06-26,6.3,5.96,90,80,84,Nausea,Mild,Improved,1
9342,PT-09342,31,M,NIMHANS Bengaluru,Phase III,ORX-505,Infectious Disease,Low Dose,2023-12-08,2023-12-15,7.46,7.19,131,65,79,None,None,Improved,1
9343,PT-09343,18,F,Apollo Chennai,Phase III,ORX-606,Rheumatology,Placebo,2024-05-24,2024-06-07,6.44,6.04,131,67,74,Dizziness,Mild,Worsened,0
9344,PT-09344,57,M,AIIMS Delhi,Phase IV,ORX-505,Infectious Disease,High Dose,2024-04-15,2024-04-29,6.02,3.69,137,70,69,None,None,No Change,0
9345,PT-09345,47,F,Kolkata Clinical Center,Phase II,ORX-303,Cardiology,Low Dose,2024-02-04,2024-05-04,7.29,7.81,123,82,54,None,None,Improved,0
9346,PT-09346,55,F,Indore Medical Institute,Phase III,ORX-606,Rheumatology,Low Dose,2023-08-11,2023-10-06,6.37,8.88,124,87,86,None,None,No Change,0
9347,PT-09347,43,F,PGI Chandigarh,Phase I,ORX-303,Cardiology,Placebo,2023-03-14,2023-06-12,7.72,9.35,114,55,59,Nausea,Mild,Improved,0
9348,PT-09348,60,F,Kolkata Clinical Center,Phase II,ORX-404,Neurology,Low Dose,2023-09-26,2023-10-10,6.63,8.32,141,74,67,Fever,None,No Change,0
9349,PT-09349,37,M,Bhopal Research Hospital,Phase IV,ORX-505,Infectious Disease,Placebo,2024-09-19,2024-12-18,4.72,4.57,140,70,56,None,None,Worsened,0
9350,PT-09350,30,M,AIIMS Delhi,Phase III,ORX-404,Neurology,High Dose,2023-06-08,2023-09-06,8.4,8.72,131,101,54,Nausea,Severe,Worsened,0
9351,PT-09351,41,F,Kolkata Clinical Center,Phase IV,ORX-202,Diabetes,Placebo,2024-11-16,2025-01-11,7.87,8.18,142,90,96,None,None,No Change,0
9352,PT-09352,57,M,Bhopal Research Hospital,Phase I,ORX-202,Diabetes,Placebo,2024-03-25,2024-04-22,5.81,5.01,97,93,94,None,None,Worsened,0
9353,PT-09353,25,M,Bhopal Research Hospital,Phase I,ORX-404,Neurology,High Dose,2024-09-12,2024-11-07,6.74,4.76,125,72,61,None,None,Worsened,0
9354,PT-09354,44,M,Apollo Chennai,Phase III,ORX-505,Infectious Disease,High Dose,2024-02-16,2024-03-15,9.46,9.77,123,81,104,Fever,Mild,Improved,0
9355,PT-09355,65,M,Fortis Mumbai,Phase I,ORX-202,Diabetes,Low Dose,2023-06-06,2023-09-04,6.83,6.88,110,82,88,None,None,No Change,0
9356,PT-09356,61,M,PGI Chandigarh,Phase III,ORX-202,Diabetes,Placebo,2023-11-10,2023-12-08,6.43,6.93,130,78,104,None,None,Improved,0
9357,PT-09357,39,F,Kolkata Clinical Center,Phase I,ORX-202,Diabetes,Low Dose,2024-04-01,2024-04-08,5.87,4.87,141,70,89,Rash,Moderate,Improved,1
9358,PT-09358,31,F,AIIMS Delhi,Phase II,ORX-202,Diabetes,High Dose,2023-04-15,2023-07-14,7.11,8.7,112,57,97,None,None,Improved,0
9359,PT-09359,22,F,Kolkata Clinical Center,Phase II,ORX-505,Infectious Disease,High Dose,2024-05-12,2024-05-19,6.23,6.48,140,53,73,None,None,Improved,0
9360,PT-09360,58,F,Fortis Mumbai,Phase III,ORX-101,Oncology,High Dose,2023-01-10,2023-03-07,9.63,8.12,147,74,92,None,None,Improved,1
9361,PT-09361,28,F,NIMHANS Bengaluru,Phase III,ORX-606,Rheumatology,Low Dose,2023-03-07,2023-03-14,6.92,6.87,145,88,71,None,None,Improved,1
9362,PT-09362,36,M,PGI Chandigarh,Phase I,ORX-101,Oncology,Low Dose,2023-07-11,2023-08-08,9.33,9.18,119,88,86,Fatigue,None,No Change,0
9363,PT-09363,23,M,Fortis Mumbai,Phase III,ORX-101,Oncology,Low Dose,2024-01-03,2024-01-31,7.78,6.03,116,70,76,Fever,Mild,No Change,0
9364,PT-09364,38,F,Fortis Mumbai,Phase III,ORX-101,Oncology,Placebo,2024-04-12,2024-05-10,6.96,4.85,126,68,109,None,None,Improved,1
9365,PT-09365,38,F,PGI Chandigarh,Phase III,ORX-404,Neurology,Low Dose,2023-03-21,2023-05-16,6.89,7.12,151,67,86,Rash,None,No Change,0
9366,PT-09366,60,F,Kolkata Clinical Center,Phase III,ORX-202,Diabetes,Placebo,2023-03-26,2023-06-24,7.42,7.17,118,78,76,None,None,Improved,1
9367,PT-09367,38,F,PGI Chandigarh,Phase IV,ORX-202,Diabetes,Placebo,2024-10-27,2024-11-24,8.27,7.08,143,97,83,None,None,No Change,0
9368,PT-09368,18,M,Fortis Mumbai,Phase III,ORX-606,Rheumatology,Low Dose,2023-04-11,2023-04-25,7.93,6.96,118,86,93,Fever,Moderate,Improved,1
9369,PT-09369,18,F,NIMHANS Bengaluru,Phase III,ORX-101,Oncology,Low Dose,2023-05-11,2023-08-09,7.27,8.66,108,79,69,None,None,Worsened,0
9370,PT-09370,56,F,Apollo Chennai,Phase III,ORX-101,Oncology,Low Dose,2024-01-15,2024-01-22,5.7,3.89,142,84,61,None,None,Improved,1
9371,PT-09371,43,M,Kolkata Clinical Center,Phase III,ORX-303,Cardiology,High Dose,2023-05-06,2023-06-03,5.66,6.09,133,73,69,None,None,Worsened,0
9372,PT-09372,37,F,Bhopal Research Hospital,Phase I,ORX-606,Rheumatology,High Dose,2024-09-06,2024-10-04,5.91,6.72,148,77,73,Fatigue,None,No Change,0
9373,PT-09373,27,F,Bhopal Research Hospital,Phase III,ORX-505,Infectious Disease,High Dose,2023-11-24,2023-12-01,7.01,7.05,149,71,54,None,None,Improved,0
9374,PT-09374,28,F,Fortis Mumbai,Phase III,ORX-606,Rheumatology,Placebo,2023-07-21,2023-10-19,7.87,7.43,145,82,100,Rash,None,Improved,1
9375,PT-09375,19,M,Indore Medical Institute,Phase III,ORX-505,Infectious Disease,Low Dose,2024-05-14,2024-06-11,4.21,5.03,113,83,79,Headache,Severe,No Change,0
9376,PT-09376,50,F,AIIMS Delhi,Phase IV,ORX-101,Oncology,Low Dose,2023-11-02,2024-01-31,6.63,5.37,109,89,88,None,None,No Change,0
9377,PT-09377,40,F,Indore Medical Institute,Phase I,ORX-303,Cardiology,Low Dose,2023-05-06,2023-08-04,6.48,6.6,101,105,84,None,None,Improved,0
9378,PT-09378,42,M,NIMHANS Bengaluru,Phase III,ORX-202,Diabetes,Low Dose,2023-08-19,2023-11-17,8.2,8.36,132,59,83,None,None,No Change,0
9379,PT-09379,68,F,Fortis Mumbai,Phase I,ORX-606,Rheumatology,Placebo,2024-04-18,2024-05-16,6.53,7.0,143,85,80,Headache,None,No Change,0
9380,PT-09380,53,F,AIIMS Delhi,Phase II,ORX-303,Cardiology,High Dose,2023-10-03,2023-10-10,7.7,9.0,145,90,92,Dizziness,None,Improved,0
9381,PT-09381,56,M,NIMHANS Bengaluru,Phase III,ORX-303,Cardiology,Low Dose,2024-04-29,2024-05-13,4.7,4.2,116,85,70,None,None,Worsened,0
9382,PT-09382,54,F,Kolkata Clinical Center,Phase II,ORX-505,Infectious Disease,Placebo,2024-07-26,2024-08-23,6.69,7.82,157,64,82,Headache,Severe,Worsened,0
9383,PT-09383,37,F,Kolkata Clinical Center,Phase I,ORX-303,Cardiology,High Dose,2023-01-11,2023-02-08,7.5,7.63,104,70,66,None,None,No Change,0
9384,PT-09384,36,M,Apollo Chennai,Phase III,ORX-606,Rheumatology,Low Dose,2024-04-13,2024-04-20,6.57,6.89,132,71,73,None,None,Improved,0
9385,PT-09385,18,F,Apollo Chennai,Phase II,ORX-101,Oncology,Low Dose,2024-07-05,2024-10-03,9.62,9.24,145,91,77,Headache,Mild,No Change,0
9386,PT-09386,18,M,Apollo Chennai,Phase III,ORX-505,Infectious Disease,Placebo,2024-03-08,2024-03-22,6.53,6.45,129,94,77,None,None,No Change,0
9387,PT-09387,74,M,PGI Chandigarh,Phase II,ORX-505,Infectious Disease,Low Dose,2024-07-14,2024-10-12,5.93,5.99,109,92,67,None,None,Worsened,0
9388,PT-09388,18,M,AIIMS Delhi,Phase I,ORX-606,Rheumatology,High Dose,2023-09-19,2023-11-14,5.42,4.59,156,90,84,Headache,Moderate,No Change,0
9389,PT-09389,43,M,Bhopal Research Hospital,Phase III,ORX-606,Rheumatology,Low Dose,2024-09-26,2024-10-24,5.85,4.61,118,74,68,None,None,Improved,1
9390,PT-09390,29,M,Indore Medical Institute,Phase III,ORX-404,Neurology,Placebo,2023-08-09,2023-11-07,7.21,6.13,148,95,86,None,None,No Change,0
9391,PT-09391,52,F,Fortis Mumbai,Phase III,ORX-606,Rheumatology,High Dose,2023-05-30,2023-08-28,5.34,7.0,122,91,89,None,None,No Change,0
9392,PT-09392,28,F,AIIMS Delhi,Phase III,ORX-505,Infectious Disease,Low Dose,2023-03-15,2023-05-10,6.45,6.4,100,80,45,Headache,Mild,Improved,1
9393,PT-09393,45,M,Apollo Chennai,Phase IV,ORX-505,Infectious Disease,Low Dose,2023-03-12,2023-05-07,8.85,8.45,101,75,86,None,None,Improved,1
9394,PT-09394,47,M,Fortis Mumbai,Phase III,ORX-101,Oncology,High Dose,2024-01-26,2024-02-23,7.74,7.19,114,83,78,None,None,Improved,1
9395,PT-09395,61,F,Indore Medical Institute,Phase III,ORX-303,Cardiology,Low Dose,2023-01-09,2023-03-06,6.64,6.28,125,109,67,None,None,Improved,1
9396,PT-09396,38,F,NIMHANS Bengaluru,Phase III,ORX-505,Infectious Disease,High Dose,2023-07-31,2023-08-14,6.05,6.82,152,79,94,None,None,No Change,0
9397,PT-09397,50,M,Fortis Mumbai,Phase I,ORX-404,Neurology,High Dose,2024-01-20,2024-03-16,8.04,6.75,130,104,98,Headache,None,Worsened,0
9398,PT-09398,57,F,Indore Medical Institute,Phase III,ORX-101,Oncology,High Dose,2024-05-30,2024-06-27,8.34,10.13,142,74,94,None,None,No Change,0
9399,PT-09399,43,F,Bhopal Research Hospital,Phase III,ORX-303,Cardiology,High Dose,2024-01-22,2024-04-21,7.79,7.49,115,85,91,Nausea,None,No Change,0
9400,PT-09400,56,M,Bhopal Research Hospital,Phase II,ORX-202,Diabetes,Placebo,2024-01-05,2024-02-02,7.78,7.2,98,81,85,Headache,Mild,Improved,1
9401,PT-09401,18,M,PGI Chandigarh,Phase II,ORX-202,Diabetes,Low Dose,2023-11-16,2023-12-14,7.12,6.63,111,91,91,None,None,Improved,1
9402,PT-09402,74,M,PGI Chandigarh,Phase II,ORX-505,Infectious Disease,Low Dose,2024-11-15,2024-11-29,7.17,7.93,113,77,87,None,None,Improved,0
9403,PT-09403,34,M,Indore Medical Institute,Phase III,ORX-303,Cardiology,High Dose,2024-02-24,2024-04-20,7.01,7.36,127,70,69,None,None,Improved,0
9404,PT-09404,40,F,Apollo Chennai,Phase III,ORX-505,Infectious Disease,Placebo,2024-06-26,2024-07-10,7.91,7.21,90,91,87,None,None,Improved,1
9405,PT-09405,27,M,NIMHANS Bengaluru,Phase III,ORX-202,Diabetes,High Dose,2024-01-01,2024-01-15,5.84,6.66,123,91,68,None,None,No Change,0
9406,PT-09406,55,F,Kolkata Clinical Center,Phase III,ORX-303,Cardiology,Low Dose,2024-02-04,2024-02-18,6.09,6.07,134,57,79,Headache,None,No Change,0
9407,PT-09407,33,M,NIMHANS Bengaluru,Phase II,ORX-101,Oncology,Low Dose,2023-10-07,2023-12-02,8.51,8.32,123,100,51,None,None,No Change,0
9408,PT-09408,75,F,Indore Medical Institute,Phase III,ORX-101,Oncology,Placebo,2024-05-02,2024-07-31,9.45,8.7,143,87,45,None,None,Improved,1
9409,PT-09409,43,M,Kolkata Clinical Center,Phase II,ORX-404,Neurology,Placebo,2024-01-20,2024-04-19,5.68,4.06,122,78,95,None,None,Improved,1
9410,PT-09410,32,M,AIIMS Delhi,Phase IV,ORX-505,Infectious Disease,Placebo,2024-06-02,2024-07-28,6.73,7.56,124,75,89,None,None,Worsened,0
9411,PT-09411,53,F,AIIMS Delhi,Phase III,ORX-101,Oncology,High Dose,2024-02-10,2024-03-09,7.32,7.75,105,75,105,None,None,Improved,0
9412,PT-09412,18,M,NIMHANS Bengaluru,Phase II,ORX-202,Diabetes,Placebo,2023-04-19,2023-05-17,6.39,4.93,129,89,93,Headache,Mild,No Change,0
9413,PT-09413,38,F,Kolkata Clinical Center,Phase II,ORX-404,Neurology,Low Dose,2024-02-01,2024-02-08,6.09,4.39,128,107,69,None,None,Improved,1
9414,PT-09414,43,F,Fortis Mumbai,Phase III,ORX-101,Oncology,High Dose,2024-04-14,2024-04-21,7.36,6.58,153,96,89,None,None,No Change,0
9415,PT-09415,60,M,PGI Chandigarh,Phase I,ORX-101,Oncology,High Dose,2024-01-04,2024-04-03,6.38,4.94,115,85,73,None,None,Worsened,0
9416,PT-09416,54,F,Kolkata Clinical Center,Phase III,ORX-303,Cardiology,High Dose,2023-11-22,2023-12-06,7.33,5.72,150,75,89,None,None,Improved,1
9417,PT-09417,31,F,Bhopal Research Hospital,Phase II,ORX-303,Cardiology,High Dose,2024-01-03,2024-02-28,6.14,,102,65,83,Headache,Mild,Improved,1
9418,PT-09418,30,M,Kolkata Clinical Center,Phase III,ORX-505,Infectious Disease,Low Dose,2023-10-14,2023-11-11,7.62,7.31,143,69,92,None,None,No Change,0
9419,PT-09419,30,M,Bhopal Research Hospital,Phase IV,ORX-505,Infectious Disease,High Dose,2023-09-16,2023-09-23,3.91,3.68,112,99,82,Nausea,None,No Change,0
9420,PT-09420,43,M,Fortis Mumbai,Phase III,ORX-303,Cardiology,High Dose,2023-08-16,2023-08-30,7.44,6.59,158,75,84,Rash,Severe,No Change,0
9421,PT-09421,31,F,PGI Chandigarh,Phase IV,ORX-101,Oncology,High Dose,2024-02-17,2024-04-13,7.2,5.69,132,82,85,None,None,Worsened,0
9422,PT-09422,52,F,PGI Chandigarh,Phase III,ORX-505,Infectious Disease,Low Dose,2023-07-12,2023-07-19,7.23,8.67,127,82,76,None,None,No Change,0
9423,PT-09423,48,F,NIMHANS Bengaluru,Phase II,ORX-606,Rheumatology,Placebo,2023-04-19,2023-07-18,6.86,6.13,141,81,92,None,None,Worsened,0
9424,PT-09424,18,M,Apollo Chennai,Phase II,ORX-202,Diabetes,Low Dose,2023-05-09,2023-07-04,9.03,9.43,127,81,86,None,None,No Change,0
9425,PT-09425,28,M,AIIMS Delhi,Phase II,ORX-101,Oncology,High Dose,2023-12-03,2023-12-31,7.25,6.99,91,86,59,None,None,Improved,1
9426,PT-09426,62,F,PGI Chandigarh,Phase III,ORX-202,Diabetes,Placebo,2024-02-08,2024-02-22,8.81,9.77,122,77,50,None,None,Improved,0
9427,PT-09427,55,F,Bhopal Research Hospital,Phase I,ORX-404,Neurology,Placebo,2024-11-17,2024-11-24,5.39,3.69,122,68,64,None,None,Improved,1
9428,PT-09428,45,F,PGI Chandigarh,Phase III,ORX-404,Neurology,High Dose,2024-02-11,2024-02-25,8.26,8.34,131,95,79,Fatigue,Mild,Improved,0
9429,PT-09429,36,M,NIMHANS Bengaluru,Phase III,ORX-202,Diabetes,High Dose,2023-02-08,2023-02-22,6.28,6.37,108,86,72,Headache,None,Improved,0
9430,PT-09430,31,F,NIMHANS Bengaluru,Phase III,ORX-101,Oncology,High Dose,2023-10-08,2023-10-15,6.17,6.64,112,78,71,Fatigue,Mild,No Change,0
9431,PT-09431,61,F,Kolkata Clinical Center,Phase II,ORX-101,Oncology,Low Dose,2024-07-27,2024-08-24,9.05,9.46,121,86,65,None,None,Improved,0
9432,PT-09432,48,F,Fortis Mumbai,Phase II,ORX-202,Diabetes,High Dose,2024-04-08,2024-07-07,5.09,4.9,127,87,77,None,None,Improved,1
9433,PT-09433,58,F,Fortis Mumbai,Phase III,ORX-101,Oncology,High Dose,2024-07-05,2024-10-03,6.28,6.56,136,95,94,None,None,Improved,0
9434,PT-09434,29,F,PGI Chandigarh,Phase I,ORX-404,Neurology,Low Dose,2024-03-09,2024-06-07,7.82,6.37,148,71,72,Nausea,None,Improved,1
9435,PT-09435,48,F,Indore Medical Institute,Phase II,ORX-606,Rheumatology,High Dose,2023-09-20,2023-12-19,8.09,8.02,141,82,81,None,None,Improved,1
9436,PT-09436,18,F,Kolkata Clinical Center,Phase III,ORX-101,Oncology,Low Dose,2024-06-20,2024-07-18,8.43,7.77,120,105,45,Headache,Moderate,Improved,1
9437,PT-09437,46,F,Fortis Mumbai,Phase III,ORX-202,Diabetes,Placebo,2023-07-03,2023-07-10,4.51,4.42,115,50,93,Nausea,None,No Change,0
9438,PT-09438,24,M,AIIMS Delhi,Phase III,ORX-505,Infectious Disease,Low Dose,2023-12-06,2023-12-13,8.34,7.06,119,54,83,Dizziness,Moderate,No Change,0
9439,PT-09439,35,M,NIMHANS Bengaluru,Phase III,ORX-404,Neurology,High Dose,2023-07-10,2023-09-04,6.76,6.27,98,90,70,None,None,No Change,0
9440,PT-09440,81,F,Fortis Mumbai,Phase III,ORX-101,Oncology,High Dose,2023-02-20,2023-02-27,6.62,5.87,103,62,90,None,None,Improved,1
9441,PT-09441,61,F,AIIMS Delhi,Phase II,ORX-101,Oncology,High Dose,2024-10-05,2024-10-19,6.52,6.23,150,85,84,Dizziness,None,Worsened,0
9442,PT-09442,46,F,Indore Medical Institute,Phase IV,ORX-303,Cardiology,High Dose,2024-05-22,2024-07-17,6.42,6.36,161,75,90,Nausea,None,No Change,0
9443,PT-09443,47,M,NIMHANS Bengaluru,Phase III,ORX-303,Cardiology,Placebo,2023-10-29,2023-11-26,6.49,6.9,142,88,102,Dizziness,None,Improved,0
9444,PT-09444,74,F,NIMHANS Bengaluru,Phase IV,ORX-505,Infectious Disease,Low Dose,2024-08-26,2024-11-24,7.26,6.77,102,100,76,None,None,Worsened,0
9445,PT-09445,35,M,Fortis Mumbai,Phase IV,ORX-505,Infectious Disease,Placebo,2023-11-29,2023-12-06,6.08,4.83,159,92,57,None,None,Improved,1
9446,PT-09446,21,F,NIMHANS Bengaluru,Phase III,ORX-505,Infectious Disease,High Dose,2024-11-24,2024-12-22,7.35,6.03,123,100,92,Nausea,Mild,Improved,1
9447,PT-09447,18,M,Apollo Chennai,Phase IV,ORX-404,Neurology,High Dose,2024-08-28,2024-09-25,5.99,5.81,148,72,83,None,None,Improved,1
9448,PT-09448,37,F,Fortis Mumbai,Phase II,ORX-202,Diabetes,Low Dose,2024-04-08,2024-04-15,9.3,9.46,124,64,63,Dizziness,None,Worsened,0
9449,PT-09449,18,M,Indore Medical Institute,Phase III,ORX-202,Diabetes,High Dose,2024-05-03,2024-05-17,7.53,7.73,140,74,95,None,None,Worsened,0
9450,PT-09450,70,M,AIIMS Delhi,Phase III,ORX-505,Infectious Disease,High Dose,2024-11-20,2024-11-27,6.4,7.06,130,75,95,None,None,No Change,0
9451,PT-09451,25,F,Fortis Mumbai,Phase IV,ORX-404,Neurology,High Dose,2024-09-06,2024-09-20,5.42,4.66,123,62,84,None,None,No Change,0
9452,PT-09452,32,F,Indore Medical Institute,Phase II,ORX-303,Cardiology,High Dose,2024-09-16,2024-09-23,5.63,5.81,120,94,84,None,None,No Change,0
9453,PT-09453,41,M,AIIMS Delhi,Phase III,ORX-505,Infectious Disease,Placebo,2024-08-22,2024-08-29,8.52,8.5,127,88,85,Nausea,Severe,No Change,0
9454,PT-09454,27,M,Apollo Chennai,Phase II,ORX-303,Cardiology,Placebo,2023-11-12,2024-02-10,10.03,9.69,129,60,79,None,None,No Change,0
9455,PT-09455,47,M,Fortis Mumbai,Phase I,ORX-505,Infectious Disease,High Dose,2024-05-09,2024-08-07,5.82,4.48,111,78,80,Rash,None,Improved,1
9456,PT-09456,41,F,PGI Chandigarh,Phase III,ORX-606,Rheumatology,High Dose,2024-01-03,2024-01-17,7.56,,137,86,81,None,None,Improved,0
9457,PT-09457,49,M,Fortis Mumbai,Phase II,ORX-202,Diabetes,High Dose,2023-11-06,2023-11-20,7.02,6.03,126,89,87,None,None,Improved,1
9458,PT-09458,53,F,Indore Medical Institute,Phase II,ORX-202,Diabetes,Low Dose,2024-07-28,2024-08-04,6.63,6.03,124,74,90,Fatigue,None,Worsened,0
9459,PT-09459,18,M,PGI Chandigarh,Phase I,ORX-303,Cardiology,High Dose,2024-05-17,2024-08-15,9.63,11.09,128,86,89,Rash,None,No Change,0
9460,PT-09460,32,M,Fortis Mumbai,Phase II,ORX-303,Cardiology,Low Dose,2024-11-14,2024-11-28,7.88,8.67,95,64,88,Rash,Mild,Improved,0
9461,PT-09461,40,F,Bhopal Research Hospital,Phase IV,ORX-303,Cardiology,Low Dose,2024-04-12,2024-07-11,6.74,6.04,107,77,59,Fatigue,None,Improved,1
9462,PT-09462,65,M,Fortis Mumbai,Phase IV,ORX-303,Cardiology,Placebo,2023-03-20,2023-03-27,7.36,7.06,139,115,63,None,None,Worsened,0
9463,PT-09463,18,M,PGI Chandigarh,Phase III,ORX-606,Rheumatology,High Dose,2024-06-22,2024-09-20,7.16,5.12,121,92,99,None,None,Improved,1
9464,PT-09464,19,F,Bhopal Research Hospital,Phase II,ORX-404,Neurology,High Dose,2024-06-17,2024-08-12,6.07,6.0,141,91,98,None,None,No Change,0
9465,PT-09465,56,F,Indore Medical Institute,Phase III,ORX-303,Cardiology,Low Dose,2023-05-22,2023-08-20,7.06,7.61,129,85,71,None,None,Worsened,0
9466,PT-09466,47,M,Kolkata Clinical Center,Phase IV,ORX-303,Cardiology,Low Dose,2023-07-11,2023-10-09,5.24,5.78,109,71,45,None,None,Improved,0
9467,PT-09467,31,F,AIIMS Delhi,Phase II,ORX-202,Diabetes,High Dose,2023-09-04,2023-12-03,6.05,5.85,104,76,68,None,None,Improved,1
9468,PT-09468,18,M,Indore Medical Institute,Phase IV,ORX-606,Rheumatology,Low Dose,2024-04-23,2024-05-07,7.49,6.89,128,91,78,None,None,Improved,1
9469,PT-09469,39,F,PGI Chandigarh,Phase III,ORX-505,Infectious Disease,Low Dose,2024-08-28,2024-09-25,8.31,7.61,118,90,67,Nausea,None,Improved,1
9470,PT-09470,63,M,Fortis Mumbai,Phase IV,ORX-101,Oncology,High Dose,2023-03-28,2023-04-04,7.39,8.4,126,93,55,None,None,No Change,0
9471,PT-09471,65,M,PGI Chandigarh,Phase II,ORX-101,Oncology,Placebo,2024-04-30,2024-05-14,8.03,,143,66,71,Fatigue,Moderate,Improved,1
9472,PT-09472,31,F,AIIMS Delhi,Phase III,ORX-606,Rheumatology,Low Dose,2023-02-15,2023-03-01,8.3,9.03,119,66,64,None,None,Improved,0
9473,PT-09473,46,F,Apollo Chennai,Phase I,ORX-606,Rheumatology,Placebo,2024-11-30,2025-01-25,7.24,6.53,113,101,69,None,None,Improved,1
9474,PT-09474,31,M,Indore Medical Institute,Phase III,ORX-202,Diabetes,Low Dose,2024-11-01,2025-01-30,8.58,7.92,137,71,85,None,None,Worsened,0
9475,PT-09475,56,M,Indore Medical Institute,Phase III,ORX-505,Infectious Disease,High Dose,2023-06-18,2023-08-13,5.86,4.98,111,75,100,None,None,Improved,1
9476,PT-09476,49,F,PGI Chandigarh,Phase III,ORX-202,Diabetes,High Dose,2023-08-12,2023-08-19,9.54,10.47,148,99,94,Headache,Severe,Improved,0
9477,PT-09477,72,M,AIIMS Delhi,Phase III,ORX-303,Cardiology,Low Dose,2024-03-22,2024-04-05,7.85,8.07,139,76,89,None,None,Improved,0
9478,PT-09478,65,F,Bhopal Research Hospital,Phase II,ORX-202,Diabetes,Placebo,2024-01-09,2024-03-05,6.48,5.31,118,98,74,None,None,No Change,0
9479,PT-09479,27,M,Bhopal Research Hospital,Phase III,ORX-101,Oncology,Placebo,2023-05-24,2023-08-22,5.95,4.74,115,65,86,None,None,Improved,1
9480,PT-09480,41,F,NIMHANS Bengaluru,Phase IV,ORX-505,Infectious Disease,Placebo,2023-03-14,2023-03-21,7.84,5.37,147,81,85,None,None,Improved,1
9481,PT-09481,69,F,NIMHANS Bengaluru,Phase III,ORX-101,Oncology,Placebo,2023-01-07,2023-04-07,7.64,9.14,94,78,52,None,None,Improved,0
9482,PT-09482,50,M,Kolkata Clinical Center,Phase III,ORX-101,Oncology,Low Dose,2023-08-25,2023-10-20,7.29,5.91,167,77,47,Rash,None,No Change,0
9483,PT-09483,55,F,AIIMS Delhi,Phase III,ORX-101,Oncology,High Dose,2024-08-08,2024-08-15,8.03,7.2,142,70,72,None,None,Improved,1
9484,PT-09484,51,F,Bhopal Research Hospital,Phase III,ORX-404,Neurology,High Dose,2023-03-24,2023-06-22,8.31,7.71,119,81,49,None,None,Improved,1
9485,PT-09485,40,F,Bhopal Research Hospital,Phase I,ORX-303,Cardiology,High Dose,2023-08-27,2023-09-10,4.82,3.67,102,88,67,None,None,Improved,1
9486,PT-09486,64,F,PGI Chandigarh,Phase III,ORX-303,Cardiology,Low Dose,2023-03-20,2023-03-27,4.98,4.36,129,87,108,Fatigue,None,Improved,1
9487,PT-09487,18,M,Fortis Mumbai,Phase III,ORX-101,Oncology,Placebo,2024-01-20,2024-02-03,6.29,7.69,111,87,64,None,None,No Change,0
9488,PT-09488,22,M,AIIMS Delhi,Phase III,ORX-505,Infectious Disease,Placebo,2023-04-11,2023-04-18,6.22,7.6,107,78,74,None,None,No Change,0
9489,PT-09489,59,M,Bhopal Research Hospital,Phase III,ORX-404,Neurology,Low Dose,2024-01-31,2024-03-27,8.55,8.25,90,71,61,Headache,None,Improved,1
9490,PT-09490,63,F,AIIMS Delhi,Phase III,ORX-303,Cardiology,Low Dose,2023-12-11,2024-01-08,6.09,7.21,135,95,109,Fatigue,Severe,Improved,0
9491,PT-09491,29,M,Fortis Mumbai,Phase III,ORX-202,Diabetes,Low Dose,2024-06-03,2024-07-01,5.26,,145,74,78,None,None,Improved,1
9492,PT-09492,64,M,Kolkata Clinical Center,Phase IV,ORX-505,Infectious Disease,Low Dose,2023-06-14,2023-08-09,8.54,7.62,132,70,57,None,None,Improved,1
9493,PT-09493,66,F,Bhopal Research Hospital,Phase III,ORX-303,Cardiology,Placebo,2023-05-30,2023-06-13,4.64,4.41,121,88,68,Dizziness,Moderate,No Change,0
9494,PT-09494,63,F,AIIMS Delhi,Phase III,ORX-404,Neurology,Placebo,2024-02-16,2024-04-12,6.93,7.84,131,69,85,None,None,Improved,0
9495,PT-09495,51,F,PGI Chandigarh,Phase III,ORX-303,Cardiology,High Dose,2024-03-03,2024-03-10,7.07,6.0,143,70,65,None,None,Improved,1
9496,PT-09496,53,M,Apollo Chennai,Phase III,ORX-505,Infectious Disease,Placebo,2024-09-10,2024-11-05,6.95,4.78,110,86,74,Fatigue,None,Improved,1
9497,PT-09497,43,F,PGI Chandigarh,Phase IV,ORX-606,Rheumatology,High Dose,2024-11-02,2024-11-09,7.51,7.53,130,50,77,Rash,Severe,Improved,0
9498,PT-09498,36,F,NIMHANS Bengaluru,Phase III,ORX-202,Diabetes,Placebo,2024-06-30,2024-09-28,7.24,7.8,108,82,84,None,None,Improved,0
9499,PT-09499,40,F,AIIMS Delhi,Phase III,ORX-202,Diabetes,High Dose,2023-04-26,2023-07-25,5.63,4.15,127,74,51,Headache,Mild,Improved,1
9500,PT-09500,32,F,Indore Medical Institute,Phase III,ORX-303,Cardiology,High Dose,2023-01-18,2023-02-15,5.64,5.91,101,99,108,None,None,Worsened,0
9501,PT-09501,33,F,Bhopal Research Hospital,Phase III,ORX-202,Diabetes,Placebo,2023-04-28,2023-05-26,6.46,6.91,147,76,71,None,None,Improved,0
9502,PT-09502,38,M,Bhopal Research Hospital,Phase IV,ORX-303,Cardiology,Low Dose,2024-06-10,2024-07-08,6.18,6.6,130,73,78,Headache,None,No Change,0
9503,PT-09503,38,M,Fortis Mumbai,Phase III,ORX-101,Oncology,High Dose,2023-04-22,2023-04-29,10.2,9.58,141,87,75,Nausea,Mild,No Change,0
9504,PT-09504,52,M,NIMHANS Bengaluru,Phase III,ORX-202,Diabetes,Low Dose,2023-11-03,2023-11-10,7.45,9.29,126,50,108,None,None,No Change,0
9505,PT-09505,36,M,Kolkata Clinical Center,Phase III,ORX-202,Diabetes,High Dose,2023-06-28,2023-08-23,7.3,6.41,117,68,49,Rash,None,Improved,1
9506,PT-09506,33,M,AIIMS Delhi,Phase III,ORX-202,Diabetes,Low Dose,2024-01-13,2024-03-09,7.82,5.94,137,109,82,Headache,None,No Change,0
9507,PT-09507,22,F,NIMHANS Bengaluru,Phase II,ORX-606,Rheumatology,Placebo,2023-05-13,2023-07-08,7.68,8.14,151,84,86,Headache,None,Improved,0
9508,PT-09508,58,F,Indore Medical Institute,Phase III,ORX-101,Oncology,Low Dose,2023-09-16,2023-12-15,7.92,7.81,116,93,70,Rash,None,No Change,0
9509,PT-09509,85,F,Fortis Mumbai,Phase III,ORX-101,Oncology,High Dose,2023-12-22,2023-12-29,6.43,6.75,105,76,69,Dizziness,Severe,Improved,0
9510,PT-09510,23,M,Apollo Chennai,Phase III,ORX-101,Oncology,Low Dose,2023-09-09,2023-09-23,6.51,6.44,123,96,64,Nausea,Mild,Improved,1
9511,PT-09511,56,F,Apollo Chennai,Phase III,ORX-505,Infectious Disease,Low Dose,2024-03-28,2024-04-04,6.49,7.11,142,94,75,None,None,Improved,0
9512,PT-09512,66,M,PGI Chandigarh,Phase III,ORX-202,Diabetes,Low Dose,2023-09-01,2023-09-08,5.21,5.21,130,92,76,Nausea,None,Improved,0
9513,PT-09513,29,F,Kolkata Clinical Center,Phase III,ORX-303,Cardiology,High Dose,2023-04-27,2023-05-25,5.89,5.48,123,92,91,None,None,Improved,1
9514,PT-09514,45,F,PGI Chandigarh,Phase II,ORX-101,Oncology,High Dose,2024-06-09,2024-07-07,7.23,7.79,123,79,59,Fatigue,None,No Change,0
9515,PT-09515,59,M,Bhopal Research Hospital,Phase I,ORX-202,Diabetes,Placebo,2024-07-24,2024-08-07,7.09,7.72,106,76,91,None,None,Improved,0
9516,PT-09516,50,M,Apollo Chennai,Phase II,ORX-202,Diabetes,Low Dose,2023-07-07,2023-10-05,5.78,6.21,104,91,64,Headache,None,No Change,0
9517,PT-09517,64,F,Kolkata Clinical Center,Phase I,ORX-202,Diabetes,High Dose,2023-03-17,2023-05-12,7.34,7.25,126,83,79,None,None,Improved,1
9518,PT-09518,56,F,NIMHANS Bengaluru,Phase IV,ORX-606,Rheumatology,Placebo,2024-07-23,2024-08-20,7.12,8.04,114,92,85,None,None,Improved,0
9519,PT-09519,64,M,Bhopal Research Hospital,Phase I,ORX-404,Neurology,Placebo,2024-07-02,2024-09-30,7.35,7.24,133,67,83,None,None,Improved,1
9520,PT-09520,85,F,NIMHANS Bengaluru,Phase II,ORX-101,Oncology,High Dose,2024-05-15,2024-06-12,9.13,8.03,95,82,93,Fatigue,Mild,No Change,0
9521,PT-09521,44,M,Kolkata Clinical Center,Phase III,ORX-303,Cardiology,Placebo,2023-09-01,2023-09-15,9.47,8.36,132,80,88,Headache,Moderate,Improved,1
9522,PT-09522,57,F,NIMHANS Bengaluru,Phase I,ORX-202,Diabetes,High Dose,2023-03-10,2023-04-07,8.63,8.11,150,86,97,Dizziness,Mild,No Change,0
9523,PT-09523,68,F,Apollo Chennai,Phase III,ORX-101,Oncology,Placebo,2023-04-21,2023-06-16,7.22,6.22,131,93,56,Dizziness,None,No Change,0
9524,PT-09524,37,F,Bhopal Research Hospital,Phase IV,ORX-606,Rheumatology,High Dose,2023-12-18,2024-02-12,8.02,5.29,109,74,76,Dizziness,Moderate,No Change,0
9525,PT-09525,39,M,Kolkata Clinical Center,Phase III,ORX-505,Infectious Disease,Placebo,2023-05-03,2023-08-01,6.84,5.24,159,74,51,Rash,Mild,Improved,1
9526,PT-09526,63,M,Kolkata Clinical Center,Phase III,ORX-303,Cardiology,Low Dose,2023-09-05,2023-10-03,6.27,4.78,140,75,80,Fever,None,Improved,1
9527,PT-09527,34,F,PGI Chandigarh,Phase II,ORX-505,Infectious Disease,Placebo,2024-04-11,2024-06-06,6.64,5.35,106,120,66,Headache,Mild,No Change,0
9528,PT-09528,21,F,Indore Medical Institute,Phase III,ORX-202,Diabetes,Low Dose,2023-12-20,2024-03-19,8.56,8.4,128,76,72,Fever,Mild,No Change,0
9529,PT-09529,40,M,PGI Chandigarh,Phase II,ORX-303,Cardiology,Low Dose,2024-09-15,2024-11-10,8.56,7.94,148,81,75,Headache,Moderate,No Change,0
9530,PT-09530,28,F,Kolkata Clinical Center,Phase III,ORX-101,Oncology,Low Dose,2023-07-03,2023-07-10,9.77,9.39,127,104,83,None,None,Improved,1
9531,PT-09531,53,F,Indore Medical Institute,Phase III,ORX-202,Diabetes,High Dose,2024-05-17,2024-05-24,7.27,6.17,149,65,64,None,None,No Change,0
9532,PT-09532,32,F,Fortis Mumbai,Phase I,ORX-606,Rheumatology,High Dose,2024-06-04,2024-07-30,7.5,7.09,94,109,88,None,None,No Change,0
9533,PT-09533,37,F,AIIMS Delhi,Phase III,ORX-505,Infectious Disease,High Dose,2024-02-04,2024-05-04,7.72,7.72,122,86,83,None,None,Worsened,0
9534,PT-09534,62,M,Bhopal Research Hospital,Phase II,ORX-404,Neurology,Low Dose,2024-07-24,2024-07-31,7.28,7.17,124,76,67,Nausea,Mild,Improved,1
9535,PT-09535,32,F,Bhopal Research Hospital,Phase I,ORX-606,Rheumatology,Placebo,2023-10-05,2023-10-19,6.64,6.03,146,77,73,None,None,Improved,1
9536,PT-09536,40,F,Bhopal Research Hospital,Phase I,ORX-404,Neurology,Low Dose,2024-06-14,2024-09-12,7.14,8.27,121,88,82,Nausea,Mild,Improved,0
9537,PT-09537,45,F,AIIMS Delhi,Phase III,ORX-101,Oncology,Placebo,2024-02-06,2024-02-20,6.05,6.12,93,69,70,Nausea,Moderate,No Change,0
9538,PT-09538,41,M,Kolkata Clinical Center,Phase IV,ORX-404,Neurology,Low Dose,2024-03-06,2024-04-03,7.3,8.15,139,84,73,None,None,Worsened,0
9539,PT-09539,39,F,Apollo Chennai,Phase I,ORX-202,Diabetes,High Dose,2023-06-06,2023-07-04,5.84,3.54,105,96,68,Rash,Moderate,No Change,0
9540,PT-09540,36,F,Kolkata Clinical Center,Phase III,ORX-202,Diabetes,High Dose,2023-06-10,2023-09-08,8.43,5.65,117,68,82,Nausea,None,Improved,1
9541,PT-09541,53,M,PGI Chandigarh,Phase II,ORX-303,Cardiology,Placebo,2023-11-09,2024-02-07,7.89,8.85,137,84,112,None,None,Improved,0
9542,PT-09542,18,F,PGI Chandigarh,Phase III,ORX-101,Oncology,Low Dose,2023-10-25,2023-11-08,9.84,11.01,125,73,68,None,None,No Change,0
9543,PT-09543,40,M,Kolkata Clinical Center,Phase I,ORX-404,Neurology,Low Dose,2024-09-09,2024-11-04,8.64,6.02,164,81,94,Fatigue,None,Improved,1
9544,PT-09544,25,M,Indore Medical Institute,Phase I,ORX-404,Neurology,Placebo,2024-04-11,2024-06-06,8.07,8.02,138,73,72,Nausea,None,Improved,1
9545,PT-09545,25,F,Bhopal Research Hospital,Phase II,ORX-606,Rheumatology,High Dose,2024-10-21,2024-12-16,8.12,8.93,133,50,96,None,None,No Change,0
9546,PT-09546,46,M,Kolkata Clinical Center,Phase II,ORX-202,Diabetes,High Dose,2023-09-08,2023-12-07,4.01,2.08,109,81,63,None,None,Improved,1
9547,PT-09547,30,F,Indore Medical Institute,Phase II,ORX-101,Oncology,Placebo,2023-03-06,2023-03-20,8.3,8.97,145,62,91,Nausea,Moderate,Improved,0
9548,PT-09548,37,M,Kolkata Clinical Center,Phase IV,ORX-303,Cardiology,High Dose,2024-09-14,2024-09-28,9.56,9.39,149,88,84,None,None,Improved,1
9549,PT-09549,39,M,Fortis Mumbai,Phase II,ORX-101,Oncology,Placebo,2023-11-09,2024-02-07,8.65,9.09,122,76,68,None,None,Improved,0
9550,PT-09550,58,F,Indore Medical Institute,Phase III,ORX-101,Oncology,Low Dose,2024-04-16,2024-06-11,7.48,7.34,121,99,57,Fever,Mild,Improved,1
9551,PT-09551,57,F,AIIMS Delhi,Phase II,ORX-303,Cardiology,Placebo,2024-09-17,2024-12-16,8.38,7.69,101,86,94,Dizziness,Mild,Worsened,0
9552,PT-09552,73,M,Bhopal Research Hospital,Phase II,ORX-303,Cardiology,Low Dose,2024-08-20,2024-11-18,7.99,7.04,140,88,82,Rash,Severe,No Change,0
9553,PT-09553,30,M,Indore Medical Institute,Phase II,ORX-101,Oncology,Placebo,2023-02-01,2023-03-29,7.92,7.94,171,83,101,None,None,Improved,0
9554,PT-09554,67,F,Fortis Mumbai,Phase IV,ORX-404,Neurology,Low Dose,2023-12-17,2023-12-24,7.26,7.97,113,79,70,None,None,Improved,0
9555,PT-09555,42,F,Indore Medical Institute,Phase I,ORX-202,Diabetes,High Dose,2023-10-06,2023-11-03,4.79,6.01,122,91,81,Rash,None,Improved,0
9556,PT-09556,40,M,Apollo Chennai,Phase I,ORX-202,Diabetes,Low Dose,2024-08-28,2024-10-23,5.67,4.44,123,76,64,Fever,Mild,No Change,0
9557,PT-09557,34,F,Bhopal Research Hospital,Phase I,ORX-101,Oncology,Low Dose,2024-06-25,2024-07-09,7.75,8.14,107,71,81,None,None,Improved,0
9558,PT-09558,42,F,Apollo Chennai,Phase IV,ORX-606,Rheumatology,Placebo,2023-07-10,2023-09-04,6.76,7.19,131,62,66,Nausea,None,Improved,0
9559,PT-09559,18,F,Indore Medical Institute,Phase III,ORX-404,Neurology,Placebo,2023-03-01,2023-03-15,6.98,5.39,96,57,105,Headache,None,Improved,1
9560,PT-09560,23,F,Apollo Chennai,Phase II,ORX-505,Infectious Disease,Low Dose,2024-11-21,2024-12-05,6.82,6.47,130,89,77,None,None,Worsened,0
9561,PT-09561,37,F,AIIMS Delhi,Phase III,ORX-606,Rheumatology,High Dose,2023-01-10,2023-02-07,7.46,7.25,128,89,69,Headache,Moderate,Improved,1
9562,PT-09562,41,F,Fortis Mumbai,Phase III,ORX-404,Neurology,Low Dose,2024-01-23,2024-02-06,5.61,4.99,116,94,57,None,None,No Change,0
9563,PT-09563,37,M,Fortis Mumbai,Phase I,ORX-101,Oncology,Placebo,2023-07-07,2023-09-01,6.57,6.77,105,82,79,None,None,Improved,0
9564,PT-09564,59,M,Kolkata Clinical Center,Phase IV,ORX-505,Infectious Disease,Low Dose,2023-09-12,2023-11-07,6.17,4.6,136,65,70,None,None,Worsened,0
9565,PT-09565,41,M,Fortis Mumbai,Phase II,ORX-505,Infectious Disease,Low Dose,2023-07-08,2023-07-15,7.94,6.15,122,82,65,None,None,Improved,1
9566,PT-09566,39,F,Apollo Chennai,Phase I,ORX-202,Diabetes,Low Dose,2023-11-07,2023-12-05,8.27,7.41,121,92,74,None,None,Improved,1
9567,PT-09567,66,M,Apollo Chennai,Phase III,ORX-202,Diabetes,Low Dose,2023-07-28,2023-10-26,5.23,4.59,141,73,74,Headache,None,Improved,1
9568,PT-09568,65,M,AIIMS Delhi,Phase II,ORX-202,Diabetes,Low Dose,2023-02-24,2023-03-24,6.27,6.3,141,82,78,None,None,No Change,0
9569,PT-09569,28,M,Apollo Chennai,Phase II,ORX-505,Infectious Disease,High Dose,2023-08-15,2023-10-10,8.08,6.55,135,75,72,Fatigue,None,Improved,1
9570,PT-09570,41,F,Fortis Mumbai,Phase III,ORX-303,Cardiology,Low Dose,2024-04-22,2024-05-20,7.8,8.81,130,73,57,None,None,Improved,0
9571,PT-09571,63,F,Indore Medical Institute,Phase III,ORX-101,Oncology,Placebo,2023-03-17,2023-06-15,7.41,6.8,129,91,72,None,None,Improved,1
9572,PT-09572,34,M,PGI Chandigarh,Phase II,ORX-505,Infectious Disease,High Dose,2023-08-23,2023-08-30,5.63,4.26,121,94,70,None,None,Improved,1
9573,PT-09573,49,F,Indore Medical Institute,Phase III,ORX-505,Infectious Disease,High Dose,2024-05-20,2024-08-18,8.55,8.49,163,82,75,Dizziness,Mild,No Change,0
9574,PT-09574,38,F,NIMHANS Bengaluru,Phase II,ORX-202,Diabetes,Placebo,2024-10-08,2024-10-22,9.59,10.29,101,107,84,Headache,Mild,Improved,0
9575,PT-09575,47,M,Apollo Chennai,Phase I,ORX-101,Oncology,Low Dose,2023-08-24,2023-11-22,7.82,6.56,131,78,72,Nausea,None,Improved,1
9576,PT-09576,60,M,Kolkata Clinical Center,Phase II,ORX-303,Cardiology,High Dose,2023-04-01,2023-05-27,6.88,6.57,133,93,95,Fever,None,No Change,0
9577,PT-09577,45,F,Bhopal Research Hospital,Phase III,ORX-101,Oncology,High Dose,2023-01-27,2023-02-03,6.75,8.06,90,92,75,Nausea,None,No Change,0
9578,PT-09578,54,F,Bhopal Research Hospital,Phase III,ORX-202,Diabetes,Placebo,2024-11-25,2025-02-23,7.25,8.0,135,64,57,None,None,Improved,0
9579,PT-09579,41,M,Apollo Chennai,Phase II,ORX-202,Diabetes,High Dose,2024-03-18,2024-04-01,7.93,8.71,115,55,84,Fatigue,None,Improved,0
9580,PT-09580,45,M,Bhopal Research Hospital,Phase III,ORX-404,Neurology,Placebo,2023-06-23,2023-07-21,7.37,5.98,149,72,82,None,None,No Change,0
9581,PT-09581,49,F,Apollo Chennai,Phase IV,ORX-505,Infectious Disease,Placebo,2023-08-16,2023-08-30,7.86,6.79,111,92,85,Fatigue,None,Improved,1
9582,PT-09582,50,M,Indore Medical Institute,Phase III,ORX-606,Rheumatology,High Dose,2024-08-31,2024-11-29,8.55,8.46,121,88,84,None,None,Improved,1
9583,PT-09583,52,F,Fortis Mumbai,Phase I,ORX-606,Rheumatology,Low Dose,2024-07-28,2024-08-25,6.14,4.86,143,80,50,Headache,Moderate,Improved,1
9584,PT-09584,23,M,AIIMS Delhi,Phase I,ORX-404,Neurology,Low Dose,2024-05-22,2024-08-20,5.62,6.18,127,82,73,Dizziness,Moderate,No Change,0
9585,PT-09585,28,F,Bhopal Research Hospital,Phase III,ORX-101,Oncology,Low Dose,2024-09-26,2024-10-03,8.11,8.3,115,98,88,Dizziness,Mild,Improved,0
9586,PT-09586,31,M,NIMHANS Bengaluru,Phase III,ORX-404,Neurology,Low Dose,2024-10-21,2024-12-16,6.86,6.12,133,64,68,None,None,Worsened,0
9587,PT-09587,57,F,Kolkata Clinical Center,Phase II,ORX-202,Diabetes,High Dose,2024-04-08,2024-04-22,5.3,4.72,105,92,82,Headache,Moderate,Improved,1
9588,PT-09588,21,M,AIIMS Delhi,Phase I,ORX-606,Rheumatology,High Dose,2023-04-20,2023-05-04,5.95,5.56,90,68,66,None,None,Improved,1
9589,PT-09589,65,F,Kolkata Clinical Center,Phase III,ORX-505,Infectious Disease,Placebo,2024-05-14,2024-06-11,6.51,6.7,119,90,56,Fever,Moderate,Worsened,0
9590,PT-09590,33,M,AIIMS Delhi,Phase II,ORX-202,Diabetes,Low Dose,2023-11-05,2023-12-31,7.07,6.83,133,84,85,Nausea,None,Worsened,0
9591,PT-09591,44,F,Apollo Chennai,Phase IV,ORX-606,Rheumatology,High Dose,2023-05-20,2023-07-15,7.41,6.1,98,68,54,None,None,Improved,1
9592,PT-09592,48,F,NIMHANS Bengaluru,Phase II,ORX-202,Diabetes,High Dose,2023-01-04,2023-01-18,8.33,7.07,146,87,70,Fever,None,No Change,0
9593,PT-09593,39,F,NIMHANS Bengaluru,Phase III,ORX-404,Neurology,High Dose,2023-09-21,2023-12-20,8.54,6.05,148,92,69,Headache,None,No Change,0
9594,PT-09594,43,F,NIMHANS Bengaluru,Phase III,ORX-505,Infectious Disease,High Dose,2024-06-06,2024-07-04,9.15,7.57,124,89,80,None,None,No Change,0
9595,PT-09595,45,M,Indore Medical Institute,Phase III,ORX-505,Infectious Disease,High Dose,2024-05-30,2024-08-28,9.38,7.98,108,51,62,Nausea,None,No Change,0
9596,PT-09596,34,M,Fortis Mumbai,Phase III,ORX-101,Oncology,High Dose,2023-08-09,2023-09-06,7.58,8.05,110,80,97,Headache,None,No Change,0
9597,PT-09597,42,F,Indore Medical Institute,Phase III,ORX-505,Infectious Disease,Low Dose,2024-08-06,2024-09-03,7.82,8.43,111,68,100,None,None,Worsened,0
9598,PT-09598,54,F,PGI Chandigarh,Phase III,ORX-404,Neurology,Placebo,2024-10-16,2024-10-30,5.61,4.26,124,98,91,None,None,No Change,0
9599,PT-09599,62,M,PGI Chandigarh,Phase III,ORX-505,Infectious Disease,High Dose,2023-02-16,2023-03-16,6.68,6.27,113,77,62,None,None,Improved,1
9600,PT-09600,31,F,Kolkata Clinical Center,Phase III,ORX-505,Infectious Disease,High Dose,2023-03-14,2023-06-12,6.33,5.8,135,101,72,None,None,Improved,1
9601,PT-09601,54,M,Bhopal Research Hospital,Phase I,ORX-202,Diabetes,Placebo,2024-05-15,2024-08-13,6.98,7.45,105,75,87,Rash,None,Improved,0
9602,PT-09602,54,M,Indore Medical Institute,Phase III,ORX-404,Neurology,High Dose,2023-03-06,2023-04-03,7.92,8.79,96,66,85,None,None,Improved,0
9603,PT-09603,58,M,Bhopal Research Hospital,Phase II,ORX-606,Rheumatology,Low Dose,2023-01-28,2023-02-25,7.99,10.02,111,86,77,None,None,Improved,0
9604,PT-09604,54,M,NIMHANS Bengaluru,Phase III,ORX-202,Diabetes,Low Dose,2024-03-16,2024-06-14,7.65,6.79,134,83,79,Nausea,None,Improved,1
9605,PT-09605,63,F,NIMHANS Bengaluru,Phase III,ORX-303,Cardiology,Placebo,2023-04-18,2023-07-17,10.18,8.05,151,89,67,Fatigue,None,No Change,0
9606,PT-09606,39,M,Kolkata Clinical Center,Phase III,ORX-505,Infectious Disease,High Dose,2024-11-20,2024-11-27,8.26,7.9,127,73,67,Fever,None,Worsened,0
9607,PT-09607,29,M,NIMHANS Bengaluru,Phase III,ORX-101,Oncology,Low Dose,2024-01-01,2024-01-15,6.59,6.07,134,72,88,Headache,None,Improved,1
9608,PT-09608,30,F,Bhopal Research Hospital,Phase III,ORX-202,Diabetes,Low Dose,2024-11-04,2024-11-18,8.12,6.94,164,89,89,Headache,None,Improved,1
9609,PT-09609,42,M,AIIMS Delhi,Phase I,ORX-505,Infectious Disease,Low Dose,2023-09-14,2023-09-28,7.93,6.4,110,78,99,Fatigue,None,No Change,0
9610,PT-09610,61,F,Fortis Mumbai,Phase II,ORX-101,Oncology,High Dose,2023-05-27,2023-08-25,4.52,3.23,126,97,81,None,None,Improved,1
9611,PT-09611,18,F,Fortis Mumbai,Phase I,ORX-505,Infectious Disease,Placebo,2023-03-08,2023-05-03,5.79,6.04,131,83,93,Fatigue,Mild,Worsened,0
9612,PT-09612,39,M,PGI Chandigarh,Phase III,ORX-606,Rheumatology,High Dose,2024-07-13,2024-09-07,8.04,9.12,132,71,72,Headache,None,No Change,0
9613,PT-09613,30,F,AIIMS Delhi,Phase III,ORX-505,Infectious Disease,Low Dose,2023-07-30,2023-08-13,4.51,3.4,139,82,97,Fever,Moderate,Improved,1
9614,PT-09614,47,F,AIIMS Delhi,Phase III,ORX-505,Infectious Disease,Placebo,2024-05-10,2024-05-24,8.26,6.28,120,78,66,Fatigue,None,Improved,1
9615,PT-09615,69,M,Indore Medical Institute,Phase IV,ORX-404,Neurology,Placebo,2024-07-26,2024-08-23,4.88,4.38,148,91,72,Dizziness,None,No Change,0
9616,PT-09616,30,F,Indore Medical Institute,Phase IV,ORX-606,Rheumatology,Placebo,2024-11-17,2025-02-15,8.51,7.64,113,94,82,Nausea,None,Improved,1
9617,PT-09617,39,F,AIIMS Delhi,Phase III,ORX-404,Neurology,High Dose,2024-06-01,2024-06-29,7.59,7.59,127,83,47,Headache,None,Improved,0
9618,PT-09618,43,F,Apollo Chennai,Phase I,ORX-303,Cardiology,High Dose,2024-07-06,2024-08-03,6.43,5.31,115,76,73,Headache,Moderate,Improved,1
9619,PT-09619,47,M,Kolkata Clinical Center,Phase III,ORX-404,Neurology,Placebo,2023-06-05,2023-06-19,6.32,6.39,141,90,91,Headache,None,Improved,0
9620,PT-09620,35,M,Bhopal Research Hospital,Phase IV,ORX-202,Diabetes,High Dose,2023-07-07,2023-07-14,6.88,6.7,120,68,70,None,None,Improved,1
9621,PT-09621,71,F,AIIMS Delhi,Phase III,ORX-202,Diabetes,Low Dose,2023-07-01,2023-07-29,6.31,5.19,118,88,82,None,None,Improved,1
9622,PT-09622,56,M,AIIMS Delhi,Phase II,ORX-606,Rheumatology,Placebo,2023-08-09,2023-08-16,10.24,10.58,144,116,84,None,None,Worsened,0
9623,PT-09623,38,F,PGI Chandigarh,Phase III,ORX-101,Oncology,High Dose,2023-12-24,2023-12-31,6.84,7.39,105,58,66,None,None,No Change,0
9624,PT-09624,58,F,Bhopal Research Hospital,Phase III,ORX-202,Diabetes,High Dose,2023-10-24,2024-01-22,7.91,7.37,147,89,82,Nausea,None,Improved,1
9625,PT-09625,44,M,NIMHANS Bengaluru,Phase I,ORX-202,Diabetes,Placebo,2023-08-05,2023-09-30,8.28,8.56,123,91,68,Nausea,None,Improved,0
9626,PT-09626,48,M,Fortis Mumbai,Phase III,ORX-303,Cardiology,Low Dose,2023-11-23,2024-02-21,7.68,6.98,130,89,62,None,None,Improved,1
9627,PT-09627,47,M,Bhopal Research Hospital,Phase IV,ORX-404,Neurology,High Dose,2024-09-07,2024-12-06,9.86,8.71,146,80,94,None,None,Worsened,0
9628,PT-09628,33,F,Kolkata Clinical Center,Phase I,ORX-404,Neurology,High Dose,2023-06-01,2023-08-30,7.21,8.8,124,89,86,None,None,Improved,0
9629,PT-09629,18,M,PGI Chandigarh,Phase III,ORX-404,Neurology,Low Dose,2023-07-19,2023-08-02,7.74,6.22,139,83,62,None,None,No Change,0
9630,PT-09630,25,M,Fortis Mumbai,Phase IV,ORX-303,Cardiology,Placebo,2024-08-27,2024-10-22,7.11,8.95,157,86,85,Fatigue,Mild,No Change,0
9631,PT-09631,54,M,Fortis Mumbai,Phase III,ORX-404,Neurology,High Dose,2024-03-12,2024-06-10,6.56,5.54,143,74,98,None,None,No Change,0
9632,PT-09632,23,F,AIIMS Delhi,Phase IV,ORX-404,Neurology,Low Dose,2024-07-13,2024-09-07,6.12,6.99,122,80,87,Nausea,Mild,Improved,0
9633,PT-09633,63,M,Kolkata Clinical Center,Phase III,ORX-606,Rheumatology,Low Dose,2024-04-03,2024-07-02,7.93,7.79,142,86,93,None,None,Improved,1
9634,PT-09634,85,F,PGI Chandigarh,Phase IV,ORX-303,Cardiology,Low Dose,2024-09-28,2024-10-05,7.81,6.63,146,80,82,Rash,None,No Change,0
9635,PT-09635,50,F,AIIMS Delhi,Phase III,ORX-202,Diabetes,Low Dose,2024-04-15,2024-05-13,6.5,5.77,90,80,85,Headache,Mild,Worsened,0
9636,PT-09636,45,F,NIMHANS Bengaluru,Phase III,ORX-101,Oncology,Placebo,2023-06-17,2023-07-15,6.65,6.59,111,69,85,Nausea,Mild,Improved,1
9637,PT-09637,54,M,Kolkata Clinical Center,Phase III,ORX-606,Rheumatology,Low Dose,2024-08-08,2024-11-06,7.81,7.14,147,68,73,Headache,None,No Change,0
9638,PT-09638,56,F,Apollo Chennai,Phase IV,ORX-202,Diabetes,High Dose,2024-04-18,2024-05-16,8.23,7.14,166,80,79,Dizziness,Moderate,Worsened,0
9639,PT-09639,60,F,Indore Medical Institute,Phase II,ORX-505,Infectious Disease,Low Dose,2023-09-26,2023-12-25,9.06,8.72,149,76,101,None,None,Improved,1
9640,PT-09640,45,M,PGI Chandigarh,Phase III,ORX-303,Cardiology,Placebo,2023-09-24,2023-11-19,7.58,6.87,131,73,77,None,None,No Change,0
9641,PT-09641,45,F,AIIMS Delhi,Phase I,ORX-606,Rheumatology,Low Dose,2024-08-03,2024-11-01,5.93,5.02,90,67,77,None,None,Worsened,0
9642,PT-09642,60,M,PGI Chandigarh,Phase I,ORX-505,Infectious Disease,High Dose,2023-12-08,2023-12-22,6.77,6.34,148,91,89,Nausea,Moderate,No Change,0
9643,PT-09643,46,M,PGI Chandigarh,Phase III,ORX-404,Neurology,High Dose,2024-01-31,2024-02-28,6.61,6.57,151,103,111,Rash,Mild,No Change,0
9644,PT-09644,69,M,NIMHANS Bengaluru,Phase II,ORX-202,Diabetes,Placebo,2024-06-25,2024-07-02,7.25,5.77,138,95,45,None,None,Improved,1
9645,PT-09645,21,M,Bhopal Research Hospital,Phase III,ORX-101,Oncology,High Dose,2024-04-08,2024-05-06,6.65,5.56,99,86,95,None,None,Worsened,0
9646,PT-09646,41,M,Bhopal Research Hospital,Phase I,ORX-101,Oncology,Placebo,2023-05-23,2023-08-21,5.21,4.99,108,69,91,Nausea,None,Improved,1
9647,PT-09647,64,F,Fortis Mumbai,Phase III,ORX-404,Neurology,Placebo,2023-06-15,2023-06-29,6.85,7.11,108,88,72,Headache,None,Improved,0
9648,PT-09648,23,M,Apollo Chennai,Phase III,ORX-505,Infectious Disease,Low Dose,2024-10-06,2024-10-13,6.11,6.08,101,78,92,Fatigue,None,Improved,1
9649,PT-09649,37,F,Fortis Mumbai,Phase II,ORX-404,Neurology,Placebo,2023-02-05,2023-04-02,5.35,4.7,140,66,94,None,None,Improved,1
9650,PT-09650,57,M,AIIMS Delhi,Phase III,ORX-505,Infectious Disease,High Dose,2024-09-25,2024-12-24,7.62,7.74,130,86,79,None,None,No Change,0
9651,PT-09651,59,M,Kolkata Clinical Center,Phase I,ORX-606,Rheumatology,Low Dose,2023-03-25,2023-04-22,8.75,7.61,115,77,69,None,None,Worsened,0
9652,PT-09652,63,M,PGI Chandigarh,Phase I,ORX-606,Rheumatology,Placebo,2023-08-26,2023-09-09,5.4,5.49,152,75,98,None,None,Improved,0
9653,PT-09653,63,F,PGI Chandigarh,Phase II,ORX-202,Diabetes,High Dose,2023-06-01,2023-06-08,6.78,7.12,113,68,71,Headache,None,No Change,0
9654,PT-09654,66,F,Fortis Mumbai,Phase IV,ORX-505,Infectious Disease,Low Dose,2024-08-31,2024-09-07,6.65,6.29,109,92,89,None,None,No Change,0
9655,PT-09655,33,M,Bhopal Research Hospital,Phase III,ORX-101,Oncology,Placebo,2023-10-03,2023-10-10,4.42,3.69,135,81,79,Rash,None,No Change,0
9656,PT-09656,50,M,Fortis Mumbai,Phase II,ORX-404,Neurology,High Dose,2024-05-13,2024-08-11,6.59,5.06,141,71,61,None,None,No Change,0
9657,PT-09657,53,F,Indore Medical Institute,Phase III,ORX-505,Infectious Disease,High Dose,2023-06-10,2023-08-05,5.87,4.74,156,101,94,None,None,No Change,0
9658,PT-09658,57,F,Apollo Chennai,Phase II,ORX-505,Infectious Disease,Placebo,2023-03-23,2023-06-21,8.59,9.95,147,85,90,Fatigue,None,Improved,0
9659,PT-09659,37,F,Bhopal Research Hospital,Phase III,ORX-505,Infectious Disease,Low Dose,2023-03-10,2023-05-05,7.38,7.15,125,78,96,None,None,Worsened,0
9660,PT-09660,29,M,PGI Chandigarh,Phase I,ORX-505,Infectious Disease,Placebo,2024-08-11,2024-10-06,7.38,5.82,91,96,96,Headache,None,Improved,1
9661,PT-09661,37,F,Fortis Mumbai,Phase II,ORX-404,Neurology,Low Dose,2024-06-03,2024-06-17,7.26,6.6,122,76,84,Fatigue,None,Improved,1
9662,PT-09662,38,M,Bhopal Research Hospital,Phase III,ORX-303,Cardiology,Low Dose,2023-01-10,2023-02-07,7.7,8.8,135,83,69,Headache,Mild,Improved,0
9663,PT-09663,44,M,Fortis Mumbai,Phase I,ORX-303,Cardiology,Low Dose,2023-06-08,2023-09-06,5.2,6.18,110,58,76,None,None,No Change,0
9664,PT-09664,50,F,PGI Chandigarh,Phase I,ORX-202,Diabetes,High Dose,2024-11-25,2025-02-23,8.79,8.61,144,93,89,Headache,Severe,Improved,1
9665,PT-09665,26,M,Indore Medical Institute,Phase III,ORX-303,Cardiology,Placebo,2024-10-13,2024-11-10,7.81,6.17,163,90,69,Headache,None,Improved,1
9666,PT-09666,51,M,Bhopal Research Hospital,Phase III,ORX-202,Diabetes,High Dose,2024-05-04,2024-08-02,5.99,4.19,143,70,75,None,None,Improved,1
9667,PT-09667,48,M,Bhopal Research Hospital,Phase II,ORX-303,Cardiology,High Dose,2023-08-15,2023-08-29,6.98,5.66,129,83,90,None,None,Improved,1
9668,PT-09668,84,F,Apollo Chennai,Phase II,ORX-101,Oncology,Low Dose,2024-03-23,2024-06-21,4.83,3.71,132,94,82,Nausea,None,No Change,0
9669,PT-09669,62,F,PGI Chandigarh,Phase II,ORX-404,Neurology,High Dose,2023-10-07,2024-01-05,5.42,4.74,154,71,45,None,None,Improved,1
9670,PT-09670,31,F,Indore Medical Institute,Phase III,ORX-101,Oncology,High Dose,2024-02-09,2024-05-09,7.72,7.26,104,73,59,None,None,Improved,1
9671,PT-09671,25,M,NIMHANS Bengaluru,Phase I,ORX-303,Cardiology,Placebo,2023-05-21,2023-06-04,6.15,5.84,90,98,76,None,None,No Change,0
9672,PT-09672,27,M,Fortis Mumbai,Phase III,ORX-101,Oncology,Low Dose,2024-01-10,2024-01-17,6.03,5.06,128,83,75,Headache,Mild,No Change,0
9673,PT-09673,32,M,Kolkata Clinical Center,Phase IV,ORX-303,Cardiology,Low Dose,2024-06-11,2024-08-06,7.19,4.92,106,73,59,None,None,Improved,1
9674,PT-09674,41,F,Kolkata Clinical Center,Phase III,ORX-404,Neurology,Low Dose,2024-02-08,2024-05-08,5.59,6.74,101,100,49,Nausea,None,Improved,0
9675,PT-09675,77,F,AIIMS Delhi,Phase II,ORX-202,Diabetes,Low Dose,2023-06-12,2023-07-10,7.9,8.21,103,78,74,None,None,Improved,0
9676,PT-09676,43,M,Kolkata Clinical Center,Phase I,ORX-101,Oncology,Placebo,2024-10-02,2024-10-16,8.73,8.95,125,93,94,Fatigue,None,No Change,0
9677,PT-09677,35,F,Kolkata Clinical Center,Phase III,ORX-505,Infectious Disease,Placebo,2023-09-08,2023-09-22,6.48,8.03,123,74,75,Headache,None,No Change,0
9678,PT-09678,62,F,PGI Chandigarh,Phase II,ORX-505,Infectious Disease,Low Dose,2024-08-10,2024-08-17,8.06,7.55,139,85,76,Rash,None,No Change,0
9679,PT-09679,40,M,Indore Medical Institute,Phase II,ORX-404,Neurology,High Dose,2023-10-25,2023-12-20,7.38,6.6,129,81,57,None,None,Improved,1
9680,PT-09680,36,F,AIIMS Delhi,Phase III,ORX-303,Cardiology,Placebo,2023-03-31,2023-04-07,6.89,8.16,125,85,108,Dizziness,None,No Change,0
9681,PT-09681,19,M,Apollo Chennai,Phase I,ORX-101,Oncology,High Dose,2024-01-14,2024-01-21,5.36,4.26,122,79,70,None,None,No Change,0
9682,PT-09682,25,M,NIMHANS Bengaluru,Phase III,ORX-505,Infectious Disease,High Dose,2023-04-27,2023-05-04,8.37,7.56,149,69,105,Headache,None,Improved,1
9683,PT-09683,18,M,AIIMS Delhi,Phase III,ORX-404,Neurology,High Dose,2023-04-18,2023-05-16,7.18,5.88,128,70,47,None,None,Improved,1
9684,PT-09684,32,M,Fortis Mumbai,Phase III,ORX-606,Rheumatology,Placebo,2023-07-11,2023-10-09,9.12,7.82,137,82,71,None,None,Worsened,0
9685,PT-09685,77,F,Fortis Mumbai,Phase II,ORX-101,Oncology,Placebo,2023-06-30,2023-07-28,6.82,6.58,129,100,57,None,None,Improved,1
9686,PT-09686,80,M,NIMHANS Bengaluru,Phase IV,ORX-101,Oncology,High Dose,2024-02-25,2024-03-24,9.02,8.98,139,79,80,Headache,None,No Change,0
9687,PT-09687,51,M,Indore Medical Institute,Phase II,ORX-505,Infectious Disease,Low Dose,2023-09-02,2023-10-28,6.11,7.08,132,83,65,None,None,Improved,0
9688,PT-09688,63,M,Fortis Mumbai,Phase III,ORX-202,Diabetes,High Dose,2024-06-04,2024-07-02,7.14,6.27,108,80,61,None,None,Improved,1
9689,PT-09689,50,M,Indore Medical Institute,Phase II,ORX-606,Rheumatology,Placebo,2023-06-27,2023-07-11,8.13,7.38,132,96,75,None,None,Improved,1
9690,PT-09690,43,F,AIIMS Delhi,Phase IV,ORX-404,Neurology,Low Dose,2023-11-11,2023-12-09,7.21,6.41,121,72,84,Dizziness,None,Improved,1
9691,PT-09691,43,F,PGI Chandigarh,Phase III,ORX-202,Diabetes,High Dose,2024-05-07,2024-06-04,7.92,8.44,109,71,87,Nausea,None,No Change,0
9692,PT-09692,40,F,Bhopal Research Hospital,Phase III,ORX-505,Infectious Disease,Low Dose,2024-04-05,2024-05-31,7.3,6.97,110,88,81,None,None,Worsened,0
9693,PT-09693,28,F,NIMHANS Bengaluru,Phase III,ORX-202,Diabetes,Low Dose,2023-07-29,2023-09-23,7.0,6.5,141,96,77,None,None,Improved,1
9694,PT-09694,18,F,Fortis Mumbai,Phase III,ORX-101,Oncology,High Dose,2023-12-25,2024-01-08,8.07,9.65,140,78,83,Fatigue,Moderate,No Change,0
9695,PT-09695,57,F,Fortis Mumbai,Phase I,ORX-505,Infectious Disease,Low Dose,2023-09-18,2023-09-25,7.34,8.12,107,77,84,Nausea,None,No Change,0
9696,PT-09696,56,F,NIMHANS Bengaluru,Phase III,ORX-505,Infectious Disease,Low Dose,2024-02-07,2024-05-07,6.54,5.74,116,73,85,Headache,Mild,No Change,0
9697,PT-09697,44,F,Bhopal Research Hospital,Phase II,ORX-606,Rheumatology,High Dose,2023-10-20,2024-01-18,8.76,7.37,125,90,82,Headache,Mild,No Change,0
9698,PT-09698,27,F,Indore Medical Institute,Phase II,ORX-606,Rheumatology,Placebo,2024-11-05,2024-11-12,8.58,8.27,162,80,94,Nausea,None,Worsened,0
9699,PT-09699,39,M,NIMHANS Bengaluru,Phase III,ORX-202,Diabetes,Low Dose,2024-04-29,2024-05-13,6.92,6.96,97,57,68,None,None,No Change,0
9700,PT-09700,24,F,Indore Medical Institute,Phase III,ORX-101,Oncology,Low Dose,2024-02-25,2024-03-10,4.49,4.76,113,77,79,None,None,Improved,0
9701,PT-09701,53,M,Bhopal Research Hospital,Phase IV,ORX-101,Oncology,High Dose,2023-07-01,2023-07-29,7.54,7.32,136,76,68,None,None,Improved,1
9702,PT-09702,18,M,Fortis Mumbai,Phase II,ORX-303,Cardiology,Low Dose,2023-01-01,2023-02-26,7.97,6.95,163,90,91,Headache,Moderate,Worsened,0
9703,PT-09703,56,M,PGI Chandigarh,Phase IV,ORX-505,Infectious Disease,Low Dose,2024-02-11,2024-04-07,7.84,7.87,138,84,69,Headache,None,Worsened,0
9704,PT-09704,26,M,Apollo Chennai,Phase I,ORX-606,Rheumatology,Low Dose,2023-02-14,2023-02-21,7.71,8.47,125,83,59,Headache,Moderate,No Change,0
9705,PT-09705,37,M,PGI Chandigarh,Phase II,ORX-505,Infectious Disease,Low Dose,2024-01-08,2024-03-04,5.73,4.28,129,81,89,Nausea,None,Improved,1
9706,PT-09706,57,F,NIMHANS Bengaluru,Phase III,ORX-101,Oncology,Placebo,2024-03-05,2024-04-02,6.15,4.01,110,73,85,Headache,Mild,Improved,1
9707,PT-09707,54,M,Bhopal Research Hospital,Phase II,ORX-101,Oncology,Placebo,2024-08-12,2024-10-07,7.14,7.41,174,80,74,None,None,No Change,0
9708,PT-09708,31,F,Bhopal Research Hospital,Phase I,ORX-606,Rheumatology,Placebo,2024-02-21,2024-03-06,7.58,8.21,119,77,70,None,None,Improved,0
9709,PT-09709,26,F,AIIMS Delhi,Phase I,ORX-101,Oncology,Placebo,2024-04-06,2024-05-04,7.36,7.11,127,104,83,Headache,Mild,Improved,1
9710,PT-09710,27,M,Kolkata Clinical Center,Phase II,ORX-202,Diabetes,Placebo,2023-04-19,2023-04-26,7.96,7.25,122,79,74,None,None,No Change,0
9711,PT-09711,49,M,PGI Chandigarh,Phase II,ORX-505,Infectious Disease,Low Dose,2024-05-09,2024-05-16,9.74,9.01,129,84,70,None,None,Improved,1
9712,PT-09712,38,F,PGI Chandigarh,Phase II,ORX-101,Oncology,Low Dose,2023-03-07,2023-03-21,8.39,7.53,112,103,61,Dizziness,None,Worsened,0
9713,PT-09713,59,M,PGI Chandigarh,Phase III,ORX-101,Oncology,Low Dose,2024-07-07,2024-07-14,6.96,5.46,121,79,55,Nausea,Mild,Improved,1
9714,PT-09714,51,M,PGI Chandigarh,Phase III,ORX-404,Neurology,Low Dose,2023-10-30,2024-01-28,7.59,6.88,136,84,96,None,None,No Change,0
9715,PT-09715,27,F,Fortis Mumbai,Phase III,ORX-404,Neurology,Placebo,2024-10-07,2024-10-21,6.85,7.35,137,54,54,None,None,Improved,0
9716,PT-09716,45,M,PGI Chandigarh,Phase II,ORX-606,Rheumatology,High Dose,2023-11-20,2024-02-18,9.17,8.38,139,82,86,None,None,Improved,1
9717,PT-09717,62,M,PGI Chandigarh,Phase III,ORX-404,Neurology,High Dose,2024-01-14,2024-04-13,8.33,8.75,116,80,85,None,None,No Change,0
9718,PT-09718,52,F,Fortis Mumbai,Phase III,ORX-303,Cardiology,High Dose,2023-01-31,2023-02-14,7.91,5.92,149,61,67,Nausea,None,Improved,1
9719,PT-09719,48,F,Fortis Mumbai,Phase III,ORX-303,Cardiology,High Dose,2023-04-21,2023-07-20,7.16,8.04,106,77,50,None,None,Improved,0
9720,PT-09720,47,F,Fortis Mumbai,Phase II,ORX-505,Infectious Disease,Placebo,2023-11-16,2023-12-14,6.95,5.43,151,94,79,None,None,No Change,0
9721,PT-09721,63,M,PGI Chandigarh,Phase IV,ORX-303,Cardiology,Placebo,2023-06-23,2023-06-30,7.09,7.33,143,69,84,None,None,Improved,0
9722,PT-09722,47,F,Bhopal Research Hospital,Phase III,ORX-505,Infectious Disease,High Dose,2023-10-19,2023-11-02,5.97,4.42,136,78,57,Headache,Mild,Worsened,0
9723,PT-09723,54,F,Kolkata Clinical Center,Phase III,ORX-606,Rheumatology,Low Dose,2023-09-23,2023-11-18,8.32,6.87,127,100,65,None,None,Improved,1
9724,PT-09724,72,F,NIMHANS Bengaluru,Phase II,ORX-404,Neurology,Placebo,2023-10-01,2023-10-29,6.81,6.35,102,65,68,None,None,Improved,1
9725,PT-09725,59,F,AIIMS Delhi,Phase III,ORX-202,Diabetes,Low Dose,2024-11-29,2025-01-24,10.01,11.95,125,77,64,Nausea,None,Worsened,0
9726,PT-09726,62,M,Kolkata Clinical Center,Phase III,ORX-606,Rheumatology,Placebo,2023-11-17,2023-11-24,6.33,5.72,136,87,69,Fever,Mild,Improved,1
9727,PT-09727,43,F,Apollo Chennai,Phase III,ORX-202,Diabetes,Placebo,2023-07-17,2023-09-11,6.5,5.35,109,64,83,None,None,Improved,1
9728,PT-09728,41,F,Indore Medical Institute,Phase II,ORX-202,Diabetes,Low Dose,2024-11-03,2024-11-17,5.84,4.33,105,74,93,Headache,Moderate,No Change,0
9729,PT-09729,34,F,PGI Chandigarh,Phase II,ORX-404,Neurology,Placebo,2023-12-20,2024-01-03,7.87,8.87,131,72,76,Rash,None,Improved,0
9730,PT-09730,44,M,Kolkata Clinical Center,Phase I,ORX-303,Cardiology,High Dose,2023-06-06,2023-06-13,9.27,7.31,148,61,89,None,None,Improved,1
9731,PT-09731,38,M,Bhopal Research Hospital,Phase III,ORX-404,Neurology,High Dose,2023-08-12,2023-08-19,9.39,9.6,138,70,103,None,None,No Change,0
9732,PT-09732,85,M,AIIMS Delhi,Phase III,ORX-303,Cardiology,High Dose,2023-01-15,2023-01-29,9.61,8.31,124,67,69,None,None,Improved,1
9733,PT-09733,49,M,Kolkata Clinical Center,Phase III,ORX-505,Infectious Disease,Placebo,2024-03-30,2024-04-27,8.08,8.16,97,81,85,None,None,No Change,0
9734,PT-09734,60,F,PGI Chandigarh,Phase II,ORX-606,Rheumatology,Placebo,2023-03-12,2023-03-19,7.71,7.75,123,85,114,Headache,None,No Change,0
9735,PT-09735,64,M,NIMHANS Bengaluru,Phase III,ORX-202,Diabetes,Low Dose,2023-07-10,2023-07-24,7.64,7.89,129,82,91,None,None,Improved,0
9736,PT-09736,35,F,NIMHANS Bengaluru,Phase III,ORX-202,Diabetes,Low Dose,2023-12-21,2023-12-28,7.04,5.41,141,94,86,None,None,Improved,1
9737,PT-09737,41,M,Fortis Mumbai,Phase IV,ORX-505,Infectious Disease,Low Dose,2023-02-20,2023-02-27,7.15,6.88,147,94,57,None,None,Improved,1
9738,PT-09738,30,M,Indore Medical Institute,Phase I,ORX-101,Oncology,Placebo,2024-11-27,2024-12-11,7.72,6.12,144,78,87,Nausea,None,Improved,1
9739,PT-09739,45,M,NIMHANS Bengaluru,Phase IV,ORX-606,Rheumatology,High Dose,2024-05-17,2024-05-31,7.08,5.7,118,80,75,None,None,Improved,1
9740,PT-09740,56,F,NIMHANS Bengaluru,Phase III,ORX-101,Oncology,High Dose,2023-06-05,2023-06-12,6.43,6.0,155,91,79,None,None,Improved,1
9741,PT-09741,21,M,Apollo Chennai,Phase II,ORX-606,Rheumatology,Placebo,2023-05-09,2023-05-16,5.55,5.73,141,58,87,Rash,None,Worsened,0
9742,PT-09742,36,M,AIIMS Delhi,Phase II,ORX-202,Diabetes,Placebo,2024-07-04,2024-08-01,6.71,7.11,141,80,87,Fever,Mild,Improved,0
9743,PT-09743,39,M,NIMHANS Bengaluru,Phase III,ORX-303,Cardiology,High Dose,2024-01-03,2024-04-02,6.25,6.99,151,74,70,Dizziness,None,No Change,0
9744,PT-09744,59,M,Fortis Mumbai,Phase III,ORX-202,Diabetes,Low Dose,2023-10-01,2023-11-26,6.37,6.69,109,78,91,None,None,Improved,0
9745,PT-09745,29,F,AIIMS Delhi,Phase II,ORX-505,Infectious Disease,High Dose,2024-07-10,2024-10-08,6.49,6.43,95,82,94,None,None,Improved,1
9746,PT-09746,58,F,AIIMS Delhi,Phase II,ORX-505,Infectious Disease,Placebo,2023-02-10,2023-02-24,7.14,6.76,154,98,76,None,None,Worsened,0
9747,PT-09747,34,F,AIIMS Delhi,Phase III,ORX-202,Diabetes,High Dose,2024-11-16,2024-11-30,8.23,8.85,152,89,73,Fatigue,None,Improved,0
9748,PT-09748,18,M,Fortis Mumbai,Phase III,ORX-606,Rheumatology,High Dose,2024-03-15,2024-03-22,9.53,10.57,114,84,74,None,None,No Change,0
9749,PT-09749,46,M,NIMHANS Bengaluru,Phase IV,ORX-606,Rheumatology,High Dose,2024-09-15,2024-09-22,6.72,6.94,107,77,90,None,None,No Change,0
9750,PT-09750,18,F,Fortis Mumbai,Phase IV,ORX-202,Diabetes,Low Dose,2023-02-02,2023-03-02,7.57,6.68,157,85,66,Nausea,Mild,Improved,1
9751,PT-09751,68,F,Apollo Chennai,Phase II,ORX-202,Diabetes,Low Dose,2023-04-29,2023-07-28,7.23,6.94,143,74,98,None,None,No Change,0
9752,PT-09752,54,F,Bhopal Research Hospital,Phase III,ORX-303,Cardiology,Low Dose,2023-07-13,2023-10-11,6.43,5.64,105,85,75,None,None,Worsened,0
9753,PT-09753,50,F,Kolkata Clinical Center,Phase III,ORX-303,Cardiology,High Dose,2023-09-02,2023-12-01,5.16,4.29,110,87,69,Fever,None,Improved,1
9754,PT-09754,52,F,AIIMS Delhi,Phase III,ORX-404,Neurology,High Dose,2024-03-17,2024-03-24,6.56,7.62,128,92,76,Headache,None,Improved,0
9755,PT-09755,59,F,Bhopal Research Hospital,Phase II,ORX-303,Cardiology,High Dose,2024-10-02,2024-12-31,6.27,5.83,119,104,61,None,None,No Change,0
9756,PT-09756,78,M,Kolkata Clinical Center,Phase IV,ORX-101,Oncology,High Dose,2024-07-23,2024-09-17,5.55,5.81,116,85,75,Fatigue,Mild,Worsened,0
9757,PT-09757,31,M,Indore Medical Institute,Phase IV,ORX-404,Neurology,Low Dose,2024-02-06,2024-03-05,7.3,6.52,138,69,84,Nausea,Mild,Worsened,0
9758,PT-09758,58,M,Indore Medical Institute,Phase II,ORX-202,Diabetes,High Dose,2024-11-15,2024-11-22,7.07,5.48,159,87,67,None,None,Improved,1
9759,PT-09759,52,F,PGI Chandigarh,Phase III,ORX-505,Infectious Disease,Low Dose,2024-10-17,2025-01-15,5.19,5.85,166,91,63,Headache,Mild,Improved,0
9760,PT-09760,18,M,Apollo Chennai,Phase II,ORX-303,Cardiology,Low Dose,2023-01-30,2023-02-13,8.84,8.3,120,95,69,Headache,Moderate,Improved,1
9761,PT-09761,57,M,Indore Medical Institute,Phase I,ORX-606,Rheumatology,Placebo,2024-07-21,2024-10-19,7.23,7.05,157,76,69,None,None,No Change,0
9762,PT-09762,41,F,AIIMS Delhi,Phase III,ORX-202,Diabetes,High Dose,2024-10-12,2024-11-09,5.76,6.2,142,81,65,Nausea,None,No Change,0
9763,PT-09763,18,F,NIMHANS Bengaluru,Phase IV,ORX-202,Diabetes,Low Dose,2023-12-03,2024-01-28,6.2,5.59,93,111,83,Nausea,Moderate,Improved,1
9764,PT-09764,53,F,Apollo Chennai,Phase III,ORX-606,Rheumatology,High Dose,2024-02-11,2024-03-10,7.02,7.28,122,80,97,None,None,Improved,0
9765,PT-09765,62,F,Indore Medical Institute,Phase III,ORX-101,Oncology,High Dose,2024-10-18,2024-10-25,7.19,8.61,126,75,79,Fatigue,Mild,No Change,0
9766,PT-09766,49,M,NIMHANS Bengaluru,Phase III,ORX-606,Rheumatology,Low Dose,2023-12-30,2024-03-29,5.77,5.81,166,93,87,None,None,Improved,0
9767,PT-09767,52,F,Indore Medical Institute,Phase I,ORX-202,Diabetes,Low Dose,2023-01-20,2023-01-27,6.0,4.71,130,76,57,Dizziness,Moderate,No Change,0
9768,PT-09768,39,F,Fortis Mumbai,Phase I,ORX-303,Cardiology,High Dose,2024-08-14,2024-08-21,7.74,7.86,113,81,83,None,None,No Change,0
9769,PT-09769,24,F,Kolkata Clinical Center,Phase I,ORX-404,Neurology,Placebo,2024-09-20,2024-10-18,6.27,5.86,111,78,112,Dizziness,None,Improved,1
9770,PT-09770,20,M,Apollo Chennai,Phase II,ORX-606,Rheumatology,Placebo,2024-06-16,2024-06-23,8.91,8.82,105,90,78,None,None,Improved,1
9771,PT-09771,64,M,NIMHANS Bengaluru,Phase IV,ORX-606,Rheumatology,Placebo,2023-01-27,2023-04-27,7.99,7.77,122,96,72,None,None,No Change,0
9772,PT-09772,22,F,NIMHANS Bengaluru,Phase II,ORX-505,Infectious Disease,High Dose,2024-02-07,2024-04-03,4.92,3.41,142,77,67,None,None,Improved,1
9773,PT-09773,38,M,Apollo Chennai,Phase III,ORX-505,Infectious Disease,Low Dose,2023-02-11,2023-02-25,8.2,8.37,130,74,72,Fatigue,None,Improved,0
9774,PT-09774,42,M,AIIMS Delhi,Phase IV,ORX-101,Oncology,Low Dose,2024-06-06,2024-06-13,6.13,5.63,110,86,84,Fatigue,None,Improved,1
9775,PT-09775,62,F,Fortis Mumbai,Phase III,ORX-505,Infectious Disease,High Dose,2024-08-25,2024-09-01,7.51,7.32,112,81,63,None,None,Improved,1
9776,PT-09776,18,F,Fortis Mumbai,Phase II,ORX-606,Rheumatology,High Dose,2023-10-26,2023-11-09,6.88,6.03,139,70,117,None,None,Improved,1
9777,PT-09777,37,M,Bhopal Research Hospital,Phase II,ORX-303,Cardiology,High Dose,2023-01-02,2023-04-02,7.12,6.21,142,79,64,Dizziness,None,Improved,1
9778,PT-09778,18,M,Indore Medical Institute,Phase II,ORX-202,Diabetes,Low Dose,2023-08-11,2023-09-08,7.89,8.07,134,79,73,None,None,No Change,0
9779,PT-09779,57,F,Apollo Chennai,Phase I,ORX-101,Oncology,Placebo,2024-06-06,2024-08-01,7.08,7.69,126,80,83,Nausea,None,Improved,0
9780,PT-09780,67,M,Fortis Mumbai,Phase II,ORX-101,Oncology,High Dose,2024-04-19,2024-07-18,8.61,8.17,121,67,87,None,None,No Change,0
9781,PT-09781,18,M,Apollo Chennai,Phase IV,ORX-202,Diabetes,High Dose,2023-09-22,2023-09-29,9.25,9.61,114,96,85,Rash,None,Worsened,0
9782,PT-09782,52,M,AIIMS Delhi,Phase III,ORX-202,Diabetes,High Dose,2024-08-24,2024-08-31,6.88,6.98,102,82,68,None,None,Improved,0
9783,PT-09783,40,F,Fortis Mumbai,Phase II,ORX-202,Diabetes,Low Dose,2023-01-20,2023-02-17,6.37,5.4,151,64,83,Headache,Severe,Improved,1
9784,PT-09784,26,M,Apollo Chennai,Phase I,ORX-101,Oncology,Placebo,2023-08-21,2023-08-28,8.79,8.77,102,86,68,None,None,No Change,0
9785,PT-09785,48,F,Fortis Mumbai,Phase I,ORX-303,Cardiology,High Dose,2024-07-01,2024-07-29,5.61,6.31,92,72,62,None,None,Improved,0
9786,PT-09786,51,F,Indore Medical Institute,Phase II,ORX-404,Neurology,High Dose,2023-12-30,2024-01-27,6.61,6.04,116,65,74,Dizziness,Mild,Worsened,0
9787,PT-09787,24,F,PGI Chandigarh,Phase III,ORX-606,Rheumatology,Low Dose,2024-07-24,2024-09-18,5.0,5.16,105,99,97,None,None,No Change,0
9788,PT-09788,59,M,NIMHANS Bengaluru,Phase III,ORX-303,Cardiology,Placebo,2023-06-18,2023-07-02,5.84,,90,71,89,Nausea,Moderate,Improved,0
9789,PT-09789,57,M,NIMHANS Bengaluru,Phase III,ORX-202,Diabetes,High Dose,2024-06-11,2024-07-09,6.33,5.22,124,80,71,None,None,Improved,1
9790,PT-09790,71,F,Apollo Chennai,Phase III,ORX-606,Rheumatology,Placebo,2023-11-03,2024-02-01,6.38,7.3,135,94,57,Fever,None,No Change,0
9791,PT-09791,61,M,AIIMS Delhi,Phase I,ORX-404,Neurology,Placebo,2024-10-17,2024-10-31,8.39,7.39,143,64,71,Nausea,None,Improved,1
9792,PT-09792,63,M,Apollo Chennai,Phase III,ORX-101,Oncology,Placebo,2023-02-13,2023-04-10,6.98,6.34,153,58,75,None,None,No Change,0
9793,PT-09793,43,F,PGI Chandigarh,Phase III,ORX-606,Rheumatology,Low Dose,2023-01-24,2023-04-24,6.24,7.08,111,71,45,Headache,Mild,No Change,0
9794,PT-09794,62,F,Bhopal Research Hospital,Phase II,ORX-606,Rheumatology,Placebo,2023-02-12,2023-04-09,6.8,6.11,124,96,100,None,None,Improved,1
9795,PT-09795,18,M,Fortis Mumbai,Phase IV,ORX-404,Neurology,Low Dose,2023-06-10,2023-09-08,6.64,5.22,123,80,53,Nausea,Mild,Improved,1
9796,PT-09796,50,M,Fortis Mumbai,Phase II,ORX-202,Diabetes,Placebo,2023-04-06,2023-06-01,6.66,6.96,128,61,86,None,None,Improved,0
9797,PT-09797,23,M,AIIMS Delhi,Phase III,ORX-505,Infectious Disease,Placebo,2023-08-09,2023-08-16,5.72,5.04,122,60,75,None,None,Improved,1
9798,PT-09798,43,F,Bhopal Research Hospital,Phase I,ORX-101,Oncology,High Dose,2024-06-11,2024-07-09,7.05,5.13,130,89,59,Rash,None,No Change,0
9799,PT-09799,27,M,AIIMS Delhi,Phase II,ORX-404,Neurology,Low Dose,2023-07-25,2023-08-22,8.14,9.17,125,76,80,None,None,Improved,0
9800,PT-09800,66,F,AIIMS Delhi,Phase IV,ORX-303,Cardiology,High Dose,2023-05-29,2023-08-27,6.18,5.34,118,64,89,Nausea,None,Improved,1
9801,PT-09801,49,M,Fortis Mumbai,Phase II,ORX-606,Rheumatology,High Dose,2023-04-16,2023-05-14,4.78,4.37,157,85,100,None,None,Improved,1
9802,PT-09802,36,F,Bhopal Research Hospital,Phase III,ORX-606,Rheumatology,Low Dose,2023-01-07,2023-01-14,8.36,9.14,126,77,93,None,None,Improved,0
9803,PT-09803,53,M,AIIMS Delhi,Phase III,ORX-101,Oncology,High Dose,2024-02-25,2024-03-10,8.34,8.32,126,80,73,None,None,Improved,1
9804,PT-09804,51,M,PGI Chandigarh,Phase III,ORX-303,Cardiology,Placebo,2023-09-02,2023-12-01,6.99,6.82,113,71,86,Nausea,Mild,Improved,1
9805,PT-09805,51,F,Bhopal Research Hospital,Phase III,ORX-404,Neurology,High Dose,2024-10-25,2024-11-01,6.68,7.52,113,87,84,None,None,No Change,0
9806,PT-09806,45,M,Bhopal Research Hospital,Phase II,ORX-101,Oncology,Placebo,2023-02-16,2023-05-17,8.72,9.78,107,54,71,Headache,Mild,Worsened,0
9807,PT-09807,29,M,NIMHANS Bengaluru,Phase III,ORX-404,Neurology,Low Dose,2024-07-15,2024-08-12,6.68,7.91,176,70,81,None,None,Improved,0
9808,PT-09808,48,M,NIMHANS Bengaluru,Phase III,ORX-101,Oncology,Low Dose,2023-02-23,2023-03-23,7.61,5.98,150,92,71,None,None,Improved,1
9809,PT-09809,64,M,Apollo Chennai,Phase III,ORX-202,Diabetes,Placebo,2023-03-02,2023-03-09,5.47,3.55,132,87,75,None,None,Improved,1
9810,PT-09810,62,M,Apollo Chennai,Phase II,ORX-202,Diabetes,High Dose,2023-07-18,2023-09-12,6.41,7.09,142,104,53,Fever,None,Improved,0
9811,PT-09811,37,F,Apollo Chennai,Phase III,ORX-303,Cardiology,Low Dose,2024-05-16,2024-06-13,6.11,6.41,156,77,86,None,None,No Change,0
9812,PT-09812,68,M,AIIMS Delhi,Phase I,ORX-303,Cardiology,High Dose,2024-05-24,2024-06-21,7.59,7.82,92,100,73,Rash,Mild,No Change,0
9813,PT-09813,85,F,Kolkata Clinical Center,Phase II,ORX-606,Rheumatology,Placebo,2024-03-18,2024-04-15,6.18,6.21,142,51,102,Dizziness,None,No Change,0
9814,PT-09814,56,F,Bhopal Research Hospital,Phase IV,ORX-202,Diabetes,Placebo,2023-02-21,2023-05-22,5.41,5.34,134,80,69,None,None,No Change,0
9815,PT-09815,43,M,AIIMS Delhi,Phase IV,ORX-101,Oncology,High Dose,2023-08-30,2023-09-06,8.23,8.57,128,84,76,None,None,Improved,0
9816,PT-09816,29,F,Kolkata Clinical Center,Phase I,ORX-303,Cardiology,High Dose,2023-08-16,2023-09-13,7.13,6.07,110,52,72,None,None,Improved,1
9817,PT-09817,57,M,Apollo Chennai,Phase II,ORX-606,Rheumatology,Placebo,2023-04-14,2023-06-09,8.67,8.67,104,80,61,Headache,Mild,No Change,0
9818,PT-09818,75,M,NIMHANS Bengaluru,Phase III,ORX-404,Neurology,Low Dose,2023-11-13,2023-11-27,6.74,5.89,144,81,93,None,None,Improved,1
9819,PT-09819,27,M,AIIMS Delhi,Phase I,ORX-404,Neurology,Low Dose,2023-02-21,2023-03-07,7.31,7.36,90,73,69,Nausea,Moderate,No Change,0
9820,PT-09820,45,F,AIIMS Delhi,Phase IV,ORX-505,Infectious Disease,Low Dose,2023-01-24,2023-03-21,6.83,6.69,123,95,107,Nausea,None,Improved,1
9821,PT-09821,20,M,NIMHANS Bengaluru,Phase III,ORX-303,Cardiology,Placebo,2023-09-21,2023-10-19,7.23,7.81,115,85,72,Dizziness,Mild,No Change,0
9822,PT-09822,28,F,Kolkata Clinical Center,Phase IV,ORX-404,Neurology,Low Dose,2023-04-07,2023-05-05,5.98,3.36,130,84,64,None,None,Improved,1
9823,PT-09823,40,F,Indore Medical Institute,Phase III,ORX-101,Oncology,High Dose,2023-04-03,2023-04-17,5.47,5.55,120,91,73,None,None,Worsened,0
9824,PT-09824,29,M,Apollo Chennai,Phase I,ORX-101,Oncology,High Dose,2024-07-23,2024-07-30,6.56,7.51,165,63,90,None,None,Worsened,0
9825,PT-09825,27,M,PGI Chandigarh,Phase III,ORX-606,Rheumatology,High Dose,2023-08-10,2023-08-24,6.29,6.08,136,73,86,None,None,Improved,1
9826,PT-09826,63,F,AIIMS Delhi,Phase III,ORX-505,Infectious Disease,Placebo,2024-02-21,2024-03-06,8.07,6.8,119,92,99,None,None,No Change,0
9827,PT-09827,24,F,Kolkata Clinical Center,Phase III,ORX-101,Oncology,Placebo,2024-11-17,2025-01-12,7.56,7.82,102,94,107,Fever,None,Improved,0
9828,PT-09828,55,F,Fortis Mumbai,Phase III,ORX-303,Cardiology,Placebo,2024-07-11,2024-07-25,7.88,6.8,119,74,65,Dizziness,Moderate,Improved,1
9829,PT-09829,41,M,NIMHANS Bengaluru,Phase IV,ORX-404,Neurology,Low Dose,2024-11-07,2025-02-05,7.57,6.4,121,85,48,None,None,Worsened,0
9830,PT-09830,60,F,PGI Chandigarh,Phase IV,ORX-303,Cardiology,Low Dose,2024-08-18,2024-10-13,7.46,7.26,148,93,86,Dizziness,None,Improved,1
9831,PT-09831,49,F,NIMHANS Bengaluru,Phase II,ORX-505,Infectious Disease,High Dose,2023-07-13,2023-09-07,7.19,6.27,110,86,83,None,None,Improved,1
9832,PT-09832,47,F,Fortis Mumbai,Phase II,ORX-606,Rheumatology,Placebo,2023-11-20,2023-12-04,5.59,2.8,129,59,82,None,None,Improved,1
9833,PT-09833,76,M,Bhopal Research Hospital,Phase III,ORX-202,Diabetes,Low Dose,2023-01-01,2023-01-15,7.6,6.8,109,75,77,Dizziness,None,No Change,0
9834,PT-09834,62,M,Kolkata Clinical Center,Phase III,ORX-101,Oncology,Low Dose,2023-02-18,2023-04-15,7.37,6.71,140,99,82,Nausea,None,Improved,1
9835,PT-09835,48,F,Fortis Mumbai,Phase IV,ORX-505,Infectious Disease,Placebo,2023-07-07,2023-10-05,5.21,,101,79,66,None,None,Improved,1
9836,PT-09836,37,M,Apollo Chennai,Phase II,ORX-606,Rheumatology,Placebo,2023-02-19,2023-03-19,6.18,5.1,94,84,87,None,None,Improved,1
9837,PT-09837,46,M,Bhopal Research Hospital,Phase IV,ORX-202,Diabetes,Placebo,2024-01-16,2024-01-30,7.64,7.66,135,92,94,None,None,Improved,0
9838,PT-09838,70,M,PGI Chandigarh,Phase II,ORX-404,Neurology,Low Dose,2024-04-04,2024-05-02,4.89,4.91,106,98,78,None,None,Worsened,0
9839,PT-09839,49,M,Kolkata Clinical Center,Phase II,ORX-303,Cardiology,Placebo,2024-05-22,2024-07-17,7.34,7.13,157,96,100,None,None,Improved,1
9840,PT-09840,41,M,Fortis Mumbai,Phase III,ORX-303,Cardiology,Placebo,2023-08-19,2023-11-17,4.65,4.92,107,77,77,None,None,No Change,0
9841,PT-09841,45,F,Kolkata Clinical Center,Phase II,ORX-505,Infectious Disease,High Dose,2023-04-26,2023-05-10,7.97,6.74,139,79,114,Dizziness,None,No Change,0
9842,PT-09842,19,F,Apollo Chennai,Phase II,ORX-404,Neurology,Low Dose,2024-06-13,2024-06-20,7.35,7.51,120,75,96,None,None,No Change,0
9843,PT-09843,58,M,NIMHANS Bengaluru,Phase III,ORX-404,Neurology,High Dose,2023-07-04,2023-07-11,6.24,4.51,138,85,85,None,None,Improved,1
9844,PT-09844,42,F,PGI Chandigarh,Phase IV,ORX-404,Neurology,Low Dose,2023-09-21,2023-10-05,8.23,9.27,155,72,112,None,None,Improved,0
9845,PT-09845,55,F,Indore Medical Institute,Phase I,ORX-505,Infectious Disease,High Dose,2023-03-07,2023-03-14,5.49,5.48,132,80,75,None,None,Improved,1
9846,PT-09846,56,F,PGI Chandigarh,Phase III,ORX-202,Diabetes,Low Dose,2024-11-29,2024-12-27,8.05,7.12,118,75,75,None,None,Improved,1
9847,PT-09847,59,F,Apollo Chennai,Phase II,ORX-505,Infectious Disease,Placebo,2023-01-22,2023-02-19,8.64,8.05,147,87,79,None,None,Improved,1
9848,PT-09848,74,F,NIMHANS Bengaluru,Phase IV,ORX-606,Rheumatology,High Dose,2024-03-25,2024-04-08,7.59,7.07,143,67,74,Rash,Mild,Improved,1
9849,PT-09849,49,M,PGI Chandigarh,Phase II,ORX-303,Cardiology,High Dose,2024-08-01,2024-10-30,8.06,7.88,104,71,71,Nausea,Mild,Worsened,0
9850,PT-09850,48,M,Bhopal Research Hospital,Phase II,ORX-202,Diabetes,Low Dose,2024-09-30,2024-10-14,5.64,6.51,133,85,75,Headache,None,Improved,0
9851,PT-09851,21,M,Indore Medical Institute,Phase IV,ORX-606,Rheumatology,Placebo,2023-03-27,2023-05-22,7.31,7.58,125,94,77,Nausea,None,No Change,0
9852,PT-09852,56,M,Apollo Chennai,Phase IV,ORX-101,Oncology,Low Dose,2024-01-22,2024-02-19,7.07,7.01,143,69,87,None,None,No Change,0
9853,PT-09853,61,M,Fortis Mumbai,Phase III,ORX-606,Rheumatology,Low Dose,2024-02-09,2024-02-23,9.83,9.49,90,60,65,Fatigue,Mild,Improved,1
9854,PT-09854,65,M,Apollo Chennai,Phase II,ORX-303,Cardiology,Low Dose,2023-09-03,2023-10-01,9.84,9.07,128,51,87,Fatigue,None,Improved,1
9855,PT-09855,47,F,PGI Chandigarh,Phase IV,ORX-303,Cardiology,Placebo,2024-05-28,2024-06-04,6.9,5.63,121,65,65,Nausea,Mild,No Change,0
9856,PT-09856,24,M,PGI Chandigarh,Phase I,ORX-202,Diabetes,Placebo,2023-03-04,2023-03-11,5.98,4.54,138,68,77,None,None,No Change,0
9857,PT-09857,27,F,Fortis Mumbai,Phase III,ORX-101,Oncology,Placebo,2023-11-23,2024-01-18,5.94,4.55,145,79,67,Rash,None,Worsened,0
9858,PT-09858,28,F,PGI Chandigarh,Phase III,ORX-606,Rheumatology,Low Dose,2024-03-14,2024-03-21,5.59,4.54,102,76,68,Fever,Moderate,Improved,1
9859,PT-09859,32,M,Apollo Chennai,Phase IV,ORX-101,Oncology,Placebo,2024-03-20,2024-04-17,8.69,8.07,124,97,58,None,None,Improved,1
9860,PT-09860,37,M,AIIMS Delhi,Phase III,ORX-505,Infectious Disease,High Dose,2024-01-07,2024-02-04,5.34,5.0,138,52,90,None,None,Worsened,0
9861,PT-09861,49,F,Apollo Chennai,Phase IV,ORX-101,Oncology,Placebo,2024-07-17,2024-10-15,7.24,5.73,141,102,72,Nausea,None,Worsened,0
9862,PT-09862,39,F,Fortis Mumbai,Phase III,ORX-101,Oncology,Placebo,2024-08-04,2024-08-18,7.23,6.47,124,94,77,None,None,Worsened,0
9863,PT-09863,49,F,Indore Medical Institute,Phase II,ORX-505,Infectious Disease,High Dose,2023-11-18,2024-01-13,9.64,10.56,109,102,97,Fatigue,None,No Change,0
9864,PT-09864,68,M,Apollo Chennai,Phase III,ORX-303,Cardiology,Placebo,2024-06-03,2024-07-29,6.45,6.24,120,83,102,Nausea,Mild,Improved,1
9865,PT-09865,47,F,Kolkata Clinical Center,Phase IV,ORX-202,Diabetes,Low Dose,2024-01-14,2024-04-13,5.14,4.4,116,103,66,None,None,No Change,0
9866,PT-09866,38,M,Kolkata Clinical Center,Phase III,ORX-505,Infectious Disease,High Dose,2024-07-24,2024-08-21,6.75,7.79,145,88,81,Fatigue,Mild,Improved,0
9867,PT-09867,48,M,PGI Chandigarh,Phase III,ORX-101,Oncology,Low Dose,2023-05-26,2023-06-02,7.29,8.74,105,50,84,None,None,Worsened,0
9868,PT-09868,67,M,Apollo Chennai,Phase IV,ORX-404,Neurology,Low Dose,2023-01-30,2023-03-27,7.42,5.24,141,69,60,Fatigue,None,Improved,1
9869,PT-09869,29,F,Bhopal Research Hospital,Phase II,ORX-202,Diabetes,Low Dose,2024-06-27,2024-09-25,5.27,5.05,116,66,111,Dizziness,None,Improved,1
9870,PT-09870,36,M,NIMHANS Bengaluru,Phase I,ORX-505,Infectious Disease,Low Dose,2023-06-03,2023-06-10,7.26,8.26,140,104,68,Nausea,None,No Change,0
9871,PT-09871,61,F,Kolkata Clinical Center,Phase II,ORX-404,Neurology,Placebo,2024-06-28,2024-08-23,7.79,8.28,143,72,117,Nausea,Mild,Improved,0
9872,PT-09872,18,M,PGI Chandigarh,Phase IV,ORX-101,Oncology,Low Dose,2024-04-13,2024-06-08,6.16,6.38,133,83,88,None,None,Improved,0
9873,PT-09873,31,M,Kolkata Clinical Center,Phase I,ORX-101,Oncology,High Dose,2023-01-19,2023-03-16,8.21,7.69,153,78,84,Fatigue,None,Worsened,0
9874,PT-09874,55,M,Fortis Mumbai,Phase II,ORX-505,Infectious Disease,Low Dose,2023-09-29,2023-10-06,8.29,7.92,122,72,84,Dizziness,None,Improved,1
9875,PT-09875,18,M,NIMHANS Bengaluru,Phase III,ORX-404,Neurology,Low Dose,2023-04-08,2023-06-03,7.57,7.52,161,74,80,None,None,Worsened,0
9876,PT-09876,47,F,Indore Medical Institute,Phase III,ORX-404,Neurology,Placebo,2024-07-28,2024-08-25,5.87,5.47,103,93,86,None,None,Improved,1
9877,PT-09877,51,F,NIMHANS Bengaluru,Phase II,ORX-101,Oncology,Low Dose,2023-06-13,2023-07-11,6.44,7.31,108,82,61,None,None,No Change,0
9878,PT-09878,42,M,Apollo Chennai,Phase III,ORX-606,Rheumatology,Placebo,2023-02-12,2023-03-12,8.73,8.75,111,75,72,Headache,None,Improved,0
9879,PT-09879,31,F,Bhopal Research Hospital,Phase III,ORX-202,Diabetes,Placebo,2024-10-14,2025-01-12,7.53,9.09,117,105,77,Rash,None,No Change,0
9880,PT-09880,50,M,Kolkata Clinical Center,Phase IV,ORX-505,Infectious Disease,Low Dose,2023-01-28,2023-04-28,7.51,5.59,136,52,80,None,None,Improved,1
9881,PT-09881,47,F,Fortis Mumbai,Phase III,ORX-505,Infectious Disease,Low Dose,2023-02-06,2023-02-20,5.36,5.02,122,80,75,Headache,Mild,Improved,1
9882,PT-09882,35,F,AIIMS Delhi,Phase II,ORX-606,Rheumatology,High Dose,2024-10-23,2024-10-30,7.29,7.67,123,81,87,Headache,None,No Change,0
9883,PT-09883,81,M,Kolkata Clinical Center,Phase III,ORX-606,Rheumatology,Placebo,2023-09-03,2023-12-02,6.97,5.04,111,89,99,Nausea,None,Improved,1
9884,PT-09884,29,M,Fortis Mumbai,Phase III,ORX-202,Diabetes,Placebo,2023-05-03,2023-05-17,7.15,6.77,114,100,94,None,None,No Change,0
9885,PT-09885,50,M,Fortis Mumbai,Phase I,ORX-202,Diabetes,Placebo,2023-05-15,2023-06-12,6.7,7.16,137,76,91,None,None,Improved,0
9886,PT-09886,50,F,Kolkata Clinical Center,Phase II,ORX-101,Oncology,Placebo,2023-09-24,2023-10-22,5.21,3.91,104,94,68,None,None,No Change,0
9887,PT-09887,55,M,Bhopal Research Hospital,Phase II,ORX-505,Infectious Disease,High Dose,2024-01-17,2024-02-14,9.81,10.12,120,73,73,Nausea,Mild,Improved,0
9888,PT-09888,28,M,PGI Chandigarh,Phase IV,ORX-101,Oncology,High Dose,2024-05-29,2024-06-26,5.83,4.7,137,75,74,None,None,Improved,1
9889,PT-09889,52,M,Fortis Mumbai,Phase II,ORX-101,Oncology,Placebo,2023-08-17,2023-10-12,8.07,5.94,96,77,62,None,None,No Change,0
9890,PT-09890,58,M,Kolkata Clinical Center,Phase II,ORX-303,Cardiology,Low Dose,2023-11-17,2023-12-15,6.64,7.86,119,85,68,None,None,No Change,0
9891,PT-09891,52,F,Fortis Mumbai,Phase II,ORX-303,Cardiology,High Dose,2024-06-09,2024-06-16,7.81,8.21,125,97,82,None,None,Improved,0
9892,PT-09892,34,F,NIMHANS Bengaluru,Phase I,ORX-606,Rheumatology,Low Dose,2023-05-19,2023-07-14,6.44,6.69,150,68,88,None,None,Improved,0
9893,PT-09893,21,M,Bhopal Research Hospital,Phase III,ORX-303,Cardiology,Low Dose,2023-01-14,2023-04-14,6.46,6.5,112,99,86,None,None,Worsened,0
9894,PT-09894,26,M,Bhopal Research Hospital,Phase II,ORX-303,Cardiology,Low Dose,2023-10-17,2023-10-24,7.99,6.4,128,92,87,None,None,Improved,1
9895,PT-09895,43,F,NIMHANS Bengaluru,Phase III,ORX-303,Cardiology,Low Dose,2024-08-29,2024-09-26,6.79,5.34,131,91,106,Nausea,Moderate,No Change,0
9896,PT-09896,37,M,Fortis Mumbai,Phase III,ORX-505,Infectious Disease,Low Dose,2023-09-23,2023-10-21,8.22,8.5,119,90,66,None,None,No Change,0
9897,PT-09897,49,M,Indore Medical Institute,Phase III,ORX-404,Neurology,Placebo,2023-02-16,2023-02-23,6.95,6.95,137,75,77,Fatigue,None,Improved,1
9898,PT-09898,42,F,Bhopal Research Hospital,Phase I,ORX-303,Cardiology,Low Dose,2024-05-23,2024-08-21,5.89,5.16,117,68,66,Nausea,Mild,Improved,1
9899,PT-09899,40,M,Kolkata Clinical Center,Phase III,ORX-101,Oncology,Placebo,2023-01-26,2023-02-09,7.27,5.75,149,89,76,None,None,No Change,0
9900,PT-09900,25,M,Apollo Chennai,Phase II,ORX-202,Diabetes,Low Dose,2023-01-16,2023-04-16,6.94,6.3,108,68,88,Fatigue,Moderate,Improved,1
9901,PT-09901,39,F,Apollo Chennai,Phase III,ORX-404,Neurology,Low Dose,2023-07-28,2023-08-25,8.26,7.85,141,90,84,None,None,No Change,0
9902,PT-09902,63,F,Fortis Mumbai,Phase I,ORX-505,Infectious Disease,High Dose,2023-12-14,2024-01-11,7.32,5.58,103,74,88,None,None,Improved,1
9903,PT-09903,38,M,Indore Medical Institute,Phase III,ORX-505,Infectious Disease,Low Dose,2023-01-27,2023-02-10,7.45,7.53,130,54,61,Fever,None,Improved,0
9904,PT-09904,73,F,NIMHANS Bengaluru,Phase III,ORX-404,Neurology,Placebo,2024-11-26,2024-12-24,7.59,4.76,129,103,81,None,None,Worsened,0
9905,PT-09905,45,F,Apollo Chennai,Phase III,ORX-404,Neurology,Low Dose,2023-05-14,2023-08-12,5.01,4.36,98,67,57,None,None,Improved,1
9906,PT-09906,72,F,Apollo Chennai,Phase III,ORX-404,Neurology,Low Dose,2023-01-06,2023-01-20,8.07,8.93,104,84,63,None,None,No Change,0
9907,PT-09907,30,M,Indore Medical Institute,Phase III,ORX-101,Oncology,Placebo,2023-09-19,2023-11-14,7.76,,133,66,79,None,None,Improved,1
9908,PT-09908,50,M,Indore Medical Institute,Phase III,ORX-303,Cardiology,High Dose,2024-06-04,2024-07-02,6.39,5.75,98,56,106,None,None,No Change,0
9909,PT-09909,48,M,PGI Chandigarh,Phase I,ORX-303,Cardiology,Low Dose,2024-05-13,2024-05-27,6.77,7.09,112,83,93,None,None,No Change,0
9910,PT-09910,27,F,PGI Chandigarh,Phase I,ORX-404,Neurology,Low Dose,2024-11-30,2025-02-28,6.61,4.97,143,84,94,Headache,None,Improved,1
9911,PT-09911,58,M,Apollo Chennai,Phase II,ORX-505,Infectious Disease,Placebo,2023-12-29,2024-02-23,6.89,6.86,135,90,98,Headache,Moderate,No Change,0
9912,PT-09912,27,F,Apollo Chennai,Phase II,ORX-505,Infectious Disease,Placebo,2024-03-31,2024-04-28,4.95,3.6,136,86,70,None,None,Improved,1
9913,PT-09913,40,F,Indore Medical Institute,Phase III,ORX-303,Cardiology,High Dose,2024-09-11,2024-10-09,6.2,5.7,115,101,96,Headache,Mild,No Change,0
9914,PT-09914,56,F,NIMHANS Bengaluru,Phase III,ORX-303,Cardiology,Low Dose,2023-04-11,2023-05-09,7.24,7.86,129,83,53,Headache,None,No Change,0
9915,PT-09915,49,F,PGI Chandigarh,Phase IV,ORX-202,Diabetes,Placebo,2024-01-31,2024-02-14,5.65,4.89,131,71,84,None,None,Improved,1
9916,PT-09916,61,F,NIMHANS Bengaluru,Phase III,ORX-505,Infectious Disease,High Dose,2023-09-22,2023-10-20,6.14,5.85,105,67,82,Nausea,Mild,Improved,1
9917,PT-09917,56,F,NIMHANS Bengaluru,Phase III,ORX-202,Diabetes,Low Dose,2024-06-13,2024-07-11,5.39,6.83,119,84,70,None,None,Improved,0
9918,PT-09918,40,M,PGI Chandigarh,Phase III,ORX-101,Oncology,High Dose,2023-07-13,2023-07-20,9.02,9.98,98,75,119,Headache,Mild,Worsened,0
9919,PT-09919,38,M,Apollo Chennai,Phase II,ORX-606,Rheumatology,High Dose,2024-11-14,2025-01-09,7.71,8.33,143,50,82,Dizziness,None,Improved,0
9920,PT-09920,72,M,Indore Medical Institute,Phase II,ORX-303,Cardiology,Low Dose,2024-01-10,2024-01-24,7.24,5.9,109,79,87,Nausea,Severe,Improved,1
9921,PT-09921,85,M,Bhopal Research Hospital,Phase IV,ORX-101,Oncology,Low Dose,2024-03-12,2024-04-09,6.85,6.96,100,61,71,None,None,Improved,0
9922,PT-09922,52,F,Indore Medical Institute,Phase III,ORX-404,Neurology,Low Dose,2023-01-17,2023-03-14,7.1,6.74,123,81,73,None,None,No Change,0
9923,PT-09923,23,M,AIIMS Delhi,Phase III,ORX-606,Rheumatology,High Dose,2023-07-07,2023-08-04,5.41,6.23,113,79,94,None,None,No Change,0
9924,PT-09924,40,M,Fortis Mumbai,Phase III,ORX-101,Oncology,Low Dose,2023-10-21,2024-01-19,8.25,7.05,155,84,77,Nausea,Mild,Worsened,0
9925,PT-09925,42,F,Indore Medical Institute,Phase III,ORX-101,Oncology,Low Dose,2024-05-10,2024-07-05,8.12,7.93,90,76,82,None,None,Improved,1
9926,PT-09926,29,M,Bhopal Research Hospital,Phase I,ORX-101,Oncology,Placebo,2024-02-03,2024-02-10,6.6,5.85,156,89,82,Fatigue,Mild,Improved,1
9927,PT-09927,26,F,AIIMS Delhi,Phase III,ORX-202,Diabetes,High Dose,2023-05-01,2023-05-08,6.38,6.74,139,64,97,Nausea,None,Worsened,0
9928,PT-09928,31,F,Kolkata Clinical Center,Phase III,ORX-202,Diabetes,Placebo,2024-10-16,2024-10-30,7.63,9.69,120,84,70,Fatigue,None,Improved,0
9929,PT-09929,47,M,Kolkata Clinical Center,Phase I,ORX-202,Diabetes,Low Dose,2023-09-13,2023-10-11,8.91,8.34,122,95,60,Nausea,None,No Change,0
9930,PT-09930,46,F,Kolkata Clinical Center,Phase III,ORX-101,Oncology,Low Dose,2024-05-25,2024-06-22,6.33,5.71,112,64,47,None,None,No Change,0
9931,PT-09931,37,F,Bhopal Research Hospital,Phase III,ORX-202,Diabetes,Placebo,2024-02-14,2024-02-21,7.47,7.81,103,83,85,None,None,No Change,0
9932,PT-09932,50,M,Apollo Chennai,Phase IV,ORX-404,Neurology,High Dose,2024-04-22,2024-05-20,7.51,5.16,125,81,85,Dizziness,None,Worsened,0
9933,PT-09933,67,M,PGI Chandigarh,Phase IV,ORX-404,Neurology,Low Dose,2023-12-22,2023-12-29,6.89,6.18,130,82,84,Dizziness,None,No Change,0
9934,PT-09934,53,M,PGI Chandigarh,Phase III,ORX-606,Rheumatology,Placebo,2023-01-03,2023-02-28,6.99,7.04,124,64,61,None,None,Improved,0
9935,PT-09935,18,M,AIIMS Delhi,Phase II,ORX-303,Cardiology,High Dose,2023-02-22,2023-03-22,9.2,9.95,146,79,91,Headache,None,Improved,0
9936,PT-09936,59,M,Indore Medical Institute,Phase III,ORX-202,Diabetes,High Dose,2023-04-30,2023-05-14,5.45,4.35,137,76,68,None,None,Improved,1
9937,PT-09937,58,M,Fortis Mumbai,Phase II,ORX-606,Rheumatology,Placebo,2023-10-29,2023-11-12,6.21,8.04,156,79,95,None,None,Improved,0
9938,PT-09938,47,F,Fortis Mumbai,Phase III,ORX-505,Infectious Disease,Low Dose,2023-02-03,2023-05-04,6.7,8.08,135,71,84,Rash,None,Improved,0
9939,PT-09939,71,F,Apollo Chennai,Phase III,ORX-303,Cardiology,Placebo,2023-08-31,2023-09-07,7.2,6.99,122,86,64,None,None,Improved,1
9940,PT-09940,32,M,AIIMS Delhi,Phase II,ORX-202,Diabetes,Low Dose,2024-08-12,2024-08-26,6.79,6.54,148,80,89,None,None,Improved,1
9941,PT-09941,37,M,PGI Chandigarh,Phase I,ORX-101,Oncology,Placebo,2024-07-02,2024-07-09,7.91,8.59,125,86,69,Nausea,Mild,Improved,0
9942,PT-09942,54,F,Apollo Chennai,Phase III,ORX-101,Oncology,High Dose,2023-12-09,2023-12-23,3.84,1.97,138,62,71,Fever,Mild,Improved,1
9943,PT-09943,67,M,NIMHANS Bengaluru,Phase III,ORX-404,Neurology,Low Dose,2024-09-11,2024-12-10,8.24,9.99,129,81,78,None,None,Worsened,0
9944,PT-09944,30,F,NIMHANS Bengaluru,Phase III,ORX-404,Neurology,Low Dose,2023-07-24,2023-08-21,6.94,5.41,149,90,61,None,None,Improved,1
9945,PT-09945,34,F,Bhopal Research Hospital,Phase III,ORX-202,Diabetes,Placebo,2023-06-09,2023-06-23,7.67,7.51,109,82,85,Fatigue,None,No Change,0
9946,PT-09946,54,M,Apollo Chennai,Phase III,ORX-303,Cardiology,Low Dose,2024-05-11,2024-05-25,9.22,9.05,105,69,95,Fatigue,None,No Change,0
9947,PT-09947,70,M,AIIMS Delhi,Phase I,ORX-202,Diabetes,Low Dose,2023-04-08,2023-07-07,7.16,7.1,129,78,57,Headache,Moderate,Improved,1
9948,PT-09948,52,M,Indore Medical Institute,Phase II,ORX-303,Cardiology,High Dose,2024-05-21,2024-05-28,9.34,9.09,122,76,84,None,None,No Change,0
9949,PT-09949,63,M,PGI Chandigarh,Phase I,ORX-202,Diabetes,High Dose,2024-04-13,2024-06-08,7.84,5.76,159,91,75,None,None,Improved,1
9950,PT-09950,36,F,Fortis Mumbai,Phase III,ORX-202,Diabetes,Placebo,2024-01-09,2024-01-23,6.66,7.04,92,88,81,None,None,Improved,0
9951,PT-09951,49,F,PGI Chandigarh,Phase III,ORX-606,Rheumatology,Placebo,2024-04-22,2024-05-20,5.8,3.87,168,83,105,None,None,Improved,1
9952,PT-09952,59,F,Apollo Chennai,Phase III,ORX-101,Oncology,Placebo,2024-04-27,2024-05-25,7.33,7.14,147,96,84,None,None,Improved,1
9953,PT-09953,62,F,Apollo Chennai,Phase IV,ORX-404,Neurology,High Dose,2024-09-11,2024-09-25,8.57,,117,87,67,Nausea,None,No Change,0
9954,PT-09954,38,F,Bhopal Research Hospital,Phase IV,ORX-101,Oncology,High Dose,2024-11-01,2024-11-15,7.68,7.21,151,74,48,Dizziness,Moderate,Improved,1
9955,PT-09955,65,M,AIIMS Delhi,Phase I,ORX-404,Neurology,High Dose,2023-09-10,2023-10-08,7.26,6.94,113,59,66,None,None,Worsened,0
9956,PT-09956,54,M,Bhopal Research Hospital,Phase I,ORX-101,Oncology,Low Dose,2024-07-29,2024-09-23,6.96,6.26,97,103,77,None,None,No Change,0
9957,PT-09957,82,M,Fortis Mumbai,Phase III,ORX-606,Rheumatology,High Dose,2023-06-28,2023-07-05,7.64,8.64,115,63,75,None,None,No Change,0
9958,PT-09958,53,M,PGI Chandigarh,Phase IV,ORX-303,Cardiology,Low Dose,2023-04-29,2023-05-06,8.0,7.96,169,86,73,Headache,None,No Change,0
9959,PT-09959,41,F,Kolkata Clinical Center,Phase III,ORX-606,Rheumatology,High Dose,2024-03-21,2024-06-19,6.23,6.1,147,98,73,None,None,Improved,1
9960,PT-09960,44,F,Kolkata Clinical Center,Phase III,ORX-101,Oncology,Low Dose,2024-09-26,2024-10-10,6.43,6.9,105,73,45,Headache,None,Improved,0
9961,PT-09961,26,F,Apollo Chennai,Phase IV,ORX-101,Oncology,Low Dose,2024-10-10,2024-12-05,6.49,5.63,104,68,95,None,None,Improved,1
9962,PT-09962,32,M,Apollo Chennai,Phase III,ORX-606,Rheumatology,Placebo,2024-09-28,2024-11-23,5.03,3.69,109,81,83,None,None,Improved,1
9963,PT-09963,23,F,Indore Medical Institute,Phase IV,ORX-202,Diabetes,Placebo,2024-08-17,2024-08-24,7.56,8.42,146,88,83,None,None,Improved,0
9964,PT-09964,39,M,Apollo Chennai,Phase II,ORX-101,Oncology,Low Dose,2024-02-10,2024-02-17,8.9,8.89,113,80,68,Fatigue,None,Improved,1
9965,PT-09965,42,M,Bhopal Research Hospital,Phase II,ORX-505,Infectious Disease,High Dose,2023-07-28,2023-10-26,8.66,8.1,113,94,95,None,None,No Change,0
9966,PT-09966,32,M,Bhopal Research Hospital,Phase I,ORX-505,Infectious Disease,High Dose,2023-05-20,2023-06-03,8.98,9.44,118,96,60,None,None,No Change,0
9967,PT-09967,37,M,Indore Medical Institute,Phase I,ORX-101,Oncology,Low Dose,2023-12-26,2024-02-20,5.89,4.61,143,81,62,None,None,Improved,1
9968,PT-09968,35,M,AIIMS Delhi,Phase III,ORX-202,Diabetes,Low Dose,2023-04-15,2023-04-29,6.4,6.23,168,84,81,Nausea,None,Improved,1
9969,PT-09969,69,M,NIMHANS Bengaluru,Phase III,ORX-404,Neurology,Placebo,2024-02-11,2024-04-07,6.55,7.35,120,77,73,None,None,Improved,0
9970,PT-09970,43,F,AIIMS Delhi,Phase II,ORX-303,Cardiology,Low Dose,2023-01-18,2023-02-15,6.99,6.91,120,83,55,Headache,Moderate,Worsened,0
9971,PT-09971,57,M,Kolkata Clinical Center,Phase II,ORX-101,Oncology,Low Dose,2024-01-12,2024-03-08,8.56,8.36,141,71,99,None,None,No Change,0
9972,PT-09972,48,F,PGI Chandigarh,Phase III,ORX-606,Rheumatology,High Dose,2024-09-10,2024-09-24,5.27,5.97,140,104,101,None,None,Improved,0
9973,PT-09973,66,F,Bhopal Research Hospital,Phase III,ORX-303,Cardiology,High Dose,2024-04-28,2024-05-12,7.77,8.01,108,78,119,None,None,Improved,0
9974,PT-09974,18,M,Apollo Chennai,Phase III,ORX-404,Neurology,Low Dose,2023-05-28,2023-06-04,7.57,7.14,143,84,95,Fatigue,None,Improved,1
9975,PT-09975,45,M,PGI Chandigarh,Phase III,ORX-606,Rheumatology,Low Dose,2023-08-29,2023-11-27,8.13,8.06,122,76,95,Dizziness,None,No Change,0
9976,PT-09976,54,M,PGI Chandigarh,Phase II,ORX-404,Neurology,High Dose,2023-02-01,2023-02-08,8.4,9.12,118,78,73,None,None,Improved,0
9977,PT-09977,61,F,Apollo Chennai,Phase II,ORX-404,Neurology,High Dose,2023-08-16,2023-10-11,7.31,7.07,109,91,90,Headache,None,Improved,1
9978,PT-09978,53,F,Apollo Chennai,Phase IV,ORX-202,Diabetes,High Dose,2024-11-04,2025-02-02,7.4,7.93,127,99,88,Headache,None,Improved,0
9979,PT-09979,24,M,NIMHANS Bengaluru,Phase III,ORX-202,Diabetes,Low Dose,2024-09-06,2024-09-13,7.04,6.93,115,94,50,None,None,Improved,1
9980,PT-09980,57,M,Apollo Chennai,Phase II,ORX-101,Oncology,Low Dose,2023-09-21,2023-09-28,8.03,5.84,129,76,97,None,None,Improved,1
9981,PT-09981,31,M,Bhopal Research Hospital,Phase III,ORX-606,Rheumatology,Placebo,2024-08-24,2024-09-07,8.16,8.66,120,97,72,None,None,Improved,0
9982,PT-09982,66,F,Bhopal Research Hospital,Phase I,ORX-505,Infectious Disease,Placebo,2023-11-23,2023-12-21,10.33,,139,76,103,Fatigue,Mild,Improved,0
9983,PT-09983,59,M,AIIMS Delhi,Phase III,ORX-101,Oncology,Low Dose,2024-07-23,2024-10-21,6.65,7.6,129,90,72,None,None,No Change,0
9984,PT-09984,29,M,Indore Medical Institute,Phase I,ORX-606,Rheumatology,Placebo,2024-06-09,2024-06-23,6.14,5.39,137,78,66,Fatigue,None,No Change,0
9985,PT-09985,29,M,PGI Chandigarh,Phase IV,ORX-202,Diabetes,Low Dose,2023-04-27,2023-05-04,8.72,8.21,92,81,72,None,None,Improved,1
9986,PT-09986,48,F,Bhopal Research Hospital,Phase I,ORX-606,Rheumatology,Low Dose,2023-02-10,2023-04-07,6.52,7.28,125,79,73,Rash,None,Improved,0
9987,PT-09987,52,F,NIMHANS Bengaluru,Phase I,ORX-101,Oncology,Placebo,2024-05-06,2024-07-01,7.67,6.92,128,78,89,Nausea,Moderate,No Change,0
9988,PT-09988,24,F,Fortis Mumbai,Phase III,ORX-101,Oncology,Low Dose,2024-03-15,2024-03-22,6.79,6.22,153,96,83,Headache,None,No Change,0
9989,PT-09989,29,F,PGI Chandigarh,Phase I,ORX-303,Cardiology,Low Dose,2023-02-03,2023-02-10,7.27,8.56,125,83,80,Fever,Moderate,Improved,0
9990,PT-09990,31,F,PGI Chandigarh,Phase III,ORX-101,Oncology,Placebo,2023-05-13,2023-05-20,6.23,5.1,122,87,80,Fatigue,None,No Change,0
9991,PT-09991,53,M,Bhopal Research Hospital,Phase III,ORX-303,Cardiology,Low Dose,2024-07-13,2024-08-10,9.79,11.73,129,93,87,Headache,None,No Change,0
9992,PT-09992,62,F,NIMHANS Bengaluru,Phase IV,ORX-505,Infectious Disease,High Dose,2024-02-18,2024-03-03,8.45,7.57,163,100,91,None,None,Worsened,0
9993,PT-09993,55,M,NIMHANS Bengaluru,Phase II,ORX-606,Rheumatology,High Dose,2023-08-02,2023-08-09,7.68,7.46,142,85,83,Dizziness,None,Improved,1
9994,PT-09994,45,F,Indore Medical Institute,Phase III,ORX-606,Rheumatology,Placebo,2023-06-07,2023-09-05,7.04,8.36,131,78,82,None,None,Improved,0
9995,PT-09995,27,F,Bhopal Research Hospital,Phase II,ORX-202,Diabetes,High Dose,2023-02-08,2023-02-22,8.48,8.2,124,78,57,Headache,Moderate,Improved,1
9996,PT-09996,76,F,Apollo Chennai,Phase III,ORX-505,Infectious Disease,Placebo,2024-01-20,2024-03-16,7.59,8.93,125,89,90,Fever,None,Improved,0
9997,PT-09997,54,F,Fortis Mumbai,Phase II,ORX-303,Cardiology,Placebo,2023-07-31,2023-08-14,6.82,4.95,171,74,115,Headache,Mild,No Change,0
9998,PT-09998,37,M,Kolkata Clinical Center,Phase II,ORX-202,Diabetes,Placebo,2023-05-04,2023-06-29,9.01,9.26,141,76,74,Dizziness,None,Improved,0
9999,PT-09999,40,F,Fortis Mumbai,Phase I,ORX-303,Cardiology,Placebo,2023-05-24,2023-05-31,7.53,7.05,120,72,67,Headache,Mild,Improved,1
10000,PT-10000,53,F,PGI Chandigarh,Phase III,ORX-303,Cardiology,Low Dose,2024-05-02,2024-05-16,6.36,4.97,130,55,77,None,None,Improved,1
